PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lee, S; Challa-Malladi, M; Bratton, SB; Wright, CW				Lee, Sunhee; Challa-Malladi, Madhavi; Bratton, Shawn B.; Wright, Casey W.			Nuclear Factor-kappa B-inducing Kinase (NIK) Contains an Amino-terminal Inhibitor of Apoptosis (IAP)-binding Motif (IBM) That Potentiates NIK Degradation by Cellular IAP1 (c-IAP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTAGONISTS INDUCE; SIGNALING PATHWAY; STRUCTURAL BASIS; LYMPHOMA-CELLS; SMAC/DIABLO; ACTIVATION; BINDING; PROTEIN; TRAF3; CIAP1	Activation of the noncanonical NF-kappa B pathway hinges on the stability of the NF-kappa B-inducing kinase (NIK), which is kept at low levels basally by a protein complex consisting of the E3 ubiquitin ligases cellular inhibitor of apoptosis 1 and 2 (c-IAP1/2) proteins and the tumor necrosis factor receptor-associated factors 2 and 3 (TRAF2/3). NIK is brought into close proximity to the c-IAPs through a TRAF2-TRAF3 bridge where TRAF2 recruits c-IAP1/2 and TRAF3 binds to NIK. However, it is not clear how the c-IAPs specifically recognize and ubiquitylate NIK in the complex. We have identified an IAP-binding motif (IBM) at the amino terminus of NIK. IBMs are utilized by a number of proapoptotic proteins to antagonize IAP function. Here, we utilize mutational studies to demonstrate that wild-type NIK is destabilized in the presence of c-IAP1, whereas the NIK IBM mutant is stable. NIK interacts with the second baculovirus IAP repeat (BIR2) domain of c-IAP1 via the IBM, and this interaction, in turn, provides substrate recognition for c-IAP1 mediated ubiquitylation and degradation of NIK. Furthermore, in the presence of the NIK IBM mutant, we observed an elevated processing of p100 to p52 followed by increased expression of NF-kappa B target genes. Together, these findings reveal the novel identification and function of the NIK IBM, which promotes c-IAP1-dependent ubiquitylation of NIK, resulting in optimal NIK turnover to ensure that noncanonical NF-kappa B signaling is off in the absence of an activating signal.	[Wright, Casey W.] Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, Ctr Mol & Cellular Toxicol, Austin, TX 78712 USA; [Lee, Sunhee; Challa-Malladi, Madhavi; Bratton, Shawn B.; Wright, Casey W.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Bratton, Shawn B.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; UTMD Anderson Cancer Center	Wright, CW (corresponding author), Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, BME 3-510C,107 West Dean Keeton St,Stop C0875, Austin, TX 78712 USA.	Cww@austin.utexas.edu		Wright, Casey/0000-0002-9512-1264; Bratton, Shawn/0000-0003-2895-5020	National Institutes of Health [CA129521, GM096101]; American Cancer Society [121549-RSG-11-180-01-TBE]; NATIONAL CANCER INSTITUTE [R01CA129521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants CA129521 and GM096101 (to S. B. B.) and a Research Starter Grant from the American Cancer Society 121549-RSG-11-180-01-TBE (to C. W. W.).	ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Bista P, 2010, J BIOL CHEM, V285, P12971, DOI 10.1074/jbc.M109.076091; Blankenship JW, 2009, BIOCHEM J, V417, P149, DOI 10.1042/BJ20081885; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Choi YE, 2009, J BIOL CHEM, V284, P12772, DOI 10.1074/jbc.M807550200; Csomos RA, 2009, J BIOL CHEM, V284, P20531, DOI 10.1074/jbc.M109.029983; Csomos RA, 2009, BIOCHEM J, V420, P83, DOI 10.1042/BJ20082140; de Leon-Boenig G, 2012, STRUCTURE, V20, P1704, DOI 10.1016/j.str.2012.07.013; Demchenko YN, 2010, BLOOD, V115, P3541, DOI 10.1182/blood-2009-09-243535; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dueber EC, 2011, SCIENCE, V334, P376, DOI 10.1126/science.1207862; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Giglione C, 2004, CELL MOL LIFE SCI, V61, P1455, DOI 10.1007/s00018-004-3466-8; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; He JQ, 2007, J BIOL CHEM, V282, P3688, DOI 10.1074/jbc.M610271200; Hunter AM, 2003, J BIOL CHEM, V278, P7494, DOI 10.1074/jbc.C200695200; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Lopez J, 2011, MOL CELL, V42, P569, DOI 10.1016/j.molcel.2011.04.008; Morrison MD, 2005, J BIOL CHEM, V280, P10018, DOI 10.1074/jbc.M413634200; Muro I, 2014, CELL CYCLE, V13, P1918, DOI 10.4161/cc.28895; Razani B, 2011, IMMUNOL REV, V244, P44, DOI 10.1111/j.1600-065X.2011.01059.x; Samuel T, 2006, J BIOL CHEM, V281, P1080, DOI 10.1074/jbc.M509381200; Silke J, 2001, J CELL SCI, V114, P1821; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Wilkinson JC, 2004, J BIOL CHEM, V279, P51082, DOI 10.1074/jbc.M408655200; Wright CW, 2007, J BIOL CHEM, V282, P10252, DOI 10.1074/jbc.M608817200; Wright CW, 2005, J CLIN INVEST, V115, P2673, DOI 10.1172/JCI26251; Wright CW, 2002, J BIOL CHEM, V277, P2454, DOI 10.1074/jbc.M110500200; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Yeh TC, 2013, P NATL ACAD SCI USA, V110, P14284, DOI 10.1073/pnas.1306179110; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	43	18	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30680	30689		10.1074/jbc.M114.587808	http://dx.doi.org/10.1074/jbc.M114.587808			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25246529	hybrid, Green Published			2022-12-25	WOS:000344549700044
J	Fraga, H; Malheiro, AC; Moutinho-Pereira, J; Cardoso, RM; Soares, PMM; Cancela, JJ; Pinto, JG; Santos, JA				Fraga, Helder; Malheiro, Aureliano C.; Moutinho-Pereira, Jose; Cardoso, Rita M.; Soares, Pedro M. M.; Cancela, Javier J.; Pinto, Joaquim G.; Santos, Joao A.			Integrated Analysis of Climate, Soil, Topography and Vegetative Growth in Iberian Viticultural Regions	PLOS ONE			English	Article							GRAPEVINE ROOT-SYSTEM; WATER-USE EFFICIENCY; WINE PRODUCTION; ENSEMBLE PROJECTIONS; DEFICIT IRRIGATION; GROWING REGIONS; QUALITY; TEMPERATURE; MANAGEMENT; PHENOLOGY	The Iberian viticultural regions are convened according to the Denomination of Origin (DO) and present different climates, soils, topography and management practices. All these elements influence the vegetative growth of different varieties throughout the peninsula, and are tied to grape quality and wine type. In the current study, an integrated analysis of climate, soil, topography and vegetative growth was performed for the Iberian DO regions, using state-of-the-art datasets. For climatic assessment, a categorized index, accounting for phenological/thermal development, water availability and grape ripening conditions was computed. Soil textural classes were established to distinguish soil types. Elevation and aspect (orientation) were also taken into account, as the leading topographic elements. A spectral vegetation index was used to assess grapevine vegetative growth and an integrated analysis of all variables was performed. The results showed that the integrated climate-soil-topography influence on vine performance is evident. Most Iberian vineyards are grown in temperate dry climates with loamy soils, presenting low vegetative growth. Vineyards in temperate humid conditions tend to show higher vegetative growth. Conversely, in cooler/warmer climates, lower vigour vineyards prevail and other factors, such as soil type and precipitation acquire more important roles in driving vigour. Vines in prevailing loamy soils are grown over a wide climatic diversity, suggesting that precipitation is the primary factor influencing vigour. The present assessment of terroir characteristics allows direct comparison among wine regions and may have great value to viticulturists, particularly under a changing climate.	[Fraga, Helder; Malheiro, Aureliano C.; Moutinho-Pereira, Jose; Santos, Joao A.] UTAD, Ctr Res & Technol Agroenvironm & Biol Sci, Vila Real, Portugal; [Cardoso, Rita M.; Soares, Pedro M. M.] Univ Lisbon, CGUL, Inst Dom Luiz, P-1699 Lisbon, Portugal; [Soares, Pedro M. M.] ADEC, Inst Super Engn Lisboa, Lisbon, Portugal; [Cancela, Javier J.] Univ Santiago de Compostela, GI Proyectos & Planificac 1716, Escuela Politecn Super, Dept Ingn Agroforestal, Lugo, Spain; [Pinto, Joaquim G.] Univ Reading, Dept Meteorol, Reading, Berks, England; [Pinto, Joaquim G.] Univ Cologne, Inst Geophys & Meteorol, Cologne, Germany	University of Tras-os-Montes & Alto Douro; Universidade de Lisboa; Polytechnic Institute of Lisbon; Universidade de Santiago de Compostela; University of Reading; University of Cologne	Fraga, H (corresponding author), UTAD, Ctr Res & Technol Agroenvironm & Biol Sci, Vila Real, Portugal.	hfraga@utad.pt	Fraga, Helder/D-8507-2012; Cardoso, Rita M./A-1464-2013; Malheiro, Aureliano C./AAV-6852-2020; Malheiro, Aureliano C./H-6155-2011; Pereira, José Manuel Moutinho/J-6950-2013; Santos, João/HHZ-5595-2022; Soares, Pedro MM/K-6239-2012; Pinto, Joaquim G/A-7352-2009; Cancela, Javier J./I-3253-2014; Santos, João Andrade/G-8805-2011	Fraga, Helder/0000-0002-7946-8786; Cardoso, Rita M./0000-0002-0259-6827; Malheiro, Aureliano C./0000-0001-6606-1787; Malheiro, Aureliano C./0000-0001-6606-1787; Pereira, José Manuel Moutinho/0000-0001-5825-559X; Soares, Pedro MM/0000-0002-9155-5874; Pinto, Joaquim G/0000-0002-8865-1769; Cancela, Javier J./0000-0003-2089-7778; Santos, João Andrade/0000-0002-8135-5078	national (FCT - Fundacao para a Ciencia e a Tecnologia); European Union Funds (FEDER/COMPETE - Operational Competitiveness Programme) [PTDC/AGR-ALI/110877/2009, FCOMP-01-0124-FEDER-022692, PEst-OE/AGR/UI4033/2014]; PRODER - Inovacao (GreenVitis project) [IF0018]; ON2 ENOEXEL [NORTE-07-0124-FEDER-000032]; EUPORIAS - 7th Framework Programme for Research [308291]	national (FCT - Fundacao para a Ciencia e a Tecnologia); European Union Funds (FEDER/COMPETE - Operational Competitiveness Programme); PRODER - Inovacao (GreenVitis project); ON2 ENOEXEL; EUPORIAS - 7th Framework Programme for Research	This study was supported by national (FCT - Fundacao para a Ciencia e a Tecnologia) and European Union Funds (FEDER/COMPETE - Operational Competitiveness Programme), under the projects PTDC/AGR-ALI/110877/2009, FCOMP-01-0124-FEDER-022692, PEst-OE/AGR/UI4033/2014, by PRODER - Inovacao (GreenVitis project IF0018), by ON2 ENOEXEL (NORTE-07-0124-FEDER-000032), and by EUPORIAS - 7th Framework Programme for Research, Grant Agreement 308291. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEMET/IMP, 2011, IB CLIM ATL; Andrade C, 2014, ATMOS SCI LETT, V15, P149, DOI 10.1002/asl2.485; [Anonymous], 2008, GUIDELINES SURVEYING; Bindi M, 1996, CLIMATE RES, V7, P213, DOI 10.3354/cr007213; Bohm J, 2010, PORTUGAL VITICOLA GR; Bramley RGV, 2007, J INT SCI VIGNE VIN, V41, P1; Buttner G, 2006, EEA CORINE LAND COV; Caetano M, 2006, GLOBAL DEVELOPMENTS IN ENVIRONMENTAL EARTH OBSERVATION FROM SPACE, P459; Carbonneau A, 2003, PHYTOLINE, P61; Cardoso RM, 2013, INT J CLIMATOL, V33, P2591, DOI 10.1002/joc.3616; Carey VA, 2008, J INT SCI VIGNE VIN, V42, P185; Chaves MM, 2007, ANN APPL BIOL, V150, P237, DOI 10.1111/j.1744-7348.2006.00123.x; Chaves MM, 2010, ANN BOT-LONDON, V105, P661, DOI 10.1093/aob/mcq030; Cunha M, 2010, S EUR ASS REM SENS L, P68; Cunha M, 2010, INT J REMOTE SENS, V31, P3125, DOI 10.1080/01431160903154382; Duchene E, 2005, AGRON SUSTAIN DEV, V25, P93, DOI 10.1051/agro:2004057; EEA, 2002, CORINE LAND COV UPD; Failla O, 2004, AM J ENOL VITICULT, V55, P128; FAO/IIASA/ISRIC/ISSCAS/JRC, 2012, HARM WORLD SOIL DAT; Field SK, 2009, AM J ENOL VITICULT, V60, P164; Flexas J, 2010, AUST J GRAPE WINE R, V16, P106, DOI 10.1111/j.1755-0238.2009.00057.x; Fraga H, 2014, AGR FOREST METEOROL, V185, P26, DOI 10.1016/j.agrformet.2013.11.003; Fraga H, 2014, REG ENVIRON CHANGE, V14, P295, DOI 10.1007/s10113-013-0490-y; Fraga H, 2013, INT J BIOMETEOROL, V57, P909, DOI 10.1007/s00484-012-0617-8; Fraga H, 2012, CIENC TEC VITIVINIC, V27, P39; Genovese G, 2001, AGRONOMIE, V21, P91, DOI 10.1051/agro:2001111; Gouveia C, 2011, CLIM RES, V48, P349, DOI 10.3354/cr01006; Hall A, 2008, AUST J GRAPE WINE R, V14, P9, DOI 10.1111/j.1755-0238.2008.00002.x; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; HUETE A, 1994, REMOTE SENS ENVIRON, V49, P224, DOI 10.1016/0034-4257(94)90018-3; Huete AR, 1997, REMOTE SENS ENVIRON, V59, P440, DOI 10.1016/S0034-4257(96)00112-5; Huglin P., 1978, COMPTES RENDUS ACAD; IVV, 2011, VINH AG PORT AN 2010; JACKSON DI, 1993, AM J ENOL VITICULT, V44, P409; Johnson LF, 2001, APPL ENG AGRIC, V17, P557; Jones G.V., 2005, P 14 GESCO S GEIS GE; Jones GV, 2008, CLIM RES, V35, P241, DOI 10.3354/cr00708; Jones GV, 2010, AM J ENOL VITICULT, V61, P313; Jones GV, 2000, AM J ENOL VITICULT, V51, P249; Jones GV, 2000, INT J CLIMATOL, V20, P813, DOI 10.1002/1097-0088(20000630)20:8&lt;813::AID-JOC495&gt;3.0.CO;2-W; Jones GV, 2005, CLIMATIC CHANGE, V73, P319, DOI 10.1007/s10584-005-4704-2; Jones GV, 2004, GEOSCI CAN, V31, P167; Jones GV, 2004, B AM METEOROL SOC, V85, P504; Jones GV, 2006, NEWFOUNDLAND; Juma NG, 1999, INTRO SOIL SCI SOIL, V1; Keller M, 2010, SCIENCE OF GRAPEVINES: ANATOMY AND PHYSIOLOGY, P1; Keller M, 2010, AUST J GRAPE WINE R, V16, P56, DOI 10.1111/j.1755-0238.2009.00077.x; Koundouras S., 1999, Journal International des Sciences de la Vigne et du Vin, V33, P149; Lopes CM, 2011, SCI HORTIC-AMSTERDAM, V129, P603, DOI 10.1016/j.scienta.2011.04.033; Mackenzie DE, 2005, WATER SCI TECHNOL, V51, P27, DOI 10.2166/wst.2005.0004; Magalhaes N., 2008, TRATADO VITICULTURA; Malheiro AC, 2011, ATLAS CASTAS PENINSU, P155; Malheiro AC, 2013, J INT SCI VIGNE VIN, V47, P287; Malheiro AC, 2010, CLIM RES, V43, P163, DOI 10.3354/cr00918; MORLAT R, 1993, VITIS, V32, P35; Morlat R, 2003, AM J ENOL VITICULT, V54, P1; Nascimbene J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076167; Camps JO, 2012, INT J BIOMETEOROL, V56, P853, DOI 10.1007/s00484-011-0489-3; OIV (International Organization of Vine and Wine), 2012, STAT REP WORLD VIT; Pennec A, 2011, REMOTE SENS LETT, V2, P337, DOI 10.1080/01431161.2010.507610; Riou C., 1994, DETERMINISME CLIMATI; Santos JA, 2013, CLIMATIC CHANGE, V117, P211, DOI 10.1007/s10584-012-0538-x; Santos JA, 2012, CLIM RES, V51, P89, DOI 10.3354/cr01056; Santos JA, 2011, INT J BIOMETEOROL, V55, P119, DOI 10.1007/s00484-010-0318-0; Skamarock C., 2008, NCARTN475STR, DOI [10.5065/D68S4MVH, DOI 10.5065/D68S4MVH]; Soares PMM, 2012, CLIM DYNAM, V39, P2497, DOI 10.1007/s00382-012-1315-2; Song JQ, 2014, FOOD CHEM, V153, P52, DOI 10.1016/j.foodchem.2013.12.037; Taylor J. A., 2004, DIGITAL TERROIRS PRE; Tonietto J, 2004, AGR FOREST METEOROL, V124, P81, DOI 10.1016/j.agrformet.2003.06.001; Tramontini S, 2013, PLANT SOIL, V368, P215, DOI 10.1007/s11104-012-1507-x; USDA, 2006, SOIL MECH LEV 1; van Leeuwen C, 2004, AM J ENOL VITICULT, V55, P207; Van Leeuwen C, 2009, J INT SCI VIGNE VIN, V43, P121; Webb LB, 2008, CLIM RES, V36, P89, DOI 10.3354/cr00739; WINKEL T, 1995, GEODERMA, V68, P67, DOI 10.1016/0016-7061(95)00026-K; Winkler AJ, 1974, GEN VITICULTURE; Yau IH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061994; Zsofi Z, 2011, SCI HORTIC-AMSTERDAM, V127, P494, DOI 10.1016/j.scienta.2010.11.014	78	51	51	4	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108078	10.1371/journal.pone.0108078	http://dx.doi.org/10.1371/journal.pone.0108078			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251495	Green Accepted, Green Published, gold			2022-12-25	WOS:000342492700074
J	Horter, S; Stringer, B; Venis, S; du Cros, P				Horter, Shona; Stringer, Beverley; Venis, Sarah; du Cros, Philipp			"I Can Also Serve as an Inspiration'': A Qualitative Study of the TB&Me Blogging Experience and Its Role in MDR-TB Treatment	PLOS ONE			English	Article							SOCIAL MEDIA; PATIENT EMPOWERMENT; SUPPORT	Background: In 2011, Medecins Sans Frontieres (MSF) established a blogging project, "TB&Me,'' to enable patients with multidrug-resistant tuberculosis (MDR-TB) to share their experiences. By September 2012, 13 MDR-TB patients had blogged, either directly or with assistance, from the UK, Australia, Philippines, Swaziland, Central African Republic, Uganda, South Africa, India, and Armenia. Due to the lack of research on the potential for social media to support MDR-TB treatment and the innovative nature of the blog, we decided to conduct a qualitative study to examine patient and staff experiences. Our aim was to identify potential risks and benefits associated with blogging to enable us to determine whether social media had a role to play in supporting patients with MDR-TB. Methods and Findings: Participants were identified and selected purposively. TB&Me bloggers, project staff, MSF headquarters staff involved with TB and WHO European Region TB policy advisors were invited to participate in a semi-structured interview. Twenty interviews were conducted (five with bloggers). Data analysis drew upon principles of grounded theory, with constant comparison of data, cases and categories, and attention to deviant cases. We found that the TB&Me blog was associated with identified health benefits, with no reported instances of harm. There were three main findings: blogging was reported as useful for adherence to DR-TB treatment and supportive of the treatment-taking process by all bloggers and project staff; blogging provided support to patients (peer support, shared experience and reduction in isolation); and the blog was perceived as giving patients strength and voice. Conclusion: The TB&Me blog was seen to be associated with positive identified health and emotional benefits. Component 5 of the Stop TB Global Plan highlights the importance of empowering TB patients and communities. Blogging could be a useful tool to help achieve that ambition.	[Horter, Shona; Stringer, Beverley; Venis, Sarah; du Cros, Philipp] MSF, London, England	Doctors Without Borders	Horter, S (corresponding author), MSF, London, England.	shona_horter@yahoo.co.uk		du Cros, Philipp/0000-0002-3599-029X	MSF programme operations	MSF programme operations	This research was funded as part of MSF programme operations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KN, 2012, GOV INFORM Q, V29, P462, DOI 10.1016/j.giq.2012.07.004; Attree P, 2011, HEALTH EXPECT, V14, P48, DOI 10.1111/j.1369-7625.2010.00620.x; Basit TN, 2003, EDUC RES-UK, V45, P143, DOI 10.1080/0013188032000133548; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Chiang CY, 2010, INT J TUBERC LUNG D, V14, P672; Eytan Ted, 2011, Perm J, V15, P71; Green J, 2009, QUALITATIVE METHODS; Lober William B, 2011, Semin Oncol Nurs, V27, P169, DOI 10.1016/j.soncn.2011.04.002; Macq J, 2007, TROP MED INT HEALTH, V12, P873, DOI 10.1111/j.1365-3156.2007.01858.x; McDaniel BT, 2012, MATERN CHILD HLTH J, V16, P1509, DOI 10.1007/s10995-011-0918-2; Oh HJ, 2012, HEALTH COMMUN, V27, P30, DOI 10.1080/10410236.2011.567449; Phillips J, 2012, BRIT J COMMUNITY NUR, V16, P504; Rains SA, 2011, COMMUN MONOGR, V78, P511, DOI 10.1080/03637751.2011.618142; Stop TB Partnership, 2010, GLOB PLAN STOP TB 20; Thackeray R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-242; Timimi FK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-83; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; van Uden-Kraan CF, 2009, PATIENT EDUC COUNS, V74, P61, DOI 10.1016/j.pec.2008.07.044; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2006, STOP TB STRAT BUILD	21	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108591	10.1371/journal.pone.0108591	http://dx.doi.org/10.1371/journal.pone.0108591			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ0SJ	25251404	Green Published, Green Submitted, gold			2022-12-25	WOS:000342492700145
J	Mehraj, J; Akmatov, MK; Strompl, J; Gatzemeier, A; Layer, F; Werner, G; Pieper, DH; Medina, E; Witte, W; Pessler, F; Krause, G				Mehraj, Jaishri; Akmatov, Manas K.; Stroempl, Julia; Gatzemeier, Anja; Layer, Franziska; Werner, Guido; Pieper, Dietmar H.; Medina, Eva; Witte, Wolfgang; Pessler, Frank; Krause, Gerard			Methicillin-Sensitive and Methicillin-Resistant Staphylococcus aureus Nasal Carriage in a Random Sample of Non-Hospitalized Adult Population in Northern Germany	PLOS ONE			English	Article							UNITED-STATES; RISK-FACTORS; HIGH PREVALENCE; COMMUNITY; COLONIZATION; MRSA; INDIVIDUALS; EVOLUTION; STRAINS	Objective: The findings from truly randomized community-based studies on Staphylococcus aureus nasal colonization are scarce. Therefore we have examined point prevalence and risk factors of S. aureus nasal carriage in a non-hospitalized population of Braunschweig, northern Germany. Methods: A total of 2026 potential participants were randomly selected through the resident's registration office and invited by mail. They were requested to collect a nasal swab at home and return it by mail. S. aureus was identified by culture and PCR. Logistic regression was used to determine risk factors of S. aureus carriage. Results: Among the invitees, 405 individuals agreed to participate and 389 provided complete data which was included in the analysis. The median age of the participants was 49 years (IQR: 39-61) and 61% were females. S. aureus was isolated in 85 (21.9%; 95% CI: 18.0-26.2%) of the samples, five of which were MRSA (1.29%; 95% CI: 0.55-2.98%). In multiple logistic regression, male sex (OR = 3.50; 95% CI: 2.01-6.11) and presence of allergies (OR = 2.43; 95% CI: 1.39-4.24) were found to be associated with S. aureus nasal carriage. Fifty five different spa types were found, that clustered into nine distinct groups. MRSA belonged to the hospital-associated spa types t032 and t025 (corresponds to MLST CC 22), whereas MSSA spa types varied and mostly belonged to spa-CC 012 (corresponds to MLST CC 30), and spa-CC 084 (corresponds to MLST CC 15). Conclusion: This first point prevalence study of S. aureus in a non-hospitalized population of Germany revealed prevalence, consistent with other European countries and supports previous findings on male sex and allergies as risk factors of S. aureus carriage. The detection of hospital-associated MRSA spa types in the community indicates possible spread of these strains from hospitals into the community.	[Mehraj, Jaishri; Akmatov, Manas K.; Stroempl, Julia; Gatzemeier, Anja; Pessler, Frank; Krause, Gerard] Helmholtz Ctr Infect Res, Dept Epidemiol, Braunschweig, Germany; [Mehraj, Jaishri; Krause, Gerard] Hannover Med Sch, Hannover, Germany; [Akmatov, Manas K.; Pessler, Frank] TWINCORE, Ctr Expt & Clin Infect Res, Hannover, Germany; [Layer, Franziska; Werner, Guido; Witte, Wolfgang] Robert Koch Inst, Wernigerode, Germany; [Pieper, Dietmar H.] Helmholtz Ctr Infect Res, Microbial Interact & Proc Res Grp, Braunschweig, Germany; [Medina, Eva] Helmholtz Ctr Infect Res, Infect Immunol Res Grp, Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Robert Koch Institute; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research	Mehraj, J (corresponding author), Helmholtz Ctr Infect Res, Dept Epidemiol, Braunschweig, Germany.	Jaishri.Mehraj@helmholtz-hzi.de		Krause, Gerard/0000-0003-3328-8808; Mehraj, Jaishri/0000-0003-3239-8968; Layer, Franziska/0000-0002-4613-6478	Helmholtz Centre for Infection Research, Braunschweig, Germany; German Academic Exchange Service (Deutscher Akademischer Austausch Dienst: DAAD); Higher Education Commission (HEC) of Pakistan	Helmholtz Centre for Infection Research, Braunschweig, Germany; German Academic Exchange Service (Deutscher Akademischer Austausch Dienst: DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Higher Education Commission (HEC) of Pakistan(Higher Education Commission of Pakistan)	This project was financed through internal funds of the Helmholtz Centre for Infection Research, Braunschweig, Germany. JM is supported by a joint doctoral scholarship from the German Academic Exchange Service (Deutscher Akademischer Austausch Dienst: DAAD) and the Higher Education Commission (HEC) of Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abudu L, 2001, EPIDEMIOL INFECT, V126, P351, DOI 10.1017/S0950268801005416; Akmatov MK, 2014, INT J INFECT DIS, V25, P4, DOI 10.1016/j.ijid.2014.01.021; Akmatov MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048508; Andersen PS, 2013, EUR J CLIN MICROBIOL, V32, P1321, DOI 10.1007/s10096-013-1882-0; Anwer MS, 2004, JCPSP-J COLL PHYSICI, V14, P661; Best N, 2011, NEW ZEAL MED J, V124, P31; Biber A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042864; Chaberny IF, 2008, INFECTION, V36, P526, DOI 10.1007/s15010-008-7436-1; Espadinha D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059960; European Centre for Disease Prevention and Control, 2012, ANT RES SURV EUR 201; Ficca G, 2006, MED MALADIES INFECT, V36, P207, DOI 10.1016/j.medmal.2005.11.016; Gamblin J, 2013, J MED MICROBIOL, V62, P437, DOI 10.1099/jmm.0.051854-0; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Graham PL, 2006, ANN INTERN MED, V144, P318, DOI 10.7326/0003-4819-144-5-200603070-00006; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Halablab MA, 2010, EPIDEMIOL INFECT, V138, P702, DOI 10.1017/S0950268809991233; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Herrmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073876; Holden MTG, 2013, GENOME RES, V23, P653, DOI 10.1101/gr.147710.112; Holtfreter S, 2007, J CLIN MICROBIOL, V45, P2669, DOI 10.1128/JCM.00204-07; Jappe U, 1998, J INVEST DERMATOL, V110, P844, DOI 10.1046/j.1523-1747.1998.00177.x; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; Layer F, 2012, BUNDESGESUNDHEITSBLA, V55, P1377, DOI 10.1007/s00103-012-1560-x; Lu PL, 2005, J CLIN MICROBIOL, V43, P132, DOI 10.1128/JCM.43.1.132-139.2005; Mainous AG, 2006, ANN FAM MED, V4, P132, DOI 10.1370/afm.526; Melles DC, 2008, J CLIN MICROBIOL, V46, P235, DOI 10.1128/JCM.00887-07; Mellmann A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-98; Munckhof WJ, 2009, CLIN MICROBIOL INFEC, V15, P149, DOI 10.1111/j.1469-0691.2008.02652.x; MURAKAMI K, 1991, J CLIN MICROBIOL, V29, P2240, DOI 10.1128/JCM.29.10.2240-2244.1991; Pastacaldi C, 2011, ALLERGY, V66, P549, DOI 10.1111/j.1398-9995.2010.02502.x; Saxena S, 2003, JPN J INFECT DIS, V56, P54; Schweickert B, 2012, EUR J CLIN MICROBIOL, V31, P1855, DOI 10.1007/s10096-011-1511-8; Skramm I, 2011, APMIS, V119, P522, DOI 10.1111/j.1600-0463.2011.02758.x; Stadt Braunschweig Referat Stadtentwicklung und Statistik, 2013, ENTW EINW SEIT 1988; Statistisches Bundesamt destatis, 2013, POP BAS 2011 CENS; Strommenger B, 2006, J CLIN MICROBIOL, V44, P2533, DOI 10.1128/JCM.00420-06; Tavares A, 2014, EUR J CLIN MICROBIOL, V33, P423, DOI 10.1007/s10096-013-1972-z; van Cleef BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009385; van der Donk CFM, 2013, EUR J CLIN MICROBIOL, V32, P989, DOI 10.1007/s10096-013-1835-7; Wardyn SE, 2012, MICROB DRUG RESIST, V18, P427, DOI 10.1089/mdr.2011.0239; Wichmann HE, 2012, BUNDESGESUNDHEITSBLA, V55, P781, DOI 10.1007/s00103-012-1499-y; Zanelli G, 2002, EPIDEMIOL INFECT, V129, P417, DOI 10.1017/S0950268802007434; Zanger P, 2012, CLIN INFECT DIS, V55, P1625, DOI 10.1093/cid/cis778	43	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107937	10.1371/journal.pone.0107937	http://dx.doi.org/10.1371/journal.pone.0107937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251407	gold, Green Published, Green Submitted			2022-12-25	WOS:000342492700060
J	Xu, YY; Ling, J; Yang, M; Wang, H; Zhang, S; Zhang, XH; Zhu, YM				Xu, Yuyang; Ling, Jie; Yang, Min; Wang, Hao; Zhang, Shuai; Zhang, Xuhui; Zhu, Yimin			Rs7206790 and rs11644943 in FTO Gene Are Associated with Risk of Obesity in Chinese School-Age Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; FAT MASS; CHILDHOOD OBESITY; METABOLIC SYNDROME; TASTE PREFERENCES; ENERGY-INTAKE; VARIANTS; CHILDREN; WEIGHT	To evaluate the associations between candidate FTO single nucleotide polymorphisms (SNPs) and obesity, a case-control study was conducted among Chinese school-age children, which included 500 obese cases and 500 matched controls (age, gender and location). We selected 24 candidate FTO tag-SNPs via bio-informatics analysis and performed genotyping using SNPScan technology. Results indicated that rs7206790 and rs11644943 were significantly associated with obesity among school-age children in both additive and recessive models (P < 0.05) after adjusting confounders. Comparing rs7206790 CC and CG genotype of carriers, those carrying the GG genotype had an increased risk of obesity (adjusted odds ratio [OR], 3.76; 95% Confidence interval [CI], 1.24-11.43). Carriers of the AA allele of rs11644943 had a lower risk of obesity (adjusted OR, 0.16; 95% CI, 0.04-0.72) compared with those of the T allele (TT and TA). These two SNPs (rs7206790 and rs11644943) were not Linkage Disequilibrium (LD) with previous reported obesity-associated SNPs. Under the recessive model adjusted for age and gender and location, rs7206790 GG allele carriers had significantly increased BMIs (P = 0.012), weight (P = 0.012), waist circumferences (WC) (P = 0.045) and hip circumferences (HC) (P = 0.033). Conversely, rs11644943 AA allele carriers had significantly decreased BMIs (P = 0.006), WC (P = 0.037) and Waist-to-height ratios (WHtR) (P = 0.012). A dose-response relationship was found between the number of risk alleles in rs7206790, rs11644943 and rs9939609 and the risk of obesity. The Genetic Risk Score (GRS) of the reference group was 3; in comparison, those of 2, 4, and >= 5 had ORs for obesity of 0.24 (95% CI, 0.05-1.13), 1.49 (95% CI, 1.10-2.01), and 5.20 (95% CI, 1.75-15.44), respectively. This study confirmed the role of FTO variation on genetic susceptibility to obesity. We reported two new obesity-related FTO SNPs (rs7206790 and rs11644943) among Chinese school-age children.	[Xu, Yuyang; Ling, Jie; Zhu, Yimin] Zhejiang Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hangzhou 310027, Zhejiang, Peoples R China; [Xu, Yuyang; Zhang, Xuhui] Hangzhou Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Yang, Min] Zhejiang Univ, Sch Publ Hlth, Dept Nutr, Hangzhou 310027, Zhejiang, Peoples R China; [Wang, Hao; Zhang, Shuai] Zhejiang Univ, Sch Publ Hlth, Dept Pathol, Hangzhou 310027, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Zhu, YM (corresponding author), Zhejiang Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hangzhou 310027, Zhejiang, Peoples R China.	zhuym@zju.edu.cn	Zhu, Yimin/D-6387-2017	Zhu, Yimin/0000-0001-8409-7636	National Key Technology R&D Program of China [2012BAI02B03]; Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents; Fundamental Research Funds for the Central Universities; Program for Zhejiang Leading Team of Science and Technology Innovation; Hangzhou Medical & Health Science and Technology Foundation [20110733Q19]; Medical & Health Science and Technology Foundation [2011Z016]	National Key Technology R&D Program of China(National Key Technology R&D Program); Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for Zhejiang Leading Team of Science and Technology Innovation; Hangzhou Medical & Health Science and Technology Foundation; Medical & Health Science and Technology Foundation	This study has been supported by National Key Technology R&D Program of China (2012BAI02B03), Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents, Fundamental Research Funds for the Central Universities and Program for Zhejiang Leading Team of Science and Technology Innovation. Hangzhou Medical & Health Science and Technology Foundation (20110733Q19), and Key project of Medical & Health Science and Technology Foundation (2011Z016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beilin L, 2008, CLIN EXP PHARMACOL P, V35, P409, DOI 10.1111/j.1440-1681.2008.04887.x; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Cha S, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/nep162; Chang YC, 2008, DIABETES, V57, P2245, DOI 10.2337/db08-0377; Cheung Man-Ka Marcella, 2011, Front Endocrinol (Lausanne), V2, P4, DOI 10.3389/fendo.2011.00004; Cook S, 2003, ARCH PEDIAT ADOL MED, V157, P821, DOI 10.1001/archpedi.157.8.821; Cui ZH, 2010, INT J PEDIATR OBES, V5, P365, DOI 10.3109/17477166.2010.490262; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Fang HY, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-136; Field AE, 2005, OBES RES, V13, P163, DOI 10.1038/oby.2005.21; Flynn MAT, 2006, OBES REV, V7, P7, DOI 10.1111/j.1467-789X.2006.00242.x; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Grant SFA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001746; Group of China Obesity Task Force, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P97; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Hotta K, 2008, J HUM GENET, V53, P546, DOI 10.1007/s10038-008-0283-1; Ji CY, 2004, CHINESE J EPIDEMIOLG, V25, P6; Kaklamani V, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-52; Kibriya MG, 2009, BREAST CANCER RES TR, V114, P463, DOI 10.1007/s10549-008-0039-9; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Lanigan J, 2010, P NUTR SOC, V69, P204, DOI 10.1017/S0029665110000029; Li HX, 2008, DIABETES, V57, P264, DOI 10.2337/db07-1130; Loos RJF, 2008, OBES REV, V9, P246, DOI 10.1111/j.1467-789X.2008.00481.x; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Low LCK, 2010, WORLD J PEDIATR, V6, P197, DOI 10.1007/s12519-010-0217-9; Matsushita Y, 2009, INT J OBESITY, V33, P1191, DOI 10.1038/ijo.2009.153; Pang XH, 2005, CHINESE J EPIDEMIOLG, V39, P4; Prentice AM, 2001, BRIT MED BULL, V60, P51, DOI 10.1093/bmb/60.1.51; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi L, 2008, NUTR REV, V66, P684, DOI 10.1111/j.1753-4887.2008.00128.x; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Rutters F, 2011, J CLIN ENDOCR METAB, V96, pE939, DOI 10.1210/jc.2010-2413; Salbe AD, 2004, AM J CLIN NUTR, V79, P372; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Talmud PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4838; Tercjak Magdalena, 2010, Pediatr Endocrinol Diabetes Metab, V16, P109; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Timpson NJ, 2009, DIABETES, V58, P505, DOI 10.2337/db08-0906; Wiegand S, 2005, INT J OBESITY, V29, pS136, DOI 10.1038/sj.ijo.0803081; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zhu YM, 2011, J ZHEJIANG U MED SCI, V3, P001	43	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108050	10.1371/journal.pone.0108050	http://dx.doi.org/10.1371/journal.pone.0108050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251416	Green Published, Green Submitted, gold			2022-12-25	WOS:000342492700072
J	Yamamoto, C; Furuta, K; Taki, M; Morisaka, T				Yamamoto, Chisato; Furuta, Keisuke; Taki, Michihiro; Morisaka, Tadamichi			Captive Bottlenose Dolphins (Tursiops truncatus) Spontaneously Using Water Flow to Manipulate Objects	PLOS ONE			English	Article							TOOL-USE; CHIMPANZEES; BEHAVIOR; PLAY	Several terrestrial animals and delphinids manipulate objects in a tactile manner, using parts of their bodies, such as their mouths or hands. In this paper, we report that bottlenose dolphins (Tursiops truncatus) manipulate objects not by direct bodily contact, but by spontaneous water flow. Three of four dolphins at Suma Aqualife Park performed object manipulation with food. The typical sequence of object manipulation consisted of a three step procedure. First, the dolphins released the object from the sides of their mouths while assuming a head-down posture near the floor. They then manipulated the object around their mouths and caught it. Finally, they ceased to engage in their head-down posture and started to swim. When the dolphins moved the object, they used the water current in the pool or moved their head. These results showed that dolphins manipulate objects using movements that do not directly involve contact between a body part and the object. In the event the dolphins dropped the object on the floor, they lifted it by making water flow in one of three methods: opening and closing their mouths repeatedly, moving their heads lengthwise, or making circular head motions. This result suggests that bottlenose dolphins spontaneously change their environment to manipulate objects. The reason why aquatic animals like dolphins do object manipulation by changing their environment but terrestrial animals do not may be that the viscosity of the aquatic environment is much higher than it is in terrestrial environments. This is the first report thus far of any non-human mammal engaging in object manipulation using several methods to change their environment.	[Yamamoto, Chisato] Nagasaki Univ, Grad Sch Fisheries Sci & Environm Studies, Nagasaki 852, Japan; [Taki, Michihiro] Miyajima Publ Aquarium, Hiroshima, Japan; [Morisaka, Tadamichi] Kyoto Univ, Wildlife Res Ctr, Sakyo Ku, Kyoto, Japan; [Morisaka, Tadamichi] Tokai Univ, Inst Innovat Sci & Technol, Shimizu ku, Shizuoka, Japan	Nagasaki University; Kyoto University; Tokai University	Yamamoto, C (corresponding author), Nagasaki Univ, Grad Sch Fisheries Sci & Environm Studies, Nagasaki 852, Japan.	kurousagi0914@gmail.com	Morisaka, Tadamichi/AAJ-7388-2021; Yamamoto, Chisato/U-8506-2018; Yamamoto, Chisato/AAD-5291-2021	Morisaka, Tadamichi/0000-0001-7051-3184; Yamamoto, Chisato/0000-0001-9263-0963; 	Japan Society for the Promotion of Science [23220006]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (grant number 23220006, http://www.jsps.go.jp/j-grantsinaid/ to TM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkovich V.M., 1991, P67; Chappell J, 2002, ANIM COGN, V5, P71, DOI 10.1007/s10071-002-0130-2; Clapham PJ, 2000, CETACEAN SOCIETIES, P173; Hall SL, 1998, APPL ANIM BEHAV SCI, V58, P143, DOI 10.1016/S0168-1591(97)00136-6; Hayashi M, 2007, CORTEX, V43, P308, DOI 10.1016/S0010-9452(08)70457-X; Hayashi M, 2007, ANIM COGN, V10, P89, DOI 10.1007/s10071-006-0040-9; Heinrich B., 1998, ANIMAL PLAY EVOLUTIO, P27, DOI [DOI 10.1017/CBO9780511608575.003, 10.1017/CBO9780511608575.003]; Kitagawa T, 2011, FISHERIES SCI, V77, P217, DOI 10.1007/s12562-011-0321-3; Krutzen M, 2005, P NATL ACAD SCI USA, V102, P8939, DOI 10.1073/pnas.0500232102; Kuba MJ, 2010, ANIM COGN, V13, P507, DOI 10.1007/s10071-009-0301-5; Kuczaj SA, 2007, J MAR BIOL ASSOC UK, V87, P141, DOI 10.1017/S0025315407054999; Marshall CD, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P406; Matsusaka T, 2006, PRIMATES, V47, P113, DOI 10.1007/s10329-005-0158-4; Mendes N, 2007, BIOL LETTERS, V3, P453, DOI 10.1098/rsbl.2007.0198; Nahallage CAD, 2007, AM J PRIMATOL, V69, P267, DOI 10.1002/ajp.20348; Nishida T, 2003, AM J PRIMATOL, V60, P167, DOI 10.1002/ajp.10099; Paulos R.D., 2010, INT J COMP PSYCHOL, V23, P701, DOI DOI 10.1016/J.SOCSCIMED.2010.01.002; Pitman RL, 2012, MAR MAMMAL SCI, V28, P16, DOI 10.1111/j.1748-7692.2010.00453.x; Sazima Ivan, 2008, Biota Neotrop., V8; Takeshita H, 1996, PRIMATES, V37, P423, DOI 10.1007/BF02381377; Tavolga M. C., 1966, WHALES DOLPHINS PORP, P718; TORIGOE T, 1985, Primates, V26, P182, DOI 10.1007/BF02382017; Werth AJ, 2006, J MAMMAL, V87, P579, DOI 10.1644/05-MAMM-A-279R1.1; Werth AJ, 2006, J MORPHOL, V267, P1415, DOI 10.1002/jmor.10486; Wiley D, 2011, BEHAVIOUR, V148, P575, DOI 10.1163/000579511X570893; Wursic B, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P885; WURSIG B, 1979, FISH B-NOAA, V77, P399	27	2	3	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107796	10.1371/journal.pone.0107796	http://dx.doi.org/10.1371/journal.pone.0107796			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250625	Green Published, gold, Green Submitted			2022-12-25	WOS:000342492700047
J	Caine, C; Kasherov, P; Silber, J; Lalouette, A				Caine, Charlotte; Kasherov, Petar; Silber, Joel; Lalouette, Alexis			Mef2 Interacts with the Notch Pathway during Adult Muscle Development in Drosophila melanogaster	PLOS ONE			English	Article							ASYMMETRIC CELL-DIVISION; VESTIGIAL GENE-PRODUCT; SENSE ORGAN LINEAGE; TRANSCRIPTION FACTOR; FLIGHT MUSCLES; WING FORMATION; MADS BOX; DIFFERENTIATION; ACTIVATION; TWIST	Myogenesis of indirect flight muscles (IFMs) in Drosophila melanogaster follows a well-defined cellular developmental scheme. During embryogenesis, a set of cells, the Adult Muscle Precursors (AMPs), are specified. These cells will become proliferating myoblasts during the larval stages which will then give rise to the adult IFMs. Although the cellular aspect of this developmental process is well studied, the molecular biology behind the different stages is still under investigation. In particular, the interactions required during the transition from proliferating myoblasts to differentiated myoblasts ready to fuse to the muscle fiber. It has been previously shown that the Notch pathway is active in proliferating myoblasts, and that this pathway is inhibited in developing muscle fibers. Furthermore, the Myocyte Enhancing Factor 2 (Mef2), Vestigial (Vg) and Scalloped (Sd) transcription factors are necessary for IFM development and that Vg is required for Notch pathway repression in differentiating fibers. Here we examine the interactions between Notch and Mef2 and mechanisms by which the Notch pathway is inhibited during differentiation. We show that Mef2 is capable of inhibiting the Notch pathway in non myogenic cells. A previous screen for Mef2 potential targets identified Delta a component of the Notch pathway. Dl is expressed in Mef2 and Sd-positive developing fibers. Our results show that Mef2 and possibly Sd regulate a Dl enhancer specifically expressed in the developing IFMs and that Mef2 is required for Dl expression in developing IFMs.	[Caine, Charlotte; Kasherov, Petar; Silber, Joel; Lalouette, Alexis] Univ Paris Diderot, Sorbonne Paris Cite, CNRS, Inst Jacques Monod,UMR 7592, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Lalouette, A (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, CNRS, Inst Jacques Monod,UMR 7592, Paris, France.	lalouette.alexis@ijm.univ-paris-diderot.fr			Association Franc, aise contre les Myopathies (AFM) [15738]	Association Franc, aise contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	This work was supported by the Association Franc, aise contre les Myopathies (AFM; grant #15738; http://www.afm-telethon.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Anant S, 1998, DEVELOPMENT, V125, P1361; Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ARTAVANISTSAKONAS S, 1991, TRENDS GENET, V7, P403, DOI 10.1016/0168-9525(91)90264-Q; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; BATE M, 1991, DEVELOPMENT, V113, P79; Baylies MK, 1998, CELL, V93, P921, DOI 10.1016/S0092-8674(00)81198-8; Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Benhra N, 2010, MOL BIOL CELL, V21, P2078, DOI 10.1091/mbc.E09-11-0926; Bernard F, 2006, DEV BIOL, V295, P164, DOI 10.1016/j.ydbio.2006.03.022; Bernard F, 2003, DEV BIOL, V260, P391, DOI 10.1016/S0012-1606(03)00255-0; Bernard F, 2010, DEVELOPMENT, V137, P2633, DOI 10.1242/dev.053181; Bernard F, 2009, DEV BIOL, V332, P258, DOI 10.1016/j.ydbio.2009.05.573; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; Bray S, 1998, SEMIN CELL DEV BIOL, V9, P591, DOI 10.1006/scdb.1998.0262; Bray S, 2010, CURR TOP DEV BIOL, V92, P253, DOI 10.1016/S0070-2153(10)92008-5; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; CAHILL MA, 1994, FEBS LETT, V344, P105, DOI 10.1016/0014-5793(94)00320-3; CAMPBELL S, 1992, GENE DEV, V6, P367, DOI 10.1101/gad.6.3.367; CAMPOSORTEGA JA, 1988, TRENDS NEUROSCI, V11, P400, DOI 10.1016/0166-2236(88)90077-X; Chen ZM, 2012, DEVELOPMENT, V139, P3543, DOI 10.1242/dev.082719; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Cripps RM, 1998, DEV BIOL, V203, P106, DOI 10.1006/dbio.1998.9040; Cripps RM, 1998, GENE DEV, V12, P422, DOI 10.1101/gad.12.3.422; Crossley A.C., 1978, P499; de Celis JF, 2000, DEVELOPMENT, V127, P1291; deCelis JF, 1996, DEVELOPMENT, V122, P359; deCelis JF, 1997, DEVELOPMENT, V124, P3241; del Alamo D, 2011, CURR BIOL, V21, pR40, DOI 10.1016/j.cub.2010.10.034; Deng H, 2009, MOL BIOL CELL, V20, P256, DOI 10.1091/mbc.E08-03-0288; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Doherty D, 1997, DEVELOPMENT, V124, P3881; Dutta D, 2006, MOL B INT U, P125, DOI 10.1007/0-387-32963-3_11; Elgar SJ, 2008, P NATL ACAD SCI USA, V105, P918, DOI 10.1073/pnas.0711255105; FERNANDES J, 1991, DEVELOPMENT, V113, P67; Gildor B, 2012, DEVELOPMENT, V139, P4040, DOI 10.1242/dev.077495; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Gunthorpe D, 1999, DEV BIOL, V215, P130, DOI 10.1006/dbio.1999.9449; Halder G, 1998, GENE DEV, V12, P3900, DOI 10.1101/gad.12.24.3900; IRVINE KD, 1994, CELL, V79, P595, DOI 10.1016/0092-8674(94)90545-2; Klein T, 1999, DEVELOPMENT, V126, P913; Krejci A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000140; Kumar JP, 2001, CELL, V104, P687, DOI 10.1016/S0092-8674(01)00265-3; Lai EC, 2000, DEVELOPMENT, V127, P3441; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Le Bras S, 2012, J CELL SCI, V125, P4886, DOI 10.1242/jcs.110171; LILLY B, 1995, SCIENCE, V267, P688, DOI 10.1126/science.7839146; Liotta D, 2007, CURR BIOL, V17, P1409, DOI 10.1016/j.cub.2007.07.039; Lovato TL, 2005, DEV BIOL, V288, P612, DOI 10.1016/j.ydbio.2005.09.007; Lovato TL, 2009, GENETICS, V183, P107, DOI 10.1534/genetics.109.105056; Maeda T, 2002, J BIOL CHEM, V277, P48889, DOI 10.1074/jbc.M206858200; Maeda T, 2002, BIOCHEM BIOPH RES CO, V294, P791, DOI 10.1016/S0006-291X(02)00556-9; Manning L, 1999, DEVELOPMENT, V126, P2063; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Ng M, 1996, NATURE, V381, P316, DOI 10.1038/381316a0; Nguyen T, 2002, DIFFERENTIATION, V70, P438, DOI 10.1046/j.1432-0436.2002.700806.x; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; OLSON EN, 1995, DEV BIOL, V172, P2, DOI 10.1006/dbio.1995.0002; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; RANGANAYAKULU G, 1995, DEV BIOL, V171, P169, DOI 10.1006/dbio.1995.1269; Reddy GV, 1999, DEVELOPMENT, V126, P2083; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Simmonds AJ, 1998, GENE DEV, V12, P3815, DOI 10.1101/gad.12.24.3815; Soler C, 2012, DEVELOPMENT, V139, P1270, DOI 10.1242/dev.077875; Soler C, 2009, MECH DEVELOP, V126, P595, DOI 10.1016/j.mod.2009.03.003; Srivastava A, 2004, GENETICS, V166, P1833, DOI 10.1534/genetics.166.4.1833; Sudarsan V, 2001, DEV CELL, V1, P829, DOI 10.1016/S1534-5807(01)00089-2; Taylor MV, 2006, MOL B INT U, P169, DOI 10.1007/0-387-32963-3_14; TAYLOR MV, 1995, CURR BIOL, V5, P740, DOI 10.1016/S0960-9822(95)00149-7; THISSE B, 1988, EMBO J, V7, P2175, DOI 10.1002/j.1460-2075.1988.tb03056.x; UI K, 1987, IN VITRO CELL DEV B, V23, P707; Vaudin P, 1999, DEVELOPMENT, V126, P4807; WILLIAMS JA, 1991, GENE DEV, V5, P2481, DOI 10.1101/gad.5.12b.2481; Zider A, 1998, J NEUROGENET, V12, P87, DOI 10.3109/01677069809167258	81	7	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108149	10.1371/journal.pone.0108149	http://dx.doi.org/10.1371/journal.pone.0108149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247309	Green Published, gold, Green Submitted			2022-12-25	WOS:000342351800067
J	Sanokawa-Akakura, R; Ostrakhovitch, EA; Akakura, S; Goodwin, S; Tabibzadeh, S				Sanokawa-Akakura, Reiko; Ostrakhovitch, Elena A.; Akakura, Shin; Goodwin, Scott; Tabibzadeh, Siamak			A H2S-Nampt Dependent Energetic Circuit Is Critical to Survival and Cytoprotection from Damage in Cancer Cells	PLOS ONE			English	Article							POTENTIALLY LETHAL DAMAGE; CYSTATHIONINE-BETA-SYNTHASE; HYDROGEN-SULFIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; SULFANE SULFUR; PROLIFERATION; H2S; INHIBITION; INDUCTION; MECHANISM	We recently demonstrated that cancer cells that recover from damage exhibit increased aerobic glycolysis, however, the molecular mechanism by which cancer cells survive the damage and show increased aerobic glycolysis remains unknown. Here, we demonstrate that diverse cancer cells that survive hypoxic or oxidative damage show rapid cell proliferation, and develop tolerance to damage associated with increased production of hydrogen sulfide (H2S) which drives up-regulation of nicotinamide phosphoribosyltransferase (Nampt). Consistent with existence of a H2S-Nampt energetic circuit, in damage recovered cancer cells, H2S, Nampt and ATP production exhibit a significant correlation. Moreover, the treatment of cancer cells with H2S donor, NaHS, coordinately increases Nampt and ATP levels, and protects cells from drug induced damage. Inhibition of cystathionine beta synthase (CBS) or cystathionase (CTH), enzymes which drive generation of H2S, decreases Nampt production while suppression of Nampt pathway by FK866, decreases H2S and ATP levels. Damage recovered cells isolated from tumors grown subcutaneously in athymic mice also show increased production of H2S, Nampt and ATP levels, associated with increased glycolysis and rapid proliferation. Together, these data show that upon recovery from potential lethal damage, H2S-Nampt directs energy expenditure and aerobic glycolysis in cancer cells, leads to their exponential growth, and causes a high degree of tolerance to damage. Identification of H2S-Nampt as a pathway responsible for induction of damage tolerance in cancer cells may underlie resistance to therapy and offers the opportunity to target this pathway as a means in treatment of cancer.	[Sanokawa-Akakura, Reiko; Ostrakhovitch, Elena A.; Akakura, Shin; Tabibzadeh, Siamak] Frontiers Biosci Res Inst Aging & Canc, Irvine, CA 92618 USA; [Goodwin, Scott; Tabibzadeh, Siamak] Univ Calif Irvine, Dept Radiol Sci, Irvine, CA 92717 USA	University of California System; University of California Irvine	Tabibzadeh, S (corresponding author), Frontiers Biosci Res Inst Aging & Canc, Irvine, CA 92618 USA.	fbs@bioscience.org						Akakura S, 2014, BIOCHEM BIOPH RES CO, V448, P461, DOI 10.1016/j.bbrc.2014.04.138; Basker R, 2012, FASEB J, V21, P247; BOUCHER Y, 1990, CANCER RES, V50, P4478; Cai WJ, 2010, CELL BIOL INT, V34, P565, DOI 10.1042/CBI20090368; Cao QH, 2010, ANTIOXID REDOX SIGN, V12, P1101, DOI 10.1089/ars.2009.2915; Cao Y, 2006, AM J PHYSIOL-CELL PH, V291, pC503, DOI 10.1152/ajpcell.00547.2005; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Fu M, 2012, P NATL ACAD SCI USA, V109, P2943, DOI 10.1073/pnas.1115634109; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Guo H, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2011.10.013; Hasmann M, 2003, CANCER RES, V63, P7436; HELLER DP, 1994, INT J RADIAT BIOL, V66, P41, DOI 10.1080/09553009414550931; Jurkowska H, 2008, AMINO ACIDS, V34, P231, DOI 10.1007/s00726-007-0471-2; Kajimura M, 2010, ANTIOXID REDOX SIGN, V13, P157, DOI 10.1089/ars.2009.2657; Kamoun P, 2004, AMINO ACIDS, V26, P243, DOI 10.1007/s00726-004-0072-x; KERY V, 1994, J BIOL CHEM, V269, P25283; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Lan AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025921; Predmore BL, 2012, ANTIOXID REDOX SIGN, V17, P119, DOI 10.1089/ars.2012.4612; Modis K, 2013, FASEB J, V27, P601, DOI 10.1096/fj.12-216507; Papapetropoulos A, 2009, P NATL ACAD SCI USA, V106, P21972, DOI 10.1073/pnas.0908047106; PHILLIPS RA, 1966, RADIAT RES, V29, P413, DOI 10.2307/3572022; Pupo E, 2011, FREE RADICAL BIO MED, V51, P1765, DOI 10.1016/j.freeradbiomed.2011.08.007; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; Shen YQ, 2013, INT J MOL SCI, V14, P13093, DOI 10.3390/ijms140713093; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Sivarajah A, 2009, SHOCK, V31, P267, DOI 10.1097/SHK.0b013e318180ff89; Szabo C, 2013, P NATL ACAD SCI USA, V110, P12474, DOI 10.1073/pnas.1306241110; Tan B, 2013, J BIOL CHEM, V288, P3500, DOI 10.1074/jbc.M112.394510; Taylor KACC, 1996, APPL BIOCHEM BIOTECH, V56, P49, DOI 10.1007/BF02787869; VARNES ME, 1986, RADIAT RES, V108, P80, DOI 10.2307/3576972; Wang MX, 2014, BIOCHEM GENET, V52, P29, DOI 10.1007/s10528-013-9624-7; Wen YD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053147; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yang C, 2011, PLOS ONE, V6; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhang Q, 2014, PHARM RES, V1043-6618; Zhang T, 2009, J BIOL CHEM, V284, P20408, DOI 10.1074/jbc.M109.016469	39	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108537	10.1371/journal.pone.0108537	http://dx.doi.org/10.1371/journal.pone.0108537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25248148	Green Published, gold			2022-12-25	WOS:000342351800098
J	Eng, KH; Ruggeri, C				Eng, Kevin H.; Ruggeri, Christina			Connecting Prognostic Ligand Receptor Signaling Loops in Advanced Ovarian Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; CELLS	Understanding cancer cell signal transduction is a promising lead for uncovering therapeutic targets and building treatment-specific markers for epithelial ovarian cancer. To brodaly assay the many known transmembrane receptor systems, previous studies have employed gene expression data measured on high-throughput microarrays. Starting with the knowledge of validated ligand-receptor pairs (LRPs), these studies postulate that correlation of the two genes implies functional autocrine signaling. It is our goal to consider the additional weight of evidence that prognosis (progression-free survival) can bring to prioritize ovarian cancer specific signaling mechanism. We survey three large studies of epithelial ovarian cancers, with gene expression measurements and clinical information, by modeling survival times both categorically (long/short survival) and continuously. We use differential correlation and proportional hazards regression to identify sets of LRPs that are both prognostic and correlated. Of 475 candidate LRPs, 77 show reproducible evidence of correlation; 55 show differential correlation. Survival models identify 16 LRPs with reproduced, significant interactions. Only two pairs show both interactions and correlation (PDGFA similar to PDGFRA and COL1A1 similar to CD44) suggesting that the majority of prognostically useful LRPs act without positive feedback. We further assess the connectivity of receptors using a Gaussian graphical model finding one large graph and a number of smaller disconnected networks. These LRPs can be organized into mutually exclusive signaling clusters suggesting different mechanisms apply to different patients. We conclude that a mix of autocrine and endocrine LRPs influence prognosis in ovarian cancer, there exists a heterogenous mix of signaling themes across patients, and we point to a number of novel applications of existing targeted therapies which may benefit ovarian cancer.	[Eng, Kevin H.; Ruggeri, Christina] Roswell Pk Canc Inst, Dept Biostat & Bioinformat, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Eng, KH (corresponding author), Roswell Pk Canc Inst, Dept Biostat & Bioinformat, Buffalo, NY 14263 USA.	kevin.eng@roswellpark.org		Eng, Kevin/0000-0001-5636-0812	Roswell Park Cancer Institute, National Cancer Institute [P30CA016056]; Roswell Park Alliance Foundation; RPCI-UPCI Ovarian SPORE [P50CA159981]; NATIONAL CANCER INSTITUTE [P30CA016056, P50CA159981] Funding Source: NIH RePORTER	Roswell Park Cancer Institute, National Cancer Institute; Roswell Park Alliance Foundation; RPCI-UPCI Ovarian SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Roswell Park Cancer Institute, National Cancer Institute grant P30CA016056 (www.cancer.gov), a grant from the Roswell Park Alliance Foundation (KHE), and the RPCI-UPCI Ovarian SPORE (P50CA159981). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Best D. J., 1975, Applied Statistics, V24, P377, DOI 10.2307/2347111; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Castellano G, 2006, CANCER RES, V66, P10709, DOI 10.1158/0008-5472.CAN-06-1327; Eng KH, 2014, BIOINFORMATICS, V30, P1690, DOI 10.1093/bioinformatics/btu065; Graeber TG, 2001, NAT GENET, V29, P295, DOI 10.1038/ng755; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Nowak AK, 2002, CANCER RES, V62, P2353; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Shedden K, 2005, METHODS OF MICROARRAY DATA ANALYSIS IV, P121, DOI 10.1007/0-387-23077-7_10; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Trojandt S, 2013, CANCER IMMUNOL IMMUN, V62, P1315, DOI 10.1007/s00262-013-1431-9; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Yap TA, 2009, NAT REV CANCER, V9, P167, DOI 10.1038/nrc2583; Yoshihara K, 2012, CLIN CANCER RES, V18, P1374, DOI 10.1158/1078-0432.CCR-11-2725; Zandi R, 2007, CELL SIGNAL, V19, P2013, DOI 10.1016/j.cellsig.2007.06.023; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhao SD, 2014, BIOMETRIKA IN PRESS	19	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107193	10.1371/journal.pone.0107193	http://dx.doi.org/10.1371/journal.pone.0107193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244152	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800024
J	He, WX; Ding, XY; Zhang, RX; Chen, J; Zhang, DX; Wu, XH				He, Wenxin; Ding, Xiuyong; Zhang, Ruxiang; Chen, Jing; Zhang, Daoxing; Wu, Xihong			Electrically-Evoked Frequency-Following Response (EFFR) in the Auditory Brainstem of Guinea Pigs	PLOS ONE			English	Article							INFERIOR COLLICULUS; COCHLEAR IMPLANT; POTENTIALS; HEARING; NERVE; SPEECH; TONES; ABR; STIMULATION; ARTIFACT	It is still a difficult clinical issue to decide whether a patient is a suitable candidate for a cochlear implant and to plan postoperative rehabilitation, especially for some special cases, such as auditory neuropathy. A partial solution to these problems is to preoperatively evaluate the functional integrity of the auditory neural pathways. For evaluating the strength of phase-locking of auditory neurons, which was not reflected in previous methods using electrically evoked auditory brainstem response (EABR), a new method for recording phase-locking related auditory responses to electrical stimulation, called the electrically evoked frequency-following response (EFFR), was developed and evaluated using guinea pigs. The main objective was to assess feasibility of the method by testing whether the recorded signals reflected auditory neural responses or artifacts. The results showed the following: 1) the recorded signals were evoked by neuron responses rather than by artifact; 2) responses evoked by periodic signals were significantly higher than those evoked by the white noise; 3) the latency of the responses fell in the expected range; 4) the responses decreased significantly after death of the guinea pigs; and 5) the responses decreased significantly when the animal was replaced by an electrical resistance. All of these results suggest the method was valid. Recording obtained using complex tones with a missing fundamental component and using pure tones with various frequencies were consistent with those obtained using acoustic stimulation in previous studies.	[He, Wenxin; Chen, Jing; Wu, Xihong] Peking Univ, Speech & Hearing Res Ctr, Beijing 100871, Peoples R China; [He, Wenxin; Chen, Jing; Wu, Xihong] Peking Univ, Key Lab Machine Percept, Minist Educ, Beijing 100871, Peoples R China; [Ding, Xiuyong; Zhang, Ruxiang; Zhang, Daoxing] Capital Med Univ, Beijing Friendship Hosp, Dept Otorhinolaryngol Head & Neck Surg, Beijing, Peoples R China	Peking University; Peking University; Capital Medical University	Chen, J (corresponding author), Peking Univ, Speech & Hearing Res Ctr, Beijing 100871, Peoples R China.	chenj@cis.pku.edu.cn; wxh@cis.pku.edu.cn			research special fund for public welfare industry of health [201202001]; "Twelfth Five-Year" National Science & Technology Support Program of China [2012BAI12B01]; National Natural Science Foundation of China [61121002, 81170906, 61473008]; Royal Society, UK	research special fund for public welfare industry of health; "Twelfth Five-Year" National Science & Technology Support Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Royal Society, UK(Royal Society of London)	The work was supported by the research special fund for public welfare industry of health (No. 201202001); The "Twelfth Five-Year" National Science & Technology Support Program of China (No. 2012BAI12B01); the National Natural Science Foundation of China (No. 61121002, No. 81170906, No. 61473008); and a Newton alumni funding by the Royal Society, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHOR LJ, 1980, ELECTROEN CLIN NEURO, V48, P154, DOI 10.1016/0013-4694(80)90301-6; Aiken SJ, 2008, HEARING RES, V245, P35, DOI 10.1016/j.heares.2008.08.004; Akhoun I, 2008, CLIN NEUROPHYSIOL, V119, P922, DOI 10.1016/j.clinph.2007.12.010; BATRA R, 1986, HEARING RES, V21, P167, DOI 10.1016/0378-5955(86)90037-7; Burkard RF., 2007, AUDITORY EVOKED POTE; Chandrasekaran B, 2010, PSYCHOPHYSIOLOGY, V47, P236, DOI 10.1111/j.1469-8986.2009.00928.x; Derbyshire AJ, 1935, AM J PHYSIOL, V113, P476, DOI 10.1152/ajplegacy.1935.113.2.476; Du Y, 2011, NEUROSCI BIOBEHAV R, V35, P2046, DOI 10.1016/j.neubiorev.2011.05.008; Du Y, 2009, EUR J NEUROSCI, V30, P1779, DOI 10.1111/j.1460-9568.2009.06947.x; DUM N, 1982, ARCH OTO-RHINO-LARYN, V236, P59, DOI 10.1007/BF00464058; Evans E.F., 1975, HDB SENSORY PHYSL, P1; GALBRAITH GC, 1994, ELECTROEN CLIN NEURO, V92, P321, DOI 10.1016/0168-5597(94)90100-7; GARDI J, 1979, AUDIOLOGY, V18, P353; GERKEN GM, 1975, ELECTROEN CLIN NEURO, V38, P379, DOI 10.1016/0013-4694(75)90262-X; Gibson William P R, 2008, Cochlear Implants Int, V9, P1, DOI 10.1179/cim.2008.9.1.1; HARRISON RV, 1984, ARCH OTO-RHINO-LARYN, V240, P271; Ingham NJ, 1998, ACTA OTO-LARYNGOL, V118, P673; JEWETT DL, 1971, BRAIN, V94, P681, DOI 10.1093/brain/94.4.681; Johnson KL, 2005, EAR HEARING, V26, P424, DOI 10.1097/01.aud.0000179687.71662.6e; Katz J., 2010, HDB CLIN AUDIOLOGY; Kileny PR, 2004, INT J AUDIOL, V43, pS16; Liu LF, 2006, J NEUROPHYSIOL, V95, P1926, DOI 10.1152/jn.00497.2005; MARSH JT, 1968, LARYNGOSCOPE, V78, P1149, DOI 10.1288/00005537-196807000-00003; MARSH JT, 1970, SCIENCE, V169, P1222, DOI 10.1126/science.169.3951.1222; Martin BA, 2007, J AM ACAD AUDIOL, V18, P126, DOI 10.3766/jaaa.18.2.5; Mason JA, 1998, PEDIATRICS, V101, P221, DOI 10.1542/peds.101.2.221; Miller CA, 2008, HEARING RES, V242, P184, DOI 10.1016/j.heares.2008.04.005; MOLLER AR, 1986, ELECTROEN CLIN NEURO, V65, P361, DOI 10.1016/0168-5597(86)90015-8; Moore BC, 2012, INTRO PSYCHOL HEARIN; Moore DR, 2009, NAT NEUROSCI, V12, P686, DOI 10.1038/nn.2326; MOUSHEGIAN G, 1973, ELECTROEN CLIN NEURO, V35, P665, DOI 10.1016/0013-4694(73)90223-X; MOUSHEGIAN G, 1964, J NEUROPHYSIOL, V27, P1174, DOI 10.1152/jn.1964.27.6.1174; Ping JL, 2008, NEUROREPORT, V19, P1377, DOI 10.1097/WNR.0b013e32830c1cfa; Polak M, 2004, J NEUROSCI METH, V134, P141, DOI 10.1016/j.jneumeth.2003.11.003; SIMMONS FB, 1984, ANN OTO RHINOL LARYN, V93, P97, DOI 10.1177/00034894840930S417; Skoe E, 2010, EAR HEARING, V31, P302, DOI 10.1097/AUD.0b013e3181cdb272; SMITH JC, 1975, ELECTROEN CLIN NEURO, V39, P465, DOI 10.1016/0013-4694(75)90047-4; SMITH JC, 1978, SCIENCE, V201, P639, DOI 10.1126/science.675250; STARR A, 1976, ELECTROEN CLIN NEURO, V41, P595, DOI 10.1016/0013-4694(76)90005-5; STARR A, 1979, ANN OTO RHINOL LARYN, V88, P550, DOI 10.1177/000348947908800419; STILLMAN RD, 1978, ELECTROEN CLIN NEURO, V44, P438, DOI 10.1016/0013-4694(78)90028-7; STILLMAN RD, 1976, AUDIOLOGY, V15, P10; TAPP R, 2009, J PHARMACOL TOXICOL, V60, P231, DOI DOI 10.1016/j.vascn.2009.04.094; VANDENHONERT C, 1986, HEARING RES, V21, P109, DOI 10.1016/0378-5955(86)90033-X; WADA SI, 1983, ELECTROEN CLIN NEURO, V56, P352, DOI 10.1016/0013-4694(83)90261-4; Wang L, 2009, ACOUST PHYS+, V55, P857, DOI 10.1134/S1063771009060207; Wever EG, 1930, P NATL ACAD SCI USA, V16, P344, DOI 10.1073/pnas.16.5.344; Xiong M, 2011, ACTA OTO-LARYNGOL, V131, P914, DOI 10.3109/00016489.2011.577448	48	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e106719	10.1371/journal.pone.0106719	http://dx.doi.org/10.1371/journal.pone.0106719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244253	Green Published, gold, Green Submitted			2022-12-25	WOS:000343679800014
J	Izquierdo-Garcia, JL; Cai, LM; Chaumeil, MM; Eriksson, P; Robinson, AE; Pieper, RO; Phillips, JJ; Ronen, SM				Izquierdo-Garcia, Jose L.; Cai, Larry M.; Chaumeil, Myriam M.; Eriksson, Pia; Robinson, Aaron E.; Pieper, Russell O.; Phillips, Joanna J.; Ronen, Sabrina M.			Glioma Cells with the IDH1 Mutation Modulate Metabolic Fractional Flux through Pyruvate Carboxylase	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; ENERGY-METABOLISM; GLUTAMINE; ASTROCYTES; BRAIN; GLIOBLASTOMA; GLYCOLYSIS; GLUCOSE; GROWTH	Background: Over 70% of low-grade gliomas carry a heterozygous R132H mutation in the gene coding for isocitrate dehydrogenase 1 (IDH1). This confers the enzyme with the novel ability to convert alpha-ketoglutarate to 2-hydroxyglutarate, ultimately leading to tumorigenesis. The major source of 2-hydroxyglutarate production is glutamine, which, in cancer, is also a source for tricarboxylic acid cycle (TCA) anaplerosis. An alternate source of anaplerosis is pyruvate flux via pyruvate carboxylase (PC), which is a common pathway in normal astrocytes. The goal of this study was to determine whether PC serves as a source of TCA anaplerosis in IDH1 mutant cells wherein glutamine is used for 2-hydroxyglutarate production. Methods: Immortalized normal human astrocytes engineered to express heterozygous mutant IDH1 or wild-type IDH1 were investigated. Flux of pyruvate via PC and via pyruvate dehydrogenase (PDH) was determined by using magnetic resonance spectroscopy to probe the labeling of [2-C-13] glucose-derived C-13-labeled glutamate and glutamine. Activity assays, RT-PCR and western blotting were used to probe the expression and activity of relevant enzymes. The Cancer Genome Atlas (TCGA) data was analyzed to assess the expression of enzymes in human glioma samples. Results: Compared to wild-type cells, mutant IDH1 cells significantly increased fractional flux through PC. This was associated with a significant increase in PC activity and expression. Concurrently, PDH activity significantly decreased, likely mediated by significantly increased inhibitory PDH phosphorylation by PDH kinase 3. Consistent with the observation in cells, analysis of TCGA data indicated a significant increase in PC expression in mutant IDH-expressing human glioma samples compared to wild-type IDH. Conclusions: Our findings suggest that changes in PC and PDH may be an important part of cellular adaptation to the IDH1 mutation and may serve as potential therapeutic targets.	[Izquierdo-Garcia, Jose L.; Cai, Larry M.; Chaumeil, Myriam M.; Eriksson, Pia; Ronen, Sabrina M.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Robinson, Aaron E.; Pieper, Russell O.; Phillips, Joanna J.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Izquierdo-Garcia, JL (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.	jose.izquierdo@uscf.edu	Izquierdo Garcia, Jose/L-2654-2015; Izquierdo-Garcia, Jose/L-3293-2013	Izquierdo-Garcia, Jose/0000-0002-7907-3776; Chaumeil, Myriam/0000-0002-2110-4613	National Institutes of Health [R01 CA172845]; NATIONAL CANCER INSTITUTE [R01CA172845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health R01 CA172845 (to SMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Brat DJ, 2008, J NEURO-ONCOL, V89, P287, DOI 10.1007/s11060-008-9618-1; Brekke E, 2012, GLIA, V60, P147, DOI 10.1002/glia.21265; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cairns RA, 2013, CANCER DISCOV, V3, P730, DOI 10.1158/2159-8290.CD-13-0083; Chaumeil MM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3429; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Chesnelong C, 2013, NEUROONCOL; Choi C, 2012, NAT MED, V18, P624, DOI 10.1038/nm.2682; Chung YL, 2003, J NATL CANCER I, V95, P1624, DOI 10.1093/jnci/djg084; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Daye D, 2012, SEMIN CELL DEV BIOL, V23, P362, DOI 10.1016/j.semcdb.2012.02.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Denton R M, 1979, Essays Biochem, V15, P37; Filipp FV, 2012, PIGM CELL MELANOMA R, V25, P732, DOI 10.1111/pcmr.12000; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HERTZ E, 1979, IN VITRO CELL DEV B, V15, P429; HERTZ L, 1980, BRAIN RES, V181, P482, DOI 10.1016/0006-8993(80)90634-4; Hertz L, 2011, MAGN RESON IMAGING, V29, P1319, DOI 10.1016/j.mri.2011.04.013; Itoh Y, 2003, P NATL ACAD SCI USA, V100, P4879, DOI 10.1073/pnas.0831078100; Izquierdo-Garcia JL, 2014, METABOLIC REPROGRAMI; Lebon V, 2002, J NEUROSCI, V22, P1523, DOI 10.1523/JNEUROSCI.22-05-01523.2002; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Oz G, 2004, J NEUROSCI, V24, P11273, DOI 10.1523/JNEUROSCI.3564-04.2004; Rajagopalan KN, 2011, J NUCL MED, V52, P1005, DOI 10.2967/jnumed.110.084244; Schousboe Arne, 2013, Front Endocrinol (Lausanne), V4, P102, DOI 10.3389/fendo.2013.00102; Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666; SHANK RP, 1985, BRAIN RES, V329, P364, DOI 10.1016/0006-8993(85)90552-9; SONNEWALD U, 1993, DEV NEUROSCI-BASEL, V15, P351, DOI 10.1159/000111355; Sonoda Y, 2001, CANCER RES, V61, P4956; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Teicher BA, 2012, CLIN CANCER RES, V18, P5537, DOI 10.1158/1078-0432.CCR-12-2587; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Thompson CB, 2009, NEW ENGL J MED, V360, P813, DOI 10.1056/NEJMe0810213; Tyagi RK, 1996, MAGN RESON MED, V35, P194, DOI 10.1002/mrm.1910350210; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Yang C, 2014, J BIOL CHEM	39	51	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e108289	10.1371/journal.pone.0108289	http://dx.doi.org/10.1371/journal.pone.0108289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243911	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800083
J	Mineshita, M; Kida, H; Handa, H; Nishine, H; Furuya, N; Nobuyama, S; Inoue, T; Matsuoka, S; Miyazawa, T				Mineshita, Masamichi; Kida, Hirotaka; Handa, Hiroshi; Nishine, Hiroki; Furuya, Naoki; Nobuyama, Seiichi; Inoue, Takeo; Matsuoka, Shin; Miyazawa, Teruomi			The Correlation between Lung Sound Distribution and Pulmonary Function in COPD Patients	PLOS ONE			English	Article							AIR-FLOW OBSTRUCTION; RESPIRATORY SOUNDS; VOLUME REDUCTION; BREATH SOUNDS; EMPHYSEMA; VENTILATION; DISEASE	Background: Regional lung sound intensity in chronic obstructive pulmonary disease (COPD) patients is influenced by the severity and distribution of emphysema, obstructed peripheral airways, and altered ribcage and diaphragm configurations and movements due to hyperinflation. Changes in the lung sound distribution accompanied by pulmonary function improvements in COPD patients were observed after bronchodilator inhalation. We investigated the association of lung sound distribution with pulmonary functions, and the effects of emphysematous lesions on this association. These studies were designed to acquire the basic knowledge necessary for the application of lung sound analysis in the physiological evaluation of COPD patients. Methods: Pulmonary function tests and the percentage of upper-and lower-lung sound intensity (quantitative lung data [QLD]) were evaluated in 47 stable male COPD patients (54 - 82 years of age). In 39 patients, computed tomography taken within 6 months of the study was available and analyzed. Results: The ratio of lower QLD to upper QLD showed significant positive correlations with FEV1 %predicted (%FEV1; rho = 0.45, p<0.005) and MEF50 %predicted (%MEF50; rho = 0.46, p<0.005). These correlations were not observed in COPD patients with dominant emphysema (% low attenuation area >40%, n = 20) and were stronger in less emphysematous patients (n = 19, %FEV1; rho = 0.64, p<0.005, %MEF50; rho = 0.71, p<0.001). Conclusions: In COPD patients, the ratio of lower- to upper-lung sound intensities decreased according to the severity of obstructive changes, although emphysematous lesions considerably affected lung sound distribution.	[Mineshita, Masamichi; Kida, Hirotaka; Handa, Hiroshi; Nishine, Hiroki; Furuya, Naoki; Nobuyama, Seiichi; Inoue, Takeo; Miyazawa, Teruomi] St Marianna Univ, Sch Med, Dept Internal Med, Div Resp & Infect Dis, Kawasaki, Kanagawa, Japan; [Matsuoka, Shin] St Marianna Univ, Sch Med, Dept Radiol, Kawasaki, Kanagawa, Japan	Saint Marianna University; Saint Marianna University	Mineshita, M (corresponding author), St Marianna Univ, Sch Med, Dept Internal Med, Div Resp & Infect Dis, Kawasaki, Kanagawa, Japan.	m-mine@marianna-u.ac.jp	Furuya, Naoki/AAP-6618-2020	Furuya, Naoki/0000-0001-7162-5946	Japan Society for the Promotion of Science [24591143]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (C) Grant number (24591143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Lung Association, 2020, GUID PULM FUNCT TEST; Becker HD, 2009, RESPIRATION, V77, P179, DOI 10.1159/000182972; Bohadana A, 2014, NEW ENGL J MED, V370, P744, DOI 10.1056/NEJMra1302901; BUIST AS, 1973, AM REV RESPIR DIS, V108, P1078; Dellinger RP, 2008, RESPIRATION, V75, P60, DOI 10.1159/000103558; Dellinger RP, 2007, CRIT CARE, V11, DOI 10.1186/cc5706; Detterbeck F, 2013, ANN THORAC SURG, V95, P968, DOI 10.1016/j.athoracsur.2012.07.045; Fain S, 2010, J MAGN RESON IMAGING, V32, P1398, DOI 10.1002/jmri.22375; Gasparini S, 2012, RESPIRATION, V84, P250, DOI 10.1159/000341171; GILMARTIN JJ, 1984, THORAX, V39, P264, DOI 10.1136/thx.39.4.264; Herth FJF, 2013, EUR RESPIR J, V41, P302, DOI 10.1183/09031936.00015312; Ingenito EP, 2001, AM J RESP CRIT CARE, V164, P295, DOI 10.1164/ajrccm.164.2.2011085; KRAMAN SS, 1980, AM REV RESPIR DIS, V122, P303; LEVINE S, 1988, J APPL PHYSIOL, V65, P888, DOI 10.1152/jappl.1988.65.2.888; Maher TM, 2008, THORAX, V63, P542, DOI 10.1136/thx.2007.086405; MARTINEZ FJ, 1990, AM REV RESPIR DIS, V142, P276, DOI 10.1164/ajrccm/142.2.276; Mineshita M, 2014, RESPIR INVESTIG, V52, P28, DOI 10.1016/j.resinv.2013.05.008; Mineshita M, 2014, RESPIRATION, V87, P45, DOI 10.1159/000350228; PARDEE NE, 1976, CHEST, V70, P341, DOI 10.1378/chest.70.3.341; Park EA, 2010, RADIOLOGY, V256, P985, DOI 10.1148/radiol.10091502; Pasterkamp H, 1997, AM J RESP CRIT CARE, V156, P974, DOI 10.1164/ajrccm.156.3.9701115; PLOYSONGSANG Y, 1982, AM REV RESPIR DIS, V126, P526; ROCA J, 1990, AM REV RESPIR DIS, V141, P1026, DOI 10.1164/ajrccm/141.4_Pt_1.1026; Shah PL, 2014, THORAX, V69, P280, DOI 10.1136/thoraxjnl-2013-203743; Shi C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086638; Wang Z, 2008, J ASTHMA, V45, P575, DOI 10.1080/02770900802017744	26	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107506	10.1371/journal.pone.0107506	http://dx.doi.org/10.1371/journal.pone.0107506			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244247	gold, Green Published, Green Submitted			2022-12-25	WOS:000343679800038
J	Sethi, R; Ylanne, J				Sethi, Ritika; Ylanne, Jari			Small-Angle X-Ray Scattering Reveals Compact Domain-Domain Interactions in the N-Terminal Region of Filamin C	PLOS ONE			English	Article							BIOLOGICAL MACROMOLECULES; STRUCTURAL BASIS; AUTO-INHIBITION; BINDING; RESOLUTION; PROTEINS; BEAMLINE; FRAGMENT; SAXS	Filamins are multi-domain, actin cross-linking, and scaffolding proteins. In addition to the actin cross-linking function, filamins have a role in mechanosensor signaling. The mechanosensor function is mediated by domain-domain interaction in the C-terminal region of filamins. Recently, we have shown that there is a three-domain interaction module in the N-terminal region of filamins, where the neighboring domains stabilize the structure of the middle domain and thereby regulate its interaction with ligands. In this study, we have used small-angle X-ray scattering as a tool to screen for potential domain-domain interactions in the N-terminal region. We found evidence of four domain-domain interactions with varying flexibility. These results confirm our previous study showing that domains 3, 4, and 5 exist as a compact three domain module. In addition, we report interactions between domains 11-12 and 14-15, which are thus new candidate sites for mechanical regulation.	[Sethi, Ritika] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; Univ Jyvaskyla, Nanosci Ctr, Jyvaskyla, Finland	University of Jyvaskyla; University of Jyvaskyla	Sethi, R (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland.	ritika.sethi@jyu.fi		Ylanne, Jari/0000-0003-4627-021X; Sethi, Ritika/0000-0001-6015-7710	Marie Curie Actions FP 7 grant; Sigrid Juselius Foundation; Academy of Finland [114713, 138327]	Marie Curie Actions FP 7 grant; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland)	This work has been funded by Marie Curie Actions FP 7 grant to Initial Training Network MUZIC (Muscle Z-disk Protein Complexes: from atomic structure to physiological function) (RS, JY), and the Sigrid Juselius Foundation and Academy of Finland (JY: 114713 and 138327). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Djinovic-Carugo K, 2010, CURR PROTEIN PEPT SC, V11, P639, DOI 10.2174/138920310794109111; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; Ehrlicher AJ, 2011, NATURE, V478, P260, DOI 10.1038/nature10430; Gardel ML, 2006, P NATL ACAD SCI USA, V103, P1762, DOI 10.1073/pnas.0504777103; Gazdag EM, 2014, J STRUCT BI IN PRESS; Gileadi Opher, 2008, V426, P221, DOI 10.1007/978-1-60327-058-8_14; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Heikkinen OK, 2009, J BIOL CHEM, V284, P25450, DOI 10.1074/jbc.M109.019661; Ithychanda SS, 2009, J BIOL CHEM, V284, P35113, DOI 10.1074/jbc.M109.060954; Jacques DA, 2012, ACTA CRYSTALLOGR D, V68, P620, DOI 10.1107/S0907444912012073; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Light S, 2012, J STRUCT BIOL, V179, P289, DOI 10.1016/j.jsb.2012.02.010; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Pentikainen U, 2009, J MOL BIOL, V393, P644, DOI 10.1016/j.jmb.2009.08.035; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Petoukhov MV, 2007, CURR OPIN STRUC BIOL, V17, P562, DOI 10.1016/j.sbi.2007.06.009; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pudas R, 2005, STRUCTURE, V13, P111, DOI 10.1016/j.str.2004.10.014; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Razinia Z, 2012, ANNU REV BIOPHYS, V41, P227, DOI 10.1146/annurev-biophys-050511-102252; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Rognoni L, 2012, P NATL ACAD SCI USA, V21, P1; Ruskamo S, 2012, BIOCHEM J, V446, P261, DOI 10.1042/BJ20120361; Sethi R, 2014, J BIOL CHEM, V289, P8588, DOI 10.1074/jbc.M113.537456; Shkumatov AV, 2011, PROTEINS, V79, P2122, DOI 10.1002/prot.23033; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2002, CURR OPIN STRUC BIOL, V12, P654, DOI 10.1016/S0959-440X(02)00363-9; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tossavainen H, 2012, J AM CHEM SOC, V134, P6660, DOI 10.1021/ja2114882; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268	40	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107457	10.1371/journal.pone.0107457	http://dx.doi.org/10.1371/journal.pone.0107457			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243668	Green Published, gold, Green Submitted			2022-12-25	WOS:000343679800033
J	Tian, XH; Fan, J; Yu, M; Zhao, Y; Fang, Y; Bai, SL; Hou, WJ; Tong, H				Tian, Xiaohong; Fan, Jun; Yu, Miao; Zhao, Yu; Fang, Yan; Bai, Shuling; Hou, Weijian; Tong, Hao			Adipose Stem Cells Promote Smooth Muscle Cells to Secrete Elastin in Rat Abdominal Aortic Aneurysm	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE-9; EXPRESSION; MODEL	Background: Abdominal aortic aneurysm (AAA) is a life-threatening disease and its prevalence rate increases with social aging. The degradation of elastic is an important factor in the formation of AAA. Methods: Adipose derived stem cells (ADSCs) and bone marrow mesenchymal stem cells (BMSCs) were isolated from rats, and identified by Oil red O and alizarin red staining after adipogenesis and osteogenesis induction. In addition, ADSCs were also identified by flow cytometry with CD markers. AAA model in rats was established, and smooth muscle cells (SMCs) were isolated from AAA aortic wall and identified by immunohistochemistry. ADSCs or BMSCs were co-cultured with AAA aortic wall for in vitro experiment, and ADSCs were injected into AAA model for in vivo test. Then orcein staining was used for observing the morphology of elastic fiber, Western blot and real-time PCR were used respectively to detect the protein and gene expression of elastin, gelatinases spectrum analysis was used to detect the activity of matrix metalloproteinase-2 (MMP-2) and MMP-9. Results: Lots of red lipid droplets were visible by Oil red O staining after adipogenesis induction, and black calcium nodules appeared by alizarin red staining after osteogenesis induction. The results of flow cytometry showed that ADSCs expressed CD44 and CD105, but exhibited negligible expression of CD31 and CD45. SMCs exhibited spindle-like morphology and alpha-actin protein was positive in cytoplasm. After co-cultured with ADSCs or BMSCs, the elastic fiber recovered normal winding shape, both the gene and protein expression of elastin increased, and the activity of MMP-2 decreased. The in vivo result was similar to that of in vitro. Conclusions: ADSCs promote the expression of elastin in SMCs and contribute to the reconstruction of elastic fiber, which may provide new ideas for treating AAA.	[Tian, Xiaohong; Fan, Jun; Yu, Miao; Bai, Shuling; Hou, Weijian; Tong, Hao] China Med Univ, Coll Basic Med Sci, Dept Tissue Engn, Shenyang, Liaoning, Peoples R China; [Zhao, Yu] China Med Univ, Shengjing Hosp, Dept Plast Surg, Shenyang, Liaoning, Peoples R China; [Fang, Yan] Liaoning Med Univ, Dept Anat, Jinzhou, Liaoning, Peoples R China	China Medical University; China Medical University; Jinzhou Medical University	Bai, SL (corresponding author), China Med Univ, Coll Basic Med Sci, Dept Tissue Engn, Shenyang, Liaoning, Peoples R China.	shuling_bai@126.com	Tian, Xiaohong/AAL-9715-2020		National Natural Science Foundation of China [30772215]; Liaoning Education Department [051525]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Liaoning Education Department	The study was supported by National Natural Science Foundation of China (30772215) and Liaoning Education Department (serial number: 051525). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Collins MJ, 2008, J CLIN PATHOL, V61, P519, DOI 10.1136/jcp.2006.046250; De Bruin JL, 2010, NEW ENGL J MED, V362, P1881, DOI 10.1056/NEJMoa0909499; [樊艳 Fan Yan], 2014, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V18, P900; [房艳 Fang Yan], 2013, [解剖学杂志, Chinese Journal of Anatomy], V36, P896; Fang Y, 2012, INT J MOL MED, V30, P85, DOI 10.3892/ijmm.2012.977; Fu XM, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-175; Gu Yong-quan, 2013, Zhonghua Yi Xue Za Zhi, V93, P644; Hashizume R, 2011, J VASC SURG, V54, P1743, DOI 10.1016/j.jvs.2011.06.109; Hsieh HL, 2004, CELL SIGNAL, V16, P1163, DOI 10.1016/j.cellsig.2004.03.021; Lesauskaite V, 2006, HUM PATHOL, V37, P1076, DOI 10.1016/j.humpath.2006.03.017; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Monaco E, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt7; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; Pezet M, 2008, REJUV RES, V11, P97, DOI 10.1089/rej.2007.0587; Tan Z, 2006, J GUANGXI MED U, V23, P786; Tanaka A, 2009, J VASC SURG, V50, P1423, DOI 10.1016/j.jvs.2009.08.062; Thompson Robert W, 2002, Curr Probl Surg, V39, P110, DOI 10.1067/msg.2002.121421; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang JQ, 2013, PLAST RECONSTR SURG, V131, p174E, DOI 10.1097/PRS.0b013e3182789bb2; Wang YI, 2011, AM J PHYSIOL-HEART C, V300, pH784, DOI 10.1152/ajpheart.01036.2010; Yamashita A, 2001, WORLD J SURG, V25, P259, DOI 10.1007/s002680020062; Yamawaki-Ogata A, 2010, BIOMATERIALS, V31, P9554, DOI 10.1016/j.biomaterials.2010.08.069; Zuo W, 2014, EUR J NEUROSCI, V39, P2107, DOI 10.1111/ejn.12551	23	17	18	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e108105	10.1371/journal.pone.0108105	http://dx.doi.org/10.1371/journal.pone.0108105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243605	Green Submitted, gold, Green Published			2022-12-25	WOS:000343679800068
J	Caboni, P; Liori, B; Kumar, A; Santoru, ML; Asthana, S; Pieroni, E; Fais, A; Era, B; Cacace, E; Ruggiero, V; Atzori, L				Caboni, Pierluigi; Liori, Barbara; Kumar, Amit; Santoru, Maria Laura; Asthana, Shailendra; Pieroni, Enrico; Fais, Antonella; Era, Benedetta; Cacace, Enrico; Ruggiero, Valeria; Atzori, Luigi			Metabolomics Analysis and Modeling Suggest a Lysophosphocholines-PAF Receptor Interaction in Fibromyalgia	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; MOLECULAR-DYNAMICS; TACTILE ALLODYNIA; EXPRESSION; CRITERIA; CLONING; IMPACT; CDNA	Fibromyalgia Syndrome (FMS) is a chronic disease characterized by widespread pain, and difficult to diagnose and treat. We analyzed the plasma metabolic profile of patients with FMS by using a metabolomics approach combining Liquid Chromatography-Quadrupole-Time Of Flight/Mass Spectrometry (LC-Q-TOF/MS) with multivariate statistical analysis, aiming to discriminate patients and controls. LC-Q-TOF/MS analysis of plasma (FMS patients: n = 22 and controls: n = 21) identified many lipid compounds, mainly lysophosphocholines (lysoPCs), phosphocholines and ceramides. Multivariate statistical analysis was performed to identify the discriminating metabolites. A protein docking and molecular dynamic (MD) study was then performed, using the most discriminating lysoPCs, to validate the binding to Platelet Activating Factor (1-alkyl-2acetyl-sn-glycero-3-phosphocholine, PAF) Receptor (PAFr). Discriminating metabolites between FMS patients and controls were identified as 1-tetradecanoyl-sn-glycero-3-phosphocholine [PC(14:0/0:0)] and 1-hexadecanoyl-sn-glycero-3-phosphocholine [PC(16:0/0:0)]. MD and docking indicate that the ligands investigated have similar potentialities to activate the PAFr receptor. The application of a metabolomic approach discriminated FMS patients from controls, with an over-representation of PC(14:0/0:0) and PC(16:0/0:0) compounds in the metabolic profiles. These results and the modeling of metabolite-PAFr interaction, allowed us to hypothesize that lipids oxidative fragmentation might generate lysoPCs in abundance, that in turn will act as PAF-like bioactivators. Overall results suggest disease biomarkers and potential therapeutical targets for FMS.	[Caboni, Pierluigi; Liori, Barbara; Fais, Antonella; Era, Benedetta] Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy; [Kumar, Amit; Santoru, Maria Laura; Asthana, Shailendra; Atzori, Luigi] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [Kumar, Amit; Pieroni, Enrico] CRS4, Biomed Dept, Cagliari, Italy; [Cacace, Enrico; Ruggiero, Valeria] Univ Cagliari, Dept Med Sci Mario Aresu, Cagliari, Italy	University of Cagliari; University of Cagliari; University of Cagliari	Atzori, L (corresponding author), Univ Cagliari, Dept Biomed Sci, Cagliari, Italy.	latzori@unica.it	Kumar, Amit/F-5259-2012; Atzori, Luigi/A-6169-2016	Kumar, Amit/0000-0002-2547-0071; Atzori, Luigi/0000-0002-0606-4959; pieroni, enrico/0000-0002-4246-6963; ERA, BENEDETTA/0000-0002-4154-9740; Ruggiero, Valeria/0000-0002-2550-8703	RAS [LR7/2007, CRP-24879]; University of Cagliari	RAS(Russian Academy of SciencesRegione Sardegna); University of Cagliari	This study was partially supported by the RAS-LR7/2007 [grant number CRP-24879] and University of Cagliari. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altindag O, 2006, REDOX REP, V11, P131, DOI 10.1179/135100006X116628; Belaunzaran OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018268; Bennett R, 2005, CLIN EXP RHEUMATOL, V23, pS154; DEMOPOULOS CA, 1979, J BIOL CHEM, V254, P9355; Dworkin RH, 2005, J RHEUMATOL, V32, P1; Fais A, 2013, CLIN BIOCHEM, V46, P37, DOI 10.1016/j.clinbiochem.2012.09.009; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frisch M., 2016, GAUSSIAN 16 REVISION; GELBARD HA, 1994, J VIROL, V68, P4628, DOI 10.1128/JVI.68.7.4628-4635.1994; Griffin JL, 2011, NAT REV CARDIOL, V8, P630, DOI 10.1038/nrcardio.2011.138; Gui CS, 2007, PROTEINS, V67, P41, DOI 10.1002/prot.21213; Hasegawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010467; Ishii I, 1997, J BIOL CHEM, V272, P7846, DOI 10.1074/jbc.272.12.7846; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; Karabina SA, 2006, BBA-MOL CELL BIOL L, V1761, P1351, DOI 10.1016/j.bbalip.2006.05.008; Kumar A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454125; KUNZ D, 1992, J BIOL CHEM, V267, P9101; Morita K, 2004, PAIN, V111, P351, DOI 10.1016/j.pain.2004.07.016; Morita K, 2008, PAIN, V138, P525, DOI 10.1016/j.pain.2008.01.030; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; NAKAMURA M, 1991, J BIOL CHEM, V266, P20400; Nicholson JK, 2012, NATURE, V491, P384, DOI 10.1038/nature11708; Oestvang J, 2011, J LIPIDS, V2011, DOI 10.1155/2011/532145; Ozgocmen S, 2006, RHEUMATOL INT, V26, P598, DOI 10.1007/s00296-005-0079-y; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; SUBBAIAH PV, 1985, J BIOL CHEM, V260, P5308; Tsoupras AB, 2013, J INORG BIOCHEM, V120, P63, DOI 10.1016/j.jinorgbio.2012.12.004; Tsuda M, 2011, BIOL PHARM BULL, V34, P1159, DOI 10.1248/bpb.34.1159; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weljie AM, 2007, J PROTEOME RES, V6, P3456, DOI 10.1021/pr070123j; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; YE RD, 1991, BIOCHEM BIOPH RES CO, V180, P105, DOI 10.1016/S0006-291X(05)81261-6; Young SP, 2013, ARTHRITIS RHEUM-US, V65, P2015, DOI 10.1002/art.38021	36	39	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107626	10.1371/journal.pone.0107626	http://dx.doi.org/10.1371/journal.pone.0107626			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238064	Green Published, gold, Green Submitted			2022-12-25	WOS:000342491600037
J	Caniattil, MCDL; Marchioro, AA; Guilherme, ALF; Tsuneto, LT				da Costa Lima Caniattil, Marcela Caleffi; Marchioro, Ariella Andrade; Falavigna Guilherme, Ana Lucia; Tsuneto, Luiza Tamie			Association of Cytokines in Individuals Sensitive and Insensitive to Dust Mites in a Brazilian Population	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; TGF-BETA-1 GENE POLYMORPHISMS; HYGIENE HYPOTHESIS; ALLERGIC RHINITIS; IRANIAN PATIENTS; DISEASE; INTERLEUKIN-1-ALPHA; ASTHMA; PREVALENCE; CHILDREN	Introduction: Allergic reaction to dust mites is a relatively common condition among children, triggering cutaneous and respiratory responses that have a great impact on the health of this population. Anaphylactic hypersensitivity is characterized by an exacerbated response involving the production of regulatory cytokines responsible for stimulating the production of IgE antibodies. Objective: To investigate an association of variants in cytokine genes (IL1A(-889), IL1B(-511,) (+3962), IL1R(1970), IL1RA(11100), IL4RA(+1902), IL12(-1188), IFNG(+874), TGFB1(codon 10, codon 25), TNFA(-308,-238), IL2(-330,+166), IL4(-1098,-590,-33), IL6(-174,nt565), and IL10(-1082,-819,-592)) between patients sensitive to dust mites and a control group. Methods: A total of 254 patients were grouped as atopic and non-atopic according to sensitivity as evaluated by the Prick Test and to cytokine genotyping by the polymerase chain reaction-sequence specific primers (PCR-SSP) method using the Cytokine Genotyping Kit. Results: A comparison between individuals allergic to Dermatophagoides farinae, Dermatophagoides pteronyssinus, and Blomia tropicalis and a non-atopic control group showed significant differences between allele and genotype frequencies in the regulatory regions of cytokine genes, with important evidence for IL4(-590) in T/C (10.2% vs. 43.1%, odd ratio [OR] = 0.15, p = 5.2 10(-8), pc = 0.0000011, and 95% confidence interval [95% CI] = 0.07-0.32) and T/T genotypes (42.9% vs. 13.8%, OR = 4.69, p = 2.5 10(-6), pc = 0.000055, and 95% CI = 2.42-9.09). Other associations were observed in the pro-inflammatory cytokines IL1A(-889) (T/T, C, and T) and IL2(-330) (G/T and T/T) and the anti-inflammatory cytokines IL4RA(+1902) (A and G), IL4(-590) (T/C, T/T, C, and T), and IL10(-592) (A/A, C/A, A, and C). Conclusion: Our results suggest a possible association between single nucleotide polymorphisms (SNPs) in cytokine genes and hypersensitivity to dust mites.	[da Costa Lima Caniattil, Marcela Caleffi; Marchioro, Ariella Andrade] Univ Estadual Maringa, Postgrad Program Hlth Sci, Maringa, Parana, Brazil; [Falavigna Guilherme, Ana Lucia; Tsuneto, Luiza Tamie] Univ Estadual Maringa, Dept Basic Hlth Sci, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa	Tsuneto, LT (corresponding author), Univ Estadual Maringa, Dept Basic Hlth Sci, Maringa, Parana, Brazil.	lttsuneto@uem.br			PROAP; Immunogenetics Laboratory of UEM (Laboratorio de Imunogenetica da UEM, LIG-UEM)	PROAP; Immunogenetics Laboratory of UEM (Laboratorio de Imunogenetica da UEM, LIG-UEM)	For the financial resources obtained, the authors would like to thank PROAP and the Immunogenetics Laboratory of UEM (Laboratorio de Imunogenetica da UEM, LIG-UEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Jacob CMA, 2013, CLINICS, V68, P1004, DOI 10.6061/clinics/2013(07)19; Alberto EJC, 2008, PEDIAT ALLERG IMM-UK, V19, P716, DOI 10.1111/j.1399-3038.2007.00709.x; Amirzargar AA, 2006, EUR CYTOKINE NETW, V17, P84; Atambay Metin, 2006, Turkiye Parazitol Derg, V30, P327; Atanasovska-Stojanovska A, 2013, BRATISL MED J, V114, P380, DOI 10.4149/BLL_2013_080; Balakrishnan VS, 2004, KIDNEY INT, V65, P1449, DOI 10.1111/j.1523-1755.2004.00531.x; Barr A, 1999, SAS SOFTWARE VERSION; Baye TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016522; Belanger M, 2011, J NEUROCHEM, V116, P564, DOI 10.1111/j.1471-4159.2010.07135.x; Bidwell J, 1999, GENES IMMUN, V1, P3, DOI 10.1038/sj.gene.6363645; Bush RK, 2009, J ALLERGY CLIN IMMUN, V123, P575, DOI 10.1016/j.jaci.2009.01.062; Celedon JC, 2004, HUM MOL GENET, V13, P1649, DOI 10.1093/hmg/ddh171; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Chelluri EP, 2013, IJRRMS, V3, P5; Chen TY, 2011, HUM IMMUNOL, V72, P603, DOI 10.1016/j.humimm.2011.03.018; Chong WP, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-82; Christensen U, 2006, EUR J HUM GENET, V14, P227, DOI 10.1038/sj.ejhg.5201541; Cianciarullo MA, 2008, J HUM GROWTH DEV, V18, P135; De Jongh CM, 2008, CONTACT DERMATITIS, V58, P269, DOI 10.1111/j.1600-0536.2008.01317.x; De Sario Manuela, 2005, Epidemiol Prev, V29, P86; Du Y, 2000, NEUROLOGY, V55, P480, DOI 10.1212/WNL.55.4.480; Endam LM, 2010, ARCH OTOLARYNGOL, V136, P187, DOI 10.1001/archoto.2009.219; Ertabaklar Hatice, 2006, Turkiye Parazitoloji Dergisi, V30, P29; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FernandezCaldas E, 1997, ALLERGY, V52, P383, DOI 10.1111/j.1398-9995.1997.tb01016.x; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Franceschi Danilo A. S., 2009, Rev. Bras. Hematol. Hemoter., V31, P241; Goedecke V, 2003, GENES IMMUN, V4, P74, DOI 10.1038/sj.gene.6363930; Grimaldi LME, 2000, ANN NEUROL, V47, P361, DOI 10.1002/1531-8249(200003)47:3<361::AID-ANA12>3.3.CO;2-E; GUO SW, 1992, AM J HUM GENET, V51, P1111; Hoffmann SC, 2001, TRANSPLANTATION, V72, P1444, DOI 10.1097/00007890-200110270-00019; Hollegaard MV, 2006, GENES IMMUN, V7, P269, DOI 10.1038/sj.gene.6364301; Hosseini-Farahabadi S, 2007, IRAN J ALLERGY ASTHM, V6, P9; Howson JMM, 2012, DIABETES, V61, P3012, DOI 10.2337/db11-1694; Hunninghake GM, 2008, J ALLERGY CLIN IMMUN, V122, P93, DOI 10.1016/j.jaci.2008.03.015; Hussain SK, 2008, CANCER EPIDEM BIOMAR, V17, P1790, DOI 10.1158/1055-9965.EPI-07-2753; Illig T, 2004, J CLIN ENDOCR METAB, V89, P5053, DOI 10.1210/jc.2004-0355; Jeng JR, 2005, AM J HYPERTENS, V18, P517, DOI 10.1016/j.amjhyper.2004.10.028; Karjalainen J, 2002, J ALLERGY CLIN IMMUN, V110, P429, DOI 10.1067/mai.2002.126784; Kim DS, 2003, J LARYNGOL OTOL, V117, P946, DOI 10.1258/002221503322683812; Landeck L, 2013, J EUR ACAD DERMATOL, V27, P1040, DOI 10.1111/j.1468-3083.2012.04474.x; Lin YJ, 2008, CLIN IMMUNOL, V129, P36, DOI 10.1016/j.clim.2008.05.011; Liu X, 2004, J ALLERGY CLIN IMMUN, V113, P489, DOI 10.1016/j.jaci.2003.12.037; LORD PCW, 1991, J CLIN INVEST, V87, P1312, DOI 10.1172/JCI115134; LOWENTHAL JW, 1985, NATURE, V315, P669, DOI 10.1038/315669a0; Lu MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027363; Maitra A, 2008, THROMB HAEMOSTASIS, V99, P944, DOI 10.1160/TH07-11-0686; Martinez Jimenez Norma E, 2010, Rev Alerg Mex, V57, P3; Medeiros M, 2002, INT ARCH ALLERGY IMM, V129, P237, DOI 10.1159/000066776; Meenagh A, 2002, HUM IMMUNOL, V63, P1055, DOI 10.1016/S0198-8859(02)00440-8; Micheal S, 2013, J INVEST ALLERG CLIN, V23, P107; Miyake Y, 2013, SCAND J IMMUNOL, V77, P413, DOI 10.1111/sji.12043; Morales-de-Leon Guadalupe, 2012, Rev Alerg Mex, V59, P107; Movahedi M, 2013, AM J OTOLARYNG, V34, P676, DOI 10.1016/j.amjoto.2013.05.002; Ngoc LP, 2005, CURR OPIN ALLERGY CL, V5, P161, DOI 10.1097/01.all.0000162309.97480.45; Nicoll JAR, 2000, ANN NEUROL, V47, P365, DOI 10.1002/1531-8249(200003)47:3<365::AID-ANA13>3.0.CO;2-G; Padron-Morales J, 2013, J INVEST ALLERG CLIN, V23, P487; Pastorino AC, 2008, ALLERGOL IMMUNOPATH, V36, P9, DOI 10.1157/13115665; Peden D, 2010, J ALLERGY CLIN IMMUN, V125, pS150, DOI 10.1016/j.jaci.2009.10.073; Petersen A, 1998, CLIN EXP ALLERGY, V28, P315; Postal M, 2013, CYTOKINES, VS1043-4666; Pravica V, 1999, EUR J IMMUNOGENET, V26, P1, DOI 10.1046/j.1365-2370.1999.00122.x; Rao M, 2007, KIDNEY INT, V72, P549, DOI 10.1038/sj.ki.5002391; Read RC, 2000, J INFECT DIS, V182, P1557, DOI 10.1086/315889; Romagnani S, 2004, IMMUNOLOGY, V112, P352, DOI 10.1111/j.1365-2567.2004.01925.x; Sarinho ECS, 2009, ALLERGOL IMMUNOPATH, V37, P239, DOI 10.1016/j.aller.2009.03.009; Shaker OG, 2013, HUM IMMUNOL, VS0198-8859; Sharma S, 2009, AM J RESP CRIT CARE, V179, P356, DOI 10.1164/rccm.200808-1268OC; Shin HD, 2005, ALLERGY, V60, P900, DOI 10.1111/j.1398-9995.2005.00619.x; SMITH KA, 1985, P NATL ACAD SCI USA, V82, P864, DOI 10.1073/pnas.82.3.864; Tahmasebi Z, 2013, RHEUMATOL INT, V33, P2591, DOI 10.1007/s00296-013-2784-2; Thompson Mollie E, 2003, Curr Pain Headache Rep, V7, P342, DOI 10.1007/s11916-003-0032-2; Triola MF, 2003, STATDISK VERSION 8 4; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; VanderMeide PH, 1996, BIOTHERAPY, V8, P243, DOI 10.1007/BF01877210; Vishnumaya CP, 2013, INT J BIOASSAYS, V2, P723; Wallaert B, 2011, RESP ALLERGIES SOINS, V760, P38; WEBER A, 1987, ALLERGY, V42, P464, DOI 10.1111/j.1398-9995.1987.tb00364.x; Wine E, 2013, J CROHNS COLITIS, VS1873-9946; Woolf B., 1995, ANN HUM GENET, V19, P251; World Allergy Organization, 2011, WHO WHIT BOOK ALL EX; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490	82	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107921	10.1371/journal.pone.0107921	http://dx.doi.org/10.1371/journal.pone.0107921			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238536	Green Published, Green Submitted, gold			2022-12-25	WOS:000342491600065
J	Franken, R; Hibender, S; den Hartog, AW; Radonic, T; de Vries, CJM; Zwinderman, AH; Groenink, M; Mulder, BJM; de Waard, V				Franken, Romy; Hibender, Stijntje; den Hartog, Alexander W.; Radonic, Teodora; de Vries, Carlie J. M.; Zwinderman, Aeilko H.; Groenink, Maarten; Mulder, Barbara J. M.; de Waard, Vivian			No Beneficial Effect of General and Specific Anti-Inflammatory Therapies on Aortic Dilatation in Marfan Mice	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ANGIOTENSIN-II; MOUSE MODEL; TGF-BETA; SMAD PATHWAY; ANEURYSM; DOXYCYCLINE; INHIBITION; GROWTH; ROOT	Aims: Patients with Marfan syndrome have an increased risk of life/threatening aortic complications, mostly preceded by aortic dilatation. In the FBN1(C1039G/+) Marfan mouse model, losartan decreases aortic root dilatation. We recently confirmed this beneficial effect of losartan in adult patients with Marfan syndrome. The straightforward translation of this mouse model to man is reassuring to test novel treatment strategies. A number of studies have shown signs of inflammation in aortic tissue of Marfan patients. This study examined the efficacy of anti-inflammatory therapies in attenuating aortic root dilation in Marfan syndrome and compared effects to the main preventative agent, losartan. Methods and Results: To inhibit inflammation in FBN1(C1039G/+) Marfan mice, we treated the mice with losartan (angiotensin II receptor type 1 inhibitor), methylprednisolone (corticosteroid) or abatacept (T-cell-specific inhibitor). Treatment was initiated in adult Marfan mice with already existing aortic root dilatation, and applied for eight weeks. Methylprednisolone- or abatacept-treated mice did not reveal a reduction in aortic root dilatation. In this short time frame, losartan was the only treatment that significantly reduced aorta inflammation, transforming growth factor-beta (TGF-beta) signaling and aortic root dilatation rate in these adult Marfan mice. Moreover, the methylprednisolone-treated mice had significantly more aortic alcian blue staining as a marker for aortic damage. Conclusion: Anti-inflammatory agents do not reduce the aortic dilatation rate in Marfan mice, but possibly increase aortic damage. Currently, the most promising therapeutic drug in Marfan syndrome is losartan, by blocking the angiotensin II receptor type 1 and thereby inhibiting pSmad2 signaling.	[Franken, Romy; den Hartog, Alexander W.; Groenink, Maarten; Mulder, Barbara J. M.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Franken, Romy; den Hartog, Alexander W.; Groenink, Maarten; Mulder, Barbara J. M.] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Hibender, Stijntje; de Vries, Carlie J. M.; de Waard, Vivian] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Radonic, Teodora] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Zwinderman, Aeilko H.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands; [Groenink, Maarten] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	de Waard, V (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	v.dewaard@amc.uva.nl	Radonic, Teodora/HGU-0171-2022	Radonic, Teodora/0000-0002-6015-5202; Franken, Romy/0000-0002-2260-2753; den Hartog, Alexander/0000-0003-1700-9514	AMC;  [2008B115]	AMC; 	The work was supported by the following: grant 2008B115 https://www.hartstichting.nl/downloads/platform-overzicht-universiteit-van-amsterdam (MG); and AMC PhD Scholarship (SH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett D, 2010, J TOXICOL ENV HEAL A, V73, P711, DOI 10.1080/15287391003614018; Carvajal G, 2008, KIDNEY INT, V74, P585, DOI 10.1038/ki.2008.213; Chen XF, 2013, CURR OPIN PHARMACOL, V13, P180, DOI 10.1016/j.coph.2013.01.002; Christensen AD, 2013, CLIN EXP IMMUNOL, V171, P220, DOI 10.1111/cei.12005; Chung AWY, 2008, CIRC RES, V102, pE73, DOI 10.1161/CIRCRESAHA.108.174367; Dai Q, 2007, BRIT J PHARMACOL, V152, P1042, DOI 10.1038/sj.bjp.0707454; de Witte P, 2011, HEART, V97, P2063, DOI 10.1136/heartjnl-2011-300169; Engelfriet PM, 2006, HEART, V92, P1238, DOI 10.1136/hrt.2005.081638; Englesbe MJ, 2003, J VASC SURG, V37, P27, DOI 10.1067/mva.2003.57; Ewing MM, 2013, INT J CARDIOL, V168, P1965, DOI 10.1016/j.ijcard.2012.12.085; Franken R, 2014, NETH HEART J; Franken R, 2012, PROG PEDIATR CARDIOL, V34, P9, DOI 10.1016/j.ppedcard.2012.05.003; Franken R, 2013, INT J CARDIOL, V168, P2441, DOI 10.1016/j.ijcard.2013.03.033; Gomez D, 2013, CIRC RES, V113, P881, DOI 10.1161/CIRCRESAHA.113.301989; Groenink M, 2013, EUR HEART J, V34, P3491, DOI 10.1093/eurheartj/eht334; Guo G, 2006, CIRCULATION, V114, P1855, DOI 10.1161/CIRCULATIONAHA.105.601674; Guo G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020138; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hartog AW, 2012, EXPERT OPIN PHARMACO, V13, P647, DOI 10.1517/14656566.2012.665446; He RM, 2006, J THORAC CARDIOV SUR, V131, P671, DOI 10.1016/j.jtcvs.2005.09.018; Kim HS, 2005, INVEST OPHTH VIS SCI, V46, P840, DOI 10.1167/iovs.04-0929; Kim KL, 2013, CIRC J, V77, P952, DOI 10.1253/circj.CJ-12-0874; Kurakula K, 2013, MOL CELL ENDOCRINOL, V368, P71, DOI 10.1016/j.mce.2012.05.014; Lindeman JHN, 2011, CIRCULATION, V124, pE463, DOI 10.1161/CIRCULATIONAHA.110.008573; Lindeman JHN, 2009, CIRCULATION, V119, P2209, DOI 10.1161/CIRCULATIONAHA.108.806505; Liu Z, 2011, J IMMUNOL, V187, P1506, DOI 10.4049/jimmunol.1004142; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Malhotra N, 2013, IMMUNOLOGY, V139, P1, DOI 10.1111/imm.12076; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; McLoughlin D, 2011, CIRCULATION, V124, pS168, DOI 10.1161/CIRCULATIONAHA.110.012187; Meijboom LJ, 2005, AM J CARDIOL, V96, P1441, DOI 10.1016/j.amjcard.2005.06.094; Meijboom LJ, 2000, INT J CARDIAC IMAG, V16, P161, DOI 10.1023/A:1006429603062; Meijer CA, 2013, ANN INTERN MED, V159, P815, DOI 10.7326/0003-4819-159-12-201312170-00007; Nataatmadja M, 2003, CIRCULATION, V108, P329, DOI 10.1161/01.cir.0000087660.82721.15; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Radonic T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032963; REILLY JM, 1990, ARCH SURG-CHICAGO, V125, P707; Rodriguez-Vita J, 2005, CIRCULATION, V111, P2509, DOI 10.1161/01.CIR.0000165133.84978.E2; Vinh A, 2010, CIRCULATION, V122, P2529, DOI 10.1161/CIRCULATIONAHA.109.930446; Xiong W, 2008, J VASC SURG, V47, P166, DOI 10.1016/j.jvs.2007.09.016; Yang HHC, 2010, J THORAC CARDIOV SUR, V140, P305, DOI 10.1016/j.jtcvs.2009.10.039; Yu Q, 2000, GENE DEV, V14, P163	43	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107221	10.1371/journal.pone.0107221	http://dx.doi.org/10.1371/journal.pone.0107221			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238161	Green Published, Green Submitted, gold			2022-12-25	WOS:000342491600022
J	Hayward, MR; AbuOun, M; La Ragione, RM; Tchorzewska, MA; Cooley, WA; Everest, DJ; Petrovska, L; Jansen, VAA; Woodward, MJ				Hayward, Matthew R.; AbuOun, Manal; La Ragione, Roberto M.; Tchorzewska, Monika A.; Cooley, William A.; Everest, David J.; Petrovska, Liljana; Jansen, Vincent A. A.; Woodward, Martin J.			SPI-23 of S. Derby: Role in Adherence and Invasion of Porcine Tissues	PLOS ONE			English	Article							SALMONELLA-ENTERICA SEROVARS; EPITHELIAL-CELL LINE; IN-VITRO; TYPHIMURIUM INFECTION; HOST ADAPTATION; VIRULENCE	Salmonella enterica serovars Derby and Mbandaka are isolated from different groups of livestock species in the UK. S. Derby is predominantly isolated from pigs and turkeys and S. Mbandaka is predominantly isolated from cattle and chickens. Alignment of the genome sequences of two isolates of each serovar led to the discovery of a new putative Salmonella pathogenicity island, SPI-23, in the chromosome sequence of S. Derby isolates. SPI-23 is 37 kb in length and contains 42 ORFs, ten of which are putative type III effector proteins. In this study we use porcine jejunum derived cell line IPEC-J2 and in vitro organ culture of porcine jejunum and colon, to characterise the association and invasion rates of S. Derby and S. Mbandaka, and tissue tropism of S. Derby respectively. We show that S. Derby invades and associates to an IPEC-J2 monolayer in significantly greater numbers than S. Mbandaka, and that S. Derby preferentially attaches to porcine jejunum over colon explants. We also show that nine genes across SPI-23 are up-regulated to a greater degree in the jejunum compared to the colon explants. Furthermore, we constructed a mutant of the highly up-regulated, pilV-like gene, potR, and find that it produces an excess of surface pili compared to the parent strain which form a strong agglutinating phenotype interfering with association and invasion of IPEC-J2 monolayers. We suggest that potR may play a role in tissue tropism.	[Hayward, Matthew R.; La Ragione, Roberto M.] European Mol Biol Lab, Dept Struct & Computat Biol, Heidelberg, Germany; [Hayward, Matthew R.; AbuOun, Manal; Petrovska, Liljana] Anim Hlth & Vet Labs Agcy, Dept Bacteriol, Addlestone, Surrey, England; [Hayward, Matthew R.; Jansen, Vincent A. A.] Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England; [La Ragione, Roberto M.] Univ Surrey, Fac Hlth & Med Sci, Sch Vet Med, Guildford GU2 5XH, Surrey, England; [Tchorzewska, Monika A.] Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England; [Cooley, William A.; Everest, David J.] Anim Hlth & Vet Labs Agcy, Microscopy Facil, Addlestone, Surrey, England; [Woodward, Martin J.] Univ Reading, Dept Food & Nutr Sci, Reading, Berks, England	European Molecular Biology Laboratory (EMBL); Veterinary Laboratories Agency; University of London; Royal Holloway University London; University of Surrey; University of Bristol; Veterinary Laboratories Agency; University of Reading	Hayward, MR (corresponding author), European Mol Biol Lab, Dept Struct & Computat Biol, Heidelberg, Germany.	hayward@embl.de	La Ragione, Roberto M/Q-9916-2017; Petrovska, Liljana/D-7319-2011	La Ragione, Roberto M/0000-0001-5861-613X; Jansen, Vincent A.A./0000-0002-6518-2090	Engineering and Physical Sciences Research Council (EPSRC); Animal Health and Veterinary Laboratories Agency (AHVLA); Biotechnology and Biological Sciences Research Council (BBSRC) partners of the ERASysBio+ initiative under the EU ERA-NET Plus scheme in FP7 [BB/I004548/1]; Biotechnology and Biological Sciences Research Council [BB/I004548/1] Funding Source: researchfish; BBSRC [BB/I004548/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Animal Health and Veterinary Laboratories Agency (AHVLA); Biotechnology and Biological Sciences Research Council (BBSRC) partners of the ERASysBio+ initiative under the EU ERA-NET Plus scheme in FP7(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Engineering and Physical Sciences Research Council (EPSRC) www.epsrc.ac.uk 4 year studentship awarded to MRH. Animal Health and Veterinary Laboratories Agency (AHVLA) http://www.defra.gov.uk/ahvla-en/ seedcorn internal investment fund to MRH. Biotechnology and Biological Sciences Research Council (BBSRC) partners of the ERASysBio+ initiative supported under the EU ERA-NET Plus scheme in FP7 www.bbsrc.ac.uk BB/I004548/1 to VAAJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHVLA DEFRA, 2011, ANN REPORT; Baumler AJ, 1998, INFECT IMMUN, V66, P4579; CDC PHLIS, 2010, SALM ANN SURV 2009, V2010; Center for Disease Control and Prevention (CDC), 2011, NAT ENT DIS SURV SAL; Collins JW, 2010, APPL ENVIRON MICROB, V76, P6645, DOI 10.1128/AEM.03115-09; Green BT, 2006, VET MICROBIOL, V113, P117, DOI 10.1016/j.vetmic.2005.10.022; Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004; Hayward MR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-365; HOBEN DA, 1973, APPL MICROBIOL, V26, P126, DOI 10.1128/AEM.26.1.126-127.1973; Kingsley RA, 2000, MOL MICROBIOL, V36, P1006, DOI 10.1046/j.1365-2958.2000.01907.x; Lopez-Garrido J, 2010, GENETICS, V184, P637, DOI 10.1534/genetics.109.108985; Morris C, 2003, INFECT IMMUN, V71, P1141, DOI 10.1128/IAI.71.3.1141-1146.2003; Paulin SM, 2002, INFECT IMMUN, V70, P6788, DOI 10.1128/IAI.70.12.6788-6797.2002; Samudrala R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000375; Santos RL, 2009, TRENDS MICROBIOL, V17, P498, DOI 10.1016/j.tim.2009.08.008; Schierack P, 2006, HISTOCHEM CELL BIOL, V125, P293, DOI 10.1007/s00418-005-0067-z; Schmidt LD, 2008, COMP IMMUNOL MICROB, V31, P63, DOI 10.1016/j.cimid.2007.04.003; Searle LEJ, 2009, J MED MICROBIOL, V58, P37, DOI 10.1099/jmm.0.004390-0; Seth-Smith HMB, 2008, J INFECT DEV COUNTR, V2, P267, DOI 10.3855/jidc.220; Suar M, 2006, INFECT IMMUN, V74, P632, DOI 10.1128/IAI.74.1.632-644.2006; Tam CKP, 2006, INFECT IMMUN, V74, P5414, DOI 10.1128/IAI.00172-06; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; Watson PR, 2000, MICROBIOL-UK, V146, P1639, DOI 10.1099/00221287-146-7-1639; White AP, 2008, INFECT IMMUN, V76, P1048, DOI 10.1128/IAI.01383-07; WOOD RL, 1989, AM J VET RES, V50, P1015	25	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107857	10.1371/journal.pone.0107857	http://dx.doi.org/10.1371/journal.pone.0107857			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238397	Green Submitted, gold, Green Published			2022-12-25	WOS:000342491600056
J	Li, GY; Wang, XQ; Hibshoosh, H; Jin, C; Halmos, B				Li, Guangyuan; Wang, Xiaoqi; Hibshoosh, Hanina; Jin, Cheng; Halmos, Balazs			Modulation of ErbB2 Blockade in ErbB2-Positive Cancers: The Role of ErbB2 Mutations and PHLDA1	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; HUMAN-BREAST-CANCER; IN-SITU HYBRIDIZATION; LUNG-CANCER; LAPATINIB RESISTANCE; GENE AMPLIFICATION; SOMATIC MUTATIONS; DOWN-REGULATION; CELL CARCINOMA; EXPRESSION	We set out to study the key effectors of resistance and sensitivity to ErbB2 tyrosine kinase inhibitors, such as lapatinib in ErbB2-positive breast and lung cancers. A cell-based in vitro site-directed mutagenesis lapatinib resistance model identified several mutations, including the gatekeeper ErbB2 mutation ErbB2-T798I, as mediating resistance. ErbB2-T798I engineered cell models indeed show resistance to lapatinib but remain sensitive to the irreversible EGFR/ErbB2 inhibitor, PD168393, suggestive of potential alternative treatment strategies to overcome resistance. Gene expression profiling studies identified a select group of downstream targets regulated by ErbB2 signaling and define PHLDA1 as an immediately downregulated gene upon oncogenic ErbB2 signaling inhibition. We find significant down-regulation of PHLDA1 in primary breast cancer and PHLDA1 is statistically significantly less expressed in ErbB2 negative compared with ErbB2 positive tumors consistent with its regulation by ErbB2. Lastly, PHLDA1 overexpression blocks AKT signaling, inhibits cell growth and enhances lapatinib sensitivity further supporting an important negative growth regulator function. Our findings suggest that PHLDA1 might have key inhibitory functions in ErbB2 driven lung and breast cancer cells and a better understanding of its functions might point at novel therapeutic options. In summary, our studies define novel ways of modulating sensitivity and resistance to ErbB2 inhibition in ErbB2-dependent cancers.	[Li, Guangyuan] Case Western Reserve Univ, Dept Pathol, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Li, Guangyuan; Wang, Xiaoqi; Jin, Cheng; Halmos, Balazs] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Div Hematol Oncol, New York, NY 10027 USA; [Hibshoosh, Hanina] Columbia Univ, Med Ctr, Dept Pathol, New York, NY USA	Case Western Reserve University; Case Western Reserve University Hospital; Columbia University; Columbia University	Halmos, B (corresponding author), Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Div Hematol Oncol, New York, NY 10027 USA.	bh2376@columbia.edu			American Cancer Society [RSG-08-303-01-TBE]; NIH/National Cancer Institute Specialized Program of Research Excellence in Human Lung Cancer grant [P50 CA90578-04]; NATIONAL CANCER INSTITUTE [P50CA090578] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NIH/National Cancer Institute Specialized Program of Research Excellence in Human Lung Cancer grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the American Cancer Society (grant No RSG-08-303-01-TBE to BH) and NIH/National Cancer Institute Specialized Program of Research Excellence in Human Lung Cancer grant P50 CA90578-04 (BH). Histopathology assistance was provided by the Molecular Pathology Shared Resource, Herbert Irving Comprehensive Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin DN, 2004, ONCOGENE, V23, P1428, DOI 10.1038/sj.onc.1207257; Antonescu CR, 2005, CLIN CANCER RES, V11, P4182, DOI 10.1158/1078-0432.CCR-04-2245; Burris HA, 2004, ONCOLOGIST, V9, P10, DOI 10.1634/theoncologist.9-suppl_3-10; Callahan R, 2011, CURR OPIN OBSTET GYN, V23, P37, DOI 10.1097/GCO.0b013e3283414e87; Carlisle RE, 2012, AM J PHYSIOL-RENAL, V303, pF467, DOI 10.1152/ajprenal.00481.2011; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Doebele RC, 2010, LUNG CANCER, V69, P1, DOI 10.1016/j.lungcan.2009.12.009; Frank D, 1999, MAMM GENOME, V10, P1150, DOI 10.1007/s003359901182; Johnson EO, 2011, J CELL SCI, V124, P2711, DOI 10.1242/jcs.084970; Kakiuchi S, 2004, HUM MOL GENET, V13, P3029, DOI 10.1093/hmg/ddh331; Kancha RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026760; Kawase T, 2009, CELL, V136, P535, DOI 10.1016/j.cell.2008.12.002; Kobayashi S, 2006, CANCER RES, V66, P11389, DOI 10.1158/0008-5472.CAN-06-2318; Lee JW, 2006, CANCER LETT, V237, P89, DOI 10.1016/j.canlet.2005.05.026; Lee JW, 2006, CLIN CANCER RES, V12, P57, DOI 10.1158/1078-0432.CCR-05-0976; Liu L, 2009, CANCER RES, V69, P6871, DOI 10.1158/0008-5472.CAN-08-4490; Nagai MA, 2007, BREAST CANCER RES TR, V106, P49, DOI 10.1007/s10549-006-9475-6; Neef R, 2002, CANCER RES, V62, P5920; Oberg HH, 2004, CELL DEATH DIFFER, V11, P674, DOI 10.1038/sj.cdd.4401407; Pauletti G, 1996, ONCOGENE, V13, P63; Rexer BN, 2013, CLIN CANCER RES, V19, P5390, DOI 10.1158/1078-0432.CCR-13-1038; Sakthianandeswaren A, 2011, CANCER RES, V71, P3709, DOI 10.1158/0008-5472.CAN-10-2342; Santin AD, 2008, INT J GYNECOL OBSTET, V102, P128, DOI 10.1016/j.ijgo.2008.04.008; Sellheyer K, 2012, BRIT J DERMATOL, V166, P88, DOI 10.1111/j.1365-2133.2011.10612.x; Sellheyer K, 2012, J CUTAN PATHOL, V39, P835, DOI 10.1111/j.1600-0560.2012.01949.x; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Shousha S, 2009, HISTOPATHOLOGY, V54, P248, DOI 10.1111/j.1365-2559.2008.03185.x; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Storey John D, 2003, Methods Mol Biol, V224, P149; Trowe T, 2008, CLIN CANCER RES, V14, P2465, DOI 10.1158/1078-0432.CCR-07-4367; Xia W, 2006, P NATL ACAD SCI USA, V103, P7795, DOI 10.1073/pnas.0602468103; Xia WL, 2002, ONCOGENE, V21, P6255, DOI 10.1038/sj.onc.1205794; Yu Z, 2007, CANCER RES, V67, P10417, DOI 10.1158/0008-5472.CAN-07-1248; Zhang ZF, 2010, CARCINOGENESIS, V31, P577, DOI 10.1093/carcin/bgq020	36	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e106349	10.1371/journal.pone.0106349	http://dx.doi.org/10.1371/journal.pone.0106349			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238247	gold, Green Published, Green Submitted			2022-12-25	WOS:000342491600007
J	Martin, FA; McLoughlin, A; Rochfort, KD; Davenport, C; Murphy, RP; Cummins, PM				Martin, Fiona A.; McLoughlin, Alisha; Rochfort, Keith D.; Davenport, Colin; Murphy, Ronan P.; Cummins, Philip M.			Regulation of Thrombomodulin Expression and Release in Human Aortic Endothelial Cells by Cyclic Strain	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SHEAR-STRESS; SERUM THROMBOMODULIN; OXIDATIVE STRESS; VASCULAR-TONE; GROWTH-FACTOR; OXIDIZED LDL; TNF-ALPHA; IN-VIVO; ACTIVATION	Background and Objectives: Thrombomodulin (TM), an integral membrane glycoprotein expressed on the lumenal surface of vascular endothelial cells, promotes anti-coagulant and anti-inflammatory properties. Release of functional TM from the endothelium surface into plasma has also been reported. Much is still unknown however about how endothelial TM is regulated by physiologic hemodynamic forces (and particularly cyclic strain) intrinsic to endothelial-mediated vascular homeostasis. Methods: This study employed human aortic endothelial cells (HAECs) to investigate the effects of equibiaxial cyclic strain (7.5%, 60 cycles/min, 24 hrs), and to a lesser extent, laminar shear stress (10 dynes/cm(2), 24 hrs), on TM expression and release. Time-, dose-and frequency-dependency studies were performed. Results: Our initial studies demonstrated that cyclic strain strongly downregulated TM expression in a p38-and receptor tyrosine kinase-dependent manner. This was in contrast to the upregulatory effect of shear stress. Moreover, both forces significantly upregulated TM release over a 48 hr period. With continuing focus on the cyclic strain-induced TM release, we noted both dose (0-7.5%) and frequency (0.5-2.0 Hz) dependency, with no attenuation of strain-induced TM release observed following inhibition of MAP kinases (p38, ERK-1/2), receptor tyrosine kinase, or eNOS. The concerted impact of cyclic strain and inflammatory mediators on TM release from HAECs was also investigated. In this respect, both TNF alpha (100 ng/ml) and ox-LDL (10-50 mu g/ml) appeared to potentiate strain-induced TM release. Finally, inhibition of neither MMPs (GM6001) nor rhomboids (3,4-dichloroisocoumarin) had any effect on strain-induced TM release. However, significantly elevated levels (2.1 fold) of TM were observed in isolated microparticle fractions following 7.5% strain for 24 hrs. Conclusions: A preliminary in vitro investigation into the effects of cyclic strain on TM in HAECs is presented. Physiologic cyclic strain was observed to downregulate TM expression, whilst upregulating in a time-, dose-and frequency-dependent manner the release of TM.	[Martin, Fiona A.; McLoughlin, Alisha; Rochfort, Keith D.; Davenport, Colin; Cummins, Philip M.] Dublin City Univ, Sch Biotechnol, Dublin 9, Ireland; [Murphy, Ronan P.] Dublin City Univ, Sch Hlth & Human Performance, Dublin 9, Ireland; [Murphy, Ronan P.; Cummins, Philip M.] Dublin City Univ, Ctr Prevent Med, Dublin 9, Ireland	Dublin City University; Dublin City University; Dublin City University	Cummins, PM (corresponding author), Dublin City Univ, Sch Biotechnol, Dublin 9, Ireland.	phil.cummins@dcu.ie	Rochfort, Keith/R-7009-2019; Murphy, Ronan P./V-6697-2019	Rochfort, Keith/0000-0003-1198-5952; Murphy, Ronan P./0000-0002-4579-8007; Davenport, Colin/0000-0001-6854-6147	National Development Plan/Higher Education Authority of Ireland	National Development Plan/Higher Education Authority of Ireland	This work was funded by the National Development Plan/Higher Education Authority of Ireland Programme for Research in Third Level Institutes - HEA/PRTLI Cycle 4; T3/Targeted Therapeutics & Theranostics (PMC), and the National Development Plan/Higher Education Authority of Ireland Programme for Research in Third Level Institutes - HEA/PRTLI Cycle 5; BioAT - BioAnalysis and Therapeutics (PMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi M, 2006, J ORTHOP RES, V24, P1782, DOI 10.1002/jor.20211; Ando J, 2011, ANTIOXID REDOX SIGN, V15, P1389, DOI 10.1089/ars.2010.3361; Bartzeliotou AI, 2007, CLIN BIOCHEM, V40, P765, DOI 10.1016/j.clinbiochem.2007.01.013; Boehme MWJ, 1996, IMMUNOLOGY, V87, P134; Chen SC, 2008, ACTA CARDIOL SIN, V24, P144; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chu M, 1998, THROMB HAEMOSTASIS, V80, P119, DOI 10.1055/s-0037-1615150; David-Dufilho M, 2005, J BIOL CHEM, V280, P35999, DOI 10.1074/jbc.M506374200; Dekker RJ, 2002, BLOOD, V100, P1689, DOI 10.1182/blood-2002-01-0046; Dekker RJ, 2005, AM J PATHOL, V167, P609, DOI 10.1016/S0002-9440(10)63002-7; Dharmasaroja P, 2012, CLIN APPL THROMB-HEM, V18, P289, DOI 10.1177/1076029611432744; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; Fitzpatrick PA, 2009, INT J BIOCHEM CELL B, V41, P2287, DOI 10.1016/j.biocel.2009.05.011; Groen H C, 2008, Neth Heart J, V16, P280; Guinan AF, 2013, CARDIOVASC RES, V99, P545, DOI 10.1093/cvr/cvt127; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Hendrickson RJ, 1999, J PHARMACOL EXP THER, V289, P1293; Hong SC, 2008, INT J CARDIOL, V123, P180, DOI 10.1016/j.ijcard.2006.11.111; Hosaka Y, 1998, THROMB HAEMOSTASIS, V79, P371, DOI 10.1055/s-0037-1614994; Hsu HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004853; Ishibazawa A, 2011, INVEST OPHTH VIS SCI, V52, P8496, DOI 10.1167/iovs.11-7686; Ishii H, 2003, BLOOD, V101, P4765, DOI 10.1182/blood-2002-08-2428; Jay MT, 1997, EXP PHYSIOL, V82, P349, DOI 10.1113/expphysiol.1997.sp004030; Kario K, 2007, HYPERTENSION, V49, P771, DOI 10.1161/01.HYP.0000259736.67231.18; Lacroix R, 2007, BLOOD, V110, P2432, DOI 10.1182/blood-2007-02-069997; Lacroix R, 2012, HAEMATOL-HEMATOL J, V97, P1864, DOI 10.3324/haematol.2012.066167; Latham SL, 2013, FASEB J, V27, P672, DOI 10.1096/fj.12-216531; Li C, 2002, J AM COLL CARDIOL, V39, P1852, DOI 10.1016/S0735-1097(02)01873-9; Li YH, 2007, THROMB HAEMOSTASIS, V97, P658, DOI 10.1160/TH06-12-0690; Lin PY, 2010, J THROMB THROMBOLYS, V29, P52, DOI 10.1007/s11239-009-0318-2; Lin SM, 2008, CRIT CARE MED, V36, P683, DOI 10.1097/CCM.0B013E31816537D8; Lohi O, 2004, CURR BIOL, V14, P236, DOI 10.1016/j.cub.2004.01.025; MacGregor IR, 1997, AM J RESP CRIT CARE, V155, P47, DOI 10.1164/ajrccm.155.1.9001288; Martin FA, 2013, AM J PHYSIOL-HEART C, V304, pH1585, DOI 10.1152/ajpheart.00096.2013; Matsushita H, 2001, J CELL BIOCHEM, P99; Nan BC, 2005, THROMB RES, V115, P417, DOI 10.1016/j.thromres.2004.10.010; Porreca E, 2004, ATHEROSCLEROSIS, V175, P139, DOI 10.1016/j.atherosclerosis.2004.03.010; REDL H, 1995, J INFECT DIS, V171, P1522, DOI 10.1093/infdis/171.6.1522; Rochfort KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101815; Rossi J, 2010, LIFE SCI, V87, P92, DOI 10.1016/j.lfs.2010.05.008; Rousseau A, 2009, EUR J OBSTET GYN R B, V146, P46, DOI 10.1016/j.ejogrb.2009.06.001; Satta N, 1997, BRIT J HAEMATOL, V96, P534, DOI 10.1046/j.1365-2141.1997.d01-2059.x; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sperry JL, 2003, CIRC RES, V92, P41, DOI 10.1161/01.RES.0000048196.11060.A0; Suzuma I, 2001, DIABETES, V50, P444, DOI 10.2337/diabetes.50.2.444; Sweeney NV, 2004, BIOCHEM BIOPH RES CO, V320, P325, DOI 10.1016/j.bbrc.2004.05.174; TAKADA Y, 1994, BIOCHEM BIOPH RES CO, V205, P1345, DOI 10.1006/bbrc.1994.2813; TEASDALE MS, 1994, IMMUNOL CELL BIOL, V72, P480, DOI 10.1038/icb.1994.72; Thacher TN, 2010, J VASC RES, V47, P336, DOI 10.1159/000265567; Tineli Rafael Angelo, 2007, Rev Bras Cir Cardiovasc, V22, P87; Vion AC, 2013, PULM CIRC, V3, P95, DOI 10.4103/2045-8932.109921; Vion AC, 2013, CIRC RES, V112, P1323, DOI 10.1161/CIRCRESAHA.112.300818; Vischer UM, 2000, ARTERIOSCL THROM VAS, V20, P883, DOI 10.1161/01.ATV.20.3.883; Wang DS, 2001, ENDOTHELIUM-NEW YORK, V8, P283, DOI 10.3109/10623320109090806; Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z; Weiss C, 1998, MED SCI SPORT EXER, V30, P1205, DOI 10.1097/00005768-199808000-00004; Wolf EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072307; Wu CT, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-375; Wu HL, 2008, BIOCHEM BIOPH RES CO, V367, P162, DOI 10.1016/j.bbrc.2007.12.135; Zhang ZY, 2013, CELL SIGNAL, V25, P332, DOI 10.1016/j.cellsig.2012.10.006; Zycinska K, 2009, EUR J MED RES, V14, P268, DOI 10.1186/2047-783X-14-S4-268	61	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e108254	10.1371/journal.pone.0108254	http://dx.doi.org/10.1371/journal.pone.0108254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238231	Green Published, Green Submitted, gold			2022-12-25	WOS:000342491600087
J	Morwood, CJ; Lappas, M				Morwood, Carrington J.; Lappas, Martha			The Citrus Flavone Nobiletin Reduces Pro-Inflammatory and Pro-Labour Mediators in Fetal Membranes and Myometrium: Implications for Preterm Birth	PLOS ONE			English	Article							HUMAN GESTATIONAL TISSUES; TUMOR-NECROSIS-FACTOR; FACTOR-KAPPA-B; PREMATURE RUPTURE; MATRIX METALLOPROTEINASES; OXIDATIVE STRESS; MESSENGER-RNA; INFECTION; RISK; MATRIX-METALLOPROTEINASE-9	Spontaneous preterm birth is the leading cause of infant death and of neurological disabilities in survivors. A significant proportion of spontaneous preterm births are associated with infection. Infection activates inflammation which induces a cascade of events that leads to myometrial contractions and rupture of fetal membranes. In non-gestational tissues, the citrus flavone nobiletin has been shown to exert potent anti-inflammatory properties. Thus, in this study, we sought to determine the effect of nobiletin on pro-inflammatory mediators in human fetal membranes and myometrium. Human fetal membranes and myometrium were treated with bacterial endotoxin lipopolysaccharide (LPS) in the absence or presence of nobiletin. In addition, the effect of nobiletin in fetal membranes taken from spontaneous preterm deliveries with and without infection (i.e. histological chorioamnionitis) was also examined. In human fetal membranes and myometrium, nobiletin significantly decreased LPS-stimulated expression of pro-inflammatory cytokines (TNF-alpha, IL-1 beta, IL-6 and IL-8) and MMP-9 expression and pro-MMP-9 secretion. Additionally, nobiletin significantly decreased COX-2 expression and subsequent prostaglandin (PG) E-2 production. Notably, nobiletin was also able to reduce the expression and production of pro-inflammatory cytokines and MMP-9 in fetal membranes taken from women after spontaneous preterm birth. In conclusion, our study demonstrates that nobiletin can reduce infection-induced pro-inflammatory mediators in human fetal membranes and myometrium. These in vitro studies further support the increasing volume and quality of evidence that high fruit and vegetable intake in pregnancy is associated with a decreased risk of adverse pregnancy outcomes.	[Morwood, Carrington J.; Lappas, Martha] Mercy Hosp Women, Mercy Perinatal Res Ctr, Heidelberg, Vic, Australia; [Morwood, Carrington J.; Lappas, Martha] Univ Melbourne, Dept Obstet & Gynaecol, Obstet Nutr & Endocrinol Grp, Melbourne, Vic 3010, Australia	University of Melbourne	Lappas, M (corresponding author), Mercy Hosp Women, Mercy Perinatal Res Ctr, Heidelberg, Vic, Australia.	mlappas@unimelb.edu.au			National Health and Medical Research Council [1047025]; Medical Research Foundation for Women and Babies	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Foundation for Women and Babies	Associate Professor Martha Lappas is supported by a Career Development Fellowship from the National Health and Medical Research Council, grant no. 1047025 (http://www.nhmrc.gov.aul. This work was supported by the Medical Research Foundation for Women and Babies (http://www.mrfwb.org.aul. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asemi Z, 2013, NUTRITION, V29, P619, DOI 10.1016/j.nut.2012.11.020; Assini JM, 2013, CURR OPIN LIPIDOL, V24, P34, DOI 10.1097/MOL.0b013e32835c07fd; Baek SH, 2012, PHARM BIOL, V50, P1210, DOI 10.3109/13880209.2012.664151; Bashiri A, 2006, J PERINAT MED, V34, P5, DOI 10.1515/JPM.2006.001; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Brown AS, 2009, AM J PSYCHIAT, V166, P683, DOI 10.1176/appi.ajp.2008.08010089; Chappell LC, 2013, BMJ, V347; Chappell LC, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6398; Choi SJ, 2007, EUR J OBSTET GYN R B, V132, P182, DOI 10.1016/j.ejogrb.2006.07.024; Christiaens I, 2008, J REPROD IMMUNOL, V79, P50, DOI 10.1016/j.jri.2008.04.002; COLLIN R, 1989, CLIN LAB HAEMATOL, V11, P156, DOI 10.1111/j.1365-2257.1989.tb00200.x; Cui YJ, 2010, BIOL PHARM BULL, V33, P1814, DOI 10.1248/bpb.33.1814; Elovitz MA, 2004, TRENDS ENDOCRIN MET, V15, P479, DOI 10.1016/j.tem.2004.10.009; Englund-Ogge L, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1446; French JI, 1996, SEMIN PERINATOL, V20, P344, DOI 10.1016/S0146-0005(96)80002-4; Gibb W, 1996, J ENDOCRINOL, V150, P497, DOI 10.1677/joe.0.1500497; Gibb W, 1998, ANN MED, V30, P235, DOI 10.3109/07853899809005850; Gibb W, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P2925; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gotsch F, 2009, J MATERN-FETAL NEO M, V22, P5, DOI 10.1080/14767050902860690; Haas DM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6226; Hodek JM, 2010, ACTA PAEDIATR, V99, P98; Hodgson EJ, 2010, PRETERM BIRTH PREVEN, pxiv; Ishiwa J, 2000, J RHEUMATOL, V27, P20; Jang SE, 2013, INT IMMUNOPHARMACOL, V17, P502, DOI 10.1016/j.intimp.2013.07.012; Jung UJ, 2006, INT J BIOCHEM CELL B, V38, P1134, DOI 10.1016/j.biocel.2005.12.002; Kawaii S, 1999, BIOSCI BIOTECH BIOCH, V63, P896, DOI 10.1271/bbb.63.896; Keelan JA, 2003, PLACENTA, V24, pS33, DOI 10.1053/plac.2002.0948; Keelan JA, 2001, PROSTAG OTH LIPID M, V66, P265, DOI 10.1016/S0090-6980(01)00164-2; Lappas M, 2004, J CLIN ENDOCR METAB, V89, P2365, DOI 10.1210/jc.2003-031385; Lappas M, 2002, J CLIN ENDOCR METAB, V87, P4667, DOI 10.1210/jc.2002-020613; Lappas M, 2011, BIOL REPROD, V84, P167, DOI 10.1095/biolreprod.110.086983; Li SM, 2009, J FUNCT FOODS, V1, P2, DOI 10.1016/j.jff.2008.09.003; Lim R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092505; Lim R, 2013, MOL HUM REPROD, V19, P451, DOI 10.1093/molehr/gat015; Lin N, 2003, BIOCHEM PHARMACOL, V65, P2065, DOI 10.1016/S0006-2952(03)00203-X; LYE SJ, 1990, J REPROD FERTIL, V90, P483, DOI 10.1530/jrf.0.0900483; MATSUZAKI N, 1993, AM J OBSTET GYNECOL, V168, P94, DOI 10.1016/S0002-9378(12)90892-3; McCowan LME, 2010, BJOG-INT J OBSTET GY, V117, P1599, DOI 10.1111/j.1471-0528.2010.02737.x; McLaren J, 2000, MOL HUM REPROD, V6, P1033, DOI 10.1093/molehr/6.11.1033; Meissner A, 1999, MOL HUM REPROD, V5, P252, DOI 10.1093/molehr/5.3.252; Menon R, 2004, J SOC GYNECOL INVEST, V11, P427, DOI 10.1016/j.jsgi.2004.04.001; Menon R, 2007, BEST PRACT RES CL OB, V21, P467, DOI 10.1016/j.bpobgyn.2007.01.008; Mikkelsen TB, 2008, ACTA OBSTET GYN SCAN, V87, P325, DOI 10.1080/00016340801899347; Minagawa A, 2001, JPN J CANCER RES, V92, P1322, DOI 10.1111/j.1349-7006.2001.tb02156.x; Mitchell BF, 2004, PROSTAG LEUKOTR ESS, V70, P167, DOI 10.1016/j.plefa.2003.04.006; Murakami A, 2000, CANCER RES, V60, P5059; Murakami A, 2001, BIOSCI BIOTECH BIOCH, V65, P194, DOI 10.1271/bbb.65.194; Myhre R, 2013, J NUTR, V143, P1100, DOI 10.3945/jn.112.173229; Norman JE, 2013, LANCET, V381, P184, DOI 10.1016/S0140-6736(12)61956-4; North RA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1875; OLSON DM, 1995, SEMIN PERINATOL, V19, P52, DOI 10.1016/S0146-0005(95)80047-6; Ou M., 1999, REGULAR CHINESE MED; Parry S, 1998, NEW ENGL J MED, V338, P663, DOI 10.1056/NEJM199803053381006; Potijk MR, 2012, ARCH DIS CHILD, V97, P112, DOI 10.1136/adc.2011.300131; Roh CR, 2000, MOL HUM REPROD, V6, P96, DOI 10.1093/molehr/6.1.96; ROMERO R, 1994, ANN NY ACAD SCI, V734, P414, DOI 10.1111/j.1749-6632.1994.tb21771.x; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; ROMERO R, 1988, CLIN OBSTET GYNECOL, V31, P553, DOI 10.1097/00003081-198809000-00006; ROMERO R, 1989, AM J OBSTET GYNECOL, V161, P336, DOI 10.1016/0002-9378(89)90515-2; Romero R, 2001, PAEDIATR PERINAT EP, V15, P41, DOI 10.1046/j.1365-3016.2001.00007.x; Rovira N, 2011, EARLY HUM DEV, V87, P253, DOI 10.1016/j.earlhumdev.2011.01.024; Roza JM, 2007, ALTERN THER HEALTH M, V13, P44; Russell RB, 2007, PEDIATRICS, V120, pE1, DOI 10.1542/peds.2006-2386; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; St-Louis I, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-103; Tsatas D, 1999, J REPROD FERTIL, V116, P43; Tu FF, 1998, OBSTET GYNECOL, V92, P446, DOI 10.1016/S0029-7844(98)00222-1; Vadillo-Ortega F, 2005, BJOG-INT J OBSTET GY, V112, P19, DOI 10.1111/j.1471-0528.2005.00579.x; VadilloOrtega F, 1996, AM J OBSTET GYNECOL, V174, P1371, DOI 10.1016/S0002-9378(96)70687-7; VanMeir CAV, 1997, PLACENTA, V18, P109, DOI 10.1016/S0143-4004(97)90081-3; Wall C, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/485201; Walle T, 2007, MOL PHARMACEUT, V4, P826, DOI 10.1021/mp700071d; Walle T, 2007, SEMIN CANCER BIOL, V17, P354, DOI 10.1016/j.semcancer.2007.05.002; Walle T, 2007, BIOCHEM PHARMACOL, V73, P1288, DOI 10.1016/j.bcp.2006.12.028; Weiss A, 2007, FRONT BIOSCI-LANDMRK, V12, P649, DOI 10.2741/2089; Weissenbacher T, 2013, ARCH GYNECOL OBSTET, V287, P673, DOI 10.1007/s00404-012-2629-3	77	22	25	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e108390	10.1371/journal.pone.0108390	http://dx.doi.org/10.1371/journal.pone.0108390			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238390	gold, Green Submitted, Green Published			2022-12-25	WOS:000342491600096
J	Su, CH; McStay, GP; Tzagoloff, A				Su, Chen-Hsien; McStay, Gavin P.; Tzagoloff, Alexander			Assembly of the Rotor Component of Yeast Mitochondrial ATP Synthase Is Enhanced When Atp9p Is Supplied by Atp9p-Cox6p Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; SACCHAROMYCES-CEREVISIAE; NUCLEAR GENE; ESCHERICHIA-COLI; OXIDATIVE-PHOSPHORYLATION; ADENOSINE TRIPHOSPHATASE; MESSENGER-RNA; NATIVE PAGE; SUBUNIT; TRANSLATION	The Atp9p ring is one of several assembly modules of yeast mitochondrial ATP synthase. The ring, composed of 10 copies of Atp9p, is part of the rotor that couples proton translocation to synthesis or hydrolysis of ATP. We present evidence that before its assembly with other ATP synthase modules, most of Atp9p is present in at least three complexes with masses of 200-400 kDa that co-immunopurify with Cox6p. Pulse-labeling analysis disclosed a time-dependent reduction of radiolabeled Atp9p in the complexes and an increase of Atp9p in the ring form of wild type yeast and of mss51, pet111, and pet494 mutants lacking Cox1p, Cox2p, and Cox3p, respectively. Ring formation was not significantly different from wild type in an mss51 or atp10 mutant. The atp10 mutation blocks the interaction of the Atp9p ring with other modules of the ATP synthase. In contrast, ring formation was reduced in a cox6 mutant, consistent with a role of Cox6p in oligomerization of Atp9p. Cox6p involvement in ATP synthase assembly is also supported by studies showing that ring formation in cells adapting from fermentative to aerobic growth was less efficient in mitochondria of the cox6 mutant than the parental respiratory-competent strain or a cox4 mutant. We speculate that the constitutive and Cox6p-independent rate of Atp9p oligomerization may be sufficient to produce the level of ATP synthase needed for maintaining a membrane potential but limiting for optimal oxidative phosphorylation.	[Su, Chen-Hsien; Tzagoloff, Alexander] Columbia Univ, Dept Biol Sci, New York, NY 10128 USA; [McStay, Gavin P.] New York Inst Technol, Dept Life Sci, Old Westbury, NY 11568 USA	Columbia University; New York Institute Technology	Tzagoloff, A (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10128 USA.	spud@columbia.edu	McStay, Gavin/K-9574-2013	McStay, Gavin/0000-0003-1363-8719	National Institutes of Health [HL22174]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL022174, R37HL022174, R01HL022174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL22174.	ACKERMAN SH, 1990, J BIOL CHEM, V265, P9952; Arechaga I, 2002, FEBS LETT, V515, P189, DOI 10.1016/S0014-5793(02)02447-X; Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Barros MH, 2002, FEBS LETT, V516, P119, DOI 10.1016/S0014-5793(02)02514-0; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; CHEN WL, 1969, J BIOL CHEM, V244, P2767; COSTANZO MC, 1986, MOL CELL BIOL, V6, P3694, DOI 10.1128/MCB.6.11.3694; Deckers-Hebestreit G, 2013, BIOCHEM SOC T, V41, P1288, DOI 10.1042/BST20130096; DOWHAN W, 1985, EMBO J, V4, P179, DOI 10.1002/j.1460-2075.1985.tb02334.x; Fontanesi F, 2010, MOL CELL BIOL, V30, P245, DOI 10.1128/MCB.00983-09; FORSBURG SL, 1989, ANNU REV CELL BIOL, V5, P153, DOI 10.1146/annurev.cb.05.110189.001101; Giraud MF, 2012, J STRUCT BIOL, V177, P490, DOI 10.1016/j.jsb.2011.10.015; Glerum DM, 1998, ANAL BIOCHEM, V260, P38, DOI 10.1006/abio.1998.2683; GUARENTE L, 1987, ANNU REV GENET, V21, P425, DOI 10.1146/annurev.genet.21.1.425; HADIKUSUMO RG, 1988, BIOCHIM BIOPHYS ACTA, V933, P212, DOI 10.1016/0005-2728(88)90072-2; Heinemeyer J, 2007, J BIOL CHEM, V282, P12240, DOI 10.1074/jbc.M610545200; Herrmann J. M., 1994, CELL BIOL LAB HDB, VI, P538; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; KOERNER TJ, 1991, METHODS ENZYMOL, V194, P477; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lichty JJ, 2005, PROTEIN EXPRES PURIF, V41, P98, DOI 10.1016/j.pep.2005.01.019; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McStay GP, 2013, J BIOL CHEM, V288, P26546, DOI 10.1074/jbc.M113.498592; McStay GP, 2013, MOL BIOL CELL, V24, P440, DOI 10.1091/mbc.E12-10-0749; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Ozaki Y, 2008, BIOCHEM BIOPH RES CO, V367, P663, DOI 10.1016/j.bbrc.2007.12.170; PENEFSKY HS, 1965, J BIOL CHEM, V240, P4694; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Perez-Martinez X, 2009, MOL BIOL CELL, V20, P4371, DOI 10.1091/mbc.E09-06-0522; PERLMAN PS, 1974, ARCH BIOCHEM BIOPHYS, V162, P248, DOI 10.1016/0003-9861(74)90125-8; POUTRE CG, 1987, GENETICS, V115, P637; Rak M, 2011, EMBO J, V30, P920, DOI 10.1038/emboj.2010.364; Rak M, 2009, P NATL ACAD SCI USA, V106, P18509, DOI 10.1073/pnas.0910351106; REPETTO B, 1989, MOL CELL BIOL, V9, P2695, DOI 10.1128/MCB.9.6.2695; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Stuart RA, 2008, J BIOENERG BIOMEMBR, V40, P411, DOI 10.1007/s10863-008-9168-4; Su CH, 2014, MOL BIOL CELL, V25, P965, DOI [10.1091/mbc.E13-0-0575, 10.1091/mbc.E13-10-0575]; Suzuki T, 2007, P NATL ACAD SCI USA, V104, P20776, DOI 10.1073/pnas.0708075105; TZAGOLOFF A, 1969, J BIOL CHEM, V244, P5027; Tzagoloff A, 2004, J BIOL CHEM, V279, P19775, DOI 10.1074/jbc.M401506200; Wittig I, 2005, PROTEOMICS, V5, P4338, DOI 10.1002/pmic.200500081; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yumen I, 2012, PROTEIN EXPRES PURIF, V82, P396, DOI 10.1016/j.pep.2012.02.005; Zeng XM, 2008, MOL BIOL CELL, V19, P1366, DOI 10.1091/mbc.E07-08-0746	50	12	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31605	31616		10.1074/jbc.M114.602706	http://dx.doi.org/10.1074/jbc.M114.602706			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25253699	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000344549900060
J	Wang, YJ; He, HW; Liu, LN; Gao, CY; Xu, S; Zhao, P; Xia, QY				Wang, Yejing; He, Huawei; Liu, Lina; Gao, Chunyan; Xu, Shui; Zhao, Ping; Xia, Qingyou			Inactivation and Unfolding of Protein Tyrosine Phosphatase from Thermus thermophilus HB27 during Urea and Guanidine Hydrochloride Denaturation	PLOS ONE			English	Article							MUSCLE CREATINE-KINASE; C-TERMINAL DOMAIN; MOLTEN GLOBULE; STABILITY; STATE; STABILIZATION; THERMODYNAMICS; PURIFICATION; FLUORESCENCE; DEPENDENCE	The effects of urea and guanidine hydrochloride (GdnHCl) on the activity, conformation and unfolding process of protein tyrosine phosphatase (PTPase), a thermostable low molecular weight protein from Thermus thermophilus HB27, have been studied. Enzymatic activity assays showed both urea and GdnHCl resulted in the inactivation of PTPase in a concentration and time-dependent manner. Inactivation kinetics analysis suggested that the inactivation of PTPase induced by urea and GdnHCl were both monophasic and reversible processes, and the effects of urea and GdnHCl on PTPase were similar to that of mixed-type reversible inhibitors. Far-ultraviolet (UV) circular dichroism (CD), Tryptophan and 1-anilinonaphthalene -8-sulfonic acid (ANS) fluorescence spectral analyses indicated the existence of a partially active and an inactive molten globule-like intermediate during the unfolding processes induced by urea and GdnHCl, respectively. Based on the sequence alignment and the homolog Tt1001 protein structure, we discussed the possible conformational transitions of PTPase induced by urea and GdnHCl and compared the conformations of these unfolding intermediates with the transient states in bovine PTPase and its complex structures in detail. Our results may be able to provide some valuable clues to reveal the relationship between the structure and enzymatic activity, and the unfolding pathway and mechanism of PTPase.	[Wang, Yejing; He, Huawei; Liu, Lina; Gao, Chunyan; Zhao, Ping; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Wang, Yejing; He, Huawei; Xu, Shui] Southwest Univ, Coll Biotechnol, Chongqing, Peoples R China	Southwest University - China; Southwest University - China	He, HW (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	hehuawei@swu.edu.cn; xiaqy@swu.edu.cn	liu, li/HGC-0900-2022		National Basic Research Program of China [2012CB114602]; Fundamental Research Funds for the Central Universities [SWU112111, XDJK2013A019, SWU112086, XDJK2013C049]	National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	HH was supported by the National Basic Research Program of China (2012CB114602) and the Fundamental Research Funds for the Central Universities (SWU112111, XDJK2013A019). YW was supported by the Fundamental Research Funds for the Central Universities (SWU112086, XDJK2013C049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUNE KC, 1969, BIOCHEMISTRY-US, V8, P4586, DOI 10.1021/bi00839a053; Bhuyan AK, 2002, BIOCHEMISTRY-US, V41, P13386, DOI 10.1021/bi020371n; Bonincontro A, 2004, BIOPHYS J, V86, P1118, DOI 10.1016/S0006-3495(04)74186-7; BREMS DN, 1990, J BIOL CHEM, V265, P5504; Burke TR, 1998, BIOPOLYMERS, V47, P225, DOI 10.1002/(SICI)1097-0282(1998)47:3<225::AID-BIP3>3.0.CO;2-O; Chen Z, 2012, BIOPHYS J, V103, P558, DOI 10.1016/j.bpj.2012.07.002; Denu JM, 1998, CURR OPIN CHEM BIOL, V2, P633, DOI 10.1016/S1367-5931(98)80095-1; Deshpande RA, 2003, BBA-PROTEINS PROTEOM, V1648, P184, DOI 10.1016/S1570-9639(03)00133-X; DOLGIKH DA, 1981, FEBS LETT, V136, P311, DOI 10.1016/0014-5793(81)80642-4; Easty D, 2006, CURR CANCER DRUG TAR, V6, P519, DOI 10.2174/156800906778194603; Ferreon ACM, 2004, BIOCHEMISTRY-US, V43, P13357, DOI 10.1021/bi048666j; Halim Adyani Azizah Abd, 2013, Biosci Biotechnol Biochem, V77, P87; He HW, 2007, INT J BIOCHEM CELL B, V39, P1816, DOI 10.1016/j.biocel.2007.04.028; He HW, 2005, BIOPHYS J, V89, P2650, DOI 10.1529/biophysj.105.066142; Hendriks WJAJ, 2008, FEBS J, V275, P816, DOI 10.1111/j.1742-4658.2008.06249.x; Henne A, 2004, NAT BIOTECHNOL, V22, P547, DOI 10.1038/nbt956; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Inouye K, 2000, J BIOCHEM-TOKYO, V128, P363, DOI 10.1093/oxfordjournals.jbchem.a022762; Inui T, 2003, J BIOL CHEM, V278, P2845, DOI 10.1074/jbc.M209934200; Jana S, 2006, BIOCHEMISTRY-MOSCOW+, V71, P1230, DOI 10.1134/S0006297906110083; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Kuby SA, 1991, STUDY ENZYMES, V1, P20; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; MAYR LM, 1993, BIOCHEMISTRY-US, V32, P7994, DOI 10.1021/bi00082a021; MITCHINSON C, 1985, J MOL BIOL, V184, P331, DOI 10.1016/0022-2836(85)90384-5; Mok YK, 1999, J MOL BIOL, V289, P619, DOI 10.1006/jmbi.1999.2769; MONERA OD, 1994, PROTEIN SCI, V3, P1984, DOI 10.1002/pro.5560031110; Mustelin T, 2006, ADV EXP MED BIOL, V584, P53; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; PACE C N, 1975, Critical Reviews in Biochemistry, V3, P1, DOI 10.3109/10409237509102551; Povarova OI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015035; Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X; PRIVALOV PL, 1974, J MOL BIOL, V86, P665, DOI 10.1016/0022-2836(74)90188-0; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Shortle DR, 1996, CURR OPIN STRUC BIOL, V6, P24, DOI 10.1016/S0959-440X(96)80091-1; Smith JS, 1996, BIOCHEMISTRY-US, V35, P7292, DOI 10.1021/bi960341i; Stoker AW, 2005, J ENDOCRINOL, V185, P19, DOI 10.1677/joe.1.06069; Tabernero L, 1999, BIOCHEMISTRY-US, V38, P11651, DOI 10.1021/bi990381x; TONKS NK, 1988, J BIOL CHEM, V263, P6722; UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042; Vassilenko KS, 2002, BBA-PROTEIN STRUCT M, V1594, P168, DOI 10.1016/S0167-4838(01)00303-X; Wang GF, 2000, INT J BIOCHEM CELL B, V32, P873, DOI 10.1016/S1357-2725(00)00027-3; Wang WQ, 2003, CURR TOP MED CHEM, V3, P739, DOI 10.2174/1568026033452302; Wang YJ, 2009, ACTA BIOCH BIOPH SIN, V41, P689, DOI 10.1093/abbs/gmp057; WONG KP, 1973, J BIOL CHEM, V248, P8518; Xie J, 2007, BIOORGAN MED CHEM, V15, P458, DOI 10.1016/j.bmc.2006.09.036; YAO M, 1995, BIOCHEMISTRY-US, V34, P3771, DOI 10.1021/bi00011a035; Zhang M, 1997, BIOCHEMISTRY-US, V36, P15, DOI 10.1021/bi961804n; ZHANG ZY, 1991, J BIOL CHEM, V266, P1516	51	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107932	10.1371/journal.pone.0107932	http://dx.doi.org/10.1371/journal.pone.0107932			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255086	Green Submitted, Green Published, gold			2022-12-25	WOS:000344862300044
J	Barnes, RT; Gallagher, ME; Masiello, CA; Liu, ZL; Dugan, B				Barnes, Rebecca T.; Gallagher, Morgan E.; Masiello, Caroline A.; Liu, Zuolin; Dugan, Brandon			Biochar-Induced Changes in Soil Hydraulic Conductivity and Dissolved Nutrient Fluxes Constrained by Laboratory Experiments	PLOS ONE			English	Article							GRAIN-SIZE DISTRIBUTION; BLACK CARBON; PHYSICAL-PROPERTIES; NITROUS-OXIDE; CHEMICAL-COMPOSITION; ORGANIC-CARBON; SANDY SOIL; CHARCOAL; TEMPERATURE; TRANSPORT	The addition of charcoal (or biochar) to soil has significant carbon sequestration and agronomic potential, making it important to determine how this potentially large anthropogenic carbon influx will alter ecosystem functions. We used column experiments to quantify how hydrologic and nutrient-retention characteristics of three soil materials differed with biochar amendment. We compared three homogeneous soil materials (sand, organic-rich topsoil, and clay-rich Hapludert) to provide a basic understanding of biochar-soil-water interactions. On average, biochar amendment decreased saturated hydraulic conductivity (K) by 92% in sand and 67% in organic soil, but increased K by 328% in clay-rich soil. The change in K for sand was not predicted by the accompanying physical changes to the soil mixture; the sand-biochar mixture was less dense and more porous than sand without biochar. We propose two hydrologic pathways that are potential drivers for this behavior: one through the interstitial biochar-sand space and a second through pores within the biochar grains themselves. This second pathway adds to the porosity of the soil mixture; however, it likely does not add to the effective soil K due to its tortuosity and smaller pore size. Therefore, the addition of biochar can increase or decrease soil drainage, and suggests that any potential improvement of water delivery to plants is dependent on soil type, biochar amendment rate, and biochar properties. Changes in dissolved carbon (C) and nitrogen (N) fluxes also differed; with biochar increasing the C flux from organic-poor sand, decreasing it from organic-rich soils, and retaining small amounts of soil-derived N. The aromaticity of C lost from sand and clay increased, suggesting lost C was biochar-derived; though the loss accounts for only 0.05% of added biochar-C. Thus, the direction and magnitude of hydraulic, C, and N changes associated with biochar amendments are soil type (composition and particle size) dependent.	[Barnes, Rebecca T.; Gallagher, Morgan E.; Masiello, Caroline A.; Liu, Zuolin; Dugan, Brandon] Rice Univ, Dept Earth Sci, Houston, TX USA	Rice University	Barnes, RT (corresponding author), Colorado Coll, Environm Program, Colorado Springs, CO 80903 USA.	becca.barnes@coloradocollege.edu	Barnes, Rebecca T/U-9595-2019; Barnes, Rebecca T/A-2659-2011; Masiello, Caroline/A-2653-2011	Barnes, Rebecca T/0000-0001-6385-1062; Barnes, Rebecca T/0000-0001-6385-1062; Masiello, Caroline/0000-0003-2102-6229; Gallagher, Morgan/0000-0002-7971-4537	National Science Foundation [NSF-EAR-0911685]; US Department of Agriculture [2011-67009-20074]; Rice University's Shell Center for Sustainability	National Science Foundation(National Science Foundation (NSF)); US Department of Agriculture(United States Department of Agriculture (USDA)); Rice University's Shell Center for Sustainability	This work was supported by National Science Foundation (NSF-EAR-0911685) to CAM & BD (www.nsf.gov), US Department of Agriculture (2011-67009-20074) to CAM (www.usda.gov), Rice University's Shell Center for Sustainability to CAM (shellcenter.rice.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALYAMANI MS, 1993, GROUND WATER, V31, P551, DOI 10.1111/j.1745-6584.1993.tb00587.x; Angst TE, 2013, J ENVIRON QUAL, V42, P672, DOI 10.2134/jeq2012.0341; [Anonymous], 2019, D2216 ASTM; [Anonymous], 1981, INTRO GEOTECHNICAL; Asada T, 2002, J HEALTH SCI, V48, P473, DOI 10.1248/jhs.48.473; Asai H, 2009, FIELD CROP RES, V111, P81, DOI 10.1016/j.fcr.2008.10.008; ASTM, 2007, D176284 ASTM INT; ASTM D5084-10, 2010, STANDARD TEST METHOD; [ASTM International Materials ASfTa], 2006, MAT ASFTA; Atkinson CJ, 2010, PLANT SOIL, V337, P1, DOI 10.1007/s11104-010-0464-5; Baldock JA, 2002, ORG GEOCHEM, V33, P1093, DOI 10.1016/S0146-6380(02)00062-1; Baronti S, 2014, EUR J AGRON, V53, P38, DOI 10.1016/j.eja.2013.11.003; Bell MJ, 2011, SCI TOTAL ENVIRON, V409, P1704, DOI 10.1016/j.scitotenv.2011.01.031; Boadu FK, 2000, J GEOTECH GEOENVIRON, V126, P739, DOI 10.1061/(ASCE)1090-0241(2000)126:8(739); Brewer CE, 2014, BIOMASS BIOENERG, V66, P176, DOI 10.1016/j.biombioe.2014.03.059; Briggs C, 2012, SOIL SCI, V177, P263, DOI 10.1097/SS.0b013e3182482784; Brodowski S, 2007, GEODERMA, V139, P220, DOI 10.1016/j.geoderma.2007.02.004; Bruun EW, 2014, SOIL USE MANAGE, V30, P109, DOI 10.1111/sum.12102; Bruun EW, 2012, SOIL SCI SOC AM J, V76, P1142, DOI 10.2136/sssaj2011.0101; Carman PC, 1937, T I CHEM ENG-LOND, V15, P150; Chan KY, 2007, AUST J SOIL RES, V45, P629, DOI 10.1071/SR07109; Cheng CH, 2008, GEOCHIM COSMOCHIM AC, V72, P1598, DOI 10.1016/j.gca.2008.01.010; Clough TJ, 2010, J ENVIRON QUAL, V39, P1218, DOI 10.2134/jeq2010.0204; Crawford BR, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2006JB004634; Devereux RC, 2012, EARTH ENV SCI T R SO, V103, P13, DOI 10.1017/S1755691012000011; Dittmar T, 2012, NAT GEOSCI, V5, P618, DOI [10.1038/ngeo1541, 10.1038/NGEO1541]; Foereid B, 2011, PLANT SOIL, V345, P223, DOI 10.1007/s11104-011-0773-3; Gaskin J.W., 2007, POTENTIAL PYROLYSIS; Glaser B, 2002, BIOL FERT SOILS, V35, P219, DOI 10.1007/s00374-002-0466-4; Hardie M, 2014, PLANT SOIL, V376, P347, DOI 10.1007/s11104-013-1980-x; Herath HMSK, 2013, GEODERMA, V209, P188, DOI 10.1016/j.geoderma.2013.06.016; Jaffe R, 2013, SCIENCE, V340, P345, DOI 10.1126/science.1231476; Jones DL, 2012, SOIL BIOL BIOCHEM, V45, P113, DOI 10.1016/j.soilbio.2011.10.012; Kammann C.I., 2011, PLANT SOIL; Kammann C, 2012, J ENVIRON QUAL, V41, P1052, DOI 10.2134/jeq2011.0132; Kinney TJ, 2012, BIOMASS BIOENERG, V41, P34, DOI 10.1016/j.biombioe.2012.01.033; Klute A., 1986, METHODS SOIL ANAL 1; KOZENY J., 1927, STIZUNGSBER AKAD WIS, V136, P271; Krull E.S., 2009, BIOCHAR ENV MANAGEME, P53, DOI DOI 10.4324/9781849770552; Kuhlbusch T.A., 1996, BIOMASS BURNING GLOB, P160; Laird DA, 2010, GEODERMA, V158, P443, DOI 10.1016/j.geoderma.2010.05.013; Lehmann J., 2006, Mitigation and Adaptation Strategies for Global Change, V11, P403, DOI 10.1007/s11027-005-9006-5; Lehmann J, 2007, FRONT ECOL ENVIRON, V5, P381, DOI 10.1890/1540-9295(2007)5[381:BITB]2.0.CO;2; Lei O, 2013, J SOILS SEDIMENTS; Liang B, 2006, SOIL SCI SOC AM J, V70, P1719, DOI 10.2136/sssaj2005.0383; Major J, 2009, BIOCHAR ENV MANAGEME, P271; Major J, 2010, GLOBAL CHANGE BIOL, V16, P1366, DOI 10.1111/j.1365-2486.2009.02044.x; Masiello CA, 2004, MAR CHEM, V92, P201, DOI 10.1016/j.marchem.2004.06.043; Mishra SK, 2003, HYDROL PROCESS, V17, P2629, DOI 10.1002/hyp.1257; Mukherjee A, 2013, GEODERMA, V193, P122, DOI 10.1016/j.geoderma.2012.10.002; Mukome FND, 2013, GEODERMA, V200, P90, DOI 10.1016/j.geoderma.2013.02.004; NEUZIL CE, 1994, WATER RESOUR RES, V30, P145, DOI 10.1029/93WR02930; Norwood MJ, 2013, ORG GEOCHEM, V56, P111, DOI 10.1016/j.orggeochem.2012.12.008; Novak JM, 2010, GEODERMA, V154, P281, DOI 10.1016/j.geoderma.2009.10.014; Novak J. M., 2009, Annals of Environmental Science, V3, P195; Novak JM, 2012, SOIL SCI, V177, P310, DOI 10.1097/SS.0b013e31824e5593; Oguntunde PG, 2008, J PLANT NUTR SOIL SC, V171, P591, DOI 10.1002/jpln.200625185; Oliveira IB, 1996, SOIL SCI SOC AM J, V60, P49, DOI 10.2136/sssaj1996.03615995006000010010x; Rajkovich S, 2011, BIOL FERTILITY SOILS; Rayment G, 2010, SOIL CHEM METHODS; Schneider MPW, 2010, ORG GEOCHEM, V41, P1082, DOI 10.1016/j.orggeochem.2010.07.001; Singh BP, 2010, J ENVIRON QUAL, V39, P1224, DOI 10.2134/jeq2009.0138; Steiner C, 2008, J PLANT NUTR SOIL SC, V171, P893, DOI 10.1002/jpln.200625199; Stubbins A, 2010, LIMNOL OCEANOGR, V55, P1467, DOI 10.4319/lo.2010.55.4.1467; Sun H, 2012, IND ENG CHEM RES, V51, P3587, DOI 10.1021/ie201309r; TRYON EH, 1948, ECOL MONOGR, V18, P81, DOI 10.2307/1948629; Uzoma KC, 2011, J FOOD AGRIC ENVIRON, V9, P1137; Wang C, 2013, J HYDROL, V499, P140, DOI 10.1016/j.jhydrol.2013.06.055; Wang DJ, 2013, ENVIRON SCI TECHNOL, V47, P821, DOI 10.1021/es303794d; Weishaar JL, 2003, ENVIRON SCI TECHNOL, V37, P4702, DOI 10.1021/es030360x; Wheeler FF, 1976, SOIL SURVEY HARRIS C, P152; Woolf D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1053; Yu LQ, 2013, BIOL FERT SOILS, V49, P119, DOI 10.1007/s00374-012-0703-4; Zhang W, 2010, ECOHYDROLOGY, V3, P497, DOI 10.1002/eco.160	74	169	177	12	140	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108340	10.1371/journal.pone.0108340	http://dx.doi.org/10.1371/journal.pone.0108340			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251677	Green Submitted, Green Published, gold			2022-12-25	WOS:000342492700112
J	He, WY; Kang, XJ; Du, HZ; Song, B; Lu, ZY; Huang, YL; Wang, D; Sun, XF; Yu, Y; Fan, Y				He, WenYin; Kang, XiangJin; Du, HongZi; Song, Bing; Lu, ZhenYu; Huang, Yuling; Wang, Ding; Sun, Xiaofang; Yu, Yang; Fan, Yong			Defining Differentially Methylated Regions Specific for the Acquisition of Pluripotency and Maintenance in Human Pluripotent Stem Cells via Microarray	PLOS ONE			English	Article							EPIGENETIC MEMORY; GENE-REGULATION; SOMATIC-CELLS; COPY NUMBER; EPIGENOMICS; STABILITY; IPSCS; ES	Background: Epigenetic regulation is critical for the maintenance of human pluripotent stem cells. It has been shown that pluripotent stem cells, such as embryonic stem cells and induced pluripotent stem cells, appear to have a hypermethylated status compared with differentiated cells. However, the epigenetic differences in genes that maintain stemness and regulate reprogramming between embryonic stem cells and induced pluripotent stem cells remain unclear. Additionally, differential methylation patterns of induced pluripotent stem cells generated using diverse methods require further study. Methodology: Here, we determined the DNA methylation profiles of 10 human cell lines, including 2 ESC lines, 4 virally derived iPSC lines, 2 episomally derived iPSC lines, and the 2 parental cell lines from which the iPSCs were derived using Illumina's Infinium HumanMethylation450 BeadChip. The iPSCs exhibited a hypermethylation status similar to that of ESCs but with distinct differences from the parental cells. Genes with a common methylation pattern between iPSCs and ESCs were classified as critical factors for stemness, whereas differences between iPSCs and ESCs suggested that iPSCs partly retained the parental characteristics and gained de novo methylation aberrances during cellular reprogramming. No significant differences were identified between virally and episomally derived iPSCs. This study determined in detail the de novo differential methylation signatures of particular stem cell lines. Conclusions: This study describes the DNA methylation profiles of human iPSCs generated using both viral and episomal methods, the corresponding somatic cells, and hESCs. Series of ss-DMRs and ES-iPS-DMRs were defined with high resolution. Knowledge of this type of epigenetic information could be used as a signature for stemness and self-renewal and provides a potential method for selecting optimal pluripotent stem cells for human regenerative medicine.	[He, WenYin; Kang, XiangJin; Du, HongZi; Song, Bing; Huang, Yuling; Wang, Ding; Sun, Xiaofang; Fan, Yong] Guangzhou Med Univ, Affiliated Hosp 3, Guangdong Higher Educ Inst, Key Lab Major Obstetr Dis Guangdong Prov,Key Lab, Guangzhou, Guangdong, Peoples R China; [Yu, Yang] Peking Univ, Hosp 3, Ctr Reprod Med, Dept Obstet & Gynecol, Beijing 100871, Peoples R China; [Lu, ZhenYu] Union Stem Cell & Gene Engn Co Ltd, Tianjin, Peoples R China	Guangzhou Medical University; Peking University	Sun, XF (corresponding author), Guangzhou Med Univ, Affiliated Hosp 3, Guangdong Higher Educ Inst, Key Lab Major Obstetr Dis Guangdong Prov,Key Lab, Guangzhou, Guangdong, Peoples R China.	xiaofangsun@hotmail.com; yuyang5012@hotmail.com; yongfan2011@gmail.com			Ministry of Science and Technology of China [2014CB943203]; Ph.D. Programs Foundation of Ministry of Education of China [20110001120008]; National Natural Science Foundation of China [81100473, 81100404, 81370766, U1132005]; Guangdong Natural Science Funds [S2013010014781]; Zhujiang Science and Technology Star Project of Guangzhou [2012J2200006]; Guangdong Province Higher Education Funding [2013KJCX0149, Yq2013135]; Union Stem Cell & Gene Engineering Co., Ltd.	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Funds; Zhujiang Science and Technology Star Project of Guangzhou; Guangdong Province Higher Education Funding; Union Stem Cell & Gene Engineering Co., Ltd.	This work was supported in part by grants from the Ministry of Science and Technology of China Grants (973 program; 2014CB943203), Ph.D. Programs Foundation of Ministry of Education of China (20110001120008), the National Natural Science Foundation of China (81100473, 81100404, 81370766, U1132005), Guangdong Natural Science Funds (S2013010014781), the Zhujiang Science and Technology Star Project of Guangzhou (2012J2200006) and Guangdong Province Higher Education Funding (2013KJCX0149, Yq2013135). Union Stem Cell & Gene Engineering Co., Ltd. provided support in the form of a salary for author ZYL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Chang G, 2013, CELL RES; Chen Z, 2012, PROTEIN CELL, V3, P271, DOI 10.1007/s13238-012-2922-8; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Fazzari MJ, 2010, METHODS MOL BIOL, V620, P243, DOI 10.1007/978-1-60761-580-4_7; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Huang K, 2014, STEM CELL REP, V2, P36, DOI 10.1016/j.stemcr.2013.11.003; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Ma H, 2014, NATURE, V511, P177, DOI 10.1038/nature13551; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Nishino K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002085; Nishino K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013017; Nissenbaum J, 2013, STEM CELL REP, V1, P509, DOI 10.1016/j.stemcr.2013.11.007; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Ruiz S, 2012, P NATL ACAD SCI USA, V109, P16196, DOI 10.1073/pnas.1202352109; Sun XF, 2008, HUM REPROD, V23, P2185, DOI 10.1093/humrep/den137; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Vaskova EA, 2013, ACTA NATURAE, V5, P15, DOI 10.32607/20758251-2013-5-4-15-21; Wang AY, 2011, STEM CELLS DEV, V20, P1937, DOI 10.1089/scd.2010.0574; Wang Y-C, 2013, CELL RES; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang WQ, 2012, PROTEIN CELL, V3, P241, DOI 10.1007/s13238-012-2804-0; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	40	11	12	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108350	10.1371/journal.pone.0108350	http://dx.doi.org/10.1371/journal.pone.0108350			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250679	gold, Green Submitted, Green Published			2022-12-25	WOS:000342492700116
J	Li, JH; Dong, F; Lu, Y; Yan, QY; Shim, H				Li, Junhui; Dong, Fei; Lu, Ying; Yan, Qiuyan; Shim, Hojae			Mechanisms Controlling Arsenic Uptake in Rice Grown in Mining Impacted Regions in South China	PLOS ONE			English	Article							PADDY RICE; LEAD/ZINC MINE; IRON PLAQUE; CONTAMINATION; SOIL; ACCUMULATION; LEAD; ENVIRONMENT; METABOLISM; CULTIVARS	Foods produced on soils impacted by Pb-Zn mining activities are a potential health risk due to plant uptake of the arsenic ( As) associated with such mining. A field survey was undertaken in two Pb-Zn mining-impacted paddy fields in Guangdong Province, China to assess As accumulation and translocation, as well as other factors influencing As in twelve commonly grown rice cultivars. The results showed that grain As concentrations in all the surveyed rice failed national food standards, irrespective of As speciation. Among the 12 rice cultivars, "SY-89'' and "DY-162'' had the least As in rice grain. No significant difference for As concentration in grain was observed between the rice grown in the two areas that differed significantly for soil As levels, suggesting that the amount of As contamination in the soil is not necessarily the overriding factor controlling the As content in the rice grain. The iron and manganese plaque on the root surface curtailed As accumulation in rice roots. Based on our results, the accumulation of As within rice plants was strongly associated with such soil properties such as silicon, phosphorus, organic matter, pH, and clay content. Understanding the factors and mechanisms controlling As uptake is important to develop mitigation measures that can reduce the amount of As accumulated in rice grains produced on contaminated soils.	[Li, Junhui; Dong, Fei; Lu, Ying] South China Agr Univ, Coll Nat Resources & Environm, Guangzhou, Guangdong, Peoples R China; [Dong, Fei] Agr Bur Xiangfen Cty, Xiangfen, Shanxi Province, Peoples R China; [Yan, Qiuyan] Shanxi Acad Agr Sci, Inst Wheat Res, Linfen, Peoples R China; [Shim, Hojae] Univ Macau, Fac Sci & Technol, Dept Civil & Environm Engn, Macau, Peoples R China	South China Agricultural University; Shanxi Agricultural University; University of Macau	Lu, Y (corresponding author), South China Agr Univ, Coll Nat Resources & Environm, Guangzhou, Guangdong, Peoples R China.	luying@scau.edu.cn; hjshim@umac.mo	Shim, Hojae/AAL-7052-2020	Shim, Hojae/0000-0002-6863-8292				Banerjee M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02195; Chinese Environmental Protection Agency, 2008, 156182008 GB CHIN EN; Chinese Food Standards Agency, 2005, 27622005 GB; Dave R, 2013, ARCH ENVIRON CON TOX, V64, P235, DOI 10.1007/s00244-012-9818-8; Deng J, 2005, Mineral Deposit Research: Meeting the Global Challenge, Vols 1 and 2, P107, DOI 10.1007/3-540-27946-6_28; DeSesso JM, 1998, REPROD TOXICOL, V12, P385, DOI 10.1016/S0890-6238(98)00021-5; Duan GL, 2013, METALLOMICS, V5, P784, DOI 10.1039/c3mt20277a; Dudka S, 1999, WATER AIR SOIL POLL, V113, P127, DOI 10.1023/A:1005028905396; Fan JB, 2010, PEDOSPHERE, V20, P446, DOI 10.1016/S1002-0160(10)60034-3; Farooq M, 2011, SOIL TILL RES, V111, P87, DOI 10.1016/j.still.2010.10.008; Heikens A, 2007, REV ENVIRON CONTAM T, V189, P43, DOI 10.1007/978-0-387-35368-5_3; Hu Y, 2012, WATER MINERAL PROCES, P371; Kennedy D, 2002, SCIENCE, V296, P13, DOI 10.1126/science.296.5565.13; Liao XY, 2005, ENVIRON INT, V31, P791, DOI 10.1016/j.envint.2005.05.030; Liu CP, 2010, ENVIRON POLLUT, V158, P820, DOI 10.1016/j.envpol.2009.09.029; Liu HY, 2005, SCI TOTAL ENVIRON, V339, P153, DOI 10.1016/j.scitotenv.2004.07.030; Liu WJ, 2006, ENVIRON SCI TECHNOL, V40, P5730, DOI 10.1021/es060800v; Liu WJ, 2004, J EXP BOT, V55, P1707, DOI 10.1093/jxb/erh205; Lu HZ, 1983, CHINESE J GEOCHEMIST, V2, P45; Lu R., 2000, ANAL METHODS SOILS A; Lu Y, 2010, ENVIRON POLLUT, V158, P1536, DOI 10.1016/j.envpol.2009.12.022; MORENOJIMENEZ E, 2012, FATE ARSENIC SOIL PL, V215, P1; Norton GJ, 2013, ENVIRON POLLUT, V177, P38, DOI 10.1016/j.envpol.2013.01.049; Oyarzun R, 2009, ENVIRON GEOL, V58, P761, DOI 10.1007/s00254-008-1550-3; Peng SB, 2006, FIELD CROP RES, V96, P252, DOI 10.1016/j.fcr.2005.07.007; Sahoo PK, 2013, GEOSCI J, V17, P107, DOI 10.1007/s12303-013-0004-4; Smith E, 1998, ADV AGRON, V64, P149, DOI 10.1016/S0065-2113(08)60504-0; Stone R, 2008, SCIENCE, V321, P184, DOI 10.1126/science.321.5886.184; Wei XJ, 2013, J GEOCHEM EXPLOR, V128, P124, DOI 10.1016/j.gexplo.2013.02.003; Williams PN, 2006, ENVIRON SCI TECHNOL, V40, P4903, DOI 10.1021/es060222i; Williams PN, 2007, ENVIRON SCI TECHNOL, V41, P6854, DOI 10.1021/es070627i; Williams PN, 2009, ENVIRON SCI TECHNOL, V43, P637, DOI 10.1021/es802412r; Xu J, 2013, J HAZARD MATER, V260, P483, DOI 10.1016/j.jhazmat.2013.06.001; Yang QW, 2008, ENVIRON MONIT ASSESS, V147, P65, DOI 10.1007/s10661-007-0098-0; Zavala YJ, 2008, ENVIRON SCI TECHNOL, V42, P3856, DOI 10.1021/es702747y; Zhang HH, 2006, ENVIRON POLLUT, V144, P492, DOI 10.1016/j.envpol.2006.01.029; Zhao FJ, 2009, NEW PHYTOL, V181, P777, DOI 10.1111/j.1469-8137.2008.02716.x; Zhao FJ, 2013, ENVIRON SCI TECHNOL, V47, P3957, DOI 10.1021/es304295n; Zhao FJ, 2010, ANNU REV PLANT BIOL, V61, P535, DOI 10.1146/annurev-arplant-042809-112152; Zhu YG, 2008, ENVIRON SCI TECHNOL, V42, P5008, DOI 10.1021/es8001103	45	21	25	7	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108300	10.1371/journal.pone.0108300	http://dx.doi.org/10.1371/journal.pone.0108300			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251438	Green Published, gold, Green Submitted			2022-12-25	WOS:000342492700108
J	Liu, Y; Su, C; Zhang, H; Li, XT; Pei, JF				Liu, Yong; Su, Chao; Zhang, Hong; Li, Xiaoting; Pei, Jingfei			Interaction of Soil Heavy Metal Pollution with Industrialisation and the Landscape Pattern in Taiyuan City, China	PLOS ONE			English	Article							MULTIVARIATE; ECOLOGY; INDEXES	Many studies indicated that industrialization and urbanization caused serious soil heavy metal pollution from industrialized age. However, fewer previous studies have conducted a combined analysis of the landscape pattern, urbanization, industrialization, and heavy metal pollution. This paper was aimed at exploring the relationships of heavy metals in the soil (Pb, Cu, Ni, As, Cd, Cr, Hg, and Zn) with landscape pattern, industrialisation, urbanisation in Taiyuan city using multivariate analysis. The multivariate analysis included correlation analysis, analysis of variance (ANOVA), independent-sample T test, and principal component analysis (PCA). Geographic information system (GIS) was also applied to determine the spatial distribution of the heavy metals. The spatial distribution maps showed that the heavy metal pollution of the soil was more serious in the centre of the study area. The results of the multivariate analysis indicated that the correlations among heavy metals were significant, and industrialisation could significantly affect the concentrations of some heavy metals. Landscape diversity showed a significant negative correlation with the heavy metal concentrations. The PCA showed that a two-factor model for heavy metal pollution, industrialisation, and the landscape pattern could effectively demonstrate the relationships between these variables. The model explained 86.71% of the total variance of the data. Moreover, the first factor was mainly loaded with the comprehensive pollution index (P), and the second factor was primarily loaded with landscape diversity and dominance (H and D). An ordination of 80 samples could show the pollution pattern of all the samples. The results revealed that local industrialisation caused heavy metal pollution of the soil, but such pollution could respond negatively to the landscape pattern. The results of the study could provide a basis for agricultural, suburban, and urban planning.	[Liu, Yong; Su, Chao; Zhang, Hong; Li, Xiaoting] Shanxi Univ, Inst Loess Plateau, Taiyuan, Shanxi, Peoples R China; [Pei, Jingfei] Shanxi Univ, Sch Math Sci, Taiyuan, Shanxi, Peoples R China	Shanxi University; Shanxi University	Liu, Y (corresponding author), Shanxi Univ, Inst Loess Plateau, Taiyuan, Shanxi, Peoples R China.	liuyong@sxu.edu.cn			National Natural Science Foundation of China [41271513, 41101558]; Important Specialized Science and Technology Item of Shanxi Province, China [20121101011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Important Specialized Science and Technology Item of Shanxi Province, China	This work was financially supported by the National Natural Science Foundation of China under Grants 41271513, 41101558 and by the Important Specialized Science and Technology Item of Shanxi Province, China under Grant 20121101011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade JM, 2007, ANAL CHIM ACTA, V603, P20, DOI 10.1016/j.aca.2007.09.043; [Anonymous], 2008, THESIS; BRIZKISHORE BH, 1992, ENVIRON GEOL WATER S, V19, P3, DOI 10.1007/BF01740571; Carlon C, 2001, ENVIRON POLLUT, V111, P417, DOI 10.1016/S0269-7491(00)00089-0; Forman R.T.T., 1986, LANDSCAPE ECOL; Fu BJ, 2000, J ARID ENVIRON, V44, P291, DOI 10.1006/jare.1999.0600; [韩敏 HAN Min], 2005, [地理科学进展, Progress in geography], V24, P42; HULSHOFF RM, 1995, LANDSCAPE ECOL, V10, P101, DOI 10.1007/BF00153827; LEDUC A, 1994, LANDSCAPE ECOL, V9, P279, DOI 10.1007/BF00129239; Lewis-Beck M.S., 1994, FACTOR ANAL RELATED; Li, 1994, J GEOL MIN RES N CHI, V02, P188; Liding C., 2008, ACTA ECOL SIN, V28, P5521, DOI [10.1016/S1872-2032(09)60011-1, DOI 10.1016/S1872-2032(09)60011-1, DOI 10.1016/S1]; Lin YP, 2002, LANDSCAPE URBAN PLAN, V62, P19, DOI 10.1016/S0169-2046(02)00094-4; Liu PWG, 2009, ATMOS ENVIRON, V43, P2104, DOI 10.1016/j.atmosenv.2009.01.055; O'Neill RV, 1988, LANDSCAPE ECOL, V1, P153, DOI 10.1007/BF00162741; Roger LO, 2012, WATER RES, V2012, P3110, DOI DOI 10.1016/J.WATRES.2012.03.028; Song X., 2007, GEOGRAPHIC INFORM SY; TURNER MG, 1990, PHOTOGRAMM ENG REM S, V56, P379; TURNER MG, 1989, ANNU REV ECOL SYST, V20, P171, DOI 10.1146/annurev.es.20.110189.001131; URBAN DL, 1987, BIOSCIENCE, V37, P119, DOI 10.2307/1310366; Wang HW, 2006, LINEAR NONLINEAR APP; Wei ZY, 2011, PROCEDIA ENVIRON SCI, V10, P1946, DOI 10.1016/j.proenv.2011.09.305; Zhang H, 2005, CHEMOSPHERE, V60, P762, DOI 10.1016/j.chemosphere.2005.04.023; Zhang W. T., 2011, SPSS STAT ANAL FDN, P265	24	20	27	7	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e105798	10.1371/journal.pone.0105798	http://dx.doi.org/10.1371/journal.pone.0105798			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251460	gold, Green Published, Green Submitted			2022-12-25	WOS:000342492700008
J	Shraim, M; Blagojevic-Bucknall, M; Mallen, CD; Dunn, KM				Shraim, Mujahed; Blagojevic-Bucknall, Milisa; Mallen, Christian D.; Dunn, Kate M.			The Association between GP Consultations for Non-Specific Physical Symptoms in Children and Parents: A Case-Control Study	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; FUNCTIONAL ABDOMINAL-PAIN; CHRONIC BENIGN PAIN; GENERAL-PRACTICE; PRIMARY-CARE; HEALTH-CARE; INTERGENERATIONAL TRANSMISSION; ADOLESCENTS; PREVALENCE	Background: Non-specific physical symptoms (NSPS) such as abdominal pain, headache and musculoskeletal pain are widespread in the community, and are common reasons for visiting a general practitioner (GP). Causes of NSPS are multifactorial, but may include parental influences. Objective: To investigate associations between GP consultations for NSPS in parents and their children. Methods: Matched case-control study using GP consultation data from 12 GP practices in the United Kingdom. Participants were 1328 children who consulted a GP for NSPS in 2009 (cases), 3980 controls who consulted a GP in 2009 but not for NSPS, plus parents of cases and controls (n = 8354). Primary outcome measure: child consultation status for NSPS. Results: Maternal consultation for NSPS was associated with significantly increased odds of their child consulting for NSPS (odds ratio (OR) 1.51, 95% confidence intervals (CI) 1.33, 1.73); there was no significant association with paternal consultations (OR 0.87, 95% CI 0.71, 1.08). Each additional maternal consultation for NSPS was associated with an increase in the rate ratio for number of consultations for NSPS in the child by 1.03 (95% CI 1.01, 1.05). This overall association was clearest in maternal-child consultations for painful NSPS and for specific bodily systems including gastrointestinal, musculoskeletal and neurologic symptoms. Conclusions: Maternal GP consultation for NSPS is associated with increased odds of GP consultations for NSPS in children. This study included a large sample of children and parents and used medical records data which is not subject to recall bias. However, analysis was based on medical records, thus the presence of NSPS not leading to consultations is unknown. Medical practitioners managing children with NSPS need to be aware of this association.	[Shraim, Mujahed; Blagojevic-Bucknall, Milisa; Mallen, Christian D.; Dunn, Kate M.] Keele Univ, Arthrit Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England; [Shraim, Mujahed] Univ Massachusetts, Dept Work Environm, Lowell, MA USA; [Shraim, Mujahed] Liberty Mutual Res Inst Safety, Ctr Disabil Res, Hopkinton, MA USA	Keele University; University of Massachusetts System; University of Massachusetts Lowell; Liberty Mutual Research Institute for Safety	Dunn, KM (corresponding author), Keele Univ, Arthrit Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England.	k.m.dunn@keele.ac.uk	Shraim, Mujahed/AAD-4647-2020; Chalumeau, Martin/F-4293-2017	Shraim, Mujahed/0000-0001-7972-8210; Chalumeau, Martin/0000-0001-8175-3706; Blagojevic-Bucknall, Milica/0000-0001-7230-7771	NHS Research and Development Support for New Medical Schools; Arthritis Research UK [19634]; Wellcome Trust [083572]; NIHR National School for Primary Care Research Fellowship; North Staffordshire Primary Care Research Consortium; Keele University Research Institute for Primary Care and Health Sciences; National Institute for Health Research [SPCR-004] Funding Source: researchfish; Versus Arthritis [19634] Funding Source: researchfish	NHS Research and Development Support for New Medical Schools; Arthritis Research UK(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission); NIHR National School for Primary Care Research Fellowship; North Staffordshire Primary Care Research Consortium; Keele University Research Institute for Primary Care and Health Sciences; National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis)	MS was funded by NHS Research and Development Support for New Medical Schools. CDM is funded by a Clinician Scientist Fellowship (19634) from Arthritis Research UK. KMD is funded through a Research Career Development Fellowship from the Wellcome Trust (083572). MB is supported by a NIHR National School for Primary Care Research Fellowship. CiPCA is funded by the North Staffordshire Primary Care Research Consortium and Keele University Research Institute for Primary Care and Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Campo JV, 2007, ARCH PEDIAT ADOL MED, V161, P131, DOI 10.1001/archpedi.161.2.131; Cardol M, 2006, ANN FAM MED, V4, P506, DOI 10.1370/afm.584; Cardol M, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-4; Craig TKJ, 2002, PSYCHOL MED, V32, P805, DOI 10.1017/S0033291702005846; De Lusignan S, 2005, MED INFORM INTERNET, V30, P89, DOI 10.1080/14639230500298651; Department for Communities and Local Government, 2007, ENGLISH INDICES DEPR; Department of Health, 2011, A LANSL MOV FORW MOD; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Domenech-Llaberia E, 2004, J AM ACAD CHILD PSY, V43, P598, DOI 10.1097/00004583-200405000-00013; El-Metwally A, 2008, EUR SPINE J, V17, P502, DOI 10.1007/s00586-008-0605-1; Eminson M, 1996, J CHILD PSYCHOL PSYC, V37, P519, DOI 10.1111/j.1469-7610.1996.tb01438.x; Garber J., 1991, PSYCHOL ASSESSMENT, V3, P588, DOI DOI 10.1037/1040-3590.3.4.588; Gilman J, 1998, EPICALC 2000 1 02; Groholt EK, 2003, EUR J EPIDEMIOL, V18, P965, DOI 10.1023/A:1025889912964; Husain Kaneez, 2007, Child Adolesc Ment Health, V12, P2, DOI 10.1111/j.1475-3588.2006.00419.x; IBM Corp, 2011, IBM SPSS STAT WIND 2; Jackson JL, 2008, PSYCHOSOM MED, V70, P430, DOI 10.1097/PSY.0b013e31816aa0ee; Jordan K, 2007, BRIT J GEN PRACT, V57, P7; Jordan K, 2006, J CLIN EPIDEMIOL, V59, P791, DOI 10.1016/j.jclinepi.2005.12.008; Jordan KP, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-144; Kashikar-Zuck S, 2008, ARTHRIT RHEUM-ARTHR, V59, P1392, DOI 10.1002/art.24099; LARSSON B, 1995, HEADACHE, V35, P513, DOI 10.1111/j.1526-4610.1995.hed3509513.x; Levy RL, 2000, AM J GASTROENTEROL, V95, P451, DOI 10.1111/j.1572-0241.2000.01766.x; Levy RL, 2001, GASTROENTEROLOGY, V121, P799, DOI 10.1053/gast.2001.27995; Levy RL, 2007, WORLD J GASTROENTERO, V13, P2397, DOI 10.3748/wjg.v13.i17.2397; Levy RL, 2010, AM J GASTROENTEROL, V105, P946, DOI 10.1038/ajg.2010.106; Little P, 2001, BRIT J GEN PRACT, V51, P977; Masiero S, 2010, ACTA PAEDIATR, V99, P1224, DOI 10.1111/j.1651-2227.2010.01770.x; Morris-Yates A, 1998, AM J GASTROENTEROL, V93, P1311; Perquin CW, 2001, PAIN, V94, P205, DOI 10.1016/S0304-3959(01)00355-4; Perquin CW, 2000, PAIN, V87, P51, DOI 10.1016/S0304-3959(00)00269-4; Peters S, 2002, FAM PRACT, V19, P665, DOI 10.1093/fampra/19.6.665; Porcheret M, 2004, J AM MED INFORM ASSN, V11, P78, DOI 10.1197/jamia.M1362; Rask CU, 2009, EUR J EPIDEMIOL, V24, P625, DOI 10.1007/s10654-009-9366-3; Reid S, 2001, BRIT MED J, V322, P767, DOI 10.1136/bmj.322.7289.767; Roth-Isigkeit A, 2004, ACTA PAEDIATR, V93, P258, DOI 10.1080/08035250310022577; Shraim M, 2013, BRIT J GEN PRACT, V63, pE318, DOI 10.3399/bjgp13X667178; SPECKENS AEM, 1995, BRIT MED J, V311, P1328, DOI 10.1136/bmj.311.7016.1328; StataCorp, 2011, STATA STAT SOFTWARE; Sumathipala A, 2000, PSYCHOL MED, V30, P747, DOI 10.1017/S0033291799002160; van Eekelen FCA, 2002, BRIT J GEN PRACT, V52, P211; WALKER LS, 1992, J PEDIATR PSYCHOL, V17, P49, DOI 10.1093/jpepsy/17.1.49; Walker LS, 2009, J PEDIATR PSYCHOL, V34, P430, DOI 10.1093/jpepsy/jsn093; WHITEHEAD WE, 1994, PSYCHOSOM MED, V56, P541, DOI 10.1097/00006842-199411000-00010	46	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108039	10.1371/journal.pone.0108039	http://dx.doi.org/10.1371/journal.pone.0108039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ0SJ	25251344	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000342492700071
J	Sun, L; Kawano-Yamashita, E; Nagata, T; Tsukamoto, H; Furutani, Y; Koyanagi, M; Terakita, A				Sun, Lanfang; Kawano-Yamashita, Emi; Nagata, Takashi; Tsukamoto, Hisao; Furutani, Yuji; Koyanagi, Mitsumasa; Terakita, Akihisa			Distribution of Mammalian-Like Melanopsin in Cyclostome Retinas Exhibiting a Different Extent of Visual Functions	PLOS ONE			English	Article							HORIZONTAL CELLS; GANGLION-CELLS; EPTATRETUS-BURGERI; PETROMYZON-MARINUS; COUPLED RHODOPSIN; CHICKEN RETINA; PHOTORECEPTORS; EXPRESSION; RESPONSES; LAMPREY	Mammals contain 1 melanopsin (Opn4) gene that is expressed in a subset of retinal ganglion cells to serve as a photopigment involved in non-image-forming vision such as photoentrainment of circadian rhythms. In contrast, most nonmammalian vertebrates possess multiple melanopsins that are distributed in various types of retinal cells; however, their functions remain unclear. We previously found that the lamprey has only 1 type of mammalian-like melanopsin gene, which is similar to that observed in mammals. Here we investigated the molecular properties and localization of melanopsin in the lamprey and other cyclostome hagfish retinas, which contribute to visual functions including image-forming vision and mainly to non-image-forming vision, respectively. We isolated 1 type of mammalian-like melanopsin cDNA from the eyes of each species. We showed that the recombinant lamprey melanopsin was a blue light-sensitive pigment and that both the lamprey and hagfish melanopsins caused light-dependent increases in calcium ion concentration in cultured cells in a manner that was similar to that observed for mammalian melanopsins. We observed that melanopsin was distributed in several types of retinal cells, including horizontal cells and ganglion cells, in the lamprey retina, despite the existence of only 1 melanopsin gene in the lamprey. In contrast, melanopsin was almost specifically distributed to retinal ganglion cells in the hagfish retina. Furthermore, we found that the melanopsin-expressing horizontal cells connected to the rhodopsin-containing short photoreceptor cells in the lamprey. Taken together, our findings suggest that in cyclostomes, the global distribution of melanopsin in retinal cells might not be related to the melanopsin gene number but to the extent of retinal contribution to visual function.	[Sun, Lanfang; Kawano-Yamashita, Emi; Nagata, Takashi; Koyanagi, Mitsumasa; Terakita, Akihisa] Osaka City Univ, Grad Sch Sci, Dept Biol & Geosci, Osaka 558, Japan; [Tsukamoto, Hisao; Furutani, Yuji] Inst Mol Sci, Dept life & Coordinat Complex Mol Sci, Okazaki, Aichi 444, Japan; [Tsukamoto, Hisao; Furutani, Yuji] Grad Univ Adv Studies SOKENDAI, Dept Struct Mol Sci, Okazaki, Aichi, Japan; [Koyanagi, Mitsumasa] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan	Osaka Metropolitan University; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST)	Terakita, A (corresponding author), Osaka City Univ, Grad Sch Sci, Dept Biol & Geosci, Osaka 558, Japan.	terakita@sci.osaka-cu.ac.jp	Furutani, Yuji/J-8337-2019; Nagata, Takashi/ABB-1780-2020	Furutani, Yuji/0000-0001-5284-8773; Nagata, Takashi/0000-0001-5379-2951; Koyanagi, Mitsumasa/0000-0002-7741-918X; Terakita, Akihisa/0000-0002-8379-8913	Japanese Ministry of Education, Science, Sports, and Culture; Japan Society for the Promotion of Science for Young Scientists; Grants-in-Aid for Scientific Research [26291070, 25840122] Funding Source: KAKEN	Japanese Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding provided by Grants-in-aid for Scientific Research from the Japanese Ministry of Education, Science, Sports, and Culture (to M. K. and A. T.) http://www.jsps.go.jp/english/e-grants/ and E.K.Y. is supported by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists. https://www.jsps.go.jp/english/e-pd/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailes HJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2987; Bellingham J, 2006, PLOS BIOL, V4, P1334, DOI 10.1371/journal.pbio.0040254; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Berson DM, 2003, TRENDS NEUROSCI, V26, P314, DOI 10.1016/S0166-2236(03)00130-9; BURKHARDT DA, 1977, J NEUROPHYSIOL, V40, P53, DOI 10.1152/jn.1977.40.1.53; Chaurasia SS, 2005, J NEUROCHEM, V92, P158, DOI 10.1111/j.1471-4159.2004.02874.x; Cheng N, 2009, NATURE, V460, P899, DOI 10.1038/nature08175; Davies WIL, 2011, CELL MOL LIFE SCI, V68, P4115, DOI 10.1007/s00018-011-0785-4; DICKSON DH, 1979, EXP EYE RES, V29, P45, DOI 10.1016/0014-4835(79)90165-9; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FERNHOLM B, 1975, VISION RES, V15, P253, DOI 10.1016/0042-6989(75)90215-1; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; HOLMGREN S, 1981, MAR BIOL LETT, V2, P265; Jenkins A, 2001, INVEST OPHTH VIS SCI, V42, pS671; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kawano-Yamashita E, 2007, J EXP BIOL, V210, P3821, DOI 10.1242/jeb.007161; Kikkawa S, 1996, BIOCHEMISTRY-US, V35, P15857, DOI 10.1021/bi961360v; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Koyanagi M, 2004, P NATL ACAD SCI USA, V101, P6687, DOI 10.1073/pnas.0400819101; Koyanagi M, 2002, FEBS LETT, V531, P525, DOI 10.1016/S0014-5793(02)03616-5; Koyanagi M, 2008, PHOTOCHEM PHOTOBIOL, V84, P1024, DOI 10.1111/j.1751-1097.2008.00369.x; KUSUNOKI T, 1983, BRAIN RES, V262, P295, DOI 10.1016/0006-8993(83)91021-1; LEE YJ, 1994, NEURON, V13, P1143, DOI 10.1016/0896-6273(94)90052-3; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Matos-Cruz V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025111; Matsuyama T, 2012, BIOCHEMISTRY-US, V51, P5454, DOI 10.1021/bi3004999; Muradov H, 2008, VISION RES, V48, P2302, DOI 10.1016/j.visres.2008.07.006; OOKASOUDA S, 1995, NEUROSCI LETT, V192, P201, DOI 10.1016/0304-3940(95)11645-D; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Pires SS, 2007, P R SOC B, V274, P2791, DOI 10.1098/rspb.2007.0976; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Raible F, 2006, DEV BIOL, V300, P461, DOI 10.1016/j.ydbio.2006.08.070; RANGANATHAN R, 1995, ANNU REV NEUROSCI, V18, P283; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SIMINOFF R, 1985, BIOL CYBERN, V52, P307, DOI 10.1007/BF00355753; TERAKITA A, 1993, FEBS LETT, V330, P197, DOI 10.1016/0014-5793(93)80272-V; Terakita A, 2008, J NEUROCHEM, V105, P883, DOI 10.1111/j.1471-4159.2007.05184.x; Thoreson WB, 2008, J NEUROSCI, V28, P5691, DOI 10.1523/JNEUROSCI.0403-08.2008; Tomonari S, 2005, DEV DYNAM, V234, P783, DOI 10.1002/dvdy.20600; Tomonari S, 2007, GENE EXPR PATTERNS, V7, P746, DOI 10.1016/j.modgep.2007.06.001; Tsukamoto H, 2013, J BIOL CHEM, V288, P28207, DOI 10.1074/jbc.M113.472464; Verweij J, 2003, J NEUROSCI, V23, P10249; Villar-Cheda B, 2006, BRAIN RES, V1068, P118, DOI 10.1016/j.brainres.2005.11.014; Wada S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039003	49	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108209	10.1371/journal.pone.0108209	http://dx.doi.org/10.1371/journal.pone.0108209			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251771	gold, Green Published, Green Submitted			2022-12-25	WOS:000342492700094
J	Yoo, JK; Braciale, TJ				Yoo, Jae-Kwang; Braciale, Thomas J.			IL-21 Promotes Late Activator APC-Mediated T Follicular Helper Cell Differentiation in Experimental Pulmonary Virus Infection	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ANTIBODY-PRODUCTION; IN-VITRO; INTERLEUKIN-21; RESPONSES; GENERATION; AUTOIMMUNITY; TUBERCULOSIS; EXPRESSION; EXPANSION	IL-21 is a type-I cytokine that has pleiotropic immuno-modulatory effects. Primarily produced by activated T cells including NKT and T-FH cells, IL-21 plays a pivotal role in promoting T-FH differentiation through poorly understood cellular and molecular mechanisms. Here, employing a mouse model of influenza A virus (IAV) infection, we demonstrate that IL-21, initially produced by NKT cells, promotes T-FH differentiation by promoting the migration of late activator antigen presenting cell (LAPC), a recently identified T-FH inducer, from the infected lungs into the draining lymph nodes (dLN). LAPC migration from IAV-infected lung into the dLN is CXCR3-CXCL9 dependent. IL-21-induced TNF-alpha production by conventional T cells is critical to stimulate CXCL9 expression by DCs in the dLN, which supports LAPC migration into the dLN and ultimately facilitates T-FH differentiation. Our results reveal a previously unappreciated mechanism for IL-21 modulation of T-FH responses during respiratory virus infection.	[Yoo, Jae-Kwang] Amgen Inc, Inflammat Res, Seattle, WA USA; [Yoo, Jae-Kwang; Braciale, Thomas J.] Univ Virginia, Carter Ctr Immunol Res, Charlottesville, VA 22903 USA; [Braciale, Thomas J.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Braciale, Thomas J.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA	Amgen; University of Virginia; University of Virginia; University of Virginia	Braciale, TJ (corresponding author), Univ Virginia, Carter Ctr Immunol Res, Charlottesville, VA 22903 USA.	tjb2r@virginia.edu			U.S. Public Health Service grants [AI-15608, HL-33391, AI-37293, U19 AI-083024]; American Lung Association; Amgen Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083024, R01AI015608, R01AI037293, R37AI015608] Funding Source: NIH RePORTER	U.S. Public Health Service grants(United States Department of Health & Human ServicesUnited States Public Health Service); American Lung Association; Amgen Inc.(Amgen); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by U.S. Public Health Service grants AI-15608, HL-33391, AI-37293 and U19 AI-083024 to T.J.B. and Senior Research Training Fellowship from American Lung Association to J.K.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Amgen Inc. provided support in the form of salary for author Jae-Kwang Yoo, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the author contributions section.	Algood HMS, 2005, CLIN INFECT DIS, V41, pS189, DOI 10.1086/429994; Algood HMS, 2004, J IMMUNOL, V172, P6846, DOI 10.4049/jimmunol.172.11.6846; Antonelli A, 2010, CYTOKINE, V50, P260, DOI 10.1016/j.cyto.2010.01.009; Antonelli A, 2009, J CLIN ENDOCR METAB, V94, P1803, DOI 10.1210/jc.2008-2450; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; Boyden AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040733; Brady J, 2010, J IMMUNOL, V185, P6679, DOI 10.4049/jimmunol.0903354; Chapman TJ, 2005, VIROLOGY, V340, P296, DOI 10.1016/j.virol.2005.06.023; Coquet JM, 2007, J IMMUNOL, V178, P2827, DOI 10.4049/jimmunol.178.5.2827; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Czermak BJ, 1999, J IMMUNOL, V162, P2321; Dienz O, 2009, J EXP MED, V206, P69, DOI 10.1084/jem.20081571; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Gorski SA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003615; Graham MB, 1997, J EXP MED, V186, P2063, DOI 10.1084/jem.186.12.2063; Harada M, 2006, J EXP MED, V203, P2929, DOI 10.1084/jem.20062206; Janatpour MJ, 2001, J EXP MED, V194, P1375, DOI 10.1084/jem.194.9.1375; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Li J, 2006, SCAND J IMMUNOL, V64, P515, DOI 10.1111/j.1365-3083.2006.01795.x; Liu SJ, 2007, INT IMMUNOL, V19, P1213, DOI 10.1093/intimm/dxm093; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Skak K, 2008, NAT REV DRUG DISCOV, V7, P231, DOI 10.1038/nrd2482; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Nguyen V, 2012, J IMMUNOL, V189, P1081, DOI 10.4049/jimmunol.1200318; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Waffarn EE, 2011, J IMMUNOL, V186, P3823, DOI 10.4049/jimmunol.1002090; Yoo JK, 2012, J EXP MED, V209, P1853, DOI 10.1084/jem.20112256; Yoo JK, 2010, ANTIVIR RES, V88, P64, DOI 10.1016/j.antiviral.2010.07.006; Yoo JK, 2010, J EXP MED, V207, P1435, DOI 10.1084/jem.20091373; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002	36	4	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e105872	10.1371/journal.pone.0105872	http://dx.doi.org/10.1371/journal.pone.0105872			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251568	gold, Green Published, Green Submitted			2022-12-25	WOS:000342492700010
J	Bao, MH; Zhang, YW; Lou, XY; Cheng, Y; Zhou, HH				Bao, Mei-hua; Zhang, Yi-wen; Lou, Xiao-ya; Cheng, Yu; Zhou, Hong-hao			Protective Effects of Let-7a and Let-7b on Oxidized Low-Density Lipoprotein Induced Endothelial Cell Injuries	PLOS ONE			English	Article							NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; SIGNALING PATHWAY; INDUCED APOPTOSIS; KNOCKOUT MICE; OX-LDL; DYSFUNCTION; EXPRESSION; RECEPTOR; LOX-1	Lectin-like low-density lipoprotein receptor 1 (LOX-1) is a receptor for oxidized low density lipoprotein (oxLDL) in endothelial cells. The activation of LOX-1 by oxLDL stimulates the apoptosis and dysfunction of endothelial cells, and contributes to atherogenesis. However, the regulatory factors for LOX-1 are still unclear. MicroRNAs are small, endogenous, non-coding RNAs that regulate gene expressions at a post-transcriptional level. The let-7 family is the second microRNA been discovered, which plays important roles in cardiovascular diseases. Let-7a and let-7b were predicted to target LOX-1 3'-UTR and be highly expressed in endothelial cells. The present study demonstrated that LOX-1 was a target of let-7a and let-7b. They inhibited the expression of LOX-1 by targeting the positions of 310-316 in LOX-1 3'-UTR. Over-expression of let-7a and let-7b inhibited the oxLDL-induced endothelial cell apoptosis, NO deficiency, ROS over-production, LOX-1 upregulation and endothelial nitric oxide synthase (eNOS) downregulation. Moreover, we found that oxLDL treatment induced p38MAPK phosphorylation, NF-kappa B nuclear translocation, I kappa B degradation and PKB dephosphorylation. Let-7a or let-7b over-expression attenuated these alterations significantly. The present study may provide a new insight into the protective properties of let-7a and let-7b in preventing the endothelial dysfunction associated with cardiovascular disease, such as atherosclerosis.	[Bao, Mei-hua] Changsha Med Univ, Inst Neurosci, Dept Human Anat Histol & Embryol, Changsha, Hunan, Peoples R China; [Bao, Mei-hua; Zhang, Yi-wen; Lou, Xiao-ya; Cheng, Yu; Zhou, Hong-hao] Cent S Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha, Hunan, Peoples R China; [Bao, Mei-hua; Zhang, Yi-wen; Lou, Xiao-ya; Cheng, Yu; Zhou, Hong-hao] Cent S Univ, Inst Clin Pharmacol, Hunan Key Lab Pharmacogenet, Changsha, Hunan, Peoples R China	Changsha Medical University; Central South University; Central South University	Zhou, HH (corresponding author), Cent S Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha, Hunan, Peoples R China.	HHzhou2003@163.com			Construct program of the key discipline in Hunan Province, National Sciences Foundation of China [81300231]; Hunan Provincial Natural Sciences Foundation of China [13JJ4112]	Construct program of the key discipline in Hunan Province, National Sciences Foundation of China; Hunan Provincial Natural Sciences Foundation of China	This work was supported by the Construct program of the key discipline in Hunan Province, National Sciences Foundation of China ( No. 81300231), Hunan Provincial Natural Sciences Foundation of China (No. 13JJ4112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao MH, 2013, INT J MOL SCI, V14, P23086, DOI 10.3390/ijms141123086; Bao MH, 2013, J ETHNOPHARMACOL, V146, P543, DOI 10.1016/j.jep.2013.01.019; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Celermajer DS, 1997, J AM COLL CARDIOL, V30, P325, DOI 10.1016/S0735-1097(97)00189-7; Chen KC, 2011, J CELL SCI, V124, P4115, DOI 10.1242/jcs.092767; Chen MJ, 2002, PHARMACOL THERAPEUT, V95, P89, DOI 10.1016/S0163-7258(02)00236-X; Choy JC, 2001, J MOL CELL CARDIOL, V33, P1673, DOI 10.1006/jmcc.2001.1419; Cominacini L, 2000, J BIOL CHEM, V275, P12633, DOI 10.1074/jbc.275.17.12633; Ding ZF, 2013, INT J CARDIOL, V168, P1378, DOI 10.1016/j.ijcard.2012.12.045; Du XL, 1999, FREE RADICAL BIO MED, V27, P752, DOI 10.1016/S0891-5849(99)00079-9; Ho FM, 2006, CELL SIGNAL, V18, P391, DOI 10.1016/j.cellsig.2005.05.009; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Imanishi T, 2002, CIRC J, V66, P1060, DOI 10.1253/circj.66.1060; Jiang F, 2001, EUR J PHARMACOL, V424, P141, DOI 10.1016/S0014-2999(01)01140-2; Kataoka H, 1999, CIRCULATION, V99, P3110, DOI 10.1161/01.CIR.99.24.3110; Khan MS, 2011, CHEM-BIOL INTERACT, V193, P12, DOI 10.1016/j.cbi.2011.04.007; Knowles JW, 2000, J CLIN INVEST, V105, P451, DOI 10.1172/JCI8376; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Lee WJ, 2010, J VASC SURG, V52, P1290, DOI 10.1016/j.jvs.2010.04.085; Li DY, 2003, ARTERIOSCL THROM VAS, V23, P816, DOI 10.1161/01.ATV.0000066685.13434.FA; Li DY, 2001, CARDIOVASC RES, V52, P130, DOI 10.1016/S0008-6363(01)00371-6; LIAO JK, 1995, J BIOL CHEM, V270, P319, DOI 10.1074/jbc.270.1.319; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Oemar BS, 1998, CIRCULATION, V97, P2494, DOI 10.1161/01.CIR.97.25.2494; Ogura S, 2009, CIRC J, V73, P1993, DOI 10.1253/circj.CJ-09-0587; Ou HC, 2010, J APPL PHYSIOL, V108, P1745, DOI 10.1152/japplphysiol.00879.2009; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Robbesyn F, 2004, FREE RADICAL RES, V38, P541, DOI 10.1080/10715760410001665244; Satoh M, 2011, J CARD FAIL, V17, P923, DOI 10.1016/j.cardfail.2011.07.012; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Smirnova IV, 2004, AM J PHYSIOL-HEART C, V287, pH782, DOI 10.1152/ajpheart.00822.2003; Stein S, 2011, CELL CYCLE, V10, P640, DOI 10.4161/cc.10.4.14863; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Xu XB, 2007, ARTERIOSCL THROM VAS, V27, P871, DOI 10.1161/01.ATV.0000259358.31234.37; Yoshida H, 1998, BIOCHEM J, V334, P9, DOI 10.1042/bj3340009; Yoshimoto R, 2011, CARDIOVASC DRUG THER, V25, P379, DOI 10.1007/s10557-011-6324-6	36	48	53	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e106540	10.1371/journal.pone.0106540	http://dx.doi.org/10.1371/journal.pone.0106540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247304	gold, Green Submitted, Green Published			2022-12-25	WOS:000342351800011
J	Nascimento, DSM; Castro-Lopes, JM; Neto, FLM				Marques Nascimento, Diana Sofia; Castro-Lopes, Jose Manuel; Moreira Neto, Fani Lourenca			Satellite Glial Cells Surrounding Primary Afferent Neurons Are Activated and Proliferate during Monoarthritis in Rats: Is There a Role for ATF3?	PLOS ONE			English	Article							MURINE SENSORY GANGLIA; TRIGEMINAL GANGLION; TRANSCRIPTION FACTOR-3; PAIN; EXPRESSION; INFLAMMATION; RECEPTORS; INJURY; COMMUNICATION; MODEL	Joint inflammatory diseases are debilitating and very painful conditions that still lack effective treatments. Recently, glial cells were shown to be crucial for the development and maintenance of chronic pain, constituting novel targets for therapeutic approaches. At the periphery, the satellite glial cells (SGCs) that surround the cell bodies of primary afferents neurons in the dorsal root ganglia (DRG) display hypertrophy, proliferation, and activation following injury and/or inflammation. It has been suggested that the expression of neuronal injury factors might initially trigger these SGCs-related events. We then aimed at evaluating if SGCs are involved in the establishment/maintenance of articular inflammatory pain, by using the monoarthritis (MA) model, and if the neuronal injury marker activating transcriptional factor 3 (ATF3) is associated with these SGCs' reactive changes. Western Blot (WB) analysis of the glial fibrillary acidic protein (GFAP) expression was performed in L4-L5 DRGs from control non-inflamed rats and MA animals at different time-points of disease (4, 7, and 14d, induced by complete Freund's adjuvant injection into the left hind paw ankle joint). Data indicate that SGCs activation is occurring in MA animals, particularly after day 7 of disease evolution. Additionally, double-immunostaining for ATF3 and GFAP in L5 DRG sections shows that SGCs's activation significantly increases around stressed neurons at 7d of disease, when compared with control animals. The specific labelling of GFAP in SGCs rather than in other cell types was also confirmed by immunohistochemical labeling. Finally, BrdU incorporation indicates that proliferation of SGCs is also significantly increased after 7 days of MA. Data indicate that SGCs play an important role in the mechanisms of articular inflammation, with 7 days of disease being a critical time-point in the MA model, and suggest that ATF3 might be involved in SGCs' reactive changes such as activation.	[Marques Nascimento, Diana Sofia; Castro-Lopes, Jose Manuel; Moreira Neto, Fani Lourenca] Univ Porto, Fac Med Porto, CIM, Dept Biol Expt, P-4100 Oporto, Portugal; [Marques Nascimento, Diana Sofia; Castro-Lopes, Jose Manuel; Moreira Neto, Fani Lourenca] IBMC, Morphophysiol Somatosensory Syst Grp, Oporto, Portugal	Universidade do Porto; Universidade do Porto	Neto, FLM (corresponding author), Univ Porto, Fac Med Porto, CIM, Dept Biol Expt, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	fanineto@med.up.pt	Nascimento, Diana/AAL-7873-2020; Nascimento, Diana S M/T-6787-2018; Neto, Fani/S-5991-2019; Neto, Fani/J-8302-2013; Castro-Lopes, Jose/J-9346-2013	Nascimento, Diana/0000-0003-3765-4801; Nascimento, Diana S M/0000-0003-3765-4801; Neto, Fani/0000-0002-2352-3336; Neto, Fani/0000-0002-2352-3336; Castro-Lopes, Jose/0000-0002-0357-7409	Catedra em Medicina da Dor Fundacao Grunenthal/Faculdade de Medicina da Universidade do Porto; Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [SFRH/BD/79497/2011]	Catedra em Medicina da Dor Fundacao Grunenthal/Faculdade de Medicina da Universidade do Porto; Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology)	Catedra em Medicina da Dor Fundacao Grunenthal/Faculdade de Medicina da Universidade do Porto partially granted this study. The first author received a doctoral grant(SFRH/BD/79497/2011) by Fundacao para a Ciencia e a Tecnologia (FCT), Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajima H, 2001, ARCH HISTOL CYTOL, V64, P503, DOI 10.1679/aohc.64.503; Borges G, 2014, ANESTHESIOLOGY, V120, P1476, DOI 10.1097/ALN.0000000000000177; Braz JM, 2010, PAIN, V150, P290, DOI 10.1016/j.pain.2010.05.005; BUTLER SH, 1992, PAIN, V48, P73, DOI 10.1016/0304-3959(92)90133-V; CASTROLOPES JM, 1992, EUR J NEUROSCI, V4, P296, DOI 10.1111/j.1460-9568.1992.tb00877.x; Ceruti S, 2011, J NEUROSCI, V31, P3638, DOI 10.1523/JNEUROSCI.6440-10.2011; Chen Y, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-9; Donegan M, 2013, GLIA, V61, P2000, DOI 10.1002/glia.22571; Elson K, 2004, EXP NEUROL, V186, P99, DOI 10.1016/j.expneurol.2003.10.017; Elson K, 2004, GLIA, V45, P105, DOI 10.1002/glia.10294; Elson K, 2003, J GEN VIROL, V84, P1079, DOI 10.1099/vir.0.19035-0; Gascon E, 2010, ARCH PHARM RES, V33, P1489, DOI 10.1007/s12272-010-1003-x; Gunjigake KK, 2009, ACTA HISTOCHEM CYTOC, V42, P143, DOI 10.1267/ahc.09017; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Hanani M, 2002, NEUROSCIENCE, V114, P279, DOI 10.1016/S0306-4522(02)00279-8; Hanani M, 2012, BRAIN RES, V1487, P183, DOI 10.1016/j.brainres.2012.03.070; Hunt D, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-9; Hunt D, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00007; Inglis JJ, 2007, ARTHRITIS RHEUM-US, V56, P4015, DOI 10.1002/art.23063; Isacsson A, 2005, SCAND J PLAST RECONS, V39, P65, DOI 10.1080/02844310410004892; Jasmin L, 2010, NEURON GLIA BIOL, V6, P63, DOI 10.1017/S1740925X10000098; Liu FY, 2012, BRAIN RES, V1427, P65, DOI 10.1016/j.brainres.2011.10.016; LU X, 1991, J NEUROSCI, V11, P972; Nascimento D, 2011, NEUROSIGNALS, V19, P210, DOI 10.1159/000330195; Neto FL, 2000, MOL BRAIN RES, V81, P140; Ohara PT, 2009, NEUROSCIENTIST, V15, P450, DOI 10.1177/1073858409336094; Pannese E, 1981, Adv Anat Embryol Cell Biol, V65, P1; Schaible HG, 2009, EXP BRAIN RES, V196, P153, DOI 10.1007/s00221-009-1782-9; Siemionow K, 2009, SPINE, V34, P1631, DOI 10.1097/BRS.0b013e3181ab1f68; Souza GR, 2013, P NATL ACAD SCI USA, V110, P11193, DOI 10.1073/pnas.1307445110; STEPHENSON JL, 1995, EXP NEUROL, V131, P11, DOI 10.1016/0014-4886(95)90003-9; Takeda M, 2007, PAIN, V129, P155, DOI 10.1016/j.pain.2006.10.007; Takeda M, 2009, NEUROSCI BIOBEHAV R, V33, P784, DOI 10.1016/j.neubiorev.2008.12.005; Warwick RA, 2013, EUR J PAIN, V17, P571, DOI 10.1002/j.1532-2149.2012.00219.x; Zhang HJ, 2009, GLIA, V57, P1588, DOI 10.1002/glia.20872; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	36	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108152	10.1371/journal.pone.0108152	http://dx.doi.org/10.1371/journal.pone.0108152			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247596	gold, Green Published, Green Submitted			2022-12-25	WOS:000342351800069
J	de Cuevas, RMA; Al-Sonboli, N; Al-Aghbari, N; Yassin, MA; Cuevas, LE; Theobald, SJ				de Cuevas, Rachel M. Anderson; Al-Sonboli, Najla; Al-Aghbari, Nasher; Yassin, Mohammed A.; Cuevas, Luis E.; Theobald, Sally J.			Barriers to Completing TB Diagnosis in Yemen: Services Should Respond to Patients' Needs	PLOS ONE			English	Article							TUBERCULOSIS SERVICES; PULMONARY TUBERCULOSIS; ADDIS-ABABA; GENDER; DETERMINANTS; MANAGEMENT; POVERTY; STIGMA; MALAWI; FAMILY	Objectives and Background: Obtaining a diagnosis of tuberculosis (TB) is a prerequisite for accessing specific treatment, yet one third of estimated new cases are missed worldwide by National Programmes. This study investigated economic, geographical, socio-cultural and health system factors hindering adults' attendance and completion of the TB diagnostic process in Yemen, to inform interventions designed to improve patient access to services. Methodology: The study employed a mixed methods design comprising a cross-sectional survey and In-Depth-Interviews (IDIs) and Focus Group Discussions (FGDs) among patients abandoning the diagnosis or registering for treatment. Adults with cough of >= 2 weeks attending a large governmental referral centre in Sana'a, Yemen, between 2009 and 2010, were eligible to participate. Results: 497 and 446 (89.7%) participants were surveyed the first and second day of attending the services and 48 IDIs and 12 FGDs were also conducted. The majority of patients were disadvantaged and had poor literacy (61% illiterate), had travelled from rural areas (47%) and attended with companions (84%). Key barriers for attendance identified were clinic and transport costs (augmented by companions), distance from home, a preference for private services, strong social stigma and a lack of understanding of the diagnostic process. There were discrepancies between patient-and doctor-reported diagnosis and 46% of patients were unaware that TB treatment is free. Females faced more difficulties to attend than men. The laboratory practice of providing first-day negative smear results and making referrals to the private sector also discouraged patients from returning. Strategies to bring TB diagnostic services closer to communities and address the multiple barriers patients face to attend, will be important to increase access to TB diagnosis and care.	[de Cuevas, Rachel M. Anderson; Yassin, Mohammed A.; Theobald, Sally J.] Univ Liverpool, Liverpool Sch Trop Med, Dept Int Publ Hlth, Liverpool L3 5QA, Merseyside, England; [Al-Sonboli, Najla; Al-Aghbari, Nasher] Sanaa Univ, Fac Med, Sanaa, Yemen; [Cuevas, Luis E.] Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool; Liverpool School of Tropical Medicine; University of Liverpool	de Cuevas, RMA (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Dept Int Publ Hlth, Liverpool L3 5QA, Merseyside, England.	rma@liv.ac.uk	de Cuevas, Rachel M Anderson/P-9185-2017; Cuevas, Luis E/I-3697-2015	de Cuevas, Rachel M Anderson/0000-0001-7790-5332; Cuevas, Luis E/0000-0002-6581-0587; Yassin, Mohammed Ahmed/0000-0002-9766-2072; Theobald, Sally/0000-0002-9053-211X	Economic and Social Research Council (ESRC) [RES-167-25-0387]; Department for International Development (DfID) [RES-167-25-0387]; Economic and Social Research Council [ES/F027702/1, ES/L007746/1] Funding Source: researchfish; ESRC [ES/F027702/1, ES/L007746/1] Funding Source: UKRI	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department for International Development (DfID); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The study was funded by a joint research programme of the Economic and Social Research Council (ESRC) and the Department for International Development (DfID). Grant Reference: RES-167-25-0387. LEC, SJT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, ANN REP NAT TUB CONT; [Anonymous], YEM TUB PROF; Atre S, 2011, GLOB PUBLIC HEALTH, V6, P56, DOI 10.1080/17441690903334240; Banerjee A, 2000, INT J TUBERC LUNG D, V4, P1047; Bates I, 2004, LANCET INFECT DIS, V4, P267, DOI 10.1016/S1473-3099(04)01002-3; Cambanis A, 2005, TROP MED INT HEALTH, V10, P330, DOI 10.1111/j.1365-3156.2005.01393.x; Chard SE, 2009, MED ANTHROPOL Q, V23, P257, DOI 10.1111/j.1548-1387.2009.01059.x; Cuevas LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000443; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Gebremariam MK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-651; Gilpin C, 2011, TUBERC RES TREAT, V2011, DOI DOI 10.1155/2011/548617; Horna-Campos OJ, 2007, EMERG INFECT DIS, V13, P1491, DOI 10.3201/eid1310.060793; Kemp JR, 2007, B WORLD HEALTH ORGAN, V85, P580, DOI 10.2471/BLT.06.033167; Khan A, 2000, SOC SCI MED, V50, P247, DOI 10.1016/S0277-9536(99)00279-8; Khan MS, 2009, TROP MED INT HEALTH, V14, P1437, DOI 10.1111/j.1365-3156.2009.02406.x; Lienhardt C, 2012, NAT REV MICROBIOL, V10, P407, DOI 10.1038/nrmicro2797; Long NH, 2001, HEALTH POLICY, V58, P69, DOI 10.1016/S0168-8510(01)00143-9; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Macq J, 2006, Psychol Health Med, V11, P346, DOI 10.1080/13548500600595277; Mauch V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-43; Meessen B, 2011, HEALTH POLICY PLANN, V26, pII16, DOI 10.1093/heapol/czr062; OECD, 2012, 2012 SIGI SOC I GEND; Rajeswari R, 1999, INT J TUBERC LUNG D, V3, P869; Ramsay A, 2010, INT J TUBERC LUNG D, V14, P165; Ramsay A, 2009, J TROP MED-US, V2009, DOI 10.1155/2009/398767; Ritchie J, 1994, QUALITATIVE DATA ANA; RUBEL AJ, 1992, PUBLIC HEALTH REP, V107, P626; Sagbakken M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-11; Sagbakken M, 2008, QUAL HEALTH RES, V18, P1356, DOI 10.1177/1049732308322596; Somma D, 2008, INT J TUBERC LUNG D, V12, P856; Squire SB, 2005, INT J TUBERC LUNG D, V9, P25; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Waisbord S, 2007, SOC SCI MED, V65, P2130, DOI 10.1016/j.socscimed.2007.06.023; Wei X, 2008, INT J TUBERC LUNG D, V12, P538; Wells WA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018964; Whitehead M, 2001, LANCET, V358, P833, DOI 10.1016/S0140-6736(01)05975-X; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2005, ADDR POV TB CONTR OP; Yan F, 2007, HEALTH POLICY, V82, P186, DOI 10.1016/j.healthpol.2006.08.001; Yassin MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063174	40	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e105194	10.1371/journal.pone.0105194	http://dx.doi.org/10.1371/journal.pone.0105194			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6FX	25244396	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000343679800003
J	Franck, N; Maris, M; Nalbandian, S; Talukdar, S; Schenk, S; Hofmann, HP; Bullough, D; Osborn, O				Franck, Niclas; Maris, Michael; Nalbandian, Sarah; Talukdar, Saswata; Schenk, Simon; Hofmann, Hans-Peter; Bullough, David; Osborn, Olivia			Knock-Down of IL-1Ra in Obese Mice Decreases Liver Inflammation and Improves Insulin Sensitivity	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; HIGH-FAT DIET; METABOLIC-SYNDROME; ADIPOSE-TISSUE; FOOD-INTAKE; DISEASE; MECHANISMS; ANTISENSE; PROTECTS; LEPTIN	Interleukin 1 Receptor antagonist (IL-1Ra) is highly elevated in obesity and is widely recognized as an anti-inflammatory cytokine. While the anti-inflammatory role of IL-1Ra in the pancreas is well established, the role of IL-1Ra in other insulin target tissues and the contribution of systemic IL-1Ra levels to the development of insulin resistance remains to be defined. Using antisense knock down of IL-1Ra in vivo, we show that normalization of IL-1Ra improved insulin sensitivity due to decreased inflammation in the liver and improved hepatic insulin sensitivity and these effects were independent of changes in body weight. A similar effect was observed in IL1-R1 KO mice, suggesting that at high concentrations of IL-1Ra typically observed in obesity, IL-1Ra can contribute to the development of insulin resistance in a mechanism independent of IL-1Ra binding to IL-1R1. These results demonstrate that normalization of plasma IL-1Ra concentration improves insulin sensitivity in diet-induced obese mice.	[Franck, Niclas; Maris, Michael; Nalbandian, Sarah; Osborn, Olivia] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Maris, Michael] Katholieke Univ Leuven, Leuven, Belgium; [Talukdar, Saswata; Hofmann, Hans-Peter; Bullough, David] Pfizer Inc, Res Labs, Cambridge, MA USA; [Schenk, Simon] Univ Calif San Diego, Dept Orthoped Surg, La Jolla, CA 92093 USA	University of California System; University of California San Diego; KU Leuven; Pfizer; University of California System; University of California San Diego	Osborn, O (corresponding author), Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA.	oosborn@ucsd.edu	osborn, olivia/R-1460-2018	osborn, olivia/0000-0003-0516-7937; Schenk, Simon/0000-0002-8224-3203	National Institutes of Health (NIH) [DK-033651, DK-074868, T32-DK-007494, DK-063491]; Pfizer; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK033651, T32DK007494, R01DK033651, P01DK074868, P30DK063491] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (NIH) grants: DK-033651, DK-074868, T32-DK-007494, DK-063491 and from a grant from Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AREND W P, 1990, Progress in Growth Factor Research, V2, P193, DOI 10.1016/0955-2235(90)90018-F; Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; BORASCHI D, 1995, J IMMUNOL, V155, P4719; Boutin H, 2003, MOL NEUROBIOL, V27, P239, DOI 10.1385/MN:27:3:239; Carstensen M, 2010, DIABETES, V59, P1222, DOI 10.2337/db09-1199; Chida D, 2008, DIABETOLOGIA, V51, P1698, DOI 10.1007/s00125-008-1075-z; Di Martino MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089659; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Gabay C, 1997, J CLIN INVEST, V99, P2930, DOI 10.1172/JCI119488; Garcia MC, 2006, DIABETES, V55, P1205, DOI 10.2337/db05-1304; GREENFEDER SA, 1995, J BIOL CHEM, V270, P13757, DOI 10.1074/jbc.270.23.13757; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Gupta N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010682; Halvorsen B, 2010, EUR J ENDOCRINOL, V162, P267, DOI 10.1530/EJE-09-0706; Herder C, 2009, DIABETES CARE, V32, P421, DOI 10.2337/dc08-1161; Juge-Aubry CE, 2003, DIABETES, V52, P1104, DOI 10.2337/diabetes.52.5.1104; KOCH T, 2008, RSC BIOMOL SCI, P103; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Loscher CE, 2003, J NEUROIMMUNOL, V137, P117, DOI 10.1016/S0165-5728(03)00072-9; Luheshi GN, 1998, ANN NY ACAD SCI, V856, P83, DOI 10.1111/j.1749-6632.1998.tb08316.x; Luheshi GN, 1999, P NATL ACAD SCI USA, V96, P7047, DOI 10.1073/pnas.96.12.7047; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; Matsuki T, 2003, J EXP MED, V198, P877, DOI 10.1084/jem.20030299; McGillicuddy FC, 2011, DIABETES, V60, P1688, DOI 10.2337/db10-1278; Meier CA, 2002, J CLIN ENDOCR METAB, V87, P1184, DOI 10.1210/jc.87.3.1184; Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751; Moschos SA, 2011, MOL THER, V19, P2163, DOI 10.1038/mt.2011.206; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Osborn O, 2008, CYTOKINE, V44, P141, DOI 10.1016/j.cyto.2008.07.004; Owyang AM, 2010, ENDOCRINOLOGY, V151, P2515, DOI 10.1210/en.2009-1124; Salomaa V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010100; Saltevo J, 2008, DIABETES-METAB RES, V24, P378, DOI 10.1002/dmrr.831; Sanchez-Alavez M, 2011, J BIOL CHEM, V286, P14983, DOI 10.1074/jbc.M110.188540; Sauter NS, 2008, ENDOCRINOLOGY, V149, P2208, DOI 10.1210/en.2007-1059; Somm E, 2006, DIABETOLOGIA, V49, P387, DOI 10.1007/s00125-005-0046-x; Somm E, 2005, DIABETES, V54, P3503, DOI 10.2337/diabetes.54.12.3503; Stanton R, 2012, NUCLEIC ACID THER, V22, P344, DOI 10.1089/nat.2012.0366; STEELE R, 1956, AM J PHYSIOL, V187, P15, DOI 10.1152/ajplegacy.1956.187.1.15; van Asseldonk EJP, 2011, J CLIN ENDOCR METAB, V96, P2119, DOI 10.1210/jc.2010-2992; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08	43	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107487	10.1371/journal.pone.0107487	http://dx.doi.org/10.1371/journal.pone.0107487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244011	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800036
J	Fulton, JE; Arango, J; Ali, RA; Bohorquez, EB; Lund, AR; Ashwell, CM; Settar, P; O'Sullivan, NP; Koci, MD				Fulton, Janet E.; Arango, Jesus; Ali, Rizwana A.; Bohorquez, Elaine B.; Lund, Ashlee R.; Ashwell, Chris M.; Settar, Petek; O'Sullivan, Neil P.; Koci, Matthew D.			Genetic Variation within the Mx Gene of Commercially Selected Chicken Lines Reveals Multiple Haplotypes, Recombination and a Protein under Selection Pressure	PLOS ONE			English	Article							DIFFERENTIAL ANTIVIRAL ACTIVITY; AVIAN INFLUENZA-VIRUS; RESISTANCE; POLYMORPHISMS; CELLS; EVOLUTIONARY; ASSOCIATIONS; POSITION-631; SPECIFICITY; PROMOTER	The Mx protein is one of the best-characterized interferon-stimulated antiviral mediators. Mx homologs have been identified in most vertebrates examined; however, their location within the cell, their level of activity, and the viruses they inhibit vary widely. Recent studies have demonstrated multiple Mx alleles in chickens and some reports have suggested a specific variant (S631N) within exon 14 confers antiviral activity. In the current study, the complete genome of nine elite egg-layer type lines were sequenced and multiple variants of the Mx gene identified. Within the coding region and upstream putative promoter region 36 SNP variants were identified, producing a total of 12 unique haplotypes. Each elite line contained from one to four haplotypes, with many of these haplotypes being found in only one line. Observation of changes in haplotype frequency over generations, as well as recombination, suggested some unknown selection pressure on the Mx gene. Trait association analysis with either individual SNP or haplotypes showed a significant effect of Mx haplotype on several egg production related traits, and on mortality following Marek's disease virus challenge in some lines. Examination of the location of the various SNP within the protein suggests synonymous SNP tend to be found within structural or enzymatic regions of the protein, while non-synonymous SNP are located in less well defined regions. The putative resistance variant N631 was found in five of the 12 haplotypes with an overall frequency of 47% across the nine lines. Two Mx recombinants were identified within the elite populations, indicating that novel variation can arise and be maintained within intensively selected lines. Collectively, these results suggest the conflicting reports in the literature describing the impact of the different SNP on chicken Mx function may be due to the varying context of haplotypes present in the populations studied.	[Fulton, Janet E.; Arango, Jesus; Lund, Ashlee R.; Settar, Petek; O'Sullivan, Neil P.] Hy Line Int, Dallas Ctr, W Des Moines, IA 50266 USA; [Ali, Rizwana A.; Bohorquez, Elaine B.; Ashwell, Chris M.; Koci, Matthew D.] N Carolina State Univ, Prestage Dept Poultry Sci, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Fulton, JE (corresponding author), Hy Line Int, Dallas Ctr, W Des Moines, IA 50266 USA.	jfulton@hyline.com; mdkoci@ncsu.edu	; Ashwell, Christopher/N-1332-2016	Koci, Matthew/0000-0002-5766-4049; Ashwell, Christopher/0000-0002-8190-1147	North Carolina Agriculture Foundation; Hy-Line International	North Carolina Agriculture Foundation; Hy-Line International	EB was supported in part by a grant from the North Carolina Agriculture Foundation. NCAF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Analyses conducted by MK and CA were supported in part by a grant from Hy-Line International. Hy-Line International provided support in the form of salaries for authors JEF, JA, ARL, PS and NPO, and did have a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Balkissoon D, 2007, IMMUNOGENETICS, V59, P687, DOI 10.1007/s00251-007-0235-5; BAZZIGHER L, 1993, VIROLOGY, V195, P100, DOI 10.1006/viro.1993.1350; Benfield CTO, 2008, J VIROL, V82, P7533, DOI 10.1128/JVI.00185-08; Benfield CTO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012151; Berlin S, 2008, IMMUNOGENETICS, V60, P689, DOI 10.1007/s00251-008-0324-0; BERNASCONI D, 1995, J INTERF CYTOK RES, V15, P47, DOI 10.1089/jir.1995.15.47; Clark AG, 2004, GENET EPIDEMIOL, V27, P321, DOI 10.1002/gepi.20025; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Ewald SJ, 2011, IMMUNOGENETICS, V63, P363, DOI 10.1007/s00251-010-0509-1; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; Fulton JE, 2013, AVIAN DIS, V57, P519, DOI 10.1637/10408-100212-Reg.1; Gao S, 2011, IMMUNITY, V35, P514, DOI 10.1016/j.immuni.2011.07.012; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; HORISBERGER MA, 1985, J BIOL CHEM, V260, P1730; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; KASAI Y, 1992, MOL CELL BIOL, V12, P2884, DOI 10.1128/MCB.12.6.2884; Ko JH, 2004, ANIM GENET, V35, P119, DOI 10.1111/j.1365-2052.2004.01096.x; Ko JH, 2002, GENOME RES, V12, P595, DOI 10.1101/gr.210702. Article published online before print in March ; Kranis A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-59; Leabman MK, 2003, P NATL ACAD SCI USA, V100, P5896, DOI 10.1073/pnas.0730857100; Li XY, 2007, POULTRY SCI, V86, P786, DOI 10.1093/ps/86.4.786; Li XY, 2006, POULTRY SCI, V85, P1327, DOI 10.1093/ps/85.7.1327; Livant EJ, 2007, ANIM GENET, V38, P177, DOI 10.1111/j.1365-2052.2007.01577.x; Mitchell PS, 2012, CELL HOST MICROBE, V12, P598, DOI 10.1016/j.chom.2012.09.005; PITOSSI F, 1993, J VIROL, V67, P6726, DOI 10.1128/JVI.67.11.6726-6732.1993; Sartika Tike, 2011, BMC Proc, V5 Suppl 4, pS37, DOI 10.1186/1753-6561-5-S4-S37; SCHUMACHER B, 1994, VIROLOGY, V203, P144, DOI 10.1006/viro.1994.1464; Schusser B, 2011, J VIROL, V85, P8307, DOI 10.1128/JVI.00535-11; Semagn K, 2014, MOL BREEDING, V33, P1, DOI 10.1007/s11032-013-9917-x; Seyama T, 2006, BIOCHEM GENET, V44, P437, DOI 10.1007/s10528-006-9040-3; Sironi L, 2008, VIROLOGY; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Wang Y, 2012, POULTRY SCI, V91, P3019, DOI 10.3382/ps.2012-02471; Watanabe T, 2007, CYTOGENET GENOME RES, V117, P370, DOI 10.1159/000103200; Wolc A, 2011, POULTRY SCI, V90, P30, DOI 10.3382/ps.2010-01118; Yin CG, 2010, POULTRY SCI, V89, P2259, DOI 10.3382/ps.2010-00826	36	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e108054	10.1371/journal.pone.0108054	http://dx.doi.org/10.1371/journal.pone.0108054			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244433	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800063
J	Sellitto, M; di Pellegrino, G				Sellitto, Manuela; di Pellegrino, Giuseppe			Errors Affect Hypothetical Intertemporal Food Choice in Women	PLOS ONE			English	Article							DUTCH EATING BEHAVIOR; PREFRONTAL CORTEX; SELF-CONTROL; DECISION-MAKING; NEGATIVE AFFECT; SUBJECTIVE-PROBABILITY; RESPONSE-INHIBITION; REWARD SENSITIVITY; NUCLEUS-ACCUMBENS; COGNITIVE CONTROL	Growing evidence suggests that the ability to control behavior is enhanced in contexts in which errors are more frequent. Here we investigated whether pairing desirable food with errors could decrease impulsive choice during hypothetical temporal decisions about food. To this end, healthy women performed a Stop-signal task in which one food cue predicted high-error rate, and another food cue predicted low-error rate. Afterwards, we measured participants' intertemporal preferences during decisions between smaller-immediate and larger-delayed amounts of food. We expected reduced sensitivity to smaller-immediate amounts of food associated with high-error rate. Moreover, taking into account that deprivational states affect sensitivity for food, we controlled for participants' hunger. Results showed that pairing food with high-error likelihood decreased temporal discounting. This effect was modulated by hunger, indicating that, the lower the hunger level, the more participants showed reduced impulsive preference for the food previously associated with a high number of errors as compared with the other food. These findings reveal that errors, which are motivationally salient events that recruit cognitive control and drive avoidance learning against error-prone behavior, are effective in reducing impulsive choice for edible outcomes.	[Sellitto, Manuela; di Pellegrino, Giuseppe] Univ Bologna, Dipartimento Psicol, Bologna, Italy; [Sellitto, Manuela; di Pellegrino, Giuseppe] Polo Sci Didattico Cesena, Ctr Studi & Ric Neurosci Cognit, Cesena, Italy	University of Bologna	di Pellegrino, G (corresponding author), Univ Bologna, Dipartimento Psicol, Bologna, Italy.	g.dipellegrino@unibo.it	di Pellegrino, Giuseppe/AAC-7149-2022	di Pellegrino, Giuseppe/0000-0001-7080-4758; Sellitto, Manuela/0000-0002-3987-7526	Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale (PRIN) grant from Ministero Istruzione Universitae Ricerca [2010XPMFW4_009]	Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale (PRIN) grant from Ministero Istruzione Universitae Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by a Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale (PRIN) grant from Ministero Istruzione Universitae Ricerca (PRIN 2010, protocol number: 2010XPMFW4_009) awarded to GdP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSLIE G, 1975, PSYCHOL BULL, V82, P463, DOI 10.1037/h0076860; [Anonymous], 1991, BRIT MED J, V302, P1194; Appelhans BM, 2012, APPETITE, V59, P576, DOI 10.1016/j.appet.2012.07.009; Appelhans BM, 2011, OBESITY, V19, P2175, DOI 10.1038/oby.2011.57; Avena NM, 2008, NEUROSCIENCE, V156, P865, DOI 10.1016/j.neuroscience.2008.08.017; Bates K, 2009, J CONSUM AFF, V43, P249, DOI 10.1111/j.1745-6606.2009.01139.x; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; Bechara A, 1999, J NEUROSCI, V19, P5473; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Beer-Borst S, 2000, EUR J CLIN NUTR, V54, P253, DOI 10.1038/sj.ejcn.1600934; Bickel WK, 2007, DRUG ALCOHOL DEPEN, V90, pS85, DOI 10.1016/j.drugalcdep.2006.09.016; Bickel WK, 2008, ADV HEALTH ECON HEAL, V20, P289, DOI 10.1016/S0731-2199(08)20012-9; Bickel WK, 2009, J NEUROSCI, V29, P8839, DOI 10.1523/JNEUROSCI.5319-08.2009; Bickel WK, 2013, APPETITE; Borghans L, 2006, ECON HUM BIOL, V4, P39, DOI 10.1016/j.ehb.2005.10.001; Bos PA, 2010, P NATL ACAD SCI USA, P1; Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bowden DJ, 2013, RADIOGRAPHICS, V33, P1171, DOI 10.1148/rg.334125160; Brooks S, 2011, CLIN PSYCHOL REV, V31, P37, DOI 10.1016/j.cpr.2010.09.006; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Caccialanza R, 2004, EUR J CLIN NUTR, V58, P1217, DOI 10.1038/sj.ejcn.1601949; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; CHANNON S, 1990, INT J EAT DISORDER, V9, P447, DOI 10.1002/1098-108X(199007)9:4&lt;447::AID-EAT2260090411&gt;3.0.CO;2-0; Charlton SR, 2008, BEHAV PROCESS, V77, P334, DOI 10.1016/j.beproc.2007.08.002; Cook E, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P137; Dalton M, 2013, OBESITY FACTS, V6, P348, DOI 10.1159/000354599; Davis C, 2004, OBES RES, V12, P929, DOI 10.1038/oby.2004.113; Davis C, 2007, APPETITE, V48, P12, DOI 10.1016/j.appet.2006.05.016; Davis C, 2010, APPETITE, V54, P208, DOI 10.1016/j.appet.2009.11.002; Del Parigi A, 2002, AM J CLIN NUTR, V75, P1017, DOI 10.1093/ajcn/75.6.1017; di Pellegrino G, 2011, Q J EXP PSYCHOL, V64, P560, DOI 10.1080/17470218.2010.504031; Epstein LH, 2010, PHYSIOL BEHAV, V100, P438, DOI 10.1016/j.physbeh.2010.04.029; Epstein LH, 2003, PHYSIOL BEHAV, V78, P221, DOI 10.1016/S0031-9384(02)00978-2; Epstein LH, 1996, PSYCHOSOM MED, V58, P160, DOI 10.1097/00006842-199603000-00011; Estle SJ, 2007, PSYCHOL SCI, V18, P58, DOI 10.1111/j.1467-9280.2007.01849.x; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Fenske MJ, 2006, CURR DIR PSYCHOL SCI, V15, P312, DOI 10.1111/j.1467-8721.2006.00459.x; Ferrey AE, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00575; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; Fortuna JL, 2012, J PSYCHOACTIVE DRUGS, V44, P56, DOI 10.1080/02791072.2012.662092; Frank MJ, 2005, NEURON, V47, P495, DOI 10.1016/j.neuron.2005.06.020; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Frischen A, 2012, J EXP PSYCHOL HUMAN, V38, P169, DOI 10.1037/a0025981; Fujita K, 2009, PSYCHOL SCI, V20, P799, DOI 10.1111/j.1467-9280.2009.02372.x; Gearhardt AN, 2011, ARCH GEN PSYCHIAT, V68, P808, DOI 10.1001/archgenpsychiatry.2011.32; Gehring WJ, 1995, ELECTROEN CLIN NEURO, V44; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Hajcak G, 2008, PSYCHOL SCI, V19, P103, DOI 10.1111/j.1467-9280.2008.02053.x; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hawk LW, 2004, APPETITE, V43, P285, DOI 10.1016/j.appet.2004.06.008; Heatherton TF, 2011, TRENDS COGN SCI, V15, P132, DOI 10.1016/j.tics.2010.12.005; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Houben K, 2011, DRUG ALCOHOL DEPEN, V116, P132, DOI 10.1016/j.drugalcdep.2010.12.011; Inzlicht M, 2012, J EXP PSYCHOL GEN, V141, P799, DOI 10.1037/a0027586; Johnson MW, 2002, J EXP ANAL BEHAV, V77, P129, DOI 10.1901/jeab.2002.77-129; Kalenscher T, 2005, CURR BIOL, V15, P594, DOI 10.1016/j.cub.2005.02.052; Kang MJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00104; KIRBY KN, 1995, PSYCHOL SCI, V6, P83, DOI 10.1111/j.1467-9280.1995.tb00311.x; Kishinevsky FI, 2012, APPETITE, V58, P582, DOI 10.1016/j.appet.2011.11.029; Knight JA, 2011, ANN CLIN LAB SCI, V41, P107; Kringelbach ML, 2004, NEUROSCIENCE, V126, P807, DOI 10.1016/j.neuroscience.2004.04.035; LAPPALAINEN R, 1990, APPETITE, V14, P81, DOI 10.1016/0195-6663(90)90002-P; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Luo S, 2014, SOC COGN AFFECT NEUR, V9, P283, DOI 10.1093/scan/nss132; Luu P, 2000, J EXP PSYCHOL GEN, V129, P43, DOI 10.1037//0096-3445.129.1.43; Manwaring JL, 2011, PSYCHOL REC, V61, P561, DOI 10.1007/BF03395777; Mazur J.E., 1987, QUANTITATIVE ANAL BE, V5, P55; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; Michalska KJ, 2013, DEV COGN NEUROS-NETH, V3, P22, DOI 10.1016/j.dcn.2012.08.001; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miltner WHR, 2003, BIOL PSYCHOL, V64, P157, DOI 10.1016/S0301-0511(03)00107-8; MISCHEL W, 1988, J PERS SOC PSYCHOL, V54, P687, DOI 10.1037/0022-3514.54.4.687; Mogg K, 1998, BEHAV RES THER, V36, P227, DOI 10.1016/S0005-7967(97)00062-4; MYERSON J, 1995, J EXP ANAL BEHAV, V64, P263, DOI 10.1901/jeab.1995.64-263; Myerson J, 2003, J ECON PSYCHOL, V24, P619, DOI 10.1016/S0167-4870(03)00005-9; Myrseth KOR, 2009, CURR DIR PSYCHOL SCI, V18, P247, DOI 10.1111/j.1467-8721.2009.01645.x; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Notebaert W, 2009, COGNITION, V111, P275, DOI 10.1016/j.cognition.2009.02.002; Odum AL, 2003, BEHAV PROCESS, V64, P305, DOI 10.1016/S0376-6357(03)00145-1; Peters J, 2010, BEHAV BRAIN RES, V213, P135, DOI 10.1016/j.bbr.2010.04.031; Piech RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006581; RACHLIN H, 1991, J EXP ANAL BEHAV, V55, P233, DOI 10.1901/jeab.1991.55-233; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Samuelson PA, 1936, REV ECON STUD, V4, P155; Schebendach J, 2013, APPETITE, V62, P70, DOI 10.1016/j.appet.2012.11.009; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Seibt B, 2007, EUR J SOC PSYCHOL, V37, P359, DOI 10.1002/ejsp.365; Sellitto M, 2011, REV NEUROSCIENCE, V22, P565, DOI 10.1515/RNS.2011.046; Sellitto M, 2010, J NEUROSCI, V30, P16429, DOI 10.1523/JNEUROSCI.2516-10.2010; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; SMALLEY KJ, 1990, AM J CLIN NUTR, V52, P405, DOI 10.1093/ajcn/52.3.405; Smeets PAM, 2006, AM J CLIN NUTR, V83, P1297, DOI 10.1093/ajcn/83.6.1297; Stafford LD, 2008, APPETITE, V51, P731, DOI 10.1016/j.appet.2008.04.020; Svaldi J, 2010, APPETITE, V55, P685, DOI 10.1016/j.appet.2010.10.002; Takahashi T, 2005, MED HYPOTHESES, V65, P691, DOI 10.1016/j.mehy.2005.04.040; Takahashi T, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-52; Umberg EN, 2012, J CLIN PSYCHOPHARM, V32, P376, DOI 10.1097/JCP.0b013e318252464f; Valdesolo P, 2006, PSYCHOL SCI, V17, P476, DOI 10.1111/j.1467-9280.2006.01731.x; van der Helden J, 2010, CEREB CORTEX, V20, P1596, DOI 10.1093/cercor/bhp224; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; Volkow N. D., 2011, CURR TOP BEHAV NEURO; Wagner DD, 2013, PSYCHOL SCI, V24, P2262, DOI 10.1177/0956797613492985; Wagner DD, 2012, J COGNITIVE NEUROSCI, V24, P1625, DOI 10.1162/jocn_a_00238; Wang XT, 2010, PSYCHOL SCI, V21, P183, DOI 10.1177/0956797609358096; Weller RE, 2008, APPETITE, V51, P563, DOI 10.1016/j.appet.2008.04.010; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]	108	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e108422	10.1371/journal.pone.0108422	http://dx.doi.org/10.1371/journal.pone.0108422			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6FX	25244534	gold, Green Published, Green Submitted			2022-12-25	WOS:000343679800088
J	Shen, ZS; Li, Q; Deng, HX; Lu, DK; Song, HJ; Guo, JM				Shen, Zhisen; Li, Qun; Deng, Hongxia; Lu, Dakai; Song, Haojun; Guo, Junming			Long Non-Coding RNA Profiling in Laryngeal Squamous Cell Carcinoma and Its Clinical Significance: Potential Biomarkers for LSCC	PLOS ONE			English	Article							GASTRIC-CANCER; UP-REGULATION; EXPRESSION; HOTAIR; GENE	Long non-coding RNAs (IncRNAs) are novel transcripts that may play important roles in cancer. Our study aimed to resolve the IncRNA profile of larynx squamous cell carcinoma (LSCC) and to determine its clinical significance. The global lncRNA expression profile in LSCC tissues was measured by lncRNA microarray. Distinctly expressed lncRNAs were identified and levels of AC026166.2-001 and RP11-169D4.1-001 lncRNAs in 87 LSCC samples and paired adjacent normal tissue were analyzed by real-time quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR). The clinical significance of these IncRNAs in laryngeal cancer was analyzed and survival data were estimated by the Kaplan-Meier method and the logrank test. A receiver operating characteristic (ROC) curve was constructed to check the diagnostic value. In the lncRNA expression profile of tumor samples, 684 lncRNAs were upregulated and 747 lncRNAs were downregulated (fold-change > 2.0). Of these, AC026166.2-001 and RP11-169D4.1-001 were distinctly dysregulated, with AC026166.2-001 exhibiting lower expression in cancer tissues and RP11-169D4.1-001 higher expression. We verified that both AC026166.2-001 and RP11169D4.1- 001 were expressed at a lower level in cervical lymph nodes compared with paired laryngeal cancer tissues and paired normal tissues. RP11-169D4.1-001 levels were positively correlated with lymph node metastasis (P = 0.007). From the survival analysis, decreased levels of AC026166.2-001 and RP11-169D4.1-001 were associated with poorer prognosis. The area under the ROC curve was up to 0.65 and 0.67, respectively, and the cut-off point of Delta Ct was 11.23 and 10.53, respectively. AC026166.2-001 and RP11-169D4.1-001 may act as novel biomarkers in LSCC and may be potential therapeutic targets for LSCC patients. Both AC026166.2-001 and RP11-169D4.1-001 could be independent prognostic factors for survival in LSCC.	[Shen, Zhisen; Li, Qun; Deng, Hongxia] Ningbo Univ, Lihuili Hosp, Dept Otorhinolaryngol Head & Neck Surg, Ningbo 315211, Zhejiang, Peoples R China; [Li, Qun; Lu, Dakai; Song, Haojun; Guo, Junming] Ningbo Univ, Sch Med, Zhejiang Prov Key Lab Pathophysiol, Ningbo 315211, Zhejiang, Peoples R China	Ningbo University; Ningbo University	Shen, ZS (corresponding author), Ningbo Univ, Lihuili Hosp, Dept Otorhinolaryngol Head & Neck Surg, Ningbo 315211, Zhejiang, Peoples R China.	szs7216@sina.com; junmingguo@yahoo.com	Guo, Junming/G-4520-2015; Guo, Junming/S-2690-2019	Guo, Junming/0000-0003-2026-1075; Guo, Junming/0000-0003-2026-1075	Scientific Innovation Team Project of Ningbo [2012B82019]; Medical and Health Research Project of Zhejiang Province [2012ZDA042]; Zhejiang Provincial Natural Science Foundation of China [Y14H160014]; Ningbo Natural Science Foundation [2012A610208, 2012A610217]; Ningbo Social Developmental Key Research Project [2008C50019, 2012C5015]; K.C. Wong Magna Fund in Ningbo University	Scientific Innovation Team Project of Ningbo; Medical and Health Research Project of Zhejiang Province; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Ningbo Natural Science Foundation; Ningbo Social Developmental Key Research Project; K.C. Wong Magna Fund in Ningbo University	This work was supported by the Scientific Innovation Team Project of Ningbo (No. 2012B82019), the Medical and Health Research Project of Zhejiang Province (No. 2012ZDA042), Zhejiang Provincial Natural Science Foundation of China (No. Y14H160014), Ningbo Natural Science Foundation (No. 2012A610208 and No. 2012A610217), Ningbo Social Developmental Key Research Project (No. 2008C50019 and No. 2012C5015), and the K.C. Wong Magna Fund in Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almadori G, 2005, EUR J CANCER, V41, P683, DOI 10.1016/j.ejca.2004.10.031; Beckedorff FC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003705; Chen FJ, 2013, MOL CARCINOGEN, V52, P908, DOI 10.1002/mc.21944; Cooke SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4644; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Feng J., 2012, HEAD NECK ONCOL, V4, P46; Ge XS, 2013, CANCER SCI, V104, P1675, DOI 10.1111/cas.12296; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P664, DOI 10.1038/nsmb.2315; KELLER AZ, 1965, AM J PUBLIC HEALTH N, V55, P1578, DOI 10.2105/AJPH.55.10.1578; Li DD, 2013, AM J PATHOL, V182, P64, DOI 10.1016/j.ajpath.2012.08.042; Li W, 2013, J GENET GENOMICS, V40, P171, DOI 10.1016/j.jgg.2013.03.003; Lv XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063516; Marioni G, 2006, CANCER TREAT REV, V32, P504, DOI 10.1016/j.ctrv.2006.07.002; Mei DY, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0709-2; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Qiu MT, 2013, TUMOR BIOL, V34, P613, DOI 10.1007/s13277-013-0658-6; Reis EM, 2005, CANCER RES, V65, P1693, DOI 10.1158/0008-5472.CAN-04-3506; Roberts TC, 2014, EPIGENETICS-US, V9, P13, DOI 10.4161/epi.26700; Shen Z, 2010, J LARYNGOL OTOL, V124, P1183, DOI 10.1017/S0022215110001015; Shen ZS, 2012, MED ONCOL, V29, P2473, DOI 10.1007/s12032-011-0156-x; Shen ZS, 2011, MED ONCOL, V28, P601, DOI 10.1007/s12032-010-9474-7; Song HJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-225; Sun WL, 2013, TUMOR BIOL, V34, P2697, DOI 10.1007/s13277-013-0821-0; Takahashi K, 2014, HEPATOLOGY, V60, P744, DOI 10.1002/hep.27043; Tang JY, 2013, SCI WORLD J, V2013, DOI DOI 10.1155/2013/943539; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085234, 10.1371/journal.pone.0110024, 10.1371/journal.pone.0096339, 10.1371/journal.pone.0108223]; Yu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042377	30	67	68	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e108237	10.1371/journal.pone.0108237	http://dx.doi.org/10.1371/journal.pone.0108237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243407	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800078
J	Sun, XT; Feng, ZW; Zhang, LL; Hou, TJ; Li, YY				Sun, Xiaotian; Feng, Zhiwei; Zhang, Liling; Hou, Tingjun; Li, Youyong			The Selective Interaction between Silica Nanoparticles and Enzymes from Molecular Dynamics Simulations	PLOS ONE			English	Article							STRUCTURE PREDICTION; CARBON NANOTUBE; GRAPHENE OXIDE; ACTIVE-SITES; PROTEIN; DOCKING; GOLD; ADSORPTION; WATER; VALIDATION	Nanoscale particles have become promising materials in many fields, such as cancer therapeutics, diagnosis, imaging, drug delivery, catalysis, as well as biosensors. In order to stimulate and facilitate these applications, there is an urgent need for the understanding of the interaction mode between the nano-particles and proteins. In this study, we investigate the orientation and adsorption between several enzymes (cytochrome c, RNase A, lysozyme) and 4 nm/11 nm silica nanoparticles (SNPs) by using molecular dynamics (MD) simulation. Our results show that three enzymes are adsorbed onto the surfaces of both 4 nm and 11 nm SNPs during our MD simulations and the small SNPs induce greater structural stabilization. The active site of cytochrome c is far away from the surface of 4 nm SNPs, while it is adsorbed onto the surface of 11 nm SNPs. We also explore the influences of different groups (-OH2-COOH2-NH2 and CH3) coated onto silica nanoparticles, which show significantly different impacts. Our molecular dynamics results indicate the selective interaction between silicon nanoparticles and enzymes, which is consistent with experimental results. Our study provides useful guides for designing/modifying nanomaterials to interact with proteins for their bio-applications.	[Li, Youyong] Soochow Univ, Inst Funct Nano & Soft Mat FUNSOM, Suzhou, Peoples R China; Soochow Univ, Collaborat Innovat Ctr Suzhou Nano Sci & Technol, Suzhou, Peoples R China	Soochow University - China; Soochow University - China	Li, YY (corresponding author), Soochow Univ, Inst Funct Nano & Soft Mat FUNSOM, Suzhou, Peoples R China.	yyli@suda.edu.cn	Hou, Tingjun/D-7216-2012; Sun, Xiaotian/ABG-9504-2020; Li, Youyong/D-3836-2011; Hou, Tingjun/C-7492-2011	Sun, Xiaotian/0000-0002-2769-6242; Li, Youyong/0000-0002-5248-2756; Hou, Tingjun/0000-0001-7227-2580	National Basic Research Program of China (973 Program) [2012CB932400, 2010CB934500]; National Natural Science Foundation of China [91233115, 21273158, 91227201]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Fund for Innovative Research Teams of Jiangsu Higher Education Institutions	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Fund for Innovative Research Teams of Jiangsu Higher Education Institutions	The work is supported by the National Basic Research Program of China (973 Program, Grant No. 2012CB932400 and 2010CB934500), the National Natural Science Foundation of China (Grant No. 91233115, 21273158, and 91227201), a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). This is also a project supported by the Fund for Innovative Research Teams of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyris D, 2008, J PHYS CHEM C, V112, P13587, DOI 10.1021/jp803234a; Aubin-Tam ME, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034001; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cycon H.L, 1987, SCHRDINGER OPERATORS; Doucet N, 2009, BIOCHEMISTRY-US, V48, P7160, DOI 10.1021/bi900830g; Dutta S, 2010, BIOORGAN MED CHEM, V18, P6538, DOI 10.1016/j.bmc.2010.06.077; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; Frampton MB, 2012, SILICON-NETH, V4, P51, DOI 10.1007/s12633-011-9087-6; Friling SR, 2010, NANOSCALE, V2, P98, DOI 10.1039/b9nr00226j; Gill A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016788; He Y, 2010, NANO TODAY, V5, P282, DOI 10.1016/j.nantod.2010.06.008; Hsin J, 2008, CURR PROTOC BIOINFOR, V7, P1; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; Jin LL, 2012, ACS NANO, V6, P4864, DOI 10.1021/nn300217z; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Katoch J, 2012, NANO LETT, V12, P2342, DOI 10.1021/nl300286k; Kim J, 2006, CHEM ENG SCI, V61, P1017, DOI 10.1016/j.ces.2005.05.067; Kirk O, 2002, CURR OPIN BIOTECH, V13, P345, DOI 10.1016/S0958-1669(02)00328-2; Li J, 2003, NANO LETT, V3, P55, DOI 10.1021/nl025778s; Liptak MD, 2010, J AM CHEM SOC, V132, P9753, DOI 10.1021/ja102098p; Luckarift HR, 2004, NAT BIOTECHNOL, V22, P211, DOI 10.1038/nbt931; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Morison IM, 2008, NAT GENET, V40, P387, DOI 10.1038/ng.103; Patra N, 2009, NANO LETT, V9, P3766, DOI 10.1021/nl9019616; Patwardhan SV, 2012, J AM CHEM SOC, V134, P6244, DOI 10.1021/ja211307u; Peters BL, 2012, LANGMUIR, V28, P17443, DOI 10.1021/la3023166; Pollastri G, 2005, BIOINFORMATICS, V21, P1719, DOI 10.1093/bioinformatics/bti203; Rao SN, 2007, J CHEM INF MODEL, V47, P2159, DOI 10.1021/ci6004299; Sahoo D, 2011, J NANOPART RES, V13, P6755, DOI 10.1007/s11051-011-0583-9; Scanlon TC, 2010, ACS CHEM BIOL, V5, P809, DOI 10.1021/cb1001119; Shrivastava S, 2012, NANO LETT, V12, P1583, DOI 10.1021/nl2044524; Sun XT, 2014, ACS APPL MATER INTER, V6, P7153, DOI 10.1021/am500167c; Takahashi H, 2000, CHEM MATER, V12, P3301, DOI 10.1021/cm000487a; Thompson AB, 2011, ACS APPL MATER INTER, V3, P2979, DOI 10.1021/am200459a; Vangala K, 2012, J PHYS CHEM C, V116, P3645, DOI 10.1021/jp2107318; Venkatachalam CM, 2003, J MOL GRAPH MODEL, V21, P289, DOI 10.1016/S1093-3263(02)00164-X; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Walkey CD, 2012, J AM CHEM SOC, V134, P2139, DOI 10.1021/ja2084338; WLODAWER A, 1988, BIOCHEMISTRY-US, V27, P2705, DOI 10.1021/bi00408a010; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Wu JF, 2010, ELECTROCHEM COMMUN, V12, P175, DOI 10.1016/j.elecom.2009.11.020; Yang W, 2012, IET NANOBIOTECHNOL, V6, P26, DOI 10.1049/iet-nbt.2011.0029; Yang ZP, 2008, MICROPOR MESOPOR MAT, V111, P359, DOI 10.1016/j.micromeso.2007.08.009; Zsila F, 2011, ORG BIOMOL CHEM, V9, P4127, DOI 10.1039/c0ob01221a; Zuo G, 2011, J PHYS CHEM C, V115, P23323, DOI 10.1021/jp208967t; Zuo GH, 2010, ACS NANO, V4, P7508, DOI 10.1021/nn101762b	50	32	34	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107696	10.1371/journal.pone.0107696	http://dx.doi.org/10.1371/journal.pone.0107696			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243748	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800045
J	Blair, PS; Sidebotham, P; Pease, A; Fleming, PJ				Blair, Peter S.; Sidebotham, Peter; Pease, Anna; Fleming, Peter J.			Bed-Sharing in the Absence of Hazardous Circumstances: Is There a Risk of Sudden Infant Death Syndrome? An Analysis from Two Case-Control Studies Conducted in the UK	PLOS ONE			English	Article							SLEEP ENVIRONMENT; POPULATION	Objective: The risk of sudden infant death syndrome (SIDS) among infants who co-sleep in the absence of hazardous circumstances is unclear and needs to be quantified. Design: Combined individual-analysis of two population-based case-control studies of SIDS infants and controls comparable for age and time of last sleep. Setting: Parents of 400 SIDS infants and 1386 controls provided information from five English health regions between 19936 (population: 17.7 million) and one of these regions between 2003-6 (population: 4.9 million). Results: Over a third of SIDS infants (36%) were found co-sleeping with an adult at the time of death compared to 15% of control infants after the reference sleep (multivariate OR = 3.9 [95% CI: 2.7-5.6]). The multivariable risk associated with co-sleeping on a sofa (OR = 18.3 [95% CI: 7.1-47.4]) or next to a parent who drank more than two units of alcohol (OR = 18.3 [95% CI: 7.7-43.5]) was very high and significant for infants of all ages. The risk associated with co-sleeping next to someone who smoked was significant for infants under 3 months old (OR = 8.9 [95% CI: 5.3-15.1]) but not for older infants (OR = 1.4 [95% CI: 0.7-2.8]). The multivariable risk associated with bed-sharing in the absence of these hazards was not significant overall (OR = 1.1 [95% CI: 0.6-2.0]), for infants less than 3 months old (OR = 1.6 [95% CI: 0.96-2.7]), and was in the direction of protection for older infants (OR = 0.1 [95% CI: 0.01-0.5]). Dummy use was associated with a lower risk of SIDS only among co-sleepers and prone sleeping was a higher risk only among infants sleeping alone. Conclusion: These findings support a public health strategy that underlines specific hazardous co-sleeping environments parents should avoid. Sofa-sharing is not a safe alternative to bed-sharing and bed-sharing should be avoided if parents consume alcohol, smoke or take drugs or if the infant is pre-term.	[Blair, Peter S.; Pease, Anna; Fleming, Peter J.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Sidebotham, Peter] Univ Warwick, Sch Med, Warwick, England	University of Bristol; University of Warwick	Blair, PS (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	p.s.blair@bris.ac.uk	Blair, Peter S/C-1213-2009; Fleming, Peter/O-3231-2019; Sidebotham, Peter D/E-3011-2010; Pease, Anna/T-4544-2019	Fleming, Peter/0000-0003-2521-5764; Sidebotham, Peter D/0000-0003-4891-6926; Blair, Peter/0000-0002-7832-8087; Pease, Anna/0000-0002-3472-1047	Lullaby Trust; Department of Health (England); Charitable Trusts of University Hospitals Bristol; Babes in Arms	Lullaby Trust; Department of Health (England); Charitable Trusts of University Hospitals Bristol; Babes in Arms	The two studies were funded by both cot death charities the Foundation for the Study of Infant Deaths (FSID) now the Lullaby Trust and Babes in Arms. There was also funding received from the Department of Health (England) and the Charitable Trusts of University Hospitals Bristol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, ONS STAT B UN DEATH; Ball HL, 2013, SOC SCI MED, V79, P84, DOI 10.1016/j.socscimed.2012.03.025; Blair PS, 2012, FORENSIC SCI MED PAT, V8, P312, DOI 10.1007/s12024-011-9294-x; Blair PS, 2010, PEDIATRICS, V126, pE1119, DOI 10.1542/peds.2010-1277; Blair PS, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3666; Blair PS, 2006, LANCET, V367, P314, DOI 10.1016/S0140-6736(06)67968-3; Blair PS, 2004, ARCH DIS CHILD, V89, P1106, DOI 10.1136/adc.2003.038067; Blair PS, 1999, BRIT MED J, V319, P1457, DOI 10.1136/bmj.319.7223.1457; Blair PS, 2013, BMJ OPEN; Byard RW, 2012, J PAEDIATR CHILD H, V48, P947, DOI 10.1111/j.1440-1754.2012.02565.x; Byard RW, 2012, J PAEDIATR CHILD H, V48, P517, DOI 10.1111/j.1440-1754.2011.02226.x; Carpenter RG, 2004, LANCET, V363, P185, DOI 10.1016/S0140-6736(03)15323-8; Carpenter R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002299; COLE TJ, 1991, ARCH DIS CHILD, V66, P1077, DOI 10.1136/adc.66.9.1077; Fleming PJ, 1996, BMJ-BRIT MED J, V313, P191, DOI 10.1136/bmj.313.7051.191; Hauck FR, 2003, PEDIATRICS, V111, P1207; Howel D, 2013, J HUM LACT; Kattwinkel J, 2005, PEDIATRICS, V116, P1245, DOI 10.1542/peds.2005-1499; McGarvey C, 2003, ARCH DIS CHILD, V88, P1058, DOI 10.1136/adc.88.12.1058; Renz-Polster, 2013, BMJ OPEN; Russell CK, 2013, BMJ OPEN; Statement from the International Society for the study and Prevention of perinatal and Infant Death (ISPID), 2013, FEAR BAS PREV STRAT; Tappin D, 2002, BMJ-BRIT MED J, V325, P1007, DOI 10.1136/bmj.325.7371.1007; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X	24	83	83	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107799	10.1371/journal.pone.0107799	http://dx.doi.org/10.1371/journal.pone.0107799			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238618	Green Submitted, Green Published, gold			2022-12-25	WOS:000342491600050
J	Szaloki, G; Krasznai, ZT; Toth, A; Vizkeleti, L; Szollosi, AG; Trencsenyi, G; Lajtos, I; Juhasz, I; Krasznai, Z; Marian, T; Balazs, M; Szabo, G; Goda, K				Szaloki, Gabor; Krasznai, Zoard T.; Toth, Agnes; Vizkeleti, Laura; Szoelloesi, Attila G.; Trencsenyi, Gyorgy; Lajtos, Imre; Juhasz, Istvan; Krasznai, Zoltan; Marian, Terez; Balazs, Margit; Szabo, Gabor; Goda, Katalin			The Strong In Vivo Anti-Tumor Effect of the UIC2 Monoclonal Antibody Is the Combined Result of Pgp Inhibition and Antibody Dependent Cell-Mediated Cytotoxicity	PLOS ONE			English	Article							RESISTANCE-MODULATING AGENTS; P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE; ABC TRANSPORTERS; FC-RECEPTORS; CANCER; EXPRESSION; COMBINATION; METABOLISM; ADRIAMYCIN	P-glycoprotein (Pgp) extrudes a large variety of chemotherapeutic drugs from the cells, causing multidrug resistance (MDR). The UIC2 monoclonal antibody recognizes human Pgp and inhibits its drug transport activity. However, this inhibition is partial, since UIC2 binds only to 10-40% of cell surface Pgps, while the rest becomes accessible to this antibody only in the presence of certain substrates or modulators (e.g. cyclosporine A (CsA)). The combined addition of UIC2 and 10 times lower concentrations of CsA than what is necessary for Pgp inhibition when the modulator is applied alone, decreased the EC50 of doxorubicin (DOX) in KB-V1 (Pgp(+)) cells in vitro almost to the level of KB-3-1 (Pgp(-)) cells. At the same time, UIC2 alone did not affect the EC50 value of DOX significantly. In xenotransplanted severe combined immunodeficient (SCID) mice co-treated with DOX, UIC2 and CsA, the average weight of Pgp(+) tumors was only similar to 10% of the untreated control and in 52% of these animals we could not detect tumors at all, while DOX treatment alone did not decrease the weight of Pgp(+) tumors. These data were confirmed by visualizing the tumors in vivo by positron emission tomography (PET) based on their increased (18)FDG accumulation. Unexpectedly, UIC2+DOX treatment also decreased the size of tumors compared to the DOX only treated animals, as opposed to the results of our in vitro cytotoxicity assays, suggesting that immunological factors are also involved in the antitumor effect of in vivo UIC2 treatment. Since UIC2 binding itself did not affect the viability of Pgp expressing cells, but it triggered in vitro cell killing by peripheral blood mononuclear cells (PBMCs), it is concluded that the impressive in vivo anti-tumor effect of the DOX-UIC2-CsA treatment is the combined result of Pgp inhibition and antibody dependent cell-mediated cytotoxicity (ADCC).	[Szaloki, Gabor; Toth, Agnes; Krasznai, Zoltan; Szabo, Gabor; Goda, Katalin] Univ Debrecen, Fac Med, Dept Biophys & Cell Biol, Debrecen, Hungary; [Krasznai, Zoard T.] Univ Debrecen, Fac Med, Dept Obstet & Gynecol, Debrecen, Hungary; [Vizkeleti, Laura; Balazs, Margit] Univ Debrecen, Fac Med, Dept Prevent Med, Debrecen, Hungary; [Szoelloesi, Attila G.] Univ Debrecen, Fac Med, Dept Physiol, Debrecen, Hungary; [Trencsenyi, Gyorgy; Lajtos, Imre; Marian, Terez] Univ Debrecen, Fac Med, Dept Nucl Med, Debrecen, Hungary; [Juhasz, Istvan] Univ Debrecen, Fac Med, Dept Dermatol, Debrecen, Hungary; [Juhasz, Istvan] Univ Debrecen, Fac Med, Dept Surg & Operat Tech, Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen	Goda, K (corresponding author), Univ Debrecen, Fac Med, Dept Biophys & Cell Biol, Debrecen, Hungary.	goda@med.unideb.hu	Goda, Katalin/L-8986-2019; Vizkeleti, Laura/T-4416-2017; Trencsenyi, Gyorgy/A-9676-2012	Vizkeleti, Laura/0000-0001-6870-3499; 	Szodoray Grant from the University of Debrecen; Astellas Pharma Kft; Libra Foundation; Hungarian National Science and Research Foundation (OTKA) grants [PD75994, K72762, NK101337]; TAMOP grants [TAMOP 4.2.2-08/1-2008-0015, TAMOP 4.2.1/B-09/1/KONV-2010-0007, TAMOP 4.2.2.A-11/1/KONV-2012-0023]; TAMOP [4.2.4. A/2-11-1-2012-0001]	Szodoray Grant from the University of Debrecen; Astellas Pharma Kft; Libra Foundation; Hungarian National Science and Research Foundation (OTKA) grants(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); TAMOP grants; TAMOP	This work was supported by Szodoray Grant from the University of Debrecen (recipients are Katalin Goda and Zoard T. Krasznai) and Astellas Pharma Kft and Libra Foundation (recipient is Gabor Szaloki). The work was also supported by Hungarian National Science and Research Foundation (OTKA) grants PD75994, K72762, NK101337 and by TAMOP grants: TAMOP 4.2.2-08/1-2008-0015, TAMOP 4.2.1/B-09/1/KONV-2010-0007 and TAMOP 4.2.2.A-11/1/KONV-2012-0023 "VED-ELEM" project. Gabor Szaloki's research was realized in the frames of TAMOP 4.2.4. A/2-11-1-2012-0001 "National Excellence Program - Elaborating and operating an inland student and researcher personal support system convergence program." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA SI, 1985, SOMAT CELL MOLEC GEN, V11, P117, DOI 10.1007/BF01534700; Ambudkar SV, 2006, EUR J PHARM SCI, V27, P392, DOI 10.1016/j.ejps.2005.10.010; Barok M, 2007, MOL CANCER THER, V6, P2065, DOI 10.1158/1535-7163.MCT-06-0766; Bleeker WK, 2004, J IMMUNOL, V173, P4699, DOI 10.4049/jimmunol.173.7.4699; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; Bougoin S, 2008, NEUROENDOCRINOL LETT, V29, P438; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; CHAUDHARY PM, 1992, BLOOD, V80, P2735; Chico I, 2001, J CLIN ONCOL, V19, P832, DOI 10.1200/JCO.2001.19.3.832; Friedenberg WR, 2006, CANCER-AM CANCER SOC, V106, P830, DOI 10.1002/cncr.21666; Glavinas Hristos, 2004, Current Drug Delivery, V1, P27, DOI 10.2174/1567201043480036; Goda K, 2007, J PHARMACOL EXP THER, V320, P81, DOI 10.1124/jpet.106.110155; Gottesman Michael M, 2006, Discov Med, V6, P18; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; HAMACHER K, 1986, J NUCL MED, V27, P235; JACHEZ B, 1994, ANTI-CANCER DRUG, V5, P655, DOI 10.1097/00001813-199412000-00008; Krasznai ZT, 2010, EUR J PHARM SCI, V41, P665, DOI 10.1016/j.ejps.2010.09.009; Leonard GD, 2003, ONCOLOGIST, V8, P411, DOI 10.1634/theoncologist.8-5-411; Loscher Wolfgang, 2005, NeuroRx, V2, P86, DOI 10.1602/neurorx.2.1.86; Mankoff DA, 2001, SEMIN RADIAT ONCOL, V11, P16, DOI 10.1053/srao.2001.18100; Marian T, 2003, EUR J NUCL MED MOL I, V30, P1147, DOI 10.1007/s00259-003-1204-3; MECHETNER EB, 1992, P NATL ACAD SCI USA, V89, P5824, DOI 10.1073/pnas.89.13.5824; Nagy H, 2004, BIOCHEM BIOPH RES CO, V315, P942, DOI 10.1016/j.bbrc.2004.01.156; Naito M, 1996, INT J CANCER, V67, P435, DOI 10.1002/(SICI)1097-0215(19960729)67:3<435::AID-IJC20>3.3.CO;2-#; Pauwels EKJ, 1998, NUCL MED BIOL, V25, P317, DOI 10.1016/S0969-8051(97)00226-6; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; RITTMANNGRAUER LS, 1992, CANCER RES, V52, P1810; Rosenberg MF, 1997, J BIOL CHEM, V272, P10685; Schinkel AH, 1997, P NATL ACAD SCI USA, V94, P4028, DOI 10.1073/pnas.94.8.4028; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; SCHINKEL AH, 1993, INT J CANCER, V55, P478, DOI 10.1002/ijc.2910550326; Schneider-Merck T, 2010, J IMMUNOL, V184, P512, DOI 10.4049/jimmunol.0900847; Senior AE, 2012, J BIOL CHEM, V287, P30049, DOI 10.1074/jbc.X112.402313; SHEN DW, 1986, J BIOL CHEM, V261, P7762; Sikic BI, 1997, CANCER CHEMOTH PHARM, V40, pS13, DOI 10.1007/s002800051055; Szakacs G, 2008, DRUG DISCOV TODAY, V13, P379, DOI 10.1016/j.drudis.2007.12.010; VANDEWINKEL JGJ, 1991, J LEUKOCYTE BIOL, V49, P511, DOI 10.1002/jlb.49.5.511; Wahl RL, 1996, J NUCL MED, V37, P1038; Watanabe T, 1997, J NATL CANCER I, V89, P512, DOI 10.1093/jnci/89.7.512; Yano S, 1999, INT J CANCER, V82, P105, DOI 10.1002/(SICI)1097-0215(19990702)82:1<105::AID-IJC18>3.0.CO;2-C; Zhou Y, 1999, ARCH BIOCHEM BIOPHYS, V367, P74, DOI 10.1006/abbi.1999.1221	42	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107875	10.1371/journal.pone.0107875	http://dx.doi.org/10.1371/journal.pone.0107875			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238617	Green Published, gold, Green Submitted			2022-12-25	WOS:000342491600058
J	Zhang, JG; Li, XY; Wang, YZ; Zhang, QD; Gu, SY; Wu, X; Zhu, GH; Li, Q; Liu, GL				Zhang, Ji-Gang; Li, Xiao-Yu; Wang, Yu-Zhu; Zhang, Qi-Di; Gu, Sheng-Ying; Wu, Xin; Zhu, Guan-Hua; Li, Qin; Liu, Gao-Lin			ROCK Is Involved in Vasculogenic Mimicry Formation in Hepatocellular Carcinoma Cell Line	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN-MELANOMA CELLS; FUNCTIONAL-SIGNIFICANCE; RHO-GTPASES; KINASE; CANCER; METASTASIS; INVASION; ANGIOGENESIS; ACTIVATION	Ras homolog family member A (RhoA) and Rho-associated coiled coil-containing protein kinases 1 and 2 (ROCK1 and 2) are key regulators of focal adhesion, actomyosin contraction and cell motility. RhoA/ROCK signaling has emerged as an attractive target for the development of new cancer therapeutics. Whether RhoA/ROCK is involved in regulating the formation of tumor cell vasculogenic mimicry (VM) is largely unknown. To confirm this hypothesis, we performed in vitro experiments using hepatocellular carcinoma (HCC) cell lines. Firstly, we demonstrated that HCC cells with higher active RhoA/ROCK expression were prone to form VM channels, as compared with RhoA/ROCK low-expressing cells. Furthermore, Y27632 (a specific inhibitor of ROCK) rather than exoenzyme C3 (a specific inhibitor of RhoA) effectively inhibited the formation of tubular network structures in a dose-dependent manner. To elucidate the possible mechanism of ROCK on VM formation, real-time qPCR, western blot and immunofluorescence were used to detect changes of the key VM-related factors, including VE-cadherin, erythropoietin-producing hepatocellular carcinoma-A2 (EphA2), phosphoinositide 3-kinase (PI3K), matrix metalloproteinase (MMP) 14, MMP2, MMP9 and laminin 5 gamma 2-chain (LAMC2), and epithelial-mesenchymal-transition (EMT) markers: E-cadherin and Vimentin. The results showed that all the expression profiles were attenuated by blockage of ROCK. In addition, in vitro cell migration and invasion assays showed that Y27632 inhibited the migration and invasion capacity of HCC cell lines in a dose-dependent manner markedly. These data indicate that ROCK is an important mediator in the formation of tumor cell VM, and suggest that ROCK inhibition may prove useful in the treatment of VM in HCC.	[Zhang, Ji-Gang; Li, Xiao-Yu; Wang, Yu-Zhu; Gu, Sheng-Ying; Wu, Xin; Zhu, Guan-Hua; Li, Qin; Liu, Gao-Lin] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Pharm, Shanghai 200030, Peoples R China; [Zhang, Qi-Di] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Gastroenterol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Li, Q (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Pharm, Shanghai 200030, Peoples R China.	liqin0626@hotmail.com; gaolinliu@aliyun.com			National Natural Science Foundation of China (NSFC) [81372310, 81100800]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (NSFC, No.81372310) and (NSFC, No.81100800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryan BA, 2010, FASEB J, V24, P3186, DOI 10.1096/fj.09-145102; Carton I, 2002, AM J PHYSIOL-CELL PH, V283, pC115, DOI 10.1152/ajpcell.00038.2001; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Grise F, 2009, BBA-REV CANCER, V1795, P137, DOI 10.1016/j.bbcan.2008.12.003; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Hendrix MJC, 2001, P NATL ACAD SCI USA, V98, P8018, DOI 10.1073/pnas.131209798; Jin-Lu M, 2011, BIOCHEM BIOPH RES CO, V408, P686, DOI 10.1016/j.bbrc.2011.04.089; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Kirschmann DA, 2012, CLIN CANCER RES, V18, P2726, DOI 10.1158/1078-0432.CCR-11-3237; Koga T, 2006, EXP EYE RES, V82, P362, DOI 10.1016/j.exer.2005.07.006; Komander D, 2008, EMBO J, V27, P3175, DOI 10.1038/emboj.2008.226; Lee J, 2010, J BIOL CHEM, V285, P26618, DOI 10.1074/jbc.M109.073155; Leung T, 1996, MOL CELL BIOL, V16, P5313; Lin MT, 2007, INT J CANCER, V120, P2600, DOI 10.1002/ijc.22599; Lirdprapamongkol K, 2009, J AGR FOOD CHEM, V57, P3055, DOI 10.1021/jf803366f; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Noma K, 2012, J CARDIOL, V60, P1, DOI 10.1016/j.jjcc.2012.03.005; Nunes KP, 2010, CELL MOL LIFE SCI, V67, P3823, DOI 10.1007/s00018-010-0460-1; Paulis YWJ, 2010, BBA-REV CANCER, V1806, P18, DOI 10.1016/j.bbcan.2010.01.001; Quigley JP, 1998, CELL, V94, P281, DOI 10.1016/S0092-8674(00)81470-1; Riento K, 2005, EMBO J, V24, P1170, DOI 10.1038/sj.emboj.7600612; Seftor REB, 2001, CANCER RES, V61, P6322; Shi JJ, 2013, J CARDIOVASC PHARM, V62, P341, DOI 10.1097/FJC.0b013e3182a3718f; Shi JJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.10; Sun BC, 2008, HUM PATHOL, V39, P444, DOI 10.1016/j.humpath.2007.07.018; Sun HR, 2006, MICROCIRCULATION, V13, P237, DOI 10.1080/10739680600556944; Sun HW, 2007, WORLD J GASTROENTERO, V13, P3517, DOI 10.3748/wjg.v13.i25.3517; Sun T, 2010, HEPATOLOGY, V51, P545, DOI 10.1002/hep.23311; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Wang JY, 2008, CANCER BIOL THER, V7, P758, DOI 10.4161/cbt.7.5.5765; Wang SY, 2012, CANCER BIOL THER, V13, P341, DOI 10.4161/cbt.19108; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Wong CCL, 2009, HEPATOLOGY, V49, P1583, DOI 10.1002/hep.22836; Xu B, 2011, PLACENTA, V32, P241, DOI 10.1016/j.placenta.2010.12.005; Zhao XL, 2011, J CELL MOL MED, V15, P691, DOI 10.1111/j.1582-4934.2010.01052.x	40	34	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107661	10.1371/journal.pone.0107661	http://dx.doi.org/10.1371/journal.pone.0107661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238232	Green Submitted, Green Published, gold			2022-12-25	WOS:000342491600039
J	Zeymer, C; Fischer, S; Reinstein, J				Zeymer, Cathleen; Fischer, Sebastian; Reinstein, Jochen			trans-Acting Arginine Residues in the AAA plus Chaperone ClpB Allosterically Regulate the Activity through Inter- and Intradomain Communication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DISAGGREGATING MACHINE; NUCLEOTIDE-BINDING DOMAINS; THERMUS-THERMOPHILUS; ATP-BINDING; MOLECULAR CHAPERONE; HSP104; THERMOTOLERANCE; HYDROLYSIS; MECHANISM; SUBUNITS	The molecular chaperone ClpB/Hsp104, a member of the AAA+ superfamily (ATPases associated with various cellular activities), rescues proteins from the aggregated state in collaboration with the DnaK/Hsp70 chaperone system. ClpB/Hsp104 forms a hexameric, ring-shaped complex that functions as a tightly regulated, ATP-powered molecular disaggregation machine. Highly conserved and essential arginine residues, often called arginine fingers, are located at the subunit interfaces of the complex, which also harbor the catalytic sites. Several AAA+ proteins, including ClpB/Hsp104, possess a pair of such trans-acting arginines in the N-terminal nucleotide binding domain (NBD1), both of which were shown to be crucial for oligomerization and ATPase activity. Here, we present a mechanistic study elucidating the role of this conserved arginine pair. First, we found that the arginines couple nucleotide binding to oligomerization of NBD1, which is essential for the activity. Next, we designed a set of covalently linked, dimeric ClpBNBD1 variants, carrying single subunits deficient in either ATP binding or hydrolysis, to study allosteric regulation and intersubunit communication. Using this well defined environment of site-specifically modified, cross-linked AAA+ domains, we found that the conserved arginine pair mediates the cooperativity of ATP binding and hydrolysis in an allosteric fashion.	[Zeymer, Cathleen; Fischer, Sebastian; Reinstein, Jochen] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany	Max Planck Society	Reinstein, J (corresponding author), Max Planck Inst Med Res, Dept Biomol Mech, Jahnstr 29, D-69120 Heidelberg, Germany.	jochen.reinstein@mpimf-heidelberg.mpg.de		Zeymer, Cathleen/0000-0001-7138-381X	Max Planck Society; German National Academic Foundation	Max Planck Society(Max Planck Society); German National Academic Foundation	This work was supported by the Max Planck Society and by a Ph.D. scholarship from the German National Academic Foundation (to C. Z.).	Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Fernandez-Higuero JA, 2011, J BIOL CHEM, V286, P25547, DOI 10.1074/jbc.M111.231365; Beinker P, 2005, J BIOL CHEM, V280, P37965, DOI 10.1074/jbc.M506672200; Biter AB, 2012, J STRUCT BIOL, V179, P172, DOI 10.1016/j.jsb.2012.05.007; Carroni M, 2014, ELIFE, V3, DOI 10.7554/eLife.02481; DeSantis ME, 2012, CELL, V151, P778, DOI 10.1016/j.cell.2012.09.038; Diemand AV, 2006, J STRUCT BIOL, V156, P230, DOI 10.1016/j.jsb.2006.04.011; Le DTV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067815; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Franzmann TM, 2011, J BIOL CHEM, V286, P17992, DOI 10.1074/jbc.M110.216176; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; HAZES B, 1988, PROTEIN ENG, V2, P119, DOI 10.1093/protein/2.2.119; Hodson S, 2012, J STRUCT BIOL, V179, P161, DOI 10.1016/j.jsb.2012.05.015; Klostermeier D, 1999, J MOL BIOL, V287, P511, DOI 10.1006/jmbi.1999.2636; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002; Lee S, 2010, P NATL ACAD SCI USA, V107, P8135, DOI 10.1073/pnas.1003572107; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Miot M, 2011, P NATL ACAD SCI USA, V108, P6915, DOI 10.1073/pnas.1102828108; Oguchi Y, 2012, NAT STRUCT MOL BIOL, V19, P1338, DOI 10.1038/nsmb.2441; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Rosenzweig R, 2013, SCIENCE, V339, P1080, DOI 10.1126/science.1233066; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Schlee S, 2001, J MOL BIOL, V306, P889, DOI 10.1006/jmbi.2001.4455; Seyffer F, 2012, NAT STRUCT MOL BIOL, V19, P1347, DOI 10.1038/nsmb.2442; Sielaff B, 2010, J MOL BIOL, V402, P30, DOI 10.1016/j.jmb.2010.07.030; Stinson BM, 2013, CELL, V153, P628, DOI 10.1016/j.cell.2013.03.029; Thrall SH, 1996, BIOCHEMISTRY-US, V35, P4609, DOI 10.1021/bi9526387; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang F, 2011, NATURE, V471, P331, DOI 10.1038/nature09780; Wang Q, 2005, J BIOL CHEM, V280, P40515, DOI 10.1074/jbc.M509636200; Watanabe Y, 2005, J BIOL CHEM, V280, P24562, DOI 10.1074/jbc.M414623200; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Wendler P, 2012, BBA-MOL CELL RES, V1823, P2, DOI 10.1016/j.bbamcr.2011.06.014; Werbeck ND, 2008, J MOL BIOL, V378, P178, DOI 10.1016/j.jmb.2008.02.026; Werbeck ND, 2011, BIOCHEMISTRY-US, V50, P899, DOI 10.1021/bi1018286; Werbeck ND, 2009, BIOCHEMISTRY-US, V48, P7240, DOI 10.1021/bi900880c; Yamasaki T, 2011, FEBS J, V278, P2395, DOI 10.1111/j.1742-4658.2011.08167.x; Zeymer C, 2014, ACTA CRYSTALLOGR D, V70, P582, DOI 10.1107/S1399004713030629; Zeymer C, 2013, J BIOL CHEM, V288, P7065, DOI 10.1074/jbc.M112.432583; Zolkiewski M, 2012, ARCH BIOCHEM BIOPHYS, V520, P1, DOI 10.1016/j.abb.2012.01.012	42	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.608828	http://dx.doi.org/10.1074/jbc.M114.608828			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25253689	hybrid, Green Published			2022-12-25	WOS:000345335000047
J	Takakusagi, Y; Matsumoto, S; Saito, K; Matsuo, M; Kishimoto, S; Wojtkowiak, JW; DeGraff, W; Kesarwala, AH; Choudhuri, R; Devasahayam, N; Subramanian, S; Munasinghe, JP; Gillies, RJ; Mitchell, JB; Hart, CP; Krishna, MC				Takakusagi, Yoichi; Matsumoto, Shingo; Saito, Keita; Matsuo, Masayuki; Kishimoto, Shun; Wojtkowiak, Jonathan W.; DeGraff, William; Kesarwala, Aparna H.; Choudhuri, Rajani; Devasahayam, Nallathamby; Subramanian, Sankaran; Munasinghe, Jeeva P.; Gillies, Robert J.; Mitchell, James B.; Hart, Charles P.; Krishna, Murali C.			Pyruvate Induces Transient Tumor Hypoxia by Enhancing Mitochondrial Oxygen Consumption and Potentiates the Anti-Tumor Effect of a Hypoxia-Activated Prodrug TH-302	PLOS ONE			English	Article							HYPERBARIC-OXYGEN; CYCLING HYPOXIA; CANCER-THERAPY; MICE; MICROVASCULATURE; PHARMACOKINETICS; FLUCTUATIONS; MISONIDAZOLE; IRRADIATION; CARCINOMA	Background: TH-302 is a hypoxia-activated prodrug (HAP) of bromo isophosphoramide mustard that is selectively activated within hypoxic regions in solid tumors. Our recent study showed that intravenously administered bolus pyruvate can transiently induce hypoxia in tumors. We investigated the mechanism underlying the induction of transient hypoxia and the combination use of pyruvate to potentiate the anti-tumor effect of TH-302. Methodology/Results: The hypoxia-dependent cytotoxicity of TH-302 was evaluated by a viability assay in murine SCCVII and human HT29 cells. Modulation in cellular oxygen consumption and in vivo tumor oxygenation by the pyruvate treatment was monitored by extracellular flux analysis and electron paramagnetic resonance (EPR) oxygen imaging, respectively. The enhancement of the anti-tumor effect of TH-302 by pyruvate treatment was evaluated by monitoring the growth suppression of the tumor xenografts inoculated subcutaneously in mice. TH-302 preferentially inhibited the growth of both SCCVII and HT29 cells under hypoxic conditions (0.1% O-2), with minimal effect under aerobic conditions (21% O-2). Basal oxygen consumption rates increased after the pyruvate treatment in SCCVII cells in a concentration-dependent manner, suggesting that pyruvate enhances the mitochondrial respiration to consume excess cellular oxygen. In vivo EPR oxygen imaging showed that the intravenous administration of pyruvate globally induced the transient hypoxia 30 min after the injection in SCCVII and HT29 tumors at the size of 500-1500 mm(3). Pretreatment of SCCVII tumor bearing mice with pyruvate 30 min prior to TH-302 administration, initiated with small tumors (similar to 550 mm(3)), significantly delayed tumor growth. Conclusions/Significance: Our in vitro and in vivo studies showed that pyruvate induces transient hypoxia by enhancing mitochondrial oxygen consumption in tumor cells. TH-302 therapy can be potentiated by pyruvate pretreatment if started at the appropriate tumor size and oxygen concentration.	[Takakusagi, Yoichi; Matsumoto, Shingo; Saito, Keita; Matsuo, Masayuki; Kishimoto, Shun; DeGraff, William; Choudhuri, Rajani; Devasahayam, Nallathamby; Subramanian, Sankaran; Mitchell, James B.; Krishna, Murali C.] NCI, Radiat Biol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Wojtkowiak, Jonathan W.; Gillies, Robert J.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Kesarwala, Aparna H.] NCI, Radiat Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Munasinghe, Jeeva P.] NINDS, Bethesda, MD 20892 USA; [Hart, Charles P.] Threshold Pharmaceut, San Francisco, CA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Krishna, MC (corresponding author), NCI, Radiat Biol Branch, Ctr Canc Res, Bethesda, MD 20892 USA.	murali@helix.nih.gov	Takakusagi, Yoichi/AAA-1998-2021	Takakusagi, Yoichi/0000-0002-6786-0748; Matsumoto, Shingo/0000-0003-2698-0839; Hart, Charles/0000-0003-4440-726X; Kesarwala, Aparna/0000-0001-8297-9643; Gillies, Robert/0000-0002-8888-7747	Intramural Research Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH); NATIONAL CANCER INSTITUTE [ZIABC011577] Funding Source: NIH RePORTER	Intramural Research Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brizel DM, 1997, INT J RADIAT ONCOL, V38, P285, DOI 10.1016/S0360-3016(97)00101-6; Brown JM, 2007, METHOD ENZYMOL, V435, P297, DOI 10.1016/S0076-6879(07)35015-5; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; BUSH RS, 1978, BRIT J CANCER, V37, P302; Cairns RA, 2009, CLIN CANCER RES, V15, P7170, DOI 10.1158/1078-0432.CCR-09-1676; Cardenas-Navia LI, 2004, CANCER RES, V64, P6010, DOI 10.1158/0008-5472.CAN-03-0947; CHAPLIN DJ, 1987, CANCER RES, V47, P597; Duan JX, 2008, J MED CHEM, V51, P2412, DOI 10.1021/jm701028q; Farrar CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017228; FU KK, 1984, INT J RADIAT ONCOL, V10, P1473, DOI 10.1016/0360-3016(84)90371-7; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Ganjoo KN, 2011, ONCOLOGY-BASEL, V80, P50, DOI 10.1159/000327739; GRAY LH, 1953, BRIT J RADIOL, V26, P638, DOI 10.1259/0007-1285-26-312-638; GUICHARD M, 1986, RADIAT RES, V105, P115, DOI 10.2307/3576731; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Hu JS, 2010, BLOOD, V116, P1524, DOI 10.1182/blood-2010-02-269126; Kimura H, 1996, CANCER RES, V56, P5522; Matsumoto S, 2008, J CLIN INVEST, V118, P1965, DOI 10.1172/JCI34928; Matsumoto S, 2011, CANCER RES, V71, P6350, DOI 10.1158/0008-5472.CAN-11-2025; Meng FY, 2012, MOL CANCER THER, V11, P740, DOI 10.1158/1535-7163.MCT-11-0634; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; National Research Council, 1996, GUIDE CARE USE LAB A, V7th ed., P140, DOI [10.17226/5140, DOI 10.17226/5140]; Nelson SJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006070; Saito K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049456; Saito K, 2012, MAGN RESON MED, V67, P801, DOI 10.1002/mrm.23065; Sorg BS, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2003369; SUIT HD, 1981, RADIAT RES, V87, P360, DOI 10.2307/3575590; SUIT HD, 1967, RADIOLOGY, V89, P713, DOI 10.1148/89.4.713; Sun JD, 2012, CLIN CANCER RES, V18, P758, DOI 10.1158/1078-0432.CCR-11-1980; TEICHER BA, 1980, J MED CHEM, V23, P955, DOI 10.1021/jm00182a027; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Weiss GJ, 2011, CLIN CANCER RES, V17, P2997, DOI 10.1158/1078-0432.CCR-10-3425; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Yasui H, 2010, CANCER RES, V70, P6427, DOI 10.1158/0008-5472.CAN-10-1350; Zhang X, 2012, ISMRM 20 ANN M	35	27	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107995	10.1371/journal.pone.0107995	http://dx.doi.org/10.1371/journal.pone.0107995			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254649	Green Published, gold, Green Submitted			2022-12-25	WOS:000344862300050
J	Zhang, H; Liang, X; Duan, C; Liu, CG; Zhao, ZW				Zhang, Hao; Liang, Xi; Duan, Chao; Liu, Caigang; Zhao, Zuowei			Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; ARSENIC TRIOXIDE; CARCINOMA CELLS; PROGESTERONE-RECEPTOR; EXPRESSION; TUMORIGENICITY	Galectin-3 has a relatively high level of expression in triple-negative breast cancers and is a potential marker for this disease. However, the clinical and prognostic implications of galectin-3 expression in breast cancer remain unclear. We examined mastectomy specimens from 1086 breast cancer cases and matching, adjacent non-cancerous tissues using immunohistochemistry. Overall, triple-negative breast cancers expressed galectin-3 more strongly than did other breast cancers types (63.59% vs 21.36%, P = 0.001). Galectin-3 expression was not found to be an independent prognostic factor for breast cancer by Cox regression analysis, but was associated with chemotherapeutic resistance. Apoptosis was only weakly induced by arsenic trioxide (ATO) treatment in galectin-3-positive breast cancer cells (MDA-MB-231 and MCF-7), although ATO treatment up-regulated galectin-3 expression. Knockdown of galectin-3 in MDA-MB-231 cells sensitized them to killing by ATO. These findings support a possible role for galectin-3 as a marker for triple-negative breast cancer progression and as a therapeutic target in combination with ATO treatment, although the mechanisms that underlie this synergy require further investigation.	[Zhang, Hao; Liang, Xi; Liu, Caigang; Zhao, Zuowei] Dalian Med Univ, Hosp 2, Dept Breast Surg, Dalian, Peoples R China; [Duan, Chao] Benxi Cent Hosp, Dept Cardiothorac, Benxi, Peoples R China	Dalian Medical University	Liu, CG (corresponding author), Dalian Med Univ, Hosp 2, Dept Breast Surg, Dalian, Peoples R China.	angel-s205@163.com	Liu, Caigang/C-7179-2018	Liu, Caigang/0000-0003-2083-235X; Zhang, Hao/0000-0002-0049-1220	China National Natural Science Foundation [81102029, 81172047]; Liaoning National Natural Science Foundation [2013021006]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Liaoning National Natural Science Foundation	This study was funded by the China National Natural Science Foundation (No. 81102029 and 81172047) and Liaoning National Natural Science Foundation (No. 2013021006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baj G, 2002, BREAST CANCER RES TR, V73, P61, DOI 10.1023/A:1015272401822; BAO Q, 1995, J CELL SCI, V108, P2791; Berenson JR, 2006, CLIN LYMPHOMA MYELOM, V7, P192, DOI 10.3816/CLM.2006.n.058; Chen Z, 2002, SEMIN HEMATOL, V39, P22, DOI 10.1053/shem.2002.33611; Chow SKY, 2004, J ENDOCRINOL, V182, P325, DOI 10.1677/joe.0.1820325; DAGHER SF, 1995, P NATL ACAD SCI USA, V92, P1213, DOI 10.1073/pnas.92.4.1213; Dilda PJ, 2007, CANCER TREAT REV, V33, P542, DOI 10.1016/j.ctrv.2007.05.001; Evens AM, 2004, LEUKEMIA RES, V28, P891, DOI 10.1016/j.leukres.2004.01.011; Gaffan J, 2006, J CLIN ONCOL, V24, P1932, DOI 10.1200/JCO.2005.02.6617; Honjo Y, 2001, CLIN CANCER RES, V7, P661; Kasami M, 2008, BREAST, V17, P523, DOI 10.1016/j.breast.2008.04.002; Koo JS, 2011, YONSEI MED J, V52, P89, DOI 10.3349/ymj.2011.52.1.89; LeMarer N, 1996, J CELL PHYSIOL, V168, P51, DOI 10.1002/(SICI)1097-4652(199607)168:1<51::AID-JCP7>3.0.CO;2-7; Ma CX, 2009, ONCOLOGY-NY, V23, P133; Moon BK, 2001, AM J PATHOL, V159, P1055, DOI 10.1016/S0002-9440(10)61780-4; Murgo AJ, 2001, ONCOLOGIST, V6, P22, DOI 10.1634/theoncologist.6-suppl_2-22; NANGIAMAKKER P, 1995, INT J ONCOL, V7, P1079; Pal SK, 2011, BREAST CANCER RES TR, V125, P627, DOI 10.1007/s10549-010-1293-1; Rody A, 2004, ONCOL REP, V12, P695; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; SATO S, 1992, J BIOL CHEM, V267, P6983; Schneider BP, 2008, CLIN CANCER RES, V14, P8010, DOI 10.1158/1078-0432.CCR-08-1208; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tallman MS, 2008, BEST PRACT RES CL HA, V21, P659, DOI 10.1016/j.beha.2008.09.002; Tischkowitz M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-134; Verstovsek S, 2006, HEMATOL ONCOL, V24, P181, DOI 10.1002/hon.787	26	39	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e103482	10.1371/journal.pone.0103482	http://dx.doi.org/10.1371/journal.pone.0103482			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254965	Green Published, gold, Green Submitted			2022-12-25	WOS:000344862300003
J	Kaur, J; Nygren, A; Vigmond, EJ				Kaur, Jaspreet; Nygren, Anders; Vigmond, Edward J.			Fitting Membrane Resistance along with Action Potential Shape in Cardiac Myocytes Improves Convergence: Application of a Multi-Objective Parallel Genetic Algorithm	PLOS ONE			English	Article							COMPUTATIONAL MODEL; ATRIAL CELL; REPOLARIZATION; INSIGHTS	Fitting parameter sets of non-linear equations in cardiac single cell ionic models to reproduce experimental behavior is a time consuming process. The standard procedure is to adjust maximum channel conductances in ionic models to reproduce action potentials (APs) recorded in isolated cells. However, vastly different sets of parameters can produce similar APs. Furthermore, even with an excellent AP match in case of single cell, tissue behaviour may be very different. We hypothesize that this uncertainty can be reduced by additionally fitting membrane resistance (R-m). To investigate the importance of R-m, we developed a genetic algorithm approach which incorporated R-m data calculated at a few points in the cycle, in addition to AP morphology. Performance was compared to a genetic algorithm using only AP morphology data. The optimal parameter sets and goodness of fit as computed by the different methods were compared. First, we fit an ionic model to itself, starting from a random parameter set. Next, we fit the AP of one ionic model to that of another. Finally, we fit an ionic model to experimentally recorded rabbit action potentials. Adding the extra objective (R-m, at a few voltages) to the AP fit, lead to much better convergence. Typically, a smaller MSE (mean square error, defined as the average of the squared error between the target AP and AP that is to be fitted) was achieved in one fifth of the number of generations compared to using only AP data. Importantly, the variability in fit parameters was also greatly reduced, with many parameters showing an order of magnitude decrease in variability. Adding R-m to the objective function improves the robustness of fitting, better preserving tissue level behavior, and should be incorporated.	[Kaur, Jaspreet; Nygren, Anders; Vigmond, Edward J.] Univ Calgary, Calgary, AB T2N 1N4, Canada; [Vigmond, Edward J.] Univ Bordeaux 1, LIYRC Inst, Bordeaux, France	University of Calgary; UDICE-French Research Universities; Universite de Bordeaux	Kaur, J (corresponding author), Univ Calgary, Calgary, AB T2N 1N4, Canada.	jakaur@ucalgary.ca			Natural Sciences and Engineering Research Council of Canada; Chancellor's challenge Graduate Scholarship; Faculty of Graduate Studies scholarship; Queen Elizabeth II Graduate Scholarship; Investment of the Future grant from the government of France through the Agence National de la Recherche [ANR-10-IAHU-04]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Chancellor's challenge Graduate Scholarship; Faculty of Graduate Studies scholarship; Queen Elizabeth II Graduate Scholarship; Investment of the Future grant from the government of France through the Agence National de la Recherche	This work was in part supported by The Natural Sciences and Engineering Research Council of Canada, a Chancellor's challenge Graduate Scholarship, Faculty of Graduate Studies scholarship and Queen Elizabeth II Graduate Scholarship. This work was also partly supported through the Investment of the Future grant, ANR-10-IAHU-04, from the government of France through the Agence National de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed AA, 2013, COMPUT MATH METHOD M, V2013, P1; BEELER GW, 1977, J PHYSIOL-LONDON, V268, P177, DOI 10.1113/jphysiol.1977.sp011853; Bernus O, 2002, AM J PHYSIOL-HEART C, V282, pH2296, DOI 10.1152/ajpheart.00731.2001; Bot CT, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00421; Carro J, 2011, PHILOS T R SOC A, V369, P4205, DOI 10.1098/rsta.2011.0127; Cherry EM, 2007, HEART RHYTHM, V4, P1553, DOI 10.1016/j.hrthm.2007.08.017; CLERC L, 1976, J PHYSIOL-LONDON, V255, P335, DOI 10.1113/jphysiol.1976.sp011283; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; Dastgheib Z. S., 2009, Journal of Applied Sciences, V9, P555, DOI 10.3923/jas.2009.555.560; Deb K., 2001, MULTIOBJECTIVE OPTIM; Dokos S, 2004, PROG BIOPHYS MOL BIO, V85, P407, DOI 10.1016/j.pbiomolbio.2004.02.002; Dokos S, 2003, P 5 IFAC S MOD CONTR; Fink M, 2008, PROG BIOPHYS MOL BIO, V96, P357, DOI 10.1016/j.pbiomolbio.2007.07.011; Grandi E, 2011, CIRC RES, V109, P1055, DOI 10.1161/CIRCRESAHA.111.253955; Grandi E, 2010, J MOL CELL CARDIOL, V48, P112, DOI 10.1016/j.yjmcc.2009.09.019; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Iyer V, 2004, BIOPHYS J, V87, P1507, DOI 10.1529/biophysj.104.043299; Lin WY, 2003, J INF SCI ENG, V19, P889; Mahajan A, 2008, BIOPHYS J, V94, P392, DOI 10.1529/biophysj.106.98160; Nygren A, 1998, CIRC RES, V82, P63; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Rohr S, 2004, CARDIOVASC RES, V62, P309, DOI 10.1016/j.cardiores.2003.11.035; Sarkar AX, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000914; SEPULVEDA NG, 1987, BIOPHYS J, V51, P557, DOI 10.1016/S0006-3495(87)83381-7; Syed Z, 2005, MED BIOL ENG COMPUT, V43, P561, DOI 10.1007/BF02351029; Ten Tusscher KHWJ, 2006, PROG BIOPHYS MOL BIO, V90, P326, DOI 10.1016/j.pbiomolbio.2005.05.015; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Vigmond EJ, 2003, J ELECTROCARDIOL, V36, P69, DOI 10.1016/j.jelectrocard.2003.09.017; Weber FM, 2008, COMPUTERS IN CARDIOLOGY 2008, VOLS 1 AND 2, P61, DOI 10.1109/CIC.2008.4748977; WINFREE AT, 1994, SCIENCE, V266, P1003, DOI 10.1126/science.7973648; Zaniboni M, 2000, AM J PHYSIOL-HEART C, V278, pH677, DOI 10.1152/ajpheart.2000.278.3.H677	31	25	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107984	10.1371/journal.pone.0107984	http://dx.doi.org/10.1371/journal.pone.0107984			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250956	Green Published, gold, Green Submitted			2022-12-25	WOS:000342492700068
J	Soon, SS; Chia, WK; Chan, MLS; Ho, GF; Jian, X; Deng, YH; Tan, CS; Sharma, A; Segelov, E; Mehta, S; Ali, R; Toh, HC; Wee, HL				Soon, Swee Sung; Chia, Whay-Kuang; Chan, Mun-ling Sarah; Ho, Gwo Fuang; Jian, Xiao; Deng, Yan Hong; Tan, Chuen-Seng; Sharma, Atul; Segelov, Eva; Mehta, Shaesta; Ali, Raghib; Toh, Han-Chong; Wee, Hwee-Lin			Cost-Effectiveness of Aspirin Adjuvant Therapy in Early Stage Colorectal Cancer in Older Patients	PLOS ONE			English	Article							II COLON-CANCER; PREVENTION; SURVIVAL; CARCINOMA; RISK; CHEMOPREVENTION; CAPECITABINE; POPULATION; RESECTION; TRIAL	Background & Aims: Recent observational studies showed that post-operative aspirin use reduces cancer relapse and death in the earliest stages of colorectal cancer. We sought to evaluate the cost-effectiveness of aspirin as an adjuvant therapy in Stage I and II colorectal cancer patients aged 65 years and older. Methods: Two five-state Markov models were constructed separately for Stage I and II colorectal cancer using TreeAge Pro 2014. Two hypothetical cohorts of 10,000 individuals at a starting age of 65 years and with colorectal cancer in remission were put through the models separately. Cost-effectiveness of aspirin was evaluated against no treatment (Stage I and II) and capecitabine (Stage II) over a 20-year period from the United States societal perspective. Extensive one-way sensitivity analyses and multivariable Probabilistic Sensitivity Analyses (PSA) were performed. Results: In the base case analyses, aspirin was cheaper and more effective compared to other comparators in both stages. Sensitivity analyses showed that no treatment and capecitabine (Stage II only) can be cost-effective alternatives if the utility of taking aspirin is below 0.909, aspirin's annual fatal adverse event probability exceeds 0.57%, aspirin's relative risk of disease progression is 0.997 or more, or when capecitabine's relative risk of disease progression is less than 0.228. Probabilistic Sensitivity Analyses (PSA) further showed that aspirin could be cost-effective 50% to 80% of the time when the willingness-to-pay threshold was varied from USD20,000 to USD100,000. Conclusion: Even with a modest treatment benefit, aspirin is likely to be cost-effective in Stage I and II colorectal cancer, thus suggesting a potential unique role in secondary prevention in this group of patients.	[Soon, Swee Sung; Chan, Mun-ling Sarah; Wee, Hwee-Lin] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore; [Chia, Whay-Kuang; Toh, Han-Chong] Natl Canc Ctr Singapore, Dept Med Oncol, Singapore, Singapore; [Ho, Gwo Fuang] Univ Malaya, Med Ctr, Dept Radiat Oncol, Kuala Lumpur, Malaysia; [Jian, Xiao; Deng, Yan Hong] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Tan, Chuen-Seng] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Sharma, Atul] All India Inst Med Sci, Dept Oncol, New Delhi, India; [Segelov, Eva] Univ Sydney, Natl Hlth & Med Res Council Clin Trials Ctr, Sydney, NSW 2006, Australia; [Mehta, Shaesta] Tata Mem Hosp, Dept Digest Dis & Nutr, Bombay 400012, Maharashtra, India; [Ali, Raghib] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England	National University of Singapore; National Cancer Centre Singapore (NCCS); Universiti Malaya; Sun Yat Sen University; National University of Singapore; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Sydney; Tata Memorial Centre (TMC); Tata Memorial Hospital; University of Oxford	Wee, HL (corresponding author), Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore.	phawhl@nus.edu.sg	Segelov, Eva/Q-7611-2019; HO, GWO FUANG/B-8634-2010; Wee, Hwee Lin/D-4126-2012; Tan, Chuen Seng/K-1078-2013; Tan, Chuen Seng/I-6854-2019	Segelov, Eva/0000-0002-4410-6144; HO, GWO FUANG/0000-0002-2620-9174; Wee, Hwee Lin/0000-0002-7150-1801; Tan, Chuen Seng/0000-0002-6513-2309; Tan, Chuen Seng/0000-0002-6513-2309	National University of Singapore (NUS) Undergraduate Research Opportunities Programme in Science (UROPS); National Medical Research Council (NMRC) [NMRC/1226/2009]; Silent Foundation	National University of Singapore (NUS) Undergraduate Research Opportunities Programme in Science (UROPS)(National University of Singapore); National Medical Research Council (NMRC)(National Medical Research Council, Singapore); Silent Foundation	This study is supported by the following program grants: (1) National University of Singapore (NUS) Undergraduate Research Opportunities Programme in Science (UROPS) (http://www.science.nus.edu.sg/undergraduate-studies/ugenh/urops-main), (2) National Medical Research Council (NMRC) (Project number: NMRC/1226/2009) (http://www.nmrc.gov.sg/content/nmrc_internet/home.html), and (3) the Silent Foundation (http://www.silent.org.sg/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2014, STAT US COMM HOSP ST; Agency for Healthcare Research and Quality, 2014, HCUPNET BRIEF DESCR; American Cancer Society, 2013, COL CANC WHAT AR KEY; Benns M, 2013, J TRAUMA ACUTE CARE, V75, P426, DOI 10.1097/TA.0b013e31829cfa19; Briggs A, 2006, DECISION MODELLING H; Calonge N, 2009, ANN INTERN MED, V150, P396; Centers for Medicare and Medicaid Services, 2013, FEE SCHED DAT FEE SC; Centers for Medicare and Medicaid Services, 2013, DAT PHYS FEE SCHED; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Chan AT, 2009, JAMA-J AM MED ASSOC, V302, P649, DOI 10.1001/jama.2009.1112; Chia WK, 2012, NAT REV CLIN ONCOL, V9, P561, DOI 10.1038/nrclinonc.2012.137; Chu E, 2009, ONCOLOGY-BASEL, V77, P244, DOI 10.1159/000236048; de Leon MP, 2000, DIGEST LIVER DIS, V32, P312, DOI 10.1016/S1590-8658(00)80024-9; Di Gregorio C, 2005, INT J COLORECTAL DIS, V20, P147, DOI 10.1007/s00384-004-0665-6; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Ferlay J, 2010, DATABASE GLOBOCAN 20; Figueredo A, 2004, J CLIN ONCOL, V22, P3395, DOI 10.1200/JCO.2004.03.087; Fontana M, 2014, CIRCULATION, V129, P2539, DOI 10.1161/CIRCULATIONAHA.113.007595; Genentech USA Inc, 2011, HIGHL PRESCR INF XEL; Gorelick PB, 2005, STROKE, V36, P1801, DOI 10.1161/01.STR.0000174189.81153.85; Gravelle H, 2001, HEALTH ECON, V10, P587, DOI 10.1002/hec.618; Gray R, 2007, LANCET, V370, P2020, DOI 10.1016/s0140-6736(07)61866-2; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Hernandez-Diaz S, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-22; Hunt TL, 2009, PHARMACOECONOMICS, V27, P299, DOI 10.2165/00019053-200927040-00003; Hur C, 2004, CANCER-AM CANCER SOC, V101, P189, DOI 10.1002/cncr.20329; Ito Y, 2012, JPN J CLIN ONCOL, V42, P974, DOI 10.1093/jjco/hys132; Kelley RK, 2011, CLIN COLORECTAL CANC, V10, P73, DOI 10.1016/j.clcc.2011.03.001; Ladabaum U, 2001, ANN INTERN MED, V135, P769, DOI 10.7326/0003-4819-135-9-200111060-00007; Levit K, 2007, FACTS FIGURES STAT H; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Liew G, 2013, JAMA INTERN MED, V173, P258, DOI 10.1001/jamainternmed.2013.1583; Manfredi S, 2006, BRIT J SURG, V93, P1115, DOI 10.1002/bjs.5349; Mant D, 2013, J CLIN ONCOL, V31; McQuaid KR, 2006, AM J MED, V119, P624, DOI 10.1016/j.amjmed.2005.10.039; MOERTEL CG, 1995, ANN INTERN MED, V122, P321, DOI 10.7326/0003-4819-122-5-199503010-00001; NAGLIE IG, 1992, MED DECIS MAKING, V12, P239, DOI 10.1177/0272989X9201200401; National Cancer Institute, 2013, PROV QUEST ID PERPL; National Center for Health Statistics, 2013, HLTH US 2012 SPEC FE; Pence BC, 2013, CANCER EPIDEM BIOMAR, V22, P399, DOI 10.1158/1055-9965.EPI-12-0658; Ramsey SD, 2000, CANCER-AM CANCER SOC, V88, P1294, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1294::AID-CNCR4>3.3.CO;2-D; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Scheithauer W, 2003, ANN ONCOL, V14, P1735, DOI 10.1093/annonc/mdg500; Song Xue, 2011, J Med Econ, V14, P1, DOI 10.3111/13696998.2010.536870; Suleiman S, 2002, GASTROENTEROLOGY, V122, P78, DOI 10.1053/gast.2002.29689; Sung JJY, 2005, LANCET ONCOL, V6, P871, DOI 10.1016/S1470-2045(05)70422-8; Surveillance Epidemiology and End Results Program, 2013, DAT SEER STAT SEER 9; Surveillance Epidemiology and End Results Program, 2013, DAT SEER STAT SEER 1; Tol J, 2010, CLIN THER, V32, P437, DOI 10.1016/j.clinthera.2010.03.012; Twelves C, 2005, NEW ENGL J MED, V352, P2696, DOI 10.1056/NEJMoa043116; United States Department of Labor, 2013, REAL EARN NOV 2013; United States Department of Labor, 2013, US BUR LAB STAT CONS; USA Social Security Administration, 2012, RET PLANN BEN YEAR B; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Yabroff KR, 2005, MED CARE, V43, P640, DOI 10.1097/01.mlr.0000167177.45020.4a	55	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107866	10.1371/journal.pone.0107866	http://dx.doi.org/10.1371/journal.pone.0107866			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250815	gold, Green Published			2022-12-25	WOS:000342492700052
J	Zuberogoitia, I; del Real, J; Torres, JJ; Rodriguez, L; Alonso, M; Zabala, J				Zuberogoitia, Inigo; del Real, Javier; Torres, Juan Jose; Rodriguez, Luis; Alonso, Maria; Zabala, Jabi			Ungulate Vehicle Collisions in a Peri-Urban Environment: Consequences of Transportation Infrastructures Planned Assuming the Absence of Ungulates	PLOS ONE			English	Article							DEER CAPREOLUS-CAPREOLUS; BOAR SUS-SCROFA; ROE DEER; MITIGATION; LANDSCAPE; WILD; DISPERSAL; ACCIDENTS; SELECTION; PATTERNS	Ungulate vehicle collisions (UVC) provoke serious damage, including human casualties, and a large number of measures have been developed around the world to avoid collisions. We analyse the main factors involved in UVC in a road network built in the absence of ungulates, where mitigation structures to avoid UVC were not adequately considered. Ungulate population greatly increased during the last two decades and now Roe Deer and Wild Boars are widely distributed over the study area, but even after this increase, the road network was not adapted to avoid UVC. A total of 235 Roe Deer (RDVC) and 153 Wild Boar vehicle collisions (WBVC) were recorded between January 2008 and December 2011. We randomly selected 289 sample points (87 RDVC, 60 WBVC and 142 controls) separated by at least 500 metres from the next closest point and measured 19 variables that could potentially influence the vehicle collisions. We detected variations in the frequency of RDVC on a monthly basis, and WBVC was higher at weekends but no significant differences were detected on a monthly basis. UVC were more likely to occur at locations where sinuosity of the road, velocity, surface of shrub and deciduous forest area were greater, the presence of fences entered with positive relationship and distance to the nearest building was less. RDVC were more likely to occur at locations where timber forest area increased and distance to the nearest building decreased and WBVC was related to open fields cover and also to the presence of fences. Sinuosity and velocity entered in both cases as significant factors. Major roads, in which the traffic volume is greater and faster, caused more accidents with ungulates than secondary roads. Nowadays, the high frequency of ungulate road-kills deserves a new strategy in order to adapt infrastructure and adopt mitigation measures.	[Zuberogoitia, Inigo; Torres, Juan Jose] Estudios Medioambient Icarus SL, Bilbao, Bizkaia, Spain; [del Real, Javier; Rodriguez, Luis; Alonso, Maria] Saitec SA Leioa, Bizkaia, Spain; [Zabala, Jabi] Arrigorriaga, Biscay, Spain		Zuberogoitia, I (corresponding author), Estudios Medioambient Icarus SL, Bilbao, Bizkaia, Spain.	zuberogoitia@icarus.es	Iñigo, Zuberogoitia/H-5062-2019; Zabala, Jabi/B-8157-2009	Zabala, Jabi/0000-0002-1425-1594; Zuberogoitia, Inigo/0000-0002-8945-7386	Basque Government [IG-2012/0000281, IG-2013/0000703]	Basque Government(Basque Government)	This work has been developed as part of the Project "FORD - Aplicacion de tecnologias de la informacion a la mejora de la seguridad en infraestructuras de transporte: sistemas de deteccion de fauna", which has been financed by the Basque Government (Res. No: IG-2012/0000281 and IG-2013/0000703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare that there are no competing interests or financial disclosure and that this does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.	Acevedo Pelayo, 2009, Galemys, V21, P13; Aihartza J. R., 1999, Miscellania Zoologica (Barcelona), V22, P41; Alvarez J, 1985, DOC RED FRAGM HABITA, P336; Andersen R, 1996, BIOL CONSERV, V77, P169, DOI 10.1016/0006-3207(96)00004-3; Ascensao F, 2013, ECOL MODEL, V257, P36, DOI 10.1016/j.ecolmodel.2013.02.026; Balciauskas Linas, 2008, Acta Biologica Universitatis Daugavpiliensis, V8, P89; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Clevenger AP, 2001, WILDLIFE SOC B, V29, P646; Colino-Rabanal VJ, 2012, ANIM BIODIV CONSERV, V35, P247; Colino-Rabanal VJ, 2011, THESIS U SALAMANCA; Conover MR, 2002, RESOLVING WILDLIFE C; Coulon A, 2004, MOL ECOL, V13, P2841, DOI 10.1111/j.1365-294X.2004.02253.x; Diaz ER, 2010, MADR 14 INT C PROJ E, P1196; Diputacion Foral de Bizkaia, 2014, EV TRAF; Emap, 2011, EV TRAF CARR BIZK; Fonseca C, 2008, EUR J WILDLIFE RES, V54, P361, DOI 10.1007/s10344-007-0144-9; Ford AT, 2011, WILDLIFE BIOL, V17, P253, DOI 10.2981/09-051; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Found R, 2011, J ENVIRON MANAGE, V92, P2486, DOI 10.1016/j.jenvman.2011.05.010; GeoEuskadi, 2013, IND CART CART BAS; Gordon IJ, 2009, WILDLIFE BIOL, V15, P1, DOI 10.2981/06-087; Gurrutxaga M, 2010, J NAT CONSERV, V18, P318, DOI 10.1016/j.jnc.2010.01.005; Hood GM, 2013, POPTOOLS; Hothorn T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029510; Huijser MP, 2009, ECOL SOC, V14; Instituto Nacional de Estadistica (Spanish Statistical Office), 2014, DEM POBL; Lopez-Lopez P, 2013, BIRD STUDY, V60, P555, DOI 10.1080/00063657.2013.842537; Madsen AB, 2002, WILDLIFE BIOL, V8, P55, DOI 10.2981/wlb.2002.008; Malo JE, 2004, J APPL ECOL, V41, P701, DOI 10.1111/j.0021-8901.2004.00929.x; Monge J, 2012, FORESTA, V55, P54; Ng Janet W., 2008, Human-Wildlife Conflicts, V2, P34; Palazon S, 2012, ORYX, V46, P614, DOI 10.1017/S0030605312000920; Palomo L, 2002, ATLAS MAMIFEROS TERR; Penis S., 2005, GALEMYS, V17, P13; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; Rodriguez-Refojos C, 2011, MIDDLE SIZED CARNIVO, P105; Said S, 2005, J ZOOL, V267, P301, DOI 10.1017/S0952836905007454; Said S, 2005, LANDSCAPE ECOL, V20, P1003, DOI 10.1007/s10980-005-7518-8; Scillitani L., 2009, EUR J WILDLIFE RES, V56, P307, DOI [10.1007/s10344-009-0314-z, DOI 10.1007/s10344-009-0314-z]; Segues Echazarreta F., 2008, THESIS; Seiler A, 2003, THESIS SWEDISH U AGR; Serrano D, 2008, BASIC APPL ECOL, V9, P771, DOI 10.1016/j.baae.2007.08.013; Thurfjell H, 2011, THESIS SWEDISH U AGR; Torres RT, 2011, ECOL RES, V26, P781, DOI 10.1007/s11284-011-0837-0; VerCauteren KC, 2006, WILDLIFE SOC B, V34, P191, DOI 10.2193/0091-7648(2006)34[191:FADMAR]2.0.CO;2; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; WAHLSTROM LK, 1995, J ZOOL, V235, P455, DOI 10.1111/j.1469-7998.1995.tb01762.x; Zar JH, 1999, BIOSTATISTCAL ANAL; Zuberogoitia I, 2013, BIODIVERS CONSERV, V22, P169, DOI 10.1007/s10531-012-0410-3; Zuberogoitia I, 2013, EUR J WILDLIFE RES, V59, P421, DOI 10.1007/s10344-012-0687-2; Zuberogoitia Inigo, 2011, P70; [No title captured], DOI DOI 10.1016/j.jenvman.2010.11.027	52	24	27	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107713	10.1371/journal.pone.0107713	http://dx.doi.org/10.1371/journal.pone.0107713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251376	gold, Green Published			2022-12-25	WOS:000342492700040
J	Lemee, L; Hong, E; Etienne, M; Deghmane, AE; Delbos, V; Terrade, A; Berthelot, G; Caron, F; Taha, MK				Lemee, Ludovic; Hong, Eva; Etienne, Manuel; Deghmane, Ala-Eddine; Delbos, Valerie; Terrade, Aude; Berthelot, Gilles; Caron, Francois; Taha, Muhamed-Kheir			Genetic Diversity and Levels of Expression of Factor H Binding Protein among Carriage Isolates of Neisseria meningitidis	PLOS ONE			English	Article							VACCINE 4CMENB; SEROGROUP; GENOTYPES; DISEASE	The prevention of meningococcal disease may be improved by recombinant vaccines such as 4CMenB and rLP2086 that target the factor H binding protein (fHbp), an immunogenic surface component of Neisseria meningitidis present as one of three variants. Whether such vaccines decrease carriage of invasive isolates and thus induce herd immunity is unknown. We analyzed the genetic diversity and levels of expression of fHbp among 268 carriage strains and compare them to those of 467 invasive strains. fhbp gene sequencing showed higher proportions of variants 2 and 3 among carriage isolates (p<0.0001). Carriage isolates expressed lower levels of fHbp (p<0.01) but that remain high enough to predict targeting by antibodies against fHbp particularly in group B isolates belonging to the frequent hypervirulent clonal complexes in Europe and North America (cc32, cc41/44, cc269). This suggests that fHbp targeting meningococcal vaccines might reduce, at least in part, the acquisition of some hyperinvasive isolates.	[Lemee, Ludovic; Etienne, Manuel; Delbos, Valerie; Caron, Francois] Ctr Hosp Univ, Rouen, France; [Hong, Eva; Deghmane, Ala-Eddine; Terrade, Aude; Taha, Muhamed-Kheir] Inst Pasteur, Natl Reference Ctr Meningococci, Paris, France; [Hong, Eva; Deghmane, Ala-Eddine; Terrade, Aude; Taha, Muhamed-Kheir] Inst Pasteur, Invas Bacterial Infect Unit, Paris, France; [Berthelot, Gilles] Ctr Hosp Gen, Dieppe, France	CHU de Rouen; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Taha, MK (corresponding author), Inst Pasteur, Natl Reference Ctr Meningococci, Paris, France.	mktaha@pasteur.fr	ETIENNE, Manuel/D-7705-2015; Deghmane, Ala-Eddine/CAF-2140-2022	ETIENNE, Manuel/0000-0002-7301-2614; 	French Ministry of Health "Programme Hospitalier de Recherche Clinique"; Institut Pasteur; Institut de Veille; STFC [ST/J001465/1] Funding Source: UKRI	French Ministry of Health "Programme Hospitalier de Recherche Clinique"; Institut Pasteur(European Commission); Institut de Veille; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The study was supported by institutional funding by the French Ministry of Health "Programme Hospitalier de Recherche Clinique," the Institut Pasteur, and the Institut de Veille. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brehony C, 2007, FEMS MICROBIOL REV, V31, P15, DOI 10.1111/j.1574-6976.2006.00056.x; Caron F, 2011, LANCET INFECT DIS, V11, P455, DOI 10.1016/S1473-3099(11)70027-5; Claus H, 2005, J INFECT DIS, V191, P1263, DOI 10.1086/428590; Delbos V, 2013, EUR J CLIN MICROBIOL, V32, P1451, DOI 10.1007/s10096-013-1897-6; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Hong E, 2013, VACCINE, V31, P1113, DOI 10.1016/j.vaccine.2012.12.022; Hong E, 2012, VACCINE, V31, P183, DOI 10.1016/j.vaccine.2012.10.072; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Loh E, 2013, NATURE, V502, P237, DOI 10.1038/nature12616; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Marsh JW, 2011, VACCINE, V29, P6049, DOI 10.1016/j.vaccine.2011.06.025; Marshall HS, 2013, VACCINE, V31, P1569, DOI 10.1016/j.vaccine.2013.01.021; Murphy E, 2009, J INFECT DIS, V200, P379, DOI 10.1086/600141; Ramsay ME, 2003, BRIT MED J, V326, P365, DOI 10.1136/bmj.326.7385.365; Schneider MC, 2007, TRENDS MICROBIOL, V15, P233, DOI 10.1016/j.tim.2007.03.005; Seib KL, 2011, INFECT IMMUN, V79, P970, DOI 10.1128/IAI.00891-10; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Taha MK, 2004, J CLIN MICROBIOL, V42, P4158, DOI 10.1128/JCM.42.9.4158-4163.2004; Taha MK, 2013, LANCET, V382, P936, DOI 10.1016/S0140-6736(13)61926-1; Vazquez JA, 2003, ANTIMICROB AGENTS CH, V47, P3430, DOI 10.1128/AAC.47.11.3430-3434.2003; Vogel U, 2013, LANCET INFECT DIS, V13, P416, DOI 10.1016/S1473-3099(13)70006-9; Yazdankhah SP, 2004, J CLIN MICROBIOL, V42, P5146, DOI 10.1128/JCM.42.11.5146-5153.2004; Zarantonelli ML, 2008, CLIN MICROBIOL INFEC, V14, P467, DOI 10.1111/j.1469-0691.2008.01955.x	25	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107240	10.1371/journal.pone.0107240	http://dx.doi.org/10.1371/journal.pone.0107240			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247300	Green Submitted, Green Published, gold			2022-12-25	WOS:000342351800019
J	Esmaeilpour, M; Naderifar, V; Shukur, Z				Esmaeilpour, Mansour; Naderifar, Vahideh; Shukur, Zarina			Design Pattern Mining Using Distributed Learning Automata and DNA Sequence Alignment	PLOS ONE			English	Article								Context: Over the last decade, design patterns have been used extensively to generate reusable solutions to frequently encountered problems in software engineering and object oriented programming. A design pattern is a repeatable software design solution that provides a template for solving various instances of a general problem. Objective: This paper describes a new method for pattern mining, isolating design patterns and relationship between them; and a related tool, DLA-DNA for all implemented pattern and all projects used for evaluation. DLA-DNA achieves acceptable precision and recall instead of other evaluated tools based on distributed learning automata (DLA) and deoxyribonucleic acid (DNA) sequences alignment. Method: The proposed method mines structural design patterns in the object oriented source code and extracts the strong and weak relationships between them, enabling analyzers and programmers to determine the dependency rate of each object, component, and other section of the code for parameter passing and modular programming. The proposed model can detect design patterns better that available other tools those are Pinot, PTIDEJ and DPJF; and the strengths of their relationships. Results: The result demonstrate that whenever the source code is build standard and non-standard, based on the design patterns, then the result of the proposed method is near to DPJF and better that Pinot and PTIDEJ. The proposed model is tested on the several source codes and is compared with other related models and available tools those the results show the precision and recall of the proposed method, averagely 20% and 9.6% are more than Pinot, 27% and 31% are more than PTIDEJ and 3.3% and 2% are more than DPJF respectively. Conclusion: The primary idea of the proposed method is organized in two following steps: the first step, elemental design patterns are identified, while at the second step, is composed to recognize actual design patterns.	[Esmaeilpour, Mansour; Naderifar, Vahideh] Islamic Azad Univ, Coll Engn, Dept Comp Engn, Hamedan Branch, Hamadan, Iran; [Shukur, Zarina] Univ Kebangsaan Malaysia, Fac Informat Sci & Technol, Software Technol & Management Res Ctr, Bangi 43600, Malaysia	Islamic Azad University; Universiti Kebangsaan Malaysia	Esmaeilpour, M (corresponding author), Islamic Azad Univ, Coll Engn, Dept Comp Engn, Hamedan Branch, Hamadan, Iran.	esmaeilpour@iauh.ac.ir	Esmaeilpour, Mansour/J-6458-2016	Esmaeilpour, Mansour/0000-0002-2475-518X	Hamedan Branch, Islamic Azad University (IAUH); Malaysia Ministry of Higher Education	Hamedan Branch, Islamic Azad University (IAUH)(Islamic Azad University); Malaysia Ministry of Higher Education(Ministry of Education, Malaysia)	We would like to thank Hamedan Branch, Islamic Azad University (IAUH) that sponsored us in during this research plan. As well as appreciate Universiti Kebangsaan Malaysia (UKM) for the postdoctoral scheme and Malaysia Ministry of Higher Education for providing the Fundamental Research Grant Scheme (FRGS).	Alexander C., 1977, PATTERN LANGUAGE TOW; Alipour M., 2005, 10 ANN CSI COMP C TE, P271; Antoniol G, 2001, J SYST SOFTWARE, V59, P181, DOI 10.1016/S0164-1212(01)00061-9; Arcelli F, 2010, 2 INT C PERV PATT AP; Balanyi Z, 2003, PROC IEEE INT CONF S, P305, DOI 10.1109/ICSM.2003.1235436; Binun A, 2012, 16 EUR C SOFTW MAINT; Boetcher J., 1998, PEDAGOGY LEARNING ST; De Lucia A, 2011, 6 WORKSH IT ECL COMM, P40; De Lucia A, 2009, J SYST SOFTWARE, V82, P1177, DOI 10.1016/j.jss.2009.02.012; Dong J, 2007, ECBS 2007: 14TH ANNUAL IEEE INTERNATIONAL CONFERENCE AND WORKSHOPS ON THE ENGINEERING OF COMPUTER-BASED SYSTEMS, PROCEEDINGS, P371; Dong J, 2009, INT J SOFTW ENG KNOW, V19, P823, DOI 10.1142/S021819400900443X; Dong J, 2009, IEEE T SYST MAN CY A, V39, P1271, DOI 10.1109/TSMCA.2009.2028012; Dong J, 2008, APPLIED COMPUTING 2008, VOLS 1-3, P765; Esmaeilpour M, 2012, INT J INNOV COMPUT I, V8, P8063; Ferenc R, 2005, PROC IEEE INT CONF S, P295; Fontana FA, 2011, J SYST SOFTWARE, V84, P2334, DOI 10.1016/j.jss.2011.07.006; Gamma E, 1995, DESIGN PATTERN ELEME; Gueheneuc Y. -G., 2004, CASCON 04, P28; Gueheneuc YG, 2008, IEEE T SOFTWARE ENG, V34, P667, DOI 10.1109/TSE.2008.48; Gueheneuc YG, 2004, 11TH WORKING CONFERENCE ON REVERSE ENGINEERING, PROCEEDINGS, P172, DOI 10.1109/WCRE.2004.21; Hachemi A, 2012, CARI2012 ALG; Keller R. K., 1999, Proceedings of the 1999 International Conference on Software Engineering (IEEE Cat. No.99CB37002), P226, DOI 10.1109/ICSE.1999.841012; Kramer C, 2006, WORK C REV ENG WCRE, P208; Loo KN, 2012, IEEE SOFTWARE, V29, P64, DOI 10.1109/MS.2012.20; Loo KN, 2010, 2 INT C COMP ENG TEC, p[V6, V6]; Manai Y, 2007, IEEE I C ELECT CIRC, P483, DOI 10.1109/ICECS.2007.4511035; Mount D. W., 2001, BIOINFORMATICS SEQUE; Narendra KS, 1972, INT C CYB SOC WASH D; Noble J, 1998, AUSTR SOFTW ENG C AD; PARNAS DL, 1972, COMMUN ACM, V15, P1053, DOI 10.1145/361598.361623; Rouchka EC, 2006, ACM CROSSROADS, V13; Shi N, 2006, IEEE INT CONF AUTOM, P123; Shimomura T., 2010, Proceedings Fifth International Conference on Software Engineering Advances (ICSEA 2010), P213, DOI 10.1109/ICSEA.2010.39; Tsantalis N, 2006, IEEE T SOFTWARE ENG, V32, P896, DOI 10.1109/TSE.2006.112; Tsetlin ML, 1973, MATH SCI ENG, V102, P3; Wirfs-Brock R, 1990, DESIGNING OBJECT ORI; Zhou H, 2011, BMC GENOMICS S3, V12, pS20; Zhou H, 2013, BMC SYSTEMS BIOL, V7, P6; Zhou HF, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-5; Zhou HF, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S2-S2; ZIMMER W, 1995, PATTERN LANGUAGES OF PROGRAM DESIGN, P345; Zimmer W, 1994, PATTERN LANGUAGES PR	42	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e106313	10.1371/journal.pone.0106313	http://dx.doi.org/10.1371/journal.pone.0106313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243670	Green Submitted, gold, Green Published			2022-12-25	WOS:000343679800009
J	Jacquot, A; Francius, G; Razafitianamaharavo, A; Dehghani, F; Tamayol, A; Linder, M; Arab-Tehrany, E				Jacquot, Adrien; Francius, Gregory; Razafitianamaharavo, Angelina; Dehghani, Fariba; Tamayol, Ali; Linder, Michel; Arab-Tehrany, Elmira			Morphological and Physical Analysis of Natural Phospholipids-Based Biomembranes	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; SUPPORTED LIPID-BILAYERS; MEMBRANES; SPECTROSCOPY; PROBE; AFM; NANOMECHANICS; LIPOSOMES; MODEL; FLUORESCENCE	Background: Liposomes are currently an important part of biological, pharmaceutical, medical and nutritional research, as they are considered to be among the most effective carriers for the introduction of various types of bioactive agents into target cells. Scope of Review: In this work, we study the lipid organization and mechanical properties of biomembranes made of marine and plant phospholipids. Membranes based on phospholipids extracted from rapeseed and salmon are studied in the form of liposome and as supported lipid bilayer. Dioleylphosphatidylcholine (DOPC) and dipalmitoylphosphatidylcholine (DPPC) are used as references to determine the lipid organization of marine and plant phospholipid based membranes. Atomic force microscopy (AFM) imaging and force spectroscopy measurements are performed to investigate the membranes' topography at the micrometer scale and to determine their mechanical properties. Major Conclusions: The mechanical properties of the membranes are correlated to the fatty acid composition, the morphology, the electrophoretic mobility and the membrane fluidity. Thus, soft and homogeneous mechanical properties are evidenced for salmon phospholipids membrane containing various polyunsaturated fatty acids. Besides, phase segregation in rapeseed membrane and more important mechanical properties were emphasized for this type of membranes by contrast to the marine phospholipids based membranes. General Significance: This paper provides new information on the nanomechanical and morphological properties of membrane in form of liposome by AFM. The originality of this work is to characterize the physico/chemical properties of the nanoliposome from the natural sources containing various fatty acids and polar head.	[Jacquot, Adrien; Linder, Michel; Arab-Tehrany, Elmira] Univ Lorraine, Lab Ingn Biomol, TSA, F-40602 Vandoeuvre Les Nancy, France; [Francius, Gregory] Univ Lorraine, Lab Chim Phys & Microbiol Environm, UMR 7564, Villers Les Nancy, France; [Francius, Gregory] CNRS, Lab Chim Phys & Microbiol Environm, UMR 7564, Villers Les Nancy, France; [Razafitianamaharavo, Angelina] Univ Lorraine, Lab Interdisciplinaire Environm Continentaux, UMR 7360, Vandoeuvre Les Nancy, France; [Razafitianamaharavo, Angelina] CNRS, UMR 7360, Vandoeuvre Les Nancy, France; [Dehghani, Fariba] Univ Sydney, Sch Chem & Biomol Engn, Sydney, NSW 2006, Australia; [Tamayol, Ali] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Biomed Engn,Dept Med, Cambridge, MA 02138 USA	Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lorraine; University of Sydney; Harvard University; Brigham & Women's Hospital	Arab-Tehrany, E (corresponding author), Univ Lorraine, Lab Ingn Biomol, TSA, F-40602 Vandoeuvre Les Nancy, France.	elmira.arab-tehrany@univ-lorraine.fr	Francius, Gregory/A-4246-2015; Francius, Gregory/P-6058-2019; Rafitianamaharavo, Angelina/F-3630-2019; LINDER, Michel/C-9058-2016	Francius, Gregory/0000-0001-8533-9449; Francius, Gregory/0000-0001-8533-9449; arab tehrany, elmira/0000-0002-2182-8531; Dehghani, Fariba/0000-0002-7805-8101; Rafitianamaharavo, Angelina/0000-0002-7199-3017; LINDER, Michel/0000-0002-8658-6828	French Ministry of Research and Education (MESR)	French Ministry of Research and Education (MESR)(Ministry of Research, France)	This work was supported by French Ministry of Research and Education (MESR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackman RG, 1998, J AM OIL CHEM SOC, V75, P541, DOI 10.1007/s11746-998-0263-9; An HJ, 2010, BIOPHYS J, V99, P834, DOI 10.1016/j.bpj.2010.04.072; Attwood SJ, 2013, INT J MOL SCI, V14, P3514, DOI 10.3390/ijms14023514; Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3; Chiantia S, 2006, CHEMPHYSCHEM, V7, P2409, DOI 10.1002/cphc.200600464; Choucair A, 2007, BBA-BIOMEMBRANES, V1768, P146, DOI 10.1016/j.bbamem.2006.09.005; Deleu M, 2013, BBA-BIOMEMBRANES, V1828, P801, DOI 10.1016/j.bbamem.2012.11.007; Dufrene YF, 1997, LANGMUIR, V13, P4779, DOI 10.1021/la970221r; Fathi M, 2012, TRENDS FOOD SCI TECH, V23, P13, DOI 10.1016/j.tifs.2011.08.003; Garcia-Manyes S, 2005, BIOPHYS J, V89, P4261, DOI 10.1529/biophysj.105.065581; Garcia-Manyes S, 2006, ELECTROCHIM ACTA, V51, P5029, DOI 10.1016/j.electacta.2006.03.062; Garcia-Manyes S, 2010, BBA-BIOMEMBRANES, V1798, P741, DOI 10.1016/j.bbamem.2009.12.019; Ikai A, 2003, CELL BIOCHEM BIOPHYS, V39, P257, DOI 10.1385/CBB:39:3:257; Levy R, 2002, NANOTECHNOLOGY, V13, P33, DOI 10.1088/0957-4484/13/1/307; Linder M, 2002, EUR J LIPID SCI TECH, V104, P455, DOI 10.1002/1438-9312(200208)104:8<455::AID-EJLT455>3.0.CO;2-Q; Maherani B, 2011, CURR NANOSCI, V7, P436, DOI 10.2174/157341311795542453; Mingeot-Leclercq MP, 2008, NAT PROTOC, V3, P1654, DOI 10.1038/nprot.2008.149; Montano GA, 2013, ADV FUNCT MATER, V23, P2576, DOI 10.1002/adfm.201203429; Morandat S, 2013, ANAL BIOANAL CHEM, V405, P1445, DOI 10.1007/s00216-012-6383-y; Pera I, 2004, BIOPHYS J, V87, P2446, DOI 10.1529/biophysj.104.044214; Picas L, 2012, CHEM PHYS LIPIDS, V165, P845, DOI 10.1016/j.chemphyslip.2012.10.005; PRENDERGAST FG, 1981, BIOCHEMISTRY-US, V20, P7333, DOI 10.1021/bi00529a002; Re F, 2011, NANOMED-NANOTECHNOL, V7, P551, DOI 10.1016/j.nano.2011.05.004; Redondo-Morata L, 2012, LANGMUIR, V28, P12851, DOI 10.1021/la302620t; Shimanouchi T, 2009, COLLOID SURFACE B, V73, P156, DOI 10.1016/j.colsurfb.2009.05.014; Sneddon IN., 1965, INT J ENG SCI, V3, P47, DOI [10.1016/0020-7225(65)90019-4, DOI 10.1016/0020-7225(65)90019-4, 10.1016/0020-7225(65)90019-4.477, DOI 10.1016/0020-7225(65)90019-4.477]; Sullan RMA, 2009, LANGMUIR, V25, P12874, DOI 10.1021/la903442s; Tehrany EA, 2012, COLLOID SURFACE B, V95, P75, DOI 10.1016/j.colsurfb.2012.02.024; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Yokokawa M, 2008, J MICROSC-OXFORD, V232, P82, DOI 10.1111/j.1365-2818.2008.02071.x	30	20	20	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107435	10.1371/journal.pone.0107435	http://dx.doi.org/10.1371/journal.pone.0107435			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238543	Green Published, gold, Green Submitted			2022-12-25	WOS:000342491600025
J	Reddy, AT; Lakshmi, SP; Zhang, YZ; Reddy, RC				Reddy, Aravind T.; Lakshmi, Sowmya P.; Zhang, Yingze; Reddy, Raju C.			Nitrated fatty acids reverse pulmonary fibrosis by dedifferentiating myofibroblasts and promoting collagen uptake by alveolar macrophages	FASEB JOURNAL			English	Article						TGF; collagen; MFG-E8	ACTIVATED-RECEPTOR-GAMMA; GROWTH-FACTOR-BETA; GENE-EXPRESSION; CELL-MEMBRANE; MURINE MODEL; DIFFERENTIATION; INFLAMMATION; MECHANISMS; CURCUMIN; DELIVERY	Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal disease, thought to be largely transforming growth factor beta (TGF beta) driven, for which there is no effective therapy. We assessed the potential benefits in IPF of nitrated fatty acids (NFAs), which are unique endogenous agonists of peroxisome proliferator- activated receptor gamma (PPAR gamma), a nuclear hormone receptor that exhibits wound-healing and antifibrotic properties potentially useful for IPF therapy. We found that pulmonary PPAR gamma is down-regulated in patients with IPF. In vitro, knockdown or knockout of PPAR gamma expression in isolated human and mouse lung fibroblasts induced a profibrotic phenotype, whereas treating human fibroblasts with NFAs up-regulated PPAR gamma and blocked TGF beta signaling and actions. NFAs also converted TGF beta to inactive monomers in cell-free solution, suggesting an additional mechanism through which they may inhibit TGF beta. In vivo, treating mice bearing experimental pulmonary fibrosis with NFAs reduced disease severity. Also, NFAs up-regulated the collagen-targeting factor milk fat globule-EGF factor 8 (MFG-E8), stimulated collagen uptake and degradation by alveolar macrophages, and promoted myofibroblast dedifferentiation. Moreover, treating mice with established pulmonary fibrosis using NFAs reversed their existing myofibroblast differentiation and collagen deposition. These findings raise the prospect of treating IPF with NFAs to halt and perhaps even reverse the progress of IPF.	[Reddy, Aravind T.; Lakshmi, Sowmya P.; Zhang, Yingze; Reddy, Raju C.] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA; [Reddy, Aravind T.; Lakshmi, Sowmya P.; Reddy, Raju C.] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Reddy, RC (corresponding author), Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, 3459 Fifth Ave, Pittsburgh, PA 15213 USA.	reddyrc@upmc.edu	Reddy, Raju C/GLR-5338-2022; Reddy, Aravind/P-1847-2018; Lakshmi, Sowmya P./P-1851-2018	Reddy, Raju C/0000-0001-7079-1520; Reddy, Aravind/0000-0001-8628-3467; Lakshmi, Sowmya P./0000-0003-1708-9462; Zhang, YIngze/0000-0001-8042-6105	U.S. Department of Veterans Affairs; U.S. National Institutes of Health [HL-093196]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093196] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs(US Department of Veterans Affairs); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Merit Review Award from the U.S. Department of Veterans Affairs and by U.S. National Institutes of Health grant HL-093196 (to R.C.R).	American Thoracic Society, 2002, Am J Respir Crit Care Med, V165, P277; Artaud-Macari E, 2013, ANTIOXID REDOX SIGN, V18, P66, DOI 10.1089/ars.2011.4240; Atabai K, 2009, J CLIN INVEST, V119, P3713, DOI 10.1172/JCI40053; Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Baker PRS, 2004, P NATL ACAD SCI USA, V101, P11577, DOI 10.1073/pnas.0402587101; Blakytny R, 2006, INT J BIOCHEM CELL B, V38, P1363, DOI 10.1016/j.biocel.2006.01.017; Burgess HA, 2005, AM J PHYSIOL-LUNG C, V288, pL1146, DOI 10.1152/ajplung.00383.2004; Diaz KT, 2012, J AEROSOL MED PULM D, V25, P79, DOI 10.1089/jamp.2011.0919; Fu MG, 2003, BIOCHEM J, V370, P1019, DOI 10.1042/BJ20021503; Garrison G, 2013, AM J RESP CELL MOL, V48, P550, DOI 10.1165/rcmb.2012-0262OC; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kusunoki R, 2012, DIGESTION, V85, P103, DOI 10.1159/000334679; Lakshmi SP, 2012, AM J PHYSIOL-LUNG C, V303, pL758, DOI 10.1152/ajplung.00107.2012; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Li ZB, 2012, J CELL SCI, V125, P3957, DOI 10.1242/jcs.090365; Lichtenberger Frank J, 2006, J Inflamm (Lond), V3, P7, DOI 10.1186/1476-9255-3-7; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Michalik L, 2006, J CLIN INVEST, V116, P598, DOI 10.1172/JCI27958; Milam JE, 2008, AM J PHYSIOL-LUNG C, V294, pL891, DOI 10.1152/ajplung.00333.2007; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Narala VR, 2009, GENE THER MOL BIOL, V13, P20; O'Donnell VB, 1999, METHOD ENZYMOL, V301, P454; Reddy AT, 2012, J IMMUNOL, V189, P5411, DOI 10.4049/jimmunol.1201487; Reddy AT, 2012, PPAR RES, V2012, DOI 10.1155/2012/617063; Richeldi L, 2012, EUR RESPIR REV, V21, P147, DOI 10.1183/09059180.00000912; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sime PJ, 2008, J INVEST MED, V56, P534, DOI 10.2310/JIM.0b013e31816464e9; Sugimoto H, 2012, NAT MED, V18, P396, DOI 10.1038/nm.2629; Tampe B, 2014, J AM SOC NEPHROL, V25, P905, DOI 10.1681/ASN.2013070723; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Xu L, 2012, INT IMMUNOPHARMACOL, V12, P556, DOI 10.1016/j.intimp.2012.01.012; Zhao CY, 2006, BIOCHEM BIOPH RES CO, V350, P385, DOI 10.1016/j.bbrc.2006.09.069; Zheng SZ, 2007, AM J PHYSIOL-GASTR L, V292, pG113, DOI 10.1152/ajpgi.00200.2006	38	54	55	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2014	28	12					5299	5310		10.1096/fj.14-256263	http://dx.doi.org/10.1096/fj.14-256263			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AU9EN	25252739	Green Published			2022-12-25	WOS:000345894500024
J	Buechner, VL; Maier, MA; Lichtenfeld, S; Schwarz, S				Buechner, Vanessa L.; Maier, Markus A.; Lichtenfeld, Stephanie; Schwarz, Sascha			Red - Take a Closer Look	PLOS ONE			English	Article							THREATENING FACIAL EXPRESSIONS; MANDRILLS MANDRILLUS-SPHINX; PHYSICAL ATTRACTIVENESS; ATTENTIONAL BIAS; FACE RECOGNITION; HUMAN AMYGDALA; COSMETICS USE; COLOR; PERCEPTION; WOMEN	Color research has shown that red is associated with avoidance of threat (e. g., failure) or approach of reward (e. g., mating) depending on the context in which it is perceived. In the present study we explored one central cognitive process that might be involved in the context dependency of red associations. According to our theory, red is supposed to highlight the relevance (importance) of a goal-related stimulus and correspondingly intensifies the perceivers' attentional reaction to it. Angry and happy human compared to non-human facial expressions were used as goal-relevant stimuli. The data indicate that the color red leads to enhanced attentional engagement to angry and happy human facial expressions (compared to neutral ones) - the use of non-human facial expressions does not bias attention. The results are discussed with regard to the idea that red induced attentional biases might explain the red-context effects on motivation.	[Buechner, Vanessa L.; Maier, Markus A.; Lichtenfeld, Stephanie] Univ Munich, Munich, Germany; [Schwarz, Sascha] Univ Wuppertal, Wuppertal, Germany	University of Munich; University of Wuppertal	Buechner, VL (corresponding author), Univ Munich, Munich, Germany.	vanessa.buechner@psy.lmu.de	Schwarz, Sascha/B-9353-2008	Schwarz, Sascha/0000-0001-6762-7770; Buechner, Vanessa/0000-0002-0681-5927; Lichtenfeld, Stephanie/0000-0003-3485-9078	German Research Foundation (Deutsche Forschungsgemeinschaft) [MA 2447/4-1]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This research was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft [http://www.dfg.de]). Grant # MA 2447/4-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson RP, 1997, PSYCHOL METHODS, V2, P315, DOI 10.1037/1082-989X.2.4.315; [Anonymous], 1976, COLOUR ARCHITECTURE; Armony J.L., 1999, COGNITIVE NEUROSCIEN, P1067; Bergman TJ, 2009, INT J PRIMATOL, V30, P791, DOI 10.1007/s10764-009-9374-x; BIELERT C, 1989, J ZOOL, V219, P569, DOI 10.1111/j.1469-7998.1989.tb02601.x; Bradley BP, 1998, COGNITION EMOTION, V12, P737, DOI 10.1080/026999398379411; BURT DM, 1995, P ROY SOC B-BIOL SCI, V259, P137, DOI 10.1098/rspb.1995.0021; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; CASH TF, 1989, J SOC PSYCHOL, V129, P349, DOI 10.1080/00224545.1989.9712051; Changizi MA, 2006, BIOL LETT-UK, V2, P217, DOI 10.1098/rsbl.2006.0440; Corson R., 1972, FASHIONS MAKEUP ANCI; COX CL, 1986, SEX ROLES, V14, P51, DOI 10.1007/BF00287847; DERRYBERRY D, 1994, J PERS SOC PSYCHOL, V66, P1128, DOI 10.1037/0022-3514.66.6.1128; Deschner T, 2004, HORM BEHAV, V46, P204, DOI 10.1016/j.yhbeh.2004.03.013; DIXSON AF, 1983, ADV STUD BEHAV, V13, P63, DOI 10.1016/S0065-3454(08)60286-7; Drummond PD, 1999, PSYCHOPHYSIOLOGY, V36, P325, DOI 10.1017/S0048577299980344; Drummond PD, 1997, PERS INDIV DIFFER, V23, P575, DOI 10.1016/S0191-8869(97)00077-9; Drummond PD, 2001, PSYCHOPHYSIOLOGY, V38, P190, DOI 10.1111/1469-8986.3820190; Ekman P., 1997, INNOVATIONS SOCIAL S, V10, P333, DOI [DOI 10.1080/13511610.1997.9968538, 10.1080/13511610.1997.9968538]; Elliot AJ, 2008, J PERS SOC PSYCHOL, V95, P1150, DOI 10.1037/0022-3514.95.5.1150; Elliot AJ, 2007, CURR DIR PSYCHOL SCI, V16, P250, DOI 10.1111/j.1467-8721.2007.00514.x; Elliot AJ, 2007, J EXP PSYCHOL GEN, V136, P154, DOI 10.1037/0096-3445.136.1.154; Elliot AJ, 2014, ANNU REV PSYCHOL, V65, P95, DOI 10.1146/annurev-psych-010213-115035; Elliot AJ, 2012, ADV EXP SOC PSYCHOL, V45, P61, DOI 10.1016/B978-0-12-394286-9.00002-0; Elliot AJ, 2010, J EXP PSYCHOL GEN, V139, P399, DOI 10.1037/a0019689; Elliot AJ, 2009, PERS SOC PSYCHOL B, V35, P365, DOI 10.1177/0146167208328330; Fetterman AK, 2012, COGNITION EMOTION, V26, P1445, DOI 10.1080/02699931.2012.673477; Fink B, 2006, EVOL HUM BEHAV, V27, P433, DOI 10.1016/j.evolhumbehav.2006.08.007; Fox E, 2002, COGNITION EMOTION, V16, P355, DOI 10.1080/02699930143000527; Fox E, 2001, J EXP PSYCHOL GEN, V130, P681, DOI 10.1037/0096-3445.130.4.681; Fridlund A.J., 1994, HUMAN FACIAL EXPRESS; Gable PA, 2012, BIOL PSYCHOL, V90, P150, DOI 10.1016/j.biopsycho.2012.02.006; Gangestad SW, 2000, BEHAV BRAIN SCI, V23, P573, DOI 10.1017/S0140525X0000337X; Gerald MS, 2009, BEHAV PROCESS, V80, P7, DOI 10.1016/j.beproc.2008.08.001; Goethe J.W.V., 1810, THEORY COLOURS; Goldstein K., 1942, OCCUP THER J RES, V21, P147, DOI DOI 10.4314/NJBAS.V21I2.9; GRAHAM JA, 1981, INT J COSMETIC SCI, V3, P199, DOI 10.1111/j.1467-2494.1981.tb00283.x; Grossmann T, 2010, RESTOR NEUROL NEUROS, V28, P219, DOI 10.3233/RNN-2010-0499; Gueguen N, 2012, AGGRESSIVE BEHAV, V38, P166, DOI 10.1002/ab.21416; Gueguen N, 2012, COLOR RES APPL, V37, P76, DOI 10.1002/col.21757; Harmon-Jones E, 2012, SOC PERSONAL PSYCHOL, V6, P314, DOI 10.1111/j.1751-9004.2012.00432.x; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; HILL H, 1995, P ROY SOC B-BIOL SCI, V261, P367, DOI 10.1098/rspb.1995.0161; Hill RA, 2005, NATURE, V435, P293, DOI 10.1038/435293a; Jacob C, 2010, INT J HOSP MANAG, V29, P188, DOI 10.1016/j.ijhm.2009.04.003; Jacobs L, 1991, INT MARKET REV, V8; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Katchadourian H. A., 1984, FUNDAMENTALS HUMAN S; Kayser DN, 2010, EUR J SOC PSYCHOL, V40, P901, DOI 10.1002/ejsp.757; KENRICK DT, 1992, BEHAV BRAIN SCI, V15, P75, DOI 10.1017/S0140525X00067595; Lee KJ, 1997, PERCEPTION, V26, P733, DOI 10.1068/p260733; Li NP, 2006, J PERS SOC PSYCHOL, V90, P468, DOI 10.1037/0022-3514.90.3.468; Low BS., 1979, EVOLUTIONARY BIOL HU, P462; Maier MA, 2008, PERS SOC PSYCHOL B, V34, P1530, DOI 10.1177/0146167208323104; Maner JK, 2007, J PERS SOC PSYCHOL, V93, P389, DOI 10.1037/0022-3514.93.3.389; Matts PJ, 2007, J AM ACAD DERMATOL, V57, P977, DOI 10.1016/j.jaad.2007.07.040; MCARTHUR LZ, 1983, PSYCHOL REV, V90, P215, DOI 10.1037/0033-295X.90.3.215; Meier BP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040333; Mogg K, 1999, COGNITION EMOTION, V13, P713, DOI 10.1080/026999399379050; Moller AC, 2009, EMOTION, V9, P898, DOI 10.1037/a0017811; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Moskowitz GB, 2002, J EXP SOC PSYCHOL, V38, P397, DOI 10.1016/S0022-1031(02)00001-X; Mulhern R., 2003, International Journal of Cosmetic Science, V25, P199, DOI 10.1046/j.1467-2494.2003.00188.x; Nash R, 2006, J APPL SOC PSYCHOL, V36, P493, DOI 10.1111/j.0021-9029.2006.00016.x; Naz K., 2004, COLL STUDENT J, V38, P396; Park B, 2005, PERS SOC PSYCHOL REV, V9, P108, DOI 10.1207/s15327957pspr0902_2; Prokop P, 2013, ETHOLOGY, V119, P605, DOI 10.1111/eth.12102; Pryke SR, 2002, BEHAV ECOL, V13, P622, DOI 10.1093/beheco/13.5.622; Richetin J, 2007, ANN PSYCHOL, V107, P65; Roberts SC, 2010, EVOL PSYCHOL-US, V8, P350, DOI 10.1177/147470491000800304; Rosenthal Robert., 1985, CONTRAST ANAL FOCUSE; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; Schaffer SE, 2007, FOOD DRUG LAW J, V62, P165; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Setchell JM, 2005, ETHOLOGY, V111, P25, DOI 10.1111/j.1439-0310.2004.01054.x; Setchell JM, 2006, P ROY SOC B-BIOL SCI, V273, P2395, DOI 10.1098/rspb.2006.3573; SINGH D, 1993, J PERS SOC PSYCHOL, V65, P293, DOI 10.1037/0022-3514.65.2.293; Sotchell JM, 2001, HORM BEHAV, V39, P177, DOI 10.1006/hbeh.2000.1628; Stephen ID, 2010, PERCEPTION, V39, P1104, DOI 10.1068/p6730; Stephen ID, 2009, INT J PRIMATOL, V30, P845, DOI 10.1007/s10764-009-9380-z; Stephen ID, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005083; Tarr M. J., 2010, J VISION, V1, P337, DOI [10.1167/1.3.337, DOI 10.1167/1.3.337]; Vuilleumier P, 2001, NEUROLOGY, V56, P153, DOI 10.1212/WNL.56.2.153; Waitt C, 2006, AM J PRIMATOL, V68, P738, DOI 10.1002/ajp.20264; Workman J. E., 1991, CLOTH TEXT RES J, V10, P63, DOI DOI 10.1177/0887302X9101000109; Yip AW, 2002, PERCEPTION, V31, P995, DOI 10.1068/p3376; Young SG, 2013, EMOTION, V13, P380, DOI 10.1037/a0032471	87	29	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108111	10.1371/journal.pone.0108111	http://dx.doi.org/10.1371/journal.pone.0108111			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254380	Green Accepted, gold, Green Published			2022-12-25	WOS:000344862300056
J	Lu, Y; Gong, YY; Lian, J; Wang, L; Kretlow, JD; Zhou, GD; Cao, YL; Liu, W; Zhang, WJ				Lu, Yang; Gong, Yiyi; Lian, Jie; Wang, Ling; Kretlow, James D.; Zhou, Guangdong; Cao, Yilin; Liu, Wei; Zhang, Wen Jie			Expansion of Endothelial Progenitor Cells in High Density Dot Culture of Rat Bone Marrow Cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; PERIPHERAL-BLOOD; ANGIOGENESIS; NICHE; TRANSPLANTATION; DISEASE; MATRIX; GROWTH; FORM	In vitro expansion of endothelial progenitor cells (EPCs) remains a challenge in stem cell research and its application. We hypothesize that high density culture is able to expand EPCs from bone marrow by mimicking cell-cell interactions of the bone marrow niche. To test the hypothesis, rat bone marrow cells were either cultured in high density (2x10(5) cells/cm(2)) by seeding total 9x10(5) cells into six high density dots or cultured in regular density (1.6x10(4) cells/cm(2)) with the same total number of cells. Flow cytometric analyses of the cells cultured for 15 days showed that high density cells exhibited smaller cell size and higher levels of marker expression related to EPCs when compared to regular density cultured cells. Functionally, these cells exhibited strong angiogenic potentials with better tubal formation in vitro and potent rescue of mouse ischemic limbs in vivo with their integration into neo-capillary structure. Global gene chip and ELISA analyses revealed up-regulated gene expression of adhesion molecules and enhanced protein release of pro-angiogenic growth factors in high density cultured cells. In summary, high density cell culture promotes expansion of bone marrow contained EPCs that are able to enhance tissue angiogenesis via paracrine growth factors and direct differentiation into endothelial cells.	[Lu, Yang; Gong, Yiyi; Lian, Jie; Wang, Ling; Zhou, Guangdong; Cao, Yilin; Liu, Wei; Zhang, Wen Jie] Shanghai Jiao Tong Univ, Dept Plast & Reconstruct Surg, Sch Med,Shanghai Peoples Hosp 9, Shanghai Key Lab Tissue Engn,Natl Tissue Engn Ctr, Shanghai 200030, Peoples R China; [Kretlow, James D.] Baylor Coll Med, Div Plast Surg, Houston, TX 77030 USA	Shanghai Jiao Tong University; Baylor College of Medicine	Liu, W (corresponding author), Shanghai Jiao Tong Univ, Dept Plast & Reconstruct Surg, Sch Med,Shanghai Peoples Hosp 9, Shanghai Key Lab Tissue Engn,Natl Tissue Engn Ctr, Shanghai 200030, Peoples R China.	liuwei_2000@yahoo.com; wenjieboshi@yahoo.com.cn			Major State Basic Research Development Program of China [2007CB948004, 2011CB964704]; National Basic Research Program of China [30800231, 31170944]	Major State Basic Research Development Program of China(National Basic Research Program of China); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the Major State Basic Research Development Program of China (2007CB948004, and 2011CB964704), and the National Basic Research Program of China (30800231, and 31170944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alakel N, 2009, EXP HEMATOL, V37, P504, DOI 10.1016/j.exphem.2008.12.005; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 2011, STEM CELLS, V29, P1650, DOI 10.1002/stem.745; Au P, 2008, BLOOD, V111, P1302, DOI 10.1182/blood-2007-06-094318; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Critser PJ, 2010, CURR OPIN ORGAN TRAN, V15, P68, DOI 10.1097/MOT.0b013e32833454b5; Foubert P, 2008, CIRC RES, V103, P751, DOI 10.1161/CIRCRESAHA.108.175083; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Iba O, 2002, CIRCULATION, V106, P2019, DOI 10.1161/01.CIR.0000031332.45480.79; Jeong JO, 2009, CIRCULATION, V119, P699, DOI 10.1161/CIRCULATIONAHA.108.789297; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Masuda H, 2011, CIRC RES, V109, P20, DOI 10.1161/CIRCRESAHA.110.231837; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Peng R, 2012, BIOMATERIALS, V33, P6008, DOI 10.1016/j.biomaterials.2012.05.010; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang H, 1998, CIRC RES, V83, P832, DOI 10.1161/01.RES.83.8.832; Wara AK, 2011, BLOOD, V118, P6461, DOI 10.1182/blood-2011-06-363457; Whyte JL, 2011, STEM CELL RES, V6, P238, DOI 10.1016/j.scr.2011.02.001; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Zhou HZ, 2011, TISSUE ENG PT A, V17, P2603, DOI 10.1089/ten.tea.2011.0048	30	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107127	10.1371/journal.pone.0107127	http://dx.doi.org/10.1371/journal.pone.0107127			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254487	Green Submitted, gold, Green Published			2022-12-25	WOS:000344862300017
J	Ahmadi, M; Lopez-Bao, JV; Kaboli, M				Ahmadi, Mohsen; Vicente Lopez-Bao, Jose; Kaboli, Mohammad			Spatial Heterogeneity in Human Activities Favors the Persistence of Wolves in Agroecosystems	PLOS ONE			English	Article							DEN SITE SELECTION; CANIS-LUPUS; LARGE CARNIVORES; HABITAT SELECTION; RENDEZVOUS SITES; WOLF; CONSERVATION; LANDSCAPE; MODEL; REPRODUCTION	As human populations expand, there is increasing demand and pressure for land. Under this scenario, behavioural flexibility and adaptation become important processes leading to the persistence of large carnivores in human-dominated landscapes such as agroecosystems. A growing interest has recently emerged on the outcome of the coexistence between wolves and humans in these systems. It has been suggested that spatial heterogeneity in human activities would be a major environmental factor modulating vulnerability and persistence of this contentious species in agroecosystems. Here, we combined information from 35 den sites detected between 2011 and 2012 in agroecosystems of western Iran (Hamedan province), a set of environmental variables measured at landscape and fine spatial scales, and generalized linear models to identify patterns of den site selection by wolves in a highly-modified agroecosystem. On a landscape level, wolves selected a mixture of rangelands with scattered dry-farms on hillsides (showing a low human use) to locate their dens, avoiding areas with high densities of settlements and primary roads. On a fine spatial scale, wolves primarily excavated dens into the sides of elevated steep-slope hills with availability of water bodies in the vicinity of den sites, and wolves were relegated to dig in places with coarse-soil particles. Our results suggest that vulnerability of wolves in human-dominated landscapes could be compensated by the existence of spatial heterogeneity in human activities. Such heterogeneity would favor wolf persistence in agroecosystems favoring a land sharing model of coexistence between wolves and people.	[Ahmadi, Mohsen; Kaboli, Mohammad] Univ Tehran, Fac Nat Resources, Dept Environm Sci, Karaj, Iran; [Vicente Lopez-Bao, Jose] Univ Oviedo, CSIC, PA, Res Unit Biodivers, Mieres, Spain; [Vicente Lopez-Bao, Jose] Swedish Univ Agr Sci SLU, Dept Ecol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden	University of Tehran; Consejo Superior de Investigaciones Cientificas (CSIC); University of Oviedo; Swedish University of Agricultural Sciences	Kaboli, M (corresponding author), Univ Tehran, Fac Nat Resources, Dept Environm Sci, Karaj, Iran.	mkaboli@ut.ac.ir	Ahmadi, Mohsen/J-7360-2017; Ahmadi, Mohsen/AAW-7357-2021; VICENTE, LIERN/B-6112-2008	Ahmadi, Mohsen/0000-0002-9657-699X; Ahmadi, Mohsen/0000-0002-9657-699X; VICENTE, LIERN/0000-0001-5883-9640; Lopez-Bao, Jose Vicente/0000-0001-9213-998X	Department of Environmental Sciences, Faculty of Natural Resources, University of Tehran; "Juan de la Cierva" research contract from the Spanish Ministry of Economy and Competitiveness	Department of Environmental Sciences, Faculty of Natural Resources, University of Tehran; "Juan de la Cierva" research contract from the Spanish Ministry of Economy and Competitiveness	The study was supported by Department of Environmental Sciences, Faculty of Natural Resources, University of Tehran, and provincial bureau of Department of Environment, Hamedan province. JVLB was supported by a "Juan de la Cierva" research contract from the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi M, 2013, ECOL RES, V28, P513, DOI 10.1007/s11284-013-1040-2; Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; BALLARD WB, 1983, CAN FIELD NAT, V97, P299; Bateman PW, 2012, J ZOOL, V287, P1, DOI 10.1111/j.1469-7998.2011.00887.x; Behdarvand N, 2014, BIOL CONSERV, V177, P156, DOI 10.1016/j.biocon.2014.06.024; Blanco JC, 2007, J ZOOL, V273, P114, DOI 10.1111/j.1469-7998.2007.00305.x; Blanco J.C., 2002, ECOLOGIA CENSOS PERC; Blanco JC, 2005, CAN J ZOOL, V83, P312, DOI 10.1139/Z05-016; Boitani L., 2000, ACTION PLAN CONSERVA; Boitani Luigi, 2003, P317; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Capitani C, 2006, ACTA THERIOL, V51, P395, DOI 10.1007/BF03195186; Chavez AS, 2006, J WILDLIFE MANAGE, V70, P1079, DOI 10.2193/0022-541X(2006)70[1079:LUAMOW]2.0.CO;2; Ciarniello LM, 2005, URSUS, V16, P47, DOI 10.2192/1537-6176(2005)016[0047:DBADSS]2.0.CO;2; CONWAY GR, 1987, AGR SYST, V24, P95, DOI 10.1016/0308-521X(87)90056-4; Corsi F, 1999, CONSERV BIOL, V13, P150, DOI 10.1046/j.1523-1739.1999.97269.x; Darvishsefat A. A., 2006, ATLAS PROTECTED AREA; Dellinger JA, 2013, BIOL CONSERV, V157, P324, DOI 10.1016/j.biocon.2012.09.004; Eggermann J, 2011, MAMM BIOL, V76, P217, DOI 10.1016/j.mambio.2010.10.010; ESRI, 2010, ARCGIS 9 3; Falcucci A, 2013, BIOL CONSERV, V158, P63, DOI 10.1016/j.biocon.2012.08.029; Farshad A, 2003, GEOGR ANN A, V85A, P277, DOI 10.1111/j.0435-3676.2003.00205.x; Fox J., 2019, R COMPANION APPL REG, V3rd Edn; Frame PF, 2008, ARCTIC, V61, P134; Frame PF, 2007, J WILDLIFE MANAGE, V71, P316, DOI 10.2193/2005-744; FRWMO, 2010, IR FOR RANG WAT MAN; Gittleman JL, 2001, CONSERV BIOL SER, V5, P1; Glenz C, 2001, LANDSCAPE URBAN PLAN, V55, P55, DOI 10.1016/S0169-2046(01)00119-0; Habib B, 2007, J ZOOL, V272, P259, DOI 10.1111/j.1469-7998.2006.00265.x; Harrington F.H., 1982, P81; Hosseini-Zavarei F, 2013, J ZOOL, V290, P127, DOI 10.1111/jzo.12022; Iliopoulos Y, 2014, EUR J WILDLIFE RES, V60, P23, DOI 10.1007/s10344-013-0746-3; Imani Harsini J, 2012, THESIS U TEHRAN; Jedrzejewski W, 2008, ANIM CONSERV, V11, P377, DOI 10.1111/j.1469-1795.2008.00193.x; Jedrzejewski W, 2004, DIVERS DISTRIB, V10, P225, DOI 10.1111/j.1366-9516.2004.00073.x; Latham ADM, 2011, ECOL APPL, V21, P2854, DOI 10.1890/11-0666.1; Lemeshow S., 2000, MODEL BUILDING STRAT, P91; Liberg O, 2012, P ROY SOC B-BIOL SCI, V279, P910, DOI 10.1098/rspb.2011.1275; Llaneza L, 2012, DIVERS DISTRIB, V18, P459, DOI 10.1111/j.1472-4642.2011.00869.x; Lopez-Bao JV, 2013, CONSERV LETT, V6, P448, DOI 10.1111/conl.12014; McLoughlin PD, 2004, J MAMMAL, V85, P576, DOI 10.1644/BJK-119; Mech LD, 2006, WILDLIFE SOC B, V34, P874, DOI 10.2193/0091-7648(2006)34[874:PFOAWL]2.0.CO;2; Mech L. David, 2003, P1; Meghna Agarwala, 2009, Tropical Resources: Bulletin of the Yale Tropical Resources Institute, V28, P48; Meriggi A, 1996, J APPL ECOL, V33, P1561, DOI 10.2307/2404794; Muntifering JR, 2006, ANIM CONSERV, V9, P103, DOI 10.1111/j.1469-1795.2005.00008.x; Norris DR, 2002, CAN J ZOOL, V80, P866, DOI [10.1139/z02-067, 10.1139/Z02-067]; Packer C, 2013, ECOL LETT, V16, P635, DOI 10.1111/ele.12091; Person DK, 2009, NORTHWEST SCI, V83, P211, DOI 10.3955/046.083.0305; R Core Team, 2021, R LANG ENV STAT COMP; Reyahi-Khoram M, 2011, INT C CHEM BIOL ENV; Safikhani K, 2007, WATERSHED MANAGEMENT, V74, P138; Schuette P, 2013, BIOL CONSERV, V158, P301, DOI 10.1016/j.biocon.2012.08.008; Theuerkauf J, 2003, CAN J ZOOL, V81, P163, DOI 10.1139/Z02-190; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Tourani M, 2014, MAMMALIA, V78, P117, DOI 10.1515/mammalia-2012-0119; Trapp JR, 2008, CAN FIELD NAT, V122, P49, DOI 10.22621/cfn.v122i1.543; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Unger DE, 2009, RECOVERY OF GRAY WOLVES IN THE GREAT LAKES REGION OF THE UNITED STATES, P175, DOI 10.1007/978-0-387-85952-1_11; Unger DE, 1999, THESIS U WISCONSIN; Weaver JL, 1996, CONSERV BIOL, V10, P964, DOI 10.1046/j.1523-1739.1996.10040964.x; Wikramanayake E, 2004, CONSERV BIOL, V18, P839, DOI 10.1111/j.1523-1739.2004.00145.x; Woodroffe R, 2011, J ZOOL, V283, P88, DOI 10.1111/j.1469-7998.2010.00747.x; Woodroffe R., 2005, PEOPLE WILDLIFE CONF; Young S.P., 1944, WOLVES N AM; Ziaie H., 2008, FIELD GUIDE MAMMALS	66	20	20	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108080	10.1371/journal.pone.0108080	http://dx.doi.org/10.1371/journal.pone.0108080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251567	Green Published, Green Submitted, gold			2022-12-25	WOS:000342492700075
J	Ghosh, SS; Bie, JH; Wang, J; Ghosh, S				Ghosh, Siddhartha S.; Bie, Jinghua; Wang, Jing; Ghosh, Shobha			Oral Supplementation with Non-Absorbable Antibiotics or Curcumin Attenuates Western Diet-Induced Atherosclerosis and Glucose Intolerance in LDLR-/- Mice - Role of Intestinal Permeability and Macrophage Activation	PLOS ONE			English	Article							HIGH-FAT DIET; NEPHRECTOMIZED RATS ROLE; GUT MICROBIOTA; REDUCES ATHEROSCLEROSIS; ALKALINE-PHOSPHATASE; INDUCED OBESITY; RENAL-FAILURE; INFLAMMATION; BARRIER; TRIAL	Association between circulating lipopolysaccharide (LPS) and metabolic diseases (such as Type 2 Diabetes and atherosclerosis) has shifted the focus from Western diet-induced changes in gut microbiota per se to release of gut bacteria-derived products into circulation as the possible mechanism for the chronic inflammatory state underlying the development of these diseases. Under physiological conditions, an intact intestinal barrier prevents this release of LPS underscoring the importance of examining and modulating the direct effects of Western diet on intestinal barrier function. In the present study we evaluated two strategies, namely selective gut decontamination and supplementation with oral curcumin, to modulate Western-diet (WD) induced changes in intestinal barrier function and subsequent development of glucose intolerance and atherosclerosis. LDLR-/- mice were fed WD for 16 weeks and either received non-absorbable antibiotics (Neomycin and polymyxin) in drinking water for selective gut decontamination or gavaged daily with curcumin. WD significantly increased intestinal permeability as assessed by in vivo translocation of FITC-dextran and plasma LPS levels. Selective gut decontamination and supplementation with curcumin significantly attenuated the WD-induced increase in plasma LPS levels (3.32 vs 1.90 or 1.51 EU/ml, respectively) and improved intestinal barrier function at multiple levels (restoring intestinal alkaline phosphatase activity and expression of tight junction proteins, ZO-1 and Claudin-1). Consequently, both these interventions significantly reduced WD-induced glucose intolerance and atherosclerosis in LDLR-/- mice. Activation of macrophages by low levels of LPS (50 ng/ml) and its exacerbation by fatty acids is likely the mechanism by which release of trace amounts of LPS into circulation due to disruption of intestinal barrier function induces the development of these diseases. These studies not only establish the important role of intestinal barrier function, but also identify oral supplementation with curcumin as a potential therapeutic strategy to improve intestinal barrier function and prevent the development of metabolic diseases.	[Ghosh, Siddhartha S.; Bie, Jinghua; Wang, Jing; Ghosh, Shobha] Virginia Commonwealth Univ, Med Ctr, Dept Internal Med, Richmond, VA 23284 USA	Virginia Commonwealth University	Ghosh, S (corresponding author), Virginia Commonwealth Univ, Med Ctr, Dept Internal Med, Richmond, VA 23284 USA.	shobha@vcu.edu			National Institutes of Health [HL069946, HL097346]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097346, R01HL069946] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Institutes of Health HL069946; National Institutes of Health HL097346. The funders had no role in study design, data collection and analyses, decision to publish or preparation of the manuscript.	Bengmark S, 2013, PHARMACOL RES, V69, P87, DOI 10.1016/j.phrs.2012.09.002; Bentala H, 2002, SHOCK, V18, P561, DOI 10.1097/00024382-200212000-00013; Bie JH, 2014, J LIPID RES, V55, P729, DOI 10.1194/jlr.M046524; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Coban D, 2012, MOL NUTR FOOD RES, V56, P1270, DOI 10.1002/mnfr.201100818; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; Deng H, 2013, J BIOL CHEM, V288, P3897, DOI 10.1074/jbc.M112.424390; Dhillon N, 2008, CLIN CANCER RES, V14, P4491, DOI 10.1158/1078-0432.CCR-08-0024; Genth-Zotz S, 2002, AM J CARDIOL, V90, P1226, DOI 10.1016/S0002-9149(02)02839-4; Ghosh SS, 2012, AM J PHYSIOL-RENAL, V302, pF439, DOI 10.1152/ajprenal.00356.2010; Ghosh SS, 2009, AM J PHYSIOL-RENAL, V296, pF1146, DOI 10.1152/ajprenal.90732.2008; Gonzalez-Hernandez LA, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-90; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; GUIOT HFL, 1992, EPIDEMIOL INFECT, V109, P349, DOI 10.1017/S0950268800050342; Hasan ST, 2014, ATHEROSCLEROSIS, V232, P40, DOI 10.1016/j.atherosclerosis.2013.10.016; Irving GRB, 2013, CANCER PREV RES, V6, P119, DOI 10.1158/1940-6207.CAPR-12-0281; Keita AV, 2010, NEUROGASTROENT MOTIL, V22, P718, DOI 10.1111/j.1365-2982.2010.01498.x; Kiffer-Moreira T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089374; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Lee HJ, 2012, XENOBIOTICA, V42, P791, DOI 10.3109/00498254.2012.660508; Maitra U, 2011, J IMMUNOL, V186, P4467, DOI 10.4049/jimmunol.1003300; Maradana MR, 2013, MOL NUTR FOOD RES, V57, P1550, DOI 10.1002/mnfr.201200791; Martinez-Medina M, 2014, GUT, V63, P116, DOI 10.1136/gutjnl-2012-304119; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Midura-Kiela MT, 2012, AM J PHYSIOL-GASTR L, V302, pG85, DOI 10.1152/ajpgi.00275.2011; Miles JM, 2003, DIABETES, V52, P675, DOI 10.2337/diabetes.52.3.675; Montenegro L, 2014, CURR DRUG SAF; Narisawa S, 2003, MOL CELL BIOL, V23, P7525, DOI 10.1128/MCB.23.21.7525-7530.2003; O'Connor CM, 2003, JAMA-J AM MED ASSOC, V290, P1459, DOI 10.1001/jama.290.11.1459; Pendyala S, 2012, GASTROENTEROLOGY, V142, P1100, DOI 10.1053/j.gastro.2012.01.034; Sandek A, 2009, CURR DRUG METAB, V10, P22, DOI 10.2174/138920009787048374; Suzuki T, 2011, J NUTR, V141, P87, DOI 10.3945/jn.110.125633; Tuin A, 2009, GUT, V58, P379, DOI 10.1136/gut.2007.128868; Vaziri ND, 2013, AM J NEPHROL, V37, P518, DOI 10.1159/000351171; Wang N, 2012, DIGEST DIS SCI, V57, P1792, DOI 10.1007/s10620-012-2094-7; Yao QH, 2013, INT J CLIN EXP PATHO, V6, P2342	37	103	111	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108577	10.1371/journal.pone.0108577	http://dx.doi.org/10.1371/journal.pone.0108577			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251395	Green Published, Green Submitted, gold			2022-12-25	WOS:000342492700144
J	Hou, ZB; Xu, CH; Xie, HY; Xu, H; Zhan, P; Yu, LK; Fang, XF				Hou, Zhibo; Xu, Chunhua; Xie, Haiyan; Xu, Huae; Zhan, Ping; Yu, Like; Fang, Xuefeng			Long Noncoding RNAs Expression Patterns Associated with Chemo Response to Cisplatin Based Chemotherapy in Lung Squamous Cell Carcinoma Patients	PLOS ONE			English	Article							POOR-PROGNOSIS; CANCER; HOTAIR; NETWORK; HOX; REPRESSION; RESISTANCE; GENCODE; STAGE	Background: There is large variability among lung squamous cell carcinoma patients in response to treatment with cisplatin based chemotherapy. LncRNA is potentially a new type of predictive marker that can identify subgroups of patients who benefit from chemotherapy and it will have great value for treatment guidance. Methods: Differentially expressed lncRNAs and mRNA were identified using microarray profiling of tumors with partial response (PR) vs. with progressive disease (PD) from advanced lung squamous cell carcinoma patients treated with cisplatin based chemotherapy and validated by quantitative real-time PCR (qPCR). Furthermore, the expression of AC006050.3-003 was assessed in another 60 tumor samples. Results: Compared with the PD samples, 953 lncRNAs were consistently upregulated and 749 lncRNAs were downregulated consistently among the differentially expressed lncRNAs in PR samples (Fold Change >= 2.0-fold, p<0.05). Pathway analyses showed that some classical pathways, including "Nucleotide excision repair,'' that participated in cisplatin chemo response were differentially expressed between PR and PD samples. Coding-non-coding gene co-expression network identified many lncRNAs, such as lncRNA AC006050.3-003, that potentially played a key role in chemo response. The expression of lncRNA AC006050.3-003 was significantly lower in PR samples compared to the PD samples in another 60 lung squamous cell carcinoma patients. Receiver operating characteristic curve analysis revealed that lncRNA AC006050.3-003 was a valuable biomarker for differentiating PR patients from PD patients with an area under the curve of 0.887 (95% confidence interval 0.779, 0.954). Conclusions: LncRNAs seem to be involved in cisplatin-based chemo response and may serve as biomarkers for treatment response and candidates for therapy targets in lung squamous cell carcinoma.	[Hou, Zhibo; Xu, Chunhua; Xie, Haiyan; Zhan, Ping; Yu, Like] Southeast Univ, Sch Med, Nanjing Chest Hosp, Dept Resp Med 1, Nanjing, Jiangsu, Peoples R China; [Hou, Zhibo; Xu, Chunhua; Xie, Haiyan; Zhan, Ping; Yu, Like] Clin Ctr Nanjing Resp Dis & Imaging, Nanjing, Jiangsu, Peoples R China; [Xu, Huae] Nanjing Med Univ, Affiliated Hosp 1, Dept Pharm, Nanjing, Jiangsu, Peoples R China; [Fang, Xuefeng] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China	Southeast University - China; Nanjing Medical University; Zhejiang University	Yu, LK (corresponding author), Southeast Univ, Sch Med, Nanjing Chest Hosp, Dept Resp Med 1, Nanjing, Jiangsu, Peoples R China.	likeyunj@yeah.net; xffang@zju.edu.cn	Xu, Huae/ABG-8460-2021	Xu, Huae/0000-0001-9124-303X	National Natural Science Foundation of China [81101580]; Major Project of Nanjing Medical Science and Technique Development Fund [ZDX12013]; General Project of Nanjing Medical Science and Technology Development Fund [YKK13090]; Young Professional Personnel Training Fund of Nanjing Chest Hospital	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Project of Nanjing Medical Science and Technique Development Fund; General Project of Nanjing Medical Science and Technology Development Fund; Young Professional Personnel Training Fund of Nanjing Chest Hospital	This study was supported by the National Natural Science Foundation of China (No. 81101580), the Major Project of Nanjing Medical Science and Technique Development Fund (No. ZDX12013), the General Project of Nanjing Medical Science and Technology Development Fund (No. YKK13090) and Young Professional Personnel Training Fund of Nanjing Chest Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bahlani S, 2011, ONCOGENE, V30, P4219, DOI 10.1038/onc.2011.134; Ardizzoni A, 2007, J NATL CANCER I, V99, P847, DOI 10.1093/jnci/djk196; Azzoli CG, 2012, J ONCOL PRACT, V8, P63, DOI 10.1200/JOP.2011.000374; Baggstrom MQ, 2007, J THORAC ONCOL, V2, P845, DOI 10.1097/JTO.0b013e31814617a2; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bhan A, 2014, CHEMMEDCHEM; Calvo R, 2000, P NATL ACAD SCI USA, V97, P12776, DOI 10.1073/pnas.97.23.12776; Cantile M, 2003, ONCOGENE, V22, P6462, DOI 10.1038/sj.onc.1206808; Crino L, 2010, ANN ONCOL, V21, pv103, DOI 10.1093/annonc/mdq207; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Li DD, 2013, AM J PATHOL, V182, P64, DOI 10.1016/j.ajpath.2012.08.042; Liao Q, 2011, NUCLEIC ACIDS RES, V39, P3864, DOI 10.1093/nar/gkq1348; Liu XH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-464; Liu ZY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0066666, 10.1371/journal.pone.0055618]; Mainguy G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000356; Nakagawa T, 2013, BIOCHEM BIOPH RES CO, V436, P319, DOI 10.1016/j.bbrc.2013.05.101; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pikor LA, 2013, LUNG CANC; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rosell Rafael, 2003, Cancer Control, V10, P297; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sessa L, 2007, RNA, V13, P223, DOI 10.1261/rna.266707; Shang XY, 2013, MOL PHARMACOL, V83, P85, DOI 10.1124/mol.112.079798; Stewart DJ, 2007, CRIT REV ONCOL HEMAT, V63, P12, DOI 10.1016/j.critrevonc.2007.02.001; Tsang WP, 2007, ONCOGENE, V26, P4877, DOI 10.1038/sj.onc.1210266; Yang Y, 2013, PLOS ONE, V8; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y	41	34	35	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108133	10.1371/journal.pone.0108133	http://dx.doi.org/10.1371/journal.pone.0108133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250788	Green Published, Green Submitted, gold			2022-12-25	WOS:000342492700085
J	Miyoshi, Y; Yoshioka, Y; Suzuki, K; Miyazaki, T; Koura, M; Saigoh, K; Kajimura, N; Monobe, Y; Kusunoki, S; Matsuda, J; Watanabe, M; Hayasaka, N				Miyoshi, Yuka; Yoshioka, Yoshichika; Suzuki, Kinuko; Miyazaki, Taisuke; Koura, Minako; Saigoh, Kazumasa; Kajimura, Naoko; Monobe, Yoko; Kusunoki, Susumu; Matsuda, Junichiro; Watanabe, Masahiko; Hayasaka, Naoto			A New Mouse Allele of Glutamate Receptor Delta 2 with Cerebellar Atrophy and Progressive Ataxia	PLOS ONE			English	Article							PURKINJE CELL SYNAPSES; MUTANT MICE; SPINOCEREBELLAR ATAXIAS; HOT-SPOT; PARALLEL; MUTATION; GENE; GLUR-DELTA-2; LURCHER; CBLN1	Spinocerebellar degenerations (SCDs) are a large class of sporadic or hereditary neurodegenerative disorders characterized by progressive motion defects and degenerative changes in the cerebellum and other parts of the CNS. Here we report the identification and establishment from a C57BL/6J mouse colony of a novel mouse line developing spontaneous progressive ataxia, which we refer to as ts3. Frequency of the phenotypic expression was consistent with an autosomal recessive Mendelian trait of inheritance, suggesting that a single gene mutation is responsible for the ataxic phenotype of this line. The onset of ataxia was observed at about three weeks of age, which slowly progressed until the hind limbs became entirely paralyzed in many cases. Micro-MRI study revealed significant cerebellar atrophy in all the ataxic mice, although individual variations were observed. Detailed histological analyses demonstrated significant atrophy of the anterior folia with reduced granule cells (GC) and abnormal morphology of cerebellar Purkinje cells (PC). Study by ultra-high voltage electron microscopy (UHVEM) further indicated aberrant morphology of PC dendrites and their spines, suggesting both morphological and functional abnormalities of the PC in the mutants. Immunohistochemical studies also revealed defects in parallel fiber (PF)-PC synapse formation and abnormal distal extension of climbing fibers (CF). Based on the phenotypic similarities of the ts3 mutant with other known ataxic mutants, we performed immunohistological analyses and found that expression levels of two genes and their products, glutamate receptor delta2 (grid2) and its ligand, cerebellin1 (Cbln1), are significantly reduced or undetectable. Finally, we sequenced the candidate genes and detected a large deletion in the coding region of the grid2 gene. Our present study suggests that ts3 is a new allele of the grid2 gene, which causes similar but different phenotypes as compared to other grid2 mutants.	[Miyoshi, Yuka; Hayasaka, Naoto] Kinki Univ, Sch Med, Dept Anat & Neurobiol, Osakasayama, Osaka, Japan; [Yoshioka, Yoshichika] Osaka Univ, Immunol Frontier Res Ctr, Biofunct Imaging Lab, Suita, Osaka, Japan; [Suzuki, Kinuko] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan; [Suzuki, Kinuko] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Miyazaki, Taisuke; Watanabe, Masahiko] Hokkaido Univ, Grad Sch Med, Dept Anat, Sapporo, Hokkaido, Japan; [Koura, Minako; Matsuda, Junichiro] Natl Inst Biomed Innovat, Lab Expt Anim Models, Ibaraki, Osaka, Japan; [Saigoh, Kazumasa; Kusunoki, Susumu] Kinki Univ, Sch Med, Dept Neurol, Osakasayama, Osaka, Japan; [Kajimura, Naoko] Osaka Univ, Res Ctr Ultra High Voltage Elect Microscopy, Ibaraki, Osaka, Japan; [Monobe, Yoko] Natl Inst Biomed Innovat, Sect Lab Equipment, Ibaraki, Osaka, Japan; [Hayasaka, Naoto] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama, Japan	Kindai University (Kinki University); Osaka University; Tokyo Metropolitan Institute of Gerontology; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Hokkaido University; National Institute of Health Sciences - Japan; Kindai University (Kinki University); Osaka University; National Institute of Health Sciences - Japan; Japan Science & Technology Agency (JST)	Hayasaka, N (corresponding author), Kinki Univ, Sch Med, Dept Anat & Neurobiol, Osakasayama, Osaka, Japan.	naotohayasaka@yahoo.co.jp	Saigoh, Kazumasa/AAG-2956-2020; Kajimura, Naoko/R-9267-2019; WATANABE, Masahiko/A-4055-2012; saigoh, Kazumasa/AFK-6417-2022; saigoh, Kazumasa/AAG-4678-2022; Watanabe, Masahiko/S-3614-2019	Saigoh, Kazumasa/0000-0002-0905-5935; WATANABE, Masahiko/0000-0001-5037-7138; Watanabe, Masahiko/0000-0001-5037-7138	Japan Society for the Promotion of Science [19590235, 21590264]; PRESTO Program from Japan Science and Technology Agency (JST); "Nanotechnology Network Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan" at the Research Center for Ultrahigh Voltage Electron Microscopy, Osaka University (Handai Multi-Functional Nano-Foundry); Grants-in-Aid for Scientific Research [23228001] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); PRESTO Program from Japan Science and Technology Agency (JST); "Nanotechnology Network Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan" at the Research Center for Ultrahigh Voltage Electron Microscopy, Osaka University (Handai Multi-Functional Nano-Foundry); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-Aid for Scientific Research: No. 19590235 and 21590264 from the Japan Society for the Promotion of Science and the PRESTO Program from Japan Science and Technology Agency (JST). This work was also supported in part by "Nanotechnology Network Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan" at the Research Center for Ultrahigh Voltage Electron Microscopy, Osaka University (Handai Multi-Functional Nano-Foundry). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKI T, 1993, BRAIN RES, V627, P341, DOI 10.1016/0006-8993(93)90339-O; Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946; CADDY KWT, 1979, PHILOS T ROY SOC B, V287, P167, DOI 10.1098/rstb.1979.0055; Dickie, 1966, MOUSE NEWS LETT, V34, P30; Grossman AW, 2006, BRAIN RES, V1084, P158, DOI 10.1016/j.brainres.2006.02.044; Grusser-Cornehls U, 2001, PROG NEUROBIOL, V63, P489, DOI 10.1016/S0301-0082(00)00024-1; GUASTAVINO JM, 1990, BRAIN RES, V523, P199, DOI 10.1016/0006-8993(90)91488-3; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; Hirasawa M, 2007, MOL CELL NEUROSCI, V35, P161, DOI 10.1016/j.mcn.2007.02.013; Hisano K, 2009, J ANESTH, V23, P363, DOI 10.1007/s00540-009-0766-z; Hohn A, 2013, REDOX BIOL, V1, P140, DOI 10.1016/j.redox.2013.01.006; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Kurihara H, 1997, J NEUROSCI, V17, P9613; Kuroyanagi T, 2010, BIOCHEM BIOPH RES CO, V398, P537, DOI 10.1016/j.bbrc.2010.06.114; Lalonde R, 2007, BRAIN RES, V1140, P51, DOI 10.1016/j.brainres.2006.01.031; LALONDE R, 1995, NEUROSCI RES, V22, P423, DOI 10.1016/0168-0102(95)00916-H; Lalonde R, 1996, NEUROBIOL LEARN MEM, V65, P113, DOI 10.1006/nlme.1996.0013; Lalouette A, 1998, GENOMICS, V50, P9, DOI 10.1006/geno.1998.5314; Manto MU, 2005, CEREBELLUM, V4, P2, DOI 10.1080/14734220510007914; Matsuda K, 2010, SCIENCE, V328, P363, DOI 10.1126/science.1185152; Matsuda S, 2002, EUR J NEUROSCI, V16, P1507, DOI 10.1046/j.1460-9568.2002.02219.x; Mishina M, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00090; Miura E, 2009, EUR J NEUROSCI, V29, P693, DOI 10.1111/j.1460-9568.2009.06632.x; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; Miyazaki T, 2010, J NEUROSCI, V30, P15196, DOI 10.1523/JNEUROSCI.0934-10.2010; Motohashi J, 2007, BRAIN RES, V1140, P153, DOI 10.1016/j.brainres.2006.03.068; Nakagama S, 1998, J COMP NEUROL, V395, P112, DOI 10.1002/(SICI)1096-9861(19980525)395:1<112::AID-CNE8>3.0.CO;2-3; Nakamura M, 2004, EUR J NEUROSCI, V20, P2929, DOI 10.1111/j.1460-9568.2004.03768.x; Oda S, 1973, Jikken Dobutsu, V22, P281; Paulson HL, 2009, J NEURO-OPHTHALMOL, V29, P227, DOI 10.1097/WNO0b013e3181b416de; PHILLIPS RITA J. S., 1960, JOUR GENET, V57, P35, DOI 10.1007/BF02985337; Robinson KO, 2005, MAMM GENOME, V16, P32, DOI 10.1007/s00335-004-2423-z; Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8; Takeuchi T, 2005, J NEUROSCI, V25, P2146, DOI 10.1523/JNEUROSCI.4740-04.2005; Taroni F, 2004, NAT REV NEUROSCI, V5, P641, DOI 10.1038/nrn1474; Wang Y, 2003, EUR J NEUROSCI, V17, P1581, DOI 10.1046/j.1460-9568.2003.02595.x; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	37	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107867	10.1371/journal.pone.0107867	http://dx.doi.org/10.1371/journal.pone.0107867			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250835	gold, Green Published, Green Submitted			2022-12-25	WOS:000342492700053
J	Pyne, DG; Liu, J; Abdelgawad, M; Sun, Y				Pyne, Derek G.; Liu, Jun; Abdelgawad, Mohamed; Sun, Yu			Digital Microfluidic Processing of Mammalian Embryos for Vitrification	PLOS ONE			English	Article							FERTILITY PRESERVATION; PLURONIC ADDITIVES; BOVINE OOCYTES; MOUSE EMBRYOS; CRYOPRESERVATION; PERMEABILITY; SURVIVAL; DROPLETS; CANCER	Cryopreservation is a key technology in biology and clinical practice. This paper presents a digital microfluidic device that automates sample preparation for mammalian embryo vitrification. Individual micro droplets manipulated on the microfluidic device were used as micro-vessels to transport a single mouse embryo through a complete vitrification procedure. Advantages of this approach, compared to manual operation and channel-based microfluidic vitrification, include automated operation, cryoprotectant concentration gradient generation, and feasibility of loading and retrieval of embryos.	[Pyne, Derek G.; Liu, Jun; Sun, Yu] Univ Toronto, Dept Mech & Ind Engn, Toronto, ON, Canada; [Abdelgawad, Mohamed] Assiut Univ, Dept Mech Engn, Assiut, Egypt	University of Toronto; Egyptian Knowledge Bank (EKB); Assiut University	Abdelgawad, M (corresponding author), Assiut Univ, Dept Mech Engn, Assiut, Egypt.	mohamed.abdelgawad1@eng.au.edu.eg; sun@mie.utoronto.ca	Abdelgawad, Mohamed/D-5329-2012; Liu, Jun/K-2919-2019	Abdelgawad, Mohamed/0000-0001-6711-1336; Liu, Jun/0000-0002-5815-2483; Sun, Yu/0000-0001-7895-0741	NSERC (Natural Sciences and Engineering Research Council of Canada); Canada Research Chairs Program	NSERC (Natural Sciences and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs Program(Canada Research Chairs)	This work was supported by the Grants from NSERC (Natural Sciences and Engineering Research Council of Canada) via a Discovery Grant (http://www.nserc-crsng.gc.ca/index_eng.asp); and the Canada Research Chairs Program (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelHafez FF, 2010, REPROD BIOMED ONLINE, V20, P209, DOI 10.1016/j.rbmo.2009.11.013; ALI J, 1993, J REPROD FERTIL, V99, P471, DOI 10.1530/jrf.0.0990471; Au SH, 2011, LANGMUIR, V27, P8586, DOI 10.1021/la201185c; Barbulovic-Nad I, 2010, LAB CHIP, V10, P1536, DOI 10.1039/c002147d; BERTHIER J, 2006, ARTECH HSE MICROEL S, P1; Chang YH, 2006, BIOMED MICRODEVICES, V8, P215, DOI 10.1007/s10544-006-8171-y; Dhali A, 2009, THERIOGENOLOGY, V71, P1408, DOI 10.1016/j.theriogenology.2009.01.011; Heo YS, 2011, LAB CHIP, V11, P3530, DOI 10.1039/c1lc20377k; HOGAN B, 1986, MANIPULATING MOUSE E; *IRV SCI, 2011, SIMPL EMBR VITR PROT; Jonsson-Niedziolka M, 2011, LAB CHIP, V11, P490, DOI 10.1039/c0lc00203h; Khosravi-Farsani S, 2010, J ASSIST REPROD GEN, V27, P233, DOI 10.1007/s10815-010-9411-x; Kuwayama M, 2005, REPROD BIOMED ONLINE, V11, P608, DOI 10.1016/S1472-6483(10)61169-8; Kuwayama M, 2007, THERIOGENOLOGY, V67, P73, DOI 10.1016/j.theriogenology.2006.09.014; Lai D, 2013, FERTIL STERIL, V100, pS107, DOI 10.1016/j.fertnstert.2013.07.1682; Lee SJ, 2006, J CLIN ONCOL, V24, P2917, DOI 10.1200/JCO.2006.06.5888; Luk VN, 2008, LANGMUIR, V24, P6382, DOI 10.1021/la7039509; Martino A, 1996, BIOL REPROD, V54, P1059, DOI 10.1095/biolreprod54.5.1059; Medeiros CMO, 2002, THERIOGENOLOGY, V57, P327, DOI 10.1016/S0093-691X(01)00674-4; Mullen SE, 2008, FERTIL STERIL, V89, P1812, DOI 10.1016/j.fertnstert.2007.06.013; NAKAO K, 1997, EXP ANIM; Newton H, 1999, J REPROD FERTIL, V117, P27; Oktay K, 1998, FERTIL STERIL, V69, P1, DOI 10.1016/S0015-0282(97)00207-0; *OR, 2011, MEDICULT VITR COOL; Otoi T, 1998, CRYOBIOLOGY, V37, P77, DOI 10.1006/cryo.1998.2103; Park S, 2011, LAB CHIP, V11, P2212, DOI 10.1039/c1lc20111e; Pegg DE, 2010, CRYOBIOLOGY, V60, pS36, DOI 10.1016/j.cryobiol.2010.02.003; Pollack MG, 2000, APPL PHYS LETT, V77, P1725, DOI 10.1063/1.1308534; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Reubinoff BE, 2001, HUM REPROD, V16, P2187, DOI 10.1093/humrep/16.10.2187; Riggs R, 2010, FERTIL STERIL, V93, P109, DOI 10.1016/j.fertnstert.2008.09.084; Saragusty J, 2011, REPRODUCTION, V141, P1, DOI 10.1530/REP-10-0236; Shaw JM, 2003, HUM REPROD UPDATE, V9, P583, DOI 10.1093/humupd/dmg041; Sista RS, 2008, LAB CHIP, V8, P2188, DOI 10.1039/b807855f; Song YS, 2009, LAB CHIP, V9, P1874, DOI 10.1039/b823062e; Sonmezer M, 2004, HUM REPROD UPDATE, V10, P251, DOI 10.1093/humupd/dmh021; Srinivasan V, 2004, LAB CHIP, V4, P310, DOI 10.1039/b403341h; Swain JE, 2013, LAB CHIP, V13, P1213, DOI 10.1039/c3lc41290c; TROUNSON A, 1983, NATURE, V305, P707, DOI 10.1038/305707a0; Tsang WH, 2010, BIRTH DEFECTS RES C, V90, P163, DOI 10.1002/bdrc.20186; Vajta G, 2006, REPROD BIOMED ONLINE, V12, P779, DOI 10.1016/S1472-6483(10)61091-7; *VITR, 2011, RAP I VIRT CLEAV STA; Wallace WHB, 2005, LANCET ONCOL, V6, P209, DOI 10.1016/S1470-2045(05)70092-9; WHITTINGHAM DG, 1971, NATURE, V233, P125, DOI 10.1038/233125a0; Zhang JQ, 2009, J ASSIST REPROD GEN, V26, P621, DOI 10.1007/s10815-009-9370-2	45	33	35	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108128	10.1371/journal.pone.0108128	http://dx.doi.org/10.1371/journal.pone.0108128			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250666	gold, Green Published, Green Submitted			2022-12-25	WOS:000342492700082
J	Sato, J; Kinugasa, M; Satomi-Kobayashi, S; Hatakeyama, K; Knox, AJ; Asada, Y; Wierman, ME; Hirata, K; Rikitake, Y				Sato, Junya; Kinugasa, Mitsuo; Satomi-Kobayashi, Seimi; Hatakeyama, Kinta; Knox, Aaron J.; Asada, Yujiro; Wierman, Margaret E.; Hirata, Ken-ichi; Rikitake, Yoshiyuki			Family with Sequence Similarity 5, Member C (FAM5C) Increases Leukocyte Adhesion Molecules in Vascular Endothelial Cells: Implication in Vascular Inflammation	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN; AMERICAN-HEART-ASSOCIATION; REACTIVE OXYGEN; RESPIRATORY-CHAIN; ATHEROSCLEROSIS; ARTERIOSCLEROSIS; DIFFERENTIATION; DEFINITION; COMMITTEE; COUNCIL	Identification of the regulators of vascular inflammation is important if we are to understand the molecular mechanisms leading to atherosclerosis and consequent ischemic heart disease, including acute myocardial infarction. Gene polymorphisms in family with sequence similarity 5, member C (FAM5C) are associated with an increased risk of acute myocardial infarction, but little is known about the function of this gene product in blood vessels. Here, we report that the regulation of the expression and function of FAM5C in endothelial cells. We show here that FAM5C is expressed in endothelial cells in vitro and in vivo. Immunofluorescence microcopy showed localization of FAM5C in the Golgi in cultured human endothelial cells. Immunohistochemistry on serial sections of human coronary artery showed that FAM5C-positive endothelium expressed intercellular adhesion molecule-1 (ICAM-1) or vascular cell adhesion molecule-1 (VCAM-1). In cultured human endothelial cells, the overexpression of FAM5C increased the reactive oxygen species (ROS) production, nuclear factor-kappa B (NF-kappa B) activity and the expression of ICAM-1, VCAM-1 and E-selectin mRNAs, resulting in enhanced monocyte adhesion. FAM5C was upregulated in response to inflammatory stimuli, such as TNF-alpha, in an NF-kappa B- and JNK-dependent manner. Knockdown of FAM5C by small interfering RNA inhibited the increase in the TNF-alpha-induced production of ROS, NF-kappa B activity and expression of these leukocyte adhesion molecule mRNAs, resulting in reduced monocyte adhesion. These results suggest that in endothelial cells, when FAM5C is upregulated in response to inflammatory stimuli, it increases the expression of leukocyte adhesion molecules by increasing ROS production and NF-kappa B activity.	[Sato, Junya; Kinugasa, Mitsuo; Satomi-Kobayashi, Seimi; Hirata, Ken-ichi; Rikitake, Yoshiyuki] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kobe, Hyogo 657, Japan; [Hatakeyama, Kinta; Asada, Yujiro] Miyazaki Univ, Fac Med, Dept Pathol, Miyazaki, Japan; [Knox, Aaron J.; Wierman, Margaret E.] Univ Colorado, Dept Med Physiol & Biophys, Aurora, CO USA; [Rikitake, Yoshiyuki] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Signal Transduct, Kobe, Hyogo, Japan	Kobe University; University of Miyazaki; University of Colorado System; University of Colorado Anschutz Medical Campus; Kobe University	Rikitake, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kobe, Hyogo 657, Japan.	rikitake@med.kobe-u.ac.jp			Japan Society for the Promotion of Science [25461128]; Global Center of Excellence; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Rese; SENSHIN Medical Research Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global Center of Excellence(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Rese; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation)	Funding: This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (C) (25461128) (https://www.jsps.go.jp/english/e-grants/) (to Y. Rikitake), and grants from the Global Center of Excellence (http://www.jsps.go.jp/english/e-globalcoe/index.html) (to M. Kinugasa, arch ad no K. Hirata, Y. Rikitake), the Takeda Science Foundation (http://www.takeda-sci.or.jp), the Mochida Memorial Foundation for Medical and Pharmaceutical Rese (http://www.mochida.co.jp/zaidan/), and the SENSHIN Medical Research Foundation (http://www.mt-pharma.co.jp/zaidan/) (to Y. Rikitake). The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albayrak T, 2003, MOL BIOL CELL, V14, P3082, DOI 10.1091/mbc.e02-10-0631; Carvalho FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010053; Chen L, 2012, DIS MARKERS, V32, P195, DOI [10.1155/2012/473251, 10.3233/DMA-2011-0877]; Cline JL, 2011, BIOL RES NURS; Connelly JJ, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-33; Kawano H, 2004, MOL BRAIN RES, V125, P60, DOI 10.1016/j.molbrainres.2004.04.001; Kinugasa M, 2012, CIRC RES, V110, P716, DOI 10.1161/CIRCRESAHA.111.256834; Kurogane Y, 2012, ARTERIOSCL THROM VAS, V32, P988, DOI 10.1161/ATVBAHA.111.244004; Kuroiwa T, 2009, ONCOL REP, V22, P1005, DOI 10.3892/or_00000528; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Mehta A, 2004, J BIOL CHEM, V279, P11798, DOI 10.1074/jbc.M309341200; O'Malley Y, 2006, J BIOL CHEM, V281, P39766, DOI 10.1074/jbc.M608268200; Rajagopalan S, 1996, J CLIN INVEST, V98, P2572, DOI 10.1172/JCI119076; Ribeiro FV, 2012, ORAL DIS, V18, P147, DOI 10.1111/j.1601-0825.2011.01855.x; Sato Y, 2005, HEART, V91, P526, DOI 10.1136/hrt.2004.034058; Satomi-Kobayashi S, 2012, J BIOL CHEM, V287, P30336, DOI 10.1074/jbc.M111.329110; Shorts-Cary L, 2007, ENDOCRINOLOGY, V148, P967, DOI 10.1210/en.2006-0905; STARY HC, 1994, CIRCULATION, V89, P2462, DOI 10.1161/01.CIR.89.5.2462; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Tanaka K, 2012, BIOCHEM BIOPH RES CO, V418, P134, DOI 10.1016/j.bbrc.2011.12.147; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478	23	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107236	10.1371/journal.pone.0107236	http://dx.doi.org/10.1371/journal.pone.0107236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251368	Green Submitted, gold, Green Published			2022-12-25	WOS:000342492700024
J	Desai, M; Kaur, N; Hu, JP				Desai, Mintu; Kaur, Navneet; Hu, Jianping			Ectopic Expression of the RING Domain of the Arabidopsis PEROXIN2 Protein Partially Suppresses the Phenotype of the Photomorphogenic Mutant De-Etiolated1	PLOS ONE			English	Article							E3 UBIQUITIN LIGASES; HIGHER-PLANTS; LIGHT-RESPONSE; BINDING-SITES; HY5; SUBSTITUTION; COP1; PEROXISOMES; METHIONINE; HYPOCOTYL	The Arabidopsis CONSTITUTIVE PHOTOMORPHOGENIC/DE-ETIOLATED 1/FUSCA (COP/DET1/FUS) proteins repress photomorphogenesis by degrading positive regulators of photomorphogenesis, such as the transcription factor LONG HYPOCOTYL5 (HY5). The gain-of-function mutant ted3, which partially suppresses the det1 mutant, contains a missense mutation of a Val-to-Met substitution before the C-terminal RING finger domain of the peroxisomal membrane protein PEROXIN2 (PEX2). We hypothesized that a truncated PEX2 protein, which only contains the C-terminal RING domain, is initiated by the ted3 mutation and by-passes the function of DET1 in the nucleus. Although we have not been able to detect this hypothetic peptide in vivo, we show in this study that, when fused with a fluorescent protein and overexpressed, the PEX2 RING domain can localize to the nucleus, where it is able to interact with HY5, and PEX2 RING domain overexpression in det1 also partially suppresses the det1 phenotype. Compared with det1, ted3 det1 plants have significantly decreased levels of the HY5 protein and the expression of most of the analyzed HY5 target genes is altered to levels comparable to those in hy5. We conclude that compromised activity of HY5 may have been mainly responsible for the partial reversal of the det1 phenotype in ted3 det1. Our data support the notion that, when appropriately localized, some RING finger domains may be able to achieve neomorphic effects in the cell.	[Desai, Mintu; Kaur, Navneet; Hu, Jianping] Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; [Hu, Jianping] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Hu, JP (corresponding author), Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA.	huji@msu.edu			National Science Foundation [MCB 0618335, MCB 1330441]; Chemical Sciences, Geosciences and Biosciences Division; Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy [DE-FG02-91ER20021]	National Science Foundation(National Science Foundation (NSF)); Chemical Sciences, Geosciences and Biosciences Division(United States Department of Energy (DOE)); Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by the National Science Foundation (http://www.nsf.gov), MCB 0618335 and MCB 1330441, to JH and the Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy (http://science.energy.gov/) (DE-FG02-91ER20021) to JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANG LH, 1994, PLANT CELL, V6, P613, DOI 10.1105/tpc.6.5.613; BEEVERS H, 1979, ANNU REV PLANT PHYS, V30, P159, DOI 10.1146/annurev.pp.30.060179.001111; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Desai M, 2008, PLANT PHYSIOL, V146, P1117, DOI 10.1104/pp.107.113555; Hu JP, 2012, PLANT CELL, V24, P2279, DOI 10.1105/tpc.112.096586; Hu JP, 2008, PLANT SIGNAL BEHAV, V3, P801, DOI 10.4161/psb.3.10.5876; Hu JP, 2002, SCIENCE, V297, P405, DOI 10.1126/science.1073633; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Kami C, 2010, CURR TOP DEV BIOL, V91, P29, DOI 10.1016/S0070-2153(10)91002-8; Kaur Navneet, 2013, Subcell Biochem, V69, P195, DOI 10.1007/978-94-007-6889-5_11; Kaur N, 2013, J INTEGR PLANT BIOL, V55, P108, DOI 10.1111/jipb.12014; KAZEMIESFARJANI P, 1993, MOL ENDOCRINOL, V7, P37, DOI 10.1210/me.7.1.37; Lau OS, 2012, TRENDS PLANT SCI, V17, P584, DOI 10.1016/j.tplants.2012.05.004; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; McNellis TW, 1996, PLANT CELL, V8, P1491, DOI 10.1105/tpc.8.9.1491; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; MURRAY EW, 1992, AM J HUM GENET, V50, P199; Nakazawa M, 2001, PLANT J, V25, P213, DOI 10.1046/j.1365-313x.2001.00957.x; Nezames CD, 2012, PLANT PHYSIOL, V160, P38, DOI 10.1104/pp.112.198879; Okumoto K, 2014, J BIOL CHEM, V289, P14089, DOI 10.1074/jbc.M113.527937; ORTH U, 1994, HUM MOL GENET, V3, P1699, DOI 10.1093/hmg/3.9.1699; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Oyama T, 1997, GENE DEV, V11, P2983, DOI 10.1101/gad.11.22.2983; Pepper AE, 1997, GENETICS, V145, P1125; Platta HW, 2009, MOL CELL BIOL, V29, P5505, DOI 10.1128/MCB.00388-09; Song YH, 2008, PLANT PHYSIOL, V146, P1862, DOI 10.1104/pp.107.113217; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286	29	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108473	10.1371/journal.pone.0108473	http://dx.doi.org/10.1371/journal.pone.0108473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25248106	Green Published, Green Submitted, gold			2022-12-25	WOS:000342351800089
J	Maxwell, BG; Maxwell, TG; Wong, JK				Maxwell, Bryan G.; Maxwell, Thane G.; Wong, Jim K.			Decentralization of Care for Adults with Congenital Heart Disease in the United States: A Geographic Analysis of Outpatient Surgery	PLOS ONE			English	Article							NONCARDIAC SURGERY; PREVALENCE; CHILDREN; LOST	Background: Guidelines recommend that adults with congenital heart disease (CHD) undergo noncardiac surgery in regionalized centers of expertise, but no studies have assessed whether this occurs in the United States. We hypothesized that adults with CHD are less likely than children to receive care at specialized CHD centers. Methods: Using a comprehensive state ambulatory surgical registry (California Ambulatory Surgery Database, 2005-2011), we calculated the proportion of adult and pediatric patients with CHD who had surgery at a CHD center, distance to the nearest CHD center, and distance to the facility where surgery was performed. Results: Patients with CHD accounted for a larger proportion of the pediatric population (n = 11,254, 1.0%) than the adult population (n = 10,547, 0.07%). Only 2,741 (26.0%) adults with CHD had surgery in a CHD center compared to 6,403 (56.9%) children (p<0.0001). Adult CHD patients who had surgery at a non-specialty center (11.9 +/- 15.4 miles away) lived farther from the nearest CHD center (37.9 +/- 43.0 miles) than adult CHD patients who had surgery at a CHD center (23.2 +/- 28.4 miles; p<0.0001). Pediatric CHD patients who had surgery at a non-specialty center (18.0 +/- 20.7 miles away) lived farther from the nearest CHD center (35.7 +/- 45.2 miles) than pediatric CHD patients who had surgery at a CHD center (22.4 +/- 26.0 miles; p<0.0001). Conclusions: Unlike children with CHD, most adults with CHD (74%) do not have outpatient surgery at a CHD center. For both adults and children with CHD, greater distance from a CHD center is associated with having surgery at a non-specialty center. These results have significant public health implications in that they suggest a failing to achieve adequate regional access to specialized ACHD care. Further studies will be required to evaluate potential strategies to more reliably direct this vulnerable population to centers of expertise.	[Maxwell, Bryan G.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Maxwell, Thane G.] Metropolitan State Univ, Dept Social Sci, St Paul, MN USA; [Wong, Jim K.] Stanford Univ, Dept Anesthesiol Perioperat & Pain Med, Stanford, CA 94305 USA	Johns Hopkins University; Metropolitan State University; Stanford University	Maxwell, BG (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.	bmaxwell@jhu.edu			Open Access Promotion Fund of the Johns Hopkins University Libraries	Open Access Promotion Fund of the Johns Hopkins University Libraries	Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Automated Licensing Information and Report Tracking System (ALIRTS), CAL OFF STAT HEAL PL; Bonow RO, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; Chang  RKR, 2004, CAN J CARDIOL, V20, P877; Cook NL, 2009, CIRCULATION, V119, P2463, DOI 10.1161/CIRCULATIONAHA.108.825133; Diller GP, 2005, CIRCULATION, V112, P828, DOI 10.1161/CIRCULATIONAHA.104.529800; Fleisher LA, 2007, J AM COLL CARDIOL, V50, P1707, DOI 10.1016/j.jacc.2007.09.001; Gurvitz M, 2013, J AM COLL CARDIOL, V61, P2180, DOI 10.1016/j.jacc.2013.02.048; Gurvitz MZ, 2007, J AM COLL CARDIOL, V49, P875, DOI 10.1016/j.jacc.2006.09.051; Hanchette CL, 2003, HLTH INFORMAT SER, P431; Mackie AS, 2009, CIRCULATION, V120, P302, DOI 10.1161/CIRCULATIONAHA.108.839464; Marelli AJ, 2007, CIRCULATION, V115, P163, DOI 10.1161/CIRCULATIONAHA.106.627224; Maxwell BG, 2013, ANESTHESIOLOGY, V119, P762, DOI 10.1097/ALN.0b013e3182a56de3; McClure RJ, 1996, ARCH DIS CHILD, V74, P121, DOI 10.1136/adc.74.2.121; O'Leary JM, 2013, JAMA-J AM MED ASSOC, V309, P984, DOI 10.1001/jama.2013.564; Oechslin EN, 2000, AM J CARDIOL, V86, P1111, DOI 10.1016/S0002-9149(00)01169-3; US Census Bureau, ZIP COD TAB AR FREQ; Vis Jeroen C, 2012, Ned Tijdschr Geneeskd, V156, pA3767; Wacker A, 2005, AM J CARDIOL, V95, P776, DOI 10.1016/j.amjcard.2004.11.036	18	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e106730	10.1371/journal.pone.0106730	http://dx.doi.org/10.1371/journal.pone.0106730			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247694	gold, Green Submitted, Green Published			2022-12-25	WOS:000342351800014
J	Nordgaard, JC; Kruse, LS; Gammeltoft, S; Kruuse, CR				Nordgaard, Julie Caroe; Kruse, Lars Schack; Gammeltoft, Steen; Kruuse, Christina Rostrup			Role of Ser102 and Ser104 as Regulators of cGMP Hydrolysis by PDE5A	PLOS ONE			English	Article							NITRIC-OXIDE; PHOSPHODIESTERASE-5; MIGRAINE; PHOSPHORYLATION; SILDENAFIL; EXPRESSION; HEADACHE; CGRP; NO	Background: Phosphodiesterases (PDEs) cleave phosphodiester bonds in cyclic nucleotides and play diverse roles in cell biology. PDE5A is a cytoplasmic phosphodiesterase which specifically degrades cyclic guanosine monophosphate (cGMP), a cell signaling molecule that plays important roles in neuronal signaling and vascular smooth muscle contraction. Inhibition of PDE5A induces headache resembling migraine headaches. Aim: To test the hypothesis that Ser102 and Ser104 in PDE5A and/or their phosphoserine derivatives 1) regulate the intracellular localization and/or activity of PDE5A, and 2) modulate the interaction between PDE5A and pharmaceutical reagents in clinical or pre-clinical use for migraine headaches and other types of vascular dysfunction. Methods: Wild type PDE5A or PDE5A with substitution mutations (Ser102Ala, Ser104Ala or Ser102Ala/Ser104Ala) were overexpressed in SK-N-AS neuroblastoma cells as C-terminal fusions with green fluorescent protein. Transfected cells were treated with sildenafil, cilostazol, glyceryl trinitrate, calcitonin gene-related peptide (CGRP) or sumatriptan. PDE5A-GFP fusion proteins were localized in fixed cells by immunofluorescence and PDE activity was quantified in cell extracts by standard in vitro assay using [H-3] cGMP. Results: The intracellular distribution of wild-type, single and double mutant PDE5A was similar and was not altered by exposure to sildenafil, cilostazol, glyceryl trinitrate, calcitonin gene-related peptide (CGRP) or sumatriptan. PDE5 activity was similar for wild type, Ser102Ala and Ser104Ala PDE5A, but activity of the Ser102Ala/Ser104Ala mutant was approximately two-fold higher than wild type. Double mutant Ser102Ala/Ser104Ala migrated as a single band on a native acrylamide gel, while wild-type and single mutant PDE5A migrated as a doublet. Interpretation: Ser102 and Ser104 may influence the conformational flexibility of PDE5A, which may in turn influence phosphorylation status, allosteric regulation by cGMP or other as yet unknown regulatory mechanisms for PDE5A. PDE5A activation could be important in reversal of migraine-like headache.	[Nordgaard, Julie Caroe; Kruuse, Christina Rostrup] Univ Copenhagen, Glostrup Hosp, Lundbeck Fdn Ctr Neurovasc Signaling LUCENS, Glostrup Res Inst, Glostrup, Denmark; [Kruse, Lars Schack] Univ Copenhagen, Glostrup Hosp, Dept Clin Expt Res, Glostrup, Denmark; [Gammeltoft, Steen] Univ Copenhagen, Glostrup Hosp, Dept Diagnost, Clin Biochem Sect, Glostrup, Denmark; [Kruuse, Christina Rostrup] Univ Copenhagen, Herlev Hosp, Dept Neurol, Neurovasc Res Unit, DK-2730 Herlev, Denmark	Lundbeckfonden; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital	Kruuse, CR (corresponding author), Univ Copenhagen, Glostrup Hosp, Lundbeck Fdn Ctr Neurovasc Signaling LUCENS, Glostrup Res Inst, Glostrup, Denmark.	ckruuse@dadlnet.dk		Kruuse, Christina/0000-0002-4210-0523	LUCENS; A.P. Moller Foundation; Cool Sorption Foundation	LUCENS; A.P. Moller Foundation; Cool Sorption Foundation	LUCENS. A.P. Moller Foundation for the Advancement of Medical Science. Christian and Ottilia Brorsons travel grant. Cool Sorption Foundation of 1988. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Birk S, 2004, J CEREBR BLOOD F MET, V24, P1352, DOI 10.1097/01.WCB.0000143536.22131.D7; COHEN PS, 1995, CANCER RES, V55, P2380; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Corbin JD, 2011, CELL SIGNAL, V23, P778, DOI 10.1016/j.cellsig.2010.12.005; Corbin JD, 2000, EUR J BIOCHEM, V267, P2760, DOI 10.1046/j.1432-1327.2000.01297.x; Eftekhari S, 2010, NEUROSCIENCE, V169, P683, DOI 10.1016/j.neuroscience.2010.05.016; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Francis Sharron H., 2009, V191, P367, DOI 10.1007/978-3-540-68964-5_16; Hansen JM, 2010, CEPHALALGIA, V30, P1179, DOI 10.1177/0333102410368444; Kleppisch Thomas, 2009, V191, P549, DOI 10.1007/978-3-540-68964-5_24; Kruse LS, 2006, NEUROSCI LETT, V404, P202, DOI 10.1016/j.neulet.2006.05.045; Kruuse C, 2003, BRAIN, V126, P241, DOI 10.1093/brain/awg009; Kruuse C, 2002, J CEREBR BLOOD F MET, V22, P1124, DOI 10.1097/00004647-200209000-00010; Lassen LH, 2002, CEPHALALGIA, V22, P54, DOI 10.1046/j.1468-2982.2002.00310.x; Li HG, 2000, J PATHOL, V190, P244, DOI 10.1002/(SICI)1096-9896(200002)190:3<244::AID-PATH575>3.0.CO;2-8; Messlinger K, 2012, HEADACHE, V52, P1411, DOI 10.1111/j.1526-4610.2012.02212.x; Nordgaard JC, 2014, CEPHALALGIA, V34, P503, DOI 10.1177/0333102413515345; OLESEN J, 1993, NEUROREPORT, V4, P1027, DOI 10.1097/00001756-199308000-00008; Poyner DR, 2002, PHARMACOL REV, V54, P233, DOI 10.1124/pr.54.2.233; Schankin CJ, 2010, HEADACHE, V50, P431, DOI 10.1111/j.1526-4610.2009.01512.x; Spitzenberg V, 2010, J CANCER RES CLIN, V136, P1881, DOI 10.1007/s00432-010-0847-2; Sudo T, 2000, BIOCHEM PHARMACOL, V59, P347, DOI 10.1016/S0006-2952(99)00346-9; Tepper SJ, 2001, NEUROLOGIST, V7, P279, DOI 10.1097/00127893-200109000-00002; THOMAS MK, 1990, J BIOL CHEM, V265, P14971	26	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107627	10.1371/journal.pone.0107627	http://dx.doi.org/10.1371/journal.pone.0107627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247292	Green Published, Green Submitted, gold			2022-12-25	WOS:000342351800027
J	Poliakova, K; Adebola, A; Leung, CL; Favre, B; Liem, RKH; Schepens, I; Borradori, L				Poliakova, Kseniia; Adebola, Adijat; Leung, Conrad L.; Favre, Bertrand; Liem, Ronald K. H.; Schepens, Isabelle; Borradori, Luca			BPAG1a and b Associate with EB1 and EB3 and Modulate Vesicular Transport, Golgi Apparatus Structure, and Cell Migration in C2.7 Myoblasts	PLOS ONE			English	Article							DROSOPHILA SHORT STOP; LINKING FACTOR MACF; BINDING-PROTEIN; SKELETAL-MUSCLE; ACTIN; LOCALIZATION; PLAKIN; SPECTRAPLAKINS; MICROTUBULES; ORGANIZATION	BPAG1a and BPAG1b (BPAG1a/b) constitute two major isoforms encoded by the dystonin (Dst) gene and show homology with MACF1a and MACF1b. These proteins are members of the plakin family, giant multi-modular proteins able to connect the intermediate filament, microtubule and microfilament cytoskeletal networks with each other and to distinct cell membrane sites. They also serve as scaffolds for signaling proteins that modulate cytoskeletal dynamics. To gain better insights into the functions of BPAG1a/b, we further characterized their C-terminal region important for their interaction with microtubules and assessed the role of these isoforms in the cytoskeletal organization of C2.7 myoblast cells. Our results show that alternative splicing does not only occur at the 59 end of Dst and Macf1 pre-mRNAs, as previously reported, but also at their 39 end, resulting in expression of additional four mRNA variants of BPAG1 and MACF1. These isoform-specific C-tails were able to bundle microtubules and bound to both EB1 and EB3, two microtubule plus end proteins. In the C2.7 cell line, knockdown of BPAG1a/b had no major effect on the organization of the microtubule and microfilament networks, but negatively affected endocytosis and maintenance of the Golgi apparatus structure, which became dispersed. Finally, knockdown of BPAG1a/b caused a specific decrease in the directness of cell migration, but did not impair initial cell adhesion. These data provide novel insights into the complexity of alternative splicing of Dst pre-mRNAs and into the role of BPAG1a/b in vesicular transport, Golgi apparatus structure as well as in migration in C2.7 myoblasts.	[Poliakova, Kseniia; Favre, Bertrand; Schepens, Isabelle; Borradori, Luca] Univ Bern, Dept Clin Res, Bern, Switzerland; [Poliakova, Kseniia] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Poliakova, Kseniia; Favre, Bertrand; Borradori, Luca] Univ Hosp Bern, Inselspital, Dept Dermatol, CH-3010 Bern, Switzerland; [Adebola, Adijat; Leung, Conrad L.] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA	University of Bern; University of Bern; University of Bern; University Hospital of Bern; Columbia University	Poliakova, K (corresponding author), Univ Bern, Dept Clin Res, Bern, Switzerland.	kseniia.poliakova@insel.ch		Schepens, Isabelle/0000-0002-6718-9608	Swiss National Foundation for Research [3100A0-121966]; Telethon Action Suisse; Swiss Foundation for Research on Muscle Diseases; National Institutes of Health (NIH) [NS047711]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047711] Funding Source: NIH RePORTER	Swiss National Foundation for Research(Swiss National Science Foundation (SNSF)); Telethon Action Suisse; Swiss Foundation for Research on Muscle Diseases; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Swiss National Foundation for Research (grant numbers 3100A0-121966), www.snf.ch; Telethon Action Suisse, www.telethon.ch; Swiss Foundation for Research on Muscle Diseases, www.fsrmm.ch; and National Institutes of Health (NIH) (grant numbers NS047711), www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Abramovici H, 2007, CELL MOTIL CYTOSKEL, V64, P549, DOI 10.1002/cm.20204; Almeida-Souza L, 2011, J NEUROSCI, V31, P15320, DOI 10.1523/JNEUROSCI.3266-11.2011; Alves-Silva J, 2012, J NEUROSCI, V32, P9143, DOI 10.1523/JNEUROSCI.0416-12.2012; Applewhite DA, 2013, MOL BIOL CELL, V24, P2885, DOI 10.1091/mbc.E12-11-0798; Applewhite DA, 2010, MOL BIOL CELL, V21, P1714, DOI 10.1091/mbc.E10-01-0011; Bhanot K, 2011, J PROTEOME RES, V10, P5118, DOI 10.1021/pr200564g; Bouameur JE, 2013, J INVEST DERMATOL; Boudreau-Lariviere C, 2002, DIFFERENTIATION, V70, P247, DOI 10.1046/j.1432-0436.2002.700603.x; Boyer JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009465; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Buey RM, 2012, J BIOL CHEM, V287, P28227, DOI 10.1074/jbc.M112.373928; CHANGEUX JP, 1986, J PHYSIOL-LONDON, V378, P497, DOI 10.1113/jphysiol.1986.sp016232; CORTHESYTHEULAZ I, 1992, J CELL BIOL, V118, P1333, DOI 10.1083/jcb.118.6.1333; Dalpe G, 1999, DEV BIOL, V210, P367, DOI 10.1006/dbio.1999.9263; Darido C, 2013, ADV WOUND CARE, V2, P87, DOI 10.1089/wound.2011.0352; De Repentigny Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021093; Dixit R, 2008, J BIOL CHEM, V283, P33611, DOI 10.1074/jbc.M804840200; Drabek K, 2006, CURR BIOL, V16, P2259, DOI 10.1016/j.cub.2006.09.065; Edvardson S, 2012, ANN NEUROL, V71, P569, DOI 10.1002/ana.23524; Fletcher SJ, 2009, BIOCHEM SOC T, V37, P1072, DOI 10.1042/BST0371072; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Giorda R, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.012260; Goryunov D, 2007, BRAIN RES, V1140, P179, DOI 10.1016/j.brainres.2006.04.068; Groves RW, 2010, J INVEST DERMATOL, V130, P1551, DOI 10.1038/jid.2010.19; GUO LF, 1995, CELL, V81, P233, DOI 10.1016/0092-8674(95)90333-X; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Jefferson JJ, 2004, NAT REV MOL CELL BIO, V5, P542, DOI 10.1038/nrm1425; Jefferson JJ, 2007, J MOL BIOL, V366, P244, DOI 10.1016/j.jmb.2006.11.036; Jefferson JJ, 2006, EXP CELL RES, V312, P2712, DOI 10.1016/j.yexcr.2006.04.025; Jiang K, 2012, CURR BIOL, V22, P1800, DOI 10.1016/j.cub.2012.07.047; Kioka N, 1999, J CELL BIOL, V144, P59, DOI 10.1083/jcb.144.1.59; Kumar P, 2012, TRENDS CELL BIOL, V22, P418, DOI 10.1016/j.tcb.2012.05.005; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Leung CL, 1999, J CELL BIOL, V147, P1275, DOI 10.1083/jcb.147.6.1275; Leung CL, 2001, J CELL BIOL, V154, P691, DOI 10.1083/jcb.200012098; Lin CM, 2005, J CELL SCI, V118, P3727, DOI 10.1242/jcs.02510; Liu JJ, 2007, P NATL ACAD SCI USA, V104, P2223, DOI 10.1073/pnas.0602222104; Liu JJ, 2003, J CELL BIOL, V163, P223, DOI 10.1083/jcb.200306075; Liu L, 2012, J INVEST DERMATOL, V132, P742, DOI 10.1038/jid.2011.379; McElwee M, 2013, J VIROL, V87, P11008, DOI 10.1128/JVI.01633-13; Millarte V, 2012, SCI WORLD J, DOI 10.1100/2012/498278; Morrison EE, 1998, ONCOGENE, V17, P3471, DOI 10.1038/sj.onc.1202247; Ortega E, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.197467; Pasdeloup D, 2013, J VIROL, V87, P2857, DOI 10.1128/JVI.02676-12; Pool M, 2005, MAMM GENOME, V16, P909, DOI 10.1007/s00335-005-0073-4; Rezniczek GA, 2007, J CELL BIOL, V176, P965, DOI 10.1083/jcb.200604179; Roberts RL, 2000, J LEUKOCYTE BIOL, V68, P627; Roper K, 2002, J CELL SCI, V115, P4215, DOI 10.1242/jcs.00157; Ryan SD, 2012, J CELL BIOL, V196, P727, DOI 10.1083/jcb.201107096; SALVATORI G, 1995, J CELL SCI, V108, P2733; Sanchez-Soriano N, 2009, J CELL SCI, V122, P2534, DOI 10.1242/jcs.046268; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Sonnenberg A, 2007, J MOL BIOL, V368, P1379, DOI 10.1016/j.jmb.2007.02.090; Steiner-Champliaud MF, 2010, EXP CELL RES, V316, P297, DOI 10.1016/j.yexcr.2009.11.010; Subramanian A, 2003, CURR BIOL, V13, P1086, DOI 10.1016/S0960-9822(03)00416-0; Sutterlin C, 2010, J CELL BIOL, V188, P621, DOI 10.1083/jcb.200910001; Sun DM, 2001, J CELL SCI, V114, P161; Vaughan KT, 2005, BBA-MOL CELL RES, V1744, P316, DOI 10.1016/j.bbamcr.2005.05.001; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Wu XY, 2011, CELL, V144, P341, DOI 10.1016/j.cell.2010.12.033; Yang YM, 1999, CELL, V98, P229, DOI 10.1016/S0092-8674(00)81017-X; Yang YM, 1996, CELL, V86, P655, DOI 10.1016/S0092-8674(00)80138-5; Young KG, 2003, J CELL SCI, V116, P4543, DOI 10.1242/jcs.00764; Zhang T, 2009, J CELL SCI, V122, P1401, DOI 10.1242/jcs.039255	65	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107535	10.1371/journal.pone.0107535	http://dx.doi.org/10.1371/journal.pone.0107535			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244344	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800039
J	Talebizadeh, N; Yu, ZH; Kronschlager, M; Soderberg, P				Talebizadeh, Nooshin; Yu, Zhaohua; Kronschlager, Martin; Soderberg, Per			Modelling the Time Evolution of Active Caspase-3 Protein in the Rat Lens after In Vivo Exposure to Ultraviolet Radiation-B	PLOS ONE			English	Article							INDUCED CATARACT; APOPTOSIS; AGE	Purpose: To introduce a model for the time evolution of active caspase-3 protein expression in albino rat lens up to 24 hours after in vivo exposure to low dose UVR in the 300 nm wavelength region (UVR-300 nm). Methods: Forty Sprague-Dawley rats were unilaterally exposed in vivo to 1 kJ/m(2) UVR-300 nm for 15 minutes. At 0.5, 8, 16, and 24 hours after the UVR exposure, the exposed and contralateral not-exposed lenses were removed and processed for immunohistochemistry. The differences in the probability of active caspase-3 expression at four different time points after exposure were used to determine the time evolution of active caspase-3 expression. A logistic model was introduced for the expression of active caspase-3. The parameters for the exposed and the not exposed lenses were estimated for the observation time points. Results: The exposure to UVR-300 nm impacted on the parameters of the logistic model. Further, the parameters of the model varied with time after exposure to UVR-300 nm. Conclusion: The logistic model predicts the impact of exposure to UVR-300 nm on the spatial distribution of probability of active caspase-3 protein expression, depending on time.	[Talebizadeh, Nooshin; Yu, Zhaohua; Kronschlager, Martin; Soderberg, Per] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Uppsala University	Talebizadeh, N (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	nooshin.talebizadeh@neuro.uu.se		Talebizadeh, Nooshin/0000-0001-7325-7358; Kronschlager, Martin/0000-0002-9175-6203	Gun och Bertil Stohnes stiftelse; Swedish Research Council; Konung Gustav V:s och Drottning Victorias Frimurarstiftelse Ogonfonden; Carmen och Bertil Regners fond for forskning; Uppsala Lans Landsting's Research grants (ALF);  [K2008-63X-15035-05-2]	Gun och Bertil Stohnes stiftelse; Swedish Research Council(Swedish Research CouncilEuropean Commission); Konung Gustav V:s och Drottning Victorias Frimurarstiftelse Ogonfonden; Carmen och Bertil Regners fond for forskning; Uppsala Lans Landsting's Research grants (ALF); 	Gun och Bertil Stohnes stiftelse, Swedish Research Council, project K2008-63X-15035-05-2, Konung Gustav V:s och Drottning Victorias Frimurarstiftelse Ogonfonden, Carmen och Bertil Regners fond for forskning and Uppsala Lans Landsting's Research grants (ALF). NT PS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala M, 2007, INVEST OPHTH VIS SCI, V48, P4187, DOI 10.1167/iovs.06-0660; Ayala MN, 2000, EXP EYE RES, V70, P451, DOI 10.1006/exer.1999.0801; Dong XQ, 2003, INVEST OPHTH VIS SCI, V44, P1150, DOI 10.1167/iovs.02-0541; Galichanin K, 2012, EXP EYE RES, V97, P19, DOI 10.1016/j.exer.2012.02.003; Galichanin K, 2010, EXP EYE RES, V91, P369, DOI 10.1016/j.exer.2010.06.009; Kim Seong-Taeck, 2011, Korean J Ophthalmol, V25, P196, DOI 10.3341/kjo.2011.25.3.196; Klockars A, 2010, ENCY RES DESIGN, P978; Kronschlager M, 2013, CURR EYE RES, V38, P880, DOI 10.3109/02713683.2013.783079; McCarty CA, 2002, DEV OPHTHALMOL, V35, P21; Michael R, 1998, INVEST OPHTH VIS SCI, V39, P2681; Mody VC, 2006, ACTA OPHTHALMOL SCAN, V84, P390, DOI 10.1111/j.1600-0420.2006.00640.x; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Soderberg PG, 2002, DEV OPHTHALMOL, V35, P70; Talebizadeh N, 2014, ACTA OPHTHALMOL; Taylor HR, 1999, EYE, V13, P445, DOI 10.1038/eye.1999.119; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806	16	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e106926	10.1371/journal.pone.0106926	http://dx.doi.org/10.1371/journal.pone.0106926			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244366	Green Published, gold, Green Submitted			2022-12-25	WOS:000343679800015
J	Fiala, O; Zahorakova, D; Pospisilova, L; Kucerova, J; Matejckova, M; Martasek, P; Roth, J; Ruzicka, E				Fiala, Ondrej; Zahorakova, Daniela; Pospisilova, Lenka; Kucerova, Jana; Matejckova, Milada; Martasek, Pavel; Roth, Jan; Ruzicka, Evzen			Parkin (PARK 2) Mutations Are Rare in Czech Patients with Early-Onset Parkinson's Disease	PLOS ONE			English	Article							NONMOTOR SYMPTOMS; GENE-MUTATIONS; METAANALYSIS; VARIANT; PINK1; ASSOCIATION; FREQUENCY; DIAGNOSIS; FEATURES	Objective: The aim of the study is to determine the frequency of parkin allelic variants in Czech early-onset Parkinson's disease patients and healthy controls. Methods: A total of 70 early-onset Parkinson's disease patients (age at onset <= 40 years) and 75 controls were screened for the sequence variants and exon rearrangements in the parkin gene. Results: Parkin mutations were identified in five patients (7.1%): the p. R334C point mutation was present in one patient, four patients had exon deletions. The detected mutations were observed in the heterozygous state except one homozygous deletion of the exon 4. No mutations were obtained in control subjects. A novel sequence variant p.V380I (c.1138G>A) was identified in one control. Non-pathogenic polymorphisms p. S167N and p.D394N were seen in similar percentage in patients and controls, polymorphism p.V380L was almost twice as frequent in controls as in patients. Conclusions: Our study contributes to the growing body of evidence on the low frequency of the parkin mutations in the early-onset Parkinson's disease suggesting the potential role of other genes in the pathogenesis of the disease.	[Fiala, Ondrej; Roth, Jan; Ruzicka, Evzen] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic; [Fiala, Ondrej; Roth, Jan; Ruzicka, Evzen] Charles Univ Prague, Fac Med 1, Ctr Clin Neurosci, Prague, Czech Republic; [Fiala, Ondrej; Zahorakova, Daniela; Pospisilova, Lenka; Kucerova, Jana; Martasek, Pavel; Roth, Jan; Ruzicka, Evzen] Charles Univ Prague, Gen Univ Hosp, Prague, Czech Republic; [Fiala, Ondrej] Inst Neuropsychiat Care INEP, Prague, Czech Republic; [Zahorakova, Daniela; Pospisilova, Lenka; Kucerova, Jana; Martasek, Pavel] Charles Univ Prague, Fac Med 1, Dept Pediat & Adolescent Med, Prague, Czech Republic; [Matejckova, Milada] Thomayers Univ Hosp, Dept Pathol & Mol Med, Prague, Czech Republic	Charles University Prague; Charles University Prague; Charles University Prague; General University Hospital Prague; Charles University Prague; Thomayer Hospital	Fiala, O (corresponding author), Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic.	fiala@inep.cz	Růžička, Evžen/F-9299-2017; Martásek, Pavel/G-6622-2017; Zahorakova, Daniela/F-4393-2017; Roth, Jan/O-1817-2017	Růžička, Evžen/0000-0002-4893-9661; Martásek, Pavel/0000-0001-6165-4444; Zahorakova, Daniela/0000-0001-6192-1274; Roth, Jan/0000-0002-5247-7746	Czech Ministry of Health [IGA NT/11331, RVO-VFN64165/2012]; Charles University in Prague [PRVOUK P26/LF1/4, UNCE 204011/2012]	Czech Ministry of Health(Ministry of Health, Czech Republic); Charles University in Prague	This work was supported by the Czech Ministry of Health, IGA NT/11331 (OF, MM, and ER); Czech Ministry of Health, RVO-VFN64165/2012 (DZ and PM); Charles University in Prague, PRVOUK P26/LF1/4 (JR and ER); and Charles University in Prague, UNCE 204011/2012 (DZ, JK, and PM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozi M, 2013, EUR J NEUROL; Brooks J, 2009, J MED GENET, V46, P375, DOI 10.1136/jmg.2008.063917; Bruggemann N, 1993, PARKIN TYPE EARLY ON; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Choi JM, 2008, NEUROGENETICS, V9, P263, DOI 10.1007/s10048-008-0138-0; Cookson MR, 2003, HUM MOL GENET, V12, P2957, DOI 10.1093/hmg/ddg328; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; de Mena L, 2013, J MOL NEUROSCI, V50, P264, DOI 10.1007/s12031-012-9942-y; Fiala O, 2010, NEUROENDOCRINOL LETT, V31, P187; Gallagher DA, 2010, MOVEMENT DISORD, V25, P2493, DOI 10.1002/mds.23394; Gaweda-Walerych K, 2012, PARKINSONISM RELAT D, V18, P520, DOI 10.1016/j.parkreldis.2012.01.021; Grunewald A, 2013, JAMA NEUROL, V70, P1186, DOI 10.1001/jamaneurol.2013.488; Camacho JLG, 2012, MOVEMENT DISORD, V27, P1047, DOI 10.1002/mds.25030; Hagenah JM, 2007, J NEUROL, V254, P1407, DOI 10.1007/s00415-007-0567-y; Hilker R, 2001, ANN NEUROL, V49, P367, DOI 10.1002/ana.74; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Kay DM, 2007, ANN NEUROL, V61, P47, DOI 10.1002/ana.21039; Khan NL, 2003, BRAIN, V126, P1279, DOI 10.1093/brain/awg142; Khan NL, 2002, BRAIN, V125, P2248, DOI 10.1093/brain/awf237; Kilarski LL, 2012, MOVEMENT DISORD, V27, P1522, DOI 10.1002/mds.25132; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klein C, 2007, LANCET NEUROL, V6, P652, DOI 10.1016/S1474-4422(07)70174-6; Koziorowski D, 2010, PARKINSONISM RELAT D, V16, P136, DOI 10.1016/j.parkreldis.2009.06.010; Lubbe S, 2014, J NEUROL, V261, P259, DOI 10.1007/s00415-013-7003-2; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Marder KS, 2010, ARCH NEUROL-CHICAGO, V67, P731, DOI 10.1001/archneurol.2010.95; Mellick GD, 2009, PARKINSONISM RELAT D, V15, P105, DOI 10.1016/j.parkreldis.2007.11.016; Monroy-Jaramillo N, 2014, AM J MED GENET B, V165, P235, DOI 10.1002/ajmg.b.32228; Padmaja MV, 2012, NEUROSCI LETT, V523, P145, DOI 10.1016/j.neulet.2012.06.062; Schlitter AM, 2006, ACTA NEUROL SCAND, V113, P9, DOI 10.1111/j.1600-0404.2005.00532.x; Schrag A, 2006, LANCET NEUROL, V5, P355, DOI 10.1016/S1474-4422(06)70411-2; Spica V, 2013, J NEUROL, V260, P131, DOI 10.1007/s00415-012-6600-9; Thenganatt MA, 2014, JAMA NEUROL, V71, P499, DOI 10.1001/jamaneurol.2013.6233; Twelves D, 2003, MOVEMENT DISORD, V18, P19, DOI 10.1002/mds.10305; Van Den Eeden SK, 2003, AM J EPIDEMIOL, V157, P1015, DOI 10.1093/aje/kwg068; Moura KCV, 2013, DIS MARKERS, V2013, P181, DOI 10.1155/2013/597158; Walter U, 2004, MOVEMENT DISORD, V19, P1445, DOI 10.1002/mds.20232; Zhang Y, 2013, AM J MED GENET B, V162B, P235, DOI 10.1002/ajmg.b.32138; Zhang Y, 2012, NEUROSCI LETT, V524, P60, DOI 10.1016/j.neulet.2012.07.007; Zhang Y, 2012, AM J MED GENET B, V159B, P38, DOI 10.1002/ajmg.b.31250	42	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107585	10.1371/journal.pone.0107585	http://dx.doi.org/10.1371/journal.pone.0107585			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238391	Green Published, gold, Green Submitted			2022-12-25	WOS:000342491600032
J	Kagerer, S; Wehrum, S; Klucken, T; Walter, B; Vaitl, D; Stark, R				Kagerer, Sabine; Wehrum, Sina; Klucken, Tim; Walter, Bertram; Vaitl, Dieter; Stark, Rudolf			Sex Attracts: Investigating Individual Differences in Attentional Bias to Sexual Stimuli	PLOS ONE			English	Article							CONFIDENCE-INTERVALS; EMOTIONAL RESPONSES; SPINAL REFLEXES; AROUSAL; MODULATION; BEHAVIOR; ANXIETY; WOMEN; INTERFERENCE; RELIABILITY	We investigated the impact of sexual stimuli and the influence of sexual motivation on the performance in a dot-probe task and a line-orientation task in a large sample of males and females. All pictures (neutral, erotic) were rated on the dimensions of valence, arousal, disgust, and sexual arousal. Additionally, questionnaires measuring sexual interest/desire/motivation were employed. The ratings of the sexual stimuli point to a successful picture selection because sexual arousal did not differ between the sexes. The stimuli were equally arousing for men and women. Higher scores in the employed questionnaires measuring sexual interest/desire/motivation led to higher sexual arousal ratings of the sex pictures. Attentional bias towards sex pictures was observed in both experimental tasks. The attentional biases measured by the dot-probe and the line-orientation task were moderately intercorrelated suggesting attentional bias as a possible marker for a sex-attention trait. Finally, only the sexual sensation seeking score correlated with the attentional biases of the two tasks. Future research is needed to increase the predictive power of these indirect measures of sexual interest.	[Kagerer, Sabine; Wehrum, Sina; Klucken, Tim; Stark, Rudolf] Univ Giessen, Dept Psychotherapy & Syst Neurosci, D-35390 Giessen, Germany; [Kagerer, Sabine; Wehrum, Sina; Klucken, Tim; Walter, Bertram; Vaitl, Dieter; Stark, Rudolf] Univ Giessen, Bender Inst Neuroimaging, D-35390 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Kagerer, S (corresponding author), Univ Giessen, Dept Psychotherapy & Syst Neurosci, D-35390 Giessen, Germany.	sabine.kagerer@psychol.uni-giessen.de	Klucken, Tim/F-7669-2013; Walter, Bertram/AAD-4695-2021	Klucken, Tim/0000-0003-2433-6652; 	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [STA 475/11-1]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	The project was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation); Funding Number: STA 475/11-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GM, 1993, PSYCHONEUROENDOCRINO, V18, P91, DOI 10.1016/0306-4530(93)90060-X; Anderson AK, 2005, J EXP PSYCHOL GEN, V134, P258, DOI 10.1037/0096-3445.134.2.258; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; BARLOW DH, 1986, J CONSULT CLIN PSYCH, V54, P140, DOI 10.1037/0022-006X.54.2.140; Baumeister RF, 2000, PSYCHOL BULL, V126, P347, DOI 10.1037/0033-2909.126.3.347; Baumeister RF, 2001, PERS SOC PSYCHOL REV, V5, P242, DOI 10.1207/S15327957PSPR0503_5; BONNET M, 1995, PSYCHOPHYSIOLOGY, V32, P367, DOI 10.1111/j.1469-8986.1995.tb01219.x; Both S, 2004, J SEX RES, V41, P242, DOI 10.1080/00224490409552232; Both S, 2003, PSYCHOPHYSIOLOGY, V40, P174, DOI 10.1111/1469-8986.00019; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brand M, 2011, CYBERPSYCH BEH SOC N, V14, P371, DOI 10.1089/cyber.2010.0222; Brauer M, 2012, ARCH SEX BEHAV, V41, P891, DOI 10.1007/s10508-011-9820-7; Buodo G, 2002, MOTIV EMOTION, V26, P123, DOI 10.1023/A:1019886501965; de Jong DC, 2009, J SEX RES, V46, P237, DOI 10.1080/00224490902747230; Georgiadis JR, 2012, PROG NEUROBIOL, V98, P49, DOI 10.1016/j.pneurobio.2012.05.004; Georgiadis JR, 2009, HUM BRAIN MAPP, V30, P3089, DOI 10.1002/hbm.20733; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Hahn A, 2014, J EXP PSYCHOL GEN, V143, P1369, DOI 10.1037/a0035028; Hiller J, 2005, J MENS HLTH GENDER, V2, P339, DOI DOI 10.1016/j.jmhg.2005.05.003; Hogarth LC, 2003, BEHAV PHARMACOL, V14, P153, DOI 10.1097/00008877-200303000-00007; HOLM S, 1979, SCAND J STAT, V6, P65; KALICHMAN SC, 1995, J PERS ASSESS, V65, P586, DOI 10.1207/s15327752jpa6503_16; Kelley K, 2005, EDUC PSYCHOL MEAS, V65, P51, DOI 10.1177/0013164404264850; Kirby KN, 2013, BEHAV RES METHODS, V45, P905, DOI 10.3758/s13428-013-0330-5; LAAN E, 1994, ARCH SEX BEHAV, V23, P153, DOI 10.1007/BF01542096; LeDoux J. E., 1996, EMOTIONAL BRAIN MYST; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; Mathews A, 1998, COGNITIVE THER RES, V22, P539, DOI 10.1023/A:1018738019346; Mogg K, 1998, BEHAV RES THER, V36, P809, DOI 10.1016/S0005-7967(98)00063-1; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Most SB, 2005, PSYCHON B REV, V12, P654, DOI 10.3758/BF03196754; Most SB, 2007, COGNITION EMOTION, V21, P964, DOI 10.1080/02699930600959340; Panksepp J, 1998, AFFECTIVE NEUROSCIEN, Vxii; Pessoa L, 2005, NEUROIMAGE, V28, P249, DOI 10.1016/j.neuroimage.2005.05.048; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1985, COGNITIVE NEUROPSYCH, V2, P211, DOI 10.1080/02643298508252866; Prause N, 2008, ARCH SEX BEHAV, V37, P934, DOI 10.1007/s10508-007-9236-6; R Core Team, 2014, R LANG ENV STAT COMP; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Rupp HA, 2008, ARCH SEX BEHAV, V37, P206, DOI 10.1007/s10508-007-9217-9; Rupp HA, 2007, HORM BEHAV, V51, P524, DOI 10.1016/j.yhbeh.2007.01.008; Schimmack U, 2005, EMOTION, V5, P55, DOI 10.1037/1528-3542.5.1.55; Sell R.L., 1996, J GAY LESBIAN BISEXU, V1, P295, DOI 10.1007/BF03372244; SHAFFER JP, 1986, J AM STAT ASSOC, V81, P826, DOI 10.2307/2289016; Spector IP, 1996, J SEX MARITAL THER, V22, P175; Stippekohl B, 2012, PSYCHOPHARMACOLOGY, V222, P593, DOI 10.1007/s00213-012-2670-8; Tsujimura A, 2009, J SEX MED, V6, P1011, DOI 10.1111/j.1743-6109.2008.01031.x; Wehrum S, 2013, J SEX MED, V10, P1328, DOI 10.1111/jsm.12096; WRIGHT LW, 1994, J PSYCHOPATHOL BEHAV, V16, P221, DOI 10.1007/BF02229209; Wright LW, 1999, J SEX RES, V36, P145, DOI 10.1080/00224499909551979; Yiend J, 2010, COGNITION EMOTION, V24, P3, DOI 10.1080/02699930903205698; [No title captured], DOI DOI 10.1037/H0040995	52	35	35	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107795	10.1371/journal.pone.0107795	http://dx.doi.org/10.1371/journal.pone.0107795			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ0RY	25238545	Green Published, gold, Green Submitted			2022-12-25	WOS:000342491600049
J	Thorsen, K; Agafonov, O; Selsto, CH; Jolma, IW; Ni, XY; Drengstig, T; Ruoff, P				Thorsen, Kristian; Agafonov, Oleg; Selsto, Christina H.; Jolma, Ingunn W.; Ni, Xiao Y.; Drengstig, Tormod; Ruoff, Peter			Robust Concentration and Frequency Control in Oscillatory Homeostats	PLOS ONE			English	Article							CALCIUM OSCILLATIONS; TEMPERATURE-COMPENSATION; PERFECT ADAPTATION; CA2+ OSCILLATIONS; NEGATIVE FEEDBACK; P53; DYNAMICS; CLOCK; MODEL; IDENTIFICATION	Homeostatic and adaptive control mechanisms are essential for keeping organisms structurally and functionally stable. Integral feedback is a control theoretic concept which has long been known to keep a controlled variable A robustly (i.e. perturbation-independent) at a given set-point Aset by feeding the integrated error back into the process that generates A. The classical concept of homeostasis as robust regulation within narrow limits is often considered as unsatisfactory and even incompatible with many biological systems which show sustained oscillations, such as circadian rhythms and oscillatory calcium signaling. Nevertheless, there are many similarities between the biological processes which participate in oscillatory mechanisms and classical homeostatic (non-oscillatory) mechanisms. We have investigated whether biological oscillators can show robust homeostatic and adaptive behaviors, and this paper is an attempt to extend the homeostatic concept to include oscillatory conditions. Based on our previously published kinetic conditions on how to generate biochemical models with robust homeostasis we found two properties, which appear to be of general interest concerning oscillatory and homeostatic controlled biological systems. The first one is the ability of these oscillators ("oscillatory homeostats'') to keep the average level of a controlled variable at a defined set-point by involving compensatory changes in frequency and/or amplitude. The second property is the ability to keep the period/frequency of the oscillator tuned within a certain well-defined range. In this paper we highlight mechanisms that lead to these two properties. The biological applications of these findings are discussed using three examples, the homeostatic aspects during oscillatory calcium and p53 signaling, and the involvement of circadian rhythms in homeostatic regulation.	[Thorsen, Kristian; Drengstig, Tormod] Univ Stavanger, Dept Elect Engn & Comp Sci, Stavanger, Norway; [Agafonov, Oleg; Selsto, Christina H.; Jolma, Ingunn W.; Ni, Xiao Y.; Ruoff, Peter] Univ Stavanger, Ctr Organelle Res, Stavanger, Norway	Universitetet i Stavanger; Universitetet i Stavanger	Ruoff, P (corresponding author), Univ Stavanger, Ctr Organelle Res, Stavanger, Norway.	peter.ruoff@uis.no		Ruoff, Peter/0000-0003-4430-0382	Norwegian Research Council [167087/V40, 183085/S10]; Faculty of Science and Technology, University of Stavanger	Norwegian Research Council(Research Council of NorwayEuropean Commission); Faculty of Science and Technology, University of Stavanger	Funding provided by Grant no. 167087/V40 by Norwegian Research Council (http://www.forskningsradet.no) for IWJ and Grant no. 183085/S10 by Norwegian Research Council (http://www.forskningsradet.no) for XYN. This research was also funded by Program Area Fund "Organelle Biology" and the Program Area Fund "Biomedical data analysis group" from the Faculty of Science and Technology, University of Stavanger (https://www.uis.no/fakulteter-institutter-ogsentre/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U., 2006, INTRO SYSTEMS BIOL D; Andronov AA., 1966, THEORY OSCILLATORS; Ang J, 2013, BIOPHYS J, V104, P505, DOI 10.1016/j.bpj.2012.12.015; Ang J, 2010, J THEOR BIOL, V266, P723, DOI 10.1016/j.jtbi.2010.07.034; Asher G, 2002, P NATL ACAD SCI USA, V99, P3099, DOI 10.1073/pnas.052706799; B?nning E., 1963, PHYSL CLOCK; Bernard C., 1957, INTRO LIT CORRES TON; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2005, ANNU REV PHYSIOL, V67, P1, DOI 10.1146/annurev.physiol.67.040103.152647; BERRIDGE MJ, 1988, FASEB J, V2, P3074, DOI 10.1096/fasebj.2.15.2847949; Bird GS, 2005, J PHYSIOL-LONDON, V562, P697, DOI 10.1113/jphysiol.2004.077289; Bodalia A, 2013, ACTA PHARMACOL SIN, V34, P49, DOI 10.1038/aps.2012.139; Bonny O, 2009, CELL CYCLE, V8, P4015, DOI 10.4161/cc.8.24.10224; Cannon W.B., 1939, WISDOM BODY, DOI [10.1097/00000441-193907000-00031, DOI 10.1097/00000441-193907000-00031]; Cannon WB, 1929, PHYSIOL REV, V9, P399, DOI 10.1152/physrev.1929.9.3.399; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Cheng HP, 2008, PHYSIOL REV, V88, P1491, DOI 10.1152/physrev.00030.2007; Curtis H, 1957, BROOKHAVEN S BIOL; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Dowse H.B., 1987, Journal of Biological Rhythms, V2, P65, DOI 10.1177/074873048700200106; Drengstig T, 2012, BIOPHYS J, V103, P2000, DOI 10.1016/j.bpj.2012.09.033; Drengstig T, 2012, J PHYS CHEM B, V116, P5355, DOI 10.1021/jp3004568; Drengstig T, 2008, J PHYS CHEM B, V112, P16752, DOI 10.1021/jp806818c; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; DUPONT G, 1991, CELL CALCIUM, V12, P73, DOI 10.1016/0143-4160(91)90010-C; Edmunds LN, 1988, CELLULAR MOL BASES B; EISWIRTH M, 1991, ADV CHEM PHYS, V80, P127; El-Samad H, 2002, J THEOR BIOL, V214, P17, DOI 10.1006/jtbi.2001.2422; FRANCK UF, 1980, BER BUNSEN PHYS CHEM, V84, P334, DOI 10.1002/bbpc.19800840407; Fu W, 2009, J BIOL CHEM, V284, P13987, DOI 10.1074/jbc.M901758200; Galton VA, 2007, ENDOCRINOLOGY, V148, P3080, DOI 10.1210/en.2006-1727; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Geva-Zatorsky N, 2010, P NATL ACAD SCI USA, V107, P13550, DOI 10.1073/pnas.1001107107; Giacomello M, 2013, INT J BIOCHEM CELL B, V45, P753, DOI 10.1016/j.biocel.2012.09.016; GOLDBETER A, 1990, P NATL ACAD SCI USA, V87, P1461, DOI 10.1073/pnas.87.4.1461; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; Goldbeter A., 1996, BIOCH OSCILLATIONS C; Goodwin B., 1963, TEMPORAL ORG CELLS; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; GRIFFITH JS, 1968, J THEOR BIOL, V20, P202, DOI 10.1016/0022-5193(68)90189-6; Hancock J., 2010, CELL SIGNALLING; Heinrich R., 1996, REGULATION CELLULAR; HERS HG, 1990, J INHERIT METAB DIS, V13, P395, DOI 10.1007/BF01799497; HIGGINS J, 1967, IND ENG CHEM, V59, P18, DOI 10.1021/ie50689a006; Hong CI, 2007, P NATL ACAD SCI USA, V104, P1195, DOI 10.1073/pnas.0601378104; Huang YS, 2012, PLANT CELL ENVIRON, V35, P917, DOI 10.1111/j.1365-3040.2011.02462.x; Hughes GM, 1964, HOMEOSTASIS FEEDBACK; Ingalls B.P., 2006, SYSTEM MODELING CELL, P243; IWASAKI K, 1995, P NATL ACAD SCI USA, V92, P10317, DOI 10.1073/pnas.92.22.10317; Jeong J, 2009, TRENDS PLANT SCI, V14, P280, DOI 10.1016/j.tplants.2009.02.006; Jolma IW, 2010, BIOPHYS J, V98, P743, DOI 10.1016/j.bpj.2009.11.013; Katebi, 2002, CONTROL ENG INTRO CO; Knoke B, 2010, THEOR BIOSCI, V129, P25, DOI 10.1007/s12064-010-0080-1; Lahav G, 2008, ADV EXP MED BIOL, V641, P28; Langley L. L., 1973, HOMEOSTASIS ORIGINS; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lloyd D, 2001, ScientificWorldJournal, V1, P133; Lotka AJ, 1910, J PHYS CHEM-US, V14, P271, DOI 10.1021/j150111a004; Lotka AJ, 1920, J AM CHEM SOC, V42, P1595, DOI 10.1021/ja01453a010; Marks F, 2009, CELLULAR SIGNAL PROC; Maroto M., 2008, CELLULAR OSCILLATORY; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Miller AJ, 2008, ANN BOT-LONDON, V101, P485, DOI 10.1093/aob/mcm313; Milsum JH, 1966, BIOL CONTROL SYSTEMS; MOOREEDE MC, 1986, AM J PHYSIOL, V250, pR737, DOI 10.1152/ajpregu.1986.250.5.R737; Mrosovsky N., 1990, RHEOSTASIS PHYSL CHA; Ni XY, 2009, BIOPHYS J, V97, P1244, DOI 10.1016/j.bpj.2009.06.030; NOGGLE JH, 1996, PHYS CHEM; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; O'Dea EL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100148; Osundiji MA, 2013, ENDOCRIN METAB CLIN, V42, P1, DOI 10.1016/j.ecl.2012.11.006; Parekh AB, 2011, TRENDS BIOCHEM SCI, V36, P78, DOI 10.1016/j.tibs.2010.07.013; Politi A, 2006, BIOPHYS J, V90, P3120, DOI 10.1529/biophysj.105.072249; POWELL T, 1974, MED BIOL ENG, V12, P287, DOI 10.1007/BF02477793; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Putney JW, 2008, J PHYSIOL-LONDON, V586, P3055, DOI 10.1113/jphysiol.2008.153221; Radhakrishnan K., 1993, NASA REFERENCE PUBLI; Rensing L, 2002, CHRONOBIOL INT, V19, P807, DOI 10.1081/CBI-120014569; RUOFF P, 1994, NATURWISSENSCHAFTEN, V81, P456; RUOFF P, 1992, J INTERDISCIPL CYCLE, V23, P92, DOI 10.1080/09291019209360133; Savageau M, 1976, BIOCH SYSTEMS ANAL S; Schapira AHV, 2013, BRAIN, V136, P2015, DOI 10.1093/brain/awt180; Schulkin J., 2004, ALLOSTASIS HOMEOSTAS; Schuster S, 2002, EUR J BIOCHEM, V269, P1333, DOI 10.1046/j.0014-2956.2001.02720.x; Shuttleworth TJ, 1999, CELL CALCIUM, V25, P237, DOI 10.1054/ceca.1999.0022; Sneyd J, 2004, P NATL ACAD SCI USA, V101, P1392, DOI 10.1073/pnas.0303472101; Sontag E. D., 2004, Systems Biology, V1, P9, DOI 10.1049/sb:20045006; Sterling P., 1988, HDB LIFE STRESS COGN, P629, DOI DOI 10.1016/0005-7967(90)90076-U; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Thorsen K, 2014, AM J PHYSL IN PRESS; Thorsen K, 2013, INT CONF SYST SCI EN, P165, DOI 10.1109/ICSSE.2013.6614653; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Voit E. O., 2013, ISRN BIOMATH, V2013, P53, DOI [10.1155/2013/897658, DOI 10.1155/2013/897658]; von Bertalanffy L., 1975, PERSPECTIVES GEN SYS; Wiener N., 1954, HUMAN USE HUMAN BEIN; Wiener N., 1961, CYBERNETICS CONTROL, V2nd; WOODS NM, 1986, NATURE, V319, P600, DOI 10.1038/319600a0; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649; ZIMMERMAN WF, 1968, J INSECT PHYSIOL, V14, P669, DOI 10.1016/0022-1910(68)90226-6	101	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107766	10.1371/journal.pone.0107766	http://dx.doi.org/10.1371/journal.pone.0107766			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238410	Green Published, gold			2022-12-25	WOS:000342491600048
J	Zaramela, LS; Vencio, RZN; ten-Caten, F; Baliga, NS; Koide, T				Zaramela, Livia S.; Vencio, Ricardo Z. N.; ten-Caten, Felipe; Baliga, Nitin S.; Koide, Tie			Transcription Start Site Associated RNAs (TSSaRNAs) Are Ubiquitous in All Domains of Life	PLOS ONE			English	Article							REVEAL; BOX	A plethora of non-coding RNAs has been discovered using high-resolution transcriptomics tools, indicating that transcriptional and post-transcriptional regulation is much more complex than previously appreciated. Small RNAs associated with transcription start sites of annotated coding regions (TSSaRNAs) are pervasive in both eukaryotes and bacteria. Here, we provide evidence for existence of TSSaRNAs in several archaeal transcriptomes including: Halobacterium salinarum, Pyrococcus furiosus, Methanococcus maripaludis, and Sulfolobus solfataricus. We validated TSSaRNAs from the model archaeon Halobacterium salinarum NRC-1 by deep sequencing two independent small-RNA enriched (RNA-seq) and a primary-transcript enriched (dRNA-seq) strand-specific libraries. We identified 652 transcripts, of which 179 were shown to be primary transcripts (similar to 7% of the annotated genome). Distinct growth-associated expression patterns between TSSaRNAs and their cognate genes were observed, indicating a possible role in environmental responses that may result from RNA polymerase with varying pausing rhythms. This work shows that TSSaRNAs are ubiquitous across all domains of life.	[Zaramela, Livia S.; ten-Caten, Felipe; Koide, Tie] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biochem & Immunol, BR-14049 Ribeirao Preto, Brazil; [Vencio, Ricardo Z. N.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil; [Baliga, Nitin S.] Inst Syst Biol, Seattle, WA USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Institute for Systems Biology (ISB)	Koide, T (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biochem & Immunol, BR-14049 Ribeirao Preto, Brazil.	tkoide@fmrp.usp.br	Caten, Felipe ten/O-8235-2018; Zaramela, Lívia Soares/AAD-2687-2022; Koide, Tie/D-4406-2014	Caten, Felipe ten/0000-0001-7771-1490; Zaramela, Lívia Soares/0000-0002-1065-3799; baliga, nitin/0000-0001-9157-5974; Koide, Tie/0000-0003-4760-2423	Projeto Jovem Pesquisador em Centros Emergentes da Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [09/09532-0]; Edital Universal do Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [473660/2013-0, 470120/2009-6, 476724/2013-9]; Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA) [1640/2009]; Nucleo de Pesquisa em Ciencia Genomica (NAP-CG) da Universidade de Sao Paulo; FAPESP [11/07487-7, 11/14455-4]	Projeto Jovem Pesquisador em Centros Emergentes da Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Edital Universal do Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA); Nucleo de Pesquisa em Ciencia Genomica (NAP-CG) da Universidade de Sao Paulo; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Projeto Jovem Pesquisador em Centros Emergentes da Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, http://fapesp.br/en/) [09/09532-0 to TK]; Edital Universal do Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [473660/2013-0 to TK, 470120/2009-6 to TK, 476724/2013-9 to RZNV]; Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA) [1640/2009 to TK]; Nucleo de Pesquisa em Ciencia Genomica (NAP-CG) da Universidade de Sao Paulo; and fellowships FAPESP [11/07487-7 to LSZ and 11/14455-4 to FC]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amman F, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-89; Ammar R, 2012, ELIFE, V1, DOI 10.7554/eLife.00078; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baliga NS, 1999, J BACTERIOL, V181, P2513, DOI 10.1128/JB.181.8.2513-2518.1999; Bare JC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-382; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Buckley MS, 2014, GENE DEV, V28, P14, DOI 10.1101/gad.231886.113; Chan PP, 2012, NUCLEIC ACIDS RES, V40, pD646, DOI 10.1093/nar/gkr990; Chen ZJ, 2012, ENV MICROBIOL REP, V4, P633, DOI 10.1111/j.1758-2229.2012.00389.x; Cserzo M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-56; Gong H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002120; Henriques T, 2013, MOL CELL, P1; Hot D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-207; Jager D, 2009, P NATL ACAD SCI USA, V106, P21878, DOI 10.1073/pnas.0909051106; Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407; Jorjani H, 2014, BIOINFORMATICS, V30, P971, DOI 10.1093/bioinformatics/btt752; Koide T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.42; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lease RA, 2004, J BACTERIOL, V186, P6179, DOI 10.1128/JB.186.18.6179-6185.2004; Lucas A, 2006, GENERFOLD R GENES SE; Martens B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076569; Pfeiffer F, 2008, ARCH MICROBIOL, V190, P281, DOI 10.1007/s00203-008-0389-z; Randau L, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r63; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Stern DL, 2013, NAT REV GENET, V14, P751, DOI 10.1038/nrg3483; Su AAH, 2013, NUCLEIC ACIDS RES, V41, P6250, DOI 10.1093/nar/gkt317; Taft RJ, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-13; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Toffano-Nioche C, 2013, RNA BIOL, V10, P1211, DOI 10.4161/rna.25567; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109; Yoon SH, 2011, GENOME RES, V21, P1892, DOI 10.1101/gr.122218.111; Yus E, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.16	35	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107680	10.1371/journal.pone.0107680	http://dx.doi.org/10.1371/journal.pone.0107680			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238539	Green Submitted, Green Published, gold			2022-12-25	WOS:000342491600041
J	Schwarzer, A; Holtmann, H; Brugman, M; Meyer, J; Schauerte, C; Zuber, J; Steinemann, D; Schlegelberger, B; Li, Z; Baum, C				Schwarzer, A.; Holtmann, H.; Brugman, M.; Meyer, J.; Schauerte, C.; Zuber, J.; Steinemann, D.; Schlegelberger, B.; Li, Z.; Baum, C.			Hyperactivation of mTORC1 and mTORC2 by multiple oncogenic events causes addiction to eIF4E-dependent mRNA translation in T-cell leukemia	ONCOGENE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; GLUCOCORTICOID RESISTANCE; STEM-CELLS; COMPLEX 2; C-MYC; PTEN; ACTIVATION; PATHWAY; AKT; INHIBITION	High activation of the PI3K-AKT-mTOR pathway is characteristic for T-cell acute lymphoblastic leukemia (T-ALL). The activity of the master regulator of this pathway, PTEN, is often impaired in T-ALL. However, experimental evidence suggests that input from receptor tyrosine kinases (RTKs) is required for sustained mTOR activation, even in the absence of PTEN. We previously reported the expression of Neurotrophin receptor tyrosine kinases (TRKs) and their respective ligands in primary human leukemia samples. In the present study we aimed to dissect the downstream signaling cascades of TRK-induced T-ALL in a murine model and show that T-ALLs induced by deregulated receptor tyrosine kinase signaling acquire activating mutations in Notch1 and lose PTEN during clonal evolution. Some clones additionally lost one allele of the homeodomain transcription factor Cux1. All events independently led to a gradual hyperactivation of both mTORC1 and mTORC2 signaling. We dissected the role of the individual mTOR complexes by shRNA knockdown and found that the separate depletion of mTORC1 or mTORC2 reduced the growth of T-ALL blasts, but was not sufficient to induce apoptosis. In contrast, knockdown of the mTOR downstream effector eIF4E caused a striking cytotoxic effect, demonstrating a critical addiction to cap-dependent mRNA-translation. Although high mTORC2-AKT activation is commonly associated with drug-resistance, we demonstrate that T-ALL displaying a strong mTORC2-AKT activation were specifically susceptible to 4EGI-1, an inhibitor of the eIF4E-eIF4G interaction. To decipher the mechanism of 4EGI-1, we performed a genome-wide analysis of mRNAs that are translationally regulated by 4EGI-1 in T-ALL. 4EGI-1 effectively reduced the ribosomal occupancy of mRNAs that were strongly upregulated in T-ALL blasts compared with normal thymocytes including transcripts important for translation, mitochondria and cell cycle progression, such as cyclins and ribosomal proteins. These data suggest that disrupting the eIF4E-eIF4G interaction constitutes a promising therapy strategy in mTOR-deregulated T-cell leukemia.	[Schwarzer, A.; Brugman, M.; Meyer, J.; Li, Z.; Baum, C.] Hannover Med Sch, Inst Expt Hematol, D-30625 Hannover, Germany; [Holtmann, H.; Schauerte, C.] Hannover Med Sch, Inst Biochem, D-30625 Hannover, Germany; [Zuber, J.] Res Inst Mol Pathol IMP, Vienna, Austria; [Steinemann, D.; Schlegelberger, B.] Hannover Med Sch, Inst Cell & Mol Pathol, D-30625 Hannover, Germany	Hannover Medical School; Hannover Medical School; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Hannover Medical School	Schwarzer, A (corresponding author), Hannover Med Sch, Inst Expt Hematol, OE6960,Carl Neuberg Str 1, D-30625 Hannover, Germany.	schwarzer.adrian@mh-hannover.de	Brugman, Martijn/F-3389-2011; Schwarzer, Adrian/AAA-2571-2022; Zuber, Johannes/E-7517-2011	Brugman, Martijn/0000-0003-2675-2705; Zuber, Johannes/0000-0001-8810-6835; Schwarzer, Adrian/0000-0001-5684-2280	Hannover Biomedical Research School (HBRS); MD-PhD program 'Molecular Medicine'; Deutsche Krebshilfe [108245, 109800]; Deutsche Jose Carreras Leukamie-Stiftung [DJCLS F10/06]; Deutsche Forschungsgemeinschaft [Li 1608/2-1, SFB738]; DFG-Cluster of Excellence REBIRTH	Hannover Biomedical Research School (HBRS); MD-PhD program 'Molecular Medicine'; Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Jose Carreras Leukamie-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG-Cluster of Excellence REBIRTH	AS was supported by the Hannover Biomedical Research School (HBRS) and the MD-PhD program 'Molecular Medicine'. We thank Dr Jan Cools, Center for Human Genetics, KULeuven, Leuven for the MOHITO cell line. We thank Dr Phillip Ivanyi and Professor Anke Franzke, Department of Hematology, MHH for providing human T-ALL cell lines. We thank Rena-Mareike Struss, Institute of Experimental Hematology, Hannover Medical School for help with mouse experiments and Anneke Doerrie, Institute of Biochemistry, for assistance in polysome profiling experiments. We thank Axel Schambach, Institute of Experimental Hematology, for providing pRSF91. IRES. dTomato and pRRL.PPT.SF.IRES.EGFP. WPRE vectors. We thank Thomas Neumann and Maike Stahlhut for performing the microarray experiments. We thank the Cell Sorting Unit of Hannover Medical School for performing sorting experiments and Michael Morgan for proofreading the manuscript. This work was supported by the Deutsche Krebshilfe (grants: 108245 and 109800), the Deutsche Jose Carreras Leukamie-Stiftung (grant: DJCLS F10/06), the Deutsche Forschungsgemeinschaft (grants: Li 1608/2-1 and SFB738) and the DFG-Cluster of Excellence REBIRTH.	Ashworth TD, 2010, BLOOD, V116, P5455, DOI 10.1182/blood-2010-05-286328; Aster JC, 2008, ANNU REV PATHOL-MECH, V3, P587, DOI 10.1146/annurev.pathmechdis.3.121806.154300; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Blackburn JS, 2014, CANCER CELL, V25, P366, DOI 10.1016/j.ccr.2014.01.032; Bonnet M, 2011, BLOOD, V117, P6650, DOI 10.1182/blood-2011-02-336842; Chan SM, 2007, BLOOD, V110, P278, DOI 10.1182/blood-2006-08-039883; Chen LM, 2012, ONCOTARGET, V3, P869, DOI 10.18632/oncotarget.598; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Clappier E, 2011, J EXP MED, V208, P653, DOI 10.1084/jem.20110105; Curry NL, 2013, CANCER DISCOV, V3, P908, DOI 10.1158/2159-8290.CD-12-0507; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Dello Sbarba P, 2014, HYPOXIA, V2, P1; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Gokbuget N, 2012, BLOOD, V120, P2032, DOI 10.1182/blood-2011-12-399287; Graeber TG, 2001, NAT GENET, V29, P295, DOI 10.1038/ng755; Gutierrez A, 2011, J EXP MED, V208, P1595, DOI 10.1084/jem.20101691; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Jo OD, 2008, J BIOL CHEM, V283, P23274, DOI 10.1074/jbc.M801185200; Kleppe M, 2011, HAEMATOL-HEMATOL J, V96, P779, DOI 10.3324/haematol.2010.035931; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Larsson O, 2011, BIOINFORMATICS, V27, P1440, DOI 10.1093/bioinformatics/btr146; Lee JY, 2010, CELL STEM CELL, V7, P593, DOI 10.1016/j.stem.2010.09.015; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Lee K, 2012, J EXP MED, V209, P713, DOI 10.1084/jem.20111470; Li ZX, 2009, BLOOD, V113, P2028, DOI 10.1182/blood-2008-05-155200; Lin CJ, 2012, CELL REPORTS, V1, P325, DOI 10.1016/j.celrep.2012.02.010; Meyer J, 2007, LEUKEMIA, V21, P2171, DOI 10.1038/sj.leu.2404882; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Mulloy JC, 2005, P NATL ACAD SCI USA, V102, P4016, DOI 10.1073/pnas.0404701102; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Pearse RN, 2005, BLOOD, V105, P4429, DOI 10.1182/blood-2004-08-3096; Piovan E, 2013, CANCER CELL, V24, P766, DOI 10.1016/j.ccr.2013.10.022; RAMSAY G, 1984, P NATL ACAD SCI-BIOL, V81, P7742, DOI 10.1073/pnas.81.24.7742; Ren MQ, 2009, BLOOD, V114, P1576, DOI 10.1182/blood-2009-03-212704; Renne C, 2008, LEUKEMIA RES, V32, P163, DOI 10.1016/j.leukres.2007.05.019; Rhein M, 2011, ANN HEMATOL, V90, P283, DOI 10.1007/s00277-010-1065-3; Schatz JH, 2011, J EXP MED, V208, P1799, DOI 10.1084/jem.20110846; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Silva A, 2008, J CLIN INVEST, V118, P3762, DOI 10.1172/JCI34616; Soulier J, 2005, BLOOD, V106, P274, DOI 10.1182/blood-2004-10-3900; Subramaniam PS, 2012, CANCER CELL, V21, P459, DOI 10.1016/j.ccr.2012.02.029; Tamburini J, 2009, BLOOD, V114, P1618, DOI 10.1182/blood-2008-10-184515; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Trinquand A, 2013, J CLIN ONCOL, V31, P4333, DOI 10.1200/JCO.2012.48.5292; van Vlierberghe P, 2008, BRIT J HAEMATOL, V143, P153, DOI 10.1111/j.1365-2141.2008.07314.x; Wasag B, 2011, HAEMATOL-HEMATOL J, V96, P922, DOI 10.3324/haematol.2010.036558; Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wong CC, 2014, NAT GENET, V46, P33, DOI 10.1038/ng.2846	55	18	19	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2015	34	27					3593	3604		10.1038/onc.2014.290	http://dx.doi.org/10.1038/onc.2014.290			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM1IQ	25241901				2022-12-25	WOS:000357434900011
J	Barta, ML; Thomas, K; Yuan, HL; Lovell, S; Battaile, KP; Schramm, VL; Hefty, PS				Barta, Michael L.; Thomas, Keisha; Yuan, Hongling; Lovell, Scott; Battaile, Kevin P.; Schramm, Vern L.; Hefty, P. Scott			Structural and Biochemical Characterization of Chlamydia trachomatis Hypothetical Protein CT263 Supports That Menaquinone Synthesis Occurs through the Futalosine Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chlamydia; Crystallography; Enzyme Kinetics; Quinone; Respiration	TRANSITION-STATE ANALOGS; ESCHERICHIA-COLI; 5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE; I-TASSER; ELECTRON-TRANSPORT; ENZYME; BIOSYNTHESIS; HELICOBACTER; INHIBITOR; SEQUENCE	The obligate intracellular human pathogen Chlamydia trachomatis is the etiological agent of blinding trachoma and sexually transmitted disease. Genomic sequencing of Chlamydia indicated this medically important bacterium was not exclusively dependent on the host cell for energy. In order for the electron transport chain to function, electron shuttling between membrane-embedded complexes requires lipid-soluble quinones (e.g. menaquionone or ubiquinone). The sources or biosynthetic pathways required to obtain these electron carriers within C. trachomatis are poorly understood. The 1.58 angstrom crystal structure of C. trachomatis hypothetical protein CT263 presented here supports a role in quinone biosynthesis. Although CT263 lacks sequence-based functional annotation, the crystal structure of CT263 displays striking structural similarity to 5-methylthioadenosine nucleosidase (MTAN) enzymes. Although CT263 lacks the active site-associated dimer interface found in prototypical MTANs, co-crystal structures with product (adenine) or substrate (5-methylthioadenosine) indicate that the canonical active site residues are conserved. Enzymatic characterization of CT263 indicates that the futalosine pathway intermediate 6-amino-6-deoxyfutalosine (k(cat)/K-m = 1.8 x 10(3) m(-1) s(-1)), but not the prototypical MTAN substrates (e.g. S-adenosylhomocysteine and 5-methylthioadenosine), is hydrolyzed. Bioinformatic analyses of the chlamydial proteome also support the futalosine pathway toward the synthesis of menaquinone in Chlamydiaceae. This report provides the first experimental support for quinone synthesis in Chlamydia. Menaquinone synthesis provides another target for agents to combat C. trachomatis infection.	[Barta, Michael L.; Hefty, P. Scott] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Thomas, Keisha; Yuan, Hongling; Schramm, Vern L.] Yeshiva Univ, Dept Biochem, Albert Einstein Coll Med, Bronx, NY 10461 USA; [Lovell, Scott] Univ Kansas, Del Shankel Struct Biol Ctr, Prot Struct Lab, Lawrence, KS 66047 USA; [Battaile, Kevin P.] Hauptman Woodward Med Res Inst, Ind Macromol Crystallog Assoc, Collaborat Access Team, Argonne, IL 60439 USA	University of Kansas; Yeshiva University; Albert Einstein College of Medicine; University of Kansas; Hauptman Woodward Medical Research Institute	Hefty, PS (corresponding author), Univ Kansas, 1200 Sunnyside Ave, Lawrence, KS 66045 USA.	pshefty@ku.edu		Battaile, Kevin/0000-0003-0833-3259	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Hauptman-Woodward Medical Research Institute; National Institutes of Health from the NCRR [5P20RR017708-10]; National Institutes of Health from NIGMS [8 P20 GM103420-10]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041916, P30GM110761, R37GM041916, P20GM103420] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Hauptman-Woodward Medical Research Institute; National Institutes of Health from the NCRR; National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contact DE-AC02-06CH11357 and use of the IMCA-CAT beamline 17-ID by the companies of the Industrial Macromolecular Crystallography Association through a contract with the Hauptman-Woodward Medical Research Institute. Use of the COBRE-PSF Protein Structure Laboratory at Kansas University was supported by National Institutes of Health Grant 5P20RR017708-10 from the NCRR and Grant 8 P20 GM103420-10 from the NIGMS. We acknowledge the proteomics facility at Albert Einstein College of Medicine for conducting the mass spectroscopy analysis. We thank Brandon L. Garcia for critical reading and discussion of the manuscript. We thank Liang Tang and Haiyan Zhao for assistance with analytical size exclusion chromatography analysis.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; Allart B, 1998, EUR J BIOCHEM, V256, P155, DOI 10.1046/j.1432-1327.1998.2560155.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; BEATTY WL, 1994, MICROBIOL REV, V58, P686, DOI 10.1128/MMBR.58.4.686-699.1994; BENTLEY R, 1982, MICROBIOL REV, V46, P241, DOI 10.1128/MMBR.46.3.241-280.1982; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Binet R, 2011, MBIO, V2, DOI 10.1128/mBio.00051-11; Bonner CA, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00017; Brooijmans R, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-28; Choi-Rhee EJ, 2005, CHEM BIOL, V12, P589, DOI 10.1016/j.chembiol.2005.04.012; Collingro A, 2011, MOL BIOL EVOL, V28, P3253, DOI 10.1093/molbev/msr161; Dairi T, 2009, J ANTIBIOT, V62, P347, DOI 10.1038/ja.2009.46; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans P, 2012, SCIENCE, V336, P986, DOI 10.1126/science.1222162; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Furie B, 1999, BLOOD, V93, P1798, DOI 10.1182/blood.V93.6.1798.406k22_1798_1808; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gutierrez JA, 2009, NAT CHEM BIOL, V5, P251, DOI 10.1038/nchembio.153; Haapalainen AM, 2013, STRUCTURE, V21, P963, DOI 10.1016/j.str.2013.04.009; Hiratsuka T, 2008, SCIENCE, V321, P1670, DOI 10.1126/science.1160446; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Juul N, 2007, J BACTERIOL, V189, P6723, DOI 10.1128/JB.00279-07; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kim RQ, 2014, ACTA CRYSTALLOGR D, V70, P177, DOI 10.1107/S1399004713026655; Kurosu M, 2010, MOLECULES, V15, P1531, DOI 10.3390/molecules15031531; Lee JE, 2005, J MOL BIOL, V352, P559, DOI 10.1016/j.jmb.2005.07.027; Lee JE, 2005, J BIOL CHEM, V280, P18274, DOI 10.1074/jbc.M414471200; Lee JE, 2003, J BIOL CHEM, V278, P8761, DOI 10.1074/jbc.M210836200; Lee JE, 2001, STRUCTURE, V9, P941, DOI 10.1016/S0969-2126(01)00656-6; Meganathan R, 2001, VITAM HORM, V61, P173; MILLER CH, 1968, J BIOL CHEM, V243, P92; Mishra V, 2012, BIOCHEMISTRY-US, V51, P9763, DOI 10.1021/bi301221k; Omsland A, 2014, FEMS MICROBIOL REV, V38, P779, DOI 10.1111/1574-6976.12059; Omsland A, 2012, P NATL ACAD SCI USA, V109, P19781, DOI 10.1073/pnas.1212831109; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; PAJULA RL, 1979, FEBS LETT, V99, P343, DOI 10.1016/0014-5793(79)80988-6; Parveen N, 2011, MOL MICROBIOL, V79, P7, DOI 10.1111/j.1365-2958.2010.07455.x; RAGIONE ED, 1985, BIOCHEM J, V232, P335, DOI 10.1042/bj2320335; RAINA A, 1982, BIOCHEM J, V204, P697, DOI 10.1042/bj2040697; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Ronning DR, 2010, PROTEIN SCI, V19, P2498, DOI 10.1002/pro.524; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Singh V, 2005, BIOCHEMISTRY-US, V44, P11647, DOI 10.1021/bi050863a; Siu KKW, 2008, ACTA CRYSTALLOGR F, V64, P343, DOI 10.1107/S1744309108009275; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Sturm MB, 2009, ANAL CHEM, V81, P2847, DOI 10.1021/ac8026433; SUFRIN JR, 1995, ANTIMICROB AGENTS CH, V39, P2511, DOI 10.1128/AAC.39.11.2511; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; Wang SZ, 2012, BIOCHEMISTRY-US, V51, P6892, DOI 10.1021/bi3009664; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Yu CM, 2006, J CHROMATOGR A, V1132, P99, DOI 10.1016/j.chroma.2006.07.017; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zeyhle P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099122; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588; Zhi XY, 2014, GENOME BIOL EVOL, V6, P149, DOI 10.1093/gbe/evu007	69	13	13	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32214	32229		10.1074/jbc.M114.594325	http://dx.doi.org/10.1074/jbc.M114.594325			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25253688	Green Published, hybrid			2022-12-25	WOS:000345314700048
J	Auer, M; Nicolussi, A; Schutz, G; Furtmuller, PG; Obinger, C				Auer, Markus; Nicolussi, Andrea; Schuetz, Georg; Furtmueller, Paul G.; Obinger, Christian			How Covalent Heme to Protein Bonds Influence the Formation and Reactivity of Redox Intermediates of a Bacterial Peroxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELOPEROXIDASE COMPOUND-I; MAMMALIAN PEROXIDASES; EOSINOPHIL PEROXIDASE; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; LACTOPEROXIDASE; LINKAGE; OXIDATION; KINETICS; BINDING	The most striking feature of mammalian peroxidases, including myeloperoxidase and lactoperoxidase (LPO) is the existence of covalent bonds between the prosthetic group and the protein, which has a strong impact on their (electronic) structure and biophysical and chemical properties. Recently, a novel bacterial heme peroxidase with high structural and functional similarities to LPO was described. Being released from Escherichia coli, it contains mainly heme b, which can be autocatalytically modified and covalently bound to the protein by incubation with hydrogen peroxide. In the present study, we investigated the reactivity of these two forms in their ferric, compound I and compound II state in a multi-mixing stopped-flow study. Upon heme modification, the reactions between the ferric proteins with cyanide or H2O2 were accelerated. Moreover, apparent bimolecular rate constants of the reaction of compound I with iodide, thiocyanate, bromide, and tyrosine increased significantly and became similar to LPO. Kinetic data are discussed and compared with known structure-function relationships of the mammalian peroxidases LPO and myeloperoxidase.	[Auer, Markus; Nicolussi, Andrea; Schuetz, Georg; Furtmueller, Paul G.; Obinger, Christian] Univ Nat Resources & Life Sci, Vienna Inst BioTechnol, Div Biochem, Dept Chem, A-1190 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna	Furtmuller, PG (corresponding author), Univ Nat Resources & Life Sci, Vienna Inst BioTechnol, Div Biochem, Dept Chem, Muthgasse 18, A-1190 Vienna, Austria.	paul.furtmueller@boku.ac.at; christian.obinger@boku.ac.at	Obinger, Christian/AAV-3173-2021; Furtmüller, Paul G./Y-5819-2018	Furtmüller, Paul G./0000-0002-1199-2469; Obinger, Christian/0000-0002-7133-3430	Austrian Science Fund [P20664, P25270]; Doctoral Program BioToP-Biomolecular Technology of Proteins [FWF W1224]	Austrian Science Fund(Austrian Science Fund (FWF)); Doctoral Program BioToP-Biomolecular Technology of Proteins	This work was supported by Austrian Science Fund Projects P20664 and P25270 and the Doctoral Program BioToP-Biomolecular Technology of Proteins (FWF W1224).	Arnhold J, 2006, EUR J INORG CHEM, P3801, DOI 10.1002/ejic.200600436; Auer M, 2013, J BIOL CHEM, V288, P27181, DOI 10.1074/jbc.M113.477067; Banerjee S, 2011, BIOTECHNOL J, V6, P231, DOI 10.1002/biot.201000375; Battistuzzi G, 2011, BIOCHEMISTRY-US, V50, P7987, DOI [10.1021/bi20084321, 10.1021/bi2008432]; Battistuzzi G, 2010, ARCH BIOCHEM BIOPHYS, V500, P21, DOI 10.1016/j.abb.2010.03.002; Battistuzzi G, 2010, ARCH BIOCHEM BIOPHYS, V494, P72, DOI 10.1016/j.abb.2009.11.021; Blair-Johnson M, 2001, BIOCHEMISTRY-US, V40, P13990, DOI 10.1021/bi0111808; BOLSCHER BGJM, 1984, BIOCHIM BIOPHYS ACTA, V788, P1, DOI 10.1016/0167-4838(84)90290-5; Brogioni S, 2008, BBA-PROTEINS PROTEOM, V1784, P843, DOI 10.1016/j.bbapap.2008.02.014; Carpena X, 2009, J BIOL CHEM, V284, P25929, DOI 10.1074/jbc.M109.002154; Colas C, 2002, J BIOL CHEM, V277, P7191, DOI 10.1074/jbc.M109523200; DePillis GD, 1997, J BIOL CHEM, V272, P8857; DOLMAN D, 1968, BIOCHEMISTRY-US, V7, P3991, DOI 10.1021/bi00851a028; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Furtmuller PG, 2000, FEBS LETT, V484, P139, DOI 10.1016/S0014-5793(00)02143-8; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Furtmuller PG, 2002, BIOCHEMISTRY-US, V41, P11895, DOI 10.1021/bi026326x; Furtmuller PG, 2000, BIOCHEMISTRY-US, V39, P15578, DOI 10.1021/bi0020271; Furtmuller PG, 1998, BIOCHEMISTRY-US, V37, P17923, DOI 10.1021/bi9818772; HARRIMAN A, 1987, J PHYS CHEM-US, V91, P6102, DOI 10.1021/j100308a011; Jantschko W, 2002, ARCH BIOCHEM BIOPHYS, V398, P12, DOI 10.1006/abbi.2001.2674; Lardinois OM, 1999, J BIOL CHEM, V274, P35441, DOI 10.1074/jbc.274.50.35441; MARQUEZ LA, 1994, BIOCHEMISTRY-US, V33, P1447, DOI 10.1021/bi00172a022; Marquez LA, 1995, J BIOL CHEM, V270, P30434, DOI 10.1074/jbc.270.51.30434; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Oxvig C, 1999, J BIOL CHEM, V274, P16953, DOI 10.1074/jbc.274.24.16953; Singh AK, 2008, J MOL BIOL, V376, P1060, DOI 10.1016/j.jmb.2007.12.012; Zamocky M, 2008, PROTEINS, V72, P589, DOI 10.1002/prot.21950; Zederbauer M, 2005, BIOCHEMISTRY-US, V44, P6482, DOI 10.1021/bi0501737; Zederbauer M, 2007, NAT PROD REP, V24, P571, DOI 10.1039/b604178g; Zederbauer M, 2007, J BIOL CHEM, V282, P17041, DOI 10.1074/jbc.M610685200; Zederbauer M, 2007, BIOCHEM BIOPH RES CO, V356, P450, DOI 10.1016/j.bbrc.2007.02.157	32	13	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31480	31491		10.1074/jbc.M114.595157	http://dx.doi.org/10.1074/jbc.M114.595157			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25246525	Green Published, hybrid			2022-12-25	WOS:000344549900050
J	Kwa, MQ; Huynh, J; Aw, J; Zhang, LY; Nguyen, T; Reynolds, EC; Sweet, MJ; Hamilton, JA; Scholz, GM				Kwa, Mei Qi; Huynh, Jennifer; Aw, Jiamin; Zhang, Lianyi; Thao Nguyen; Reynolds, Eric C.; Sweet, Matthew J.; Hamilton, John A.; Scholz, Glen M.			Receptor-interacting Protein Kinase 4 and Interferon Regulatory Factor 6 Function as a Signaling Axis to Regulate Keratinocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; POPLITEAL PTERYGIUM SYNDROME; C-ASSOCIATED KINASE; HUMAN EPIDERMAL-KERATINOCYTES; AUTOSOMAL-RECESSIVE FORM; BARTSOCAS-PAPAS SYNDROME; SQUAMOUS-CELL CARCINOMA; TRANSCRIPTION FACTORS; GENE-EXPRESSION; PKC-DELTA	Receptor-interacting protein kinase 4 (RIPK4) and interferon regulatory factor 6 (IRF6) are critical regulators of keratinocyte differentiation, and their mutation causes the related developmental epidermal disorders Bartsocas-Papas syndrome and popliteal pterygium syndrome, respectively. However, the signaling pathways in which RIPK4 and IRF6 operate to regulate keratinocyte differentiation are poorly defined. Here we identify and mechanistically define a direct functional relationship between RIPK4 and IRF6. Gene promoter reporter and in vitro kinase assays, coimmunoprecipitation experiments, and confocal microscopy demonstrated that RIPK4 directly regulates IRF6 trans-activator activity and nuclear translocation. Gene knockdown and overexpression studies indicated that the RIPK4-IRF6 signaling axis controls the expression of key transcriptional regulators of keratinocyte differentiation, including Grainyhead-like 3 and OVO-like 1. Additionally, we demonstrate that the p.Ile121Asn missense mutation in RIPK4, which has been identified recently in Bartsocas-Papas syndrome, inhibits its kinase activity, thereby preventing RIPK4-mediated IRF6 activation and nuclear translocation. We show, through mutagenesis-based experiments, that Ser-413 and Ser-424 in IRF6 are important for its activation by RIPK4. RIPK4 is also important for the regulation of IRF6 expression by the protein kinase C pathway. Therefore, our findings not only provide important mechanistic insights into the regulation of keratinocyte differentiation by RIPK4 and IRF6, but they also suggest one mechanism by which mutations in RIPK4 may cause epidermal disorders (e.g. Bartsocas-Papas syndrome), namely by the impaired activation of IRF6 by RIPK4.	[Kwa, Mei Qi; Huynh, Jennifer; Aw, Jiamin; Zhang, Lianyi; Reynolds, Eric C.; Scholz, Glen M.] Univ Melbourne, Melbourne Dent Sch, Oral Hlth Cooperat Res Ctr, Melbourne, Vic 3010, Australia; [Kwa, Mei Qi; Huynh, Jennifer; Aw, Jiamin; Zhang, Lianyi; Reynolds, Eric C.; Scholz, Glen M.] Univ Melbourne, Bio21 Inst, Melbourne, Vic 3010, Australia; [Kwa, Mei Qi; Huynh, Jennifer; Thao Nguyen; Hamilton, John A.; Scholz, Glen M.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3010, Australia; [Sweet, Matthew J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Sweet, Matthew J.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia	University of Melbourne; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; University of Queensland; University of Queensland	Scholz, GM (corresponding author), Univ Melbourne, Melbourne Dent Sch, Melbourne, Vic 3010, Australia.	glenms@unimelb.edu.au	Zhang, Lianyi/H-7491-2014; Nguyen, Thao/GWN-0419-2022; Sweet, Matthew J/F-2229-2011; Kwa, Mei/I-6802-2018	Sweet, Matthew J/0000-0002-0406-8139; Kwa, Mei/0000-0001-8890-3391; Hamilton, John A/0000-0002-9493-9224; Reynolds, Eric/0000-0002-6618-4856; Scholz, Glen/0000-0003-2722-6344	National Health and Medical Research Council Project [628769]; Oral Health CRC	National Health and Medical Research Council Project(National Health and Medical Research Council (NHMRC) of Australia); Oral Health CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was supported by National Health and Medical Research Council Project Grant 628769 and the Oral Health CRC.	Adhikary G, 2010, J INVEST DERMATOL, V130, P2017, DOI 10.1038/jid.2010.108; Bahr C, 2000, J BIOL CHEM, V275, P36350, DOI 10.1074/jbc.M004771200; BARTSOCAS CS, 1972, J MED GENET, V9, P222, DOI 10.1136/jmg.9.2.222; Biggs LC, 2012, J INVEST DERMATOL, V132, P50, DOI 10.1038/jid.2011.272; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Botti E, 2011, P NATL ACAD SCI USA, V108, P13710, DOI 10.1073/pnas.1110931108; Bushdid PB, 1998, NATURE, V392, P615, DOI 10.1038/33435; Chen LJ, 2001, J BIOL CHEM, V276, P21737, DOI 10.1074/jbc.M008069200; Chew YC, 2013, J BIOL CHEM, V288, P17759, DOI 10.1074/jbc.M113.477133; Chew YC, 2011, J BIOL CHEM, V286, P28772, DOI 10.1074/jbc.M110.205245; de la Garza G, 2013, J INVEST DERMATOL, V133, P68, DOI 10.1038/jid.2012.269; Denning MF, 2004, INT J BIOCHEM CELL B, V36, P1141, DOI 10.1016/j.biocel.2003.12.004; Deucher A, 2002, J BIOL CHEM, V277, P17032, DOI 10.1074/jbc.M109076200; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; DLUGOSZ AA, 1994, J INVEST DERMATOL, V102, P409, DOI 10.1111/1523-1747.ep12372171; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; FUCHS E, 1988, TRENDS GENET, V4, P277, DOI 10.1016/0168-9525(88)90169-2; GORLIN RJ, 1968, PEDIATRICS, V41, P503; Gugasyan R, 2004, MOL CELL BIOL, V24, P5733, DOI 10.1128/MCB.24.13.5733-5745.2004; HENNEKAM RCM, 1994, AM J MED GENET, V53, P102, DOI 10.1002/ajmg.1320530203; Holland PM, 2002, CURR BIOL, V12, P1424, DOI 10.1016/S0960-9822(02)01075-8; Hopkin AS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002829; Huang XD, 2013, SCIENCE, V339, P1441, DOI 10.1126/science.1232253; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Kalay E, 2012, AM J HUM GENET, V90, P76, DOI 10.1016/j.ajhg.2011.11.014; Kanegae Y, 1998, NATURE, V392, P611, DOI 10.1038/33429; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Kwa MQ, 2014, J BIOL CHEM, V289, P19758, DOI 10.1074/jbc.M114.584540; Luscher B, 2012, EUR J CELL BIOL, V91, P506, DOI 10.1016/j.ejcb.2011.07.005; Madison KC, 2003, J INVEST DERMATOL, V121, P231, DOI 10.1046/j.1523-1747.2003.12359.x; MATSUI MS, 1992, J INVEST DERMATOL, V99, P565, DOI 10.1111/1523-1747.ep12667411; Matsuzawa N, 2010, AM J MED GENET A, V152A, P2262, DOI 10.1002/ajmg.a.33338; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; Meylan E, 2002, EMBO REP, V3, P1201, DOI 10.1093/embo-reports/kvf236; Mitchell K, 2012, AM J HUM GENET, V90, P69, DOI 10.1016/j.ajhg.2011.11.013; Moran ST, 2003, J BIOL CHEM, V278, P21526, DOI 10.1074/jbc.M301575200; Muto A, 2002, J BIOL CHEM, V277, P31871, DOI 10.1074/jbc.M202222200; Nair M, 2006, J CELL BIOL, V173, P253, DOI 10.1083/jcb.200508196; Panne D, 2007, J BIOL CHEM, V282, P22816, DOI 10.1074/jbc.M703019200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Ratushny V, 2012, J CLIN INVEST, V122, P464, DOI 10.1172/JCI57415; Restivo G, 2011, EMBO J, V30, P4571, DOI 10.1038/emboj.2011.325; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; Rountree RB, 2010, J INVEST DERMATOL, V130, P102, DOI 10.1038/jid.2009.223; SCHINDLER U, 1994, MOL CELL BIOL, V14, P5820, DOI 10.1128/MCB.14.9.5820; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Teng A, 2007, BBA-MOL BASIS DIS, V1772, P89, DOI 10.1016/j.bbadis.2006.08.012; Thomason HA, 2010, J CLIN INVEST, V120, P1561, DOI 10.1172/JCI40266; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Watt FM, 1989, CURR OPIN CELL BIOL, V1, P1107, DOI 10.1016/S0955-0674(89)80058-4; Watt FM, 2008, NAT REV CANCER, V8, P234, DOI 10.1038/nrc2328; WATT FM, 1983, J INVEST DERMATOL, V81, pS100, DOI 10.1111/1523-1747.ep12540786; Werner S, 2001, ONCOGENE, V20, P7494, DOI 10.1038/sj.onc.1204937; Yu ZQ, 2006, DEV BIOL, V299, P122, DOI 10.1016/j.ydbio.2006.07.015	56	41	41	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31077	31087		10.1074/jbc.M114.589382	http://dx.doi.org/10.1074/jbc.M114.589382			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25246526	hybrid, Green Published			2022-12-25	WOS:000344549900017
J	Manoharan, P; Basford, JE; Pilcher-Roberts, R; Neumann, J; Hui, DY; Lingrel, JB				Manoharan, Palanikumar; Basford, Joshua E.; Pilcher-Roberts, Robyn; Neumann, Jonathan; Hui, David Y.; Lingrel, Jerry B.			Reduced Levels of microRNAs miR-124a and miR-150 Are Associated with Increased Proinflammatory Mediator Expression in Kruppel-like Factor 2 (KLF2)-deficient Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOE-DEFICIENT MICE; TRANSCRIPTION FACTOR; RHEUMATOID-ARTHRITIS; CELL MIGRATION; KEY REGULATOR; ATHEROSCLEROSIS; ACTIVATION; PROLIFERATION; SYNOVIOCYTES; INFLAMMATION	Previous studies have shown that the myeloid-specific deficiency of the transcription factor Kruppel-like factor 2 (KLF2) accelerates atherosclerosis in hypercholesterolemic Ldlr(-/-) mice due to the enhanced adhesion of myeloid cells to activated endothelial cells in the vessel wall. This study revealed elevated basal inflammation with elevated plasma levels of Ccl2, Ccl4, Ccl5, and Ccl11 in the myeloid-specific KLF2 knock-out (myeKlf2(-/-)) mice. Peritoneal macrophages isolated from myeKlf2(-/-) mice showed increased mRNA levels of several inflammatory mediators, including Ccl2, Ccl5, Ccl7, Cox-2, Cxcl1, and IL-6. In contrast, the levels of two microRNAs, miR-124a and miR-150, were lower in Klf2(-/-) macrophages compared with Klf2(+/+) macrophages. Additional studies showed a direct inverse relationship between miR-124a levels with Ccl2 expression, with anti-miR-124a increasing Ccl2 mRNA levels in Klf2(+/+) macrophages, whereas the restoration of miR-124a levels in Klf2(-/-) macrophages significantly reduced Ccl2 mRNA expression. Likewise, the inverse relationship was observed between miR-150 levels and Cxcl1 expression in Klf2(+/+) and Klf2(-/-) mice. Moreover, miR150 likely regulates the miR124a expression and thus augments expression of inflammatory mediators in myeKlf2(-/-) macrophages. This study documented that the transcription factor KLF2 modulates inflammatory chemokine production via regulation of microRNA expression levels in immune cells.	[Manoharan, Palanikumar; Pilcher-Roberts, Robyn; Neumann, Jonathan; Lingrel, Jerry B.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Basford, Joshua E.; Hui, David Y.] Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Lingrel, JB (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, 231 Albert Sabin Way,POB 670524, Cincinnati, OH 45267 USA.	lingrejb@ucmail.uc.edu			National Institutes of Health [HL78806, DK74932]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077, UL1TR001425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL78806 (to J. B L.) and DK74932 (to D. Y. H.).	Allen KL, 2011, BLOOD, V117, P6383, DOI 10.1182/blood-2010-10-313072; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; Das M, 2007, P NATL ACAD SCI USA, V104, P15759, DOI 10.1073/pnas.0707782104; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Kawano S, 2011, ANN RHEUM DIS, V70, pI88, DOI 10.1136/ard.2010.138669; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Lai LH, 2013, J BIOL CHEM, V288, P7956, DOI 10.1074/jbc.M112.445429; Lindenblatt C, 2009, CELL CYCLE, V8, P2019, DOI 10.4161/cc.8.13.8816; Lingrel JB, 2012, CIRC RES, V110, P1294, DOI 10.1161/CIRCRESAHA.112.267310; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; MOSER B, 1990, J EXP MED, V171, P1797, DOI 10.1084/jem.171.5.1797; Nakamachi Y, 2009, ARTHRITIS RHEUM-US, V60, P1294, DOI 10.1002/art.24475; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Nayak L, 2013, AM J PATHOL, V182, P1696, DOI 10.1016/j.ajpath.2013.01.029; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; O'Connell RM, 2011, BLOOD, V118, P2960, DOI 10.1182/blood-2011-03-291971; Rhodes CJ, 2013, AM J RESP CRIT CARE, V187, P294, DOI 10.1164/rccm.201205-0839OC; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Tamminen M, 1999, ARTERIOSCL THROM VAS, V19, P847, DOI 10.1161/01.ATV.19.4.847; Tano N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023114; Wani MA, 1998, TRANSGENIC RES, V7, P229, DOI 10.1023/A:1008809809843; Wu JH, 2005, BIOCHEMISTRY-US, V44, P11098, DOI 10.1021/bi050166i; Yu JC, 2013, NEUROL SCI, V34, P1283, DOI 10.1007/s10072-012-1228-1; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zhuang GQ, 2012, CIRCULATION, V125, P2892, DOI 10.1161/CIRCULATIONAHA.111.087817	38	47	51	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31638	31646		10.1074/jbc.M114.579763	http://dx.doi.org/10.1074/jbc.M114.579763			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25248747	hybrid, Green Published			2022-12-25	WOS:000344549900063
J	Samejima, K; Ogawa, H; Ageichik, AV; Peterson, KL; Kaufmann, SH; Kanemaki, MT; Earnshaw, WC				Samejima, Kumiko; Ogawa, Hiromi; Ageichik, Alexander V.; Peterson, Kevin L.; Kaufmann, Scott H.; Kanemaki, Masato T.; Earnshaw, William C.			Auxin-induced Rapid Degradation of Inhibitor of Caspase-activated DNase (ICAD) Induces Apoptotic DNA Fragmentation, Caspase Activation, and Cell Death A CELL SUICIDE MODULE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE DISRUPTION REVEALS; PLASMA-MEMBRANE; LEUKEMIA-CELLS; PHOSPHATIDYLSERINE; CLEAVAGE; PROTEIN; OVEREXPRESSION; INVOLVEMENT; EXPRESSION; NUCLEASES	Caspase-activated DNase (CAD) is a major apoptotic nuclease, responsible for DNA fragmentation and chromatin condensation during apoptosis. CAD is normally activated in apoptosis as a result of caspase cleavage of its inhibitory chaperone ICAD. Other aspects of CAD regulation are poorly understood. In particular, it has been unclear whether direct CAD activation in non-apoptotic living cells can trigger cell death. Taking advantage of the auxin-inducible degron (AID) system, we have developed a suicide system with which ICAD is rapidly degraded in living cells in response to the plant hormone auxin. Our studies demonstrate that rapid ICAD depletion is sufficient to activate CAD and induce cell death in DT40 and yeast cells. In the vertebrate cells, ectopic CAD activation triggered caspase activation and subsequent hallmarks of caspase-dependent apoptotic changes, including phosphatidylserine exposure and nuclear fragmentation. These observations not only suggest that CAD activation drives apoptosis through a positive feedback loop, but also identify a unique suicide system that can be used for controlling gene-modified organisms.	[Samejima, Kumiko; Ogawa, Hiromi; Ageichik, Alexander V.; Earnshaw, William C.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3BF, Midlothian, Scotland; [Peterson, Kevin L.; Kaufmann, Scott H.] Mayo Clin, Rochester, MN 55905 USA; [Kanemaki, Masato T.] Res Org Informat & Syst, Natl Inst Genet, Frontier Res Ctr, Mishima, Shizuoka 4118540, Japan; [Kanemaki, Masato T.] SOKENDAI, Dept Genet, Mishima, Shizuoka 4118540, Japan; [Kanemaki, Masato T.] Japan Sci & Technol Agcy JST, PREST, Kawaguchi, Saitama 3320012, Japan	University of Edinburgh; Mayo Clinic; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST)	Samejima, K (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Kings Bldg, Edinburgh EH9 3BF, Midlothian, Scotland.	kumiko.samejima@ed.ac.uk; bill.earnshaw@ed.ac.uk	Kanemaki, Masato/Q-3246-2019; Earnshaw, William/AAY-7438-2020	Kanemaki, Masato/0000-0002-7657-1649; Kaufmann, Scott/0000-0002-4900-7145; Earnshaw, William/0000-0002-7191-0621	 [077707];  [092076]; NATIONAL CANCER INSTITUTE [R01CA166741] Funding Source: NIH RePORTER	; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Itaru Samejima for comments on the manuscript. Sorting of GFP-positive cells and,flow cytometry assays for caspase activity and TUNEL positivity were performed in the How cytometry facility, Institute of Immunology and Infection Research, Edinburgh, Scotland, United Kingdom with assistance of Dr, Martin Waterfall. We thank Dr, Richard Grainger and Professor jean D. Beggs, Ph. D., for their advice on the yeast experiments. The Wellcome Trust Centre for Cell Biology is supported by Core Grants 077707 and 092076.	Adrain C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.291pe62; Ageichik AV, 2007, J BIOL CHEM, V282, P27374, DOI 10.1074/jbc.M704307200; Ben-Yehudah A, 2003, CLIN CANCER RES, V9, P1179; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Callus BA, 2007, CELL DEATH DIFFER, V14, P73, DOI 10.1038/sj.cdd.4402034; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Hackbarth JS, 2004, BIOTECHNIQUES, V37, P835; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; KAUFMANN SH, 1989, CANCER RES, V49, P5870; Kelle A, 2009, EMBO REP, V10, pS23, DOI 10.1038/embor.2009.119; Kimura Y, 2004, ORAL ONCOL, V40, P390, DOI 10.1016/j.oraloncology.2003.07.001; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Korfali N, 2004, J BIOL CHEM, V279, P1030, DOI 10.1074/jbc.M306277200; Launay S, 2005, ONCOGENE, V24, P5137, DOI 10.1038/sj.onc.1208524; Lee SH, 2013, CELL DEATH DIFFER, V20, P64, DOI 10.1038/cdd.2012.93; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Martin SJ, 1996, J BIOL CHEM, V271, P28753, DOI 10.1074/jbc.271.46.28753; Mathew M, 2013, APOPTOSIS, V18, P882, DOI 10.1007/s10495-013-0840-8; McIlroy D, 1999, ONCOGENE, V18, P4401, DOI 10.1038/sj.onc.1202868; McQuade JM, 2002, PHYSIOL BEHAV, V76, P315, DOI 10.1016/S0031-9384(02)00716-3; Nagata S, 2005, ANNU REV IMMUNOL, V23, P853, DOI 10.1146/annurev.immunol.23.021704.115811; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Orth JD, 2012, MOL BIOL CELL, V23, P567, DOI 10.1091/mbc.E11-09-0781; Poreba M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008680; Ruchaud S, 2002, EMBO J, V21, P1967, DOI 10.1093/emboj/21.8.1967; Samejima K, 2005, NAT REV MOL CELL BIO, V6, P677, DOI 10.1038/nrm1715; Samejima K, 1998, J CELL BIOL, V143, P225, DOI 10.1083/jcb.143.1.225; Samejima K, 2008, P NATL ACAD SCI USA, V105, P2457, DOI 10.1073/pnas.0712083105; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; WILLIAMS JR, 1974, NATURE, V252, P754, DOI 10.1038/252754a0; Woo EJ, 2004, MOL CELL, V14, P531, DOI 10.1016/S1097-2765(04)00258-8; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Xiao F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm486	37	25	26	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31617	31623		10.1074/jbc.M114.583542	http://dx.doi.org/10.1074/jbc.M114.583542			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25248749	Green Published, hybrid			2022-12-25	WOS:000344549900061
J	Braun, TP; Szumowski, M; Levasseur, PR; Grossberg, AJ; Zhu, XX; Agarwal, A; Marks, DL				Braun, Theodore P.; Szumowski, Marek; Levasseur, Peter R.; Grossberg, Aaron J.; Zhu, XinXia; Agarwal, Anupriya; Marks, Daniel L.			Muscle Atrophy in Response to Cytotoxic Chemotherapy Is Dependent on Intact Glucocorticoid Signaling in Skeletal Muscle	PLOS ONE			English	Article							FACTOR-KAPPA-B; CARDIAC-HYPERTROPHY; CANCER CACHEXIA; NLRP3 INFLAMMASOME; IMMUNE-SYSTEM; ADRENAL AXIS; IN-VIVO; ACTIVATION; AUTOPHAGY; ATROGIN-1	Cancer cachexia is a syndrome of weight loss that results from the selective depletion of skeletal muscle mass and contributes significantly to cancer morbidity and mortality. The driver of skeletal muscle atrophy in cancer cachexia is systemic inflammation arising from both the cancer and cancer treatment. While the importance of tumor derived inflammation is well described, the mechanism by which cytotoxic chemotherapy contributes to cancer cachexia is relatively unexplored. We found that the administration of chemotherapy to mice produces a rapid inflammatory response. This drives activation of the hypothalamic-pituitary-adrenal axis, which increases the circulating level of corticosterone, the predominant endogenous glucocorticoid in rodents. Additionally, chemotherapy administration results in a significant loss of skeletal muscle mass 18 hours after administration with a concurrent induction of genes involved with the ubiquitin proteasome and autophagy lysosome systems. However, in mice lacking glucocorticoid receptor expression in skeletal muscle, chemotherapy-induced muscle atrophy is completely blocked. This demonstrates that cytotoxic chemotherapy elicits significant muscle atrophy driven by the production of endogenous glucocorticoids. Further, it argues that pharmacotherapy targeting the glucocorticoid receptor, given in concert with chemotherapy, is a viable therapeutic strategy in the treatment of cancer cachexia.	[Braun, Theodore P.; Szumowski, Marek; Levasseur, Peter R.; Zhu, XinXia; Marks, Daniel L.] Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Portland, OR 97201 USA; [Braun, Theodore P.] Oregon Hlth & Sci Univ, MD PhD Program, Portland, OR 97201 USA; [Agarwal, Anupriya] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Agarwal, Anupriya] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA; [Grossberg, Aaron J.] Providence St Vincent Med Ctr, Dept Internal Med, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Marks, DL (corresponding author), Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Portland, OR 97201 USA.	marksd@ohsu.edu	Marks, Daniel/C-3712-2009; Grossberg, Aaron/AAD-6686-2021	Grossberg, Aaron/0000-0003-4690-4948; Braun, Theodore/0000-0002-6248-2143	National Institutes of Health (NIH) [DK 70333]; Canadian Institutes of Health Research [200948]; NIH [DK 084646]; Rubenstein Radiation Research Scholarship; AMA Foundation; Portland ARCS Chapter; NATIONAL CANCER INSTITUTE [R00CA151670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK084646, R01DK070333] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rubenstein Radiation Research Scholarship; AMA Foundation; Portland ARCS Chapter; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by National Institutes of Health (NIH) DK 70333 and Canadian Institutes of Health Research 200948 to DLM; NIH DK 084646, Rubenstein Radiation Research Scholarship, the AMA Foundation and the Portland ARCS Chapter to TPB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Bethin KE, 2000, P NATL ACAD SCI USA, V97, P9317, DOI 10.1073/pnas.97.16.9317; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Braun TP, 2013, FASEB J, V27, P3572, DOI 10.1096/fj.13-230375; Braun TP, 2011, J EXP MED, V208, P2449, DOI 10.1084/jem.20111020; Bruchard M, 2013, NAT MED, V19, P57, DOI 10.1038/nm.2999; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Damrauer J.S., 2008, BASIC APPL MYOL, V18, P139, DOI [10.4081/ejtm.2018.7590, DOI 10.4081/EJTM.2018.7590, DOI 10.4081/ejtm.2018.7590]; DEWYS WD, 1986, CLINICS ONCOL, V5, P251; Dhabhar FS, 1999, P NATL ACAD SCI USA, V96, P1059, DOI 10.1073/pnas.96.3.1059; Doyle A, 2011, FASEB J, V25, P99, DOI 10.1096/fj.10-164152; Dulger H, 2004, INT J CLIN PRACT, V58, P545, DOI 10.1111/j.1368-5031.2004.00149.x; Gilson H, 2007, ENDOCRINOLOGY, V148, P452, DOI 10.1210/en.2006-0539; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; He WA, 2013, J CLIN INVEST, V123, P4821, DOI 10.1172/JCI68523; Janelsins MC, 2012, SUPPORT CARE CANCER, V20, P831, DOI 10.1007/s00520-011-1158-0; Kobayashi S, 2010, J BIOL CHEM, V285, P793, DOI 10.1074/jbc.M109.070037; Li HH, 2007, J CLIN INVEST, V117, P3211, DOI 10.1172/JCI31757; Limberaki E, 2011, HEALTH, V03, P512, DOI [DOI 10.4236/health.2011.38085, DOI 10.4236/HEALTH.2011.38085]; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Morley JE, 2006, AM J CLIN NUTR, V83, P735, DOI 10.1093/ajcn/83.4.735; Morrow GR, 2002, PSYCHOPHYSIOLOGY, V39, P491, DOI 10.1017/S0048577202991195; MUKAIDA N, 1994, J BIOL CHEM, V269, P13289; Richey LM, 2007, CLIN CANCER RES, V13, P6561, DOI 10.1158/1078-0432.CCR-07-0116; Robert F, 2012, CANCER RES, V72, P747, DOI 10.1158/0008-5472.CAN-11-2739; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sauter KAD, 2011, CANCER BIOL THER, V11, P1008, DOI 10.4161/cbt.11.12.15540; Schakman O, 2012, AM J PHYSIOL-ENDOC M, V303, pE729, DOI 10.1152/ajpendo.00060.2012; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; Tan BHL, 2009, CLIN CANCER RES, V15, P6973, DOI 10.1158/1078-0432.CCR-09-1525; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Usui S, 2011, CIRC RES, V109, P161, DOI 10.1161/CIRCRESAHA.110.238717; Weymann KB, 2014, BRAIN BEHAV IMMUN, V37, P84, DOI 10.1016/j.bbi.2013.11.003; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32; Zhang S, 2012, NAT MED, V18, P1639, DOI 10.1038/nm.2919	37	57	57	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e106489	10.1371/journal.pone.0106489	http://dx.doi.org/10.1371/journal.pone.0106489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254959	gold, Green Published, Green Submitted			2022-12-25	WOS:000344862300011
J	Casado, I; Martinez-Baz, I; Burgui, R; Irisarri, F; Arriazu, M; Elia, F; Navascues, A; Ezpeleta, C; Aldaz, P; Castilla, J				Casado, Itziar; Martinez-Baz, Ivan; Burgui, Rosana; Irisarri, Fatima; Arriazu, Maite; Elia, Fernando; Navascues, Ana; Ezpeleta, Carmen; Aldaz, Pablo; Castilla, Jesus		Primary Hlth Care Sentinel Network	Household Transmission of Influenza A(H1N1)pdm09 in the Pandemic and Post-Pandemic Seasons	PLOS ONE			English	Article							A H1N1 VIRUS; NEW-YORK-CITY; RISK-FACTORS; OUTBREAK; FAMILIES; CONTACTS; VACCINE; NAVARRE; COHORT; SCHOOL	Background: The transmission of influenza viruses occurs person to person and is facilitated by contacts within enclosed environments such as households. The aim of this study was to evaluate secondary attack rates and factors associated with household transmission of laboratory-confirmed influenza A(H1N1)pdm09 in the pandemic and post-pandemic seasons. Methods: During the 2009-2010 and 2010-2011 influenza seasons, 76 sentinel physicians in Navarra, Spain, took nasopharyngeal and pharyngeal swabs from patients diagnosed with influenza-like illness. A trained nurse telephoned households of those patients who were laboratory-confirmed for influenza A(H1N1) pdm09 to ask about the symptoms, risk factors and vaccination status of each household member. Results: In the 405 households with a patient laboratory-confirmed for influenza A(H1N1) pdm09, 977 susceptible contacts were identified; 16% of them (95% CI 14-19%) presented influenza-like illness and were considered as secondary cases. The secondary attack rate was 14% in 2009-2010 and 19% in the 2010-2011 season (p = 0.049), an increase that mainly affected persons with major chronic conditions. In the multivariate logistic regression analysis, the risk of being a secondary case was higher in the 2010-2011 season than in the 2009-2010 season (adjusted odds ratio: 1.72; 95% CI 1.17-2.54), and in children under 5 years, with a decreasing risk in older contacts. Influenza vaccination was associated with lesser incidence of influenza-like illness near to statistical significance (adjusted odds ratio: 0.29; 95% CI 0.08-1.03). Conclusion: The secondary attack rate in households was higher in the second season than in the first pandemic season. Children had a greater risk of infection. Preventive measures should be maintained in the second pandemic season, especially in high-risk persons.	[Casado, Itziar; Navascues, Ana; Ezpeleta, Carmen] Complejo Hosp Navarra, Pamplona, Spain; [Casado, Itziar; Martinez-Baz, Ivan; Burgui, Rosana; Irisarri, Fatima; Arriazu, Maite; Castilla, Jesus] Inst Salud Publ Navarra, Pamplona, Spain; [Martinez-Baz, Ivan; Burgui, Rosana; Irisarri, Fatima; Arriazu, Maite; Castilla, Jesus] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Elia, Fernando] Serv Navarro Salud, Direcc Atenc Primaria, Pamplona, Spain; [Aldaz, Pablo] Ctr Salud San Juan, Serv Navarro Salud, Pamplona, Spain	Servicio Navarro de Salud - Osasunbidea; Public Health Institute of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Servicio Navarro de Salud - Osasunbidea; Servicio Navarro de Salud - Osasunbidea	Castilla, J (corresponding author), Inst Salud Publ Navarra, Pamplona, Spain.	jcastilc@navarra.es	Casado, Itziar/B-1341-2017; Castilla, Jesus/B-9048-2008; Casado, Itziar/AAE-2973-2021; Martínez-Baz, Iván/H-4954-2017; Cenoz, Manuel García/B-5647-2013; Reina, Gabriel/F-2709-2017; FERNANDEZ-ALONSO, MIRIAN/Q-4471-2016	Casado, Itziar/0000-0001-6879-4984; Castilla, Jesus/0000-0002-6396-7265; Casado, Itziar/0000-0001-6879-4984; Martínez-Baz, Iván/0000-0002-3405-2277; Cenoz, Manuel García/0000-0001-7316-9104; Reina, Gabriel/0000-0003-4079-9753; FERNANDEZ-ALONSO, MIRIAN/0000-0001-8047-2734	Instituto de Salud Carlos III [GR09/0028, GR09/0029, PS12/00087]; I-MOVE Program - European Centre for Disease Prevention and Control	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); I-MOVE Program - European Centre for Disease Prevention and Control	This study was supported by the Instituto de Salud Carlos III (GR09/0028, GR09/0029 and PS12/00087) and by the I-MOVE Program funded by the European Centre for Disease Prevention and Control. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Carcione D, 2011, EURO SURVEILL, V16; Carrat F, 2002, ARCH INTERN MED, V162, P1842, DOI 10.1001/archinte.162.16.1842; Castilla J, 2011, VACCINE, V29, P5919, DOI 10.1016/j.vaccine.2011.06.063; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; France AM, 2010, J INFECT DIS, V201, P984, DOI 10.1086/651145; Glatman-Freedman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050228; Godoy P, 2012, PREV MED, V54, P434, DOI 10.1016/j.ypmed.2012.04.009; Gubareva LV, 2002, J INFECT DIS, V186, P1575, DOI 10.1086/345372; Lau LLH, 2012, EPIDEMIOLOGY, V23, P531, DOI 10.1097/EDE.0b013e31825588b8; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Levy JW, 2013, AM J EPIDEMIOL, V177, P1443, DOI 10.1093/aje/kws402; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; Looker C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013702; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Martinez-Baz I, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-191; Mohamed AG, 2012, INFLUENZA OTHER RESP, V6, pe25, DOI 10.1111/j.1750-2659.2011.00308.x; Nishiura H, 2011, J INT MED RES, V39, P619, DOI 10.1177/147323001103900231; Nishiura H, 2011, EMERG INFECT DIS, V17, P746, DOI [10.3201/eid1704.100525, 10.3201/eid1706.100525]; Pedroni E, 2010, EURO SURVEILL, V15; Petrie JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075339; Thai PQ, 2014, J INFECTION, V68, P581, DOI 10.1016/j.jinf.2014.01.008; Remschmidt C, 2013, INFLUENZA OTHER RESP, V7, P418, DOI 10.1111/j.1750-2659.2012.00407.x; Sikora C, 2010, J CLIN VIROL, V49, P90, DOI 10.1016/j.jcv.2010.06.015; Vargas-Leguas H, 2011, REV ESP SALUD PUBLIC, V85, P57, DOI 10.1590/S1135-57272011000100007; Viboud C, 2004, BRIT J GEN PRACT, V54, P684; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P249; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	28	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108485	10.1371/journal.pone.0108485	http://dx.doi.org/10.1371/journal.pone.0108485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254376	Green Published, gold, Green Submitted			2022-12-25	WOS:000344862300088
J	Lee, SY; Slagle-Webb, B; Rizk, E; Patel, A; Miller, PA; Sung, SS; Connor, JR				Lee, Sang Y.; Slagle-Webb, Becky; Rizk, Elias; Patel, Akshal; Miller, Patti A.; Sung, Shen-Shu; Connor, James R.			Characterization of a Novel Anti-Cancer Compound for Astrocytomas	PLOS ONE			English	Article							CELL-CYCLE ARREST; TOPOISOMERASE-II INHIBITOR; MALIGNANT GLIOMA; PHASE-II; ANTITUMOR AGENT; ACCURATE DOCKING; MISMATCH REPAIR; BRAIN-TUMORS; IN-VITRO; TEMOZOLOMIDE	The standard chemotherapy for brain tumors is temozolomide (TMZ), however, as many as 50% of brain tumors are reportedly TMZ resistant leaving patients without a chemotherapeutic option. We performed serial screening of TMZ resistant astrocytoma cell lines, and identified compounds that are cytotoxic to these cells. The most cytotoxic compound was an analog of thiobarbituric acid that we refer to as CC-I. There is a dose-dependent cytotoxic effect of CC-I in TMZ resistant astrocytoma cells. Cell death appears to occur via apoptosis. Following CC-I exposure, there was an increase in astrocytoma cells in the S and G2/M phases. In in vivo athymic (nu/nu) nude mice subcutaneous and intracranial tumor models, CC-I completely inhibited tumor growth without liver or kidney toxicity. Molecular modeling and enzyme activity assays indicate that CC-I selectively inhibits topoisomerase II alpha similar to other drugs in its class, but its cytotoxic effects on astrocytoma cells are stronger than these compounds. The cytotoxic effect of CC-I is stronger in cells expressing unmethylated O-6-methylguanine methyltransferase (MGMT) but is still toxic to cells with methylated MGMT. CC-I can also enhance the toxic effect of TMZ on astrocytoma when the two compounds are combined. In conclusion, we have identified a compound that is effective against astrocytomas including TMZ resistant astrocytomas in both cell culture and in vivo brain tumor models. The enhanced cytotoxicity of CC-I and the safety profile of this family of drugs could provide an interesting tool for broader evaluation against brain tumors.	[Lee, Sang Y.; Slagle-Webb, Becky; Rizk, Elias; Patel, Akshal; Connor, James R.] Penn State Univ, Penn State MS Hershey Med Ctr, Coll Med, Dept Neurosurg, Hershey, PA 17033 USA; [Miller, Patti A.] Penn State Univ, Penn State MS Hershey Med Ctr, Coll Med, Dept Radiol, Hershey, PA USA; [Sung, Shen-Shu] Penn State Univ, Penn State MS Hershey Med Ctr, Coll Med, Dept Pharmacol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Lee, SY (corresponding author), Penn State Univ, Penn State MS Hershey Med Ctr, Coll Med, Dept Neurosurg, Hershey, PA 17033 USA.	SYL3@psu.edu		Lee, Sang/0000-0003-3911-8316	National Cancer Institute of the National Institutes of Health [R21CA167406]; Elsa U. Pardee Foundation; Tara Leah Witmer Endowment; NATIONAL CANCER INSTITUTE [R21CA167406] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Elsa U. Pardee Foundation; Tara Leah Witmer Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project is funded, in part, by a grant with the National Cancer Institute of the National Institutes of Health under Award Number R21CA167406 to SL. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This study also supported in part by the Elsa U. Pardee Foundation and the Tara Leah Witmer Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	American Cancer Society, 2012, CANC FACTS FIG 2012; Atallah Ehab, 2005, Curr Treat Options Oncol, V6, P185; Balas VI, 2011, EUR J MED CHEM, V46, P2835, DOI 10.1016/j.ejmech.2011.04.005; Balas VI, 2008, BIOINORG CHEM APPL, V2008, DOI 10.1155/2008/654137; BECK WT, 1996, PRINCIPLES CANC DRUG, P487; Bhonde MR, 2006, ONCOGENE, V25, P165, DOI 10.1038/sj.onc.1209017; BREWER AD, 1985, BIOCHEM PHARMACOL, V34, P2047, DOI 10.1016/0006-2952(85)90335-1; Bruce JN, 2011, NEUROSURGERY, V69, P1272, DOI 10.1227/NEU.0b013e3182233e24; Cahill DP, 2007, CLIN CANCER RES, V13, P2038, DOI 10.1158/1078-0432.CCR-06-2149; CEBO B, 1980, FARMACO-ED SCI, V35, P248; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chen Y, 2005, ANTICANCER RES, V25, P4203; de Almeida SF, 2007, J BIOL CHEM, V282, P27905, DOI 10.1074/jbc.M702672200; DRAKE FH, 1989, CANCER RES, V49, P2578; Falaschi A, 2007, CELL CYCLE, V6, P1705, DOI 10.4161/cc.6.14.4495; Friedman HS, 2000, CLIN CANCER RES, V6, P2585; Friedman HS, 1998, J CLIN ONCOL, V16, P3851, DOI 10.1200/JCO.1998.16.12.3851; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; GLOVER A, 1987, INVEST NEW DRUG, V5, P137; Gong YX, 2006, MOL PHARMACOL, V69, P1320, DOI 10.1124/mol.105.018978; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964; Jakob J, 2009, INT J RADIAT ONCOL, V75, P810, DOI 10.1016/j.ijrobp.2008.11.032; Kanzawa T, 2003, BRIT J CANCER, V89, P922, DOI 10.1038/sj.bjc.6601193; Kolb RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050281; Lee JH, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-18; Lee SY, 2007, FASEB J, V21, P564, DOI 10.1096/fj.06-6397com; Lee SY, 2011, INT J CANCER, V129, P2104, DOI 10.1002/ijc.25888; Marchesia F, 2007, PHARMACOL RES, V56, P275, DOI 10.1016/j.phrs.2007.08.003; Matsumoto Y, 2005, J MED INVESTIG, V52, P41, DOI 10.2152/jmi.52.41; McClendon AK, 2007, MUTAT RES-FUND MOL M, V623, P83, DOI 10.1016/j.mrfmmm.2007.06.009; Melguizo C, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-250; Mellai M, 2012, J NEURO-ONCOL, V107, P617, DOI 10.1007/s11060-011-0787-y; Minturn JE, 2011, PEDIATR BLOOD CANCER, V56, P39, DOI 10.1002/pbc.22690; Moore MJ, 1998, INVEST NEW DRUG, V16, P77, DOI 10.1023/A:1006043332368; Nishikawa R, 2010, NEUROL MED-CHIR, V50, P713, DOI 10.2176/nmc.50.713; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Park DK, 2007, CANCER CHEMOTH PHARM, V50, P160; Peignan L, 2011, NEUROCHEM RES, V36, P1397, DOI 10.1007/s11064-011-0464-8; Rajamaki S, 2009, BIOORG MED CHEM LETT, V19, P3615, DOI 10.1016/j.bmcl.2009.04.132; Schmidt F, 2008, ONCOL REP, V19, P1061; Singh P, 2009, BIOORG MED CHEM LETT, V19, P3054, DOI 10.1016/j.bmcl.2009.04.014; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Theeler BJ, 2011, CURR TREAT OPTION NE, V13, P386, DOI 10.1007/s11940-011-0130-0; Uzzaman M, 2007, J NEUROSURG, V106, P646, DOI 10.3171/jns.2007.106.4.646; van Brussel JP, 2000, CANCER CHEMOTH PHARM, V45, P509, DOI 10.1007/s002800051027; Vlachostergios PJ, 2013, INVEST NEW DRUG, V31, P1169, DOI 10.1007/s10637-013-9968-1; Wang HY, 2013, FOOD CHEM TOXICOL, V55, P396, DOI 10.1016/j.fct.2012.12.059; WARRELL RP, 1989, METABOLISM, V38, P550, DOI 10.1016/0026-0495(89)90215-1; Yip S, 2009, CLIN CANCER RES, V15, P4622, DOI 10.1158/1078-0432.CCR-08-3012	51	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108166	10.1371/journal.pone.0108166	http://dx.doi.org/10.1371/journal.pone.0108166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255031	Green Published, Green Submitted, gold			2022-12-25	WOS:000344862300059
J	Iser, BPM; Malta, DC; Duncan, BB; de Moura, L; Vigo, A; Schmidt, MI				Moehlecke Iser, Betine Pinto; Malta, Deborah Carvalho; Duncan, Bruce Bartholow; de Moura, Lenildo; Vigo, Alvaro; Schmidt, Maria Ines			Prevalence, Correlates, and Description of Self-Reported Diabetes in Brazilian Capitals - Results from a Telephone Survey	PLOS ONE			English	Article							HEALTH; HYPERTENSION; POPULATION; AGREEMENT; GLUCOSE; VALIDATION; MELLITUS; PATIENT; WOMEN	Introduction: The prevalence of diabetes is increasing worldwide. The objective of this study is to estimate the prevalence of self-reported diabetes in Brazilian adults and to describe its population correlates as well as the clinical characteristics of the reported cases. Methods: We analyzed basic and supplementary data of 54.144 subjects participating in VIGITEL 2011 (Surveillance System for Risk and Protective Factors for Chronic Diseases), a telephone survey based on a probabilistic sample of subjects >= 18 years old residing in Brazilian state capitals and the Federal District. Estimates reported are weighted so as to represent the surveyed population. Results: The prevalence of self-reported diabetes was 6.3% (95% CI 5.9-6.7), increasing markedly with age and nutritional status, and decreasing with level of education. Prevalence was higher among those self-declaring their race/color as black. Most cases (90%) reported the diagnosis being made at 35 years or older. The vast majority (99.8%) of self-reported cases informed having previously performed at least one glucose test, and 76% of those not reporting diabetes also informed having previously performed glucose testing. Most cases (92.6%) reported following some form of diabetes treatment, 79% taking medication. Conclusion: The estimated prevalence of known diabetes found, 6.3%, is consistent with estimates given by international summaries. The additional data collected in VIGITEL 2011 regarding previous glucose testing and current treatment support the use of telephone-based information to monitor the prevalence of known diabetes in Brazilian capitals.	[Moehlecke Iser, Betine Pinto; Duncan, Bruce Bartholow; Vigo, Alvaro; Schmidt, Maria Ines] Univ Fed Rio Grande do Sul, Sch Med, Post Grad Studies Program Epidemiol, Porto Alegre, RS, Brazil; [Moehlecke Iser, Betine Pinto; Malta, Deborah Carvalho] Minist Hlth, Secretariat Hlth Surveillance, Dept Non Communicable Dis Surveillance & Hlth Pro, Brasilia, DF, Brazil; [de Moura, Lenildo] Pan Amer Hlth Org, Unit Noncommunicable Dis & Mental Hlth, Brasilia, DF, Brazil	Universidade Federal do Rio Grande do Sul; Pan American Health Organization	Iser, BPM (corresponding author), Univ Fed Rio Grande do Sul, Sch Med, Post Grad Studies Program Epidemiol, Porto Alegre, RS, Brazil.	betinee@gmail.com	Duncan, Bruce B/L-4140-2016; Malta, Deborah C/H-7880-2012; Schmidt, Maria Inês/AGP-6441-2022; Malta, Deborah Carvalho/GNM-8218-2022; Vigo, Alvaro/S-2243-2019; Schmidt, Maria/V-3196-2019; Schmidt, Maria Inês/AGT-5691-2022; Malta, Deborah Carvalho/L-2491-2019; Moehlecke Iser, Betine/F-7580-2013	Duncan, Bruce B/0000-0002-7491-2630; Malta, Deborah C/0000-0002-8214-5734; Schmidt, Maria Inês/0000-0002-3837-0731; Malta, Deborah Carvalho/0000-0002-8214-5734; Vigo, Alvaro/0000-0002-5797-9470; Malta, Deborah Carvalho/0000-0002-8214-5734; Moehlecke Iser, Betine/0000-0001-6061-2541	Secretariat of Health Surveillance of the Ministry of Health (SVS/MS) of Brazil, Brasilia-DF	Secretariat of Health Surveillance of the Ministry of Health (SVS/MS) of Brazil, Brasilia-DF	Vigitel is a telephone survey funded by the Secretariat of Health Surveillance of the Ministry of Health (SVS/MS) of Brazil, Brasilia-DF. (http://portalsaude.saude.gov.br/index.php/o-ministerio/principal/secretarias/svs). The funding is related to the telephone survey Vigitel, which originate this paper, but not specifically related to this analyses, which used secondary data. Therefore, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc12-s064, 10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc11-S062]; Andrade F, 2009, REV PANAM SALUD PUBL, V26, P9, DOI 10.1590/S1020-49892009000700002; Bener A, 2009, DIABETES RES CLIN PR, V84, P99, DOI 10.1016/j.diabres.2009.02.003; Bernal Regina, 2009, Rev. Saúde Pública, V43, P421, DOI 10.1590/S0034-89102009005000024; Bernal Regina Tomie Ivata, 2014, Rev. bras. epidemiol., V17, P163, DOI 10.1590/1415-790X201400010013ENG; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Analise de SituacAo de Saude, 2011, PLAN AC ESTR ENF DOE; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude Departamento de Vigilancia de Doencas e Agravos nao transmissiveis e Promocao de Saude, 2013, VIG FAT RISC PROT DO; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Danaei Goodarz, 2009, Popul Health Metr, V7, P16, DOI 10.1186/1478-7954-7-16; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Englert H, 2010, J PUBLIC HEALTH-UK, V32, P387, DOI 10.1093/pubmed/fdq013; Espelt A, 2011, J EPIDEMIOL COMMUNIT; Francisco Priscila Maria Stolses Bergamo, 2011, Rev. bras. epidemiol., V14, P5, DOI 10.1590/S1415-790X2011000500002; Goldman N, 2003, J CLIN EPIDEMIOL, V56, P148, DOI 10.1016/S0895-4356(02)00580-2; Huerta JM, 2009, REV ESP CARDIOL, V62, P143, DOI 10.1016/S0300-8932(09)70156-3; Instituto Brasileiro de Geografia e Estatisticas - IBGE, 2012, CENS DEM POP RES; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Bernal RTI, 2013, REV SAUDE PUBL, V47, P316, DOI 10.1590/S0034-8910.2013047003798; Lima-Costa MF, 2007, REV SAUDE PUBL, V41, P943; MALERBI DA, 1992, DIABETES CARE, V15, P1509, DOI 10.2337/diacare.15.11.1509; Martin LM, 2000, AM J PREV MED, V18, P215, DOI 10.1016/S0749-3797(99)00158-0; McNeely MJ, 2004, DIABETES CARE, V27, P66, DOI 10.2337/diacare.27.1.66; Ministerio do Planejamento Orcamento e Gestao & Instituto Brasileiro de Geografia e Estatistica, 2011, CENS DEM 2010 CAR PO; Mokdad AH, 2010, PREV CHRONIC DIS, V7; Moser EG, 2012, DIABETES RES CLIN PR, V97, P16, DOI 10.1016/j.diabres.2012.01.027; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Passos Valéria Maria de Azeredo, 2005, Sao Paulo Med. J., V123, P66, DOI 10.1590/S1516-31802005000200007; de Freitas LRS, 2012, EPIDEMIOL SERV SAUDE, V21, P7, DOI 10.5123/S1679-49742012000100002; Schenker N, 2010, STAT MED, V29, P533, DOI 10.1002/sim.3809; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Schmidt MI, 2009, REV SAUDE PUBL, V43, P74, DOI 10.1590/S0034-89102009000900010; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Simpson CF, 2004, J AM GERIATR SOC, V52, P123, DOI 10.1111/j.1532-5415.2004.52021.x; Francisco PMSB, 2010, CAD SAUDE PUBLICA, V26, P175, DOI 10.1590/S0102-311X2010000100018; WHO, 2011, GLOB STAT REP NONC D; Wu SC, 2000, PUBLIC HEALTH, V114, P137, DOI 10.1016/S0033-3506(00)00323-1; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang XP, 2008, DIABETES CARE, V31, P1748, DOI 10.2337/dc08-0572; Zindah Meyasser, 2008, Prev Chronic Dis, V5, pA17	39	19	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108044	10.1371/journal.pone.0108044	http://dx.doi.org/10.1371/journal.pone.0108044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT3UZ	25255096	Green Published, gold, Green Submitted			2022-12-25	WOS:000344862300052
J	Zhu, PY; Lu, ZX; Heong, K; Chen, GH; Zheng, XS; Xu, HX; Yang, YJ; Nicol, HI; Gurr, GM				Zhu, Pingyang; Lu, Zhongxian; Heong, Kongluen; Chen, Guihua; Zheng, Xusong; Xu, Hongxing; Yang, Yajun; Nicol, Helen I.; Gurr, Geoff M.			Selection of Nectar Plants for Use in Ecological Engineering to Promote Biological Control of Rice Pests by the Predatory Bug, Cyrtorhinus lividipennis, (Heteroptera: Miridae)	PLOS ONE			English	Article							COCCINELLIDAE POPULATION-DENSITY; COLEOMEGILLA-MACULATA COLEOPTERA; PARASITOIDS; FOOD; HYMENOPTERA; MANAGEMENT; HEMIPTERA; CANNIBALISM; LEPIDOPTERA; PLANTHOPPER	Ecological engineering for pest management involves the identification of optimal forms of botanical diversity to incorporate into a farming system to suppress pests, by promoting their natural enemies. Whilst this approach has been extensively researched in many temperate crop systems, much less has been done for rice. This paper reports the influence of various plant species on the performance of a key natural enemy of rice planthopper pests, the predatory mirid bug, Cyrtorhinus lividipennis. Survival of adult males and females was increased by the presence of flowering Tagetes erecta, Trida procumbens, Emilia sonchifolia (Compositae), and Sesamum indicum (Pedaliaceae) compared with water or nil controls. All flower treatments resulted in increased consumption of brown plant hopper, Nilaparvata lugens, and for female C. lividipennis, S. indicum was the most favorable. A separate study with a wider range of plant species and varying densities of prey eggs showed that S. indicum most strongly promoted predation by C. lividipennis. Reflecting this, S. indicum gave a relatively high rate of prey search and low prey handling time. On this basis, S. indicum was selected for more detailed studies to check if its potential incorporation into the farming system would not inadvertently benefit Cnaphalocrocis medinalis and Marasmia patnalis, serious Lepidoptera pests of rice. Adult longevity and fecundity of both pests was comparable for S. indicum and water treatments and significantly lower than the honey solution treatment. Findings indicate that S. indicumis well suited for use as an ecological engineering plant in the margins of rice crops. Sesame indicum can be a valuable crop as well as providing benefits to C. lividipennis whilst denying benefit to key pests.	[Zhu, Pingyang; Lu, Zhongxian; Zheng, Xusong; Xu, Hongxing; Yang, Yajun] Zhejiang Acad Agr Sci, Inst Plant Protect & Microbiol, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China; [Zhu, Pingyang; Chen, Guihua] Jinhua Plant Protect Stn, Jinhua, Peoples R China; [Heong, Kongluen] Int Rice Res Inst, Crop & Environm Sci Div, Manila, Philippines; [Nicol, Helen I.] Charles Sturt Univ, Sch Agr & Wine Sci, Orange, NSW, Australia; [Gurr, Geoff M.] Fujian Agr & Forestry Univ, Inst Appl Ecol, Fuzhou, Fujian, Peoples R China; [Gurr, Geoff M.] New South Wales Dept Primary Ind, Graham Ctr Agr Innovat, Orange, Australia; [Gurr, Geoff M.] Charles Sturt Univ, Orange, NSW, Australia	Zhejiang Academy of Agricultural Sciences; CGIAR; International Rice Research Institute (IRRI); Charles Sturt University; Fujian Agriculture & Forestry University; NSW Department of Primary Industries; Charles Sturt University	Lu, ZX (corresponding author), Zhejiang Acad Agr Sci, Inst Plant Protect & Microbiol, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China.	luzxmh@gmail.com; ggurr@csu.edu.au	GURR, GEOFFREY M/F-3519-2011; Zhu, Pingyang/N-8516-2014; Yang, Yajun/HGC-2463-2022; Heong, KL/Z-4533-2019	Gurr, Geoff/0000-0001-5008-7966	National Basic Research Program of China [2010CB126200]; Agro-Industry R&D Special Fund of China [200903051, 201003031]; Asian Development Bank [TA7648-R-RDTA]	National Basic Research Program of China(National Basic Research Program of China); Agro-Industry R&D Special Fund of China; Asian Development Bank	Funding for this study was provided jointly by the National Basic Research Program of China (973, Grant No. 2010CB126200), the Agro-Industry R&D Special Fund of China (Grant No. 200903051 and 201003031), and the Asian Development Bank (TA7648-R-RDTA) coordinated by the International Rice Research Institute, Los Banos Philippines. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS P, 1987, THEOR POPUL BIOL, V32, P262, DOI 10.1016/0040-5809(87)90050-5; Baggen LR, 1998, BIOL CONTROL, V11, P9, DOI 10.1006/bcon.1997.0566; Baggen LR, 1999, ENTOMOL EXP APPL, V91, P155, DOI 10.1023/A:1003627130449; Begum M, 2004, BIOL CONTROL, V30, P584, DOI 10.1016/j.biocontrol.2004.03.005; Begum M, 2006, J APPL ECOL, V43, P547, DOI 10.1111/j.1365-2664.2006.01168.x; Bowie MH, 1999, INT J PEST MANAGE, V45, P69, DOI 10.1080/096708799228076; Chen CM, 1985, J PLANT PROTECTION, V12, P69; Cheng J., 2009, PLANTHOPPERS NEW THR, P157; CHINAJARIYAWONG A, 1987, J AUST ENTOMOL SOC, V26, P37; Cottrell TE, 1998, ENVIRON ENTOMOL, V27, P1375, DOI 10.1093/ee/27.6.1375; Cottrell TE, 1998, ENVIRON ENTOMOL, V27, P1402, DOI 10.1093/ee/27.6.1402; Eubanks MD, 1999, ECOLOGY, V80, P1253, DOI 10.1890/0012-9658(1999)080[1253:TECOVI]2.0.CO;2; Eubanks Micky D., 2005, P148, DOI 10.1017/CBO9780511542220.007; Evans EW, 2010, AGR FOREST ENTOMOL, V12, P41, DOI 10.1111/j.1461-9563.2009.00448.x; Gillespie DR, 2000, ECOL ENTOMOL, V25, P380, DOI 10.1046/j.1365-2311.2000.00285.x; Gurr GM, 2011, ANN APPL BIOL, V158, P149, DOI 10.1111/j.1744-7348.2010.00455.x; Gurr GM, 2010, BIOL CONTROL, V52, P198, DOI 10.1016/j.biocontrol.2009.02.013; Gurr G.M., 2005, PLANT FOOD CARNIVORO, P341; Gurr GM, 2012, AGR FOREST ENTOMOL, V14, P1, DOI 10.1111/j.1461-9563.2011.00550.x; Gurr Geoff M., 2012, P214; Gurr GM, 2003, BASIC APPL ECOL, V4, P107, DOI 10.1078/1439-1791-00122; Heimpel George E., 2005, P267, DOI 10.1017/CBO9780511542220.010; Hossain Z, 2002, J APPL ECOL, V39, P445, DOI 10.1046/j.1365-2664.2002.00729.x; Igarashi K, 2013, APPL ENTOMOL ZOOL, V48, P403, DOI 10.1007/s13355-013-0185-3; Jervis MA, 2004, ECOLOGICAL ENGINEERING FOR PEST MANAGEMENT: ADVANCES IN HABITAT MANIPULATION FOR ARTHROPODS, P65; Jorgensen SE, 1996, ECOL ENG, V7, P373, DOI 10.1016/S0925-8574(96)00018-3; Katti G, 2007, BIOL CONTROL INSECT, P22; Lakshmi V. Jhansi, 2005, Journal of Biological Control, V19, P93; Landis DA, 2000, EMERGING TECHNOLOGIES FOR INTEGRATED PEST MANAGEMENT, P226; Lauprasert P, 2006, J SCI RES CHULALONGK, V31, P121; Lou Yong-Gen, 2011, Chinese Journal of Applied Entomology, V48, P231; Matsumura M, 1999, P ASS PLANT PROTECTI; Mitsunaga T, 2006, APPL ENTOMOL ZOOL, V41, P277, DOI 10.1303/aez.2006.277; Portillo N, 2012, J INSECT PHYSIOL, V58, P397, DOI 10.1016/j.jinsphys.2011.12.013; Pumarino L, 2012, ENTOMOL EXP APPL, V145, P181, DOI 10.1111/eea.12002; Put K, 2012, BIOL CONTROL, V63, P172, DOI 10.1016/j.biocontrol.2012.06.011; Reynes T.M, 1975, Philippine Ent, V3, P79; Rivero A, 1999, RES POPUL ECOL, V41, P39, DOI 10.1007/PL00011981; ROGERS D, 1972, J ANIM ECOL, V41, P369, DOI 10.2307/3474; Savary S, 2012, CROP PROT, V32, P54, DOI 10.1016/j.cropro.2011.10.012; Schaefer C. W., 2000, HETEROPTERA EC IMPOR; Settele J, 2008, NATURE, V456, P570, DOI 10.1038/456570a; Shearer PW, 2004, J ECON ENTOMOL, V97, P789, DOI 10.1603/0022-0493(2004)097[0789:IOPENO]2.0.CO;2; Sigsgaard L, 2007, B ENTOMOL RES, V97, P533, DOI 10.1017/S0007485307005196; Urbaneja-Bernat P, 2013, BIOCONTROL, V58, P57, DOI 10.1007/s10526-012-9466-y; VSN International, 2011, GENSTAT WINDOWS; Wackers FL, 2007, ANNU REV ENTOMOL, V52, P301, DOI 10.1146/annurev.ento.52.110405.091352; Wackers FL, 2000, OIKOS, V90, P197, DOI 10.1034/j.1600-0706.2000.900124.x; Wackers FL, 2005, PLANT-PROVIDED FOOD FOR CARNIVOROUS INSECTS: PROTECTIVE MUTUALISM AND ITS APPLICATIONS, P17, DOI 10.1017/CBO9780511542220.003; Wu Z.C, 1991, JIANGXI PLANT PROTEC, V4, P136; Zhang RW, 1998, ECOL ENG, V11, P17, DOI 10.1016/S0925-8574(98)00041-X; Zhou J, 1986, HUAN AGR SCI, V6, P22; Zhu CB, 1981, NAT ENEMIES INSECTS, V4, P25; Zhu PY, 2013, BIOL CONTROL, V64, P83, DOI 10.1016/j.biocontrol.2012.09.014	54	31	38	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108669	10.1371/journal.pone.0108669	http://dx.doi.org/10.1371/journal.pone.0108669			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254377	Green Submitted, gold, Green Published			2022-12-25	WOS:000344862300104
J	Zhuang, YX; Chan, DK; Haugrud, AB; Miskimins, WK				Zhuang, Yongxian; Chan, Daniel K.; Haugrud, Allison B.; Miskimins, W. Keith			Mechanisms by Which Low Glucose Enhances the Cytotoxicity of Metformin to Cancer Cells Both In Vitro and In Vivo	PLOS ONE			English	Article							ANTIDIABETIC DRUG METFORMIN; ACTIVATED PROTEIN-KINASE; RESPIRATORY-CHAIN; DIABETIC-PATIENTS; KETOGENIC DIET; BRAIN CANCER; INHIBITION; TUMOR; AMPK; METABOLISM	Different cancer cells exhibit altered sensitivity to metformin treatment. Recent studies suggest these findings may be due in part to the common cell culture practice of utilizing high glucose, and when glucose is lowered, metformin becomes increasingly cytotoxic to cancer cells. In low glucose conditions ranging from 0 to 5 mM, metformin was cytotoxic to breast cancer cell lines MCF7, MDAMB231 and SKBR3, and ovarian cancer cell lines OVCAR3, and PA-1. MDAMB231 and SKBR3 were previously shown to be resistant to metformin in normal high glucose medium. When glucose was increased to 10 mM or above, all of these cell lines become less responsive to metformin treatment. Metformin treatment significantly reduced ATP levels in cells incubated in media with low glucose (2.5 mM), high fructose (25 mM) or galactose (25 mM). Reductions in ATP levels were not observed with high glucose (25 mM). This was compensated by enhanced glycolysis through activation of AMPK when oxidative phosphorylation was inhibited by metformin. However, enhanced glycolysis was either diminished or abolished by replacing 25 mM glucose with 2.5 mM glucose, 25 mM fructose or 25 mM galactose. These findings suggest that lowering glucose potentiates metformin induced cell death by reducing metformin stimulated glycolysis. Additionally, under low glucose conditions metformin significantly decreased phosphorylation of AKT and various targets of mTOR, while phospho-AMPK was not significantly altered. Thus inhibition of mTOR signaling appears to be independent of AMPK activation. Further in vivo studies using the 4T1 breast cancer mouse model confirmed that metformin inhibition of tumor growth was enhanced when serum glucose levels were reduced via low carbohydrate ketogenic diets. The data support a model in which metformin treatment of cancer cells in low glucose medium leads to cell death by decreasing ATP production and inhibition of survival signaling pathways. The enhanced cytotoxicity of metformin against cancer cells was observed both in vitro and in vivo.	[Zhuang, Yongxian; Haugrud, Allison B.; Miskimins, W. Keith] Sanford Res USD, Canc Biol Res Ctr, Sioux Falls, SD 57104 USA; [Chan, Daniel K.] Univ S Dakota, Sanford Sch Med, Vermillion, SD 57069 USA	Sanford Health; University of South Dakota	Zhuang, YX (corresponding author), Sanford Res USD, Canc Biol Res Ctr, Sioux Falls, SD 57104 USA.	Yongxian.Zhuang@sanfordhealth.org			Susan G. Komen for the Cure [KG100497]; COBRE from National Institute of General Medical Sciences at the National Institutes of Health [5P20GM10358]; COBRE from National Cancer Institute; PHS from National Cancer Institute [1R01CA180033-01]; NATIONAL CANCER INSTITUTE [R01CA180033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103548] Funding Source: NIH RePORTER	Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); COBRE from National Institute of General Medical Sciences at the National Institutes of Health; COBRE from National Cancer Institute; PHS from National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported through grant KG100497 (W. K. Miskimins) from Susan G. Komen for the Cure. Seahorse XF24 experiments were supported by COBRE award 5P20GM10358 (W. K Miskimins) from the National Institute of General Medical Sciences at the National Institutes of Health. The project was also supported in part by a COBRE pilot award (Y. Zhuang) and PHS grant 1R01CA180033-01 (W. K. Miskimins) from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade BM, 2012, THYROID, V22, P1063, DOI 10.1089/thy.2012.0041; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Batandier C, 2006, J BIOENERG BIOMEMBR, V38, P33, DOI 10.1007/s10863-006-9003-8; Ben Sahra I, 2010, CANCER RES, V70, P2465, DOI 10.1158/0008-5472.CAN-09-2782; Bonini MG, 2013, IUBMB LIFE, V65, P889, DOI 10.1002/iub.1213; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; De Lorenzo MS, 2011, CARCINOGENESIS, V32, P1381, DOI 10.1093/carcin/bgr107; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Gotlieb WH, 2008, GYNECOL ONCOL, V110, P246, DOI 10.1016/j.ygyno.2008.04.008; Habibollahi P, 2013, J NUCL MED, V54, P252, DOI 10.2967/jnumed.112.107011; Han L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027074; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Javeshghani S, 2012, CANCER RES, V72, P6257, DOI 10.1158/0008-5472.CAN-12-2907; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lea MA, 2011, ANTICANCER RES, V31, P421; Lee C, 2011, ONCOGENE, V30, P3305, DOI 10.1038/onc.2011.91; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Matsuo J, 2012, MOL CANCER THER, V11, P1082, DOI 10.1158/1535-7163.MCT-11-0871; Menendez JA, 2012, CELL CYCLE, V11, P2782, DOI 10.4161/cc.20948; Oleksyszyn J, 2011, MED HYPOTHESES, V77, P171, DOI 10.1016/j.mehy.2011.04.001; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; RIZKALLA SW, 1986, DIABETES METAB, V12, P219; Saito S, 2009, CANCER RES, V69, P4225, DOI 10.1158/0008-5472.CAN-08-2689; Salpeter SR, 2010, COCHRANE DATABASE SY; Sandulache VC, 2011, CANCER; Sandulache VC, 2011, CANCER-AM CANCER SOC, V117, P2926, DOI 10.1002/cncr.25868; Seyfried TN, 2011, BBA-BIOENERGETICS, V1807, P577, DOI 10.1016/j.bbabio.2010.08.009; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Sinnett-Smith J, 2013, BIOCHEM BIOPH RES CO, V430, P352, DOI 10.1016/j.bbrc.2012.11.010; Smith TAD, 2013, NUCL MED BIOL, V40, P858, DOI 10.1016/j.nucmedbio.2013.05.006; Vazquez-Martin A, 2009, CELL CYCLE, V8, P88, DOI 10.4161/cc.8.1.7499; Wu H, 2011, J PATHOL; Wu SB, 2012, BBA-MOL BASIS DIS, V1822, P233, DOI 10.1016/j.bbadis.2011.09.014; Zhou WH, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-5; Zhu Zongjian, 2011, J Carcinog, V10, P17; Zhuang Yongxian, 2008, J Mol Signal, V3, P18, DOI 10.1186/1750-2187-3-18; Zhuang YX, 2011, MOL CANCER RES, V9, P603, DOI 10.1158/1541-7786.MCR-10-0343	41	81	85	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108444	10.1371/journal.pone.0108444	http://dx.doi.org/10.1371/journal.pone.0108444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254953	Green Published, gold, Green Submitted			2022-12-25	WOS:000344862300083
J	Bo, S; Musso, G; Beccuti, G; Fadda, M; Fedele, D; Gambino, R; Gentile, L; Durazzo, M; Ghigo, E; Cassader, M				Bo, Simona; Musso, Giovanni; Beccuti, Guglielmo; Fadda, Maurizio; Fedele, Debora; Gambino, Roberto; Gentile, Luigi; Durazzo, Marilena; Ghigo, Ezio; Cassader, Maurizio			Consuming More of Daily Caloric Intake at Dinner Predisposes to Obesity. A 6-Year Population-Based Prospective Cohort Study	PLOS ONE			English	Article							ENERGY-INTAKE; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; WEIGHT-LOSS; CIRCADIAN VARIATION; INSULIN-RESISTANCE; EATING PATTERNS; BODY-MASS; BREAKFAST; TIME	Background/Objectives: It has been hypothesized that assuming most of the caloric intake later in the day leads to metabolic disadvantages, but few studies are available on this topic. Aim of our study was to prospectively examine whether eating more of the daily caloric intake at dinner leads to an increased risk of obesity, hyperglycemia, metabolic syndrome, and non-alcoholic fatty liver disease (NAFLD). Subjects/Methods: 1245 non-obese, non-diabetic middle-aged adults from a population-based cohort underwent a 3-day food record questionnaire at enrollment. Anthropometric values, blood pressure, blood metabolic variables, and estimated liver fat were measured at baseline and at 6-year follow-up. Design: Prospective cohort study. Results: Subjects were divided according to tertiles of percent daily caloric intake at dinner. A significant increase in the incidence rate of obesity (from 4.7 to 11.4%), metabolic syndrome (from 11.1 to 16.1%), and estimated NAFLD (from 16.5 to 23.8%) was observed from the lower to higher tertile. In a multiple logistic regression model adjusted for multiple covariates, subjects in the highest tertile showed an increased risk of developing obesity (OR = 2.33; 95% CI 1.17-4.65; p = 0.02), metabolic syndrome (OR = 1.52; 95% CI 1.01-2.30; p = 0.04), and NAFLD (OR = 1.56; 95% CI 1.10-2.22; p = 0.01). Conclusions: Consuming more of the daily energy intake at dinner is associated with an increased risk of obesity, metabolic syndrome, and NAFLD.	[Bo, Simona; Beccuti, Guglielmo; Fedele, Debora; Gambino, Roberto; Durazzo, Marilena; Ghigo, Ezio; Cassader, Maurizio] Univ Turin, Dept Med Sci, Turin, Italy; [Musso, Giovanni] Gradenigo Hosp, Emergency Dept, Turin, Italy; [Fadda, Maurizio] Citta Salute & Sci, Dietol Unit, Turin, Italy; [Gentile, Luigi] Hosp Asti, Diabet Clin, Asti, Italy	University of Turin; Humanitas Hospital Gradenigo; A.O.U. Citta della Salute e della Scienza di Torino	Bo, S (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.	simona.bo@unito.it	GAMBINO, Roberto/AAC-7517-2022; Bo, Simona/AAC-1110-2019; Beccuti, Guglielmo/AAI-5452-2021; Musso, Giovanni/AAB-7884-2022; Fadda, Maurizio/K-3091-2016	GAMBINO, Roberto/0000-0003-1902-3627; Beccuti, Guglielmo/0000-0003-3163-2361; Fadda, Maurizio/0000-0001-9205-8450; DURAZZO, Marilena/0000-0003-2450-5911; Bo, Simona/0000-0001-6862-8628	Regione Piemonte	Regione Piemonte(Regione Piemonte)	This study was supported by a grant from: Regione Piemonte, 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Naimi S, 2004, CHRONOBIOL INT, V21, P937, DOI 10.1081/CBI-200037171; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Almoosawi S, 2013, INT J OBESITY, V37, P725, DOI 10.1038/ijo.2012.103; Almoosawi S, 2012, EUR J CLIN NUTR, V66, P678, DOI 10.1038/ejcn.2011.210; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Baron KG, 2011, OBESITY, V19, P1374, DOI 10.1038/oby.2011.100; Berg C, 2009, APPETITE, V52, P21, DOI 10.1016/j.appet.2008.07.008; Bo S, 2005, DIABETES-METAB RES, V21, P515, DOI 10.1002/dmrr.561; Bo Simona, 2007, PLoS Clin Trials, V2, pe17, DOI 10.1371/journal.pctr.0020017; Bo S, 2006, AM J CLIN NUTR, V84, P1062, DOI 10.1093/ajcn/84.5.1062; Bray MS, 2010, INT J OBESITY, V34, P1589, DOI 10.1038/ijo.2010.63; Cahill LE, 2013, CIRCULATION, V128, P337, DOI 10.1161/CIRCULATIONAHA.113.001474; de Castro JM, 2004, J NUTR, V134, P104, DOI 10.1093/jn/134.1.104; de Castro JM, 2009, BRIT J NUTR, V102, P1228, DOI 10.1017/S0007114509371640; Eckel-Mahan KL, 2012, P NATL ACAD SCI USA, V109, P5541, DOI 10.1073/pnas.1118726109; ELOSUA R, 1994, AM J EPIDEMIOL, V139, P1197, DOI 10.1093/oxfordjournals.aje.a116966; Esquirol Y, 2009, CHRONOBIOL INT, V26, P544, DOI 10.1080/07420520902821176; Farshchi HR, 2005, AM J CLIN NUTR, V81, P388; Ferrari P, 2002, PUBLIC HEALTH NUTR, V5, P1329, DOI 10.1079/PHN2002409; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Forslund HB, 2002, EUR J CLIN NUTR, V56, P740, DOI 10.1038/sj.ejcn.1601387; Garaulet M, 2013, INT J OBESITY, V37, P604, DOI 10.1038/ijo.2012.229; Garaulet M, 2009, AM J CLIN NUTR, V90, P1466, DOI 10.3945/ajcn.2009.27536; Gluck ME, 2011, OBESITY, V19, P319, DOI 10.1038/oby.2010.206; GOETZ F, 1976, EXPERIENTIA, V32, P1081, DOI 10.1007/BF01933983; GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569; GOO RH, 1987, GASTROENTEROLOGY, V93, P515, DOI 10.1016/0016-5085(87)90913-9; Gregori D, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-132; Hibi M, 2013, AM J PHYSIOL-REG I, V304, pR94, DOI 10.1152/ajpregu.00115.2012; Jakubowicz D, 2013, OBESITY, V21, P2504, DOI 10.1002/oby.20460; JENKINS DJA, 1989, NEW ENGL J MED, V321, P929, DOI 10.1056/NEJM198910053211403; Kant AK, 1997, INT J OBESITY, V21, P407, DOI 10.1038/sj.ijo.0800422; Keim NL, 1997, J NUTR, V127, P75, DOI 10.1093/jn/127.1.75; KNUTSSON A, 1986, LANCET, V2, P89; Kotronen A, 2009, GASTROENTEROLOGY, V137, P865, DOI 10.1053/j.gastro.2009.06.005; Kroke A, 1999, AM J CLIN NUTR, V70, P439; Leidy HJ, 2013, AM J CLIN NUTR, V97, P677, DOI 10.3945/ajcn.112.053116; Levitsky DA, 2013, PHYSIOL BEHAV, V119, P9, DOI 10.1016/j.physbeh.2013.05.006; Lucassen EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056519; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mekary RA, 2012, AM J CLIN NUTR, V95, P1182, DOI 10.3945/ajcn.111.028209; RAVUSSIN E, 1985, J CLIN INVEST, V76, P1268, DOI 10.1172/JCI112083; ROMON M, 1993, AM J CLIN NUTR, V57, P476, DOI 10.1093/ajcn/57.4.476; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Summerbell CD, 1996, EUR J CLIN NUTR, V50, P513; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; Timlin MT, 2007, NUTR REV, V65, P268, DOI 10.1111/j.1753-4887.2007.tb00304.x; Tsuchida Y, 2013, J PHYSIOL ANTHROPOL, V32, DOI 10.1186/1880-6805-32-9; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; VANCAUTER E, 1985, J ENDOCRINOL INVEST, V8, P381, DOI 10.1007/BF03348519; VANCAUTER E, 1992, AM J PHYSIOL, V262, pE467, DOI 10.1152/ajpendo.1992.262.4.E467; VANCAUTER E, 1989, J CLIN ENDOCR METAB, V69, P604; Wang JB, 2014, J HUM NUTR DIET, V27, P255, DOI 10.1111/jhn.12141	55	89	90	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108467	10.1371/journal.pone.0108467	http://dx.doi.org/10.1371/journal.pone.0108467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250617	Green Submitted, gold, Green Published			2022-12-25	WOS:000342492700132
J	Dohi, K; Kraemer, BC; Erickson, MA; McMillan, PJ; Kovac, A; Flachbartova, Z; Hansen, KM; Shah, GN; Sheibani, N; Salameh, T; Banks, WA				Dohi, Kenji; Kraemer, Brian C.; Erickson, Michelle A.; McMillan, Pamela J.; Kovac, Andrej; Flachbartova, Zuzana; Hansen, Kim M.; Shah, Gul N.; Sheibani, Nader; Salameh, Therese; Banks, William A.			Molecular Hydrogen in Drinking Water Protects against Neurodegenerative Changes Induced by Traumatic Brain Injury	PLOS ONE			English	Article							INDUCED OXIDATIVE DAMAGE; BARRIER; TRANSPORT; PERICYTES; MATRIX-METALLOPROTEINASE-9; PERMEABILITY; EXPRESSION; CYTOKINES; ALPHA	Traumatic brain injury (TBI) in its various forms has emerged as a major problem for modern society. Acute TBI can transform into a chronic condition and be a risk factor for neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, probably through induction of oxidative stress and neuroinflammation. Here, we examined the ability of the antioxidant molecular hydrogen given in drinking water (molecular hydrogen water; mHW) to alter the acute changes induced by controlled cortical impact (CCI), a commonly used experimental model of TBI. We found that mHW reversed CCI-induced edema by about half, completely blocked pathological tau expression, accentuated an early increase seen in several cytokines but attenuated that increase by day 7, reversed changes seen in the protein levels of aquaporin-4, HIF-1, MMP-2, and MMP-9, but not for amyloid beta peptide 1-40 or 1-42. Treatment with mHW also reversed the increase seen 4 h after CCI in gene expression related to oxidation/carbohydrate metabolism, cytokine release, leukocyte or cell migration, cytokine transport, ATP and nucleotide binding. Finally, we found that mHW preserved or increased ATP levels and propose a new mechanism for mHW, that of ATP production through the Jagendorf reaction. These results show that molecular hydrogen given in drinking water reverses many of the sequelae of CCI and suggests that it could be an easily administered, highly effective treatment for TBI.	[Dohi, Kenji; Kraemer, Brian C.; Erickson, Michelle A.; Kovac, Andrej; Hansen, Kim M.; Salameh, Therese; Banks, William A.] Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA 98108 USA; [Dohi, Kenji] Jikei Univ, Sch Med, Dept Emergency Med, Tokyo, Japan; [Kraemer, Brian C.; Kovac, Andrej; Hansen, Kim M.; Salameh, Therese; Banks, William A.] Univ Washington, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA USA; [Kraemer, Brian C.; McMillan, Pamela J.] Vet Affairs Puget Sound Hlth Care Syst, Mental Illness Res Educ & Clin Ctr, Seattle, WA USA; [McMillan, Pamela J.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Flachbartova, Zuzana] Univ Vet Med & Pharm, Dept Microbiol & Immunol, Lab Biomed Microbiol & Immunol, Kosice, Slovakia; [Shah, Gul N.] St Louis Univ, Sch Med, Edward Doisy Res Ctr, Div Endocrinol,Dept Internal Med, St Louis, MO USA; [Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Jikei University; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; University of Veterinary Medicine Kosice; Saint Louis University; University of Wisconsin System; University of Wisconsin Madison	Banks, WA (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA 98108 USA.	wabanks1@uw.edu	Banks, William A/K-1330-2017; Erickson, Michelle/U-7754-2019; Erickson, Michelle/AAR-8717-2021; Sheibani, Nader/AAG-2379-2020; Erickson, Michelle/G-4815-2014	Banks, William A/0000-0002-0496-3619; Sheibani, Nader/0000-0003-2723-9217; Erickson, Michelle/0000-0002-2575-1594; dohi, kenji/0000-0002-4451-0382	Kiban C grant [23592683]; VA Merit Review [RO-1 AG029839, R0-1 NS064131];  [RO-1 DK083485]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES019851, P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029839] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002619] Funding Source: NIH RePORTER	Kiban C grant; VA Merit Review(US Department of Veterans Affairs); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	KD was supported by Kiban C grant number 23592683. WAB was supported by VA Merit Review; RO-1 AG029839. WAB and GNS was supported by RO-1 DK083485. BCK was supported by VA Merit Review; R0-1 NS064131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks William A., 1997, V73, P353; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; De Gasperi Rita, 2012, Front Neurol, V3, P177, DOI 10.3389/fneur.2012.00177; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Erickson MA, 2012, J ALZHEIMERS DIS, V28, P951, DOI 10.3233/JAD-2011-111517; Guthrie CR, 2009, HUM MOL GENET, V18, P1825, DOI 10.1093/hmg/ddp099; Halliday MR, 2013, JAMA NEUROL, V70, P1198, DOI 10.1001/jamaneurol.2013.3841; Hawkins BE, 2013, J BIOL CHEM; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; JAGENDORF AT, 1966, P NATL ACAD SCI USA, V55, P170, DOI 10.1073/pnas.55.1.170; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Keep RF, 2012, TRANSL STROKE RES, V3, P263, DOI 10.1007/s12975-012-0152-2; Kovac A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-139; Miyamoto K, 2014, J MOL NEUROSCI; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Pan WH, 2006, J NEUROIMMUNOL, V174, P119, DOI 10.1016/j.jneuroim.2006.02.006; Pan WH, 1997, NEUROSCI BIOBEHAV R, V21, P603, DOI 10.1016/S0149-7634(96)00047-4; Pan WH, 1996, AM J PHYSIOL-ENDOC M, V271, pE636, DOI 10.1152/ajpendo.1996.271.4.E636; Pan WH, 2000, EXP NEUROL, V170, P357, DOI 10.1006/exnr.2001.7702; Pan WH, 1998, BRAIN RES, V788, P87, DOI 10.1016/S0006-8993(97)01525-4; Price TO, 2012, ENDOCRINOLOGY, V153, P362, DOI 10.1210/en.2011-1638; Reyes TM, 1999, BRAIN RES, V851, P215, DOI 10.1016/S0006-8993(99)02189-7; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Shah GN, 2013, J PHARMACOL EXP THER, V344, P637, DOI 10.1124/jpet.112.201400; Silverberg GD, 2010, J NEUROPATH EXP NEUR, V69, P1034, DOI 10.1097/NEN.0b013e3181f46e25; Soustiel JF, 2010, NEUROTHERAPEUTICS, V7, P13, DOI 10.1016/j.nurt.2009.11.001; Verma S, 2006, BRAIN BEHAV IMMUN, V20, P449, DOI 10.1016/j.bbi.2005.10.005; Wick Jeannette Y, 2012, Consult Pharm, V27, P392, DOI 10.4140/TCP.n.2012.392	33	33	35	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108034	10.1371/journal.pone.0108034	http://dx.doi.org/10.1371/journal.pone.0108034			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251220	Green Published, Green Submitted, gold			2022-12-25	WOS:000342492700070
J	Dunham, NR; Peper, ST; Baxter, CE; Kendall, RJ				Dunham, Nicholas R.; Peper, Steven T.; Baxter, Catherine E.; Kendall, Ronald J.			The Parasitic Eyeworm Oxyspirura petrowi as a Possible Cause of Decline in the Threatened Lesser Prairie-Chicken (Tympanuchus pallidicinctus)	PLOS ONE			English	Article							RED GROUSE; POPULATIONS; TETRAONIDAE; TEXAS	Lesser prairie-chickens (Tympanuchus pallidicinctus) have been declining range wide since the early 1900's despite efforts to establish conservation and improve their habitat. In early 2014, the lesser prairie-chicken was listed as a threatened species under the U. S Endangered Species Act and the need to find out why they are declining is more important than ever. Nine hunter shot lesser prairie-chickens were donated and sampled for the presence or absence of the eyeworm Oxyspirura petrowi, a known parasite that can cause damage to the eye of its host, and common environmental contaminants. Eyeworm infection was found in 7 of 9 birds (78% infection rate) with an infection range between 0-16 O. petrowi per bird. Breast, liver, and fat tissue samples from the lesser prairie-chickens were analyzed for the frequency of 20 organochlorine pesticides. Femurs and livers were also tested on these birds for metal contaminants. Pesticides were found in several samples above the detection limits but were still in the low ng/g range. Notable was the ubiquitous presence of endrin aldehyde across all tissues. One femur showed 5.66 mu g/g of lead (Pb) but this is still relatively low. No liver samples had elevated mercury (Hg) above detection limits. The presence of these organochlorines is consistent with the historic use of pesticides in this region. With pesticide and metals found in such low levels and parasitic nematode infections at rather high levels, it is recommended that these parasites be further evaluated as a contributing factor to the decline of the lesser prairie-chicken.	[Dunham, Nicholas R.; Peper, Steven T.; Baxter, Catherine E.; Kendall, Ronald J.] Texas Tech Univ, Inst Environm & Human Hlth, Wildlife Toxicol Lab, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Kendall, RJ (corresponding author), Texas Tech Univ, Inst Environm & Human Hlth, Wildlife Toxicol Lab, Lubbock, TX 79409 USA.	ron.kendall@ttu.edu	Dunham, Nicholas/AAF-6592-2020					ADDISON EM, 1969, CAN J ZOOLOG, V47, P1223, DOI 10.1139/z69-191; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Cattadori IM, 2005, NATURE, V433, P737, DOI 10.1038/nature03276; Cieslik E, 2011, FOOD CHEM, V125, P773, DOI 10.1016/j.foodchem.2010.09.019; Dunham NR, 2014, J WILDLIFE DIS, V50, P552, DOI 10.7589/2013-10-275; Dunham NR, 2014, J PARASITOL; ERICKSON AB, 1949, J WILDLIFE MANAGE, V13, P188, DOI 10.2307/3796088; Fimreite N, 1984, ENV CONTAM TOXICOL, V33, P121; Friend M, 1999, FIELD MANUAL WILDLIF, P295; Hagen CA, 2004, WILDLIFE SOC B, V32, P69, DOI 10.2193/0091-7648(2004)32[69:GFMLPP]2.0.CO;2; Hellou J, 2012, ENVIRON REV, V21, P53; HUDSON PJ, 1992, J ANIM ECOL, V61, P681, DOI 10.2307/5623; Kendall RJ, 1996, ENVIRON TOXICOL CHEM, V15, P4, DOI 10.1002/etc.5620150103; Mackay Donald, 1997, ILLUSTRATED HDB PHYS; MCCLURE HE, 1949, J WILDLIFE MANAGE, V13, P304, DOI 10.2307/3795873; PENCE DB, 1979, P HELM SOC WASH, V46, P146; Robel RJ, 2003, WILDLIFE BIOL, V9, P341, DOI 10.2981/wlb.2003.023; Ruff M. D., 1984, Diseases of poultry., P614; SCHWABE CALVIN W., 1951, PACIFIC SCI, V5, P18; United States Environmental Protection Agency (EPA), 2020, SW846 US EPA; United States Fish and Wildlife Service, 2014, FED REG, V79; US EPA, 1996, 3050B USEPA	22	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108244	10.1371/journal.pone.0108244	http://dx.doi.org/10.1371/journal.pone.0108244			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250776	Green Published, gold, Green Submitted			2022-12-25	WOS:000342492700101
J	Ferreira-Paim, K; Ferreira, TB; Andrade-Silva, L; Mora, DJ; Springer, DJ; Heitman, J; Fonseca, FM; Matos, D; Melhem, MSC; Silva-Vergara, ML				Ferreira-Paim, Kennio; Ferreira, Thatiana Bragine; Andrade-Silva, Leonardo; Mora, Delio Jose; Springer, Deborah J.; Heitman, Joseph; Fonseca, Fernanda Machado; Matos, Dulcilena; Carvalho Melhem, Maarcia Souza; Silva-Vergara, Mario Leon			Phylogenetic Analysis of Phenotypically Characterized Cryptococcus laurentii Isolates Reveals High Frequency of Cryptic Species	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; BASIDIOMYCETOUS YEAST; SP NOV.; NEOFORMANS; GATTII; PATIENT; IDENTIFICATION; SUBSTITUTIONS; EPIDEMIOLOGY; MENINGITIS	Background: Although Cryptococcus laurentii has been considered saprophytic and its taxonomy is still being described, several cases of human infections have already reported. This study aimed to evaluate molecular aspects of C. laurentii isolates from Brazil, Botswana, Canada, and the United States. Methods: In this study, 100 phenotypically identified C. laurentii isolates were evaluated by sequencing the 18S nuclear ribosomal small subunit rRNA gene (18S-SSU), D1/D2 region of 28S nuclear ribosomal large subunit rRNA gene (28S-LSU), and the internal transcribed spacer (ITS) of the ribosomal region. Results: BLAST searches using 550-bp, 650-bp, and 550-bp sequenced amplicons obtained from the 18S-SSU, 28S-LSU, and the ITS region led to the identification of 75 C. laurentii strains that shared 99-100% identity with C. laurentii CBS 139. A total of nine isolates shared 99% identity with both Bullera sp. VY-68 and C. laurentii RY1. One isolate shared 99% identity with Cryptococcus rajasthanensis CBS 10406, and eight isolates shared 100% identity with Cryptococcus sp. APSS 862 according to the 28S-LSU and ITS regions and designated as Cryptococcus aspenensis sp. nov. (CBS 13867). While 16 isolates shared 99% identity with Cryptococcus flavescens CBS 942 according to the 18S-SSU sequence, only six were confirmed using the 28S-LSU and ITS region sequences. The remaining 10 shared 99% identity with Cryptococcus terrestris CBS 10810, which was recently described in Brazil. Through concatenated sequence analyses, seven sequence types in C. laurentii, three in C. flavescens, one in C. terrestris, and one in the C. aspenensis sp. nov. were identified. Conclusions: Sequencing permitted the characterization of 75% of the environmental C. laurentii isolates from different geographical areas and the identification of seven haplotypes of this species. Among sequenced regions, the increased variability of the ITS region in comparison to the 18S-SSU and 28S-LSU regions reinforces its applicability as a DNA barcode.	[Ferreira-Paim, Kennio; Ferreira, Thatiana Bragine; Andrade-Silva, Leonardo; Mora, Delio Jose; Fonseca, Fernanda Machado; Silva-Vergara, Mario Leon] Triangulo Mineiro Fed Univ, Dept Infect & Parasit Dis, Uberaba, MG, Brazil; [Springer, Deborah J.; Heitman, Joseph] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA; [Heitman, Joseph] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Heitman, Joseph] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA; [Matos, Dulcilena; Carvalho Melhem, Maarcia Souza] Adolfo Lutz Inst, Publ Hlth Reference Lab, Sao Paulo, Brazil	Universidade Federal do Triangulo Mineiro; Duke University; Duke University; Duke University; Instituto Adolfo Lutz	Ferreira-Paim, K (corresponding author), Triangulo Mineiro Fed Univ, Dept Infect & Parasit Dis, Uberaba, MG, Brazil.	kenniopaim@gmail.com	Fonseca, Fernanda/E-8285-2018; Heitman, Joseph/ABC-6006-2021; Fonseca, Fernanda Machado/AAV-8930-2021; Mora, Delio José/G-1614-2012; andrade-silva, leonardo/AAA-4356-2020; FONSECA, FERNANDA/HDN-9451-2022; Ferreira-Paim, Kennio/A-8194-2013	Fonseca, Fernanda/0000-0002-5326-0776; andrade-silva, leonardo/0000-0002-0485-229X; FONSECA, FERNANDA/0000-0002-0315-6479; Ferreira-Paim, Kennio/0000-0002-6035-8392; MELHEM, MARCIA/0000-0002-1335-8808; Castro e Silva, Dulcilena de Matos/0000-0003-2772-0609	Fundacao de Amparo a Pesquisa de Minas Gerais-FAPEMIG [APQ-01735-10]	Fundacao de Amparo a Pesquisa de Minas Gerais-FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by Fundacao de Amparo a Pesquisa de Minas Gerais-FAPEMIG APQ-01735-10 [to M. L. S. V.]. K. F. P. is a research fellow of CAPES: Process number 9313/13-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminnejad M, 2012, MYCOPATHOLOGIA, V173, P337, DOI 10.1007/s11046-011-9491-x; Andrade-Silva L, 2010, FUNGAL BIOL-UK, V114, P438, DOI 10.1016/j.funbio.2010.03.005; Averbuch D, 2002, MED MYCOL, V40, P479, DOI 10.1080/714031137; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Banerjee P, 2013, INDIAN J MED MICROBI, V31, P75, DOI 10.4103/0255-0857.108731; Bauters TGM, 2002, MYCOPATHOLOGIA, V153, P133, DOI 10.1023/A:1014551200043; Bovers M, 2008, EMERG INFECT DIS, V14, P1105, DOI 10.3201/eid1407.080122; Bovers M, 2006, FEMS YEAST RES, V6, P599, DOI 10.1111/j.1567-1364.2006.00082.x; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; Crestani J, 2009, INT J SYST EVOL MICR, V59, P631, DOI 10.1099/ijs.0.001800-0; Danesi P, 2014, FEMS YEAST RES, V14, P897, DOI 10.1111/1567-1364.12178; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fell JW, 1999, INT J SYST BACTERIOL, V49, P907, DOI 10.1099/00207713-49-2-907; Fell JW, 2000, INT J SYST EVOL MICR, V50, P1351, DOI 10.1099/00207713-50-3-1351; Ferreira-Paim K, 2012, MYCOPATHOLOGIA, V174, P41, DOI 10.1007/s11046-011-9500-0; Ferreira-Paim K, 2011, MYCOSES, V54, pE294, DOI 10.1111/j.1439-0507.2010.01901.x; Filion T, 2006, MYCOPATHOLOGIA, V162, P363, DOI 10.1007/s11046-006-0066-1; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Granados DP, 2005, MICROB ECOL, V49, P282, DOI 10.1007/s00248-004-0236-y; Guerreiro MA, 2013, EUKARYOT CELL, V12, P746, DOI 10.1128/EC.00065-13; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Johnson LB, 1998, MYCOSES, V41, P277, DOI 10.1111/j.1439-0507.1998.tb00338.x; Kaocharoen S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002297; Kasuga T, 2002, MOL BIOL EVOL, V19, P2318, DOI 10.1093/oxfordjournals.molbev.a004056; Kidd SE, 2007, APPL ENVIRON MICROB, V73, P1433, DOI 10.1128/AEM.01330-06; Kiertiburanakul S., 2001, Journal of Infectious Diseases and Antimicrobial Agents, V18, P112; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kordossis T, 1998, MED MYCOL, V36, P335, DOI 10.1080/02681219880000521; Kufferath H, 1920, ANN B SOC R SCI MED, V74, P16; Kurtzman CP, 1997, J CLIN MICROBIOL, V35, P1216, DOI 10.1128/JCM.35.5.1216-1223.1997; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Litvintseva AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019688; Lockhart SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074737; Lodder J, 1934, VERHANDEL KONINKL AC, V32, P1; Manfredi R, 2006, AIDS PATIENT CARE ST, V20, P227, DOI 10.1089/apc.2006.20.227; Marimon R, 2007, J CLIN MICROBIOL, V45, P3198, DOI 10.1128/JCM.00808-07; McCulloh RJ, 2011, PEDIATR INFECT DIS J, V30, P1111, DOI 10.1097/INF.0b013e31822d14fd; Nagy LG, 2013, MYCOLOGIA, V105, P112, DOI 10.3852/12-136; Pino-Bodas R, 2013, MOL ECOL RESOUR, V13, P1058, DOI 10.1111/1755-0998.12086; Randhawa HS, 2005, MED MYCOL, V43, P67, DOI 10.1080/13693780410001712025; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rosario I, 2010, MYCOPATHOLOGIA, V169, P315, DOI 10.1007/s11046-009-9262-0; Saito K, 1922, MITT JPN J BOT, V1, P1; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Scicluna SM, 2006, PROTIST, V157, P77, DOI 10.1016/j.protis.2005.12.001; Scorzetti G, 2000, ANTON LEEUW INT J G, V77, P153, DOI 10.1023/A:1002124504936; Shankar Esaki Muthu, 2006, Can Respir J, V13, P275; Simon G, 2005, PEDIATR INFECT DIS J, V24, P935, DOI 10.1097/01.inf.0000180979.47410.45; SKINNER CE, 1950, AM MIDL NAT, V43, P242, DOI 10.2307/2421894; STAIB F, 1963, Z HYG INFEKTIONSKR, V149, P329, DOI 10.1007/BF02157302; Steenbergen JN, 2000, J CLIN MICROBIOL, V38, P1974, DOI 10.1128/JCM.38.5.1974-1976.2000; Sugita T, 2000, J CLIN MICROBIOL, V38, P1468, DOI 10.1128/JCM.38.4.1468-1471.2000; Sugita T, 1999, J CLIN MICROBIOL, V37, P1985, DOI 10.1128/JCM.37.6.1985-1993.1999; Takashima M, 2003, INT J SYST EVOL MICR, V53, P1187, DOI 10.1099/ijs.0.02498-0; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka R, 1996, J MED VET MYCOL, V34, P299; Tay ST, 2008, MYCOSES, V51, P515, DOI 10.1111/j.1439-0507.2008.01516.x; Teixeira MM, 2009, MOL PHYLOGENET EVOL, V52, P273, DOI 10.1016/j.ympev.2009.04.005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Warren K, 2014, NEUROLOGY S, V82, P323; Yurkov AM, 2013, MYCOL PROG, V12, P777, DOI 10.1007/s11557-012-0873-3	66	18	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108633	10.1371/journal.pone.0108633	http://dx.doi.org/10.1371/journal.pone.0108633			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251413	Green Published, Green Submitted, gold			2022-12-25	WOS:000342492700146
J	Ghekiere, A; Van Cauwenberg, J; de Geus, B; Clarys, P; Cardon, G; Salmon, J; De Bourdeaudhuij, I; Deforche, B				Ghekiere, Ariane; Van Cauwenberg, Jelle; de Geus, Bas; Clarys, Peter; Cardon, Greet; Salmon, Jo; De Bourdeaudhuij, Ilse; Deforche, Benedicte			Critical Environmental Factors for Transportation Cycling in Children: A Qualitative Study Using Bike-Along Interviews	PLOS ONE			English	Article							PHYSICAL-ACTIVITY LEVELS; ACTIVE SCHOOL TRANSPORT; BUILT ENVIRONMENT; WALKING; NEIGHBORHOOD; QUESTIONNAIRE; ASSOCIATIONS; RELIABILITY; FRAMEWORK; ATTITUDES	Background: Environmental factors are found to influence transport-related physical activity, but have rarely been studied in relation with cycling for transport to various destinations in 10-12 yr old children. The current qualitative study used 'bike-along interviews' with children and parents to allow discussion of detailed environmental factors that may influence children's cycling for transport, while cycling in the participant's neighborhood. Methods: Purposeful convenience sampling was used to recruit 35 children and one of their parents residing in (semi-) urban areas. Bike-along interviews were conducted to and from a randomly chosen destination (e. g. library) within a 15 minutes' cycle trip in the participant's neighborhood. Participants wore a GoPro camera to objectively assess environmental elements, which were subsequently discussed with participants. Content analysis and arising themes were derived using a grounded theory approach. Results: The discussed environmental factors were categorized under traffic, urban design, cycling facilities, road design, facilities at destination, aesthetics, topography, weather, social control, stranger danger and familiar environment. Across these categories many environmental factors were (in) directly linked to road safety. This was illustrated by detailed discussions of the children's visibility, familiarity with specific traffic situations, and degree of separation, width and legibility of cycle facilities. Conclusion: Road safety is of major concern in this 10-12 yr old study population. Bike-along interviews were able to identify new, detailed and context-specific physical environmental factors which could inform policy makers to promote children's cycling for transport. However, future studies should investigate whether hypothetical changes to such micro environmental features influence perceptions of safety and if this in turn could lead to changes in children's cycling for transport.	[Ghekiere, Ariane; Van Cauwenberg, Jelle; Clarys, Peter; Deforche, Benedicte] Vrije Univ Brussel, Fac Phys Educ & Phys Therapy, Dept Human Biometry & Biomech, Brussels, Belgium; [Ghekiere, Ariane; Van Cauwenberg, Jelle; Cardon, Greet; De Bourdeaudhuij, Ilse; Deforche, Benedicte] Univ Ghent, Fac Med & Hlth Sci, Dept Movement & Sport Sci, B-9000 Ghent, Belgium; [Van Cauwenberg, Jelle] Fund Sci Res Flanders FWO, Brussels, Belgium; [de Geus, Bas] Vrije Univ Brussel, Fac Phys Educ & Phys Therapy, Dept Human Physiol, Brussels, Belgium; [Salmon, Jo] Deakin Univ, Ctr Phys Act & Nutr Res, Sch Exercise & Nutr Sci, Melbourne, Vic, Australia	Vrije Universiteit Brussel; Ghent University; Vrije Universiteit Brussel; Deakin University	Ghekiere, A (corresponding author), Vrije Univ Brussel, Fac Phys Educ & Phys Therapy, Dept Human Biometry & Biomech, Brussels, Belgium.	Ariane.Ghekiere@vub.ac.be	De+Bourdeaudhuij, Ilse/AAC-5528-2019; de Geus, Bas/F-5335-2011; Salmon, Jo/C-1226-2009; Salmon, Jo/X-2630-2019	De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; de Geus, Bas/0000-0001-7447-0230; Salmon, Jo/0000-0002-4734-6354; Salmon, Jo/0000-0002-4734-6354; Van Cauwenberg, Jelle/0000-0003-1292-6241; Cardon, Greet/0000-0003-4983-6557	Vrije Universiteit Brussel [OZR1937BOF]; National Health and Medical Research Council of Australia [APP1026216]	Vrije Universiteit Brussel; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The study was supported by a research grant from the Vrije Universiteit Brussel (OZR1937BOF). JS is supported by a National Health and Medical Research Council of Australia Principal Research Fellowship (APP1026216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlport KN, 2008, HEALTH EDUC BEHAV, V35, P221, DOI 10.1177/1090198106288794; Serrano-Sanchez JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038693; Baranowski T, 1998, AM J PREV MED, V15, P266, DOI 10.1016/S0749-3797(98)00080-4; Brug J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034742; Carpiano RM, 2009, HEALTH PLACE, V15, P263, DOI 10.1016/j.healthplace.2008.05.003; Carver A, 2008, HEALTH PLACE, V14, P217, DOI 10.1016/j.healthplace.2007.06.004; Cerin E, 2013, PREV MED, V56, P86, DOI 10.1016/j.ypmed.2012.10.024; Chillon P, 2012, PREV MED, V55, P108, DOI 10.1016/j.ypmed.2012.05.019; Christie N, 2011, J TRANSP GEOGR, V19, P943, DOI 10.1016/j.jtrangeo.2010.12.003; Cooper AR, 2005, AM J PREV MED, V29, P179, DOI 10.1016/j.amepre.2005.05.009; Cooper AR, 2008, PREV MED, V47, P324, DOI 10.1016/j.ypmed.2008.06.009; Cornelis E., 2012, BELGIAN DAILY MOBILI; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; D'Haese S, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-88; Davison KK, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-19; de Vries SI, 2010, BUILT ENV CORRELATES; Ding D, 2012, HEALTH PLACE, V18, P100, DOI 10.1016/j.healthplace.2011.08.021; Ducheyne F, 2013, ACCIDENT ANAL PREV, V59, P38, DOI 10.1016/j.aap.2013.05.018; Ducheyne F, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-142; Faulkner GEJ, 2009, PREV MED, V48, P3, DOI 10.1016/j.ypmed.2008.10.017; Fraser SDS, 2011, EUR J PUBLIC HEALTH, V21, P738, DOI 10.1093/eurpub/ckq145; Garrard J, 2012, URBAN IND ENVIRON, P211; Goodman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071790; Hillman M., 1990, ONE FALSE MOVE; Kerr J, 2006, MED SCI SPORT EXER, V38, P787, DOI 10.1249/01.mss.0000210208.63565.73; Kremers SPJ, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-9; Kusenbach M, 2003, ETHNOGRAPHY, V4, P455, DOI DOI 10.1177/146613810343007; Lenders SLL, 2006, DELINEATION FLEMISH; Li ZB, 2012, TRANSPORT RES D-TR E, V17, P256, DOI 10.1016/j.trd.2011.12.001; Lin JJ, 2011, TRANSPORT POLICY, V18, P246, DOI 10.1016/j.tranpol.2010.08.008; Lubans DR, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-5; Mammen G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-862; Martensen H, 2014, RISK ANAL RIS ERNST; Matton L, 2007, RES Q EXERCISE SPORT, V78, P293; McMillan TE, 2005, J PLAN LIT, V19, P440, DOI 10.1177/0885412204274173; McNeil N, 2013, INCREASE BICYCLING D; Mobiel Vlaanderen, 2013, RAPP OND VERPL VLAAN; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Ogilvie D, 2004, BMJ-BRIT MED J, V329, P763, DOI 10.1136/bmj.38216.714560.55; Ortega FB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060871; Owen CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030932; Panter JR, 2010, J EPIDEMIOL COMMUN H, V64, P41, DOI 10.1136/jech.2009.086918; Panter JR, 2010, AM J PREV MED, V38, P268, DOI 10.1016/j.amepre.2009.10.040; Panter JR, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-34; Pont K, 2009, HEALTH PLACE, V15, P849, DOI 10.1016/j.healthplace.2009.02.002; Pucher J, 2012, URBAN IND ENVIRON, P1; Saelens BE, 2003, AM J PUBLIC HEALTH, V93, P1552, DOI 10.2105/AJPH.93.9.1552; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Schindler, 2008, BUSINESS RES METHODS; Trapp GSA, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-123; Van Cauwenberg J, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-37; Van Cauwenberg J, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-85; Vlaamse Overheid, 2012, BEV VLAAND; Vladutiu CJ, 2006, INJURY PREV, V12, P35, DOI 10.1136/ip.2004.007153; *WHO, 2006, PREV DIS HLTH ENV ES; Wong BYM, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-39; Yeung J, 2008, TRANSPORT RES A-POL, V42, P895, DOI 10.1016/j.tra.2007.12.007	57	38	38	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e106696	10.1371/journal.pone.0106696	http://dx.doi.org/10.1371/journal.pone.0106696			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ0SJ	25250738	Green Published, Green Submitted, gold			2022-12-25	WOS:000342492700016
J	Hsing, J; Peters, DC; Knowles, BR; Manning, WJ; Josephson, ME				Hsing, Jeff; Peters, Dana C.; Knowles, Benjamin R.; Manning, Warren J.; Josephson, Mark E.			Cardiovascular Magnetic Resonance Imaging of Scar Development Following Pulmonary Vein Isolation: A Prospective Study	PLOS ONE			English	Article							LATE GADOLINIUM ENHANCEMENT; RADIOFREQUENCY ABLATION LESIONS; ATRIAL-FIBRILLATION; CATHETER ABLATION; MYOCARDIAL-INFARCTION; DIAGNOSTIC-ACCURACY; DELAYED ENHANCEMENT; ANTRUM ISOLATION; VISUALIZATION; CONDUCTION	Aims: Cardiovascular magnetic resonance (MR) provides non-invasive assessment of early (24-hour) edema and injury following pulmonary vein isolation (by ablation) and subsequent scar formation. We hypothesize that 24-hours after ablation, cardiovascular MR would demonstrate a pattern of edema and injury due to ablation and the severity would correlate with subsequent scar. Methods: Fifteen atrial fibrillation patients underwent cardiovascular MR prior to pulmonary vein isolation, 24-hours post (N = 11) and 30-days post (N = 7) ablation, with T2-weighted (T2W) and late gadolinium enhancement (LGE) imaging. Left atrial wall thickness, edema enhancement ratio and LGE enhancement were assessed at each time point. Volumes of LGE and edema enhancement were measured, and the circumferential presence of injury was assessed at 24-hours, including comparison with LGE enhancement at 30 days. Results: Left atrial wall thickness was increased 24-hours post-ablation (10.7 +/- 4.1 mm vs. 7.0 +/- 1.8 mm pre-PVI, p<0.05). T2W enhancement at 24-hours showed increased edema enhancement ratio (1.5 +/- 0.4 for post-ablation, vs. 0.9 +/- 0.2 pre-ablation, p<0.001). Edema and LGE volumes at 24-hours were correlated with 30-day LGE volume (R = 0.76, p = 0.04, and R = 0.74, p = 0.09, respectively). Using a 16 segment model for assessment, 24-hour T2W had sensitivity, specificity, and accuracy of 82%, 63%, and 79% respectively, for predicting 30-day LGE. 24-hour LGE had sensitivity, specificity, and accuracy of 91%, 47%, and 84%. Conclusions: Increased left atrial wall thickening and edema were characterized on cardiovascular MR early post-ablation, and found to correlate with 30-day LGE scar.	[Hsing, Jeff; Peters, Dana C.; Knowles, Benjamin R.; Manning, Warren J.; Josephson, Mark E.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Cardiovasc Div, Boston, MA 02215 USA; [Manning, Warren J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Radiol, Boston, MA 02215 USA; [Peters, Dana C.] Yale Univ, Sch Med, Dept Radiol, New Haven, CT 06510 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Yale University	Peters, DC (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Cardiovasc Div, Boston, MA 02215 USA.	dana.peters@yale.edu		Peters, Dana/0000-0001-7556-4642	NIH [NHLBI R21 HL 098573, R21 HL103463]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL098573, R21HL103463] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by in part by grants from the NIH (NHLBI R21 HL 098573 & R21 HL103463). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aty H, 2004, CIRCULATION, V109, P2411, DOI 10.1161/01.CIR.0000127428.10985.C6; Arujuna A, 2012, CIRC-ARRHYTHMIA ELEC, V5, P691, DOI 10.1161/CIRCEP.111.966523; Badger TJ, CIRCULATION ARRHYTHM, V3, P249; Badger TJ, 2009, CIRC-ARRHYTHMIA ELEC, V2, P620, DOI 10.1161/CIRCEP.109.871939; Badger TJ, 2009, HEART RHYTHM, V6, P161, DOI 10.1016/j.hrthm.2008.10.042; Beinart R, 2011, J CARDIOVASC ELECTR, V22, P1232, DOI 10.1111/j.1540-8167.2011.02100.x; Dickfeld T, 2006, J AM COLL CARDIOL, V47, P370, DOI 10.1016/j.jacc.2005.07.070; Dickfeld T, 2007, HEART RHYTHM, V4, P208, DOI 10.1016/j.hrthm.2006.10.019; Essebag V, 2006, J INTERV CARD ELECTR, V17, P111, DOI 10.1007/s10840-006-9057-x; Gutberlet M, 2008, RADIOLOGY, V246, P401, DOI 10.1148/radiol.2461062179; Hunter RJ, 2013, J CARDIOVASC ELECTR, V24, P396, DOI 10.1111/jce.12063; Karim R, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-105; Kim RJ, 1999, CIRCULATION, V100, P1992, DOI 10.1161/01.CIR.100.19.1992; Knowles BR, 2010, IEEE T BIO-MED ENG, V57, P1467, DOI 10.1109/TBME.2009.2038791; Kolandaivelu A, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-21; Look D. C., 1970, Review of Scientific Instruments, V41, P250, DOI 10.1063/1.1684482; Malcolme-Lawes LC, 2013, HEART RHYTHM; Malcolme-Lawes LC, 2013, CIRC-ARRHYTHMIA ELEC, V6, P632, DOI 10.1161/CIRCEP.113.000193; McGann C, J AM COLL CARDIOL, V58, P177; McGann CJ, 2008, J AM COLL CARDIOL, V52, P1263, DOI 10.1016/j.jacc.2008.05.062; Nanthakumar K, 2004, CIRCULATION, V109, P1226, DOI 10.1161/01.CIR.0000121423.78120.49; Nordbeck P, 2013, HEART RHYTHM, V10, P938, DOI 10.1016/j.hrthm.2011.12.017; Okada T, 2007, J AM COLL CARDIOL, V49, P1436, DOI 10.1016/j.jacc.2006.10.076; Ouyang FF, 2005, CIRCULATION, V111, P127, DOI 10.1161/01.CIR.0000151289.73085.36; Peters DC, 2007, RADIOLOGY, V243, P690, DOI 10.1148/radiol.2433060417; Peters DC, 2013, J MAGN RESON IMAGING, V38, P1210, DOI 10.1002/jmri.23954; Peters DC, 2009, JACC-CARDIOVASC IMAG, V2, P308, DOI 10.1016/j.jcmg.2008.10.016; Peters NS, 2002, LANCET, V359, P593, DOI 10.1016/S0140-6736(02)07748-6; Ranjan R, 2011, CIRC-ARRHYTHMIA ELEC, V4, P279, DOI 10.1161/CIRCEP.110.960567; Schmidt EJ, 2009, CIRC-ARRHYTHMIA ELEC, V2, P695, DOI 10.1161/CIRCEP.109.882472; Schmidt EJ, 2013, EUROPACE; Simonetti OP, 2001, RADIOLOGY, V218, P215, DOI 10.1148/radiology.218.1.r01ja50215; Sorgente A, 2012, AM J CARDIOL, V109, P1179, DOI 10.1016/j.amjcard.2011.11.058; Suenari K, 2013, HEART VESSELS, V28, P360, DOI 10.1007/s00380-012-0253-6; Taclas JE, 2010, HEART RHYTHM, V7, P489, DOI 10.1016/j.hrthm.2009.12.007; Truong MT, 2003, AM J ROENTGENOL, V181, P1109, DOI 10.2214/ajr.181.4.1811109; Vergara GR, 2011, HEART RHYTHM, V8, P295, DOI 10.1016/j.hrthm.2010.10.032; Verma A, 2004, J CARDIOVASC ELECTR, V15, P1335, DOI 10.1046/j.1540-8167.2004.04428.x; Verma A, 2005, CIRCULATION, V112, P627, DOI 10.1161/CIRCULATIONAHA.104.533190; Wu KC, 1998, CIRCULATION, V97, P765, DOI 10.1161/01.CIR.97.8.765; Yokokawa M, CIRC J, V74, P1538	41	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e104844	10.1371/journal.pone.0104844	http://dx.doi.org/10.1371/journal.pone.0104844			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251403	Green Submitted, Green Published, gold			2022-12-25	WOS:000342492700005
J	Mukkavilli, R; Gundala, SR; Yang, CH; Donthamsetty, S; Cantuaria, G; Jadhav, GR; Vangala, S; Reid, MD; Aneja, R				Mukkavilli, Rao; Gundala, Sushma R.; Yang, Chunhua; Donthamsetty, Shashikiran; Cantuaria, Guilherme; Jadhav, Gajanan R.; Vangala, Subrahmanyam; Reid, Michelle D.; Aneja, Ritu			Modulation of Cytochrome P450 Metabolism and Transport across Intestinal Epithelial Barrier by Ginger Biophenolics	PLOS ONE			English	Article							DRUG-INTERACTIONS; LIVER-MICROSOMES; CYP1A2 ACTIVITY; P-GLYCOPROTEIN; CACO-2 CELLS; ENZYMES; EXPRESSION; 3A; PHARMACOKINETICS; GLUCURONIDATION	Natural and complementary therapies in conjunction with mainstream cancer care are steadily gaining popularity. Ginger extract (GE) confers significant health-promoting benefits owing to complex additive and/or synergistic interactions between its bioactive constituents. Recently, we showed that preservation of natural "milieu'' confers superior anticancer activity on GE over its constituent phytochemicals, 6-gingerol (6G), 8-gingerol (8G), 10-gingerol (10G) and 6-shogaol (6S), through enterohepatic recirculation. Here we further evaluate and compare the effects of GE and its major bioactive constituents on cytochrome P450 (CYP) enzyme activity in human liver microsomes by monitoring metabolites of CYP-specific substrates using LC/MS/MS detection methods. Our data demonstrate that individual gingerols are potent inhibitors of CYP isozymes, whereas GE exhibits a much higher half-maximal inhibition value, indicating no possible herb-drug interactions. However, GE's inhibition of CYP1A2 and CYP2C8 reflects additive interactions among the constituents. In addition, studies performed to evaluate transporter-mediated intestinal efflux using Caco-2 cells revealed that GE and its phenolics are not substrates of P-glycoprotein (Pgp). Intriguingly, however, 10G and 6S were not detected in the receiver compartment, indicating possible biotransformation across the Caco-2 monolayer. These data strengthen the notion that an interplay of complex interactions among ginger phytochemicals when fed as whole extract dictates its bioactivity highlighting the importance of consuming whole foods over single agents. Our study substantiates the need for an in-depth analysis of hepatic biotransformation events and distribution profiles of GE and its active phenolics for the design of safe regimens.	[Mukkavilli, Rao; Jadhav, Gajanan R.; Vangala, Subrahmanyam] Advinus Therapeut Ltd, Bangalore, Karnataka, India; [Gundala, Sushma R.; Yang, Chunhua; Donthamsetty, Shashikiran; Aneja, Ritu] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA; [Cantuaria, Guilherme] Northside Hosp Canc Inst, Atlanta, GA USA; [Reid, Michelle D.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA	University System of Georgia; Georgia State University; Emory University	Aneja, R (corresponding author), Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA.	raneja@gsu.edu	Yang, C./N-5421-2014	Yang, C./0000-0003-0805-1008	National Cancer Institute at the National Institutes of Health [R00CA131489, R01 CA169127]; American Cancer Society [121728-RSG-12-004-01-CNE]; Advinus Therapeutics Limited; NATIONAL CANCER INSTITUTE [R00CA131489, R01CA169127] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Advinus Therapeutics Limited; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants to RA from the National Cancer Institute at the National Institutes of Health (R00CA131489, R01 CA169127) (http://www.cancer.gov/) and American Cancer Society (121728-RSG-12-004-01-CNE) (http://www.cancer.org/). Advinus Therapeutics Limited provided support in the form of salaries for authors [CY,SD,RA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ameer B, 1997, CLIN PHARMACOKINET, V33, P103, DOI 10.2165/00003088-199733020-00003; ARTURSSON P, 1991, BIOCHEM BIOPH RES CO, V175, P880, DOI 10.1016/0006-291X(91)91647-U; Bailey David G, 2004, Am J Cardiovasc Drugs, V4, P281, DOI 10.2165/00129784-200404050-00002; BAILEY DG, 1989, CLIN INVEST MED, V12, P357; BAILEY DG, 1994, CLIN PHARMACOKINET, V26, P91, DOI 10.2165/00003088-199426020-00002; Bear WL, 2000, ANTICANCER RES, V20, P3323; Bear WL, 2000, ANTICANCER RES, V20, P3609; Brahmbhatt M, 2013, NUTR CANCER, V65, P263, DOI 10.1080/01635581.2013.749925; Chavez ML, 2006, LIFE SCI, V78, P2146, DOI 10.1016/j.lfs.2005.12.009; Chen CY, 2009, MOLECULES, V14, P959, DOI 10.3390/molecules14030959; Coleman M. D, 2010, HUMAN DRUG METABOLIS; Du LP, 2004, TOXICOL APPL PHARM, V195, P278, DOI 10.1016/j.taap.2003.09.020; Dugasani S, 2010, J ETHNOPHARMACOL, V127, P515, DOI 10.1016/j.jep.2009.10.004; FDA, 2014, CONS REG SUBST ADD F; Fontana RJ, 1999, GASTROENTEROLOGY, V117, P89, DOI 10.1016/S0016-5085(99)70554-8; Gibbs MA, 1999, DRUG METAB DISPOS, V27, P180; GOLDSTEIN JA, 1994, PHARMACOGENETICS, V4, P285, DOI 10.1097/00008571-199412000-00001; GOVINDARAJAN VS, 1982, CRC CR REV FOOD SCI, V17, P189; GOVINDARAJAN VS, 1982, CRC CR REV FOOD SCI, V17, P1; Gundala SR, 2014, CARCINOGENESIS; HUKKINEN SK, 1995, CLIN PHARMACOL THER, V58, P127, DOI 10.1016/0009-9236(95)90188-4; Ioannides C, 2002, XENOBIOTICA, V32, P451, DOI 10.1080/00498250210124147; Jeong CH, 2009, CANCER RES, V69, P5584, DOI 10.1158/0008-5472.CAN-09-0491; Karna P, 2011, BR J NUTR, V18, P1; Kim SO, 2005, ONCOGENE, V24, P2558, DOI 10.1038/sj.onc.1208446; Kimura Y, 2010, FOOD CHEM TOXICOL, V48, P429, DOI 10.1016/j.fct.2009.10.041; Kundu JK, 2005, MUTAT RES-FUND MOL M, V591, P123, DOI 10.1016/j.mrfmmm.2005.04.019; Li M, 2013, ACTA PHARMACOL SIN, V34, P1237, DOI 10.1038/aps.2013.49; Lin JH, 2003, CLIN PHARMACOKINET, V42, P59, DOI 10.2165/00003088-200342010-00003; Markowitz JS, 2003, JAMA-J AM MED ASSOC, V290, P1500, DOI 10.1001/jama.290.11.1500; McFadyen MCE, 2004, MOL CANCER THER, V3, P363; Meinl W, 2008, DRUG METAB DISPOS, V36, P276, DOI 10.1124/dmd.107.018036; Misaka S, 2013, DRUG METAB PHARMACOK, V28, P244, DOI 10.2133/dmpk.DMPK-12-RG-101; Murray M, 2006, CURR DRUG METAB, V7, P67, DOI 10.2174/138920006774832569; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Nelson DR, 2011, BBA-PROTEINS PROTEOM, V1814, P14, DOI 10.1016/j.bbapap.2010.08.008; Paine MF, 2006, DRUG METAB DISPOS, V34, P880, DOI 10.1124/dmd.105.008672; Perera V, 2012, CLIN PHARMACOL THER, V92, P511, DOI 10.1038/clpt.2012.139; PETERS WHN, 1989, BIOCHEM J, V264, P613, DOI 10.1042/bj2640613; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rendic S, 2010, CURR DRUG METAB, V11, P4, DOI 10.2174/138920010791110917; Rodriguez-Antona C, 2006, ONCOGENE, V25, P1679, DOI 10.1038/sj.onc.1209377; Rodriguez-Fragoso L, 2011, J FOOD SCI, V76, pR112, DOI 10.1111/j.1750-3841.2011.02155.x; Sabolovic N, 2000, LIFE SCI, V67, P185, DOI 10.1016/S0024-3205(00)00616-0; Scheepens A, 2010, GENES NUTR, V5, P75, DOI 10.1007/s12263-009-0148-z; Schinkel AH, 1997, SEMIN CANCER BIOL, V8, P161, DOI 10.1006/scbi.1997.0068; SchmiedlinRen P, 1997, MOL PHARMACOL, V51, P741, DOI 10.1124/mol.51.5.741; Seow A, 2001, CARCINOGENESIS, V22, P673, DOI 10.1093/carcin/22.4.673; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; Tanaka E, 1998, J CLIN PHARM THER, V23, P403, DOI 10.1046/j.1365-2710.1998.00086.x; Vasala PA, 2004, HDB HERBS SPICES; Walle UK, 1999, BIOCHEM PHARMACOL, V58, P431, DOI 10.1016/S0006-2952(99)00133-1; Wang B, 2009, DRUG METAB REV, V41, P573, DOI 10.1080/03602530903118729; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Youdim KA, 2003, J NEUROCHEM, V85, P180, DOI 10.1046/j.1471-4159.2003.01652.x; Zhang L, 2007, MOL PHARMACEUT, V4, P833, DOI 10.1021/mp700077z; Zhang YC, 2001, CLIN PHARMACOKINET, V40, P159, DOI 10.2165/00003088-200140030-00002; Zick SM, 2008, CANCER EPIDEM BIOMAR, V17, P1930, DOI 10.1158/1055-9965.EPI-07-2934; Zick Suzanna M, 2010, Int J Biomed Sci, V6, P233	59	26	28	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108386	10.1371/journal.pone.0108386	http://dx.doi.org/10.1371/journal.pone.0108386			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251219	Green Published, gold			2022-12-25	WOS:000342492700121
J	Rocha, AV; Rivera, LO; Martinez, J; Prestes, NP; Caparroz, R				Rocha, Amanda V.; Rivera, Luis O.; Martinez, Jaime; Prestes, Nemora P.; Caparroz, Renato			Biogeography of Speciation of Two Sister Species of Neotropical Amazona (Aves, Psittaciformes) Based on Mitochondrial Sequence Data	PLOS ONE			English	Article							HISTORICAL BIOGEOGRAPHY; VICARIANCE; DISPERSAL; TUCUMANA; DIVERSIFICATION; QUATERNARY; NEUTRALITY; MIGRATION; BOLIVIA; FOREST	Coalescent theory provides powerful models for population genetic inference and is now increasingly important in estimates of divergence times and speciation research. We use molecular data and methods based on coalescent theory to investigate whether genetic evidence supports the hypothesis of A. pretrei and A. tucumana as separate species and whether genetic data allow us to assess which allopatric model seems to better explain the diversification process in these taxa. We sampled 13 A. tucumana from two provinces in northern Argentina and 28 A. pretrei from nine localities of Rio Grande do Sul, Brazil. A 491 bp segment of the mitochondrial gene cytochrome c oxidase I was evaluated using the haplotype network and phylogenetic methods. The divergence time and other demographic quantities were estimated using the isolation and migration model based on coalescent theory. The network and phylogenetic reconstructions showed similar results, supporting reciprocal monophyly for these two taxa. The divergence time of lineage separation was estimated to be approximately 1.3 million years ago, which corresponds to the lower Pleistocene. Our results enforce the current taxonomic status for these two Amazon species. They also support that A. pretrei and A. tucumana diverged with little or no gene flow approximately 1.3 million years ago, most likely after the establishment of a small population in the Southern Yungas forest by dispersion of a few founders from the A. pretrei ancestral population. This process may have been favored by habitat corridors formed in hot and humid periods of the Quaternary. Considering that these two species are considered threatened, the results were evaluated for their implications for the conservation of these two species.	[Rocha, Amanda V.; Caparroz, Renato] Univ Brasilia, Inst Ciencias Biol, Lab Genet Biodivers, Brasilia, DF, Brazil; [Rivera, Luis O.] Univ Nacl Jujuy CONICET, Ctr Invest Transferencia Jujuy, San Salvador De Jujuy, Argentina; [Martinez, Jaime; Prestes, Nemora P.] Projeto Charao Assoc Amigos Meio Ambiente, Carazinho, RS, Brazil; [Prestes, Nemora P.] Univ Passo Fundo, Inst Ciencias, Passo Fundo, RS, Brazil	Universidade de Brasilia; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade de Passo Fundo	Caparroz, R (corresponding author), Univ Brasilia, Inst Ciencias Biol, Lab Genet Biodivers, Brasilia, DF, Brazil.	renatocz@yahoo.com.br		Martinez, Jaime/0000-0002-7164-1951; Pauletti Prestes, Nemora/0000-0003-3291-2955	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Capes	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work is supported by graduate scholarships for A. V. Rocha by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Capes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, THREATENED BIRDS AM; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Birdlife International, 2013, SPEC FACTSH TUC AM A; Bruford Michael W., 1992, P225; BUSH GL, 1975, ANNU REV ECOL SYST, V6, P339, DOI 10.1146/annurev.es.06.110175.002011; Caparroz R, 2009, DIVERS DISTRIB, V15, P459, DOI 10.1111/j.1472-4642.2009.00558.x; Cunningham Clifford W., 1998, P297; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darwin C., 1858, J PROC LINN SOC ZOOL, V3, P54; de Queiroz A, 2005, TRENDS ECOL EVOL, V20, P68, DOI 10.1016/j.tree.2004.11.006; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Diefenbach K.H., 1986, Trochilus, V7, P72; Dobzhansky T, 1970, GENETIC EVOLUTIONARY; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fitzpatrick JW, 1980, S SPECIATION S AM BI, P1273; Forshaw J. M., 1977, PARROTS WORLD, Vsecond; FU YX, 1993, GENETICS, V133, P693; Hein J., 2005, GENE GENEALOGIES VAR; Hernandez RM, 2005, J S AM EARTH SCI, V19, P495, DOI 10.1016/j.jsames.2005.06.007; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hulka C, 2006, J S AM EARTH SCI, V21, P135, DOI 10.1016/j.jsames.2005.08.003; IRIONDO M, 1993, GEOMORPHOLOGY, V7, P289, DOI 10.1016/0169-555X(93)90059-B; IUCN, 2013, IUCN RED LIST THREAT; IUCN, 2022, IUCN RED LIST THREAT; Johnson NK, 2002, MOL ECOL, V11, P2065, DOI 10.1046/j.1365-294X.2002.01588.x; Ledru MP, 2007, DIVERS DISTRIB, V13, P761, DOI 10.1111/j.1472-4642.2007.00389.x; Lopez-Lanus B., 2008, CATEGORIZACION AVES; Machado ABM, 2008, LIVRO VERMELHO FAUNA, V2; Martinez J., 2002, ECOLOGIA CONSERVACAO, P173; Martinez J, 2008, BIOLOGIA CONSERVACAO, P105; Mata JR, 2006, BIRDS S AM NONPASSER; MAYR E., 1942, Systematics and the origin of species from the viewpoint of a zoologist.; Newton I., 2003, SPECIATION BIOGEOGRA; Nichols R, 2001, TRENDS ECOL EVOL, V16, P358, DOI 10.1016/S0169-5347(01)02203-0; Nielsen R, 2001, GENETICS, V158, P885; Noonan BP, 2006, AM NAT, V168, P730, DOI 10.1086/509052; NORES M, 1992, AUK, V109, P346, DOI 10.2307/4088203; Palumbi Stephen R., 1996, P205; Pennington RT, 2000, J BIOGEOGR, V27, P261, DOI 10.1046/j.1365-2699.2000.00397.x; Pereira SL, 2006, MOL BIOL EVOL, V23, P1731, DOI 10.1093/molbev/msl038; Peters JL, 1937, CHECKLIST BIRDS WORL; Prado Dariene E., 1993, Candollea, V48, P615; Prestes NP, 2011, ICMBIO MMA SERIE ESP, P34; Quintero E, 2013, ZOOL SCR, V42, P28, DOI 10.1111/j.1463-6409.2012.00567.x; Rambaut A., 2007, TRACER V1 5; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Ridgely R., 1981, GUIDE BIRDS PANAMA; Rivera L, 2007, ORYX, V41, P101, DOI 10.1017/S0030605306001384; Rivera L, 2014, EMU, V114, P41, DOI 10.1071/MU12062; Rivera L, 2012, BIRD CONSERV INT, V22, P398, DOI 10.1017/S0959270911000414; Rivera L, 2010, ORYX, V44, P110, DOI 10.1017/S0030605309990950; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Russello MA, 2004, MOL PHYLOGENET EVOL, V30, P421, DOI 10.1016/S1055-7903(03)00192-1; Sanmartin I, 2001, BIOL J LINN SOC, V73, P345, DOI 10.1006/bijl.2001.0542; Schunck F, 2011, ICMBIO MMA SERIE ESP; SHORT L L, 1975, Bulletin of the American Museum of Natural History, V154, P163; Simpson BB, 1979, S AM HERPETOFAUNA IT, P157; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van der Hammen T., 1983, TROPICAL SAVANNAS, P19; Van der Hammen T., 1974, J BIOGEOGR, V1, P3, DOI DOI 10.2307/3038066; Voelker G, 1999, EVOLUTION, V53, P1536, DOI 10.1111/j.1558-5646.1999.tb05417.x; Voelker G, 2002, CONDOR, V104, P725, DOI 10.1650/0010-5422(2002)104[0725:SAHBOW]2.0.CO;2; VUILLEUMIER FRANCOIS, 1965, BULL MUS COMP ZOOL HARVARD UNIV, V134, P1; Waters JM, 2000, SYST BIOL, V49, P777, DOI 10.1080/106351500750049824; Waters JM, 2000, MOL ECOL, V9, P1815, DOI 10.1046/j.1365-294x.2000.01082.x; Weir JT, 2011, MOL ECOL, V20, P4550, DOI 10.1111/j.1365-294X.2011.05294.x; Willis Edwin O., 1992, Ornitologia Neotropical, V3, P1; Yoder AD, 2006, ANNU REV ECOL EVOL S, V37, P405, DOI 10.1146/annurev.ecolsys.37.091305.110239	71	10	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108096	10.1371/journal.pone.0108096	http://dx.doi.org/10.1371/journal.pone.0108096			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251765	Green Published, gold, Green Submitted			2022-12-25	WOS:000342492700077
J	Chen, XQ; Yan, F; Liu, B; Liu, S; Kong, Y; Zheng, J; Li, YX; Gong, SS; Han, DM; Zhang, L				Chen, Xueqing; Yan, Fei; Liu, Bo; Liu, Sha; Kong, Ying; Zheng, Jun; Li, Yongxin; Gong, Shusheng; Han, Demin; Zhang, Luo			The Development of Auditory Skills in Young Children with Mondini Dysplasia after Cochlear Implantation	PLOS ONE			English	Article							SENSORINEURAL HEARING-LOSS; INNER-EAR MALFORMATIONS; VESTIBULAR AQUEDUCT; TONE PERCEPTION; CLASSIFICATION; FEATURES; INFANTS; POPULATIONS; PERFORMANCE; DEFORMITIES	The aim of this study is to survey and compare the development of auditory skills in young children with Mondini dysplasia and profoundly-deaf young children with radiologically normal inner ears over a period of 3 years after cochlear implantation. A total of 545 young children (age 7 to 36 months) with prelingual, severe to profound hearing loss participated in this study. All children received cochlear implantation. Based on whether or not there was a Mondini dysplasia as diagnosed with CT scanning, the subjects were divided into 2 groups: (A) 514 young children with radiologically normal inner ears and (B) 31 young children with Mondini dysplasia. The Infant-Toddler Meaningful Auditory Integration Scale (IT-MAIS) was used to assess the children's auditory skills that include vocalization changes, spontaneous alerting to sounds in everyday living environments, and the ability to derive meaning from sounds. The assessment was performed prior to surgery and at 1, 3, 6, 9, 12, 24, and 36 months after implant device switch-on. The mean scores for overall auditory skills were not significantly different between groups A and B at pre-surgery, 1, 12, 24, and 36 months post-surgery, but were significantly different at 3, 6, and 9 months post-surgery. The mean scores for all auditory skills in children with Mondini dysplasia showed significant improvement over time. The mean scores for the three subcategories of auditory skills in children with Mondini dysplasia also showed significant differences at pre-surgery, 1, 3, 6, and 9 months, however, there were no significant differences at 12, 24, and 36 months. Overall, the auditory skills of young children with Mondini dysplasia developed rapidly after cochlear implantation, in a similar manner to that of young children with radiologically normal inner ears. Cochlear implantation is an effective intervention for young children with Mondini dysplasia.	[Chen, Xueqing; Liu, Bo; Liu, Sha; Kong, Ying; Zheng, Jun; Li, Yongxin; Gong, Shusheng; Han, Demin; Zhang, Luo] Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Chen, Xueqing; Liu, Bo; Liu, Sha; Kong, Ying; Zheng, Jun; Li, Yongxin; Gong, Shusheng; Han, Demin; Zhang, Luo] Capital Med Univ, Beijing Inst Otolaryngol, Beijing, Peoples R China; [Yan, Fei] Capital Med Univ, Beijing Tongren Hosp, Dept Radiol, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Zhang, L (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China.	dr.luozhang@gmail.com		Zhang, Luo/0000-0002-0910-9884	Beijing Municipal Health Bureau [2011-1017-01, 2009-3-29]; Ministry of Health of the People's Republic of China [201202001]; Capital Medical University [12JL12]; National Natural Science Foundation of China [81371103]	Beijing Municipal Health Bureau; Ministry of Health of the People's Republic of China; Capital Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded in part by the capital health research and development of special from the Beijing Municipal Health Bureau (No. 2011-1017-01), the research special fund for public welfare industry of health from the Ministry of Health of the People's Republic of China (No. 201202001), the promotion grant for high-level scientific and technological elites in medical science from the Beijing Municipal Health Bureau (No. 2009-3-29), key projects in basic and clinical research cooperation funds from Capital Medical University No. 12JL12), and the National Natural Science Foundation of China (No. 81371103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli PJ, 1999, LARYNGOSCOPE, V109, P1642, DOI 10.1097/00005537-199910000-00018; Arnoldner C, 2004, INT J PEDIATR OTORHI, V68, P457, DOI 10.1016/j.ijporl.2003.11.018; Chen XQ, 2011, INT J PEDIATR OTORHI, V75, P943, DOI 10.1016/j.ijporl.2011.04.015; Chen XQ, 2010, ACTA OTO-LARYNGOL, V130, P263, DOI 10.3109/00016480903150528; CLOPTON BM, 1980, ANN OTO RHINOL LARYN, V89, P5, DOI 10.1177/00034894800890S202; Dettman SJ, 1997, COCHLEAR IMPLANTATIO, P171; Han DM, 2009, EAR HEARING, V30, P169, DOI 10.1097/AUD.0b013e31819342cf; JACKLER RK, 1987, LARYNGOSCOPE, V97, P2; Janssens S, 1996, EUR ARCH OTO-RHINO-L, V253, P301; Jensen J, 1967, J Laryngol Otol, V81, P27, DOI 10.1017/S0022215100066731; Kanchanalarp Chanida, 2005, Journal of the Medical Association of Thailand, V88, P484; KIANG NYS, 1979, ACTA OTO-LARYNGOL, V87, P204, DOI 10.3109/00016487909126408; Kim LS, 2006, ANN OTO RHINOL LARYN, V115, P205, DOI 10.1177/000348940611500309; Li Yong-xin, 2004, Zhonghua Er Bi Yan Hou Ke Za Zhi, V39, P89; LINTHICUM FH, 1991, AM J OTOL, V12, P8; Mafong DD, 2002, LARYNGOSCOPE, V112, P1, DOI 10.1097/00005537-200201000-00001; MANGABEIRAALBERNAZ PL, 1983, ACTA OTO-LARYNGOL, V95, P627, DOI 10.3109/00016488309139454; McClay JE, 2002, ARCH OTOLARYNGOL, V128, P664, DOI 10.1001/archotol.128.6.664; MIYAMOTO RT, 1986, AM J OTOL, V7, P258; Mondini C., 1791, BONONIAE, V7, P419; Munro KJ, 1996, BRIT J AUDIOL, V30, P369, DOI 10.3109/03005369609078424; Osberger MJ, 1997, AM J OTOL, V18, pS79; OTTE J, 1978, LARYNGOSCOPE, V88, P1231; PHELPS PD, 1992, J LARYNGOL OTOL, V106, P967, DOI 10.1017/S0022215100121486; Rance G, 1997, COCHLEAR IMPLANTATIO, P147; Robbins AM, 2004, ARCH OTOLARYNGOL, V130, P570; SCHMIDT JM, 1985, ACTA OTO-LARYNGOL, V99, P14, DOI 10.3109/00016488509119140; Sennaroglu L, 2002, LARYNGOSCOPE, V112, P2230, DOI 10.1097/00005537-200212000-00019; SILVERSTEIN H, 1988, AM J OTOL, V9, P451; STUDEBAKER GA, 1985, J SPEECH HEAR RES, V28, P455, DOI 10.1044/jshr.2803.455; Suzuki C, 1998, ARCH OTOLARYNGOL, V124, P462, DOI 10.1001/archotol.124.4.462; Wu CC, 2005, LARYNGOSCOPE, V115, P132, DOI 10.1097/01.mlg.0000150691.85387.3f; Zheng YQ, 2002, INT J PEDIATR OTORHI, V63, P29, DOI 10.1016/S0165-5876(01)00642-5; Zhou N, 2013, OTOL NEUROTOL, V34, P499, DOI 10.1097/MAO.0b013e318287ca86	34	6	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108079	10.1371/journal.pone.0108079	http://dx.doi.org/10.1371/journal.pone.0108079			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247792	Green Submitted, Green Published, gold			2022-12-25	WOS:000342351800063
J	Hornok, S; Abichu, G; Meli, ML; Tanczos, B; Sulyok, KM; Gyuranecz, M; Gonczi, E; Farkas, R; Hofmann-Lehmann, R				Hornok, Sandor; Abichu, Getachew; Meli, Marina L.; Tanczos, Balazs; Sulyok, Kinga M.; Gyuranecz, Miklos; Goenczi, Eniko; Farkas, Robert; Hofmann-Lehmann, Regina			Influence of the Biotope on the Tick Infestation of Cattle and on the Tick-Borne Pathogen Repertoire of Cattle Ticks in Ethiopia	PLOS ONE			English	Article							MOLECULAR-DETECTION; THEILERIA-BUFFELI; SPOTTED-FEVER; INFECTION; RICKETTSIAE; HUMANS; AGENTS; DOGS	Background: The majority of vector-borne infections occur in the tropics, including Africa, but molecular eco-epidemiological studies are seldom reported from these regions. In particular, most previously published data on ticks in Ethiopia focus on species distribution, and only a few molecular studies on the occurrence of tick-borne pathogens or on ecological factors influencing these. The present study was undertaken to evaluate, if ticks collected from cattle in different Ethiopian biotopes harbour (had access to) different pathogens. Methods: In South-Western Ethiopia 1032 hard ticks were removed from cattle grazing in three kinds of tick biotopes. DNA was individually extracted from one specimen of both sexes of each tick species per cattle. These samples were molecularly analysed for the presence of tick-borne pathogens. Results: Amblyomma variegatum was significantly more abundant on mid highland, than on moist highland. Rhipicephalus decoloratus was absent from savannah lowland, where virtually only A. cohaerens was found. In the ticks Coxiella burnetii had the highest prevalence on savannah lowland. PCR positivity to Theileria spp. did not appear to depend on the biotope, but some genotypes were unique to certain tick species. Significantly more A. variegatum specimens were rickettsia-positive, than those of other tick species. The presence of rickettsiae (R. africae) appeared to be associated with mid highland in case of A. variegatum and A. cohaerens. The low level of haemoplasma positivity seemed to be equally distributed among the tick species, but was restricted to one biotope type. Conclusions: The tick biotope, in which cattle are grazed, will influence not only the tick burden of these hosts, but also the spectrum of pathogens in their ticks. Thus, the presence of pathogens with alternative (non-tick-borne) transmission routes, with transstadial or with transovarial transmission by ticks appeared to be associated with the biotope type, with the tick species, or both, respectively.	[Hornok, Sandor; Tanczos, Balazs; Farkas, Robert] Szent Istvan Univ, Fac Vet Sci, Dept Parasitol & Zool, Budapest, Hungary; [Abichu, Getachew] Natl Res Ctr, Dept Parasitol, Arachnoentomol Unit, Sebeta, Ethiopia; [Meli, Marina L.; Goenczi, Eniko; Hofmann-Lehmann, Regina] Univ Zurich, Vetsuisse Fac, Clin Lab, Zurich, Switzerland; [Meli, Marina L.; Goenczi, Eniko; Hofmann-Lehmann, Regina] Univ Zurich, Vetsuisse Fac, Ctr Clin Studies, Zurich, Switzerland; [Sulyok, Kinga M.; Gyuranecz, Miklos] Hungarian Acad Sci, Agr Res Ctr, Vet Med Res Inst, Budapest, Hungary	Hungarian University of Agriculture & Life Sciences; University of Zurich; University of Zurich; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute	Hornok, S (corresponding author), Szent Istvan Univ, Fac Vet Sci, Dept Parasitol & Zool, Budapest, Hungary.	Hornok.Sandor@aotk.szie.hu	Farkas, Robert/ABB-1990-2021; Hofmann-Lehmann, Regina/C-6528-2009	Hofmann-Lehmann, Regina/0000-0001-9750-4296; Gyuranecz, Miklos/0000-0002-5698-5713	Lendulet program of the Hungarian Academy of Sciences [LP2012-22]; Research Faculty budget of the SZIU-FVS [KK-UK-12006]	Lendulet program of the Hungarian Academy of Sciences; Research Faculty budget of the SZIU-FVS	MG, KMS and the study in part were supported by the Lendulet program (LP2012-22) of the Hungarian Academy of Sciences. Additional funding was provided by the Research Faculty budget of the SZIU-FVS (KK-UK-12006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abera M, 2010, TROP ANIM HEALTH PRO, V42, P1677, DOI 10.1007/s11250-010-9620-4; Benin S, 2006, STRATEGIES SUSTAINAB; Bishop R, 2004, PARASITOLOGY, V129, pS271, DOI 10.1017/S0031182003004748; Boretti FS, 2009, APPL ENVIRON MICROB, V75, P3230, DOI 10.1128/AEM.00220-09; Ceci L, 1997, VET REC, V140, P581, DOI 10.1136/vr.140.22.581; Chaisi ME, 2013, VET PARASITOL, V191, P132, DOI 10.1016/j.vetpar.2012.08.005; Hoogstraal H., 1956, African Ixodoidea, V1, P1; Jongejan F, 2004, PARASITOLOGY, V129, pS3, DOI 10.1017/S0031182004005967; Kamau J, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-22; Kumsa B, 2014, TROP ANIM HEALTH PRO, V46, P27, DOI 10.1007/s11250-013-0442-z; LEVIN BR, 1990, PARASITOLOGY, V100, pS103, DOI 10.1017/S0031182000073054; Lodos J, 2000, VET PARASITOL, V87, P315, DOI 10.1016/S0304-4017(99)00187-9; Loftis AD, 2006, EXP APPL ACAROL, V40, P67, DOI 10.1007/s10493-006-9025-2; Mediannikov O, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000654; Mekonnen S, 2001, ONDERSTEPOORT J VET, V68, P243; MEKONNEN S, 1992, INSECT SCI APPL, V13, P661, DOI 10.1017/S1742758400016271; Mekonnen S, 1994, TICK TICK BORNE DIS, P19; Mekonnen S., 2007, ETHIOPIAN VET J, V11, P1; Muhlnickel CJ, 2002, AUST VET J, V80, P606, DOI 10.1111/j.1751-0813.2002.tb10961.x; Mura A, 2008, T ROY SOC TROP MED H, V102, P945, DOI 10.1016/j.trstmh.2008.03.015; NEITZ W. O., 1940, ONDERSTEPOORT JOUR VET SCI AND ANIMAL INDUST, V14, P9; Olmeda AS, 1997, ACTA TROP, V67, P229, DOI 10.1016/S0001-706X(97)00045-4; PEGRAM R G, 1981, Bulletin of Entomological Research, V71, P339, DOI 10.1017/S0007485300008397; Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541; PHILIP CB, 1966, B WORLD HEALTH ORGAN, V35, P127; Reye AL, 2012, APPL ENVIRON MICROB, V78, P2562, DOI 10.1128/AEM.06686-11; Rogers RJ, 1996, AUSTR VET J, V42, P42; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Socolovschi C, 2009, CLIN MICROBIOL INFEC, V15, P317, DOI 10.1111/j.1469-0691.2008.02278.x; Stenos J, 2005, AM J TROP MED HYG, V73, P1083, DOI 10.4269/ajtmh.2005.73.1083; Stockham SL, 2000, VET PATHOL, V37, P11, DOI 10.1354/vp.37-1-11; Surafel Asrate, 2012, Journal of Veterinary Medicine and Animal Health, V4, P84; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomassone L., 2005, Parassitologia (Rome), V47, P247; Walker A., 2003, BIOSCIENCE REPORTS; Willi B, 2009, J CLIN MICROBIOL, V47, P4049, DOI 10.1128/JCM.01478-09; Yang ZB, 2007, REV MED MICROBIOL, V18, P1	38	20	20	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e106452	10.1371/journal.pone.0106452	http://dx.doi.org/10.1371/journal.pone.0106452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25248165	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000342351800010
J	Lawlor, PN; Kalisky, T; Rosner, R; Rosner, MR; Kording, KP				Lawlor, Patrick Nathan; Kalisky, Tomer; Rosner, Robert; Rosner, Marsha Rich; Kording, Konrad Paul			Conceptualizing Cancer Drugs as Classifiers	PLOS ONE			English	Article							HETEROGENEITY; EVOLUTION; PREDICTION; REGRESSION; DYNAMICS; PATHWAY	Cancer and healthy cells have distinct distributions of molecular properties and thus respond differently to drugs. Cancer drugs ideally kill cancer cells while limiting harm to healthy cells. However, the inherent variance among cells in both cancer and healthy cell populations increases the difficulty of selective drug action. Here we formalize a classification framework based on the idea that an ideal cancer drug should maximally discriminate between cancer and healthy cells. More specifically, this discrimination should be performed on the basis of measurable cell markers. We divide the problem into three parts which we explore with examples. First, molecular markers should discriminate cancer cells from healthy cells at the single-cell level. Second, the effects of drugs should be statistically predicted by these molecular markers. Third, drugs should be optimized for classification performance. We find that expression levels of a handful of genes suffice to discriminate well between individual cells in cancer and healthy tissue. We also find that gene expression predicts the efficacy of some cancer drugs, suggesting that these cancer drugs act as suboptimal classifiers using gene profiles. Finally, we formulate a framework that defines an optimal drug, and predicts drug cocktails that may target cancer more accurately than the individual drugs alone. Conceptualizing cancer drugs as solving a discrimination problem in the high-dimensional space of molecular markers promises to inform the design of new cancer drugs and drug cocktails.	[Lawlor, Patrick Nathan; Kording, Konrad Paul] Northwestern Univ, Rehabil Inst Chicago, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Kalisky, Tomer] Bar Ilan Univ, Dept Engn, Ramat Gan, Israel; [Rosner, Robert] Univ Chicago, Dept Phys, Chicago, IL 60637 USA; [Rosner, Marsha Rich] Univ Chicago, Ben May Dept Canc Res, Chicago, IL USA; [Lawlor, Patrick Nathan; Kording, Konrad Paul] Northwestern Univ, Rehabil Inst Chicago, Dept Physiol, Chicago, IL 60611 USA	Northwestern University; Shirley Ryan AbilityLab; Bar Ilan University; University of Chicago; University of Chicago; Northwestern University; Shirley Ryan AbilityLab	Kording, KP (corresponding author), Northwestern Univ, Rehabil Inst Chicago, Dept Phys Med & Rehabil, Chicago, IL 60611 USA.	kk@northwestern.edu	Kording, Konrad/A-1233-2007	Kording, Konrad/0000-0001-8408-4499	National Institutes of Health [5P01NS044393, R01NS063399]; University of Chicago Women's Board; Machiah Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063399, T32NS041234, P01NS044393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Women's Board; Machiah Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	PL was supported by National Institutes of Health 5P01NS044393. KK was supported by National Institutes of Health R01NS063399. RR and MR were supported by the University of Chicago Women's Board. TK was funded by the Machiah Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bishop C.M., 2006, PATTERN RECOGNITION; Bozic I, 2013, ELIFE, V2, DOI 10.7554/eLife.00747; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Freund Y., 1995, COMPUTATIONAL LEARNI; Fu XP, 2012, MOL THER, V20, P339, DOI 10.1038/mt.2011.265; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lee MJ, 2012, CELL, V149, P780, DOI 10.1016/j.cell.2012.03.031; Liao D, 2012, PHYS BIOL, V9; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Pisco AO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3467; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Scholkopf B., 2001, LEARNING KERNELS; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Tan AC, 2003, APPL BIOINFORMATICS, V2, P1, DOI DOI 10.1186/1471-2105-9-275; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yun JU, 2011, EMBO J, V30, P4500, DOI 10.1038/emboj.2011.312; Zhao BY, 2014, CANCER DISCOV, V4, P166, DOI 10.1158/2159-8290.CD-13-0465	30	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e106444	10.1371/journal.pone.0106444	http://dx.doi.org/10.1371/journal.pone.0106444			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25248130	Green Published, Green Submitted, gold			2022-12-25	WOS:000342351800009
J	Layfield, S; Burge, W; Mitchell, W; Ross, L; Denning, C; Amthor, F; Visscher, K				Layfield, Stephen; Burge, Wesley; Mitchell, William; Ross, Lesley; Denning, Christine; Amthor, Frank; Visscher, Kristina			The Effect of Speed of Processing Training on Microsaccade Amplitude	PLOS ONE			English	Article							CONFIDENCE-INTERVALS; OLDER DRIVERS; IMPACT; RISK	Older adults experience cognitive deficits that can lead to driving errors and a loss of mobility. Fortunately, some of these deficits can be ameliorated with targeted interventions which improve the speed and accuracy of simultaneous attention to a central and a peripheral stimulus called Speed of Processing training. To date, the mechanisms behind this effective training are unknown. We hypothesized that one potential mechanism underlying this training is a change in distribution of eye movements of different amplitudes. Microsaccades are small amplitude eye movements made when fixating on a stimulus, and are thought to counteract the "visual fading" that occurs when static stimuli are presented. Due to retinal anatomy, larger microsaccadic eye movements are needed to move a peripheral stimulus between receptive fields and counteract visual fading. Alternatively, larger microsaccades may decrease performance due to neural suppression. Because larger microsaccades could aid or hinder peripheral vision, we examine the distribution of microsaccades during stimulus presentation. Our results indicate that there is no statistically significant change in the proportion of large amplitude microsaccades during a Useful Field of View-like task after training in a small sample of older adults. Speed of Processing training does not appear to result in changes in microsaccade amplitude, suggesting that the mechanism underlying Speed of Processing training is unlikely to rely on microsaccades.	[Layfield, Stephen] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA; [Burge, Wesley; Amthor, Frank] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA; [Mitchell, William] Univ Alabama Birmingham, Dept Neurosci, Birmingham, AL USA; [Ross, Lesley] Penn State Univ, Dept Human Dev & Family Studies, State Coll, PA USA; [Denning, Christine] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA; [Visscher, Kristina] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Visscher, K (corresponding author), Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA.	kristina.visscher@gmail.com	; Ross, Lesley/B-4842-2019	Visscher, Kristina/0000-0003-0737-4024; Ross, Lesley/0000-0002-3794-158X	Dana Foundation; UAB Center for Clinical And Translational Science [UL1 TR000165]; Vision Science Research Center [P30 EY003039]; Civitan International Research Center; McKnight Brain Research Foundation; Edward R. Roybal Center for Translational Research on Aging and Mobility [NIA 2 P30 AG022838]; KMV; LAR; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000165] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025777] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY003039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG022838] Funding Source: NIH RePORTER	Dana Foundation; UAB Center for Clinical And Translational Science; Vision Science Research Center; Civitan International Research Center; McKnight Brain Research Foundation; Edward R. Roybal Center for Translational Research on Aging and Mobility; KMV; LAR; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding provided by Dana Foundation; https://www.dana.org/, UAB Center for Clinical And Translational Science - UL1 TR000165 - nih.gov, Vision Science Research Center - P30 EY003039 - nih.gov, Civitan International Research Center - http://www.uab.edu/medicine/circ/, McKnight Brain Research Foundation - http://tmbrf.org/ and Edward R. Roybal Center for Translational Research on Aging and Mobility - NIA 2 P30 AG022838 - nih.gov. Authors who received funding: KMV & LAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstey KJ, 2011, NEUROPSYCHOLOGY, V25, P613, DOI 10.1037/a0023835; Ball K, 2007, J GERONTOL B-PSYCHOL, V62, P19, DOI 10.1093/geronb/62.special_issue_1.19; Ball KK, 2006, J AM GERIATR SOC, V54, P77, DOI 10.1111/j.1532-5415.2005.00568.x; Betta E, 2006, NEUROREPORT, V17, P1001, DOI 10.1097/01.wnr.0000223392.82198.6d; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Burge WK, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00684; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Edwards JD, 2005, J CLIN EXP NEUROPSYC, V27, P529, DOI 10.1080/13803390490515432; Edwards JD, 2005, AGING MENT HEALTH, V9, P262, DOI 10.1080/13607860412331336788; Engbert R, 2006, P NATL ACAD SCI USA, V103, P7192, DOI 10.1073/pnas.0509557103; Federal Highway Administration Department of Transportation (US), HIGHW STAT 2009; Fonda SJ, 2001, J GERONTOL B-PSYCHOL, V56, pS343, DOI 10.1093/geronb/56.6.S343; Herrington TM, 2009, J NEUROSCI, V29, P5793, DOI 10.1523/JNEUROSCI.4412-08.2009; Kandel E., 2000, PRINCIPLES NEURAL SC; Kleiner M, 2007, PERCEPTION, V36, P14; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Martinez-Conde S, 2013, NAT REV NEUROSCI, V14, P83, DOI 10.1038/nrn3405; McCamy MB, 2012, J NEUROSCI, V32, P9194, DOI 10.1523/JNEUROSCI.0515-12.2012; Owsley C, 2004, J AM GERIATR SOC, V52, P1901, DOI 10.1111/j.1532-5415.2004.52516.x; Owsley C, 2002, GERONTOLOGY, V48, P254, DOI 10.1159/000058360; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; Ross LA, 2009, J GERONTOL B-PSYCHOL, V64, P163, DOI 10.1093/geronb/gbn034; Siegenthaler E, 2014, EUR J NEUROSCI, V39, P287, DOI 10.1111/ejn.12395; WEYMOUTH FW, 1958, AM J OPHTHALMOL, V46, P102, DOI 10.1016/0002-9394(58)90042-4; WURTZ RH, 1968, SCIENCE, V162, P1148, DOI 10.1126/science.162.3858.1148	27	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107808	10.1371/journal.pone.0107808	http://dx.doi.org/10.1371/journal.pone.0107808			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP8TL	25248099	Green Submitted, gold, Green Published			2022-12-25	WOS:000342351800041
J	Noe, AR; Espinosa, D; Li, XM; Coelho-Dos-Reis, JGA; Funakoshi, R; Giardina, S; Jin, HF; Retallack, DM; Haverstock, R; Allen, JR; Vedvick, TS; Fox, CB; Reed, SG; Ayala, R; Roberts, B; Winram, SB; Sacci, J; Tsuji, M; Zavala, F; Gutierrez, GM				Noe, Amy R.; Espinosa, Diego; Li, Xiangming; Coelho-dos-Reis, Jordana G. A.; Funakoshi, Ryota; Giardina, Steve; Jin, Hongfan; Retallack, Diane M.; Haverstock, Ryan; Allen, Jeffrey R.; Vedvick, Thomas S.; Fox, Christopher B.; Reed, Steven G.; Ayala, Ramses; Roberts, Brian; Winram, Scott B.; Sacci, John; Tsuji, Moriya; Zavala, Fidel; Gutierrez, Gabriel M.			A Full-Length Plasmodium falciparum Recombinant Circumsporozoite Protein Expressed by Pseudomonas fluorescens Platform as a Malaria Vaccine Candidate	PLOS ONE			English	Article							MEDIATED PROTECTIVE IMMUNITY; RECEPTOR 4 AGONIST; T-CELL EPITOPES; IMPROVES IMMUNOGENICITY; ADENOVIRUS; IMMUNIZATION; SPOROZOITES; ANTIBODIES; EMULSION; SAFETY	The circumsporozoite protein (CSP) of Plasmodium falciparum is a major surface protein, which forms a dense coat on the sporozoite's surface. Preclinical research on CSP and clinical evaluation of a CSP fragment-based RTS, S/AS01 vaccine have demonstrated a modest degree of protection against P. falciparum, mediated in part by humoral immunity and in part by cell-mediated immunity. Given the partial protective efficacy of the RTS, S/AS01 vaccine in a recent Phase 3 trial, further improvement of CSP-based vaccines is crucial. In this report, we describe the preclinical development of a full-length, recombinant CSP (rCSP)-based vaccine candidate against P. falciparum malaria suitable for current Good Manufacturing Practice (cGMP) production. Utilizing a novel high-throughput Pseudomonas fluorescens expression platform, we demonstrated greater efficacy of full-length rCSP as compared to N-terminally truncated versions, rapidly down-selected a promising lead vaccine candidate, and developed a high-yield purification process to express immunologically active, intact antigen for clinical trial material production. The rCSP, when formulated with various adjuvants, induced antigen-specific antibody responses as measured by enzyme-linked immunosorbent assay (ELISA) and immunofluorescence assay (IFA), as well as CD4+ T-cell responses as determined by ELISpot. The adjuvanted rCSP vaccine conferred protection in mice when challenged with transgenic P. berghei sporozoites containing the P. falciparum repeat region of CSP. Furthermore, heterologous prime/boost regimens with adjuvanted rCSP and an adenovirus type 35-vectored CSP (Ad35CS) showed modest improvements in eliciting CSP-specific T-cell responses and anti-malarial protection, depending on the order of vaccine delivery. Collectively, these data support the importance of further clinical development of adjuvanted rCSP, either as a stand-alone product or as one of the components in a heterologous prime/boost strategy, ultimately acting as an effective vaccine candidate for the mitigation of P. falciparum-induced malaria.	[Noe, Amy R.; Giardina, Steve; Ayala, Ramses; Roberts, Brian; Winram, Scott B.; Gutierrez, Gabriel M.] Leidos Inc, Frederick, MD 21702 USA; [Espinosa, Diego; Zavala, Fidel] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Malaria Res Inst, Baltimore, MD USA; [Espinosa, Diego; Zavala, Fidel] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Li, Xiangming; Coelho-dos-Reis, Jordana G. A.; Funakoshi, Ryota; Tsuji, Moriya] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, HIV & Malaria Vaccine Program, New York, NY 10021 USA; [Jin, Hongfan; Retallack, Diane M.; Haverstock, Ryan; Allen, Jeffrey R.] Pfenex Inc, San Diego, CA USA; [Vedvick, Thomas S.; Fox, Christopher B.; Reed, Steven G.] Infect Dis Res Inst, Seattle, WA USA; [Sacci, John] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Rockefeller University; University System of Maryland; University of Maryland Baltimore	Gutierrez, GM (corresponding author), Leidos Inc, Frederick, MD 21702 USA.	gabriel.m.gutierrez@leidos.com	Espinosa, Diego/AAT-6950-2020; Coelho-dos-Reis, Jordana/HGU-6453-2022	Gutierrez, Gabriel/0000-0001-8487-0414; Espinosa, Diego A./0000-0002-4364-5031; Funakoshi, Ryota/0000-0002-5616-8051; Tsuji, Moriya/0000-0001-8587-277X; Noe, Amy/0000-0002-5230-9742	NIAID/DMID Malaria Vaccine Production Support Services (MVPSS) [AI-N01-054210]	NIAID/DMID Malaria Vaccine Production Support Services (MVPSS)	This work was funded by NIAID/DMID Malaria Vaccine Production Support Services (MVPSS) contract number AI-N01-054210 to Leidos Health Inc. and executed through subcontracts to Johns Hopkins University, Aaron Diamond AIDS Research Center, Pfenex Inc., and the University of Maryland as well as a material transfer agreement with the Infectious Disease Research Institute. Co-authors Amy R. Noe, Steve Giardina, Ramses Ayala, Brian Roberts, Scott B. Winram and Gabriel M. Gutierrez are employed by Leidos Inc. Leidos Inc., as directed by the MVPSS prime contract, provided support in the form of salaries for authors, ARN, SG, RA, BR, SBW and GMG and Leidos Inc. planned the work, designed the experiments, conducted data analysis, made the decision to publish, and played a major role in manuscript preparation but had no role in data collection. The specific roles of these authors are articulated in the Author Contributions section. Coauthors Hongfan Jin, Diane Retallack, Ryan Haverstock and Jeff Allen are employed by Pfenex Inc. Pfenex Inc., as directed by an MVPSS subcontract, provided support in the form of salaries for authors HJ, DR, RH and JA, and Pfenex Inc. performed study design, conducted data collection and analysis, and assisted in preparation of the manuscript regarding expression and analytical testing of recombinant CSP. Pfenex, Inc. did not play an additional role in planning the work or the decision to publish. The specific roles of these authors are articulated in the Author Contributions section.	Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Anderson RC, 2010, COLLOID SURFACE B, V75, P123, DOI 10.1016/j.colsurfb.2009.08.022; [Anonymous], MAL FACT SHEET; Arama C, 2012, VACCINE, V30, P4040, DOI 10.1016/j.vaccine.2012.04.029; Asante KP, 2011, LANCET INFECT DIS, V11, P741, DOI 10.1016/S1473-3099(11)70100-1; Baldwin SL, 2013, J IMMUNOL, V191, P2514, DOI 10.4049/jimmunol.1301161; Ballou WR, 2009, PARASITE IMMUNOL, V31, P492, DOI 10.1111/j.1365-3024.2009.01143.x; Behzad H, 2012, J INFECT DIS, V205, P466, DOI 10.1093/infdis/jir769; Bongfen SE, 2009, VACCINE, V27, P328, DOI 10.1016/j.vaccine.2008.09.097; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Bruna-Romero O, 2001, INT J PARASITOL, V31, P1499, DOI 10.1016/S0020-7519(01)00265-X; CalvoCalle JM, 1997, J IMMUNOL, V159, P1362; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; Coler RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013677; Coppi A, 2005, J EXP MED, V201, P27, DOI 10.1084/jem.20040989; Coppi A, 2007, CELL HOST MICROBE, V2, P316, DOI 10.1016/j.chom.2007.10.002; Creech CB, 2013, HUM VACC IMMUNOTHER, V9, P2548, DOI 10.4161/hv.26038; Doolan DL, 1997, IMMUNITY, V7, P97, DOI 10.1016/S1074-7613(00)80513-0; Dunachie SJ, 2003, J EXP BIOL, V206, P3771, DOI 10.1242/jeb.00642; Fox CB, 2012, CLIN VACCINE IMMUNOL, V19, P1633, DOI 10.1128/CVI.00235-12; Gomes R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001610; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Haaland P, 2011, CALIBFIT STAT MODELS; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; HU SL, 1992, SCIENCE, V255, P456, DOI 10.1126/science.1531159; Kastenmuller K, 2013, INFECT IMMUN, V81, P789, DOI 10.1128/IAI.01108-12; Keefer MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041936; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; LI SQ, 1993, P NATL ACAD SCI USA, V90, P5214, DOI 10.1073/pnas.90.11.5214; Lu S, 2006, SPRINGER SEMIN IMMUN, V28, P255, DOI 10.1007/s00281-006-0028-1; Lu S, 2009, CURR OPIN IMMUNOL, V21, P346, DOI 10.1016/j.coi.2009.05.016; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Ndungu FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052870; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Ophorst OJAE, 2006, INFECT IMMUN, V74, P313, DOI 10.1128/IAI.74.1.313-320.2006; Ouedraogo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078679; Persson C, 2002, J IMMUNOL, V169, P6681, DOI 10.4049/jimmunol.169.12.6681; Plassmeyer ML, 2009, J BIOL CHEM, V284, P26951, DOI 10.1074/jbc.M109.013706; R Core Team, 2012, R LANG ENV STAT COMP; Radosevic K, 2010, CLIN VACCINE IMMUNOL, V17, P1687, DOI 10.1128/CVI.00311-10; Rathore D, 2002, J BIOL CHEM, V277, P7092, DOI 10.1074/jbc.M106862200; RENIA L, 1991, P NATL ACAD SCI USA, V88, P7963, DOI 10.1073/pnas.88.18.7963; Retallack DM, 2012, PROTEIN EXPRES PURIF, V81, P157, DOI 10.1016/j.pep.2011.09.010; Reyes-Sandoval A, 2007, IMMUNOLOGY, V121, P158, DOI 10.1111/j.1365-2567.2006.02552.x; Rieckmann K H, 1979, Bull World Health Organ, V57 Suppl 1, P261; Rodrigues EG, 1997, J IMMUNOL, V158, P1268; RODRIGUES M, 1993, IMMUNOLOGY, V80, P1; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; SCHOFIELD L, 1990, B WORLD HEALTH ORGAN, V68, P66; Shiratsuchi T, 2010, J CLIN INVEST, V120, P3688, DOI 10.1172/JCI39812; Shott JP, 2008, VACCINE, V26, P2818, DOI 10.1016/j.vaccine.2008.03.080; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stewart VA, 2007, INFECT IMMUN, V75, P2283, DOI 10.1128/IAI.01879-06; TAM JP, 1990, J EXP MED, V171, P299, DOI 10.1084/jem.171.1.299; Treanor JJ, 2013, VACCINE, V31, P5760, DOI 10.1016/j.vaccine.2013.08.064; Trieu A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007948; VERGARA U, 1985, J IMMUNOL, V134, P3445; Windish HP, 2011, VACCINE, V29, P7842, DOI 10.1016/j.vaccine.2011.07.094; Yang TC, 2007, EXPERT REV VACCINES, V6, P347, DOI 10.1586/14760584.6.3.347; YOSHIDA N, 1980, SCIENCE, V207, P71, DOI 10.1126/science.6985745; ZAVALA F, 1987, J EXP MED, V166, P1591, DOI 10.1084/jem.166.5.1591	62	34	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107764	10.1371/journal.pone.0107764	http://dx.doi.org/10.1371/journal.pone.0107764			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247295	Green Submitted, Green Published, gold			2022-12-25	WOS:000342351800035
J	Tarantola, M; Bae, A; Fuller, D; Bodenschatz, E; Rappel, WJ; Loomis, WF				Tarantola, Marco; Bae, Albert; Fuller, Danny; Bodenschatz, Eberhard; Rappel, Wouter-Jan; Loomis, William F.			Cell Substratum Adhesion during Early Development of Dictyostelium discoideum	PLOS ONE			English	Article							FORCE SPECTROSCOPY; SHEAR-FLOW; SOLID SUBSTRATE; RECEPTOR; CYTOKINESIS; EXPRESSION; SURFACES; MOTILITY; CAMP; INTEGRINS	Vegetative and developed amoebae of Dictyostelium discoideum gain traction and move rapidly on a wide range of substrata without forming focal adhesions. We used two independent assays to quantify cell-substrate adhesion in mutants and in wild-type cells as a function of development. Using a microfluidic device that generates a range of hydrodynamic shear stress, we found that substratum adhesion decreases at least 10 fold during the first 6 hr of development of wild type cells. This result was confirmed using a single-cell assay in which cells were attached to the cantilever of an atomic force probe and allowed to adhere to untreated glass surfaces before being retracted. Both of these assays showed that the decrease in substratum adhesion was dependent on the cAMP receptor CAR1 which triggers development. Vegetative cells missing talin as the result of a mutation in talA exhibited slightly reduced adhesive properties compared to vegetative wildtype cells. In sharp contrast to wild-type cells, however, these talA mutant cells did not show further reduction of adhesion during development such that after 5 hr of development they were significantly more adhesive than developed wild type cells. In addition, both assays showed that substrate adhesion was reduced in 0 hr cells when the actin cytoskeleton was disrupted by latrunculin. Consistent with previous observations, substrate adhesion was also reduced in 0 hr cells lacking the membrane proteins SadA or SibA as the result of mutations in sadA or sibA. However, there was no difference in the adhesion properties between wild type AX3 cells and these mutant cells after 6 hr of development, suggesting that neither SibA nor SadA play an essential role in substratum adhesion during aggregation. Our results provide a quantitative framework for further studies of cell substratum adhesion in Dictyostelium.	[Tarantola, Marco; Bodenschatz, Eberhard] Max Planck Inst Dynam & Self Org MPIDS, Lab Fluid Dynam Pattern Format & Biocomplex, Gottingen, Germany; [Tarantola, Marco; Bae, Albert; Rappel, Wouter-Jan] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Bodenschatz, Eberhard] Univ Gottingen, Inst Nonlinear Dynam, Gottingen, Germany; [Bodenschatz, Eberhard] Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA; [Bae, Albert; Rappel, Wouter-Jan] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Loomis, William F.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	Max Planck Society; University of California System; University of California San Diego; University of Gottingen; Cornell University; University of California System; University of California San Diego; University of California System; University of California San Diego	Loomis, WF (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	wloomis@ucsd.edu		Bodenschatz, Eberhard/0000-0002-2901-0144	National Institutes of Health grant [PO1 GM 078586]; Max Planck Society;  [SFB 937]; Direct For Mathematical & Physical Scien [1308264] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM078586] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Society(Max Planck Society); ; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by SFB 937, National Institutes of Health grant PO1 GM 078586 and Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit M, 2000, NAT CELL BIOL, V2, P313, DOI 10.1038/35014000; Bruckert F, 2002, J MUSCLE RES CELL M, V23, P651, DOI 10.1023/A:1024407107588; Cornillon S, 2000, J BIOL CHEM, V275, P34287, DOI 10.1074/jbc.M006725200; Cornillon S, 2008, EUKARYOT CELL, V7, P1600, DOI 10.1128/EC.00155-08; Cornillon S, 2006, EMBO REP, V7, P617, DOI 10.1038/sj.embor.7400701; Dao L, 2013, J MOL RECOGNIT, V26, P578, DOI 10.1002/jmr.2303; Decave E, 2003, J CELL SCI, V116, P4331, DOI 10.1242/jcs.00726; Decave E, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.108101; Decave E, 2002, BIOPHYS J, V82, P2383, DOI 10.1016/S0006-3495(02)75583-5; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Fey P, 2002, J CELL BIOL, V159, P1109, DOI 10.1083/jcb.200206067; Friedrichs J, 2013, METHODS, V60, P169, DOI 10.1016/j.ymeth.2013.01.006; Friedrichs J, 2010, NAT PROTOC, V5, P1353, DOI 10.1038/nprot.2010.89; Froquet R, 2012, MOL BIOL CELL, V23, P679, DOI 10.1091/mbc.E11-04-0338; Gebbie L, 2004, MOL BIOL CELL, V15, P3915, DOI 10.1091/mbc.E03-12-0908; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; HYNES RO, 1994, BIOESSAYS, V16, P663, DOI 10.1002/bies.950160912; Ingber DE, 2003, P NATL ACAD SCI USA, V100, P1472, DOI 10.1073/pnas.0530201100; Iranfar N, 2003, EUKARYOT CELL, V2, P664, DOI 10.1128/EC.2.4.664-670.2003; Klein HA, 1998, HUM FAC ERG SOC P, P1271; KLEIN P, 1985, J BIOL CHEM, V260, P1757; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Loomis WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042033; MANN SKO, 1989, P NATL ACAD SCI USA, V86, P1924, DOI 10.1073/pnas.86.6.1924; Muller DJ, 2009, NAT CHEM BIOL, V5, P383, DOI 10.1038/nchembio.181; Nicol A, 1999, J CELL SCI, V112, P3923; Niewohner J, 1997, J CELL BIOL, V138, P349, DOI 10.1083/jcb.138.2.349; NIR S, 1977, J MEMBRANE BIOL, V31, P1, DOI 10.1007/BF01869396; Parikh A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r35; Reymond CD, 1995, EXPERIENTIA, V51, P1166, DOI 10.1007/BF01944734; Sebe-Pedros A, 2010, P NATL ACAD SCI USA, V107, P10142, DOI 10.1073/pnas.1002257107; Selhuber-Unkel C, 2010, BIOPHYS J, V98, P543, DOI 10.1016/j.bpj.2009.11.001; SIEGERT F, 1995, CURR BIOL, V5, P937, DOI 10.1016/S0960-9822(95)00184-9; SUN TJ, 1991, GENE DEV, V5, P572, DOI 10.1101/gad.5.4.572; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; Tsujioka M, 2012, P NATL ACAD SCI USA, V109, P12992, DOI 10.1073/pnas.1208296109; Tulla M, 2008, FEBS LETT, V582, P3520, DOI 10.1016/j.febslet.2008.09.022; Tuxworth RI, 2001, CURR BIOL, V11, P318, DOI 10.1016/S0960-9822(01)00097-5; WEBER I, 1995, J CELL SCI, V108, P1519; Weber I, 2002, CELL MOTIL CYTOSKEL, V53, P136, DOI 10.1002/cm.10065; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zhang XH, 2006, EXP BIOL MED, V231, P1306, DOI 10.1177/153537020623100804	42	21	21	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e106574	10.1371/journal.pone.0106574	http://dx.doi.org/10.1371/journal.pone.0106574			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247557	gold, Green Published, Green Submitted			2022-12-25	WOS:000342351800013
J	Gowrishankar, G; Namavari, M; Jouannot, EB; Hoehne, A; Reeves, R; Hardy, J; Gambhir, SS				Gowrishankar, Gayatri; Namavari, Mohammad; Jouannot, Erwan Benjamin; Hoehne, Aileen; Reeves, Robert; Hardy, Jonathan; Gambhir, Sanjiv Sam			Investigation of 6-[F-18]-Fluoromaltose as a Novel PET Tracer for Imaging Bacterial Infection	PLOS ONE			English	Article							ESCHERICHIA-COLI; IN-VIVO; MALTOSE; PROBES; AGENT	Despite advances in the field of nuclear medicine, the imaging of bacterial infections has remained a challenge. The existing reagents suffer from poor sensitivity and specificity. In this study we investigate the potential of a novel PET (positron emission tomography) tracer that overcomes these limitations. Methods: 6-[F-18]-fluoromaltose was synthesized. Its behavior in vitro was evaluated in bacterial and mammalian cultures. Detailed pharmacokinetic and biodistribution profiles for the tracer were obtained from a murine model. Results: 6-[F-18]-fluoromaltose is taken up by multiple strains of pathogenic bacteria. It is not taken up by mammalian cancer cell lines. 6-[F-18]-fluoromaltose is retained in infected muscles in a murine model of bacterial myositis. It does not accumulate in inflamed tissue. Conclusion: We have shown that 6-[F-18]-fluoromaltose can be used to image bacterial infection in vivo with high specificity. We believe that this class of agents will have a significant impact on the clinical management of patients.	[Gowrishankar, Gayatri; Namavari, Mohammad; Hoehne, Aileen; Reeves, Robert; Gambhir, Sanjiv Sam] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; [Jouannot, Erwan Benjamin] Sanofi R&D, Paris, France; [Hardy, Jonathan] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Gambhir, Sanjiv Sam] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Sanofi-Aventis; Sanofi France; Stanford University; Stanford University	Gambhir, SS (corresponding author), Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA.	gayatrig@stanford.edu	Hardy, Jonathan/AAO-9306-2020					Akhtar MS, 2005, J NUCL MED, V46, P567; Britton KE, 2002, J CLIN PATHOL, V55, P817, DOI 10.1136/jcp.55.11.817; Bunschoten A, 2013, BIOCONJUGATE CHEM, V24, P1971, DOI 10.1021/bc4003037; Diaz LA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001007; FERENCI T, 1980, EUR J BIOCHEM, V108, P631, DOI 10.1111/j.1432-1033.1980.tb04758.x; Hardy J, 2004, SCIENCE, V303, P851, DOI 10.1126/science.1092712; James ML, 2012, PHYSIOL REV, V92, P897, DOI 10.1152/physrev.00049.2010; Jones SA, 2008, INFECT IMMUN, V76, P2531, DOI 10.1128/IAI.00096-08; Landau BR, 2007, AM J PHYSIOL-ENDOC M, V293, pE237, DOI 10.1152/ajpendo.00022.2007; Leevy W Matthew, 2007, Drug Discov Today Dis Models, V4, P91, DOI 10.1016/j.ddmod.2007.07.001; Machens HG, 1996, MICROSURG, V17, P272, DOI 10.1002/(SICI)1098-2752(1996)17:5<272::AID-MICR7>3.0.CO;2-L; Namavari M, SYNTHESIS 18F LABELL; Ning XH, 2011, NAT MATER, V10, P602, DOI [10.1038/NMAT3074, 10.1038/nmat3074]; Peterson KL, 2013, NUCL MED BIOL, V40, P638, DOI 10.1016/j.nucmedbio.2013.01.005; Sachin K, 2010, BIOCONJUGATE CHEM, V21, P2282, DOI 10.1021/bc1002983; Saeed M, 2004, J NUCL MED, V45, P849; Sasser TA, 2013, CURR TOP MED CHEM, V13, P479; Shelburne SA, 2006, INFECT IMMUN, V74, P4605, DOI 10.1128/IAI.00477-06; Tang EN, 2014, J BIOMED NANOTECHNOL, V10, P856, DOI 10.1166/jbn.2014.1852; van Oosten M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3584; YOUNG JM, 1971, J CLIN INVEST, V50, P986	21	60	62	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107951	10.1371/journal.pone.0107951	http://dx.doi.org/10.1371/journal.pone.0107951			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243851	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800058
J	Ichii, O; Otsuka-Kanazawa, S; Nakamura, T; Ueno, M; Kon, Y; Chen, WP; Rosenberg, AZ; Kopp, JB				Ichii, Osamu; Otsuka-Kanazawa, Saori; Nakamura, Teppei; Ueno, Masaaki; Kon, Yasuhiro; Chen, Weiping; Rosenberg, Avi Z.; Kopp, Jeffrey B.			Podocyte Injury Caused by Indoxyl Sulfate, a Uremic Toxin and Aryl-Hydrocarbon Receptor Ligand	PLOS ONE			English	Article							NF-KAPPA-B; REGULATES RENAL EXPRESSION; GENE-EXPRESSION; 3-INDOXYL SULFATE; UP-REGULATION; PROGRESSION; ACTIVATION; CELLS; DIFFERENTIATION; NEPHROPATHY	Indoxyl sulfate is a uremic toxin and a ligand of the aryl-hydrocarbon receptor (AhR), a transcriptional regulator. Elevated serum indoxyl sulfate levels may contribute to progressive kidney disease and associated vascular disease. We asked whether indoxyl sulfate injures podocytes in vivo and in vitro. Mice exposed to indoxyl sulfate for 8 w exhibited prominent tubulointerstitial lesions with vascular damage. Indoxyl sulfate-exposed mice with microalbuminuria showed ischemic changes, while more severely affected mice showed increased mesangial matrix, segmental solidification, and mesangiolysis. In normal mouse kidneys, AhR was predominantly localized to the podocyte nuclei. In mice exposed to indoxyl sulfate for 2 h, isolated glomeruli manifested increased Cyp1a1 expression, indicating AhR activation. After 8 w of indoxyl sulfate, podocytes showed foot process effacement, cytoplasmic vacuoles, and a focal granular and wrinkled pattern of podocin and synaptopodin expression. Furthermore, vimentin and AhR expression in the glomerulus was increased in the indoxyl sulfate-exposed glomeruli compared to controls. Glomerular expression of characteristic podocyte mRNAs was decreased, including Actn4, Cd2ap, Myh9, Nphs1, Nphs2, Podxl, Synpo, and Wt1. In vitro, immortalized-mouse podocytes exhibited AhR nuclear translocation beginning 30 min after 1 mM indoxyl sulfate exposure, and there was increased phospho-Rac1/Cdc42 at 2 h. After exposure to indoxyl sulfate for 24 h, mouse podocytes exhibited a pro-inflammatory phenotype, perturbed actin cytoskeleton, decreased expression of podocyte-specific genes, and decreased cell viability. In immortalized human podocytes, indoxyl sulfate treatment caused cell injury, decreased mRNA expression of podocyte-specific proteins, as well as integrins, collagens, cytoskeletal proteins, and bone morphogenetic proteins, and increased cytokine and chemokine expression. We propose that basal levels of AhR activity regulate podocyte function under normal conditions, and that increased activation of podocyte AhR by indoxyl sulfate contributes to progressive glomerular injury.	[Ichii, Osamu; Otsuka-Kanazawa, Saori; Nakamura, Teppei; Kon, Yasuhiro] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Anat Lab, Sapporo, Hokkaido 060, Japan; [Ichii, Osamu; Kopp, Jeffrey B.] NIDDK, Kidney Dis Sect, NIH, Bethesda, MD USA; [Nakamura, Teppei; Ueno, Masaaki] Japan Food Res Labs, Chitose Lab, Sect Biol Safety Res, Chitose, Japan; [Chen, Weiping] NIDDK, Microarray Core Facil, NIH, Bethesda, MD USA; [Rosenberg, Avi Z.] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA	Hokkaido University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ichii, O (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Anat Lab, Sapporo, Hokkaido 060, Japan.	ichi-o@vetmed.hokudai.ac.jp	Chen, Wei/GZK-7348-2022; Kopp, Jeffrey B/O-2681-2015	Kopp, Jeffrey B/0000-0001-9052-186X; Rosenberg, Avi/0000-0003-2356-950X; NAKAMURA, Teppei/0000-0003-3204-0245; Kon, Yasuhiro/0000-0002-8859-6122	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan [24688033]; Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH)	This work was partially supported by grants from the Institutional Program for Young Researcher Overseas Visits from the Japan Society for the Promotion of Science, a Grant-in-Aid for Young Scientists (A) (No. 24688033, Dr. Ichii) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by the Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH) (Dr. Kopp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson DR, 2012, SEMIN NEPHROL, V32, P342, DOI 10.1016/j.semnephrol.2012.06.005; Adelibieke Y, 2012, J RENAL NUTR, V22, P86, DOI 10.1053/j.jrn.2011.10.027; Adijiang A, 2011, J RENAL NUTR, V21, P105, DOI 10.1053/j.jrn.2010.10.020; ANDERSON LM, 1987, CANCER RES, V47, P6079; Aoyama I, 2001, AM J KIDNEY DIS, V37, pS7, DOI 10.1053/ajkd.2001.20731; BARALDI A, 1995, NEPHROL DIAL TRANSPL, V10, P1155, DOI 10.1093/ndt/10.7.1155; Barouki Robert, 2012, Drug Metabolism and Drug Interactions, V27, P3, DOI 10.1515/dmdi-2011-0035; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Bock KW, 2009, BIOL CHEM, V390, P1225, DOI 10.1515/BC.2009.138; Chang CC, 2009, CELL MOL LIFE SCI, V66, P3193, DOI 10.1007/s00018-009-0102-7; de Loor H, 2009, J CHROMATOGR A, V1216, P4684, DOI 10.1016/j.chroma.2009.04.015; Dey A, 1999, BIOCHEM PHARMACOL, V58, P525, DOI 10.1016/S0006-2952(99)00110-0; Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175; Enomoto A, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022017.96399.B2; Falahatpisheh MH, 2011, MOL MED, V17, P1275, DOI 10.2119/molmed.2011.00125; Fernandez D, 2013, BIOCHEM BIOPH RES CO, V432, P302, DOI 10.1016/j.bbrc.2013.01.112; Gao SY, 2007, CELL TISSUE RES, V328, P391, DOI 10.1007/s00441-006-0365-3; Gelasco AK, 2006, AM J PHYSIOL-RENAL, V290, pF1551, DOI 10.1152/ajprenal.00281.2004; George B, 2012, SEMIN NEPHROL, V32, P307, DOI 10.1016/j.semnephrol.2012.06.002; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Jiang YZ, 2010, J HISTOCHEM CYTOCHEM, V58, P679, DOI 10.1369/jhc.2010.955955; Kajiyama H, 2009, AM J NEPHROL, V29, P153, DOI 10.1159/000151770; Kanasaki K, 2008, DEV BIOL, V313, P584, DOI 10.1016/j.ydbio.2007.10.047; KEMENY E, 1995, CLIN NEPHROL, V43, P71; Kim SH, 2012, LAB INVEST, V92, P488, DOI 10.1038/labinvest.2011.194; Kimura J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016472; Kobayashi N, 2002, NEPHRON, V91, P480, DOI 10.1159/000064291; Miyamoto Y, 2011, THER APHER DIAL, V15, P129, DOI 10.1111/j.1744-9987.2010.00884.x; Miyazaki T, 2000, NEPHROL DIAL TRANSPL, V15, P1773, DOI 10.1093/ndt/15.11.1773; Moriguchi T, 2003, P NATL ACAD SCI USA, V100, P5652, DOI 10.1073/pnas.1037886100; Mozar A, 2012, NEPHROL DIAL TRANSPL, V27, P2176, DOI 10.1093/ndt/gfr647; Mutsaers HAM, 2013, BBA-MOL BASIS DIS, V1832, P142, DOI 10.1016/j.bbadis.2012.09.006; Ng HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091517; Nishimura N, 2008, TOXICOL APPL PHARM, V231, P374, DOI 10.1016/j.taap.2008.05.012; NIWA T, 1994, AM J NEPHROL, V14, P207, DOI 10.1159/000168716; Niwa T, 2012, J RENAL NUTR, V22, P102, DOI 10.1053/j.jrn.2011.10.032; Norman JT, 2006, CLIN EXP PHARMACOL P, V33, P989, DOI 10.1111/j.1440-1681.2006.04476.x; Papeta N, 2009, J CLIN INVEST, V119, P1178, DOI 10.1172/JCI37131; Patrakka J, 2009, NAT REV NEPHROL, V5, P463, DOI 10.1038/nrneph.2009.108; Peng YS, 2012, J CELL BIOCHEM, V113, P1034, DOI 10.1002/jcb.23435; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Ronco P, 2005, J AM SOC NEPHROL, V16, P1205, DOI 10.1681/ASN.2004121080; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schoentaube J, 2009, CELL MICROBIOL, V11, P1816, DOI 10.1111/j.1462-5822.2009.01373.x; Schroeder JC, 2010, BIOCHEMISTRY-US, V49, P393, DOI 10.1021/bi901786x; Schupp N, 2010, TOXINS, V2, P2340, DOI 10.3390/toxins2102340; Scott RP, 2012, J AM SOC NEPHROL, V23, P1149, DOI 10.1681/ASN.2011121206; Shimizu H, 2012, LIFE SCI, V90, P525, DOI 10.1016/j.lfs.2012.01.013; Shimizu H, 2011, AM J NEPHROL, V33, P319, DOI 10.1159/000324885; Srivastava T, 2013, J CELL COMMUN SIGNAL, V7, P49, DOI 10.1007/s12079-012-0184-0; Sun CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034026; Sun KH, 2000, IMMUNOLOGY, V99, P352, DOI 10.1046/j.1365-2567.2000.00970.x; Tumur Z, 2010, AM J NEPHROL, V31, P435, DOI 10.1159/000299798; Ueda H, 2008, J AM SOC NEPHROL, V19, P685, DOI 10.1681/ASN.2006090983; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Vogel CFA, 2009, BIOCHEM PHARMACOL, V77, P734, DOI 10.1016/j.bcp.2008.09.036; Wang GF, 2009, RAPID COMMUN MASS SP, V23, P2061, DOI 10.1002/rcm.4111; Yu M, 2011, CLIN J AM SOC NEPHRO, V6, P30, DOI 10.2215/CJN.05340610; ZOJA C, 1991, AM J PATHOL, V138, P991; Zou J, 2006, VIRCHOWS ARCH, V448, P485, DOI 10.1007/s00428-005-0134-9; Zuo YQ, 2006, J AM SOC NEPHROL, V17, P2832, DOI 10.1681/ASN.2005080878	61	53	62	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e108448	10.1371/journal.pone.0108448	http://dx.doi.org/10.1371/journal.pone.0108448			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244654	Green Submitted, Green Published, gold			2022-12-25	WOS:000343679800089
J	Ishikawa, T; Kato-Yamada, Y				Ishikawa, Toru; Kato-Yamada, Yasuyuki			Severe MgADP Inhibition of Bacillus subtilis F-1-ATPase Is Not Due to the Absence of Nucleotide Binding to the Noncatalytic Nucleotide Binding Sites	PLOS ONE			English	Article							MITOCHONDRIAL ADENOSINE-TRIPHOSPHATASE; APPARENT NEGATIVE COOPERATIVITY; ALPHA(3)BETA(3)GAMMA COMPLEX; CATALYTIC SITE; KINETIC MECHANISM; ATP SYNTHASE; PS3; SUBSTITUTION; HYDROLYSIS; ROTATION	F-1-ATPase from Bacillus subtilis (BF1) is severely suppressed by the MgADP inhibition. Here, we have tested if this is due to the loss of nucleotide binding to the noncatalytic site that is required for the activation. Measurements with a tryptophan mutant of BF1 indicated that the noncatalytic sites could bind ATP normally. Furthermore, the mutant BF1 that cannot bind ATP to the noncatalytic sites showed much lower ATPase activity. It was concluded that the cause of strong MgADP inhibition of BF1 is not the weak nucleotide binding to the noncatalytic sites but the other steps required for the activation.	[Ishikawa, Toru; Kato-Yamada, Yasuyuki] Rikkyo Univ, Dept Life Sci, Toshima Ku, Tokyo 171, Japan; [Kato-Yamada, Yasuyuki] Rikkyo Univ, Res Ctr Life Sci, Toshima Ku, Tokyo 171, Japan	Rikkyo University; Rikkyo University	Kato-Yamada, Y (corresponding author), Rikkyo Univ, Dept Life Sci, Toshima Ku, Tokyo 171, Japan.	katoyama@rikkyo.ac.jp			Japanese Society for the Promotion of Science [23770157]; Strategic Research Foundation from the Ministry of Education, Culture, Sports, Science and Technology of Japan [S1201003]	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Strategic Research Foundation from the Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported in parts by the Grant-in-Aid for Young Scientists (B) (No. 23770157) from the Japanese Society for the Promotion of Science, the Strategic Research Foundation Grant-aided Project for Private Universities (No. S1201003) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (www.mext.go.jp) (to Y.K.-Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 1999, BIOCHEM J, V343, P135, DOI 10.1042/0264-6021:3430135; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DROBINSKAYA IY, 1985, FEBS LETT, V182, P419, DOI 10.1016/0014-5793(85)80346-X; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; Jault JM, 1996, J BIOL CHEM, V271, P28818, DOI 10.1074/jbc.271.46.28818; Jault JM, 1995, BIOCHEMISTRY-US, V34, P16412, DOI 10.1021/bi00050a023; JAULT JM, 1993, J BIOL CHEM, V268, P1558; Matsui T, 1997, J BIOL CHEM, V272, P8215, DOI 10.1074/jbc.272.13.8215; MILGROM YM, 1990, J BIOL CHEM, V265, P18725; MILGROM YM, 1991, J BIOL CHEM, V266, P11551; Mizumoto J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073888; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Ono S, 2003, BBA-BIOENERGETICS, V1607, P35, DOI 10.1016/j.bbabio.2003.08.006; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; VASILYEVA EA, 1982, BIOCHEM J, V202, P15, DOI 10.1042/bj2020015; VASILYEVA EA, 1982, BIOCHEM J, V202, P9, DOI 10.1042/bj2020009; WEBER J, 1994, J BIOL CHEM, V269, P11261; Yokoyama K, 1998, J BIOL CHEM, V273, P20504, DOI 10.1074/jbc.273.32.20504; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; ZHOU JM, 1988, BIOCHEMISTRY-US, V27, P5129, DOI 10.1021/bi00414a027	22	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107197	10.1371/journal.pone.0107197	http://dx.doi.org/10.1371/journal.pone.0107197			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244289	gold, Green Published, Green Submitted			2022-12-25	WOS:000343679800025
J	Vsevolozhskaya, OA; Zaykin, DV; Greenwood, MC; Wei, CS; Lu, Q				Vsevolozhskaya, Olga A.; Zaykin, Dmitri V.; Greenwood, Mark C.; Wei, Changshuai; Lu, Qing			Functional Analysis of Variance for Association Studies	PLOS ONE			English	Article							MISSING HERITABILITY; RARE VARIANTS; LINEAR-MODELS; TESTS; LOCI; PERMUTATION; COMMON; TRIGLYCERIDES	While progress has been made in identifying common genetic variants associated with human diseases, for most of common complex diseases, the identified genetic variants only account for a small proportion of heritability. Challenges remain in finding additional unknown genetic variants predisposing to complex diseases. With the advance in next-generation sequencing technologies, sequencing studies have become commonplace in genetic research. The ongoing exome-sequencing and whole-genome-sequencing studies generate a massive amount of sequencing variants and allow researchers to comprehensively investigate their role in human diseases. The discovery of new disease-associated variants can be enhanced by utilizing powerful and computationally efficient statistical methods. In this paper, we propose a functional analysis of variance (FANOVA) method for testing an association of sequence variants in a genomic region with a qualitative trait. The FANOVA has a number of advantages: (1) it tests for a joint effect of gene variants, including both common and rare; (2) it fully utilizes linkage disequilibrium and genetic position information; and (3) allows for either protective or risk-increasing causal variants. Through simulations, we show that FANOVA outperform two popularly used methods - SKAT and a previously proposed method based on functional linear models (FLM), - especially if a sample size of a study is small and/or sequence variants have low to moderate effects. We conduct an empirical study by applying three methods (FANOVA, SKAT and FLM) to sequencing data from Dallas Heart Study. While SKAT and FLM respectively detected ANGPTL 4 and ANGPTL 3 associated with obesity, FANOVA was able to identify both genes associated with obesity.	[Vsevolozhskaya, Olga A.; Wei, Changshuai; Lu, Qing] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Zaykin, Dmitri V.] NIEHS, NIH, Res Triangle Pk, NC 27709 USA; [Greenwood, Mark C.] Montana State Univ, Dept Math Sci, Bozeman, MT 59717 USA	Michigan State University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Montana State University System; Montana State University Bozeman	Vsevolozhskaya, OA (corresponding author), Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA.	vsevoloz@msu.edu; qlu@msu.edu	Zaykin, Dmitri/C-3752-2019; Wei, Changshuai/A-7750-2015; Vsevolozhskaya, Olga/AAX-5846-2020	Zaykin, Dmitri/0000-0002-9444-2859; Wei, Changshuai/0000-0003-0148-6797; 	National Institute on Drug Abuse [T32DA021129]; National Institutes of Health, National Institute of Environmental Health Sciences; NIDA [K01DA033346]; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA033346, T32DA021129] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a National Institute on Drug Abuse T32 research training program grant award (T32DA021129), QL's NIDA Mentored Research Scientist Development Award (K01DA033346), and by DVZ's Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences. The content is the sole responsibility of the authors and does not necessarily represent the official views of Michigan State University, the National Institute on Drug Abuse, the National Institute of Environmental Health Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Boos DD, 2000, J AM STAT ASSOC, V95, P486, DOI 10.2307/2669393; Cuevas A, 2004, COMPUT STAT DATA AN, V47, P111, DOI 10.1016/j.csda.2003.10.021; DAGOSTINO RB, 1972, AM STAT, V26, P30; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Fan RZ, 2013, GENET EPIDEMIOL, V37, P726, DOI 10.1002/gepi.21757; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Goldstein DB, 2013, NATURE REV GENETICS; Green P.J., 1993, NONPARAMETRIC REGRES, DOI DOI 10.1201/B15710; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Horvath L, 2012, INFERENCE FUNCTIONAL, DOI DOI 10.1007/978-1-4614-3655-3; HUDSON RR, 1985, GENETICS, V109, P611; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kennedy PE, 1996, COMMUN STAT-SIMUL C, V25, P923, DOI 10.1080/03610919608813350; Kinnamon DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030238; Lee S, 2013, SKAT SNP SET SEQUENC; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Legry V, 2009, J CLIN ENDOCR METAB, V94, P5070, DOI 10.1210/jc.2009-0769; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015., 10.1016/j.ajhg.2011.07.015]; Luo L, 2012, J MED GENET, V49, P513, DOI 10.1136/jmedgenet-2012-100798; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; ODEN NL, 1991, J AM STAT ASSOC, V86, P1074, DOI 10.2307/2290526; Otto SP, 2000, GENETICS, V156, P2093; R Core Team, 2021, R LANG ENV STAT COMP; Ramsay J., 2005, FUNCTIONAL DATA ANAL, DOI 10.1007/b98888; Ramsay J. O., 2013, FDA FUNCTIONAL DATA; Raychaudhuri S, 2011, CELL, V147, P57, DOI 10.1016/j.cell.2011.09.011; Reimherr M, 2014, ANN APPL STAT; Reiss PT, 2010, BIOMETRICS, V60; Reynolds CA, 2006, TWIN RES HUM GENET, V9, P17, DOI 10.1375/twin.9.1.17; Robciuc MR, 2010, J LIPID RES, V51, P824, DOI 10.1194/jlr.M002618; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Shen Q, 2004, STAT SINICA, V14, P1239; Smart-Halajko MC, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-89; TERBRAAK CJF, 1992, LECT NOTES ECON MATH, V376, P79; van Buuren S, 2011, J STAT SOFTW, V45, P1; Vsevolozhskaya OA, 2014, ANN APPL STAT; Vseyolozhskaya OA, 2013, COMPUT STAT DATA AN, V67, P175, DOI 10.1016/j.csda.2013.05.005; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Wood S.N., 2017, GEN ADDITIVE MODELS, V2, P1, DOI [DOI 10.1201/9781315370279, 10.1201/9781315370279]; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yashin AI, 2010, AGING-US, V2, P612, DOI 10.18632/aging.100191; Zhang J.T., 2013, ANAL VARIANCE FUNCTI	50	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e105074	10.1371/journal.pone.0105074	http://dx.doi.org/10.1371/journal.pone.0105074			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244256	Green Published, gold			2022-12-25	WOS:000343679800002
J	Cheng, EC; Kang, DW; Wang, Z; Lin, HF				Cheng, Ee-Chun; Kang, Dongwan; Wang, Zhong; Lin, Haifan			PIWI Proteins Are Dispensable for Mouse Somatic Development and Reprogramming of Fibroblasts into Pluripotent Stem Cells	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; PRIMORDIAL GERM-CELLS; SELF-RENEWAL; BIOCONDUCTOR PACKAGE; PIRNA PATHWAY; INDUCTION; ACTIVATION; ENCODES; LIN28; GENE	PIWI proteins play essential and conserved roles in germline development, including germline stem cell maintenance and meiosis. Because germline regulators such as OCT4, NANOG, and SOX2 are known to be potent factors that reprogram differentiated somatic cells into induced pluripotent stem cells (iPSCs), we investigated whether the PIWI protein family is involved in iPSC production. We find that all three mouse Piwi genes, Miwi, Mili, and Miwi2, are expressed in embryonic stem cells (ESCs) at higher levels than in fibroblasts, with Mili being the highest. However, mice lacking all three Piwi genes are viable and female fertile, and are only male sterile. Furthermore, embryonic fibroblasts derived from Miwi/Mili/Miwi2 triple knockout embryos can be efficiently reprogrammed into iPS cells. These iPS cells expressed pluripotency markers and were capable of differentiating into all three germ layers in teratoma assays. Genome/wide expression profiling reveals that the triple knockout iPS cells are very similar to littermate control iPS cells. These results indicate that PIWI proteins are dispensable for direct reprogramming of mouse fibroblasts.	[Cheng, Ee-Chun; Lin, Haifan] Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06520 USA; [Cheng, Ee-Chun; Lin, Haifan] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Kang, Dongwan; Wang, Zhong] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA	Yale University; Yale University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Lin, HF (corresponding author), Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06520 USA.	haifan.lin@yale.edu	Wang, Zhong/J-3244-2019	Wang, Zhong/0000-0002-6307-0458	National Institutes of Health [R37HD42012]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD042012] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the National Institutes of Health Grant R37HD42012 to H.L. D.K. and Z.W. were supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson RA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-136; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Gangaraju VK, 2011, NAT GENET, V43, P153, DOI 10.1038/ng.743; Gillis AJM, 2011, INT J ANDROL, V34, pE160, DOI 10.1111/j.1365-2605.2011.01148.x; Grabole N, 2013, EMBO REP, V14, P629, DOI 10.1038/embor.2013.67; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Harris AN, 2001, DEVELOPMENT, V128, P2823; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Izadyar F, 2008, REPRODUCTION, V135, P771, DOI 10.1530/REP-07-0479; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Kirino Y, 2009, NAT CELL BIOL, V11, P652, DOI 10.1038/ncb1872; Kuijk EW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010987; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lee DF, 2012, NAT PROTOC, V7, P729, DOI 10.1038/nprot.2012.018; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu SX, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-141; Ma ZY, 2011, NAT STRUCT MOL BIOL, V18, P120, DOI 10.1038/nsmb.2000; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Mani SR, 2013, DEV BIOL; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Matzuk MM, 2009, DEV CELL, V17, P160, DOI 10.1016/j.devcel.2009.07.020; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; Nagamatsu G, 2011, J BIOL CHEM, V286, P10641, DOI 10.1074/jbc.M110.216390; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Nolde MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071950; Peng JC, 2013, CURR OPIN CELL BIOL, V25, P190, DOI 10.1016/j.ceb.2013.01.010; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Specchia V, 2010, NATURE, V463, P662, DOI 10.1038/nature08739; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson T, 2009, ANNU REV CELL DEV BI, V25, P355, DOI 10.1146/annurev.cellbio.24.110707.175327; Unhavaithaya Y, 2009, J BIOL CHEM, V284, P6507, DOI 10.1074/jbc.M809104200; Ventea S, 2012, STEM CELLS, V30, P1008, DOI 10.1002/stem.1077; Vourekas A, 2012, NAT STRUCT MOL BIOL, V19, P773, DOI 10.1038/nsmb.2347; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zheng K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-38; Zwaka TP, 2005, DEVELOPMENT, V132, P227, DOI 10.1242/dev.01586	57	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e97821	10.1371/journal.pone.0097821	http://dx.doi.org/10.1371/journal.pone.0097821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238487	Green Published, Green Submitted, gold			2022-12-25	WOS:000342491600001
J	Chibly, AM; Querin, L; Harris, Z; Limesand, KH				Chibly, Alejandro M.; Querin, Lauren; Harris, Zoey; Limesand, Kirsten H.			Label-Retaining Cells in the Adult Murine Salivary Glands Possess Characteristics of Adult Progenitor Cells	PLOS ONE			English	Article							NECK-CANCER; STEM-CELLS; RADIATION-THERAPY; RENAL PAPILLA; SWEAT GLANDS; HEAD; IDENTIFICATION; PROLIFERATION; POPULATIONS; DYSFUNCTION	Radiotherapy is the primary treatment for patients with head and neck cancer, which account for roughly 500,000 annual cases worldwide. Dysfunction of the salivary glands and associated conditions like xerostomia and dysphagia are often developed by these patients, greatly diminishing their life quality. Current preventative and palliative care fail to deliver an improvement in the quality of life, thus accentuating the need for regenerative therapies. In this study, a model of label retaining cells (LRCs) in murine salivary glands was developed, in which LRCs demonstrated proliferative potential and possessed markers of putative salivary progenitors. Mice were labeled with 5-Ethynyl-2'-deoxyuridine (EdU) at postnatal day 10 and chased for 8 weeks. Tissue sections from salivary glands obtained at the end of chase demonstrated co-localization between LRCs and the salivary progenitor markers keratin 5 and keratin 14, as well as kit mRNA, indicating that LRCs encompass a heterogeneous population of salivary progenitors. Proliferative potential of LRCs was demonstrated by a sphere assay, in which LRCs were found in primary and secondary spheres and they co-localized with the proliferation marker Ki67 throughout sphere formation. Surprisingly, LRCs were shown to be radio-resistant and evade apoptosis following radiation treatment. The clinical significance of these findings lie in the potential of this model to study the mechanisms that prevent salivary progenitors from maintaining homeostasis upon exposure to radiation, which will in turn facilitate the development of regenerative therapies for salivary gland dysfunction.	[Chibly, Alejandro M.; Limesand, Kirsten H.] Univ Arizona, Canc Biol Grad Program, Tucson, AZ 85721 USA; [Querin, Lauren; Harris, Zoey; Limesand, Kirsten H.] Univ Arizona, Dept Nutr Sci, Tucson, AZ USA	University of Arizona; University of Arizona	Limesand, KH (corresponding author), Univ Arizona, Canc Biol Grad Program, Tucson, AZ 85721 USA.	limesank@u.arizona.edu	Kim, Ji-Youn/A-5779-2017	Martinez Chibly, Agustin Alejandro/0000-0001-7747-4990	National Institutes of Health [R01DE018888]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023534, R01DE018888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	National Institutes of Health R01DE018888 to KHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2009, AM J PHYSIOL-RENAL, V297, pF809, DOI 10.1152/ajprenal.90650.2008; Avila JL, 2009, INT J RADIAT ONCOL, V73, P523, DOI 10.1016/j.ijrobp.2008.09.036; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barker N, 2010, CELL STEM CELL, V7, P656, DOI 10.1016/j.stem.2010.11.016; Bullard T, 2008, DEV BIOL, V320, P72, DOI 10.1016/j.ydbio.2008.04.018; Castadot P, 2010, SEMIN RADIAT ONCOL, V20, P84, DOI 10.1016/j.semradonc.2009.11.002; Chen L, 2014, ARCH DERMATOL RES, V306, P157, DOI 10.1007/s00403-013-1397-7; Choi J, 2009, CELL STEM CELL, V5, P6, DOI 10.1016/j.stem.2009.06.006; Cmelak AJ, 2012, CRIT REV ONCOL HEMAT, V84, P261, DOI 10.1016/j.critrevonc.2012.04.004; Collins R, 2005, QUAL SAF HEALTH CARE, V14, P144, DOI 10.1136/qshc.2005.013961; Coppes RP, 2011, ORAL DIS, V17, P143, DOI 10.1111/j.1601-0825.2010.01723.x; Denny PC, 1999, ANAT REC, V254, P408, DOI 10.1002/(SICI)1097-0185(19990301)254:3<408::AID-AR12>3.0.CO;2-G; DENNY PC, 1993, ANAT REC, V235, P475, DOI 10.1002/ar.1092350316; Dirix P, 2006, CANCER-AM CANCER SOC, V107, P2525, DOI 10.1002/cncr.22302; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dost F, 2013, AUST DENT J, V58, P11, DOI 10.1111/adj.12023; Duque A, 2011, J NEUROSCI, V31, P15205, DOI 10.1523/JNEUROSCI.3092-11.2011; George AL, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-24; Gil-Perotin S, 2013, ANAT REC, V296, P1435, DOI 10.1002/ar.22746; Grundmann O, 2009, J DENT RES, V88, P894, DOI 10.1177/0022034509343143; Grundmann O, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-417; Gu JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095968; Hsu YC, 2012, NAT REV MOL CELL BIO, V13, P103, DOI 10.1038/nrm3272; Jensen SB, 2003, SUPPORT CARE CANCER, V11, P207, DOI 10.1007/s00520-002-0407-7; Jham BC, 2008, CLIN ORAL INVEST, V12, P19, DOI 10.1007/s00784-007-0149-5; Kimoto M, 2008, J HISTOCHEM CYTOCHEM, V56, P15, DOI 10.1369/jhc.7A7269.2007; Knox SM, 2010, SCIENCE, V329, P1645, DOI 10.1126/science.1192046; Knox SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2493; Konings AWT, 2005, INT J RADIAT ONCOL, V62, P1187, DOI 10.1016/j.ijrobp.2004.12.051; Lee AWM, 2012, SEMIN RADIAT ONCOL, V22, P233, DOI 10.1016/j.semradonc.2012.03.008; Leung Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074174; Li FS, 2010, J GASTROENTEROL, V45, P113, DOI 10.1007/s00535-009-0139-2; Limesand KH, 2010, INT J RADIAT ONCOL, V78, P579, DOI 10.1016/j.ijrobp.2010.03.035; Limesand KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004663; Lombaert IMA, 2011, ORAL DIS, V17, P445, DOI 10.1111/j.1601-0825.2010.01783.x; Lombaert IMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002063; Lombaert IMA, 2013, STEM CELL REP, V1, P604, DOI 10.1016/j.stemcr.2013.10.013; Lu CP, 2012, CELL, V150, P136, DOI 10.1016/j.cell.2012.04.045; Maeshima Akito, 2007, Clin Exp Nephrol, V11, P269, DOI 10.1007/s10157-007-0500-9; Marcus KJ, 2010, SEMIN RADIAT ONCOL, V20, P52, DOI 10.1016/j.semradonc.2009.09.004; Metcalfe C, 2014, CELL STEM CELL, V14, P149, DOI 10.1016/j.stem.2013.11.008; Morgan-Bathke M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05206; Nanduri LSY, 2011, RADIOTHER ONCOL, V99, P367, DOI 10.1016/j.radonc.2011.05.085; Nelson DA, 2013, BIOL OPEN, V2, P439, DOI 10.1242/bio.20134309; Oliver JA, 2004, J CLIN INVEST, V114, P795, DOI 10.1172/JCI200420921; Oliver JA, 2009, J AM SOC NEPHROL, V20, P2315, DOI 10.1681/ASN.2008111203; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Rades D, 2004, RADIOTHER ONCOL, V70, P261, DOI 10.1016/j.radonc.2003.10.005; Redman RS, 2008, BIOTECH HISTOCHEM, V83, P103, DOI 10.1080/10520290802374683; Roth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038965; Rovira M, 2010, P NATL ACAD SCI USA, V107, P75, DOI 10.1073/pnas.0912589107; Rugel-Stahl A, 2012, STEM CELL RES, V8, P379, DOI 10.1016/j.scr.2012.01.002; Smith GH, 2005, DEVELOPMENT, V132, P681, DOI 10.1242/dev.01609; Teng CB, 2007, DIFFERENTIATION, V75, P702, DOI 10.1111/j.1432-0436.2007.00170.x; Terskikh VV, 2012, STEM CELL REV REP, V8, P414, DOI 10.1007/s12015-011-9299-6; VALDEZ IH, 1993, INT J RADIAT ONCOL, V25, P41, DOI 10.1016/0360-3016(93)90143-J; You S, 2011, CELL TISSUE RES, V346, P317, DOI 10.1007/s00441-011-1271-x; Zeng CB, 2010, BRAIN RES, V1319, P21, DOI 10.1016/j.brainres.2009.12.092	58	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107893	10.1371/journal.pone.0107893	http://dx.doi.org/10.1371/journal.pone.0107893			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238060	Green Published, Green Submitted, gold			2022-12-25	WOS:000342491600061
J	Packham, IM; Watson, SP; Bicknell, R; Egginton, S				Packham, Ian M.; Watson, Steve P.; Bicknell, Roy; Egginton, Stuart			In Vivo Evidence for Platelet-Induced Physiological Angiogenesis by a COX Driven Mechanism	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RAT SKELETAL-MUSCLE; COLORECTAL-CANCER; VEGF; PLASMA; AGGREGATION; SEVOFLURANE; DENSITY; CELLS; SERUM	We sought to determine a role for platelets in in vivo angiogenesis, quantified by changes in the capillary to fibre ratio (C:F) of mouse skeletal muscle, utilising two distinct forms of capillary growth to identify differential effects. Capillary sprouting was induced by muscle overload, and longitudinal splitting by chronic hyperaemia. Platelet depletion was achieved by anti-GPIb alpha antibody treatment. Sprouting induced a significant increase in C:F (1.42 +/- 0.02 vs. contralateral 1.29 +/- 0.02, P<0.001) that was abolished by platelet depletion, while the significant C:F increase caused by splitting (1.40 +/- 0.03 vs. control 1.28 +/- 0.03, P<0.01) was unaffected. Granulocyte/monocyte depletion showed this response was not immune-regulated. VEGF overexpression failed to rescue angiogenesis following platelet depletion, suggesting the mechanism is not simply reliant on growth factor release. Sprouting occurred normally following antibody-induced GPVI shedding, suggesting platelet activation via collagen is not involved. BrdU pulse-labelling showed no change in the proliferative potential of cells associated with capillaries after platelet depletion. Inhibition of platelet activation by acetylsalicylic acid abolished sprouting, but not splitting angiogenesis, paralleling the response to platelet depletion. We conclude that platelets differentially regulate mechanisms of angiogenesis in vivo, likely via COX signalling. Since endothelial proliferation is not impaired, we propose a link between COX1 and induction of endothelial migration.	[Packham, Ian M.; Watson, Steve P.; Egginton, Stuart] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Ctr Cardiovasc Sci, Birmingham, W Midlands, England; [Bicknell, Roy] Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Ctr Cardiovasc Sci, Birmingham, W Midlands, England; [Egginton, Stuart] Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds, W Yorkshire, England	University of Birmingham; University of Birmingham; University of Leeds	Egginton, S (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Ctr Cardiovasc Sci, Birmingham, W Midlands, England.	s.egginton@leeds.ac.uk	Watson, Stephen P/Q-6292-2016	Watson, Stephen P/0000-0002-7846-7423; Egginton, Stuart/0000-0002-3084-9692; Bicknell, Roy/0000-0002-0941-8919	British Heart Foundation [PG/08/018/24599]	British Heart Foundation(British Heart Foundation)	This work was funded by grant PG/08/018/24599 from the British Heart Foundation awarded to S.E., R.B., and S.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2000, CANCER RES, V60, P2898; Bergmeier W, 2000, BLOOD, V95, P886, DOI 10.1182/blood.V95.3.886.003k45_886_893; Brill A, 2004, CARDIOVASC RES, V63, P226, DOI 10.1016/j.cardiores.2004.04.012; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Dhanjal TS, 2007, BLOOD, V109, P4237, DOI 10.1182/blood-2006-10-050740; Dogan IV, 1999, ANESTH ANALG, V88, P432, DOI 10.1097/00000539-199902000-00039; EGGINTON S, 1990, J ANAT, V168, P73; Egginton S, 2001, CARDIOVASC RES, V49, P634, DOI 10.1016/S0008-6363(00)00282-0; Etulain J, 2013, BRIT J PHARMACOL, V170, P255, DOI 10.1111/bph.12250; GASIC GJ, 1968, P NATL ACAD SCI USA, V61, P46, DOI 10.1073/pnas.61.1.46; Gnatenko DV, 2006, BLOOD, V108, P3983, DOI 10.1182/blood-2006-06-026518; Haas TL, 2000, AM J PHYSIOL-HEART C, V279, pH1540, DOI 10.1152/ajpheart.2000.279.4.H1540; HansenSmith FM, 1996, CELL TISSUE RES, V286, P123, DOI 10.1007/s004410050681; Hirakata H, 1997, CAN J ANAESTH, V44, P1157, DOI 10.1007/BF03013337; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Kakudo N, 2014, MED MOL MORPHOL, DOI [10.1007/s00795-014-0083-y4, DOI 10.1007/S00795-014-0083-Y4]; Kisucka J, 2006, P NATL ACAD SCI USA, V103, P855, DOI 10.1073/pnas.0510412103; Klement GL, 2009, BLOOD, V113, P2835, DOI 10.1182/blood-2008-06-159541; Kusumanto Yoka H., 2003, Angiogenesis, V6, P283, DOI 10.1023/B:AGEN.0000029415.62384.ba; Lopez-Holgado N, 2009, CYTOTHERAPY, V11, P1041, DOI 10.3109/14653240903191719; Lorrain J, 2004, J PHARMACOL EXP THER, V309, P235, DOI 10.1124/jpet.103.059873; Lui S, 2004, GENERATION CHARACTER, P408; Mammoto T, 2013, MICROVASC RES, V89, P15, DOI 10.1016/j.mvr.2013.04.008; Manegold PC, 2003, BLOOD, V101, P1970, DOI 10.1182/blood.V101.5.1970; MASOTTI G, 1979, LANCET, V2, P1213; Massberg S, 2003, J EXP MED, V197, P41, DOI 10.1084/jem.20020945; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Peterson JE, 2012, ANGIOGENESIS, V15, P265, DOI 10.1007/s10456-012-9259-z; Pietramaggiori G, 2010, J SURG RES, V160, P169, DOI 10.1016/j.jss.2008.09.010; Pinedo HM, 1998, LANCET, V352, P1775, DOI 10.1016/S0140-6736(98)05095-8; Pipili-Synetos E, 1998, BRIT J PHARMACOL, V125, P1252, DOI 10.1038/sj.bjp.0702191; Salgado R, 2001, CLIN CANCER RES, V7, P1481; Salgado Roberto, 2001, Angiogenesis, V4, P37, DOI 10.1023/A:1016611230747; Scherer SS, 2012, PLAST RECONSTR SURG, V129, p46E, DOI 10.1097/PRS.0b013e3182362010; Solanilla A, 2009, RHEUMATOLOGY, V48, P1036, DOI 10.1093/rheumatology/kep154; Tilan JU, 2013, FASEB J, V27, P2244, DOI 10.1096/fj.12-213546; Ulrych T, 2011, J THROMB HAEMOST, V9, P790, DOI 10.1111/j.1538-7836.2011.04194.x; WENCELDRAKE JD, 1985, BLOOD, V65, P929; Williams JL, 2006, MICROCIRCULATION, V13, P499, DOI 10.1080/10739680600785717; Wragg JW, 2014, MICROCIRCULATION, V21, P290, DOI 10.1111/micc.12119; Zhou AL, 1998, ANAT REC, V252, P49, DOI 10.1002/(SICI)1097-0185(199809)252:1<49::AID-AR6>3.0.CO;2-9; Zhou AL, 1998, CELL TISSUE RES, V293, P293, DOI 10.1007/s004410051121	44	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107503	10.1371/journal.pone.0107503	http://dx.doi.org/10.1371/journal.pone.0107503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238071	Green Published, gold			2022-12-25	WOS:000342491600029
J	Brun, SN; Markant, SL; Esparza, LA; Garcia, G; Terry, D; Huang, JM; Pavlyukov, MS; Li, XN; Grant, GA; Crawford, JR; Levy, ML; Conway, EM; Smith, LH; Nakano, I; Berezov, A; Greene, MI; Wang, Q; Wechsler-Reya, RJ				Brun, S. N.; Markant, S. L.; Esparza, L. A.; Garcia, G.; Terry, D.; Huang, J-M; Pavlyukov, M. S.; Li, X-N; Grant, G. A.; Crawford, J. R.; Levy, M. L.; Conway, E. M.; Smith, L. H.; Nakano, I.; Berezov, A.; Greene, M. I.; Wang, Q.; Wechsler-Reya, R. J.			Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma	ONCOGENE			English	Article							CELL LUNG-CANCER; PHASE-II; DRUG-RESISTANCE; EXPRESSION; YM155; INHIBITOR; APOPTOSIS; SUPPRESSANT; DELIVERY; PATHWAY	Medulloblastoma (MB) is a highly malignant brain tumor that occurs primarily in children. Although surgery, radiation and high-dose chemotherapy have led to increased survival, many MB patients still die from their disease, and patients who survive suffer severe long-term side effects as a consequence of treatment. Thus, more effective and less toxic therapies for MB are critically important. Development of such therapies depends in part on identification of genes that are necessary for growth and survival of tumor cells. Survivin is an inhibitor of apoptosis protein that regulates cell cycle progression and resistance to apoptosis, is frequently expressed in human MB and when expressed at high levels predicts poor clinical outcome. Therefore, we hypothesized that Survivin may have a critical role in growth and survival of MB cells and that targeting it may enhance MB therapy. Here we show that Survivin is overexpressed in tumors from patched (Ptch) mutant mice, a model of Sonic hedgehog (SHH)-driven MB. Genetic deletion of survivin in Ptch mutant tumor cells significantly inhibits proliferation and causes cell cycle arrest. Treatment with small-molecule antagonists of Survivin impairs proliferation and survival of both murine and human MB cells. Finally, Survivin antagonists impede growth of MB cells in vivo. These studies highlight the importance of Survivin in SHH-driven MB, and suggest that it may represent a novel therapeutic target in patients with this disease.	[Brun, S. N.; Markant, S. L.; Esparza, L. A.; Wechsler-Reya, R. J.] NCI, Sanford Burnham Med Res Inst, Designated Canc Ctr, Initiat & Maintenance Program, La Jolla, CA 92037 USA; [Brun, S. N.; Markant, S. L.; Esparza, L. A.; Wechsler-Reya, R. J.] Sanford Consortium Regenerat Med, La Jolla, CA USA; [Brun, S. N.; Markant, S. L.; Wechsler-Reya, R. J.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA; [Garcia, G.] SBMRI, Histopathol Core, La Jolla, CA USA; [Terry, D.; Smith, L. H.] SBMRI, Conrad Prebys Ctr Chem Genom, Lake Nona, FL USA; [Huang, J-M; Wang, Q.] Samuel Oschin Comprehens Canc Inst, Cedars Sinai Womens Canc Program, Los Angeles, CA USA; [Pavlyukov, M. S.; Nakano, I.] Ohio State Univ, Dept Neurol Surg, Columbus, OH 43210 USA; [Pavlyukov, M. S.; Nakano, I.] Ohio State Univ, James Comprehens Canc Ctr, Columbus, OH 43210 USA; [Li, X-N] Baylor Coll Med, Texas Childrens Canc Ctr, Brain Tumor Program, Houston, TX 77030 USA; [Li, X-N] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Grant, G. A.] Stanford Univ, Lucile Packard Childrens Hosp, Dept Neurosurg, Stanford, CA 94305 USA; [Crawford, J. R.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Crawford, J. R.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Crawford, J. R.; Levy, M. L.] Rady Childrens Hosp, San Diego, CA USA; [Levy, M. L.] Univ Calif San Diego, Dept Neurosurg, La Jolla, CA 92093 USA; [Conway, E. M.] Univ British Columbia, Ctr Blood Res, Dept Med, Div Hematol, Vancouver, BC V5Z 1M9, Canada; [Smith, L. H.] Sanford Burnham Med Res Inst, Cardiopathobiol Program, Lake Nona, FL USA; [Berezov, A.] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Greene, M. I.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Sanford Burnham Prebys Medical Discovery Institute; Duke University; Cedars Sinai Medical Center; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Lucile Packard Children's Hospital (LPCH); Stanford University; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of British Columbia; Sanford Burnham Prebys Medical Discovery Institute; Cedars Sinai Medical Center; University of Pennsylvania	Wechsler-Reya, RJ (corresponding author), NCI, Sanford Burnham Med Res Inst, Designated Canc Ctr, Initiat & Maintenance Program, 2880 Torrey Pines Scen Dr, La Jolla, CA 92037 USA.	rwreya@sanfordburnham.org	Pavlyukov, Marat S/E-7314-2014; Levy, Michael/AAL-4647-2020; Wang, Qiang/N-7310-2015; Pavlyukov, Marat S/ABB-6791-2021; Nakano, Ichiro/AAR-9562-2020; Crawford, John/ABH-2134-2021	Wang, Qiang/0000-0001-9409-0251; Nakano, Ichiro/0000-0002-0916-3207; Conway, Edward/0000-0003-0081-0305; Smith, Layton/0000-0003-2621-9740	Canadian Institutes for Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); NCI [5P30CA030199, R01 CA122759]; Cedars-Sinai/Sanford-Burnham Grant Program for Cancer Research; Research Leadership Award from the California Institute for Regenerative Medicine [CIRM LA1-01747];  [5R01CA08948]; NATIONAL CANCER INSTITUTE [P30CA030199, R01CA159859, R01CA122759] Funding Source: NIH RePORTER	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cedars-Sinai/Sanford-Burnham Grant Program for Cancer Research; Research Leadership Award from the California Institute for Regenerative Medicine; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We appreciate the support of the Sanford-Burnham Shared Resources, including Amy Cortez, Jonna Hurtado and Yoav Altman (Flow Cytometry); Robbin Newlin (Histopathology); Danielle McAnally, Michael Vicchiarelli and Arianna Mangravita-Novo (Chemical Genomics); Lili Lacarra, Adriana Charbono and Kenny Venegas (Animal facility); and Anthony Pinkerton and members of the Medicinal Chemistry Resource for generation of S12 and LLP3. We are also grateful to Ana Miletic-Sedy and Robert Rickert for sharing Survivin<SUP>fl/fl</SUP> mice; and to Robert Margolis for helpful discussions. We thank the Flanders Institute for Biotechnology (VIB), Belgium, for allowing us to use the Survivin<SUP>fl/fl</SUP> mice. EMC is supported by grants from the Canadian Institutes for Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC). He holds a Tier 1 Canada Research Chair (CRC) in Endothelial Cell Biology. MIG is supported by Grant 5R01CA08948. This work was supported by NCI award number 5P30CA030199 and R01 CA122759 and by the Cedars-Sinai/Sanford-Burnham Grant Program for Cancer Research. RWR is the recipient of a Research Leadership Award from the California Institute for Regenerative Medicine (CIRM LA1-01747).	Adida C, 2000, BRIT J HAEMATOL, V111, P196, DOI 10.1046/j.1365-2141.2000.02328.x; Adida C, 1998, AM J PATHOL, V152, P43; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Amakye D, 2013, NAT MED, V19, P1410, DOI 10.1038/nm.3389; Arora R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003713; Becker JC, 2012, CANCER IMMUNOL IMMUN, V61, P2091, DOI 10.1007/s00262-012-1266-9; Berezov A, 2012, ONCOGENE, V31, P1938, DOI 10.1038/onc.2011.377; Blomstrand M, 2012, NEURO-ONCOLOGY, V14, P882, DOI 10.1093/neuonc/nos120; Brown MT, 1996, CLIN CANCER RES, V2, P963; Carrasco RA, 2011, MOL CANCER THER, V10, P221, DOI 10.1158/1535-7163.MCT-10-0756; Chakravarti A, 2004, ONCOGENE, V23, P7494, DOI 10.1038/sj.onc.1208049; Cheng Qiuying, 2012, Int J Biochem Mol Biol, V3, P179; Ellis T, 2003, GENESIS, V36, P158, DOI 10.1002/gene.10208; Fangusaro JR, 2006, PEDIATR BLOOD CANCER, V47, P4, DOI 10.1002/pbc.20805; Fangusaro JR, 2005, BRIT J CANCER, V92, P359, DOI 10.1038/sj.bjc.6602317; Fossati P, 2009, CANCER TREAT REV, V35, P79, DOI 10.1016/j.ctrv.2008.09.002; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Grinstein E, 2002, ONCOGENE, V21, P1485, DOI 10.1038/sj.onc.1205211; Grossman D, 2001, CANCER METAST REV, V20, P3, DOI 10.1023/A:1013123532723; Guvenc H, 2013, CLIN CANCER RES, V19, P631, DOI 10.1158/1078-0432.CCR-12-0647; Haberler C, 2006, EUR J CANCER, V42, P2996, DOI 10.1016/j.ejca.2006.05.038; Hall WA, 2006, EXPERT OPIN DRUG DEL, V3, P371, DOI 10.1517/17425247.3.3.371; Huang LN, 2013, MOL BIOL REP, V40, P917, DOI 10.1007/s11033-012-2132-8; Iwasa T, 2008, CLIN CANCER RES, V14, P6496, DOI 10.1158/1078-0432.CCR-08-0468; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Kunwar S, 2007, J CLIN ONCOL, V25, P837, DOI 10.1200/JCO.2006.08.1117; Lewis KD, 2011, INVEST NEW DRUG, V29, P161, DOI 10.1007/s10637-009-9333-6; Li XN, 2007, NEUROPATH APPL NEURO, V33, P67, DOI 10.1111/j.1365-2990.2006.00782.x; Ling X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045571; Machold R, 2005, NEURON, V48, P17, DOI 10.1016/j.neuron.2005.08.028; Markant SL, 2013, CANCER RES, V73, P6310, DOI 10.1158/0008-5472.CAN-12-4258; Minematsu T, 2012, BIOPHARM DRUG DISPOS, V33, P160, DOI 10.1002/bdd.1781; Morrison DJ, 2012, LEUKEMIA, V26, P271, DOI 10.1038/leu.2011.199; Mulhern RK, 2005, J CLIN ONCOL, V23, P5511, DOI 10.1200/JCO.2005.00.703; Nagaraj S, 2007, J IMMUNOTHER, V30, P169, DOI 10.1097/01.cji.0000211329.83890.ba; Nakahara T, 2007, CANCER RES, V67, P8014, DOI 10.1158/0008-5472.CAN-07-1343; Nakahara T, 2011, ANTI-CANCER DRUG, V22, P454, DOI 10.1097/CAD.0b013e328344ac68; Nakahara T, 2011, CANCER SCI, V102, P614, DOI 10.1111/j.1349-7006.2010.01834.x; Nakamura N, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013243; Northcott PA, 2012, EXPERT REV NEUROTHER, V12, P871, DOI [10.1586/ERN.12.66, 10.1586/ern.12.66]; Okamoto K, 2012, MOL CANCER THER, V11, P204, DOI 10.1158/1535-7163.MCT-11-0638; Olie RA, 2000, CANCER RES, V60, P2805; Oliver TG, 2005, DEVELOPMENT, V132, P2425, DOI 10.1242/dev.01793; Packer R J, 1999, Neuro Oncol, V1, P232, DOI 10.1093/neuonc/1.3.232; Packer RJ, 2008, ARCH NEUROL-CHICAGO, V65, P1419, DOI 10.1001/archneur.65.11.1419; Pan SF, 2010, ACS MED CHEM LETT, V1, P130, DOI 10.1021/ml1000307; Park E, 2011, BLOOD, V118, P2191, DOI 10.1182/blood-2011-04-351239; Rodon J, 2014, CLIN CANCER RES, V20, P1900, DOI 10.1158/1078-0432.CCR-13-1710; Rodel F, 2008, INT J RADIAT ONCOL, V71, P247, DOI 10.1016/j.ijrobp.2008.02.011; Rosa J, 2006, MOL BIOL CELL, V17, P1483, DOI 10.1091/mbc.e05-08-0723; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Saito T, 2008, BRIT J CANCER, V98, P345, DOI 10.1038/sj.bjc.6604160; Serwer LP, 2012, ADV DRUG DELIVER REV, V64, P590, DOI 10.1016/j.addr.2012.01.004; Shirai K, 2009, J NEURO-ONCOL, V91, P353, DOI 10.1007/s11060-008-9720-4; Talbot DC, 2010, CLIN CANCER RES, V16, P6150, DOI 10.1158/1078-0432.CCR-10-1932; Tanioka M, 2011, CANCER CHEMOTH PHARM, V68, P505, DOI 10.1007/s00280-010-1506-7; Tao YF, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-619; Tolcher AW, 2012, ANN ONCOL, V23, P968, DOI 10.1093/annonc/mdr353; Wheatley SP, 2005, INT REV CYTOL, V247, P35, DOI 10.1016/S0074-7696(05)47002-3; Xing Z, 2004, J EXP MED, V199, P69, DOI 10.1084/jem.20031588; Yamanaka K, 2011, CLIN CANCER RES, V17, P5423, DOI 10.1158/1078-0432.CCR-10-3410; Yamashita SI, 2007, ANTICANCER RES, V27, P2803; Yamauchi T, 2012, BIOCHEM BIOPH RES CO, V425, P711, DOI 10.1016/j.bbrc.2012.07.103; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Yue ZJ, 2008, J CELL BIOL, V183, P279, DOI 10.1083/jcb.200806118; Zhao XM, 2012, NEURO-ONCOLOGY, V14, P574, DOI 10.1093/neuonc/nos061; Zhu K, 2007, VACCINE, V25, P7955, DOI 10.1016/j.vaccine.2007.08.050	68	39	41	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2015	34	29					3770	3779		10.1038/onc.2014.304	http://dx.doi.org/10.1038/onc.2014.304			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM9BV	25241898	Green Submitted, Green Accepted			2022-12-25	WOS:000358001600003
J	Matsuyama, M; Nomori, A; Nakakuni, K; Shimono, A; Fukushima, M				Matsuyama, Makoto; Nomori, Akane; Nakakuni, Kyonni; Shimono, Akihiko; Fukushima, Masaki			Secreted Frizzled-related Protein 1 (Sfrp1) Regulates the Progression of Renal Fibrosis in a Mouse Model of Obstructive Nephropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT/BETA-CATENIN; INTERSTITIAL FIBROSIS; URETERAL OBSTRUCTION; SIGNALING CONTROLS; WNT ANTAGONIST; CELL POLARITY; KIDNEY; MECHANISMS; ACTIVATION; EXPRESSION	Renal fibrosis is responsible for progressive renal diseases that cause chronic renal failure. Sfrp1 (secreted Frizzled-related protein 1) is highly expressed in kidney, although little is known about connection between the protein and renal diseases. Here, we focused on Sfrp1 to investigate its roles in renal fibrosis using a mouse model of unilateral ureteral obstruction (UUO). In wild-type mice, the expression of Sfrp1 protein was markedly increased after UUO. The kidneys from Sfrp1 knock-out mice showed significant increase in expression of myofibrobast markers, alpha-smooth muscle actin (alpha SMA). Sfrp1 deficiency also increased protein levels of the fibroblast genes, vimentin, and decreased those of the epithelial genes, E-cadherin, indicated that enhanced epithelial-to-mesenchymal transition. There was no difference in the levels of canonical Wnt signaling; rather, the levels of phosphorylated c-Jun and JNK were more increased in the Sfrp1(-/-) obstructed kidney. Moreover, the apoptotic cell population was significantly elevated in the obstructed kidneys from Sfrp1(-/-) mice following UUO but was slightly increased in those from wild-type mice. These results indicate that Sfrp1 is required for inhibition of renal damage through the non-canonical Wnt/PCP pathway.	[Matsuyama, Makoto; Nomori, Akane] Shigei Med Res Inst, Div Mol Genet, Minami Ku, Okayama 7010202, Japan; [Nakakuni, Kyonni; Fukushima, Masaki] Shigei Med Res Hosp, Minami Ku, Okayama 7010202, Japan; [Shimono, Akihiko] TransGenic Inc, Kobe, Hyogo 6500047, Japan		Matsuyama, M (corresponding author), Shigei Med Res Inst, Div Mol Genet, Minami Ku, 2117 Yamada, Okayama 7010202, Japan.	matsuyama@shigei.or.jp		Matsuyama, Makoto/0000-0003-2606-059X	Ryobi Teien Memory Foundation	Ryobi Teien Memory Foundation(Ryobi Teien Memory Foundation)	This work was supported in part by the Ryobi Teien Memory Foundation.	Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; DiRocco DP, 2013, J AM SOC NEPHROL, V24, P1399, DOI 10.1681/ASN.2012050512; Elzi DJ, 2012, MOL CELL BIOL, V32, P4388, DOI 10.1128/MCB.06023-11; Farris AB, 2012, CURR OPIN NEPHROL HY, V21, P289, DOI 10.1097/MNH.0b013e3283521cfa; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Gauger KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078320; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; He X, 2008, NAT CELL BIOL, V10, P11, DOI 10.1038/ncb0108-11; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Kawakami T, 2013, J PATHOL, V229, P221, DOI 10.1002/path.4121; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Kusaka M, 2010, ENDOCRINOLOGY, V151, P5893, DOI 10.1210/en.2010-0915; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Ma FY, 2007, J AM SOC NEPHROL, V18, P472, DOI 10.1681/ASN.2006060604; MacDonald BT, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.036; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Matsuyama Makoto, 2012, Methods Mol Biol, V839, P229, DOI 10.1007/978-1-61779-510-7_18; Matsuyama M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000427; Melkonyan HS, 1997, P NATL ACAD SCI USA, V94, P13636, DOI 10.1073/pnas.94.25.13636; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; Mii Y, 2011, DEV GROWTH DIFFER, V53, P911, DOI 10.1111/j.1440-169X.2011.01299.x; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Ren SY, 2013, P NATL ACAD SCI USA, V110, P1440, DOI 10.1073/pnas.1211179110; Sado Y, 2006, ACTA HISTOCHEM CYTOC, V39, P89, DOI 10.1267/ahc.06001; Satoh W, 2006, DEVELOPMENT, V133, P989, DOI 10.1242/dev.02274; Satoh W, 2008, GENESIS, V46, P92, DOI 10.1002/dvg.20369; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Stambe C, 2004, J AM SOC NEPHROL, V15, P370, DOI 10.1097/01.ASN.0000109669.23650.56; Surendran K, 2005, J AM SOC NEPHROL, V16, P2373, DOI 10.1681/ASN.2004110949; Tampe D, 2014, NAT REV NEPHROL, V10, P226, DOI 10.1038/nrneph.2014.14; Trevant B, 2008, J CELL PHYSIOL, V217, P113, DOI 10.1002/jcp.21482; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Yoshino K, 2001, MECH DEVELOP, V102, P45, DOI 10.1016/S0925-4773(01)00282-9; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhang P, 2012, J BIOL CHEM, V287, P21290, DOI 10.1074/jbc.M112.357202; Zhou D, 2013, SCI REP-UK, V3, DOI 10.1038/srep01878	44	30	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31526	31533		10.1074/jbc.M114.584565	http://dx.doi.org/10.1074/jbc.M114.584565			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25253698	hybrid, Green Published			2022-12-25	WOS:000344549900054
J	Rao, DK; Liu, HY; Ambudkar, SV; Mayer, M				Rao, Divya K.; Liu, Haiyan; Ambudkar, Suresh V.; Mayer, Michael			A Combination of Curcumin with Either Gramicidin or Ouabain Selectively Kills Cells That Express the Multidrug Resistance-linked ABCG2 Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; P-GLYCOPROTEIN; ATPASE ACTIVITY; COLLATERAL SENSITIVITY; CARDIAC-GLYCOSIDES; DRUG-RESISTANCE; TUMOR-CELLS; K+-ATPASE; APOPTOSIS; PROTEIN	This paper introduces a strategy to kill selectively multidrug-resistant cells that express the ABCG2 transporter (also called breast cancer resistance protein, or BCRP). The approach is based on specific stimulation of ATP hydrolysis by ABCG2 transporters with subtoxic doses of curcumin combined with stimulation of ATP hydrolysis by Na+, K+-ATPase with subtoxic doses of gramicidin A or ouabain. After 72 h of incubation with the drug combinations, the resulting over consumption of ATP by both pathways inhibits the efflux activity of ABCG2 transporters, leads to depletion of intracellular ATP levels below the viability threshold, and kills resistant cells selectively over cells that lack ABCG2 transporters. This strategy, which was also tested on a clinically relevant human breast adenocarcinoma cell line (MCF-7/FLV1), exploits the overexpression of ABCG2 transporters and induces caspase-dependent apoptotic cell death selectively in resistant cells. This work thus introduces a novel strategy to exploit collateral sensitivity (CS) with a combination of two clinically used compounds that individually do not exert CS. Collectively, this work expands the current knowledge on ABCG2-mediated CS and provides a potential strategy for discovery of CS drugs against drug-resistant cancer cells.	[Rao, Divya K.; Liu, Haiyan; Mayer, Michael] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Mayer, Michael] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Ambudkar, Suresh V.] NCI, Lab Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Mayer, M (corresponding author), Univ Michigan, Dept Biomed Engn, 1101 Beal Ave, Ann Arbor, MI 48109 USA.	mimayer@umich.edu	Ambudkar, Suresh V/L-1317-2016; Mayer, Michael/C-1299-2010; Mayer, Michael/AAS-1777-2020	Mayer, Michael/0000-0002-6148-5756; 	National Institutes of Health [1R01GM081705]; Intramural Research Program of the NCI National Institutes of Health Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081705] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NCI National Institutes of Health Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01GM081705 (to M. M.) and by the Intramural Research Program of the NCI National Institutes of Health Center for Cancer Research (to S.V.A.).	ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197; Ambudkar SV, 1998, METHOD ENZYMOL, V292, P504; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; ANNER BM, 1994, MOL MEMBR BIOL, V11, P247, DOI 10.3109/09687689409160434; Carroll RE, 2011, CANCER PREV RES, V4, P354, DOI 10.1158/1940-6207.CAPR-10-0098; Chearwae W, 2006, MOL CANCER THER, V5, P1995, DOI 10.1158/1535-7163.MCT-06-0087; Chen JQ, 2006, BREAST CANCER RES TR, V96, P1, DOI 10.1007/s10549-005-9053-3; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Ding XW, 2010, LIFE SCI, V86, P631, DOI 10.1016/j.lfs.2010.02.012; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Fanciulli M, 2000, CLIN CANCER RES, V6, P1590; Fearon K. C., 1987, CANCER RES, V47, P3684; Gatenby RA, 2009, CANCER RES, V69, P4894, DOI 10.1158/0008-5472.CAN-08-3658; GODFRAIND T, 1977, NATURE, V265, P165, DOI 10.1038/265165a0; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Hagen P, 1939, J PHARMACOL EXP THER, V67, P50; Haimeur A, 2004, CURR DRUG METAB, V5, P21, DOI 10.2174/1389200043489199; Hardwick LJA, 2007, BRIT J PHARMACOL, V151, P163, DOI 10.1038/sj.bjp.0707218; HAROLD FM, 1967, J BACTERIOL, V94, P53, DOI 10.1128/JB.94.1.53-60.1967; Heffeter P, 2007, BIOCHEM PHARMACOL, V73, P1873, DOI 10.1016/j.bcp.2007.03.002; HLADKY SB, 1970, NATURE, V225, P451, DOI 10.1038/225451a0; Hoffman MM, 1996, J GEN PHYSIOL, V108, P295, DOI 10.1085/jgp.108.4.295; James AM, 1999, EUR J BIOCHEM, V259, P462, DOI 10.1046/j.1432-1327.1999.00066.x; Karwatsky J, 2003, BIOCHEMISTRY-US, V42, P12163, DOI 10.1021/bi034149+; Krishnamurthy P, 2006, ANNU REV PHARMACOL, V46, P381, DOI 10.1146/annurev.pharmtox.46.120604.141238; Kusuhara H, 2012, BRIT J PHARMACOL, V166, P1793, DOI 10.1111/j.1476-5381.2012.01887.x; Laberge RM, 2007, BIOCHEM PHARMACOL, V73, P1727, DOI 10.1016/j.bcp.2007.02.005; Laberge RM, 2009, ARCH BIOCHEM BIOPHYS, V491, P53, DOI 10.1016/j.abb.2009.09.012; LEACH FR, 1986, METHOD ENZYMOL, V133, P51; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Leonard Gregory D, 2002, Curr Opin Investig Drugs, V3, P1652; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; LINN SC, 1995, EUR J CANCER, V31A, P1291, DOI 10.1016/0959-8049(95)00278-Q; Litman T, 1997, BBA-MOL BASIS DIS, V1361, P159, DOI 10.1016/S0925-4439(97)00026-4; Moreno-Sanchez R, 2009, BIOFACTORS, V35, P209, DOI 10.1002/biof.31; NOBES CD, 1989, BIOCHIM BIOPHYS ACTA, V976, P241, DOI 10.1016/S0005-2728(89)80236-1; NOBLE D, 1980, CARDIOVASC RES, V14, P495, DOI 10.1093/cvr/14.9.495; Oselkin M, 2010, NEUROSCI LETT, V473, P67, DOI 10.1016/j.neulet.2009.10.021; Pluchino KM, 2012, DRUG RESIST UPDATE, V15, P98, DOI 10.1016/j.drup.2012.03.002; Robey RW, 2008, BIOCHEM PHARMACOL, V75, P1302, DOI 10.1016/j.bcp.2007.12.001; Robey RW, 2001, CLIN CANCER RES, V7, P145; ROTTENBERG H, 1989, BIOCHEMISTRY-US, V28, P4355, DOI 10.1021/bi00436a035; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SCHATZMANN HJ, 1953, HELV PHYSIOL PHARM A, V11, P346; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Shim H, 1998, P NATL ACAD SCI USA, V95, P1511, DOI 10.1073/pnas.95.4.1511; Shishodia S, 2007, CURR PROB CANCER, V31, P243, DOI 10.1016/j.currproblcancer.2007.04.001; Shukla S, 2008, EXPERT OPIN DRUG MET, V4, P205, DOI 10.1517/17425255.4.2.205; Shukla S, 2006, BIOCHEMISTRY-US, V45, P8940, DOI 10.1021/bi060552f; Silva AS, 2012, CANCER RES, V72, P6362, DOI 10.1158/0008-5472.CAN-12-2235; STANKOVIC CJ, 1989, SCIENCE, V244, P813, DOI 10.1126/science.2471263; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Szakacs G, 2014, CHEM REV, V114, P5753, DOI 10.1021/cr4006236; van der Heijden J, 2004, ANN RHEUM DIS, V63, P131, DOI 10.1136/ard.2003.006494; Wallace KB, 2000, ANNU REV PHARMACOL, V40, P353, DOI 10.1146/annurev.pharmtox.40.1.353; WOODWARD GE, 1954, CANCER RES, V14, P599	58	26	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31397	31410		10.1074/jbc.M114.576819	http://dx.doi.org/10.1074/jbc.M114.576819			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25253691	Green Published, hybrid			2022-12-25	WOS:000344549900043
J	Cucak, H; Vistisen, D; Witte, D; Philipsen, A; Rosendahl, A				Cucak, Helena; Vistisen, Dorte; Witte, Daniel; Philipsen, Annelotte; Rosendahl, Alexander			Reduction of Specific Circulating Lymphocyte Populations with Metabolic Risk Factors in Patients at Risk to Develop Type 2 Diabetes	PLOS ONE			English	Article							REGULATORY T-CELLS; TOLL-LIKE RECEPTORS; TISSUE INFLAMMATION; ADIPOSE-TISSUE; OBESITY; AUTOIMMUNITY; MODULATION; EXPRESSION; EXPANSION; IMMUNITY	Low-grade inflammation, characterized by increased pro-inflammatory cytokine levels, is present in patients with obesity-linked insulin resistance, hyperglycemia and hyperlipidemia and considered to play a leading role to progression into type 2 diabetes (T2D). In adipose tissue in obese patients and in pancreatic islets in T2D patients cellular inflammation is present. However, the systemic leukocyte compartment and the circulating endothelial/precursor compartment in patients at risk to develop T2D has so far not been analyzed in detail. To address this, peripheral blood cells from a cohort of 20 subjects at risk to develop diabetes with normal to impaired glucose tolerance were analyzed by flow cytometry using a wide range of cellular markers and correlated to known metabolic risk factors for T2D i.e. fasting plasma glucose (FPG), 2 h plasma glucose (2 h PG), HbA1c, body mass index (BMI), homeostasis model assessment of beta-cell function (HOMA-B), homeostasis model assessment of insulin sensitivity (HOMA-IS) and fasting insulin (FI). The four highest ranked cell markers for each risk factor were identified by random forest analysis. In the cohort, a significant negative correlation between the number of TLR4(+) CD4 T cells and increased FPG was demonstrated. Similarly, with increased BMI the frequency of TLR4(+) B cells was significantly decreased, as was the frequency of IL-21R(+) CD4 T cells. Unlinked to metabolic risk factors, the frequency of regulatory T cells was reduced and TLR4(+) CD4 T cells were increased with age. Taken together, in this small cohort of subjects at risk to develop T2D, a modulation of the circulating immune cell pool was demonstrated to correlate with risk factors like FPG and BMI. This may provide novel insights into the inflammatory mechanisms involved in the progression to diabetes in subjects at risk.	[Cucak, Helena; Rosendahl, Alexander] Novo Nordisk AS, Hagedorn Res Inst, Dept Diabet Complicat Biol, Malov, Denmark; [Vistisen, Dorte; Witte, Daniel; Philipsen, Annelotte] Steno Diabet Ctr, Dept Clin Epidemiol, DK-2820 Gentofte, Denmark	Novo Nordisk; Hagedorn Research Institute; Steno Diabetes Center	Rosendahl, A (corresponding author), Novo Nordisk AS, Hagedorn Res Inst, Dept Diabet Complicat Biol, Malov, Denmark.	axrd@novonordisk.com	Witte, Daniel R/C-1722-2008; Witte, Daniel/AAF-9535-2019	Witte, Daniel R/0000-0002-0769-2922; Witte, Daniel/0000-0002-0769-2922; Vistisen, Dorte/0000-0001-5045-5351				Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Baker C, 2007, CLIN EXP IMMUNOL, V147, P472, DOI 10.1111/j.1365-2249.2006.03307.x; Beutler B, 2003, J LEUKOCYTE BIOL, V74, P479, DOI 10.1189/jlb.0203082; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Carlsson LMS, 2012, NEW ENGL J MED, V367, P695, DOI 10.1056/NEJMoa1112082; Catalan V, 2007, OBES SURG, V17, P1464, DOI 10.1007/s11695-008-9424-z; Cucak H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090685; Deenick EK, 2007, IMMUNOL CELL BIOL, V85, P503, DOI 10.1038/sj.icb.7100114; Dejaco C, 2006, IMMUNOLOGY, V117, P289, DOI 10.1111/j.1365-2567.2005.02317.x; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Ehses JA, 2009, P NATL ACAD SCI USA, V106, P13998, DOI 10.1073/pnas.0810087106; Fabrizi M, 2014, DIABETES, V63, P2086, DOI 10.2337/db13-0939; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Hoechst B, 2011, BLOOD, V117, P6532, DOI 10.1182/blood-2010-11-317321; Holden SE, 2013, DIABETES OBES METAB, V15, P844, DOI 10.1111/dom.12123; Itoh M, 1999, J IMMUNOL, V162, P5317; Jagannathan-Bogdan M, 2011, J IMMUNOL, V186, P1162, DOI 10.4049/jimmunol.1002615; Johansen NB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1078; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kolberg JA, 2009, DIABETES CARE, V32, P1207, DOI 10.2337/dc08-1935; Lages CS, 2008, J IMMUNOL, V181, P1835, DOI 10.4049/jimmunol.181.3.1835; Leibson CL, 2001, DIABETES CARE, V24, P1584, DOI 10.2337/diacare.24.9.1584; Lippi G, 2010, BLOOD TRANSFUS-ITALY, V8, P94, DOI 10.2450/2009.0142-09; Liu GW, 2007, IMMUNOLOGY, V122, P149, DOI 10.1111/j.1365-2567.2007.02651.x; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Mikirova NA, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-106; Naser KA, 2006, INT J CLIN PRACT, V60, P1093, DOI 10.1111/j.1742-1241.2006.01003.x; Nguyen DM, 2010, GASTROENTEROL CLIN N, V39, P1, DOI 10.1016/j.gtc.2009.12.014; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Raynor J, 2012, CURR OPIN IMMUNOL, V24, P482, DOI 10.1016/j.coi.2012.04.005; Rimmele T, 2013, CRIT CARE, V17, DOI 10.1186/cc12587; Samad F, 1997, MOL MED, V3, P37, DOI 10.1007/BF03401666; Santner-Nanan B, 2008, INT IMMUNOL, V20, P375, DOI 10.1093/intimm/dxm151; Scotland RS, 2011, BLOOD, V118, P5918, DOI 10.1182/blood-2011-03-340281; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Stentz FB, 2003, CURR DRUG TARGETS, V4, P493, DOI 10.2174/1389450033490966; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Tian J, 2001, J IMMUNOL, V167, P1081, DOI 10.4049/jimmunol.167.2.1081; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vozarova B, 2002, DIABETES, V51, P455, DOI 10.2337/diabetes.51.2.455; Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Xu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079858; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Yoav Benjamini, 2001, Behavioural Brain Research, V125, P279, DOI 10.1016/S0166-4328(01)00297-2	51	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107140	10.1371/journal.pone.0107140	http://dx.doi.org/10.1371/journal.pone.0107140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254631	Green Published, Green Submitted, gold			2022-12-25	WOS:000344862300018
J	Muvea, AM; Meyhofer, R; Subramanian, S; Poehling, HM; Ekesi, S; Maniania, NK				Muvea, Alexander M.; Meyhoefer, Rainer; Subramanian, Sevgan; Poehling, Hans-Michael; Ekesi, Sunday; Maniania, Nguya K.			Colonization of Onions by Endophytic Fungi and Their Impacts on the Biology of Thrips tabaci	PLOS ONE			English	Article							YELLOW-SPOT-VIRUS; BEAUVERIA-BASSIANA ASCOMYCOTA; FRANKLINIELLA-OCCIDENTALIS; METARHIZIUM-ANISOPLIAE; THYSANOPTERA THRIPIDAE; COSMOPOLITES-SORDIDUS; BANANA WEEVIL; INOCULATION; LEPIDOPTERA; SUPPRESSION	Endophytic fungi, which live within host plant tissues without causing any visible symptom of infection, are important mutualists that mediate plant-herbivore interactions. Thrips tabaci (Lindeman) is one of the key pests of onion, Allium cepa L., an economically important agricultural crop cultivated worldwide. However, information on endophyte colonization of onions, and their impacts on the biology of thrips feeding on them, is lacking. We tested the colonization of onion plants by selected fungal endophyte isolates using two inoculation methods. The effects of inoculated endophytes on T. tabaci infesting onion were also examined. Seven fungal endophytes used in our study were able to colonize onion plants either by the seed or seedling inoculation methods. Seed inoculation resulted in 1.47 times higher mean percentage post-inoculation recovery of all the endophytes tested as compared to seedling inoculation. Fewer thrips were observed on plants inoculated with Clonostachys rosea ICIPE 707, Trichoderma asperellum M2RT4, Trichoderma atroviride ICIPE 710, Trichoderma harzianum 709, Hypocrea lixii F3ST1 and Fusarium sp. ICIPE 712 isolates as compared to those inoculated with Fusarium sp. ICIPE 717 and the control treatments. Onion plants colonized by C. rosea ICIPE 707, T. asperellum M2RT4, T. atroviride ICIPE 710 and H. lixii F3ST1 had significantly lower feeding punctures as compared to the other treatments. Among the isolates tested, the lowest numbers of eggs were laid by T. tabaci on H. lixii F3ST1 and C. rosea ICIPE 707 inoculated plants. These results extend the knowledge on colonization of onions by fungal endophytes and their effects on Thrips tabaci.	[Muvea, Alexander M.; Meyhoefer, Rainer; Poehling, Hans-Michael] Leibniz Univ Hannover, Inst Hort Prod Syst, D-30167 Hannover, Germany; [Muvea, Alexander M.; Subramanian, Sevgan; Ekesi, Sunday; Maniania, Nguya K.] Int Ctr Insect Physiol & Ecol, IPM Cluster, Plant Hlth Div, Nairobi, Kenya	Leibniz University Hannover; International Centre of Insect Physiology & Ecology (ICIPE)	Subramanian, S (corresponding author), Int Ctr Insect Physiol & Ecol, IPM Cluster, Plant Hlth Div, POB 30772, Nairobi, Kenya.	ssubramania@icipe.org	, Subramanian/H-8531-2014; Meyhoefer, Rainer/C-4962-2014; Ekesi, Sunday/P-8944-2019	, Subramanian/0000-0003-4447-0744; Meyhoefer, Rainer/0000-0001-5624-001X; muvea, alexander/0000-0002-5132-756X	BMZ (German Federal Ministry for Economic Cooperation and Development) through GIZ (Deutsche Gesellschaft fur Internationale Zusammenarbeit) [11.7860.7-001.00, 81141840]	BMZ (German Federal Ministry for Economic Cooperation and Development) through GIZ (Deutsche Gesellschaft fur Internationale Zusammenarbeit)	This study was funded by the BMZ (The German Federal Ministry for Economic Cooperation and Development) through GIZ (Deutsche Gesellschaft fur Internationale Zusammenarbeit) through a project grant entitled "Implementation of integrated thrips and tospovirus management strategies in small-holder vegetable cropping systems of Eastern Africa" (Project number: 11.7860.7-001.00, Contract number: 81141840) to which we are grateful. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akello J, 2008, CROP PROT, V27, P1437, DOI 10.1016/j.cropro.2008.07.003; Akello J., 2007, 8th African Crop Science Society Conference, El-Minia, Egypt, 27-31 October 2007, P857; Akello J, 2012, ZEF ECOLOGY DEV SERI, V86, P137; Akello J, 2008, ENTOMOL EXP APPL, V129, P157, DOI 10.1111/j.1570-7458.2008.00759.x; Akello J, 2007, J INVERTEBR PATHOL, V96, P34, DOI 10.1016/j.jip.2007.02.004; Akutse KS, 2013, FUNGAL ECOL, V6, P293, DOI 10.1016/j.funeco.2013.01.003; Athman SY, 2006, THESIS U PRETORIA; Backman PA, 2008, BIOL CONTROL, V46, P1, DOI 10.1016/j.biocontrol.2008.03.009; BARROWS JB, 1977, MYCOLOGIA, V69, P1173, DOI 10.2307/3758940; Bates D., 2015, LINEAR MIXED EFFECTS, V67, P1, DOI 10.18637/jss.v067.i01; BING LA, 1991, ENVIRON ENTOMOL, V20, P1207, DOI 10.1093/ee/20.4.1207; Birithia R, 2013, PLANT PATHOL, V62, P1407, DOI 10.1111/ppa.12057; Birithia R, 2011, PLANT DIS, V95, P1195, DOI 10.1094/PDIS-01-11-0057; Bittleston LS, 2011, BIOL LETTERS, V7, P30, DOI 10.1098/rsbl.2010.0456; Brownbridge M, 2012, BIOL CONTROL, V61, P194, DOI 10.1016/j.biocontrol.2012.01.002; Cherry A, 2004, INT J PEST MANAGE, V50, P67, DOI 10.1080/09670870310001637426; Diaz-Montano J, 2011, J ECON ENTOMOL, V104, P1, DOI 10.1603/EC10269; Dingle J, 2003, MYCOL RES, V107, P310, DOI 10.1017/S0953756203007512; Ekesi S, 2002, ADV MICROBIAL CONTRO, P165; Everitt BS, 2013, HSAUR HDB STAT ANAL; Guo LD, 2008, J INTEGR PLANT BIOL, V50, P997, DOI 10.1111/j.1744-7909.2008.00394.x; Gurulingappa P, 2010, BIOL CONTROL, V55, P34, DOI 10.1016/j.biocontrol.2010.06.011; Hsu CL, 2010, ENVIRON ENTOMOL, V39, P266, DOI 10.1603/EN09165; Infonet-Biovision, 2013, ON; Jallow MFA, 2004, BASIC APPL ECOL, V5, P183, DOI 10.1078/1439-1791-00224; Kritzman A, 2001, PLANT DIS, V85, P838, DOI 10.1094/PDIS.2001.85.8.838; Lehtonen PT, 2006, BIOL LETTERS, V2, P620, DOI 10.1098/rsbl.2006.0499; Maniania NK, 2002, MYCOPATHOLOGIA, V155, P229, DOI 10.1023/A:1021177626246; Maniania NK, 2003, CROP PROT, V22, P553, DOI 10.1016/S0261-2194(02)00221-1; Marcelino J, 2008, MYCOLOGIA, V100, P353, DOI 10.3852/07-174R; Martin NA, 2003, NEW ZEAL J CROP HORT, V31, P99, DOI 10.1080/01140671.2003.9514242; Morse JG, 2006, ANNU REV ENTOMOL, V51, P67, DOI 10.1146/annurev.ento.51.110104.151044; Narla R. D., 2011, Journal of Biological Sciences, V11, P52, DOI 10.3923/jbs.2011.52.57; Nawrocka B., 2003, Bulletin OILB/SROP, V26, P321; Nyasani JO, 2013, J APPL ENTOMOL, V137, P204, DOI 10.1111/j.1439-0418.2012.01723.x; Ownley BH, 2008, J INVERTEBR PATHOL, V98, P267, DOI 10.1016/j.jip.2008.01.010; Parsa S, 2013, JOVE-J VIS EXP, DOI 10.3791/50360; Posada F, 2007, MYCOL RES, V111, P748, DOI 10.1016/j.mycres.2007.03.006; Qi G, 2011, J APPL MICROBIOL, V110, P1314, DOI 10.1111/j.1365-2672.2011.04985.x; R Development Core Team, 2011, R LANG ENV STAT COMP, P18; Schulz B, 1998, SYMBIOSIS, V25, P213; Schwartz HF, 2009, SOUTHWEST ENTOMOL, V34, P13, DOI 10.3958/059.034.0102; Scott-Brown AS, 2002, J CHEM ECOL, V28, P2399, DOI 10.1023/A:1021471732625; Shiberu T., 2013, Journal of Plant Pathology and Microbiology, V4, P161; Stone JK, 2000, BOOK SOIL P, P3; Stone JK, 2004, BIODIVERSITY FUNGI I, P241, DOI DOI 10.13140/RG.2.1.2497.0726; Strobel G, 2004, J NAT PROD, V67, P257, DOI 10.1021/np030397v; Tefera T, 2009, BIOCONTROL, V54, P663, DOI 10.1007/s10526-009-9216-y; Tibbets TM, 1999, OECOLOGIA, V118, P297, DOI 10.1007/s004420050730; Vega FE, 2008, BIOL CONTROL, V46, P72, DOI 10.1016/j.biocontrol.2008.01.008; Vega FE, 2010, FUNGAL ECOL, V3, P122, DOI [10.1016/j.funeco.2009.05.001, 10.1016/j.funeco.2009.07.002]; Venables W.N., 2002, MODERN APPL STAT S P, Vfourth, DOI [10.1007/978-0-387-21706-2, DOI 10.1007/978-0-387-21706-2_10]; Waiganjo MM, 2008, ACTA HORTIC, P193, DOI 10.17660/ActaHortic.2008.767.19	53	65	71	2	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108242	10.1371/journal.pone.0108242	http://dx.doi.org/10.1371/journal.pone.0108242			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254657	Green Published, gold, Green Submitted			2022-12-25	WOS:000344862300066
J	Baulch, JE; Aypar, U; Waters, KM; Yang, AJ; Morgan, WF				Baulch, Janet E.; Aypar, Umut; Waters, Katrina M.; Yang, Austin J.; Morgan, William F.			Genetic and Epigenetic Changes in Chromosomally Stable and Unstable Progeny of Irradiated Cells	PLOS ONE			English	Article							INDUCED GENOMIC INSTABILITY; BIOINFORMATICS RESOURCE MANAGER; NF-KAPPA-B; IONIZING-RADIATION; MITOCHONDRIAL DYSFUNCTION; DNA HYPOMETHYLATION; MAMMALIAN-CELLS; SYSTEMS BIOLOGY; MICRORNA; CANCER	Radiation induced genomic instability is a well-studied phenomenon, the underlying mechanisms of which are poorly understood. Persistent oxidative stress, mitochondrial dysfunction, elevated cytokine levels and epigenetic changes are among the mechanisms invoked in the perpetuation of the phenotype. To determine whether epigenetic aberrations affect genomic instability we measured DNA methylation, mRNA and microRNA (miR) levels in well characterized chromosomally stable and unstable clonally expanded single cell survivors of irradiation. While no changes in DNA methylation were observed for the gene promoters evaluated, increased LINE-1 methylation was observed for two unstable clones (LS12 and CS9) and decreased Alu element methylation was observed for the other two unstable clones (115 and Fe5.0-8). These relationships also manifested for mRNA and miR expression. mRNA identified for the LS12 and CS9 clones were most similar to each other (261 mRNA), while the 115 and Fe5.0-8 clones were more similar to each other, and surprisingly also similar to the two stable clones, 114 and 118 (286 mRNA among these four clones). Pathway analysis showed enrichment for pathways involved in mitochondrial function and cellular redox, themes routinely invoked in genomic instability. The commonalities between the two subgroups of clones were also observed for miR. The number of miR for which anti-correlated mRNA were identified suggests that these miR exert functional effects in each clone. The results demonstrate significant genetic and epigenetic changes in unstable cells, but similar changes are almost as equally common in chromosomally stable cells. Possible conclusions might be that the chromosomally stable clones have some other form of instability, or that some of the observed changes represent a sort of radiation signature and that other changes are related to genomic instability. Irrespective, these findings again suggest that a spectrum of changes both drive genomic instability and permit unstable cells to persist and proliferate.	[Baulch, Janet E.] Univ Calif Irvine, Dept Radiat Oncol, Irvine, CA 92697 USA; [Aypar, Umut] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Waters, Katrina M.] Pacific NW Natl Lab, Fundamental & Computat Sci Directorate, Richland, WA USA; [Yang, Austin J.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Morgan, William F.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA	University of California System; University of California Irvine; Mayo Clinic; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University System of Maryland; University of Maryland Baltimore; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Baulch, JE (corresponding author), Univ Calif Irvine, Dept Radiat Oncol, Irvine, CA 92697 USA.	jbaulch@uci.edu		Waters, Katrina/0000-0003-4696-5396	NASA [NNX13AK69G, NNX13AK70G]; Battelle Memorial Institute, Pacific Northwest Division [DE-AC05-76RL0 1830]; U.S. Department of Energy, Office of Biological and Environmental Research Low Dose Science Program	NASA(National Aeronautics & Space Administration (NASA)); Battelle Memorial Institute, Pacific Northwest Division; U.S. Department of Energy, Office of Biological and Environmental Research Low Dose Science Program	This work was supported by NASA Grants NNX13AK69G and NNX13AK70G to JEB as well as by Battelle Memorial Institute, Pacific Northwest Division, under Contract DE-AC05-76RL0 1830 with the U.S. Department of Energy, Office of Biological and Environmental Research Low Dose Science Program. The U. S. government retains and the publisher, by accepting the article for publication, acknowledges that the U. S. government retains a nonexclusive, paid-up, irrevocable, worldwide license to publish or reproduce the published form of this article, or allow others to do so, for U. S. government purposes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aypar U, 2011, INT J RADIAT BIOL, V87, P179, DOI 10.3109/09553002.2010.522686; Aypar U, 2011, MUTAT RES-FUND MOL M, V707, P24, DOI 10.1016/j.mrfmmm.2010.12.003; Bestor TH, 2005, CELL, V122, P322, DOI 10.1016/j.cell.2005.07.024; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Cannell IG, 2010, CELL CYCLE, V9, P2726, DOI 10.4161/cc.9.14.12182; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Coates PJ, 2004, MUTAT RES-FUND MOL M, V568, P5, DOI 10.1016/j.mrfmmm.2004.06.042; Dayal D, 2008, BIOCHEM J, V413, P185, DOI 10.1042/BJ20071643; Dayal D, 2009, RADIAT RES, V172, P737, DOI 10.1667/RR1617.1; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Galletta BJ, 2010, CURR OPIN BIOTECH, V21, P604, DOI 10.1016/j.copbio.2010.06.006; Gonzalgo ML, 1997, CANCER RES, V57, P594; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Horita Y, 2008, J BIOL CHEM, V283, P6013, DOI 10.1074/jbc.M706538200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kim GJ, 2006, MUTAGENESIS, V21, P361, DOI 10.1093/mutage/gel048; Kim GJ, 2006, CANCER RES, V66, P10377, DOI 10.1158/0008-5472.CAN-05-3036; Kim MS, 2011, HISTOPATHOLOGY, V58, P660, DOI 10.1111/j.1365-2559.2011.03819.x; Kirchhausen T, 2014, COLD SPRING HARB PER, V6; Kovalchuk O, 2008, ENVIRON MOL MUTAGEN, V49, P16, DOI 10.1002/em.20361; Laiakis EC, 2008, MUTAT RES-FUND MOL M, V640, P74, DOI 10.1016/j.mrfmmm.2007.12.006; LEBEAU MM, 1992, GENOMICS, V14, P529, DOI 10.1016/S0888-7543(05)80261-7; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Limoli CL, 1998, CANCER RES, V58, P3712; Limoli CL, 1997, CANCER RES, V57, P5557; Limoli CL, 2000, INT J RADIAT BIOL, V76, P1599, DOI 10.1080/09553000050201082; Little JB, 2000, CARCINOGENESIS, V21, P397, DOI 10.1093/carcin/21.3.397; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARDER BA, 1993, MOL CELL BIOL, V13, P6667, DOI 10.1128/MCB.13.11.6667; Mayanagi T, 2011, CELL ADHES MIGR, V5, P150, DOI 10.4161/cam.5.2.14398; Merrifield Matt, 2013, Frontiers in Genetics, V4, P40, DOI 10.3389/fgene.2013.00040; Morgan WF, 2003, RADIAT RES, V159, P567, DOI 10.1667/0033-7587(2003)159[0567:NADEOE]2.0.CO;2; Morgan WF, 2003, RADIAT RES, V159, P581, DOI 10.1667/0033-7587(2003)159[0581:NADEOE]2.0.CO;2; Olczak M, 2013, BIOCHEM BIOPH RES CO, V434, P473, DOI 10.1016/j.bbrc.2013.03.098; Owens KM, 2012, FREE RADICAL BIO MED, V52, P160, DOI 10.1016/j.freeradbiomed.2011.10.435; Plass C, 2013, NAT REV GENET, V14, P765, DOI 10.1038/nrg3554; Rajagopalan S, 2012, ENVIRON MOL MUTAGEN, V53, P44, DOI 10.1002/em.20674; Shah AR, 2007, BIOINFORMATICS, V23, P906, DOI 10.1093/bioinformatics/btm031; Snyder AR, 2005, ENVIRON MOL MUTAGEN, V45, P177, DOI 10.1002/em.20092; Stahlhut C, 2013, GENOME MED, V5, DOI 10.1186/gm516; Thomas SN, 2012, FREE RADICAL BIO MED, V53, P618, DOI 10.1016/j.freeradbiomed.2012.03.025; Tilton SC, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-311; Topalian SL, 2001, MOL CELL BIOL, V21, P5614, DOI 10.1128/MCB.21.16.5614-5623.2001; Venkataraman K, 2005, GENE DEV, V19, P1315, DOI 10.1101/gad.1298605; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032	49	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107722	10.1371/journal.pone.0107722	http://dx.doi.org/10.1371/journal.pone.0107722			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251398	gold, Green Published, Green Submitted			2022-12-25	WOS:000342492700041
J	Leon, JX; Heuvelink, GBM; Phinn, SR				Leon, Javier X.; Heuvelink, Gerard B. M.; Phinn, Stuart R.			Incorporating DEM Uncertainty in Coastal Inundation Mapping	PLOS ONE			English	Article							SEA-LEVEL RISE; SPATIAL PREDICTION; AIRBORNE LIDAR; ELEVATION DATA; CLIMATE-CHANGE; GEOSTATISTICS; ADAPTATION; TOPOGRAPHY; IMPACT; SLOPE	Coastal managers require reliable spatial data on the extent and timing of potential coastal inundation, particularly in a changing climate. Most sea level rise (SLR) vulnerability assessments are undertaken using the easily implemented bathtub approach, where areas adjacent to the sea and below a given elevation are mapped using a deterministic line dividing potentially inundated from dry areas. This method only requires elevation data usually in the form of a digital elevation model (DEM). However, inherent errors in the DEM and spatial analysis of the bathtub model propagate into the inundation mapping. The aim of this study was to assess the impacts of spatially variable and spatially correlated elevation errors in high-spatial resolution DEMs for mapping coastal inundation. Elevation errors were best modelled using regression-kriging. This geostatistical model takes the spatial correlation in elevation errors into account, which has a significant impact on analyses that include spatial interactions, such as inundation modelling. The spatial variability of elevation errors was partially explained by land cover and terrain variables. Elevation errors were simulated using sequential Gaussian simulation, a Monte Carlo probabilistic approach. 1,000 error simulations were added to the original DEM and reclassified using a hydrologically correct bathtub method. The probability of inundation to a scenario combining a 1 in 100 year storm event over a 1 m SLR was calculated by counting the proportion of times from the 1,000 simulations that a location was inundated. This probabilistic approach can be used in a risk-aversive decision making process by planning for scenarios with different probabilities of occurrence. For example, results showed that when considering a 1% probability exceedance, the inundated area was approximately 11% larger than mapped using the deterministic bathtub approach. The probabilistic approach provides visually intuitive maps that convey uncertainties inherent to spatial data and analysis.	[Leon, Javier X.] Univ Queensland, Global Change Inst, Brisbane, Qld, Australia; [Leon, Javier X.; Phinn, Stuart R.] Univ Queensland, Sch Geog Planning & Environm Management, St Lucia, Qld, Australia; [Heuvelink, Gerard B. M.] Wageningen Univ, Soil Geog & Landscape Grp, NL-6700 AP Wageningen, Netherlands	University of Queensland; University of Queensland; Wageningen University & Research	Leon, JX (corresponding author), Univ Queensland, Global Change Inst, Brisbane, Qld, Australia.	j.leonpatino@uq.edu.au	Phinn, Stuart R/J-8457-2013; Leon, Javier/J-3971-2012; Heuvelink, Gerard/AAD-5916-2022	Phinn, Stuart R/0000-0002-2605-6104; Leon, Javier/0000-0002-4201-5804; Heuvelink, Gerard/0000-0003-0959-9358	Australian Research Council SuperScience grant [FS100100024]	Australian Research Council SuperScience grant(Australian Research Council)	JL and SP received funds from Australian Research Council SuperScience grant #FS100100024. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAMHatch Pty, 2009, LID ORTH ACQ SE QUEE; Adger WN, 2009, CLIMATIC CHANGE, V93, P335, DOI 10.1007/s10584-008-9520-z; Aguilar FJ, 2010, ISPRS J PHOTOGRAMM, V65, P103, DOI 10.1016/j.isprsjprs.2009.09.003; Arroyo LA, 2010, FOREST ECOL MANAG, V259, P598, DOI 10.1016/j.foreco.2009.11.018; Bater CW, 2009, COMPUT GEOSCI-UK, V35, P289, DOI 10.1016/j.cageo.2008.09.001; Bell J, 2013, WETLANDS, P1; Callaghan DP, 2008, COAST ENG, V55, P375, DOI 10.1016/j.coastaleng.2007.12.003; Cardno, 2009, STORM TID HAZ STUD M; Chow TE, 2009, INT J GEOGR INF SCI, V23, P1277, DOI 10.1080/13658810802344127; Cimmery V., 2010, SAGA USER GUIDE UPDA; Cooper HM, 2013, CLIMATIC CHANGE, V121, P635, DOI 10.1007/s10584-013-0987-x; Coveney S, 2011, INT J GEOGR INF SCI, V25, P1191, DOI 10.1080/13658816.2010.545064; Eldeiry AA, 2010, J IRRIG DRAIN ENG, V136, P355, DOI 10.1061/(ASCE)IR.1943-4774.0000208; Erdogan S, 2010, COMPUT GEOSCI-UK, V36, P34, DOI 10.1016/j.cageo.2009.06.005; ESRI, 2012, ARCGIS DESKT; Fraile-Jurado P, 2013, GEO-MAR LETT, V33, P225, DOI 10.1007/s00367-012-0317-8; Gallant JC, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001426; Geddes A, 2012, INT J GEOGR INF SYST, V27, P785; Gesch DB, 2007, DIGITAL ELEVATION MO, P620; Gesch DB, 2013, J COASTAL RES, P197, DOI [10.2112/SI63-016.1, 10.2112/S163-016.1]; Gesch DB, 2009, J COASTAL RES, V25, P49, DOI [10.2112/SI53-006.1, 10.2112/S153-006.1]; Goovaerts P., 1997, GEOSTATISTICS NATURA, DOI DOI 10.2307/1270969; Guisan A, 1999, PLANT ECOL, V143, P107, DOI 10.1023/A:1009841519580; Haig J, 2014, NATURE, V505, P667, DOI 10.1038/nature12882; Harris P, 2010, MATH GEOSCI, V42, P657, DOI 10.1007/s11004-010-9284-7; Hengl T, 2004, GEODERMA, V120, P75, DOI 10.1016/j.geoderma.2003.08.018; Hengl T, 2010, HYDROL EARTH SYST SC, V14, P1153, DOI 10.5194/hess-14-1153-2010; Hengl T, 2008, COMPUT GEOSCI-UK, V34, P1886, DOI 10.1016/j.cageo.2008.01.005; Hengl T, 2007, COMPUT GEOSCI-UK, V33, P1301, DOI 10.1016/j.cageo.2007.05.001; Hengl T, 2009, SCIENTOMETRICS, V80, P491, DOI 10.1007/s11192-009-0073-3; Heuvelink G.B., 1998, ERROR PROPAGATION EN; Heuvelink GBM, 2010, INT J GEOGR INF SCI, V24, P365, DOI 10.1080/13658810802646687; Horton BP, 2014, QUATERNARY SCI REV, V84, P1, DOI 10.1016/j.quascirev.2013.11.002; Iwahashi J, 2007, GEOMORPHOLOGY, V86, P409, DOI 10.1016/j.geomorph.2006.09.012; Lallias-Tacon S, 2014, GEOMORPHOLOGY, V214, P307, DOI 10.1016/j.geomorph.2014.02.014; Li J, 2014, ENVIRON MODELL SOFTW, V53, P173, DOI 10.1016/j.envsoft.2013.12.008; Lichter M, 2011, J COASTAL RES, V27, P757, DOI 10.2112/JCOASTRES-D-10-00072.1; Liu XY, 2008, PROG PHYS GEOG, V32, P31, DOI 10.1177/0309133308089496; McGregor HV, 2013, NATURE GEOSCI; Minasny B, 2007, GEODERMA, V140, P324, DOI 10.1016/j.geoderma.2007.04.028; Mondal P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048191; Moser SC, 2014, WIRES CLIM CHANGE, V5, P337, DOI 10.1002/wcc.276; Nicholls RJ, 2010, SCIENCE, V328, P1517, DOI 10.1126/science.1185782; Oksanen J, 2006, INT J GEOGR INF SCI, V20, P345, DOI 10.1080/13658810500433891; Pardo-Iguzquiza E, 2008, COMPUT GEOSCI-UK, V34, P1073, DOI 10.1016/j.cageo.2007.09.020; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Poulter B, 2008, INT J GEOGR INF SCI, V22, P167, DOI 10.1080/13658810701371858; R Core Team, 2021, R LANG ENV STAT COMP; Ranasinghe R, 2013, NAT CLIM CHANGE, V3, P83, DOI [10.1038/NCLIMATE1664, 10.1038/nclimate1664]; Reuter HI, 2009, DEV SOIL SCI, V33, P87, DOI 10.1016/S0166-2481(08)00004-4; Riley SJ., 1999, INTERMOUNT J SCI, V5, P23, DOI DOI 10.1016/j.geomorph.2010.11.003; Romstad B, 2012, GEOMORPHOLOGY, V139, P293, DOI 10.1016/j.geomorph.2011.10.031; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Saunders MI, 2014, NAT CLIM CHANGE, V4, P724, DOI 10.1038/NCLIMATE2274; Saunders MI, 2013, GLOBAL CHANGE BIOL, V19, P2569, DOI 10.1111/gcb.12218; Schmid K, 2014, J COASTAL RES, V30, P548, DOI 10.2112/JCOASTRES-D-13-00118.1; Schmidt KA, 2011, J COASTAL RES, V27, P116, DOI 10.2112/JCOASTRES-D-10-00188.1; Sibson R., 1981, INTERPRETING MULTIVA, P21, DOI DOI 10.1007/3-540-26772-7_8; Spiegelhalter D, 2011, SCIENCE, V333, P1393, DOI 10.1126/science.1191181; Su J, 2006, PHOTOGRAMM ENG REM S, V72, P1265, DOI 10.14358/PERS.72.11.1265; Sun W, 2012, GEODERMA, V171, P16, DOI 10.1016/j.geoderma.2011.02.010; Walsh KJE, 2012, GLOBAL PLANET CHANGE, V80-81, P149, DOI 10.1016/j.gloplacha.2011.10.006; Webster R., 2007, STAT PRACTICE; Zandbergen PA, 2011, INT J REMOTE SENS, V32, P409, DOI 10.1080/01431160903474939; Zhang KQ, 2013, CLIMATIC CHANGE, V118, P487, DOI 10.1007/s10584-012-0645-8	65	51	52	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108727	10.1371/journal.pone.0108727	http://dx.doi.org/10.1371/journal.pone.0108727			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250763	gold, Green Published, Green Submitted			2022-12-25	WOS:000342492700152
J	Lozano-Jaramillo, M; Rico-Guevara, A; Cadena, CD				Lozano-Jaramillo, Maria; Rico-Guevara, Alejandro; Daniel Cadena, Carlos			Genetic Differentiation, Niche Divergence, and the Origin and Maintenance of the Disjunct Distribution in the Blossomcrown Anthocephala floriceps (Trochilidae)	PLOS ONE			English	Article							MOLECULAR PHYLOGENETICS; SPECIES DISTRIBUTION; RANGE LIMITS; DISPERSAL; DIVERSIFICATION; PHYLOGEOGRAPHY; CONSERVATISM; ECOLOGY; HUMMINGBIRDS; BIOGEOGRAPHY	Studies of the origin and maintenance of disjunct distributions are of special interest in biogeography. Disjunct distributions can arise following extinction of intermediate populations of a formerly continuous range and later maintained by climatic specialization. We tested hypotheses about how the currently disjunct distribution of the Blossomcrown (Anthocephala floriceps), a hummingbird species endemic to Colombia, arose and how is it maintained. By combining molecular data and models of potential historical distributions we evaluated: (1) the timing of separation between the two populations of the species, (2) whether the disjunct distribution could have arisen as a result of fragmentation of a formerly widespread range due to climatic changes, and (3) if the disjunct distribution might be currently maintained by specialization of each population to different climatic conditions. We found that the two populations are reciprocally monophyletic for mitochondrial and nuclear loci, and that their divergence occurred ca. 1.4 million years before present (95% credibility interval 0.7-2.1 mybp). Distribution models based on environmental data show that climate has likely not been suitable for a fully continuous range over the past 130,000 years, but the potential distribution 6,000 ybp was considerably larger than at present. Tests of climatic divergence suggest that significant niche divergence between populations is a likely explanation for the maintenance of their disjunct ranges. However, based on climate the current range of A. floriceps could potentially be much larger than it currently is, suggesting other ecological or historical factors have influenced it. Our results showing that the distribution of A. floriceps has been discontinous for a long period of time and that populations exhibit different climatic niches have taxonomic and conservation implications.	[Lozano-Jaramillo, Maria; Daniel Cadena, Carlos] Univ Los Andes, Dept Ciencias Biol, Lab Biol Evolut Vertebrados, Bogota, Colombia; [Rico-Guevara, Alejandro] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA	Universidad de los Andes (Colombia); University of Connecticut	Cadena, CD (corresponding author), Univ Los Andes, Dept Ciencias Biol, Lab Biol Evolut Vertebrados, Bogota, Colombia.	ccadena@uniandes.edu.co		Rico-Guevara, Alejandro/0000-0003-4067-5312; Lozano-Jaramillo, Maria/0000-0001-8344-4827	Facultad de Ciencias at the Universidad de los Andes, Bogota, Colombia	Facultad de Ciencias at the Universidad de los Andes, Bogota, Colombia	The study was financed by the Facultad de Ciencias at the Universidad de los Andes, Bogota, Colombia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh F, 2013, J BIOGEOGR, V40, P1807, DOI 10.1111/jbi.12121; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barker NP, 2007, J BIOGEOGR, V34, P2012, DOI 10.1111/j.1365-2699.2007.01749.x; BAUM DA, 1995, MONOG SYST BOTAN, V53, P289; Brown JH, 2000, GLOBAL ECOL BIOGEOGR, V9, P87, DOI 10.1046/j.1365-2699.2000.00186.x; Brown JH, 1998, BIOGEOGRAPHY; Cadena CD, 2007, ECOGRAPHY, V30, P491, DOI 10.1111/j.2007.0906-7590.05045.x; Cadena CD, 2010, BIOL J LINN SOC, V99, P152, DOI 10.1111/j.1095-8312.2009.01333.x; Carranza S., 2003, Systematics and Biodiversity, V1, P275, DOI 10.1017/S1477200003001099; Carstens BC, 2007, EVOLUTION, V61, P1439, DOI 10.1111/j.1558-5646.2007.00117.x; Cavender-Bares J, 2011, J BIOGEOGR, V38, P962, DOI 10.1111/j.1365-2699.2010.02451.x; Collar Nigel J., 2013, Conservacion Colombiana, V19, P31; Conti E, 2002, EVOLUTION, V56, P1931; Cracraft J., 1983, Current Ornithology, V1, P159; Darwin Database, 2014, DAT BIOMAP; de Queiroz A, 2005, TRENDS ECOL EVOL, V20, P68, DOI 10.1016/j.tree.2004.11.006; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; de Queiroz Kevin, 2005, Proceedings of the California Academy of Sciences, V56, P196; Donoghue MJ, 2011, P NATL ACAD SCI USA, V108, P6341, DOI 10.1073/pnas.1103801108; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards SV, 2000, EVOLUTION, V54, P1839; Ornelas JF, 2014, J BIOGEOGR, V41, P168, DOI 10.1111/jbi.12184; Gamble T, 2011, J EVOLUTION BIOL, V24, P231, DOI 10.1111/j.1420-9101.2010.02184.x; Gatson JK, 2003, STRUCTURE DYNAMICS G; Gonzalez C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-38; Graham CH, 2010, J BIOGEOGR, V37, P1863, DOI 10.1111/j.1365-2699.2010.02356.x; Graham CH, 2009, P NATL ACAD SCI USA, V106, P19673, DOI 10.1073/pnas.0901649106; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Gutierrez-Pinto N, 2012, MOL PHYLOGENET EVOL, V64, P156, DOI 10.1016/j.ympev.2012.03.011; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hilty SL, 1986, GUIDE BIRDS COLOMBIA; Holt RD, 2005, OIKOS, V108, P3, DOI 10.1111/j.0030-1299.2005.13145.x; Knowles LL, 2004, J EVOLUTION BIOL, V17, P1, DOI 10.1046/j.1420-9101.2003.00644.x; Krabbe Niels, 2005, BULLETIN OF THE BRITISH ORNITHOLOGISTS CLUB, V125, P93; Laverde RO, 2014, J AVIAN BIO IN PRESS; McCormack JE, 2010, EVOLUTION, V64, P1231, DOI 10.1111/j.1558-5646.2009.00900.x; McGuire JA, 2007, SYST BIOL, V56, P837, DOI 10.1080/10635150701656360; McGuire JA, 2014, CURR BIOL, V24, P910, DOI 10.1016/j.cub.2014.03.016; Michalak I, 2010, J BIOGEOGR, V37, P1214, DOI 10.1111/j.1365-2699.2010.02306.x; Miller MJ, 2011, CONDOR, V113, P806, DOI 10.1525/cond.2011.100226; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; MORITZ C, 1995, PHILOS T R SOC B, V349, P113, DOI 10.1098/rstb.1995.0097; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Parra JL, 2009, MOL PHYLOGENET EVOL, V53, P425, DOI 10.1016/j.ympev.2009.07.006; Peterson AT, 2001, CONDOR, V103, P599, DOI 10.1650/0010-5422(2001)103[0599:PSGDBO]2.0.CO;2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Popp M, 2011, P NATL ACAD SCI USA, V108, P6520, DOI 10.1073/pnas.1012249108; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Poux C, 2006, SYST BIOL, V55, P228, DOI 10.1080/10635150500481390; Powell M, 2005, BIOL CONSERV, V123, P165, DOI 10.1016/j.biocon.2004.11.004; R Development Core Team, 2012, R LANG ENV STAT COMP; Remsen JV, 2005, AUK, V122, P403, DOI 10.1642/0004-8038(2005)122[0403:PPARMC]2.0.CO;2; Renner SS, 2005, TRENDS PLANT SCI, V10, P550, DOI 10.1016/j.tplants.2005.09.010; Richards CL, 2007, J BIOGEOGR, V34, P1833, DOI 10.1111/j.1365-2699.2007.01814.x; Rodriguez-Gomez F, 2013, J BIOGEOGR, V40, P1360, DOI 10.1111/jbi.12093; Roy MS, 1998, IBIS, V140, P265, DOI 10.1111/j.1474-919X.1998.tb04388.x; Salaman PGW, 2002, SERIE LIBROS ROJOS E, P257; Sambrook J, 2001, MOL CLONING LAB MANU; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; SEUTIN G, 1994, EVOLUTION, V48, P1041, DOI 10.1111/j.1558-5646.1994.tb05292.x; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Shipley JR, 2013, AUK, V130, P476, DOI 10.1525/auk.2013.12151; Smith BT, 2010, ECOGRAPHY, V33, P333, DOI 10.1111/j.1600-0587.2009.06335.x; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; Strewe Ralf, 2003, Ornitologia Colombiana, V1, P29; Templeton A.R., 1989, P3; Valderrama E, 2014, J BIOGEOGR, V41, P1533, DOI 10.1111/jbi.12317; Veloz SD, 2012, GLOBAL CHANGE BIOL, V18, P1698, DOI 10.1111/j.1365-2486.2011.02635.x; Vidal N, 2008, BIOL LETTERS, V4, P115, DOI 10.1098/rsbl.2007.0531; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Wellenreuther M, 2012, ECOLOGY, V93, P1353; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Witt JDS, 2011, J BIOGEOGR, V38, P1557, DOI 10.1111/j.1365-2699.2011.02497.x; Wooten JA, 2012, J EVOLUTION BIOL, V25, P317, DOI 10.1111/j.1420-9101.2011.02426.x	76	5	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108345	10.1371/journal.pone.0108345	http://dx.doi.org/10.1371/journal.pone.0108345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251766	Green Submitted, Green Published, gold			2022-12-25	WOS:000342492700113
J	Moran, D; Softley, R; Warrant, EJ				Moran, Damian; Softley, Rowan; Warrant, Eric J.			Eyeless Mexican Cavefish Save Energy by Eliminating the Circadian Rhythm in Metabolism	PLOS ONE			English	Article							ASTYANAX-MEXICANUS; OXYGEN-CONSUMPTION; EVOLUTION; FISH; TEMPERATURE; FASCIATUS; SYSTEM; POPULATIONS; CHARACIDAE; ANIMALS	The eyed surface form and eyeless cave form of the Mexican tetra Astyanax mexicanus experience stark differences in the daily periodicities of light, food and predation, factors which are likely to have a profound influence on metabolism. We measured the metabolic rate of Pachon cave and surface fish at a fixed swimming speed under light/dark and constant dark photoperiods. In constant darkness surface forms exhibited a circadian rhythm in metabolism with an increase in oxygen demand during the subjective daytime, whereas cave forms did not. The lack of circadian rhythm in metabolism leads to a 27% energy savings for Pachon cave fish compared to surface fish when comparing both forms in their natural photoperiods. When surface forms were tested under constant dark conditions they expended 38% more energy than cave forms under equivalent conditions. Elimination of the circadian rhythm in metabolism may be a general feature of animals that live in perpetually dark food-limited environments such as caves or the deep sea.	[Moran, Damian; Softley, Rowan; Warrant, Eric J.] Lund Univ, Dept Biol, Lund, Sweden	Lund University	Moran, D (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	damian.moran@plantandfood.co.nz	Moran, Damian/G-6015-2011	Moran, Damian/0000-0001-9097-0147; Warrant, Eric/0000-0001-7480-7016	European Research Agency; Erasmus Work Placement Grant; Swedish Research Council	European Research Agency; Erasmus Work Placement Grant; Swedish Research Council(Swedish Research CouncilEuropean Commission)	DM was supported by a Marie Curie Fellowship from the European Research Agency. RS was supported by an Erasmus Work Placement Grant. EW acknowledges the ongoing support of the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES A, 1992, J NEUROSCI, V12, P840, DOI 10.1523/jneurosci.12-03-00840.1992; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Beale A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3769; Beamish F.W., 1979, FISH PHYSL LOCOMOTIO, P101, DOI DOI 10.1139/cjfas-2015-0209; Benstaali C, 2001, LIFE SCI, V68, P2645, DOI 10.1016/S0024-3205(01)01081-5; Bibliowicz J, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-25; Borowsky Richard, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.emo107; BUSHNELL PG, 1994, POLAR BIOL, V14, P43; Carrier J, 1997, J BIOL RHYTHM, V12, P266, DOI 10.1177/074873049701200308; Clark TD, 2013, J EXP BIOL, V216, P2771, DOI 10.1242/jeb.084251; Duboue ER, 2011, CURR BIOL, V21, P671, DOI 10.1016/j.cub.2011.03.020; Duffy JE, 2002, J BIOL RHYTHM, V17, P4, DOI 10.1177/074873002129002294; ERCKENS W, 1982, Z NATURFORSCH C, V37, P1253; Falcon J, 2010, GEN COMP ENDOCR, V165, P469, DOI 10.1016/j.ygcen.2009.04.026; Herrmann JP, 2000, J FISH BIOL, V57, P746, DOI [10.1006/jfbi.2000.1348, 10.1111/j.1095-8649.2000.tb00272.x]; HUPPOP K, 1986, ENVIRON BIOL FISH, V17, P299, DOI 10.1007/BF00001496; Huppop K, 2000, ECOSY WORLD, V30, P159; Huppop K., 1987, International Journal of Speleology, V16, P59; Jeffery WR, 2001, DEV BIOL, V231, P1, DOI 10.1006/dbio.2000.0121; Jeffery WR, 2000, DEV GENES EVOL, V210, P223, DOI 10.1007/s004270050308; Jobling M., 1994, FISH BIOENERGETICS; Kim WS, 1997, MAR ECOL PROG SER, V153, P293, DOI 10.3354/meps153293; Li Min-Dian, 2012, Yale Journal of Biology and Medicine, V85, P387; Lin JD, 2008, CELL CYCLE, V7, P453, DOI 10.4161/cc.7.4.5442; MITCHELL RW, 1977, SPEC PUBL MUS TEXAS, V12, P1; Montgomery JC, 2001, ENVIRON BIOL FISH, V62, P87, DOI 10.1023/A:1011873111454; Murray G, 2002, CHRONOBIOL INT, V19, P1151, DOI 10.1081/CBI-120015956; Niven JE, 2008, CURR BIOL, V18, pR27, DOI 10.1016/j.cub.2007.11.020; Parzefall J., 1983, Memoires de Biospeologie, V10, P171; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Piccione G, 2011, J VET BEHAV, V6, P115, DOI 10.1016/j.jveb.2010.11.003; Protas M, 2012, WIRES DEV BIOL, V1, P823, DOI 10.1002/wdev.61; Rohner N, 2013, SCIENCE, V342, P1372, DOI 10.1126/science.1240276; Rosenthal GG, 2001, AM NAT, V158, P146, DOI 10.1086/321309; ROSS LG, 1988, COMP BIOCHEM PHYS A, V89, P637, DOI 10.1016/0300-9629(88)90846-8; Salin K, 2010, COMP BIOCHEM PHYS A, V156, P451, DOI 10.1016/j.cbpa.2010.03.030; SMIT H, 1965, CAN J ZOOLOG, V43, P623, DOI 10.1139/z65-063; Strecker U, 2012, MOL PHYLOGENET EVOL, V62, P62, DOI 10.1016/j.ympev.2011.09.005; Vansteensel MJ, 2008, BRAIN RES REV, V58, P18, DOI 10.1016/j.brainresrev.2007.10.009; Wilkens H, 1988, EVOL BIOL, V23, P271, DOI [10.1007/978-1-4613-1043-3_8, DOI 10.1007/978-1-4613-1043-3_]; Wilkens H, 1986, J ZOOL SYST EVOL RES, V24, P223, DOI [10.1111/j.1439-0469.1986.tb00630.x, DOI 10.1111/J.1439-0469.1986.TB00630.X]; Yoshizawa M, 2010, CURR BIOL, V20, P1631, DOI 10.1016/j.cub.2010.07.017; Zhdanova IV, 2005, FISH PHYSIOL, V24, P197, DOI DOI 10.1016/S1546-5098(05)24006-2	43	69	69	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107877	10.1371/journal.pone.0107877	http://dx.doi.org/10.1371/journal.pone.0107877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251018	Green Submitted, gold, Green Published			2022-12-25	WOS:000342492700055
J	Capasso, D; de Paola, I; Liguoro, A; Del Gatto, A; Di Gaetano, S; Guarnieri, D; Saviano, M; Zaccaro, L				Capasso, Domenica; de Paola, Ivan; Liguoro, Annamaria; Del Gatto, Annarita; Di Gaetano, Sonia; Guarnieri, Daniela; Saviano, Michele; Zaccaro, Laura			RGDechi-hCit: alpha v beta 3 Selective Pro-Apoptotic Peptide as Potential Carrier for Drug Delivery into Melanoma Metastatic Cells	PLOS ONE			English	Article							ALPHA(V)BETA(3) INTEGRIN; MALIGNANT-MELANOMA; IN-VITRO; RGD PEPTIDES; ADHESION; CILENGITIDE; EXPRESSION; GLIOBLASTOMA; VITRONECTIN; ANTAGONISTS	alpha v beta 3 integrin is an important tumor marker widely expressed on the surface of cancer cells. Recently, we reported some biological features of RGDechi-hCit, an alpha v beta 3 selective peptide antagonist. In the present work, we mainly investigated the pro-apoptotic activity of the molecule and its ability to penetrate the membrane of WM266 cells, human malignant melanoma cells expressing high levels of alpha v beta 3 integrin. For the first time we demonstrated the pro-apoptotic effect and the ability of RGDechi-hCit to enter into cell overexpressing alpha v beta 3 integrin mainly by clathrin- and caveolin-mediated endocytosis. Furthermore, we deepened and confirmed the selectivity, anti-adhesion, and anti-proliferative features of the peptide. Altogether these experiments give insight into the biological behavior of RGDechi-hCit and have important implications for the employment of the peptide as a new selective carrier to deliver drugs into the cell and as a therapeutic and diagnostic tool for metastatic melanoma. Moreover, since the peptide shows a pro-apoptotic effect, a great perspective could be the development of a new class of selective systems containing RGDechi-hCit and pro-apoptotic molecules or other therapeutic agents to attain a synergic action.	[Capasso, Domenica] Univ Naples Federico II, Dept Pharm, Naples, Italy; [de Paola, Ivan; Del Gatto, Annarita; Di Gaetano, Sonia; Zaccaro, Laura] CNR, Inst Biostruct & Bioimaging, I-80125 Naples, Italy; [Liguoro, Annamaria] Scarl, Diagnost & Mol Pharmaceut, Naples, Italy; [Guarnieri, Daniela] CRIB Italian Inst Technol, Ctr Adv Biomaterials Hlth Care, Naples, Italy; [Saviano, Michele] CNR, Inst Crystallog, Bari, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR)	Zaccaro, L (corresponding author), CNR, Inst Biostruct & Bioimaging, I-80125 Naples, Italy.	lzaccaro@unina.it	Del Gatto, Annarita/AAY-1478-2020; Saviano, Michele/R-1693-2016; de Paola, Ivan/B-6867-2017	Saviano, Michele/0000-0001-5086-2459; de Paola, Ivan/0000-0003-1508-6591; Di Gaetano, Sonia/0000-0001-5523-3619; Capasso, Domenica/0000-0001-7201-3431; Guarnieri, Daniela/0000-0002-0947-7724	FIRB MIUR "RENAME" [2010-RBAP114AMK]; Programma Operativo Nazionale Ricerca e Competitivita [PON 01_02388]	FIRB MIUR "RENAME"(Ministry of Education, Universities and Research (MIUR)); Programma Operativo Nazionale Ricerca e Competitivita(Ministry of Education, Universities and Research (MIUR))	This study was supported by FIRB MIUR "RENAME" 2010-RBAP114AMK and Programma Operativo Nazionale Ricerca e Competitivita 2007-2013 PON 01_02388. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adderley SR, 2000, J BIOL CHEM, V275, P5760, DOI 10.1074/jbc.275.8.5760; Aguzzi MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025352; Aguzzi MS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-84; Alam MR, 2008, NUCLEIC ACIDS RES, V36, P2764, DOI 10.1093/nar/gkn115; ALBELDA SM, 1990, CANCER RES, V50, P6757; Andersen MH, 2007, CLIN CANCER RES, V13, P5991, DOI 10.1158/1078-0432.CCR-07-0686; Angeletti C, 1998, BIOCHEMISTRY-US, V37, P15114, DOI 10.1021/bi9810104; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Castel S, 2001, LAB INVEST, V81, P1615, DOI 10.1038/labinvest.3780375; Chen K, 2011, THERANOSTICS, V1, P189, DOI 10.7150/thno/v01p0189; Coste J, 1990, PYBOP NEW PEPTIDE CO; DAVIS GE, 1992, BIOCHEM BIOPH RES CO, V182, P1025, DOI 10.1016/0006-291X(92)91834-D; De Deyne PG, 1998, J CELL SCI, V111, P2729; Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g; Del Gatto A, 2006, J MED CHEM, V49, P3416, DOI 10.1021/jm060233m; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; FIELDS C G, 1991, Peptide Research, V4, P95; Fogel M, 2003, CANCER LETT, V189, P237, DOI 10.1016/S0304-3835(02)00513-X; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Garbe C, 2010, EUR J CANCER, V46, P270, DOI 10.1016/j.ejca.2009.10.032; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GILLIES RJ, 1986, ANAL BIOCHEM, V159, P109, DOI 10.1016/0003-2697(86)90314-3; GLADSON CL, 1991, J CLIN INVEST, V88, P1924, DOI 10.1172/JCI115516; Grossman D, 2001, CANCER METAST REV, V20, P3, DOI 10.1023/A:1013123532723; Haass NK, 2005, PIGM CELL RES, V18, P150, DOI 10.1111/j.1600-0749.2005.00235.x; HANSEN SH, 1993, J CELL BIOL, V121, P61, DOI 10.1083/jcb.121.1.61; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jilaveanu LB, 2009, CLIN DERMATOL, V27, P614, DOI 10.1016/j.clindermatol.2008.09.020; Kanda S, 2000, ARTERIOSCL THROM VAS, V20, P998, DOI 10.1161/01.ATV.20.4.998; Lautenschlaeger T, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-246; Liapis H, 1997, HUM PATHOL, V28, P443, DOI 10.1016/S0046-8177(97)90033-2; Marshall JF, 1998, BRIT J CANCER, V77, P522, DOI 10.1038/bjc.1998.85; Matsuki K, 2008, J ORTHOP SCI, V13, P524, DOI 10.1007/s00776-008-1281-z; Maubant S, 2006, BLOOD, V108, P3035, DOI 10.1182/blood-2006-05-023580; McGary EC, 2002, CANCER BIOL THER, V1, P459, DOI 10.4161/cbt.1.5.158; Millard M, 2011, THERANOSTICS, V1, P154, DOI 10.7150/thno/v01p0154; Mizejewski GJ, 1999, P SOC EXP BIOL MED, V222, P124, DOI 10.1046/j.1525-1373.1999.d01-122.x; Monfregola L, 2011, AMINO ACIDS, V41, P981, DOI 10.1007/s00726-010-0798-6; Oliveira-Ferrer L, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-86; Pisano M, 2013, ANTICANCER RES, V33, P871; Plow EF, 2001, THROMB HAEMOSTASIS, V86, P34; Reardon DA, 2011, FUTURE ONCOL, V7, P339, DOI [10.2217/fon.11.8, 10.2217/FON.11.8]; Rosenow Felix, 2008, Neoplasia, V10, P168, DOI 10.1593/neo.07898; Santulli G, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-7; Scaringi C, 2012, ANTICANCER RES, V32, P4213; Seiffert D, 1997, J BIOL CHEM, V272, P13705, DOI 10.1074/jbc.272.21.13705; Tabatabai G, 2010, TARGET ONCOL, V5, P175, DOI 10.1007/s11523-010-0156-3; White DE, 2007, J MAMMARY GLAND BIOL, V12, P135, DOI 10.1007/s10911-007-9045-5; Yin AA, 2013, CRIT REV ONCOL HEMAT, V87, P265, DOI 10.1016/j.critrevonc.2013.01.007; ZACCARO L, 2007, CURRENT TOPICS BIOCH, V9, P45; Zaccaro L, 2009, CURR MED CHEM, V16, P780, DOI 10.2174/092986709787549307; Zaffaroni N, 2005, J CELL MOL MED, V9, P360, DOI 10.1111/j.1582-4934.2005.tb00361.x; Zannetti A, 2009, CLIN CANCER RES, V15, P5224, DOI 10.1158/1078-0432.CCR-08-3270; Zhaofei L, 2008, DRUG DEVELOP RES, V69, P329	55	24	25	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e106441	10.1371/journal.pone.0106441	http://dx.doi.org/10.1371/journal.pone.0106441			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25248000	gold, Green Submitted, Green Published			2022-12-25	WOS:000342351800008
J	Liu, J; Liu, S; Sun, K; Sheng, YH; Gu, YJ; Gao, YZ				Liu, Juan; Liu, Shuang; Sun, Kai; Sheng, Yuehui; Gu, Yujun; Gao, Yanzheng			Colonization on Root Surface by a Phenanthrene-Degrading Endophytic Bacterium and Its Application for Reducing Plant Phenanthrene Contamination	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; NONIONIC-SURFACTANT; STRAIN; SOIL; DEGRADATION; PHYTOREMEDIATION; PYRENE; WATER; NAPHTHALENE; VEGETABLES	A phenanthrene-degrading endophytic bacterium, Pn2, was isolated from Alopecurus aequalis Sobol grown in soils contaminated with polycyclic aromatic hydrocarbons (PAHs). Based on morphology, physiological characteristics and the 16S rRNA gene sequence, it was identified as Massilia sp. Strain Pn2 could degrade more than 95% of the phenanthrene (150 mg.L-1) in a minimal salts medium (MSM) within 48 hours at an initial pH of 7.0 and a temperature of 30 degrees C. Pn2 could grow well on the MSM plates with a series of other PAHs, including naphthalene, acenaphthene, anthracene and pyrene, and degrade them to different degrees. Pn2 could also colonize the root surface of ryegrass (Lolium multiflorum Lam), invade its internal root tissues and translocate into the plant shoot. When treated with the endophyte Pn2 under hydroponic growth conditions with 2 mg.L-1 of phenanthrene in the Hoagland solution, the phenanthrene concentrations in ryegrass roots and shoots were reduced by 54% and 57%, respectively, compared with the endophyte-free treatment. Strain Pn2 could be a novel and useful bacterial resource for eliminating plant PAH contamination in polluted environments by degrading the PAHs inside plants. Furthermore, we provide new perspectives on the control of the plant uptake of PAHs via endophytic bacteria.	[Liu, Juan; Liu, Shuang; Sun, Kai; Sheng, Yuehui; Gu, Yujun; Gao, Yanzheng] Nanjing Agr Univ, Coll Resources & Environm Sci, Inst Organ Contaminant Control & Soil Remediat, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Gao, YZ (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Inst Organ Contaminant Control & Soil Remediat, Nanjing, Jiangsu, Peoples R China.	gaoyanzheng@njau.edu.cn		Gao, Yanzheng/0000-0002-3814-3555; Sun, Kai/0000-0002-1907-9711	National Science Foundation of China [41201501, 31270574, 41171380, 41171193]; Science Foundation of Jiangsu Province [BK2012370, BE2011780]; Doctoral Fund of Ministry of Education of China [20120097120012]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Jiangsu Province; Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This work was financially supported by the National Science Foundation of China (41201501, 31270574, 41171380, and 41171193), the Science Foundation of Jiangsu Province (BK2012370 and BE2011780) and the Doctoral Fund of Ministry of Education of China (20120097120012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreolli M, 2013, CHEMOSPHERE, V92, P688, DOI 10.1016/j.chemosphere.2013.04.033; Bandara WMMS, 2006, J BIOSCIENCES, V31, P645, DOI 10.1007/BF02708417; Binet P, 2000, SOIL BIOL BIOCHEM, V32, P2011, DOI 10.1016/S0038-0717(00)00100-0; Bodour AA, 2003, ENVIRON MICROBIOL, V5, P888, DOI 10.1046/j.1462-2920.2003.00481.x; Child R, 2007, APPL MICROBIOL BIOT, V75, P655, DOI 10.1007/s00253-007-0840-0; Collins C, 2006, ENVIRON SCI TECHNOL, V40, P45, DOI 10.1021/es0508166; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Dong RB, 1999, ENV DEV, V14, P10; Gao YZ, 2008, CHEMOSPHERE, V72, P636, DOI 10.1016/j.chemosphere.2008.02.032; Gao YZ, 2013, PLANT SOIL, V365, P171, DOI 10.1007/s11104-012-1386-1; Gao YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050467; Gao YZ, 2006, CHEMOSPHERE, V63, P1560, DOI 10.1016/j.chemosphere.2005.09.058; Gao YZ, 2004, CHEMOSPHERE, V55, P1169, DOI 10.1016/j.chemosphere.2004.01.037; Gao YZ, 2005, SCI TOTAL ENVIRON, V336, P171, DOI 10.1016/j.scitotenv.2004.05.027; Germaine KJ, 2006, FEMS MICROBIOL ECOL, V57, P302, DOI 10.1111/j.1574-6941.2006.00121.x; Germaine KJ, 2009, FEMS MICROBIOL LETT, V296, P226, DOI 10.1111/j.1574-6968.2009.01637.x; Ghosal D, 2013, RES MICROBIOL, V164, P155, DOI 10.1016/j.resmic.2012.11.003; Harish S, 2008, APPL SOIL ECOL, V39, P187, DOI 10.1016/j.apsoil.2007.12.006; Jacob J, 1996, PURE APPL CHEM, V68, P301, DOI 10.1351/pac199668020301; Jacques RJS, 2005, INT BIODETER BIODEGR, V56, P143, DOI 10.1016/j.ibiod.2005.06.005; Jha P.N., 2013, GREENER J AGR SCI, V3, P73, DOI DOI 10.15580/GJAS.2013.2.010313354; Jiao XC, 2007, ENVIRON POLLUT, V148, P230, DOI 10.1016/j.envpol.2006.10.025; Kang H, 2003, CAN J MICROBIOL, V49, P139, DOI 10.1139/W03-009; Kipopoulou AM, 1999, ENVIRON POLLUT, V106, P369, DOI 10.1016/S0269-7491(99)00107-4; Kvesitadze E., 2009, INT J BIOL BIOMED EN, V3, P458, DOI DOI 10.1119/3.3024&rep=rep1&type=pdf; Li JQ, 2010, BIORESOURCE TECHNOL, V101, P7479, DOI 10.1016/j.biortech.2010.04.030; Liu L, 2007, ENVIRON MICROBIOL, V9, P465, DOI 10.1111/j.1462-2920.2006.01163.x; Ma Y, 2011, BIOTECHNOL ADV, V29, P248, DOI 10.1016/j.biotechadv.2010.12.001; Malfanova N, 2011, MICROB BIOTECHNOL, V4, P523, DOI 10.1111/j.1751-7915.2011.00253.x; Mallick S, 2007, MICROBIOL-SGM, V153, P2104, DOI 10.1099/mic.0.2006/004218-0; Mastretta Chiara, 2006, Biotechnol Genet Eng Rev, V23, P175; Moody JD, 2001, APPL ENVIRON MICROB, V67, P1476, DOI 10.1128/AEM.67.4.1476-1483.2001; Moody JD, 2004, APPL ENVIRON MICROB, V70, P340, DOI 10.1128/AEM.70.1.340-345.2004; Newman LA, 2005, TRENDS BIOTECHNOL, V23, P6, DOI 10.1016/j.tibtech.2004.11.010; Peng AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083054; Reinhold-Hurek B, 2011, CURR OPIN PLANT BIOL, V14, P435, DOI 10.1016/j.pbi.2011.04.004; Romero MC, 1998, ENVIRON POLLUT, V101, P355, DOI 10.1016/S0269-7491(98)00056-6; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; Samanta SK, 1999, APPL MICROBIOL BIOT, V53, P98, DOI 10.1007/s002530051621; Sgroy V, 2009, APPL MICROBIOL BIOT, V85, P371, DOI 10.1007/s00253-009-2116-3; Sheng XF, 2008, INT BIODETER BIODEGR, V62, P88, DOI 10.1016/j.ibiod.2007.12.003; Siciliano SD, 2001, APPL ENVIRON MICROB, V67, P2469, DOI 10.1128/AEM.67.6.2469-2475.2001; Sun K, 2014, PLANT SOIL, V374, P251, DOI 10.1007/s11104-013-1875-x; Taghavi S, 2005, APPL ENVIRON MICROB, V71, P8500, DOI 10.1128/AEM.71.12.8500-8505.2005; Tao S, 2004, SCI TOTAL ENVIRON, V320, P11, DOI 10.1016/S0048-9697(03)00453-4; Toledo FL, 2006, SYST APPL MICROBIOL, V29, P244, DOI 10.1016/j.syapm.2005.09.003; Voutsa D, 1998, SCI TOTAL ENVIRON, V218, P203, DOI 10.1016/S0048-9697(98)00206-X; Weyens N, 2009, CURR OPIN BIOTECH, V20, P248, DOI 10.1016/j.copbio.2009.02.012; Weyens N, 2009, ENVIRON SCI TECHNOL, V43, P9413, DOI 10.1021/es901997z; Weyens N, 2009, TRENDS BIOTECHNOL, V27, P591, DOI 10.1016/j.tibtech.2009.07.006; Wu NY, 2008, ENVIRON POLLUT, V151, P569, DOI 10.1016/j.envpol.2007.04.005; Wu YC, 2008, SOIL BIOL BIOCHEM, V40, P789, DOI 10.1016/j.soilbio.2007.10.013; Yamazoe A, 2004, APPL MICROBIOL BIOT, V65, P211, DOI 10.1007/s00253-003-1541-y; Yaws CL, 1999, CHEM PROPERTIES HDB, P340; Zhan XH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-52; Zhang J, 2012, BIORESOURCE TECHNOL, V124, P83, DOI 10.1016/j.biortech.2012.08.044; Zhang W, 2010, ECOTOXICOLOGY, V19, P96, DOI 10.1007/s10646-009-0393-3; Zhu LZ, 2008, J HAZARD MATER, V150, P308, DOI 10.1016/j.jhazmat.2007.04.102	58	26	31	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108249	10.1371/journal.pone.0108249	http://dx.doi.org/10.1371/journal.pone.0108249			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247301	gold, Green Submitted, Green Published			2022-12-25	WOS:000342351800075
J	Khan, SA; Uddin, I; Moeez, S; Ahmad, A				Khan, Shadab Ali; Uddin, Imran; Moeez, Sana; Ahmad, Absar			Fungus-Mediated Preferential Bioleaching of Waste Material Such as Fly - Ash as a Means of Producing Extracellular, Protein Capped, Fluorescent and Water Soluble Silica Nanoparticles	PLOS ONE			English	Article							BIOCONJUGATED NANOPARTICLES; METALS; SAND	In this paper, we for the first time show the ability of the mesophilic fungus Fusarium oxysporum in the bioleaching of waste material such as Fly-ash for the extracellular production of highly crystalline and highly stable, protein capped, fluorescent and water soluble silica nanoparticles at ambient conditions. When the fungus Fusarium oxysporum is exposed to Fly-ash, it is capable of selectively leaching out silica nanoparticles of quasi-spherical morphology within 24 h of reaction. These silica nanoparticles have been completely characterized by UV-vis spectroscopy, Photoluminescence (PL), Transmission electron microscopy (TEM), X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR) and Energy dispersive analysis of Xrays (EDAX).	[Khan, Shadab Ali; Uddin, Imran; Moeez, Sana; Ahmad, Absar] CSIR, Div Biochem Sci, Natl Chem Lab Pashan, Pune, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Ahmad, A (corresponding author), CSIR, Div Biochem Sci, Natl Chem Lab Pashan, Pune, Maharashtra, India.	a.ahmad@ncl.res.in			Council of Scientific and Industrial Research (CSIR), New Delhi; Department of Biotechnology, Government of India (New Delhi); CSIR, New Delhi [NWP0051]	Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India (New Delhi)(Department of Biotechnology (DBT) India); CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	S. A. K. thanks the Council of Scientific and Industrial Research (CSIR), New Delhi for Senior Research Fellowship. A. A. thanks the Department of Biotechnology, Government of India (New Delhi) for the Tata Innovation Fellowship award and financial support through NWP0051 CSIR, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal V, 2005, J MATER CHEM, V15, P2583, DOI 10.1039/b503008k; Bansal V, 2005, ADV MATER, V17, P889, DOI 10.1002/adma.200401176; Bansal V, 2007, LANGMUIR, V23, P4993, DOI 10.1021/la062535x; Bansal V, 2006, J AM CHEM SOC, V128, P14059, DOI 10.1021/ja062113+; Bosshard PP, 1996, ENVIRON SCI TECHNOL, V30, P3066, DOI 10.1021/es960151v; Brombacher C, 1997, APPL MICROBIOL BIOT, V48, P577, DOI 10.1007/s002530051099; Corma A, 1997, CHEM REV, V97, P2373, DOI 10.1021/cr960406n; Cui JR, 2008, J HAZARD MATER, V158, P228, DOI 10.1016/j.jhazmat.2008.02.001; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Frances IH, 2008, HIGH TEMPERATURE AER; Innocenzi P, 2003, J PHYS CHEM B, V107, P4711, DOI 10.1021/jp026609z; Kulkarni S, 2008, J NON-CRYST SOLIDS, V354, P3433, DOI 10.1016/j.jnoncrysol.2008.03.025; Kumar MNVR, 2004, J NANOSCI NANOTECHNO, V4, P876, DOI 10.1166/jnn.2004.120; Miller JD, 2005, MINER ENG, V18, P855, DOI 10.1016/j.mineng.2005.02.011; Mizutani S, 1996, WASTE MANAGE, V16, P537, DOI 10.1016/S0956-053X(96)00095-5; Palomo A, 1999, CEMENT CONCRETE RES, V29, P1323, DOI 10.1016/S0008-8846(98)00243-9; Pavesi L, 2000, NATURE, V408, P440, DOI 10.1038/35044012; Santra S, 2001, J BIOMED OPT, V6, P160, DOI 10.1117/1.1353590; Verstraete W, 2002, J BIOTECHNOL, V94, P93, DOI 10.1016/S0168-1656(01)00421-7; Wang L, 2006, NANO LETT, V6, P84, DOI 10.1021/nl052105b; Zhao XJ, 2004, P NATL ACAD SCI USA, V101, P15027, DOI 10.1073/pnas.0404806101; Zhao XJ, 2003, ANAL CHEM, V75, P3476, DOI 10.1021/ac034330o; Zhao XJ, 2003, J AM CHEM SOC, V125, P11474, DOI 10.1021/ja0358854	23	14	14	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107597	10.1371/journal.pone.0107597	http://dx.doi.org/10.1371/journal.pone.0107597			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244567	Green Published, gold, Green Submitted			2022-12-25	WOS:000343679800041
J	Lang'at, JKS; Kairo, JG; Mencuccini, M; Bouillon, S; Skov, MW; Waldron, S; Huxham, M				Lang'at, Joseph Kipkorir Sigi; Kairo, James G.; Mencuccini, Maurizio; Bouillon, Steven; Skov, Martin W.; Waldron, Susan; Huxham, Mark			Rapid Losses of Surface Elevation following Tree Girdling and Cutting in Tropical Mangroves	PLOS ONE			English	Article							SEA-LEVEL; CARBON; FORESTS; RESPIRATION; DYNAMICS; FLUXES; KENYA; BAY	The importance of mangrove forests in carbon sequestration and coastal protection has been widely acknowledged. Large-scale damage of these forests, caused by hurricanes or clear felling, can enhance vulnerability to erosion, subsidence and rapid carbon losses. However, it is unclear how small-scale logging might impact on mangrove functions and services. We experimentally investigated the impact of small-scale tree removal on surface elevation and carbon dynamics in a mangrove forest at Gazi bay, Kenya. The trees in five plots of a Rhizophora mucronata (Lam.) forest were first girdled and then cut. Another set of five plots at the same site served as controls. Treatment induced significant, rapid subsidence (-32.1 +/- 8.4 mm yr(-1) compared with surface elevation changes of +4.2 +/- 1.4 mm yr(-1) in controls). Subsidence in treated plots was likely due to collapse and decomposition of dying roots and sediment compaction as evidenced from increased sediment bulk density. Sediment effluxes of CO2 and CH4 increased significantly, especially their heterotrophic component, suggesting enhanced organic matter decomposition. Estimates of total excess fluxes from treated compared with control plots were 25.3 +/- 7.4 tCO(2) ha(-1) yr(-1) (using surface carbon efflux) and 35.6 +/- 76.9 tCO(2) ha(-1) yr(-1) (using surface elevation losses and sediment properties). Whilst such losses might not be permanent (provided cut areas recover), observed rapid subsidence and enhanced decomposition of soil sediment organic matter caused by small-scale harvesting offers important lessons for mangrove management. In particular mangrove managers need to carefully consider the trade-offs between extracting mangrove wood and losing other mangrove services, particularly shoreline stabilization, coastal protection and carbon storage.	[Lang'at, Joseph Kipkorir Sigi; Kairo, James G.] Kenya Marine & Fisheries Res Inst, Mombasa, Kenya; [Lang'at, Joseph Kipkorir Sigi; Huxham, Mark] Edinburgh Napier Univ, Sch Life Sport & Social Sci, Edinburgh, Midlothian, Scotland; [Mencuccini, Maurizio] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland; [Bouillon, Steven] Katholieke Univ Leuven, Dept Earth & Environm Sci, Leuven, Belgium; [Skov, Martin W.] Bangor Univ, Sch Ocean Sci, Menai Bridge, Gwynedd, Wales; [Waldron, Susan] Univ Glasgow, Sch Geog & Earth Sci, Glasgow, South Lanarkshi, Scotland; [Mencuccini, Maurizio] Univ Autonoma Barcelona, Ctr Ecol Res & Forestry Applicat, E-08193 Barcelona, Spain	Edinburgh Napier University; University of Edinburgh; KU Leuven; Bangor University; University of Glasgow; Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF)	Huxham, M (corresponding author), Edinburgh Napier Univ, Sch Life Sport & Social Sci, Edinburgh, Midlothian, Scotland.	m.huxham@napier.ac.uk	Huxham, Mark/D-4427-2015; Bouillon, Steven/C-5177-2011; Mencuccini, Maurizio/B-9052-2011; Lang'at, Kipkorir Sigi/R-2840-2018	Huxham, Mark/0000-0001-7877-6675; Bouillon, Steven/0000-0001-7669-2929; Mencuccini, Maurizio/0000-0003-0840-1477; Lang'at, Kipkorir Sigi/0000-0003-2931-6634; Skov, Martin/0000-0002-7204-3865; WALDRON, SUSAN/0000-0002-2683-0761; James, Kairo/0000-0001-8325-2550	UK Natural Environment Research Council [NE/G009589/1]; Earthwatch Institute; AVIVA Ltd, London, UK; NERC [NE/G009589/1] Funding Source: UKRI; Natural Environment Research Council [NE/G009589/1] Funding Source: researchfish	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Earthwatch Institute; AVIVA Ltd, London, UK; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by grants from the UK Natural Environment Research Council (Grant No. NE/G009589/1), Earthwatch Institute and AVIVA Ltd, London, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, with the exception of volunteers from Earthwatch Institute who helped in field work.	Abuodha PAW, 2001, HYDROBIOLOGIA, V458, P255, DOI 10.1023/A:1013130916811; Alongi D.M., 2009, ENERGETICS MANGROVE, DOI [10.1007/978-1-4020-4271-3, DOI 10.1007/978-1-4020-4271-3]; Alongi DM, 2012, CARBON MANAG, V3, P313, DOI [10.4155/cmt.12.20, 10.4155/CMT.12.20]; Alongi DM, 2012, BIOGEOCHEMISTRY, V109, P151, DOI 10.1007/s10533-011-9616-9; Andersen CP, 2005, EUR J FOREST RES, V124, P155, DOI 10.1007/s10342-005-0072-8; Barr JG, 2012, AGR FOREST METEOROL, V153, P54, DOI 10.1016/j.agrformet.2011.07.022; Blodau Christian, 2002, Environmental Reviews, V10, P111, DOI 10.1139/a02-004; Bosire JO, 2003, AQUAT BOT, V76, P267, DOI 10.1016/S0304-3770(03)00054-8; Bouillon S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003052; Breithaupt JL, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2012GB004375; Cahoon DR, 2003, J ECOL, V91, P1093, DOI 10.1046/j.1365-2745.2003.00841.x; Cerone P., 2000, HDB ANALYTIC COMPUTA, P65; Chmura GL, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001917; Couwenberg J, 2010, GLOBAL CHANGE BIOL, V16, P1715, DOI 10.1111/j.1365-2486.2009.02016.x; Dahdouh-Guebas F, 2000, ECON BOT, V54, P513, DOI 10.1007/BF02866549; Dahdouh-Guebas F, 2004, MAR ECOL PROG SER, V272, P77, DOI 10.3354/meps272077; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; FAO, 2007, 153 FAO; Fujimoto K, 1999, ECOL RES, V14, P409, DOI 10.1046/j.1440-1703.1999.00313.x; Gleason SM, 2002, BIOTROPICA, V34, P190, DOI 10.1111/j.1744-7429.2002.tb00530.x; GOLLEY F, 1962, ECOLOGY, V43, P9, DOI 10.2307/1932034; Goreau T., 2007, GREENHOUSE GAS CARBO, P239; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Huxham M, 2010, ESTUAR COAST SHELF S, V88, P135, DOI 10.1016/j.ecss.2010.03.021; Kayler ZE, 2010, OECOLOGIA, V163, P227, DOI 10.1007/s00442-009-1531-6; Kirui KB, 2012, OCEAN COAST MANAGE, DOI [10.1016/j.ocecoaman.2011.1012.1004, DOI 10.1016/J.OCECOAMAN.2011.1012.1004]; Krauss KW, 2010, ECOSYSTEMS, V13, P129, DOI 10.1007/s10021-009-9307-8; Kristensen E, 2007, GREENHOUSE GAS CARBO, P61; Kristensen E, 2008, AQUAT BOT, V89, P201, DOI 10.1016/j.aquabot.2007.12.005; Laffoley D., 2009, MANAGEMENT NATURAL C; Locatelli B., 2010, IUFRO World Series, V25, P21; Lovelock CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021279; Mckee KL, 2007, GLOBAL ECOL BIOGEOGR, V16, P545, DOI 10.1111/j.1466-8238.2007.00317.x; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Middleton BA, 2001, J ECOL, V89, P818, DOI 10.1046/j.0022-0477.2001.00602.x; Miller JB, 2003, TELLUS B, V55, P207, DOI 10.1034/j.1600-0889.2003.00020.x; Nellemann C., 2009, BLUE CARBON; Nicholls RJ, 2010, SCIENCE, V328, P1517, DOI 10.1126/science.1185782; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Taylor ML., 2003, UNEP WCMC BIODIVERSI, V13; Trumper K, 2009, UNEP RAPID RESPONSE; TWILLEY RR, 1992, WATER AIR SOIL POLL, V64, P265, DOI 10.1007/BF00477106; UNEP, 1998, E AFR ATL COAST RES; Valiela I., 2009, GLOBAL LOSS COASTAL, P107; VALIELA I, 2001, BIOSCIENCE, V51, P807, DOI DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; Wass P., 1995, KENYAS INDIGENOUS FO; Whelan K.R.T., 2005, THESIS FLORIDA INT U	49	68	69	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107868	10.1371/journal.pone.0107868	http://dx.doi.org/10.1371/journal.pone.0107868			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244646	Green Published, Green Accepted, gold			2022-12-25	WOS:000343679800053
J	Terwijn, M; Zeijlemaker, W; Kelder, A; Rutten, AP; Snel, AN; Scholten, WJ; Pabst, T; Verhoef, G; Lowenberg, B; Zweegman, S; Ossenkoppele, GJ; Schuurhuis, GJ				Terwijn, Monique; Zeijlemaker, Wendelien; Kelder, Angele; Rutten, Arjo P.; Snel, Alexander N.; Scholten, Willemijn J.; Pabst, Thomas; Verhoef, Gregor; Lowenberg, Bob; Zweegman, Sonja; Ossenkoppele, Gert J.; Schuurhuis, Gerrit J.			Leukemic Stem Cell Frequency: A Strong Biomarker for Clinical Outcome in Acute Myeloid Leukemia	PLOS ONE			English	Article							RESIDUAL DISEASE DETECTION; ALDEHYDE DEHYDROGENASE-ACTIVITY; INITIATING CELLS; PROGENITOR CELLS; SIDE POPULATION; MARKER; DIAGNOSIS; SUBPOPULATION; HETEROGENEITY; CHEMOTHERAPY	Introduction: Treatment failure in acute myeloid leukemia is probably caused by the presence of leukemia initiating cells, also referred to as leukemic stem cells, at diagnosis and their persistence after therapy. Specific identification of leukemia stem cells and their discrimination from normal hematopoietic stem cells would greatly contribute to risk stratification and could predict possible relapses. Results: For identification of leukemic stem cells, we developed flow cytometric methods using leukemic stem cell associated markers and newly-defined (light scatter) aberrancies. The nature of the putative leukemic stem cells and normal hematopoietic stem cells, present in the same patient's bone marrow, was demonstrated in eight patients by the presence or absence of molecular aberrancies and/or leukemic engraftment in NOD-SCID IL-2R gamma-/- mice. At diagnosis (n = 88), the frequency of the thus defined neoplastic part of CD34+CD38- putative stem cell compartment had a strong prognostic impact, while the neoplastic parts of the CD34+CD38+ and CD34- putative stem cell compartments had no prognostic impact at all. After different courses of therapy, higher percentages of neoplastic CD34+CD38- cells in complete remission strongly correlated with shorter patient survival (n = 91). Moreover, combining neoplastic CD34+CD38- frequencies with frequencies of minimal residual disease cells (n = 91), which reflect the total neoplastic burden, revealed four patient groups with different survival. Conclusion and Perspective: Discrimination between putative leukemia stem cells and normal hematopoietic stem cells in this large-scale study allowed to demonstrate the clinical importance of putative CD34+CD38- leukemia stem cells in AML. Moreover, it offers new opportunities for the development of therapies directed against leukemia stem cells, that would spare normal hematopoietic stem cells, and, moreover, enables in vivo and ex vivo screening for potential efficacy and toxicity of new therapies.	[Terwijn, Monique; Zeijlemaker, Wendelien; Kelder, Angele; Rutten, Arjo P.; Snel, Alexander N.; Scholten, Willemijn J.; Zweegman, Sonja; Ossenkoppele, Gert J.; Schuurhuis, Gerrit J.] Vrije Univ Amsterdam, Med Ctr, Dept Hematol, Amsterdam, Netherlands; [Pabst, Thomas] Univ Bern, Univ Hosp Bern, Inselspital, Dept Med Oncol, Bern, Switzerland; [Verhoef, Gregor] Univ Hosp Leuven, Dept Hematol, Leuven, Belgium; [Lowenberg, Bob] Erasmus Univ, Med Ctr, Dept Hematol, Rotterdam, Netherlands	Vrije Universiteit Amsterdam; University of Bern; University Hospital of Bern; KU Leuven; University Hospital Leuven; Erasmus University Rotterdam; Erasmus MC	Schuurhuis, GJ (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Hematol, Amsterdam, Netherlands.	gj.schuurhuis@vumc.nl		Zweegman, Sonja/0000-0002-5011-1820	Netherlands Cancer Foundation KWF [2006-3695]	Netherlands Cancer Foundation KWF	This work was supported by Netherlands Cancer Foundation KWF grant 2006-3695. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachas C, 2012, LEUKEMIA, V26, P1313, DOI 10.1038/leu.2011.383; Bakker ABH, 2004, CANCER RES, V64, P8443, DOI 10.1158/0008-5472.CAN-04-1659; Becker MW, 2011, BLOOD REV, V25, P75, DOI 10.1016/j.blre.2010.11.001; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Buccisano F, 2012, BLOOD, V119, P332, DOI 10.1182/blood-2011-08-363291; Cheung AMS, 2007, LEUKEMIA, V21, P1423, DOI 10.1038/sj.leu.2404721; Cloos J, 2006, LEUKEMIA, V20, P1217, DOI 10.1038/sj.leu.2404246; Costello RT, 2000, CANCER RES, V60, P4403; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Feuring-Buske M, 2001, BLOOD, V97, P3882, DOI 10.1182/blood.V97.12.3882; Freeman SD, 2013, J CLIN ONCOL, V31, P4123, DOI 10.1200/JCO.2013.49.1753; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Hosen N, 2007, P NATL ACAD SCI USA, V104, P11008, DOI 10.1073/pnas.0704271104; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jan M, 2011, P NATL ACAD SCI USA, V108, P5009, DOI 10.1073/pnas.1100551108; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; Jordan CT, 2002, LEUKEMIA, V16, P559, DOI 10.1038/sj.leu.2402446; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Moshaver B, 2008, STEM CELLS, V26, P3059, DOI 10.1634/stemcells.2007-0861; Pearce DJ, 2005, STEM CELLS, V23, P752, DOI 10.1634/stemcells.2004-0292; Ran D, 2012, EXP HEMATOL, V40, P155, DOI 10.1016/j.exphem.2011.10.005; Ran D, 2009, EXP HEMATOL, V37, P1423, DOI 10.1016/j.exphem.2009.10.001; Roshal M, 2013, LEUKEMIA, V27, P728, DOI 10.1038/leu.2012.217; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Taussig DC, 2010, BLOOD, V115, P1976, DOI 10.1182/blood-2009-02-206565; Taussig DC, 2005, BLOOD, V106, P4086, DOI 10.1182/blood-2005-03-1072; Terwijn M, 2013, J CLIN ONCOL, V31, P3889, DOI 10.1200/JCO.2012.45.9628; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; Van Der Pol MA, 2003, HAEMATOLOGICA, V88, P983; van Rhenen A, 2007, LEUKEMIA, V21, P1700, DOI 10.1038/sj.leu.2404754; van Rhenen A, 2005, CLIN CANCER RES, V11, P6520, DOI 10.1158/1078-0432.CCR-05-0468; van Rhenen A, 2007, BLOOD, V110, P2659, DOI 10.1182/blood-2007-03-083048; Vergez F, 2011, HAEMATOL-HEMATOL J, V96, P1792, DOI 10.3324/haematol.2011.047894; Witte KE, 2011, PEDIATR HEMAT ONCOL, V28, P91, DOI 10.3109/08880018.2010.528171; Wulf GG, 2001, BLOOD, V98, P1166, DOI 10.1182/blood.V98.4.1166	38	136	142	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107587	10.1371/journal.pone.0107587	http://dx.doi.org/10.1371/journal.pone.0107587			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244440	Green Published, gold, Green Submitted			2022-12-25	WOS:000343679800040
J	Wang, JC; Xu, RH; Liu, AZ				Wang, Jiancai; Xu, Ronghua; Liu, Aizhong			IRDL Cloning: A One-Tube, Zero-Background, Easy-to-Use, Directional Cloning Method Improves Throughput in Recombinant DNA Preparation	PLOS ONE			English	Article							LIGATION-INDEPENDENT CLONING; PLANT FUNCTIONAL GENOMICS; TOXIN-ANTITOXIN SYSTEMS; ONE-STEP; PCR PRODUCTS; POSITIVE-SELECTION; ESCHERICHIA-COLI; VECTOR; TRANSFORMATION; GENE	Rapid and efficient construction of expression vectors and subsequent transformation are basic recombinant methods for the investigation of gene functionality. Although novel cloning methods have recently been developed, many laboratories worldwide continue to use traditional restriction digestion-ligation methods to construct expression vectors owing to financial constraints and the unavailability of appropriate vectors. We describe an improved restriction digestion-ligation (IRDL) cloning method that combines the advantage of directional cloning from double digestion-ligation with that of a low background observed by using a positive selection marker gene ccdB to facilitate digestion and ligation in a single tube. The IRDL cloning overcomes the time-consuming and laborious limits of traditional methods, thereby providing an easy-to-use, low-cost, and one-step strategy for directional cloning of target DNA fragments into an expression vector. As a proof-of-concept example, we developed two yeast vectors to demonstrate the feasibility and the flexibility of the IRDL cloning method. This method would provide an effective and easy-to-use system for gene cloning and functional genomics studies.	[Wang, Jiancai] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Wang, Jiancai; Xu, Ronghua; Liu, Aizhong] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Plant Resources & Sustainable Use, Kunming, Peoples R China; [Liu, Aizhong] Chinese Acad Sci, Kunming Inst Bot, Kunming, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Xu, RH (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Plant Resources & Sustainable Use, Kunming, Peoples R China.	ronghua.xu08@gmail.com; aizhongliu@xtbg.ac.cn			National NSFC [31300569]; "Hundreds of Talents" program of the Chinese Academy of Sciences	National NSFC(National Natural Science Foundation of China (NSFC)); "Hundreds of Talents" program of the Chinese Academy of Sciences	This work was supported by the National NSFC (Grant no. 31300569 to RX) and by the "Hundreds of Talents" program of the Chinese Academy of Sciences (AL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Blommel Paul G., 2009, V498, P55, DOI 10.1007/978-1-59745-196-3_4; Chandrasekaran U, 2013, INT J AGRIC BIOL, V15, P435; Chattoraj P, 2008, BMB REP, V41, P363, DOI 10.5483/BMBRep.2008.41.5.363; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Fozo EM, 2012, RNA BIOL, V9, P1504, DOI 10.4161/rna.22568; Gerdes K, 2000, J BACTERIOL, V182, P561, DOI 10.1128/JB.182.3.561-572.2000; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Guo B, 2002, PCR CLONING PROTOCOL, P115; Hartley JL, 2006, CURR OPIN BIOTECH, V17, P359, DOI 10.1016/j.copbio.2006.06.011; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; Kamphuis MB, 2007, PROTEIN PEPTIDE LETT, V14, P113, DOI 10.2174/092986607779816096; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Li MZ, 2005, NAT GENET, V37, P311, DOI 10.1038/ng1505; Mok WWK, 2013, CHEMBIOCHEM, V14, P733, DOI 10.1002/cbic.201300033; Mondon P, 2000, FEMS MICROBIOL LETT, V187, P41, DOI 10.1111/j.1574-6968.2000.tb09134.x; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Oh SK, 2010, MOL CELLS, V30, P557, DOI 10.1007/s10059-010-0156-2; Sambrook J, 2001, MOL CLONING LAB MANU; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Siloto RMP, 2009, LIPIDS, V44, P963, DOI 10.1007/s11745-009-3336-0; Thieme F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020556; Tillett D, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e26; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Walker A, 2008, PLASMID, V59, P155, DOI 10.1016/j.plasmid.2008.02.002; Wang CT, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059576, 10.1371/journal.pone.]; Xu GY, 2010, NEW PHYTOL, V187, P240, DOI 10.1111/j.1469-8137.2010.03253.x; Xu RH, 2014, FUNCT PLANT BIOL, V41, P321, DOI 10.1071/FP12388; [徐荣华 Xu Ronghua], 2013, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V35, P123; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Yashiroda Y, 2008, CURR OPIN CHEM BIOL, V12, P55, DOI 10.1016/j.cbpa.2008.01.024; Young-Jun C, 2002, CRIT REV BIOTECHNOL, V22, P225, DOI 10.1080/07388550290789504; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288; ZHOU MY, 1995, BIOTECHNIQUES, V19, P34	39	4	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107907	10.1371/journal.pone.0107907	http://dx.doi.org/10.1371/journal.pone.0107907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243603	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800056
J	Zimmermann, C; Romero, Y; Warnefors, M; Bilican, A; Borel, C; Smith, LB; Kotaja, N; Kaessmann, H; Nef, S				Zimmermann, Celine; Romero, Yannick; Warnefors, Maria; Bilican, Adem; Borel, Christelle; Smith, Lee B.; Kotaja, Noora; Kaessmann, Henrik; Nef, Serge			Germ Cell-Specific Targeting of DICER or DGCR8 Reveals a Novel Role for Endo-siRNAs in the Progression of Mammalian Spermatogenesis and Male Fertility	PLOS ONE			English	Article							GENE-EXPRESSION; SMALL RNAS; MICRORNA BIOGENESIS; MIRNA BIOGENESIS; MOUSE; DROSHA; PROTEIN; TRANSCRIPTS; EVOLUTION; PATHWAYS	Small non-coding RNAs act as critical regulators of gene expression and are essential for male germ cell development and spermatogenesis. Previously, we showed that germ cell-specific inactivation of Dicer1, an endonuclease essential for the biogenesis of micro-RNAs (miRNAs) and endogenous small interfering RNAs (endo-siRNAs), led to complete male infertility due to alterations in meiotic progression, increased spermatocyte apoptosis and defects in the maturation of spermatozoa. To dissect the distinct physiological roles of miRNAs and endo-siRNAs in spermatogenesis, we compared the testicular phenotype of mice with Dicer1 or Dgcr8 depletion in male germ cells. Dgcr8 mutant mice, which have a defective miRNA pathway while retaining an intact endo-siRNA pathway, were also infertile and displayed similar defects, although less severe, to Dicer1 mutant mice. These included cumulative defects in meiotic and haploid phases of spermatogenesis, resulting in oligo-, terato-, and azoospermia. In addition, we found by RNA sequencing of purified spermatocytes that inactivation of Dicer1 and the resulting absence of miRNAs affected the fine tuning of protein-coding gene expression by increasing low level gene expression. Overall, these results emphasize the essential role of miRNAs in the progression of spermatogenesis, but also indicate a role for endo-siRNAs in this process.	[Zimmermann, Celine; Romero, Yannick; Borel, Christelle; Nef, Serge] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Warnefors, Maria; Bilican, Adem; Kaessmann, Henrik] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Warnefors, Maria; Bilican, Adem; Kaessmann, Henrik] Swiss Inst Bioinformat, Lausanne, Switzerland; [Smith, Lee B.] Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Kotaja, Noora] Univ Turku, Inst Biomed, Dept Physiol, Turku, Finland	University of Geneva; University of Lausanne; Swiss Institute of Bioinformatics; University of Edinburgh; University of Turku	Nef, S (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	Serge.Nef@unige.ch	Kaessmann, Henrik/B-4989-2013; borel, christelle/AAC-9645-2019; Nef, Serge/AAV-6445-2020	Kaessmann, Henrik/0000-0001-7563-839X; Nef, Serge/0000-0001-5462-0676; Smith, Lee/0000-0002-4103-3074; Kotaja, Noora/0000-0003-1503-9170	Swiss National Science Foundation [3100A0-119862, 31003A-135227]; Departement de l'Instruction Publique of the State of Geneva; EMBO; Academy of Finland; Novo Nordisk Foundation; Sigrid Juselius Foundation; MRC [G1100354, G1002033] Funding Source: UKRI; Medical Research Council [G1002033, G1100354] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Departement de l'Instruction Publique of the State of Geneva; EMBO(European Molecular Biology Organization (EMBO)); Academy of Finland(Academy of Finland); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Sigrid Juselius Foundation(Sigrid Juselius Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was supported by grant no. 3100A0-119862 and 31003A-135227 to SN from the Swiss National Science Foundation and by the Departement de l'Instruction Publique of the State of Geneva. MW was supported by an EMBO long-term fellowship. NK is supported by the Academy of Finland, the Novo Nordisk Foundation and the Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, the decision to publish, or preparation of the manuscript.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barchi M, 2009, METHODS MOL BIOL, V558, P299, DOI 10.1007/978-1-60761-103-5_18; Bouhallier F, 2010, RNA, V16, P720, DOI 10.1261/rna.1963810; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Buchold GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015317; Dunoyer P, 2009, M S-MED SCI, V25, P505, DOI 10.1051/medsci/2009255505; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Fagegaltier D, 2009, P NATL ACAD SCI USA, V106, P21258, DOI 10.1073/pnas.0809208105; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Greenlee AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046359; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Gromak N, 2013, CELL REP, V5, P1499, DOI 10.1016/j.celrep.2013.11.032; Guerif F, 2002, INT J ANDROL, V25, P358, DOI 10.1046/j.1365-2605.2002.00382.x; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; He ZP, 2009, REPRODUCTION, V137, P901, DOI 10.1530/REP-08-0494; Hikim APS, 2003, J STEROID BIOCHEM, V85, P175, DOI 10.1016/S0960-0760(03)00193-6; Kadener S, 2009, RNA, V15, P537, DOI 10.1261/rna.1319309; Karginov FV, 2010, MOL CELL, V38, P781, DOI 10.1016/j.molcel.2010.06.001; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Korhonen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024821; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lejeune E, 2011, CURR OPIN CELL BIOL, V23, P258, DOI 10.1016/j.ceb.2011.03.005; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maatouk DM, 2008, BIOL REPROD, V79, P696, DOI 10.1095/biolreprod.108.067827; Meunier J, 2013, GENOME RES, V23, P34, DOI 10.1101/gr.140269.112; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Murchison EP, 2004, CURR OPIN CELL BIOL, V16, P223, DOI 10.1016/j.ceb.2004.04.003; Papaioannou MD, 2009, DEV BIOL, V326, P250, DOI 10.1016/j.ydbio.2008.11.011; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Romero Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025241; Sadate-Ngatchou PI, 2008, GENESIS, V46, P738, DOI 10.1002/dvg.20437; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Song R, 2011, P NATL ACAD SCI USA, V108, P13159, DOI 10.1073/pnas.1108567108; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Triboulet R, 2009, RNA, V15, P1005, DOI 10.1261/rna.1591709; Verdel A, 2009, INT J DEV BIOL, V53, P245, DOI 10.1387/ijdb.082691av; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Wu JW, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-64; Wu QX, 2012, J BIOL CHEM, V287, P25173, DOI 10.1074/jbc.M112.362053; Yadav RP, 2013, MOL CELL ENDOCRINOL; Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024; Yang QL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066809	57	54	62	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107023	10.1371/journal.pone.0107023	http://dx.doi.org/10.1371/journal.pone.0107023			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244517	gold, Green Published, Green Submitted			2022-12-25	WOS:000343679800016
J	Munoz-Moreno, JA; Peerez-Alvarez, N; Munnoz-Morillo, A; Prats, A; Garolera, M; Jurado, MA; Fumaz, CR; Negredo, E; Ferrer, MJ; Clotet, B				Munoz-Moreno, Jose A.; Perez-Alvarez, Nuria; Munoz-Morillo, Amalia; Prats, Anna; Garolera, Maite; Angels Jurado, M.; Fumaz, Carmina R.; Negredo, Eugenia; Ferrer, Maria J.; Clotet, Bonaventura			Classification Models for Neurocognitive Impairment in HIV Infection Based on Demographic and Clinical Variables	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ANTIRETROVIRAL THERAPY; CEREBROSPINAL-FLUID; COGNITIVE RESERVE; CD4 NADIR; DISORDERS; EDUCATION; AGE; INDIVIDUALS; PREDICTOR	Objective: We used demographic and clinical data to design practical classification models for prediction of neurocognitive impairment (NCI) in people with HIV infection. Methods: The study population comprised 331 HIV-infected patients with available demographic, clinical, and neurocognitive data collected using a comprehensive battery of neuropsychological tests. Classification and regression trees (CART) were developed to obtain detailed and reliable models to predict NCI. Following a practical clinical approach, NCI was considered the main variable for study outcomes, and analyses were performed separately in treatment-naive and treatment-experienced patients. Results: The study sample comprised 52 treatment-naive and 279 experienced patients. In the first group, the variables identified as better predictors of NCI were CD4 cell count and age (correct classification [CC]: 79.6%, 3 final nodes). In treatment-experienced patients, the variables most closely related to NCI were years of education, nadir CD4 cell count, central nervous system penetration-effectiveness score, age, employment status, and confounding comorbidities (CC: 82.1%, 7 final nodes). In patients with an undetectable viral load and no comorbidities, we obtained a fairly accurate model in which the main variables were nadir CD4 cell count, current CD4 cell count, time on current treatment, and past highest viral load (CC: 88%, 6 final nodes). Conclusion: Practical classification models to predict NCI in HIV infection can be obtained using demographic and clinical variables. An approach based on CART analyses may facilitate screening for HIV-associated neurocognitive disorders and complement clinical information about risk and protective factors for NCI in HIV-infected patients.	[Munoz-Moreno, Jose A.; Perez-Alvarez, Nuria; Prats, Anna; Fumaz, Carmina R.; Negredo, Eugenia; Ferrer, Maria J.; Clotet, Bonaventura] Hosp Badalona Germans Trias & Pujol, Fundacio Lluita SIDA, Badalona, Catalonia, Spain; [Munoz-Moreno, Jose A.; Prats, Anna; Fumaz, Carmina R.; Negredo, Eugenia; Ferrer, Maria J.; Clotet, Bonaventura] Univ Autonoma Barcelona, Cerdanyola Del Valles, Catalonia, Spain; [Perez-Alvarez, Nuria] Univ Politecn Cataluna, Barcelona, Catalonia, Spain; [Munoz-Morillo, Amalia; Angels Jurado, M.] Univ Barcelona, Barcelona, Catalonia, Spain; [Garolera, Maite] Consorci Sanitari Hosp Terrassa, Terrassa, Catalonia, Spain; [Garolera, Maite; Angels Jurado, M.] Univ Barcelona, Grp Recerca Consolidat Neuropsicol, Barcelona, Catalonia, Spain; [Clotet, Bonaventura] IrsiCaixa, Inst Recerca SIDA, Barcelona, Catalonia, Spain; [Clotet, Bonaventura] Univ Vic, Vic, Catalonia, Spain	Hospital Germans Trias i Pujol; Autonomous University of Barcelona; Universitat Politecnica de Catalunya; University of Barcelona; University of Barcelona; Institut de Recerca de la Sida - IrsiCaixa; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC)	Munoz-Moreno, JA (corresponding author), Hosp Badalona Germans Trias & Pujol, Fundacio Lluita SIDA, Badalona, Catalonia, Spain.	jmunoz@flsida.org	Garolera, Maite/A-3109-2015; Garolera, Maite/D-7811-2012; Muñoz-Moreno, Jose A./P-1242-2014; Perez-Alvarez, Nuria/O-9244-2014; JURADO, MARIA ANGELES/E-1745-2011	Garolera, Maite/0000-0001-7443-8249; Garolera, Maite/0000-0001-7443-8249; Muñoz-Moreno, Jose A./0000-0002-7239-5422; Perez-Alvarez, Nuria/0000-0001-6582-1553; JURADO, MARIA ANGELES/0000-0002-9403-1670; Prats, Anna/0000-0002-3586-4525; Negredo, Eugenia/0000-0001-5298-1734	Fundacio Lluita contra la SIDA	Fundacio Lluita contra la SIDA	This study was supported by the Fundacio Lluita contra la SIDA (www.flsida.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Antinori A, 2013, CLIN INFECT DIS, V56, P1004, DOI 10.1093/cid/cis975; Beck A, 1979, COGNITIVE THERAPY DE; Beck AT, 1996, PSYCHOL ASSESS; Benton AL, 1994, MULTILINGUAL APHASIA; BREIMAN L., 1984, CRC PRESS; Canestri A, 2010, CLIN INFECT DIS, V50, P773, DOI 10.1086/650538; Cysique LA, 2010, HIV MED, V11, P642, DOI 10.1111/j.1468-1293.2010.00834.x; Cysique LA, 2011, J NEUROPSYCH CLIN N, V23, P83, DOI 10.1176/appi.neuropsych.23.1.83; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Ellis RJ, 1997, ANN NEUROL, V42, P679, DOI 10.1002/ana.410420503; Ellis RJ, 2011, AIDS, V25, P1747, DOI 10.1097/QAD.0b013e32834a40cd; European AIDS Clinical Society (EACS), 2013, EACS GUID VERS 7 0 A; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Golden C.J., 1978, STROOP COLOR WORD TE; Gorman AA, 2009, NEUROPSYCHOL REV, V19, P186, DOI 10.1007/s11065-009-9095-0; Heaton R. K., 1993, MANUAL REVISED EXPAN; Joint United Nations Programme on HIV/AIDS (UNAIDS), 1998, COGN NEUR IMP EARL H; Kim YJ, 2011, J CLIN NURS, V20, P1518, DOI 10.1111/j.1365-2702.2010.03618.x; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Letendre Scott L, 2010, Top HIV Med, V18, P45; Lovejoy TI, 2009, J BEHAV MED, V32, P389, DOI 10.1007/s10865-009-9212-9; Malaspina L, 2011, J NEUROVIROL, V17, P110, DOI 10.1007/s13365-010-0008-z; Matthews C, 1964, INSTRUCTION MANUAL A; McArthur JC, 1997, ANN NEUROL, V42, P689, DOI 10.1002/ana.410420504; Morgan EE, 2012, AIDS BEHAV, V16, P2279, DOI 10.1007/s10461-012-0229-7; Munoz-Moreno JA, 2008, AIDS RES HUM RETROV, V24, P1301, DOI 10.1089/aid.2007.0310; Munoz-Moreno JA, 2010, J NEUROVIROL, V16, P208, DOI 10.3109/13550281003767710; Paradise M, 2009, INT PSYCHOGERIATR, V21, P25, DOI 10.1017/S1041610208008053; Poletti M, 2011, PARKINSONISM RELAT D, V17, P579, DOI 10.1016/j.parkreldis.2011.03.013; REITAN RM, 1985, TRAIL MAKING TEST HA; REITAN RM, 1985, GROOVED PEGBOARD HAL; Schouten J, 2011, AIDS, V25, P561, DOI 10.1097/QAD.0b013e3283437f9a; Sevigny JJ, 2007, ARCH NEUROL-CHICAGO, V64, P97, DOI 10.1001/archneur.64.1.97; Sharp ES, 2011, ALZ DIS ASSOC DIS, V25, P289, DOI 10.1097/WAD.0b013e318211c83c; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Smith A., 1973, SYMBOL DIGIT MODALIT, DOI 10.1037/t27513-000; Smurzynski M, 2011, AIDS, V25, P357, DOI 10.1097/QAD.0b013e32834171f8; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Tozzi V, 2004, INT J STD AIDS, V15, P254, DOI 10.1258/095646204773557794; Tozzi V, 2009, JAIDS-J ACQ IMM DEF, V52, P56, DOI 10.1097/QAI.0b013e3181af83d6; Valcour V, 2006, J NEUROVIROL, V12, P387, DOI 10.1080/13550280600915339; Valcour V, 2011, J INT NEUROPSYCH SOC, V17, P190, DOI 10.1017/S1355617710001438; Valcour Victor G, 2011, Top Antivir Med, V19, P175; Vassallo M, 2014, AIDS, V28, P493, DOI 10.1097/QAD.0000000000000096; Wechsler D., 1997, WECHSLER ADULT INTEL; Woods SP, 2011, REHABIL PSYCHOL, V56, P77, DOI 10.1037/a0022753	47	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107625	10.1371/journal.pone.0107625	http://dx.doi.org/10.1371/journal.pone.0107625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25237895	Green Published, gold			2022-12-25	WOS:000342491600036
J	Verhagen, J; Gabrysova, L; Shepard, ER; Wraith, DC				Verhagen, Johan; Gabrysova, Leona; Shepard, Ella R.; Wraith, David C.			CTLA-4 Modulates the Differentiation of Inducible Foxp3(+) Treg Cells but IL-10 Mediates Their Function in Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							REGULATORY T-CELLS; MICE; SELF; REPERTOIRE; ACTIVATION; EXPRESSION; INDUCTION; SELECTION; COLITIS	In vitro induced Foxp3(+) T regulatory (iTreg) cells form a novel and promising target for therapeutic tolerance induction. However, the potential of these cells as a target for the treatment of various immune diseases, as well as the factors involved in their development and function, remain debated. Here, we demonstrate in a myelin basic protein (MBP)-specific murine model of CNS autoimmune disease that adoptive transfer of antigen-specific iTreg cells ameliorates disease progression. Moreover, we show that the co-stimulatory molecule CTLA-4 mediates in vitro differentiation of iTreg cells. Finally, we demonstrate that the secreted, immunosuppressive cytokine IL-10 controls the ability of antigen-specific iTreg cells to suppress autoimmune disease. Overall, we conclude that antigen-specific iTreg cells, which depend on various immune regulatory molecules for their differentiation and function, represent a major target for effective immunotherapy of autoimmune disease.	[Verhagen, Johan; Gabrysova, Leona; Shepard, Ella R.; Wraith, David C.] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England	University of Bristol	Verhagen, J (corresponding author), Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England.	Johan.Verhagen@bristol.ac.uk		Wraith, David/0000-0003-2147-5614; Verhagen, Johan/0000-0001-8414-1342; Gabrysova, Leona/0000-0003-3529-1306	Wellcome Trust [091074/z/09/z]	Wellcome Trust(Wellcome TrustEuropean Commission)	The authors are supported by Wellcome Trust Programme grant number 091074/z/09/z (www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2013, NAT IMMUNOL, V14, P307, DOI 10.1038/ni.2554; Anderson AC, 2000, J EXP MED, V191, P761, DOI 10.1084/jem.191.5.761; Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Chattopadhyay G, 2013, J IMMUNOL, V191, P5875, DOI 10.4049/jimmunol.1301693; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Gabrysova L, 2009, J EXP MED, V206, P1755, DOI 10.1084/jem.20082118; Iglesias A, 2001, GLIA, V36, P220, DOI 10.1002/glia.1111; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Ng THS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00129; Schmitt EG, 2012, J IMMUNOL, V189, P5638, DOI 10.4049/jimmunol.1200936; Selvaraj RK, 2008, J IMMUNOL, V180, P2830, DOI 10.4049/jimmunol.180.5.2830; Verhagen J, 2014, J IMMUNOL METHODS, V414, P58, DOI 10.1016/j.jim.2014.07.012; Verhagen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061334; Verhagen J, 2013, P NATL ACAD SCI USA, V110, pE221, DOI 10.1073/pnas.1208573110; Verhagen J, 2009, P NATL ACAD SCI USA, V106, P3306, DOI 10.1073/pnas.0803186106; Wing K, 2011, TRENDS IMMUNOL, V32, P428, DOI 10.1016/j.it.2011.06.002; Zhang H, 2010, J IMMUNOL, V184, P6629, DOI 10.4049/jimmunol.0904044; Zheng SG, 2006, J IMMUNOL, V176, P3321, DOI 10.4049/jimmunol.176.6.3321	18	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e108023	10.1371/journal.pone.0108023	http://dx.doi.org/10.1371/journal.pone.0108023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238105	Green Published, gold, Green Submitted			2022-12-25	WOS:000342491600077
J	Loskutov, YV; Kozyulina, PY; Kozyreva, VK; Ice, RJ; Jones, BC; Roston, TJ; Smolkin, MB; Ivanov, AV; Wysolmerski, RB; Pugacheva, EN				Loskutov, Y. V.; Kozyulina, P. Y.; Kozyreva, V. K.; Ice, R. J.; Jones, B. C.; Roston, T. J.; Smolkin, M. B.; Ivanov, A. V.; Wysolmerski, R. B.; Pugacheva, E. N.			NEDD9/Arf6-dependent endocytic trafficking of matrix metalloproteinase 14: a novel mechanism for blocking mesenchymal cell invasion and metastasis of breast cancer	ONCOGENE			English	Article							NUCLEOTIDE EXCHANGE FACTORS; GROWTH-FACTOR; MEMBRANE TRAFFICKING; ARF6 GTPASE; WILD-TYPE; MT1-MMP; ACTIVATION; PROTEIN; NEDD9; MIGRATION	NEDD9 is an established marker of invasive and metastatic cancers. NEDD9 downregulation has been shown to dramatically reduce cell invasion and metastasis in multiple tumors. The mechanisms by which NEDD9 regulates invasion are largely unknown. In the current study, we have found that NEDD9 is required for matrix metalloproteinase 14 (MMP14) enzymatic recovery/recycling through the late endosomes to enable disengagement of tissue inhibitor of matrix metalloproteinase 2 (TIMP2) and tumor invasion. Depletion of NEDD9 decreases targeting of the MMP14/TIMP2 complex to late endosomes and increases trafficking of MMP14 from early/sorting endosomes back to the surface in a small GTPase ADP ribosylation factor-6 (Arf6)-dependent manner. NEDD9 directly binds to Arf6-GTPase-activating protein, ARAP3 and Arf6-effector GGA3, thereby facilitating the Arf6 inactivation required for MMP14/TIMP2 targeting to late endosomes. Re-expression of NEDD9 or a decrease in Arf6 activity is sufficient to restore MMP14 activity and the invasive properties of tumor cells. Importantly, NEDD9 inhibition by Vivo-Morpholinos, an antisense therapy, decreases primary tumor growth and metastasis in xenograft models of breast cancer. Collectively, our findings uncover a novel mechanism to control tumor-cell dissemination through NEDD9/Arf6-dependent regulation of MMP14/TIMP2 trafficking, and validate NEDD9 as a clinically relevant therapeutic target to treat metastatic cancer.	[Loskutov, Y. V.; Kozyreva, V. K.; Ice, R. J.; Ivanov, A. V.; Wysolmerski, R. B.; Pugacheva, E. N.] W Virginia Univ, Sch Med, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA; [Kozyulina, P. Y.; Jones, B. C.; Roston, T. J.; Ivanov, A. V.; Pugacheva, E. N.] W Virginia Univ, Sch Med, Dept Biochem, Morgantown, WV 26506 USA; [Smolkin, M. B.] W Virginia Univ, Sch Med, Dept Pathol, Morgantown, WV 26506 USA; [Wysolmerski, R. B.] W Virginia Univ, Sch Med, Dept Neurobiol & Anat, Morgantown, WV 26506 USA	West Virginia University; West Virginia University; West Virginia University; West Virginia University	Pugacheva, EN (corresponding author), Robert C Byrd Hlth Sci Ctr, MBRCC Rm 2823,1 Med Ctr Dr, Morgantown, WV 26506 USA.	epugacheva@hsc.wvu.edu	Kozyulina, Polina/AAO-2762-2020; Jones, Brandon/AAB-6130-2019	Kozyulina, Polina/0000-0001-8520-3445; Jones, Brandon/0000-0002-3743-2590; Ivanov, Alexey/0000-0002-8617-4604; Loskutov, Juergen/0000-0003-3472-4093; Kozyreva, Varvara/0000-0003-3447-0070	Mary Babb Randolph Cancer Center; NIH [P20 RR016440, P30 RR032138/GM103488, P20 RR016477, P30 GM103488, P30 RR032138, RCP1101809]; NIH-NCI [CA148671]; Susan G Komen For the Cure Foundation [KG100539]; NIH/NCRR [5 P20 RR016440-09]; NATIONAL CANCER INSTITUTE [R21CA208875, R01CA148671] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR032138, P20RR016440, P20RR016477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103488] Funding Source: NIH RePORTER	Mary Babb Randolph Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G Komen For the Cure Foundation(Susan G. Komen Breast Cancer Foundation); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Mrs Yoho and Drs Schaller and Weed for critically reading the manuscript and providing administrative support during manuscript preparation. We also thank the West Virginia University Microscope Imaging Facility, supported by the Mary Babb Randolph Cancer Center and NIH grants P20 RR016440, P30 RR032138/GM103488 and P20 RR016477. The WVU Flow Cytometry Core Facility was supported by NIH grants P30 GM103488, P30 RR032138 and RCP1101809. We also thank Mr Farrugia for his assistance in the analysis of the microarray data. This work was supported by grants from the NIH-NCI (CA148671 to ENP), the Susan G Komen For the Cure Foundation (KG100539 to ENP) and in part by NIH/NCRR (5 P20 RR016440-09).	Ahn J, 2012, J CELL SCI, V125, P1814, DOI 10.1242/jcs.101444; Aikawa Y, 2003, J CELL BIOL, V162, P647, DOI 10.1083/jcb.200212142; Anders N, 2008, CELL MOL LIFE SCI, V65, P3433, DOI 10.1007/s00018-008-8227-7; Anilkumar N, 2005, FASEB J, V19, P1326, DOI 10.1096/fj.04-3651fje; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Bravo-Cordero JJ, 2007, EMBO J, V26, P1499, DOI 10.1038/sj.emboj.7601606; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Cai DP, 2003, J IMMUNOL, V170, P969, DOI 10.4049/jimmunol.170.2.969; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Fang ZY, 2006, MOL CELL PROTEOMICS, V5, P1437, DOI 10.1074/mcp.M600050-MCP200; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Giampieri S, 2010, CANCER RES, V70, P3435, DOI 10.1158/0008-5472.CAN-10-0466; Gu JJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002632; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hakulinen J, 2008, J CELL BIOCHEM, V105, P1211, DOI 10.1002/jcb.21923; Hattula K, 2006, J CELL SCI, V119, P4866, DOI 10.1242/jcs.03275; Hemmann S, 2007, J HEPATOL, V46, P955, DOI 10.1016/j.jhep.2007.02.003; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Ice RJ, 2013, CANCER RES, V73, P3168, DOI 10.1158/0008-5472.CAN-12-4008; Jin YJ, 2014, INT J CANCER, V134, P2294, DOI 10.1002/ijc.28568; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Kondo S, 2012, CLIN CANCER RES, V18, P6326, DOI 10.1158/1078-0432.CCR-11-2162; Little JL, 2014, ONCOGENE, V33, P411, DOI 10.1038/onc.2012.607; Lucas JT, 2010, ONCOGENE, V29, P4449, DOI 10.1038/onc.2010.185; Maquoi E, 2000, J BIOL CHEM, V275, P11368, DOI 10.1074/jbc.275.15.11368; McLaughlin SL, 2014, MOL CANCER RES, V12, P69, DOI 10.1158/1541-7786.MCR-13-0300; NETZELARNETT S, 1991, ANAL BIOCHEM, V195, P86, DOI 10.1016/0003-2697(91)90299-9; O'Neill GM, 2007, CANCER RES, V67, P8975, DOI 10.1158/0008-5472.CAN-07-1328; Oblander SA, 2005, DEV BIOL, V277, P255, DOI 10.1016/j.ydbio.2004.09.033; Pahwa S, 2014, CANCERS, V6, P416, DOI 10.3390/cancers6010416; Paleotti O, 2005, J BIOL CHEM, V280, P21661, DOI 10.1074/jbc.m503099200; Parachoniak CA, 2011, DEV CELL, V20, P751, DOI 10.1016/j.devcel.2011.05.007; PETERS PJ, 1995, J CELL BIOL, V128, P1003, DOI 10.1083/jcb.128.6.1003; Polette M, 2004, CRIT REV ONCOL HEMAT, V49, P179, DOI 10.1016/j.critrevonc.2003.10.008; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Radhakrishna H, 1996, J CELL BIOL, V134, P935, DOI 10.1083/jcb.134.4.935; Radhakrishna H, 1999, J CELL SCI, V112, P855; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Radisky ES, 2010, J MAMMARY GLAND BIOL, V15, P201, DOI 10.1007/s10911-010-9177-x; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Remacle AG, 2006, ONCOGENE, V25, P5648, DOI 10.1038/sj.onc.1209572; Sabe H, 2009, TRAFFIC, V10, P982, DOI 10.1111/j.1600-0854.2009.00917.x; Sakagami H, 2008, TOHOKU J EXP MED, V214, P191, DOI 10.1620/tjem.214.191; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; SCHMID S, 1989, J CELL BIOL, V108, P1291, DOI 10.1083/jcb.108.4.1291; Schweitzer JK, 2011, SEMIN CELL DEV BIOL, V22, P39, DOI 10.1016/j.semcdb.2010.09.002; Shteyn E, 2011, J CELL BIOL, V194, P873, DOI 10.1083/jcb.201106010; Spang A, 2010, FEBS LETT, V584, P2646, DOI 10.1016/j.febslet.2010.04.005; Speranza MC, 2012, ONCOTARGET, V3, P724; Strongin AY, 2010, BBA-MOL CELL RES, V1803, P133, DOI 10.1016/j.bbamcr.2009.04.009; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Wang X, 2004, J BIOL CHEM, V279, P9331, DOI 10.1074/jbc.M312369200; Williams KC, 2011, J BIOL CHEM, V286, P43405, DOI 10.1074/jbc.M111.297069; Worthylake R, 1999, J BIOL CHEM, V274, P8865, DOI 10.1074/jbc.274.13.8865; Yu XZ, 2012, J CELL BIOL, V199, P527, DOI 10.1083/jcb.201203025; Zhong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035058; Zucker S, 2004, EXP CELL RES, V293, P164, DOI 10.1016/j.yexcr.2003.10.007	61	23	25	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2015	34	28					3662	3675		10.1038/onc.2014.297	http://dx.doi.org/10.1038/onc.2014.297			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM4TZ	25241893	Green Accepted			2022-12-25	WOS:000357679100005
J	Xie, SW; Naslavsky, N; Caplan, S				Xie, Shuwei; Naslavsky, Naava; Caplan, Steve			Diacylglycerol Kinase alpha Regulates Tubular Recycling Endosome Biogenesis and Major Histocompatibility Complex Class I Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endocytosis; Intracellular Trafficking; Membrane Trafficking; Phosphatidic Acid; Receptor Recycling; Clathrin-independent Endocytosis; Diacylglycerol Kinase; Major Histocompatibility Complex Class I; Structured Illumination Microscopy; Tubular Recycling Endosome	PHOSPHATIDIC-ACID; ADAPTER PROTEIN; EPS15 HOMOLOGY; EHD1 INTERACT; CLATHRIN; ENDOCYTOSIS; DOMAIN; ARF6; INTERSECTIN; VESICLES	Background: Major histocompatibility complex class I (MHC I) trafficking is crucial for antigen presentation. Results: Diacylglycerol kinase (DGK) depletion interferes with tubular recycling endosome (TRE) biogenesis and delays MHC I recycling to the plasma membrane. Conclusion: DGK mediates MHC I recycling by interacting with MICAL-L1 and generating phosphatidic acid. Significance: A novel role for DGK in generating phosphatidic acid for TRE biogenesis and MHC I recycling. Major histocompatibility complex class I (MHC I) presents intracellular-derived peptides to cytotoxic T lymphocytes and its subcellular itinerary is important in regulating the immune response. While a number of diacylglycerol kinase isoforms have been implicated in clathrin-dependent internalization, MHC I lacks the typical motifs known to mediate clathrin-dependent endocytosis. Here we show that depletion of diacylglycerol kinase (DGK), a kinase devoid of a clathrin-dependent adaptor protein complex 2 binding site, caused a delay in MHC I recycling to the plasma membrane without affecting the rate of MHC I internalization. We demonstrate that DGK knock-down causes accumulation of intracellular and surface MHC I, resulting from decreased degradation. Furthermore, we provide evidence that DGK is required for the generation of phosphatidic acid required for tubular recycling endosome (TRE) biogenesis. Moreover, we show that DGK forms a complex with the TRE hub protein, MICAL-L1. Given that MICAL-L1 and the F-BAR-containing membrane-tubulating protein Syndapin2 associate selectively with phosphatidic acid, we propose a positive feedback loop in which DGK generates phosphatidic acid to drive its own recruitment to TRE via its interaction with MICAL-L1. Our data support a novel role for the involvement of DGK in TRE biogenesis and MHC I recycling.	[Naslavsky, Naava; Caplan, Steve] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Naslavsky, Naava; Caplan, Steve] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Naslavsky, N (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	nnaslavsky@unmc.edu; scaplan@unmc.edu	Xie, Shuwei/ABA-4923-2021		National Institutes of Health [R01GM087455, R01GM074876]; National Institute of General Medical Sciences of the National Institutes of Health [5P30GM106397]; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106397, R01GM074876, R01GM087455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01GM087455, R01GM074876, and an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under Grant number 5P30GM106397. Structured Illumination (SIM) images were obtained and processed at the UNMC Advanced Microscopy Core Facility.	Adams A, 2000, J BIOL CHEM, V275, P27414; Anton LC, 2014, J LEUKOCYTE BIOL, V95, P551, DOI 10.1189/jlb.1113599; Antonescu CN, 2010, MOL BIOL CELL, V21, P2944, DOI 10.1091/mbc.E10-05-0421; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Cai BS, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00022; Cai BS, 2013, J BIOL CHEM, V288, P30172, DOI 10.1074/jbc.M113.488627; Cai BS, 2012, MOL BIOL CELL, V23, P1874, DOI 10.1091/mbc.E11-10-0881; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Donaldson JG, 2009, TRAFFIC, V10, P1745, DOI 10.1111/j.1600-0854.2009.00979.x; Donaldson JG, 2009, BBA-MOL CELL BIOL L, V1791, P845, DOI 10.1016/j.bbalip.2009.05.011; Donaldson JG, 2009, CELL SIGNAL, V21, P1, DOI 10.1016/j.cellsig.2008.06.020; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Giridharan SSP, 2013, MOL BIOL CELL, V24, P1776, DOI 10.1091/mbc.E13-01-0026; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Jovanovic OA, 2006, MOL BIOL CELL, V17, P327, DOI 10.1091/mbc.E05-06-0523; Jovic M, 2007, J CELL SCI, V120, P802, DOI 10.1242/jcs.03383; Kawasaki T, 2008, BIOCHEM J, V409, P471, DOI 10.1042/BJ20070755; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Mettlen M, 2009, MOL BIOL CELL, V20, P3251, DOI 10.1091/mbc.E09-03-0256; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Rahajeng J, 2012, TRAFFIC, V13, P82, DOI 10.1111/j.1600-0854.2011.01294.x; Rainero E, 2012, J CELL BIOL, V196, P277, DOI 10.1083/jcb.201109112; Sharma M, 2008, TRAFFIC, V9, P995, DOI 10.1111/j.1600-0854.2008.00732.x; Sharma M, 2009, MOL BIOL CELL, V20, P5181, DOI 10.1091/mbc.E09-06-0535; Shindou H, 2009, J LIPID RES, V50, pS46, DOI 10.1194/jlr.R800035-JLR200; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tebar F, 1996, J BIOL CHEM, V271, P28727, DOI 10.1074/jbc.271.46.28727; Yamabhai M, 1998, J BIOL CHEM, V273, P31401, DOI 10.1074/jbc.273.47.31401; YLANNE J, 1995, J BIOL CHEM, V270, P9550	34	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31914	31926		10.1074/jbc.M114.594291	http://dx.doi.org/10.1074/jbc.M114.594291			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25248744	Green Published, hybrid			2022-12-25	WOS:000345314700022
J	Lu, ZC; Li, Q; Liu, WX; Wan, FH				Lu, Zhi-Chuang; Li, Qian; Liu, Wan-Xue; Wan, Fang-Hao			Transient Receptor Potential Is Essential for High Temperature Tolerance in Invasive Bemisia tabaci Middle East Asia Minor 1 Cryptic Species	PLOS ONE			English	Article							SHOCK-PROTEIN GENES; HEAT-SHOCK; WHITEFLY TRANSCRIPTOME; TRP CHANNELS; EXPRESSION; DIVERGENCE; PAINLESS; RNA	Temperature is an important factor in affecting population dynamics and diffusion distribution of organisms. Alien species can successfully invade and colonize to various temperature environments, and one of important reasons is that alien species have a strong resistance to stress temperature. Recently, researchers have focused on the mechanisms of temperature sensing to determine the sensing and regulation mechanisms of temperature adaptation. The transient receptor potential (TRP) is one of the key components of an organism's temperature perception system. TRP plays important roles in perceiving temperature, such as avoiding high temperature, low temperature and choosing the optimum temperature. To assess high temperature sensation and the heat resistance role of the TRP gene, we used 3' and 5' rapid-amplification of cDNA ends to isolate the full-length cDNA sequence of the TRP gene from Bemisia tabaci (Gennadius) MEAM1 (Middle East Asia Minor 1), examined the mRNA expression profile under various temperature conditions, and identified the heat tolerance function. This is the first study to characterize the TRP gene of invasive B. tabaci MEAM1 (MEAM1 BtTRP). The full-length cDNA of MEAM1 BtTRP was 3871 bp, and the open reading frames of BtTRP was 3501 bp, encoding 1166 amino acids. Additionally, the BtTRP mRNA expression level was significantly increased at 35 degrees C. Furthermore, compared with control treatments, the survival rate of B. tabaci MEAM1 adults was significantly decreased under high temperature stress conditions after feeding with dsRNA BtTRP. Collectively, these results showed that MEAM1 BtTRP is a key element in sensing high temperature and plays an essential role in B. tabaci MEAM1 heat tolerance ability. Our data improved our understanding of the mechanism of temperature sensation in B. tabaci MEAM1 at the molecular level and could contribute to the understanding of the thermal biology of B. tabaci MEAM1 within the context of global climate change.	[Lu, Zhi-Chuang; Li, Qian; Liu, Wan-Xue; Wan, Fang-Hao] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Wan, Fang-Hao] Minist Agr, Ctr Management Invas Alien Species, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Ministry of Agriculture & Rural Affairs	Wan, FH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	wanfanghao@caas.cn			National Natural Science Foundation of China [31100269]; National Basic Research and Development Program [2009CB119200]; Ministry of Science and Technology, China; Common Wealth Special Fund for the Agricultural Industry [201303019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research and Development Program(National Basic Research Program of China); Ministry of Science and Technology, China(Ministry of Science and Technology, China); Common Wealth Special Fund for the Agricultural Industry	This research project was supported by the National Natural Science Foundation of China (31100269), and the National Basic Research and Development Program (Grant No. 2009CB119200), and the Ministry of Science and Technology, China, and Common Wealth Special Fund for the Agricultural Industry (No. 201303019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandell M, 2007, CURR OPIN NEUROBIOL, V17, P490, DOI 10.1016/j.conb.2007.07.014; Bowler K, 2008, BIOL REV, V83, P339, DOI 10.1111/j.1469-185X.2008.00046.x; BROADBENT AB, 1989, CAN ENTOMOL, V121, P1027, DOI 10.4039/Ent1211027-11; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; CHEEK S, 1994, PESTIC SCI, V42, P135, DOI 10.1002/ps.2780420211; Cui XH, 2008, J INSECT SCI, V8; Damann N, 2008, CURR BIOL, V18, pR880, DOI 10.1016/j.cub.2008.07.063; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; [段波 Duan Bo], 2005, [生物物理学报, Acta Biophysica Sinica], V21, P245; Fowler MA, 2013, LIFE SCI, V92, P394, DOI 10.1016/j.lfs.2012.07.029; Ghanim M, 2007, INSECT BIOCHEM MOLEC, V37, P732, DOI 10.1016/j.ibmb.2007.04.006; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Han Chong-Yang, 2008, Sheng Li Ke Xue Jin Zhan, V39, P27; Han Q, 2009, J CHENGDU MED COLL, V4, P220; Hensel H, 1981, Monogr Physiol Soc, V38, P1; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Kwon Y, 2008, NAT NEUROSCI, V11, P871, DOI 10.1038/nn.2170; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Lee Y, 2005, NAT GENET, V37, P305, DOI 10.1038/ng1513; Lu C., 2000, BEIJING SCI, V18, P4; Lu ZC, 2011, J EXP BIOL, V214, P764, DOI 10.1242/jeb.047415; Lu ZC, 2008, COMP BIOCHEM PHYS D, V3, P257, DOI 10.1016/j.cbd.2008.06.003; Matsuura H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-228; MILES P. W., 1965, J INSECT PHYSIOL, V11, P1261, DOI 10.1016/0022-1910(65)90119-8; Montell C, 2005, PFLUG ARCH EUR J PHY, V451, P19, DOI 10.1007/s00424-005-1426-2; Neely GG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024343; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Patapoutian A, 2005, CHEM SENSES, V30, pI193, DOI 10.1093/chemse/bjh180; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Sato A, 2014, P NATL ACAD SCI USA, V111, pE1249, DOI 10.1073/pnas.1322134111; Sokabe T, 2008, J NEUROSCI, V28, P9929, DOI 10.1523/JNEUROSCI.2757-08.2008; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wan FH, 2009, SCI CHINA SER C, V52, P88, DOI 10.1007/s11427-008-0135-4; Wang XW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-529; Wang XW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-458; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Yu H, 2009, J APPL ENTOMOL, V133, P602, DOI 10.1111/j.1439-0418.2009.01403.x; Yu H, 2012, BIOL INVASIONS, V14, P1587, DOI 10.1007/s10530-012-0171-7	42	6	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108428	10.1371/journal.pone.0108428	http://dx.doi.org/10.1371/journal.pone.0108428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254364	Green Published, Green Submitted, gold			2022-12-25	WOS:000344862300080
J	Ishii, A; Kurosawa, A; Saito, S; Adachi, N				Ishii, Ayako; Kurosawa, Aya; Saito, Shinta; Adachi, Noritaka			Analysis of the Role of Homology Arms in Gene-Targeting Vectors in Human Cells	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; DNA-LIGASE-IV; IONIZING-RADIATION; STEM-CELLS; RECOMBINATION; INTEGRATION; DEFICIENT; REPAIR; NEUROSPORA; PATHWAYS	Random integration of targeting vectors into the genome is the primary obstacle in human somatic cell gene targeting. Non-homologous end-joining (NHEJ), a major pathway for repairing DNA double-strand breaks, is thought to be responsible for most random integration events; however, absence of DNA ligase IV (LIG4), the critical NHEJ ligase, does not significantly reduce random integration frequency of targeting vector in human cells, indicating robust integration events occurring via a LIG4-independent mechanism. To gain insights into the mechanism and robustness of LIG4-independent random integration, we employed various types of targeting vectors to examine their integration frequencies in LIG4-proficient and deficient human cell lines. We find that the integration frequency of targeting vector correlates well with the length of homology arms and with the amount of repetitive DNA sequences, especially SINEs, present in the arms. This correlation was prominent in LIG4-deficient cells, but was also seen in LIG4-proficient cells, thus providing evidence that LIG4-independent random integration occurs frequently even when NHEJ is functionally normal. Our results collectively suggest that random integration frequency of conventional targeting vectors is substantially influenced by homology arms, which typically harbor repetitive DNA sequences that serve to facilitate LIG4-independent random integration in human cells, regardless of the presence or absence of functional NHEJ.	[Ishii, Ayako; Kurosawa, Aya; Saito, Shinta; Adachi, Noritaka] Yokohama City Univ, Grad Sch Nanobiosci, Yokohama, Kanagawa 232, Japan; [Adachi, Noritaka] Yokohama City Univ, Adv Med Res Ctr, Yokohama, Kanagawa 232, Japan	Yokohama City University; Yokohama City University	Adachi, N (corresponding author), Yokohama City Univ, Grad Sch Nanobiosci, Yokohama, Kanagawa 232, Japan.	nadachi@yokohama-cu.ac.jp	Kurosawa, Aya/O-5165-2018	Kurosawa, Aya/0000-0001-8909-2789	Yokohama City University [G2201/G2301/G2401/S2501]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan	Yokohama City University; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from Yokohama City University (Strategic Research Promotion G2201/G2301/G2401/S2501) and by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2001, P NATL ACAD SCI USA, V98, P12109, DOI 10.1073/pnas.201271098; Adachi N, 2013, GENE TECHNOLOGY, V3; Adachi Noritaka, 2008, V435, P17, DOI 10.1007/978-1-59745-232-8_2; Banuelos CA, 2008, DNA REPAIR, V7, P1471, DOI 10.1016/j.dnarep.2008.05.005; Callinan P, 2006, GENOME DYN, V1, P104, DOI 10.1159/000092503; Chiruvella KK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012757; Cortizas EM, 2013, J IMMUNOL, V191, P5751, DOI 10.4049/jimmunol.1301300; Decottignies Anabelle, 2013, Frontiers in Genetics, V4, P48, DOI 10.3389/fgene.2013.00048; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Fattah FJ, 2008, P NATL ACAD SCI USA, V105, P8703, DOI 10.1073/pnas.0712060105; Iiizumi S, 2008, NUCLEIC ACIDS RES, V36, P6333, DOI 10.1093/nar/gkn649; Iiizumi S, 2006, BIOTECHNIQUES, V41, P311, DOI 10.2144/000112233; Ishibashi K, 2006, P NATL ACAD SCI USA, V103, P14871, DOI 10.1073/pnas.0604477103; JEGGO PA, 1989, MUTAT RES, V218, P75, DOI 10.1016/0921-8777(89)90013-X; Kan YN, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004251; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Mae SI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2378; Marie A, 2010, NUCLEIC ACIDS RES, V38, P5706, DOI 10.1093/nar/gkq379; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; Oh S, 2014, DNA REPAIR IN PRESS; Oh S, 2013, NUCLEIC ACIDS RES, V41, P1734, DOI 10.1093/nar/gks1326; Pannunzio NR, 2014, DNA REPAIR, V17, P74, DOI 10.1016/j.dnarep.2014.02.006; Paul K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059505; Sado K, 2001, J BIOL CHEM, V276, P9742, DOI 10.1074/jbc.M010530200; So S, 2006, GENES CELLS, V11, P363, DOI 10.1111/j.1365-2443.2006.00944.x; So S, 2004, J BIOL CHEM, V279, P55433, DOI 10.1074/jbc.M409827200; Suzuki K, 2010, CHROMOSOME RES, V18, P191, DOI 10.1007/s10577-010-9111-5; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Truong LN, 2013, P NATL ACAD SCI USA, V110, P7720, DOI 10.1073/pnas.1213431110; Vasquez KM, 2001, P NATL ACAD SCI USA, V98, P8403, DOI 10.1073/pnas.111009698; Wang HC, 2005, CANCER RES, V65, P4020, DOI 10.1158/0008-5472.CAN-04-3055; Watson JEV, 1995, GENOME RES, V5, P444, DOI 10.1101/gr.5.5.444	33	14	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108236	10.1371/journal.pone.0108236	http://dx.doi.org/10.1371/journal.pone.0108236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250686	Green Published, gold, Green Submitted			2022-12-25	WOS:000342492700099
J	Maastrup, R; Hansen, BM; Kronborg, H; Bojesen, SN; Hallum, K; Frandsen, A; Kyhnaeb, A; Svarer, I; Hallstrom, I				Maastrup, Ragnhild; Hansen, Bo Moelholm; Kronborg, Hanne; Bojesen, Susanne Norby; Hallum, Karin; Frandsen, Annemi; Kyhnaeb, Anne; Svarer, Inge; Hallstrom, Inger			Breastfeeding Progression in Preterm Infants Is Influenced by Factors in Infants, Mothers and Clinical Practice: The Results of a National Cohort Study with High Breastfeeding Initiation Rates	PLOS ONE			English	Article							NEONATAL INTENSIVE-CARE; HUMAN-MILK; PREMATURE-INFANTS; RANDOMIZED-TRIAL; FOLLOW-UP; OUTCOMES; AGE; PREVALENCE; MILESTONES; PREDICTORS	Background and Aim: Many preterm infants are not capable of exclusive breastfeeding from birth. To guide mothers in breastfeeding, it is important to know when preterm infants can initiate breastfeeding and progress. The aim was to analyse postmenstrual age (PMA) at breastfeeding milestones in different preterm gestational age (GA) groups, to describe rates of breastfeeding duration at pre-defined times, as well as analyse factors associated with PMA at the establishment of exclusive breastfeeding. Methods: The study was part of a prospective survey of a national Danish cohort of preterm infants based on questionnaires and structured telephone interviews, including 1,221 mothers and their 1,488 preterm infants with GA of 2436 weeks. Results: Of the preterm infants, 99% initiated breastfeeding and 68% were discharged exclusively breastfed. Breastfeeding milestones were generally reached at different PMAs for different GA groups, but preterm infants were able to initiate breastfeeding at early times, with some delay in infants less than GA 32 weeks. Very preterm infants had lowest mean PMA (35.5 weeks) at first complete breastfeed, and moderate preterm infants had lowest mean PMA at the establishment of exclusive breastfeeding (36.4 weeks). Admitting mothers to the NICU together with the infant and minimising the use of a pacifier during breastfeeding transition were associated with 1.6 (95% CI 0.4-2.8) and 1.2 days (95% CI 0.1-2.3) earlier establishment of exclusive breastfeeding respectively. Infants that were small for gestational age were associated with 5.6 days (95% CI 4.1-7.0) later establishment of exclusive breastfeeding. Conclusion: Breastfeeding competence is not developed at a fixed PMA, but is influenced by multiple factors in infants, mothers and clinical practice. Admitting mothers together with their infants to the NICU and minimising the use of pacifiers may contribute to earlier establishment of exclusive breastfeeding.	[Maastrup, Ragnhild] Copenhagen Univ Hosp, Rigshosp, Knowledge Ctr Breastfeeding Infants Special Needs, Dept Neonatol, Copenhagen, Denmark; [Maastrup, Ragnhild; Hallstrom, Inger] Lund Univ, Fac Med, Dept Hlth Sci, Lund, Sweden; [Maastrup, Ragnhild; Bojesen, Susanne Norby; Hallum, Karin; Frandsen, Annemi; Kyhnaeb, Anne; Svarer, Inge] Danish Natl Panel Experts Breastfeeding Infants S, Copenhagen, Denmark; [Hansen, Bo Moelholm; Bojesen, Susanne Norby] Copenhagen Univ Hosp Herlev, Dept Neonatol, Herlev, Denmark; [Kronborg, Hanne] Univ Aarhus, Dept Publ Hlth, Sect Nursing, Aarhus, Denmark; [Hallum, Karin] Viborg Reg Hosp, Dept Neonatol, Viborg, Denmark; [Frandsen, Annemi] Holbaek Univ Hosp, Dept Paediat, Holbaek, Denmark; [Kyhnaeb, Anne] Copenhagen Univ Hosp Hvidovre, Dept Neonatol, DK-2650 Hvidovre, Denmark; [Svarer, Inge] Odense Univ Hosp, Dept Neonatol, DK-5000 Odense, Denmark	Rigshospitalet; University of Copenhagen; Lund University; University of Copenhagen; Aarhus University; Aarhus University; University of Copenhagen; University of Southern Denmark; Odense University Hospital	Maastrup, R (corresponding author), Copenhagen Univ Hosp, Rigshosp, Knowledge Ctr Breastfeeding Infants Special Needs, Dept Neonatol, Copenhagen, Denmark.	Ragnhild.maastrup@regionh.dk		Hansen, Bo Molholm/0000-0002-3087-3983; Maastrup, Ragnhild/0000-0001-8719-5717; Kristensson Hallstrom, Inger/0000-0002-9402-6230	Swedish Research Council; Soester Marie Dalgaards Foundation [1177]; Neonatal Department at Rigshospitalet Copenhagen; Juliane Marie Centre at Rigshospitalet Copenhagen	Swedish Research Council(Swedish Research CouncilEuropean Commission); Soester Marie Dalgaards Foundation; Neonatal Department at Rigshospitalet Copenhagen; Juliane Marie Centre at Rigshospitalet Copenhagen	The authors disclosed receipt of the following financial support for the research and authorship of this article: Funding to support the research was received from The Swedish Research Council: http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html; Soester Marie Dalgaards Foundation: http://www.diakonissestiftelsen.dk/Default.aspx?ID = 1177; the Neonatal Department at Rigshospitalet Copenhagen: http://www.rigshospitalet.dk/menu/AFDELINGER/Juliane+Marie+Centret/Klinikker/Neonatalklinikken/; and Juliane Marie Centre at Rigshospitalet Copenhagen: http://www.rigshospitalet.dk/menu/AFDELINGER/Juliane+Marie+Centret/In+English/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstrom S, 2007, ACTA PAEDIATR, V96, P1450, DOI 10.1111/j.1651-2227.2007.00502.x; Allerman Beck S, 2009, J NEONATAL NURSING, V15, P88, DOI DOI 10.1016/J.JNN.2009.01.006; Als H, 2004, PEDIATRICS, V113, P846, DOI 10.1542/peds.113.4.846; Altman D.G., 1991, PRACTICAL STATISTIC; Amaizu N, 2008, ACTA PAEDIATR, V97, P61, DOI 10.1111/j.1651-2227.2007.00548.x; Anderson JW, 1999, AM J CLIN NUTR, V70, P525; [Anonymous], 2013, ETHICAL PRINCIPLES M; Australian Bureau of Statistics, 2001, 4810 0 55 001 BREAST; Blackmon LR, 2004, PEDIATRICS, V114, P1362, DOI 10.1542/peds.2004-1915; Blomqvist YT, 2013, ACTA PAEDIATR, V102, P22, DOI 10.1111/apa.12056; Bonet M, 2011, ARCH DIS CHILD-FETAL, V96, pF450, DOI 10.1136/adc.2009.179564; Bragelien R, 2007, ACTA PAEDIATR, V96, P1430, DOI 10.1111/j.1651-2227.2007.00448.x; Christensen AM, 2011, ANN REPORT CHILDREN; Clum D, 1996, J Hum Lact, V12, P287, DOI 10.1177/089033449601200413; Conde-Agudelo A, 2011, COCHRANE DB SYST REV, V16; Cristofalo EA, 2013, J PEDIATR-US, V163, P1592, DOI 10.1016/j.jpeds.2013.07.011; Demirci JR, 2013, BREASTFEED MED, V8, P277, DOI 10.1089/bfm.2012.0075; Dodrill P, 2008, J PERINATOL, V28, P549, DOI 10.1038/jp.2008.56; Flacking R, 2007, ACTA PAEDIATR, V96, P1126, DOI 10.1111/j.1651-2227.2007.00386.x; Flacking Renee, 2003, J Hum Lact, V19, P157, DOI 10.1177/0890334403252563; Gomez P, 1998, AN ESP PEDIATR, V48, P631; Hoddinott P, 2008, BMJ-BRIT MED J, V336, P881, DOI 10.1136/bmj.39521.566296.BE; Horbar JD, 2012, PEDIATRICS, V129, P1019, DOI 10.1542/peds.2011-3028; Howe LD, 2013, EPIDEMIOLOGY, V24, P1, DOI 10.1097/EDE.0b013e31827623b1; Inder TE, 2005, PEDIATRICS, V115, P286, DOI 10.1542/peds.2004-0326; Jadcherla SR, 2010, J PERINATOL, V30, P201, DOI 10.1038/jp.2009.149; Kronborg H, 2004, SCAND J PUBLIC HEALT, V32, P210, DOI 10.1080/14034940310019218; Lau C, 2012, ACTA PAEDIATR, V101, pe269, DOI 10.1111/j.1651-2227.2012.02662.x; Lau C, 2012, INT J PEDIAT, V2012, DOI 10.1155/2012/572341; Li RW, 2003, PEDIATRICS, V111, P1198; LUCAS A, 1990, LANCET, V336, P1519, DOI 10.1016/0140-6736(90)93304-8; Maastrup R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089077; Maastrup R, 2012, J HUM LACT, V28, P370, DOI 10.1177/0890334412440846; Meier P P, 2000, J Hum Lact, V16, P106, DOI 10.1177/089033440001600205; Mewes AUJ, 2006, PEDIATRICS, V118, P23, DOI 10.1542/peds.2005-2675; Morelius E, 2012, ACTA PAEDIATR, V101, P14, DOI 10.1111/j.1651-2227.2011.02398.x; Morley R, 2004, PEDIATRICS, V113, P515, DOI 10.1542/peds.113.3.515; Nyqvist KH, 2008, ACTA PAEDIATR, V97, P776, DOI 10.1111/j.1651-2227.2008.00810.x; Nyqvist KH, 2013, J HUM LACT, V29, P300, DOI 10.1177/0890334413489775; Nyqvist KH, 1999, EARLY HUM DEV, V55, P247, DOI 10.1016/S0378-3782(99)00025-0; Ortenstrand A, 2010, PEDIATRICS, V125, pE278, DOI 10.1542/peds.2009-1511; Parker M, 2013, J HUM LACT, V29, P354, DOI 10.1177/0890334413489374; Perrella SL, 2012, BREASTFEED MED, V7, P255, DOI 10.1089/bfm.2011.0118; Pineda R, 2011, J PERINATOL, V31, P540, DOI 10.1038/jp.2010.205; Pineda RG, 2011, BREASTFEED MED, V6, P15, DOI 10.1089/bfm.2010.0010; Pinelli J, 2002, JOGNN-J OBST GYN NEO, V31, P582, DOI 10.1111/j.1552-6909.2002.tb00084.x; Polit D., 2010, ESSENTIALS NURSING R, V7th; Renfrew MJ, 2009, HLTH TECHNOL ASSESS, V13; Ronnestad A, 2005, PEDIATRICS, V115, pE269, DOI 10.1542/peds.2004-1833; Schanler RJ, 1999, PEDIATRICS, V103, P1150, DOI 10.1542/peds.103.6.1150; Scher MS, 2009, CLIN NEUROPHYSIOL, V120, P1812, DOI 10.1016/j.clinph.2009.08.004; Simpson C, 2002, PEDIATRICS, V110, P517, DOI 10.1542/peds.110.3.517; Smith MM, 2003, AM J EPIDEMIOL, V158, P1075, DOI 10.1093/aje/kwg257; Smithers LG, 2003, ASIA PAC J CLIN NU S, V12, pS43; Verder H, 2007, ACTA PAEDIATR, V96, P482, DOI 10.1111/j.1651-2227.2007.00263.x; Wataker H, 2012, J PERINAT NEONAT NUR, V26, P336, DOI 10.1097/JPN.0b013e31826d928b; Winterstein AG, 2013, JAMA PEDIATR, V167, P1118, DOI 10.1001/jamapediatrics.2013.2636; World Health Organization, 2008, IND ASS INF YOUNG CH	58	71	75	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108208	10.1371/journal.pone.0108208	http://dx.doi.org/10.1371/journal.pone.0108208			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251690	Green Published, gold, Green Submitted			2022-12-25	WOS:000342492700093
J	Thompson, JMD; Waldie, KE; Wall, CR; Murphy, R; Mitchell, EA				Thompson, John M. D.; Waldie, Karen E.; Wall, Clare R.; Murphy, Rinky; Mitchell, Edwin A.		ABC Study Grp	Associations between Acetaminophen Use during Pregnancy and ADHD Symptoms Measured at Ages 7 and 11 Years	PLOS ONE			English	Article							DIFFICULTIES QUESTIONNAIRE; PSYCHOMETRIC PROPERTIES; GESTATIONAL-AGE; BIRTH-WEIGHT; STRENGTHS; CHILDREN; VERSION; SCALE; RISK	Objective: Our aim was to replicate and extend the recently found association between acetaminophen use during pregnancy and ADHD symptoms in school-age children. Methods: Participants were members of the Auckland Birthweight Collaborative Study, a longitudinal study of 871 infants of European descent sampled disproportionately for small for gestational age. Drug use during pregnancy (acetaminophen, aspirin, antacids, and antibiotics) were analysed in relation to behavioural difficulties and ADHD symptoms measured by parent report at age 7 and both parent-and child-report at 11 years of age. The analyses included multiple covariates including birthweight, socioeconomic status and antenatal maternal perceived stress. Results: Acetaminophen was used by 49.8% of the study mothers during pregnancy. We found significantly higher total difficulty scores (Strengths and Difficulty Questionnaire parent report at age 7 and child report at age 11) if acetaminophen was used during pregnancy, but there were no significant differences associated with any of the other drugs. Children of mothers who used acetaminophen during pregnancy were also at increased risk of ADHD at 7 and 11 years of age (Conners' Parent Rating Scale-Revised). Conclusions: These findings strengthen the contention that acetaminophen exposure in pregnancy increases the risk of ADHD-like behaviours. Our study also supports earlier claims that findings are specific to acetaminophen.	[Thompson, John M. D.; Mitchell, Edwin A.] Univ Auckland, Dept Paediat, Auckland, New Zealand; [Waldie, Karen E.] Univ Auckland, Sch Psychol, Auckland 1, New Zealand; [Wall, Clare R.] Univ Auckland, Discipline Nutr, Auckland 1, New Zealand; [Murphy, Rinky] Univ Auckland, Dept Med, Auckland, New Zealand	University of Auckland; University of Auckland; University of Auckland; University of Auckland	Waldie, KE (corresponding author), Univ Auckland, Sch Psychol, Auckland 1, New Zealand.	k.waldie@auckland.ac.nz		Wall, Clare/0000-0003-1062-3909; Waldie, Karen/0000-0001-7909-0464	Health Research Council of New Zealand; Hawkes Bay Medical Research Foundation; Child Health Research Foundation; Becroft Foundation; Auckland Medical Research Foundation; National Heart Foundation; Cure Kids; Starship Foundation; Auckland District Health Board	Health Research Council of New Zealand(Health Research Council of New Zealand); Hawkes Bay Medical Research Foundation; Child Health Research Foundation; Becroft Foundation; Auckland Medical Research Foundation; National Heart Foundation(National Heart Foundation of Australia); Cure Kids; Starship Foundation; Auckland District Health Board	The initial study was funded by the Health Research Council of New Zealand. The 12 month postal questionnaire was funded by Hawkes Bay Medical Research Foundation. The 3.5 year follow-up study was funded by Child Health Research Foundation, Becroft Foundation and Auckland Medical Research Foundation. The 7 year follow-up study was funded by Child Health Research Foundation. The 11 year follow-up was funded by Child Health Research Foundation and the National Heart Foundation. E. A. Mitchell and J. M. D. Thompson are supported by Cure Kids. The 31/2, 7 and 11 year follow-ups were conducted in the Children's Research Centre which is supported in part by the Starship Foundation and the Auckland District Health Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbac T, 1987, PSYCHOL BULL, V101, P2; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Conners C. K., 2001, CONNERS RATING SCALE, P83; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P257, DOI 10.1023/A:1022602400621; Cooper M, 2014, JAMA PEDIAT, DOI [10.1001/jamapediatrics.2013.4914, DOI 10.1001/JAMAPEDIATRICS.2013.4914]; ELLEY WB, 1985, NEW ZEAL J EDUC STUD, V20, P115; Goodman R, 1999, J CHILD PSYCHOL PSYC, V40, P791, DOI 10.1017/S0021963099004096; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Liew Z, 2014, JAMA PEDIATR, V168, P313, DOI 10.1001/jamapediatrics.2013.4914; Linnet KM, 2006, ARCH DIS CHILD, V91, P655, DOI 10.1136/adc.2005.088872; Mannuzza Salvatore, 2003, J Atten Disord, V7, P93; McDougall J, 2013, CHILD CARE HLTH DEV, V39, P512, DOI 10.1111/cch.12050; Rodriguez A, 2005, J CHILD PSYCHOL PSYC, V46, P246, DOI 10.1111/j.1469-7610.2004.00359.x; Shoval G, 2013, EUR PSYCHIAT, V28, P235, DOI 10.1016/j.eurpsy.2012.02.009; Thompson JMD, 2001, J PAEDIATR CHILD H, V37, P369, DOI 10.1046/j.1440-1754.2001.00684.x; Van den Bergh BRH, 2004, CHILD DEV, V75, P1085, DOI 10.1111/j.1467-8624.2004.00727.x; Werler MM, 2005, AM J OBSTET GYNECOL, V193, P771, DOI 10.1016/j.ajog.2005.02.100	17	84	88	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108210	10.1371/journal.pone.0108210	http://dx.doi.org/10.1371/journal.pone.0108210			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ0SJ	25251831	gold, Green Published, Green Submitted			2022-12-25	WOS:000342492700095
J	Wang, YM; Zhang, HM; Tang, SL; Liu, XD; O'Neil, A; Turner, A; Chai, FX; Chen, FY; Berk, M				Wang, Yiming; Zhang, Hongming; Tang, Songlin; Liu, Xingde; O'Neil, Adrienne; Turner, Alyna; Chai, Fangxian; Chen, Fanying; Berk, Michael			Assessing Regional Cerebral Blood Flow in Depression Using 320-Slice Computed Tomography	PLOS ONE			English	Article							LATE-LIFE DEPRESSION; ELECTROCONVULSIVE-THERAPY; MAJOR DEPRESSION; CT; ANTIDEPRESSANT; BRAIN; MATTER; CORTEX	While there is evidence that the development and course of major depressive disorder (MDD) symptomatology is associated with vascular disease, and that there are changes in energy utilization in the disorder, the extent to which cerebral blood flow is changed in this condition is not clear. This study utilized a novel imaging technique previously used in coronary and stroke patients, 320-slice Computed-Tomography (CT), to assess regional cerebral blood flow (rCBF) in those with MDD and examine the pattern of regional cerebral perfusion. Thirty nine participants with depressive symptoms (Hamilton Depression Rating Scale 24 (HAMD24) score >20, and Self-Rating Depression Scale (SDS) score >53) and 41 healthy volunteers were studied. For all subjects, 3 ml of venous blood was collected to assess hematological parameters. Trancranial Doppler (TCD) ultrasound was utilized to measure parameters of cerebral artery rCBFV and analyse the Pulsatility Index (PI). 16 subjects (8 = MDD; 8 = healthy) also had rCBF measured in different cerebral artery regions using 320-slice CT. Differences among groups were analyzed using ANOVA and Pearson's tests were employed in our statistical analyses. Compared with the control group, whole blood viscosity (including high\middle\low shear rate) and hematocrit (HCT) were significantly increased in the MDD group. PI values in different cerebral artery regions and parameters of rCBFV in the cerebral arteries were decreased in depressive participants, and there was a positive relationship between rCBFV and the corresponding vascular rCBF in both gray and white matter. rCBF of the left gray matter was lower than that of the right in MDD. Major depression is characterized by a wide range of CBF impairments and prominent changes in gray matter blood flow. 320-slice CT appears to be a valid and promising tool for measuring rCBF, and could thus be employed in psychiatric settings for biomarker and treatment response purposes.	[Wang, Yiming; Tang, Songlin; Chai, Fangxian] Guiyang Med Univ, Hosp Affiliated, Dept Psychiat, Guiyang, Guizhou, Peoples R China; [Zhang, Hongming] Gen Hosp Jinan Mil Reg, Dept Cardiol, Jinan, Peoples R China; [Tang, Songlin] First Peoples Hosp Shaoyang, Dept Neurol, Shaoyang, Hunan, Peoples R China; [Liu, Xingde] Guiyang Med Univ, Hosp Affiliated, Dept Cardiol, Guiyang, Guizhou, Peoples R China; [O'Neil, Adrienne; Turner, Alyna; Berk, Michael] Deakin Univ, Sch Med, IMPACT Strateg Res Ctr, Geelong, Vic 3217, Australia; [O'Neil, Adrienne; Berk, Michael] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Turner, Alyna; Berk, Michael] Univ Melbourne, Dept Psychiat, Parkville, Vic 3052, Australia; Univ Melbourne, Dept Psychiat, Parkville, Vic 3052, Australia; [Turner, Alyna] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia; [Chen, Fanying] Guiyang Med Univ, Mental Hlth Educ & Counseling Ctr, Guiyang, Guizhou, Peoples R China; [Berk, Michael] Univ Melbourne, Dept Psychiat, Orygen Youth Hlth Res Ctr, Parkville, Vic 3052, Australia; [Berk, Michael] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia	Guizhou Medical University; Guizhou Medical University; Deakin University; Monash University; University of Melbourne; University of Melbourne; University of Newcastle; Guizhou Medical University; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Wang, YM (corresponding author), Guiyang Med Univ, Hosp Affiliated, Dept Psychiat, Guiyang, Guizhou, Peoples R China.	yimingw66@yahoo.com; lxd@gmc.edu.cn	Berk, Michael/M-7891-2013; Berk, Michael/M-3585-2019	Berk, Michael/0000-0002-5554-6946; Berk, Michael/0000-0002-5554-6946; Turner, Alyna/0000-0001-7389-2546	National Natural Science Foundation of China [2012 31260237]; Qiankehe Diquhe [(2012) 7001]; Qiankehe [2011, 005, 2006, 2065, 2008, 3063]; High-Level Personnel Research Conditions, Special Assistant Funding [TZJF-2008 55]; Guizhou Province Special Fund for Outstanding Scientific and Technology Education Talents [2012, 35]; Guizhou Province Overseas Students studying science and technology [0011 006]; Scientific and Technology Projects in Guiyang City, China [2009]; NHMRC Senior Principal Research Fellowship [1059660];  [3-008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qiankehe Diquhe; Qiankehe; High-Level Personnel Research Conditions, Special Assistant Funding; Guizhou Province Special Fund for Outstanding Scientific and Technology Education Talents; Guizhou Province Overseas Students studying science and technology; Scientific and Technology Projects in Guiyang City, China; NHMRC Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); 	This study was supported by a Grant for YW from National Natural Science Foundation of China, (Project Grant 2012 31260237), YW has received Grant/Research Support from the Science and Technology Fund of Guizhou Province, China, Qiankehe Diquhe (2012) 7001, Qiankehe (LG, 2011, 005, J, 2006, 2065, SY, 2008, 3063), which was supported by High-Level Personnel Research Conditions, Special Assistant Funding (TZJF-2008 55), Guizhou Province Special Fund for Outstanding Scientific and Technology Education Talents 2012, 35, Guizhou Province Overseas Students studying science and technology activities funded projects 0011 006 and Scientific and Technology Projects in Guiyang City, China, 2009, Zhu subjects agriculture in Contract 3-008 for study design, the collection, analysis, and interpretation of data and the writing of the manuscript. MB is supported by a NHMRC Senior Principal Research Fellowship 1059660.	Aihua N, 2007, CHIN GEN PRAC CHIN, V10, P1944; [Anonymous], 2012, ULTRASOUND MED; Awata S, 1998, PSYCHIAT CLIN NEUROS, V52, P97, DOI 10.1111/j.1440-1819.1998.tb00980.x; Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Botteron KN, 2002, BIOL PSYCHIAT, V51, P342, DOI 10.1016/S0006-3223(01)01280-X; Brockmann H, 2009, PSYCHIAT RES-NEUROIM, V173, P107, DOI 10.1016/j.pscychresns.2008.10.006; Cenic A, 1999, AM J NEURORADIOL, V20, P63; Cody DD, 2007, RADIOGRAPHICS, V27, P1829, DOI 10.1148/rg.276075120; Colloby SJ, 2012, BRIT J PSYCHIAT, V200, P150, DOI 10.1192/bjp.bp.111.092387; Coolens C, 2009, MED PHYS, V36, P5120, DOI 10.1118/1.3246352; Davies J, 2003, AM J PSYCHIAT, V160, P374, DOI 10.1176/appi.ajp.160.2.374; Evangelista Antonietta, 2011, BMJ Case Rep, V2011, DOI 10.1136/bcr.05.2011.4200; GOSLING RG, 1974, P ROY SOC MED, V67, P447, DOI 10.1177/00359157740676P113; Hardoy MC, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-148; Hroudova J, 2013, MITOCHONDRION, V13, P795, DOI 10.1016/j.mito.2013.05.005; Ishizaki J, 2008, INT J GERIATR PSYCH, V23, P805, DOI 10.1002/gps.1980; JAN KM, 1975, CIRCULATION, V51, P1079, DOI 10.1161/01.CIR.51.6.1079; Kawakatsu S, 1994, Nihon Rinsho, V52, P1180; Kessler H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015712; Koenig M, 2001, STROKE, V32, P431, DOI 10.1161/01.STR.32.2.431; Kume K, 2011, GERIATR GERONTOL INT, V11, P77, DOI 10.1111/j.1447-0594.2010.00645.x; Kwater A, 2009, BLOOD PRESSURE, V18, P130, DOI 10.1080/08037050902975114; LECHIN F, 1995, BIOL PSYCHIAT, V38, P166, DOI 10.1016/0006-3223(94)00258-5; Liang S, 2006, CHIN J PSYCHIA, V39, P81, DOI [10.1080/08037050902975114, DOI 10.1080/08037050902975114]; LOWE GDO, 1986, CLIN SCI, V71, P137, DOI 10.1042/cs0710137; Milo TJ, 2001, J ECT, V17, P15, DOI 10.1097/00124509-200103000-00004; Navarro V, 2001, NEUROIMAGE, V14, P202, DOI 10.1006/nimg.2001.0787; Nobler MS, 2000, AM J GERIAT PSYCHIAT, V8, P289, DOI 10.1176/appi.ajgp.8.4.289; Oda K, 2003, BIOL PSYCHIAT, V53, P150, DOI 10.1016/S0006-3223(02)01548-2; Orosz A, 2012, BRAIN CONNECT, V2, P303, DOI 10.1089/brain.2012.0101; POST RM, 1987, BIOL PSYCHIAT, V22, P545, DOI 10.1016/0006-3223(87)90182-X; Sacher J, 2012, J AFFECT DISORDERS, V140, P142, DOI 10.1016/j.jad.2011.08.001; Shankar Jai Jai Shiva, 2011, Indian J Radiol Imaging, V21, P209, DOI 10.4103/0971-3026.85370; Siebert E, 2009, BRIT J RADIOL, V82, P561, DOI 10.1259/bjr/27721218; Smith GS, 2009, INT J GERIATR PSYCH, V24, P798, DOI 10.1002/gps.2185; Song ZJ, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-S1-S7; Takano Harumasa, 2006, Keio Journal of Medicine, V55, P153, DOI 10.2302/kjm.55.153; Taylor WD, 2013, MOL PSYCHIATR, V18, P963, DOI 10.1038/mp.2013.20; Vangu MDT, 2003, PROG NEURO-PSYCHOPH, V27, P15, DOI 10.1016/S0278-5846(02)00309-3; Wong ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002350	40	15	16	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107735	10.1371/journal.pone.0107735	http://dx.doi.org/10.1371/journal.pone.0107735			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251476	Green Published, Green Submitted, gold			2022-12-25	WOS:000342492700044
J	Chu, TJ; Bunce, K; Shaw, P; Shridhar, V; Althouse, A; Hubel, C; Peters, D				Chu, Tianjiao; Bunce, Kimberly; Shaw, Patricia; Shridhar, Varsha; Althouse, Andrew; Hubel, Carl; Peters, David			Comprehensive Analysis of Preeclampsia-Associated DNA Methylation in the Placenta	PLOS ONE			English	Article							EARLY-ONSET PREECLAMPSIA; GENE-EXPRESSION; PREGNANCY; SMOKING; DISEASE; WOMEN; RISK; HYPOMETHYLATION; TRANSCRIPTION; HYPERTENSION	Background: A small number of recent reports have suggested that altered placental DNA methylation may be associated with early onset preeclampsia. It is important that further studies be undertaken to confirm and develop these findings. We therefore undertook a systematic analysis of DNA methylation patterns in placental tissue from 24 women with preeclampsia and 24 with uncomplicated pregnancy outcome. Methods: We analyzed the DNA methylation status of approximately 27,000 CpG sites in placental tissues in a massively parallel fashion using an oligonucleotide microarray. Follow up analysis of DNA methylation at specific CpG loci was performed using the Epityper MassArray approach and high-throughput bisulfite sequencing. Results: Preeclampsia-specific DNA methylation changes were identified in placental tissue samples irrespective of gestational age of delivery. In addition, we identified a group of CpG sites within specific gene sequences that were only altered in early onset-preeclampsia (EOPET) although these DNA methylation changes did not correlate with altered mRNA transcription. We found evidence that fetal gender influences DNA methylation at autosomal loci but could find no clear association between DNA methylation and gestational age. Conclusion: Preeclampsia is associated with altered placental DNA methylation. Fetal gender should be carefully considered during the design of future studies in which placental DNA is analyzed at the level of DNA methylation. Further large-scale analyses of preeclampsia-associated DNA methylation are necessary.	[Chu, Tianjiao; Shridhar, Varsha; Hubel, Carl; Peters, David] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA; [Chu, Tianjiao; Bunce, Kimberly; Shaw, Patricia; Shridhar, Varsha; Althouse, Andrew; Hubel, Carl; Peters, David] Univ Pittsburgh, Magee Womens Res Inst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Peters, D (corresponding author), Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA.	david.peters@mail.hgen.pitt.edu	Althouse, Andrew/AAF-5053-2019; Peters, David/AAD-4629-2019; Althouse, Andrew/AAF-4836-2019	Althouse, Andrew/0000-0002-8654-5014; 	Magee-Womens Research Institute and Foundation ,University of Pittsburgh Clinical and Translational Science Institute [R01 HD068578, P01 HD030367, UL1RR024153, UL1TR000005]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD030367, R01HD068578] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	Magee-Womens Research Institute and Foundation ,University of Pittsburgh Clinical and Translational Science Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The study was supported by funding from the Magee-Womens Research Institute and Foundation (DGP), R01 HD068578 (DGP), P01 HD030367 (CAH), UL1RR024153 (CAH) and UL1TR000005 (University of Pittsburgh Clinical and Translational Science Institute) (CAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, AM J OBSTET GYNECOL, V183, pS1; Blair JD, 2013, MOL HUM REPROD, V19, P697, DOI 10.1093/molehr/gat044; Blattler A, 2013, J BIOL CHEM, V288, P34287, DOI 10.1074/jbc.R113.512517; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Bunce K, 2012, PRENATAL DIAG, V32, P542, DOI 10.1002/pd.3853; Carty DM, 2008, TRENDS CARDIOVAS MED, V18, P186, DOI 10.1016/j.tcm.2008.07.002; Chaouat G, 2011, J REPROD IMMUNOL, V89, P163, DOI 10.1016/j.jri.2010.12.006; Cheng J, 2013, EXP THER MED, V5, P1687, DOI 10.3892/etm.2013.1069; CHESLEY LC, 1980, KIDNEY INT, V18, P234, DOI 10.1038/ki.1980.131; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Farina A, 2009, PRENATAL DIAG, V29, P1038, DOI 10.1002/pd.2344; Founds SA, 2009, PLACENTA, V30, P15, DOI 10.1016/j.placenta.2008.09.015; Gheorghe CP, 2010, INT J DEV BIOL, V54, P507, DOI 10.1387/ijdb.082770cg; Jeyabalan A, 2008, AM J HYPERTENS, V21, P943, DOI 10.1038/ajh.2008.219; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412; Kang JH, 2011, J HYPERTENS, V29, P928, DOI 10.1097/HJH.0b013e328344a82c; Knoefler Martin, 2013, Frontiers in Genetics, V4, P190, DOI 10.3389/fgene.2013.00190; Lapaire O, 2012, FETAL DIAGN THER, V31, P147, DOI 10.1159/000337325; Lehavi O, 2005, FETAL DIAGN THER, V20, P235, DOI 10.1159/000083911; Liu JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010028; Macintire K, 2014, REPROD FERT DEVELOP, V26, P351, DOI 10.1071/RD12384; Nicole W, 2012, ENVIRON HEALTH PERSP, V120, pA402, DOI 10.1289/ehp.120-a402a; Nielsen SS, 2012, J PARKINSON DIS, V2, P303, DOI 10.3233/JPD-012129; Nishizawa H, 2008, MOL HUM REPROD, V14, P595, DOI 10.1093/molehr/gan054; Rajakumar A, 2011, PLACENTA, V32, P70, DOI 10.1016/j.placenta.2010.10.004; Roberts JM, 2013, J REPROD IMMUNOL, V99, P1, DOI 10.1016/j.jri.2013.05.003; Roberts JM, 2005, HYPERTENSION, V46, P1263, DOI 10.1161/01.HYP.0000188703.27002.14; Roberts VHJ, 2007, PLACENTA, V28, P270, DOI 10.1016/j.placenta.2006.04.008; Siedlinski M, 2012, EPIGENETICS-US, V7, P720, DOI 10.4161/epi.20319; Sood R, 2006, P NATL ACAD SCI USA, V103, P5478, DOI 10.1073/pnas.0508035103; Suter M, 2011, EPIGENETICS-US, V6, P1284, DOI 10.4161/epi.6.11.17819; Tsai HW, 2009, EPIGENETICS-US, V4, P47, DOI 10.4161/epi.4.1.7288; Tullis KM, 2003, ENDOCRINOLOGY, V144, P1854, DOI 10.1210/en.2002-0190; Varkonyi T, 2011, PLACENTA, V32, pS21, DOI 10.1016/j.placenta.2010.04.014; Wagner PK, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-48; Waxman DJ, 2003, GENE DEV, V17, P2607, DOI 10.1101/gad.1154603; Winn VD, 2011, PREGNANCY HYPERTENS, V1, P100, DOI 10.1016/j.preghy.2010.12.001; Wiwi CA, 2004, MOL ENDOCRINOL, V18, P1975, DOI 10.1210/me.2004-0129; Yuen RKC, 2010, EUR J HUM GENET, V18, P1006, DOI 10.1038/ejhg.2010.63; Zeilinger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063812	44	54	57	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107318	10.1371/journal.pone.0107318	http://dx.doi.org/10.1371/journal.pone.0107318			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247495	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000342351800021
J	Fouhy, F; Ogilvie, LA; Jones, BV; Ross, RP; Ryan, AC; Dempsey, EM; Fitzgerald, GF; Stanton, C; Cotter, PD				Fouhy, Fiona; Ogilvie, Lesley A.; Jones, Brian V.; Ross, R. Paul; Ryan, Anthony C.; Dempsey, Eugene M.; Fitzgerald, Gerald F.; Stanton, Catherine; Cotter, Paul D.			Identification of Aminoglycoside and beta-Lactam Resistance Genes from within an Infant Gut Functional Metagenomic Library	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; STAPHYLOCOCCUS-AUREUS; CTX-M; MICROBIOTA; REVEALS; PCR; AMPICILLIN; COLONIZATION; PREVALENCE; DIVERSITY	The infant gut microbiota develops rapidly during the first 2 years of life, acquiring microorganisms from diverse sources. During this time, significant opportunities exist for the infant to acquire antibiotic resistant bacteria, which can become established and constitute the infant gut resistome. With increased antibiotic resistance limiting our ability to treat bacterial infections, investigations into resistance reservoirs are highly pertinent. This study aimed to explore the nascent resistome in antibiotically-naive infant gut microbiomes, using a combination of metagenomic approaches. Faecal samples from 22 six-month-old infants without previous antibiotic exposure were used to construct a pooled metagenomic library, which was functionally screened for ampicillin and gentamicin resistance. Our library of similar to 220Mb contained 0.45 ampicillin resistant hits/Mb and 0.059 gentamicin resistant hits/Mb. PCR-based analysis of fosmid clones and uncloned metagenomic DNA, revealed a diverse and abundant aminoglycoside and beta-lactam resistance reservoir within the infant gut, with resistance determinants exhibiting homology to those found in common gut inhabitants, including Escherichia coli, Enterococcus sp., and Clostridium difficile, as well as to genes from cryptic environmental bacteria. Notably, the genes identified differed from those revealed when a sequence-driven PCR-based screen of metagenomic DNA was employed. Carriage of these antibiotic resistance determinants conferred substantial, but varied (2-512x), increases in antibiotic resistance to their bacterial host. These data provide insights into the infant gut resistome, revealing the presence of a varied aminoglycoside and beta-lactam resistance reservoir even in the absence of selective pressure, confirming the infant resistome establishes early in life, perhaps even at birth.	[Fouhy, Fiona; Ross, R. Paul; Stanton, Catherine; Cotter, Paul D.] Teagasc Food Res Ctr, Fermoy, Cork, Ireland; [Fouhy, Fiona; Fitzgerald, Gerald F.] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland; [Ogilvie, Lesley A.; Jones, Brian V.] Univ Brighton, Sch Pharm & Biomol Sci, Brighton, E Sussex, England; [Jones, Brian V.] Queen Victoria Hosp NHS Fdn Trust, E Grinstead, W Sussex, England; [Ross, R. Paul; Fitzgerald, Gerald F.; Stanton, Catherine; Cotter, Paul D.] Alimentary Pharmabiot Ctr, Cork, Ireland; [Ryan, Anthony C.; Dempsey, Eugene M.] Natl Univ Ireland Univ Coll Cork, Dept Paediat & Child Hlth, Cork, Ireland; [Dempsey, Eugene M.] Natl Univ Ireland Univ Coll Cork, Matern Hosp, Dept Neonatol, Cork, Ireland	Teagasc; University College Cork; University of Brighton; University College Cork; University College Cork; University College Cork	Cotter, PD (corresponding author), Teagasc Food Res Ctr, Moorepk, Fermoy, Cork, Ireland.	paul.cotter@teagasc.ie	Stanton, Catherine/A-9549-2015; Ross, Paul/A-7584-2015; Cotter, Paul/B-7781-2008; Cotter, Paul/AAX-5449-2021; Dempsey, Eugene/AAG-3037-2021; Dempsey, Eugene Michael/H-8051-2015	Stanton, Catherine/0000-0002-6724-7011; Ross, Paul/0000-0003-4876-8839; Cotter, Paul/0000-0002-5465-9068; Cotter, Paul/0000-0002-5465-9068; Dempsey, Eugene Michael/0000-0002-6266-3462; Fouhy, Fiona/0000-0002-8285-7694; Jones, Brian/0000-0002-1211-9186; Ogilvie, Lesley/0000-0001-9794-2915	Irish Research Council EMBARK scholarship; Irish Government [11/PI/1137]; Science Foundation of Ireland-funded centre for Science Engineering and Technology; Alimentary Pharmabiotic Centre; Irish Government; UK Medical Research Council [G0901553]; Hospital Infection Society; Society for Applied Microbiology; University of Brighton; Medical Research Council [G0901553] Funding Source: researchfish; MRC [G0901553] Funding Source: UKRI	Irish Research Council EMBARK scholarship(Irish Research Council for Science, Engineering and Technology); Irish Government; Science Foundation of Ireland-funded centre for Science Engineering and Technology(Science Foundation Ireland); Alimentary Pharmabiotic Centre(Science Foundation Ireland); Irish Government; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Hospital Infection Society; Society for Applied Microbiology; University of Brighton; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	FF is in receipt of an Irish Research Council EMBARK scholarship and is a Teagasc Walsh fellow. Research in the PDC laboratory is supported by the Irish Government under the National Development Plan through the Science Foundation Ireland Investigator award 11/PI/1137. This research was supported by the Science Foundation of Ireland-funded centre for Science Engineering and Technology, the Alimentary Pharmabiotic Centre, and the Irish Government under the National Development plan (INFANTMET: http://eldermet.ucc.ie). LAO and BVJ are funded by the UK Medical Research Council (grant number G0901553 awarded to BVJ), with work in the laboratory of BVJ also supported by the Hospital Infection Society, the Society for Applied Microbiology and the University of Brighton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Bailey JK, 2011, J ANTIMICROB CHEMOTH, V66, P745, DOI 10.1093/jac/dkq529; Bartoloni A, 2009, INT J ANTIMICROB AG, V33, P125, DOI 10.1016/j.ijantimicag.2008.07.029; Boehm G, 2008, J NUTR, V138, p1818S, DOI 10.1093/jn/138.9.1818S; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Brinas L, 2002, ANTIMICROB AGENTS CH, V46, P3156, DOI 10.1128/AAC.46.10.3156-3163.2002; Cheng G, 2012, FEMS MICROBIOL LETT, V336, P11, DOI 10.1111/j.1574-6968.2012.02647.x; Coque TM, 2002, ANTIMICROB AGENTS CH, V46, P500, DOI 10.1128/AAC.46.2.500-510.2002; DALE JW, 1985, FEBS LETT, V191, P39, DOI 10.1016/0014-5793(85)80989-3; de Vries LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021644; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Donato JJ, 2010, APPL ENVIRON MICROB, V76, P4396, DOI 10.1128/AEM.01763-09; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fouhy F, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-25; Fouhy F, 2012, ANTIMICROB AGENTS CH, V56, P5811, DOI 10.1128/AAC.00789-12; Fouhy F, 2012, GUT MICROBES, V3, P203, DOI 10.4161/gmic.20169; Gloux K, 2007, APPL ENVIRON MICROB, V73, P3734, DOI 10.1128/AEM.02204-06; Gueimonde M, 2006, FEMS IMMUNOL MED MIC, V48, P21, DOI 10.1111/j.1574-695X.2006.00112.x; Heuer H, 2002, FEMS MICROBIOL ECOL, V42, P289, DOI 10.1111/j.1574-6941.2002.tb01019.x; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Jones BV, 2007, NAT METHODS, V4, P55, DOI 10.1038/NMETH964; Kirtzalidou E, 2011, ANAEROBE, V17, P440, DOI 10.1016/j.anaerobe.2011.05.007; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Le Huerou-Luron I, 2010, NUTR RES REV, V23, P23, DOI 10.1017/S0954422410000065; Lopes MD, 2005, INT J FOOD MICROBIOL, V103, P191, DOI 10.1016/j.ijfoodmicro.2004.12.025; Lorenz P, 2005, NAT REV MICROBIOL, V3, P510, DOI 10.1038/nrmicro1161; Marques TM, 2010, CURR OPIN BIOTECH, V21, P149, DOI 10.1016/j.copbio.2010.03.020; Martiny AC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00238; Millar M, 2008, J CLIN MICROBIOL, V46, P560, DOI 10.1128/JCM.00832-07; Monstein HJ, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-7; Moore AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078822; MOROSINI MI, 1995, ANTIMICROB AGENTS CH, V39, P458, DOI 10.1128/AAC.39.2.458; Ogilvie LA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3420; Pallecchi L, 2008, EXPERT REV ANTI-INFE, V6, P725, DOI 10.1586/14787210.6.5.725; Pallecchi L, 2007, ANTIMICROB AGENTS CH, V51, P1179, DOI 10.1128/AAC.01101-06; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Penders J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00087; Qin X, 2009, ANTIMICROB AGENTS CH, V53, P340, DOI 10.1128/AAC.01442-08; Rivera AM, 2011, MAYO CLIN PROC, V86, P1230, DOI 10.4065/mcp.2011.0514; Rolain JM, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00173; Roy S, 2010, EUR J CLIN MICROBIOL, V29, P1495, DOI 10.1007/s10096-010-1030-z; Schmitz FJ, 1999, J ANTIMICROB CHEMOTH, V43, P253, DOI 10.1093/jac/43.2.253; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Tanaka S, 2009, FEMS IMMUNOL MED MIC, V56, P80, DOI 10.1111/j.1574-695X.2009.00553.x; TENOVER FC, 1994, J CLIN MICROBIOL, V32, P2729, DOI 10.1128/JCM.32.11.2729-2737.1994; Vakulenko SB, 2003, ANTIMICROB AGENTS CH, V47, P1423, DOI 10.1128/AAC.47.4.1423-1426.2003; VANHOOF R, 1994, J MED MICROBIOL, V41, P282, DOI 10.1099/00222615-41-4-282; Westerbeek EAM, 2006, CLIN NUTR, V25, P361, DOI 10.1016/j.clnu.2006.03.002; Zhang L, 2013, ANTIMICROB AGENTS CH, V57, P3659, DOI 10.1128/AAC.00670-13; Zhang L, 2011, APPL ENVIRON MICROB, V77, P7134, DOI 10.1128/AEM.05087-11	50	36	37	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108016	10.1371/journal.pone.0108016	http://dx.doi.org/10.1371/journal.pone.0108016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247417	gold, Green Published, Green Submitted			2022-12-25	WOS:000342351800052
J	Imada, T; Nakamura, S; Kitamura, N; Shibuya, I; Tsubota, K				Imada, Toshihiro; Nakamura, Shigeru; Kitamura, Naoki; Shibuya, Izumi; Tsubota, Kazuo			Oral Administration of Royal Jelly Restores Tear Secretion Capacity in Rat Blink-Suppressed Dry Eye Model by Modulating Lacrimal Gland Function	PLOS ONE			English	Article							IN-VITRO; PREVALENCE; MECHANISMS; PROTECTS; DISEASE; STRESS; HEALTH; COLON	Tears are secreted from the lacrimal gland (LG), a dysfunction in which induces dry eye, resulting in ocular discomfort and visual impairment. Honey bee products are used as a nutritional source in daily life and medicine; however, little is known about their effects on dry eye. The aim of the present study was to investigate the effects of honey bee products on tear secretion capacity in dry eye. We selected raw honey, propolis, royal jelly (RJ), pollen, or larva from commercially available honey bee products. Tear secretion capacity was evaluated following the oral administration of each honey bee product in a rat blink-suppressed dry eye model. Changes in tear secretion, LG ATP content, and LG mitochondrial levels were measured. RJ restored the tear secretion capacity and decrease in LG ATP content and mitochondrial levels to the largest extent. Royal jelly can be used as a preventative intervention for dry eye by managing tear secretion capacity in the LG.	[Imada, Toshihiro; Nakamura, Shigeru; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Kitamura, Naoki; Shibuya, Izumi] Tottori Univ, Fac Agr, Dept Vet Physiol, Tottori 680, Japan	Keio University; Tottori University	Nakamura, S (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	vdtwork@gmail.com		Shibuya, Izumi/0000-0003-4137-5856	Yamada Bee company, Inc.	Yamada Bee company, Inc.	This work was supported by a Yamada research grant from Yamada Bee company, Inc. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. This funding source had no involvement in the study design, data collection and analysis decision to publish, or preparation of the manuscript.	Bogdanov S, 2008, J AM COLL NUTR, V27, P677, DOI 10.1080/07315724.2008.10719745; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Dartt DA, 2009, PROG RETIN EYE RES, V28, P155, DOI 10.1016/j.preteyeres.2009.04.003; Friedman NJ, 2010, CURR OPIN OPHTHALMOL, V21, P310, DOI 10.1097/ICU.0b013e32833a8c15; Garcia-Bueno B, 2007, NEUROPSYCHOPHARMACOL, V32, P1251, DOI 10.1038/sj.npp.1301252; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Hamm-Alvarez SF, 1998, ADV DRUG DELIVER REV, V29, P229, DOI 10.1016/S0169-409X(97)00081-1; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Inokuchi Y, 2006, EVID-BASED COMPL ALT, V3, P71, DOI 10.1093/ecam/nek005; Israeli E, 2008, DIGEST DIS SCI, V53, P88, DOI 10.1007/s10620-007-9827-z; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; Karaca T, 2012, ALLERGOL IMMUNOPATH, V40, P357, DOI 10.1016/j.aller.2011.09.004; Koh S, 2003, AM J OPHTHALMOL, V136, P513, DOI 10.1016/S0002-9394(03)00317-9; Lemp MA, 2008, AM J OPHTHALMOL, V146, P350, DOI 10.1016/j.ajo.2008.05.016; Mansour AM, 2002, CLIN EXP OPHTHALMOL, V30, P149, DOI 10.1046/j.1442-6404.2002.00482.x; Mathers William D., 2000, CLAO Journal, V26, P159; MIRCHEFF AK, 1989, CURR EYE RES, V8, P607, DOI 10.3109/02713688908995761; MISHIMA S, 1965, ARCH OPHTHALMOL-CHIC, V73, P233; Nakamura R, 2010, INT IMMUNOPHARMACOL, V10, P1107, DOI 10.1016/j.intimp.2010.06.013; Nakamura S, 2005, INVEST OPHTH VIS SCI, V46, P2379, DOI 10.1167/iovs.04-1344; Nakamura S, 2007, INVEST OPHTH VIS SCI, V48, P1552, DOI 10.1167/iovs.06-1027; Nakamura S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011119; Okamoto I, 2003, LIFE SCI, V73, P2029, DOI 10.1016/S0024-3205(03)00562-9; Pagliarone AC, 2009, J ETHNOPHARMACOL, V125, P230, DOI 10.1016/j.jep.2009.07.005; SAITO Y, 1987, J MEMBRANE BIOL, V98, P135, DOI 10.1007/BF01872126; SAKAMOTO R, 1993, INVEST OPHTH VIS SCI, V34, P3510; Schaumberg DA, 2003, AM J OPHTHALMOL, V136, P318, DOI 10.1016/S0002-9394(03)00218-6; Schaumberg DA, 2009, ARCH OPHTHALMOL-CHIC, V127, P763, DOI 10.1001/archophthalmol.2009.103; Shimizu Tomomi, 2008, Antiviral Chemistry & Chemotherapy, V19, P7; Souza RM, 2007, Z NATURFORSCH C, V62, P801; Takaki-Doi S, 2009, ACTA MED OKAYAMA, V63, P57; Terada Y, 2011, J AGR FOOD CHEM, V59, P2627, DOI 10.1021/jf1041646; TSUBOTA K, 1993, NEW ENGL J MED, V328, P584, DOI 10.1056/NEJM199302253280817; Uchino M, 2008, OPHTHALMOLOGY, V115, P1982, DOI 10.1016/j.ophtha.2008.06.022; Wang CC, 2007, MOL BIOL CELL, V18, P1056, DOI 10.1091/mbc.E06-10-0974; Wang XX, 2009, CELL STRESS CHAPERON, V14, P639, DOI 10.1007/s12192-009-0116-y; Wei W, 2009, ELECTROPHORESIS, V30, P1949, DOI 10.1002/elps.200800721; WOOD RL, 1986, INVEST OPHTH VIS SCI, V27, P1293; World Health Organization, 1987, WHO OFFS PUBL, V99; Wu KJ, 2006, EXP EYE RES, V83, P84, DOI 10.1016/j.exer.2005.11.009; Zainol MI, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-129	41	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e106338	10.1371/journal.pone.0106338	http://dx.doi.org/10.1371/journal.pone.0106338			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243778	Green Submitted, Green Published, gold			2022-12-25	WOS:000343679800010
J	Lei, NF; Li, J; Ni, SJ; Chen, JS				Lei, Ningfei; Li, Jun; Ni, Shijun; Chen, Jinsong			Effects of Clonal Integration on Microbial Community Composition and Processes in the Rhizosphere of the Stoloniferous Herb Glechoma longituba (Nakai) Kuprian	PLOS ONE			English	Article							FITNESS-RELATED TRAITS; ORGANIC-MATTER; EXOENZYME ACTIVITY; MYCORRHIZAL FUNGI; EXTRACTION METHOD; ENZYME-ACTIVITIES; NITROGEN UPTAKE; SOIL-NITROGEN; CARBON FLOW; PLANT	The effects of rhizodeposition on soil C and N availabilities lead to substantial changes of microbial community composition and processes in the rhizosphere of plants. Under heterogeneous light, photosynthates can be translocated or shared between exposed and shaded ramets by clonal integration. Clonal integration may enhance the rhizodeposition of the shaded ramets, which further influences nutrient recycling in their rhizosphere. To test the hypothesis, we conducted a pot experiment by the stoloniferous herb Glechoma longituba subjected to heterogeneous light. Microbial biomass and community composition in the rhizosphere of shaded offspring ramets, assessed by phospholipid fatty acids (PLFAs) analysis, were markedly altered by clonal integration. Clonal integration positively affected C, N availabilities, invertase and urease activities, N mineralization (N-min) and nitrification rates (N-nitri) in the rhizosphere of shaded offspring ramets. However, an opposite pattern was also observed in phenoloxidase (POXase) and peroxidase (PODase) activities. Our results demonstrated that clonal integration facilitated N assimilation and uptake in the rhizosphere of shaded offspring ramets. The experiment provides insights into the mechanism of nutrient recycling mediated by clonal integration.	[Lei, Ningfei; Li, Jun; Ni, Shijun] Chengdu Univ Technol, Chengdu, Peoples R China; [Chen, Jinsong] Sichuan Normal Univ, Chengdu, Peoples R China	Chengdu University of Technology; Sichuan Normal University	Ni, SJ (corresponding author), Chengdu Univ Technol, Chengdu, Peoples R China.	nsj@cdut.edu.cn; cjs74@163.com			National Natural Science Foundation of China [31170502]; Study On the Breed of Trichosanthes kirilowii New Varieties and Supporting Technology [2011NZ0098-12-07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Study On the Breed of Trichosanthes kirilowii New Varieties and Supporting Technology	This project was supported by the National Natural Science Foundation of China (Grant No. 31170502) and the Study On the Breed of Trichosanthes kirilowii New Varieties and Supporting Technology (Grant No. 2011NZ0098-12-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERT P, 1986, OECOLOGIA, V70, P227, DOI 10.1007/BF00379244; Alpert P, 1999, PLANT ECOL, V141, P99, DOI 10.1023/A:1009823015170; APPEL T, 1993, SOIL BIOL BIOCHEM, V25, P685, DOI 10.1016/0038-0717(93)90108-N; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Baldrian P, 2009, OECOLOGIA, V161, P657, DOI 10.1007/s00442-009-1433-7; Barea JM, 2005, J EXP BOT, V56, P1761, DOI 10.1093/jxb/eri197; Blagodatskaya E, 2010, GLOBAL CHANGE BIOL, V16, P836, DOI 10.1111/j.1365-2486.2009.02006.x; Brant JB, 2006, OECOLOGIA, V148, P650, DOI 10.1007/s00442-006-0402-7; Brierley EDR, 2001, PLANT SOIL, V229, P97, DOI 10.1023/A:1004823132574; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Butler JL, 2004, SOIL BIOL BIOCHEM, V36, P371, DOI 10.1016/j.soilbio.2003.10.011; Carter MR, 1993, SOIL SAMPLING METHOD, P599; Chantigny MH, 1999, SOIL BIOL BIOCHEM, V31, P543, DOI 10.1016/S0038-0717(98)00139-4; Chen DM, 2012, APPL SOIL ECOL, V53, P108, DOI 10.1016/j.apsoil.2011.10.014; Cheng W. X., 2005, Roots and soil management: interactions between roots and the soil, P119; De Boer W, 2001, SOIL BIOL BIOCHEM, V33, P853, DOI 10.1016/S0038-0717(00)00247-9; Du JA, 2010, FLORA, V205, P399, DOI 10.1016/j.flora.2009.12.018; EVANS JP, 1991, OECOLOGIA, V86, P268, DOI 10.1007/BF00317540; Fontaine S, 2003, SOIL BIOL BIOCHEM, V35, P837, DOI 10.1016/S0038-0717(03)00123-8; Fu SL, 2004, PLANT SOIL, V263, P345, DOI 10.1023/B:PLSO.0000047745.30929.32; Gianfreda L, 2005, SCI TOTAL ENVIRON, V341, P265, DOI 10.1016/j.scitotenv.2004.10.005; GIANFREDA L, 1995, SOIL BIOL BIOCHEM, V27, P1201, DOI 10.1016/0038-0717(95)00034-C; Grayston SJ, 1997, APPL SOIL ECOL, V5, P29, DOI 10.1016/S0929-1393(96)00126-6; Green CT, 2000, HYDROGEOL J, V8, P126, DOI 10.1007/s100400050013; Gregorich EG, 1998, J ENVIRON QUAL, V27, P209, DOI 10.2134/jeq1998.00472425002700010029x; Gu Y, 2009, EUR J SOIL BIOL, V45, P436, DOI 10.1016/j.ejsobi.2009.06.003; He WM, 2011, J ECOL, V99, P1202, DOI 10.1111/j.1365-2745.2011.01848.x; Hobbie EA, 2007, NEW PHYTOL, V173, P447, DOI 10.1111/j.1469-8137.2007.01984.x; Hogberg MN, 2007, OECOLOGIA, V150, P590, DOI 10.1007/s00442-006-0562-5; Hutsch BW, 2002, J PLANT NUTR SOIL SC, V165, P397, DOI 10.1002/1522-2624(200208)165:4<397::AID-JPLN397>3.0.CO;2-C; Johnsen AR, 2008, SOIL BIOL BIOCHEM, V40, P814, DOI 10.1016/j.soilbio.2007.10.017; Jones DL, 2009, PLANT SOIL, V321, P5, DOI 10.1007/s11104-009-9925-0; Jones DL, 2004, NEW PHYTOL, V163, P459, DOI 10.1111/j.1469-8137.2004.01130.x; Kaiser C, 2010, NEW PHYTOL, V187, P843, DOI 10.1111/j.1469-8137.2010.03321.x; KANDELER E, 1988, BIOL FERT SOILS, V6, P68, DOI 10.1007/BF00257924; Keeney D. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P643; Koranda M, 2011, SOIL BIOL BIOCHEM, V43, P551, DOI 10.1016/j.soilbio.2010.11.022; Kuzyakov Y, 2002, J PLANT NUTR SOIL SC, V165, P382, DOI 10.1002/1522-2624(200208)165:4<382::AID-JPLN382>3.0.CO;2-#; Kuzyakov Y, 2001, SOIL BIOL BIOCHEM, V33, P1915, DOI 10.1016/S0038-0717(01)00117-1; Liao MJ, 2003, ACTA OECOL, V24, P231, DOI 10.1016/j.actao.2003.07.001; Lindahl BD, 2007, NEW PHYTOL, V173, P611, DOI 10.1111/j.1469-8137.2006.01936.x; MOBLEY HLT, 1989, MICROBIOL REV, V53, P85, DOI 10.1128/MMBR.53.1.85-108.1989; Murphy DV, 2000, BIOL FERT SOILS, V30, P374, DOI 10.1007/s003740050018; Nelson N, 1944, J BIOL CHEM, V153, P375; Norton JM, 1996, SOIL BIOL BIOCHEM, V28, P351, DOI 10.1016/0038-0717(95)00155-7; Olsson PA, 1999, FEMS MICROBIOL ECOL, V29, P303, DOI 10.1111/j.1574-6941.1999.tb00621.x; Perucci P, 2000, SOIL BIOL BIOCHEM, V32, P1927, DOI 10.1016/S0038-0717(00)00168-1; Priha O, 1999, FEMS MICROBIOL ECOL, V30, P187, DOI 10.1111/j.1574-6941.1999.tb00647.x; Rajaniemi TK, 2009, SOIL BIOL BIOCHEM, V41, P102, DOI 10.1016/j.soilbio.2008.10.001; Ren Wen, 2011, Journal of Forestry Research (Harbin), V22, P569, DOI 10.1007/s11676-011-0200-x; RILEY D, 1970, SOIL SCI SOC AM PRO, V34, P154, DOI 10.2136/sssaj1970.03615995003400010042x; Rinnan R, 2007, GLOBAL CHANGE BIOL, V13, P28, DOI 10.1111/j.1365-2486.2006.01263.x; Roiloa SR, 2007, ENVIRON EXP BOT, V61, P1, DOI 10.1016/j.envexpbot.2007.02.006; Schimel JP, 2003, SOIL BIOL BIOCHEM, V35, P549, DOI 10.1016/S0038-0717(03)00015-4; Sinsabaugh RL, 2010, SOIL BIOL BIOCHEM, V42, P391, DOI 10.1016/j.soilbio.2009.10.014; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; VESTAL JR, 1989, BIOSCIENCE, V39, P535, DOI 10.2307/1310976; Weintraub MN, 2007, OECOLOGIA, V154, P327, DOI 10.1007/s00442-007-0804-1; Wilsey B, 2002, PLANT ECOL, V159, P15, DOI 10.1023/A:1015556816307; WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3; Yarwood SA, 2009, FEMS MICROBIOL ECOL, V70, P151, DOI 10.1111/j.1574-6941.2009.00733.x; Zeller B, 2008, SOIL BIOL BIOCHEM, V40, P1155, DOI 10.1016/j.soilbio.2007.12.009; [张丽珍 ZHANG Li-Zhen], 2009, [生态学报, Acta Ecologica Sinica], V29, P4693; Zhou WM, 2011, ANN FOREST SCI, V68, P943, DOI 10.1007/s13595-011-0100-4	64	13	18	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e108259	10.1371/journal.pone.0108259	http://dx.doi.org/10.1371/journal.pone.0108259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243590	gold, Green Published, Green Submitted			2022-12-25	WOS:000343679800080
J	Shah, AMU; Zhao, Y; Wang, YF; Yan, GQ; Zhang, QK; Wang, LY; Tian, B; Chen, H; Hua, YJ				Shah, Amir Miraj Ul Hussain; Zhao, Ye; Wang, Yunfei; Yan, Guoquan; Zhang, Qikun; Wang, Liangyan; Tian, Bing; Chen, Huan; Hua, Yuejin			A Mur Regulator Protein in the Extremophilic Bacterium Deinococcus radiodurans	PLOS ONE			English	Article							HYDROGEN-PEROXIDE STRESS; IONIZING-RADIATION; HEME-BIOSYNTHESIS; OXIDATIVE STRESS; EXTREME RADIORESISTANCE; RESPONSE REGULATOR; MANGANESE; GENE; RESISTANCE; SURVIVAL	Ferric uptake regulator (Fur) is a transcriptional regulator that controls the expression of genes involved in the uptake of iron and manganese, as well as vital nutrients, and is essential for intracellular redox cycling. We identified a unique Fur homolog (DR0865) from Deinococcus radiodurans, which is known for its extreme resistance to radiation and oxidants. A dr0865 mutant (Mt-0865) showed a higher sensitivity to manganese stress, hydrogen peroxide, gamma irradiation and ultraviolet (UV) irradiation than the wild-type R1 strain. Cellular manganese (Mn) ion (Mn2+) analysis showed that Mn2+, copper (Cu2+), and ferric (Fe3+) ions accumulated significantly in the mutant, which suggests that the dr0865 gene is not only involved in the regulation of Mn2+ homeostasis, but also affects the uptake of other ions. In addition, transcriptome profiles under MnCl2 stress showed that the expression of many genes involved in Mn metabolism was significantly different in the wild-type R1 and DR0865 mutant (Mt-0865). Furthermore, we found that the dr0865 gene serves as a positive regulator of the manganese efflux pump gene mntE (dr1236), and as a negative regulator of Mn ABC transporter genes, such as dr2283, dr2284 and dr2523. Therefore, it plays an important role in maintaining the homoeostasis of intracellular Mn (II), and also other Mn2+, zinc (Zn2+) and Cu2+ ions. Based on its role in manganese homeostasis, DR0865 likely belongs to the Mur sub-family of Fur homolog.	[Shah, Amir Miraj Ul Hussain; Zhao, Ye; Wang, Yunfei; Wang, Liangyan; Tian, Bing; Hua, Yuejin] Zhejiang Univ, Inst Nucl Agr Sci, Key Lab Chinese, Minist Agr Nucl Agr Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Huan] Sch Lab Med & Life Sci, Zhejiang Prov Key Lab Med Genet, Minist Educ, Key Lab Lab Med, Wenzhou, Peoples R China; [Yan, Guoquan; Zhang, Qikun; Chen, Huan] Zhejiang Inst Microbiol, Lab Microbiol & Genom, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Chen, H (corresponding author), Sch Lab Med & Life Sci, Zhejiang Prov Key Lab Med Genet, Minist Educ, Key Lab Lab Med, Wenzhou, Peoples R China.	chenhuan7809@gmail.com; yjhua@zju.edu.cn	Zhao, Ye/I-2936-2014; Chen, Huan/CAH-8180-2022	Zhao, Ye/0000-0002-5455-2586; 	National Natural Science Foundation of China [31100058, 31210103904, 31370102]; Ministry of Agriculture of China [2014ZX08009-003-002, 201103007]; Program for New Century Excellent Talents in University [NCET-10-0739]; Natural Science Foundation; Science and Technology Department of Zhejiang Province of China [2013F20011, 2014F50012, 2014F30033]; Fundamental Research Funds for the Central Universities from Zhejiang University [2013QNA6015]; Key Innovation Team Program of Zhejiang Province [2010R50033]; Educational Commission of Zhejiang Province [LY13C010001, Y201329892]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Zhejiang Province of China; Fundamental Research Funds for the Central Universities from Zhejiang University; Key Innovation Team Program of Zhejiang Province; Educational Commission of Zhejiang Province	This work was supported by grants from National Natural Science Foundation of China (31100058, 31210103904, 31370102), and a major project for genetically modified organisms breeding from the Ministry of Agriculture of China (2014ZX08009-003-002), a grant from Special Fund for Agro-scientific Research in the Public Interest from the Ministry of Agriculture of China (201103007), a Program for New Century Excellent Talents in University (NCET-10-0739), the Natural Science Foundation and Educational Commission of Zhejiang Province (LY13C010001, Y201329892), a project of the Science and Technology Department of Zhejiang Province of China (2013F20011, 2014F50012, 2014F30033), the Fundamental Research Funds for the Central Universities from Zhejiang University (2013QNA6015), and Key Innovation Team Program of Zhejiang Province (2010R50033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre JD, 2013, J BIOL CHEM, V288, P8468, DOI 10.1074/jbc.M112.433540; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Anjem A, 2012, J BIOL CHEM, V287, P15544, DOI 10.1074/jbc.M111.330365; Banh A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077835; Battista JR, 1999, TRENDS MICROBIOL, V7, P362, DOI 10.1016/S0966-842X(99)01566-8; Battista JR, 1997, ANNU REV MICROBIOL, V51, P203, DOI 10.1146/annurev.micro.51.1.203; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Chen H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001602; Chen HA, 2010, BIOCHEM BIOPH RES CO, V396, P413, DOI 10.1016/j.bbrc.2010.04.106; CHEUNG HY, 1982, J GEN MICROBIOL, V128, P2395; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Dian C, 2011, MOL MICROBIOL, V79, P1260, DOI 10.1111/j.1365-2958.2010.07517.x; Diaz-Mireles E, 2004, MICROBIOL-SGM, V150, P1447, DOI 10.1099/mic.0.26961-0; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Faulkner MJ, 2011, ANTIOXID REDOX SIGN, V15, P175, DOI 10.1089/ars.2010.3682; Funayama T, 1999, MUTAT RES-DNA REPAIR, V435, P151, DOI 10.1016/S0921-8777(99)00044-0; Gaballa A, 2002, J BACTERIOL, V184, P6508, DOI 10.1128/JB.184.23.6508-6514.2002; Gao GJ, 2005, CHINESE SCI BULL, V50, P311, DOI 10.1360/982004-719; Ghosal D, 2005, FEMS MICROBIOL REV, V29, P361, DOI 10.1016/j.fmrre.2004.12.007; Gilbreath JJ, 2013, MOL MICROBIOL, V89, P304, DOI 10.1111/mmi.12278; GUTTERIDGE JMC, 1986, BIOCHEM J, V234, P225, DOI 10.1042/bj2340225; Hamza I, 1998, J BIOL CHEM, V273, P21669, DOI 10.1074/jbc.273.34.21669; Hua YJ, 2003, BIOCHEM BIOPH RES CO, V306, P354, DOI 10.1016/S0006-291X(03)00965-3; Jiao JD, 2012, DNA REPAIR, V11, P349, DOI 10.1016/j.dnarep.2011.11.008; Kamble VA, 2010, DNA REPAIR, V9, P488, DOI 10.1016/j.dnarep.2010.01.012; King KY, 2000, J BACTERIOL, V182, P5290, DOI 10.1128/JB.182.19.5290-5299.2000; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; MOODY MD, 1985, J BACTERIOL, V161, P1074, DOI 10.1128/JB.161.3.1074-1079.1985; Qi ZH, 2002, MOL CELL, V9, P155, DOI 10.1016/S1097-2765(01)00431-2; Ren SC, 2012, CELL RES, V22, P806, DOI 10.1038/cr.2012.30; REPINE JE, 1981, P NATL ACAD SCI-BIOL, V78, P1001, DOI 10.1073/pnas.78.2.1001; Rosch JW, 2008, MOL MICROBIOL, V70, P435, DOI 10.1111/j.1365-2958.2008.06425.x; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Srinivasan VB, 2012, FEBS LETT, V586, P3778, DOI 10.1016/j.febslet.2012.09.007; Sun HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035057; Sun HX, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-319; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang LY, 2008, MOL MICROBIOL, V67, P1211, DOI 10.1111/j.1365-2958.2008.06113.x; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Zhang TF, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-85; Zhu XN, 2008, APPL ENVIRON MICROB, V74, P7675, DOI 10.1128/AEM.01229-08	42	12	14	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e106341	10.1371/journal.pone.0106341	http://dx.doi.org/10.1371/journal.pone.0106341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243898	Green Submitted, gold, Green Published			2022-12-25	WOS:000343679800011
J	Arismendi, E; Rivas, E; Agusti, A; Rios, J; Barreiro, E; Vidal, J; Rodriguez-Roisin, R				Arismendi, Ebymar; Rivas, Eva; Agusti, Alvar; Rios, Jose; Barreiro, Esther; Vidal, Josep; Rodriguez-Roisin, Robert			The Systemic Inflammome of Severe Obesity before and after Bariatric Surgery	PLOS ONE			English	Article							GASTRIC BYPASS-SURGERY; ADIPOSE-TISSUE; INCREASED 8-ISOPROSTANE; CARDIOVASCULAR RISK; BREATH CONDENSATE; OXIDATIVE STRESS; INFLAMMATION; ASTHMA; NETWORK; STANDARDIZATION	Introduction: Obesity is associated with low-grade systemic inflammation. The "inflammome'' is a network layout of the inflammatory pattern. The systemic inflammome of obesity has not been described as yet. We hypothesized that it can be significantly worsened by smoking and other comorbidities frequently associated with obesity, and ameliorated by bariatric surgery (BS). Besides, whether or not these changes are mirrored in the lungs is unknown, but obesity is often associated with pulmonary inflammation and bronchial hyperresponsiveness. Objectives: We sought to: (1) describe the systemic inflammome of morbid obesity; (2) investigate the effects of sex, smoking, sleep apnea syndrome, metabolic syndrome and BS upon this systemic inflammome; and, (3) determine their interplay with pulmonary inflammation. Methods: We studied 129 morbidly obese patients (96 females; age 46 +/- 12 years; body mass index [BMI], 46 +/- 6 kg/m(2)) before and one year after BS, and 20 healthy, never-smokers, (43 +/- 7 years), with normal BMI and spirometry. Results: Before BS, compared with controls, all obese subjects displayed a strong and coordinated (inflammome) systemic inflammatory response (adiponectin, C-reactive protein, interleukin (IL)-8, IL-10, leptin, soluble tumor necrosis factor-receptor 1(sTNF-R1), and 8-isoprostane). This inflammome was not modified by sex, smoking, or coexistence of obstructive sleep apnea and/or metabolic syndrome. By contrast, it was significantly ameliorated, albeit not completely abolished, after BS. Finally, obese subjects had evidence of pulmonary inflammation (exhaled condensate) that also decreased after BS. Conclusions: The systemic inflammome of morbid obesity is independent of sex, smoking status and/or comorbidities, it is significantly reduced by BS and mirrored in the lungs.	[Arismendi, Ebymar; Agusti, Alvar; Rodriguez-Roisin, Robert] Hosp Clin Barcelona, Inst Clin Torax, Serv Pneumol, Barcelona, Spain; [Arismendi, Ebymar; Agusti, Alvar; Vidal, Josep; Rodriguez-Roisin, Robert] Hosp Clin Barcelona, Fundacio Clin Recerca Biomed, Barcelona, Spain; [Arismendi, Ebymar; Agusti, Alvar; Barreiro, Esther; Rodriguez-Roisin, Robert] CIBER Enfermedades Resp CIBERES, Barcelona, Spain; [Arismendi, Ebymar; Agusti, Alvar; Barreiro, Esther; Rodriguez-Roisin, Robert] CIBER Enfermedades Resp CIBERES, Palma De Mallorca, Spain; [Arismendi, Ebymar; Rivas, Eva; Agusti, Alvar; Rios, Jose; Vidal, Josep; Rodriguez-Roisin, Robert] Univ Barcelona, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain; [Rivas, Eva] Hosp Clin Barcelona, Serv Anestesiol & Reanimacio, Barcelona, Spain; [Rios, Jose] Univ Autonoma Barcelona, Biostat & Data Management Core Facil, Biostat Unit, E-08193 Barcelona, Spain; [Barreiro, Esther] Hosp del Mar, Dept Pulmonol, Barcelona, Spain; [Barreiro, Esther] Univ Pompeu Fabra, PRBB, Barcelona, Spain; [Vidal, Josep] Hosp Clin Barcelona, Serv Endocrinol, Inst Clin Malalties Digest & Metab, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; University of Barcelona; Hospital Clinic de Barcelona	Rodriguez-Roisin, R (corresponding author), Hosp Clin Barcelona, Inst Clin Torax, Serv Pneumol, Barcelona, Spain.	rororo@clinic.ub.es	Garcia-Navarro, Alvar Agusti/F-4474-2015; Rivas, Eva/AFU-7933-2022; Ríos, José/AAZ-2341-2020	Garcia-Navarro, Alvar Agusti/0000-0003-3271-3788; Rivas, Eva/0000-0002-5816-998X; Ríos, José/0000-0002-0716-8784; Vidal, Josep/0000-0002-4564-4518; Arismendi, Ebymar/0000-0002-7749-2838	Fondo de Investigacion Sanitaria (FIS) [PI080311]; CIBERES; Generalitat de Catalunya [2009SGR00911]; Almirall	Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); CIBERES; Generalitat de Catalunya(Generalitat de Catalunya); Almirall(Almirall)	This work was supported by Fondo de Investigacion Sanitaria (FIS) PI080311, CIBERES, Generalitat de Catalunya (2009SGR00911) and an unrestricted grant by Almirall. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti A, 2013, AM J RESP CRIT CARE, V188, P1396, DOI 10.1164/rccm.201308-1404PP; Agusti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037483; Agusti A, 2011, AM J RESP CRIT CARE, V183, P1129, DOI 10.1164/rccm.201009-1414PP; American Association of Immunologist, 2011, AM  ASS IMMUNOLOGIST, P7; Barabasi AL, 2007, NEW ENGL J MED, V357, P404, DOI 10.1056/NEJMe078114; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Carpagnano GE, 2010, J BREATH RES, V4, DOI 10.1088/1752-7155/4/3/036003; Carpagnano GE, 2002, CHEST, V122, P1162, DOI 10.1378/chest.122.4.1162; Carpagnano GE, 2008, TRANSL RES, V151, P45, DOI 10.1016/j.trsl.2007.09.004; Carpagnano GE, 2010, TRANSL RES, V155, P35, DOI 10.1016/j.trsl.2009.09.004; Celedon JC, 2001, AM J RESP CRIT CARE, V164, P1835, DOI 10.1164/ajrccm.164.10.2105033; Chirinos JA, 2014, NEW ENGL J MED, V370, P2265, DOI 10.1056/NEJMoa1306187; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Dixon AE, 2011, J ALLERGY CLIN IMMUN, V128, P508, DOI 10.1016/j.jaci.2011.06.009; Enright PL, 1998, AM J RESP CRIT CARE, V158, P1384, DOI 10.1164/ajrccm.158.5.9710086; Faintuch J, 2008, OBES SURG, V18, P854, DOI 10.1007/s11695-008-9504-0; Faner R, 2014, EUR RESP J IN PRESS; Faner R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097491; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Garcia-Aymerich J, 2011, THORAX, V66, P430, DOI 10.1136/thx.2010.154484; Horvath I, 2005, EUR RESPIR J, V26, P523, DOI 10.1183/09031936.05.00029705; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jimenez A, 2012, ANN SURG, V256, P1023, DOI 10.1097/SLA.0b013e318262ee6b; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Montuschi P, 1999, AM J RESP CRIT CARE, V160, P216, DOI 10.1164/ajrccm.160.1.9809140; Montuschi P, 2000, AM J RESP CRIT CARE, V162, P1175, DOI 10.1164/ajrccm.162.3.2001063; Morinigo R, 2007, DIABETES CARE, V30, P1906, DOI 10.2337/dc07-0189; Moy Jason, 2008, Am J Surg, V196, pe56, DOI 10.1016/j.amjsurg.2008.04.008; Muir K, 2004, PHARMACOKINETICS DRU, P235; Petrosyan M, 2008, SLEEP BREATH, V12, P207, DOI 10.1007/s11325-007-0160-8; Rivas E, 2014, CHEST; Roca J, 1998, RESP MED, V92, P454, DOI 10.1016/S0954-6111(98)90291-8; Roca J, 1998, EUR RESPIR J, V11, P1354, DOI 10.1183/09031936.98.11061354; Rodriguez-Trigo G, 2010, ANN INTERN MED, V153, P489, DOI 10.7326/0003-4819-153-8-201010190-00279; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Van HA, 2013, J OBES, V2013; Vendrell J, 2004, OBES RES, V12, P962, DOI 10.1038/oby.2004.118; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867	45	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107859	10.1371/journal.pone.0107859	http://dx.doi.org/10.1371/journal.pone.0107859			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238542	Green Published, Green Submitted, gold			2022-12-25	WOS:000342491600057
J	Kangoye, DT; Nebie, I; Yaro, JB; Debe, S; Traore, S; Ouedraogo, O; Sanou, G; Soulama, I; Diarra, A; Tiono, A; Marsh, K; Sirima, SB; Bejon, P				Kangoye, David Tiga; Nebie, Issa; Yaro, Jean-Baptiste; Debe, Siaka; Traore, Safiatou; Ouedraogo, Oumarou; Sanou, Guillaume; Soulama, Issiaka; Diarra, Amidou; Tiono, Alfred; Marsh, Kevin; Sirima, Sodiomon Bienvenu; Bejon, Philip			Plasmodium falciparum Malaria in Children Aged 0-2 Years: The Role of Foetal Haemoglobin and Maternal Antibodies to Two Asexual Malaria Vaccine Candidates (MSP3 and GLURP)	PLOS ONE			English	Article							GLUTAMATE-RICH PROTEIN; MEROZOITE SURFACE-ANTIGENS; P-AMINOBENZOIC ACID; CLINICAL MALARIA; SEASONAL MALARIA; AFRICAN INFANTS; PROTECTION; RESPONSES; AREA; TRANSMISSION	Background: Children below six months are reported to be less susceptible to clinical malaria. Maternally derived antibodies and foetal haemoglobin are important putative protective factors. We examined antibodies to Plasmodium falciparum merozoite surface protein 3 (MSP3) and glutamate-rich protein (GLURP), in children in their first two years of life in Burkina Faso and their risk of malaria. Methods: A cohort of 140 infants aged between four and six weeks was recruited in a stable transmission area of southwestern Burkina Faso and monitored for 24 months by active and passive surveillance. Malaria infections were detected by examining blood smears using light microscopy. Enzyme-linked immunosorbent assay was used to quantify total Immunoglobulin G to Plasmodium falciparum antigens MSP3 and two regions of GLURP (R0 and R2) on blood samples collected at baseline, three, six, nine, 12, 18 and 24 months. Foetal haemoglobin and variant haemoglobin fractions were measured at the baseline visit using high pressure liquid chromatography. Results: A total of 79.6% of children experienced one or more episodes of febrile malaria during monitoring. Antibody titres to MSP3 were prospectively associated with an increased risk of malaria while antibody responses to GLURP (R0 and R2) did not alter the risk. Antibody titres to MSP3 were higher among children in areas of high malaria risk. Foetal haemoglobin was associated with delayed first episode of febrile malaria and haemoglobin CC type was associated with reduced incidence of febrile malaria. Conclusions: We did not find any evidence of association between titres of antibodies to MSP3, GLURP-R0 or GLURP-R2 as measured by enzyme-linked immunosorbent assay and early protection against malaria, although anti-MSP3 antibody titres may reflect increased exposure to malaria and therefore greater risk. Foetal haemoglobin was associated with protection against febrile malaria despite the study limitations and its role is therefore worthy further investigation.	[Kangoye, David Tiga; Nebie, Issa; Yaro, Jean-Baptiste; Debe, Siaka; Traore, Safiatou; Ouedraogo, Oumarou; Sanou, Guillaume; Soulama, Issiaka; Diarra, Amidou; Tiono, Alfred; Sirima, Sodiomon Bienvenu] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Marsh, Kevin; Bejon, Philip] Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya; [Marsh, Kevin; Bejon, Philip] Univ Oxford, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Nuffield Dept Med, Oxford, England	Kenya Medical Research Institute; University of Oxford	Sirima, SB (corresponding author), Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso.	s.sirima.cnlp@fasonet.bf	SOULAMA, Issiaka/Z-1254-2019	SOULAMA, Issiaka/0000-0002-0993-0525; Nebie, Issa/0000-0003-3051-3600; SIRIMA, Sodiomon Bienvenu/0000-0002-0972-4211; SANOU, Guilllaume/0000-0003-0536-616X	European and Developing Countries Clinical Trials Partnership [IP.2008.31100.001]; UK Medical Research Council (MRC); UK Department for International Development (DFID) under the MRC/DFID; MRC [G1002624] Funding Source: UKRI; Medical Research Council [G1002624] Funding Source: researchfish	European and Developing Countries Clinical Trials Partnership; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the European and Developing Countries Clinical Trials Partnership, grant number IP.2008.31100.001 to the Malaria Vectored Vaccines Consortium (MVVC), and coordinated by the European Vaccine Initiative. PB is jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achidi EA, 1996, ACTA TROP, V61, P315, DOI 10.1016/0001-706X(96)00014-9; Amaratunga C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014798; [Anonymous], ARCH DIS CHILD; [Anonymous], 2007, J IMMUNOL; [Anonymous], TROP DIS B; [Anonymous], 2012, PLOS ONE; Bejon P, 2011, J INFECT DIS, V204, P9, DOI 10.1093/infdis/jir222; Belard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022525; Bougouma EC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-154; Branch OH, 1998, AM J TROP MED HYG, V58, P211, DOI 10.4269/ajtmh.1998.58.211; BRUCECHWATT LJ, 1952, ANN TROP MED PARASIT, V46, P173, DOI 10.1080/00034983.1952.11685522; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Courtin D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007590; Dodoo D, 2000, J INFECT DIS, V181, P1202, DOI 10.1086/315341; Dodoo D, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-108; Dodoo D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-142; Druilhe P, 2005, PLOS MED, V2, P1135, DOI 10.1371/journal.pmed.0020344; DZIEGIEL M, 1993, INFECT IMMUN, V61, P103, DOI 10.1128/IAI.61.1.103-108.1993; EDOZIEN JC, 1962, LANCET, V2, P951; Greenhouse B, 2011, J INFECT DIS, V204, P19, DOI 10.1093/infdis/jir223; HAWKING F, 1954, BMJ-BRIT MED J, V1, P425, DOI 10.1136/bmj.1.4859.425; HOGH B, 1992, AM J TROP MED HYG, V46, P307, DOI 10.4269/ajtmh.1992.46.307; HOGH B, 1995, INFECT IMMUN, V63, P4034; JACOBS RL, 1964, EXP PARASITOL, V15, P213, DOI 10.1016/0014-4894(64)90017-7; Kassim OO, 2000, J TROP PEDIATRICS, V46, P92, DOI 10.1093/tropej/46.2.92; Kicska GA, 2003, J INFECT DIS, V188, P1776, DOI 10.1086/379373; Kinyanjui SM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-242; Kitua AY, 1999, PARASITE IMMUNOL, V21, P307, DOI 10.1046/j.1365-3024.1999.00230.x; Lusingu JPA, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-48; Macdonald G., 1950, Tropical Diseases Bulletin, V47, P915; MAEGRAITH BG, 1952, BRIT MED J, V2, P1382, DOI 10.1136/bmj.2.4799.1382; Mamo H, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-51; May K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007986; McGREGOR I. A., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P170, DOI 10.1016/0035-9203(63)90058-0; Meraldi V, 2004, PARASITE IMMUNOL, V26, P265, DOI 10.1111/j.0141-9838.2004.00705.x; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; MUIRHEADTHOMSON RC, 1951, BRIT MED J, V1, P1114, DOI 10.1136/bmj.1.4715.1114; Murungi LM, 2013, VACCINE, V31, P3936, DOI 10.1016/j.vaccine.2013.06.042; Nebie I, 2008, TROP MED INT HEALTH, V13, P229, DOI 10.1111/j.1365-3156.2007.01994.x; Nhabomba AJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-121; Oeuvray C, 2000, INFECT IMMUN, V68, P2617, DOI 10.1128/IAI.68.5.2617-2620.2000; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; PASVOL G, 1976, LANCET, V1, P1269; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; Riley EM, 2000, INFECT IMMUN, V68, P5856, DOI 10.1128/IAI.68.10.5856-5863.2000; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Shear HL, 1998, BLOOD, V92, P2520, DOI 10.1182/blood.V92.7.2520.2520_2520_2526; Sirima SB, 2011, NEW ENGL J MED, V365, P1062, DOI 10.1056/NEJMc1100670; Snow RW, 1998, J INFECT DIS, V177, P819, DOI 10.1086/517818; Soe S, 2004, INFECT IMMUN, V72, P247, DOI 10.1128/IAI.72.1.247-252.2004; THEISEN M, 1995, CLIN DIAGN LAB IMMUN, V2, P30, DOI 10.1128/CDLI.2.1.30-34.1995; Tiono AB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086936; Wagner G, 1998, AM J TROP MED HYG, V59, P115, DOI 10.4269/ajtmh.1998.59.115; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Zhou Z, 2002, AM J TROP MED HYG, V66, P7, DOI 10.4269/ajtmh.2002.66.7	56	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107965	10.1371/journal.pone.0107965	http://dx.doi.org/10.1371/journal.pone.0107965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238160	Green Published, Green Submitted, gold			2022-12-25	WOS:000342491600070
J	Si, JW; Wang, N; Wang, H; Xie, J; Yang, J; Yi, H; Shi, ZX; Ma, J; Wang, W; Yang, LF; Yu, SG; Li, JC				Si, Jingwen; Wang, Ning; Wang, Huan; Xie, Juan; Yang, Jian; Yi, Hui; Shi, Zixuan; Ma, Jing; Wang, Wen; Yang, Lifang; Yu, Shigiang; Li, Junchang			HIF-1 alpha Signaling Activation by Post-Ischemia Treatment with Astragaloside IV Attenuates Myocardial Ischemia-Reperfusion Injury	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; NITRIC-OXIDE SYNTHASE; CARDIOPROTECTION; ANGIOGENESIS; SUPPRESSION; INHIBITION; EXPRESSION; PROTECTION; MYOCYTES; HEART	In this study, we evaluated the effect of astragaloside IV (Ast IV) post-ischemia treatment on myocardial ischemia-reperfusion (IR) injury (IRI). We also examined whether hypoxia inducible factor-1 alpha (HIF-1 alpha) and its downstream geneinducible nitric oxide (NO) synthase (iNOS) play roles in the cardioprotective effect of Ast IV. Cultured cardiomyocytes and perfused isolated rat hearts were exposed to Ast IV during reperfusion in the presence or absence of the HIF-1 alpha inhibitor 2methoxyestradiol (2-MeOE2). The post-ischemia treatment with Ast IV protected cardiomyocytes from the apoptosis and death induced by simulated IRI (SIRI). Additionally, in cardiomyocytes, 2-MeOE2 and HIF-1 alpha siRNA treatment each not only abolished the anti-apoptotic effect of post-ischemia treatment with Ast IV but also reversed the upregulation of HIF-1 alpha and iNOS expression. Furthermore, after treatment with Ast IV, post-ischemic cardiac functional recovery and lactate dehydrogenase (LDH) release in the coronary flow (CF) were improved, and the myocardial infarct size was decreased. Moreover, the number of apoptotic cells was reduced, and the upregulation of the anti-apoptotic protein Bcl2 and downregulation of the pro-apoptotic protein Caspase3 were reversed. 2-MeOE2 reversed these effects of Ast IV on IRinjured hearts. These results suggest that post-ischemia treatment with Ast IV can attenuate IRI by upregulating HIF-1 alpha expression, which transmits a survival signal to the myocardium.	[Si, Jingwen; Xie, Juan; Shi, Zixuan; Ma, Jing; Wang, Wen; Li, Junchang] Fourth Mil Med Univ, Xijing Hosp, Dept Tradit Chinese Med, Xian 710032, Shaanxi Provinc, Peoples R China; [Wang, Ning; Yang, Jian; Yu, Shigiang] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, Xian 710032, Shaanxi Provinc, Peoples R China; [Wang, Huan] Fourth Mil Med Univ, Tangdu Hosp, Dept Dermatol, Xian 710032, Shaanxi Provinc, Peoples R China; [Yi, Hui] Gen Mil Hosp Beijing PLA, BaYi Childrens Hosp, Dept Nephropathy & Immunol, Beijing, Peoples R China; [Yang, Lifang] Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Yang, LF (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Shaanxi Provinc, Peoples R China.	yangjian1212@hotmail.com; shigiangyu210@126.com; jingwensi111@126.com		Yu, Shiqiang/0000-0003-3519-0943; Yang, Lifang/0000-0002-4004-9883	12th National Five Years Supporting Project of China [2011BAI11B20]; National Natural Science Foundation of China [81072972, 81102687, 81270170, 81070198, 81170213, 81000938]; Academic Promotion Project of Xijing Hospital [XJZT10 M11]; Social Development Project of Shaanxi Province [2007043, 13-JC050, 2012JQ4001, 2012K15-02-01, 2012SF2-21-1]	12th National Five Years Supporting Project of China(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Academic Promotion Project of Xijing Hospital; Social Development Project of Shaanxi Province	This study was supported by grants from the 12th National Five Years Supporting Project of China (2011BAI11B20), the National Natural Science Foundation of China (81072972, 81102687, 81270170, 81070198, 81170213, and 81000938), the Academic Promotion Project of Xijing Hospital (XJZT10 M11), and the Social Development Project of Shaanxi Province (2007043, 13-JC050, 2012JQ4001, 2012K15-02-01, and 2012SF2-21-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adluri RS, 2011, ANTIOXID REDOX SIGN, V15, P1789, DOI 10.1089/ars.2010.3769; Belaidi E, 2012, FUND CLIN PHARMACOL, V26, P454, DOI 10.1111/j.1472-8206.2011.00940.x; Brune B, 2007, CARDIOVASC RES, V75, P275, DOI 10.1016/j.cardiores.2007.03.005; Cai Z, 2008, CARDIOVASC RES, V77, P463, DOI 10.1093/cvr/cvm035; Chen X, 2012, J ETHNOPHARMACOL, V139, P721, DOI 10.1016/j.jep.2011.11.035; Cheng MX, 2011, TRANSPL P, V43, P1456, DOI 10.1016/j.transproceed.2011.02.066; Dang VC, 2006, AM J PHYSIOL-HEART C, V290, pH1808, DOI 10.1152/ajpheart.00772.2005; Dijkers PF, 2009, MOL BIOL CELL, V20, P4083, DOI 10.1091/mbc.E09-05-0362; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; ESUMI K, 1991, AM J PHYSIOL, V260, pH1743, DOI 10.1152/ajpheart.1991.260.6.H1743; Gui DK, 2013, APOPTOSIS, V18, P409, DOI 10.1007/s10495-013-0801-2; Gui DK, 2013, CYTOKINE, V61, P970, DOI 10.1016/j.cyto.2013.01.008; Hausenloy DJ, 2012, CARDIOVASC RES, V94, P253, DOI 10.1093/cvr/cvs131; Hausenloy DJ, 2010, BASIC RES CARDIOL, V105, P677, DOI 10.1007/s00395-010-0121-4; Hellwig-Burgel T, 2005, J INTERF CYTOK RES, V25, P297, DOI 10.1089/jir.2005.25.297; Heusch G, 2008, CIRCULATION, V118, P1915, DOI 10.1161/CIRCULATIONAHA.108.805242; Jones SP, 2006, J MOL CELL CARDIOL, V40, P16, DOI 10.1016/j.yjmcc.2005.09.011; Kim SR, 2010, EUR J IMMUNOL, V40, P2858, DOI 10.1002/eji.200939948; Lee SH, 2000, NEW ENGL J MED, V342, P626, DOI 10.1056/NEJM200003023420904; Lei J, 2013, NITRIC OXIDE-BIOL CH, V35, P175, DOI 10.1016/j.niox.2013.09.004; Li M, 2012, NEUROCHEM INT, V60, P458, DOI 10.1016/j.neuint.2012.01.026; Li QF, 2012, BRAIN RES, V1451, P1, DOI 10.1016/j.brainres.2012.02.055; Li ZP, 2002, ACTA PHARMACOL SIN, V23, P898; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Mewton N, 2013, CIRC J, V77, P1123, DOI 10.1253/circj.CJ-13-0385; Ovize M, 2010, CARDIOVASC RES, V87, P406, DOI 10.1093/cvr/cvq129; Punn A, 2000, BIOCHEM J, V350, P891, DOI 10.1042/0264-6021:3500891; Ren S, 2013, J TRADIT CHIN MED, V33, P413, DOI 10.1016/S0254-6272(13)60189-2; Salama SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007356; Schwartz Longacre L, 2011, CIRCULATION, V124, P1172, DOI 10.1161/CIRCULATIONAHA.111.032698; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Skyschally A, 2009, BASIC RES CARDIOL, V104, P469, DOI 10.1007/s00395-009-0040-4; Smart N, 2006, CARDIOVASC RES, V69, P164, DOI 10.1016/j.cardiores.2005.08.017; Strijdom H, 2009, MOL CELL BIOCHEM, V321, P23, DOI 10.1007/s11010-008-9906-2; Wu XQ, 2013, AM J PATHOL, V182, P2005, DOI 10.1016/j.ajpath.2013.02.012; Yang Y, 2013, FREE RADICAL BIO MED, V65, P667, DOI 10.1016/j.freeradbiomed.2013.07.007; Yang Y, 2013, J PINEAL RES, V55, P275, DOI 10.1111/jpi.12070; Yellon DM, 2007, NEW ENGL J MED, V357, P2409; Zhang L, 2011, J PHARMACOL EXP THER, V338, P485, DOI 10.1124/jpet.111.180992; Zhang WD, 2006, PLANTA MED, V72, P4, DOI 10.1055/s-2005-873126; Zhao HX, 2010, BASIC RES CARDIOL, V105, P109, DOI 10.1007/s00395-009-0044-0; Zhao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044938	42	38	43	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107832	10.1371/journal.pone.0107832	http://dx.doi.org/10.1371/journal.pone.0107832			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238237	Green Published, Green Submitted, gold			2022-12-25	WOS:000342491600055
J	Daka, JL; Achilonu, I; Dirr, HW				Daka, Jonathan L.; Achilonu, Ikechukwu; Dirr, Heini W.			The Isomerization of Delta(5)-Androstene-3,17-dione by the Human Glutathione Transferase A3-3 Proceeds via a Conjugated Heteroannular Diene Intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Catalysis; Isotope Effect; Spectroscopy; Steroidogenesis; Thermodynamics; Androstene-3; 17-dione; Glutathione Transferase; Transition State; Intermediate	ENZYME-CATALYZED REACTIONS; MICROSCOPIC RATE CONSTANTS; STEROID ISOMERASE ACTIVITY; FREE-ENERGY PLOTS; 3-OXO-DELTA-5-STEROID ISOMERASE; CARBON ACIDS; ACTIVE-SITE; 3-OXO-DELTA(5)-STEROID ISOMERASE; DELTA-5-3-KETOSTEROID ISOMERASE; PROTON ABSTRACTION	The seemingly simple proton abstraction reactions underpin many chemical transformations, including isomerization reactions, and are thus of immense biological significance. Despite the energetic cost, enzyme-catalyzed proton abstraction reactions show remarkable rate enhancements. The pathways leading to these accelerated rates are numerous and on occasion partly enigmatic. The isomerization of the steroid (5)-androstene-3,17-dione by the glutathione transferase A3-3 in mammals was investigated to gain insight into the mechanism. Particular emphasis was placed on the nature of the transition state, the intermediate suspected of aiding this process, and the hydrogen bonds postulated to be the stabilizing forces of these transient species. The UV-visible detection of the intermediate places this species in the catalytic pathway, whereas fluorescence spectroscopy is used to obtain the binding constant of the analog intermediate, equilenin. Solvent isotope exchange reveals that proton abstraction from the substrate to form the intermediate is rate-limiting. Analysis of the data in terms of the Marcus formalism indicates that the human glutathione transferase A3-3 lowers the intrinsic kinetic barrier by 3 kcal/mol. The results lead to the conclusion that this reaction proceeds through an enforced concerted mechanism in which the barrier to product formation is kinetically insignificant.	[Daka, Jonathan L.; Achilonu, Ikechukwu; Dirr, Heini W.] Univ Witwatersrand, Sch Mol & Cell Biol, Prot Struct Funct Res Unit, ZA-2050 Johannesburg, South Africa	University of Witwatersrand	Dirr, HW (corresponding author), Univ Witwatersrand, Sch Mol & Cell Biol, Prot Struct Funct Res Unit, ZA-2050 Johannesburg, South Africa.	heinrich.dirr@wits.ac.za		Dirr, Heini/0000-0003-1455-7769	University of the Witwatersrand; South African National Research Foundation [60810, 65510, 68898]; South African Research Chairs Initiative of the Dept. of Science and Technology [64788]; National Research Foundation	University of the Witwatersrand; South African National Research Foundation(National Research Foundation - South Africa); South African Research Chairs Initiative of the Dept. of Science and Technology; National Research Foundation	This work was supported by the University of the Witwatersrand, Grants 60810, 65510, and 68898 from the South African National Research Foundation, and Grant 64788 from the South African Research Chairs Initiative of the Dept. of Science and Technology and National Research Foundation.	ALBERY WJ, 1980, ANNU REV PHYS CHEM, V31, P227, DOI 10.1146/annurev.pc.31.100180.001303; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; BENSON AM, 1977, P NATL ACAD SCI USA, V74, P158, DOI 10.1073/pnas.74.1.158; BENSON AM, 1976, BIOCHEM BIOPH RES CO, V69, P1073, DOI 10.1016/0006-291X(76)90482-4; BERNASCONI CF, 1992, ACCOUNTS CHEM RES, V25, P9, DOI 10.1021/ar00013a002; BEVINS CL, 1986, BIOCHEMISTRY-US, V25, P5159, DOI 10.1021/bi00366a026; BLADON P, 1952, J CHEM SOC, P2737, DOI 10.1039/jr9520002737; Caccuri AM, 1999, BIOCHEM J, V344, P419, DOI 10.1042/0264-6021:3440419; Calvaresi M, 2012, ACS CATAL, V2, P280, DOI 10.1021/cs200369b; CHIANG Y, 1991, SCIENCE, V253, P395, DOI 10.1126/science.253.5018.395; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; CLELAND WW, 1975, BIOCHEMISTRY-US, V14, P3220, DOI 10.1021/bi00685a029; COHEN AO, 1968, J PHYS CHEM-US, V72, P4249, DOI 10.1021/j100858a052; Dalby KN, 1997, J CHEM SOC PERK T 2, P1555, DOI 10.1039/a700205j; DIRR H, 1994, EUR J BIOCHEM, V220, P645, DOI 10.1111/j.1432-1033.1994.tb18666.x; DORFMAN L, 1953, CHEM REV, V53, P47, DOI 10.1021/cr60164a002; Dourado DFAR, 2014, J PHYS CHEM A, V118, P5790, DOI 10.1021/jp410810q; EAMES TCM, 1989, BIOCHEMISTRY-US, V28, P6269, DOI 10.1021/bi00441a019; GERLT JA, 1991, J AM CHEM SOC, V113, P9667, DOI 10.1021/ja00025a039; GERLT JA, 1993, BIOCHEMISTRY-US, V32, P11943, DOI 10.1021/bi00096a001; GERLT JA, 1992, J AM CHEM SOC, V114, P5928, DOI 10.1021/ja00041a004; Gu YJ, 2004, BIOCHEMISTRY-US, V43, P15673, DOI 10.1021/bi048757g; HAWKINSON DC, 1994, BIOCHEMISTRY-US, V33, P12172, DOI 10.1021/bi00206a021; HAWKINSON DC, 1991, BIOCHEMISTRY-US, V30, P10849, DOI 10.1021/bi00109a007; JENCKS WP, 1981, CHEM SOC REV, V10, P345, DOI 10.1039/cs9811000345; Johansson AS, 2001, J BIOL CHEM, V276, P33061, DOI 10.1074/jbc.M104539200; KULIOPULOS A, 1989, BIOCHEMISTRY-US, V28, P149, DOI 10.1021/bi00427a022; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; Marcus RA, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2372496; MARCUS RA, 1969, J AM CHEM SOC, V91, P7224, DOI 10.1021/ja01054a003; Montgomery R., 1996, BIOCH CASE ORIENTED, P587; Pettersson PL, 2001, J BIOL CHEM, V276, P11698, DOI 10.1074/jbc.M009146200; POLLACK RM, 1989, J AM CHEM SOC, V111, P6419, DOI 10.1021/ja00198a066; SZAJEWSKI RP, 1980, J AM CHEM SOC, V102, P2011, DOI 10.1021/ja00526a042; TALALAY P, 1955, BIOCHIM BIOPHYS ACTA, V18, P300, DOI 10.1016/0006-3002(55)90079-2; Tars K, 2010, J MOL BIOL, V397, P332, DOI 10.1016/j.jmb.2010.01.023; TIAN XQ, 1993, J BIOL CHEM, V268, P14888; WANG SF, 1963, J BIOL CHEM, V238, P576; WILLIAMS A, 1994, CHEM SOC REV, V23, P93, DOI 10.1039/cs9942300093; Woodward R. B., 1941, J AM CHEM SOC, V63, P1123; Wu ZR, 1997, SCIENCE, V276, P415, DOI 10.1126/science.276.5311.415; Yao XD, 1999, J AM CHEM SOC, V121, P6220, DOI 10.1021/ja990070+; ZENG BF, 1992, BIOCHEMISTRY-US, V31, P1521, DOI 10.1021/bi00120a032; ZENG BF, 1991, J AM CHEM SOC, V113, P3838, DOI 10.1021/ja00010a028; ZHAO QJ, 1995, BIOCHEMISTRY-US, V34, P426, DOI 10.1021/bi00002a006	45	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32243	32252		10.1074/jbc.M114.601609	http://dx.doi.org/10.1074/jbc.M114.601609			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25248748	hybrid, Green Published			2022-12-25	WOS:000345314700050
J	Conrad, MS; Sutton, BP; Dilger, RN; Johnson, RW				Conrad, Matthew S.; Sutton, Bradley P.; Dilger, Ryan N.; Johnson, Rodney W.			An In Vivo Three-Dimensional Magnetic Resonance Imaging-Based Averaged Brain Collection of the Neonatal Piglet (Sus scrofa)	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; VOXEL-BASED MORPHOMETRY; DOMESTIC PIG; GOTTINGEN MINIPIG; TEMPLATE IMAGES; VOLUMETRIC DATA; ATLAS; MRI; SEGMENTATION; MACAQUE	Due to the fact that morphology and perinatal growth of the piglet brain is similar to humans, use of the piglet as a translational animal model for neurodevelopmental studies is increasing. Magnetic resonance imaging (MRI) can be a powerful tool to study neurodevelopment in piglets, but many of the MRI resources have been produced for adult humans. Here, we present an average in vivo MRI-based atlas specific for the 4-week-old piglet. In addition, we have developed probabilistic tissue classification maps. These tools can be used with brain mapping software packages (e. g. SPM and FSL) to aid in voxel-based morphometry and image analysis techniques. The atlas enables efficient study of neurodevelopment in a highly tractable translational animal with brain growth and development similar to humans.	[Conrad, Matthew S.; Dilger, Ryan N.; Johnson, Rodney W.] Univ Illinois, Dept Anim Sci, Urbana, IL 61820 USA; [Conrad, Matthew S.; Sutton, Bradley P.; Dilger, Ryan N.; Johnson, Rodney W.] Univ Illinois, Neurosci Program, Urbana, IL USA; [Conrad, Matthew S.; Johnson, Rodney W.] Univ Illinois, Integrat Immunol & Behav Program, Urbana, IL USA; [Sutton, Bradley P.; Dilger, Ryan N.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL USA; [Sutton, Bradley P.] Univ Illinois, Dept Bioengn, Urbana, IL USA; [Dilger, Ryan N.; Johnson, Rodney W.] Univ Illinois, Div Nutr Sci, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Johnson, RW (corresponding author), Univ Illinois, Dept Anim Sci, Urbana, IL 61820 USA.	rwjohn@illinois.edu	Sutton, Bradley P./A-4801-2008	Sutton, Bradley P./0000-0002-8443-0408; Johnson, Rodney/0000-0002-2376-1852; Dilger, Ryan/0000-0003-2538-2845	National Institute of Health [R01 HD069899]; National Institute of Food and Agriculture, U.S. Department of Agriculture [538-382]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069899] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by a grant from the National Institute of Health (R01 HD069899) and the National Institute of Food and Agriculture, U.S. Department of Agriculture, under Agreement No. 538-382. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaye M, 2008, NEUROIMAGE, V43, P721, DOI 10.1016/j.neuroimage.2008.07.060; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Black KJ, 1997, J COMPUT ASSIST TOMO, V21, P881, DOI 10.1097/00004728-199711000-00006; Black KJ, 2001, NEUROIMAGE, V14, P736, DOI 10.1006/nimg.2001.0752; Black KJ, 2001, NEUROIMAGE, V14, P744, DOI 10.1006/nimg.2001.0871; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Conrad MS, 2012, DEV NEUROSCI-BASEL, V34, P291, DOI 10.1159/000339311; Conrad MS, 2012, PEDIATR RES, V71, P179, DOI 10.1038/pr.2011.21; Cross DJ, 2000, J NUCL MED, V41, P1879; DICKERSON JW, 1967, PROC R SOC SER B-BIO, V166, P384, DOI 10.1098/rspb.1967.0002; Dilger RN, 2010, BRAIN BEHAV IMMUN, V24, P1156, DOI 10.1016/j.bbi.2010.05.008; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Elmore MRP, 2012, ANIM COGN, V15, P667, DOI 10.1007/s10071-012-0495-9; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; EVANS AC, 1994, NATO ADV SCI INST SE, V264, P263; Fang MR, 2005, NEUROSIGNALS, V14, P222, DOI 10.1159/000088638; Felix B, 1999, BRAIN RES BULL, V49, P1, DOI 10.1016/S0361-9230(99)00012-X; FOX PT, 1985, J COMPUT ASSIST TOMO, V9, P141, DOI 10.1097/00004728-198501000-00025; Giedd JN, 1996, J COMP NEUROL, V366, P223, DOI 10.1002/(SICI)1096-9861(19960304)366:2<223::AID-CNE3>3.0.CO;2-7; Ishizu K, 2000, SYNAPSE, V38, P87, DOI 10.1002/1098-2396(200010)38:1<87::AID-SYN10>3.0.CO;2-C; Jakobsen S, 2006, J NUCL MED, V47, P2008; Jelsing J, 2006, J EXP BIOL, V209, P1454, DOI 10.1242/jeb.02141; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Knickmeyer RC, 2010, CEREB CORTEX, V20, P1053, DOI 10.1093/cercor/bhp166; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; McLaren DG, 2010, METHODS, V50, P157, DOI 10.1016/j.ymeth.2009.10.003; McLaren DG, 2009, NEUROIMAGE, V45, P52, DOI 10.1016/j.neuroimage.2008.10.058; Pfluger T, 1999, EPILEPSIA, V40, P414, DOI 10.1111/j.1528-1157.1999.tb00735.x; Radlowski EC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091951; Saikali S, 2010, J NEUROSCI METH, V192, P102, DOI 10.1016/j.jneumeth.2010.07.041; Sawiak SJ, 2009, NEUROBIOL DIS, V33, P20, DOI 10.1016/j.nbd.2008.09.016; Shi F, 2010, NEUROIMAGE, V49, P391, DOI 10.1016/j.neuroimage.2009.07.066; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Watanabe H, 2001, NEUROIMAGE, V14, P1089, DOI 10.1006/nimg.2001.0910; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	37	27	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107650	10.1371/journal.pone.0107650	http://dx.doi.org/10.1371/journal.pone.0107650			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254955	Green Submitted, Green Published, gold			2022-12-25	WOS:000344862300027
J	van der Heijden, KM; van der Heijden, IM; Galvao, FH; Lopes, CG; Costa, SF; Abdala, E; D'Albuquerque, LA; Levin, AS				van der Heijden, Karin M.; van der Heijden, Inneke M.; Galvao, Flavio H.; Lopes, Camila G.; Costa, Silvia F.; Abdala, Edson; D'Albuquerque, Luiz A.; Levin, Anna S.			Intestinal Translocation of Clinical Isolates of Vancomycin-Resistant Enterococcus faecalis and ESBL-Producing Escherichia coli in a Rat Model of Bacterial Colonization and Liver Ischemia/Reperfusion Injury	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; GUT-ORIGIN; TRANSPLANTATION; PERMEABILITY; BACTEREMIA; CIRRHOSIS; SEPSIS	The objectives of this study were to develop a rat model of gastrointestinal colonization with vancomycin-resistant Enterococcus faecalis (VRE) and extended-spectrum beta-lactamase (ESBL)-producing E. coli and to evaluate intestinal translocation to blood and tissues after total and partial hepatic ischemia. Methods - We developed a model of rat colonization with VRE and ESBL-E coli. Then we studied four groups of colonized rats: Group I (with hepatic pedicle occlusion causing complete liver ischemia and intestinal stasis); Group II (with partial liver ischemia without intestinal stasis); Group III (surgical manipulation without hepatic ischemia or intestinal stasis); Group IV (anesthetized without surgical manipulation). After sacrifice, portal and systemic blood, large intestine, small intestine, spleen, liver, lungs, and cervical and mesenteric lymph nodes were cultured. Endotoxin concentrations in portal and systemic blood were determined. Results - The best inocula were: VRE: 2.4x10(10) cfu and ESBL-E. coli: 1.12x10(10) cfu. The best results occurred 24 hours after inoculation and antibiotic doses of 750 mu mg/mL of water for vancomycin and 2.1 mg/mL for ceftriaxone. There was a significantly higher proportion of positive cultures for ESBL-E. coli in the lungs in Groups I, II and III when compared with Group IV (67%; 60%; 75% and 13%, respectively; p: 0.04). VRE growth was more frequent in mesenteric lymph nodes for Groups I (67%) and III (38%) than for Groups II (13%) and IV (none) (p:0.002). LPS was significantly higher in systemic blood of Group I (9.761x13.804 EU/mL-p:0.01). No differences for endotoxin occurred in portal blood. Conclusion - e developed a model of rats colonized with resistant bacteria useful to study intestinal translocation. Translocation occurred in surgical procedures with and without hepatic ischemia-reperfusion and probably occurred via the bloodstream. Translocation was probably lymphatic in the ischemia-reperfusion groups. Systemic blood endotoxin levels were higher in the group with complete hepatic ischemia.	[van der Heijden, Karin M.; van der Heijden, Inneke M.; Costa, Silvia F.; Abdala, Edson; Levin, Anna S.] Univ Sao Paulo, Dept Infect Dis, Hosp Clin, Sao Paulo, Brazil; [Galvao, Flavio H.; Lopes, Camila G.; Abdala, Edson; D'Albuquerque, Luiz A.] Univ Sao Paulo, Div Transplantat, Dept Gastroenterol, Sao Paulo, Brazil; [Costa, Silvia F.; Levin, Anna S.] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Levin, AS (corresponding author), Univ Sao Paulo, Dept Infect Dis, Hosp Clin, LIM 54, Sao Paulo, Brazil.	gcih.adm@hc.fm.usp.br	van der Heijden, Inneke Marie/O-2021-2019; D'Albuquerque, Luiz A Carneiro/I-4011-2012; Costa, Silvia F/K-4768-2012; Abdala, Edson/H-5165-2012; Levin, Anna S/C-8831-2012; Levin, Anna S./AAJ-1712-2021; Galvao, Flavio Henrique Ferreira/D-3487-2017; Figueiredo Costa, silvia/ABC-7704-2021	D'Albuquerque, Luiz A Carneiro/0000-0001-7607-7168; Costa, Silvia F/0000-0003-1087-752X; Abdala, Edson/0000-0003-0765-6654; Levin, Anna S/0000-0003-2427-8368; Levin, Anna S./0000-0003-2427-8368; Galvao, Flavio Henrique Ferreira/0000-0003-1924-3208; Figueiredo Costa, silvia/0000-0003-1087-752X; van der Heijden, Inneke Marie/0000-0002-1392-6000				Abdala E, 2007, LIVER TRANSPLANT, V13, P488, DOI 10.1002/lt.21085; Alencar SSS, 2001, ACTA CIR BRAS S1, V17, P35; Baumgart DC, 2002, CURR OPIN CLIN NUTR, V5, P685, DOI 10.1097/00075197-200211000-00012; Bellot P, 2013, LIVER INT, V33, P31, DOI 10.1111/liv.12021; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Camilleri M, 2012, AM J PHYSIOL-GASTR L, V303, pG775, DOI 10.1152/ajpgi.00155.2012; CLSI, 2012, M100S22 CLSI; Condette CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102217; de Rougemont O, 2009, LIVER TRANSPLANT, V15, P1172, DOI 10.1002/lt.21876; Deitch EA, 2012, SURG-J R COLL SURG E, V10, P350, DOI 10.1016/j.surge.2012.03.003; Goyal Ajesh, 2013, Trop Gastroenterol, V34, P136; Grootjans J, 2010, WORLD J GASTRO SURG, V2, P61, DOI 10.4240/wjgs.v2.i3.61; Guarner C, 2006, HEPATOLOGY, V44, P633, DOI 10.1002/hep.21286; Iris NE, 2013, AM J INFECT CONTROL, V41, P261, DOI 10.1016/j.ajic.2012.04.331; Karatzas T, 2014, J SURG RES; Kaufmann ME, 1998, METH MOLEC MED, V15, P33, DOI 10.1385/0-89603-498-4:33; Koh IHJ, 2002, TRANSPLANT P, V34, P1003, DOI 10.1016/S0041-1345(02)02757-4; Liong MT, 2008, NUTR REV, V66, P192, DOI 10.1111/j.1753-4887.2008.00024.x; MacFie J, 1999, GUT, V45, P223, DOI 10.1136/gut.45.2.223; McKinnell JA, 2012, INFECT CONT HOSP EP, V33, P718, DOI 10.1086/666331; Miyazaki S, 2001, J MED MICROBIOL, V50, P695, DOI 10.1099/0022-1317-50-8-695; Murray P.R., 2003, MANUAL CLIN MICROBIO, V8th; O'Boyle CJ, 1998, GUT, V42, P29, DOI 10.1136/gut.42.1.29; Oplustil CP, 2004, PROCEDIMENTOS BASICO, P544; Papadopoulos D, 2013, ARCH TRAUMA RES, V2, P63, DOI 10.5812/atr.12501; Ren ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075950; Ridley AM, 1998, METH MOLEC MED, V15, P103, DOI 10.1385/0-89603-498-4:103; Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065; TOLEDOPEREYRA LH, 1975, AM J SURG, V129, P513, DOI 10.1016/0002-9610(75)90308-6; Waynforth HB, 1992, EXPT SURG TECHNIQUES, P384; Whitman MS, 1996, ANTIMICROB AGENTS CH, V40, P1526, DOI 10.1128/AAC.40.6.1526; Zacharioudakis IM, 2014, AM J KIDNEY DIS; Zhai Y, 2013, NAT REV GASTRO HEPAT, V10, P79, DOI 10.1038/nrgastro.2012.225	33	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108453	10.1371/journal.pone.0108453	http://dx.doi.org/10.1371/journal.pone.0108453			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255079	gold, Green Submitted, Green Published			2022-12-25	WOS:000344862300084
J	Victor, VM; Rovira-Llopis, S; Saiz-Alarcon, V; Sanguesa, MC; Rojo-Bofill, L; Banuls, C; Falcon, R; Castello, R; Rojo, L; Rocha, M; Hernandez-Mijares, A				Victor, Victor M.; Rovira-Llopis, Susana; Saiz-Alarcon, Vanessa; Sangueesa, Maria C.; Rojo-Bofill, Luis; Banuls, Celia; Falcon, Rosa; Castello, Raquel; Rojo, Luis; Rocha, Milagros; Hernandez-Mijares, Antonio			Altered Mitochondrial Function and Oxidative Stress in Leukocytes of Anorexia Nervosa Patients	PLOS ONE			English	Article							LEUKOCYTE/ENDOTHELIAL CELL-INTERACTIONS; OVARY-SYNDROME PATIENTS; COMPLEX I IMPAIRMENT; EATING-DISORDERS; FREE-RADICALS; ANTIOXIDANTS; DYSFUNCTION; MUSCLE	Context: Anorexia nervosa is a common illness among adolescents and is characterised by oxidative stress. Objective: The effects of anorexia on mitochondrial function and redox state in leukocytes from anorexic subjects were evaluated. Design and setting: A multi-centre, cross-sectional case-control study was performed. Patients: Our study population consisted of 20 anorexic patients and 20 age-matched controls, all of which were Caucasian women. Main outcome measures: Anthropometric and metabolic parameters were evaluated in the study population. To assess whether anorexia nervosa affects mitochondrial function and redox state in leukocytes of anorexic patients, we measured mitochondrial oxygen consumption, membrane potential, reactive oxygen species production, glutathione levels, mitochondrial mass, and complex I and III activity in polymorphonuclear cells. Results: Mitochondrial function was impaired in the leukocytes of the anorexic patients. This was evident in a decrease in mitochondrial O-2 consumption (P<0.05), mitochondrial membrane potential (P<0.01) and GSH levels (P<0.05), and an increase in ROS production (P<0.05) with respect to control subjects. Furthermore, a reduction of mitochondrial mass was detected in leukocytes of the anorexic patients (P<0.05), while the activity of mitochondrial complex I (P<0.001), but not that of complex III, was found to be inhibited in the same population. Conclusions: Oxidative stress is produced in the leukocytes of anorexic patients and is closely related to mitochondrial dysfunction. Our results lead us to propose that the oxidative stress that occurs in anorexia takes place at mitochondrial complex I. Future research concerning mitochondrial dysfunction and oxidative stress should aim to determine the physiological mechanism involved in this effect and the physiological impact of anorexia.	[Victor, Victor M.; Rovira-Llopis, Susana; Banuls, Celia; Falcon, Rosa; Castello, Raquel; Rocha, Milagros; Hernandez-Mijares, Antonio] Fdn Promot Healthcare & Biomed Res Valencian Comm, Valencia, Spain; [Victor, Victor M.; Rovira-Llopis, Susana; Banuls, Celia; Falcon, Rosa; Castello, Raquel; Rocha, Milagros; Hernandez-Mijares, Antonio] Univ Hosp Doctor Peset, Serv Endocrinol, Valencia, Spain; [Victor, Victor M.; Rovira-Llopis, Susana; Banuls, Celia; Falcon, Rosa; Castello, Raquel; Rocha, Milagros; Hernandez-Mijares, Antonio] Univ Valencia, Inst Hlth Res INCLIVA, Valencia, Spain; [Saiz-Alarcon, Vanessa; Sangueesa, Maria C.; Rojo-Bofill, Luis; Rojo, Luis] Univ Valencia, Psychiat Serv, Dept Med, Univ Hosp La Fe, Valencia, Spain; [Rojo, Luis] Univ Valencia, CIBER Act Epidemiol & Publ Hlth, Res Grp CIBER CB 06 02 0045, Valencia, Spain; [Hernandez-Mijares, Antonio] Univ Valencia, Dept Med, Valencia, Spain	University of Valencia; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Valencia; University of Valencia	Victor, VM (corresponding author), Fdn Promot Healthcare & Biomed Res Valencian Comm, Valencia, Spain.	Victor.Victor@uv.es; hernandez_antmij@gva.es	Mijares, Antonio Hernandez/D-3411-2011; Cerviño, Alejandro/L-5853-2014; victor, victor/Q-4843-2019; Rocha, Milagros/I-4987-2015; Rovira-Llopis, Susana/AAX-8666-2021; Rocha, Milagros/ABE-4931-2020; VICTOR, VICTOR M/I-3270-2015; BaÃuls, Celia/H-7359-2017; Hernandez Mijares, Antonio/D-3411-2011	Mijares, Antonio Hernandez/0000-0003-2197-0607; Cerviño, Alejandro/0000-0001-8014-3279; Rocha, Milagros/0000-0003-2923-6546; Rovira-Llopis, Susana/0000-0002-8476-5128; Rocha, Milagros/0000-0003-2923-6546; BaÃuls, Celia/0000-0001-8077-7642; VICTOR, VICTOR/0000-0002-3027-3945; Hernandez Mijares, Antonio/0000-0003-4099-1905	FIS [PI12/1984, PI13/1025, PI13/073]; European Regional Development Fund of the European Union (FEDER) [CIBERehd CB06/04/0071, PROMETEO 2010/060]; Ministry of Health of the Valencian Regional Government [CES10/030]; Carlos III Health Institute [CP10/0360, FI11/00637]	FIS(Instituto de Salud Carlos III); European Regional Development Fund of the European Union (FEDER); Ministry of Health of the Valencian Regional Government; Carlos III Health Institute(Instituto de Salud Carlos III)	This study was financed by grants PI12/1984, PI13/1025 and PI13/073 from FIS and co-funded by the European Regional Development Fund of the European Union (FEDER), CIBERehd CB06/04/0071 and PROMETEO 2010/060. V. M. V. and M. R. are recipients of contracts from the Ministry of Health of the Valencian Regional Government and Carlos III Health Institute (CES10/030 and CP10/0360, respectively). S. R. is recipient of a predoctoral fellowship from Carlos III Health Institute (FI11/00637). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188; De la Fuente M, 2000, IMMUNOL CELL BIOL, V78, P49, DOI 10.1046/j.1440-1711.2000.00884.x; Diano S, 2011, NAT MED, V17, P1121, DOI 10.1038/nm.2421; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; Fairburn CG, 2003, LANCET, V361, P407, DOI 10.1016/S0140-6736(03)12378-1; Fisher M, 2006, PEDIATR REV, V27, P5, DOI 10.1542/pir.27-1-5; Ghaderi Ata, 2003, Eat Behav, V3, P387, DOI 10.1016/S1471-0153(02)00089-2; Grad LI, 2006, BBA-BIOENERGETICS, V1757, P115, DOI 10.1016/j.bbabio.2005.11.009; Hernandez-Mijares A, 2013, DIABETES CARE, V36, P1695, DOI 10.2337/dc12-1224; Hernandez-Mijares A, 2011, FREE RADICAL BIO MED, V50, P1215, DOI 10.1016/j.freeradbiomed.2011.01.019; Ivison SM, 2010, AM J PHYSIOL-GASTR L, V299, pG733, DOI 10.1152/ajpgi.00089.2010; James AM, 2012, TRENDS ENDOCRIN MET, V23, P429, DOI 10.1016/j.tem.2012.06.008; Katzman DK, 2005, INT J EAT DISORDER, V37, pS52, DOI 10.1002/eat.20118; Keel PK, 2010, INT J EAT DISORDER, V43, P195, DOI 10.1002/eat.20810; LUFT R, 1995, J INTERN MED, V238, P405, DOI 10.1111/j.1365-2796.1995.tb01218.x; Monsalve M, 2007, FRONT BIOSCI-LANDMRK, V12, P1131, DOI 10.2741/2132; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Moyano D, 1999, INT J EAT DISORDER, V25, P99, DOI 10.1002/(SICI)1098-108X(199901)25:1&lt;99::AID-EAT12&gt;3.0.CO;2-N; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Neumarker KJ, 1997, INT J EAT DISORDER, V21, P205, DOI 10.1002/(SICI)1098-108X(199704)21:3<205::AID-EAT1>3.0.CO;2-O; Riva A, 2005, AM J PHYSIOL-HEART C, V289, pH868, DOI 10.1152/ajpheart.00866.2004; Rocha M, 2014, MED RES REV, V34, P160, DOI 10.1002/med.21285; Rojo L, 2003, INT J EAT DISORDER, V34, P281, DOI 10.1002/eat.10179; Rovira-Llopis S, 2013, ANTIOXID REDOX SIGN, V19, P1452, DOI 10.1089/ars.2013.5307; Schagger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200; Sela S, 2004, HYPERTENSION, V44, P764, DOI 10.1161/01.HYP.0000144480.10207.34; Tajiri K, 2006, INT J EAT DISORDER, V39, P616, DOI 10.1002/eat.20326; TRACEY KJ, 1990, J CLIN INVEST, V86, P2014, DOI 10.1172/JCI114937; Ugalde C, 2004, HUM MOL GENET, V13, P659, DOI 10.1093/hmg/ddh071; Victor VM, 2011, J CLIN ENDOCR METAB, V96, P3115, DOI 10.1210/jc.2011-0651; Victor VM, 2009, J CLIN ENDOCR METAB, V94, P3505, DOI 10.1210/jc.2009-0466; Victor VM, 2005, CURR PHARM DESIGN, V11, P3141, DOI 10.2174/1381612054864894; Victor VM, 2004, INT IMMUNOPHARMACOL, V4, P327, DOI 10.1016/j.intimp.2004.01.020; Yang YTT, 2012, LIFE SCI, V90, P682, DOI 10.1016/j.lfs.2012.03.002; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103	36	18	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e106463	10.1371/journal.pone.0106463	http://dx.doi.org/10.1371/journal.pone.0106463			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254642	Green Submitted, gold, Green Published			2022-12-25	WOS:000344862300010
J	Arbour, VM; Burns, ME; Sullivan, RM; Lucas, SG; Cantrell, AK; Fry, J; Suazo, TL				Arbour, Victoria M.; Burns, Michael E.; Sullivan, Robert M.; Lucas, Spencer G.; Cantrell, Amanda K.; Fry, Joshua; Suazo, Thomas L.			A New Ankylosaurid Dinosaur from the Upper Cretaceous (Kirtlandian) of New Mexico with Implications for Ankylosaurid Diversity in the Upper Cretaceous of Western North America	PLOS ONE			English	Article							SHANXIA-TIANZHENENSIS ORNITHISCHIA; SAN-JUAN BASIN; NODOCEPHALOSAURUS-KIRTLANDENSIS; EUOPLOCEPHALUS-TUTUS; TAXONOMIC STATUS; REDESCRIPTION; OSTEODERMS; ALBERTA	A new ankylosaurid (Ankylosauria: Dinosauria), Ziapelta sanjuanensis, gen. et sp. nov., is based on a complete skull, an incomplete first cervical half ring, a possible fragment of the second cervical half ring, and additional fragmentary osteoderms. The holotype specimen is from the Upper Cretaceous (Upper Campanian, Kirtlandian Land-Vertebrate Age) Kirtland Formation (De-na-zin Member) at Hunter Wash, San Juan Basin, in northwestern New Mexico, USA. Diagnostic characters of Ziapelta include: a large, prominent triangular median nasal caputegulum; a mixture of flat and bulbous frontonasal caputegulae; ventrolaterally oriented squamosal horns with a sharp, prominent dorsal keel; and the ventral surface of basicranium with three prominent anteroposteriorly oriented fossae. A phylogenetic analysis suggests that Ziapelta is not closely related to the other ankylosaurid from the De-na-zin Member, Nodocephalosaurus, but allies it to the northern North American ankylosaurids Ankylosaurus, Anodontosaurus, Euoplocephalus, Dyoplosaurus, and Scolosaurus.	[Arbour, Victoria M.; Burns, Michael E.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Sullivan, Robert M.; Lucas, Spencer G.; Cantrell, Amanda K.; Suazo, Thomas L.] New Mexico Museum Nat Hist & Sci, Albuquerque, NM USA; [Fry, Joshua] Ft Hays State Univ, Dept Geosci, Hays, KS 67601 USA	University of Alberta	Arbour, VM (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	arbour@ualberta.ca	Burns, Michael E/GPC-8311-2022	Burns, Michael/0000-0002-9587-563X	Bureau of Land Management National Landscape Conservation System; National Sciences and Engineering Research Council Canada; Alberta Ingenuity Studentship; Izaak Walton Killam Doctoral Scholarship; Dinosaur Research Institute; University of Alberta, Department of Biological Sciences	Bureau of Land Management National Landscape Conservation System; National Sciences and Engineering Research Council Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Ingenuity Studentship; Izaak Walton Killam Doctoral Scholarship; Dinosaur Research Institute; University of Alberta, Department of Biological Sciences(University of Alberta)	Fieldwork was funded by a Bureau of Land Management National Landscape Conservation System grant (http://www.blm.gov/wo/st/en/prog/blm_special_areas/NLCS.html) to the New Mexico Museum of Natural History and Science. Funding to VMA was provided by a National Sciences and Engineering Research Council Canada Graduate Scholarship - Doctoral (http://www.nserc-crsng.gc.ca/index_eng.asp), an Alberta Ingenuity Studentship (http://www.albertatechfutures.ca/Home.aspx), an Izaak Walton Killam Doctoral Scholarship (http://killamlaureates.ca/), and the Dinosaur Research Institute (http://www.dinosaurresearch.com/). Research funding to MEB was provided by the University of Alberta, Department of Biological Sciences (http://www.biology.ualberta.ca/) and the Dinosaur Research Institute (http://www.dinosaurresearch.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbour VM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062421; Arbour VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039323; Arbour VM, ZOOL J LINN IN PRESS; Barrett PM, 1998, J VERTEBR PALEONTOL, V18, P376, DOI 10.1080/02724634.1998.10011065; Brown B, 1908, B AM MUS NAT HIST, V24, P187; Burns M.E., 2011, NEW MEXICO MUSEUM NA, V53, P169; Burns ME, 2011, NEW MEXICO MUSEUM NA, V53, P179; Burns ME, 2014, J VERTEBR PALEONTOL, V34, P835, DOI 10.1080/02724634.2014.840309; Burns ME, 2011, CRETACEOUS RES, V32, P174, DOI 10.1016/j.cretres.2010.11.007; Burns ME, 2008, J VERTEBR PALEONTOL, V28, P1102, DOI 10.1671/0272-4634-28.4.1102; Carpenter K, 2004, CAN J EARTH SCI, V41, P961, DOI 10.1139/E04-043; Eberth DA, 2012, CAN J EARTH SCI, V49, P1053, DOI 10.1139/E2012-035; Fassett James E., 1997, New Mexico Geological Society Field Conference Guidebook, V48, P239; Fassett JE, 1971, US GEOLOGICAL SURVEY, V676, P1; Ford Tracy L., 2000, Bulletin of the New Mexico Museum of Natural History and Science, V17, P157; GALTON P M, 1978, Palaeontologische Zeitschrift, V52, P138; Gilmore C. W., 1933, American Museum Novitates, V679, P1; Gilmore C.W., 1919, US GEOLOGICAL SURVEY, P1; Gilmore CW, 1916, US GEOLOGICAL SURVEY, V98Q, P279; Godefroit Pascal, 2000, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V69, P17; Goloboff P, 2008, CLADISTICS, V24, P91; Jasinski SE., 2011, NEW MEXICO MUSEUM NA, V53, P216; Kirkland James I., 1998, Bulletin of the New Mexico Museum of Natural History and Science, V14, P271; Lambe L. M., 1902, Contributions to Canadian Palaeontology, Viii, pUnpaginated; Lambe LM, 1919, T ROY SOC CAN SECT 3, V13, P39; Lee YN, 1996, J VERTEBR PALEONTOL, V16, P232, DOI 10.1080/02724634.1996.10011311; Lehman T.M., 1981, P189; Lehman Thomas M., 2001, P310; Loewen MA, 2013, TOP GRAND STAIRCASE, P445; LUCAS SG, 2000, NEW MEXICO MUSEUM NA, V17, P147; MALEEV E. A., 1952, DOKLADY AKAD NAUK SSSR, V87, P273; Marsh O.C., 1877, AM J SCI, V3, P513, DOI [10.2475/ajs.s3-14.84.513, DOI 10.2475/AJS.S3-14.84.513]; Maryanska T, 1971, PALAEONTOL POL, V25, P85; Maryaska T., 1977, PALAEONTOLOGIA POLON, V37, P85; Nopesa F., 1915, Jahrb Kgl Ungar Geol Reich Budapest, V23, P1; Nopska B.F., 1928, GEOLOGICA HUNGARICA, V1, P1; Osborn H. F., 1923, American Museum Novitates, V95, P1; Owen R., 1842, REPORTS BRIT ASS ADV, V11, P60; Owen R., 1861, MONOGRAPHS PALAEONTO, V1858, P1; Parks W. A., 1924, University of Toronto Studies Geological Series, V18, P1; Penkalski P, ACTA PALAEO IN PRESS; Roberts Eric M., 2013, P85; Sampson SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012292; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sternberg C. M., 1929, Bulletin Canada Dept Mines Ottawa, V54, P28; Sullivan R. M., 2005, GEOLOGY CHAMA BASIN, P395; Sullivan RM, 1999, J VERTEBR PALEONTOL, V19, P126, DOI 10.1080/02724634.1999.10011128; Sullivan RM, 2000, J VERTEBR PALEONTOL, V20, P218, DOI 10.1671/0272-4634(2000)020[0218:RTUAB]2.0.CO;2; Sullivan Robert M., 2003, New Mexico Geological Society Field Conference Guidebook, V54, P369; Sullivan Robert M., 2006, Bulletin of the New Mexico Museum of Natural History and Science, P7; Sullivan Robert M., 2006, BULLETIN OF THE NEW MEXICO MUSEUM OF NATURAL HISTORY AND SCIENCE, P259; Thompson RS, 2012, J SYST PALAEONTOL, V10, P301, DOI 10.1080/14772019.2011.569091; Tumanova TA, 1993, PALEONTOL ZH, V1993, P92; Upchurch P, 2000, J VERTEBR PALEONTOL, V20, P216, DOI 10.1671/0272-4634(2000)020[0216:TTSOST]2.0.CO;2; Vickaryous MK, 2003, ZOOL J LINN SOC-LOND, V137, P157, DOI 10.1046/j.1096-3642.2003.00045.x; Wilkinson M, 2001, TAXEQ3 SOFTWARE DOCU	56	21	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108804	10.1371/journal.pone.0108804	http://dx.doi.org/10.1371/journal.pone.0108804			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250819	Green Published, gold			2022-12-25	WOS:000342492700155
J	Pan, KL; Lin, JC; Lin, CL; Chen, MC; Chang, ST; Chung, CM; Hsu, JT				Pan, Kuo-Li; Lin, Jing-Chi; Lin, Chun-Liang; Chen, Mien-Cheng; Chang, Shih-Tai; Chung, Chang-Min; Hsu, Jen-Te			Impact of Gout on Left Atrial Function: A Prospective Speckle-Tracking Echocardiographic Study	PLOS ONE			English	Article							VENTRICULAR FILLING PRESSURES; CORONARY-HEART-DISEASE; URIC-ACID; DOPPLER-ECHOCARDIOGRAPHY; DIASTOLIC DYSFUNCTION; RISK-FACTOR; ALL-CAUSE; RECOMMENDATIONS; HYPERURICEMIA; INFLAMMATION	The purpose of our study was to evaluate the left ventricular (LV) and left atrial (LA) function in patients with gout. A total of 173 patients underwent a comprehensive Doppler-echocardiography examination. Participants were divided into four groups-Stage 0: control (n = 35), Stage I: asymptomatic hyperuricemia (n = 30), Stage II: gouty arthritis without tophi (n = 58), and Stage III: tophaceous gout (n = 50). Serum uric acid levels were not significantly different between stage I, II and III. Stage III patients demonstrated a higher ratio of the transmitral and myocardial peak early diastolic velocities (E/Em) (10.50 +/- 3.18 vs. 8.58 +/- 2.07; P = 0.008), and larger maximal LA volume index (LAVi) (29.60 +/- 9.89 vs. 20.07 +/- 4.76 ml/m(2); P<0.001) compared with controls. Stage III patients had decreased LV global longitudinal systolic strain (LV epsilon) compared with controls (220.2 +/- 3.06 vs. -21.79 +/- 2.27; P = 0.002). Stage III patients also had decreased peak atrial longitudinal strain rate during ventricular systole (ALSR(syst)), peak atrial longitudinal strain rate during ventricular early diastole (ALSR(early)), and peak atrial longitudinal strain rate during ventricular late diastole (ALSR(late)) compared with controls (1.73 +/- 0.48 vs. 2.05 +/- 0.55 1/s, -1.44 +/- 0.53 vs. -2.07 +/- 0.84 1/s, -2.07 +/- 0.7 vs. -2.66 +/- 0.91 1/s, respectively; all P<0.005). Multiple regression analysis revealed severity of gout had an independent negative impact on LA pump function (ALSR(late)). In conclusion, gout caused LV diastolic dysfunction, LV subclinical systolic dysfunction and LA reservoir, conduit, and booster pump dysfunction.	[Pan, Kuo-Li; Chang, Shih-Tai; Chung, Chang-Min; Hsu, Jen-Te] Chang Gung Mem Hosp, Div Cardiol, Chiayi, Taiwan; [Lin, Jing-Chi] Chang Gung Mem Hosp, Div Allergy & Immunol & Rheumatol, Chiayi, Taiwan; [Lin, Chun-Liang] Chang Gung Mem Hosp, Div Nephrol, Chiayi, Taiwan; [Pan, Kuo-Li; Lin, Jing-Chi; Lin, Chun-Liang] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Chen, Mien-Cheng] Kaohsiung Chang Gung Mem Hosp, Div Cardiol, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Pan, KL (corresponding author), Chang Gung Mem Hosp, Div Cardiol, Chiayi, Taiwan.	pankuoli64@gmail.com						ABBOTT RD, 1988, J CLIN EPIDEMIOL, V41, P237, DOI 10.1016/0895-4356(88)90127-8; APPLETON CP, 1993, J AM COLL CARDIOL, V22, P1972, DOI 10.1016/0735-1097(93)90787-2; Choi HK, 2007, CIRCULATION, V116, P894, DOI 10.1161/CIRCULATIONAHA.107.703389; Cicoira M, 2002, AM HEART J, V143, P1107, DOI 10.1067/mhj.2002.122122; Filippatos GS, 2011, EUR HEART J, V32, P712, DOI 10.1093/eurheartj/ehq473; Hirose T, 2012, EUR HEART J-CARD IMG, V13, P243, DOI 10.1093/ejechocard/jer251; Kim SY, 2010, ARTHRIT CARE RES, V62, P170, DOI 10.1002/acr.20065; Krishnan Eswar, 2012, Congest Heart Fail, V18, P138, DOI 10.1111/j.1751-7133.2011.00259.x; Krishnan E, 2010, RHEUMATOLOGY, V49, P1229, DOI 10.1093/rheumatology/keq037; Kuo CF, 2010, RHEUMATOLOGY, V49, P141, DOI 10.1093/rheumatology/kep364; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Letsas KP, 2010, HELL J CARDIOL, V51, P209; MATSUDA Y, 1983, CIRCULATION, V67, P566, DOI 10.1161/01.CIR.67.3.566; Mitsuhashi H, 2009, CIRC J, V73, P667, DOI 10.1253/circj.CJ-08-0626; Moller JE, 2003, CIRCULATION, V107, P2207, DOI 10.1161/01.CIR.0000066318.21784.43; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Neogi T, 2011, NEW ENGL J MED, V364, P443, DOI 10.1056/NEJMcp1001124; Niskanen LK, 2004, ARCH INTERN MED, V164, P1546, DOI 10.1001/archinte.164.14.1546; Ommen SR, 2000, CIRCULATION, V102, P1788; PASCUAL E, 1991, ARTHRITIS RHEUM, V34, P141, DOI 10.1002/art.1780340203; Phang RS, 2004, AM J CARDIOL, V94, P511, DOI 10.1016/j.amjcard.2004.05.009; Rosca M, 2010, J AM SOC ECHOCARDIOG, V23, P1090, DOI 10.1016/j.echo.2010.07.016; Schumacher H Ralph Jr, 2008, Cleve Clin J Med, V75 Suppl 5, pS2; Sutherland GR, 2004, J AM SOC ECHOCARDIOG, V17, P788, DOI 10.1016/j.echo.2004.03.027; Szardien S, 2012, EUR HEART J, V33, P595, DOI 10.1093/eurheartj/ehr434; Tsang TSM, 2002, AM J CARDIOL, V90, P1284, DOI 10.1016/S0002-9149(02)02864-3; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320	27	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108357	10.1371/journal.pone.0108357	http://dx.doi.org/10.1371/journal.pone.0108357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250773	Green Published, gold, Green Submitted			2022-12-25	WOS:000342492700118
J	Berglund, B; Khan, GA; Lindberg, R; Fick, J; Lindgren, PE				Berglund, Bjorn; Khan, Ghazanfar Ali; Lindberg, Richard; Fick, Jerker; Lindgren, Per-Eric			Abundance and Dynamics of Antibiotic Resistance Genes and Integrons in Lake Sediment Microcosms	PLOS ONE			English	Article							TETRACYCLINE RESISTANCE; CASSETTES	Antibiotic resistance in bacteria causing disease is an ever growing threat to the world. Recently, environmental bacteria have become established as important both as sources of antibiotic resistance genes and in disseminating resistance genes. Low levels of antibiotics and other pharmaceuticals are regularly released into water environments via wastewater, and the concern is that such environmental contamination may serve to create hotspots for antibiotic resistance gene selection and dissemination. In this study, microcosms were created from water and sediments gathered from a lake in Sweden only lightly affected by human activities. The microcosms were exposed to a mixture of antibiotics of varying environmentally relevant concentrations (i.e., concentrations commonly encountered in wastewaters) in order to investigate the effect of low levels of antibiotics on antibiotic resistance gene abundances and dynamics in a previously uncontaminated environment. Antibiotic concentrations were measured using liquid chromatography-tandem mass spectrometry. Abundances of seven antibiotic resistance genes and the class 1 integron integrase gene, intL1, were quantified using real-time PCR. Resistance genes sulI and ermB were quantified in the microcosm sediments with mean abundances 5 and 15 gene copies/10(6) 16S rRNA gene copies, respectively. Class 1 integrons were determined in the sediments with a mean concentration of 3.86x10(4) copies/10(6) 16S rRNA gene copies. The antibiotic treatment had no observable effect on antibiotic resistance gene or integron abundances.	[Berglund, Bjorn; Lindgren, Per-Eric] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Khan, Ghazanfar Ali; Lindberg, Richard; Fick, Jerker] Umea Univ, Dept Chem, Umea, Sweden; [Lindgren, Per-Eric] Cty Hosp Ryhov, Dept Microbiol, Med Serv, Jonkoping, Sweden	Linkoping University; Umea University	Berglund, B (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	bjorn.berglund@liu.se	Lindberg, Richard/C-8882-2013; Berglund Fick, Jerker/HDO-5788-2022	Fick, Jerker/0000-0002-3949-7371	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [210-2006-2132]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas)	The study was funded by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (contract number: 210-2006-2132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Berglund B, 2014, SCI TOTAL ENVIRON, V476, P29, DOI 10.1016/j.scitotenv.2013.12.128; Bhullar K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034953; Binh CTT, 2007, FEMS MICROBIOL ECOL, V62, P290, DOI 10.1111/j.1574-6941.2007.00393.x; Borjesson S, 2010, J WATER HEALTH, V8, P247, DOI 10.2166/wh.2009.159; Chander Y, 2005, J ENVIRON QUAL, V34, P1952, DOI 10.2134/jeq2005.0017; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; ENG RHK, 1991, ANTIMICROB AGENTS CH, V35, P1824, DOI 10.1128/AAC.35.9.1824; Gaze WH, 2011, ISME J, V5, P1253, DOI 10.1038/ismej.2011.15; Gillings MR, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00004; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Khan GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062712; Koenig JE, 2008, ENVIRON MICROBIOL, V10, P1024, DOI 10.1111/j.1462-2920.2007.01524.x; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Li D, 2010, APPL ENVIRON MICROB, V76, P3444, DOI 10.1128/AEM.02964-09; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; Merlin C, 2011, WATER RES, V45, P2897, DOI 10.1016/j.watres.2011.03.002; Michael CA, 2004, AM NAT, V164, P1, DOI 10.1086/421733; OECD, 2002, AER AN TRANSF AQ SED; Pei RT, 2006, WATER RES, V40, P2427, DOI 10.1016/j.watres.2006.04.017; Pruden A, 2012, ENVIRON SCI TECHNOL, V46, P11541, DOI 10.1021/es302657r; RENBERG I, 1991, Journal of Paleolimnology, V6, P167; Rosewarne CP, 2010, FEMS MICROBIOL ECOL, V72, P35, DOI 10.1111/j.1574-6941.2009.00823.x; Schmitt H, 2006, MICROB ECOL, V51, P267, DOI 10.1007/s00248-006-9035-y; Soderblom T., 2010, EURO SURVEILL, V15, P19620; Wright MS, 2008, ISME J, V2, P417, DOI 10.1038/ismej.2008.8	28	20	23	17	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108151	10.1371/journal.pone.0108151	http://dx.doi.org/10.1371/journal.pone.0108151			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247418	Green Published, gold, Green Submitted			2022-12-25	WOS:000342351800068
J	Hua, P; Pan, XP; Hu, R; Mo, XE; Shang, XY; Yang, SR				Hua, Ping; Pan, Xiao-ping; Hu, Rong; Mo, Xiao-en; Shang, Xin-yuan; Yang, Song-ran			Factors Related to Executive Dysfunction after Acute Infarct	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; WHITE-MATTER HYPERINTENSITIES; STROKE PATIENTS; ISCHEMIC-STROKE; DEPRESSION; MORTALITY; SYMPTOMS; DEMENTIA; DISEASE; MEMORY	Aim: The aim of this study was to investigate the association of infarct location with post-stroke executive dysfunction. Methods: One hundred seventy-seven patients hospitalized with acute infarction were enrolled. General information and NIHSS score at admission were recorded. The infarct site was recorded from magnetic resonance T2-W1 and FLAIR images, and the extent of white matter disease was assessed using the Fazekas score. Seven days after symptoms, executive function was assessed using the validated Chinese version of Mattis Dementia Rating Scale (MDRS) Initiation/Perseveration (I/P) [MDRS I/P]. Results: The average MDRS I/P score of the 177 infarction patients was 24.16 +/- 5.21, considerably lower than the average score (32.7 +/- 3.1) of a control group of normal individuals. Patients with infarcts in the corona radiata or basal ganglia had significantly lower MDRS I/P scores that those without infarcts at these locations. The number of infarcts in the basal ganglia was also significantly associated with low MDRS I/P scores. Male gender and low NIHSS score were significantly associated with low MDRS I/P score, and high-density lipoprotein cholesterol was significantly associated with high MDRS I/P score. The number of infarcts in areas other than the basal ganglia as well as corona radiata and the extent of white matter disease had no influence on this score. Conclusions: The number of infarcts in the basal ganglia corona radiata, low NIHSS score, and male gender are significantly and independently related to poor executive function (that is, low MDRS I/P score) after acute infarct.	[Hua, Ping] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Pan, Xiao-ping; Hu, Rong; Mo, Xiao-en; Shang, Xin-yuan; Yang, Song-ran] Guangzhou First Peoples Hosp, Guangzhou Med Coll, Dept Neurol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou Medical University; South China University of Technology	Yang, SR (corresponding author), Guangzhou First Peoples Hosp, Guangzhou Med Coll, Dept Neurol, Guangzhou, Guangdong, Peoples R China.	yangsrdr@163.com			National Natural Science Foundation Youth Science Fund [81000508]; Pearl River Science and Technology Star Fund [2012J2200090]	National Natural Science Foundation Youth Science Fund; Pearl River Science and Technology Star Fund	This work is funded by the National Natural Science Foundation Youth Science Fund (81000508) and the Pearl River Science and Technology Star Fund (2012J2200090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ay H, 2005, ANN NEUROL, V58, P688, DOI 10.1002/ana.20617; Bombois S, 2007, STROKE, V38, P2595, DOI 10.1161/STROKEAHA.107.486407; Bour A, 2011, INT J GERIATR PSYCH, V26, P679, DOI 10.1002/gps.2581; Braw Y, 2011, J AFFECT DISORDERS, V129, P342, DOI 10.1016/j.jad.2010.07.032; Carlson MC, 2009, J GERONTOL A-BIOL, V64, P110, DOI 10.1093/gerona/gln008; Chan AS, 2003, J INT NEUROPSYCH SOC, V9, P45, DOI 10.1017/S1355617703910058; Chang YL, 2010, CEREB CORTEX, V20, P1305, DOI 10.1093/cercor/bhp192; David HN, 2008, FASEB J, V22, P1275, DOI 10.1096/fj.07-9420com; FAZEKAS F, 1993, NEUROLOGY, V43, P1683, DOI 10.1212/WNL.43.9.1683; FISHER CM, 1965, NEUROLOGY, V15, P774, DOI 10.1212/WNL.15.8.774; Grau-Olivares M, 2009, EXPERT REV NEUROTHER, V9, P1201, DOI [10.1586/ern.09.73, 10.1586/ERN.09.73]; Haelewyn B, 2008, CRIT CARE MED, V36, P2651, DOI 10.1097/CCM.0b013e318183f646; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Leonards CO, 2012, STROKE, V43, P3046, DOI 10.1161/STROKEAHA.111.646554; Mezzich JE, 2002, PSYCHOPATHOLOGY, V35, P72, DOI 10.1159/000065122; Mok VCT, 2010, DEMENT GERIATR COGN, V30, P254, DOI 10.1159/000318744; Park JH, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-14; Pohjasvaara T, 2002, EUR J NEUROL, V9, P269, DOI 10.1046/j.1468-1331.2002.00396.x; Saczynski JS, 2009, STROKE, V40, P677, DOI 10.1161/STROKEAHA.108.530212; Serrano S, 2007, STROKE, V38, P105, DOI 10.1161/01.STR.0000251804.13102.c0; Shaper AG, 2000, HEART, V83, P394, DOI 10.1136/heart.83.4.394; Tang WK, 2009, J INT NEUROPSYCH SOC, V15, P62, DOI 10.1017/S1355617708090061; van Straaten ECW, 2006, STROKE, V37, P836, DOI 10.1161/01.STR.0000202585.26325.74; Wannamethee SG, 1997, INT J EPIDEMIOL, V26, P523, DOI 10.1093/ije/26.3.523; Wen HM, 2004, STROKE, V35, P1826, DOI 10.1161/01.STR.0000133686.29320.58; Werring DJ, 2004, BRAIN, V127, P2265, DOI 10.1093/brain/awh253; Yang SR, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-164	27	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108574	10.1371/journal.pone.0108574	http://dx.doi.org/10.1371/journal.pone.0108574			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247604	Green Published, gold, Green Submitted			2022-12-25	WOS:000342351800101
J	Beermann, S; Vauth, M; Hein, R; Seifert, R; Neumann, D				Beermann, Silke; Vauth, Marcus; Hein, Rabea; Seifert, Roland; Neumann, Detlef			Distinct Signalling Pathways of Murine Histamine H-1- and H-4-Receptors Expressed at Comparable Levels in HEK293 Cells	PLOS ONE			English	Article							HUMAN MONOCYTIC CELLS; BORDETELLA-PERTUSSIS; MEDIATES CHEMOTAXIS; ADENYLATE-CYCLASE; TISSUE FACTOR; GUINEA-PIG; MAP KINASE; RECEPTOR; PROTEIN; ACTIVATION	Histamine (HA) is recognized by its target cells via four G-protein-coupled receptors, referred to as histamine H-1-receptor (H1R), H2R, H3R, and H4R. Both H1R and H4R exert pro-inflammatory functions. However, their signal transduction pathways have never been analyzed in a directly comparable manner side by side. Moreover, the analysis of pharmacological properties of the murine orthologs, representing the main targets of pre-clinical research, is very important. Therefore, we engineered recombinant HEK293 cells expressing either mouse (m) H1R or mH(4)R at similar levels and analyzed HA-induced signalling in these cells. HA induced intracellular calcium mobilization via both mH(1)R and mH(4)R, with the mH(1)R being much more effective. Whereas cAMP accumulation was potentiated via the mH(1)R, it was reduced via the mH(4)R. The regulation of both second messengers via the H4R, but not the H1R, was sensitive to pertussis toxin (PTX). The mitogen-activated protein kinases (MAPKs) ERK 1/2 were massively activated downstream of both receptors and demonstrated a functional involvement in HA-induced EGR-1 gene expression. The p38 MAPK was moderately activated via both receptors as well, but was functionally involved in HA-induced EGR-1 gene expression only in H4R-expressing cells. Surprisingly, in this system p38 MAPK activity reduced the HA-induced gene expression. In summary, using this system which allows a direct comparison of mH(1)R-and mH(4)R-induced signalling, qualitative and quantitative differences on the levels of second messenger generation and also in terms of p38 MAPK function became evident.	[Beermann, Silke; Vauth, Marcus; Hein, Rabea; Seifert, Roland; Neumann, Detlef] Hannover Med Sch, Inst Pharmacol, Hannover, Germany	Hannover Medical School	Neumann, D (corresponding author), Hannover Med Sch, Inst Pharmacol, Hannover, Germany.	neumann.detlef@mh-hannover.de	Neumann, Detlef/F-6182-2011; Seifert, Roland/G-3189-2013	Neumann, Detlef/0000-0003-0145-7507; 	Deutsche Forschungsgemeinschaft [NE 647/8-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant (NE 647/8-1) from the Deutsche Forschungsgemeinschaft (www.dfg.de) to DN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Ales K, 2008, INFLAMM RES, V57, pS33, DOI 10.1007/s00011-007-0617-z; Bachert C, 2002, ALLERGY, V57, P287, DOI 10.1034/j.1398-9995.2002.1r3542.x; Barnes PJ, 2001, PULM PHARMACOL THER, V14, P329, DOI 10.1006/pupt.2000.0318; BEEBE SJ, 1994, SEMIN CANCER BIOL, V5, P285; Beermann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030285; Best JL, 2004, P NATL ACAD SCI USA, V101, P17622, DOI 10.1073/pnas.0406374101; Brighton PJ, 2011, BRIT J PHARMACOL, V162, P1603, DOI 10.1111/j.1476-5381.2010.01173.x; Cammarota M, 2003, J NEUROCHEM, V84, P453, DOI 10.1046/j.1471-4159.2003.01517.x; Carbonetti NH, 2010, FUTURE MICROBIOL, V5, P455, DOI 10.2217/FMB.09.133; cells T, J IMMUNOL, V176, P7062; Czerner CP, 2013, INFLAMM RES; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; de Esch IJP, 2005, TRENDS PHARMACOL SCI, V26, P462, DOI 10.1016/j.tips.2005.07.002; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Defer N, 2000, AM J PHYSIOL-RENAL, V279, pF400, DOI 10.1152/ajprenal.2000.279.3.F400; Desai P, 2011, EUR J IMMUNOL, V41, P1764, DOI 10.1002/eji.201040932; Dumitru CA, 2012, J LEUKOCYTE BIOL, V91, P591, DOI 10.1189/jlb.0411193; Dy M, 1996, BLOOD, V87, P3161, DOI 10.1182/blood.V87.8.3161.bloodjournal8783161; Esbenshade TA, 2003, J RECEPT SIG TRANSD, V23, P17, DOI 10.1081/RRS-120018758; Gbahou F, 2006, BRIT J PHARMACOL, V147, P744, DOI 10.1038/sj.bjp.0706666; Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429; Gutzmer R, 2005, J IMMUNOL, V174, P5224, DOI 10.4049/jimmunol.174.9.5224; HAAKSMA EEJ, 1990, PHARMACOL THERAPEUT, V47, P73, DOI 10.1016/0163-7258(90)90046-5; Hill SJ, 1997, PHARMACOL REV, V49, P253; Hoffmann E, 2008, J BIOL CHEM, V283, P12120, DOI 10.1074/jbc.M800583200; Hofstra CL, 2003, J PHARMACOL EXP THER, V305, P1212, DOI 10.1124/jpet.102.046581; Jutel M, 2001, NATURE, V413, P420, DOI 10.1038/35096564; LEURS R, 1994, J NEUROCHEM, V62, P519; LI HF, 1995, AM J RESP CELL MOL, V12, P416, DOI 10.1165/ajrcmb.12.4.7695921; Lim HD, 2008, J PHARMACOL EXP THER, V327, P88, DOI 10.1124/jpet.108.140343; Lim HD, 2006, CURR TOP MED CHEM, V6, P1365, DOI 10.2174/15680266106061365; Ling P, 2004, BRIT J PHARMACOL, V142, P161, DOI 10.1038/sj.bjp.0705729; Maintz L, 2007, AM J CLIN NUTR, V85, P1185, DOI 10.1093/ajcn/85.5.1185; Maruko T, 2005, N-S ARCH PHARMACOL, V372, P153, DOI 10.1007/s00210-005-0001-x; Medina Vanina A, 2011, Front Biosci (Elite Ed), V3, P1042; Minami T, 2007, J DENT RES, V86, P1083, DOI 10.1177/154405910708601112; Morgan RK, 2007, J IMMUNOL, V178, P8081, DOI 10.4049/jimmunol.178.12.8081; Morse KL, 2001, J PHARMACOL EXP THER, V296, P1058; MOSS J, 1983, J BIOL CHEM, V258, P1879; Nakamura T, 2000, BIOCHEM BIOPH RES CO, V279, P615, DOI 10.1006/bbrc.2000.4008; Naor Z, 2000, TRENDS ENDOCRIN MET, V11, P91, DOI 10.1016/S1043-2760(99)00232-5; Neumann D, 2010, PHARMACOLOGY, V85, P217, DOI 10.1159/000285088; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Pawlinski R, 2003, BLOOD, V101, P3940, DOI 10.1182/blood-2002-07-2303; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Reher TM, 2012, BIOCHEM PHARMACOL, V84, P192, DOI 10.1016/j.bcp.2012.04.004; Rolli M, 1999, J BIOL CHEM, V274, P19559, DOI 10.1074/jbc.274.28.19559; Rosethorne EM, 2011, MOL PHARMACOL, V79, P749, DOI 10.1124/mol.110.068395; Ruffels J, 2004, EUR J PHARMACOL, V483, P163, DOI 10.1016/j.ejphar.2003.10.032; Schneider E, 1999, EXP HEMATOL, V27, P1010, DOI 10.1016/S0301-472X(99)00039-9; Schneider EH, 2009, BIOCHEMISTRY-US, V48, P1424, DOI 10.1021/bi802050d; Schnell D, 2011, NAUNYN SCHMIEDEBERGS; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; Seifert R, 1999, TRENDS PHARMACOL SCI, V20, P383, DOI 10.1016/S0165-6147(99)01368-1; Seifert R, 2013, TRENDS PHARMACOL SCI, V34, P33, DOI 10.1016/j.tips.2012.11.001; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Slack RJ, 2011, BRIT J PHARMACOL, V164, P1627, DOI 10.1111/j.1476-5381.2011.01285.x; Strasser A, 2008, J PHARMACOL EXP THER, V324, P60, DOI 10.1124/jpet.107.129601; Strasser A, 2013, TRENDS PHARMACOL SCI, V34, P13, DOI 10.1016/j.tips.2012.10.004; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Tang XR, 2006, P NATL ACAD SCI USA, V103, P13777, DOI 10.1073/pnas.0605988103; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Thurmond RL, 2004, J PHARMACOL EXP THER, V309, P404, DOI 10.1124/jpet.103.061754; Thurmond RL, 2008, NAT REV DRUG DISCOV, V7, P41, DOI 10.1038/nrd2465; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795; Zhang M, 2006, EXPERT OPIN INV DRUG, V15, P1443, DOI 10.1517/13543784.15.11.1443; Zhu Y, 2001, MOL PHARMACOL, V59, P434, DOI 10.1124/mol.59.3.434	71	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107481	10.1371/journal.pone.0107481	http://dx.doi.org/10.1371/journal.pone.0107481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243776	gold, Green Published, Green Submitted			2022-12-25	WOS:000343679800034
J	Dusman, E; de Almeida, IV; Lucchetta, L; Vicentini, VEP				Dusman, Elisangela; de Almeida, Igor Vivian; Lucchetta, Luciano; Pimenta Vicentini, Veronica Elisa			Effect of Processing, Post-Harvest Irradiation, and Production System on the Cytotoxicity and Mutagenicity of Vitis labrusca L. Juices in HTC Cells	PLOS ONE			English	Article							IN-VITRO; GRAPE; SYNTHASE; GROWTH; FOODS; ASSAY; RADIATION; TOXICITY; EXTRACTS; PLANTS	The juices of grapes (Vitis labrusca L.) are similar to the fruit itself because the main constituents of the fruit are present in the juice. However, their quality characteristics may be modified by the harsh technological processes used for the production of integral food, such as production systems of raw materials and post-harvest treatment of grapes with ultraviolet (UV) irradiation. Therefore, the present study analyzed juices produced naturally (by liquefying the fruit) or by the technological process of extraction by steam distillation (90 degrees C) of grapes from organic and conventional production systems that were untreated or treated with UV type C (65.6 J/m(2) for 10 minutes). Using cultures of Rattus norvegicus hepatoma cells (HTC) in vitro, cytotoxic effects were assayed by the MTT test and by calculating the cytokinesis blocked proliferation index (CBPI), and mutagenic effects were measured by the cytokinesis block micronucleus assay. The results of the MTT assay and the CBPIs indicated that none of the juices were cytotoxic, including those that induced cell proliferation. The results of the micronucleus assay showed that none of the juices were mutagenic. However, the average number of micronuclei was lower in the juices produced from organic grapes, and cell proliferation, soluble acids and phenolic compounds were significantly higher. Compared with the natural juices, the integral juices of conventional grapes showed a higher average number of micronuclei as well as lower stimulation of cell proliferation and lower levels of bioactive compounds. The results demonstrate a beneficial effect of UV-C irradiation of post-harvest grapes in stimulating the synthesis of nutraceutical compounds without generating cytotoxic or mutagenic substances. Taken together, our findings support the consumption of grape juice and the application of food production techniques that enhance its nutritional value and promote its production, marketing and consumption.	[Dusman, Elisangela; de Almeida, Igor Vivian; Pimenta Vicentini, Veronica Elisa] Univ Estadual Maringa, Dept Biotechnol Genet & Cell Biol, Maringa, Parana, Brazil; [Lucchetta, Luciano] Fed Technol Univ Parana, Francisco Beltrao, Parana, Brazil	Universidade Estadual de Maringa; Universidade Tecnologica Federal do Parana	Dusman, E (corresponding author), Univ Estadual Maringa, Dept Biotechnol Genet & Cell Biol, Maringa, Parana, Brazil.	lisdusman@yahoo.com.br	/AGG-6270-2022; VICENTINI, VERONICA E. P./F-3273-2015; Almeida, Igor V/P-7968-2017; /AAQ-2244-2021	/0000-0001-9764-941X; VICENTINI, VERONICA E. P./0000-0003-1385-0058; Almeida, Igor V/0000-0003-3200-2126; /0000-0001-9764-941X; Dusman, Elisangela/0000-0002-4483-5638				Ammar EM, 2013, PHARM BIOL, V51, P339, DOI 10.3109/13880209.2012.729065; Azeredo H. M. C, 2012, FUNDAMENTOS ESTABILI; Brosche M, 2003, PHYSIOL PLANTARUM, V117, P1, DOI 10.1034/j.1399-3054.2003.1170101.x; Cantos E, 2001, J AGR FOOD CHEM, V49, P5052, DOI 10.1021/jf010366a; Charles GD, 2002, FOOD CHEM TOXICOL, V40, P1391, DOI 10.1016/S0278-6915(02)00085-6; Chis IC, 2009, DIABETES VASC DIS RE, V6, P200, DOI 10.1177/1479164109336692; Collier AC, 2003, BIOCHEM PHARMACOL, V66, P281, DOI 10.1016/S0006-2952(03)00240-5; Dani C, 2007, FOOD CHEM TOXICOL, V45, P2574, DOI 10.1016/j.fct.2007.06.022; Dani C, 2006, THESIS U CAXIAS DO S; Danon A, 1998, FEBS LETT, V437, P131, DOI 10.1016/S0014-5793(98)01208-3; EKASARI I, 1986, FOOD CHEM, V21, P125, DOI 10.1016/0308-8146(86)90157-3; Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8; Fenech M., 2003, MUTAGENESE AMBIENTAL, P201; Fernandes F, 2013, IND CROP PROD, V43, P434, DOI 10.1016/j.indcrop.2012.07.031; Grinder-Pedersen L, 2003, J AGR FOOD CHEM, V51, P5671, DOI 10.1021/jf030217n; Gueant JL, 2013, BIOCHIMIE, V95, P1033, DOI 10.1016/j.biochi.2013.01.020; Knize MG, 2002, MUTAT RES-FUND MOL M, V506, P153, DOI 10.1016/S0027-5107(02)00162-8; Lluis L, 2011, FOOD CHEM TOXICOL, V49, P1450, DOI 10.1016/j.fct.2011.03.042; Marques AYC, 2009, REV NUTR, V22, P283, DOI 10.1590/S1415-52732009000200010; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; OECD, 2010, GUID TEST CHEM IN VI; Pimentel C.V.M.B., 2005, ALIMENTOS FUNCIONAIS; Pinto EP, 2013, THESIS U FEDERAL DE; Rizzon L. A., 2007, SUCO UVA; Rizzon Luiz Antenor, 2006, Cienc. Rural, V36, P689, DOI 10.1590/S0103-84782006000200055; Rizzon LA, 2012, CIENCIA TECNOL ALIME, V32, P93, DOI 10.1590/S0101-20612012005000015; Rombaldi Cesar Valmor, 2004, Rev. Bras. Frutic., V26, P89, DOI 10.1590/S0100-29452004000100024; Shi John, 2003, Journal of Medicinal Food, V6, P291, DOI 10.1089/109662003772519831; Shibao J, 2011, REV NUTR, V24, P895, DOI 10.1590/S1415-52732011000600010; Song XY, 2010, MOL CARCINOGEN, V49, P450, DOI 10.1002/mc.20616; Szeto YT, 2013, APPL PHYSIOL NUTR ME, V38, P275, DOI 10.1139/apnm-2012-0296; Tagliazucchi D, 2013, INT J FOOD SCI TECH, V48, P808, DOI 10.1111/ijfs.12031; Tang K, 2011, RUSS J PLANT PHYSL+, V58, P603, DOI 10.1134/S1021443711040200; Vedana M. I. S., 2008, Alimentos e Nutricao, V19, P159; Versari A, 2001, J AGR FOOD CHEM, V49, P5531, DOI 10.1021/jf010672o; Wang JH, 2014, THERIOGENOLOGY, V81, P545, DOI 10.1016/j.theriogenology.2013.11.007; Zhang MH, 2013, INT J MOL MED, V31, P621, DOI 10.3892/ijmm.2013.1237	37	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107974	10.1371/journal.pone.0107974	http://dx.doi.org/10.1371/journal.pone.0107974			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244067	gold, Green Submitted, Green Published			2022-12-25	WOS:000343679800060
J	Kessens, R; Ashfield, T; Kim, SH; Innes, RW				Kessens, Ryan; Ashfield, Tom; Kim, Sang Hee; Innes, Roger W.			Determining the GmRIN4 Requirements of the Soybean Disease Resistance Proteins Rpg1b and Rpg1r Using a Nicotiana glutinosa-Based Agroinfiltration System	PLOS ONE			English	Article							INNATE IMMUNE RECEPTOR; PSEUDOMONAS-SYRINGAE; III EFFECTOR; ARABIDOPSIS-THALIANA; HOST TARGET; SPECIFICITY; GENE; ACTIVATION; PLANTS; RIN4	Rpg1b and Rpg1r are soybean disease resistance (R) genes responsible for conferring resistance to Pseudomonas syringae strains expressing the effectors AvrB and AvrRpm1, respectively. The study of these cloned genes would be greatly facilitated by the availability of a suitable transient expression system. The commonly used Niciotiana benthamiana-based system is not suitable for studying Rpg1b and Rpg1r function, however, because expression of AvrB or AvrRpm1 alone induces a hypersensitive response (HR), indicating that N. benthamiana contains endogenous R genes that recognize these effectors. To identify a suitable alternative host for transient expression assays, we screened 13 species of Nicotiana along with 11 accessions of N. tabacum for lack of response to transient expression of AvrB and AvrRpm1. We found that N. glutinosa did not respond to either effector and was readily transformable as determined by transient expression of beta-glucuronidase. Using this system, we determined that Rpg1b-mediated HR in N. glutinosa required co-expression of avrB and a soybean ortholog of the Arabidopsis RIN4 gene. All four soybean RIN4 orthologs tested worked in the assay. In contrast, Rpg1r did not require co-expression of a soybean RIN4 ortholog to recognize AvrRpm1, but recognition was suppressed by co-expression with AvrRpt2. These observations suggest that an endogenous RIN4 gene in N. glutinosa can substitute for the soybean RIN4 ortholog in the recognition of AvrRpm1 by Rpg1r.	[Kessens, Ryan; Ashfield, Tom; Kim, Sang Hee; Innes, Roger W.] Indiana Univ, Dept Biol, Bloomington, IN 47401 USA	Indiana University System; Indiana University Bloomington	Innes, RW (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47401 USA.	rinnes@indiana.edu		Innes, Roger/0000-0001-9634-1413; Kim, Sang Hee/0000-0003-1831-4633	Hutton Honors College of Indiana University; National Institute of General Medical Sciences of the National Institutes of Health [R01 GM046451]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046451] Funding Source: NIH RePORTER	Hutton Honors College of Indiana University; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	RK was the recipient of a summer research grant from the Hutton Honors College of Indiana University (http://www.indiana.edu/similar to iubhonor/). This work was supported by the National Institute of General Medical Sciences of the National Institutes of Health grant no. R01 GM046451 to RWI (http://www.nigms.nih.gov/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ade J, 2007, P NATL ACAD SCI USA, V104, P2531, DOI 10.1073/pnas.0608779104; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; ASHFIELD T, 1995, GENETICS, V141, P1597; Ashfield T, 2004, PLANT CELL, V16, P309, DOI 10.1105/tpc.016725; Ashfield T, 2014, PLANT PHYSL; Axtell MJ, 2003, MOL MICROBIOL, V49, P1537, DOI 10.1046/j.1365-2958.2003.03666.x; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Bombarely A, 2012, MOL PLANT MICROBE IN, V25, P1523, DOI 10.1094/MPMI-06-12-0148-TA; Chen NWG, 2010, NEW PHYTOL, V187, P941, DOI 10.1111/j.1469-8137.2010.03337.x; Chisholm ST, 2005, P NATL ACAD SCI USA, V102, P2087, DOI 10.1073/pnas.0409468102; Chung EH, 2011, CELL HOST MICROBE, V9, P125, DOI 10.1016/j.chom.2011.01.009; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; de Vries JS, 2006, PLANT J, V45, P31, DOI 10.1111/j.1365-313X.2005.02590.x; DEBENER T, 1991, PLANT J, V1, P289, DOI 10.1046/j.1365-313X.1991.t01-7-00999.x; DeYoung BJ, 2012, CELL MICROBIOL, V14, P1071, DOI 10.1111/j.1462-5822.2012.01779.x; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Gao ZY, 2011, P NATL ACAD SCI USA, V108, P7619, DOI 10.1073/pnas.1104410108; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; HUYNH TV, 1989, SCIENCE, V245, P1374, DOI 10.1126/science.2781284; JEFFERSON RA, 1987, BIOCHEM SOC T, V15, P17, DOI 10.1042/bst0150017; Lindeberg M, 2009, MOL PLANT PATHOL, V10, P767, DOI 10.1111/j.1364-3703.2009.00587.x; LIU CN, 1992, PLANT MOL BIOL, V20, P1071, DOI 10.1007/BF00028894; Liu J, 2011, CELL HOST MICROBE, V9, P137, DOI 10.1016/j.chom.2011.01.010; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Selote D, 2013, NEW PHYTOL, V197, P1225, DOI 10.1111/nph.12093; Selote D, 2010, PLANT PHYSIOL, V153, P1199, DOI 10.1104/pp.110.158147; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; SIMONICH MT, 1995, MOL PLANT MICROBE IN, V8, P637, DOI 10.1094/MPMI-8-0637; Wright CA, 2004, P NATL ACAD SCI USA, V101, P3269, DOI 10.1073/pnas.0400461101	30	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e108159	10.1371/journal.pone.0108159	http://dx.doi.org/10.1371/journal.pone.0108159			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244054	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800072
J	Minami, S; Sawada, K; Chikenji, G				Minami, Shintaro; Sawada, Kengo; Chikenji, George			How a Spatial Arrangement of Secondary Structure Elements Is Dispersed in the Universe of Protein Folds	PLOS ONE			English	Article							STRUCTURE ALIGNMENT ALGORITHM; NOVO STRUCTURE PREDICTION; CIRCULAR PERMUTATIONS; DATABASE; CLASSIFICATION; SIMILARITY; SPACE; SCOP; EVOLUTION; SEQUENCES	It has been known that topologically different proteins of the same class sometimes share the same spatial arrangement of secondary structure elements (SSEs). However, the frequency by which topologically different structures share the same spatial arrangement of SSEs is unclear. It is important to estimate this frequency because it provides both a deeper understanding of the geometry of protein folds and a valuable suggestion for predicting protein structures with novel folds. Here we clarified the frequency with which protein folds share the same SSE packing arrangement with other folds, the types of spatial arrangement of SSEs that are frequently observed across different folds, and the diversity of protein folds that share the same spatial arrangement of SSEs with a given fold, using a protein structure alignment program MICAN, which we have been developing. By performing comprehensive structural comparison of SCOP fold representatives, we found that approximately 80% of protein folds share the same spatial arrangement of SSEs with other folds. We also observed that many protein pairs that share the same spatial arrangement of SSEs belong to the different classes, often with an opposing N- to C-terminal direction of the polypeptide chain. The most frequently observed spatial arrangement of SSEs was the 2-layer alpha/beta packing arrangement and it was dispersed among as many as 27% of SCOP fold representatives. These results suggest that the same spatial arrangements of SSEs are adopted by a wide variety of different folds and that the spatial arrangement of SSEs is highly robust against the N-to C-terminal direction of the polypeptide chain.	[Minami, Shintaro] Nagoya Univ, Dept Complex Syst Sci, Nagoya, Aichi 4648601, Japan; [Sawada, Kengo] Nagoya Univ, Dept Appl Phys, Nagoya, Aichi 4648601, Japan; [Chikenji, George] Nagoya Univ, Dept Computat Sci & Engn, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University; Nagoya University	Chikenji, G (corresponding author), Nagoya Univ, Dept Computat Sci & Engn, Nagoya, Aichi 4648601, Japan.	chikenji@tbp.cse.nagoya-u.ac.jp		Minami, Shintaro/0000-0001-9321-9279	Japan Society for the Promotion of Science [23770174]; Tatematsu Foundation; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tatematsu Foundation; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan	S. M. and K. S. are supported by Grants in-Aid for JSPS Fellows. This work was supported by a Grant-in-Aid for Young Scientists (B) (No. 23770174) from Japan Society for the Promotion of Science and the "Tatematsu Foundation." This work was also supported, in part, by the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-78; Alberto P, 2009, PLOS COMPUT BIOL, V5; Alva V, 2008, CURR OPIN STRUC BIOL, V18, P358, DOI 10.1016/j.sbi.2008.02.006; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Andreeva A, 2010, ACTA CRYSTALLOGR F, V66, P1190, DOI 10.1107/S1744309110007177; Bonneau R, 2001, ANNU REV BIOPH BIOM, V30, P173, DOI 10.1146/annurev.biophys.30.1.173; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Chandonia JM, 2002, NUCLEIC ACIDS RES, V30, P260, DOI 10.1093/nar/30.1.260; Cheng H, 2008, NUCLEIC ACIDS RES, V36, pD211, DOI 10.1093/nar/gkm698; Cheng H, 2008, PROTEINS, V70, P1162, DOI 10.1002/prot.21783; Chikenji G, 2006, P NATL ACAD SCI USA, V103, P3141, DOI 10.1073/pnas.0508195103; CHOTHIA C, 1977, P NATL ACAD SCI USA, V74, P4130, DOI 10.1073/pnas.74.10.4130; CUNNINGHAM BA, 1979, P NATL ACAD SCI USA, V76, P3218, DOI 10.1073/pnas.76.7.3218; Dai L, 2011, J MOL BIOL, V408, P585, DOI 10.1016/j.jmb.2011.02.056; Day R, 2003, PROTEIN SCI, V12, P2150, DOI 10.1110/ps.0306803; Dokholyan NV, 2002, P NATL ACAD SCI USA, V99, P14132, DOI 10.1073/pnas.202497999; Dror O, 2003, BIOINFORMATICS, V19, pi95, DOI 10.1093/bioinformatics/btg1012; Efimov AV, 1997, PROTEINS, V28, P241, DOI 10.1002/(SICI)1097-0134(199706)28:2<241::AID-PROT12>3.0.CO;2-I; FINKELSTEIN AV, 1987, PROG BIOPHYS MOL BIO, V50, P171, DOI 10.1016/0079-6107(87)90013-7; Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335; Guerler A, 2008, PROTEIN SCI, V17, P1374, DOI 10.1110/ps.035469.108; Harrison A, 2002, J MOL BIOL, V323, P909, DOI 10.1016/S0022-2836(02)00992-0; HOLM L, 1994, NUCLEIC ACIDS RES, V22, P3600; Hou JT, 2003, P NATL ACAD SCI USA, V100, P2386, DOI 10.1073/pnas.2628030100; Kim CH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-355; Krishna SS, 2005, BIOINFORMATICS, V21, P1308, DOI 10.1093/bioinformatics/bti227; Krishnadev O, 2005, PROTEINS, V61, P152, DOI 10.1002/prot.20532; Kuziemko A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002175; Lindqvist Y, 1997, CURR OPIN STRUC BIOL, V7, P422, DOI 10.1016/S0959-440X(97)80061-9; Lo WC, 2009, NUCLEIC ACIDS RES, V37, pD328, DOI 10.1093/nar/gkn679; Lua RC, 2006, PLOS COMPUT BIOL, V2, P350, DOI 10.1371/journal.pcbi.0020045; MANSFIELD ML, 1994, NAT STRUCT BIOL, V1, P213, DOI 10.1038/nsb0494-213; Minami S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-24; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nugent T, 2012, P NATL ACAD SCI USA, V109, pE1540, DOI 10.1073/pnas.1120036109; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; PONTING CP, 1995, TRENDS BIOCHEM SCI, V20, P179, DOI 10.1016/S0968-0004(00)89003-9; PTITSYN OB, 1980, Q REV BIOPHYS, V13, P339, DOI 10.1017/S0033583500001724; Qi Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-314; Reeder PJ, 2010, BIOCHEMISTRY-US, V49, P10773, DOI 10.1021/bi100975z; Sadreyev RI, 2009, CURR OPIN STRUC BIOL, V19, P321, DOI 10.1016/j.sbi.2009.04.009; Skolnick J, 2009, P NATL ACAD SCI USA, V106, P15690, DOI 10.1073/pnas.0907683106; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Swindells MB, 1998, BIOESSAYS, V20, P884; Szustakowski JD, 2005, BIOINFORMATICS, V21, P66, DOI 10.1093/bioinformatics/bti1111; Taylor WR, 2009, STRUCTURE, V17, P1244, DOI 10.1016/j.str.2009.07.012; Teyra J, 2011, PROTEINS, V79, P499, DOI 10.1002/prot.22897; Xie L, 2008, P NATL ACAD SCI USA, V105, P5441, DOI 10.1073/pnas.0704422105; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Yuan X, 2005, BIOINFORMATICS, V21, P1010, DOI 10.1093/bioinformatics/bti128; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhu JH, 2005, PROTEINS, V58, P618, DOI 10.1002/prot.20331	53	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107959	10.1371/journal.pone.0107959	http://dx.doi.org/10.1371/journal.pone.0107959			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243952	Green Submitted, Green Published, gold			2022-12-25	WOS:000343679800059
J	Willis, EL; Eberle, R; Wolf, RF; White, GL; McFarlane, D				Willis, Erin L.; Eberle, Richard; Wolf, Roman F.; White, Gary L.; McFarlane, Dianne			The Effects of Age and Cytomegalovirus on Markers of Inflammation and Lymphocyte Populations in Captive Baboons	PLOS ONE			English	Article							T-CELLS; RHESUS MACAQUES; INFECTION; ASSOCIATION; EXPRESSION; IMBALANCE; SUBSETS; STRESS	The human immune system undergoes age-related changes that can lead to increased disease susceptibility. Using the baboon as a model for human immune system aging, we examined age-related changes in relative and absolute numbers of T cell subpopulations, cytomegalovirus (CMV) titer and markers of inflammation. In addition, the effect of gender, social status and peer group on lymphocyte subpopulations was determined. Relative and absolute numbers of total lymphocytes (CD3+), T helper cells (CD4+), and cytotoxic T cells (CD8+) increased with age. The proportion of naive T cells (CD45RA+) decreased, while the total number of cells negative for the co-stimulatory receptor, CD28 (CD28-) increased in an age-dependent manner. Furthermore, CMV titers were negatively correlated with the number of naive CD4+ cells. IL-6 and cortisol concentration were also negatively associated with T cell subpopulations. Additionally, socially dominant baboons exhibited decreases in naive CD4+ and CD8+ cells (by 65% and 52%, respectively) compared to subordinate animals. These results suggest that factors such as CMV exposure and inflammation may contribute to the age-related decline in immune health and indicate that factors like social status should be considered when studying immunosenescence in animal models.	[Willis, Erin L.; McFarlane, Dianne] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Physiol Sci, Stillwater, OK 74078 USA; [Eberle, Richard] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, Stillwater, OK 74078 USA; [Wolf, Roman F.; White, Gary L.] Univ Oklahoma, Hlth Sci Ctr, Dept Comparat Med, Oklahoma City, OK USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater; University of Oklahoma System; University of Oklahoma Health Sciences Center	McFarlane, D (corresponding author), Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Physiol Sci, Stillwater, OK 74078 USA.	diannem@okstate.edu			National Institutes of Health [P40 OD010988, P40 OD010431]; Oklahoma State University's Center for Veterinary Health Sciences Research Development Seed Grant Fund; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010431, P40OD010988] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma State University's Center for Veterinary Health Sciences Research Development Seed Grant Fund; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (P40 OD010988 and P40 OD010431 to GLW and RFW). A portion of this work was also funded by Oklahoma State University's Center for Veterinary Health Sciences Research Development Seed Grant Fund (to ELW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2002, MOL BIOL CELL; Almanzar G, 2005, J VIROL, V79, P3675, DOI 10.1128/JVI.79.6.3675-3683.2005; Anderson BH, 1999, VET RES COMMUN, V23, P399, DOI 10.1023/A:1006365324335; Antoine P, 2012, J IMMUNOL, V189, P2665, DOI 10.4049/jimmunol.1101165; Attanasio R, 2001, CLIN EXP IMMUNOL, V123, P361, DOI 10.1046/j.1365-2249.2001.01454.x; Blewett EL, 2001, ARCH VIROL, V146, P1723, DOI 10.1007/s007050170059; Boomer JS, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002436; Broere F, 2011, PRINCIPLES IMMUNOPHA, V3rd, P15, DOI DOI 10.1007/978-3-0346-0136-8; Bronikowski AM, 2002, P NATL ACAD SCI USA, V99, P9591, DOI 10.1073/pnas.142675599; Brunner S, 2011, AGEING RES REV, V10, P362, DOI 10.1016/j.arr.2010.08.003; Cannizzo ES, 2011, J PROTEOMICS, V74, P2313, DOI 10.1016/j.jprot.2011.06.005; Cevenini E, 2013, CURR OPIN CLIN NUTR, V16, P14, DOI 10.1097/MCO.0b013e32835ada13; Cicin-Sain L, 2010, J IMMUNOL, V184, P6739, DOI 10.4049/jimmunol.0904193; De Martinis M, 2005, FEBS LETT, V579, P2035, DOI 10.1016/j.febslet.2005.02.055; Fagnoni FF, 1996, IMMUNOLOGY, V88, P501, DOI 10.1046/j.1365-2567.1996.d01-689.x; Fletcher JM, 2005, J IMMUNOL, V175, P8218, DOI 10.4049/jimmunol.175.12.8218; Gesquiere LR, 2011, SCIENCE, V333, P357, DOI 10.1126/science.1207120; Gruver AL, 2007, J PATHOL, V211, P144, DOI 10.1002/path.2104; Gruys E, 2005, J Zhejiang Univ Sci B, V6, P1045, DOI 10.1631/jzus.2005.B1045; Jackson L, 2013, MMWR-MORBID MORTAL W, V62, P119; Janeway CA., 2001, IMMUNOBIOLOGY IMMUNE; Jayashankar L, 2003, CLIN DIAGN LAB IMMUN, V10, P870, DOI 10.1128/CDLI.10.5.870-875.2003; Koch S, 2007, ANN NY ACAD SCI, V1114, P23, DOI 10.1196/annals.1396.043; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Licastro Federico, 2005, Immun Ageing, V2, P8; Luckheeram RV, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/925135; MacGuire JG, 2009, COMPARATIVE MED, V59, P168; McFarlane D, 2011, J GERONTOL A-BIOL, V66, P1309, DOI 10.1093/gerona/glr146; Mocarski E.S., 2007, FIELDS VIROL, P2701; Nam KH, 1998, EXP ANIM TOKYO, V47, P159, DOI 10.1538/expanim.47.159; Naylor K, 2005, J IMMUNOL, V174, P7446, DOI 10.4049/jimmunol.174.11.7446; Olson NC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071498; Pawelec G, 2010, J COMP PATHOL, V141, pS39, DOI 10.1016/j.jcpa.2009.09.005; Pawelec G, 2009, REV MED VIROL, V19, P47, DOI 10.1002/rmv.598; Qiu CL, 2008, VET IMMUNOL IMMUNOP, V124, P313, DOI 10.1016/j.vetimm.2008.04.005; Qiu H, 2008, J EXP MED, V205, P19, DOI 10.1084/jem.20070201; Quaglia LA, 2014, AGING CLIN EXP RES, V26, P19, DOI 10.1007/s40520-013-0114-x; Romero-Steiner S, 1999, CLIN INFECT DIS, V29, P281, DOI 10.1086/520200; Saurwein-Teissl M, 2002, J IMMUNOL, V168, P5893, DOI 10.4049/jimmunol.168.11.5893; Shi Q, 2004, DNA CELL BIOL, V23, P502, DOI 10.1089/1044549041562294; Smithey MJ, 2012, J IMMUNOL, V189, P5356, DOI 10.4049/jimmunol.1201867; Stacy S, 2008, J IMMUNOL, V181, P109, DOI 10.4049/jimmunol.181.1.109; Trollor JN, 2010, DEMENT GERIATR COGN, V30, P569, DOI 10.1159/000322092; Trzonkowski P, 2003, VACCINE, V21, P3826, DOI 10.1016/S0264-410X(03)00309-8; Tung J, 2012, P NATL ACAD SCI USA, V109, P6490, DOI 10.1073/pnas.1202734109; Vallejo AN, 1998, J BIOL CHEM, V273, P8119, DOI 10.1074/jbc.273.14.8119; Vallejo AN, 2004, TRENDS MOL MED, V10, P119, DOI 10.1016/j.molmed.2004.01.002; Willis EL, 2014, GEN COMP ENDOCR, V195, P21, DOI 10.1016/j.ygcen.2013.10.004; Yan Jun, 2010, Immun Ageing, V7, P4, DOI 10.1186/1742-4933-7-4; Zhang W, 2014, EXP GERONTOL	50	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107167	10.1371/journal.pone.0107167	http://dx.doi.org/10.1371/journal.pone.0107167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244034	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800023
J	Finlay-Schultz, J; Cittelly, DM; Hendricks, P; Patel, P; Kabos, P; Jacobsen, BM; Richer, JK; Sartorius, CA				Finlay-Schultz, J.; Cittelly, D. M.; Hendricks, P.; Patel, P.; Kabos, P.; Jacobsen, B. M.; Richer, J. K.; Sartorius, C. A.			Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a	ONCOGENE			English	Article							MICRORNA EXPRESSION PROFILES; MAMMARY-GLAND DEVELOPMENT; MESENCHYMAL TRANSITION; MIR-200 FAMILY; ESTROGEN; DIFFERENTIATION; IDENTIFICATION; SUPPRESSION; PROGESTINS; PROLACTIN	Progesterone (P4) has emerged as an important hormone-regulating mammary stem cell (MaSC) populations. In breast cancer, P4 and synthetic analogs increase the number of stem-like cells within luminal estrogen receptor (ER)- and progesterone receptor (PR)-positive breast cancers. These cells gain expression of de-differentiated cell markers CD44 and cytokeratin 5 (CK5), lose luminal markers ER and PR, and are more therapy resistant. We previously described that P4 downregulation of microRNA (miR)-29a contributes to the expansion of CD44(high) and CK5(+) cells. Here we investigated P4 downregulation of miR-141, a member of the miR-200 family of tumor suppressors, in facilitating an increase in stem-like breast cancer cells. miR-141 was the sole member of the miR-200 family P4-downregulated at the mature miRNA level in luminal breast cancer cell lines. Stable inhibition of miR-141 alone increased the CD44(high) population, and potentiated P4-mediated increases in both CD44(high) and CK5(+) cells. Loss of miR-141 enhanced both mammosphere formation and tumor initiation. miR-141 directly targeted both PR and signal transducer and activator of transcription 5A (Stat5a), transcription factors important for MaSC expansion. miR-141 depletion increased PR protein levels, even in cell lines where PR expression is estrogen dependent. Stat5a suppression via small interfering RNA or a small-molecule inhibitor reduced the P4-dependent increase in CK5(+) and CD44(high) cells. These data support a mechanism by which P4-triggered loss of miR-141 facilitates breast cancer cell de-differentiation through deregulation of PR and Stat5a, two transcription factors important for controlling mammary cell fate.	[Finlay-Schultz, J.; Cittelly, D. M.; Hendricks, P.; Patel, P.; Jacobsen, B. M.; Richer, J. K.; Sartorius, C. A.] Univ Colorado, Dept Pathol, Aurora, CO 80045 USA; [Kabos, P.] Univ Colorado, Dept Med, Div Med Oncol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Finlay-Schultz, J (corresponding author), Univ Colorado, Dept Pathol, MS8104,Anschutz Med Campus,12801 E 17th Ave, Aurora, CO 80045 USA.	Jessica.Finlay-Schultz@ucdenver.edu; Carol.Sartorius@ucdenver.edu		Finlay-Schultz, Jessica/0000-0002-7855-9870; Cittelly, Diana/0000-0002-8392-0800; Jacobsen, Britta/0000-0001-8234-1690	Department of Defense BCRP grants [W81XWH-11-1-0210, W81XWH-11-1-0101]; NIH [R01 CA140985, K08 CA164048];  [P30CA046934]; NATIONAL CANCER INSTITUTE [R01CA140985, K08CA164048, P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER	Department of Defense BCRP grants(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank the University of Colorado Cancer Center Flow Cytometry and Tissue Culture Cores supported by P30CA046934 and the University of Colorado, Department of Pathology Sequencing Core for their technical assistance and services. This work was supported by Department of Defense BCRP grants W81XWH-11-1-0210 (CAS, JKR) and W81XWH-11-1-0101 (DMC) and NIH R01 CA140985 (CAS). PK was supported by NIH K08 CA164048.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Axlund SD, 2013, HORM CANCER-US, V4, P36, DOI 10.1007/s12672-012-0127-5; Bocker W, 2002, LAB INVEST, V82, P737, DOI 10.1097/01.LAB.0000017371.72714.C5; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Cittelly DM, 2013, ONCOGENE, V32, P2555, DOI 10.1038/onc.2012.275; CLARK GM, 1983, BREAST CANCER RES TR, V3, pS69, DOI 10.1007/BF01855130; Cochrane DR, 2012, MOL CELL ENDOCRINOL, V357, P50, DOI 10.1016/j.mce.2011.09.022; Cochrane DR, 2012, MOL CELL ENDOCRINOL, V355, P15, DOI 10.1016/j.mce.2011.12.020; Cochrane DR, 2009, MOL CANCER THER, V8, P1055, DOI 10.1158/1535-7163.MCT-08-1046; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Edwards DP, 2000, J SOC GYNECOL INVEST, V7, pS22, DOI 10.1177/1071557600007001S08; Finnegan EF, 2013, CRIT REV BIOCHEM MOL, V48, P51, DOI 10.3109/10409238.2012.738643; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Gonzalez-Suarez E, 2010, NATURE, V468, P103, DOI 10.1038/nature09495; Graham JD, 2009, ENDOCRINOLOGY, V150, P3318, DOI 10.1210/en.2008-1630; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grosshans H, 2010, ADV EXP MED BIOL, V700, P140; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Haga CL, 2012, J BIOL CHEM, V287, P42695, DOI 10.1074/jbc.M112.387761; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Horwitz KB, 2008, J CLIN ENDOCR METAB, V93, P3295, DOI 10.1210/jc.2008-0938; Horwitzt KB, 2008, P NATL ACAD SCI USA, V105, P5774, DOI 10.1073/pnas.0706216105; Howe EN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2867; Howell SJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2129; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Ismail PM, 2003, STEROIDS, V68, P779, DOI 10.1016/S0039-128X(03)00133-8; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kabos P, 2012, BREAST CANCER RES TR, V135, P415, DOI 10.1007/s10549-012-2164-8; Kabos P, 2011, BREAST CANCER RES TR, V128, P45, DOI 10.1007/s10549-010-1078-6; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; Li Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-731; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu C, 2012, CANCER RES, V72, P3393, DOI 10.1158/0008-5472.CAN-11-3864; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Nelson EA, 2011, BLOOD, V117, P3421, DOI 10.1182/blood-2009-11-255232; Neves Rui, 2010, BMC Res Notes, V3, P219, DOI 10.1186/1756-0500-3-219; Obr AE, 2012, MOL CELL ENDOCRINOL, V357, P4, DOI 10.1016/j.mce.2011.10.030; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pillai MM, 2014, BREAST CANCER RES TR, V146, P85, DOI 10.1007/s10549-014-3004-9; Reid Brian G, 2014, Curr Chem Genom Transl Med, V8, P27, DOI 10.2174/2213988501408010027; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Richer JK, 1998, J BIOL CHEM, V273, P31317, DOI 10.1074/jbc.273.47.31317; Rouet V, 2010, P NATL ACAD SCI USA, V107, P15199, DOI 10.1073/pnas.0911651107; Santos SJ, 2008, ENDOCRINOLOGY, V149, P329, DOI 10.1210/en.2007-0594; Sartorius CA, 2005, CANCER RES, V65, P9779, DOI 10.1158/0008-5472.CAN-05-0505; Sato T, 2014, ONCOGENE, V33, P2215, DOI 10.1038/onc.2013.172; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; Schwab R, 2013, EMBO REP, V14, P615, DOI 10.1038/embor.2013.58; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Tanos T, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005654; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Vafaizadeh V, 2012, FRONT BIOSCI-LANDMRK, V17, P1232, DOI 10.2741/3983; Vafaizadeh V, 2010, STEM CELLS, V28, P928, DOI 10.1002/stem.407; Wagner KU, 2008, J MAMMARY GLAND BIOL, V13, P93, DOI 10.1007/s10911-008-9062-z; Yamaji D, 2009, GENE DEV, V23, P2382, DOI 10.1101/gad.1840109; Yamashita H, 2006, ENDOCR-RELAT CANCER, V13, P885, DOI 10.1677/erc.1.01095	62	55	59	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2015	34	28					3676	3687		10.1038/onc.2014.298	http://dx.doi.org/10.1038/onc.2014.298			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM4TZ	25241899	Green Accepted			2022-12-25	WOS:000357679100006
J	Kimura, Y; Chihara, K; Oh, CH; Takeuchi, K; Yamauchi, S; Yoshiki, H; Fujieda, S; Sada, K				Kimura, Yukihiro; Chihara, Kazuyasu; Oh, Chisato Honj; Takeuchi, Kenji; Yamauchi, Shota; Yoshiki, Hatsumi; Fujieda, Shigeharu; Sada, Kiyonao			Dectin-1-mediated Signaling Leads to Characteristic Gene Expressions and Cytokine Secretion via Spleen Tyrosine Kinase (Syk) in Rat Mast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLUCAN RECEPTOR; KAPPA-B-ZETA; AFFINITY IGE RECEPTOR; ADAPTER PROTEIN 3BP2; TNF-ALPHA; LECTIN RECEPTORS; DENDRITIC CELLS; PERITONEAL INFLAMMATION; RHEUMATOID-ARTHRITIS; DECTIN-1 STIMULATION	Dectin-1 recognizes beta-glucan and plays important roles for the antifungal immunity through the activation of spleen tyrosine kinase (Syk) in dendritic cells or macrophages. Recently, expression of Dectin-1 was also identified in human and mouse mast cells, although its physiological roles were largely unknown. In this report, rat mast cell line RBL-2H3 was analyzed to investigate the molecular mechanism of Dectin-1-mediated activation and responses of mast cells. Treatment of cells with Dectin-1-specific agonist curdlan induced tyrosine phosphorylation of cellular proteins and the interaction of Dectin-1 with the Src homology 2 domain of Syk. These responses depended on tyrosine phosphorylation of the hemi-immunoreceptor tyrosine-based activation motif in the cytoplasmic tail of Dectin-1, whereas they were independent of the gamma-subunit of high-affinity IgE receptor. DNAmicroarray and real-time PCR analyses showed that Dectin-1-mediated signaling stimulated gene expression of transcription factor Nfkbiz and inflammatory cytokines, such as monocyte chemoattractant protein-1, IL-3, IL-4, IL-13, and tumor necrosis factor (TNF)-alpha. The response was abrogated by pretreatment with Syk inhibitor R406. These results suggest that Syk is critical for Dectin-1-mediated activation of mast cells, although the signaling differs from that triggered by Fc epsilon RI activation. In addition, these gene expressions induced by curdlan stimulation were specifically observed in mast cells, suggesting that Dectin-1-mediated signaling of mast cells offers new insight into the antifungal immunity.	[Kimura, Yukihiro; Fujieda, Shigeharu] Univ Fukui, Fac Med Sci, Dept Sensory & Locomotor Med, Div Otorhinolaryngol Head & Neck Surg, Fukui 9101193, Japan; [Kimura, Yukihiro; Chihara, Kazuyasu; Oh, Chisato Honj; Takeuchi, Kenji; Yamauchi, Shota; Yoshiki, Hatsumi; Sada, Kiyonao] Univ Fukui, Fac Med Sci, Dept Pathol Sci, Div Genome Sci & Microbiol, Fukui 9101193, Japan; [Oh, Chisato Honj] Univ Fukui, Fac Med Sci, Dept Internal Med 3, Fukui 9101193, Japan; [Chihara, Kazuyasu; Takeuchi, Kenji; Yamauchi, Shota; Sada, Kiyonao] Univ Fukui, Org Life Sci Adv Programs, Fukui 9101193, Japan	University of Fukui; University of Fukui; University of Fukui; University of Fukui	Sada, K (corresponding author), Univ Fukui, Fac Med Sci, Dept Pathol Sci, Div Genome Sci & Microbiol, 23-3 Matsuoka Shimoaizuki, Fukui 9101193, Japan.	ksada@u-fukui.ac.jp	Sada, Kiyonao/H-7373-2015; Kimura, Yukihiro/AAI-6300-2020	Sada, Kiyonao/0000-0001-6124-3100; 	Japan Society for the Promotion of Science; University of Fukui	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); University of Fukui	This work was supported in part by research funding from grants-in-aid from the Japan Society for the Promotion of Science and research funding from the University of Fukui (to S. F. and K. S.).	Ajuebor MN, 1998, J LEUKOCYTE BIOL, V63, P108, DOI 10.1002/jlb.63.1.108; Allendoerfer R, 1998, J IMMUNOL, V160, P6072; Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; BENHAMOU M, 1993, J BIOL CHEM, V268, P23318; Braselmann S, 2006, J PHARMACOL EXP THER, V319, P998, DOI 10.1124/jpet.106.109058; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Chihara K, 2014, EXP CELL RES, V322, P99, DOI 10.1016/j.yexcr.2013.12.026; Cortez-Espinosa N, 2012, METABOLISM, V61, P1538, DOI 10.1016/j.metabol.2012.03.020; DICARLO FJ, 1958, SCIENCE, V127, P756, DOI 10.1126/science.127.3301.756-a; Eberle ME, 2012, J IMMUNOL, V188, P5644, DOI 10.4049/jimmunol.1103068; Elcombe SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060086; Ferwerda G, 2008, CELL MICROBIOL, V10, P2058, DOI 10.1111/j.1462-5822.2008.01188.x; Fuller GLJ, 2007, J BIOL CHEM, V282, P12397, DOI 10.1074/jbc.M609558200; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Heinsbroek SEM, 2006, J IMMUNOL, V176, P5513, DOI 10.4049/jimmunol.176.9.5513; Hildebrand DG, 2013, J IMMUNOL, V190, P4812, DOI 10.4049/jimmunol.1300089; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; Kataoka K, 2002, J BIOL CHEM, V277, P36825, DOI 10.1074/jbc.M206756200; Kato Y, 2008, MICROBIOL IMMUNOL, V52, P418, DOI 10.1111/j.1348-0421.2008.00055.x; Kawakami K, 1996, CLIN EXP IMMUNOL, V106, P468, DOI 10.1046/j.1365-2249.1996.d01-870.x; Kelly EK, 2010, J IMMUNOL, V184, P5545, DOI 10.4049/jimmunol.0901293; KIHARA H, 1994, J BIOL CHEM, V269, P22427; Kolaczkowska E, 2001, J LEUKOCYTE BIOL, V69, P33; LeibundGut-Landmann S, 2008, BLOOD, V112, P4971, DOI 10.1182/blood-2008-05-158469; Lilly LM, 2012, J IMMUNOL, V189, P3653, DOI 10.4049/jimmunol.1201797; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; McIntosh M, 2005, APPL MICROBIOL BIOT, V68, P163, DOI 10.1007/s00253-005-1959-5; Mehrad B, 1999, J IMMUNOL, V162, P1633; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Netea MG, 1999, J IMMUNOL, V163, P1498; Ogi K, 2011, GENES CELLS, V16, P951, DOI 10.1111/j.1365-2443.2011.01539.x; Olsson S, 2007, MOL IMMUNOL, V44, P1509, DOI 10.1016/j.molimm.2006.09.004; Olynych TJ, 2006, J ALLERGY CLIN IMMUN, V118, P837, DOI 10.1016/j.jaci.2006.06.008; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Plantinga TS, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2933; Rand TG, 2013, ARCH TOXICOL, V87, P1841, DOI 10.1007/s00204-013-1042-4; Rand TG, 2010, ARCH TOXICOL, V84, P205, DOI 10.1007/s00204-009-0481-4; RAO TS, 1994, J PHARMACOL EXP THER, V269, P917; Ribbing C, 2011, ALLERGY, V66, P110, DOI 10.1111/j.1398-9995.2010.02437.x; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Sada K, 2002, BLOOD, V100, P2138, DOI 10.1182/blood-2001-12-0340; Sada K, 2001, BLOOD, V97, P1352, DOI 10.1182/blood.V97.5.1352; Sada K, 2001, J BIOCHEM-TOKYO, V130, P177, DOI 10.1093/oxfordjournals.jbchem.a002970; Salazar-Aldrete C, 2013, J CLIN IMMUNOL, V33, P368, DOI 10.1007/s10875-012-9821-x; Shukla U, 2009, J BIOL CHEM, V284, P33719, DOI 10.1074/jbc.M109.049999; Slack EC, 2007, EUR J IMMUNOL, V37, P1600, DOI 10.1002/eji.200636830; Strasser D, 2012, IMMUNITY, V36, P32, DOI 10.1016/j.immuni.2011.11.015; Takahashi M, 2009, J IMMUNOL, V183, P3463, DOI 10.4049/jimmunol.0802812; Takeshita K, 2003, J PHARMACOL EXP THER, V307, P1072, DOI 10.1124/jpet.103.057489; Tassi I, 2009, EUR J IMMUNOL, V39, P1369, DOI 10.1002/eji.200839313; Taylor PR, 2004, J IMMUNOL, V172, P1157, DOI 10.4049/jimmunol.172.2.1157; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Thornton BP, 1996, J IMMUNOL, V156, P1235; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; Vautier S, 2012, CYTOKINE, V58, P89, DOI 10.1016/j.cyto.2011.08.031; Voehringer D, 2013, NAT REV IMMUNOL, V13, P362, DOI 10.1038/nri3427; Willment JA, 2001, J BIOL CHEM, V276, P43818, DOI 10.1074/jbc.M107715200; Willment JA, 2003, J IMMUNOL, V171, P4569, DOI 10.4049/jimmunol.171.9.4569; Xie ZH, 2000, J IMMUNOL, V164, P1521, DOI 10.4049/jimmunol.164.3.1521; Xu S, 2009, J BIOL CHEM, V284, P7038, DOI 10.1074/jbc.M806650200; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200; Yang Z, 2009, IMMUNOBIOLOGY, V214, P321, DOI 10.1016/j.imbio.2008.09.002; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758	71	30	33	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31565	31575		10.1074/jbc.M114.581322	http://dx.doi.org/10.1074/jbc.M114.581322			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25246527	Green Published, hybrid			2022-12-25	WOS:000344549900057
J	Tian, J; Tep, C; Benedick, A; Saidi, N; Ryu, JC; Kim, ML; Sadasivan, S; Oberdick, J; Smeyne, R; Zhu, MX; Yoon, SO				Tian, JinBin; Tep, Chhavy; Benedick, Alex; Saidi, Nabila; Ryu, Jae Cheon; Kim, Mi Lyang; Sadasivan, Shankar; Oberdick, John; Smeyne, Richard; Zhu, Michael X.; Yoon, Sung Ok			p75 Regulates Purkinje Cell Firing by Modulating SK Channel Activity through Rac1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTROPHIC FACTOR; NMDA RECEPTOR; RHO-GTPASES; CEREBELLAR; EXPRESSION; BDNF; CONDUCTANCE; ACTIVATION; PROTEIN; GROWTH	p75 is expressed among Purkinje cells in the adult cerebellum, but its function has remained obscure. Here we report that p75 is involved in maintaining the frequency and regularity of spontaneous firing of Purkinje cells. The overall spontaneous firing activity of Purkinje cells was increased in p75(-/-) mice during the phasic firing period due to a longer firing period and accompanying reduction in silence period than in the wild type. We attribute these effects to a reduction in small conductance Ca2+-activated potassium (SK) channel activity in Purkinje cells from p75(-/-) mice compared with the wild type littermates. The mechanism by which p75 regulates SK channel activity appears to involve its ability to activate Rac1. In organotypic cultures of cerebellar slices, brain-derived neurotrophic factor increased RacGTP levels by activating p75 but not TrkB. These results correlate with a reduction in RacGTP levels in synaptosome fractions from the p75(-/-) cerebellum, but not in that from the cortex of the same animals, compared with wild type littermates. More importantly, we demonstrate that Rac1 modulates SK channel activity and firing patterns of Purkinje cells. Along with the finding that spine density was reduced in p75(-/-) cerebellum, these data suggest that p75 plays a role in maintaining normalcy of Purkinje cell firing in the cerebellum in part by activating Rac1 in synaptic compartments and modulating SK channels.	[Tep, Chhavy; Benedick, Alex; Saidi, Nabila; Ryu, Jae Cheon; Kim, Mi Lyang; Yoon, Sung Ok] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Tep, Chhavy; Oberdick, John] Ohio State Univ, Biochem Program, Columbus, OH 43210 USA; [Tian, JinBin; Zhu, Michael X.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Sadasivan, Shankar; Smeyne, Richard] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Tian, JinBin; Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; St Jude Children's Research Hospital; University of Texas System; University of Texas Health Science Center Houston	Zhu, MX (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA.	michael.x.zhu@uth.tmc.edu; sung.yoon@osumc.edu	Yoon, Sung Ok/C-5992-2012; tian, jinbin/L-6006-2019; Tian, JinBin/B-7001-2019	Tian, JinBin/0000-0002-5516-7778; Benedick, Alex/0000-0001-5044-8151; Smeyne, Richard/0000-0002-8459-5472	National Institutes of Health [NS039472, GM092759, P30NS045758]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039472, P30NS045758] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS039472 (to S.O.Y.), GM092759 (to M.X.Z.), and P30NS045758 (to the Ohio State Neuroscience Center Core).	del Rio JA, 2010, NAT PROTOC, V5, P217, DOI 10.1038/nprot.2009.202; Beech D. J., 2007, V179, P109; Bentley CA, 2000, J NEUROSCI, V20, P7706; Blum R, 2002, NATURE, V419, P687, DOI 10.1038/nature01085; Borghesani PR, 2002, DEVELOPMENT, V129, P1435; Boyer SB, 2009, J CELL PHYSIOL, V218, P385, DOI 10.1002/jcp.21610; Buttery P, 2006, P NATL ACAD SCI USA, V103, P1924, DOI 10.1073/pnas.0510655103; Carter AR, 2002, J NEUROSCI, V22, P1316, DOI 10.1523/JNEUROSCI.22-04-01316.2002; Carter AR, 2003, MOL CELL NEUROSCI, V22, P1, DOI 10.1016/S1044-7431(02)00015-5; CASTLE NA, 1989, TRENDS NEUROSCI, V12, P59, DOI 10.1016/0166-2236(89)90137-9; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chapleau C. A., 2012, NEURAL PLAST, V2012; Chen LY, 2010, J NEUROSCI, V30, P10977, DOI 10.1523/JNEUROSCI.1077-10.2010; Cingolani LA, 2002, J NEUROSCI, V22, P4456, DOI 10.1523/JNEUROSCI.22-11-04456.2002; CONSTANTI A, 1987, J PHYSIOL-LONDON, V387, P173, DOI 10.1113/jphysiol.1987.sp016569; Coulson EJ, 2008, J NEUROSCI, V28, P315, DOI 10.1523/JNEUROSCI.2699-07.2008; De Curtis I, 2008, DEV NEUROSCI-BASEL, V30, P47, DOI 10.1159/000109851; De Zeeuw CI, 2011, NAT REV NEUROSCI, V12, P327, DOI 10.1038/nrn3011; Faber ESL, 2002, J NEUROSCI, V22, P1618, DOI 10.1523/JNEUROSCI.22-05-01618.2002; Harrington AW, 2002, J NEUROSCI, V22, P156, DOI 10.1523/JNEUROSCI.22-01-00156.2002; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; He XP, 2010, J NEUROSCI, V30, P6188, DOI 10.1523/JNEUROSCI.5821-09.2010; Hosy E, 2011, J PHYSIOL-LONDON, V589, P3433, DOI 10.1113/jphysiol.2011.205823; Ito M, 1984, CEREBELLUM NEURAL CO; Karpushev AV, 2011, HYPERTENSION, V57, P996, DOI 10.1161/HYPERTENSIONAHA.110.157784; Karpushev AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008827; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Kinoshita H, 2008, HYPERTENSION, V52, P507, DOI 10.1161/HYPERTENSIONAHA.108.118216; Lang SB, 2007, J NEUROSCI, V27, P1097, DOI 10.1523/JNEUROSCI.3590-06.2007; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9; Liebau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018148; Lippman JJ, 2008, GLIA, V56, P1463, DOI 10.1002/glia.20712; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; Meyer DK, 2000, J NEUROSCI, V20, P6743, DOI 10.1523/JNEUROSCI.20-18-06743.2000; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Oh D, 2010, J NEUROSCI, V30, P14134, DOI 10.1523/JNEUROSCI.1711-10.2010; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Raman IM, 1999, J NEUROSCI, V19, P1663; Richard V, 2008, INT J DEV NEUROSCI, V26, P723, DOI 10.1016/j.ijdevneu.2008.07.010; ROCAMORA N, 1993, MOL BRAIN RES, V17, P1, DOI 10.1016/0169-328X(93)90065-W; SAH P, 1992, J NEUROPHYSIOL, V68, P2237, DOI 10.1152/jn.1992.68.6.2237; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Storey NM, 2002, CURR BIOL, V12, P27, DOI 10.1016/S0960-9822(01)00625-X; Swensen AM, 2003, J NEUROSCI, V23, P9650; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tep C, 2012, J BIOL CHEM, V287, P1600, DOI 10.1074/jbc.M111.312736; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Tolias KF, 2007, P NATL ACAD SCI USA, V104, P7265, DOI 10.1073/pnas.0702044104; van der Wijst J, 2009, MAGNESIUM RES, V22, P127; Ven TJV, 2005, J NEUROSCI, V25, P9488, DOI 10.1523/JNEIROSCI.2450-05.2005; von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; WilkBlaszczak MA, 1997, J NEUROSCI, V17, P4094; Womack M, 2002, J NEUROSCI, V22, P10603; Womack MD, 2009, NEUROSCIENCE, V162, P989, DOI 10.1016/j.neuroscience.2009.05.016; Womack MD, 2004, J NEUROSCI, V24, P3511, DOI 10.1523/JNEUROSCI.0290-04.2004; Womack MD, 2003, J NEUROSCI, V23, P2600; Xie Z, 2008, J NEUROSCI, V28, P6079, DOI 10.1523/JNEUROSCI.1170-08.2008; Xu ZQ, 2011, EUR J NEUROSCI, V33, P1376, DOI 10.1111/j.1460-9568.2011.07635.x; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005; Zhou PC, 2007, NEURON, V55, P53, DOI 10.1016/j.neuron.2007.05.030	70	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31458	31472		10.1074/jbc.M114.589937	http://dx.doi.org/10.1074/jbc.M114.589937			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25253694	Green Published, hybrid			2022-12-25	WOS:000344549900048
J	Tripathi, K; Mani, C; Barnett, R; Nalluri, S; Bachaboina, L; Rocconi, RP; Athar, M; Owen, LB; Palle, K				Tripathi, Kaushlendra; Mani, Chinnadurai; Barnett, Reagan; Nalluri, Sriram; Bachaboina, Lavanya; Rocconi, Rodney P.; Athar, Mohammed; Owen, Laurie B.; Palle, Komaraiah			Gli1 Protein Regulates the S-phase Checkpoint in Tumor Cells via Bid Protein, and Its Inhibition Sensitizes to DNA Topoisomerase 1 Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOGENE-INDUCED SENESCENCE; TRANSCRIPTION FACTORS; HEDGEHOG PATHWAY; REPLICATION FORKS; HUMAN HOMOLOG; STEM-CELL; CANCER; DAMAGE; SURVIVAL; GROWTH	Aberrant expression of hedgehog molecules, particularly Gli1, iscommonin cancers of many tissues and is responsible for their aggressive behavior and chemoresistance. Here we demonstrate a novel and tumor-specific role for aberrant Gli1 in the regulation of the S-phase checkpoint that suppresses replication stress and resistance to chemotherapy. Inhibition of Gli1 in tumor cells induced replication stress-mediated DNA damage response, attenuated their clonogenic potential, abrogated camptothecin (CPT)-induced Chk1 phosphorylation, and potentiated its cytotoxicity. However, in normal fibroblasts, Gli1 siRNAs showed no significant changes in CPT-induced Chk1 phosphorylation. Further analysis of ataxia telangiectasia and Rad3-related protein (ATR)/Chk1 signaling cascade genes in tumor cells revealed an unexpected mechanism whereby Gli1 regulates ATR-mediated Chk1 phosphorylation by transcriptional regulation of the BH3-only protein Bid. Consistent with its role in DNA damage response, Bid down-regulation in tumor cells abolished CPT-induced Chk1 phosphorylation and sensitized them to CPT. Correspondingly, Gli1 inhibition affected the expression of Bid and the association of replication protein A (RPA) with the ATR-interacting protein (ATRIP)-ATR complex, and this compromised the S-phase checkpoint. Conversely, complementation of Bid in Gli1-deficient cells restored CPT-induced Chk1 phosphorylation. An in silico analysis of the Bid promoter identified a putative Gli1 binding site, and further studies using luciferase reporter assays confirmed Gli1-dependent promoter activity. Collectively, our studies established a novel connection between aberrant Gli1 and Bid in the survival of tumor cells and their response to chemotherapy, at least in part, by regulating the S-phase checkpoint. Importantly, our data suggest a novel drug combination of Gli1 and Top1 inhibitors as an effective therapeutic strategy in treating tumors that expresses Gli1.	[Tripathi, Kaushlendra; Mani, Chinnadurai; Barnett, Reagan; Nalluri, Sriram; Bachaboina, Lavanya; Rocconi, Rodney P.; Owen, Laurie B.; Palle, Komaraiah] Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, Mobile, AL 36604 USA; [Athar, Mohammed] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA	University of South Alabama; University of Alabama System; University of Alabama Birmingham	Palle, K (corresponding author), Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, 1660 Springhill Ave, Mobile, AL 36604 USA.	kpalle@health.southalabama.edu	tripathi, kaushlendra/O-3022-2013	tripathi, kaushlendra/0000-0002-3578-2917; Barnett, Reagan/0000-0002-6612-2241	National Institutes of Health [R01GM098956, RO1 CA138998]; Abraham Mitchell Cancer Research scholar endowment grant; NATIONAL CANCER INSTITUTE [R01CA138998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098956] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abraham Mitchell Cancer Research scholar endowment grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM098956 (to K. P.) and RO1 CA138998 (to M. A.). This work was also supported by an Abraham Mitchell Cancer Research scholar endowment grant (to K. P.).	Agyeman A, 2012, ONCOTARGET, V3, P854; Athar M, 2014, CANCER RES, V74, P4967, DOI 10.1158/0008-5472.CAN-14-1666; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Burrows AE, 2008, GENE DEV, V22, P1416, DOI 10.1101/gad.1685108; Chen AY, 2012, J THORAC DIS, V4, P390, DOI 10.3978/j.issn.2072-1439.2012.07.12; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dimitrova DS, 2000, NAT CELL BIOL, V2, P686, DOI 10.1038/35036309; Frappart PO, 2009, P NATL ACAD SCI USA, V106, P1880, DOI 10.1073/pnas.0806882106; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Gershon TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007491; Gorlin RJ, 2004, GENET MED, V6, P530, DOI 10.1097/01.GIM.0000144188.15902.C4; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Harrison W, 2014, ONCOGENE, V33, P2432, DOI 10.1038/onc.2013.199; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; HSIANG YH, 1989, CANCER RES, V49, P5077; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Joost S, 2012, CANCER RES, V72, P88, DOI 10.1158/0008-5472.CAN-10-4621; Karnani N, 2011, GENE DEV, V25, P621, DOI 10.1101/gad.2029711; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kaufmann T, 2007, CELL, V129, P423, DOI 10.1016/j.cell.2007.03.017; Kaufmann WK, 2007, CELL CYCLE, V6, P1460; Koster DA, 2007, NATURE, V448, P213, DOI 10.1038/nature05938; Kudo K, 2012, ONCOGENE, V31, P4718, DOI 10.1038/onc.2011.610; Lauth M, 2007, CURR OPIN INVEST DR, V8, P457; Lauth M, 2007, CELL CYCLE, V6, P2458, DOI 10.4161/cc.6.20.4808; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Liu PJ, 2009, CELL CYCLE, V8, P125, DOI 10.4161/cc.8.1.7528; Liu Y, 2012, CELL DEATH DIFFER, V19, P1602, DOI 10.1038/cdd.2012.38; Liu Y, 2011, CELL DEATH DIFFER, V18, P841, DOI 10.1038/cdd.2010.151; Low JA, 2010, J CLIN ONCOL, V28, P5321, DOI 10.1200/JCO.2010.27.9943; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Ma CX, 2011, TRENDS MOL MED, V17, P88, DOI 10.1016/j.molmed.2010.10.009; Mazumdar T, 2011, ONCOTARGET, V2, P638; Mazumdar T, 2011, CANCER RES, V71, P5904, DOI 10.1158/0008-5472.CAN-10-4173; Mazumdar T, 2011, CANCER RES, V71, P1092, DOI 10.1158/0008-5472.CAN-10-2315; Meng E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107142; Mori Y, 2006, ONCOLOGY-BASEL, V70, P378, DOI 10.1159/000098111; Moukharskaya J, 2012, HEMATOL ONCOL CLIN N, V26, P507, DOI 10.1016/j.hoc.2012.03.002; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Palle K, 2011, CELL CYCLE, V10, P1625, DOI 10.4161/cc.10.10.15617; Paul P, 2013, ONCOTARGET, V4, P1149, DOI 10.18632/oncotarget.1074; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; Petermann E, 2006, MOL CELL BIOL, V26, P3319, DOI 10.1128/MCB.26.8.3319-3326.2006; Ping XL, 2001, J INVEST DERMATOL, V116, P614, DOI 10.1046/j.1523-1747.2001.01301.x; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Regairaz M, 2011, J CELL BIOL, V195, P739, DOI 10.1083/jcb.201104003; ROBINSON JR, 1969, INT J APPL RADIAT IS, V20, P531, DOI 10.1016/0020-708X(69)90007-6; Roos-Mattjus P, 2003, J BIOL CHEM, V278, P24428, DOI 10.1074/jbc.M301544200; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Sarosiek KA, 2013, MOL CELL, V51, P751, DOI 10.1016/j.molcel.2013.08.048; Seiler JA, 2007, MOL CELL BIOL, V27, P5806, DOI 10.1128/MCB.02278-06; Shao RG, 1997, CANCER RES, V57, P4029; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Stecca B, 2009, EMBO J, V28, P663, DOI 10.1038/emboj.2009.16; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; ten Haaf A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-298; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wilsker D, 2008, P NATL ACAD SCI USA, V105, P20752, DOI 10.1073/pnas.0806917106; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Zhu GD, 2013, ONCOL REP, V30, P904, DOI 10.3892/or.2013.2534; Zinkel SS, 2007, CELL, V130, P9, DOI 10.1016/j.cell.2007.06.035; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	73	28	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31513	31525		10.1074/jbc.M114.606483	http://dx.doi.org/10.1074/jbc.M114.606483			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25253693	hybrid, Green Published			2022-12-25	WOS:000344549900053
J	Tehseen, M; Liao, CY; Dacres, H; Dumancic, M; Trowell, S; Anderson, A				Tehseen, Muhammad; Liao, Chunyan; Dacres, Helen; Dumancic, Mira; Trowell, Stephen; Anderson, Alisha			Oligomerisation of C. elegans Olfactory Receptors, ODR-10 and STR-112, in Yeast	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTORS; RESONANCE ENERGY-TRANSFER; ODORANT RECEPTOR; BETA(2)-ADRENERGIC RECEPTORS; TRANSFER BRET; SURFACE EXPRESSION; MAMMALIAN SWEET; SPLIT-UBIQUITIN; LIVING CELLS; IN-VIVO	It is widely accepted that vertebrate G-Protein Coupled Receptors (GPCRs) associate with each other as homo-or heterodimers or higher-order oligomers. The C. elegans genome encodes hundreds of olfactory GPCRs, which may be expressed in fewer than a dozen chemosensory neurons, suggesting an opportunity for oligomerisation. Here we show, using three independent lines of evidence: co-immunoprecipitation, bioluminescence resonance energy transfer and a yeast two-hybrid assay that nematode olfactory receptors (ORs) oligomerise when heterologously expressed in yeast. Specifically, the nematode receptor ODR-10 is able to homo-oligomerise and can also form heteromers with the related nematode receptor STR-112. ODR-10 also oligomerised with the rat I7 OR but did not oligomerise with the human somatostatin receptor 5, a neuropeptide receptor. In this study, the question of functional relevance was not addressed and remains to be investigated.	[Tehseen, Muhammad; Liao, Chunyan; Dacres, Helen; Dumancic, Mira; Trowell, Stephen; Anderson, Alisha] CSIRO Food Futures Natl Res Flagship, Canberra, ACT, Australia; [Tehseen, Muhammad; Liao, Chunyan; Dacres, Helen; Dumancic, Mira; Trowell, Stephen; Anderson, Alisha] CSIRO Ecosyst Sci, Canberra, ACT, Australia; [Tehseen, Muhammad] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Ctr Desert Agr, Thuwal, Saudi Arabia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); King Abdullah University of Science & Technology	Anderson, A (corresponding author), CSIRO Food Futures Natl Res Flagship, Canberra, ACT, Australia.	alisha.anderson@csiro.au	Anderson, Alisha/AAC-3505-2021; Trowell, Stephen/AAG-8943-2019; Trowell, Stephen C/B-8043-2008; Anderson, Alisha R/C-1499-2008; Dacres, Helen/C-1858-2008	Anderson, Alisha/0000-0001-7013-116X; Trowell, Stephen C/0000-0002-0505-8741; Anderson, Alisha R/0000-0001-7013-116X; Dacres, Helen/0000-0002-8993-1906; Tehseen, Muhammad/0000-0001-9834-2372	CSIRO	CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	The research is funded by CSIRO. However, the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Ayoub MA, 2002, J BIOL CHEM, V277, P21522, DOI 10.1074/jbc.M200729200; BARGMANN CI, 1993, ANNU REV NEUROSCI, V16, P47, DOI 10.1146/annurev.ne.16.030193.000403; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Bush CF, 2007, J BIOL CHEM, V282, P19042, DOI 10.1074/jbc.M610781200; Cottet Martin, 2012, Front Endocrinol (Lausanne), V3, P92, DOI 10.3389/fendo.2012.00092; Dacres H, 2010, ANAL CHEM, V82, P432, DOI 10.1021/ac9022956; Dacres H, 2011, BIOSENS BIOELECTRON, V29, P119, DOI 10.1016/j.bios.2011.08.004; del Burgo LS, 2010, EXPERT OPIN DRUG DIS, V5, P461, DOI 10.1517/17460441003720467; Devi LA, 2001, TRENDS PHARMACOL SCI, V22, P532, DOI 10.1016/S0165-6147(00)01799-5; Dowell SJ, 2002, RECEPTOR CHANNEL, V8, P343, DOI 10.1080/10606820214647; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Fukutani Y, 2012, BIOTECHNOL BIOENG, V109, P3143, DOI 10.1002/bit.24589; Fuxe K, 2005, J MOL NEUROSCI, V26, P209, DOI 10.1385/JMN:26:2-3:209; George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gines S, 2000, P NATL ACAD SCI USA, V97, P8606, DOI 10.1073/pnas.150241097; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Hillion J, 2002, J BIOL CHEM, V277, P18091, DOI 10.1074/jbc.M107731200; Iguchi Y, 2010, J BIOCHEM, V147, P875, DOI 10.1093/jb/mvq023; Issad Tarik, 2006, V332, P195; Iyer K, 2005, SCI STKE SIGNAL TRAN, V2005, pl3; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Jordan BA, 2001, P NATL ACAD SCI USA, V98, P343, DOI 10.1073/pnas.011384898; Kroeger KM, 2003, FRONT NEUROENDOCRIN, V24, P254, DOI 10.1016/j.yfrne.2003.10.002; Lavoie C, 2002, J BIOL CHEM, V277, P35402, DOI 10.1074/jbc.M204163200; Li XD, 2009, AM J CLIN NUTR, V90, p733S, DOI 10.3945/ajcn.2009.27462G; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8; McCarroll SA, 2005, CURR BIOL, V15, P347, DOI 10.1016/j.cub.2005.02.023; Mentesana PE, 2002, METHOD ENZYMOL, V344, P92; Milligan G, 2008, BRIT J PHARMACOL, V153, pS216, DOI 10.1038/sj.bjp.0707490; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; OCARROLL AM, 1994, MOL PHARMACOL, V46, P291; Okagaki LH, 2011, EUKARYOT CELL, V10, P1306, DOI 10.1128/EC.05179-11; Pandey Pratima, 2012, J Mol Signal, V7, P3, DOI 10.1186/1750-2187-7-3; Pandey S, 2004, PLANT CELL, V16, P1616, DOI 10.1105/tpc.020321; Prinster SC, 2006, J PHARMACOL EXP THER, V318, P974, DOI 10.1124/jpet.106.106526; Radhika V, 2007, NAT CHEM BIOL, V3, P325, DOI 10.1038/nchembio882; Ramsay D, 2002, BIOCHEM J, V365, P429, DOI 10.1042/BJ20020251; Ranadive SA, 2009, CLIN ENDOCRINOL, V71, P388, DOI 10.1111/j.1365-2265.2008.03513.x; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Rios CD, 2001, PHARMACOL THERAPEUT, V92, P71, DOI 10.1016/S0163-7258(01)00160-7; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; ROBERTSON HM, 2006, PUTATIVE CHEMORECEPT, P1; Sanz G, 2009, EUROPEAN CHEMORECEPE; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; Szidonya L, 2008, J ENDOCRINOL, V196, P435, DOI 10.1677/JOE-07-0573; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Uberti MA, 2005, J PHARMACOL EXP THER, V313, P16, DOI 10.1124/jpet.104.079541; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wade F, 2011, J BIOL CHEM, V286, P15252, DOI 10.1074/jbc.M110.184580; Xu JG, 2003, J BIOL CHEM, V278, P10770, DOI 10.1074/jbc.M207968200; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151; Yoshioka K, 2001, P NATL ACAD SCI USA, V98, P7617, DOI 10.1073/pnas.121587098; Zeng FY, 1999, J BIOL CHEM, V274, P19487, DOI 10.1074/jbc.274.27.19487; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P12162, DOI 10.1073/pnas.94.22.12162; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237	66	2	2	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108680	10.1371/journal.pone.0108680	http://dx.doi.org/10.1371/journal.pone.0108680			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254556	Green Published, gold, Green Submitted			2022-12-25	WOS:000344862300105
J	Barker, JSF; Thomson, PC				Barker, J. Stuart F.; Thomson, Peter C.			Selection at the Esterase-2 Locus of Drosophila buzzatii? Perturbation-Reperturbation Experiments	PLOS ONE			English	Article							NATURAL-POPULATIONS; POLYMORPHIC INVERSION; ALLOZYME FREQUENCIES; GENETICS; CHROMOSOME-2; ENVIRONMENT; COMPLEX; CACTUS	Apparent selection affecting starch gel electrophoretic alleles at the Esterase-2 locus of Drosophila buzzatii has been detected in laboratory and natural populations. Perturbation-reperturbation of allele frequencies in replicated laboratory populations attempts to test direct selective effects at the locus versus effects of linked loci. Sequential gel electrophoresis has identified more alleles within starch classes, and three of these alleles (within the a, b and c starch alleles) were used in cage population experiments. Allele a/1.00/1.00/1.00 was set up in 10 replicate populations with allele c/1.00/1.00/1.00, and in an independent 10 replicate populations with allele b/0.99/1.01/1.00. For each set, three reperturbations were done. Replicate populations generally showed similar patterns of allele frequency change and clear directionality: effects of selection, not drift. However, four populations deviated from their replicates, indicating dissipation of linkage disequilibrium. Estimates of pre-adult viability in the F2 of pair-wise crosses among 12 sequential gel electrophoretic alleles showed very variable modes of inheritance and relative viability fitnesses. Together with the diversity of patterns of allele frequency change in the cage populations, these results suggest a gene complex, with selection acting on an interacting set of loci which may include Esterase-2.	[Barker, J. Stuart F.] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia; [Thomson, Peter C.] Univ Sydney, ReproGen, Fac Vet Sci, Anim Biosci Grp, Camden, NSW, Australia	University of New England; University of Sydney	Barker, JSF (corresponding author), Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia.	sbarker@une.edu.au	Thomson, Peter/V-7290-2019	Thomson, Peter/0000-0003-4428-444X; Barker, James/0000-0002-5232-458X	Australian Research Council [S9301, A19530757, A19803027]	Australian Research Council(Australian Research Council)	This study was supported by Australian Research Council - S9301, A19530757, A19803027 (JSFB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNASON E, 1991, GENETICS, V129, P145; Arnason Einar, 2000, P182; Barker JSF, 2013, BIOL J LINN SOC, V109, P682, DOI 10.1111/bij.12067; BARKER JSF, 1989, BIOL J LINN SOC, V37, P311, DOI 10.1111/j.1095-8312.1989.tb01908.x; BARKER JSF, 1986, GENETICS, V112, P577; BARKER JSF, 1981, AUST J BIOL SCI, V34, P613, DOI 10.1071/BI9810613; BARKER JSF, 1976, EVOLUTION, V30, P213, DOI 10.1111/j.1558-5646.1976.tb00905.x; BARKER JSF, 1987, MICROBIAL ECOL, V14, P267, DOI 10.1007/BF02012946; Barker JSF, 1999, HEREDITAS, V130, P145, DOI 10.1111/j.1601-5223.1999.00145.x; BARKER JSF, 1994, GENETICA, V92, P165, DOI 10.1007/BF00132535; BARKER JSF, 1980, NATURE, V284, P166, DOI 10.1038/284166a0; Barrett RDH, 2011, NAT REV GENET, V12, P767, DOI 10.1038/nrg3015; Bechsgaard J., 2000, Drosophila Information Service, V83, P89; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Dalziel AC, 2009, MOL ECOL, V18, P4997, DOI 10.1111/j.1365-294X.2009.04427.x; East P.D., 1982, P323; Hemani G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003295; Hey J, 1999, TRENDS ECOL EVOL, V14, P35, DOI 10.1016/S0169-5347(98)01497-9; Iriarte PJF, 2002, J EVOLUTION BIOL, V15, P226, DOI 10.1046/j.1420-9101.2002.00383.x; Kimura MA, 1985, NEUTRAL THEORY MOL E; KNIBB WR, 1988, AUST J BIOL SCI, V41, P239, DOI 10.1071/BI9880239; KNIBB WR, 1987, AUST J BIOL SCI, V40, P257, DOI 10.1071/BI9870257; Lewontin R. C., 2000, EVOL GENET, P5; Lewontin RC, 1974, GENETIC BASIS EVOLUT; Mascord LJ, 2004, THESIS U NEW ENGLAND; MULLEY JC, 1979, BIOCHEM GENET, V17, P105, DOI 10.1007/BF00484477; Piccinali RV, 2007, J MOL EVOL, V64, P158, DOI 10.1007/s00239-005-0224-y; Ranz JM, 2003, EVOLUTION, V57, P1325; Robin GCD, 2000, J MOL EVOL, V51, P149, DOI 10.1007/s002390010075; Rodriguez C, 2000, J EVOLUTION BIOL, V13, P976, DOI 10.1046/j.1420-9101.2000.00236.x; SCHAFER DJ, 1993, J HERED, V84, P188, DOI 10.1093/oxfordjournals.jhered.a111315; STARMER WT, 1986, BIOL J LINN SOC, V28, P373, DOI 10.1111/j.1095-8312.1986.tb01765.x; Stintzing FC, 2005, MOL NUTR FOOD RES, V49, P175, DOI 10.1002/mnfr.200400071; Watt AW, 1981, GENETIC STUDIES DROS, P139	34	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108147	10.1371/journal.pone.0108147	http://dx.doi.org/10.1371/journal.pone.0108147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250904	Green Published, Green Submitted, gold			2022-12-25	WOS:000342492700087
J	Maggi, C; Lomiri, S; Di Lorenzo, B; d'Antona, M; Berducci, MT				Maggi, Chiara; Lomiri, Serena; Di Lorenzo, Bianca; d'Antona, Marco; Berducci, Maria Teresa			Environmental Quality of Italian Marine Water by Means of Marine Strategy Framework Directive (MSFD) Descriptor 9	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; HEAVY-METAL CONCENTRATIONS; HEALTH-RISKS; SEAFOOD CONSUMPTION; MEDITERRANEAN SEA; TOTAL MERCURY; ADRIATIC SEA; FISH; CADMIUM; CONTAMINATION	ISPRA, on behalf of the Italian Ministry of Environment, carried out the initial assessment of environmental quality status of the 3 Italian subregions (Mediterranean Sea Region) on Descriptor 9. The approach adopted to define the GES started to verify that contaminants in fish and other seafood for human consumption did not exceed levels established by Community legislation (Reg. 1881/2006 and further updates). As the Marine Strategy Framework Directive (MSFD) requires to use health tools to assess the environment, Italy decided to adopt a statistical range of acceptance of thresholds identified by national (D. Lgs. 152/2006 concerning water quality required for mussel farms) and international legislation (Reg. 1881/2006 and further updates), which allowed to use the health results and to employ them for the assessment of environmental quality. Italy proposed that Good Environmental Status (GES) is achieved when concentrations are lower than statistical range of acceptance, estimated on samples of fish and fishery products coming from only national waters. GIS-based approach a to perform different integration levels for station, cell's grid and years, was used; the elaborations allowed to judge the environmental quality good.	[Maggi, Chiara; Lomiri, Serena; Di Lorenzo, Bianca; d'Antona, Marco; Berducci, Maria Teresa] ISPRA, Inst Environm Protect & Res, Rome, Italy	Italian Institute for Environmental Protection & Research (ISPRA)	Maggi, C (corresponding author), ISPRA, Inst Environm Protect & Res, Rome, Italy.	chiara.maggi@isprambiente.it						Andral B, 2011, ARCH ENVIRON CON TOX, V61, P261, DOI 10.1007/s00244-010-9599-x; Ban N, 2008, AQUAT CONSERV, V18, P55, DOI 10.1002/aqc.816; Baumard P, 1998, ENVIRON TOXICOL CHEM, V17, P765, DOI 10.1002/etc.5620170501; Baumard P, 1998, ESTUAR COAST SHELF S, V47, P77, DOI 10.1006/ecss.1998.0337; Borja A, 2013, MAR POLLUT BULL, V76, P16, DOI 10.1016/j.marpolbul.2013.08.042; Borja A, 2010, MAR POLLUT BULL, V60, P2175, DOI 10.1016/j.marpolbul.2010.09.026; Cameron A, 2011, EUSEAMAP PREPARATORY; Conti GO, 2012, B ENVIRON CONTAM TOX, V88, P946, DOI 10.1007/s00128-012-0611-1; Copat C, 2012, B ENVIRON CONTAM TOX, V88, P78, DOI 10.1007/s00128-011-0433-6; Cox G. W., 1997, CONSERVATION BIOL; El-Serehy HA, 2012, TURK J FISH AQUAT SC, V12, P751, DOI 10.4194/1303-2712-v12_4_03; ESMEN NA, 1977, J ENVIRON SCI HEAL A, V12, P29, DOI 10.1080/10934527709374732; Fleming LE, 2006, MAR POLLUT BULL, V53, P545, DOI 10.1016/j.marpolbul.2006.08.012; Franca S, 2005, MAR POLLUT BULL, V50, P998, DOI 10.1016/j.marpolbul.2005.06.040; Galgani F, 2011, ENVIRON MONIT ASSESS, V172, P301, DOI 10.1007/s10661-010-1335-5; GOMEZGUTIERREZ AI, 2006, ORGANIC CONTAMINANT, V65, P224; Gutierrez NL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043765; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Jakimska A, 2011, POL J ENVIRON STUD, V20, P1127; Joiris CR, 1999, MAR POLLUT BULL, V38, P188, DOI 10.1016/S0025-326X(98)00171-4; Juresa D, 2003, FOOD ADDIT CONTAM, V20, P241, DOI 10.1080/0265203021000055379; Kalay M, 1999, B ENVIRON CONTAM TOX, V63, P673, DOI 10.1007/s001289901033; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Marrone R, 2011, RIVISTA ASS ITALIANA, V1, P61; Marti-Cid R, 2007, FOOD CHEM TOXICOL, V45, P1968, DOI 10.1016/j.fct.2007.04.014; Melzer D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008673; Menzie CA, 2009, ENVIRON SCI TECHNOL, V43, P8478, DOI 10.1021/es9006405; Miniero Roberto, 2005, Ann Ist Super Sanita, V41, P487; Pastorelli AA, 2012, FOOD ADDIT CONTAM A, V29, P1913, DOI 10.1080/19440049.2012.719644; Perugini M, 2007, CHEMOSPHERE, V66, P1904, DOI 10.1016/j.chemosphere.2006.07.079; Perugini M, 2007, J AGR FOOD CHEM, V55, P2049, DOI 10.1021/jf0630926; Prioli G, 2001, CENSIMENTO NAZIONALE; Scarpato A, 2010, J ENVIRON MONITOR, V12, P924, DOI 10.1039/b920455e; Sivaperumal P, 2007, FOOD CHEM, V102, P612, DOI 10.1016/j.foodchem.2006.05.041; Storelli KM., 2007, FOOD ADDIT CONTAM, V6, P1; Storelli MM, 2008, FOOD CHEM TOXICOL, V46, P2782, DOI 10.1016/j.fct.2008.05.011; Storelli MM, 1998, FOOD ADDIT CONTAM, V15, P876, DOI 10.1080/02652039809374724; Storelli MM, 2006, FOOD ADDIT CONTAM A, V23, P25, DOI 10.1080/02652030500242023; Storelli MM, 2003, FOOD ADDIT CONTAM A, V20, P1114, DOI 10.1080/02652030310001622773; Storelli MM, 2000, FOOD ADDIT CONTAM, V17, P1007, DOI 10.1080/02652030050207792; Swartenbroux F, 2010, 24339EN2010 EUR; Tornero V, 2014, SCI TOTAL ENVIRON, V466, P820, DOI 10.1016/j.scitotenv.2013.06.106; Zou GY, 2009, ENVIRONMETRICS	43	3	3	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108463	10.1371/journal.pone.0108463	http://dx.doi.org/10.1371/journal.pone.0108463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251745	Green Published, gold			2022-12-25	WOS:000342492700130
J	Moreno, AR; Haffa, ALM				Moreno, Allison R.; Haffa, Arlene L. M.			The Impact of Fish and the Commercial Marine Harvest on the Ocean Iron Cycle	PLOS ONE			English	Article							METAL CONCENTRATIONS; WORLD FISHERIES; DISSOLVED IRON; BIOAVAILABILITY; SUSTAINABILITY; DUST	Although iron is the fourth most abundant element in the Earth's crust, bioavailable iron limits marine primary production in about one third of the ocean. This lack of iron availability has implications in climate change because the removal of carbon dioxide from the atmosphere by phytoplankton requires iron. Using literature values for global fish biomass estimates, and elemental composition data we estimate that fish biota store between 0.7-7x10(11) g of iron. Additionally, the global fish population recycles through excretion between 0.4-1.5x10(12) g of iron per year, which is of a similar magnitude as major recognized sources of iron (e. g. dust, sediments, ice sheet melting). In terms of biological impact this iron could be superior to dust inputs due to the distributed deposition and to the greater solubility of fecal pellets compared to inorganic minerals. To estimate a loss term due to anthropogenic activity the total commercial catch for 1950 to 2010 was obtained from the Food and Agriculture Organization of the United Nations. Marine catch data were separated by taxa. High and low end values for elemental composition were obtained for each taxonomic category from the literature and used to calculate iron per mass of total harvest over time. The marine commercial catch is estimated to have removed 1-6x10(9) g of iron in 1950, the lowest values on record. There is an annual increase to 0.7-3x10(10) g in 1996, which declines to 0.6-2x10(10) g in 2010. While small compared to the total iron terms in the cycle, these could have compounding effects on distribution and concentration patterns globally over time. These storage, recycling, and export terms of biotic iron are not currently included in ocean iron mass balance calculations. These data suggest that fish and anthropogenic activity should be included in global oceanic iron cycles.	[Moreno, Allison R.; Haffa, Arlene L. M.] Calif State Univ, Div Sci & Environm Policy, Seaside, CA 93955 USA		Haffa, ALM (corresponding author), Calif State Univ, Div Sci & Environm Policy, Seaside, CA 93955 USA.	ahaffa@csumb.edu	Haffa, Arlene/ABA-8965-2021		Lewis Stokes Alliances for Minority Participation by the California State University, Monterey Bay Undergraduate Research Opportunity Center; National Science Foundation under the California State University-Louis Stokes Alliance for Minority Participation Senior Alliance project [HRD-0802628]	Lewis Stokes Alliances for Minority Participation by the California State University, Monterey Bay Undergraduate Research Opportunity Center; National Science Foundation under the California State University-Louis Stokes Alliance for Minority Participation Senior Alliance project	AM was provided a stipend through a Lewis Stokes Alliances for Minority Participation obtained by the California State University, Monterey Bay Undergraduate Research Opportunity Center. This project was supported in part by the National Science Foundation under the California State University-Louis Stokes Alliance for Minority Participation Senior Alliance project (http://uroc.csumb.edu/lsamp National Science Foundation Grant Number: HRD-0802628). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. AH was unfunded. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen F, 1997, AQUACULT NUTR, V3, P239, DOI 10.1046/j.1365-2095.1997.00096.x; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Boyd PW, 2010, NAT GEOSCI, V3, P675, DOI [10.1038/NGEO964, 10.1038/ngeo964]; Boyd PW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063091; Bury N, 2003, COMP BIOCHEM PHYS C, V135, P97, DOI 10.1016/S1532-0456(03)00021-8; Chiu KH, 2011, ARCH ENVIRON CON TOX, V60, P643, DOI 10.1007/s00244-010-9572-8; Cooke SJ, 2004, BIOSCIENCE, V54, P857, DOI 10.1641/0006-3568(2004)054[0857:TRORFI]2.0.CO;2; FAO Fisheries & Aquaculture of the United Nations, 2012, FIGIS FISHSTAT PLUS; Froese R., 2014, FISHBASE WORLD WIDE; Fung IY, 2000, GLOBAL BIOGEOCHEM CY, V14, P281, DOI 10.1029/1999GB900059; Garcia-Casal MN, 2007, J NUTR, V137, P2691, DOI 10.1093/jn/137.12.2691; HART T. JOHN, 1934, DISCOVERY REPTS [GOV DEPENDENCIES FALKLAND ISLS], V8, P1; Hawkings JR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4929; Holmer M, 2006, BOT MAR, V49, P91, DOI 10.1515/BOT.2006.013; HONDA K, 1987, P NIPR S POLAR BIOL, V1, P184, DOI DOI 10.1016/0025-326X(87)90240-2; Ihde TF, 2011, FISH RES, V108, P268, DOI 10.1016/j.fishres.2010.12.016; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; Kienzle E, 2006, WALTHAM INT NUTR SCI, V1-3, P2053; MARTIN JH, 1988, NATURE, V331, P341, DOI 10.1038/331341a0; Misumi K, 2014, BIOGEOSCIENCES, V11, P33, DOI 10.5194/bg-11-33-2014; Moore JK, 2008, BIOGEOSCIENCES, V5, P631, DOI 10.5194/bg-5-631-2008; Moore JK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002220; Nicol S, 2010, FISH FISH, V11, P203, DOI 10.1111/j.1467-2979.2010.00356.x; Norse EA, 2012, MAR POLICY, V36, P307, DOI 10.1016/j.marpol.2011.06.008; Padovan A, 2012, HYDROBIOLOGIA, V687, P275, DOI 10.1007/s10750-011-0916-9; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Perrin WF, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P1; Raiswell R, 2006, J GEOCHEM EXPLOR, V88, P436, DOI 10.1016/j.gexplo.2005.08.098; Raiswell R, 2011, GEOCHEMICAL PERSPECT, V1, P81; SHIBER JG, 1981, HYDROBIOLOGIA, V83, P181, DOI 10.1007/BF00008266; Swartz W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015143; Tagliabue A, 2011, BIOGEOSCIENCES, V8, P3025, DOI 10.5194/bg-8-3025-2011; Vannuccini S., 1999, SHARK UTILIZATION MA; Watson R, 2001, NATURE, V414, P534, DOI 10.1038/35107050; Wilson RW, 2009, SCIENCE, V323, P359, DOI 10.1126/science.1157972; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; [No title captured]	38	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107690	10.1371/journal.pone.0107690	http://dx.doi.org/10.1371/journal.pone.0107690			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251284	Green Submitted, Green Published, gold			2022-12-25	WOS:000342492700039
J	Oeyen, JP; Funke, S; Bohme, W; Wesener, T				Oeyen, Jan Philip; Funke, Sebastian; Boehme, Wolfgang; Wesener, Thomas			The Evolutionary History of the Rediscovered Austrian Population of the Giant Centipede Scolopendra cingulata Latreille 1829 (Chilopoda, Scolopendromorpha)	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; IDENTIFYING SPIDERS; PHYLOGENY; PATTERNS; BIOGEOGRAPHY; SEQUENCES; CRUSTACEA; INFERENCE; ISOPODA; MARKERS	The thermophilous giant centipede Scolopendra cingulata is a voracious terrestrial predator, which uses its modified first leg pair and potent venom to capture prey. The highly variable species is the most common of the genus in Europe, occurring from Portugal in the west to Iran in the east. The northernmost occurrences are in Hungary and Romania, where it abides in small isolated fringe populations. We report the rediscovery of an isolated Austrian population of Scolopendra cingulata with the first explicit specimen records for more than 80 years and provide insights into the evolutionary history of the northernmost populations utilizing fragments of two mitochondrial genes, COI and 16S, comprising 1,155 base pairs. We test the previously proposed hypothesis of a speciation by distance scenario, which argued for a simple range expansion of the species from the southeast, via Romania, Hungary and finally to Austria, based on a comprehensive taxon sampling from seven countries, including the first European mainland samples. We argue that more complex patterns must have shaped the current distribution of S. cingulata and that the Austrian population should be viewed as an important biogeographical relict in a possible microrefugium. The unique haplotype of the Austrian population could constitute an important part of the species genetic diversity and we hope that this discovery will initiate protective measures not only for S. cingulata, but also for its habitat, since microrefugia are likely to host further rare thermophilous species. Furthermore, we take advantage of the unprecedented sampling to provide the first basic insights into the suitability of the COI fragment as a species identifying barcode within the centipede genus Scolopendra.	[Oeyen, Jan Philip; Boehme, Wolfgang; Wesener, Thomas] Zool Res Museum Alexander Koenig, Dept Arthropoda, Bonn, Germany; [Funke, Sebastian] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, D-55122 Mainz, Germany	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Johannes Gutenberg University of Mainz	Oeyen, JP (corresponding author), Zool Res Museum Alexander Koenig, Dept Arthropoda, Bonn, Germany.	janphilipoyen@gmail.com			Alexander-Koenig-Gesellschaft (AKG)	Alexander-Koenig-Gesellschaft (AKG)	Lab work and sequencing was funded by the Alexander-Koenig-Gesellschaft (AKG). Application for funding was submitted by TW. Grant-ID: Scolopendra. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Attems C., 1930, Das Tierreich Lieferung, V54, P1; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; BENNETT KD, 1991, J BIOGEOGR, V18, P103, DOI 10.2307/2845248; CAMIN JH, 1965, EVOLUTION, V19, P311, DOI 10.2307/2406441; Cassel-Lundhagen A, 2010, RELICT SPECIES: PHYLOGEOGRAPHY AND CONSERVATION BIOLOGY, P267, DOI 10.1007/978-3-540-92160-8_15; Chajec L, 2014, ARTHROPOD STRUCT DEV, V43, P27, DOI 10.1016/j.asd.2013.06.002; Christian E, 2009, ENDEMITEN KOSTBARKEI, P542; Danyi Laszlo, 2006, Norwegian Journal of Entomology, V53, P271; Danyi Laszlo, 2006, Folia Musei Historico-Naturalis Bakonyiensis, V23, P27; Decker P, 2011, ABHANDLUNGEN WESTFAL, V73, P48; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgecombe Gregory D., 2003, African Invertebrates, V44, P13; Finger A, 2010, RELICT SPECIES: PHYLOGEOGRAPHY AND CONSERVATION BIOLOGY, P309, DOI 10.1007/978-3-540-92160-8_18; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; France SC, 1996, MAR BIOL, V126, P633, DOI 10.1007/BF00351330; Franz H., 1936, Zoogeographica Jena, V3, P159; Franz H, 1938, 7 INT K ENT, V1, P102; Giribet G, 2006, P ROY SOC B-BIOL SCI, V273, P531, DOI 10.1098/rspb.2005.3365; Giribet G, 1999, PHILOS T R SOC B, V354, P215, DOI 10.1098/rstb.1999.0373; Giribet G, 2006, BIOL J LINN SOC, V89, P65, DOI 10.1111/j.1095-8312.2006.00658.x; Haider M, 2008, JUNGERBERG HACKELSBE, P1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Held C, 2000, MOL PHYLOGENET EVOL, V15, P165, DOI 10.1006/mpev.1999.0739; Kaltsas Dimitris, 2012, International Journal of Myriapodology, V7, P1, DOI 10.3897/ijm.7.2133; Kasy F., 1979, Zeitschrift der Arbeitsgemeinschaft Oesterreichischer Entomologen, V30, P1; KAUFMAN Z. S., 1962, ZOOL ZHUR, V41, P859; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Klingel H., 1960, Zeitschrift fuer Tierpsychologie, V17, P11; Kong Yi, 2013, African Journal of Pharmacy and Pharmacology, V7, P2238; Korsos Zoltan, 2006, Termeszetvedelmi Kozlemenyek, V12, P155; Latzel R, 1881, STN MITT MUS NATURKU, V25, P92, DOI [10.1002/mmnd.18810250115, DOI 10.1002/MMND.18810250115]; Lewis John G. E., 2010, International Journal of Myriapodology, V3, P83, DOI 10.1163/187525410X12578602960380; Lomolino MV, 2006, BIOGEOGRAPHY; MANTEL N, 1967, CANCER RES, V27, P209; Minelli A., 1983, LAVORI SOC ITALIANA, V8, P401; Mosblech NAS, 2011, J BIOGEOGR, V38, P419, DOI 10.1111/j.1365-2699.2010.02436.x; Murienne J, 2011, ORG DIVERS EVOL, V11, P61, DOI 10.1007/s13127-011-0041-7; Murienne J, 2010, MOL PHYLOGENET EVOL, V57, P301, DOI 10.1016/j.ympev.2010.06.022; Neff BD, 2001, EVOLUTION, V55, P1717, DOI 10.1111/j.0014-3820.2001.tb00822.x; NEI M, 2000, MOL EVOLUTION PHYLOG; Palo J, 1995, HEREDITAS, V123, P295, DOI 10.1111/j.1601-5223.1995.00295.x; Pontuale Giorgio, 1997, Annali dell'Istituto Superiore di Sanita, V33, P241; Prendini L, 2005, CAN J ZOOL, V83, P498, DOI 10.1139/Z05-025; Rabitsch W., 2009, ENDEMITEN KOSTBARKEI; Radl Ruth C., 1992, Berichte des Naturwissenschaftlich-Medizinischen Vereins in Innsbruck Supplementum, V10, P123; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rull V, 1988, CURR RES PLEISTOCENE, V5, P54; Rull V, 2009, J BIOGEOGR, V36, P481, DOI 10.1111/j.1365-2699.2008.02023.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schwendinger PJ, 2005, INVERTEBR SYST, V19, P297, DOI 10.1071/IS05023; Serinken M, 2005, INTERNET J EMERGENCY, V2, P1; Shelley RM, 2002, VIRGINIA MUSEUM NATU, V5, P1; Simaiakis S, 2008, ZOOTAXA, P39, DOI 10.11646/zootaxa.1792.1.3; Simaiakis SM, 2012, BIOL J LINN SOC, V105, P507, DOI 10.1111/j.1095-8312.2011.01813.x; Simaiakis SM, 2011, ZOOL ANZ, V250, P67, DOI 10.1016/j.jcz.2010.11.006; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Spelda J, 2011, ZOOKEYS, P123, DOI 10.3897/zookeys.156.2176; Stoev P, 2010, ZOOKEYS, P29, DOI 10.3897/zookeys.50.504; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Szalay L., 1956, Zoologischer Anzeiger, V157, P35; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Varga Z, 2003, CHANGES RANGES INVER, V105, P93; Varga Z, 2010, RELICT SPECIES: PHYLOGEOGRAPHY AND CONSERVATION BIOLOGY, P57, DOI 10.1007/978-3-540-92160-8_3; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI [10.1186/1297-9686-34-3-275, 10.1051/gse:2002009]; Voigtlaender Karin, 2011, P309; Wesener T, 2010, MOL PHYLOGENET EVOL, V57, P1184, DOI 10.1016/j.ympev.2010.08.023; Wetzer R, 2003, MOL PHYLOGENET EVOL, V27, P410, DOI 10.1016/S1055-7903(03)00021-6; Wetzer R, 2001, CONTRIB ZOOL, V70, P23, DOI 10.1163/18759866-07001002; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Wurmli M, 1972, MYRIAPODA CHILOPODA, P1; XIONG B, 1991, GENOME, V34, P306, DOI 10.1139/g91-050; Yang SL, 2013, P NATL ACAD SCI USA, V110, P17534, DOI 10.1073/pnas.1306285110; Yao XY, 2013, CLIN TOXICOL, V51, P519, DOI 10.3109/15563650.2013.804929; Ziegler Thomas, 1998, TI-Magazin, V139, P71	79	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108650	10.1371/journal.pone.0108650	http://dx.doi.org/10.1371/journal.pone.0108650			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251436	Green Submitted, Green Published, gold			2022-12-25	WOS:000342492700147
J	Theofel, I; Bartkuhn, M; Hundertmark, T; Boettger, T; Gartner, SMK; Leser, K; Awe, S; Schipper, M; Renkawitz-Pohl, R; Rathke, C				Theofel, Ina; Bartkuhn, Marek; Hundertmark, Tim; Boettger, Thomas; Gaertner, Stefanie M. K.; Leser, Katja; Awe, Stephan; Schipper, Michael; Renkawitz-Pohl, Renate; Rathke, Christina			tBRD-1 Selectively Controls Gene Activity in the Drosophila Testis and Interacts with Two New Members of the Bromodomain and Extra-Terminal (BET) Family	PLOS ONE			English	Article							GERM-CELL DIFFERENTIATION; TBP-ASSOCIATED FACTOR; 2-HYBRID SYSTEM; SPERMATID DIFFERENTIATION; CONTAINING PROTEIN; HISTONE H4; CHROMATIN; BRDT; SPERMIOGENESIS; TRANSCRIPTION	Multicellular organisms have evolved specialized mechanisms to control transcription in a spatial and temporal manner. Gene activation is tightly linked to histone acetylation on lysine residues that can be recognized by bromodomains. Previously, the testis-specifically expressed bromodomain protein tBRD-1 was identified in Drosophila. Expression of tBRD-1 is restricted to highly transcriptionally active primary spermatocytes. tBRD-1 is essential for male fertility and proposed to act as a co-factor of testis-specific TATA box binding protein-associated factors (tTAFs) for testis-specific transcription. Here, we performed microarray analyses to compare the transcriptomes of tbrd-1 mutant testes and wild-type testes. Our data confirmed that tBRD-1 controls gene activity in male germ cells. Additionally, comparing the transcriptomes of tbrd-1 and tTAF mutant testes revealed a subset of common target genes. We also characterized two new members of the bromodomain and extra-terminal (BET) family, tBRD-2 and tBRD-3. In contrast to other members of the BET family in animals, both possess only a single bromodomain, a characteristic feature of plant BET family members. Immunohistology techniques not only revealed that tBRD-2 and tBRD-3 partially co-localize with tBRD-1 and tTAFs in primary spermatocytes, but also that their proper subcellular distribution was impaired in tbrd-1 and tTAF mutant testes. Treating cultured male germ cells with inhibitors showed that localization of tBRD-2 and tBRD-3 depends on the acetylation status within primary spermatocytes. Yeast two-hybrid assays and co-immunoprecipitations using fly testes protein extracts demonstrated that tBRD-1 is able to form homodimers as well as heterodimers with tBRD-2, tBRD-3, and tTAFs. These data reveal for the first time the existence of single bromodomain BET proteins in animals, as well as evidence for a complex containing tBRDs and tTAFs that regulates transcription of a subset of genes with relevance for spermiogenesis.	[Theofel, Ina; Hundertmark, Tim; Gaertner, Stefanie M. K.; Leser, Katja; Awe, Stephan; Schipper, Michael; Renkawitz-Pohl, Renate; Rathke, Christina] Univ Marburg, Dept Biol, Marburg, Germany; [Bartkuhn, Marek] Univ Giessen, Inst Genet, D-35390 Giessen, Germany; [Boettger, Thomas] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, Bad Nauheim, Germany	Philipps University Marburg; Justus Liebig University Giessen; Max Planck Society	Rathke, C (corresponding author), Univ Marburg, Dept Biol, Marburg, Germany.	rathke@biologie.uni-marburg.de	Boettger, Thomas/E-3406-2012; Pütz-Rathke, Christina/O-5363-2016	Boettger, Thomas/0000-0003-4280-8449; Pütz-Rathke, Christina/0000-0001-9320-8510; Bartkuhn, Marek/0000-0001-6872-9082; Theofel, Ina/0000-0002-1285-2214	German Research Foundation (DFG) [RA 2150/2-1];  [TRR81]	German Research Foundation (DFG)(German Research Foundation (DFG)); 	This work was supported by the German Research Foundation (DFG) (http://www.dfg.de/) within a research grant to CR (RA 2150/2-1) and within the TRR81 to MB and RR-P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awe S, 2010, SYST BIOL REPROD MED, V56, P44, DOI 10.3109/19396360903490790; Barckmann B, 2013, DEV BIOL, V377, P33, DOI 10.1016/j.ydbio.2013.02.018; Barlev NA, 1998, MOL CELL BIOL, V18, P1349, DOI 10.1128/MCB.18.3.1349; BARTEL P, 1993, BIOTECHNIQUES, V14, P920; Beall EL, 2007, GENE DEV, V21, P904, DOI 10.1101/gad.1516607; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berkovits BD, 2012, NUCLEIC ACIDS RES, V40, P7162, DOI 10.1093/nar/gks342; Chen X, 2005, SCIENCE, V310, P869, DOI 10.1126/science.1118101; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dhar S, 2012, J BIOL CHEM, V287, P6387, DOI 10.1074/jbc.M111.288167; Dikstein R, 1996, CELL, V87, P137, DOI 10.1016/S0092-8674(00)81330-6; El-Sharnouby S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003842; Falender AE, 2005, DEV BIOL, V288, P405, DOI 10.1016/j.ydbio.2005.09.038; Falender AE, 2005, GENE DEV, V19, P794, DOI 10.1101/gad.1290105; Florence B, 2001, FRONT BIOSCI-LANDMRK, V6, pD1008, DOI 10.2741/Florence; Florence BL, 2008, DEV DYNAM, V237, P554, DOI 10.1002/dvdy.21432; Freiman RN, 2001, SCIENCE, V293, P2084, DOI 10.1126/science.1061935; Gartner SMK, 2014, JOVE-J VIS EXP, DOI 10.3791/51868; Gaucher J, 2012, EMBO J, V31, P3809, DOI 10.1038/emboj.2012.233; Hiller M, 2004, DEVELOPMENT, V131, P5297, DOI 10.1242/dev.01314; Hiller MA, 2001, GENE DEV, V15, P1021, DOI 10.1101/gad.869101; Hime GR, 1996, J CELL SCI, V109, P2779; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; IWABUCHI K, 1993, ONCOGENE, V8, P1693; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jeanmougin F, 1997, TRENDS BIOCHEM SCI, V22, P151, DOI 10.1016/S0968-0004(97)01042-6; Jones MH, 1997, GENOMICS, V45, P529, DOI 10.1006/geno.1997.5000; Kockmann T, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r18; Leser K, 2012, BIOL OPEN, V1, P597, DOI 10.1242/bio.20121255; LI B, 1993, FASEB J, V7, P957, DOI 10.1096/fasebj.7.10.8344494; Lin TY, 1996, DEVELOPMENT, V122, P1331; Lu CG, 2013, DEVELOPMENT, V140, P3522, DOI 10.1242/dev.098947; MARUSHIGE K, 1976, P NATL ACAD SCI USA, V73, P3937, DOI 10.1073/pnas.73.11.3937; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Metcalf CE, 2007, DEV DYNAM, V236, P2836, DOI 10.1002/dvdy.21294; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Peng JH, 2007, MOL CELL BIOCHEM, V294, P45, DOI 10.1007/s11010-006-9223-6; Pivot-Pajot C, 2003, MOL CELL BIOL, V23, P5354, DOI 10.1128/MCB.23.15.5354-5365.2003; Pointud JC, 2003, J CELL SCI, V116, P1847, DOI 10.1242/jcs.00391; Rahman S, 2011, MOL CELL BIOL, V31, P2641, DOI 10.1128/MCB.01341-10; Raja SJ, 2005, MOL CELL BIOL, V25, P6165, DOI 10.1128/MCB.25.14.6165-6177.2005; Rathke C, 2007, J CELL SCI, V120, P1689, DOI 10.1242/jcs.004663; Rathke C, 2014, BBA-GENE REGUL MECH, V1839, P155, DOI 10.1016/j.bbagrm.2013.08.004; Rathke C, 2010, EUR J CELL BIOL, V89, P326, DOI 10.1016/j.ejcb.2009.09.001; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Shang EY, 2007, DEVELOPMENT, V134, P3507, DOI 10.1242/dev.004481; Shang EY, 2004, GENE EXPR PATTERNS, V4, P513, DOI 10.1016/j.modgep.2004.03.002; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Vibranovski MD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000731; White-Cooper H, 1998, DEVELOPMENT, V125, P125; White-Cooper H, 2011, COLD SPRING HARB PER, P3; White-Cooper H, 2010, REPRODUCTION, V139, P11, DOI 10.1530/REP-09-0083; YE QA, 1995, EXP CELL RES, V219, P292, DOI 10.1006/excr.1995.1230; Zhou HY, 2013, P NATL ACAD SCI USA, V110, P16886, DOI 10.1073/pnas.1317034110	56	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108267	10.1371/journal.pone.0108267	http://dx.doi.org/10.1371/journal.pone.0108267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251222	gold, Green Published, Green Submitted			2022-12-25	WOS:000342492700104
J	Wang, Y; Zhou, XY; Xiang, PY; Wang, LL; Tang, H; Xie, F; Li, L; Wei, H				Wang, Yong; Zhou, Xiao-Yang; Xiang, Peng-Ying; Wang, Lu-Lu; Tang, Huan; Xie, Fei; Li, Liang; Wei, Hong			The Meganuclease I-SceI Containing Nuclear Localization Signal (NLS-I-SceI) Efficiently Mediated Mammalian Germline Transgenesis via Embryo Cytoplasmic Microinjection	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; SLEEPING-BEAUTY TRANSPOSONS; TARGETED INTEGRATION; CLONING EFFICIENCY; KNOCKOUT RATS; PIGS; INJECTION; GENERATION; EXPRESSION; TALEN	The meganuclease I-SceI has been effectively used to facilitate transgenesis in fish eggs for nearly a decade. I-SceI-mediated transgenesis is simply via embryo cytoplasmic microinjection and only involves plasmid vectors containing I-SceI recognition sequences, therefore regarding the transgenesis process and application of resulted transgenic organisms, I-SceI-mediated transgenesis is of minimal bio-safety concerns. However, currently no transgenic mammals derived from I-SceI-mediated transgenesis have been reported. In this work, we found that the native I-SceI molecule was not capable of facilitating transgenesis in mammalian embryos via cytoplasmic microinjection as it did in fish eggs. In contrast, the I-SceI molecule containing mammalian nuclear localization signal (NLS-I-SceI) was shown to be capable of transferring DNA fragments from cytoplasm into nuclear in porcine embryos, and cytoplasmic microinjection with NLS-I-SceI mRNA and circular I-SceI recognition sequence-containing transgene plasmids resulted in transgene expression in both mouse and porcine embryos. Besides, transfer of the cytoplasmically microinjected mouse and porcine embryos into synchronized recipient females both efficiently resulted in transgenic founders with germline transmission competence. These results provided a novel method to facilitate mammalian transgenesis using I-SceI, and using the NLS-I-SceI molecule, a simple, efficient and species-neutral transgenesis technology based on embryo cytoplasmic microinjection with minimal bio-safety concerns can be established for mammalian species. As far as we know, this is the first report for transgenic mammals derived from I-SceI-mediated transgenesis via embryo cytoplasmic microinjection.	[Wang, Yong; Zhou, Xiao-Yang; Xiang, Peng-Ying; Wang, Lu-Lu; Xie, Fei; Li, Liang; Wei, Hong] Third Mil Med Univ, Coll Basic Med Sci, Dept Lab Anim Sci, Chongqing, Peoples R China; [Tang, Huan] China Three Gorges Museum, Chongqing, Peoples R China	Army Medical University	Wang, Y (corresponding author), Third Mil Med Univ, Coll Basic Med Sci, Dept Lab Anim Sci, Chongqing, Peoples R China.	yongw7528@gmail.com; weihong63528@163.com			Natural Science Fund of China [31171280, 31271330, 81173126]; National 973 Project of China [2011CB944102, 2011CBA01006]; Chongqing Natural Science Fund [cstc2011jjA10049]; National Science and Technology Support Program [2011BAI15BO2]	Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); National 973 Project of China(National Basic Research Program of China); Chongqing Natural Science Fund; National Science and Technology Support Program	YW was supported by grants from Natural Science Fund of China [31171280, 31271330], National 973 Project of China [2011CB944102], Chongqing Natural Science Fund [cstc2011jjA10049]. HW was supported by grants from Natural Science Fund of China [81173126], National 973 Project of China [2011CBA01006] and National Science and Technology Support Program [2011BAI15BO2]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betthauser J, 2000, NAT BIOTECHNOL, V18, P1055, DOI 10.1038/80242; Bevacqua RJ, 2013, THERIOGENOLOGY, V80, P104, DOI 10.1016/j.theriogenology.2013.03.017; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Brem G, 2003, EMBO REPORTS, V4, P1054; Brigid H, 1996, MOUSE EMBRYO MANIPUL; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cristea S, 2013, BIOTECHNOL BIOENG, V110, P871, DOI 10.1002/bit.24733; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Garrels W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023573; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Grabher C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S10; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; HAMMER RE, 1985, NATURE, V315, P680, DOI 10.1038/315680a0; Huang YY, 2011, CELL REPROGRAM, V13, P513, DOI 10.1089/cell.2011.0032; Iqbal K, 2009, BIOTECHNIQUES, V47, P959, DOI 10.2144/000113270; Ivics Z, 2014, NAT PROTOC, V9, P810, DOI 10.1038/nprot.2014.010; Ivics Z, 2014, NAT PROTOC, V9, P794, DOI 10.1038/nprot.2014.009; Liu HL, 2014, CELL STEM CELL, V14, P323, DOI 10.1016/j.stem.2014.01.018; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Mashimo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008870; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Niu Y., 2014, CELL, V156, P1; Ogino H, 2006, MECH DEVELOP, V123, P103, DOI 10.1016/j.mod.2005.11.006; Orlando SJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq512; PAGE RL, 1995, TRANSGENIC RES, V4, P353, DOI 10.1007/BF01973753; Pan FC, 2006, DEV DYNAM, V235, P247, DOI 10.1002/dvdy.20608; PERRIN A, 1993, EMBO J, V12, P2939, DOI 10.1002/j.1460-2075.1993.tb05956.x; Rembold M, 2006, NAT PROTOC, V1, P1133, DOI 10.1038/nprot.2006.165; Rostovskaya M, 2013, GENESIS, V51, P135, DOI 10.1002/dvg.22362; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Wall RJ, 1996, THERIOGENOLOGY, V45, P57, DOI 10.1016/0093-691X(95)00355-C; Wang H., 2013, CELL, V153, P1; Whitelaw CBA, 2004, FEBS LETT, V571, P233, DOI 10.1016/j.febslet.2004.06.076; Wilson AM, 2013, TRANSGENIC RES, V22, P993, DOI 10.1007/s11248-013-9706-7; Yang DS, 2011, CELL RES, V21, P979, DOI 10.1038/cr.2011.70; Yang DS, 2010, HUM MOL GENET, V19, P3983, DOI 10.1093/hmg/ddq313; Zhao JG, 2009, BIOL REPROD, V81, P525, DOI 10.1095/biolreprod.109.077016	43	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108347	10.1371/journal.pone.0108347	http://dx.doi.org/10.1371/journal.pone.0108347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250567	Green Published, Green Submitted, gold			2022-12-25	WOS:000342492700114
J	Zhao, J; Hu, L; Ding, Y; Xu, GC; Hu, M				Zhao, Jia; Hu, Liang; Ding, Yan; Xu, Gaochao; Hu, Ming			A Heuristic Placement Selection of Live Virtual Machine Migration for Energy-Saving in Cloud Computing Environment	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; ALGORITHM	The field of live VM (virtual machine) migration has been a hotspot problem in green cloud computing. Live VM migration problem is divided into two research aspects: live VM migration mechanism and live VM migration policy. In the meanwhile, with the development of energy-aware computing, we have focused on the VM placement selection of live migration, namely live VM migration policy for energy saving. In this paper, a novel heuristic approach PS-ES is presented. Its main idea includes two parts. One is that it combines the PSO (particle swarm optimization) idea with the SA (simulated annealing) idea to achieve an improved PSO-based approach with the better global search's ability. The other one is that it uses the Probability Theory and Mathematical Statistics and once again utilizes the SA idea to deal with the data obtained from the improved PSO-based process to get the final solution. And thus the whole approach achieves a long-term optimization for energy saving as it has considered not only the optimization of the current problem scenario but also that of the future problem. The experimental results demonstrate that PS-ES evidently reduces the total incremental energy consumption and better protects the performance of VM running and migrating compared with randomly migrating and optimally migrating. As a result, the proposed PS-ES approach has capabilities to make the result of live VM migration events more high-effective and valuable.	[Zhao, Jia; Hu, Ming] ChangChun Univ Technol, Coll Comp Sci & Engn, Changchun, Peoples R China; [Zhao, Jia; Hu, Liang; Ding, Yan; Xu, Gaochao] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China	Changchun University of Technology; Jilin University	Hu, M (corresponding author), ChangChun Univ Technol, Coll Comp Sci & Engn, Changchun, Peoples R China.	zhaiyj049@sina.com			National Natural Science Foundation of China [61133011]; Natural Science Foundation of Jilin [20101525, 20101533]; Jilin Provincial Education Office (Jilin Provincial Educational and Scientific Program) [85, 103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jilin; Jilin Provincial Education Office (Jilin Provincial Educational and Scientific Program)	This work is supported by the National Natural Science Foundation of China (Grant No. 61133011), the Natural Science Foundation of Jilin (Grant No. 20101525), the Jilin Provincial Education Office (Jilin Provincial Educational and Scientific Program [2010] No. 85), the Natural Science Foundation of Jilin (Grant No. 20101533) and the Jilin Provincial Education Office (Jilin Provincial Educational and Scientific Program [2010] No. 103. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbrust M, 2010, COMMUN ACM, V53, P50, DOI 10.1145/1721654.1721672; Barham P., 2003, ACM SIGOPS OPER SYST, V37, P164, DOI DOI 10.1145/1165389.945462; Calheiros RN, 2011, SOFTWARE PRACT EXPER, V41, P23, DOI 10.1002/spe.995; Carlisle A, 2002, TSI PRESS S, V13, P265, DOI 10.1109/WAC.2002.1049555; Gaochao X, 2013, SCI WORLD J, V2013; Hu XH, 2002, IEEE C EVOL COMPUTAT, P1666, DOI 10.1109/CEC.2002.1004492; Jeyarani R, 2011, INT J INTELL INF TEC, V7, P25, DOI 10.4018/jiit.2011040102; Jeyarani R., 2009, P NAT C ADV COMP COM, P283; Li B, 2009, IEEE INT CONF CLOUD, P17, DOI 10.1109/CLOUD.2009.72; Rusu C, 2006, PROCEEDINGS OF THE 12TH IEEE REAL-TIME AND EMBEDDED TECHNOLOGY AND APPLICATIONS SYMPOSIUM, P418; Srikantaiah S, 2009, ENERGY, V10, P30; Tasgetiren MF, 2004, LECT NOTES COMPUT SC, V3172, P382; Tasgetiren MF, 2004, IEEE C EVOL COMPUTAT, P1412, DOI 10.1109/CEC.2004.1331062; Verma A, 2008, LECT NOTES COMPUT SC, V5346, P243, DOI 10.1007/978-3-540-89856-6_13; Yuhui Shi, 1998, Evolutionary Programming VII. 7th International Conference, EP98. Proceedings, P591, DOI 10.1007/BFb0040810; Yunfa Li, 2010, 2010 Third International Symposium on Electronic Commerce and Security (ISECS 2010), P332, DOI 10.1109/ISECS.2010.80	16	14	14	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108275	10.1371/journal.pone.0108275	http://dx.doi.org/10.1371/journal.pone.0108275			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251339	Green Submitted, gold, Green Published			2022-12-25	WOS:000342492700105
J	Quan, JH; Adelmant, G; Marto, JA; Look, AT; Yusufzai, T				Quan, Jinhua; Adelmant, Guillaume; Marto, Jarrod A.; Look, A. Thomas; Yusufzai, Timur			The Chromatin Remodeling Factor CHD5 Is a Transcriptional Repressor of WEE1	PLOS ONE			English	Article							HISTONE DEACETYLASE; TUMOR-SUPPRESSOR; NEUROBLASTOMA-CELLS; PHD FINGERS; DNA-DAMAGE; COMPLEXES; GENE; EXPRESSION; CANCER; RECOGNITION	Loss of the chromatin remodeling ATPase CHD5 has been linked to the progression of neuroblastoma tumors, yet the underlying mechanisms behind the tumor suppressor role of CHD5 are unknown. In this study, we purified the human CHD5 complex and found that CHD5 is a component of the full NuRD transcriptional repressor complex, which also contains methyl-CpG binding proteins and histone deacetylases. The CHD5/NuRD complex appears mutually exclusive with the related CHD4/NuRD complex as overexpression of CHD5 results in loss of the CHD4 protein in cells. Following a search for genes that are regulated by CHD5 in neuroblastoma cells, we found that CHD5 binds to and represses the G2/M checkpoint gene WEE1. Reintroduction of CHD5 into neuroblastoma cells represses WEE1 expression, demonstrating that CHD5 can function as a repressor in cells. A catalytically inactive mutant version of CHD5 is able to associate with a NuRD cofactor but fails to repress transcription. Our study shows that CHD5 is a NuRD-associated transcriptional repressor and identifies WEE1 as one of the CHD5-regulated genes that may link CHD5 to tumor suppression.	[Quan, Jinhua; Yusufzai, Timur] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Quan, Jinhua; Adelmant, Guillaume; Marto, Jarrod A.; Yusufzai, Timur] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Adelmant, Guillaume; Marto, Jarrod A.] Dana Farber Canc Inst, Blais Prote Ctr, Dept Canc Biol, Boston, MA 02115 USA; [Look, A. Thomas] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Yusufzai, T (corresponding author), Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA.	timur_yusufzai@dfci.harvard.edu			Dana-Farber Cancer Institute; William F. Milton Fund; Claudia Adams Barr Program	Dana-Farber Cancer Institute; William F. Milton Fund; Claudia Adams Barr Program	This work was supported by the Dana-Farber Cancer Institute, the William F. Milton Fund, and the Claudia Adams Barr Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelmant G, 2012, MOL CELL PROTEOMICS, V11, P411, DOI 10.1074/mcp.M111.013581; Allen HF, 2013, CELL MOL LIFE SCI, V70, P3513, DOI 10.1007/s00018-012-1256-2; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Creevey L, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-23; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Egan CM, 2013, DEV CELL, V26, P223, DOI 10.1016/j.devcel.2013.07.008; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Ficarro SB, 2009, ANAL CHEM, V81, P3440, DOI 10.1021/ac802720e; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Fujita T, 2008, JNCI-J NATL CANCER I, V100, P940, DOI 10.1093/jnci/djn176; Garcia I, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-277; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Gorringe KL, 2008, NEOPLASIA, V10, P1253, DOI 10.1593/neo.08718; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hall WA, 2013, ONCOGENE; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Lutz W, 1996, ONCOGENE, V13, P803; Moskwa P, 2011, MOL CELL, V41, P210, DOI 10.1016/j.molcel.2010.12.005; Mulero-Navarro S, 2008, EPIGENETICS-US, V3, P210, DOI 10.4161/epi.3.4.6610; Musselman CA, 2012, P NATL ACAD SCI USA, V109, P787, DOI 10.1073/pnas.1113655109; Musselman CA, 2009, BIOCHEM J, V423, P179, DOI 10.1042/BJ20090870; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Oliver SS, 2012, BIOCHEMISTRY-US, V51, P6534, DOI 10.1021/bi3006972; Paul S, 2013, CELL REP, V3, P92, DOI 10.1016/j.celrep.2012.12.009; Potts RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024515; Quan J, 2014, EPIGENETICS, V9; Quan J, 2014, J BIOL CHEM; Rozenblatt-Rosen O, 2012, NATURE, V487, P491, DOI 10.1038/nature11288; Russell MR, 2013, CANCER RES, V73, P776, DOI 10.1158/0008-5472.CAN-12-2669; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; Terhune SS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000965; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Vestin A, 2013, GENE EXPR PATTERNS, V13, P482, DOI 10.1016/j.gep.2013.09.003; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Wang F, 2005, ONCOGENE, V24, P3875, DOI 10.1038/sj.onc.1208546; Wang L, 2013, J CLIN NEUROSCI, V20, P958, DOI 10.1016/j.jocn.2012.07.021; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yasutis KM, 2013, CELL CYCLE, V12, P1501, DOI 10.4161/cc.24637; Yusufzai T, 2009, GENE DEV, V23, P2400, DOI 10.1101/gad.1831509; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	43	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108066	10.1371/journal.pone.0108066	http://dx.doi.org/10.1371/journal.pone.0108066			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247294	gold, Green Published, Green Submitted			2022-12-25	WOS:000342351800059
J	Sang, QB; Wu, XJ; Li, CF; Lu, Y				Sang, Qing-Bing; Wu, Xiao-Jun; Li, Chao-Feng; Lu, Yin			Blind Image Blur Assessment Using Singular Value Similarity and Blur Comparisons	PLOS ONE			English	Article								The increasing number of demanding consumer image applications has led to increased interest in no-reference objective image quality assessment (IQA) algorithms. In this paper, we propose a new blind blur index for still images based on singular value similarity. The algorithm consists of three steps. First, a re-blurred image is produced by applying a Gaussian blur to the test image. Second, a singular value decomposition is performed on the test image and re-blurred image. Finally, an image blur index is constructed based on singular value similarity. The experimental results obtained on four simulated databases to demonstrate that the proposed algorithm has high correlation with human judgment when assessing blur or noise distortion of images.	[Sang, Qing-Bing; Wu, Xiao-Jun; Li, Chao-Feng] Jiangnan Univ, Sch Internet Things Engn, Key Lab Adv Proc Control Light Ind, Minist Educ, Wuxi, Jiangsu, Peoples R China; [Lu, Yin] Texas Tech Univ, Dept Comp Sci, Lubbock, TX 79409 USA	Jiangnan University; Texas Tech University System; Texas Tech University	Sang, QB (corresponding author), Jiangnan Univ, Sch Internet Things Engn, Key Lab Adv Proc Control Light Ind, Minist Educ, Wuxi, Jiangsu, Peoples R China.	sangqb@163.com; xiaojun_wu_jnu@163.com	Sang, Qingbing/AAB-4778-2022		National Natural Science Foundation of China [61170120]; Program for New Century Excellent Talents in University [NCET-12-0881]; 111 Project [B12018]; Natural Science Foundation of Jiangsu Province [BK2011147]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); 111 Project(Ministry of Education, China - 111 Project); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This research is supported in part by the National Natural Science Foundation of China (No. 61170120), the Program for New Century Excellent Talents in University (NCET-12-0881), the 111 Project (B12018), and the Natural Science Foundation of Jiangsu Province (No. BK2011147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ciancio A, 2011, IEEE T IMAGE PROCESS, V20, P64, DOI 10.1109/TIP.2010.2053549; Ferzli R, 2009, IEEE T IMAGE PROCESS, V18, P717, DOI 10.1109/TIP.2008.2011760; Hassen R, 2010, INT CONF ACOUST SPEE, P2434, DOI 10.1109/ICASSP.2010.5496297; Larson EC, 2010, J ELECTRON IMAGING, V19, DOI 10.1117/1.3267105; Manish N., 2010, 5 INT WORKSH VID PRO; Narvekar ND, 2011, IEEE T IMAGE PROCESS, V20, P2678, DOI 10.1109/TIP.2011.2131660; Ninassi A., 2006, P SPIE HUMAN VISION; Ponomarenko N., 2009, ADV MOD RADIOELECTRO, V10, P30; Sheikh H., 2005, LIVE IMAGE QUALITY A; Shnayderman A, 2006, IEEE T IMAGE PROCESS, V15, P422, DOI 10.1109/TIP.2005.860605; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861	11	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108073	10.1371/journal.pone.0108073	http://dx.doi.org/10.1371/journal.pone.0108073			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247555	Green Submitted, Green Published, gold			2022-12-25	WOS:000342351800061
J	Spratt, NJ; Tomkins, AJ; Pepperall, D; McLeod, DD; Calford, MB				Spratt, Neil J.; Tomkins, Amelia J.; Pepperall, Debbie; McLeod, Damian D.; Calford, Mike B.			Allopregnanolone and Its Precursor Progesterone Do Not Reduce Injury after Experimental Stroke in Hypertensive Rats - Role of Postoperative Temperature Regulation?	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; MIDDLE CEREBRAL-ARTERY; ACUTE ISCHEMIC-STROKE; CELL-DEATH; NEUROPROTECTIVE PROPERTIES; OCCLUSION; HYPOTHERMIA; RECOMMENDATIONS; METAANALYSIS; METABOLITE	Allopregnanolone is a neurosteroid synthesized from progesterone in brain. It increases inhibition through modulation of the gamma-aminobutyric acid type A (GABA-A) receptor. Both agents are putative neuroprotectants after ischemic stroke. We sought to confirm their effectiveness in a hypertensive rat stroke model, with intra-and post-operative temperature regulation. The primary study compared allopregnanolone, progesterone or vehicle control treatments, administered 105 minutes after induction of temporary middle cerebral artery occlusion in spontaneously hypertensive rats. Temperature was controlled intraoperatively and a heat mat used in the 6 hours postoperatively to permit animal temperature self-regulation. The primary outcome was infarct volume and secondary outcomes were tests of sensory and motor function. There was no significant effect of treatment on any outcome measure. Given prior reports of GABA-A receptor agonists causing hypothermia, follow-up experiments were conducted to examine postoperative temperature regulation. These did not reveal a difference in postoperative temperature in neurosteroid-treated animals compared to control. However, in all rats maintained postoperatively in ambient temperature, moderate hypothermia was observed. This was in contrast to rats maintained over a heat mat. The lowest mean postoperative temperature was between 34.4-34.9 degrees C in all 3 groups. These data do not support a neuroprotective effect of allopregnanolone or progesterone in ischemic stroke in hypertensives in the setting of normothermia. Given previous evidence of synergy between neuroprotective agents and hypothermia, demonstration of neuroprotective effect of these agents in the absence of postoperative hypothermia would be prudent before consideration of these agents for further clinical investigation.	[Spratt, Neil J.; Tomkins, Amelia J.; Pepperall, Debbie; McLeod, Damian D.; Calford, Mike B.] Univ Newcastle, Sch Biomed Sci, Newcastle, NSW 2300, Australia; [Spratt, Neil J.; Tomkins, Amelia J.; Pepperall, Debbie; McLeod, Damian D.; Calford, Mike B.] Hunter Med Res Inst, Newcastle, NSW, Australia; [Spratt, Neil J.] Hunter New England Local Hlth Dist, Newcastle, NSW, Australia; [Calford, Mike B.] Univ Tasmania, Sch Med, Hobart, Tas, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Tasmania	Spratt, NJ (corresponding author), Univ Newcastle, Sch Biomed Sci, Newcastle, NSW 2300, Australia.	neil.spratt@newcastle.edu.au	Spratt, Neil J/K-4208-2012; MCLEOD, DAMIAN/G-7704-2013	Spratt, Neil J/0000-0002-9023-6177; MCLEOD, DAMIAN/0000-0002-1297-8984; Calford, Mike/0000-0002-5727-0234	Greater Building Society/Hunter Medical Research Institute; Sylvia and Charles Viertel charitable foundation; Royal Australian College of Physicans / High Blood Pressure Foundation; NHMRC [454417, APP1035465]	Greater Building Society/Hunter Medical Research Institute; Sylvia and Charles Viertel charitable foundation; Royal Australian College of Physicans / High Blood Pressure Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the Greater Building Society/Hunter Medical Research Institute, the Sylvia and Charles Viertel charitable foundation, the Royal Australian College of Physicans / High Blood Pressure Foundation and by the NHMRC (program grant 454417). Dr. Spratt was supported by a NHMRC Career Development Fellowship, APP1035465. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agis-Balboa RC, 2006, P NATL ACAD SCI USA, V103, P14602, DOI 10.1073/pnas.0606544103; Alkayed NJ, 2000, STROKE, V31, P161, DOI 10.1161/01.STR.31.1.161; Armstrong SR, 2005, J VET EMERG CRIT CAR, V15, P32, DOI 10.1111/j.1476-4431.2005.04033.x; Aronowski J, 1996, J CEREBR BLOOD F MET, V16, P705, DOI 10.1097/00004647-199607000-00022; Azcoitia I, 1999, J NEUROCYTOL, V28, P699, DOI 10.1023/A:1007025219044; Berger C, 2004, EXP NEUROL, V185, P305, DOI 10.1016/j.expneurol.2003.10.008; Callier S, 2001, SYNAPSE, V41, P131, DOI 10.1002/syn.1067; Campbell K, 2008, BRAIN RES B; Chaulk D, 2003, EXP NEUROL, V182, P476, DOI 10.1016/S0014-4886(03)00121-3; Chen JL, 1999, J NEUROL SCI, V171, P24, DOI 10.1016/S0022-510X(99)00247-6; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; GARCIAESTRADA J, 1993, BRAIN RES, V628, P271, DOI 10.1016/0006-8993(93)90964-O; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kumon Y, 2000, J NEUROSURG, V92, P848, DOI 10.3171/jns.2000.92.5.0848; Liu AL, 2012, ENDOCRINOLOGY, V153, P3747, DOI 10.1210/en.2012-1138; Lust WD, 2002, METAB BRAIN DIS, V17, P113, DOI 10.1023/A:1015420222334; Macleod MR, 2008, STROKE, V39, P2824, DOI 10.1161/STROKEAHA.108.515957; Macleod MM, 2008, GOOD LAB PRACTICE PR; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Parker SM, 2005, J CEREB BLOOD FLOW M, V25, pS21; Petullo D, 1999, LIFE SCI, V64, P1099, DOI 10.1016/S0024-3205(99)00038-7; Saalmann YB, 2007, J NEUROENDOCRINOL, V19, P272, DOI 10.1111/j.1365-2826.2006.01527.x; Sayeed I, 2006, ANN EMERG MED, V47, P381, DOI 10.1016/j.annemergmed.2005.12.011; Sayeed L, 2007, RESTOR NEUROL NEUROS, V25, P151; SCHALLERT T, 1984, BEHAV NEUROSCI, V98, P518; Shuaib A, 2007, NEW ENGL J MED, V357, P562, DOI 10.1056/NEJMoa070240; Spratt NJ, 2006, J NEUROSCI METH, V155, P285, DOI 10.1016/j.jneumeth.2006.01.020; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083; VanLandingham JW, 2006, NEUROPHARMACOLOGY, V51, P1078, DOI 10.1016/j.neuropharm.2006.07.015; Wong R, 2013, J CEREBR BLOOD F MET, V33, P1362, DOI 10.1038/jcbfm.2013.120; Zivin JA, 2008, STROKE, V39, P2697, DOI 10.1161/STROKEAHA.108.519488	39	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107752	10.1371/journal.pone.0107752	http://dx.doi.org/10.1371/journal.pone.0107752			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25248155	Green Published, gold			2022-12-25	WOS:000342351800034
J	Xie, X; Xu, XM; Li, N; Zhang, YH; Zhao, Y; Ma, CY; Dong, DL				Xie, Xin; Xu, Xiao-Ming; Li, Na; Zhang, Yong-Hui; Zhao, Yu; Ma, Chun-Yan; Dong, De-Li			DMH1 Increases Glucose Metabolism through Activating Akt in L6 Rat Skeletal Muscle Cells	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; PATHOLOGICAL CARDIAC-HYPERTROPHY; SUCCINATE-DEHYDROGENASE; K+ CHANNELS; KINASE; PATHWAY; ENERGY; AMPK; CONTRIBUTES; INHIBITION	DMH1(4-[6-(4-Isopropoxyphenyl) pyrazolo [1,5-a] pyrimidin-3-yl] quinoline) is a compound C analogue with the structural modifications at the 3- and 6-positions in pyrazolo[1,5-a] pyrimidine backbone. Compound C was reported to inhibit both AMPK and Akt. Our preliminary work found that DMH1 activated Akt. Since Akt was involved in glucose metabolism, we aimed to identify the effects of DMH1 on glucose metabolism in L6 rat muscle cells and the potential mechanism. Results showed that DMH1 increased lactic acid release and glucose consumption in L6 rat muscle cells in a dose-dependent manner. DMH1 activated Akt in L6 cells. Akt inhibitor inhibited DMH1-induced Akt activation and DMH1-induced increases of glucose uptake and consumption. DMH1 had no cytotoxicity in L6 cells, but inhibited mitochondrial function and reduced ATP production. DMH1 showed no effect on AMPK, but in the presence of Akt inhibitor, DMH1 significantly activated AMPK. Compound C inhibited DMH1-induced Akt activation in L6 cells. Compound C inhibited DMH1-induced increase of glucose uptake, consumption and lactic acid release in L6 cells. DMH1 inhibited PP2A activity, and PP2A activator forskolin reversed DMH1-induced Akt activation. We concluded that DMH1 increased glucose metabolism through activating Akt and DMH1 activated Akt through inhibiting PP2A activity in L6 rat muscle cells. In view of the analogue structure of DMH1 and compound C and the contrasting effects of DMH1 and compound C on Akt, the present study provides a novel leading chemical structure targeting Akt with potential use for regulating glucose metabolism.	[Xie, Xin; Xu, Xiao-Ming; Li, Na; Zhang, Yong-Hui; Zhao, Yu; Ma, Chun-Yan; Dong, De-Li] Harbin Med Univ, Dept Pharmacol, State Prov Key Labs Biomed Pharmaceut China, Key Lab Cardiovasc Res,Minist Educ, Harbin, Peoples R China	Harbin Medical University	Dong, DL (corresponding author), Harbin Med Univ, Dept Pharmacol, State Prov Key Labs Biomed Pharmaceut China, Key Lab Cardiovasc Res,Minist Educ, Harbin, Peoples R China.	dongdeli@ems.hrbmu.edu.cn			National Natural Science Foundation of China [81373406, 81173049, 81121003]; Chang Jiang Scholar Candidates Program for Provincial Universities in Heilongjiang [2011CJHB002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chang Jiang Scholar Candidates Program for Provincial Universities in Heilongjiang	This work was supported by the National Natural Science Foundation of China (81373406, 81173049, 81121003), Chang Jiang Scholar Candidates Program for Provincial Universities in Heilongjiang (2011CJHB002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041627; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Choi SS, 2013, J NAT MED-TOKYO, V67, P320, DOI 10.1007/s11418-012-0685-4; Du Y, 2010, AM J PHYSIOL-REG I, V299, pR1610, DOI 10.1152/ajpregu.00676.2009; Feschenko MS, 2002, J PHARMACOL EXP THER, V302, P111, DOI 10.1124/jpet.302.1.111; Galbo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027424; Guo Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086881; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200; Kowluru A, 2012, BIOCHEM PHARMACOL, V84, P591, DOI 10.1016/j.bcp.2012.05.003; Li Q, 2012, BIOCHEM J, V441, P859, DOI 10.1042/BJ20111604; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Neely MD, 2012, ACS CHEM NEUROSCI, V3, P482, DOI 10.1021/cn300029t; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Pollard PJ, 2003, ANN MED, V35, P632, DOI 10.1080/07853890310018458; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Sheng Y, 2014, BRIT J PHARMACOL, V171, P4970, DOI 10.1111/bph.12821; Steinberg GR, 2009, DIABETES, V58, P829, DOI 10.2337/db08-0659; Sun B, 2013, BIOCHEM BIOPH RES CO, V436, P591, DOI 10.1016/j.bbrc.2013.05.113; Sun B, 2013, HYPERTENSION, V61, P352, DOI 10.1161/HYPERTENSIONAHA.111.00562; Ugi S, 2004, MOL CELL BIOL, V24, P8778, DOI 10.1128/MCB.24.19.8778-8789.2004; Vucicevic L, 2011, AUTOPHAGY, V7, P40, DOI 10.4161/auto.7.1.13883; Wilson C, 2013, J CELL PHYSIOL, V228, P2399, DOI 10.1002/jcp.24413	28	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107776	10.1371/journal.pone.0107776	http://dx.doi.org/10.1371/journal.pone.0107776			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247550	Green Published, Green Submitted, gold			2022-12-25	WOS:000342351800037
J	Zeng, L; Tian, YM; Huang, Y; Sun, XM; Wang, FH; Deng, XW; Han, F; Lu, TX				Zeng, Lei; Tian, Yun-Ming; Huang, Ying; Sun, Xue-Ming; Wang, Feng-Hua; Deng, Xiao-Wu; Han, Fei; Lu, Tai-Xiang			Retrospective Analysis of 234 Nasopharyngeal Carcinoma Patients with Distant Metastasis at Initial Diagnosis: Therapeutic Approaches and Prognostic Factors	PLOS ONE			English	Article							SURVIVAL; CANCER; SCORE	Purpose: The purpose of this retrospective study was to identify the independent prognostic factors and optimize the treatment for nasopharyngeal carcinoma (NPC) patients with distant metastasis at initial diagnosis. Methods: A total of 234 patients referred between January 2001 and December 2010 were retrospectively analyzed. Among the 234 patients, 94 patients received chemotherapy alone (CT), and 140 patients received chemoradiotherapy (CRT). Clinical features, laboratory parameters and treatment modality were examined with univariate and multivariate analyses. Results: The median overall survival (OS) time was 22 months (range, 2-125 months), and the 1-year, 2-year, 3-year overall survival rates were 82.2%, 51.3% and 34.1%. The overall response and disease control rates of metastatic lesions after chemotherapy were 56.0% and 89.8%. The factors associated with poor response were karnofsky performance score (KPS) < 80, liver metastasis, lactate dehydrogenase (LDH) > 245 IU/L, and number of chemotherapy cycles <4. The 3-year OS of patients receiving CRT was higher than those receiving CT alone (48.2% vs. 12.4%, p<0.001). Subgroup analysis showed that significantly improved survival was also achieved by radiotherapy of the primary tumor in patients who achieved complete remission (CR)/partial remission (PR) or stable disease (SD) of metastatic lesions after chemotherapy. Significant independent prognostic factors of OS were KPS, liver metastasis, levels of LDH, and multiple metastases. Treatment modality, response to chemotherapy and chemotherapy cycles were also associated with OS. Conclusion: A combination of radiotherapy and chemotherapy seems to have survival benefits for selected patients with distant metastases at initial diagnosis. Clinical and laboratory characteristics can help to guide treatment selection. Prospective randomized studies are needed to confirm the result.	[Zeng, Lei; Tian, Yun-Ming; Huang, Ying; Sun, Xue-Ming; Deng, Xiao-Wu; Han, Fei; Lu, Tai-Xiang] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Ctr Canc, Dept Radiat Oncol,State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Zeng, Lei; Tian, Yun-Ming; Wang, Feng-Hua] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Ctr Canc, Dept Med Oncol,State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Zeng, Lei] Jiangxi Canc Hosp, Dept Radiat Oncol, Nanchang, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Han, F (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Ctr Canc, Dept Radiat Oncol,State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	hanfei@sysucc.org.cn; lutx@sysucc.org.cn	Han, Fei/AAD-7348-2021	Deng, Xiaowu/0000-0003-2923-1251; Han, Fei/0000-0002-1598-9048				Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; An X, 2011, CANCER-AM CANCER SOC, V117, P3750, DOI 10.1002/cncr.25932; AU E, 1994, ANN ONCOL, V5, P87, DOI 10.1093/oxfordjournals.annonc.a058703; Fandi A, 2000, J CLIN ONCOL, V18, P1324, DOI 10.1200/JCO.2000.18.6.1324; Foo KF, 2002, ANN ONCOL, V13, P150, DOI 10.1093/annonc/mdf002; Hui EP, 2004, CANCER-AM CANCER SOC, V101, P300, DOI 10.1002/cncr.20358; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jin Y, 2013, EUR J CANCER, V49, P1619, DOI 10.1016/j.ejca.2012.11.032; Jin Y, 2012, EUR J CANCER, V48, P882, DOI 10.1016/j.ejca.2011.09.004; Khanfira A, 2007, CANCER RADIOTHER, V11, P461, DOI 10.1016/j.canrad.2007.06.006; Lee AWM, 2012, RADIOTHER ONCOL, V104, P272, DOI 10.1016/j.radonc.2012.08.001; Liaw CC, 1997, ACTA ONCOL, V36, P159, DOI 10.3109/02841869709109224; Luo Wei, 2004, Ai Zheng, V23, P605; Ong YK, 2003, EUR J CANCER, V39, P1535, DOI 10.1016/S0959-8049(03)00310-1; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Setton J, 2012, HEAD NECK-J SCI SPEC, V34, P753, DOI 10.1002/hed.21608; Teo PML, 1996, CANCER-AM CANCER SOC, V77, P2423, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2423::AID-CNCR2>3.0.CO;2-N; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Yeh SA, 2006, JPN J CLIN ONCOL, V36, P132, DOI 10.1093/jjco/hyi245; Zhao Chong, 2004, Ai Zheng, V23, P1532; Zhou GQ, 2012, INT J RADIAT ONCOL, V82, pE359, DOI 10.1016/j.ijrobp.2011.06.1967	21	33	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108070	10.1371/journal.pone.0108070	http://dx.doi.org/10.1371/journal.pone.0108070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247415	gold, Green Published, Green Submitted			2022-12-25	WOS:000342351800060
J	Hao, Y; Liang, JF; Chow, AW; Cheung, WT; Ko, WH				Hao, Yuan; Liang, Jocelyn F.; Chow, Alison W.; Cheung, Wing-tai; Ko, Wing-hung			P2Y(6) Receptor-Mediated Proinflammatory Signaling in Human Bronchial Epithelia	PLOS ONE			English	Article							EXTRACELLULAR NUCLEOTIDES; INTERLEUKIN-8 PRODUCTION; CATIONIC PROTEIN; CL-SECRETION; P2 RECEPTORS; CELLS; RELEASE; ATP; EXPRESSION; INFLAMMATION	P2Y receptors are expressed in virtually all epithelia and are responsible for the control of fluid and electrolyte transport. In asthmatic inflammation, the bronchial epithelia are damaged by eosinophil-derived, highly toxic cationic proteins, such as major basic protein (MBP). Consequently, extracellular nucleotides are released into the extracellular space from airway epithelial cells, and act in an autocrine or paracrine fashion to regulate immune functions. Our data show damage to the human bronchial epithelial cell line, 16HBE14o-, by poly-L-arginine-induced UDP release into the extracellular medium. Activation of P2Y(6) receptor by its natural ligand, UDP, or its specific agonist, MRS 2693, led to the production of two proinflammatory cytokines, interleukin (IL)-6 and IL-8. This may have resulted from increased IL-6 and IL-8 mRNA expression, and activation of p38 and ERK1/2 MAPK, and NF-kappa B pathways. Our previous study demonstrated that UDP stimulated transepithelial Cl- secretion via both Ca2+- and cAMP-dependent pathways in 16HBE14o- epithelia. This was further confirmed in this study by simultaneous imaging of Ca2+ and cAMP levels in single cells using the Fura-2 fluorescence technique and a FRET-based approach, respectively. Moreover, the P2Y(6) receptor-mediated production of IL-6 and IL-8 was found to be dependent on Ca2+, but not the cAMP/PKA pathway. Together, these studies show that nucleotides released during the airway inflammatory processes will activate P2Y(6) receptors, which will lead to further release of inflammatory cytokines. The secretion of cytokines and the formation of such "cytokine networks'' play an important role in sustaining the airway inflammatory disease.	[Hao, Yuan; Liang, Jocelyn F.; Chow, Alison W.; Cheung, Wing-tai; Ko, Wing-hung] Chinese Univ Hong Kong, Sch Biomed Sci, Sha Tin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Ko, WH (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Sha Tin, Hong Kong, Peoples R China.	whko@cuhk.edu.hk	Ko, Hung/R-1802-2018; Cheung, Wing-Tai/AAE-2658-2020	Ko, Hung/0000-0002-2041-402X; Cheung, Wing-Tai/0000-0001-6358-7855; Hao, Yuan/0000-0003-2322-6806	Research Grant Council General Research Fund [466611]	Research Grant Council General Research Fund	The work was supported by a Research Grant Council General Research Fund (Ref. No. 466611) awarded to Wing-Hung Ko. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong S, 2007, PURINERG SIGNAL, V3, P59, DOI 10.1007/s11302-006-9037-8; Asokananthan N, 2002, J IMMUNOL, V168, P3577, DOI 10.4049/jimmunol.168.7.3577; Besada P, 2006, J MED CHEM, V49, P5532, DOI 10.1021/jm060485n; Chen XQ, 2009, ORG LETT, V11, P2181, DOI 10.1021/ol9004849; Chow AWM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012091; Communi D, 2000, CELL SIGNAL, V12, P351, DOI 10.1016/S0898-6568(00)00083-8; Cox MA, 2005, BIOCHEM BIOPH RES CO, V330, P467, DOI 10.1016/j.bbrc.2005.03.004; Coyle AJ, 2000, PROG INFLAM RES, P147; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Di Virgilio F, 2003, DRUG DEVELOP RES, V59, P171, DOI 10.1002/ddr.10191; Di Virgilio F, 2002, BRIT J PHARMACOL, V135, P831, DOI 10.1038/sj.bjp.0704524; Donaldson SH, 2000, MOL MED, V6, P969, DOI 10.1007/BF03401831; Douillet CD, 2006, AM J PHYSIOL-LUNG C, V291, pL734, DOI 10.1152/ajplung.00389.2005; Dulong S, 2007, CELL PHYSIOL BIOCHEM, V20, P483, DOI 10.1159/000107532; Frieri M, 2004, ALLERGY ASTHMA PROC, V25, P387; Grbic DM, 2008, J IMMUNOL, V180, P2659, DOI 10.4049/jimmunol.180.4.2659; Idzko M, 2003, BRIT J PHARMACOL, V138, P1244, DOI 10.1038/sj.bjp.0705145; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Khine AA, 2006, BLOOD, V107, P2936, DOI 10.1182/blood-2005-06-2314; Kim B, 2011, J IMMUNOL, V186, P3701, DOI 10.4049/jimmunol.1000212; Kim HJ, 2012, J NEUROCHEM, V121, P228, DOI 10.1111/j.1471-4159.2012.07700.x; Kim SG, 2003, CELL MOL NEUROBIOL, V23, P401, DOI 10.1023/A:1023696806609; Kukulski F, 2005, Purinergic Signal, V1, P193, DOI 10.1007/s11302-005-6217-x; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Lau WKH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022363; Lazarowski Eduardo, 2006, Novartis Found Symp, V276, P73; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Liu GD, 2009, NEUROSCI BULL, V25, P161, DOI 10.1007/s12264-009-0120-3; Mamedova LK, 2004, BIOCHEM PHARMACOL, V67, P1763, DOI 10.1016/j.bcp.2004.01.011; Marcet B, 2007, J CELL PHYSIOL, V211, P716, DOI 10.1002/jcp.20979; Marriott I, 1999, CELL IMMUNOL, V195, P147, DOI 10.1006/cimm.1999.1531; Mortaz E, 2010, EUR J PHARMACOL, V638, P1, DOI 10.1016/j.ejphar.2010.04.019; Muller T, 2005, AM J RESP CELL MOL, V33, P601, DOI 10.1165/rcmb.2005-0181OC; Nicholas RA, 1996, MOL PHARMACOL, V50, P224; NOAH TL, 1991, AM J RESP CELL MOL, V5, P484, DOI 10.1165/ajrcmb/5.5.484; Noursadeghi M, 2008, J IMMUNOL METHODS, V329, P194, DOI 10.1016/j.jim.2007.10.015; QUINTON PM, 1973, J CELL BIOL, V56, P787, DOI 10.1083/jcb.56.3.787; Relvas LJM, 2009, INVEST OPHTH VIS SCI, V50, P1241, DOI 10.1167/iovs.08-1902; Riegel AK, 2011, BLOOD, V117, P2548, DOI 10.1182/blood-2010-10-313957; Shahana S, 2002, MEDIAT INFLAMM, V11, P141, DOI 10.1080/09622935020138172; Somers GR, 1998, LAB INVEST, V78, P1375; Uratsuji H, 2012, J IMMUNOL, V188, P436, DOI 10.4049/jimmunol.1003746; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916; Warny M, 2001, J BIOL CHEM, V276, P26051, DOI 10.1074/jbc.M102568200; Wong AM, 2009, AM J RESP CELL MOL, V40, P733, DOI 10.1165/rcmb.2008-0020OC	45	28	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e106235	10.1371/journal.pone.0106235	http://dx.doi.org/10.1371/journal.pone.0106235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243587	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800008
J	Mitchell, DM; Uehlein-Klebanow, LR; Bembenek, JN				Mitchell, Diana M.; Uehlein-Klebanow, Lindsey R.; Bembenek, Joshua N.			Protease-Dead Separase Is Dominant Negative in the C. elegans Embryo	PLOS ONE			English	Article							CORTICAL GRANULE EXOCYTOSIS; ANAPHASE SPINDLE ELONGATION; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; BUDDING YEAST; MITOTIC EXIT; COHESIN; CLEAVAGE; GERMLINE; SUBSTRATE	Separase is a protease that promotes chromosome segregation at anaphase by cleaving cohesin. Several non-proteolytic functions of separase have been identified in other organisms. We created a transgenic C. elegans line that expresses protease-dead separase in embryos to further characterize separase function. We find that expression of protease-dead separase is dominant-negative in C. elegans embryos, not previously reported in other systems. The C. elegans embryo is an ideal system to study developmental processes in a genetically tractable system. However, a major limitation is the lack of an inducible gene expression system for the embryo. We have developed two methods that allow for the propagation of lines carrying dominant-negative transgenes and have applied them to characterize expression of protease-dead separase in embryos. Using these methods, we show that protease-dead separase causes embryo lethality, and that protease-dead separase cannot rescue separase mutants. These data suggest that protease-dead separase interferes with endogenous separase function, possibly by binding substrates and protecting them from cleavage.	[Mitchell, Diana M.; Uehlein-Klebanow, Lindsey R.; Bembenek, Joshua N.] Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Bembenek, JN (corresponding author), Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN 37996 USA.	bembenek@utk.edu		Bembenek, Joshua/0000-0002-0966-2268	University of Tennessee, Knoxville; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	University of Tennessee, Knoxville; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by start-up funds from the University of Tennessee, Knoxville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar RM, 2008, GENETICS, V180, P1275, DOI 10.1534/genetics.108.089433; Baskerville C, 2008, GENETICS, V178, P2361, DOI 10.1534/genetics.107.085308; Bembenek JN, 2007, DEVELOPMENT, V134, P3837, DOI 10.1242/dev.011361; Bembenek JN, 2010, CURR BIOL, V20, P259, DOI 10.1016/j.cub.2009.12.045; Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Buckley BA, 2012, NATURE, V489, P447, DOI 10.1038/nature11352; Burton NO, 2011, P NATL ACAD SCI USA, V108, P19683, DOI 10.1073/pnas.1113310108; Cabral G, 2013, CURR BIOL, V23, P1380, DOI 10.1016/j.cub.2013.06.043; Calixto A, 2010, NAT METHODS, V7, P407, DOI [10.1038/NMETH.1445, 10.1038/nmeth.1445]; Hao YS, 2006, DEV CELL, V10, P199, DOI 10.1016/j.devcel.2005.12.015; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Jensen S, 2001, J CELL BIOL, V152, P27, DOI 10.1083/jcb.152.1.27; Kudo NR, 2006, CELL, V126, P135, DOI 10.1016/j.cell.2006.05.033; Lu Y, 2009, MOL BIOL CELL, V20, P1576, DOI 10.1091/mbc.E08-10-1042; Matsuo K, 2012, CURR BIOL, V22, P915, DOI 10.1016/j.cub.2012.03.048; MCKIM KS, 1990, GENETICS, V124, P115; Mello CC, 1996, NATURE, V382, P710, DOI 10.1038/382710a0; Merritt C, 2008, CURR BIOL, V18, P1476, DOI 10.1016/j.cub.2008.08.013; Nagao K, 2004, NATURE, V430, P1044, DOI 10.1038/nature02803; Praitis V, 2001, GENETICS, V157, P1217; Richie CT, 2011, J CELL SCI, V124, P2903, DOI 10.1242/jcs.073379; Ross KE, 2004, DEV CELL, V6, P729, DOI 10.1016/S1534-5807(04)00128-5; Sander JD, 2014, NAT BIOTECHNOL; Schockel L, 2011, NAT CELL BIOL, V13, P966, DOI 10.1038/ncb2280; Schvarzstein M, 2013, P NATL ACAD SCI USA, V110, pE898, DOI 10.1073/pnas.1213888110; Severin F, 2001, J CELL BIOL, V155, P711, DOI 10.1083/jcb.200104096; Siomos MF, 2001, CURR BIOL, V11, P1825, DOI 10.1016/S0960-9822(01)00588-7; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Zeiser E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020082	33	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e108188	10.1371/journal.pone.0108188	http://dx.doi.org/10.1371/journal.pone.0108188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244427	Green Submitted, Green Published, gold			2022-12-25	WOS:000343679800075
J	Wu, WW; Hua, SR; Li, YJ; Ye, W; Liu, B; Zheng, YH; Song, XJ; Liu, CW				Wu, Weiwei; Hua, Surong; Li, Yongjun; Ye, Wei; Liu, Bao; Zheng, Yuehong; Song, Xiaojun; Liu, Changwei			Incidence, Risk Factors, Treatment and Prognosis of Popliteal Artery Embolization in the Superficial Femoral Artery Interventions	PLOS ONE			English	Article							EMBOLIC CAPTURE ANGIOPLASTY; DISTAL EMBOLIZATION; PROTECTION; BALLOON	Objective: Percutaneous transluminal angioplasty and stenting (PTA + stent) has gained acceptance as a primary treatment modality for the superficial femoral artery (SFA) diseases. Popliteal artery embolization (PAE) is a severe complication in SFA interventions. The purpose of this study was to evaluate the incidence, risk factors, treatment and prognosis of PAE in primary SFA PTA + stent. Methods: Chronic SFA arteriosclerosis cases that underwent primary PTA + stent were reviewed from a retrospectively maintained database. Runoff vessels were evaluated in all cases before and after the interventions for PAE detection. The primary patency, secondary patency and limb salvage rates were calculated using Kaplan-Meier analysis and compared using log-rank analysis. Cox multivariate regression was performed to evaluate predictors of patency and limb salvage rates. Results: There were 436 lesions treated in 388 patients with 10 PAE events (2.3%) in total. PAE rate was significantly higher in Transatlantic Inter-Society Consensus (TASC) C/D group compared with TASC A/B group (OR = 8.91, P = .002), in chronic total occlusion (CTO) lesions compared with stenotic lesions (P,. 0001), and in group with history of cerebral ischemic stroke (OR = 6.11, P = .007). PAE rates were not significantly affected by age, sex, smoking, hypertension, diabetes, hyperlipidemia and runoff status. The binary logistic regression showed that only the TASC C/D was an independent predictor of PAE (P = .031). The 12-month and 24-month primary patency, secondary patency and limb salvage rates in PAE group showed no significant differences comparing with non-PAE group. Conclusions: PAE is a rare event in primary SFA PTA + stent. TASC C/D lesion, CTO and cerebral ischemic stroke history are risk factors for PAE. PAE is typically reversible by comprehensive techniques. If the popliteal flow is restored in time, PAE has no significant effect on long-term patency and limb salvage rates.	[Wu, Weiwei; Hua, Surong; Li, Yongjun; Ye, Wei; Liu, Bao; Zheng, Yuehong; Song, Xiaojun; Liu, Changwei] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Vasc Surg, Beijing 100730, Peoples R China; [Wu, Weiwei] Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Dept Vasc Surg, Beijing 100084, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Tsinghua University	Liu, CW (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Vasc Surg, Beijing 100730, Peoples R China.	liucw@vip.sina.com		Hua, Surong/0000-0003-3630-3954				Banerjee S, 2011, CARDIOVASC REVASC ME, V12, P134; Bosiers Marc, 2008, Perspect Vasc Surg Endovasc Ther, V20, P272, DOI 10.1177/1531003508323730; Cohen SN, 2007, STROKE, V38, pE18, DOI 10.1161/STROKEAHA.106.478164; Davies MG, 2010, ANN VASC SURG, V24, P14, DOI 10.1016/j.avsg.2009.06.020; Fatini C, 2004, EUR J VASC ENDOVASC, V27, P540, DOI 10.1016/j.ejvs.2004.02.008; Goodney PP, 2006, J VASC SURG, V43, P406, DOI 10.1016/j.jvs.2005.11.012; Hadidi OF, 2012, J ENDOVASC THER, V19, P611, DOI 10.1583/JEVT-12-3977MR.1; Karnabatidis D, 2006, J ENDOVASC THER, V13, P269, DOI 10.1583/05-1771.1; Lam RC, 2007, J VASC SURG, V46, P1155, DOI 10.1016/j.jvs.2007.07.058; Lookstein RA, 2010, TECH VASC INTERV RAD, V13, P54, DOI 10.1053/j.tvir.2009.10.007; Matsi PJ, 1998, CARDIOVASC INTER RAD, V21, P361, DOI 10.1007/s002709900281; Muller-Hulsbeck S, 2009, J ENDOVASC THER, V16, P163, DOI 10.1583/08-2596.1; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Schlittenhardt D, 2004, CELL TISSUE RES, V318, P325, DOI 10.1007/s00441-004-0986-3; Shammas NW, 2008, J ENDOVASC THER, V15, P270, DOI 10.1583/08-2397.1; Shammas NW, 2011, J VASC INTERV RADIOL, V22, P1223, DOI 10.1016/j.jvir.2011.05.013; Shammas NW, 2009, J ENDOVASC THER, V16, P197, DOI 10.1583/08-2642.1; Shrikhande GV, 2011, J VASC SURG, V53, P347, DOI 10.1016/j.jvs.2010.09.008; Suri R, 2006, CATHETER CARDIO INTE, V67, P417, DOI 10.1002/ccd.20634; Zeller T, 2012, J ENDOVASC THER, V19, P826, DOI 10.1583/JEVT-12-3960MR.1	20	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107717	10.1371/journal.pone.0107717	http://dx.doi.org/10.1371/journal.pone.0107717			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238066	gold, Green Submitted, Green Published			2022-12-25	WOS:000342491600045
J	Davies, EM; Kong, AM; Tan, A; Gurung, R; Sriratana, A; Bukczynska, PE; Ooms, LM; McLean, CA; Tiganis, T; Mitchell, CA				Davies, E. M.; Kong, A. M.; Tan, A.; Gurung, R.; Sriratana, A.; Bukczynska, P. E.; Ooms, L. M.; McLean, C. A.; Tiganis, T.; Mitchell, C. A.			Differential SKIP expression in PTEN-deficient glioblastoma regulates cellular proliferation and migration	ONCOGENE			English	Article							FOCAL ADHESION KINASE; TUMOR-SUPPRESSOR GENE; PLECKSTRIN-HOMOLOGY DOMAINS; GROWTH-FACTOR RECEPTOR; HUMAN GLIOMA-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDES; IDENTIFICATION; LOCALIZATION; ACTIVATION	Glioblastoma is the most common and lethal primary malignant brain tumor in adults. The tumor suppressor gene PTEN is deleted, mutated or hypermethylated in more than 60% of glioblastoma cases resulting in hyperactivation of the phosphoinositide 3-kinase pathway, which leads to sustained PI(3,4,5)P-3 signaling, and thereby hyperactivation of Akt and other effectors. PI(3,4,5) P-3 is also hydrolyzed to PI(3,4)P-2 by inositol polyphosphate 5-phosphatases such as SKIP, but the role this pathway has in glioblastoma is unknown. Microarray expression profiling of SKIP in human glioblastoma has revealed both increased and decreased SKIP gene expression. Here we have screened PTEN-deficient glioblastoma for SKIP protein expression by immunohistochemistry and report that SKIP expression is increased in some cases or decreased relative to normal brain. Using the U-87MG PTEN-deficient cell line we show that SKIP knockdown did not further enhance cell proliferation or survival. However, SKIP overexpression in U-87MG cells suppressed anchorage-independent cell growth and growth factor-induced PI(3,4,5) P3/Akt signaling. Although, SKIP knockdown did not affect cell proliferation or survival, cell migration was significantly retarded, associated with significantly increased PI(4,5)P-2 signals, and decreased phosphorylation of the actin-regulatory protein cofilin, a PI(4,5)P-2-binding protein. Notably, overexpression of SKIP also inhibited migration of U-87MG cells to a similar degree as observed with PTEN reconstitution, however, via distinct mechanisms. PTEN reconstitution promoted sustained lamellipodia generation and focal adhesion formation. In contrast, SKIP overexpression reduced sustained lamellipodia formation, talin incorporation into focal adhesions and recruitment of PI(4,5)P-2-binding proteins to the plasma membrane. Notably, analysis of two independent ONCOMINE microarray data sets revealed a significant correlation between increased SKIP mRNA expression in glioblastoma and improved long-term survival. Therefore, SKIP expression in glioblastoma may affect the local invasion of PTEN-deficient tumors.	[Davies, E. M.; Kong, A. M.; Tan, A.; Gurung, R.; Sriratana, A.; Bukczynska, P. E.; Ooms, L. M.; Tiganis, T.; Mitchell, C. A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [McLean, C. A.] Alfred Hosp, Dept Anat Pathol, Prahran, Vic 3181, Australia	Monash University; Florey Institute of Neuroscience & Mental Health	Mitchell, CA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Bldg 64,SOBS,Wellington Rd, Clayton, Vic 3800, Australia.	christina.mitchell@monash.edu	Tiganis, Tony/AAV-3495-2020; Ooms, Lisa/AGZ-7420-2022	Tiganis, Tony/0000-0002-8065-9942; Ooms, Lisa Michelle/0000-0002-8918-9932; McLean, Catriona/0000-0002-0302-5727; Mitchell, Christina A/0000-0001-9372-3192	National Health & Medical Research Council (NHMRC), Australia [384083]	National Health & Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia)	We thank Dr Tamas Balla (NIH) for kindly providing the GFP-PH/Btk and GFP-PH/PLC delta constructs and Dr Jelena Becanovic for assistance with ONCOMINE data analysis. This work was supported by the National Health & Medical Research Council (NH&MRC), Australia, grant number 384083. We also thank the Biochemistry Imaging Facility, Department of Biochemistry and Molecular Biology, Monash University and the Monash Micro Imaging Facility for technical advice with image acquisition and analysis. Tony Tiganis is a NHMRC research fellow. The results shown here are in part based upon data generated by The Cancer Genome Atlas Research Network http://cancergenome.nih.gov/.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Baeza N, 2003, ACTA NEUROPATHOL, V106, P479, DOI 10.1007/s00401-003-0748-4; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bertagnolo V, 2007, CARCINOGENESIS, V28, P1638, DOI 10.1093/carcin/bgm078; BIEGEL JA, 1992, CANCER RES, V52, P3391; Bredel M, 2005, CANCER RES, V65, P4088, DOI 10.1158/0008-5472.CAN-04-4229; Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079; Calderwood DA, 2003, NAT CELL BIOL, V5, P694, DOI 10.1038/ncb0803-694; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Carico C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033684; Chalhoub N, 2009, GENE DEV, V23, P1619, DOI 10.1101/gad.1799609; Davies Elizabeth M, 2012, Subcell Biochem, V58, P281, DOI 10.1007/978-94-007-3012-0_8; Davies MA, 1998, CANCER RES, V58, P5285; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Duxbury MS, 2004, SURGERY, V135, P555, DOI 10.1016/j.surg.2003.10.017; Dyson Jennifer M, 2012, Subcell Biochem, V58, P215, DOI 10.1007/978-94-007-3012-0_7; Filippini G, 2008, NEURO-ONCOLOGY, V10, P79, DOI 10.1215/15228517-2007-038; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Frame M, 2008, NAT CELL BIOL, V10, P1017, DOI 10.1038/ncb0908-1017; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Furnari FB, 1997, P NATL ACAD SCI USA, V94, P12479, DOI 10.1073/pnas.94.23.12479; Golub T, 2005, J CELL BIOL, V169, P151, DOI 10.1083/jcb.200407058; Gorbatyuk VY, 2006, MOL CELL, V24, P511, DOI 10.1016/j.molcel.2006.10.007; Gu JG, 1999, J CELL BIOL, V146, P389, DOI 10.1083/jcb.146.2.389; Guadamillas MC, 2011, J CELL SCI, V124, P3189, DOI 10.1242/jcs.072165; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Gurung R, 2003, J BIOL CHEM, V278, P11376, DOI 10.1074/jbc.M209991200; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hinchliffe KA, 1996, EMBO J, V15, P6516, DOI 10.1002/j.1460-2075.1996.tb01042.x; Huang SH, 2004, MOL CELL BIOL, V24, P9102, DOI 10.1128/MCB.24.20.9102-9123.2004; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iijima M, 2004, J BIOL CHEM, V279, P16606, DOI 10.1074/jbc.M312098200; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Ijuin T, 2000, J BIOL CHEM, V275, P10870, DOI 10.1074/jbc.275.15.10870; Ijuin T, 2003, MOL CELL BIOL, V23, P1209, DOI 10.1128/MCB.23.4.1209-1220.2003; Ijuin T, 2008, MOL CELL BIOL, V28, P5184, DOI 10.1128/MCB.01990-06; Ijuin T, 2012, J BIOL CHEM, V287, P6991, DOI 10.1074/jbc.M111.335539; KAPLAN PL, 1982, P NATL ACAD SCI-BIOL, V79, P485, DOI 10.1073/pnas.79.2.485; King WG, 1997, MOL CELL BIOL, V17, P4406, DOI 10.1128/MCB.17.8.4406; Kisseleva M, 2005, MOL CELL BIOL, V25, P3956, DOI 10.1128/MCB.25.10.3956-3966.2005; Klingler-Hoffmann M, 2003, INT J CANCER, V105, P331, DOI 10.1002/ijc.11085; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Koul D, 2001, ONCOGENE, V20, P6669, DOI 10.1038/sj.onc.1204799; Koul D, 2008, CANCER BIOL THER, V7, P1321, DOI 10.4161/cbt.7.9.6954; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Leslie NR, 2007, CURR BIOL, V17, P115, DOI 10.1016/j.cub.2006.12.026; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; Mise-Omata S, 2005, BIOCHEM BIOPH RES CO, V328, P1034, DOI 10.1016/j.bbrc.2005.01.066; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Nutt CL, 2003, CANCER RES, V63, P1602; Ooms LM, 2006, MOL BIOL CELL, V17, P607, DOI 10.1091/mbc.E05-05-0469; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raftopoulou M, 2004, SCIENCE, V303, P1179, DOI 10.1126/science.1092089; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Rood BR, 2002, CANCER RES, V62, P3794; Sano T, 1999, CANCER RES, V59, P1820; Sasaki J, 2005, J EXP MED, V201, P859, DOI 10.1084/jem.20041891; SAXENA A, 1992, CANCER RES, V52, P6716; Schmid AC, 2004, FEBS LETT, V576, P9, DOI 10.1016/j.febslet.2004.08.052; Shibasaki Y, 1997, J BIOL CHEM, V272, P7578, DOI 10.1074/jbc.272.12.7578; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Takenawa T, 2001, BBA-MOL CELL BIOL L, V1533, P190, DOI 10.1016/S1388-1981(01)00165-2; Tamura M, 1999, J BIOL CHEM, V274, P20693, DOI 10.1074/jbc.274.29.20693; Tamura M, 1999, CANCER RES, V59, P442; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Yamanaka R, 2006, ONCOGENE, V25, P5994, DOI 10.1038/sj.onc.1209585; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zhang Li, 2012, Subcell Biochem, V59, P177, DOI 10.1007/978-94-007-3015-1_6; Zhao HX, 2010, BIOPHYS J, V98, P2327, DOI 10.1016/j.bpj.2010.01.046	84	15	17	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2015	34	28					3711	3727		10.1038/onc.2014.303	http://dx.doi.org/10.1038/onc.2014.303			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM4TZ	25241900				2022-12-25	WOS:000357679100009
J	Dulin, D; Barland, S; Hachair, X; Pedaci, F				Dulin, David; Barland, Stephane; Hachair, Xavier; Pedaci, Francesco			Efficient Illumination for Microsecond Tracking Microscopy	PLOS ONE			English	Article							LASER-DIODE MICROSCOPE; 3-DIMENSIONAL PARTICLE TRACKING; DIGITAL HOLOGRAPHIC MICROSCOPE; SEMICONDUCTOR-LASER; SCATTERING; RESOLUTION; TWEEZERS; DYNAMICS	The possibility to observe microsecond dynamics at the sub-micron scale, opened by recent technological advances in fast camera sensors, will affect many biophysical studies based on particle tracking in optical microscopy. A main limiting factor for further development of fast video microscopy remains the illumination of the sample, which must deliver sufficient light to the camera to allow microsecond exposure times. Here we systematically compare the main illumination systems employed in holographic tracking microscopy, and we show that a superluminescent diode and a modulated laser diode perform the best in terms of image quality and acquisition speed, respectively. In particular, we show that the simple and inexpensive laser illumination enables less than 1 mu s camera exposure time at high magnification on a large field of view without coherence image artifacts, together with a good hologram quality that allows nm-tracking of microscopic beads to be performed. This comparison of sources can guide in choosing the most efficient illumination system with respect to the specific application.	[Dulin, David] Delft Univ Technol, Dept Bionanosci, Kavli Inst Nanosci, Delft, Netherlands; [Barland, Stephane] Univ Nice Sophia Antipolis, Inst Non Lineaire Nice, CNRS, UMR 7335, Valbonne, France; [Hachair, Xavier] BBright, Rennes, France; [Pedaci, Francesco] CNRS, Ctr Biochimie Struct, INSERM, UMR5048,UM1,UMR1054,Dept Single Mol Biophys, Montpellier, France	Delft University of Technology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Pedaci, F (corresponding author), CNRS, Ctr Biochimie Struct, INSERM, UMR5048,UM1,UMR1054,Dept Single Mol Biophys, Montpellier, France.	francesco.pedaci@cbs.cnrs.fr		Dulin, David/0000-0003-4209-0377; Pedaci, Francesco/0000-0002-4530-3027	European Research Council under the European Union [306475]	European Research Council under the European Union(European Research Council (ERC))	FP acknowledges funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement n. 306475. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELKADER HI, 1992, REV SCI INSTRUM, V63, P2004, DOI 10.1063/1.1143318; Agresti JJ, 2010, P NATL ACAD SCI USA, V107, P4004, DOI 10.1073/pnas.0910781107; Basu AS, 2013, LAB CHIP, V13, P1892, DOI 10.1039/c3lc50074h; Biancaniello PL, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2387893; Braslavsky I, 2001, APPL OPTICS, V40, P5650, DOI 10.1364/AO.40.005650; Cheong FC, 2010, OPT EXPRESS, V18, P13563, DOI 10.1364/OE.18.013563; CONSIDIN.PS, 1966, J OPT SOC AM, V56, P1001, DOI 10.1364/JOSA.56.001001; Dietrich HRC, 2009, J NANOPHOTONICS, V3, DOI 10.1117/1.3174445; DINGEL B, 1992, OPT COMMUN, V93, P27, DOI 10.1016/0030-4018(92)90123-9; DINGEL B, 1993, OPT LETT, V18, P549, DOI 10.1364/OL.18.000549; Fung J, 2011, OPT EXPRESS, V19, P8051, DOI 10.1364/OE.19.008051; Garcia-Sucerquia J, 2006, APPL OPTICS, V45, P836, DOI 10.1364/AO.45.000836; Iwai T, 1996, P IEEE, V84, P765, DOI 10.1109/5.488745; Kim K, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp725; Lanco L, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2430776; Lansdorp BM, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4802678; Lee SH, 2007, OPT EXPRESS, V15, P1505, DOI 10.1364/OE.15.001505; Lipfert J, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3650461; Lipfert J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1450; Nan XL, 2008, CHEMPHYSCHEM, V9, P707, DOI 10.1002/cphc.200700839; Ortega-Arroyo J, 2012, PHYS CHEM CHEM PHYS, V14, P15625, DOI 10.1039/c2cp41013c; Otto O, 2010, OPT EXPRESS, V18, P22722, DOI 10.1364/OE.18.022722; Redding B, 2012, NAT PHOTONICS, V6, P355, DOI [10.1038/nphoton.2012.90, 10.1038/NPHOTON.2012.90]; Repetto L, 2004, OPT LETT, V29, P1132, DOI 10.1364/OL.29.001132; SALOMA C, 1990, OPT LETT, V15, P203, DOI 10.1364/OL.15.000203; SALOMA C, 1992, OPT COMMUN, V93, P4, DOI 10.1016/0030-4018(92)90119-C; Sheng J, 2006, APPL OPTICS, V45, P3893, DOI 10.1364/AO.45.003893; Soni GV, 2013, SMALL, V9, P679, DOI 10.1002/smll.201201875; Sowa Y, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3495960; Staymates ME, 2007, OPT COMMUN, V273, P252, DOI 10.1016/j.optcom.2007.01.007; Wang A, 2014, J QUANT SPECTROSC RA, V146, P499, DOI 10.1016/j.jqsrt.2013.12.019; Wirtz D, 2009, ANNU REV BIOPHYS, V38, P301, DOI 10.1146/annurev.biophys.050708.133724; Xu W, 2003, OPT LETT, V28, P164, DOI 10.1364/OL.28.000164; Xu WB, 2001, P NATL ACAD SCI USA, V98, P11301, DOI 10.1073/pnas.191361398; Yamada S, 2000, BIOPHYS J, V78, P1736, DOI 10.1016/S0006-3495(00)76725-7; Zhang ZP, 2008, APPL OPTICS, V47, P2361, DOI 10.1364/AO.47.002361	36	18	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107335	10.1371/journal.pone.0107335	http://dx.doi.org/10.1371/journal.pone.0107335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251462	gold, Green Submitted, Green Published			2022-12-25	WOS:000342492700028
J	Fukuda, H; Okuma, K; Imanaka, Y				Fukuda, Haruhisa; Okuma, Kazuhide; Imanaka, Yuichi			Can Experience Improve Hospital Management?	PLOS ONE			English	Article							ABDOMINAL AORTIC-ANEURYSM; NEW-YORK-STATE; UNITED-STATES; SURGICAL VOLUME; PROVIDER VOLUME; SURGEON VOLUME; REPAIR; MORTALITY; OUTCOMES; OPERATIONS	Background: Experience curve effects were first observed in the industrial arena as demonstrations of the relationship between experience and efficiency. These relationships were largely determined by improvements in management efficiency and quality of care. In the health care industry, volume-outcome relationships have been established with respect to quality of care improvement, but little is known about the effects of experience on management efficiency. Here, we examine the relationship between experience and hospital management in Japanese hospitals. Methods: The study sample comprised individuals who had undergone surgery for unruptured abdominal aortic aneurysms and had been discharged from participant hospitals between April 1, 2006 and December 31, 2008. We analyzed the association between case volume (both at the hospital and surgeon level) and postoperative complications using multilevel logistic regression analysis. Multilevel log-linear regression analyses were performed to investigate the associations between case volume and length of stay (LOS) before and after surgery. Results: We analyzed 909 patients and 849 patients using the hospital-level and surgeon-level analytical models, respectively. The odds ratio of postoperative complication occurrence for an increase of one surgery annually was 0.981 (P<0.001) at the hospital level and 0.982 (P<0.001) at the surgeon level. The log-linear regression analyses showed that shorter postoperative LOS was significantly associated with high hospital-level case volume (coefficient for an increase of one surgery: -0.006, P = 0.009) and surgeon-level case volume (coefficient for an increase of one surgery: -0.011, P = 0.022). Although an increase of one surgery annually at the hospital level was statistically associated with a reduction of preoperative LOS by 1.1% (P = 0.006), there was no significant association detected between surgeon-level case volume and preoperative LOS (P = 0.504). Conclusion: Experience at the hospital level may contribute to the improvement of hospital management efficiency.	[Fukuda, Haruhisa] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Care Adm & Management, Higashi Ku, Fukuoka 812, Japan; [Okuma, Kazuhide; Imanaka, Yuichi] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Healthcare Econ & Qual Management,Sakyo Ku, Kyoto, Japan	Kyushu University; Kyoto University	Imanaka, Y (corresponding author), Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Healthcare Econ & Qual Management,Sakyo Ku, Kyoto, Japan.	imanaka-y@umin.net			JSPS KAKENHI [25253033, 25713029]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 25253033 and 25713029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, RES SCI SURV 2009 AN; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cho JS, 2008, J VASC SURG, V48, P10, DOI 10.1016/j.jvs.2008.02.067; Chowdhury MM, 2007, BRIT J SURG, V94, P145, DOI 10.1002/bjs.5714; Dardik A, 1999, J VASC SURG, V30, P985, DOI 10.1016/S0741-5214(99)70036-4; Dardik A, 1998, J VASC SURG, V28, P413, DOI 10.1016/S0741-5214(98)70126-0; Dimick JB, 2003, J VASC SURG, V38, P739, DOI 10.1016/S0741-5214(03)00470-1; Dimick JB, 2002, ARCH SURG-CHICAGO, V137, P828, DOI 10.1001/archsurg.137.7.828; Dimick JB, 2002, ANN SURG, V235, P579, DOI 10.1097/00000658-200204000-00017; Dueck AD, 2004, J VASC SURG, V39, P1253, DOI 10.1016/j.jvs.2004.02.006; Dueck AD, 2004, J VASC SURG, V39, P1261, DOI 10.1016/j.jvs.2004.02.021; Elixhauser A, 2003, HEALTH AFFAIR, V22, P167, DOI 10.1377/hlthaff.22.2.167; HANNAN EL, 1992, HEALTH SERV RES, V27, P517; Henebiens M, 2007, EUR J VASC ENDOVASC, V33, P285, DOI 10.1016/j.ejvs.2006.10.010; Hill JS, 2008, J VASC SURG, V48, P29, DOI 10.1016/j.jvs.2008.02.048; HIRSCHMANN WB, 1964, HARVARD BUS REV, V42, P125; Holt PJE, 2007, BRIT J SURG, V94, P395, DOI 10.1002/bjs.5710; Kantonen I, 1998, EUR J VASC ENDOVASC, V15, P155, DOI 10.1016/S1078-5884(98)80137-8; Kazmers A, 1996, J VASC SURG, V23, P191, DOI 10.1016/S0741-5214(96)70263-X; Khuri SF, 1999, ANN SURG, V230, P414, DOI 10.1097/00000658-199909000-00014; Killeen SD, 2005, BRIT J SURG, V92, P389, DOI 10.1002/bjs.4954; Killeen SD, 2007, J VASC SURG, V45, P615, DOI 10.1016/j.jvs.2006.11.019; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; Manheim LM, 1998, J VASC SURG, V28, P45, DOI 10.1016/S0741-5214(98)70199-5; Pearce WH, 1999, J VASC SURG, V29, P768, DOI 10.1016/S0741-5214(99)70202-8; Pronovost PJ, 1999, JAMA-J AM MED ASSOC, V281, P1310, DOI 10.1001/jama.281.14.1310; Rigberg DA, 2006, J VASC SURG, V43, P224, DOI 10.1016/j.jvs.2005.10.071; Rutledge R, 1996, ANN SURG, V223, P492, DOI 10.1097/00000658-199605000-00005; Sollano JA, 1999, J THORAC CARDIOV SUR, V117, P419, DOI 10.1016/S0022-5223(99)70320-X; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; The Boston Consulting Group, 1972, PERSP EXP; Tu JV, 2001, J VASC SURG, V33, P447, DOI 10.1067/mva.2001.113487; Ward MM, 2004, J RURAL HEALTH, V20, P344, DOI 10.1111/j.1748-0361.2004.tb00048.x; Wen SW, 1996, J EPIDEMIOL COMMUN H, V50, P207, DOI 10.1136/jech.50.2.207; Young EL, 2007, J VASC SURG, V46, P1287, DOI 10.1016/j.jvs.2007.06.038	35	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e106884	10.1371/journal.pone.0106884	http://dx.doi.org/10.1371/journal.pone.0106884			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ0SJ	25250813	Green Submitted, Green Published, gold			2022-12-25	WOS:000342492700019
J	Lin, H; Wang, Q; Shen, Q; Ma, JW; Fu, JR; Zhao, YH				Lin, Hui; Wang, Qun; Shen, Qi; Ma, Junwei; Fu, Jianrong; Zhao, Yuhua			Engineering Aspergillus oryzae A-4 through the Chromosomal Insertion of Foreign Cellulase Expression Cassette to Improve Conversion of Cellulosic Biomass into Lipids	PLOS ONE			English	Article							SOLID-STATE FERMENTATION; RESISTANCE GENE PTRA; CELL OIL PRODUCTION; WHEAT-STRAW; SACCHARIFICATION; TRANSFORMATION; ENHANCEMENT; PLASMID; PROTEIN; CLONING	A genetic modification scheme was designed for Aspergillus oryzae A-4, a natural cellulosic lipids producer, to enhance its lipid production from biomass by putting the spotlight on improving cellulase secretion. Four cellulase genes were separately expressed in A-4 under the control of hlyA promoter, with the help of the successful development of a chromosomal genetic manipulation system. Comparison of cellulase activities of PCR-positive transformants showed that these transformants integrated with celA gene and with celC gene had significantly (p < 0.05) higher average FPAase activities than those strains integrated with celB gene and with celD gene. Through the assessment of cellulosic lipids accumulating abilities, celA transformant A2-2 and celC transformant D1-B1 were isolated as promising candidates, which could yield 101%-133% and 35.22%-59.57% higher amount of lipids than the reference strain A-4 (WT) under submerged (SmF) conditions and solid-state (SSF) conditions, respectively. Variability in metabolism associated to the introduction of cellulase gene in A2-2 and D1-B1 was subsequently investigated. It was noted that cellulase expression repressed biomass formation but enhanced lipid accumulation; whereas the inhibitory effect on cell growth would be shielded during cellulosic lipids production owing to the essential role of cellulase in substrate utilization. Different metabolic profiles also existed between A2-2 and D1-B1, which could be attributed to not only different transgene but also biological impacts of different integration. Overall, both simultaneous saccharification and lipid accumulation were enhanced in A2-2 and D1-B1, resulting in efficient conversion of cellulose into lipids. A regulation of cellulase secretion in natural cellulosic lipids producers could be a possible strategy to enhance its lipid production from lignocellulosic biomass.	[Lin, Hui; Ma, Junwei; Fu, Jianrong] Zhejiang Acad Agr Sci, Inst Environm Resource & Soil Fertilizer, Hangzhou, Zhejiang, Peoples R China; [Wang, Qun; Shen, Qi; Zhao, Yuhua] Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang Academy of Agricultural Sciences; Zhejiang University	Fu, JR (corresponding author), Zhejiang Acad Agr Sci, Inst Environm Resource & Soil Fertilizer, Hangzhou, Zhejiang, Peoples R China.	fujr@mail.zaas.ac.cn; yhzhao225@zju.edu.cn	Lin, Hui/GQB-0146-2022	Lin, Hui/0000-0002-5446-8069	National Natural Science Foundation of China [31070079, 41271335]; High Technology Research and Development Program of China (863 Program) [2012AA06A203]; National Key Technology R D Program [2012BAC17B04]; Science and Technology Project of Zhejiang Province [2011C13016, 2013C3303]; Environmental Science Project of Zhejiang Province [2012B006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Key Technology R D Program(National Key Technology R&D Program); Science and Technology Project of Zhejiang Province; Environmental Science Project of Zhejiang Province	This study was supported by the National Natural Science Foundation of China (31070079; 41271335), the High Technology Research and Development Program of China (863 Program) (2012AA06A203), and the National Key Technology R & D Program (2012BAC17B04), the Science and Technology Project of Zhejiang Province (2011C13016; 2013C3303), and the Environmental Science Project of Zhejiang Province (2012B006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atabani AE, 2012, RENEW SUST ENERG REV, V16, P2070, DOI 10.1016/j.rser.2012.01.003; Bando H, 2011, APPL MICROBIOL BIOT, V92, P561, DOI 10.1007/s00253-011-3446-5; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Block DHS, 2012, NUCLEIC ACIDS RES, V40, P8979, DOI 10.1093/nar/gks694; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carere CR, 2008, INT J MOL SCI, V9, P1342, DOI 10.3390/ijms9071342; Courchesne NMD, 2009, J BIOTECHNOL, V141, P31, DOI 10.1016/j.jbiotec.2009.02.018; Deng Y, 2011, METAB ENG, V13, P570, DOI 10.1016/j.ymben.2011.06.007; Dey P, 2011, BIORESOURCE TECHNOL, V102, P5815, DOI 10.1016/j.biortech.2011.02.064; Geisseler D, 2009, PEDOBIOLOGIA, V53, P87, DOI 10.1016/j.pedobi.2009.06.002; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; GOMI K, 1987, AGR BIOL CHEM TOKYO, V51, P2549; Gong ZW, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-36; Hetzler S, 2013, APPL ENVIRON MICROB, V79, P5159, DOI 10.1128/AEM.01214-13; Hetzler S, 2013, APPL ENVIRON MICROB, V79, P3122, DOI 10.1128/AEM.03678-12; Kim YS, 2003, ENZYME MICROB TECH, V33, P460, DOI 10.1016/S0141-0229(03)00148-0; Kitamoto N, 1996, APPL MICROBIOL BIOT, V46, P538, DOI 10.1007/s002530050857; Kubodera T, 2000, BIOSCI BIOTECH BIOCH, V64, P1416, DOI 10.1271/bbb.64.1416; Kubodera T, 2002, BIOSCI BIOTECH BIOCH, V66, P404, DOI 10.1271/bbb.66.404; Lin H, 2010, BIORESOURCE TECHNOL, V101, P7556, DOI 10.1016/j.biortech.2010.04.027; Liu W, 2012, BIORESOURCE TECHNOL, V118, P13, DOI 10.1016/j.biortech.2012.05.038; Mabashi Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1882, DOI 10.1271/bbb.60052; Peng XW, 2008, BIORESOURCE TECHNOL, V99, P3885, DOI 10.1016/j.biortech.2007.08.015; Roopesh K, 2006, BIORESOURCE TECHNOL, V97, P506, DOI 10.1016/j.biortech.2005.02.046; Shoji JY, 2005, FEMS MICROBIOL LETT, V244, P41, DOI 10.1016/j.femsle.2005.01.014; SINGH A, 1991, LETT APPL MICROBIOL, V12, P200, DOI 10.1111/j.1472-765X.1991.tb00539.x; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; van Rensburg E, 2012, APPL MICROBIOL BIOT, V96, P197, DOI 10.1007/s00253-012-4037-9; Zhan JM, 2013, BIORESOURCE TECHNOL, V135, P622, DOI 10.1016/j.biortech.2012.08.068; Zhao CH, 2010, METAB ENG, V12, P510, DOI 10.1016/j.ymben.2010.09.001	30	9	10	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108442	10.1371/journal.pone.0108442	http://dx.doi.org/10.1371/journal.pone.0108442			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251435	Green Submitted, Green Published, gold			2022-12-25	WOS:000342492700126
J	Pacak, CA; Hammer, PE; MacKay, AA; Dowd, RP; Wang, KR; Masuzawa, A; Sill, B; McCully, JD; Cowan, DB				Pacak, Christina A.; Hammer, Peter E.; MacKay, Allison A.; Dowd, Rory P.; Wang, Kai-Roy; Masuzawa, Akihiro; Sill, Bjoern; McCully, James D.; Cowan, Douglas B.			Superparamagnetic Iron Oxide Nanoparticles Function as a Long-Term, Multi-Modal Imaging Label for Non-Invasive Tracking of Implanted Progenitor Cells	PLOS ONE			English	Article							MR CONTRAST AGENT; FERRITE PARTICLES; ENHANCED DETECTION; STEM-CELLS; DELIVERY; THERAPY	The purpose of this study was to determine the ability of superparamagnetic iron oxide (SPIO) nanoparticles to function as a long-term tracking label for multi-modal imaging of implanted engineered tissues containing muscle-derived progenitor cells using magnetic resonance imaging (MRI) and X-ray micro-computed tomography (mu CT). SPIO-labeled primary myoblasts were embedded in fibrin sealant and imaged to obtain intensity data by MRI or radio-opacity information by mu CT. Each imaging modality displayed a detection gradient that matched increasing SPIO concentrations. Labeled cells were then incorporated in fibrin sealant, injected into the atrioventricular groove of rat hearts, and imaged in vivo and ex vivo for up to 1 year. Transplanted cells were identified in intact animals and isolated hearts using both imaging modalities. MRI was better able to detect minuscule amounts of SPIO nanoparticles, while mu CT more precisely identified the location of heavilylabeled cells. Histological analyses confirmed that iron oxide particles were confined to viable, skeletal muscle-derived cells in the implant at the expected location based on MRI and mu CT. These analyses showed no evidence of phagocytosis of labeled cells by macrophages or release of nanoparticles from transplanted cells. In conclusion, we established that SPIO nanoparticles function as a sensitive and specific long-term label for MRI and mu CT, respectively. Our findings will enable investigators interested in regenerative therapies to non-invasively and serially acquire complementary, high-resolution images of transplanted cells for one year using a single label.	[Pacak, Christina A.; MacKay, Allison A.; Dowd, Rory P.; Wang, Kai-Roy; Sill, Bjoern; Cowan, Douglas B.] Boston Childrens Hosp, Boston, MA 02115 USA; [Pacak, Christina A.; MacKay, Allison A.; Dowd, Rory P.; Wang, Kai-Roy; Sill, Bjoern; Cowan, Douglas B.] Harvard Univ, Sch Med, Dept Anaesthesia, Boston, MA 02115 USA; [Pacak, Christina A.] Univ Florida, Dept Pediat, Gainesville, FL USA; [Hammer, Peter E.] Boston Childrens Hosp, Boston, MA USA; [Hammer, Peter E.] Harvard Univ, Sch Med, Dept Cardiac Surg, Boston, MA USA; [Masuzawa, Akihiro; McCully, James D.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Masuzawa, Akihiro; McCully, James D.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; State University System of Florida; University of Florida; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Pacak, CA (corresponding author), Boston Childrens Hosp, Boston, MA 02115 USA.	pacakc@ufl.edu	Hammer, Peter/AAK-6134-2021	Cowan, Douglas/0000-0002-6309-2737; Pacak, Christina/0000-0002-7430-124X	National Institutes of Health [HL068915, HL088206]; Medical Research Grant from the Children's Heart Foundation; American Heart Association [12GRNT11910008]; New Researcher Award from the Thrasher Research Fund; Children's Hospital Medical Corporation Anesthesia Foundation; Ryan Family Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068915, R01HL088206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Grant from the Children's Heart Foundation; American Heart Association(American Heart Association); New Researcher Award from the Thrasher Research Fund; Children's Hospital Medical Corporation Anesthesia Foundation; Ryan Family Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by grants from the National Institutes of Health (HL068915 and HL088206 to DBC), a Medical Research Grant from the Children's Heart Foundation (to DBC), a Grant-in-Aid from the American Heart Association (12GRNT11910008 to DBC), a New Researcher Award from the Thrasher Research Fund (to CAP), the Children's Hospital Medical Corporation Anesthesia Foundation, and philanthropic donations to the Cardiac Conduction Fund, the Ryan Family Fund, and by David Pullman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbab AS, 2003, RADIOLOGY, V229, P838, DOI 10.1148/radiol.2293021215; BACON BR, 1987, J LAB CLIN MED, V110, P164; Bartling SH, 2011, INVEST RADIOL, V46, P178, DOI 10.1097/RLI.0b013e318205af53; Boas FE, 2011, RADIOLOGY, V259, P894, DOI 10.1148/radiol.11101782; Bulte JWM, 2004, CURR PHARM BIOTECHNO, V5, P567; Bulte JWM, 2004, NMR BIOMED, V17, P484, DOI 10.1002/nbm.924; Cahill KS, 2004, TRANSPLANTATION, V78, P1626, DOI 10.1097/01.TP.0000145528.51525.8B; Campbell NG, 2012, J CARDIOVASC TRANSL, V5, P713, DOI 10.1007/s12265-012-9378-3; Chen IY, 2009, MOL IMAGING BIOL, V11, P178, DOI 10.1007/s11307-008-0182-z; Choi YH, 2006, AM J PATHOL, V169, P72, DOI 10.2353/ajpath.2006.051163; Cianciaruso C, 2014, NANOMEDICINE-UK, V30, P1; de Rosales RTM, 2011, BIOCONJUGATE CHEM, V22, P455, DOI 10.1021/bc100483k; Emmert MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057759; Engberink RDO, 2007, RADIOLOGY, V243, P467, DOI 10.1148/radiol.2432060120; Frank JA, 2003, RADIOLOGY, V228, P480, DOI 10.1148/radiol.2281020638; GLOVER GH, 1981, MED PHYS, V8, P799, DOI 10.1118/1.595032; Jennings LE, 2009, CHEM COMMUN, P3511, DOI 10.1039/b821903f; Kedziorek DA, 2010, METHODS MOL BIOL, V660, P171, DOI 10.1007/978-1-60761-705-1_11; Kim D, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/15/155101; Nunes SS, 2011, J CARDIOVASC TRANSL, V4, P592, DOI 10.1007/s12265-011-9307-x; Pacak CA., 2009, J VIS EXP, V27; SAINI S, 1987, RADIOLOGY, V162, P217, DOI 10.1148/radiology.162.1.3786766; SAINI S, 1987, RADIOLOGY, V162, P211, DOI 10.1148/radiology.162.1.3786765; Sill B, 2009, J VIS EXP, V28, pe1139; Torrente Y, 2006, FEBS LETT, V580, P5759, DOI 10.1016/j.febslet.2006.09.031; van Tilborg GAF, 2010, BIOCONJUGATE CHEM, V21, P1794, DOI 10.1021/bc100091q; Walter GA, 2004, MAGN RESON MED, V51, P273, DOI 10.1002/mrm.10684; WEISSLEDER R, 1987, AM J ROENTGENOL, V149, P723, DOI 10.2214/ajr.149.4.723; Xiao M, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/3/035101	29	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108695	10.1371/journal.pone.0108695	http://dx.doi.org/10.1371/journal.pone.0108695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250622	gold, Green Published, Green Submitted			2022-12-25	WOS:000342492700149
J	Wang, JJ; Sun, T; Gao, N; Menon, DD; Luo, YX; Gao, Q; Li, X; Wang, W; Zhu, HP; Lv, PX; Liang, ZG; Tao, LX; Liu, XT; Guo, XH				Wang, Jingjing; Sun, Tao; Gao, Ni; Menon, Desmond Dev; Luo, Yanxia; Gao, Qi; Li, Xia; Wang, Wei; Zhu, Huiping; Lv, Pingxin; Liang, Zhigang; Tao, Lixin; Liu, Xiangtong; Guo, Xiuhua			Contourlet Textual Features: Improving the Diagnosis of Solitary Pulmonary Nodules in Two Dimensional CT Images	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; COMPUTER-AIDED DIAGNOSIS; LUNG-CANCER; CURVELET; PROBABILITY; PERFORMANCE; TRANSFORM; WAVELET; SCHEME; MODEL	Objective: To determine the value of contourlet textural features obtained from solitary pulmonary nodules in two dimensional CT images used in diagnoses of lung cancer. Materials and Methods: A total of 6,299 CT images were acquired from 336 patients, with 1,454 benign pulmonary nodule images from 84 patients (50 male, 34 female) and 4,845 malignant from 252 patients (150 male, 102 female). Further to this, nineteen patient information categories, which included seven demographic parameters and twelve morphological features, were also collected. A contourlet was used to extract fourteen types of textural features. These were then used to establish three support vector machine models. One comprised a database constructed of nineteen collected patient information categories, another included contourlet textural features and the third one contained both sets of information. Ten-fold cross-validation was used to evaluate the diagnosis results for the three databases, with sensitivity, specificity, accuracy, the area under the curve (AUC), precision, Youden index, and F-measure were used as the assessment criteria. In addition, the synthetic minority over-sampling technique (SMOTE) was used to preprocess the unbalanced data. Results: Using a database containing textural features and patient information, sensitivity, specificity, accuracy, AUC, precision, Youden index, and F-measure were: 0.95, 0.71, 0.89, 0.89, 0.92, 0.66, and 0.93 respectively. These results were higher than results derived using the database without textural features (0.82, 0.47, 0.74, 0.67, 0.84, 0.29, and 0.83 respectively) as well as the database comprising only textural features (0.81, 0.64, 0.67, 0.72, 0.88, 0.44, and 0.85 respectively). Using the SMOTE as a pre-processing procedure, new balanced database generated, including observations of 5,816 benign ROIs and 5,815 malignant ROIs, and accuracy was 0.93. Conclusion: Our results indicate that the combined contourlet textural features of solitary pulmonary nodules in CT images with patient profile information could potentially improve the diagnosis of lung cancer.	[Wang, Jingjing; Sun, Tao; Gao, Ni; Luo, Yanxia; Gao, Qi; Li, Xia; Wang, Wei; Zhu, Huiping; Tao, Lixin; Liu, Xiangtong; Guo, Xiuhua] Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China; [Wang, Jingjing; Sun, Tao; Gao, Ni; Luo, Yanxia; Gao, Qi; Wang, Wei; Zhu, Huiping; Tao, Lixin; Liu, Xiangtong; Guo, Xiuhua] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China; [Menon, Desmond Dev; Wang, Wei] Edith Cowan Univ, Sch Med Sci, Perth, WA, Australia; [Menon, Desmond Dev] Edith Cowan Univ, Sch Exercise & Hlth Sci, Perth, WA, Australia; [Li, Xia] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland; [Lv, Pingxin] Capital Med Univ, Beijing Chest Hosp, Dept Radiol, Beijing, Peoples R China; [Liang, Zhigang] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China	Capital Medical University; Edith Cowan University; Edith Cowan University; University College Cork; Capital Medical University; Capital Medical University	Guo, XH (corresponding author), Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China.	guoxiuh@ccmu.edu.cn	liu, li/HGC-0900-2022; Gao, Qi/N-8721-2019	wang, wei/0000-0002-1430-1360; Gao, Qi/0000-0002-5370-5536	Natural Science Fund of China [81172772]; Natural Science Fund of Beijing [4112015, 7131002]	Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Beijing(Beijing Natural Science Foundation)	Natural Science Fund of China (serial no.: 81172772) and the Natural Science Fund of Beijing (serial nos.: 4112015 and 7131002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Abrishami V, 2013, BIOINFORMATICS; Al-Azzawi N, 2009, IEEE ENG MED BIO, P5813, DOI 10.1109/IEMBS.2009.5335180; Blagus R, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-106; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Collins LG, 2007, AM FAM PHYSICIAN, V75, P56; Dettori L, 2007, COMPUT BIOL MED, V37, P486, DOI 10.1016/j.compbiomed.2006.08.002; Do MN, 2005, IEEE T IMAGE PROCESS, V14, P2091, DOI 10.1109/TIP.2005.859376; Eltoukhy MM, 2010, COMPUT BIOL MED, V40, P384, DOI 10.1016/j.compbiomed.2010.02.002; Exarchos K, 2014, IEEE J BIOMED HLTH I; Fang YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071114; Filipczuk P, 2013, IEEE T MED IMAGING; Gopinath B, 2013, ASIAN PAC J CANCER P, V14, P97, DOI 10.7314/APJCP.2013.14.1.97; Gould MK, 2007, CHEST, V131, P383, DOI 10.1378/chest.06-1261; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Kovalchik SA, 2013, NEW ENGL J MED, V369, P245, DOI 10.1056/NEJMoa1301851; Lazrag H, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/439597; Li Y, 2011, CLIN LUNG CANCER, V12, P313, DOI 10.1016/j.cllc.2011.06.005; Naik GR, 2010, BIOMED TECH, V55, P301, DOI 10.1515/BMT.2010.038; Paslawski Marek, 2004, Ann Univ Mariae Curie Sklodowska Med, V59, P6; Qu XH, 2012, EUR J RADIOL, V81, P1007, DOI 10.1016/j.ejrad.2011.01.126; Rahimi F, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-53; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Strauss J, 2013, STUD HEALTH TECHNOL, V192, P1024, DOI 10.3233/978-1-61499-289-9-1024; Sun T, 2013, COMPUT METH PROG BIO, V111, P519, DOI 10.1016/j.cmpb.2013.04.016; Sun T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063559; Swaminathan A, 2013, BIOMED ENG-BIOMED TE, V58, P87, DOI 10.1515/bmt-2012-0055; Toloza EM, 2003, CHEST, V123, p137S, DOI 10.1378/chest.123.1_suppl.137S; Wang H, 2010, EUR J RADIOL, V74, P124, DOI 10.1016/j.ejrad.2009.01.024; Wang H, 2011, MED ONCOL, V28, pS613, DOI 10.1007/s12032-010-9663-4; Wang JJ, 2013, ASIAN PAC J CANCER P, V14, P6019, DOI 10.7314/APJCP.2013.14.10.6019; Way TW, 2009, MED PHYS, V36, P3086, DOI 10.1118/1.3140589; Wu HF, 2013, J DIGIT IMAGING, V26, P797, DOI 10.1007/s10278-012-9547-6; Yang HX, 2013, BR J CANC; Zhu YJ, 2010, J DIGIT IMAGING, V23, P51, DOI 10.1007/s10278-009-9185-9	35	3	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108465	10.1371/journal.pone.0108465	http://dx.doi.org/10.1371/journal.pone.0108465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250576	gold, Green Submitted, Green Published			2022-12-25	WOS:000342492700131
J	Farooque, A; Singh, N; Adhikari, JS; Afrin, F; Dwarakanath, BSR				Farooque, Abdullah; Singh, Niharika; Adhikari, Jawahar Singh; Afrin, Farhat; Dwarakanath, Bilikere Srinivasa Rao			Enhanced Antitumor Immunity Contributes to the Radio-Sensitization of Ehrlich Ascites Tumor by the Glycolytic Inhibitor 2-Deoxy-D-Glucose in Mice	PLOS ONE			English	Article							ADOPTIVE CELL TRANSFER; REGULATORY T-CELLS; OXIDATIVE STRESS; CANCER-THERAPY; IONIZING IRRADIATION; GAMMA-IRRADIATION; RADIATION; APOPTOSIS; RESPONSES; OPTIMIZATION	Two-deoxy-D-glucose (2-DG), an inhibitor of glycolysis differentially enhances the radiation and chemotherapeutic drug induced cell death in cancer cells in vitro, while the local tumor control (tumor regression) following systemic administration of 2-DG and focal irradiation of the tumor results in both complete (cure) and partial response in a fraction of the tumor bearing mice. In the present studies, we investigated the effects of systemically administered 2-DG and focal irradiation of the tumor on the immune system in Ehrlich ascites tumor (EAT) bearing Strain "A" mice. Markers of different immune cells were analyzed by immune-flow cytometry and secretary cytokines by ELISA, besides monitoring tumor growth. Increase in the expression of innate (NK and monocytes) and adaptive CD4(+) cells, and a decrease in B cells (CD19) have been observed after the combined treatment, suggestive of activation of anti-tumor immune response. Interestingly, immature dendritic cells were found to be down regulated, while their functional markers CD86 and MHC II were up regulated in the remaining dendritic cells following the combination treatment. Similarly, decrease in the CD4(+) naive cells with concomitant increase in activated CD4+ cells corroborated the immune activation. Further, a shift from Th2 and Th17 to Th1 besides a decrease in inflammatory cytokines was also observed in the animals showing complete response (cure; tumor free survival). This shift was also complimented by respective antibody class switching followed by the combined treatment. The immune activation or alteration in the homeostasis favoring antitumor immune response may be due to depletion in T regulatory cells (CD4(+) CD25(+) FoxP3(+)). Altogether, these results suggest that early differential immune activation is responsible for the heterogenous response to the combined treatment. Taken together, these studies for the first time provided insight into the additional mechanisms underlying radio-sensitization by 2-DG in vivo by unraveling its potential as an immune-modulator besides direct effects on the tumor.	[Farooque, Abdullah; Singh, Niharika; Adhikari, Jawahar Singh; Dwarakanath, Bilikere Srinivasa Rao] Inst Nucl Med & Allied Sci, Div Radiat Biosci, Delhi, India; [Afrin, Farhat] Jamia Hamdard, Dept Biotechnol, Delhi, India	Defence Research & Development Organisation (DRDO); Institute of Nuclear Medicine & Allied Sciences (INMAS); Jamia Hamdard University	Dwarakanath, BSR (corresponding author), Inst Nucl Med & Allied Sci, Div Radiat Biosci, Brig SK Mazumdar Marg, Delhi, India.	bsd@inmas.drdo.in	Afrin, Farhat/F-2346-2018; SINGH, NIHARIKA/GQH-0296-2022	Afrin, Farhat/0000-0003-4443-4284; Dwarakanath, Bilikere S./0000-0001-6988-2601	Defence Research and Development Organization (DRDO), Government of India [INM-301, INM-311]; Indian Council of Medical Research (ICMR), Government of India	Defence Research and Development Organization (DRDO), Government of India(Defence Research & Development Organisation (DRDO)); Indian Council of Medical Research (ICMR), Government of India(Indian Council of Medical Research (ICMR))	This work was supported by grants INM-301 and INM-311 from Defence Research and Development Organization (DRDO), Government of India. AF was recipient of a fellowship from Indian Council of Medical Research (ICMR), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataera H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017515; Bracci L, 2014, CELL DEATH DIFFER, V21, P15, DOI 10.1038/cdd.2013.67; Byrne WL, 2011, CANCER RES, V71, P6915, DOI 10.1158/0008-5472.CAN-11-1156; Chen K, 2011, J BIOL CHEM, V286, P21993, DOI 10.1074/jbc.M111.225805; Curiel TJ, 2008, CURR OPIN IMMUNOL, V20, P241, DOI 10.1016/j.coi.2008.04.008; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Dreau D, 2000, J INTERF CYTOK RES, V20, P247, DOI 10.1089/107999000312667; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dwarakanath B. S., 1999, Indian Journal of Experimental Biology, V37, P865; Dwarakanath BS, 2005, BIOMEDICINE, V24, P36; Dwarakanath BS, 1990, P IND S MOL MECH UND, P107; DWARAKANATH BSR, 1987, INT J RADIAT ONCOL, V13, P741; DWARKANATH BS, 1989, INT J RADIAT ONCOL, V17, P1033, DOI 10.1016/0360-3016(89)90152-1; Dwarkanath BS, 2001, INT J RADIAT ONCOL, V50, P1051, DOI 10.1016/S0360-3016(01)01534-6; Elpek KG, 2007, J IMMUNOL, V178, P6840; Farooque A, 2009, J CANCER RES THER, V5, P32, DOI 10.4103/0973-1482.55138; Fedorocko P, 2002, INT J RADIAT BIOL, V78, P305, DOI 10.1080/09553000110104614; Formenti SC, 2009, LANCET ONCOL, V10, P718, DOI 10.1016/S1470-2045(09)70082-8; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Frey B, 2012, CURR MED CHEM, V19, P1751, DOI 10.2174/092986712800099811; Frey B, 2014, CANCER IMMUNOL IMMUN, V63, P29, DOI 10.1007/s00262-013-1474-y; Gupta S, 2005, CANCER BIOL THER, V4, P87; Gupta S, 2009, J CANCER RES THER, V5, P16, DOI 10.4103/0973-1482.55135; HUME DA, 1978, BIOCHEM J, V174, P703, DOI 10.1042/bj1740703; Igney FH, 2002, J LEUKOCYTE BIOL, V71, P907; Jain V, 1996, IND J NUCL MED, V11, P8; JAIN VK, 1979, INDIAN J EXP BIOL, V17, P1320; JAIN VK, 1977, INDIAN J EXP BIOL, V15, P714; Jelluma N, 2006, MOL CANCER RES, V4, P319, DOI 10.1158/1541-7786.MCR-05-0061; JHA B, 1992, INT J RADIAT BIOL, V62, P409, DOI 10.1080/09553009214552291; KALIA VK, 1982, INDIAN J EXP BIOL, V20, P884; Kanterman J, 2012, SEMIN CANCER BIOL, V22, P307, DOI 10.1016/j.semcancer.2012.02.008; KAPLAN O, 1990, CANCER RES, V50, P544; Khaitan D, 2006, CANCER BIOL THER, V5, P1142, DOI 10.4161/cbt.5.9.2986; Kidd Parris, 2003, Altern Med Rev, V8, P223; Kim R, 2006, CLIN EXP IMMUNOL, V146, P189, DOI 10.1111/j.1365-2249.2006.03215.x; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Liu X, 1997, J BIOL CHEM, V272, P11690, DOI 10.1074/jbc.272.18.11690; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Lumniczky K, 2015, CANCER LETT, V356, P114, DOI 10.1016/j.canlet.2013.08.024; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Marko AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015425; Mohanti BK, 1996, INT J RADIAT ONCOL, V35, P103, DOI 10.1016/S0360-3016(96)85017-6; Nomura K, 1999, J BIOL CHEM, V274, P29294, DOI 10.1074/jbc.274.41.29294; Ozben T, 2007, J PHARM SCI-US, V96, P2181, DOI 10.1002/jps.20874; PUROHIT SC, 1982, INT J RADIAT ONCOL, V8, P495, DOI 10.1016/0360-3016(82)90669-1; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Rubner Y, 2012, FRONT ONCOL, V2, P1, DOI [10.3389/fonc.2012.00075, 10.2389/fonc.2012.00075]; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; Singh DH, 2005, STRAHLENTHER ONKOL, V181, P507, DOI 10.1007/s00066-005-1320-z; SINGH SP, 1990, INT J RADIAT BIOL, V58, P791, DOI 10.1080/09553009014552171; Spano D, 2012, CLIN EXP METASTAS, V29, P381, DOI 10.1007/s10585-012-9457-5; Spitz DR, 2000, ANN NY ACAD SCI, V899, P349, DOI 10.1111/j.1749-6632.2000.tb06199.x; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Stoitzner P, 2008, CANCER IMMUNOL IMMUN, V57, P1665, DOI 10.1007/s00262-008-0487-4; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Sun JC, 2009, EUR J IMMUNOL, V39, P2059, DOI 10.1002/eji.200939435; Swamy R. K., 2005, Indian Journal of Experimental Biology, V43, P686; Terme M, 2008, NAT IMMUNOL, V9, P486, DOI 10.1038/ni1580; Venkatachalam P., 2007, International Journal of Human Genetics, V7, P307; Venkataramanaa Neelam K, 2013, Asian J Neurosurg, V8, P9, DOI 10.4103/1793-5482.110274; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Warburg O, 1924, BIOCHEM Z, V152, P319; Workman P, 1998, BRIT J CANCER, V77, P1; Zitvogel L, 2008, J CLIN INVEST, V118, P1991, DOI 10.1172/JCI35180	68	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108131	10.1371/journal.pone.0108131	http://dx.doi.org/10.1371/journal.pone.0108131			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25248151	Green Published, Green Submitted, gold			2022-12-25	WOS:000342351800066
J	Sarkar, S; Pandya, P; Bhadra, K				Sarkar, Sarita; Pandya, Prateek; Bhadra, Kakali			Sequence Specific Binding of Beta Carboline Alkaloid Harmalol with Deoxyribonucleotides: Binding Heterogeneity, Conformational, Thermodynamic and Cytotoxic Aspects	PLOS ONE			English	Article							ISOTHERMAL TITRATION CALORIMETRY; DRUG-DNA INTERACTIONS; SMALL MOLECULES; COOPERATIVE BINDING; BASE COMPOSITION; GAMMA-CARBOLINE; IONIC-STRENGTH; NUCLEIC-ACIDS; M-AMSA; DERIVATIVES	Background: Base dependent binding of the cytotoxic alkaloid harmalol to four synthetic polynucleotides, poly(dA).poly(dT), poly(dA-dT).poly(dA-dT), poly(dG).poly(dC) and poly(dG-dC).poly(dG-dC) was examined by various photophysical and calorimetric studies, and molecular docking. Methodology/Principal Findings: Binding data obtained from absorbance according to neighbor exclusion model indicated that the binding constant decreased in the order poly(dG-dC).poly(dG-dC)>poly(dA-dT).poly(dA-dT)>poly(dA).poly(dT)>poly(dG).poly(dC). The same trend was shown by the competition dialysis, change in fluorescence steady state intensity, stabilization against thermal denaturation, increase in the specific viscosity and perturbations in circular dichroism spectra. Among the polynucleotides, poly(dA).poly(dT) and poly(dG).poly(dC) showed positive cooperativity where as poly(dG-dC).poly(dG-dC) and poly(dA-dT).poly(dA-dT) showed non cooperative binding. Isothermal calorimetric data on the other hand showed enthalpy driven exothermic binding with a hydrophobic contribution to the binding Gibbs energy with poly(dG-dC).poly(dG-dC), and poly(dA-dT).poly(dA-dT) where as harmalol with poly(dA).poly(dT) showed entropy driven endothermic binding and with poly(dG).poly(dC) it was reported to be entropy driven exothermic binding. The study also tested the in vitro chemotherapeutic potential of harmalol in HeLa, MDA-MB-231, A549, and HepG2 cell line by MTT assay. Conclusions/Significance: Studies unequivocally established that harmalol binds strongly with hetero GC polymer by mechanism of intercalation where the alkaloid resists complete overlap to the DNA base pairs inside the intercalation cavity and showed maximum cytotoxicity on HepG2 with IC50 value of 14 mu M. The results contribute to the understanding of binding, specificity, energetic, cytotoxicity and docking of harmalol-DNA complexation that will guide synthetic efforts of medicinal chemists for developing better therapeutic agents.	[Sarkar, Sarita; Pandya, Prateek; Bhadra, Kakali] Univ Kalyani, Dept Zool, Nadia, W Bengal, India	Kalyani University	Bhadra, K (corresponding author), Univ Kalyani, Dept Zool, Nadia, W Bengal, India.	kakali_bhadra2004@yahoo.com	Pandya, Prateek/G-5915-2010	Pandya, Prateek/0000-0001-7257-3754	Council of Scientific and Industrial Research (CSIR), Government of India [37 (1538)/12/EMR-II]; CSIR; DST-PURSE	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); DST-PURSE	KB is indebted to the Council of Scientific and Industrial Research (CSIR), Government of India for the financial support (Ref. No. 37 (1538)/12/EMR-II). SS is supported by grants from the CSIR project. Authors are also grateful to DST-PURSE 2013-14 for their partial financial support. The authors thank Prof. Gopal Chakraborty, University of Calcutta, DBT-CU-IPLS Core facility, for providing ITC facilities. PP is indebted to Dr. D. S. Kothari, PDF No. F.4-2/2006(BSR)/13-557/2011. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alomar ML, 2014, J PHOTOCH PHOTOBIO B, V136, P26, DOI 10.1016/j.jphotobiol.2014.04.017; Basu P, 2014, J PHOTOCH PHOTOBIO B, V138, P282, DOI 10.1016/j.jphotobiol.2014.06.005; Bhadra K, 2007, BBA-GEN SUBJECTS, V1770, P1071, DOI 10.1016/j.bbagen.2007.03.001; Bhadra K, 2008, BBA-GEN SUBJECTS, V1780, P1054, DOI 10.1016/j.bbagen.2008.05.005; Bhadra K, 2011, MED RES REV, V31, P821, DOI 10.1002/med.20202; Biondic CM, 1993, J CHEM SOC P2, V2, P887; Bohne C, 2005, J AM CHEM SOC, V127, P76, DOI 10.1021/ja046189m; BRESLAUER KJ, 1987, P NATL ACAD SCI USA, V84, P8922, DOI 10.1073/pnas.84.24.8922; Brien R O', 2004, BIOCALORIMETRY; Butler M., 2004, ANIMAL CELL CULTURE, V2nd edn; Buurma NJ, 2007, METHODS, V42, P162, DOI 10.1016/j.ymeth.2007.01.010; Cao RH, 2007, CURR MED CHEM, V14, P479, DOI 10.2174/092986707779940998; Chaires JB, 1997, BIOPOLYMERS, V44, P201, DOI 10.1002/(SICI)1097-0282(1997)44:3<201::AID-BIP2>3.0.CO;2-Z; CHAIRES JB, 1983, BIOCHEMISTRY-US, V22, P4204, DOI 10.1021/bi00287a007; CHAIRES JB, 1982, BIOCHEMISTRY-US, V21, P3933, DOI 10.1021/bi00260a005; Chaires Jonathan B., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P339, DOI 10.2174/1568011054222292; Chang MW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011955; DEMEESTER C, 1995, MUTAT RES-REV GENET, V339, P139, DOI 10.1016/0165-1110(95)90008-X; Dervan PB, 2001, BIOORGAN MED CHEM, V9, P2215, DOI 10.1016/S0968-0896(01)00262-0; Du W, 2005, BIOCHEM BIOPH RES CO, V338, P1557; DUPORTAIL G, 1981, INT J BIOL MACROMOL, V3, P188, DOI 10.1016/0141-8130(81)90062-3; El Gendy MAM, 2012, FOOD CHEM TOXICOL, V50, P353, DOI 10.1016/j.fct.2011.10.052; ELMORE RH, 1988, NUCLEIC ACIDS RES, V16, P9707, DOI 10.1093/nar/16.20.9707; Funayama Y, 1996, MUTAT RES-FUND MOL M, V349, P183, DOI 10.1016/0027-5107(95)00176-X; Glennon RA, 2000, DRUG ALCOHOL DEPEN, V60, P121, DOI 10.1016/S0376-8716(99)00148-9; GRAVES DE, 1983, BIOCHEMISTRY-US, V22, P3941, DOI 10.1021/bi00285a033; Guan HJ, 2006, BIOCHEM BIOPH RES CO, V342, P894, DOI 10.1016/j.bbrc.2006.02.035; Guthrie KM, 2007, BIOPHYS CHEM, V126, P117, DOI 10.1016/j.bpc.2006.05.006; HA JH, 1989, J MOL BIOL, V209, P801, DOI 10.1016/0022-2836(89)90608-6; Haq I, 2002, ARCH BIOCHEM BIOPHYS, V403, P1, DOI 10.1016/S0003-9861(02)00202-3; HAYASHI K, 1977, NUCLEIC ACIDS RES, V4, P3679, DOI 10.1093/nar/4.11.3679; HERRERA JE, 1989, BIOCHEMISTRY-US, V28, P1993, DOI 10.1021/bi00431a006; HOGAN M, 1979, NATURE, V278, P521, DOI 10.1038/278521a0; Hossain M, 2008, DNA CELL BIOL, V27, P81, DOI 10.1089/dna.2007.0652; Hurley LH, 2001, BIOCHEM SOC T, V29, P692, DOI 10.1042/0300-5127:0290692; Islam MM, 2013, DYES PIGMENTS, V99, P412, DOI 10.1016/j.dyepig.2013.05.028; Islam MM, 2009, J PHYS CHEM B, V113, P1210, DOI 10.1021/jp806597w; JONES RL, 1986, BIOCHEMISTRY-US, V25, P7431, DOI 10.1021/bi00371a027; Kim H, 1997, ARCH BIOCHEM BIOPHYS, V337, P137, DOI 10.1006/abbi.1996.9771; Lamchouri F, 1999, THERAPIE, V54, P753; Maiti M, 2007, MED RES REV, V27, P649, DOI 10.1002/med.20087; MARKY LA, 1990, BIOCHEMISTRY-US, V29, P4805, DOI 10.1021/bi00472a009; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Moura DJ, 2007, MUTAGENESIS, V22, P293, DOI 10.1093/mutage/gem016; Nafisi S, 2010, J PHOTOCH PHOTOBIO B, V100, P84, DOI 10.1016/j.jphotobiol.2010.05.005; Neidle S, 2001, NAT PROD REP, V18, P291, DOI 10.1039/a705982e; Neidle S., 1981, MOL ASPECTS ANTICANC; Pandya P, 2010, J CHEM SCI, V122, P247, DOI 10.1007/s12039-010-0029-4; Patel K., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P660, DOI 10.1016/S2221-1691(12)60116-6; PEZZUTO JM, 1980, P NATL ACAD SCI-BIOL, V77, P1427, DOI 10.1073/pnas.77.3.1427; Qu XG, 2000, P NATL ACAD SCI USA, V97, P12032, DOI 10.1073/pnas.200221397; Remsen JF, 1979, BIOCHEM BIOPH RES CO, V86, P135; Ren JS, 2000, BIOCHEMISTRY-US, V39, P8439, DOI 10.1021/bi000474a; Ren JS, 1999, BIOCHEMISTRY-US, V38, P16067, DOI 10.1021/bi992070s; ROSENBERG LS, 1986, BIOCHEMISTRY-US, V25, P1002, DOI 10.1021/bi00353a008; Saboury AA, 2006, J IRAN CHEM SOC, V3, P1, DOI 10.1007/BF03245784; Saenger W, 1993, PRINCIPLES NUCL ACID; Sarkar S, 2014, J PHOTOCH PHOTOBIO B, V130, P272, DOI 10.1016/j.jphotobiol.2013.11.021; SCARIA PV, 1991, J BIOL CHEM, V266, P5417; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Sen A, 1996, BIOPHYS CHEM, V59, P155, DOI 10.1016/0301-4622(95)00137-9; Sinha R, 2006, BIOORGAN MED CHEM, V14, P800, DOI 10.1016/j.bmc.2005.09.007; Taira Z, 1997, JPN J TOX ENV HEALTH, V43, P83; Takatsuka Y, 2010, P NATL ACAD SCI USA, V107, P6559, DOI 10.1073/pnas.1001460107; Tang FQ, 2009, J BIOL CHEM, V284, P27456, DOI 10.1074/jbc.M109.033795; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; TWEEDIE DJ, 1987, DRUG METAB DISPOS, V15, P74; Uezono T, 2001, J NEURAL TRANSM, V108, P943, DOI 10.1007/s007020170014; WADKINS RM, 1989, NUCLEIC ACIDS RES, V17, P9933, DOI 10.1093/nar/17.23.9933; WARING MJ, 1981, ANNU REV BIOCHEM, V50, P159, DOI 10.1146/annurev.bi.50.070181.001111; WILSON WD, 1985, BIOCHEMISTRY-US, V24, P3991, DOI 10.1021/bi00336a029; Xiao SL, 2001, BIOORG MED CHEM LETT, V11, P437, DOI 10.1016/S0960-894X(00)00679-X	73	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108022	10.1371/journal.pone.0108022	http://dx.doi.org/10.1371/journal.pone.0108022			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247695	Green Published, Green Submitted, gold			2022-12-25	WOS:000342351800054
J	Allen, BL; Leung, LKP				Allen, Benjamin L.; Leung, Luke K. -P.			The (Non)Effects of Lethal Population Control on the Diet of Australian Dingoes	PLOS ONE			English	Article							FLUCTUATING PREY POPULATIONS; NEW-SOUTH-WALES; NICHE OVERLAP; WILD DOGS; WESTERN-AUSTRALIA; EASTERN AUSTRALIA; FEEDING-BEHAVIOR; TOP-PREDATOR; CARNIVORES; ECOLOGY	Top-predators contribute to ecosystem resilience, yet individuals or populations are often subject to lethal control to protect livestock, managed game or humans from predation. Such management actions sometimes attract concern that lethal control might affect top-predator function in ways ultimately detrimental to biodiversity conservation. The primary function of a predator is predation, which is often investigated by assessing their diet. We therefore use data on prey remains found in 4,298 Australian dingo scats systematically collected from three arid sites over a four year period to experimentally assess the effects of repeated broad-scale poison-baiting programs on dingo diet. Indices of dingo dietary diversity and similarity were either identical or near-identical in baited and adjacent unbaited treatment areas in each case, demonstrating no control-induced change to dingo diets. Associated studies on dingoes' movement behaviour and interactions with sympatric mesopredators were similarly unaffected by poison-baiting. These results indicate that mid-sized top-predators with flexible and generalist diets (such as dingoes) may be resilient to ongoing and moderate levels of population control without substantial alteration of their diets and other related aspects of their ecological function.	[Allen, Benjamin L.; Leung, Luke K. -P.] Univ Queensland, Sch Agr & Food Sci, Gatton, Qld, Australia	University of Queensland	Allen, BL (corresponding author), Biosecur Queensland, Robert Wicks Pest Anim Res Ctr, Toowoomba, Qld, Australia.	benjamin.allen@daff.qld.gov.au	Allen, Benjamin L./H-3066-2019	Allen, Benjamin L./0000-0002-1533-0163; Leung, Luke/0000-0002-8829-4925	Caring for Our Country; Natural Heritage Trust government; South Australian Arid Lands Natural Resources Management Board	Caring for Our Country; Natural Heritage Trust government; South Australian Arid Lands Natural Resources Management Board	Funding for components of this study was provided by the Caring for Our Country and Natural Heritage Trust government funding programs. Some of this funding was administered by the South Australian Arid Lands Natural Resources Management Board. These funding bodies had no role in the design, implementation, analysis or publication of this study.	Allen B., 2011, Australian Mammalogy, V33, P68, DOI 10.1071/AM10032; Allen BL, 2013, AUST VET J, V91, P261, DOI 10.1111/avj.12075; Allen BL, 2014, ENVIRON SCI POLLUT R, V21, P2178, DOI 10.1007/s11356-013-2118-7; Allen BL, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-39; Allen BL, 2012, AUST MAMMAL, V34, P251, DOI 10.1071/AM12012; Allen BL, 2012, AUST J ZOOL, V60, P137, DOI 10.1071/ZO12038; Allen Benjamin L., 2012, P79; Allen BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036426; Allen BL, AUSTRALASIAN J ENV M; Allen BL, FRONTIERS ZOOLOGY, Vxx, pxx; Allen BL, 2011, EFFICACY PARA AMINOP; Allen L. R., 2009, TECHNICAL HIGHLIGHTS, P61; Allen LR., 2013, IMPACT WILD DOG PRED; Allen LR, 2010, RESULTS WILD DOG MOV; Barrett G.W., 2003, NEW ATLAS AUSTR BIRD; Brillouin L., 1956, SCI INFORM THEORY; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; Brunner H, 2002, HAID ID INTERACTIVE; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; Carbone C, 2007, PLOS BIOL, V5, P363, DOI 10.1371/journal.pbio.0050022; CAUGHLEY G, 1980, AUST WILDLIFE RES, V7, P1, DOI 10.1071/WR9800001; Claridge AW, 2009, FOREST ECOL MANAG, V258, P814, DOI 10.1016/j.foreco.2009.05.030; Cogger H., 2014, REPTILES AMPHIBIANS; CORBETT L, 1995, WILDLIFE RES, V22, P65, DOI 10.1071/WR9950065; Corbett L. K., 2001, DINGO AUSTR ASIA; CORBETT LK, 1987, OECOLOGIA, V74, P215, DOI 10.1007/BF00379362; Cupples JB, 2011, J MAMMAL, V92, P590, DOI 10.1644/10-MAMM-A-164.1; DEH, 2009, 2010 COMM KANG HARV; Denny E., 2010, REV CAT ECOLOGY MANA; Di Marco M, 2014, CONSERV BIOL, V28, P1109, DOI 10.1111/cobi.12249; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fleming P. J. S., 2014, CARNIVORES AUSTR PRE, P105; Fleming PJS, 2012, AUST MAMMAL, V34, P119, DOI 10.1071/AM11012; Freedman AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004016; GITTLEMAN JL, 1982, BEHAV ECOL SOCIOBIOL, V10, P57, DOI 10.1007/BF00296396; Glen A. S., 2006, Australian Mammalogy, V28, P101; Glen AS, 2008, J APPL ECOL, V45, P700, DOI 10.1111/j.1365-2664.2007.01449.x; Glen AS, 2011, AUSTRAL ECOL, V36, P290, DOI 10.1111/j.1442-9993.2010.02149.x; Haber GC, 1996, CONSERV BIOL, V10, P1068, DOI 10.1046/j.1523-1739.1996.10041068.x; Hayes RD, 2003, WILDLIFE MONOGR, P1; Hayward MW, 2006, J MAMMAL, V87, P1122, DOI 10.1644/05-MAMM-A-304R2.1; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; Hone J, 2010, J APPL ECOL, V47, P507, DOI 10.1111/j.1365-2664.2010.01812.x; JOHNSON C, 2006, AUSTR MAMMAL EXTINCT; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; Kruuk H., 1989, SOCIAL BADGER; Kutsche F, 2003, FIELD GUIDE PLANTS O; Letnic M, 2011, ECOGRAPHY, V34, P827, DOI 10.1111/j.1600-0587.2010.06516.x; MARSACK P, 1990, AUST WILDLIFE RES, V17, P349, DOI 10.1071/WR9900349; Martin TG, 2011, PRIORITY THREAT MANA; Mech LD, 2010, J WILDLIFE MANAGE, V74, P1421, DOI 10.2193/2009-540; Mech LD., 1970, WOLF ECOLOGY BEHAV E; Mitchell BD, 2005, AUSTRAL ECOL, V30, P581, DOI 10.1111/j.1442-9993.2005.01473.x; Newsome AE, 2001, RANGELAND J, V23, P71, DOI 10.1071/RJ01015; NEWSOME AE, 1983, AUST J ECOL, V8, P345, DOI 10.1111/j.1442-9993.1983.tb01332.x; Newsome TM, 2014, J MAMMAL, V95, P392, DOI 10.1644/13-MAMM-A-145.1; Newsome TM, 2014, OECOLOGIA, V175, P139, DOI 10.1007/s00442-014-2889-7; Newsome TM, 2013, ECOGRAPHY, V36, P914, DOI 10.1111/j.1600-0587.2013.00056.x; Newsome TM, 2011, RESOURCES BOOM LEARN; Ordiz A, 2013, BIOL CONSERV, V168, P128, DOI 10.1016/j.biocon.2013.09.024; Pascoe JH, 2011, AUST J ZOOL, V59, P295, DOI 10.1071/ZO11082; PIANKA ER, 1974, P NATL ACAD SCI USA, V71, P2141, DOI 10.1073/pnas.71.5.2141; Purcell B.V., 2009, ORDER PACK ECOLOGY C; Purcell Brad, 2010, P1; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; ROBERTSHAW JD, 1986, AUST WILDLIFE RES, V13, P141, DOI 10.1071/WR9860141; THOMSON PC, 1992, WILDLIFE RES, V19, P531, DOI 10.1071/WR9920531; Triggs B., 2004, TRACKS SCATS OTHER T; Van Dyck S, 2008, MAMMALS AUSTR; Wallach AD, 2010, ECOL LETT, V13, P1008, DOI 10.1111/j.1461-0248.2010.01492.x; Wallach AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006861; West P., 2008, ASSESSING INVASIVE A; Winterbach HEK, 2013, MAMMAL REV, V43, P89, DOI 10.1111/j.1365-2907.2011.00209.x; Yelland L., 2012, HOLDING LINE HIST S	74	17	19	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e108251	10.1371/journal.pone.0108251	http://dx.doi.org/10.1371/journal.pone.0108251			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243466	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000343679800079
J	Naylor, AJ; McGettrick, HM; Maynard, WD; May, P; Barone, F; Croft, AP; Egginton, S; Buckley, CD				Naylor, Amy J.; McGettrick, Helen M.; Maynard, William D.; May, Philippa; Barone, Francesca; Croft, Adam P.; Egginton, Stuart; Buckley, Christopher D.			A Differential Role for CD248 (Endosialin) in PDGF-Mediated Skeletal Muscle Angiogenesis	PLOS ONE			English	Article							BLOOD-VESSEL FORMATION; ENDOTHELIAL-CELLS; PERICYTE LOSS; GROWTH-FACTOR; IN-VIVO; MICE; MARKER; TUMORS; BETA; ANGIOPOIETINS	CD248 (Endosialin) is a type 1 membrane protein involved in developmental and pathological angiogenesis through its expression on pericytes and regulation of PDGFR beta signalling. Here we explore the function of CD248 in skeletal muscle angiogenesis. Two distinct forms of capillary growth (splitting and sprouting) can be induced separately by increasing microcirculatory shear stress (chronic vasodilator treatment) or by inducing functional overload (extirpation of a synergistic muscle). We show that CD248 is present on pericytes in muscle and that CD248(-/-) mice have a specific defect in capillary sprouting. In contrast, splitting angiogenesis is independent of CD248 expression. Endothelial cells respond to prosprouting angiogenic stimulus by up-regulating gene expression for HIF1 alpha, angiopoietin 2 and its receptor TEK, PDGF-B and its receptor PDGFR beta; this response did not occur following a pro-splitting angiogenic stimulus. In wildtype mice, defective sprouting angiogenesis could be mimicked by blocking PDGFR beta signalling using the tyrosine kinase inhibitor Imatinib mesylate. We conclude that CD248 is required for PDGFR beta-dependant capillary sprouting but not splitting angiogenesis, and identify a new role for CD248 expressed on pericytes in the early stages of physiological angiogenesis during muscle remodelling.	[Naylor, Amy J.; McGettrick, Helen M.; Maynard, William D.; May, Philippa; Barone, Francesca; Croft, Adam P.; Buckley, Christopher D.] Univ Birmingham, Ctr Translat Inflammat Res, Rheumatol Res Grp, Birmingham, W Midlands, England; [McGettrick, Helen M.; Buckley, Christopher D.] Univ Birmingham, Syst Sci Hlth, Birmingham, W Midlands, England; [Egginton, Stuart] Univ Leeds, Fac Biol Sci, Leeds, W Yorkshire, England	University of Birmingham; University of Birmingham; University of Leeds	Buckley, CD (corresponding author), Univ Birmingham, Ctr Translat Inflammat Res, Rheumatol Res Grp, Birmingham, W Midlands, England.	c.d.buckley@bham.ac.uk	Buckley, Christopher/AAN-6378-2021; McGettrick, Helen M/H-3442-2011; Croft, Adam/AAN-1900-2021	Buckley, Christopher/0000-0001-6924-6402; McGettrick, Helen M/0000-0002-5950-8840; Croft, Adam/0000-0002-9487-0511; Naylor, Amy/0000-0001-8384-8215; Egginton, Stuart/0000-0002-3084-9692; Barone, Francesca/0000-0002-5287-9614	Arthritis Research UK [19791, 19899]; Systems Science for Health Initiative, University of Birmingham [5212]; Arthur Thomson Trust; British Heart Foundation [PG/08/018/24599]; Versus Arthritis [19899, 19791] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Systems Science for Health Initiative, University of Birmingham; Arthur Thomson Trust; British Heart Foundation(British Heart Foundation); Versus Arthritis(Versus Arthritis)	AJN was supported by Arthritis Research UK Programme Grant (19791), HMM was supported by Arthritis Research UK Career Development Fellowship (19899) and the Systems Science for Health Initiative, University of Birmingham (5212). WDM and PM were supported by the Arthur Thomson Trust. SE was supported by a grant from the British Heart Foundation PG/08/018/24599. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Bagley RG, 2008, MICROVASC RES, V76, P180, DOI 10.1016/j.mvr.2008.07.008; BEITZ JG, 1991, P NATL ACAD SCI USA, V88, P2021, DOI 10.1073/pnas.88.5.2021; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Betsholtz C, 2004, CYTOKINE GROWTH F R, V15, P215, DOI 10.1016/j.cytogfr.2004.03.005; Carson-Walter EB, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-417; Chislock EM, 2013, P NATL ACAD SCI US; Dolznig Helmut, 2005, Cancer Immun, V5, P10; Egginton S, 1996, MICROVASC RES, V51, P213, DOI 10.1006/mvre.1996.0022; Egginton S, 2000, ADV EXP MED BIOL, V476, P81; Egginton S, 2001, CARDIOVASC RES, V49, P634, DOI 10.1016/S0008-6363(00)00282-0; Egginton S., 1990, ADV COMP ENV PHYSL, V6, P73; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; HUDLICKA O, 1991, J PHYSIOL-LONDON, V444, P1; HUDLICKA O, 1992, PHYSIOL REV, V72, P369, DOI 10.1152/physrev.1992.72.2.369; Kim CH, 2002, CIRC RES, V90, pE25, DOI 10.1161/hh0202.104923; Kimura Y, 2007, CANCER BIOL THER, V6, P1763, DOI 10.4161/cbt.6.11.4854; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; MacFadyen JR, 2005, FEBS LETT, V579, P2569, DOI 10.1016/j.febslet.2005.03.071; Maia M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-162; Nanda A, 2006, P NATL ACAD SCI USA, V103, P3351, DOI 10.1073/pnas.0511306103; RETTIG WJ, 1992, P NATL ACAD SCI USA, V89, P10832, DOI 10.1073/pnas.89.22.10832; Ribatti D, 2011, INT J DEV BIOL, V55, P261, DOI 10.1387/ijdb.103167dr; Schultheis B, 2012, LEUKEMIA RES, V36, P271, DOI 10.1016/j.leukres.2011.09.025; Simon MP, 2008, J CELL PHYSIOL, V217, P809, DOI 10.1002/jcp.21558; Simonavicius N, 2008, MODERN PATHOL, V21, P308, DOI 10.1038/modpathol.3801006; Simonavicius N, 2012, BLOOD, V120, P1516, DOI 10.1182/blood-2011-01-332338; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Tallquist MD, 2003, PLOS BIOL, V1, P288, DOI 10.1371/journal.pbio.0000052; Thurston G, 2003, CELL TISSUE RES, V314, P61, DOI 10.1007/s00441-003-0749-6; Tomkowicz B, 2007, P NATL ACAD SCI USA, V104, P17965, DOI 10.1073/pnas.0705647104; Tomkowicz B, 2010, CANCER BIOL THER, V9, P908, DOI 10.4161/cbt.9.11.11731; Wilkinson-Berka JL, 2004, AM J PATHOL, V164, P1263, DOI 10.1016/S0002-9440(10)63214-2; Williams JL, 2006, MICROCIRCULATION, V13, P499, DOI 10.1080/10739680600785717; Williams JL, 2006, CLIN SCI, V110, P587, DOI 10.1042/CS20050185; Zhou AL, 1998, ANAT REC, V252, P49, DOI 10.1002/(SICI)1097-0185(199809)252:1<49::AID-AR6>3.0.CO;2-9; Zhou AL, 1998, CELL TISSUE RES, V293, P293, DOI 10.1007/s004410051121	40	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107146	10.1371/journal.pone.0107146	http://dx.doi.org/10.1371/journal.pone.0107146			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243742	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800021
J	Yang, T; Li, XM; Zhu, W; Chen, C; Sun, ZH; Tan, ZL; Kang, JH				Yang, Tan; Li, Xiaomin; Zhu, Wang; Chen, Cheng; Sun, Zhihong; Tan, Zhiliang; Kang, Jinghe			Alteration of Antioxidant Enzymes and Associated Genes Induced by Grape Seed Extracts in the Primary Muscle Cells of Goats In Vitro	PLOS ONE			English	Article							SKELETAL-MUSCLE; OXIDATIVE STRESS; PROANTHOCYANIDIN EXTRACT; TEA CATECHINS; GLUTATHIONE; ACTIVATION; EXPRESSION; PREVENTS; RAT; POLYPHENOLS	This study was conducted to investigate how the activity and expression of certain paramount antioxidant enzymes respond to grape seed extract (GSE) addition in primary muscle cells of goats. Gluteal primary muscle cells (PMCs) isolated from a 3-week old goat were cultivated as an unstressed cell model, or they were exposed to 100 mu M H2O2 to establish a H2O2-stimulated cell model. The activities of catalase (CAT), superoxide dismutases (SOD) and glutathione peroxidases (GPx) in combination with other relevant antioxidant indexes [i.e., reduced glutathione (GSH) and total antioxidant capacity (TAOC)] in response to GSE addition were tested in the unstressed and H2O2-stimulated cell models, and the relative mRNA levels of the CAT, GuZu-SOD, and GPx-1 genes were measured by qPCR. In unstressed PMCs, GSE addition at the dose of 10 mu g/ml strikingly attenuated the expression levels of CAT and CuZn-SOD as well as the corresponding enzyme activities. By contrast, in cells pretreated with 100 mu M H2O2, the expression and activity levels of these two antioxidant enzymes were enhanced by GSE addition at 10 mu g/ml. GSE addition promoted GPx activity in both unstressed and stressed PMCs, while the expression of the GPx 1 gene displayed partial divergence with GPx activity, which was mitigated by GSE addition at 10 mu g/ml in unstressed PMCs. GSH remained comparatively stable except for GSE addition to H2O2-stimulated PMCs at 60 mu g/ml, in which a dramatic depletion of GSH occurred. Moreover, GSE addition enhanced TAOC in unstressed (but not H2O2-stimulated) PMCs. GSE addition exerted a bidirectional modulating effect on the mRNA levels and activities of CAT and SOD in unstressed and stressed PMCs at a moderate dose, and it only exhibited a unidirectional effect on the promotion of GPx activity, reflecting its potential to improve antioxidant protection in ruminants.	[Yang, Tan; Li, Xiaomin; Zhu, Wang; Chen, Cheng; Sun, Zhihong] Southwest Univ, Key Lab Biofeed & Mol Nutr, Chongqing, Peoples R China; [Yang, Tan; Tan, Zhiliang; Kang, Jinghe] Chinese Acad Sci, Key Lab Agroecol Proc Subtrop Reg,Inst Subtrop Ag, Hunan Res Ctr Livestock & Poultry Sci,Minist Agr, South Cent Expt Stn Anim Nutr & Feed Sci, Changsha, Hunan, Peoples R China	Southwest University - China; Chinese Academy of Sciences; Ministry of Agriculture & Rural Affairs	Sun, ZH (corresponding author), Southwest Univ, Key Lab Biofeed & Mol Nutr, Chongqing, Peoples R China.	sunzh2002cn@aliyun.com; zltan@isa.ac.cn			National Program on Key Basic Research Project of China [2013CB127303, 2013CB127304]; CAS; Natural Science Foundation Project of CQ CSTC [cstc2013jjB0112, cstc2012jjA80001]; National Science & Technology Pillar Program [2012BAD14B18, 2014BAD08B11]; Fundamental Research Funds for the Central Universities [XDJK2011C030, XDJK2011B011]; National Natural Science Foundation of China [30600436, 31201826]	National Program on Key Basic Research Project of China(National Basic Research Program of China); CAS(Chinese Academy of Sciences); Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC); National Science & Technology Pillar Program; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the National Program on Key Basic Research Project of China (2013CB127303 and 2013CB127304), the CAS Presidential Scholarship (Excellence Award), the Natural Science Foundation Project of CQ CSTC (cstc2013jjB0112 and cstc2012jjA80001), the National Science & Technology Pillar Program (2012BAD14B18 and 2014BAD08B11), the Fundamental Research Funds for the Central Universities (XDJK2011C030 and XDJK2011B011), and the National Natural Science Foundation of China (30600436 and 31201826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Martin MA, 2010, J NUTR BIOCHEM, V21, P196, DOI 10.1016/j.jnutbio.2008.10.009; Aoi Wataru, 2011, Curr Aging Sci, V4, P101; Baud O, 2004, J NEUROSCI, V24, P1531, DOI 10.1523/JNEUROSCI.3989-03.2004; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Brenes A, 2010, SPAN J AGRIC RES, V8, P326, DOI 10.5424/sjar/2010082-1199; Cheah KY, 2009, CANCER BIOL THER, V8, P382, DOI 10.4161/cbt.8.4.7453; Chen LJ, 2004, CHEM RES TOXICOL, V17, P922, DOI 10.1021/tx0499315; Chen T, 2012, FREE RADICAL BIO MED, V53, P208, DOI 10.1016/j.freeradbiomed.2012.05.014; Ding Y, 2013, MOL NUTR FOOD RES, V57, P365, DOI 10.1002/mnfr.201200463; Du Y, 2007, J AGR FOOD CHEM, V55, P1695, DOI 10.1021/jf063071b; Duthie G, 2012, OXID MED CELL LONGEV, V2012, P165; El-Ashmawy IM, 2006, BASIC CLIN PHARMACOL, V99, P230, DOI 10.1111/j.1742-7843.2006.pto_497.x; Gilliam LAA, 2012, AM J PHYSIOL-CELL PH, V302, pC195, DOI 10.1152/ajpcell.00217.2011; Girnun GD, 2002, MOL ENDOCRINOL, V16, P2793, DOI 10.1210/me.2002-0020; Gong P, 2012, BIOMED RES-INDIA, V23, P551; Guler A, 2011, MED SCI MONITOR, V17, pBR326, DOI 10.12659/MSM.882042; Hanhineva K, 2010, INT J MOL SCI, V11, P1365, DOI 10.3390/ijms11041365; Hotta M, 2010, J LIPID RES, V51, P132, DOI 10.1194/jlr.M900255-JLR200; Kaur M, 2011, MOL CARCINOGEN, V50, P553, DOI 10.1002/mc.20739; Khan N, 2008, MOL MED REP, V1, P813, DOI 10.3892/mmr_00000033; Khoo NKH, 2013, REDOX BIOL, V1, P70, DOI 10.1016/j.redox.2012.12.006; Kim MJ, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/510212; Kusano C, 2008, J CELL MOL BIOL, V7, P1; Li XL, 2010, INT J MOL MED, V25, P237, DOI 10.3892/ijmm_00000336; Lynge J, 2001, J PHYSIOL-LONDON, V537, P597, DOI 10.1111/j.1469-7793.2001.00597.x; Mandic AI, 2009, APTEFF, V40, P1; Masella R, 2005, J NUTR BIOCHEM, V16, P577, DOI 10.1016/j.jnutbio.2005.05.013; McClung JM, 2010, AM J PHYSIOL-CELL PH, V298, pC542, DOI 10.1152/ajpcell.00192.2009; McClung JM, 2009, AM J PHYSIOL-CELL PH, V296, pC363, DOI 10.1152/ajpcell.00497.2008; Mellen PB, 2010, J AM COLL NUTR, V29, P469, DOI 10.1080/07315724.2010.10719883; Molina MF, 2003, BIOL PHARM BULL, V26, P1398, DOI 10.1248/bpb.26.1398; Myburgh KH, 2012, J NUTR BIOCHEM, V23, P1072, DOI 10.1016/j.jnutbio.2011.05.014; Nannelli A, 2009, TOXICOLOGY, V265, P69, DOI 10.1016/j.tox.2009.09.010; Ohta Y, 2011, AM J PHYSIOL-HEART C, V300, pH1637, DOI 10.1152/ajpheart.01185.2009; Ozkan G, 2012, RENAL FAILURE, V34, P460, DOI 10.3109/0886022X.2012.656563; Satyam SM, 2014, J NUTR HEALTH AGING, V18, P524, DOI 10.1007/s12603-014-0020-8; Shao ZH, 2003, PHARMACOL RES, V47, P463, DOI 10.1016/S1043-6618(03)00041-0; Silva LA, 2011, CELL BIOCHEM FUNCT, V29, P43, DOI 10.1002/cbf.1716; Tonon J, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-39; Ulusoy S, 2012, NEPHROLOGY, V17, P372, DOI 10.1111/j.1440-1797.2012.01565.x; Wang ZF, 2009, FREE RADICAL BIO MED, V47, P1221, DOI 10.1016/j.freeradbiomed.2009.08.001; Yang HB, 2012, BIOL TRACE ELEM RES, V147, P156, DOI 10.1007/s12011-011-9272-x; Yang WW, 2011, MOL CELL BIOCHEM, V358, P21, DOI 10.1007/s11010-011-0915-1; Yano CL, 2005, FREE RADICAL BIO MED, V39, P1378, DOI 10.1016/j.freeradbiomed.2005.07.001; Yokota T, 2009, AM J PHYSIOL-HEART C, V297, pH1069, DOI 10.1152/ajpheart.00267.2009; Zhong RZ, 2011, J AGR FOOD CHEM, V59, P11338, DOI 10.1021/jf202839t; Zhou DY, 2011, PLANTA MED, V77, P1575, DOI 10.1055/s-0030-1270957; Zhu H, 2005, FEBS LETT, V579, P3029, DOI 10.1016/j.febslet.2005.04.058	48	20	22	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107670	10.1371/journal.pone.0107670	http://dx.doi.org/10.1371/journal.pone.0107670			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238394	gold, Green Submitted, Green Published			2022-12-25	WOS:000342491600040
J	Hu, F; Pan, LT; Zhang, K; Xing, FL; Wang, XY; Lee, I; Zhang, XZ; Xu, JJ				Hu, Fen; Pan, Leiting; Zhang, Kai; Xing, Fulin; Wang, Xinyu; Lee, Imshik; Zhang, Xinzheng; Xu, Jingjun			Elevation of Extracellular Ca2+ Induces Store-Operated Calcium Entry via Calcium-Sensing Receptors: A Pathway Contributes to the Proliferation of Osteoblasts	PLOS ONE			English	Article							CA2+-SENSING RECEPTOR; MOLECULAR-MECHANISMS; PRIMARY CULTURES; S-NITROSYLATION; EXPRESSION; DIFFERENTIATION; CHANNEL; ACTIVATION; RELEASE; INFLUX	Aims: The local concentration of extracellular Ca2+ ([Ca2+](o)) in bone microenvironment is accumulated during bone remodeling. In the present study we investigated whether elevating [Ca2+](o) induced store-operated calcium entry (SOCE) in primary rat calvarial osteoblasts and further examined the contribution of elevating [Ca2+](o) to osteoblastic proliferation. Methods: Cytosolic Ca2+ concentration ([Ca2+](c)) of primary cultured rat osteoblasts was detected by fluorescence imaging using calcium-sensitive probe fura-2/AM. Osteoblastic proliferation was estimated by cell counting, MTS assay and ATP assay. Agonists and antagonists of calcium-sensing receptors (CaSR) as well as inhibitors of phospholipase C (PLC), SOCE and voltage-gated calcium (Cav) channels were applied to study the mechanism in detail. Results: Our data showed that elevating [Ca2+](o) evoked a sustained increase of [Ca2+](c) in a dose-dependent manner. This [Ca2+](c) increase was blocked by TMB-8 (Ca2+ release inhibitor), 2-APB and BTP-2 (both SOCE blockers), respectively, whereas not affected by Cav channels blockers nifedipine and verapamil. Furthermore, NPS2143 (a CaSR antagonist) or U73122 (a PLC inhibitor) strongly reduced the [Ca2+](o)-induced [Ca2+](c) increase. The similar responses were observed when cells were stimulated with CaSR agonist spermine. These data indicated that elevating [Ca2+](o) resulted in SOCE depending on the activation of CaSR and PLC in osteoblasts. In addition, high [Ca2+](o) significantly promoted osteoblastic proliferation, which was notably reversed by BAPTA-AM (an intracellular calcium chelator), 2-APB, BTP-2, TMB-8, NPS2143 and U73122, respectively, but not affected by Cav channels antagonists. Conclusions: Elevating [Ca2+](o) induced SOCE by triggering the activation of CaSR and PLC. This process was involved in osteoblastic proliferation induced by high level of extracellular Ca2+ concentration.	[Pan, Leiting] Nankai Univ, Key Lab Weak Light Nonlinear Photon, Minist Educ, TEDA Appl Phys Inst, Tianjin 300071, Peoples R China; Nankai Univ, Sch Phys, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Pan, LT (corresponding author), Nankai Univ, Key Lab Weak Light Nonlinear Photon, Minist Educ, TEDA Appl Phys Inst, Tianjin 300071, Peoples R China.	plt@nankai.edu.cn; jjxu@nankai.edu.cn	Lee, Imshik/G-6129-2010; xu, jing/GRR-8698-2022; Zhang, Xinzheng/C-5703-2009; Jingjun, Xu/A-1282-2010	Lee, Imshik/0000-0002-0098-392X; Zhang, Xinzheng/0000-0001-8128-3273; 	National Natural Science Foundation of China [11204142]; National Basic Research Program of China [2010CB934101, 11074133, 31160370]; International S&T cooperation program of China [2011DFA52870]; 111 Project [B07013]; National Science Fund for Talent Training in Basic Sciences [J1103208]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); International S&T cooperation program of China; 111 Project(Ministry of Education, China - 111 Project); National Science Fund for Talent Training in Basic Sciences	This work was supported by the National Natural Science Foundation of China (No. 11204142), the National Basic Research Program of China (No. 2010CB934101), International S&T cooperation program of China (2011DFA52870), the 111 Project (No. B07013), the National Natural Science Foundation of China (No. 11074133, No. 31160370) and the National Science Fund for Talent Training in Basic Sciences (No. J1103208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed E, 2009, MOL MEMBR BIOL, V26, P146, DOI 10.1080/09687680802612721; Baldi C, 2003, J CELL BIOCHEM, V90, P197, DOI 10.1002/jcb.10612; Bergh JJ, 2004, ENDOCRINOLOGY, V145, P426, DOI 10.1210/en.2003-0319; Breitwieser GE, 2001, AM J PHYSIOL-CELL PH, V280, pC1412, DOI 10.1152/ajpcell.2001.280.6.C1412; Caudarella R, 2011, J Endocrinol Invest, V34, P13; Chattopadhyay N, 2004, ENDOCRINOLOGY, V145, P3451, DOI 10.1210/en.2003-1127; Chaudhari A, 1997, MOL CELL BIOCHEM, V167, P31, DOI 10.1023/A:1006853009828; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101; Dvorak-Ewell MM, 2011, J BONE MINER RES, V26, P2935, DOI 10.1002/jbmr.520; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; Feng SL, 2011, BIOCHEM BIOPH RES CO, V406, P278, DOI 10.1016/j.bbrc.2011.02.033; Hattori T, 2001, CELL CALCIUM, V30, P67, DOI 10.1054/ceca.2001.0214; Henriksen K, 2009, BONE, V44, P1026, DOI 10.1016/j.bone.2009.03.671; Hiani YEL, 2009, CELL PHYSIOL BIOCHEM, V23, P335, DOI 10.1159/000218179; Hu F, 2012, BIOCHEM BIOPH RES CO, V424, P196, DOI 10.1016/j.bbrc.2012.06.115; Huang ZM, 2001, J BIOL CHEM, V276, P21351, DOI 10.1074/jbc.M010921200; Ishikawa J, 2003, J IMMUNOL, V170, P4441, DOI 10.4049/jimmunol.170.9.4441; Kanaya S, 2010, BONE, V47, P564, DOI 10.1016/j.bone.2010.05.042; Khoshniat S, 2011, BONE, V48, P894, DOI 10.1016/j.bone.2010.12.002; Koori K, 2014, CELL TISSUE RES, V357, P707, DOI 10.1007/s00441-014-1918-5; Labelle D, 2007, CELL PROLIFERAT, V40, P866, DOI 10.1111/j.1365-2184.2007.00477.x; Lee HL, 2011, BONE, V49, P242, DOI 10.1016/j.bone.2011.04.006; Leung FP, 2008, BRIT J PHARMACOL, V153, P846, DOI 10.1038/sj.bjp.0707455; Mackie EJ, 2003, INT J BIOCHEM CELL B, V35, P1301, DOI 10.1016/S1357-2725(03)00107-9; Martin TJ, 2009, CRIT REV EUKAR GENE, V19, P73, DOI 10.1615/CritRevEukarGeneExpr.v19.i1.40; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Nakahama K, 2010, CELL MOL LIFE SCI, V67, P4001, DOI 10.1007/s00018-010-0479-3; Pan LT, 2013, EUR J PHARMACOL, V715, P280, DOI 10.1016/j.ejphar.2013.05.009; Pan LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025262; Pan LT, 2008, BIOCHEM BIOPH RES CO, V377, P1320, DOI 10.1016/j.bbrc.2008.11.001; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PARTRIDGE NC, 1981, ENDOCRINOLOGY, V108, P213, DOI 10.1210/endo-108-1-213; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Rey O, 2005, J BIOL CHEM, V280, P22875, DOI 10.1074/jbc.M503455200; Riccardi D, 2009, PFLUG ARCH EUR J PHY, V458, P1007, DOI 10.1007/s00424-009-0681-z; Santillan G, 2004, J STEROID BIOCHEM, V89-90, P291, DOI 10.1016/j.jsbmb.2004.03.032; Shao Y, 2005, DEV DYNAM, V234, P54, DOI 10.1002/dvdy.20517; SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7; Suzuki Y, 2011, BIOCHEM BIOPH RES CO, V410, P317, DOI 10.1016/j.bbrc.2011.05.140; Tada H, 2010, BIOCHEM BIOPH RES CO, V394, P1093, DOI 10.1016/j.bbrc.2010.03.135; Takaoka S, 2010, HORM METAB RES, V42, P627, DOI 10.1055/s-0030-1255091; Valenti G, 2010, CELL PHYSIOL BIOCHEM, V26, P901, DOI 10.1159/000323999; Vazquez G, 2002, EMBO J, V21, P4531, DOI 10.1093/emboj/cdf467; Wiemann M, 1999, CALCIFIED TISSUE INT, V65, P479, DOI 10.1007/s002239900736; Wiemann M, 1998, CALCIFIED TISSUE INT, V63, P154, DOI 10.1007/s002239900507; Wong CK, 2012, J CELL PHYSIOL, V227, P2519, DOI 10.1002/jcp.22990; Yamaguchi T, 1998, J BONE MINER RES, V13, P1530, DOI 10.1359/jbmr.1998.13.10.1530; Yamaguchi T, 2001, AM J PHYSIOL-CELL PH, V280, pC382, DOI 10.1152/ajpcell.2001.280.2.C382; Yamauchi M, 2005, AM J PHYSIOL-ENDOC M, V288, pE608, DOI 10.1152/ajpendo.00229.2004; Zayzafoon M, 2006, J CELL BIOCHEM, V97, P56, DOI 10.1002/jcb.20675	51	38	43	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107217	10.1371/journal.pone.0107217	http://dx.doi.org/10.1371/journal.pone.0107217			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254954	Green Published, gold, Green Submitted			2022-12-25	WOS:000344862300019
J	Li, W; Tao, W; Jiang, YX; Diao, RN; Yang, JP; Xiao, LH				Li, Wei; Tao, Wei; Jiang, Yanxue; Diao, Ruinan; Yang, Jinping; Xiao, Lihua			Genotypic Distribution and Phylogenetic Characterization of Enterocytozoon bieneusi in Diarrheic Chickens and Pigs in Multiple Cities, China: Potential Zoonotic Transmission	PLOS ONE			English	Article							VIRUS-INFECTED PATIENTS; 1ST DETECTION; ENCEPHALITOZOON-CUNICULI; MICROSPORIDIOSIS; IDENTIFICATION; EPIDEMIOLOGY; SWINE; PREVALENCE; OUTBREAK; PIGEONS	This study investigated diarrheic broiler and layer chickens (<50 days; n = 14) and pigs of three age groups (preweaned <30 days, weaned approximate to 30 to 60 days, and growing >60 days; n = 64) for E. bieneusi genotypes in northeast China and evaluated the potential roles of chickens and pigs in zoonotic transmission of microsporidiosis. Two 45-day-old layer chickens in city Jixi, Heilongjiang province and one 23-day-old broiler chicken in city Songyuan, Jilin province were identified to harbor a human-pathogenic E. bieneusi genotype Henan-IV and a new genotype named CC-1, respectively, by nested PCR and sequence analysis of the ribosomal internal transcribed spacer (ITS). Eleven of 64 (17.2%) duodenal mucosal specimens from pigs in city Tianjin, city Tongliao of Inner Mongolia, cities Jilin and Songyuan of Jilin province, and cities Daqing, Harbin, and Suihua of Heilongjiang province, were positive for E. bieneusi, with the infection rates of weaned pigs (35%, 7/20) significantly higher than preweaned ones (3.6%, 1/28; P<0.05). Nucleotide sequences of the ITS were obtained from 6 pig specimens, belonging to 3 known genotypes CHN7, EbpC, and Henan-IV. That the previous reports have described the occurrence of genotypes EbpC and Henan-IV in humans and EbpC in wastewater in central China and the clustering of genotypes CC-1 and CHN7 into a major phylogenetic group of E. bieneusi genotypes with zoonotic potential indicated that chickens and pigs could be potential sources of human micorsporidiosis. To our knowledge, this is the first report describing the existence of zoonotic E. bieneusi genotypes in diarrheic chickens.	[Li, Wei; Tao, Wei; Jiang, Yanxue; Diao, Ruinan; Yang, Jinping] Northeast Agr Univ, Coll Vet Med, Harbin, Heilongjiang, Peoples R China; [Xiao, Lihua] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA	Northeast Agricultural University - China; Centers for Disease Control & Prevention - USA	Li, W (corresponding author), Northeast Agr Univ, Coll Vet Med, Harbin, Heilongjiang, Peoples R China.	neaulw@gmail.com; lax0@cdc.gov	Xiao, Lihua/B-1704-2013; Li, Wei/H-7214-2013	Xiao, Lihua/0000-0001-8532-2727; Li, Wei/0000-0002-4264-1864	Scientific Research Funds of Heilongjiang Provincial Education Department [1253HQ015]	Scientific Research Funds of Heilongjiang Provincial Education Department	This study was supported by the Scientific Research Funds of Heilongjiang Provincial Education Department (no. 1253HQ015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2010, VECTOR-BORNE ZOONOT, V10, P425, DOI 10.1089/vbz.2009.0039; Akinbo FO, 2012, AM J TROP MED HYG, V86, P441, DOI 10.4269/ajtmh.2012.11-0548; Anane S, 2010, GASTROEN CLIN BIOL, V34, P450, DOI 10.1016/j.gcb.2010.07.003; Bern C, 2005, J INFECT DIS, V191, P1658, DOI 10.1086/429674; Breitenmoser AC, 1999, PARASITOLOGY, V118, P447, DOI 10.1017/S0031182099004229; Buckholt MA, 2002, APPL ENVIRON MICROB, V68, P2595, DOI 10.1128/AEM.68.5.2595-2599.2002; Cama VA, 2007, J CLIN MICROBIOL, V45, P2708, DOI 10.1128/JCM.00725-07; Dengjel B, 2001, J CLIN MICROBIOL, V39, P4495, DOI 10.1128/JCM.39.12.4495-4499.2001; Deplazes P, 1996, J EUKARYOT MICROBIOL, V43, pS93, DOI 10.1111/j.1550-7408.1996.tb05018.x; Didier ES, 2006, CURR OPIN INFECT DIS, V19, P485, DOI 10.1097/01.qco.0000244055.46382.23; Espern A, 2007, J CLIN MICROBIOL, V45, P2999, DOI 10.1128/JCM.00684-07; Ghosh Kaya, 2009, Interdiscip Perspect Infect Dis, V2009, P926521, DOI 10.1155/2009/926521; Haro M, 2005, APPL ENVIRON MICROB, V71, P3153, DOI 10.1128/AEM.71.6.3153-3157.2005; Jeong DK, 2007, PARASITOL RES, V102, P123, DOI 10.1007/s00436-007-0740-3; Kasickova D, 2009, VET PARASITOL, V165, P125, DOI 10.1016/j.vetpar.2009.06.033; Lallo MA, 2012, VET PARASITOL, V190, P418, DOI 10.1016/j.vetpar.2012.06.030; Leelayoova S, 2006, J CLIN MICROBIOL, V44, P3001, DOI 10.1128/JCM.00945-06; Leelayoova S, 2009, J CLIN MICROBIOL, V47, P1572, DOI 10.1128/JCM.00187-09; Li N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001809; Li W, 2014, PARASITOL RES, V113, P1147, DOI 10.1007/s00436-014-3752-9; Li W, 2011, J CLIN MICROBIOL, V49, P4326, DOI 10.1128/JCM.05051-11; Lobo ML, 2006, APPL ENVIRON MICROB, V72, P7380, DOI 10.1128/AEM.01394-06; Mathis A, 2005, CLIN MICROBIOL REV, V18, P423, DOI 10.1128/CMR.18.3.423-445.2005; Matos Olga, 2012, J Parasitol Res, V2012, P981424, DOI 10.1155/2012/981424; Muller MG, 2008, VET PARASITOL, V152, P67, DOI 10.1016/j.vetpar.2007.11.019; Nemejc K, 2014, PARASITOL RES, V113, P761, DOI 10.1007/s00436-013-3707-6; Reetz J, 2002, INT J PARASITOL, V32, P785, DOI 10.1016/S0020-7519(02)00045-0; Reetz J, 2009, PARASITOL INT, V58, P285, DOI 10.1016/j.parint.2009.03.002; Rinder H, 2000, J PARASITOL, V86, P185, DOI 10.1645/0022-3395(2000)086[0185:CGRBEB]2.0.CO;2; Sak B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001162; Sak B, 2011, J CLIN MICROBIOL, V49, P1064, DOI 10.1128/JCM.01147-10; Sak B, 2008, VET PARASITOL, V153, P220, DOI 10.1016/j.vetpar.2008.01.043; Santin M, 2011, RES VET SCI, V90, P363, DOI 10.1016/j.rvsc.2010.07.014; Sulaiman IM, 2003, J EUKARYOT MICROBIOL, V50, P591, DOI 10.1111/j.1550-7408.2003.tb00642.x; Sulaiman IM, 2003, APPL ENVIRON MICROB, V69, P4495, DOI 10.1128/AEM.69.8.4495-4501.2003; Thellier M, 2008, PARASITE, V15, P349, DOI 10.1051/parasite/2008153349; Wang L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002437; Wang L, 2013, J CLIN MICROBIOL, V51, P557, DOI 10.1128/JCM.02758-12; Ye JB, 2012, EMERG INFECT DIS, V18, P1640, DOI 10.3201/eid1810.120653; Zhang X, 2011, J CLIN MICROBIOL, V49, P2006, DOI 10.1128/JCM.00372-11	40	36	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108279	10.1371/journal.pone.0108279	http://dx.doi.org/10.1371/journal.pone.0108279			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255117	gold, Green Published, Green Submitted			2022-12-25	WOS:000344862300068
J	Zhou, ZY; Zhang, YX; Wang, HT; Chen, T; Lu, WJ				Zhou, Zeyu; Zhang, Yaxin; Wang, Hongtao; Chen, Tan; Lu, Wenjing			The Comparative Photodegradation Activities of Pentachlorophenol (PCP) and Polychlorinated Biphenyls (PCBs) Using UV Alone and TiO2-Derived Photocatalysts in Methanol Soil Washing Solution	PLOS ONE			English	Article							CONTAMINATED SOILS; DEGRADATION; TIO2; SEDIMENTS; DECOMPOSITION; REMEDIATION; FABRICATION; MECHANISM; PATHWAYS; SURFACES	Photochemical treatment is increasingly being applied to remedy environmental problems. TiO2-derived catalysts are efficiently and widely used in photodegradation applications. The efficiency of various photochemical treatments, namely, the use of UV irradiation without catalyst or with TiO2/graphene-TiO2 photodegradation methods was determined by comparing the photodegadation of two main types of hydrophobic chlorinated aromatic pollutants, namely, pentachlorophenol (PCP) and polychlorinated biphenyls (PCBs). Results show that photodegradation in methanol solution under pure UV irradiation was more efficient than that with either one of the catalysts tested, contrary to previous results in which photodegradation rates were enhanced using TiO2-derived catalysts. The effects of various factors, such as UV light illumination, addition of methanol to the solution, catalyst dosage, and the pH of the reaction mixture, were examined. The degradation pathway was deduced. The photochemical treatment in methanol soil washing solution did not benefit from the use of the catalysts tested. Pure UV irradiation was sufficient for the dechlorination and degradation of the PCP and PCBs.	[Zhou, Zeyu; Wang, Hongtao; Chen, Tan; Lu, Wenjing] Tsinghua Univ, Dept Environm Sci & Engn, Beijing 100084, Peoples R China; [Zhang, Yaxin] Hunan Univ, Coll Environm Sci & Engn, Changsha, Hunan, Peoples R China	Tsinghua University; Hunan University	Wang, HT (corresponding author), Tsinghua Univ, Dept Environm Sci & Engn, Beijing 100084, Peoples R China.	htwang@tsinghua.edu.cn			National Natural Science Foundation of China [41371472]; Major Science and Technology Program for Water Pollution Control and Treatment of the Ministry of Environmental Protection of China [2011ZX07317-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science and Technology Program for Water Pollution Control and Treatment of the Ministry of Environmental Protection of China	The authors appreciate the generous financial support for this work from the National Natural Science Foundation of China (No. 41371472) and the Major Science and Technology Program for Water Pollution Control and Treatment of the Ministry of Environmental Protection of China (No. 2011ZX07317-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany E, 2013, J HAZARD MATER, V262, P151, DOI 10.1016/j.jhazmat.2013.08.003; Chand R, 2013, CHEM ENG J, V233, P369, DOI 10.1016/j.cej.2013.08.069; Cheng P, 2012, INT J HYDROGEN ENERG, V37, P2224, DOI 10.1016/j.ijhydene.2011.11.004; Clarke BO, 2010, ENVIRON INT, V36, P23; Dong DB, 2010, CHEM ENG J, V158, P378, DOI 10.1016/j.cej.2009.12.046; Eek E, 2008, CHEMOSPHERE, V71, P1629, DOI 10.1016/j.chemosphere.2008.01.051; Gomes HI, 2013, SCI TOTAL ENVIRON, V445, P237, DOI 10.1016/j.scitotenv.2012.11.098; Govindan K, 2013, MATER RES BULL, V48, P1913, DOI 10.1016/j.materresbull.2013.01.047; Jonsson S, 2010, J HAZARD MATER, V179, P393, DOI 10.1016/j.jhazmat.2010.03.017; Khanikar N, 2013, CHEM ENG J, V233, P88, DOI 10.1016/j.cej.2013.08.018; Khodadoust AP, 1999, CHEMOSPHERE, V38, P2681, DOI 10.1016/S0045-6535(98)00458-5; Li DW, 2014, SEP PURIF TECHNOL, V123, P130, DOI 10.1016/j.seppur.2013.12.029; Li J, 2013, CHEM ENG J, V219, P486, DOI 10.1016/j.cej.2013.01.031; Liu JW, 2011, APPL CATAL B-ENVIRON, V103, P470, DOI 10.1016/j.apcatb.2011.02.013; Lu GN, 2010, SCI TOTAL ENVIRON, V408, P2549, DOI 10.1016/j.scitotenv.2010.03.003; Lu SY, 2011, CHEMOSPHERE, V82, P1215, DOI 10.1016/j.chemosphere.2010.12.034; Miao XS, 1999, CHEMOSPHERE, V39, P1639, DOI 10.1016/S0045-6535(99)00062-4; Quan X, 2005, CHEMOSPHERE, V60, P266, DOI 10.1016/j.chemosphere.2004.11.044; Sato T, 2010, CHEMOSPHERE, V80, P184, DOI 10.1016/j.chemosphere.2010.02.055; Shaban YA, 2013, CHEMOSPHERE, V91, P307, DOI 10.1016/j.chemosphere.2012.11.035; Sun YF, 2012, CHEMOSPHERE, V88, P895, DOI 10.1016/j.chemosphere.2012.03.099; Tada H, 2004, LANGMUIR, V20, P4665, DOI 10.1021/la036104f; ThanhThuy TT, 2013, CHEM ENG J, V223, P379, DOI 10.1016/j.cej.2013.03.025; Xie J, 2014, RES CHEM INTERMEDIAT, V40, P1937, DOI 10.1007/s11164-013-1091-6; Xie J, 2013, MATER LETT, V91, P213, DOI 10.1016/j.matlet.2012.09.095; Zhang YX, 2014, ADV MATER RES-SWITZ, V878, P791, DOI 10.4028/www.scientific.net/AMR.878.791; Zhang YX, 2012, J HAZARD MATER, V221, P92, DOI 10.1016/j.jhazmat.2012.04.005; Zhao SF, 2010, J HAZARD MATER, V180, P86, DOI 10.1016/j.jhazmat.2010.03.076; Zhu XD, 2012, J SOIL SEDIMENT, V12, P1371, DOI 10.1007/s11368-012-0556-3; Zyoud AH, 2010, J HAZARD MATER, V173, P318, DOI 10.1016/j.jhazmat.2009.08.093	30	6	6	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108765	10.1371/journal.pone.0108765	http://dx.doi.org/10.1371/journal.pone.0108765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254664	Green Published, Green Submitted, gold			2022-12-25	WOS:000344862300106
J	Fan, YN; Meley, D; Pizer, B; See, V				Fan, Yuen Ngan; Meley, Daniel; Pizer, Barry; See, Violaine			Mir-34a Mimics Are Potential Therapeutic Agents for p53-Mutated and Chemo-Resistant Brain Tumour Cells	PLOS ONE			English	Article							DISEASE RISK; MEDULLOBLASTOMA; P53; APOPTOSIS; PROTEIN; SIRT1; CHEMOTHERAPY; MICRORNA; GROWTH; STRATIFICATION	Chemotherapeutic drug resistance and relapse remains a major challenge for paediatric (medulloblastoma) and adult (glioblastoma) brain tumour treatment. Medulloblastoma tumours and cell lines with mutations in the p53 signalling pathway have been shown to be specifically insensitive to DNA damaging agents. The aim of this study was to investigate the potential of triggering cell death in p53 mutated medulloblastoma cells by a direct activation of pro-death signalling downstream of p53 activation. Since non-coding microRNAs (miRNAs) have the ability to fine tune the expression of a variety of target genes, orchestrating multiple downstream effects, we hypothesised that triggering the expression of a p53 target miRNA could induce cell death in chemo-resistant cells. Treatment with etoposide, increased miR-34a levels in a p53-dependent fashion and the level of miR-34a transcription was correlated with the cell sensitivity to etoposide. miR-34a activity was validated by measuring the expression levels of one of its well described target: the NADH dependent sirtuin1 (SIRT1). Whilst drugs directly targeting SIRT1, were potent to trigger cell death at high concentrations only, introduction of synthetic miR-34a mimics was able to induce cell death in p53 mutated medulloblastoma and glioblastoma cell lines. Our results show that the need of a functional p53 signaling pathway can be bypassed by direct activation of miR-34a in brain tumour cells.	[Fan, Yuen Ngan; Meley, Daniel; See, Violaine] Univ Liverpool, Dept Biochem, Ctr Cell Imaging, Liverpool L69 3BX, Merseyside, England; [Meley, Daniel] Univ Tours, UPRES EA Cellules Dendrit Immunomodulat & Greffes, Tours, France; [Pizer, Barry] Alder Hey Childrens NHS Fdn Trust, Liverpool, Merseyside, England	University of Liverpool; Universite de Tours; Alder Hey Children's NHS Foundation Trust	See, V (corresponding author), Univ Liverpool, Dept Biochem, Ctr Cell Imaging, POB 147, Liverpool L69 3BX, Merseyside, England.	violaine@liverpool.ac.uk		Meley, Daniel/0000-0002-0708-2139	Alder Hey Oncology Fund [CO'B/PM 7718]; BBSRC [BB/C520471/1]; Biotechnology and Biological Sciences Research Council [BB/C520471/1] Funding Source: researchfish	Alder Hey Oncology Fund; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Alder Hey Oncology Fund (CO'B/PM 7718) and BBSRC (BB/C520471/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcendor RR, 2004, CIRC RES, V95, P971, DOI 10.1161/01.RES.0000147557.75257.ff; Anensen N, 2006, CLIN CANCER RES, V12, P3985, DOI 10.1158/1078-0432.CCR-05-1970; Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; Audrito V, 2011, CANCER RES, V71, P4473, DOI 10.1158/0008-5472.CAN-10-4452; Bacolod MD, 2009, CANCER CHEMOTH PHARM, V63, P753, DOI 10.1007/s00280-008-0792-9; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bouchie A, 2013, NAT BIOTECHNOL, V31, P577, DOI 10.1038/nbt0713-577; Cho W.C.S., 2007, MOL CANC, V6; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cole KA, 2008, MOL CANCER RES, V6, P735, DOI 10.1158/1541-7786.MCR-07-2102; Courtois S, 2002, ONCOGENE, V21, P6722, DOI 10.1038/sj.onc.1205874; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Dong Q, 1999, CANCER CHEMOTH PHARM, V43, P73, DOI 10.1007/s002800050865; Feige JN, 2008, CURR OPIN CELL BIOL, V20, P303, DOI 10.1016/j.ceb.2008.03.012; Frange P, 2009, J NEURO-ONCOL, V95, P271, DOI 10.1007/s11060-009-9927-z; FRIEDMAN HS, 1992, CANCER RES, V52, P5373; FRIEDMAN HS, 1985, J NEUROPATH EXP NEUR, V44, P592, DOI 10.1097/00005072-198511000-00005; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V377, P114, DOI 10.1016/j.bbrc.2008.09.086; Gajjar A, 2004, J CLIN ONCOL, V22, P984, DOI 10.1200/JCO.2004.06.032; Ghosh A, 2004, MOL CELL BIOL, V24, P7987, DOI 10.1128/MCB.24.18.7987-7997.2004; Gilbertson R, 2001, BRIT J CANCER, V85, P705, DOI 10.1054/bjoc.2001.1987; Guessous F, 2010, CELL CYCLE, V9, P1031, DOI 10.4161/cc.9.6.10987; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Kasinski AL, 2012, CANC RES; Kasuga C, 2008, J NEUROS-PEDIATR, V1, P305, DOI 10.3171/PED/2008/1/4/305; Kortmann RD, 2000, INT J RADIAT ONCOL, V46, P269, DOI 10.1016/S0360-3016(99)00369-7; Li LS, 2013, CLIN EXP MED, V13, P109, DOI 10.1007/s10238-012-0186-5; Meley D, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.16; Meley D, 2010, CELL DEATH IN PRESS; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Philipova T, 2011, INT J ONCOL, V38, P843, DOI 10.3892/ijo.2010.884; PIETSCH T, 1994, CANCER RES, V54, P3278; Pizer B, 2008, ARCH DIS CHILDHOOD-E, V93, P137, DOI 10.1136/adc.2007.136655; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rokhlin OW, 2008, CANCER BIOL THER, V7, P1288, DOI 10.4161/cbt.7.8.6284; See VP B, 2012, TUMORS CENTRAL NERVO, V8, P59; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Stuenkel Walter, 2007, Biotechnology Journal, V2, P1360, DOI 10.1002/biot.200700087; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Tabori U, 2010, J CLIN ONCOL, V28, P1345, DOI 10.1200/JCO.2009.23.5952; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Taylor RE, 2003, J CLIN ONCOL, V21, P1581, DOI 10.1200/JCO.2003.05.116; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Tsuchiya S, 2006, J PHARMACOL SCI, V101, P267, DOI 10.1254/jphs.CPJ06013X; Weeraratne SD, 2011, NEURO-ONCOLOGY, V13, P165, DOI 10.1093/neuonc/noq179; Wei JS, 2008, ONCOGENE, V27, P5204, DOI 10.1038/onc.2008.154; Wong S, 2007, BIOCHEM J, V407, P451, DOI 10.1042/BJ20070151; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753; Zenz T, 2009, BLOOD, V113, P3801, DOI 10.1182/blood-2008-08-172254; Zhukova N, 2013, J CLIN ONCOL, V31, P2927, DOI 10.1200/JCO.2012.48.5052	54	23	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108514	10.1371/journal.pone.0108514	http://dx.doi.org/10.1371/journal.pone.0108514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250818	Green Published, gold, Green Submitted			2022-12-25	WOS:000342492700138
J	Jia, J; Yu, B; Wu, LM; Wang, HW; Wu, ZL; Li, M; Huang, PY; Feng, SQ; Chen, P; Zheng, YL; Peng, LC				Jia, Jun; Yu, Bin; Wu, Leiming; Wang, Hongwu; Wu, Zhiliang; Li, Ming; Huang, Pengyan; Feng, Shengqiu; Chen, Peng; Zheng, Yonglian; Peng, Liangcai			Biomass Enzymatic Saccharification Is Determined by the Non-KOH-Extractable Wall Polymer Features That Predominately Affect Cellulose Crystallinity in Corn	PLOS ONE			English	Article							H2SO4 PRETREATMENTS; LIGNIN CONTENT; DILUTE-ACID; DIGESTIBILITY; STOVER; FRACTIONATION; FERMENTATION; BIOFUELS; SORGHUM; SIZE	Corn is a major food crop with enormous biomass residues for biofuel production. Due to cell wall recalcitrance, it becomes essential to identify the key factors of lignocellulose on biomass saccharification. In this study, we examined total 40 corn accessions that displayed a diverse cell wall composition. Correlation analysis showed that cellulose and lignin levels negatively affected biomass digestibility after NaOH pretreatments at p < 0.05 & 0.01, but hemicelluloses did not show any significant impact on hexoses yields. Comparative analysis of five standard pairs of corn samples indicated that cellulose and lignin should not be the major factors on biomass saccharification after pretreatments with NaOH and H2SO4 at three concentrations. Notably, despite that the non-KOH-extractable residues covered 12%-23% hemicelluloses and lignin of total biomass, their wall polymer features exhibited the predominant effects on biomass enzymatic hydrolysis including Ara substitution degree of xylan (reverse Xyl/Ara) and S/G ratio of lignin. Furthermore, the non-KOH-extractable polymer features could significantly affect lignocellulose crystallinity at p < 0.05, leading to a high biomass digestibility. Hence, this study could suggest an optimal approach for genetic modification of plant cell walls in bioenergy corn.	[Jia, Jun; Yu, Bin; Wu, Leiming; Wu, Zhiliang; Li, Ming; Huang, Pengyan; Feng, Shengqiu; Chen, Peng; Zheng, Yonglian; Peng, Liangcai] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Jia, Jun; Yu, Bin; Wu, Leiming; Wu, Zhiliang; Li, Ming; Huang, Pengyan; Feng, Shengqiu; Chen, Peng; Zheng, Yonglian; Peng, Liangcai] Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Wuhan, Peoples R China; [Jia, Jun; Yu, Bin; Wu, Leiming; Wu, Zhiliang; Li, Ming; Huang, Pengyan; Feng, Shengqiu; Chen, Peng; Peng, Liangcai] Huazhong Agr Univ, Biomass & Bioenergy Res Ctr, Wuhan, Peoples R China; [Jia, Jun; Wu, Leiming; Wu, Zhiliang; Huang, Pengyan; Feng, Shengqiu; Chen, Peng; Peng, Liangcai] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Yu, Bin; Li, Ming; Zheng, Yonglian] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan, Peoples R China; [Wang, Hongwu] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Peng, LC (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	lpeng@mail.hzau.edu.cn			111 Project of MOE [B08032]; National Natural Science Foundation of China [31200911]; China Postdoctoral Science Foundation [20100471197, 201104475]; Transgenic Plant and Animal Project of MOA [2009ZX08009-119B]; 973 Pre-project of MOST [2010CB134401]; HZAU Changjiang Scholar Promoting Project [52204-07022]	111 Project of MOE; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Transgenic Plant and Animal Project of MOA; 973 Pre-project of MOST(National Basic Research Program of China); HZAU Changjiang Scholar Promoting Project	This work was supported in part by grants from the 111 Project of MOE (B08032), the National Natural Science Foundation of China (31200911), the China Postdoctoral Science Foundation (20100471197, 201104475), the Transgenic Plant and Animal Project of MOA (2009ZX08009-119B), the 973 Pre-project of MOST (2010CB134401), and HZAU Changjiang Scholar Promoting Project (52204-07022).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arioli T, 1998, SCIENCE, V279, P717, DOI 10.1126/science.279.5351.717; Carpita NC, 2008, TRENDS PLANT SCI, V13, P415, DOI 10.1016/j.tplants.2008.06.002; Chen P, 2013, BIOL CONVERSION BIOM, P83; Davison BH, 2006, APPL BIOCHEM BIOTECH, V130, P427, DOI 10.1385/ABAB:130:1:427; Dische Z., 1962, METHODS CARBOHYDRATE, P477; Fry S. C, 1988, GROWING PLANT CELL W, DOI DOI 10.1016/0031-9422(88)83079-6; Gressel J, 2008, PLANT SCI, V174, P246, DOI 10.1016/j.plantsci.2007.11.009; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Huang JF, 2012, BIORESOURCE TECHNOL, V121, P274, DOI 10.1016/j.biortech.2012.06.015; Kim TH, 2007, APPL BIOCHEM BIOTECH, V137, P81, DOI 10.1007/s12010-007-9041-7; Lau MW, 2009, P NATL ACAD SCI USA, V106, P1368, DOI 10.1073/pnas.0812364106; Lei HW, 2009, ENERG FUEL, V23, P3254, DOI 10.1021/ef9000264; Li FC, 2013, BIORESOURCE TECHNOL, V130, P629, DOI 10.1016/j.biortech.2012.12.107; Li M, 2014, BIORESOURCE TECHNOL, V167, P14, DOI 10.1016/j.biortech.2014.04.086; Li M, 2014, BIORESOURCE TECHNOL, V169, P447, DOI 10.1016/j.biortech.2014.07.017; McCann MC, 2008, CURR OPIN PLANT BIOL, V11, P314, DOI 10.1016/j.pbi.2008.04.001; Park S, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-10; Pauly M, 2010, CURR OPIN PLANT BIOL, V13, P305, DOI 10.1016/j.pbi.2009.12.009; Peng LC, 2000, PLANTA, V211, P406, DOI 10.1007/s004250000301; PURI VP, 1984, BIOTECHNOL BIOENG, V26, P1219, DOI 10.1002/bit.260261010; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Saha BC, 2003, J IND MICROBIOL BIOT, V30, P279, DOI 10.1007/s10295-003-0049-x; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Sluiter A, 2008, NRELTP51042618; Studer MH, 2011, P NATL ACAD SCI USA, V108, P6300, DOI 10.1073/pnas.1009252108; Sun YS, 2011, APPL BIOCH; Wang H, 2012, APPL BIOCHEM BIOTECH, V167, P285, DOI 10.1007/s12010-012-9678-8; Wu ZL, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-183; Xie GS, 2011, J INTEGR PLANT BIOL, V53, P143, DOI 10.1111/j.1744-7909.2010.01022.x; Xu N, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-58; Zhang W, 2013, BIORESOURCE TECHNOL, V130, P30, DOI 10.1016/j.biortech.2012.12.029; Zhu L, 2008, BIORESOURCE TECHNOL, V99, P3817, DOI 10.1016/j.biortech.2007.07.033; Zhu ZG, 2009, BIOTECHNOL BIOENG, V103, P715, DOI 10.1002/bit.22307	34	29	29	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108449	10.1371/journal.pone.0108449	http://dx.doi.org/10.1371/journal.pone.0108449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251456	Green Published, gold, Green Submitted			2022-12-25	WOS:000342492700127
J	Sun, Q; Li, Y				Sun, Qian; Li, Yan			The Inhibitory Effect of Pseudolaric Acid B on Gastric Cancer and Multidrug Resistance via Cox-2/PKC-alpha/P-gp Pathway	PLOS ONE			English	Article							KINASE-C ISOENZYMES; P-GLYCOPROTEIN; CELL-LINE; IN-VIVO; MOLECULAR-MECHANISMS; ANTITUMOR-ACTIVITY; INDUCED APOPTOSIS; DRUG-RESISTANCE; CARCINOMA-CELLS; CYCLOOXYGENASE-2	Aim: To investigate the inhibitory effect of pseudolaric acid B on subcutaneous xenografts of human gastric adenocarcinoma and the underlying molecular mechanisms involved in its multidrug resistance. Methods: Human gastric adenocarcinoma SGC7901 cells and drug-resistant SGC7901/ADR cells were injected into nude mice to establish a subcutaneous xenograft model. The effects of pseudolaric acid B with or without adriamycin treatment were compared by determining the tumor size and weight. Cyclo-oxygenase-2, protein kinaseC-alpha and P-glycoprotein expression levels were determined by immunohistochemistry and western blot. Results: Pseudolaric acid B significantly suppressed the tumor growth induced by SGC7901 cells and SGC7901/ADR cells. The combination of pseudolaric acid B and the traditional chemotherapy drug adriamycin exhibited more potent inhibitory effects on the growth of gastric cancer in vivo than treatment with either pseudolaric acid B or adriamycin alone. Protein expression levels of cyclo-oxygenase-2, protein kinaseC-alpha and P-glycoprotein were inhibited by pseudolaric acid B alone or in combination with adriamycin in SGC7901/ADR cell xenografts. Conclusion: Pseudolaric acid B has a significant inhibitory effect and an additive inhibitory effect in combination with adriamycin on the growth of gastric cancer in vivo, which reverses the multidrug resistance of gastric neoplasm to chemotherapy drugs by downregulating the Cox-2/PKC-alpha/P-gp/mdr1 signaling pathway.	[Sun, Qian; Li, Yan] China Med Univ, Shengjing Hosp Affiliated, Dept Gastroenterol, Shenyang, Liaoning, Peoples R China	China Medical University	Li, Y (corresponding author), China Med Univ, Shengjing Hosp Affiliated, Dept Gastroenterol, Shenyang, Liaoning, Peoples R China.	yanli2955@163.com			Science Program Foundation of Shenyang Municipal Science and Technology Bureau [1091136-9-02]	Science Program Foundation of Shenyang Municipal Science and Technology Bureau	This work was supported by Science Program Foundation of Shenyang Municipal Science and Technology Bureau (1091136-9-02). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD S, 1993, MOL PHARMACOL, V43, P858; Ajani JA, 1998, ONCOLOGY-NY, V12, P44; Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Breier A, 2005, CURR CANCER DRUG TAR, V5, P457, DOI 10.2174/1568009054863636; Chen M, 2012, J CELL BIOCHEM, V113, P2474, DOI 10.1002/jcb.24122; Chen Y, 2009, CANCER BIOL THER, V8, P607, DOI 10.4161/cbt.8.7.7920; CLEMENS MJ, 1992, J CELL SCI, V103, P881; Fantappie O, 2007, CANCER RES, V67, P4915, DOI 10.1158/0008-5472.CAN-06-3952; FINE RL, 1996, ONCOLOGIST, V1, P261; Gottesman MM, 2006, FEBS LETT, V580, P998, DOI 10.1016/j.febslet.2005.12.060; Han Y, 2002, WORLD J GASTROENTERO, V8, P441, DOI 10.3748/wjg.v8.i3.441; Hou L, 2012, J CANC RES CLIN ONCO; Kalle AM, 2010, LEUKEMIA RES, V34, P1132, DOI 10.1016/j.leukres.2010.01.030; Ko JKS, 2007, EUR J PHARMACOL, V559, P1, DOI 10.1016/j.ejphar.2006.12.004; Kobunai T, 2011, ANTICANCER RES, V31, P3691; Lee SK, 2012, MOL CELLS, V34, P61, DOI 10.1007/s10059-012-0087-1; Li KS, 2005, WORLD J GASTROENTERO, V11, P7555, DOI 10.3748/wjg.v11.i48.7555; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Meric JB, 2006, CRIT REV ONCOL HEMAT, V59, P51, DOI 10.1016/j.critrevonc.2006.01.003; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Nardone G, 2004, J PATHOL, V202, P305, DOI 10.1002/path.1512; O'Brian CA, 2001, CANCER METAST REV, V20, P95, DOI 10.1023/A:1013186430906; Parkin DM, 1999, INT J CANCER, V80, P827, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;827::AID-IJC6&gt;3.0.CO;2-P; Puhlmann U, 2005, J PHARMACOL EXP THER, V312, P346, DOI 10.1124/jpet.104.071571; Ratnasinghe D, 2001, ANTICANCER RES, V21, P2141; Roy KR, 2010, CANCER CHEMOTH PHARM, V65, P903, DOI 10.1007/s00280-009-1097-3; Sorokin A, 2004, CURR PHARM DESIGN, V10, P647, DOI 10.2174/1381612043453117; Tan WF, 2004, EUR J PHARMACOL, V499, P219, DOI 10.1016/j.ejphar.2004.07.063; Vivaldi A, 2012, MOL CELL ENDOCRINOL, V355, P41, DOI 10.1016/j.mce.2012.01.015; Wong VKW, 2005, CLIN CANCER RES, V11, P6002, DOI 10.1158/1078-0432.CCR-05-0209; Xu Yong-hong, 2008, Zhongguo Yaolixue Tongbao, V24, P601; Yang SP, 2003, BIOORGAN MED CHEM, V11, P4577, DOI 10.1016/S0968-0896(03)00531-5; Yu JH, 2007, ACTA PHARMACOL SIN, V28, P1975, DOI 10.1111/j.1745-7254.2007.00706.x; Yu L, 2009, MOL PHARMACOL, V75, P1364, DOI 10.1124/mol.108.053546	35	18	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107830	10.1371/journal.pone.0107830	http://dx.doi.org/10.1371/journal.pone.0107830			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250794	gold, Green Published, Green Submitted			2022-12-25	WOS:000342492700051
J	Hutton, DL; Kondragunta, R; Moore, EM; Hung, BP; Jia, XF; Grayson, WL				Hutton, Daphne L.; Kondragunta, Renu; Moore, Erika M.; Hung, Ben P.; Jia, Xiaofeng; Grayson, Warren L.			Tumor Necrosis Factor Improves Vascularization in Osteogenic Grafts Engineered with Human Adipose-Derived Stem/Stromal Cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; TNF-ALPHA; IN-VITRO; ENDOTHELIAL-CELLS; BONE-FORMATION; GROWTH-FACTOR; ANGIOGENESIS; TISSUE; DIFFERENTIATION; INHIBITION	The innate immune response following bone injury plays an important role in promoting cellular recruitment, revascularization, and other repair mechanisms. Tumor necrosis factor-alpha (TNF) is a prominent pro-inflammatory cytokine in this cascade, and has been previously shown to improve bone formation and angiogenesis in a dose- and timing-dependent manner. This ability to positively impact both osteogenesis and vascular growth may benefit bone tissue engineering, as vasculature is essential to maintaining cell viability in large grafts after implantation. Here, we investigated the effects of exogenous TNF on the induction of adipose-derived stem/stromal cells (ASCs) to engineer pre-vascularized osteogenic tissue in vitro with respect to dose, timing, and co-stimulation with other inflammatory mediators. We found that acute (2-day), low-dose exposure to TNF promoted vascularization, whereas higher doses and continuous exposure inhibited vascular growth. Co-stimulation with platelet-derived growth factor (PDGF), another key factor released following bone injury, increased vascular network formation synergistically with TNF. ASC-seeded grafts were then cultured within polycaprolactone-fibrin composite scaffolds and implanted in nude rats for 2 weeks, resulting in further tissue maturation and increased angiogenic ingrowth in TNF-treated grafts. VEGF-A expression levels were significantly higher in TNF-treated grafts immediately prior to implantation, indicating a long-term pro-angiogenic effect. These findings demonstrate that TNF has the potential to promote vasculogenesis in engineered osteogenic grafts both in vitro and in vivo. Thus, modulation and/or recapitulation of the immune response following bone injury may be a beneficial strategy for bone tissue engineering.	[Hutton, Daphne L.; Kondragunta, Renu; Moore, Erika M.; Hung, Ben P.; Jia, Xiaofeng; Grayson, Warren L.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21218 USA; [Hutton, Daphne L.; Hung, Ben P.; Grayson, Warren L.] Johns Hopkins Univ, Sch Med, Translat Tissue Engn Ctr, Baltimore, MD USA; [Grayson, Warren L.] Johns Hopkins Univ, Sch Med, Dept Mat Sci & Engn, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Grayson, WL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21218 USA.	wgrayson@jhmi.edu	Jia, Xiaofeng/B-2145-2008	Jia, Xiaofeng/0000-0003-1445-8525	Maryland Stem Cell Research Fund [2010-MSCRFE-0150-00]; Johns Hopkins University Center for Musculoskeletal Research; American Society for Bone and Mineral Research [2013CEA13]; American Heart Association pre-doctoral fellowship [12PRE11780069]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118084] Funding Source: NIH RePORTER	Maryland Stem Cell Research Fund; Johns Hopkins University Center for Musculoskeletal Research; American Society for Bone and Mineral Research; American Heart Association pre-doctoral fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was funded by the Maryland Stem Cell Research Fund (2010-MSCRFE-0150-00), Johns Hopkins University Center for Musculoskeletal Research, and the American Society for Bone and Mineral Research (2013CEA13) (awarded to WG), as well as the American Heart Association pre-doctoral fellowship (12PRE11780069) (awarded to DH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai-Aql ZS, 2008, J DENT RES, V87, P107, DOI 10.1177/154405910808700215; Bendeck MP, 2004, CIRC RES, V94, P138, DOI 10.1161/01.RES.0000117525.23089.1A; Caplan AI, 2011, J ORTHOP RES, V29, P1795, DOI 10.1002/jor.21462; Ding J, 2009, LIFE SCI, V84, P499, DOI 10.1016/j.lfs.2009.01.013; FRATERSCHRODER M, 1987, P NATL ACAD SCI USA, V84, P5277, DOI 10.1073/pnas.84.15.5277; Frohlich M, 2010, TISSUE ENG PT A, V16, P179, DOI [10.1089/ten.tea.2009.0164, 10.1089/ten.TEA.2009.0164]; Gaston MS, 2007, J BONE JOINT SURG BR, V89B, P1553, DOI 10.1302/0301-620X.89B12; Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584; Glass GE, 2011, P NATL ACAD SCI USA, V108, P1585, DOI 10.1073/pnas.1018501108; Hawinkels LJAC, 2008, EUR J CANCER, V44, P1904, DOI 10.1016/j.ejca.2008.06.031; Hess K, 2009, BONE, V45, P367, DOI 10.1016/j.bone.2009.04.252; Hung BP, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt158; Hutton DL, 2014, CURR OPIN CHEM ENG, V3, P75, DOI 10.1016/j.coche.2013.12.002; Hutton DL, 2012, TISSUE ENG PT A, V18, P1729, DOI [10.1089/ten.tea.2011.0599, 10.1089/ten.TEA.2011.0599]; Hutton DL, 2013, TISSUE ENG PT A, V19, P2076, DOI [10.1089/ten.tea.2012.0752, 10.1089/ten.TEA.2012.0752]; Koffler J, 2011, P NATL ACAD SCI USA, V108, P14789, DOI 10.1073/pnas.1017825108; Kolar P, 2010, TISSUE ENG PART B-RE, V16, P427, DOI 10.1089/ten.TEB.2009.0687; Lam CXF, 2009, J BIOMED MATER RES A, V90A, P906, DOI 10.1002/jbm.a.32052; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; Lu ZF, 2012, STEM CELLS DEV, V21, P2420, DOI 10.1089/scd.2011.0589; Mountziaris PM, 2008, TISSUE ENG PART B-RE, V14, P179, DOI 10.1089/ten.teb.2008.0038; Mountziaris PM, 2011, TISSUE ENG PART B-RE, V17, P393, DOI [10.1089/ten.teb.2011.0182, 10.1089/ten.TEB.2011.0182]; Mountziaris PM, 2013, J BIOMAT SCI-POLYM E, V24, P1794, DOI 10.1080/09205063.2013.803455; Murnaghan M, 2006, J BONE JOINT SURG AM, V88A, P140, DOI 10.2106/JBJS.F.00454; Nakagami H, 2002, ARTERIOSCL THROM VAS, V22, P238, DOI 10.1161/hq0202.104001; Niemisto A, 2005, IEEE T MED IMAGING, V24, P549, DOI 10.1109/TMI.2004.837339; Pountos I, 2008, INJURY, V39, P384, DOI 10.1016/j.injury.2007.10.035; Sainson RCA, 2008, BLOOD, V111, P4997, DOI 10.1182/blood-2007-08-108597; Sander EA, 2011, ANN BIOMED ENG, V39, P714, DOI 10.1007/s10439-010-0192-2; SATO N, 1986, JNCI-J NATL CANCER I, V76, P1113; SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299, DOI 10.1097/00003086-198604000-00036; Temple JP, 2014, J BIOMED MATER RES A, V102, P4317, DOI 10.1002/jbm.a.35107; Thomas MV, 2011, J DENT RES, V90, P1052, DOI 10.1177/0022034510393967; VOS JG, 1980, CLIN IMMUNOL IMMUNOP, V15, P229, DOI 10.1016/0090-1229(80)90033-1; Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002; Yilmaz A, 1998, INT J CANCER, V77, P592; Zheng HC, 2006, ANTICANCER RES, V26, P3579	37	19	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107199	10.1371/journal.pone.0107199	http://dx.doi.org/10.1371/journal.pone.0107199			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25248109	Green Submitted, gold, Green Published			2022-12-25	WOS:000342351800017
J	Lee, SC; Ngui, R; Tan, TK; Aidil, RM; Lim, YAL				Lee, Soo Ching; Ngui, Romano; Tan, Tiong Kai; Aidil, Roslan Muhammad; Lim, Yvonne Ai Lian			Neglected Tropical Diseases among Two Indigenous Subtribes in Peninsular Malaysia: Highlighting Differences and Co-Infection of Helminthiasis and Sarcocystosis	PLOS ONE			English	Article							SOIL-TRANSMITTED HELMINTHIASES; ORANG-ASLI CHILDREN; LONG-TAILED MONKEY; MUSCULAR SARCOCYSTOSIS; INTESTINAL PARASITISM; WATER BUFFALO; INFECTIONS; PREVALENCE; ULTRASTRUCTURE; SCHOOLCHILDREN	Soil-transmitted helminth (STH) infections have been documented among these minority groups since 1938. However the prevalence of STH is still high among these communities. Most studies tend to consider the Orang Asli (indigenous) as a homogenous group. In contrary, different subtribes have their own cultural practices. To understand this variation better, we studied the prevalence and associated factors of STH and other gut parasitic infections among two common subtribes (i.e. Temuan and Temiar). Results showed that the prevalence of the overall STH infections was higher in the Temuan subtribe (53.2% of 171) compared to the Temiar subtribe (52.7% of 98). Trichuris trichiura (46.2%) was the most prevalent parasite in the Temuan subtribe, followed by Ascaris spp. (25.7%) and hookworm (4.1%). In contrast, Ascaris spp. (39.8%) was more prevalent among the Temiar subtribe, preceded by T. trichiura (35.7%) and finally hookworm (8.3%). There were also co-infections of helminthiasis and intestinal protozoa among both Temuan and Temiar subtribes with rates being three times higher among the Temiar compared to Temuan. The most common co-infection was with Entamoeba histolytica/dispar/moshkovskii (n = 24; 24.5%, 16.0-33.0), followed by Giardia spp. (n = 3; 3.1%, -0.3-6.5). In Temuan, STH infection individuals were also infected with Entamoeba histolytica/dispar/moshkovskii (n = 11; 6.4%, 5.0-13.8), Cryptosporidium spp. (n = 3, 1.8%, -0.2-3.8) and Giardia spp. (n = 2, 1.2%, -0.4-2.8). In comparison, there was no Cryptosporidium spp. detected among the Temiar. However, it was interesting to note that there was an occurrence of co-infection of intestinal helminthiasis and sarcocystosis (intestinal) in a Temiar individual. The last report of sarcocystosis (muscular) among the Orang Asli was in 1978. The present study highlighted the importance of understanding the variation of infections amongst the different Orang Asli subtribes. It is vital to note these differences and use this knowledge to customise effective control measures for the various subtribes.	[Lee, Soo Ching; Ngui, Romano; Tan, Tiong Kai; Aidil, Roslan Muhammad; Lim, Yvonne Ai Lian] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia	Universiti Malaya	Lim, YAL (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.	limailian@um.edu.my	Lee, Soo Ching/J-3159-2014; ROSLAN, MUHAMMAD AIDIL/GLR-2598-2022; LEE, SOO CHING/ABF-1409-2020; Ngui, Romano/H-9645-2015; Tan, Tiong Kai/F-6565-2013; LIM, YVONNE AL/B-5276-2010	Lee, Soo Ching/0000-0002-5454-2265; LEE, SOO CHING/0000-0002-5454-2265; Ngui, Romano/0000-0002-3520-579X; Tan, Tiong Kai/0000-0003-0297-1727; LIM, YVONNE AL/0000-0003-4050-6332	University of Malaya Postgraduate Research [PV024/2011B]; E-Science [16-02-03-6034]; UM/MoHE High Impact Research [H-20001-00-E000061]	University of Malaya Postgraduate Research; E-Science; UM/MoHE High Impact Research	This research work was funded by the University of Malaya Postgraduate Research Grant (PV024/2011B) (YALL), E-Science (16-02-03-6034) (YALL) and UM/MoHE High Impact Research (H-20001-00-E000061) (YALL) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 2013, EMERG INFECT DIS, V19, P1989, DOI 10.3201/eid1912.120530; Adams VJ, 2004, SAMJ S AFR MED J, V94, P972; Aini UN, 2007, ASIA PAC J CLIN NUTR, V16, P724; Al-Mekhlafi HM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002516; Al-Mekhlafi HMS, 2005, ASIA PAC J CLIN NUTR, V14, P188; Al-Mekhlafi MH, 2008, ACTA TROP, V107, P200, DOI 10.1016/j.actatropica.2008.05.022; Al-Mekhlafi M. S. Hesham, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P998; Ambu S, 2011, IEJSME, V5, P29; Anuar TS, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-40; Anuar TS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071870, 10.1371/]; Anuar TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048165; Anuar TS, 2012, INT J PARASITOL, V42, P871, DOI 10.1016/j.ijpara.2012.07.003; Azian MYN, 2007, TROP BIOMED, V24, P55; Baer A., 1999, HLTH DIS SURVIVAL BI; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P37; DISSANAIKE A S, 1974, Southeast Asian Journal of Tropical Medicine and Public Health, V5, P456; DISSANAIKE AS, 1978, Z PARASITENKD, V55, P127, DOI 10.1007/BF00384828; Drake L. J., 2001, Parasitology, V122, pS73, DOI 10.1017/S0031182000017662; DUNN FL, 1972, B WORLD HEALTH ORGAN, V46, P99; Esposito DH, 2012, EUROSURVEILLANCE, V17, P2; Ezeamama AE, 2005, J INFECT DIS, V192, P2160, DOI 10.1086/498219; Ezeamama AE, 2005, AM J TROP MED HYG, V72, P540, DOI 10.4269/ajtmh.2005.72.540; Hakim S. Lokman, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P415; Hanjeet K., 1991, Tropical Biomedicine, V8, P33; Kan S P, 1991, Southeast Asian J Trop Med Public Health, V22 Suppl, P129; KAN SP, 1979, AM J TROP MED HYG, V28, P634, DOI 10.4269/ajtmh.1979.28.634; KAN SP, 1978, Z PARASITENKD, V57, P107, DOI 10.1007/BF00927151; KAN SP, 1987, PUBLIC HEALTH, V101, P243, DOI 10.1016/S0033-3506(87)80075-6; KAN SP, 1976, INT J PARASITOL, V6, P321, DOI 10.1016/0020-7519(76)90054-0; KAN SP, 1977, Z PARASITENKD, V52, P219, DOI 10.1007/BF00380541; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Ki EB, 2011, EXP PARASITOL, V127, P724, DOI 10.1016/j.exppara.2010.11.007; KUTTY M K, 1975, Southeast Asian Journal of Tropical Medicine and Public Health, V6, P400; Lai PF, 1977, SE ASIAN J TROP MED, V68, P108; Latif B, 2013, 49 ANN C MSPTM 19 20, P23; Latif B, 2010, KOREAN J PARASITOL, V48, P213, DOI 10.3347/kjp.2010.48.3.213; Lau YL, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-257; Lau YL, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-250; Lim YAL, 2009, TROP BIOMED, V26, P110; Mohd Sham K, 1996, J CHILDRENS HLTH, V8, P31; Nasr NA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-27; Nevin HM, 1938, REPORT I MED RES FED, P145; Ngui R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000974; Norhayati M., 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P563; PRATHAP K, 1973, T ROY SOC TROP MED H, V67, P615, DOI 10.1016/0035-9203(73)90100-4; Rahmah N, 1997, Med J Malaysia, V52, P412; Rajeswari B, 1994, Asia Pac J Public Health, V7, P21; RAMALINGAM S, 1983, AM J TROP MED HYG, V32, P984, DOI 10.4269/ajtmh.1983.32.984; Samuel F, 2014, PARASITOL INT, V63, P450, DOI 10.1016/j.parint.2013.10.014; Sinniah B, 2012, TROP BIOMED, V29, P200; Skeat W. W., 1906, PAGAN RACES MALAY PE; Tappe D, 2013, TROP BIOMED, V30, P355; THOMAS V, 1978, T ROY SOC TROP MED H, V72, P303, DOI 10.1016/0035-9203(78)90211-0; Thompson RCA, 2001, INT J PARASITOL, V31, P949, DOI 10.1016/S0020-7519(01)00202-8; WALSH JA, 1986, REV INFECT DIS, V8, P228; ZAMAN V, 1975, Z PARASITENKD, V47, P169, DOI 10.1007/BF00418200; ZAMAN V, 1970, T ROY SOC TROP MED H, V64, P195, DOI 10.1016/0035-9203(70)90252-X; Zulkifli A, 1999, Med J Malaysia, V54, P453	58	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107980	10.1371/journal.pone.0107980	http://dx.doi.org/10.1371/journal.pone.0107980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25248116	gold, Green Published, Green Submitted			2022-12-25	WOS:000342351800049
J	Rees, T				Rees, Tony			Taxamatch, an Algorithm for Near ('Fuzzy') Matching of Scientific Names in Taxonomic Databases	PLOS ONE			English	Article							PACKAGE	Misspellings of organism scientific names create barriers to optimal storage and organization of biological data, reconciliation of data stored under different spelling variants of the same name, and appropriate responses from user queries to taxonomic data systems. This study presents an analysis of the nature of the problem from first principles, reviews some available algorithmic approaches, and describes Taxamatch, an improved name matching solution for this information domain. Taxamatch employs a custom Modified Damerau-Levenshtein Distance algorithm in tandem with a phonetic algorithm, together with a rule-based approach incorporating a suite of heuristic filters, to produce improved levels of recall, precision and execution time over the existing dynamic programming algorithms n-grams (as bigrams and trigrams) and standard edit distance. Although entirely phonetic methods are faster than Taxamatch, they are inferior in the area of recall since many real-world errors are non-phonetic in nature. Excellent performance of Taxamatch (as recall, precision and execution time) is demonstrated against a reference database of over 465,000 genus names and 1.6 million species names, as well as against a range of error types as present at both genus and species levels in three sets of sample data for species and four for genera alone. An ancillary authority matching component is included which can be used both for misspelled names and for otherwise matching names where the associated cited authorities are not identical.	CSIRO, Oceans & Atmosphere Flagship, Hobart, Tas, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Rees, T (corresponding author), CSIRO, Oceans & Atmosphere Flagship, Hobart, Tas, Australia.	tonyrees49@gmail.com	Rees, Tony/K-9837-2015	Rees, Tony/0000-0003-1887-5211	CSIRO Marine and Atmospheric Research (CMAR); Ocean Biogeographic Information System (OBIS); Atlas of Living Australia project	CSIRO Marine and Atmospheric Research (CMAR); Ocean Biogeographic Information System (OBIS); Atlas of Living Australia project	I thank Miroslaw Ryba for assistance with deploying the database and algorithms used here, Barbara Boehmer (U.S.A.) for permission to use her initial algorithm for Levenshtein Distance and subsequent development of the extended version to perform the MDLD tests and Michael Kennet for constructing the pseudocode version of the algorithm. I also acknowledge the efforts of two pioneer workers in this area, Thomas Metz (U.S.A., constructor of the GRIN Taxonomic Nomenclature Checker) and Eduardo Dalcin (Brazil), whose ideas, results and real-world systems have informed my own thinking in this area and the latter also for permitting me to use some of his sample misspellings as a supplement to my own test data in the present study. I thank Pamela Brodie, Donald Hobern, Margaret Cawsey, Edward King, Rod Page and an additional anonymous reviewer for helpful comments on this manuscript, also the present known Taxamatch early adopters/developers of ports to other programming languages: Mike Giddens (Silverbiology), Heimo Rainer (Vienna), Dmitry Mozzherin (Global Names Project), Paul Murray and Sam Lee (Atlas of Living Australia), Naim Matasci and Jerry Lu (iPlant), Huijie Qiao (GBIF China) and Bart Vanhoorne (WoRMS) for their interest and enthusiasm for this development activity. Preliminary accounts of this work were included as conference presentations over the period 2007-2009 with support from CSIRO Marine and Atmospheric Research (CMAR), the Ocean Biogeographic Information System (OBIS) and the Atlas of Living Australia project. Finally, my thanks are due to Sheila Brands (Netherlands) and Ellen Farr (U.S.A.) for generous assistance during the initial construction phase of the IRMNG reference database, using genus-level content from their Taxonomicom and Index Nominum Genericorum compilations, respectively.	[Anonymous], 2013, PLANT LIST VERS; Ashdown L, 2014, ORACLE DATABASE CONC; Banks RC, 2003, AUK, V120, P923, DOI 10.1642/0004-8038(2003)120[0923:FSTTAO]2.0.CO;2; Boehmer B, 2002, LEVENSHTEIN DISTANCE; Boyle B, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-16; Carvalho GH, 2010, ENVIRON MODELL SOFTW, V25, P815, DOI 10.1016/j.envsoft.2009.11.014; Cayuela L, 2012, METHODS ECOL EVOL, V3, P1078, DOI 10.1111/j.2041-210X.2012.00232.x; CGIAR (Consultative Group on International Agricultural Research), 2004, GRIN TAX NOM CHECK T; CHAPMAN AD, 2009, NUMBERS LIVING SPECI; Christen P, 2006, ICDM 2006: SIXTH IEEE INTERNATIONAL CONFERENCE ON DATA MINING, WORKSHOPS, P290; Cohen William W., 2003, P IJCAI 03 WORKSH IN, P73; Dalcin EC, 2005, THESIS U SOUTHAMPTON; DAMERAU FJ, 1964, COMMUN ACM, V7, P171, DOI 10.1145/363958.363994; David Normand, 2002, Bulletin of the British Ornithologists' Club, V122, P14; Deorowicz S, 2005, INT J AP MAT COM-POL, V15, P275; Froese R., 1997, Cybium, V21, P265; HALL PAV, 1980, COMPUT SURV, V12, P381, DOI 10.1145/356827.356830; Hernandez MA, 1998, DATA MIN KNOWL DISC, V2, P9, DOI 10.1023/A:1009761603038; Kluyver TA, 2013, ECOL EVOL, V3, P1262, DOI 10.1002/ece3.529; Kukich K., 1992, Computing Surveys, V24, P377, DOI 10.1145/146370.146380; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; LOWRANCE R, 1975, J ACM, V22, P177, DOI 10.1145/321879.321880; Manning C.D., 2008, INTRO INFORM RETRIEV; Muller A, 2007, P TDWG 2007 BRAT SLO, P34; Navarro G, 2001, ACM COMPUT SURV, V33, P31, DOI 10.1145/375360.375365; Patterson DJ, 2010, TRENDS ECOL EVOL, V25, P686, DOI 10.1016/j.tree.2010.09.004; Porter EH, 1997, ADV RECORD LINKAGE S, P190; RAUP DM, 1986, SCIENCE, V231, P1528, DOI 10.1126/science.11542058; Rees A.J.J., 1999, CODES AUSTR AQUATIC; Rees T, 2007, VLIZ SPECIAL PUBLICA, V37, P167; Robertson AM, 1998, J DOC, V54, P48, DOI 10.1108/EUM0000000007161; Schulz K. U., 2002, International Journal on Document Analysis and Recognition, V5, P67, DOI 10.1007/s10032-002-0082-8; Schulz KU, 2007, PROC INT CONF DOC, P471; Senger C, 2010, INT J MED INFORM, V79, P832, DOI 10.1016/j.ijmedinf.2010.09.005; Van Rijsbergen C, 1980, INFORM RETRIEVAL; WAGNER RA, 1974, J ACM, V21, P168, DOI 10.1145/321796.321811; YANNAKOUDAKIS EJ, 1983, INFORM PROCESS MANAG, V19, P101, DOI 10.1016/0306-4573(83)90046-8; YANNAKOUDAKIS EJ, 1983, INFORM PROCESS MANAG, V19, P87, DOI 10.1016/0306-4573(83)90045-6; ZOBEL J, 1995, SOFTWARE PRACT EXPER, V25, P331, DOI 10.1002/spe.4380250307	39	23	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107510	10.1371/journal.pone.0107510	http://dx.doi.org/10.1371/journal.pone.0107510			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247892	Green Published, gold, Green Submitted			2022-12-25	WOS:000342351800024
J	Beekman, C; Sipkens, JA; Testerink, J; Giannakopoulos, S; Kreuger, D; van Deutekom, JC; Campion, GV; de Kimpe, SJ; Lourbakos, A				Beekman, Chantal; Sipkens, Jessica A.; Testerink, Janwillem; Giannakopoulos, Stavros; Kreuger, Dyonne; van Deutekom, Judith C.; Campion, Giles V.; de Kimpe, Sjef J.; Lourbakos, Afrodite			A Sensitive, Reproducible and Objective Immunofluorescence Analysis Method of Dystrophin in Individual Fibers in Samples from Patients with Duchenne Muscular Dystrophy	PLOS ONE			English	Article							SKELETAL-MUSCLE; EXPRESSION; RESTORATION; DELETIONS; SPECTRIN; PROTEIN	Duchenne muscular dystrophy (DMD) is characterized by the absence or reduced levels of dystrophin expression on the inner surface of the sarcolemmal membrane of muscle fibers. Clinical development of therapeutic approaches aiming to increase dystrophin levels requires sensitive and reproducible measurement of differences in dystrophin expression in muscle biopsies of treated patients with DMD. This, however, poses a technical challenge due to intra-and inter-donor variance in the occurrence of revertant fibers and low trace dystrophin expression throughout the biopsies. We have developed an immunofluorescence and semi-automated image analysis method that measures the sarcolemmal dystrophin intensity per individual fiber for the entire fiber population in a muscle biopsy. Cross-sections of muscle co-stained for dystrophin and spectrin have been imaged by confocal microscopy, and image analysis was performed using Definiens software. Dystrophin intensity has been measured in the sarcolemmal mask of spectrin for each individual muscle fiber and multiple membrane intensity parameters (mean, maximum, quantiles per fiber) were calculated. A histogram can depict the distribution of dystrophin intensities for the fiber population in the biopsy. This method was tested by measuring dystrophin in DMD, Becker muscular dystrophy, and healthy muscle samples. Analysis of duplicate or quadruplicate sections of DMD biopsies on the same or multiple days, by different operators, or using different antibodies, was shown to be objective and reproducible (inter-assay precision, CV 2-17% and intra-assay precision, CV 2-10%). Moreover, the method was sufficiently sensitive to detect consistently small differences in dystrophin between two biopsies from a patient with DMD before and after treatment with an investigational compound.	[Beekman, Chantal; Sipkens, Jessica A.; Testerink, Janwillem; Giannakopoulos, Stavros; Kreuger, Dyonne; van Deutekom, Judith C.; Campion, Giles V.; de Kimpe, Sjef J.; Lourbakos, Afrodite] Prosensa Therapeut BV, Leiden, Netherlands	BioMarin Pharmaceutical Inc.; Prosensa	de Kimpe, SJ (corresponding author), Prosensa Therapeut BV, Leiden, Netherlands.	s.dekimpe@prosensa.nl			Prosensa Therapeutics BV, Leiden, the Netherlands	Prosensa Therapeutics BV, Leiden, the Netherlands	Funding provided by Prosensa Therapeutics BV, Leiden, the Netherlands. The funder provided support in the form of salaries, equipment and facilities for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony K, 2014, JAMA NEUROL, V71, P32, DOI 10.1001/jamaneurol.2013.4908; APPLEYARD ST, 1984, P NATL ACAD SCI-BIOL, V81, P776, DOI 10.1073/pnas.81.3.776; Arechavala-Gomeza V, 2010, NEUROPATH APPL NEURO, V36, P265, DOI 10.1111/j.1365-2990.2009.01056.x; Arechavala-Gomeza V, 2010, NEUROMUSCULAR DISORD, V20, P295, DOI 10.1016/j.nmd.2010.03.007; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Hollinger K, 2014, FASEB J, V28, P1600, DOI 10.1096/fj.13-241141; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Lourbakos A, 2011, NEUROMUSCULAR DISORD, V21, P643, DOI 10.1016/j.nmd.2011.06.766; Nguyen TM, 1993, AM J HUM GENET, V52, P1; NGUYEN TM, 1990, FEBS LETT, V262, P237; NICHOLSON LVB, 1990, ACTA NEUROPATHOL, V80, P239, DOI 10.1007/BF00294640; REPASKY EA, 1986, P NATL ACAD SCI USA, V83, P802, DOI 10.1073/pnas.83.3.802; Taylor LE, 2012, NEUROPATH APPL NEURO, V38, P591, DOI 10.1111/j.1365-2990.2012.01250.x; Van Deutekom J, 2013, DRUG DISCOV TODAY TH, V10, pe149, DOI DOI 10.1016/J.DDSTR.2013.04.001; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; VOIT T, 1991, NEUROPEDIATRICS, V22, P152, DOI 10.1055/s-2008-1071434	16	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107494	10.1371/journal.pone.0107494	http://dx.doi.org/10.1371/journal.pone.0107494			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244123	Green Submitted, Green Published, gold			2022-12-25	WOS:000343679800037
J	Chen, C; Ma, HW; Zhang, F; Chen, L; Xing, XS; Wang, SS; Zhang, X; Luo, Y				Chen, Chen; Ma, Hongwei; Zhang, Feng; Chen, Lu; Xing, Xuesha; Wang, Shusen; Zhang, Xue; Luo, Yang			Screening of Duchenne Muscular Dystrophy (DMD) Mutations and Investigating Its Mutational Mechanism in Chinese Patients	PLOS ONE			English	Article							BREAK-INDUCED REPLICATION; COMPARATIVE GENOMIC HYBRIDIZATION; NONRECURRENT REARRANGEMENTS; DELETION BREAKPOINTS; GENE; DUPLICATIONS; DISORDERS; SPECTRUM; INSIGHTS; MLPA	Duchenne muscular dystrophy (DMD) is a common X-linked recessive disease of muscle degeneration and death. In order to provide accurate and reliable genetic counseling and prenatal diagnosis, we screened DMD mutations in a cohort of 119 Chinese patients using multiplex ligation-dependent probe amplification (MLPA) and denaturing high performance liquid chromatography (DHPLC) followed by Sanger sequencing. In these unrelated DMD patients, we identified 11 patients with DMD small mutations (9.2%) and 81 patients with DMD deletions/duplications (del/dup) (68.1%), of which 64 (79.0%) were deletions, 16 (19.8%) were duplications, and one (1.2%) was both deletion and duplication. Furthermore, we analyzed the frequency of DMD breakpoint in the 64 deletion cases by calculating exon-deletion events of certain exon interval that revealed a novel mutation hotspot boundary. To explore why DMD rearrangement breakpoints were predisposed to specific regions (hotspot), we precisely characterized junction sequences of breakpoints at the nucleotide level in 21 patients with exon deleted/duplicated in DMD with a high-resolution SNP microarray assay. There were no exactly recurrent breakpoints and there was also no significant difference between single-exon del/dup and multiple-exon del/dup cases. The data from the current study provided a comprehensive strategy to detect DMD mutations for clinical practice, and identified two deletion hotspots at exon 43-55 and exon 10-23 by calculating exon-deletion events of certain exon interval. Furthermore, this is the first study to characterize DMD breakpoint at the nucleotide level in a Chinese population. Our observations provide better understanding of the mechanism for DMD gene rearrangements.	[Chen, Chen; Xing, Xuesha; Wang, Shusen; Luo, Yang] China Med Univ, Coll Basic Med Sci, Res Ctr Med Genom, Key Lab Med Cell Biol,Chinese Minist Educ, Shenyang, Peoples R China; [Ma, Hongwei] China Med Univ, Shengjing Hosp, Dept Dev Pediat, Shenyang, Peoples R China; [Zhang, Feng; Chen, Lu] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhang, Feng] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Zhang, Xue] Chinese Acad Med Sci, Inst Basic Med Sci, McKusick Zhang Ctr Genet Med, State Key Lab Med Mol Biol, Beijing 100730, Peoples R China; [Zhang, Xue] Peking Union Med Coll, Beijing 100021, Peoples R China	China Medical University; China Medical University; Fudan University; Fudan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Luo, Y (corresponding author), China Med Univ, Coll Basic Med Sci, Res Ctr Med Genom, Key Lab Med Cell Biol,Chinese Minist Educ, Shenyang, Peoples R China.	luoyang@mail.cmu.edu.cn	Zhang, Feng/C-7735-2009	Zhang, Feng/0000-0003-4556-8276	National Basic Research Program of China [2012CB944600]; National Natural Science Foundation of China [81170543]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (2012CB944600) and National Natural Science Foundation of China (81170543). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankala A, 2012, GENOME RES, V22, P25, DOI 10.1101/gr.123463.111; Bauters M, 2008, GENOME RES, V18, P847, DOI 10.1101/gr.075903.107; Bennett RR, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-17; BUSHBY KMD, 1991, LANCET, V337, P1022, DOI 10.1016/0140-6736(91)92671-N; Conrad DF, 2010, NAT GENET, V42, P385, DOI 10.1038/ng.564; del Gaudio D, 2008, HUM MUTAT, V29, P1100, DOI 10.1002/humu.20841; DENDUNNEN JT, 1992, HUM MOL GENET, V1, P19; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Inoue K, 2002, AM J HUM GENET, V71, P838, DOI 10.1086/342728; Ishmukhametova A, 2012, EUR J HUM GENET, V20, P1096, DOI 10.1038/ejhg.2012.51; Kidd JM, 2010, CELL, V143, P837, DOI 10.1016/j.cell.2010.10.027; Kraus E, 2001, P NATL ACAD SCI USA, V98, P8255, DOI 10.1073/pnas.151008198; Lai PS, 2002, J HUM GENET, V47, P552, DOI 10.1007/s100380200084; Lalic T, 2005, EUR J HUM GENET, V13, P1231, DOI 10.1038/sj.ejhg.5201465; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Mitsui J, 2010, AM J HUM GENET, V87, P75, DOI 10.1016/j.ajhg.2010.06.006; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Nobile C, 2002, HUM GENET, V110, P418, DOI 10.1007/s00439-002-0721-7; Oshima J, 2009, HUM GENET, V126, P411, DOI 10.1007/s00439-009-0679-9; Sheen CR, 2007, HUM MUTAT, V28, P1198, DOI 10.1002/humu.20591; Stankiewicz P, 2003, AM J HUM GENET, V72, P1101, DOI 10.1086/374385; Takeshima Y, 2006, PEDIATR RES, V59, P690, DOI 10.1203/01.pdr.0000215047.51278.7c; Takeshima Y, 2010, J HUM GENET, V55, P379, DOI 10.1038/jhg.2010.49; Toffolatti L, 2002, GENOMICS, V80, P523, DOI 10.1006/geno.2002.6861; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Tran VK, 2013, J NEUROGENET, V27, P170, DOI 10.3109/01677063.2013.830616; Walmsley GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008647; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; White S, 2002, AM J HUM GENET, V71, P365, DOI 10.1086/341942; Yang J, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-29; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399	35	15	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e108038	10.1371/journal.pone.0108038	http://dx.doi.org/10.1371/journal.pone.0108038			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244321	gold, Green Published, Green Submitted			2022-12-25	WOS:000343679800062
J	Bek-Thomsen, M; Lomholt, HB; Scavenius, C; Enghild, JJ; Bruggemann, H				Bek-Thomsen, Malene; Lomholt, Hans B.; Scavenius, Carsten; Enghild, Jan J.; Bruggemann, Holger			Proteome Analysis of Human Sebaceous Follicle Infundibula Extracted from Healthy and Acne-Affected Skin	PLOS ONE			English	Article							PROPIONIBACTERIUM-ACNES; STRAIN POPULATIONS; GENOME SEQUENCE; EXPRESSION; INDUCTION; VIMENTIN; PROTEINS; PROHIBITINS; LIPASE	Acne vulgaris is a very common disease of the pilosebaceous unit of the human skin. The pathological processes of acne are not fully understood. To gain further insight sebaceous follicular casts were extracted from 18 healthy and 20 acne-affected individuals by cyanoacrylate-gel biopsies and further processed for mass spectrometry analysis, aiming at a proteomic analysis of the sebaceous follicular casts. Human as well as bacterial proteins were identified. Human proteins enriched in acne and normal samples were detected, respectively. Normal follicular casts are enriched in proteins such as prohibitins and peroxiredoxins which are involved in the protection from various stresses, including reactive oxygen species. By contrast, follicular casts extracted from acne-affected skin contained proteins involved in inflammation, wound healing and tissue remodeling. Among the most distinguishing proteins were myeloperoxidase, lactotransferrin, neutrophil elastase inhibitor and surprisingly, vimentin. The most significant biological process among all acne-enriched proteins was `response to a bacterium'. Identified bacterial proteins were exclusively from Propionibacterium acnes. The most abundant P. acnes proteins were surface-exposed dermatan sulphate adhesins, CAMP factors, and a so far uncharacterized lipase in follicular casts extracted from normal as well as acne-affected skin. This is a first proteomic study that identified human proteins together with proteins of the skin microbiota in sebaceous follicular casts.	[Bek-Thomsen, Malene; Lomholt, Hans B.; Bruggemann, Holger] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Scavenius, Carsten; Enghild, Jan J.] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark	Aarhus University; Aarhus University	Bruggemann, H (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	brueggemann@microbiology.au.dk	; Scavenius, Carsten/Q-5941-2017	Enghild, Jan Johannes/0000-0001-9292-9172; Scavenius, Carsten/0000-0002-4304-0681; Bruggemann, Holger/0000-0001-7433-0190	Danish Medical Research council [DFF-1331-00241]	Danish Medical Research council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Danish Medical Research council (DFF-1331-00241) to HB (http://ufm.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyev OA, 2013, J INVEST DERMATOL, V133, P2292, DOI 10.1038/jid.2013.116; Bek-Thomsen M, 2008, J CLIN MICROBIOL, V46, P3355, DOI 10.1128/JCM.00799-08; Bruggemann H, 2004, SCIENCE, V305, P671, DOI 10.1126/science.1100330; Bruggemann Holger, 2012, Mob Genet Elements, V2, P145; Ceafalan L, 2012, J CELL MOL MED, V16, P1405, DOI 10.1111/j.1582-4934.2012.01580.x; Chowdhury I, 2014, J CELL PHYSIOL, V229, P998, DOI 10.1002/jcp.24531; Christensen GJM, 2014, BENEF MICROBES, V5, P201, DOI 10.3920/BM2012.0062; Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x; Craft N, 2013, J INVEST DERMATOL, V133, P2295, DOI 10.1038/jid.2013.275; Dessinioti C, 2010, CLIN DERMATOL, V28, P2, DOI 10.1016/j.clindermatol.2009.03.012; Dyrlund TF, 2012, PROTEOMICS, V12, P2792, DOI 10.1002/pmic.201200109; Eady EA, 2013, J INVEST DERMATOL, V133, P2294, DOI 10.1038/jid.2013.259; Fehri LF, 2011, INT J MED MICROBIOL, V301, P69, DOI 10.1016/j.ijmm.2010.08.014; Fitz-Gibbon S, 2013, J INVEST DERMATOL, V133, P2152, DOI 10.1038/jid.2013.21; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Grange PA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000527; GRIBBON EM, 1993, J GEN MICROBIOL, V139, P1745, DOI 10.1099/00221287-139-8-1745; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Holland C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-230; Hu Q, 2013, J PROTEOME RES, V12, P5340, DOI 10.1021/pr4006266; Ivaska Johanna, 2011, Small GTPases, V2, P51; Jugeau S, 2005, BRIT J DERMATOL, V153, P1105, DOI 10.1111/j.1365-2133.2005.06933.x; Kim J, 2002, J IMMUNOL, V169, P1535, DOI 10.4049/jimmunol.169.3.1535; Kim SU, 2013, J NEUROIMMUNOL, V259, P26, DOI 10.1016/j.jneuroim.2013.03.006; Kistowska M, 2014, J INVEST DERMATOL, V134, P677, DOI 10.1038/jid.2013.438; LEE WL, 1982, INFECT IMMUN, V35, P71, DOI 10.1128/IAI.35.1.71-78.1982; LEEMING JP, 1988, BRIT J DERMATOL, V118, P203, DOI 10.1111/j.1365-2133.1988.tb01775.x; Lodes MJ, 2006, MICROBIOL-SGM, V152, P3667, DOI 10.1099/mic.0.29219-0; Lomholt HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012277; Mak TN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-640; Mak TN, 2012, CELL MICROBIOL, V14, P1720, DOI 10.1111/j.1462-5822.2012.01833.x; McDowell A, 2005, J CLIN MICROBIOL, V43, P326, DOI 10.1128/JCM.43.1.326-334.2005; McDowell A, 2008, J MED MICROBIOL, V57, P218, DOI 10.1099/jmm.0.47489-0; McDowell A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070897; McDowell A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041480; McDowell A, 2012, J BACTERIOL, V194, P3260, DOI 10.1128/JB.00479-12; McDowell A, 2011, MICROBIOL-SGM, V157, P1990, DOI 10.1099/mic.0.049676-0; Menko AS, 2014, MOL BIOL CELL, V25, P776, DOI 10.1091/mbc.E12-12-0900; Miskin JE, 1997, MICROBIOL-UK, V143, P1745, DOI 10.1099/00221287-143-5-1745; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; Nagy I, 2005, J INVEST DERMATOL, V124, P931, DOI 10.1111/j.0022-202X.2005.23705.x; Nagy I, 2006, MICROBES INFECT, V8, P2195, DOI 10.1016/j.micinf.2006.04.001; Nakatsuji T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014797; Neumann CA, 2009, CELL CYCLE, V8, P4072, DOI 10.4161/cc.8.24.10242; Osman C, 2009, J CELL SCI, V122, P3823, DOI 10.1242/jcs.037655; PUHVEL SM, 1975, J INVEST DERMATOL, V65, P525, DOI 10.1111/1523-1747.ep12610239; Qin M, 2014, J INVEST DERMATOL, V134, P381, DOI 10.1038/jid.2013.309; Sahdo B, 2013, APMIS, V121, P652, DOI 10.1111/apm.12035; Shaheen B, 2013, J EUR ACAD DERMATOL, V27, P1, DOI 10.1111/j.1468-3083.2012.04516.x; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shu MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055380; Sorensen M, 2010, J MICROBIOL METH, V83, P211, DOI 10.1016/j.mimet.2010.09.008; Tanabe T, 2006, BBA-MOL BASIS DIS, V1762, P794, DOI 10.1016/j.bbadis.2006.07.006; Tchaptchet S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039155; Trivedi NR, 2006, J INVEST DERMATOL, V126, P1071, DOI 10.1038/sj.jid.5700213; Valanne S, 2005, MICROBIOL-SGM, V151, P1369, DOI 10.1099/mic.0.27788-0; Voros A, 2012, J BACTERIOL, V194, P1621, DOI 10.1128/JB.06758-11; Williams HC, 2012, LANCET, V379, P361, DOI 10.1016/S0140-6736(11)60321-8	58	33	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107908	10.1371/journal.pone.0107908	http://dx.doi.org/10.1371/journal.pone.0107908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238151	Green Submitted, Green Published, gold			2022-12-25	WOS:000342491600062
J	Rizzo, M; Bayo, J; Piccioni, F; Malvicini, M; Fiore, E; Peixoto, E; Garcia, MG; Aquino, JB; Campana, AG; Podesta, G; Terres, M; Andriani, O; Alaniz, L; Mazzolini, G				Rizzo, Manglio; Bayo, Juan; Piccioni, Flavia; Malvicini, Mariana; Fiore, Esteban; Peixoto, Estanislao; Garcia, Mariana G.; Aquino, Jorge B.; Gonzalez Campana, Ariel; Podesta, Gustavo; Terres, Marcelo; Andriani, Oscar; Alaniz, Laura; Mazzolini, Guillermo			Low Molecular Weight Hyaluronan-Pulsed Human Dendritic Cells Showed Increased Migration Capacity and Induced Resistance to Tumor Chemoattraction	PLOS ONE			English	Article							HUMAN-MELANOMA CELLS; MATRIX METALLOPROTEINASE-9; LYMPH-NODES; T-CELLS; INTERLEUKIN-8; CYTOKINE; RECEPTOR; INDUCTION; IMMUNOTHERAPY; EXPRESSION	We have shown that ex vivo pre-conditioning of bone marrow-derived dendritic cells (DC) with low molecular weight hyaluronan (LMW HA) induces antitumor immunity against colorectal carcinoma (CRC) in mice. In the present study we investigated the effects of LMW HA priming on human-tumor-pulsed monocytes-derived dendritic cells (DC/TL) obtained from healthy donors and patients with CRC. LMW HA treatment resulted in an improved maturation state of DC/TL and an enhanced mixed leucocyte reaction activity in vivo. Importantly, pre-conditioning of DC/TL with LMW HA increased their ability to migrate and reduced their attraction to human tumor derived supernatants. These effects were associated with increased CCR7 expression levels in DC. Indeed, a significant increase in migratory response toward CCL21 was observed in LMW HA primed tumor-pulsed monocyte-derived dendritic cells (DC/TL/LMW HA) when compared to LWM HA untreated cells (DC/TL). Moreover, LMW HA priming modulated other mechanisms implicated in DC migration toward lymph nodes such as the metalloproteinase activity. Furthermore, it also resulted in a significant reduction in DC migratory capacity toward tumor supernatant and IL8 in vitro. Consistently, LMW HA dramatically enhanced in vivo DC recruitment to tumor-regional lymph nodes and reduced DC migration toward tumor tissue. This study shows that LMW HA -a poorly immunogenic molecule-represents a promising candidate to improve human DC maturation protocols in the context of DC-based vaccines development, due to its ability to enhance their immunogenic properties as well as their migratory capacity toward lymph nodes instead of tumors.	[Rizzo, Manglio; Bayo, Juan; Piccioni, Flavia; Malvicini, Mariana; Fiore, Esteban; Peixoto, Estanislao; Garcia, Mariana G.; Aquino, Jorge B.; Mazzolini, Guillermo] Univ Austral, Fac Ciencias Biomed, Gene Therapy Lab, Derqui Pilar, Buenos Aires, Argentina; [Malvicini, Mariana; Garcia, Mariana G.; Aquino, Jorge B.; Alaniz, Laura; Mazzolini, Guillermo] Consejo Nacl Invest Cient & Tecn, CABA, Buenos Aires, DF, Argentina; [Gonzalez Campana, Ariel; Podesta, Gustavo; Terres, Marcelo; Andriani, Oscar] Univ Austral, Hosp Austral, Dept Surg, Derqui Pilar, Buenos Aires, Argentina; [Alaniz, Laura] Univ Nacl Noroeste Pcia Bs As UNNOBA, CIT NOBA, Junin, Buenos Aires, Argentina	Austral University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Austral University	Alaniz, L (corresponding author), Consejo Nacl Invest Cient & Tecn, CABA, Buenos Aires, DF, Argentina.	laualaniz@yahoo.com.ar; gmazzoli@cas.austral.edu.ar	, Ph.D/K-4540-2019; Alaniz, Laura/AAM-2676-2020	Alaniz, Laura/0000-0002-6070-6078; Bayo Fina, Juan Miguel/0000-0003-3999-0841; Fiore, Esteban/0000-0003-1059-1695; Aquino, Jorge B/0000-0002-3818-5181	Austral University [I01-12, I02-12, T13-12]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) grants [PICT-2007/00082, PICTO 2008/00115, PICT 2010/2818, PICT 2012/1407]	Austral University; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) grants	This work was supported by grants from Austral University (to MR: #I01-12; FP I02-12; MG T13-12) and from Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) grants. To LA: PICT-2007/00082; MG: PICTO 2008/00115; MG and GM: PICT 2010/2818; GM: PICT 2012/1407. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adema GJ, 2005, CURR OPIN IMMUNOL, V17, P170, DOI 10.1016/j.coi.2005.01.004; Ahamed J, 2001, J IMMUNOL, V167, P3559, DOI 10.4049/jimmunol.167.7.3559; Alaniz L, 2011, CANCER IMMUNOL IMMUN, V60, P1383, DOI 10.1007/s00262-011-1036-0; Alaniz L, 2009, MINI-REV MED CHEM, V9, P1538, DOI 10.2174/138955709790361485; Alfaro C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017922; Allavena P, 2000, IMMUNOL REV, V177, P141, DOI 10.1034/j.1600-065X.2000.17714.x; Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Banchereau J, 2001, CELL, V106, P271, DOI 10.1016/S0092-8674(01)00448-2; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bartz H, 2006, BLOOD, V108, P4102, DOI 10.1182/blood-2006-03-008946; Berzofsky JA, 2004, J CLIN INVEST, V113, P1515, DOI 10.1172/JCI200421926; Bianchi G, 2000, Dev Immunol, V7, P143, DOI 10.1155/2000/39893; Dalerba P, 2003, CRIT REV ONCOL HEMAT, V46, P33, DOI 10.1016/S1040-8428(02)00159-2; Dauer M, 2008, EXPERT REV VACCINES, V7, P1041, DOI 10.1586/14760584.7.7.1041; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; de Vries IJM, 2003, CANCER RES, V63, P12; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Do Y, 2004, J IMMUNOTHER, V27, P1, DOI 10.1097/00002371-200401000-00001; Feijoo E, 2005, INT J CANCER, V116, P275, DOI 10.1002/ijc.21046; Fieber C, 2004, J CELL SCI, V117, P359, DOI 10.1242/jcs.00831; Gebhardt C, 2007, EXP DERMATOL, V16, P636, DOI 10.1111/j.1600-0625.2007.00572.x; Giermasz AS, 2009, CANCER IMMUNOL IMMUN, V58, P1329, DOI 10.1007/s00262-008-0648-5; Gilboa E, 2004, NAT REV CANCER, V4, P401, DOI 10.1038/nrc1359; Huang D, 2010, CANCER RES, V70, P1063, DOI 10.1158/0008-5472.CAN-09-3965; Hurwitz AA, 2012, CANCER IMMUNOL IMMUN, V61, P289, DOI 10.1007/s00262-011-1181-5; Isacke CM, 2002, INT J BIOCHEM CELL B, V34, P718, DOI 10.1016/S1357-2725(01)00166-2; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kim HG, 2000, BIOCHEM BIOPH RES CO, V269, P401; Kim Y, 2008, J BIOL CHEM, V283, P22513, DOI 10.1074/jbc.M708319200; Lang S, 2002, FASEB J, V16, P286, DOI 10.1096/fj.02-0417fje; Lesley J, 2000, J BIOL CHEM, V275, P26967; Lesterhuis WJ, 2011, CLIN CANCER RES, V17, P5725, DOI 10.1158/1078-0432.CCR-11-1261; Luca M, 1997, AM J PATHOL, V151, P1105; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Mascarenhas MM, 2004, AM J RESP CELL MOL, V30, P51, DOI 10.1165/rcmb.2002-0167OC; McKee CM, 1997, J BIOL CHEM, V272, P8013, DOI 10.1074/jbc.272.12.8013; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; Miaw SC, 2010, J INVEST DERMATOL, V130, P2674, DOI 10.1038/jid.2010.170; Moler I, 2008, J IMMUNOTHER, V31, P506, DOI 10.1097/CJI.0b013e318177d9e5; Morse MA, 1999, CANCER RES, V59, P56; Mummert ME, 2005, IMMUNOL RES, V31, P189, DOI 10.1385/IR:31:3:189; MUNOZ C, 1991, J CLIN INVEST, V88, P1747, DOI 10.1172/JCI115493; Noble PW, 1996, J EXP MED, V183, P2373, DOI 10.1084/jem.183.5.2373; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Pascual V, 2008, IMMUNOL REV, V223, P39, DOI 10.1111/j.1600-065X.2008.00643.x; Ratzinger G, 2002, J IMMUNOL, V168, P4361, DOI 10.4049/jimmunol.168.9.4361; Rodriguez-Salvador J, 2005, J EXP CLIN CANC RES, V24, P463; Scandella E, 2002, BLOOD, V100, P1354, DOI 10.1182/blood-2001-11-0017; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Segura E, 2009, P NATL ACAD SCI USA, V106, P20377, DOI 10.1073/pnas.0910295106; Silk KM, 2011, GENE THER; Sozzani S, 2000, J CLIN IMMUNOL, V20, P151, DOI 10.1023/A:1006659211340; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Termeer CC, 2000, J IMMUNOL, V165, P1863, DOI 10.4049/jimmunol.165.4.1863; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; van Helden SFG, 2006, J IMMUNOL, V177, P1567, DOI 10.4049/jimmunol.177.3.1567; Verdijk P, 2008, EXPERT OPIN BIOL TH, V8, P865, DOI [10.1517/14712598.8.7.865, 10.1517/14712598.8.7.865 ]; Visintin A, 2001, J IMMUNOL, V166, P249, DOI 10.4049/jimmunol.166.1.249; Voelcker V, 2008, EXP DERMATOL, V17, P100, DOI 10.1111/j.1600-0625.2007.00638.x; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; Yamawaki H, 2009, GLYCOBIOLOGY, V19, P83, DOI 10.1093/glycob/cwn109; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	65	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107944	10.1371/journal.pone.0107944	http://dx.doi.org/10.1371/journal.pone.0107944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238610	Green Submitted, Green Published, gold			2022-12-25	WOS:000342491600066
J	Mathsyaraja, H; Thies, K; Taffany, DA; Deighan, C; Liu, T; Yu, L; Fernandez, SA; Shapiro, C; Otero, J; Timmers, C; Lustberg, MB; Chalmers, J; Leone, G; Ostrowski, MC				Mathsyaraja, H.; Thies, K.; Taffany, D. A.; Deighan, C.; Liu, T.; Yu, L.; Fernandez, S. A.; Shapiro, C.; Otero, J.; Timmers, C.; Lustberg, M. B.; Chalmers, J.; Leone, G.; Ostrowski, M. C.			CSF1-ETS2-induced microRNA in myeloid cells promote metastatic tumor growth	ONCOGENE			English	Article							BREAST-CANCER; IN-VIVO; IMMUNE-RESPONSE; MACROPHAGES; INHIBITION; DIFFERENTIATION; POLARIZATION; ANGIOGENESIS; ACTIVATION; EXPRESSION	Metastasis of solid tumors is associated with poor prognosis and bleak survival rates. Tumor-infiltrating myeloid cells (TIMs) are known to promote metastasis, but the mechanisms underlying their collaboration with tumor cells remain unknown. Here, we report an oncogenic role for microRNA (miR) in driving M2 reprogramming in TIMs, characterized by the acquisition of pro-tumor and pro-angiogenic properties. The expression of miR-21, miR-29a, miR-142-3p and miR-223 increased in myeloid cells during tumor progression in mouse models of breast cancer and melanoma metastasis. Further, we show that these miRs are regulated by the CSF1-ETS2 pathway in macrophages. A loss-of-function approach utilizing selective depletion of the miR-processing enzyme Dicer in mature myeloid cells blocks angiogenesis and metastatic tumor growth. Ectopic expression of miR-21 and miR-29a promotes angiogenesis and tumor cell proliferation through the downregulation of anti-angiogenic genes such as Col4a2, Spry1 and Timp3, whereas knockdown of the miRs impedes these processes. miR-21 and miR-29a are expressed in Csf1r+ myeloid cells associated with human metastatic breast cancer, and levels of these miRs in CD115+ non-classical monocytes correlates with metastatic tumor burden in patients. Taken together, our results suggest that miR-21 and miR-29a are essential for the pro-tumor functions of myeloid cells and the CSF1-ETS2 pathway upstream of the miRs serves as an attractive therapeutic target for the inhibition of M2 remodeling of macrophages during malignancy. In addition, miR-21 and miR-29a in circulating myeloid cells may potentially serve as biomarkers to measure therapeutic efficacy of targeted therapies for CSF1 signaling.	[Mathsyaraja, H.; Thies, K.; Taffany, D. A.; Ostrowski, M. C.] Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Mathsyaraja, H.; Thies, K.; Taffany, D. A.; Liu, T.; Shapiro, C.; Otero, J.; Timmers, C.; Lustberg, M. B.; Chalmers, J.; Leone, G.; Ostrowski, M. C.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Deighan, C.; Chalmers, J.] Ohio State Univ, Dept Chem Engn, Columbus, OH 43210 USA; [Yu, L.; Fernandez, S. A.] Ohio State Univ, Dept Biomed Informat, Ctr Biostat, Columbus, OH 43210 USA; [Shapiro, C.; Lustberg, M. B.] Ohio State Univ, Coll Med, Dept Internal Med, Columbus, OH 43210 USA; [Otero, J.] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA; [Leone, G.] Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Leone, G.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ostrowski, MC (corresponding author), Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Tumor Microenvironm Program, 598 Biomed Res Tower,460W 12th Ave, Columbus, OH 43210 USA.	michael.ostrowski@osumc.edu	Otero, Jose/AAI-4891-2020; yu, lianbo/B-3472-2010; Otero, Jose Javier/B-8955-2013; Ostrowski, Michael/H-3108-2011	Otero, Jose/0000-0003-0680-4520; Ostrowski, Michael/0000-0003-2948-6297	National Institutes of Health [NIHPO1CA097189, RO1CA053271]; Evelyn Simmers Foundation; NATIONAL CANCER INSTITUTE [P01CA097189, R01CA053271, P30CA016058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Evelyn Simmers Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Yongqi Wu for help with flow cytometry. We also wish to acknowledge the histology core, OSU Comprehensive Cancer Center Microarray, Nucleic Acids, Analytical Cytometry, Microscopy and Biostatistics Core Shared Resources for technical assistance. This work was funded through National Institutes of Health grants (NIHPO1CA097189 and RO1CA053271) and the Evelyn Simmers Foundation to MCO.	Brain O, 2013, IMMUNITY, V39, P521, DOI 10.1016/j.immuni.2013.08.035; BROCKER EB, 1987, CANCER IMMUNOL IMMUN, V25, P81; Chen PW, 2011, CLIN CANCER RES, V17, P7230, DOI 10.1158/1078-0432.CCR-11-1354; Chen Q, 2011, CANCER CELL, V20, P538, DOI 10.1016/j.ccr.2011.08.025; Cho HJ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3195; Chou J, 2013, NAT CELL BIOL, V15, P201, DOI 10.1038/ncb2672; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Conway JG, 2005, P NATL ACAD SCI USA, V102, P16078, DOI 10.1073/pnas.0502000102; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; DUNHAM LJ, 1953, JNCI-J NATL CANCER I, V13, P1299; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; FIDLER IJ, 1975, CANCER RES, V35, P218; Fowles LF, 1998, MOL CELL BIOL, V18, P5148, DOI 10.1128/MCB.18.9.5148; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gao D, 2009, TRENDS MOL MED, V15, P333, DOI 10.1016/j.molmed.2009.06.006; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Hu R, 2007, MOL CELL BIOL, V27, P4018, DOI 10.1128/MCB.01839-06; Jensen TO, 2009, J CLIN ONCOL, V27, P3330, DOI 10.1200/JCO.2008.19.9919; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P705, DOI 10.1189/jlb.1105656; Leek RD, 2002, J MAMMARY GLAND BIOL, V7, P177, DOI 10.1023/A:1020304003704; Liu G, 2013, ARTERIOSCL THROM VAS, V33, P170, DOI 10.1161/ATVBAHA.112.300068; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu TX, 2011, J IMMUNOL, V187, P3362, DOI 10.4049/jimmunol.1101235; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Marneros AG, 2001, MATRIX BIOL, V20, P337, DOI 10.1016/S0945-053X(01)00151-2; Mok S, 2014, CANCER RES, V74, P153, DOI 10.1158/0008-5472.CAN-13-1816; Mossadegh-Keller N, 2013, NATURE, V497, P239, DOI 10.1038/nature12026; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Pei XF, 2004, IN VITRO CELL DEV-AN, V40, P14; Priceman SJ, 2010, BLOOD, V115, P1461, DOI 10.1182/blood-2009-08-237412; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Rae F, 2007, DEV BIOL, V308, P232, DOI 10.1016/j.ydbio.2007.05.027; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Squadrito ML, 2012, CELL REPORTS, V1, P141, DOI 10.1016/j.celrep.2011.12.005; Strauss-Ayali D, 2007, J LEUKOCYTE BIOL, V82, P244, DOI 10.1189/jlb.0307191; Tagliani E, 2011, J EXP MED, V208, P1901, DOI 10.1084/jem.20110866; Wang T, 2012, PIGM CELL MELANOMA R, V25, P493, DOI 10.1111/j.1755-148X.2012.01005.x; Wei G, 2004, J IMMUNOL, V173, P1374, DOI 10.4049/jimmunol.173.2.1374; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; Yan HH, 2010, CANCER RES, V70, P6139, DOI 10.1158/0008-5472.CAN-10-0706; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yang M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-117; Zabuawala T, 2010, CANCER RES, V70, P1323, DOI 10.1158/0008-5472.CAN-09-1474; Zaidi MR, 2011, NATURE, V469, P548, DOI 10.1038/nature09666; Zonari E, 2013, BLOOD, V122, P243, DOI 10.1182/blood-2012-08-449306	58	48	48	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2015	34	28					3651	3661		10.1038/onc.2014.294	http://dx.doi.org/10.1038/onc.2014.294			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM4TZ	25241894	Green Accepted			2022-12-25	WOS:000357679100004
J	Lu, L; Zheng, L; Si, Y; Luo, WY; Dujardin, G; Kwan, T; Potochick, NR; Thompson, SR; Schneider, DA; King, PH				Lu, Liang; Zheng, Lei; Si, Ying; Luo, Wenyi; Dujardin, Gwendal; Kwan, Thaddaeus; Potochick, Nicholas R.; Thompson, Sunnie R.; Schneider, David A.; King, Peter H.			Hu Antigen R (HuR) Is a Positive Regulator of the RNA-binding Proteins TDP-43 and FUS/TLS IMPLICATIONS FOR AMYOTROPHIC LATERAL SCLEROSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyotrophic Lateral Sclerosis (ALS) (Lou Gehrig Disease); Astrocyte; Neuron; RNA Processing; RNA Splicing; 3 Untranslated Region	NUCLEAR FACTOR TDP-43; MESSENGER-RNA; MOTOR-NEURONS; TRANSLATIONAL CONTROL; STRESS GRANULES; RICH ELEMENTS; WIDE ANALYSIS; UP-REGULATION; CFTR EXON-9; STABILITY	Background: RNA processing abnormalities have been linked to amyotrophic lateral sclerosis (ALS). Results: HuR promotes the expression of the ALS-associated TDP-43 and FUS/TLS RNA-binding proteins. Conclusion: Through its regulation of TDP-43 and FUS/TLS, HuR potentially impacts a wide range of molecular and cellular phenotypes. Significance: A network of proteins exists to maintain RNA processing, and ALS-associated abnormalities may stem from disruption of this network. Posttranscriptional gene regulation is governed by a network of RNA-binding proteins (RBPs) that interact with regulatory elements in the mRNA to modulate multiple molecular processes, including splicing, RNA transport, RNA stability, and translation. Mounting evidence indicates that there is a hierarchy within this network whereby certain RBPs cross-regulate other RBPs to coordinate gene expression. HuR, an RNA-binding protein we linked previously to aberrant VEGF mRNA metabolism in models of SOD1-associated amyotrophic lateral sclerosis, has been identified as being high up in this hierarchy, serving as a regulator of RNA regulators. Here we investigated the role of HuR in regulating two RBPs, TDP-43 and FUS/TLS, that have been linked genetically to amyotrophic lateral sclerosis. We found that HuR promotes the expression of both RBPs in primary astrocytes and U251 cells under normal and stressed (hypoxic) conditions. For TDP-43, we found that HuR binds to the 3 untranslated region (UTR) and regulates its expression through translational efficiency rather than RNA stability. With HuR knockdown, there was a shift of TDP-43 and FUS mRNAs away from polysomes, consistent with translational silencing. The TDP-43 splicing function was attenuated upon HuR knockdown and could be rescued by ectopic TDP-43 lacking the 3 UTR regulatory elements. Finally, conditioned medium from astrocytes in which HuR or TDP-43 was knocked down produced significant motor neuron and cortical neuron toxicity in vitro. These findings indicate that HuR regulates TDP-43 and FUS/TLS expression and that loss of HuR-mediated RNA processing in astrocytes can alter the molecular and cellular landscape to produce a toxic phenotype.	[Lu, Liang; Zheng, Lei; Si, Ying; Luo, Wenyi; Kwan, Thaddaeus; King, Peter H.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA; [Lu, Liang; King, Peter H.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [King, Peter H.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Potochick, Nicholas R.; Thompson, Sunnie R.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Schneider, David A.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Lu, Liang; King, Peter H.] Birmingham Vet Affairs Med Ctr, Birmingham, AL 35294 USA; [Dujardin, Gwendal] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Buenos Aires	Lu, L (corresponding author), Sparks Ctr, Dept Neurol, Suite 260,1720 7th Ave S, Birmingham, AL 35233 USA.	luliang@uab.edu; pking@uab.edu	Dujardin, Gwendal/K-7464-2015	Dujardin, Gwendal/0000-0003-4320-6351; King, Peter/0000-0001-9391-7464; Schneider, David/0000-0003-0635-5091; Thompson, Sunnie/0000-0002-7338-8822	NINDS, National Intitutes of Health [NS064133, R21NS081743, R21NS085497, NS057664]; Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI102187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS057664, R21NS081743, R01NS064133, R21NS085497] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003035] Funding Source: NIH RePORTER	NINDS, National Intitutes of Health; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by NINDS, National Intitutes of Health Grants NS064133, R21NS081743, and R21NS085497 (to P. H. K.) and NS057664 (to L. L.). This work was also supported by a Merit Review award from the Department of Veterans Affairs (to P. H. K.).	Abdelmohsen K, 2008, BIOL CHEM, V389, P243, DOI 10.1515/BC.2008.022; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Avendano-Vazquez SE, 2012, GENE DEV, V26, P1679, DOI 10.1101/gad.194829.112; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bi FF, 2013, P NATL ACAD SCI USA, V110, P4069, DOI 10.1073/pnas.1218497110; Blackburn D, 2009, GLIA, V57, P1251, DOI 10.1002/glia.20848; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2012, TRENDS BIOCHEM SCI, V37, P237, DOI 10.1016/j.tibs.2012.03.003; Buratti E, 2011, FEBS J, V278, P3530, DOI 10.1111/j.1742-4658.2011.08257.x; Burkhart RA, 2013, RNA BIOL, V10, P1312, DOI 10.4161/rna.25274; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Dassi E, 2013, NUCLEIC ACIDS RES, V41, P3201, DOI 10.1093/nar/gkt017; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Dujardin G, 2010, NUCLEIC ACIDS RES, V38, P7273, DOI 10.1093/nar/gkq573; Durie D, 2011, ONCOGENE, V30, P1460, DOI 10.1038/onc.2010.527; Fallini C, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-17; Fialcowitz EJ, 2005, J BIOL CHEM, V280, P22406, DOI 10.1074/jbc.M500618200; Filippova N, 2012, J BIOL CHEM, V287, P32277, DOI 10.1074/jbc.M112.353912; Filippova N, 2011, MOL CANCER RES, V9, P648, DOI 10.1158/1541-7786.MCR-10-0325; Gorospe M, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00007; Haidet-Phillips AM, 2013, EXP NEUROL, V250, P250, DOI 10.1016/j.expneurol.2013.10.004; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Henics T, 1999, J BIOL CHEM, V274, P17318, DOI 10.1074/jbc.274.24.17318; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Iguchi Y, 2009, J BIOL CHEM, V284, P22059, DOI 10.1074/jbc.M109.012195; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kawai T, 2006, MOL CELL BIOL, V26, P3295, DOI 10.1128/MCB.26.8.3295-3307.2006; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; King P. H, 2000, NUCLEIC ACIDS RES, V28, pE20; Kullmann M, 2002, GENE DEV, V16, P3087, DOI 10.1101/gad.248902; Lagier-Tourenne C, 2012, NAT NEUROSCI, V15, P1488, DOI 10.1038/nn.3230; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Li XD, 2012, SPACE, P60; Li XL, 2009, J NEUROCHEM, V108, P1032, DOI 10.1111/j.1471-4159.2008.05856.x; Lin WJ, 2007, J BIOL CHEM, V282, P19958, DOI 10.1074/jbc.M702281200; Lin WJ, 2011, MOL CELL BIOL, V31, P3196, DOI 10.1128/MCB.05073-11; Lu L, 2007, J NEUROSCI, V27, P7929, DOI 10.1523/JNEUROSCI.1877-07.2007; Lu L, 2009, J BIOL CHEM, V284, P33989, DOI 10.1074/jbc.M109.067918; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Mansfield KD, 2009, BIOL CELL, V101, P169, DOI 10.1042/BC20080055; Meisner N.-C., 2011, PROPERTIES REGULATOR, P106; Meisner NC, 2007, NAT CHEM BIOL, V3, P508, DOI 10.1038/nchembio.2007.14; Meng Z, 2008, J CELL PHYSIOL, V217, P172, DOI 10.1002/jcp.21486; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Nabors LB, 2001, CANCER RES, V61, P2154; Nabors LLB, 2003, CANCER RES, V63, P4181; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Pagani F, 2000, J BIOL CHEM, V275, P21041, DOI 10.1074/jbc.M910165199; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Pullmann R, 2007, MOL CELL BIOL, V27, P6265, DOI 10.1128/MCB.00500-07; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Sama RRK, 2013, J CELL PHYSIOL, V228, P2222, DOI 10.1002/jcp.24395; Simone LE, 2013, CURR OPIN GENET DEV, V23, P35, DOI 10.1016/j.gde.2012.12.006; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Srikantan S, 2012, FRONT BIOSCI-LANDMRK, V17, P189, DOI 10.2741/3921; Suswam EA, 2005, INT J CANCER, V113, P911, DOI 10.1002/ijc.20675; Suswam EA, 2013, J NEURO-ONCOL, V113, P195, DOI 10.1007/s11060-013-1112-8; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Vaccaro A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002806; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yang CX, 2014, P NATL ACAD SCI USA, V111, pE1121, DOI 10.1073/pnas.1322641111; Zhou YQ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003895	70	26	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31792	31804		10.1074/jbc.M114.573246	http://dx.doi.org/10.1074/jbc.M114.573246			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25239623	Green Published, hybrid			2022-12-25	WOS:000345314700011
J	Chen, SR; Zhu, LH; Chen, H; Wen, L; Laumet, G; Pan, HL				Chen, Shao-Rui; Zhu, Lihong; Chen, Hong; Wen, Lei; Laumet, Geoffroy; Pan, Hui-Lin			Increased Spinal Cord Na+-K+-2Cl(-) Cotransporter-1 (NKCC1) Activity Contributes to Impairment of Synaptic Inhibition in Paclitaxel-induced Neuropathic Pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL NEUROPATHY; ACTIN POLYMERIZATION; CHLORIDE HOMEOSTASIS; SURFACE EXPRESSION; RECEPTOR-ACTIVITY; MITOTIC KINESIN; NERVOUS-SYSTEM; UP-REGULATION; A-FIBER; RAT	Microtubule-stabilizing agents, such as paclitaxel (Taxol), are effective chemotherapy drugs for treating many cancers, and painful neuropathy is a major dose-limiting adverse effect. Cation-chloride cotransporters, such as Na+-K+-2Cl(-) cotransporter-1 (NKCC1) and K+-Cl- cotransporter-2 (KCC2), critically influence spinal synaptic inhibition by regulating intracellular chloride concentrations. Here we show that paclitaxel treatment in rats significantly reduced GABA-induced membrane hyperpolarization and caused a depolarizing shift in GA BA reversal potential of dorsal horn neurons. However, paclitaxel had no significant effect on AMPA or NMDA receptor-mediated glutamatergic input from primary afferents to dorsal horn neurons. Paclitaxel treatment significantly increased protein levels, but not mRNA levels, of NKCC1 in spinal cords. Inhibition of NKCC1 with bumetanide reversed the paclitaxel effect on GABA-mediated hyperpolarization and GABA reversal potentials. Also, intrathecal bumetanide significantly attenuated hyperalgesia and allodynia induced by paclitaxel. Co-immunoprecipitation revealed that NKCC1 interacted with beta-tubulin and beta-actin in spinal cords. Remarkably, paclitaxel increased NKCC1 protein levels at the plasma membrane and reduced NKCC1 levels in the cytosol of spinal cords. In contrast, treatment with an actin-stabilizing agent had no significant effect on NKCC1 protein levels in the plasma membrane or cytosolic fractions of spinal cords. In addition, inhibition of the motor protein dynein blocked paclitaxel-induced subcellular redistribution of NKCC1, whereas inhibition of kinesin-5 mimicked the paclitaxel effect. Our findings suggest that increased NKCC1 activity contributes to diminished spinal synaptic inhibition and neuropathic pain caused by paclitaxel. Paclitaxel disrupts intracellular NKCC1 trafficking by interfering with microtubule dynamics and associated motor proteins.	[Chen, Shao-Rui; Zhu, Lihong; Chen, Hong; Wen, Lei; Laumet, Geoffroy; Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Ctr Neurosci & Pain Res, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110, 1515 Holcombe Blvd, Houston, TX 77030 USA.	huilinpan@mdanderson.org	Laumet, Geoffroy/O-7480-2019; Zhu, Li/GXH-9801-2022	Pan, Hui-Lin/0000-0001-8444-3770	National Institutes of Health [NS073935]; N. G. and Helen T. Hawkins endowment; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N. G. and Helen T. Hawkins endowment; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS073935. This work was also supported by the N. G. and Helen T. Hawkins endowment (to H.-L.P.).	Baas PW, 2013, BRAIN, V136, P2937, DOI 10.1093/brain/awt153; Boehmerle W, 2006, P NATL ACAD SCI USA, V103, P18356, DOI 10.1073/pnas.0607240103; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Cavaletti G, 2000, NEUROTOXICOLOGY, V21, P389, DOI 10.1046/j.1529-8027.2001.01008-5.x; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen J, 2006, J NEURO-ONCOL, V76, P85, DOI 10.1007/s11060-005-4171-7; Chen SR, 2014, J PHARMACOL EXP THER, V350, P301, DOI 10.1124/jpet.114.215855; Chen SR, 2003, J PHARMACOL EXP THER, V307, P676, DOI 10.1124/jpet.103.055905; Choi WS, 2005, CIRC RES, V97, P363, DOI 10.1161/01.RES.0000179535.06458.f8; COLLOT M, 1984, P NATL ACAD SCI-BIOL, V81, P788, DOI 10.1073/pnas.81.3.788; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Cramer LP, 1999, CURR BIOL, V9, P1095, DOI 10.1016/S0960-9822(99)80478-3; DEBRABANDER M, 1981, P NATL ACAD SCI-BIOL, V78, P5608; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Delpy A, 2008, J PHYSIOL-LONDON, V586, P1059, DOI 10.1113/jphysiol.2007.146993; Dina OA, 2001, NEUROSCIENCE, V108, P507, DOI 10.1016/S0306-4522(01)00425-0; Galan A, 2005, NEUROSCIENCE, V133, P245, DOI 10.1016/j.neuroscience.2005.02.025; Grisold W., 2006, NEUROL ONCOL, V14, P45; Hannaert P, 2002, N-S ARCH PHARMACOL, V365, P193, DOI 10.1007/s00210-001-0521-y; Haque SA, 2004, CELL MOTIL CYTOSKEL, V58, P10, DOI 10.1002/cm.10176; Heng YW, 2012, J CELL SCI, V125, P1579, DOI 10.1242/jcs.096818; Holzinger A, 2009, METHODS MOL BIOL, V586, P71, DOI 10.1007/978-1-60761-376-3_4; Ikeda K, 1997, HEARING RES, V107, P1, DOI 10.1016/S0378-5955(97)00009-9; Jakab RL, 2011, AM J PHYSIOL-GASTR L, V300, pG82, DOI 10.1152/ajpgi.00245.2010; Kapitein LC, 2010, CURR BIOL, V20, P290, DOI 10.1016/j.cub.2009.12.052; Lee JJ, 2006, J CLIN ONCOL, V24, P1633, DOI 10.1200/JCO.2005.04.0543; Li DP, 2002, J PHYSIOL-LONDON, V543, P807, DOI 10.1113/jphysiol.2002.020644; LIPTON RB, 1989, NEUROLOGY, V39, P368, DOI 10.1212/WNL.39.3.368; Liu X, 2013, P NATL ACAD SCI USA, V110, P11976, DOI 10.1073/pnas.1306180110; Loewen ME, 2009, AM J PHYSIOL-HEART C, V296, pH71, DOI 10.1152/ajpheart.00260.2008; Matsumoto M, 2006, J PHARMACOL EXP THER, V318, P735, DOI 10.1124/jpet.106.103614; MATTEONI R, 1987, J CELL BIOL, V105, P1253, DOI 10.1083/jcb.105.3.1253; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Myers KA, 2007, J CELL BIOL, V178, P1081, DOI 10.1083/jcb.200702074; Pan YZ, 2004, J NEUROPHYSIOL, V91, P2413, DOI 10.1152/jn.01242.2003; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Polomano RC, 2001, PAIN, V94, P293, DOI 10.1016/S0304-3959(01)00363-3; Polomano RC, 2001, PAIN MED, V2, P8, DOI 10.1046/j.1526-4637.2001.002001008.x; Price TJ, 2006, BRAIN RES, V1112, P146, DOI 10.1016/j.brainres.2006.07.012; Reynolds A, 2007, J PHYSIOL-LONDON, V582, P507, DOI 10.1113/jphysiol.2007.129718; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Rowinsky E K, 1993, J Natl Cancer Inst Monogr, P107; Saunders AM, 2007, CURR BIOL, V17, pR453, DOI 10.1016/j.cub.2007.05.001; Scripture CD, 2006, CURR NEUROPHARMACOL, V4, P165, DOI 10.2174/157015906776359568; SHPETNER HS, 1988, J CELL BIOL, V107, P1001, DOI 10.1083/jcb.107.3.1001; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Snyder JP, 2001, P NATL ACAD SCI USA, V98, P5312, DOI 10.1073/pnas.051309398; Valensin S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-196; Walter WJ, 2012, P NATL ACAD SCI USA, V109, P5289, DOI 10.1073/pnas.1116315109; Xiao WH, 2008, PAIN, V135, P262, DOI 10.1016/j.pain.2007.06.001; Ye ZY, 2012, J NEUROSCI, V32, P8560, DOI 10.1523/JNEUROSCI.1346-12.2012; Yoon SY, 2005, CELL MOTIL CYTOSKEL, V60, P181, DOI 10.1002/cm.20057; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947; Zhang LL, 2007, J NEUROPHYSIOL, V98, P266, DOI 10.1152/jn.00288.2007; Zhao YL, 2012, J BIOL CHEM, V287, P25073, DOI 10.1074/jbc.M112.378737; Zheng Y, 2008, NAT CELL BIOL, V10, P1172, DOI 10.1038/ncb1777; Zhou HY, 2012, J BIOL CHEM, V287, P33853, DOI 10.1074/jbc.M112.395830	60	30	31	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31111	31120		10.1074/jbc.M114.600320	http://dx.doi.org/10.1074/jbc.M114.600320			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25253692	Green Published, hybrid			2022-12-25	WOS:000344549900020
J	Langlois, S; Xiang, X; Young, K; Cowan, BJ; Penuela, S; Cowan, KN				Langlois, Stephanie; Xiang, Xiao; Young, Kelsey; Cowan, Bryce J.; Penuela, Silvia; Cowan, Kyle N.			Pannexin 1 and Pannexin 3 Channels Regulate Skeletal Muscle Myoblast Proliferation and Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION PROTEINS; C6 GLIOMA-CELLS; KERATINOCYTE DIFFERENTIATION; ATP; HEMICHANNELS; ACTIVATION; MEMBRANE; RELEASE; FAMILY; INFLAMMASOME	Pannexins constitute a family of three glycoproteins (Panx1, -2, and -3) forming single membrane channels. Recent work demonstrated that Panx1 is expressed in skeletal muscle and involved in the potentiation of contraction. However, Panxs functions in skeletal muscle cell differentiation, and proliferation had yet to be assessed. We show here that Panx1 and Panx3, but not Panx2, are present in human and rodent skeletal muscle, and their various species are differentially expressed in fetal versus adult human skeletal muscle tissue. Panx1 levels were very low in undifferentiated human primary skeletal muscle cells and myoblasts (HSMM) but increased drastically during differentiation and became the main Panx expressed in differentiated cells. Using HSMM, we found that Panx1 expression promotes this process, whereas it was impaired in the presence of probenecid or carbenoxolone. As for Panx3, its lower molecular weight species were prominent in adult skeletal muscle but very low in the fetal tissue and in undifferentiated skeletal muscle cells and myoblasts. Its overexpression (similar to 43-kDa species) induced HSMM differentiation and also inhibited their proliferation. On the other hand, a similar to 70-kDa immunoreactive species of Panx3, likely glycosylated, sialylated, and phosphorylated, was highly expressed in proliferative myoblasts but strikingly down-regulated during their differentiation. Reduction of its endogenous expression using two Panx3 shRNAs significantly inhibited HSMM proliferation without triggering their differentiation. In summary, our results demonstrate that Panx1 and Panx3 are co-expressed in human skeletal muscle myoblasts and play a pivotal role in dictating the proliferation and differentiation status of these cells.	[Langlois, Stephanie; Cowan, Kyle N.] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Surg, Div Paediat Surg, Ottawa, ON K1H 8L1, Canada; [Langlois, Stephanie; Xiang, Xiao; Young, Kelsey; Cowan, Kyle N.] Childrens Hosp Eastern Ontario, Apoptosis Res Ctr, Ottawa, ON K1H 8L1, Canada; [Xiang, Xiao; Cowan, Kyle N.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8L1, Canada; [Cowan, Bryce J.] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 4E8, Canada; [Penuela, Silvia] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of British Columbia; Western University (University of Western Ontario)	Cowan, KN (corresponding author), Childrens Hosp Eastern Ontario, 401 Smyth Rd,Rm 3370, Ottawa, ON K1H 8L1, Canada.	kcowan@cheo.on.ca	Penuela, Silvia/A-6961-2010	Penuela, Silvia/0000-0003-4829-5517; Xiang, Xiao/0000-0002-3969-1668; Cowan, Kyle/0000-0003-0109-7716	Department of Surgery at the Children's Hospital of Eastern Ontario; Research Institute of the Children's Hospital of Eastern Ontario	Department of Surgery at the Children's Hospital of Eastern Ontario; Research Institute of the Children's Hospital of Eastern Ontario	This work was supported by grants from the Department of Surgery at the Children's Hospital of Eastern Ontario and the Research Institute of the Children's Hospital of Eastern Ontario.	Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Araya R, 2004, BRAIN RES REV, V47, P174, DOI 10.1016/j.brainresrev.2004.06.003; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Bond SR, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00058; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Buvinic S, 2009, J BIOL CHEM, V284, P34490, DOI 10.1074/jbc.M109.057315; Celetti SJ, 2010, J CELL SCI, V123, P1363, DOI 10.1242/jcs.056093; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Cowan KN, 2012, CELL COMMUN ADHES, V19, P45, DOI 10.3109/15419061.2012.712575; Ednie AR, 2012, COMPR PHYSIOL, V2, P1269, DOI 10.1002/cphy.c110044; Filigheddu N, 2007, MOL BIOL CELL, V18, P986, DOI 10.1091/mbc.E06-05-0402; Gulbransen BD, 2012, NAT REV GASTRO HEPAT, V9, P625, DOI 10.1038/nrgastro.2012.138; Ishikawa M, 2014, J BIOL CHEM, V289, P2839, DOI 10.1074/jbc.M113.523241; Ishikawa M, 2011, J CELL BIOL, V193, P1257, DOI 10.1083/jcb.201101050; Iwamoto T, 2010, J BIOL CHEM, V285, P18948, DOI 10.1074/jbc.M110.127027; Jorquera G, 2013, J CELL SCI, V126, P1189, DOI 10.1242/jcs.116855; Lai CPK, 2009, ONCOGENE, V28, P4402, DOI 10.1038/onc.2009.283; Lai CPK, 2007, CANCER RES, V67, P1545, DOI 10.1158/0008-5472.CAN-06-1396; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2014, CHANNELS, V8, P124, DOI 10.4161/chan.27422; Penuela S, 2013, BBA-BIOMEMBRANES, V1828, P15, DOI 10.1016/j.bbamem.2012.01.017; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Porter GA, 2002, J BIOL CHEM, V277, P28942, DOI 10.1074/jbc.M203961200; Prochnow N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051767; Proulx A, 1997, DEV GENET, V20, P133, DOI 10.1002/(SICI)1520-6408(1997)20:2<133::AID-DVG6>3.0.CO;2-8; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Riquelme MA, 2013, NEUROPHARMACOLOGY, V75, P594, DOI 10.1016/j.neuropharm.2013.03.022; Ryten M, 2002, J CELL BIOL, V158, P345, DOI 10.1083/jcb.200202025; Shestopalov VI, 2008, CELL MOL LIFE SCI, V65, P376, DOI 10.1007/s00018-007-7200-1; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Turmel P, 2011, MOL REPROD DEV, V78, P124, DOI 10.1002/mrd.21280	39	41	43	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30717	30731		10.1074/jbc.M114.572131	http://dx.doi.org/10.1074/jbc.M114.572131			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25239622	hybrid, Green Published			2022-12-25	WOS:000344549700047
J	Cerbulo-Vazquez, A; Figueroa-Damian, R; Arriaga-Pizano, LA; Hernandez-Andrade, E; Mancilla-Herrera, I; Flores-Mejia, LA; Arteaga-Troncoso, G; Lopez-Macias, C; Isibasi, A; Mancilla-Ramirez, J				Cerbulo-Vazquez, Arturo; Figueroa-Damian, Ricardo; Arriaga-Pizano, Lourdes A.; Hernandez-Andrade, Edgar; Mancilla-Herrera, Ismael; Angel Flores-Mejia, Luis; Arteaga-Troncoso, Gabriel; Lopez-Macias, Constantino; Isibasi, Armando; Mancilla-Ramirez, Javier			Pregnant Women Infected with Pandemic H1N1pdm2009 Influenza Virus Displayed Overproduction of Peripheral Blood CD69+Lymphocytes and Increased Levels of Serum Cytokines	PLOS ONE			English	Article							T-CELLS; A H1N1; A(H1N1) INFECTION; IMMUNE-RESPONSE; CD69; ACTIVATION; EXPRESSION; PNEUMONIA; SEVERITY; ANTIGEN	The first pandemic of the 21st century occurred in 2009 and was caused by the H1N1pdm influenza A virus. Severe cases of H1N1pdm infection in adults are characterized by sustained immune activation, whereas pregnant women are prone to more severe forms of influenza, with increased morbi-mortality. During the H1N1pdm09 pandemic, few studies assessed the immune status of infected pregnant women. The objective of this study was to evaluate the behavior of several immune markers in 13 H1N1pdm2009 virus-infected pregnant (PH1N1) women, in comparison to pregnant women with an influenza-like illness (ILI), healthy pregnant women (HP) and healthy non-pregnant women (HW). The blood leukocyte phenotypes and the serological cytokine and chemokine concentrations of the blood leukocytes, as measured by flow cytometry, showed that the CD69+ cell counts in the T and B-lymphocytes were significantly higher in the PH1N1 group. We found that pro-inflammatory (TNF-alpha, IL-1 beta, IL-6) and anti-inflammatory (IL-10) cytokines and some chemokines (CXCL8, CXCL10), which are typically at lower levels during pregnancy, were substantially increased in the women in the ILI group. Our findings suggest that CD69 overexpression in blood lymphocytes and elevated levels of serum cytokines might be potential markers for the discrimination of H1N1 disease from other influenza-like illnesses in pregnant women.	[Cerbulo-Vazquez, Arturo] Natl Inst Perinatol INPer, Dept Cell Biol, Mexico City, DF, Mexico; [Figueroa-Damian, Ricardo; Mancilla-Herrera, Ismael; Mancilla-Ramirez, Javier] Natl Inst Perinatol INPer, Infectol & Immunol Dept, Mexico City, DF, Mexico; [Arteaga-Troncoso, Gabriel] Natl Inst Perinatol INPer, Immunobiochem Dept, Mexico City, DF, Mexico; [Arriaga-Pizano, Lourdes A.; Angel Flores-Mejia, Luis; Lopez-Macias, Constantino; Isibasi, Armando] Social Secur Mexican Inst, Natl Med Ctr Siglo 21, Med Res Unit Immunochem, Mexico City, DF, Mexico; [Hernandez-Andrade, Edgar] Wayne State Univ, Hutzel Womens Hosp, Div Maternal Fetal Med, Dept Obstet & Gynecol, Detroit, MI USA; [Angel Flores-Mejia, Luis] Univ Nacl Autonoma Mexico, Grad program Biomed Sci, Mexico City, DF, Mexico	Wayne State University; Universidad Nacional Autonoma de Mexico	Mancilla-Ramirez, J (corresponding author), Natl Inst Perinatol INPer, Infectol & Immunol Dept, Mexico City, DF, Mexico.	javiermancilla@hotmail.com	López Macías, Constatino III Roberto/ABG-3414-2021; Mancilla Ramírez, Javier/GSJ-0934-2022; Arteaga-Troncoso, Gabriel/AAS-3220-2021; Arriaga-Pizano, Lourdes/AAI-9628-2021	López Macías, Constatino III Roberto/0000-0003-0530-492X; Arriaga-Pizano, Lourdes/0000-0003-4433-2106; Mancilla Ramirez, Javier/0000-0002-9236-8149; FLORES MEJIA, LUIS ANGEL/0000-0001-8157-5233; Mancilla-Herrera, Ismael/0000-0001-8195-8082; Lopez-Macias, Constantino III Roberto/0000-0002-7756-8468	 [INPer-SALUD: 2009-C02-127102];  [IMSS-SALUD: 2009-C02-127068]	; 	This study was supported by grants from INPer-SALUD: 2009-C02-127102 and IMSS-SALUD: 2009-C02-127068. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2009, THROMB HAEMOSTASIS, V101, P36, DOI 10.1160/TH08-07-0421; AFELTRA A, 1993, ANN RHEUM DIS, V52, P457, DOI 10.1136/ard.52.6.457; Bermejo-Martin JF, 2009, CRIT CARE, V13, DOI 10.1186/cc8208; Blyth CC, 2013, INFLUENZA OTHER RESP, V7, P168, DOI 10.1111/j.1750-2659.2012.00360.x; Burioni R, 2009, LANCET, V374, P1417, DOI 10.1016/S0140-6736(09)61853-5; Calvo Aguilar Omar, 2011, Ginecol Obstet Mex, V79, P344; Cheng XW, 2011, RESP PHYSIOL NEUROBI, V175, P185, DOI 10.1016/j.resp.2010.11.004; Damoiseaux JGMC, 1998, J LEUKOCYTE BIOL, V64, P803, DOI 10.1002/jlb.64.6.803; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DEMARIA R, 1994, J EXP MED, V180, P1999, DOI 10.1084/jem.180.5.1999; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Elovitz MA, 2004, TRENDS ENDOCRIN MET, V15, P479, DOI 10.1016/j.tem.2004.10.009; Fajardo-Dolci German, 2013, Rev Med Inst Mex Seguro Soc, V51, P486; FEIN AM, 1992, CLIN CHEST MED, V13, P709; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Fox A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031535; Gao RB, 2013, AM J PATHOL, V183, P1258, DOI 10.1016/j.ajpath.2013.06.023; Goncalves LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/mrdd.10008; Gonzalez-Amaro R, 2013, TRENDS MOL MED, V19, P625, DOI 10.1016/j.molmed.2013.07.006; GRAVETT MG, 1994, AM J OBSTET GYNECOL, V171, P1660, DOI 10.1016/0002-9378(94)90418-9; Green S, 1999, J INFECT DIS, V180, P1429, DOI 10.1086/315072; Hasegawa S, 2011, CYTOKINE, V54, P167, DOI 10.1016/j.cyto.2011.01.006; Hernandez-Andrade E, 2014, ULTRASOUND OBSTET GY; Hirota M, 2000, Rinsho Byori, V48, P527; Kacerovsky M, 2014, CESKA GYNEKOL, V78, P509; Kimura H, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00276; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Kwak-Kim J, 2010, AM J REPROD IMMUNOL, V63, P611, DOI 10.1111/j.1600-0897.2010.00847.x; Lapinsky SE, 2013, CRIT CARE CLIN, V29, P509, DOI 10.1016/j.ccc.2013.03.006; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Liu SL, 2013, REV MED VIROL, V23, P3, DOI 10.1002/rmv.1712; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; MAINO VC, 1995, CYTOMETRY, V20, P127, DOI 10.1002/cyto.990200205; Matsuda K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-591; Matsumoto Y, 2012, MICROBIOL IMMUNOL, V56, P651, DOI 10.1111/j.1348-0421.2012.00489.x; MINKOFF H, 1983, OBSTET GYNECOL, V62, P137; Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Petersen CC, 2011, VIRAL IMMUNOL, V24, P165, DOI 10.1089/vim.2010.0087; Rau FC, 2009, J IMMUNOL, V183, P7661, DOI 10.4049/jimmunol.0803783; Reina-San-Martin B, 2000, PARASITOL TODAY, V16, P62, DOI 10.1016/S0169-4758(99)01591-4; Romero R, 2007, NUTR REV, V65, pS194, DOI 10.1301/nr.2007.dec.S194-S202; Sancho D, 1999, BLOOD, V93, P886, DOI 10.1182/blood.V93.3.886.403k10_886_896; Sancho D, 2003, J CLIN INVEST, V112, P872, DOI 10.1172/JCI200319112; Sappenfield Elisabeth, 2013, Infect Dis Obstet Gynecol, V2013, P752852, DOI 10.1155/2013/752852; Su LL, 2009, LANCET, V374, P1417, DOI 10.1016/S0140-6736(09)61854-7; Suryadevara M, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-357; TESTI R, 1989, J IMMUNOL, V143, P1123; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Tiwari N, 2014, J MED VIROL, V86, P1034, DOI 10.1002/jmv.23877; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Valero-Pacheco N, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/989673; Vazquez BN, 2009, J IMMUNOL, V183, P6513, DOI 10.4049/jimmunol.0900839; Ward NS, 2008, CLIN CHEST MED, V29, P617, DOI 10.1016/j.ccm.2008.06.010; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Woo PCY, 2010, J INFECT DIS, V201, P346, DOI 10.1086/649785; Yee NK, 2013, EUR J IMMUNOL, V43, P779, DOI 10.1002/eji.201242550; Zhang T, 2011, CELL BIOCHEM FUNCT, V29, P394, DOI 10.1002/cbf.1763	58	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107900	10.1371/journal.pone.0107900	http://dx.doi.org/10.1371/journal.pone.0107900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254368	Green Published, gold, Green Submitted			2022-12-25	WOS:000344862300040
J	Chen, WH; Shui, YM; Yang, JB; Wang, H; Nishii, K; Wen, F; Zhang, ZR; Moller, M				Chen, Wen-Hong; Shui, Yu-Min; Yang, Jun-Bo; Wang, Hong; Nishii, Kanae; Wen, Fang; Zhang, Zhi-Rong; Moeller, Michael			Taxonomic Status, Phylogenetic Affinities and Genetic Diversity of a Presumed Extinct Genus, Paraisometrum WT Wang (Gesneriaceae) from the Karst Regions of Southwest China	PLOS ONE			English	Article							PLANT; INFERENCE; INSIGHTS; HISTORY; RANGE; YEWS; L.	Background: The karst regions in South China have an abundance of endemic plants that face high extinction risks. The Chinese Gesneriaceae endemic Paraisometrum mileense (= Oreocharis mileensis), was presumed extinct for 100 years. After its re-discovery, the species has become one of five key plants selected by the Chinese forestry government to establish a new conservation category for plants with extremely small populations. For conservation purposes, we studied the phylogenetic and population genetic status of P. mileense at the three only known localities in Guangxi, Guizhou and Yunnan. Methodology/Principal Findings: We collected 64 samples (52 species) of Oreocharis and 8 samples from three provinces of P. mileense and generated molecular phylogenies, and inferred that P. mileense represents a relatively isolated and derived taxonomic unit within Oreocharis. Phylogeographic results of 104 samples of 12 populations of P. mileense indicated that the populations in Yunnan have derived from those in Guangxi and Guizhou. Based on AFLP data, the populations were found to harbor low levels of genetic diversity (He = 0.118), with no apparent gradient across the species' range, a restricted gene flow and significant isolation-by-distance with limited genetic differentiation among the populations across the three provinces (F-ST = 0.207, P < 0.001). The 10 populations in Yunnan were found to represent two distinct lineages residing at different altitudes and distances from villages. Conclusion/Significance: The low levels of genetic diversity found in P. mileense are perhaps a consequence of severe bottlenecks in the recent past. The distribution of the genetic diversity suggests that all populations are significant for conservation. Current in situ and ex situ measures are discussed. Further conservation actions are apparently needed to fully safeguard this conservation flagship species. Our work provides a model of an integrated study for the numerous endemic species in the karst regions with extremely small populations.	[Chen, Wen-Hong; Shui, Yu-Min; Wang, Hong] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Kunming, Yunnan, Peoples R China; [Yang, Jun-Bo; Zhang, Zhi-Rong] Chinese Acad Sci, Kunming Inst Bot, Plant Germplasm & Genom Ctr, Germplasm Bank Wild Species, Kunming, Yunnan, Peoples R China; [Nishii, Kanae; Moeller, Michael] Royal Bot Garden Edinburgh, Div Sci, Edinburgh, Midlothian, Scotland; [Wen, Fang] Guangxi Inst Bot, Guilin, Guangxi, Peoples R China; [Wen, Fang] Chinese Acad Sci, Guilin, Guangxi, Peoples R China; [Chen, Wen-Hong] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Shui, YM (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Kunming, Yunnan, Peoples R China.	ymshui@mail.kib.ac.cn; wanghong@mail.kib.ac.cn; m.moeller@rbge.ac.uk	Nishii, Kanae/O-9684-2015; Moeller, Michael/O-9748-2015	Nishii, Kanae/0000-0001-8141-8908; Moeller, Michael/0000-0002-2819-0323	National Natural Science Foundation of China [31000258, 31470306]; National Key Basic Research Program of China [2014CB954100]; Key Laboratory for Plant Diversity and Biogeography of East Asia, Kunming Institute of Botany [KLBB201304]; project of Integrated Scientific Surveys to Daweishan National Park in China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Key Laboratory for Plant Diversity and Biogeography of East Asia, Kunming Institute of Botany; project of Integrated Scientific Surveys to Daweishan National Park in China	This work was supported by the National Natural Science Foundation of China (grant no. 31000258, 31470306), the National Key Basic Research Program of China (no. 2014CB954100), the Open Project of the Key Laboratory for Plant Diversity and Biogeography of East Asia, Kunming Institute of Botany (grant no. KLBB201304) and the project of Integrated Scientific Surveys to Daweishan National Park in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; CASGRAIN P, 2005, ROYAL PACKAGE MULTIV; Chen WH, 2006, ANN BOT FENN, V43, P448; Chen WH, 2014, SYST BOT, V39, P316, DOI 10.1600/036364414X678189; Chen WH, 2013, THESIS CHINESE ACAD; Despres L, 2002, MOL ECOL, V11, P2337, DOI 10.1046/j.1365-294X.2002.01618.x; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Eckert JE, 1933, J AGRIC RES, V47, P0257; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; Gao Qi, 2011, Xibei Zhiwu Xuebao, V31, P858; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jiao Li-Juan, 2013, Plant Diversity and Resources, V35, P715, DOI 10.7677/ynzwyj201313064; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; Kokubugata G, 2011, PLANT SYST EVOL, V292, P177, DOI 10.1007/s00606-010-0410-2; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Lauterbach D, 2012, PLANT SYST EVOL, V298, P155, DOI 10.1007/s00606-011-0533-0; Li ZY, 2004, PLANTS GESNERIACEAE, P14; Liu J, 2013, NEW PHYTOL, V199, P1093, DOI 10.1111/nph.12336; Liu J, 2011, MOL ECOL RESOUR, V11, P89, DOI 10.1111/j.1755-0998.2010.02907.x; Liu Min-Lu, 2013, Plant Diversity and Resources, V35, P707, DOI 10.7677/ynzwyj201313168; Lowe A, 2007, ECOLOGICAL GENETICS, P52; Ma YP, 2013, BIODIVERS CONSERV, V22, P803, DOI 10.1007/s10531-013-0434-3; Moller M, 2011, PHYTOTAXA, V23, P1; Moller M, 2011, PLANT SYST EVOL, V292, P223, DOI 10.1007/s00606-010-0413-z; Murren CJ, 1998, AM J BOT, V85, P675, DOI 10.2307/2446537; Ni XW, 2006, GENETICA, V127, P177, DOI 10.1007/s10709-005-3227-0; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Pan KY, 1987, ACTA PHYTOTAX SINICA, V25, P164; Parzies HK, 2000, HEREDITY, V84, P476, DOI 10.1046/j.1365-2540.2000.00705.x; Pasquet RS, 2008, P NATL ACAD SCI USA, V105, P13456, DOI 10.1073/pnas.0806040105; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Poudel RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046873; Pritchard JK, 2000, GENETICS, V155, P945; Puglisi C, 2011, PHYTOTAXA, V38, P1; Rafalski JA, 1997, NONMAMMALIAN GENOME, P75; [任海 Ren Hai], 2003, [生态学报, Acta Ecologica Sinica], V23, P1012; Ribeiro RA, 2011, HEREDITY, V106, P46, DOI 10.1038/hdy.2010.64; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Shui YM, 2007, 100 YEARS LOST PLANT, V12, P3; Smith L, 2007, TIMES; Sun H, 2013, PLANTS CHINA COMPANI, P176; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tan Ying, 2011, Plant Diversity and Resources, V33, P465, DOI 10.3724/SP.J.1143.2011.11075; Vogler F, 2013, BIODIVERS CONSERV, V22, P1301, DOI 10.1007/s10531-013-0471-y; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang CN, 2004, ANN BOT-LONDON, V93, P201, DOI 10.1093/aob/mch028; Wang W.T., 1998, FLORA CHINA, V18, P268; Wang WT, 1990, FL REIPUBL POPULARIS, V69, P190; Weber Anton, 2013, Selbyana, V31, P68; Weber A, 2011, PHYTOTAXA, V23, P49, DOI 10.11646/phytotaxa.23.1.3; Wei Y.G., 2010, GESNERIACEAE S CHINA, P777; Wei Y.G, 1995, ACTA BOT YUNNANIC S7, V7, P111; Weitzmann AL, 1997, NOVON, V7, P423, DOI 10.2307/3391777; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Wright S, 1943, GENETICS, V28, P114; Xu H.G., 2011, BIODIVERSITY KARST A; [许为斌 XU Wei-Bin], 2009, [广西植物, Guihaia], V29, P581; Zhu L, 2007, LANDSCAPE ECOL, V22, P1143, DOI 10.1007/s10980-007-9096-4	65	10	14	5	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107967	10.1371/journal.pone.0107967	http://dx.doi.org/10.1371/journal.pone.0107967			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250568	Green Submitted, gold, Green Published			2022-12-25	WOS:000342492700063
J	deCastro, BR; Caldwell, KL; Jones, RL; Blount, BC; Pan, Y; Ward, C; Mortensen, ME				deCastro, B. Rey; Caldwell, Kathleen L.; Jones, Robert L.; Blount, Benjamin C.; Pan, Yi; Ward, Cynthia; Mortensen, Mary E.			Dietary Sources of Methylated Arsenic Species in Urine of the United States Population, NHANES 2003-2010	PLOS ONE			English	Article							MARKET BASKET SURVEY; US POPULATION; NATIONAL-HEALTH; MONOMETHYLARSONOUS ACID; MICROBIOLOGICAL ASSAY; TRIVALENT ARSENICALS; BANGLADESHI ADULTS; DIABETES-MELLITUS; RICE CONSUMPTION; HUMAN-CELLS	Background: Arsenic is an ubiquitous element linked to carcinogenicity, neurotoxicity, as well as adverse respiratory, gastrointestinal, hepatic, and dermal health effects. Objective: Identify dietary sources of speciated arsenic: monomethylarsonic acid (MMA), and dimethylarsinic acid (DMA). Methods: Age-stratified, sample-weighted regression of NHANES (National Health and Nutrition Examination Survey) 20032010 data (, 8,300 participants >= 6 years old) characterized the association between urinary arsenic species and the additional mass consumed of USDA-standardized food groups (24-hour dietary recall data), controlling for potential confounders. Results: For all arsenic species, the rank-order of age strata for median urinary molar concentration was children 6-11 years > adults 20-84 years > adolescents 12-19 years, and for all age strata, the rank-order was DMA > MMA. Median urinary molar concentrations of methylated arsenic species ranged from 0.56 to 3.52 mmol/mol creatinine. Statistically significant increases in urinary arsenic species were associated with increased consumption of: fish (DMA); fruits (DMA, MMA); grain products (DMA, MMA); legumes, nuts, seeds (DMA); meat, poultry (DMA); rice (DMA, MMA); rice cakes/crackers (DMA, MMA); and sugars, sweets, beverages (MMA). And, for adults, rice beverage/milk (DMA, MMA). In addition, based on US (United States) median and 90th percentile consumption rates of each food group, exposure from the following food groups was highlighted: fish; fruits; grain products; legumes, nuts, seeds; meat, poultry; and sugars, sweets, beverages. Conclusions: In a nationally representative sample of the US civilian, noninstitutionalized population, fish (adults), rice (children), and rice cakes/crackers (adolescents) had the largest associations with urinary DMA. For MMA, rice beverage/milk (adults) and rice cakes/crackers (children, adolescents) had the largest associations.	[deCastro, B. Rey; Caldwell, Kathleen L.; Jones, Robert L.; Blount, Benjamin C.; Pan, Yi; Ward, Cynthia; Mortensen, Mary E.] Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	deCastro, BR (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Atlanta, GA 30333 USA.	rdecastro@cdc.gov	Jones, Robert L/E-1170-2011; Pan, Yi/AAJ-2341-2021; deCastro, Rey/G-2874-2011	deCastro, Rey/0000-0002-1610-5849				Agency for Toxic Substances and Disease Registry U. S. Department of Health and Human Services. Syracuse Research Corporation, 2007, TOX PROF ARS; Ahuja JKA, 2012, USDA FOOD NUTR DATAS; [Anonymous], BECKNAM INSTRUMENTS; Aposhian HV, 2000, TOXICOL APPL PHARM, V165, P74, DOI 10.1006/taap.2000.8922; Apostoli P, 1997, J TOXICOL ENV HEALTH, V52, P331, DOI 10.1080/009841097159610; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Basu A, 2011, ENVIRON HEALTH PERSP, V119, P1308, DOI 10.1289/ehp.1003393; BETTLEY FR, 1975, BRIT J DERMATOL, V92, P563; Bio-Rad Laboratories, 1993, BIOR QUANT; BOENIGER MF, 1993, AM IND HYG ASSOC J, V54, P615, DOI 10.1202/0002-8894(1993)054<0615:IOURUT>2.0.CO;2; BUCHET JP, 1981, INT ARCH OCC ENV HEA, V48, P71, DOI 10.1007/BF00405933; Caldwell KL, 2009, J EXPO SCI ENV EPID, V19, P59, DOI 10.1038/jes.2008.32; Cappuyns V, 2002, SCI TOTAL ENVIRON, V295, P217, DOI 10.1016/S0048-9697(02)00096-7; Cascio C, 2011, J ENVIRON MONITOR, V13, P257, DOI 10.1039/c0em00482k; Caudill SP, 2008, STAT MED, V27, P4094, DOI 10.1002/sim.3222; CDC, 2006, AN REP GUID; CDC/National Center for Health Statistics, 2013, NAT HLTH NUTR EX SUR; Chen CJ, 2007, TOXICOL APPL PHARM, V222, P298, DOI 10.1016/j.taap.2006.12.032; CHEN CJ, 1995, HYPERTENSION, V25, P53, DOI 10.1161/01.HYP.25.1.53; Chen GQ, 2003, CANCER RES, V63, P1853; Cleland B, 2009, ENVIRON HEALTH PERSP, V117, P632, DOI 10.1289/ehp.11827; Cohen SM, 2013, CRIT REV TOXICOL, V43, P711, DOI 10.3109/10408444.2013.827152; Coppin JF, 2008, J BIOL CHEM, V283, P19342, DOI 10.1074/jbc.M802942200; CRECELIUS EA, 1977, ENVIRON HEALTH PERSP, V19, P147, DOI 10.2307/3428467; Cullen WR, 2014, CHEM RES TOXICOL, V27, P457, DOI 10.1021/tx400441h; Davis MA, 2012, ENVIRON HEALTH PERSP, V120, P1418, DOI 10.1289/ehp.1205014; Del Razo LM, 2001, TOXICOL APPL PHARM, V174, P282, DOI 10.1006/taap.2001.9226; EPPS E. A., 1939, SOIL SCI SOC AMER PROC, V4, P215; Fergusson JE, 1990, PERGAMON, Vvii; Folsom R. E. J., 2000, AM STAT ASS, P598; Gamble MV, 2006, AM J CLIN NUTR, V84, P1093, DOI 10.1093/ajcn/84.5.1093; Gamble MV, 2005, ENVIRON HEALTH PERSP, V113, P1683, DOI 10.1289/ehp.8084; Ghose N, 2014, INT J PREVENTIVE MED, V5, P89; Gilbert-Diamond D, 2011, P NATL ACAD SCI USA, V108, P20656, DOI 10.1073/pnas.1109127108; Hayakawa T, 2005, ARCH TOXICOL, V79, P183, DOI 10.1007/s00204-004-0620-x; Helsel DR, 2006, CHEMOSPHERE, V65, P2434, DOI 10.1016/j.chemosphere.2006.04.051; Howe CG, 2014, J NUTR, V144, P690, DOI 10.3945/jn.113.188789; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, REV HUM CARC C, V100 C; Jackson BP, 2012, ENVIRON HEALTH PERSP, V120, P623, DOI 10.1289/ehp.1104619; Jasinkski S.M., 1994, MAT FLOW MERCURY US; Jensen GE, 1998, ANALYST, V123, P77, DOI 10.1039/a705699k; Kligerman AD, 2003, ENVIRON MOL MUTAGEN, V42, P192, DOI 10.1002/em.10192; Lau FK, 2013, J EXPO SCI ENV EPID, V23, P207, DOI 10.1038/jes.2012.108; Le XC, 2000, ENVIRON HEALTH PERSP, V108, P1015, DOI 10.2307/3434951; Lovreglio P, 2012, CHEMOSPHERE, V86, P898, DOI 10.1016/j.chemosphere.2011.10.050; Mage DT, 2004, J EXPO ANAL ENV EPID, V14, P457, DOI 10.1038/sj.jea.7500343; MAPPES R, 1977, INT ARCH OCC ENV HEA, V40, P267, DOI 10.1007/BF00381415; MARCUSWYNER L, 1982, J ENVIRON QUAL, V11, P715, DOI 10.2134/jeq1982.00472425001100040032x; Mass MJ, 2001, CHEM RES TOXICOL, V14, P355, DOI 10.1021/tx000251l; Meacher DM, 2002, HUM ECOL RISK ASSESS, V8, P1697, DOI 10.1080/20028091057565; Molloy AM, 1997, METHOD ENZYMOL, V281, P43; Moon KA, 2013, ANN INTERN MED; National Research Council Subcommittee on Arsenic in Drinking, 1999, ARS DRINK WAT; National Toxicology Program, 2011, ARS IN ARS COMP REP; Navas-Acien A, 2008, JAMA-J AM MED ASSOC, V300, P814, DOI 10.1001/jama.300.7.814; Navas-Acien A, 2011, ENVIRON RES, V111, P110, DOI 10.1016/j.envres.2010.10.009; Navas-Acien A, 2009, EPIDEMIOLOGY, V20, P816, DOI 10.1097/EDE.0b013e3181afef88; Nesnow S, 2002, CHEM RES TOXICOL, V15, P1627, DOI 10.1021/tx025598y; Niedzwiecki MM, 2014, FREE RADICAL BIO MED, V73, P67, DOI 10.1016/j.freeradbiomed.2014.03.042; OBROIN S, 1992, J CLIN PATHOL, V45, P344, DOI 10.1136/jcp.45.4.344; Research Triangle Institute, 2012, SAS CALL SUD; Roche/Hitachi Diagnostics, 2006, MOD AN OP MAN; SAS Institute, 2010, SAS CAR; Schoof RA, 1999, FOOD CHEM TOXICOL, V37, P839, DOI 10.1016/S0278-6915(99)00073-3; Steinmaus C, 2009, EPIDEMIOLOGY, V20, P807, DOI 10.1097/EDE.0b013e3181b0fd29; Styblo M, 2000, ARCH TOXICOL, V74, P289, DOI 10.1007/s002040000134; Sun GX, 2008, ENVIRON SCI TECHNOL, V42, P7542, DOI 10.1021/es801238p; TAM GKH, 1979, TOXICOL APPL PHARM, V50, P319, DOI 10.1016/0041-008X(79)90157-1; Tao SSH, 1999, FOOD ADDIT CONTAM A, V16, P465, DOI 10.1080/026520399283759; Thomas DJ, 2007, EXP BIOL MED, V232, P3; Tokar EJ, 2012, ARCH TOXICOL, V86, P975, DOI 10.1007/s00204-012-0820-8; Tseng CH, 2008, JAMA-J AM MED ASSOC, V300, P2728, DOI 10.1001/jama.2008.812; U.S. Food and Drug Administration (FDA), 2012, ARS RIC FULL AN RES; US Environmental Protection Agency, 2001, NPDES FIN ARS RUL; US Food and Drug Administration, 2005, BOTTL WAT QUAL STAND; Vahidnia A, 2007, HUM EXP TOXICOL, V26, P823, DOI 10.1177/0960327107084539; Valenzuela OL, 2005, ENVIRON HEALTH PERSP, V113, P250, DOI 10.1289/ehp.7519; Verdon CP, 2009, ANAL BIOANAL CHEM, V393, P939, DOI 10.1007/s00216-008-2537-3; WELLS BR, 1977, AGRON J, V69, P451, DOI 10.2134/agronj1977.00021962006900030029x; Williams PN, 2007, ENVIRON SCI TECHNOL, V41, P2178, DOI 10.1021/es061489k; Williams PN, 2005, ENVIRON SCI TECHNOL, V39, P5531, DOI 10.1021/es0502324; Yan WG, 2005, CROP SCI, V45, P1223, DOI 10.2135/cropsci2004.0348; Yu LL, 2011, ANAL METHODS-UK, V3, P1107, DOI 10.1039/c0ay00611d	84	40	41	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108098	10.1371/journal.pone.0108098	http://dx.doi.org/10.1371/journal.pone.0108098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251890	gold, Green Submitted, Green Published			2022-12-25	WOS:000342492700079
J	Kwon, Y; Song, P; Yoon, JH; Ghim, J; Kim, D; Kang, B; Lee, TG; Kim, JA; Choi, JK; Youn, IK; Lee, HK; Ryu, SH				Kwon, Yonghoon; Song, Parkyong; Yoon, Jong Hyuk; Ghim, Jaewang; Kim, Dayea; Kang, Byungjun; Lee, Taehoon G.; Kim, Jin-Ah; Choi, Joong-Kwon; Youn, In Kwon; Lee, Hyeon-Kyu; Ryu, Sung Ho			Xanthene Derivatives Increase Glucose Utilization through Activation of LKB1-Dependent AMP-Activated Protein Kinase	PLOS ONE			English	Article							SKELETAL-MUSCLE; GLUT4 TRANSLOCATION; DIABETES-MELLITUS; OXIDATIVE STRESS; ENERGY SENSOR; METFORMIN; CELLS; THIAZOLIDINEDIONES; METABOLISM; MECHANISM	5' AMP-activated protein kinase (AMPK) is a highly conserved serine-threonine kinase that regulates energy expenditure by activating catabolic metabolism and suppressing anabolic pathways to increase cellular energy levels. Therefore AMPK activators are considered to be drug targets for treatment of metabolic diseases such as diabetes mellitus. To identify novel AMPK activators, we screened xanthene derivatives. We determined that the AMPK activators 9H-xanthene-9-carboxylic acid {2,2,2-trichloro-1-[3-(3-nitro-phenyl)-thioureido]-ethyl}-amide (Xn) and 9H-xanthene-9-carboxylic acid {2,2,2-trichloro-1-[3-(3-cyano- phenyl)-thioureido]-ethyl}-amide (Xc) elevated glucose uptake in L6 myotubes by stimulating translocation of glucose transporter type 4 (GLUT4). Treatment with the chemical AMPK inhibitor compound C and infection with dominant-negative AMPKa2-virus inhibited AMPK phosphorylation and glucose uptake in myotubes induced by either Xn or Xc. Of the two major upstream kinases of AMPK, we found that Xn and Xc showed LKB1 dependency by knockdown of STK11, an ortholog of human LKB1. Single intravenous administration of Xn and Xc to high-fat diet-induced diabetic mice stimulated AMPK phosphorylation of skeletal muscle and improved glucose tolerance. Taken together, these results suggest that Xn and Xc regulate glucose homeostasis through LKB1-dependent AMPK activation and that the compounds are potential candidate drugs for the treatment of type 2 diabetes mellitus.	[Kwon, Yonghoon; Song, Parkyong; Ghim, Jaewang; Kim, Dayea; Kang, Byungjun; Ryu, Sung Ho] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, Kyungbuk, South Korea; [Yoon, Jong Hyuk; Lee, Taehoon G.] NovaCell Technol Inc, Pohang, Kyungbuk, South Korea; [Kim, Jin-Ah; Choi, Joong-Kwon; Lee, Hyeon-Kyu] Korea Res Inst Chem Technol, Korea Chem Bank, Taejon 305606, South Korea; [Youn, In Kwon] Pai Chai Univ, Dept Pharmaceut Engn, Taejon, South Korea	Pohang University of Science & Technology (POSTECH); Korea Research Institute of Chemical Technology (KRICT); Pai Chai University	Ryu, SH (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, Kyungbuk, South Korea.	sungho@postech.ac.kr		Kwon, yonghoon/0000-0002-6232-4305; Ryu, Sung Ho/0000-0003-0913-3048	Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [A111345]; GyeongSangBuk-Do Forestry Environment Research Institute; NovaCell Technology, Inc.	Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; GyeongSangBuk-Do Forestry Environment Research Institute; NovaCell Technology, Inc.	This work was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (Grant Number: A111345). This work was also funded by the GyeongSangBuk-Do Forestry Environment Research Institute. Co-authors Jong Hyuk Yoon and Taehoon G. Lee are employed by NovaCell Technology, Inc. NovaCell Technology, Inc. provided support in the form of salaries for authors JHY and TGL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section. This work was also funded by the GyeongSangBuk-Do Forestry Environment Research Institute.	An ZB, 2007, J BIOL CHEM, V282, P26793, DOI 10.1074/jbc.M703701200; Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Halse R, 2003, DIABETES, V52, P9, DOI 10.2337/diabetes.52.1.9; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Holmes BF, 1999, J APPL PHYSIOL, V87, P1990, DOI 10.1152/jappl.1999.87.5.1990; Kendall DM, 2005, DIABETES CARE, V28, P1083, DOI 10.2337/diacare.28.5.1083; Koistinen HA, 2003, DIABETES, V52, P1066, DOI 10.2337/diabetes.52.5.1066; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; LeBrasseur NK, 2006, AM J PHYSIOL-ENDOC M, V291, pE175, DOI 10.1152/ajpendo.00453.2005; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Loo AEK, 2007, J AGR FOOD CHEM, V55, P9805, DOI 10.1021/jf071500f; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Miura T, 2001, PHYTOMEDICINE, V8, P85, DOI 10.1078/0944-7113-00009; Musi N, 2006, CURR MED CHEM, V13, P583, DOI 10.2174/092986706776055724; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; Narayanan PK, 2003, CYTOM PART A, V52A, P28, DOI 10.1002/cyto.a.10011; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Park IJ, 2009, ANN NY ACAD SCI, V1171, P538, DOI 10.1111/j.1749-6632.2009.04698.x; Qaseem A, 2012, ANN INTERN MED, V156, P218, DOI 10.7326/0003-4819-156-3-201202070-00011; Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Spiller HA, 2004, ANN PHARMACOTHER, V38, P776, DOI 10.1345/aph.1D468; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; Tamas P, 2006, J EXP MED, V203, P1665, DOI 10.1084/jem.20052469; Treebak JT, 2006, DIABETES, V55, P2051, DOI 10.2337/db06-0175; Wang QH, 1998, FEBS LETT, V427, P193, DOI 10.1016/S0014-5793(98)00423-2; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Yea K, 2008, J MOL MED-JMM, V86, P211, DOI 10.1007/s00109-007-0269-z; Yin J, 2008, AM J PHYSIOL-ENDOC M, V294, pE148, DOI 10.1152/ajpendo.00211.2007; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zmijewski JW, 2010, J BIOL CHEM, V285, P33154, DOI 10.1074/jbc.M110.143685; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	39	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108771	10.1371/journal.pone.0108771	http://dx.doi.org/10.1371/journal.pone.0108771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250787	Green Submitted, Green Published, gold			2022-12-25	WOS:000342492700154
J	Loh, KK; Kanai, R				Loh, Kep Kee; Kanai, Ryota			Higher Media Multi-Tasking Activity Is Associated with Smaller Gray-Matter Density in the Anterior Cingulate Cortex	PLOS ONE			English	Article							DUAL-TASK PERFORMANCE; COGNITIVE CONTROL; PREFRONTAL CORTEX; INTERFERENCE TASK; BRAIN STRUCTURE; FUNCTIONAL MRI; CONFLICT; STROOP; DISSOCIATION; SELECTION	Media multitasking, or the concurrent consumption of multiple media forms, is increasingly prevalent in today's society and has been associated with negative psychosocial and cognitive impacts. Individuals who engage in heavier media-multitasking are found to perform worse on cognitive control tasks and exhibit more socio-emotional difficulties. However, the neural processes associated with media multi-tasking remain unexplored. The present study investigated relationships between media multitasking activity and brain structure. Research has demonstrated that brain structure can be altered upon prolonged exposure to novel environments and experience. Thus, we expected differential engagements in media multitasking to correlate with brain structure variability. This was confirmed via Voxel-Based Morphometry (VBM) analyses: Individuals with higher Media Multitasking Index (MMI) scores had smaller gray matter density in the anterior cingulate cortex (ACC). Functional connectivity between this ACC region and the precuneus was negatively associated with MMI. Our findings suggest a possible structural correlate for the observed decreased cognitive control performance and socio-emotional regulation in heavy media-multitaskers. While the cross-sectional nature of our study does not allow us to specify the direction of causality, our results brought to light novel associations between individual media multitasking behaviors and ACC structure differences.	[Loh, Kep Kee] Duke NUS Grad Med Sch, Cognit Neurosci Lab, Singapore, Singapore; [Kanai, Ryota] Univ Sussex, Sackler Ctr Consciousness Sci, Brighton, E Sussex, England; [Loh, Kep Kee; Kanai, Ryota] UCL, Inst Cognit Neurosci, London, England	National University of Singapore; University of Sussex; University of London; University College London	Loh, KK (corresponding author), Duke NUS Grad Med Sch, Cognit Neurosci Lab, Singapore, Singapore.	lohkepkee@gmail.com	Loh, Kep Kee/AAV-4565-2020	Loh, Kep Kee/0000-0003-0650-224X; Kanai, Ryota/0000-0002-0186-2687	Japan Science and Technology Agency	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	Funding for this project came from a PRESTO grant from the Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzahabi R, 2013, J EXP PSYCHOL HUMAN, V39, P1485, DOI 10.1037/a0031208; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Becker MW, 2013, CYBERPSYCH BEH SOC N, V16, P132, DOI 10.1089/cyber.2012.0291; BLAKEMORE C, 1975, J PHYSIOL-LONDON, V248, P663, DOI 10.1113/jphysiol.1975.sp010995; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Bush G, 1998, HUM BRAIN MAPP, V6, P270, DOI 10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.0.CO;2-0; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Caetano SC, 2006, BIOL PSYCHIAT, V59, P702, DOI 10.1016/j.biopsych.2005.10.011; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; CORBETTA M, 1991, J NEUROSCI, V11, P2383; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Dreher JC, 2003, CEREB CORTEX, V13, P329, DOI 10.1093/cercor/13.4.329; Dux PE, 2006, NEURON, V52, P1109, DOI 10.1016/j.neuron.2006.11.009; Erickson KI, 2005, NEUROIMAGE, V28, P967, DOI 10.1016/j.neuroimage.2005.06.047; Fellows LK, 2005, BRAIN, V128, P788, DOI 10.1093/brain/awh405; Franklin TR, 2002, BIOL PSYCHIAT, V51, P134, DOI 10.1016/S0006-3223(01)01269-0; John O.P., 1999, HDB PERSONALITY THEO, V1999, P102, DOI DOI 10.1037/A0019265; Junco R., 2010, COMPUT EDUC, V56, P370; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kiehl KA, 2000, PSYCHOPHYSIOLOGY, V37, P216, DOI 10.1111/1469-8986.3720216; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Leung HC, 2000, CEREB CORTEX, V10, P552, DOI 10.1093/cercor/10.6.552; Lin FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030253; Lui KFH, 2012, PSYCHON B REV, V19, P647, DOI 10.3758/s13423-012-0245-7; Marois R, 2005, TRENDS COGN SCI, V9, P296, DOI 10.1016/j.tics.2005.04.010; Milham MP, 2001, COGNITIVE BRAIN RES, V12, P467, DOI 10.1016/S0926-6410(01)00076-3; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Ophir E, 2009, P NATL ACAD SCI USA, V106, P15583, DOI 10.1073/pnas.0903620106; Pea R, 2012, DEV PSYCHOL, V48, P327, DOI 10.1037/a0027030; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralph BC, 2013, PSYCHOL RES; Rideout V.J., 2010, HENRY J KAIS FAM FOU; Rotge JY, 2009, BIOL PSYCHIAT, V65, P75, DOI 10.1016/j.biopsych.2008.06.019; Sanbonmatsu DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054402; Swick D, 2002, P NATL ACAD SCI USA, V99, P16354, DOI 10.1073/pnas.252521499; Swick D, 2002, NEUROPSYCHOLOGIA, V40, P1240, DOI 10.1016/S0028-3932(01)00226-3; Whitfield-Gabrieli S, 2011, NEUROIMAGE, V55, P225, DOI 10.1016/j.neuroimage.2010.11.048; Yamasue H, 2003, P NATL ACAD SCI USA, V100, P9039, DOI 10.1073/pnas.1530467100; Yuan K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020708; Zhou Y, 2011, EUR J RADIOL, V79, P92, DOI 10.1016/j.ejrad.2009.10.025	48	60	62	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e106698	10.1371/journal.pone.0106698	http://dx.doi.org/10.1371/journal.pone.0106698			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250778	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000342492700017
J	Gonzalez, JM; Francis, B; Burda, S; Hess, K; Behera, D; Gupta, D; Agarwal, AN; Verma, I; Verma, A; Myneedu, VP; Niedbala, S; Laal, S				Gonzalez, Jesus M.; Francis, Bryan; Burda, Sherri; Hess, Kaitlyn; Behera, Digamber; Gupta, Dheeraj; Agarwal, Ashutosh Nath; Verma, Indu; Verma, Ajoy; Myneedu, Vithal Prasad; Niedbala, Sam; Laal, Suman			Development of a POC Test for TB Based on Multiple Immunodominant Epitopes of M. tuberculosis Specific Cell-Wall Proteins	PLOS ONE			English	Article							MICROSCOPY CENTERS; ANTIBODY DETECTION; DIAGNOSIS; INCIPIENT; ANTIGENS	The need for an accurate, rapid, simple and affordable point-of-care (POC) test for Tuberculosis (TB) that can be implemented in microscopy centers and other peripheral health-care settings in the TB-endemic countries remains unmet. This manuscript describes preliminary results of a new prototype rapid lateral flow TB test based on detection of antibodies to immunodominant epitopes (peptides) derived from carefully selected, highly immunogenic M. tuberculosis cell-wall proteins. Peptide selection was initially based on recognition by antibodies in sera from TB patients but not in PPD-/PPD+/BCG-vaccinated individuals from TB-endemic settings. The peptides were conjugated to BSA; the purified peptide-BSA conjugates striped onto nitrocellulose membrane and adsorbed onto colloidal gold particles to devise the prototype test, and evaluated for reactivity with sera from 3 PPD-, 29 PPD+, 15 PPD-unknown healthy subjects, 10 patients with non-TB lung disease and 124 smear-positive TB patients. The assay parameters were adjusted to determine positive/negative status within 15 minutes via visual or instrumented assessment. There was minimal or no reactivity of sera from non-TB subjects with the striped BSA-peptides demonstrating the lack of anti-peptide antibodies in subjects with latent TB and/or BCG vaccination. Sera from most TB patients demonstrated reactivity with one or more peptides. The sensitivity of antibody detection ranged from 28-85% with the 9 BSA-peptides. Three peptides were further evaluated with sera from 400 subjects, including additional PPD-/PPD+/PPD-unknown healthy contacts, close hospital contacts and household contacts of untreated TB patients, patients with non-TB lung disease, and HIV+TB- patients. Combination of the 3 peptides provided sensitivity and specificity >90%. While the final fully optimized lateral flow POC test for TB is under development, these preliminary results demonstrate that an antibody-detection based rapid POC lateral flow test based on select combinations of immunodominant M. tb-specific epitopes may potentially replace microscopy for TB diagnosis in TB-endemic settings.	[Gonzalez, Jesus M.; Hess, Kaitlyn; Niedbala, Sam] Lehigh Univ, Dept Chem, Bethlehem, PA 18015 USA; [Francis, Bryan; Niedbala, Sam] TB Biosci, Bethlehem, PA USA; [Burda, Sherri; Laal, Suman] NYU, Langone Med Ctr, Dept Pathol, New York, NY 10012 USA; [Behera, Digamber; Gupta, Dheeraj; Agarwal, Ashutosh Nath; Verma, Indu] Postgrad Inst Med Educ & Res, Chandigarh 160012, India; [Verma, Ajoy; Myneedu, Vithal Prasad] Natl Inst TB & Resp Dis, New Delhi, India; [Laal, Suman] Vet Affairs New York Harbor Healthcare Syst, New York, NY USA	Lehigh University; New York University; NYU Langone Medical Center; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Laal, S (corresponding author), NYU, Langone Med Ctr, Dept Pathol, New York, NY 10012 USA.	suman.laal@nyumc.org	Verma, Indu/AAF-3514-2020		Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; National Institutes of Health [1R41A1091049]	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This material is based upon work supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; employing Dr. Suman Laal, Research Microbiologist/Research Career Scientist, Research Service, Department of Veterans Affairs New York Harbor Healthcare System, New York, NY. These studies are funded by STTR-Phase 1 and Phase 2 funds from the National Institutes of Health via Grant # 1R41A1091049 awarded to TB Biosciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2009, LUNG INDIA, V26, P61, DOI 10.4103/0970-2113.53225; [Anonymous], 2011, COMM SER TESTS DIAGN; [Anonymous], 2011, AUT REAL TIM NUCL AC; Cicenas Saulius, 2007, World J Surg Oncol, V5, P22, DOI 10.1186/1477-7819-5-22; Cooke GS, 2011, LAB FREE TUBERCULOSI; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corbett EL, 2004, AM J RESP CRIT CARE, V170, P673, DOI 10.1164/rccm.200405-590OC; Denkinger CM, 2013, EXPERT REV MOL DIAGN, V13, P763, DOI 10.1586/14737159.2013.850034; Denkinger CM, 2013, EUR RESPIR J, V42, P544, DOI 10.1183/09031936.00081113; Gonzalez JM, 2011, ANAL BIOANAL CHEM, V400, P3655, DOI 10.1007/s00216-011-5051-y; GORDIN FM, 1989, AM REV RESPIR DIS, V139, P1090, DOI 10.1164/ajrccm/139.5.1090; Harikrishna J., 2012, J INDIAN ACAD CLIN M, V13, P142; Hayat M. A., 1989, COLLOIDAL GOLD PRINC, V1; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1; Kranzer K, 2010, LANCET INFECT DIS, V10, P93, DOI 10.1016/S1473-3099(09)70326-3; Lawn SD, 2013, LANCET INFECT DIS, V13, P349, DOI 10.1016/S1473-3099(13)70008-2; Nikam C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051121; O'Brien RJ, 2003, INT J TUBERC LUNG D, V7, P198; Shen GM, 2012, INFECT IMMUN, V80, P243, DOI 10.1128/IAI.05541-11; Shen GM, 2009, CLIN VACCINE IMMUNOL, V16, P49, DOI 10.1128/CVI.00334-08; Singh KK, 2005, CLIN DIAGN LAB IMMUN, V12, P354, DOI 10.1128/CDLI.12.2.354-358.2005; Singh KK, 2001, INFECT IMMUN, V69, P4185, DOI 10.1128/IAI.69.6.4185-4191.2001; Singh KK, 2009, J INFECT DIS, V200, P571, DOI 10.1086/603539; Steingart KR, 2007, THORAX, V62, P911, DOI 10.1136/thx.2006.075754; Steingart KR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001062; Steingart KR, 2007, PLOS MED, V4, P1; UNICEF UNDP WorldBank WHO, 2006, DIAGN TUB GLOB DEM M, P1; UNITAID WHO, 2013, TUB DIAGN TECHN MARK; van't Hoog AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082786; Wanchu A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002071; Wejse C, 2014, LANCET, V383, P388, DOI 10.1016/S0140-6736(13)62003-6; [WHO UNICEF AED USAID], 2008, LEISHM LEISHM HIV CO, P1	32	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e106279	10.1371/journal.pone.0106279	http://dx.doi.org/10.1371/journal.pone.0106279			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247820	gold, Green Submitted, Green Published			2022-12-25	WOS:000342351800007
J	Tong, L; Li, K; Zhou, QX				Tong, Ling; Li, Kai; Zhou, Qixing			Promoted Relationship of Cardiovascular Morbidity with Air Pollutants in a Typical Chinese Urban Area	PLOS ONE			English	Article							RISK-FACTOR; POLLUTION; MORTALITY; HEALTH; TEMPERATURE; EXPOSURE; TIANJIN; DISEASE; CITIES	Background: A large number of studies about effects of air pollutants on cardiovascular mortality have been conducted; however, those investigating association between air pollutants and cardiovascular morbidity are limited, especially in developing countries. Methods: A time-series analysis on the short-term association between outdoor air pollutants including particulate matter (PM) with diameters of 10 mm or less (PM10), sulfur dioxide (SO2) and nitrogen dioxide (NO2) and cardiovascular morbidity was conducted in Tianjin, China based on 4 years of daily data (2008-2011). The morbidity data were stratified by sex and age. The effects of air pollutants during the warm season and the cool season were also analyzed separately. Results: Each increase in PM10, SO2, and NO2 by increments of 10 mu g/m(3) in a 2-day average concentration was associated with increases in the cardiovascular morbidity of 0.19% with 95 percent confidence interval (95% CI) of 0.08-0.31, 0.43% with 95% CI of 0.03-0.84, and 0.52% with 95% CI of 20.09-1.13, respectively. The effects of air pollutants were more evident in the cool season than those in the warm season, females and the elderly were more vulnerable to outdoor air pollution. Conclusions: All estimated coefficients of PM10, SO2 and NO2 are positive but only the effect of SO2 implied statistical significance at the 5% level. Moreover, season, sex and age might modify health effects of outdoor air pollutants. This work may bring inspirations for formulating local air pollutant standards and social policy regarding cardiovascular health of residents.	[Tong, Ling] Tianjin Univ, Sch Environm Sci & Engn, Tianjin 300072, Peoples R China; [Li, Kai] Nankai Univ, Dept Ind Engn, Tianjin 300071, Peoples R China; [Tong, Ling; Zhou, Qixing] Nankai Univ, Coll Environm Sci & Engn, Key Lab Pollut Proc & Environm Criteria, Minist Educ, Tianjin 300071, Peoples R China	Tianjin University; Nankai University; Nankai University	Zhou, QX (corresponding author), Nankai Univ, Coll Environm Sci & Engn, Key Lab Pollut Proc & Environm Criteria, Minist Educ, Tianjin 300071, Peoples R China.	zhouqx@nankai.edu.cn			Ministry of Science and Technology, People's Republic of China (973 project) [2011CB503802]; National Natural Science Foundation [21037002]	Ministry of Science and Technology, People's Republic of China (973 project); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This research was financially supported by the Ministry of Science and Technology, People's Republic of China as a 973 project (grant No. 2011CB503802), and by the National Natural Science Foundation as a key project (grant No. 21037002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, 30952012 GBT; Brook RD, 2008, CLIN SCI, V115, P175, DOI 10.1042/CS20070444; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Chalamaiah M, 2012, FOOD CHEM, V135, P3020, DOI 10.1016/j.foodchem.2012.06.100; Cheng Z, 2013, ATMOS ENVIRON, V65, P186, DOI 10.1016/j.atmosenv.2012.10.022; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Fang SC, 2010, INT J ENV RES PUB HE, V7, P1773, DOI 10.3390/ijerph7041773; Grundtvig M, 2013, INT J CARDIOL, V167, P2792, DOI 10.1016/j.ijcard.2012.07.010; Guo YM, 2010, SCI TOTAL ENVIRON, V409, P300, DOI 10.1016/j.scitotenv.2010.10.013; Hu XG, 2013, CHEM REV, V113, P3815, DOI 10.1021/cr300045n; Johnson CA, 2006, PUBLIC HEALTH, V120, P1156, DOI 10.1016/j.puhe.2006.07.023; Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012; Kan HD, 2008, ENVIRON HEALTH PERSP, V116, P1463, DOI 10.1289/ehp.11290; Kan HD, 2008, ENVIRON HEALTH PERSP, V116, P1183, DOI 10.1289/ehp.10851; Kan HD, 2012, ENVIRON INT, V42, P10, DOI 10.1016/j.envint.2011.03.003; Katsouyanni K, 2001, EPIDEMIOLOGY, V12, P521, DOI 10.1097/00001648-200109000-00011; Kelly FJ, 2004, P NUTR SOC, V63, P579, DOI 10.1079/PNS2004388; Koulova A, 2014, CARDIOL REV, V22, P30, DOI 10.1097/CRD.0000000000000000; Li WF, 2009, AEROSOL AIR QUAL RES, V9, P105; Moolgavkar SH, 2000, J AIR WASTE MANAGE, V50, P1199, DOI 10.1080/10473289.2000.10464162; Roberts S, 2003, ATMOS ENVIRON, V37, P3317, DOI 10.1016/S1352-2310(03)00289-9; Roberts S, 2011, ATMOS ENVIRON, V45, P4728, DOI 10.1016/j.atmosenv.2011.04.050; Shrey K, 2011, ENVIRON TOXICOL PHAR, V31, P1, DOI 10.1016/j.etap.2010.09.002; Tsai DH, 2010, SCI TOTAL ENVIRON, V408, P1818, DOI 10.1016/j.scitotenv.2010.01.044; *WHO, 1993, INT CLASS DIS; WHO, 2006, REPORT WORKING GROUP; Wong CM, 2002, ENVIRON HEALTH PERSP, V110, P67, DOI 10.1289/ehp.0211067; Xiao ZM, 2012, J ENVIRON SCI-CHINA, V24, P112, DOI 10.1016/S1001-0742(11)60734-1; Zanobetti A, 2008, EPIDEMIOLOGY, V19, P563, DOI 10.1097/EDE.0b013e31816d652d	29	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108076	10.1371/journal.pone.0108076	http://dx.doi.org/10.1371/journal.pone.0108076			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247693	gold, Green Published, Green Submitted			2022-12-25	WOS:000342351800062
J	Wimmer, MC; Robinson, EJ; Koenig, L; Corder, E				Wimmer, Marina C.; Robinson, Elizabeth J.; Koenig, Laura; Corder, Emma			Getting the Picture: Iconicity Does Not Affect Representation-Referent Confusion	PLOS ONE			English	Article							METALINGUISTIC AWARENESS; CHILDRENS CONCEPTIONS; MEMORY; PICTORIAL; BELIEFS; INFANTS; SYMBOL; OBJECT; WORDS; MIND	Three experiments examined 3- to 5-year-olds' (N=428) understanding of the relationship between pictorial iconicity (photograph, colored drawing, schematic drawing) and the real world referent. Experiments 1 and 2 explored pictorial iconicity in picture-referent confusion after the picture-object relationship has been established. Pictorial iconicity had no effect on referential confusion when the referent changed after the picture had been taken/drawn (Experiment 1) and when the referent and the picture were different from the outset (Experiment 2). Experiment 3 investigated whether children are sensitive to iconicity to begin with. Children deemed photographs from a choice of varying iconicity representations as best representations for object reference. Together, findings suggest that iconicity plays a role in establishing a picture-object relation per se but is irrelevant once children have accepted that a picture represents an object. The latter finding may reflect domain general representational abilities.	[Wimmer, Marina C.; Koenig, Laura] Univ Plymouth, Cognit Ctr, Sch Psychol, Plymouth PL4 8AA, Devon, England; [Robinson, Elizabeth J.] Univ Warwick, Dept Psychol, Coventry CV4 7AL, W Midlands, England; [Corder, Emma] Oxford Brookes Univ, Sch Psychol, Oxford OX3 0BP, England	University of Plymouth; University of Warwick; Oxford Brookes University	Wimmer, MC (corresponding author), Univ Plymouth, Cognit Ctr, Sch Psychol, Plymouth PL4 8AA, Devon, England.	marina.wimmer@plymouth.ac.uk		Wimmer, Marina/0000-0003-0365-5718	British Academy, UK [SG111043]	British Academy, UK	This research was supported by a grant from the British Academy, UK (SG111043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEILIN H, 1991, ADV CHILD DEV BEHAV, V23, P73, DOI 10.1016/S0065-2407(08)60023-3; BLADES M, 1994, J GENET PSYCHOL, V155, P201, DOI 10.1080/00221325.1994.9914772; Callaghan TC, 2000, COGNITIVE DEV, V15, P185, DOI 10.1016/S0885-2014(00)00026-5; CHARMAN T, 1992, J CHILD PSYCHOL PSYC, V33, P1105, DOI 10.1111/j.1469-7610.1992.tb00929.x; Claxton LJ, 2011, INFANT CHILD DEV, V20, P301, DOI 10.1002/icd.699; DELOACHE JS, 1987, SCIENCE, V238, P1556, DOI 10.1126/science.2446392; DELOACHE JS, 1994, COGNITION, V52, P83, DOI 10.1016/0010-0277(94)90063-9; DeLoache JS, 2000, CHILD DEV, V71, P329, DOI 10.1111/1467-8624.00148; Doherty M, 1998, COGNITIVE DEV, V13, P279, DOI 10.1016/S0885-2014(98)90012-0; Doherty M., 2008, THEORY MIND CHILDREN, DOI 10.4324/9780203929902; Doherty MJ, 2000, J CHILD LANG, V27, P367, DOI 10.1017/S0305000900004153; Doherty MJ, 2005, COGNITIVE DEV, V20, P407, DOI 10.1016/j.cogdev.2005.05.003; Donnelly KE, 2013, COGNITION, V129, P51, DOI 10.1016/j.cognition.2013.06.002; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FOLEY MA, 1993, COGNITIVE DEV, V8, P373, DOI 10.1016/S0885-2014(05)80001-2; Jastrow Joseph., 1900, FACT FABLE PSYCHOL; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037/0033-2909.114.1.3; Jolley R.P., 2010, CHILDREN PICTURES DR; LIBEN LS, 1989, ADV CHILD DEV BEHAV, V22, P145; Liben LS, 2003, ADV CHILD DEV BEHAV, V31, P1; LINDSAY DS, 1991, J EXP CHILD PSYCHOL, V52, P297, DOI 10.1016/0022-0965(91)90065-Z; Perner J, 2002, COGNITIVE DEV, V17, P1451, DOI 10.1016/S0885-2014(02)00127-2; Perner J, 1991, UNDERSTANDING REPRES; Perner J, 2012, TRENDS COGN SCI, V16, P519, DOI 10.1016/j.tics.2012.08.004; Pierroutsakos SL, 2003, INFANCY, V4, P141, DOI 10.1207/S15327078IN0401_7; Preissler MA, 2007, PSYCHOL SCI, V18, P1, DOI 10.1111/j.1467-9280.2007.01837.x; Roberts KP, 1998, APPL COGNITIVE PSYCH, V12, P489, DOI 10.1002/(SICI)1099-0720(199810)12:5<489::AID-ACP535>3.0.CO;2-#; ROBINSON EJ, 1994, COGNITIVE DEV, V9, P165, DOI 10.1016/0885-2014(94)90002-7; Simcock G, 2006, DEV PSYCHOL, V42, P1352, DOI 10.1037/0012-1649.42.6.1352; Slaughter V, 1998, CHILD DEV, V69, P321, DOI 10.2307/1132167; Suddendorf T, 2003, CHILD DEV, V74, P896, DOI 10.1111/1467-8624.00574; Thomas GV, 1999, J EXP CHILD PSYCHOL, V74, P1, DOI 10.1006/jecp.1999.2506; Thomas GV, 2001, BRIT J DEV PSYCHOL, V19, P475, DOI 10.1348/026151001166209; Wimmer M. C., 2011, MONOGRAPHS SOC RES C, V76, P1, DOI DOI 10.1111/J.1540-5834.2011.00589.X; ZAITCHIK D, 1990, COGNITION, V35, P41, DOI 10.1016/0010-0277(90)90036-J	35	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107910	10.1371/journal.pone.0107910	http://dx.doi.org/10.1371/journal.pone.0107910			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP8TL	25247708	Green Published, Green Submitted, gold			2022-12-25	WOS:000342351800046
J	Jada, B; Soitamo, AJ; Siddiqui, SA; Murukesan, G; Aro, EM; Salakoski, T; Lehto, K				Jada, Balaji; Soitamo, Arto J.; Siddiqui, Shahid Aslam; Murukesan, Gayatri; Aro, Eva-Mari; Salakoski, Tapio; Lehto, Kirsi			Multiple Different Defense Mechanisms Are Activated in the Young Transgenic Tobacco Plants Which Express the Full Length Genome of the Tobacco Mosaic Virus, and Are Resistant against this Virus	PLOS ONE			English	Article							OXYGEN-EVOLVING COMPLEX; BUSHY STUNT VIRUS; NICOTIANA-BENTHAMIANA; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; MESSENGER-RNA; IN-VIVO; VIRAL PATHOGENICITY; IMMUNE-SYSTEM; 80S RIBOSOME	Previously described transgenic tobacco lines express the full length infectious Tobacco mosaic virus (TMV) genome under the 35S promoter (Siddiqui et al., 2007. Mol Plant Microbe Interact, 20: 1489-1494). Through their young stages these plants exhibit strong resistance against both the endogenously expressed and exogenously inoculated TMV, but at the age of about 7-8 weeks they break into TMV infection, with typical severe virus symptoms. Infections with some other viruses (Potato viruses Y, A, and X) induce the breaking of the TMV resistance and lead to synergistic proliferation of both viruses. To deduce the gene functions related to this early resistance, we have performed microarray analysis of the transgenic plants during the early resistant stage, and after the resistance break, and also of TMV-infected wild type tobacco plants. Comparison of these transcriptomes to those of corresponding wild type healthy plants indicated that 1362, 1150 and 550 transcripts were up-regulated in the transgenic plants before and after the resistance break, and in the TMV-infected wild type tobacco plants, respectively, and 1422, 1200 and 480 transcripts were down-regulated in these plants, respectively. These transcriptome alterations were distinctly different between the three types of plants, and it appears that several different mechanisms, such as the enhanced expression of the defense, hormone signaling and protein degradation pathways contributed to the TMV-resistance in the young transgenic plants. In addition to these alterations, we also observed a distinct and unique gene expression alteration in these plants, which was the strong suppression of the translational machinery. This may also contribute to the resistance by slowing down the synthesis of viral proteins. Viral replication potential may also be suppressed, to some extent, by the reduction of the translation initiation and elongation factors eIF-3 and eEF1A and B, which are required for the TMV replication complex.	[Jada, Balaji; Soitamo, Arto J.; Aro, Eva-Mari; Lehto, Kirsi] Univ Turku, Dept Biochem, Plant Mol Biol Lab, SF-20500 Turku, Finland; [Siddiqui, Shahid Aslam] Univ Helsinki, Dept Agr Sci, Helsinki, Finland; [Murukesan, Gayatri; Salakoski, Tapio] Univ Turku, Dept Informat Technol, Turku, Finland	Finland National Institute for Health & Welfare; University of Turku; University of Helsinki; University of Turku	Lehto, K (corresponding author), Univ Turku, Dept Biochem, Plant Mol Biol Lab, SF-20500 Turku, Finland.	klehto@utu.fi	Aro, Eva-Mari/Q-8664-2017; Soitamo, Arto J/C-4435-2015	Aro, Eva-Mari/0000-0002-2922-1435; Murukesan, Gayathri/0000-0003-4649-7596	Turku University Foundation; Academy of Finland [127203, 128943, 118637]	Turku University Foundation; Academy of Finland(Academy of Finland)	Research was supported by Turku University Foundation, and by the Academy of Finland, grant numbers 127203, 128943 and 118637. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink TEM, 2002, VIROLOGY, V295, P307, DOI 10.1006/viro.2002.1332; Ahlquist P, 2006, NAT REV MICROBIOL, V4, P371, DOI 10.1038/nrmicro1389; Ahlquist P, 2003, J VIROL, V77, P8181, DOI 10.1128/JVI.77.15.8181-8186.2003; Baebler S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029009; Barends S, 2003, CELL, V112, P123, DOI 10.1016/S0092-8674(02)01256-4; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bhat S, 2013, PLANT PHYSIOL, V161, P134, DOI 10.1104/pp.112.207860; Bilgin DD, 2010, PLANT CELL ENVIRON, V33, P1597, DOI 10.1111/j.1365-3040.2010.02167.x; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Burgyan J, 2011, TRENDS PLANT SCI, V16, P265, DOI 10.1016/j.tplants.2011.02.010; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calvo M, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-139; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; Culver JN, 2007, ANNU REV PHYTOPATHOL, V45, P221, DOI 10.1146/annurev.phyto.45.062806.094422; Dardick C, 2007, MOL PLANT MICROBE IN, V20, P1004, DOI 10.1094/MPMI-20-8-1004; DINER BA, 1988, J BIOL CHEM, V263, P8972; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Duprat A, 2002, PLANT J, V32, P927, DOI 10.1046/j.1365-313X.2002.01481.x; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Golem S, 2003, MOL PLANT MICROBE IN, V16, P681, DOI 10.1094/MPMI.2003.16.8.681; Harries PA, 2010, MOL PLANT MICROBE IN, V23, P1381, DOI 10.1094/MPMI-05-10-0121; Harries PA, 2009, P NATL ACAD SCI USA, V106, P17594, DOI 10.1073/pnas.0909239106; HATTA T, 1973, J GEN VIROL, V20, P37, DOI 10.1099/0022-1317-20-1-37; Hirai K, 2008, J VIROL, V82, P3250, DOI 10.1128/JVI.02139-07; Hwang J, 2013, VIROLOGY, V439, P105, DOI 10.1016/j.virol.2013.02.004; Elvira MI, 2008, J EXP BOT, V59, P1253, DOI 10.1093/jxb/ern032; Ishibashi K, 2010, MOL PLANT MICROBE IN, V23, P1413, DOI 10.1094/MPMI-04-10-0102; Jada B, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-8; Jimenez I, 2006, MOL PLANT MICROBE IN, V19, P350, DOI 10.1094/MPMI-19-0350; Kallio MA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-507; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kerekatte V, 1999, J VIROL, V73, P709, DOI 10.1128/JVI.73.1.709-717.1999; Laliberte JF, 2010, ANNU REV PHYTOPATHOL, V48, P69, DOI 10.1146/annurev-phyto-073009-114239; Lehto K, 2003, MOL PLANT MICROBE IN, V16, P1135, DOI 10.1094/MPMI.2003.16.12.1135; Leonard S, 2000, J VIROL, V74, P7730, DOI 10.1128/JVI.74.17.7730-7737.2000; Li ZH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001175; Liao DI, 2000, NAT STRUCT BIOL, V7, P749, DOI 10.1038/78973; Lieberman HB, 2011, J MOL CELL BIOL, V3, P39, DOI 10.1093/jmcb/mjq039; Liu CK, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00012; Lodha TD, 2012, MOL BIOTECHNOL, V50, P87, DOI 10.1007/s12033-011-9418-2; Lukasik E, 2009, CURR OPIN PLANT BIOL, V12, P427, DOI 10.1016/j.pbi.2009.03.001; McCartney AW, 2005, PLANT CELL, V17, P3513, DOI 10.1105/tpc.105.036350; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; NEVINS JR, 1994, CURR OPIN GENET DEV, V4, P130, DOI 10.1016/0959-437X(94)90101-5; Noueiry AO, 2000, P NATL ACAD SCI USA, V97, P12985, DOI 10.1073/pnas.240460897; Osman TAM, 1997, J VIROL, V71, P6075, DOI 10.1128/JVI.71.8.6075-6082.1997; Padmanabhan MS, 2008, J VIROL, V82, P2477, DOI 10.1128/JVI.01865-07; Pfeffer S, 2002, J VIROL, V76, P6815, DOI 10.1128/JVI.76.13.6815-6824.2002; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Postnikova OA, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-101; QUADT R, 1993, P NATL ACAD SCI USA, V90, P1498, DOI 10.1073/pnas.90.4.1498; Rodrigo G, 2011, J R SOC INTERFACE, V8, P257, DOI 10.1098/rsif.2010.0264; Schwartz M, 2004, P NATL ACAD SCI USA, V101, P11263, DOI 10.1073/pnas.0404157101; Siddiqui SA, 2007, MOL PLANT MICROBE IN, V20, P1489, DOI 10.1094/MPMI-20-12-1489; Siddiqui SA, 2011, MOL PLANT MICROBE IN, V24, P685, DOI 10.1094/MPMI-12-10-0290; Siddiqui SA, 2008, MOL PLANT MICROBE IN, V21, P178, DOI 10.1094/MPMI-21-2-0178; Sindelarova M, 2001, BIOL PLANTARUM, V44, P567, DOI 10.1023/A:1013794720767; Sogorin EA, 2012, BIOCHEMISTRY-MOSCOW+, V77, P342, DOI 10.1134/S0006297912040049; Soitamo AJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-204; Soitamo AJ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-68; Sokolenko A, 2002, CURR GENET, V41, P291, DOI 10.1007/s00294-002-0309-8; Song LP, 2011, PROTEIN CELL, V2, P273, DOI 10.1007/s13238-011-1037-y; Soosaar JLM, 2005, NAT REV MICROBIOL, V3, P789, DOI 10.1038/nrmicro1239; Thivierge K, 2005, PLANT PHYSIOL, V138, P1822, DOI 10.1104/pp.105.064105; Thomas CL, 2003, VIROLOGY, V306, P33, DOI 10.1016/S0042-6822(02)00018-1; Toribio R, 2010, P NATL ACAD SCI USA, V107, P9837, DOI 10.1073/pnas.1004110107; TYC K, 1984, EUR J BIOCHEM, V140, P503, DOI 10.1111/j.1432-1033.1984.tb08131.x; Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Voinnet O, 2001, TRENDS GENET, V17, P449, DOI 10.1016/S0168-9525(01)02367-8; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655; Wang X, 2009, J VIROL, V83, P9720, DOI 10.1128/JVI.00941-09; Wells DR, 1998, GENE DEV, V12, P3236, DOI 10.1101/gad.12.20.3236; Whitham SA, 2004, CURR OPIN PLANT BIOL, V7, P365, DOI 10.1016/j.pbi.2004.04.006; Whitham SA, 2003, PLANT J, V33, P271, DOI 10.1046/j.1365-313X.2003.01625.x; Whitham SA, 2006, MOL PLANT MICROBE IN, V19, P1207, DOI 10.1094/MPMI-19-1207; Wright KM, 2007, TRAFFIC, V8, P21, DOI 10.1111/j.1600-0854.2006.00510.x; Wu QF, 2010, CELL HOST MICROBE, V8, P12, DOI 10.1016/j.chom.2010.06.009; Zhu A, 2008, CANCER RES, V68, P1267, DOI 10.1158/0008-5472.CAN-07-2304; Zhu SF, 2005, PLANT PHYSIOL, V139, P1935, DOI 10.1104/pp.105.072306	84	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107778	10.1371/journal.pone.0107778	http://dx.doi.org/10.1371/journal.pone.0107778			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244327	Green Published, gold, Green Submitted			2022-12-25	WOS:000343679800050
J	Rakesh, KS; Jagadish, S; Vinayaka, AC; Hemshekhar, M; Paul, M; Thushara, RM; Sundaram, MS; Swaroop, TR; Mohan, CD; Basappa; Sadashiva, MP; Kemparaju, K; Girish, KS; Rangappa, KS				Rakesh, Kodagahalli S.; Jagadish, Swamy; Vinayaka, Ajjampura C.; Hemshekhar, Mahadevappa; Paul, Manoj; Thushara, Ram M.; Sundaram, Mahalingam S.; Swaroop, Toreshettahally R.; Mohan, Chakrabhavi D.; Basappa; Sadashiva, Marilinganadoddi P.; Kemparaju, Kempaiah; Girish, Kesturu S.; Rangappa, Kanchugarakoppal S.			A New Ibuprofen Derivative Inhibits Platelet Aggregation and ROS Mediated Platelet Apoptosis	PLOS ONE			English	Article							CYTOSOLIC CALCIUM; OXIDATIVE STRESS; ASPIRIN; ANTIPLATELET; CASPASE-3; VOLUME; DAMAGE; CELLS	Thrombocytopenia is a serious issue connected with the pathogenesis of several human diseases including chronic inflammation, arthritis, Alzheimer's disease, cardiovascular diseases (CVDs) and other oxidative stress-associated pathologies. The indiscriminate use of antibiotics and other biological drugs are reported to result in thrombocytopenia, which is often neglected during the treatment regime. In addition, augmented oxidative stress induced by drugs and pathological conditions has also been shown to induce thrombocytopenia, which seems to be the most obvious consequence of elevated rate of platelet apoptosis. Thus, blocking oxidative stress-induced platelet apoptosis would be of prime importance in order to negotiate thrombocytopenia and associated human pathologies. The current study presents the synthesis and platelet protective nature of novel ibuprofen derivatives. The potent anti-oxidant ibuprofen derivative 4f was selected for the study and the platelet protective efficacy and platelet aggregation inhibitory property has been demonstrated. The compound 4f dose dependently mitigates the oxidative stress-induced platelet apoptosis in both platelet rich plasma and washed platelets. The platelet protective nature of compound 4f was determined by assessing various apoptotic markers such as ROS generation, cytosolic Ca2+ levels, PS externalization, cytochrome C translocation, Caspase activation, mitochondrial membrane depolarization, cytotoxicity, LDH leakage and tyrosine phosphorylation of cytosolic proteins. Furthermore, compound 4f dose dependently ameliorated agonist induced platelet aggregation. Therefore, compound 4f can be estimated as a potential candidate in the treatment regime of pathological disorders associated with platelet activation and apoptosis. In addition, compound 4f can be used as an auxiliary therapeutic agent in pathologies associated with thrombocytopenia.	[Rakesh, Kodagahalli S.; Jagadish, Swamy; Vinayaka, Ajjampura C.; Swaroop, Toreshettahally R.; Mohan, Chakrabhavi D.; Sadashiva, Marilinganadoddi P.; Rangappa, Kanchugarakoppal S.] Univ Mysore, DOS Chem, Mysore, Karnataka, India; [Hemshekhar, Mahadevappa; Paul, Manoj; Thushara, Ram M.; Sundaram, Mahalingam S.; Kemparaju, Kempaiah; Girish, Kesturu S.] Univ Mysore, DOS Biochem, Mysore, Karnataka, India; [Basappa] Bangalore Univ, Dept Chem, Biol Chem Lab, Bangalore 560056, Karnataka, India; [Girish, Kesturu S.] Tumkur Univ, Dept Studies & Res Biochem, Tumkur, India	University of Mysore; University of Mysore; Bangalore University; Tumkur University	Girish, KS (corresponding author), Univ Mysore, DOS Biochem, Mysore, Karnataka, India.	ksgbaboo@gmail.com; rangappaks@gmail.com	Mohan, Chakrabhavi Dhananjaya/AGO-1276-2022; KS, Girish/GWZ-7128-2022; Vinayaka, Ajjampura Vinayaka/ADL-1370-2022	Vinayaka, Ajjampura Vinayaka/0000-0001-8225-3658; Basappa, Basappa/0000-0002-8844-468X; Mohan, Chakrabhavi Dhananjaya/0000-0002-6810-9219; KS, Girish/0000-0002-7284-3707; /0000-0001-6121-0771; SADASHIVA, M PANCHEGOWDA/0000-0002-1528-9447	DST-JSPS [DST/INT/JAP/P-79/09]; BRNS [2009/37/40/BRNS/2266]; UGC-MRP [39-106/2010]; CSIR [9/119 (0819) 2KR-EMR-I]	DST-JSPS; BRNS(Department of Atomic Energy (DAE)Board of Research in Nuclear Sciences (BRNS)); UGC-MRP; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	KS Rangappa thanks DST-JSPS (DST/INT/JAP/P-79/09, Dated: 20/05/2009), KS Rakesh thanks BRNS (No. 2009/37/40/BRNS/2266, Dated: 23/11/2009), S Jagadish thanks UGC-MRP (F. No. 39-106/2010 SR, Dated: 24/12/2010), AC Vinayaka thanks CSIR (SRF-Ref 9/119 (0819) 2KR-EMR-I) for financial assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas B, 2005, J BIOL CHEM, V280, P39716, DOI 10.1074/jbc.M507762200; Amor NB, 2006, BLOOD CELL MOL DIS, V36, P392, DOI 10.1016/j.bcmd.2006.03.002; Arnold DM, 2013, J THROMB HAEMOST, V11, P169, DOI 10.1111/jth.12052; Asai M, 2008, N-S ARCH PHARMACOL, V377, P423, DOI 10.1007/s00210-007-0243-x; BELLAVITE P, 1994, ANAL BIOCHEM, V216, P444, DOI 10.1006/abio.1994.1066; Bouaziz A, 2007, APOPTOSIS, V12, P489, DOI 10.1007/s10495-006-0014-z; Chu SG, 2010, J THROMB HAEMOST, V8, P148, DOI 10.1111/j.1538-7836.2009.03584.x; Crook Jodie, 2010, Paediatr Nurs, V22, P22; Dimitroulis D, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/378653; Dindar S, 2013, W INDIAN MED J, V62, P519, DOI 10.7727/wimj.2012.284; Endo H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.550; Ferlini C, 2007, NAT PROTOC, V2, P3111, DOI 10.1038/nprot.2007.397; Fisch AS, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0381-3; Garcia-Souza LF, 2014, INT J BIOCHEM CELL B, V50, P156, DOI 10.1016/j.biocel.2014.02.015; Girish KS, 2013, BIOCHEM BIOPH RES CO, V438, P198, DOI 10.1016/j.bbrc.2013.07.053; Gowert NS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090523; Gyulkhandanyan AV, 2013, BRIT J HAEMATOL, V161, P245, DOI 10.1111/bjh.12237; Hsieh CL, 2000, LIFE SCI, V66, P1387, DOI 10.1016/S0024-3205(00)00450-1; Jneid Hani, 2003, Expert Opin Emerg Drugs, V8, P349, DOI 10.1517/eoed.8.2.349.21131; Kanbay A, 2013, BLOOD COAGUL FIBRIN, V24, P532, DOI 10.1097/MBC.0b013e32835e98da; Kashiwagi H, 2013, INT J HEMATOL, V98, P24, DOI 10.1007/s12185-013-1370-4; Kumar MS, 2011, ANN HEMATOL, V90, P569, DOI 10.1007/s00277-010-1103-1; Leytin V, 2012, BLOOD REV, V26, P51, DOI 10.1016/j.blre.2011.10.002; Li J, 2014, HAEMATOLOGICA, V99, pE61, DOI 10.3324/haematol.2013.102897; Lopez JJ, 2007, J THROMB HAEMOST, V5, P1283, DOI 10.1111/j.1538-7836.2007.02505.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Pietraforte D, 2014, ANTIOXID REDOX SIGN, V21, P177, DOI 10.1089/ars.2013.5532; Rainsford KD, 2013, INT J CLIN PRACT, V67, P9, DOI 10.1111/ijcp.12055; RONOT X, 1986, BIOL CELL, V57, P1; Rosado JA, 2006, J CELL PHYSIOL, V209, P142, DOI 10.1002/jcp.20715; Ruiz-Arguelles GJ, 2014, ACTA HAEMATOL-BASEL, V132, P159, DOI 10.1159/000357934; Rukoyatkina N, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.459; Saito T, 2014, ONCOL REP, V31, P1637, DOI 10.3892/or.2014.3010; Sanz-Blasco S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002718; Saxena A, 2013, EUR J PHARMACOL, V721, P215, DOI 10.1016/j.ejphar.2013.09.032; Schror K, 1997, SEMIN THROMB HEMOST, V23, P349, DOI 10.1055/s-2007-996108; Sener A, 2012, FOLIA BIOL-PRAGUE, V58, P193; Tang WH, 2014, CIRCULATION, V129, P1598, DOI 10.1161/CIRCULATIONAHA.113.005224; Thushara RM, 2014, ARCH TOXICOL, V88, P185, DOI 10.1007/s00204-013-1185-3; Thushara RM, 2013, CURR MED CHEM, V20, P1018; Thushara RM, 2013, MOL CELL BIOCHEM, V373, P73, DOI 10.1007/s11010-012-1476-7; Todo M, 2013, ONCOL REP, V30, P2379, DOI 10.3892/or.2013.2713; Wilkinson BL, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.06.014; Wu ZH, 2013, EUR REV MED PHARMACO, V17, P2420; Yamaguchi T, 1998, BIOSCI BIOTECH BIOCH, V62, P1201, DOI 10.1271/bbb.62.1201; Yamazaki M, 2009, BIOL PHARM BULL, V32, P1043, DOI 10.1248/bpb.32.1043; Zhao LL, 2013, PLATELETS, V24, P637, DOI 10.3109/09537104.2012.754417	47	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107182	10.1371/journal.pone.0107182	http://dx.doi.org/10.1371/journal.pone.0107182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238069	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000342491600021
J	Wang, Y; Kavran, JM; Chen, Z; Karukurichi, KR; Leahy, DJ; Cole, PA				Wang, Yun; Kavran, Jennifer M.; Chen, Zan; Karukurichi, Kannan R.; Leahy, Daniel J.; Cole, Philip A.			Regulation of S-Adenosylhomocysteine Hydrolase by Lysine Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-HOMOCYSTEINE HYDROLASE; EXPRESSED PROTEIN LIGATION; METHYLATION METABOLISM; SIGNAL-TRANSDUCTION; METHIONINE CYCLE; KEY ENZYME; HISTONE H3; INHIBITOR; DEFICIENCY; ADENOSYLMETHIONINE	S-Adenosylhomocysteine hydrolase (SAHH) is an NAD(+)-dependent tetrameric enzyme that catalyzes the breakdown of S-adenosylhomocysteine to adenosine and homocysteine and is important in cell growth and the regulation of gene expression. Loss of SAHH function can result in global inhibition of cellular methyltransferase enzymes because of high levels of S-adenosylhomocysteine. Prior proteomics studies have identified two SAHH acetylation sites at Lys(401) and Lys(408) but the impact of these post-translational modifications has not yet been determined. Here we use expressed protein ligation to produce semisynthetic SAHH acetylated at Lys(401) and Lys(408) and show that modification of either position negatively impacts the catalytic activity of SAHH. X-ray crystal structures of 408-acetylated SAHH and dually acetylated SAHH have been determined and reveal perturbations in the C-terminal hydrogen bonding patterns, a region of the protein important for NAD(+) binding. These crystal structures along with mutagenesis data suggest that such hydrogen bond perturbations are responsible for SAHH catalytic inhibition by acetylation. These results suggest how increased acetylation of SAHH may globally influence cellular methylation patterns.	[Wang, Yun; Chen, Zan; Karukurichi, Kannan R.; Leahy, Daniel J.; Cole, Philip A.] Johns Hopkins Sch Med, Deptartment Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Kavran, Jennifer M.; Leahy, Daniel J.] Johns Hopkins Sch Med, Deptartment Biophys & Biophys Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Cole, PA (corresponding author), 725 N Wolfe St,316 Hunterian Bldg, Baltimore, MD 21205 USA.	pcole@jhmi.edu	Chen, Zan/D-3531-2019	Chen, Zan/0000-0001-9925-872X	National Institutes of Health; Flight Attendant Medical Research Institute Foundation; NATIONAL CANCER INSTITUTE [R01CA090466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099321, R37GM062437, R01GM099092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health and the Flight Attendant Medical Research Institute Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albaugh BN, 2011, J BIOL CHEM, V286, P24694, DOI 10.1074/jbc.M111.251579; Arbely E, 2011, P NATL ACAD SCI USA, V108, P8251, DOI 10.1073/pnas.1105028108; AULTRICHE DB, 1994, J BIOL CHEM, V269, P31472; Baric I, 2005, J INHERIT METAB DIS, V28, P885, DOI 10.1007/s10545-005-0192-9; Baric I, 2004, P NATL ACAD SCI USA, V101, P4234, DOI 10.1073/pnas.0400658101; Baric I, 2009, J INHERIT METAB DIS, V32, P459, DOI 10.1007/s10545-009-1146-4; BITONTI AJ, 1990, BIOCHEM PHARMACOL, V40, P601, DOI 10.1016/0006-2952(90)90562-Y; Bjursell MK, 2011, AM J HUM GENET, V89, P507, DOI 10.1016/j.ajhg.2011.09.004; Bolduc D, 2013, ELIFE, V2, DOI 10.7554/eLife.00691; Buist NRM, 2006, J INHERIT METAB DIS, V29, P538, DOI 10.1007/s10545-006-0240-0; Cai S, 2007, BIOORGAN MED CHEM, V15, P7281, DOI 10.1016/j.bmc.2007.08.029; Cai SM, 2010, BIOCHEMISTRY-US, V49, P8434, DOI 10.1021/bi1007595; Chalker JM, 2012, ANGEW CHEM INT EDIT, V51, P1835, DOI 10.1002/anie.201106432; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen Y, 2012, MOL CELL PROTEOMICS, V11, P1048, DOI 10.1074/mcp.M112.019547; CHIANG PK, 1979, BIOCHEM PHARMACOL, V28, P1897, DOI 10.1016/0006-2952(79)90642-7; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Clarke S., 2001, HOMOCYSTEINE HLTH DI; Dai J, 2008, CELL, V134, P1066, DOI 10.1016/j.cell.2008.07.019; Dayal S, 2001, CIRC RES, V88, P1203, DOI 10.1161/hh1101.092180; De Clercq E, 2002, NAT REV DRUG DISCOV, V1, P13, DOI 10.1038/nrd703; DELAHABA G, 1959, J BIOL CHEM, V234, P603; Dhall A, 2011, ACS CHEM BIOL, V6, P987, DOI 10.1021/cb200142c; Di Cerbo V, 2014, ELIFE, V3, DOI 10.7554/eLife.01632; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evertts AG, 2013, J BIOL CHEM, V288, P12142, DOI 10.1074/jbc.M112.428318; Flavell RR, 2009, ACCOUNTS CHEM RES, V42, P107, DOI 10.1021/ar800129c; Galloway SE, 2008, J VIROL, V82, P12280, DOI 10.1128/JVI.01225-08; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Herrmann W, 2005, CLIN CHEM, V51, P891, DOI 10.1373/clinchem.2004.044453; HOFFMAN DR, 1980, J BIOL CHEM, V255, P822; Huang R, 2010, J AM CHEM SOC, V132, P9986, DOI 10.1021/ja103954u; Huang Y, 2010, MOL BIOSYST, V6, P683, DOI 10.1039/b920120c; Jabs K, 2006, METABOLISM, V55, P252, DOI 10.1016/j.metabol.2005.08.025; Karukurichi KR, 2010, J AM CHEM SOC, V132, P1222, DOI 10.1021/ja909466d; Katada S, 2012, CELL, V148, P24, DOI 10.1016/j.cell.2012.01.001; Lammers M, 2010, NAT CHEM BIOL, V6, P331, DOI 10.1038/nchembio.342; Leal JF, 2008, CARCINOGENESIS, V29, P2089, DOI 10.1093/carcin/bgn198; Lee KM, 2011, J MED CHEM, V54, P930, DOI 10.1021/jm1010836; Lee Y, 2011, J AM CHEM SOC, V133, P19807, DOI 10.1021/ja2066175; Li FP, 2011, ANGEW CHEM INT EDIT, V50, P9611, DOI 10.1002/anie.201103754; LIU S, 1992, ANTIVIR RES, V19, P247, DOI 10.1016/0166-3542(92)90083-H; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Loehrer FMT, 2001, ATHEROSCLEROSIS, V154, P147, DOI 10.1016/S0021-9150(00)00449-4; Malanovic N, 2008, J BIOL CHEM, V283, P23989, DOI 10.1074/jbc.M800830200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER MW, 1994, EMBO J, V13, P1806, DOI 10.1002/j.1460-2075.1994.tb06449.x; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Nicolas E, 2003, MOL CELL BIOL, V23, P1614, DOI 10.1128/MCB.23.5.1614-1622.2003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALMER JL, 1979, J BIOL CHEM, V254, P1217; Perna AF, 2009, SEMIN DIALYSIS, V22, P351, DOI 10.1111/j.1525-139X.2009.00579.x; Piotukh K, 2011, J AM CHEM SOC, V133, P17536, DOI 10.1021/ja205630g; Poirier LA, 2001, METABOLISM, V50, P1014, DOI 10.1053/meta.2001.25655; Saeed M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046174; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Still AJ, 2013, J BIOL CHEM, V288, P26209, DOI 10.1074/jbc.M113.483396; Tarrant MK, 2012, NAT CHEM BIOL, V8, P262, DOI [10.1038/NCHEMBIO.771, 10.1038/nchembio.771]; Tehlivets O, 2004, FEBS LETT, V577, P501, DOI 10.1016/j.febslet.2004.10.057; Teng YW, 2011, J BIOL CHEM, V286, P36258, DOI 10.1074/jbc.M111.265348; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Turner MA, 1998, NAT STRUCT BIOL, V5, P369, DOI 10.1038/nsb0598-369; Turner MA, 2000, CELL BIOCHEM BIOPHYS, V33, P101, DOI 10.1385/CBB:33:2:101; WOLOS JA, 1993, J IMMUNOL, V151, P526; Yang XD, 2003, BIOCHEMISTRY-US, V42, P1900, DOI 10.1021/bi0262350; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206; Yuan CS, 1996, J BIOL CHEM, V271, P28009, DOI 10.1074/jbc.271.45.28009; YUAN CS, 1993, J BIOL CHEM, V268, P17030; Yuan H, 2012, EMBO J, V31, P58, DOI 10.1038/emboj.2011.382; Zheng H, 2013, MOL CELL BIOL, V33, P4960, DOI 10.1128/MCB.00874-13; Zhou JB, 2011, BLOOD, V118, P2830, DOI 10.1182/blood-2010-07-294827	79	21	22	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31361	31372		10.1074/jbc.M114.597153	http://dx.doi.org/10.1074/jbc.M114.597153			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25248746	Green Published, hybrid			2022-12-25	WOS:000344549900040
J	Behringer, V; Stevens, JMG; Hohmann, G; Mostl, E; Selzer, D; Deschner, T				Behringer, Verena; Stevens, Jeroen M. G.; Hohmann, Gottfried; Moestl, Erich; Selzer, Dieter; Deschner, Tobias			Testing the Effect of Medical Positive Reinforcement Training on Salivary Cortisol Levels in Bonobos and Orangutans	PLOS ONE			English	Article							LOWLAND GORILLAS GORILLA; NONINVASIVE SEMEN COLLECTION; SERUM CHEMISTRY VALUES; HOUSED CHIMPANZEES; VOLUNTARY MOVEMENT; STRESS RESPONSES; URINE SAMPLES; VENIPUNCTURE; VALIDATION; MACAQUES	The management of captive animals has been improved by the establishment of positive reinforcement training as a tool to facilitate interactions between caretakers and animals. In great apes, positive reinforcement training has also been used to train individuals to participate in simple medical procedures to monitor physical health. One aim of positive reinforcement training is to establish a relaxed atmosphere for situations that, without training, might be very stressful. This is especially true for simple medical procedures that can require animals to engage in behaviours that are unusual or use unfamiliar medical devices that can be upsetting. Therefore, one cannot exclude the possibility that the training itself is a source of stress. In this study, we explored the effects of medical positive reinforcement training on salivary cortisol in two groups of captive ape species, orangutans and bonobos, which were familiar to this procedure. Furthermore, we successfully biologically validated the salivary cortisol assay, which had already been validated for bonobos, for orangutans. For the biological validation, we found that cortisol levels in orangutan saliva collected during baseline conditions were lower than in samples collected during three periods that were potentially stressful for the animals. However, we did not find significant changes in salivary cortisol during medical positive reinforcement training for either bonobos or orangutans. Therefore, for bonobos and orangutans with previous exposure to medical PRT, the procedure is not stressful. Thus, medical PRT provides a helpful tool for the captive management of the two species.	[Behringer, Verena; Hohmann, Gottfried; Deschner, Tobias] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Behringer, Verena; Stevens, Jeroen M. G.] Royal Zool Soc Antwerp, Ctr Res & Conservat, Antwerp, Belgium; [Moestl, Erich] Univ Vet Med, Dept Biomed Sci Biochem, Vienna, Austria; [Selzer, Dieter] Univ Giessen, Working Grp Wildlife Biol, D-35390 Giessen, Germany	Max Planck Society; University of Veterinary Medicine Vienna; Justus Liebig University Giessen	Behringer, V (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany.	verena_behringer@eva.mpg.de	Behringer, Verena/AAE-9054-2022	Behringer, Verena/0000-0001-6338-7298	University Giessen; Max Planck Society; University of Veterinary Medicine Vienna	University Giessen; Max Planck Society(Max Planck SocietyFoundation CELLEX); University of Veterinary Medicine Vienna	This research was supported by the University Giessen, the Max Planck Society, and University of Veterinary Medicine Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L.S, 1998, MULTIPLE REGRESSION; Anestis SF, 2010, EVOL ANTHROPOL, V19, P66, DOI 10.1002/evan.20253; ANZENBERGER G, 1993, AM J PRIMATOL, V31, P223, DOI 10.1002/ajp.1350310307; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Baayen RH, 2011, LANGUAGER DATA SETS; Bates D., 2015, LINEAR MIXED EFFECTS, V67, P1, DOI 10.18637/jss.v067.i01; Beerda B, 1996, HORM BEHAV, V30, P272, DOI 10.1006/hbeh.1996.0033; BEHRINGER V, 2011, SUMATRA ORANG UTANS; Behringer V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060773; Behringer V, 2012, PHYSIOL BEHAV, V105, P476, DOI 10.1016/j.physbeh.2011.09.005; Behringer V, 2009, PRIMATES, V50, P190, DOI 10.1007/s10329-008-0121-2; Bell Barbara, 2001, P128; Bloomsmith MA, 1998, ZOO BIOL, V17, P333, DOI 10.1002/(SICI)1098-2361(1998)17:4<333::AID-ZOO6>3.0.CO;2-A; BLOOMSMITH MA, 1994, ZOO BIOL, V13, P557, DOI 10.1002/zoo.1430130605; Bloomsmith MA, 2003, ZOO BIOL, V22, P323, DOI 10.1002/zoo.10103; BOND M, 1991, GORILLA GAZ, V5, P12; Bosch JA, 2011, PSYCHONEUROENDOCRINO, V36, P449, DOI 10.1016/j.psyneuen.2010.12.019; Broder JM, 2008, ZOO BIOL, V27, P78, DOI 10.1002/zoo.20164; Brown CS, 1998, ZOO BIOL, V17, P143, DOI 10.1002/(SICI)1098-2361(1998)17:2<143::AID-ZOO9>3.0.CO;2-9; Carrasco L, 2009, ANIM WELFARE, V18, P9; Chelluri GI, 2013, APPL ANIM BEHAV SCI, V147, P306, DOI 10.1016/j.applanim.2012.06.008; CLARKE AS, 1988, LAB ANIM SCI, V38, P305; Clyde Victoria L., 2001, P125; Coleman K, 2008, J AM ASSOC LAB ANIM, V47, P37; Creel S, 2001, TRENDS ECOL EVOL, V16, P491, DOI 10.1016/S0169-5347(01)02227-3; DABBS JM, 1991, PHYSIOL BEHAV, V49, P815, DOI 10.1016/0031-9384(91)90323-G; DESMOND T, 1994, ZOO BIOL, V13, P471, DOI 10.1002/zoo.1430130509; Dettmer EL, 1996, AM J PRIMATOL, V38, P357, DOI 10.1002/(SICI)1098-2345(1996)38:4<357::AID-AJP6>3.0.CO;2-Y; Dobson AJ, 2008, INTRO GEN LINEAR MOD; Elder CM, 2001, PRIMATES, V42, P345, DOI 10.1007/BF02629625; Field A., 2009, DISCOVERING STAT USI; Fontaine R., 1979, International Zoo Yearbook, V19, P168, DOI 10.1111/j.1748-1090.1979.tb00556.x; Fox J., 2019, R COMPANION APPL REG, V3rd Edn; Gillis TE, 2012, AM J PRIMATOL, V74, P712, DOI 10.1002/ajp.22015; Goymann W, 2012, METHODS ECOL EVOL, V3, P757, DOI 10.1111/j.2041-210X.2012.00203.x; Groschl M., 2000, LAB MED, V24, P314, DOI [10.1515/labm.2000.24.6-7.314, DOI 10.1515/LABM.2000.24.6-7.314]; Heidenreich B, 2007, J EXOT PET MED, V16, P19, DOI 10.1053/j.jepm.2006.11.005; Heintz MR, 2011, AM J PRIMATOL, V73, P903, DOI 10.1002/ajp.20960; Heistermann M, 2010, ADV SCI RES, V5, P1, DOI DOI 10.5194/asr-5-1-2010; *INT PRIM SOC, 1989, PRIMATE REPORT, V25, P3; Joines S., 1977, International Zoo Yearbook, V17, P185, DOI 10.1111/j.1748-1090.1977.tb00903.x; KEITER M, 1977, INT ZOO YB, V17, P188, DOI DOI 10.1111/J.1748-1090.1977.TB00904.X; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; KIRSCHBAUM C, 1989, NEUROPSYCHOBIOLOGY, V22, P150, DOI 10.1159/000118611; Kuhar CW, 2005, ANIM WELFARE, V14, P187; Kutsukake N, 2009, AM J PRIMATOL, V71, P696, DOI 10.1002/ajp.20708; Lambeth SP, 2004, AM J PRIMATOL, V62, P37; Lambeth SP, 2006, AM J PRIMATOL, V68, P245, DOI 10.1002/ajp.20148; LAMBETH SP, 2000, AMERICAN JOURNAL OF, P79, DOI DOI 10.1002/(SICI)1098-2345(2000)51:1+<75::AID-AJP6>3.0.CO;2-X; Larsson CA, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-16; Laule G, 1993, ANIM WELF INF CENT N, V4, P8; Laule G, 2007, J APPL ANIM WELF SCI, V10, P31, DOI 10.1080/10888700701277311; Laule Gail E., 2003, Journal of Applied Animal Welfare Science, V6, P163, DOI 10.1207/S15327604JAWS0603_02; Laule GE, 1996, ZOO BIOL, V15, P587, DOI 10.1002/(SICI)1098-2361(1996)15:6<587::AID-ZOO4>3.0.CO;2-7; Lukas KE, 1998, TEACH PSYCHOL, V25, P112, DOI 10.1207/s15328023top2502_7; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Moore Beth A., 1997, Animal Keepers' Forum, V24, P537; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; O'Brien JK, 2008, ANIM WELFARE, V17, P125; Palme R, 1997, Z SAUGETIERKD, V62, P192; Perlman JE, 2004, AM J PRIMATOL, V62, P96; Perlman JE, 2012, APPL ANIM BEHAV SCI, V137, P114, DOI 10.1016/j.applanim.2011.11.003; Pomerantz O, 2009, AM J PRIMATOL, V71, P687, DOI 10.1002/ajp.20703; Prescott Mark J., 2003, Journal of Applied Animal Welfare Science, V6, P157, DOI 10.1207/S15327604JAWS0603_01; PRESCOTT MJ, 1999, INT J COMP PSYCHOL, V12, P71; Pryor Karen, 1975, LADS WIND ADVENTURES; R Core Team, 2021, R LANG ENV STAT COMP; Raper J. R., 2002, American Journal of Primatology, V57, P70; READ GF, 1990, ANN NY ACAD SCI, V595, P260, DOI 10.1111/j.1749-6632.1990.tb34300.x; Reimers M, 2007, HORM BEHAV, V51, P428, DOI 10.1016/j.yhbeh.2006.12.011; Reinhardt Viktor, 2003, Journal of Applied Animal Welfare Science, V6, P189, DOI 10.1207/S15327604JAWS0603_04; Schapiro SJ, 2005, LAB ANIMAL, V34, P37, DOI 10.1038/laban0505-37; Schielzeth H, 2009, BEHAV ECOL, V20, P416, DOI 10.1093/beheco/arn145; Seiver Dodi, 2001, P137; STONE AM, 1994, AM J PRIMATOL, V33, P242; VANDEVOORT CA, 1993, ZOO BIOL, V12, P257, DOI 10.1002/zoo.1430120303; VIDEAN EN, 2005, LAB PRIMATE NEWSL, V44, P1; VINING RF, 1983, ANN CLIN BIOCHEM, V20, P329, DOI 10.1177/000456328302000601; Whittaker Margaret, 2001, P131; WILSON MI, 1978, ACTA ENDOCRINOL-COP, V87, P424, DOI 10.1530/acta.0.0870424; WOLFLE TL, 1987, J AM VET MED ASSOC, V191, P1219; YOSHIDA H, 1997, PAN AFR NEWS, V4, P16	82	17	17	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108664	10.1371/journal.pone.0108664	http://dx.doi.org/10.1371/journal.pone.0108664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250566	Green Submitted, Green Published, gold			2022-12-25	WOS:000342492700148
J	Perazzo, KKNC; Conceicao, ACD; dos Santos, JCP; Assis, DD; Souza, CO; Druzian, JI				Carneiro Lins Perazzo, Katya Karine Nery; de Vasconcelos Conceicao, Anderson Carlos; Pires dos Santos, Juliana Caribe; Assis, Denilson de Jesus; Souza, Carolina Oliveira; Druzian, Janice Izabel			Properties and Antioxidant Action of Actives Cassava Starch Films Incorporated with Green Tea and Palm Oil Extracts	PLOS ONE			English	Article							BARRIER PROPERTIES; CAMELLIA-SINENSIS; GELATIN FILMS; EDIBLE FILMS; MODEL; FLAVONOIDS; STABILITY; CATECHINS; COATINGS; CHITOSAN	There is an interest in the development of an antioxidant packaging fully biodegradable to increase the shelf life of food products. An active film from cassava starch bio-based, incorporated with aqueous green tea extract and oil palm colorant was developed packaging. The effects of additives on the film properties were determined by measuring mechanical, barrier and thermal properties using a response surface methodology design experiment. The bio-based films were used to pack butter (maintained for 45 days) under accelerated oxidation conditions. The antioxidant action of the active films was evaluated by analyzing the peroxide index, total carotenoids, and total polyphenol. The same analysis also evaluated unpacked butter, packed in films without additives and butter packed in LDPE films, as controls. The results suggested that incorporation of the antioxidants extracts tensile strength and water vapor barrier properties (15 times lower) compared to control without additives. A lower peroxide index (231.57%), which was significantly different from that of the control (p<0.05), was detected in products packed in film formulations containing average concentration of green tea extracts and high concentration of colorant. However, it was found that the high content of polyphenols in green tea extract can be acted as a pro-oxidant agent, which suggests that the use of high concentration should be avoided as additives for films. These results support the applicability of a green tea extract and oil palm carotenoics colorant in starch films totally biodegradable and the use of these materials in active packaging of the fatty products.	[Carneiro Lins Perazzo, Katya Karine Nery; de Vasconcelos Conceicao, Anderson Carlos; Pires dos Santos, Juliana Caribe; Souza, Carolina Oliveira; Druzian, Janice Izabel] Univ Fed Bahia, Coll Pharm, Dept Food Sci, Salvador, BA, Brazil; [Assis, Denilson de Jesus] Univ Fed Bahia, Dept Chem Engn Federacao, Salvador, BA, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia	Perazzo, KKNC (corresponding author), Univ Fed Bahia, Coll Pharm, Dept Food Sci, Salvador, BA, Brazil.	katyanery@gmail.com	Druzian, Janice Izabel/G-6884-2015; Souza, Carolina O/G-8869-2015; de Jesus Assis, Denilson/E-1586-2014	de Jesus Assis, Denilson/0000-0002-9226-4155; Oliveira de Souza, Carolina/0000-0002-8028-5418; Druzian, Janice Izabel/0000-0001-8940-6098	Brazilian Committee for Postgraduate Courses in Higher Education (FAPESB); The National Council for Scientific and Technological Development [CNPq 505831/2008-2]	Brazilian Committee for Postgraduate Courses in Higher Education (FAPESB); The National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding was provided by the Brazilian Committee for Postgraduate Courses in Higher Education (FAPESB) for graduate scholarships for KP for this study. The National Council for Scientific and Technological Development funded this technology research - CNPq 505831/2008-2, with a financial incentive to acquisition of laboratory supplies and equipment for the laboratory, and also scholarships for scientific initiation and post-graduate levels MA and PhD, for other researchers working on the same study. The funders had the role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Vieira MGA, 2011, EUR POLYM J, V47, P254, DOI 10.1016/j.eurpolymj.2010.12.011; American Society for Testing Materials, 1995, ANN BOOK ASTM STAND, V15, P745; Anesini C, 2008, J AGR FOOD CHEM, V56, P9225, DOI 10.1021/jf8022782; Association of Official Analytical Chemists, 2000, OFF METH AN CD 8B 90; ASTM Standards, 1989, E9680 ASTM; Averous L, 2001, STARCH-STARKE, V53, P368, DOI 10.1002/1521-379X(200108)53:8<368::AID-STAR368>3.0.CO;2-W; Azeredo HMC, 2009, J FOOD SCI, V74, pN31, DOI 10.1111/j.1750-3841.2009.01186.x; Bonilla J, 2013, J FOOD ENG, V114, P303, DOI 10.1016/j.jfoodeng.2012.08.005; Boon CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055908; Cao GH, 1997, FREE RADICAL BIO MED, V22, P749, DOI 10.1016/S0891-5849(96)00351-6; Curcio M, 2009, J AGR FOOD CHEM, V57, P5933, DOI 10.1021/jf900778u; Falguera V, 2011, TRENDS FOOD SCI TECH, V22, P292, DOI 10.1016/j.tifs.2011.02.004; FINLEY JW, 1986, FOOD CHEM TOXICOL, V24, P999, DOI 10.1016/0278-6915(86)90280-2; Gimenez B, 2013, LWT-FOOD SCI TECHNOL, V53, P445, DOI 10.1016/j.lwt.2013.03.020; Gimenez B, 2013, FOOD HYDROCOLLOID, V30, P264, DOI 10.1016/j.foodhyd.2012.05.014; GONTARD N, 1993, J FOOD SCI, V58, P206, DOI 10.1111/j.1365-2621.1993.tb03246.x; Gramza A, 2006, EUR J LIPID SCI TECH, V108, P351, DOI 10.1002/ejlt.200500330; GRISI C.V.B., 2008, FOOD CHEM RES DEV, V1, P1; Gumel AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045214; Haugaard VK, 2001, STARCH-STARKE, V53, P189, DOI 10.1002/1521-379X(200105)53:5<189::AID-STAR189>3.0.CO;2-3; He YH, 1997, J AGR FOOD CHEM, V45, P4262, DOI 10.1021/jf9706134; Heim KE, 2002, J NUTR BIOCHEM, V13, P572, DOI 10.1016/S0955-2863(02)00208-5; Heumann BF, 1990, INFORM, V1; Immel S, 2000, STARCH-STARKE, V52, P1; Jansson A, 2004, CARBOHYD POLYM, V56, P499, DOI 10.1016/j.carbpol.2004.03.019; Khwaldia K, 2010, COMPR REV FOOD SCI F, V9, P82, DOI 10.1111/j.1541-4337.2009.00095.x; Lee ES, 2003, J PHARM PHARMACOL, V55, P1169, DOI 10.1211/0022357021396; Martin-Diana AB, 2008, INNOV FOOD SCI EMERG, V9, P593, DOI 10.1016/j.ifset.2008.04.001; Miller KS, 1997, TRENDS FOOD SCI TECH, V8, P228, DOI 10.1016/S0924-2244(97)01051-0; Montenegro MA, 2004, J AGR FOOD CHEM, V52, P367, DOI 10.1021/jf0349026; Montenegro MA, 2007, J AGR FOOD CHEM, V55, P323, DOI 10.1021/jf0622883; Moradi M, 2012, LWT-FOOD SCI TECHNOL, V46, P477, DOI 10.1016/j.lwt.2011.11.020; Munoz-Munoz JL, 2008, J AGR FOOD CHEM, V56, P9215, DOI 10.1021/jf8012162; Nerin C, 2008, J FOOD ENG, V84, P313, DOI 10.1016/j.jfoodeng.2007.05.027; Nishiyama MF, 2010, CIENCIA TECNOL ALIME, V30, P191, DOI 10.1590/S0101-20612010000500029; Passoto JA, 1998, FOOD SCI TECHNOL, V18, P624; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Schlemmer D, J THERMAL ANAL CALOR, V87, P635; Silva JBA, 2012, J FOOD SCI, V77, P14; Silva S. R. da, 2002, Ciencia e Tecnologia de Alimentos, V22, P254, DOI 10.1590/S0101-20612002000300010; Singh A., 2011, WORLD APPL SCI J, V14, P1703, DOI DOI 10.4028/WWW.SCIENTIFIC.NET/AMM.556-562.6011; Siracusa V, 2012, INT J POLYM SCI, V2012, DOI 10.1155/2012/302029; Siripatrawan U, 2010, FOOD HYDROCOLLOID, V24, P770, DOI 10.1016/j.foodhyd.2010.04.003; Song Hyeun Sung, 2013, Prev Nutr Food Sci, V18, P80, DOI 10.3746/pnf.2013.18.1.080; Souza CO, 2011, J AGR FOOD CHEM, V59, P2248, DOI 10.1021/jf1040405; Veiga-Santos P, 2005, FOOD HYDROCOLLOID, V19, P1064, DOI 10.1016/j.foodhyd.2005.02.007; Vermeiren L, 1999, TRENDS FOOD SCI TECH, V10, P77, DOI 10.1016/S0924-2244(99)00032-1; Wanasundara UN, 1998, FOOD CHEM, V63, P335, DOI 10.1016/S0308-8146(98)00025-9; Wei BX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086024; Wessling C, 2000, PACKAG TECHNOL SCI, V13, P19, DOI 10.1002/(SICI)1099-1522(200001/02)13:1<19::AID-PTS492>3.0.CO;2-B; Xiao XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022934; Xiong HG, 2008, CARBOHYD POLYM, V71, P263, DOI 10.1016/j.carbpol.2007.05.035; Zhu F, 2009, FOOD CHEM, V112, P919, DOI 10.1016/j.foodchem.2008.06.079	54	54	55	1	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e105199	10.1371/journal.pone.0105199	http://dx.doi.org/10.1371/journal.pone.0105199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251437	gold, Green Submitted, Green Published			2022-12-25	WOS:000342492700007
J	Gervassi, A; Lejarcegui, N; Dross, S; Jacobson, A; Itaya, G; Kidzeru, E; Gantt, S; Jaspan, H; Horton, H				Gervassi, Ana; Lejarcegui, Nicholas; Dross, Sandra; Jacobson, Amanda; Itaya, Grace; Kidzeru, Elvis; Gantt, Soren; Jaspan, Heather; Horton, Helen			Myeloid Derived Suppressor Cells Are Present at High Frequency in Neonates and Suppress In Vitro T Cell Responses	PLOS ONE			English	Article							CORD BLOOD; PERIPHERAL-BLOOD; VACCINE; IMMUNITY; INNATE; DISTINCT; IMMUNIZATION; MACROPHAGES; NEUTROPHILS; EXPRESSION	Over 4 million infants die each year from infections, many of which are vaccine-preventable. Young infants respond relatively poorly to many infections and vaccines, but the basis of reduced immunity in infants is ill defined. We sought to investigate whether myeloid-derived suppressor cells (MDSC) represent one potential impediment to protective immunity in early life, which may help inform strategies for effective vaccination prior to pathogen exposure. We enrolled healthy neonates and children in the first 2 years of life along with healthy adult controls to examine the frequency and function of MDSC, a cell population able to potently suppress T cell responses. We found that MDSC, which are rarely seen in healthy adults, are present in high numbers in neonates and their frequency rapidly decreases during the first months of life. We determined that these neonatal MDSC are of granulocytic origin (G-MDSC), and suppress both CD4+ and CD8+ T cell proliferative responses in a contact-dependent manner and gamma interferon production. Understanding the role G-MDSC play in infant immunity could improve vaccine responsiveness in newborns and reduce mortality due to early-life infections.	[Gervassi, Ana; Lejarcegui, Nicholas; Dross, Sandra; Jacobson, Amanda; Itaya, Grace; Horton, Helen] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Dross, Sandra; Horton, Helen] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Horton, Helen] Univ Washington, Dept Med, Seattle, WA USA; [Jaspan, Heather] Univ Washington, Seattle Childrens Hosp, Seattle, WA USA; [Kidzeru, Elvis; Jaspan, Heather] Univ Cape Town, Inst Infect Dis & Mol Med, Div Immunol, ZA-7925 Cape Town, South Africa; [Gantt, Soren] Univ British Columbia, Dept Pediat, Vancouver, BC V5Z 1M9, Canada; [Gantt, Soren] Univ British Columbia, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada	Center for Infectious Disease Research; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Cape Town; University of British Columbia; Child & Family Research Institute; University of British Columbia	Horton, H (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	helen.horton@seattlebiomed.org	Kidzeru, Elvis Banboye/GSN-5133-2022	Kidzeru, Elvis Banboye/0000-0002-4121-1846; Gantt, Soren/0000-0001-5743-3606	National Institutes of Health [R01AI100018]; National Institute of Allergy and Infectious Diseases (NIAID) [K08HD069201]; UW CFAR - NIAID [P30 AI027757]; National Cancer Institute; National Institute of Mental Health; National Institute on Drug Abuse; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Heart, Lung, and Blood Institute; National Institute on Aging; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD069201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100018, P30AI027757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UW CFAR - NIAID; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health (R01AI100018), the National Institute of Allergy and Infectious Diseases (NIAID; K08HD069201) and the UW CFAR (P30 AI027757) supported by NIAID; National Cancer Institute; National Institute of Mental Health; National Institute on Drug Abuse; the Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Heart, Lung, and Blood Institute; and National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apetoh L, 2011, CURR MOL MED, V11, P365, DOI 10.2174/156652411795976574; Bansal AS, 2010, AM J REPROD IMMUNOL, V64, P307, DOI 10.1111/j.1600-0897.2010.00864.x; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; Brandau S, 2013, SEMIN CANCER BIOL, V23, P171, DOI 10.1016/j.semcancer.2013.02.007; Chabtini L, 2013, J IMMUNOL, V190, P88, DOI 10.4049/jimmunol.1202176; CLERICI M, 1993, J CLIN INVEST, V91, P2829, DOI 10.1172/JCI116526; D'Addio F, 2011, J IMMUNOL, V187, P4530, DOI 10.4049/jimmunol.1002031; Dumitru CA, 2013, SEMIN CANCER BIOL, V23, P141, DOI 10.1016/j.semcancer.2013.02.005; Elahi S, 2013, NATURE, V504, P158, DOI 10.1038/nature12675; Fridlender ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031524; Fu BQ, 2013, P NATL ACAD SCI USA, V110, pE231, DOI 10.1073/pnas.1206322110; Gabrilovich DI, 2007, CANCER RES, V67, P425, DOI 10.1158/0008-5472.CAN-06-3037; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gans HA, 2008, VIRAL IMMUNOL, V21, P163, DOI 10.1089/vim.2007.0113; Godfrey WR, 2005, BLOOD, V105, P750, DOI 10.1182/blood-2004-06-2467; Greten TF, 2011, INT IMMUNOPHARMACOL, V11, P802, DOI 10.1016/j.intimp.2011.01.003; Hodgins DC, 2012, VACCINE, V30, P1541, DOI 10.1016/j.vaccine.2011.12.047; Hong EH, 2013, VACCINE, V31, P1377, DOI 10.1016/j.vaccine.2013.01.006; Horton H, 2006, J IMMUNOL, V177, P7406, DOI 10.4049/jimmunol.177.10.7406; Horton H, 2006, J VIROL, V80, P9779, DOI 10.1128/JVI.00794-06; Iclozan C, 2013, CANCER IMMUNOL IMMUN, V62, P909, DOI 10.1007/s00262-013-1396-8; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Kotsakis A, 2012, J IMMUNOL METHODS, V381, P14, DOI 10.1016/j.jim.2012.04.004; Lalor MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016709; Le HK, 2009, INT IMMUNOPHARMACOL, V9, P900, DOI 10.1016/j.intimp.2009.03.015; LEWIS DB, 2006, INFECT DIS FETUS NEW, P87, DOI DOI 10.1016/B0-72-160537-0/50006-2; Liu CY, 2010, J CANCER RES CLIN, V136, P35, DOI 10.1007/s00432-009-0634-0; Lo YMD, 1996, BLOOD, V88, P4390; Makrigiannakis A, 2008, AM J REPROD IMMUNOL, V60, P482, DOI 10.1111/j.1600-0897.2008.00655.x; Makrigiannakis A, 2011, J REPROD IMMUNOL, V90, P96, DOI 10.1016/j.jri.2011.03.006; Marodi L, 2006, INFECT IMMUN, V74, P1999, DOI 10.1128/IAI.74.4.1999-2006.2006; MIDTHUN K, 1991, J INFECT DIS, V164, P792, DOI 10.1093/infdis/164.4.792; Mold JE, 2010, SCIENCE, V330, P1695, DOI 10.1126/science.1196509; Montero AJ, 2012, J IMMUNOTHER, V35, P107, DOI 10.1097/CJI.0b013e318242169f; Mundy-Bosse BL, 2011, CANCER IMMUNOL IMMUN, V60, P1269, DOI 10.1007/s00262-011-1029-z; Najjar YG, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00049; Orlikowsky TW, 2003, CYTOM PART B-CLIN CY, V53B, P40, DOI 10.1002/cyto.b.10033; Ostrand-Rosenberg S, 2012, SEMIN CANCER BIOL, V22, P275, DOI 10.1016/j.semcancer.2012.01.011; Ota MOC, 2004, VACCINE, V22, P511, DOI 10.1016/j.vaccine.2003.07.020; Pillay J, 2013, CELL MOL LIFE SCI, V70, P3813, DOI 10.1007/s00018-013-1286-4; Poschke I, 2012, CLIN IMMUNOL, V144, P250, DOI 10.1016/j.clim.2012.06.003; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Raychaudhuri B, 2011, NEURO-ONCOLOGY, V13, P591, DOI 10.1093/neuonc/nor042; Rieber N, 2013, CLIN EXP IMMUNOL, V174, P45, DOI 10.1111/cei.12143; Rodriguez PC, 2009, CANCER RES, V69, P1553, DOI 10.1158/0008-5472.CAN-08-1921; Romero R, 2006, SEMIN FETAL NEONAT M, V11, P317, DOI 10.1016/j.siny.2006.05.001; Roth F, 2012, CANCER RES, V72, P1373, DOI 10.1158/0008-5472.CAN-11-2772; Rowe J, 2001, J INFECT DIS, V184, P80, DOI 10.1086/320996; Sasaki Y, 2004, MOL HUM REPROD, V10, P347, DOI 10.1093/molehr/gah044; Sharma SK, 2012, CLIN EXP IMMUNOL, V169, P281, DOI 10.1111/j.1365-2249.2012.04613.x; Somerset DA, 2004, IMMUNOLOGY, V112, P38, DOI 10.1111/j.1365-2567.2004.01869.x; Srivastava MK, 2012, ONCOIMMUNOLOGY, V1, P1650, DOI 10.4161/onci.21970; Takahata Y, 2004, EXP HEMATOL, V32, P622, DOI 10.1016/j.exphem.2004.03.012; Vekemans J, 2002, CLIN EXP IMMUNOL, V127, P495, DOI 10.1046/j.1365-2249.2002.01788.x; Villamor E, 2005, CLIN MICROBIOL REV, V18, P446, DOI 10.1128/CMR.18.3.446-464.2005; Vincent J, 2010, CANCER RES, V70, P3052, DOI 10.1158/0008-5472.CAN-09-3690; WHO, 2012, CHILD MORT REP; Wood N, 2011, CURR OPIN INFECT DIS, V24, P190, DOI 10.1097/QCO.0b013e328345d563; Yang WC, 2013, J MOL CELL BIOL, V5, P207, DOI 10.1093/jmcb/mjt009	59	60	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107816	10.1371/journal.pone.0107816	http://dx.doi.org/10.1371/journal.pone.0107816			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25248150	gold, Green Published, Green Submitted			2022-12-25	WOS:000342351800042
J	Chen, YS; Wang, GY; Wang, H; Cheng, CH; Zang, GG; Guo, XB; Liu, RH				Chen, Yongsheng; Wang, Gaoyan; Wang, Hong; Cheng, Chaohua; Zang, Gonggu; Guo, Xinbo; Liu, Rui Hai			Phytochemical Profiles and Antioxidant Activities in Six Species of Ramie Leaves	PLOS ONE			English	Article							PHENOLIC-COMPOUNDS; FERULIC ACID; CAFFEIC ACID; ASSAY; FRUITS; IDENTIFICATION; FLAVONOIDS; COMPONENTS; OXIDATION; HEALTH	Increased consumption of vegetables or plant food has been associated with decreased risk of developing major chronic diseases, such as cancers, diabetes, cardiovascular diseases, and age-related functional decline. Ramie leaves are rich in phenolics and flavonoids, which have been suggested for human health benefits. Phenolic contents, flavonoid contents, phenolic compounds, and anti-cancer properties in six species of ramie leaves were analyzed by Folin-reagent method, sodium borohydride/chloranil-based assay (SBC), HPLC method and antiproliferation, cytoxicity, respectively. Antioxidant activities were measured through peroxyl radical scavenging capacity (PSC) method, oxygen radical absorbance capacity (ORAC) method, and cellular antioxidant activity (CAA). Research indicated that Boehmeria penduliflora contained the highest total phenolic content (2313.7 +/- 27.28 mg GAE/100 g FW), and flavonoid content (1682.4 +/- 27.70 mg CAE/100 g FW). Boehmeria tricuspis showed the highest PSC value (9574.8 +/- 117.63 mu M vit. C equiv./100 g FW), while Boehmeria penduliflora indicated the highest ORAC value (330.44 +/- 16.88 mu mol Trolox equiv./g FW). The antioxidant activities were correlated with phenolic contents and flavonoid contents. Boehmeria tricuspis had the highest antiproliferative capacity with the lowest EC50 (4.11 +/- 0.19 mg/mL). The results for the analyzed ramie for CAA were significantly different from each other (p<0.05), Boehmeria tricuspis had the highest CAA value (133.63 +/- 7.10 mu mol QE/100 g). Benzoic acid, 4-coumaric acid, caffeic acid, and ferulic acid were the dominant phenolic ingredients in the ramie leaves according to HPLC analysis. Our research is the first report to study the phytochemical profiles and antioxidant activities in different species of ramie leaves for their health benefit.	[Chen, Yongsheng; Wang, Hong; Guo, Xinbo; Liu, Rui Hai] S China Univ Technol, Sch Light Ind & Food Sci, Guangzhou, Guangdong, Peoples R China; [Wang, Gaoyan; Liu, Rui Hai] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA; [Wang, Gaoyan; Cheng, Chaohua; Zang, Gonggu] Chinese Acad Agr Sci, Inst Bast Fiber Crops, Changsha, Hunan, Peoples R China; [Liu, Rui Hai] Cornell Univ, Inst Comparat & Environm Toxicol, Ithaca, NY 14853 USA	South China University of Technology; Cornell University; Chinese Academy of Agricultural Sciences; Institute of Bast Fiber Crops, CAAS; Cornell University	Guo, XB (corresponding author), S China Univ Technol, Sch Light Ind & Food Sci, Guangzhou, Guangdong, Peoples R China.	xbg720@gmail.com; rl23@cornell.edu	/Q-1866-2019; Liu, Rui Hai/C-2865-2008; Liu, Rui Hai/AAE-4865-2019; guo, xinbo/I-6764-2013	/0000-0001-8881-8525; Liu, Rui Hai/0000-0002-7018-7929; guo, xinbo/0000-0002-5688-6766	Fundamental Research Funds for the Central Universities [2014ZM0072]; Leading Talents Program in Guangdong Province; Guangzhou Science and Technology Program [2013J4500036]; Guangdong Science and Technology Program [2012B050500003]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Leading Talents Program in Guangdong Province; Guangzhou Science and Technology Program; Guangdong Science and Technology Program	The work was supported in part by the Fundamental Research Funds for the Central Universities (2014ZM0072), the Leading Talents Program in Guangdong Province (Rui Hai Liu), the Guangzhou Science and Technology Program (2013J4500036), and the Guangdong Science and Technology Program (2012B050500003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adom KK, 2005, J AGR FOOD CHEM, V53, P6572, DOI 10.1021/jf048318o; Adom KK, 2002, J AGR FOOD CHEM, V50, P6182, DOI 10.1021/jf0205099; Dong JZ, 2009, PLANT FOOD HUM NUTR, V64, P199, DOI 10.1007/s11130-009-0128-x; Eberhardt MV, 2000, NATURE, V405, P903, DOI 10.1038/35016148; Felice DL, 2009, J FUNCT FOODS, V1, P109, DOI 10.1016/j.jff.2008.09.014; FRY SC, 1979, PLANTA, V146, P343, DOI 10.1007/BF00387807; GRAF E, 1992, FREE RADICAL BIO MED, V13, P435, DOI 10.1016/0891-5849(92)90184-I; Guo XB, 2012, J AGR FOOD CHEM, V60, P11050, DOI 10.1021/jf304443u; Hakkinen SH, 2000, FOOD RES INT, V33, P517, DOI 10.1016/S0963-9969(00)00086-7; He X, 2008, J AGR FOOD CHEM, V56, P9905, DOI 10.1021/jf8015255; He XJ, 2008, J AGR FOOD CHEM, V56, P9337, DOI 10.1021/jf070954+; Huang DJ, 2002, J AGR FOOD CHEM, V50, P4437, DOI 10.1021/jf0201529; HUANG MT, 1988, CANCER RES, V48, P5941; IS K, 2008, ANTIBACTERIAL ANTIOX; Jiratanan T, 2004, J AGR FOOD CHEM, V52, P2659, DOI 10.1021/jf034861d; Lee Heejeong, 2012, Prev Nutr Food Sci, V17, P53, DOI 10.3746/pnf.2012.17.1.053; Lee YR, 2009, FOOD SCI BIOTECHNOL, V18, P1096; Liu RH, 2004, J NUTR, V134, p3479S, DOI 10.1093/jn/134.12.3479S; Liu RH, 2008, TRAC-TREND ANAL CHEM, V27, pVIII; Liu RH, 2007, J CEREAL SCI, V46, P207, DOI 10.1016/j.jcs.2007.06.010; Liu RH, 2013, ADV NUTR, V4, p384S, DOI 10.3945/an.112.003517; Malta LG, 2013, FOOD RES INT, V53, P417, DOI 10.1016/j.foodres.2013.04.024; Malta LG, 2012, FOOD RES INT, V49, P604, DOI 10.1016/j.foodres.2012.07.055; NARDINI M, 1995, FREE RADICAL BIO MED, V19, P541, DOI 10.1016/0891-5849(95)00052-Y; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Sun J, 2002, J AGR FOOD CHEM, V50, P7449, DOI 10.1021/jf0207530; Wang F., 2014, PLOS ONE, V9; WATTENBERG LW, 1980, CANCER RES, V40, P2820; Wolfe KL, 2007, J AGR FOOD CHEM, V55, P8896, DOI 10.1021/jf0715166; Yang J, 2013, INT J FOOD SCI TECH, V48, P163, DOI 10.1111/j.1365-2621.2012.03173.x; Yoon H, 2007, J AGR FOOD CHEM, V55, P3167, DOI 10.1021/jf0632379; Zhang MW, 2010, J AGR FOOD CHEM, V58, P7580, DOI 10.1021/jf1007665	32	26	27	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e108140	10.1371/journal.pone.0108140	http://dx.doi.org/10.1371/journal.pone.0108140			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243741	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800069
J	Gabrielson, M; Bjorklund, M; Carlson, J; Shoshan, M				Gabrielson, Marike; Bjoerklund, My; Carlson, Joseph; Shoshan, Maria			Expression of Mitochondrial Regulators PGC1 alpha and TFAM as Putative Markers of Subtype and Chemoresistance in Epithelial Ovarian Carcinoma	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; TRANSCRIPTION FACTOR-A; CLEAR-CELL-CARCINOMA; GENE-EXPRESSION; CANCER; DNA; METABOLISM; PGC-1-ALPHA; COACTIVATORS; DEGRADATION	Epithelial ovarian carcinoma (EOC), the major cause of gynaecological cancer death, is a heterogeneous disease classified into five subtypes. Each subtype has distinct clinical characteristics and is associated with different genetic risk factors and molecular events, but all are treated with surgery and platinum/taxane regimes. Tumour progression and chemoresistance is generally associated with major metabolic alterations, notably altered mitochondrial function(s). Here, we report for the first time that the expression of the mitochondrial regulators PGC1 alpha and TFAM varies between EOC subtypes; furthermore, we have identified a profile in clear-cell carcinoma consisting of undetectability of PGC1 alpha/TFAM, and low ER alpha/Ki-67. By contrast, high-grade serous carcinomas were characterised by a converse state of PGC1 alpha/TFAM, ER alpha positivity and a high Ki-67 index. Interestingly, loss of PGC1 alpha/TFAM and ER alpha was found also in a non-clear cell EOC cell line made highly resistant to platinum in vitro. Similar to clear-cell carcinomas, these resistant cells also showed accumulation of glycogen. Altogether, our data provide mechanistic insights into the chemoresistant nature of ovarian clear-cell carcinomas. Furthermore, these findings corroborate the need to take into account the diversity of EOC and to develop subtype specific treatment strategies.	[Gabrielson, Marike; Bjoerklund, My; Carlson, Joseph; Shoshan, Maria] Karolinska Inst, CCK, Dept Oncol Pathol, Stockholm, Sweden; [Carlson, Joseph] Karolinska Univ Hosp, Dept Pathol Cytol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Shoshan, M (corresponding author), Karolinska Inst, CCK, Dept Oncol Pathol, Stockholm, Sweden.	mimmi.shoshan@ki.se	Carlson, Joseph/G-1172-2018; Björklund, My/ABH-1150-2020; Björklund, My/P-2966-2014	Carlson, Joseph/0000-0002-3006-4107; Björklund, My/0000-0002-2325-6012; Björklund, My/0000-0002-2325-6012; Gabrielson, Marike/0000-0002-3171-1556	Swedish Cancer Society [100476, 120814]; research Council of Sweden [A0360901]; Radiumhemmet Research Foundation [124182]	Swedish Cancer Society(Swedish Cancer Society); research Council of Sweden; Radiumhemmet Research Foundation	This work was supported by Swedish Cancer Society, contracts 100476 and 120814; research Council of Sweden, contract A0360901; and Radiumhemmet Research Foundation, contract 124182. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglesio MS, 2011, GYNECOL ONCOL, V121, P407, DOI 10.1016/j.ygyno.2011.01.005; Aquilano K, 2010, J BIOL CHEM, V285, P21590, DOI 10.1074/jbc.M109.070169; Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662; Berndtsson M, 2007, INT J CANCER, V120, P175, DOI 10.1002/ijc.22132; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Chakrabarty S., 2014, MITOCHONDRION; Coleman RL, 2013, NAT REV CLIN ONCOL, V10, P211, DOI 10.1038/nrclinonc.2013.5; COOPER CE, 1991, BIOCHEM CELL BIOL, V69, P586, DOI 10.1139/o91-089; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Deblois G, 2013, ONCOGENE, V32, P3483, DOI 10.1038/onc.2012.529; du Bois A, 2003, JNCI-J NATL CANCER I, V95, P1320, DOI 10.1093/jnci/djg036; Faratian D, 2011, CLIN CANCER RES, V17, P4451, DOI 10.1158/1078-0432.CCR-10-2461; Feilchenfeldt J, 2004, CANCER LETT, V203, P25, DOI 10.1016/j.canlet.2003.08.024; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Goto A, 2001, BIOCHEM J, V354, P243, DOI 10.1042/0264-6021:3540243; Guo JH, 2011, CANCER RES, V71, P2978, DOI 10.1158/0008-5472.CAN-10-3482; Gurung A, 2013, HISTOPATHOLOGY, V62, P59, DOI 10.1111/his.12033; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hardie DG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-36; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hua WH, 1995, J STEROID BIOCHEM, V55, P279, DOI 10.1016/0960-0760(95)00187-5; Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; Klinge CM, 2008, J CELL BIOCHEM, V105, P1342, DOI 10.1002/jcb.21936; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Lau KM, 1999, P NATL ACAD SCI USA, V96, P5722, DOI 10.1073/pnas.96.10.5722; Lettieri Barbato D, 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/759583; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu B, 2013, MOL CELL, V49, P121, DOI 10.1016/j.molcel.2012.10.023; Matsushima Y, 2010, P NATL ACAD SCI USA, V107, P18410, DOI 10.1073/pnas.1008924107; OHKAWA K, 1977, CANCER-AM CANCER SOC, V40, P3019, DOI 10.1002/1097-0142(197712)40:6<3019::AID-CNCR2820400639>3.0.CO;2-M; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Sieh W, 2013, LANCET ONCOL, V14, P853, DOI 10.1016/S1470-2045(13)70253-5; Takano M, 2006, BRIT J CANCER, V94, P1369, DOI 10.1038/sj.bjc.6603116; Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Winter WE, 2007, J CLIN ONCOL, V25, P3621, DOI 10.1200/JCO.2006.10.2517; Wintzell M, 2012, CANCER BIOL THER, V13, P1454, DOI 10.4161/cbt.22007; Zhang Y, 2007, CELL RES, V17, P363, DOI 10.1038/cr.2007.11; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60	45	30	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107109	10.1371/journal.pone.0107109	http://dx.doi.org/10.1371/journal.pone.0107109			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243473	gold, Green Published, Green Submitted			2022-12-25	WOS:000343679800019
J	Ziupa, D; Beck, J; Franke, G; Feliz, SP; Hartmann, M; Koren, G; Zehender, M; Bode, C; Brunner, M; Odening, KE				Ziupa, David; Beck, Julia; Franke, Gerlind; Feliz, Stefanie Perez; Hartmann, Maximilian; Koren, Gideon; Zehender, Manfred; Bode, Christoph; Brunner, Michael; Odening, Katja E.			Pronounced Effects of HERG-Blockers E-4031 and Erythromycin on APD, Spatial APD Dispersion and Triangulation in Transgenic Long-QT Type 1 Rabbits	PLOS ONE			English	Article							TORSADES-DE-POINTES; ACTION-POTENTIAL DURATION; ANTIARRHYTHMIC AGENTS; LQT2 RABBITS; SUDDEN-DEATH; PROLONGATION; CHANNEL; REPOLARIZATION; PROARRHYTHMIA; DRUGS	Background: Prolongation of action potential duration (APD), increased spatial APD dispersion, and triangulation are major factors promoting drug-induced ventricular arrhythmia. Preclinical identification of HERG/I-Kr-blocking drugs and their pro-arrhythmic potential, however, remains a challenge. We hypothesize that transgenic long-QT type 1 (LQT1) rabbits lacking repolarizing I-Ks current may help to sensitively detect HERG/I-Kr-blocking properties of drugs. Methods: Hearts of adult female transgenic LQT1 and wild type littermate control (LMC) rabbits were Langendorff-perfused with increasing concentrations of HERG/I-Kr-blockers E-4031 (0.001-0.1 mu M, n = 9/7) or erythromycin (1-300 mu M, n = 9/7) and APD, APD dispersion, and triangulation were analyzed. Results: At baseline, APD was longer in LQT1 than in LMC rabbits in LV apex and RV mid. Erythromycin and E-4031 prolonged APD in LQT1 and LMC rabbits in all positions. However, erythromycin-induced percentaged APD prolongation related to baseline (% APD) was more pronounced in LQT1 at LV base-lateral and RV mid positions (100 mu M, LQT1, + 40.6 +/- 9.7% vs. LMC, +24.1 +/- 10.0%, p<0.05) and E-4031-induced % APD prolongation was more pronounced in LQT1 at LV base-lateral (0.01 mu M, LQT1, +29.6 +/- 10.6% vs. LMC, +19.1 +/- 3.8%, p<0.05) and LV base-septal positions. Moreover, erythromycin significantly increased spatial APD dispersion only in LQT1 and increased triangulation only in LQT1 in LV base-septal and RV mid positions. Similarly, E-4031 increased triangulation only in LQT1 in LV apex and base-septal positions. Conclusions: E-4031 and erythromycin prolonged APD and increased triangulation more pronouncedly in LQT1 than in LMC rabbits. Moreover, erythromycin increased APD dispersion only in LQT1, indicating that transgenic LQT1 rabbits could serve as sensitive model to detect HERG/I-Kr-blocking properties of drugs.	[Ziupa, David; Beck, Julia; Franke, Gerlind; Feliz, Stefanie Perez; Hartmann, Maximilian; Zehender, Manfred; Bode, Christoph; Brunner, Michael; Odening, Katja E.] Univ Freiburg, Ctr Heart, Dept Cardiol & Angiol 1, D-79106 Freiburg, Germany; [Koren, Gideon] Brown Univ, Alpert Med Sch, Rhode Isl Hosp, Cardiovasc Res Ctr,Div Cardiol, Providence, RI 02912 USA	University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Odening, KE (corresponding author), Univ Freiburg, Ctr Heart, Dept Cardiol & Angiol 1, Hugstetter Str 55, D-79106 Freiburg, Germany.	katja.odening@universitaets-herzzentrum.de	Koren, Gideon/AAG-7726-2019	Koren, Gideon/0000-0002-9234-0875; /0000-0002-0287-9560; Odening, Katja E/0000-0001-6999-841X	NHLBI NIH HHS [R01 HL110791] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110791] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Antzelevitch Charles, 2008, Cardiol J, V15, P100; Bentzen BH, 2011, J CARDIOVASC PHARM, V57, P223, DOI 10.1097/FJC.0b013e318203a44d; Biermann J, 2011, EUR J PHARMACOL, V650, P309, DOI 10.1016/j.ejphar.2010.10.016; Brunner M, 2008, J CLIN INVEST, V118, P2246, DOI 10.1172/JCI33578; Cheng JH, 1999, CARDIOVASC RES, V43, P135, DOI 10.1016/S0008-6363(99)00061-9; D'Alonzo AJ, 1999, EUR J PHARMACOL, V369, P57, DOI 10.1016/S0014-2999(99)00057-6; Gravelin L., 2012, HEART RHYTHM, V9, pP03; Guerard N. C., 2008, Journal of Pharmacological and Toxicological Methods, V58, P32, DOI 10.1016/j.vascn.2008.05.129; Haverkamp W, 2000, EUR HEART J, V21, P1216, DOI 10.1053/euhj.2000.2249; Hondeghem LM, 2001, CIRCULATION, V103, P2004; HONDEGHEM LM, 1994, J CARDIOVASC ELECTR, V5, P711, DOI 10.1111/j.1540-8167.1994.tb01193.x; [ICH_Expert_Working_Group Human Pharmaceuticals], 2005, S7B NONCL EV POT DEL; Kaab S, 2012, CIRC-CARDIOVASC GENE, V5, P91, DOI 10.1161/CIRCGENETICS.111.960930; Kannankeril PJ, 2005, HEART RHYTHM, V2, P134, DOI 10.1016/j.hrthm.2004.10.039; Kannankeril P, 2010, PHARMACOL REV, V62, P760, DOI 10.1124/pr.110.003723; Lawrence CL, 2006, BRIT J PHARMACOL, V149, P845, DOI 10.1038/sj.bjp.0706894; Lehtonen A, 2007, HEART RHYTHM, V4, P603, DOI 10.1016/j.hrthm.2007.01.019; Lu HR, 2007, EUR J PHARMACOL, V577, P221, DOI 10.1016/j.ejphar.2007.09.001; Milberg P, 2002, J PHARMACOL EXP THER, V303, P218, DOI 10.1124/jpet.102.037911; Molokhia M, 2008, BRIT J CLIN PHARMACO, V66, P386, DOI 10.1111/j.1365-2125.2008.03229.x; Napolitano C, 2000, J CARDIOVASC ELECTR, V11, P691, DOI 10.1111/j.1540-8167.2000.tb00033.x; Nerbonne JM, 2000, J PHYSIOL-LONDON, V525, P285, DOI 10.1111/j.1469-7793.2000.t01-1-00285.x; Odening KE, 2013, HEART RHYTHM, V10, P1533, DOI 10.1016/j.hrthm.2013.07.038; Odening KE, 2010, AM J PHYSIOL-HEART C, V299, pH643, DOI 10.1152/ajpheart.00074.2010; Odening KE, 2008, AM J PHYSIOL-HEART C, V295, pH2264, DOI 10.1152/ajpheart.00680.2008; Priori SG, 2001, EUROPACE, V3, P16, DOI 10.1053/eupc.2000.0141; Rampe D, 1997, N-S ARCH PHARMACOL, V355, P743, DOI 10.1007/PL00005008; Ray WA, 2004, NEW ENGL J MED, V351, P1089, DOI 10.1056/NEJMoa040582; Redfern WS, 2003, CARDIOVASC RES, V58, P32, DOI 10.1016/S0008-6363(02)00846-5; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Roden DM, 2006, J INTERN MED, V259, P59, DOI 10.1111/j.1365-2796.2005.01589.x; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Sarganas G, 2013, EUROPACE; Shimizu W, 1998, CIRCULATION, V97, P1581, DOI 10.1161/01.CIR.97.16.1581; Stanat SJC, 2003, MOL CELL BIOCHEM, V254, P1, DOI 10.1023/A:1027309703313; Thomsen MB, 2006, BRIT J PHARMACOL, V149, P1039, DOI 10.1038/sj.bjp.0706900; Yang P, 2002, CIRCULATION, V105, P1943, DOI 10.1161/01.CIR.0000014448.19052.4C; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3	38	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107210	10.1371/journal.pone.0107210	http://dx.doi.org/10.1371/journal.pone.0107210			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244401	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800026
J	Avan, A; Avan, A; Le Large, TYS; Mambrini, A; Funel, N; Maftouh, M; Ghayour-Mobarhan, M; Cantore, M; Boggi, U; Peters, GJ; Pacetti, P; Giovannetti, E				Avan, Abolfazl; Avan, Amir; Le Large, Tessa Y. S.; Mambrini, Andrea; Funel, Niccola; Maftouh, Mina; Ghayour-Mobarhan, Majid; Cantore, Maurizio; Boggi, Ugo; Peters, Godefridus J.; Pacetti, Paola; Giovannetti, Elisa			AKT1 and SELP Polymorphisms Predict the Risk of Developing Cachexia in Pancreatic Cancer Patients	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; MOLECULAR-MECHANISMS; SKELETAL-MUSCLE; ADIPOSE-TISSUE; SURVIVAL; CYTOKINES; ASSOCIATION; CONCORDANCE; ACTIVATION; GERMLINE	Pancreatic ductal adenocarcinoma (PDAC) patients have the highest risk of developing cachexia, which is a direct cause of reduced quality of life and shorter survival. Novel biomarkers to identify patients at risk of cachexia are needed and might have a substantial impact on clinical management. Here we investigated the prognostic value and association of SELP-rs6136, IL6-rs1800796 and AKT1-rs1130233 polymorphisms with cachexia in PDAC. Genotyping was performed in DNA from blood samples of a test and validation cohorts of 151 and 152 chemo-naive locally-advanced/metastatic PDAC patients, respectively. The association of SELP-rs6136, IL6-rs1800796 and AKT1-rs1130233 polymorphisms with cachexia as well as the correlation between cachexia and the candidate polymorphisms and overall survival were analyzed. Akt expression and phosphorylation in muscle biopsies were evaluated by specific ELISA assays. SELP-rs6136-AA and AKT1-rs1130233-AA/GA genotypes were associated with increased risk of developing cachexia in both cohorts (SELP: p = 0.011 and p = 0.045; AKT1: p = 0.004 and p = 0.019 for the first and second cohorts, respectively), while patients carrying AKT1-rs1130233-GG survived significantly longer (p = 0.002 and p = 0.004 for the first and second cohorts, respectively). In the multivariate analysis AKT1-rs1130233-AA/GA genotypes were significant predictors for shorter survival, with an increased risk of death of 1.7 (p = 0.002) and 1.6 (p = 0.004), in the first and second cohorts, respectively. This might be explained by the reduced phosphorylation of Akt1 in muscle biopsies from patients harboring AKT1-rs1130233-AA/GA (p = 0.003), favoring apoptosis induction. In conclusion, SELP and AKT1 polymorphisms may play a role in the risk of cachexia and death in PDAC patients, and should be further evaluated in larger prospective studies.	[Avan, Abolfazl; Avan, Amir; Le Large, Tessa Y. S.; Maftouh, Mina; Peters, Godefridus J.; Giovannetti, Elisa] Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, Amsterdam, Netherlands; [Avan, Amir; Ghayour-Mobarhan, Majid] Mashhad Univ Med Sci, Biochem Nutr Res Ctr, Mashhad, Iran; [Avan, Amir; Ghayour-Mobarhan, Majid] Mashhad Univ Med Sci, Sch Med, Dept New Sci & Technol, Mashhad, Iran; [Mambrini, Andrea; Cantore, Maurizio; Pacetti, Paola] Carrara Civ Hosp, Dept Med Oncol, Carrara, Italy; [Funel, Niccola; Boggi, Ugo; Giovannetti, Elisa] Univ Pisa, Start Up Unit, Pisa, Italy	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Mashhad University Medical Science; Mashhad University Medical Science; University of Pisa	Giovannetti, E (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, Amsterdam, Netherlands.	e.giovannetti@vumc.nl	Avan, Abolfazl/AAF-4662-2020; Ghayour-Mobarhan, Majid/AAY-5963-2020; giovannetti, elisa/F-4261-2011; Peters, Godefridus J/C-7562-2013	giovannetti, elisa/0000-0002-7565-7504; Funel, Niccola/0000-0002-5028-2363; Avan, Abolfazl/0000-0002-5537-6385; Peters, Godefridus J/0000-0002-5447-2877; maurizio, cantore/0000-0002-3360-499X; naseri, shahrokh/0000-0001-8974-2120	Netherlands Organization for Scientific Research; VENI grant [91611046]; Stimuleringfonds Open Access; CCA Foundation; Research Council at the Mashhad University of Medical Sciences, Mashhad; Istituto Toscano Tumori; AIRC Start-Up grant	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); VENI grant; Stimuleringfonds Open Access; CCA Foundation; Research Council at the Mashhad University of Medical Sciences, Mashhad; Istituto Toscano Tumori; AIRC Start-Up grant(Fondazione AIRC per la ricerca sul cancro)	This work was partially supported by grants from Netherlands Organization for Scientific Research, VENI grant (project number 91611046 (Elisa Giovannetti)) and Stimuleringfonds Open Access (Elisa Giovannetti), CCA Foundation 2012 (Amir Avan, Elisa Giovannetti, Godefridus J. Peters), Research Council at the Mashhad University of Medical Sciences, Mashhad (Amir Avan, Majid Ghayour-Mobarhan), Istituto Toscano Tumori (Elisa Giovannetti, Niccola Funel, Ugo Boggi) and AIRC Start-Up grant (Elisa Giovannetti). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argiles JM, 2003, CURR OPIN CLIN NUTR, V6, P401, DOI 10.1097/01.mco.0000078983.18774.cc; Avan A, 2014, CLIN CANCER RES, V20, P3623, DOI 10.1158/1078-0432.CCR-13-3256; Avan A, 2013, CANCER RES, V73, P6745, DOI 10.1158/0008-5472.CAN-13-0837; Bachmann J, 2013, NUTR CANCER, V65, P827, DOI 10.1080/01635581.2013.804580; Bachmann Jeannine, 2009, BMC Cancer, V9, P255, DOI 10.1186/1471-2407-9-255; Blum D, 2011, CRIT REV ONCOL HEMAT, V80, P114, DOI 10.1016/j.critrevonc.2010.10.004; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Caponi S, 2013, ANN ONCOL, V24, P734, DOI 10.1093/annonc/mds513; den Kamp CMO, 2013, AM J CLIN NUTR, V98, P738, DOI 10.3945/ajcn.113.058388; Di Sebastiano KM, 2013, BRIT J NUTR, V109, P302, DOI 10.1017/S0007114512001067; Ebrahimi B, 2004, CANCER-AM CANCER SOC, V101, P2727, DOI 10.1002/cncr.20672; Fearon KCH, 2008, EUR J CANCER, V44, P1124, DOI 10.1016/j.ejca.2008.02.033; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Frampton AE, 2014, GASTROENTEROLOGY, V146, P268, DOI 10.1053/j.gastro.2013.10.010; Galvani E, 2012, FUTURE ONCOL, V8, P1015, DOI [10.2217/FON.12.89, 10.2217/fon.12.89]; Giovannetti E, 2013, CURR PHARM DESIGN, V19, P927, DOI 10.2174/138161213804547268; Giovannetti E, 2011, PHARMACOGENOMICS, V12, P1641, DOI [10.2217/PGS.11.109, 10.2217/pgs.11.109]; Giovannetti E, 2010, MOL CANCER THER, V9, P581, DOI 10.1158/1535-7163.MCT-09-0665; Giovannetti E, 2010, CANCER RES, V70, P4528, DOI 10.1158/0008-5472.CAN-09-4467; Harris SL, 2005, P NATL ACAD SCI USA, V102, P16297, DOI 10.1073/pnas.0508390102; He WA, 2014, P NATL ACAD SCI USA, V111, P4525, DOI 10.1073/pnas.1402714111; He WA, 2013, J CLIN INVEST, V123, P4821, DOI 10.1172/JCI68523; Imoto A, 2012, INT J CANCER, V131, P2795, DOI 10.1002/ijc.27594; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Li G, 2002, NEUROSCIENCE, V115, P879, DOI 10.1016/S0306-4522(02)00447-5; Li QX, 2013, CLIN CANCER RES, V19, P6252, DOI 10.1158/1078-0432.CCR-13-1093; Marsh S, 2005, PHARMACOGENOMICS, V6, P873, DOI 10.2217/14622416.6.8.873; Martignoni ME, 2005, CLIN CANCER RES, V11, P5802, DOI 10.1158/1078-0432.CCR-05-0185; Pausch T, 2012, SURGERY, V152, pS81, DOI 10.1016/j.surg.2012.05.028; Schmitt TL, 2007, J MOL MED, V85, P647, DOI 10.1007/s00109-007-0177-2; Solheim TS, 2011, BRIT J CANCER, V105, P1244, DOI 10.1038/bjc.2011.323; STENBERG PE, 1985, J CELL BIOL, V101, P880, DOI 10.1083/jcb.101.3.880; Sugita H, 2005, AM J PHYSIOL-ENDOC M, V288, pE585, DOI 10.1152/ajpendo.00321.2004; Tan BHL, 2012, EMBO MOL MED, V4, P462, DOI 10.1002/emmm.201200231; Tan BHL, 2011, J GENET, V90, P165, DOI 10.1007/s12041-011-0027-4; Tan CR, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00088; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Tuca A, 2013, CRIT REV ONCOL HEMAT, V88, P625, DOI 10.1016/j.critrevonc.2013.07.015; Uomo G, 2006, J PANCREAS, V7, P157; van Huis-Tanja L, 2013, PHARMACOGENOMICS, V14, P2005, DOI [10.2217/PGS.13.169, 10.2217/pgs.13.169]; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Zhang DL, 2008, ANN CLIN LAB SCI, V38, P113	46	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e108057	10.1371/journal.pone.0108057	http://dx.doi.org/10.1371/journal.pone.0108057			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238546	Green Submitted, Green Published, gold			2022-12-25	WOS:000342491600081
J	Herlihey, FA; Moynihan, PJ; Clarke, AJ				Herlihey, Francesca A.; Moynihan, Patrick J.; Clarke, Anthony J.			The Essential Protein for Bacterial Flagella Formation FlgJ Functions as a beta-N-Acetylglucosaminidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-ASSISTED CATALYSIS; PEPTIDOGLYCAN HYDROLASE FLGJ; CIRCULAR-DICHROISM SPECTRA; ESCHERICHIA-COLI; LYTIC TRANSGLYCOSYLASES; SALMONELLA-TYPHIMURIUM; RHODOBACTER-SPHAEROIDES; STRUCTURAL PROTEINS; SECONDARY STRUCTURE; ROD FORMATION	The flagellum is a major virulence factor of motile pathogenic bacteria. This structure requires more than 50 proteins for its biogenesis and function, one of which is FlgJ. Homologs of FlgJ produced by the beta- and gamma-proteobacteria, such as Salmonella enterica, Vibrio spp., and both Sphingomonas sp. and Pseudomonas spp. are bifunctional, possessing an N-terminal domain responsible for proper rod assembly and a C-terminal domain possessing peptidoglycan lytic activity. Despite the amount of research conducted on FlgJ from these and other bacteria over the past 15 years, no biochemical analysis had been conducted on any FlgJ and consequently confusion exists as to whether the enzyme is a peptidoglycan hydrolase or a lytic transglycosylase. In this study, we present the development of a novel assay for glycoside lytic enzymes and its use to provide the first enzymatic characterization of the lytic domain of FlgJ from S. enterica as the model enzyme. Surprisingly, FlgJ functions as neither a muramidase nor a lytic transglycosylases but rather as a beta-N-acetylglucosaminidase. As such, FlgJ represents the first autolysin with this activity to be characterized from a Gram-negative bacterium. At its optimal pH of 4.0, the Michaelis-Menten parameters of K-m and k(cat) for FlgJ from S. enterica were determined to be 0.64 +/- 0.18 mg ml(-1) and 0.13 +/- 0.016 s(-1), respectively, using purified PG as substrate. Its catalytic residues were identified as Glu(184) and Glu(223).	[Herlihey, Francesca A.; Moynihan, Patrick J.; Clarke, Anthony J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Clarke, AJ (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	a.clarke@exec.uoguelph.ca	Moynihan, Patrick J/I-3393-2013	Moynihan, Patrick J/0000-0003-4182-6223	Canadian Institutes of Health Research Team [TGC114045]; Ontario Graduate Scholarship from the Province of Ontario	Canadian Institutes of Health Research Team(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship from the Province of Ontario	This work was supported by Canadian Institutes of Health Research Team Grant TGC114045 (to A. J. C.) and an Ontario Graduate Scholarship (to P. J. M.) from the Province of Ontario.	Apel D, 2008, BBA-BIOMEMBRANES, V1778, P1851, DOI 10.1016/j.bbamem.2007.07.005; Bai XH, 2014, J BIOL CHEM, V289, P23403, DOI 10.1074/jbc.M114.579714; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Berger CN, 2009, ISME J, V3, P261, DOI 10.1038/ismej.2008.95; Blackburn NT, 2002, BIOCHEMISTRY-US, V41, P1001, DOI 10.1021/bi011833k; Blackburn NT, 2001, J MOL EVOL, V52, P78, DOI 10.1007/s002390010136; Blackburn NT, 2000, ANAL BIOCHEM, V284, P388, DOI 10.1006/abio.2000.4707; Bublitz M, 2009, MOL MICROBIOL, V71, P1509, DOI 10.1111/j.1365-2958.2009.06619.x; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CLARKE AJ, 1993, ANAL BIOCHEM, V212, P344, DOI 10.1006/abio.1993.1339; Das M, 1998, FEMS MICROBIOL LETT, V165, P239, DOI 10.1016/S0378-1097(98)00283-3; de la Mora J, 2007, J BACTERIOL, V189, P7998, DOI 10.1128/JB.01073-07; de la Mora J, 2012, J BACTERIOL, V194, P4513, DOI 10.1128/JB.00460-12; Demchick P, 1996, J BACTERIOL, V178, P768, DOI 10.1128/jb.178.3.768-773.1996; Dijkstra AJ, 1996, J BACTERIOL, V178, P5555, DOI 10.1128/jb.178.19.5555-5562.1996; Drouillard S, 1997, BIOCHEM J, V328, P945, DOI 10.1042/bj3280945; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; Fujii M, 2008, J MOL BIOL, V379, P273, DOI 10.1016/j.jmb.2008.04.012; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; HARSHEY RM, 1994, P NATL ACAD SCI USA, V91, P8631, DOI 10.1073/pnas.91.18.8631; HASH JH, 1967, J BACTERIOL, V93, P1201, DOI 10.1128/JB.93.3.1201-1202.1967; Hashimoto W, 2009, BIOCHEM BIOPH RES CO, V381, P16, DOI 10.1016/j.bbrc.2009.01.186; Hirano T, 2001, J MOL BIOL, V312, P359, DOI 10.1006/jmbi.2001.4963; HOLTJE JV, 1975, J BACTERIOL, V124, P1067; Inagaki N, 2009, GENE, V447, P61, DOI 10.1016/j.gene.2009.08.004; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; KUBORI T, 1992, J MOL BIOL, V226, P433, DOI 10.1016/0022-2836(92)90958-M; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lood R, 2014, ANTIMICROB AGENTS CH, V58, P3073, DOI 10.1128/AAC.00115-14; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Maruyama Y, 2010, J BASIC MICROB, V50, P311, DOI 10.1002/jobm.200900249; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Moens S, 1996, CRIT REV MICROBIOL, V22, P67, DOI 10.3109/10408419609106456; Moynihan PJ, 2010, J BIOL CHEM, V285, P13264, DOI 10.1074/jbc.M110.107086; Nambu T, 1999, J BACTERIOL, V181, P1555, DOI 10.1128/JB.181.5.1555-1561.1999; Nambu T, 2006, GENES GENET SYST, V81, P381, DOI 10.1266/ggs.81.381; Pfeffer JM, 2013, J BIOL CHEM, V288, P2605, DOI 10.1074/jbc.M112.436352; Reid CW, 2004, FEBS LETT, V574, P73, DOI 10.1016/j.febslet.2004.08.006; Roure S, 2012, MOL MICROBIOL, V86, P845, DOI 10.1111/mmi.12019; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 1999, PROTEIN SCI, V8, P370; Suzuki H, 1998, J STRUCT BIOL, V124, P104, DOI 10.1006/jsbi.1998.4048; SUZUKI T, 1978, J BACTERIOL, V133, P904, DOI 10.1128/JB.133.2.904-915.1978; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; van Heijenoort J, 2011, MICROBIOL MOL BIOL R, V75, P636, DOI 10.1128/MMBR.00022-11; VANSCHELTINGA ACT, 1995, BIOCHEMISTRY-US, V34, P15619, DOI 10.1021/bi00048a003; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Viollier PH, 2003, MOL MICROBIOL, V49, P331, DOI 10.1046/j.1365-2958.2003.03576.x; Vollmer W, 2008, BBA-BIOMEMBRANES, V1778, P1714, DOI 10.1016/j.bbamem.2007.06.007; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Yokoi KJ, 2008, GENE, V416, P66, DOI 10.1016/j.gene.2008.03.004; Young GM, 1999, P NATL ACAD SCI USA, V96, P6456, DOI 10.1073/pnas.96.11.6456	53	43	43	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31029	31042		10.1074/jbc.M114.603944	http://dx.doi.org/10.1074/jbc.M114.603944			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25248745	hybrid, Green Published			2022-12-25	WOS:000344549900013
J	Fang, P; Zhou, L; Zhou, YQ; Kolls, JK; Zheng, T; Zhu, Z				Fang, Ping; Zhou, Li; Zhou, Yuqi; Kolls, Jay K.; Zheng, Tao; Zhu, Zhou			Immune Modulatory Effects of IL-22 on Allergen-Induced Pulmonary Inflammation	PLOS ONE			English	Article							EOSINOPHILIC AIRWAY INFLAMMATION; INNATE LYMPHOID-CELLS; MOUSE MODEL; IFN-GAMMA; T-CELLS; ASTHMA; LUNG; IL-17; INTERLEUKIN-22; T(H)17	IL-22 is a Th17/Th22 cytokine that is increased in asthma. However, recent animal studies showed controversial findings in the effects of IL-22 in allergic asthma. To determine the role of IL-22 in ovalbumin-induced allergic inflammation we generated inducible lung-specific IL-22 transgenic mice. Transgenic IL-22 expression and signaling activity in the lung were determined. Ovalbumin (OVA)-induced pulmonary inflammation, immune responses, and airway hyperresponsiveness (AHR) were examined and compared between IL-22 transgenic mice and wild type controls. Following doxycycline (Dox) induction, IL-22 protein was readily detected in the large (CC10 promoter) and small (SPC promoter) airway epithelial cells. IL-22 signaling was evidenced by phosphorylated STAT3. After OVA sensitization and challenge, compared to wild type littermates, IL-22 transgenic mice showed decreased eosinophils in the bronchoalveolar lavage (BAL), and in lung tissue, decreased mucus metaplasia in the airways, and reduced AHR. Among the cytokines and chemokines examined, IL-13 levels were reduced in the BAL fluid as well as in lymphocytes from local draining lymph nodes of IL-22 transgenic mice. No effect was seen on the levels of serum total or OVA-specific IgE or IgG. These findings indicate that IL-22 has immune modulatory effects on pulmonary inflammatory responses in allergen-induced asthma.	[Fang, Ping] Xi An Jiao Tong Univ, Resp Dept, Affiliated Hosp 2, Sch Med, Xian 710049, Shaanxi, Peoples R China; [Fang, Ping; Zhou, Li; Zhou, Yuqi; Zheng, Tao; Zhu, Zhou] Johns Hopkins Univ, Sch Med, Dept Internal Med, Div Allergy & Clin Immunol, Baltimore, MD USA; [Kolls, Jay K.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Div Pediat Rheumatol, Pittsburgh, PA USA	Xi'an Jiaotong University; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhu, Z (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.	zhou.zhu@yale.edu	Kolls, Jay/AAH-1829-2019	Kolls, Jay/0000-0001-5151-6304	NIH [AI075025, AI07502, HL079349, HL107151]; National Natural Science Foundation of China [81000009]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107151, R01HL079349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075025] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the following: NIH grants HL079349 and HL107151 to ZZ; NIH grants AI075025 and AI07502 to TZ; and National Natural Science Foundation of China 81000009 to PF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2012, J ALLERGY CLIN IMMUN, V129, P1438, DOI 10.1016/j.jaci.2012.05.003; Akeson AL, 2003, DEV BIOL, V264, P443, DOI 10.1016/j.ydbio.2003.09.004; Atarashi K, 2010, BENEF MICROBES, V1, P327, DOI 10.3920/BM2010.0026; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Besnard AG, 2011, AM J RESP CRIT CARE, V183, P1153, DOI 10.1164/rccm.201008-1383OC; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Cannon MJ, 2011, EXPERT OPIN BIOL TH, V11, P441, DOI 10.1517/14712598.2011.554812; Chang Y, 2012, FASEB J, V26, P5152, DOI 10.1096/fj.12-208033; Cobleigh MA, 2013, AM J PATHOL, V182, P21, DOI 10.1016/j.ajpath.2012.08.043; Dumoutier L, 2000, GENES IMMUN, V1, P488, DOI 10.1038/sj.gene.6363716; Goto M, 2009, CELL IMMUNOL, V254, P81, DOI 10.1016/j.cellimm.2008.10.002; Hellings PW, 2003, AM J RESP CELL MOL, V28, P42, DOI 10.1165/rcmb.4832; Hirose K, 2013, J ALLERGY CAIRO, V2013; Kim KW, 2012, ARTHRITIS RHEUM-US, V64, P1015, DOI 10.1002/art.33446; Laurence A, 2008, NAT MED, V14, P247, DOI 10.1038/nm0308-247; Lecart S, 2002, INT IMMUNOL, V14, P1351, DOI 10.1093/intimm/dxf096; Lee YC, 2001, J ASTHMA, V38, P665, DOI 10.1081/JAS-100107544; Liang MR, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/209179; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Middleton GW, 2012, CANCER IMMUNOL IMMUN, V61, P1, DOI 10.1007/s00262-011-1151-y; Mjosberg J, 2012, EUR J IMMUNOL, V42, P1093, DOI 10.1002/eji.201242549; Nakagome K, 2011, J IMMUNOL, V187, P5077, DOI 10.4049/jimmunol.1001560; Nograles KE, 2009, J ALLERGY CLIN IMMUN, V123, P1244, DOI 10.1016/j.jaci.2009.03.041; Oh SY, 2009, AM J RESP CELL MOL, V40, P568, DOI 10.1165/rcmb.2008-0225OC; Park O, 2011, HEPATOLOGY, V54, P252, DOI 10.1002/hep.24339; Pociask DA, 2013, AM J PATHOL, V182, P1286, DOI 10.1016/j.ajpath.2012.12.007; Res PCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014108; Scanlon ST, 2012, CURR OPIN IMMUNOL, V24, P707, DOI 10.1016/j.coi.2012.08.009; Simonian PL, 2010, J EXP MED, V207, P2239, DOI 10.1084/jem.20100061; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Souwer Y, 2010, CURR OPIN IMMUNOL, V22, P821, DOI 10.1016/j.coi.2010.10.013; Stirling RG, 2000, BRIT MED BULL, V56, P1037, DOI 10.1258/0007142001903526; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JCI33194, 10.1172/JC133194]; Takahashi K, 2011, J ALLERGY CLIN IMMUN, V128, P1067, DOI 10.1016/j.jaci.2011.06.018; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Taube C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021799; Tichelaar JW, 2000, J BIOL CHEM, V275, P11858, DOI 10.1074/jbc.275.16.11858; Witte E, 2010, CYTOKINE GROWTH F R, V21, P365, DOI 10.1016/j.cytogfr.2010.08.002; Wolk K, 2009, J MOL MED, V87, P523, DOI 10.1007/s00109-009-0457-0; Wong CK, 2001, CLIN EXP IMMUNOL, V125, P177, DOI 10.1046/j.1365-2249.2001.01602.x; Zenewicz LA, 2011, INT IMMUNOL, V23, P159, DOI 10.1093/intimm/dxr001; Zenewicz LA, 2008, EUR J IMMUNOL, V38, P3265, DOI 10.1002/eji.200838655; Zhao J, 2013, MUCOSAL IMMUNOL, V6, P335, DOI 10.1038/mi.2012.76; Zhao Y, 2010, INT ARCH ALLERGY IMM, V151, P297, DOI 10.1159/000250438; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909; Zhu Z, 2001, J BIOL CHEM, V276, P25222, DOI 10.1074/jbc.M101512200; Zhu Z, 2011, SCI REP-UK, V1, DOI 10.1038/srep00023	47	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107454	10.1371/journal.pone.0107454	http://dx.doi.org/10.1371/journal.pone.0107454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254361	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000344862300024
J	Hassan, NMM; Painter, N; Howlett, CR; Farrell, AW; Di Girolamo, N; Lyons, JG; Halliday, GM				Hassan, Nur Mohammad Monsur; Painter, Nicole; Howlett, C. Rolfe; Farrell, Andrew W.; Di Girolamo, Nick; Lyons, J. Guy; Halliday, Gary M.			Brm Inhibits the Proliferative Response of Keratinocytes and Corneal Epithelial Cells to Ultraviolet Radiation-Induced Damage	PLOS ONE			English	Article							NONMELANOMA SKIN-CANCER; INDUCED DNA-DAMAGE; BASAL LAYER; SWI/SNF; TUMORS; MICE; CARCINOGENESIS; INDUCTION; SUBUNITS; COMPLEX	Ultraviolet radiation (UV) from sunlight is the primary cause of skin and ocular neoplasia. Brahma (BRM) is part of the SWI/SNF chromatin remodeling complex. It provides energy for rearrangement of chromatin structure. Previously we have found that human skin tumours have a hotspot mutation in BRM and that protein levels are substantially reduced. Brm-/- mice have enhanced susceptibility to photocarcinogenesis. In these experiments, Brm-/- mice, with both or a single Trp53 allele were exposed to UV for 2 or 25 weeks. In wild type mice the central cornea and stroma became atrophic with increasing time of exposure while the peripheral regions became hyperplastic, presumably as a reparative process. Brm-/-, Trp53+/-, and particularly the Brm-/- Trp53+/- mice had an exaggerated hyperplastic regeneration response in the corneal epithelium and stroma so that the central epithelial atrophy or stromal loss was reduced. UV induced hyperplasia of the epidermis and corneal epithelium, with an increase in the number of dividing cells as determined by Ki-67 expression. This response was considerably greater in both the Brm-/- Trp53+/+ and Brm-/- Trp53+/- mice indicating that Brm protects from UV-induced enhancement of cell division, even with loss of one Trp53 allele. Cell division was disorganized in Brm-/- mice. Rather than being restricted to the basement membrane region, dividing cells were also present in the suprabasal regions of both tissues. Brm appears to be a tumour suppressor gene that protects from skin and ocular photocarcinogenesis. These studies indicate that Brm protects from UV-induced hyperplastic growth in both cutaneous and corneal keratinocytes, which may contribute to the ability of Brm to protect from photocarcinogenesis.	[Hassan, Nur Mohammad Monsur; Painter, Nicole; Farrell, Andrew W.; Lyons, J. Guy; Halliday, Gary M.] Royal Prince Alfred Hosp, Sydney Med Sch, Bosch Inst, Discipline Dermatol, Sydney, NSW, Australia; [Hassan, Nur Mohammad Monsur; Painter, Nicole; Farrell, Andrew W.; Lyons, J. Guy; Halliday, Gary M.] Univ Sydney, Sydney, NSW 2006, Australia; [Howlett, C. Rolfe] Univ New S Wales, Dept Pathol, Sydney, NSW, Australia; [Howlett, C. Rolfe] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW, Australia; [Di Girolamo, Nick] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Lyons, J. Guy] Royal Prince Alfred Hosp, Sydney Head & Neck Canc Inst, Canc Serv, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney	Halliday, GM (corresponding author), Royal Prince Alfred Hosp, Sydney Med Sch, Bosch Inst, Discipline Dermatol, Sydney, NSW, Australia.	gary.halliday@sydney.edu.au	Lyons, Guy/B-1319-2012; Hassan, Nur/N-5630-2014	Lyons, Guy/0000-0002-4835-4663; Hassan, Nur/0000-0002-7223-723X	National Health and Medical Research Council [632717]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Support was provided by the National Health and Medical Research Council Project grant number 632717. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar NS, 2004, P NATL ACAD SCI USA, V101, P4954, DOI 10.1073/pnas.0401141101; Bock VL, 2011, BRIT J DERMATOL, V164, P1221, DOI 10.1111/j.1365-2133.2011.10267.x; Byrne SN, 2002, J INVEST DERMATOL, V119, P858, DOI 10.1046/j.1523-1747.2002.00261.x; Coisy-Quivy M, 2006, CANCER RES, V66, P5069, DOI 10.1158/0008-5472.CAN-05-0596; Conscience I, 2006, EUR J DERMATOL, V16, P518, DOI 10.1684/ejd.2006.0024; Halliday GM, 2012, EXP DERMATOL, V21, P599, DOI 10.1111/j.1600-0625.2012.01522.x; Halliday GM, 2012, J INVEST DERMATOL, V132, P265, DOI 10.1038/jid.2011.281; Halliday GM, 2009, INT J BIOCHEM CELL B, V41, P725, DOI 10.1016/j.biocel.2008.04.026; Halliday GM, 2008, DRUG DISCOVERY TODAY, V5, P201; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jiang WD, 1999, ONCOGENE, V18, P4247, DOI 10.1038/sj.onc.1202789; Kothandapani A, 2012, EXP CELL RES, V318, P1973, DOI 10.1016/j.yexcr.2012.06.011; Lans H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000941; Melnikova VO, 2005, MUTAT RES-FUND MOL M, V571, P91, DOI 10.1016/j.mrfmmm.2004.11.015; Moloney FJ, 2009, J INVEST DERMATOL, V129, P1012, DOI 10.1038/jid.2008.319; Newkirk KM, 2007, TOXICOL PATHOL, V35, P817, DOI 10.1080/01926230701584197; Ng J, 2008, INVEST OPHTH VIS SCI, V49, P5295, DOI 10.1167/iovs.08-1988; Rebel H, 2001, CANCER RES, V61, P977; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shen H, 2008, CANCER RES, V68, P10154, DOI 10.1158/0008-5472.CAN-08-1794; Stratigos AJ, 2005, J EUR ACAD DERMATOL, V19, P180, DOI 10.1111/j.1468-3083.2005.01094.x; Surjana D, 2013, CARCINOGENESIS, V34, P1144, DOI 10.1093/carcin/bgt017; van Diest PJ, 1998, J CLIN PATHOL, V51, P716, DOI 10.1136/jcp.51.10.716; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068	25	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107931	10.1371/journal.pone.0107931	http://dx.doi.org/10.1371/journal.pone.0107931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254962	Green Published, Green Submitted, gold			2022-12-25	WOS:000344862300043
J	Impheng, H; Pongcharoen, S; Richert, L; Pekthong, D; Srisawang, P				Impheng, Hathaichanok; Pongcharoen, Sutatip; Richert, Lysiane; Pekthong, Dumrongsak; Srisawang, Piyarat			The Selective Target of Capsaicin on FASN Expression and De Novo Fatty Acid Synthesis Mediated through ROS Generation Triggers Apoptosis in HepG2 Cells	PLOS ONE			English	Article							SYNTHASE INHIBITOR ORLISTAT; CARNITINE PALMITOYLTRANSFERASE I; GROWTH-FACTOR RECEPTOR-2; PROSTATE-CANCER CELLS; CYCLE ARREST; TUMOR-GROWTH; PC-3 CELLS; PATHWAY; OXYGEN; (-)-EPIGALLOCATECHIN-3-GALLATE	The inhibition of the mammalian de novo synthesis of long-chain saturated fatty acids (LCFAs) by blocking the fatty acid synthase (FASN) enzyme activity in tumor cells that overexpress FASN can promote apoptosis, without apparent cytotoxic to non-tumor cells. The present study aimed to focus on the potent inhibitory effect of capsaicin on the fatty acid synthesis pathway inducing apoptosis of capsaicin in HepG2 cells. The use of capsaicin as a source for a new FASN inhibitor will provide new insight into its possible application as a selective anti-cancer therapy. The present findings showed that capsaicin promoted apoptosis as well as cell cycle arrest in the G0/G1 phase. The onset of apoptosis was correlated with a dissipation of mitochondrial membrane potential (Delta Psi m). Apoptotic induction by capsaicin was mediated by inhibition of FASN protein expression which was accompanied by decreasing its activity on the de novo fatty acid synthesis. The expression of FASN was higher in HepG2 cells than in normal hepatocytes that were resistant to undergoing apoptosis following capsaicin administration. Moreover, the inhibitory effect of capsaicin on FASN expression and activity was found to be mediated by an increase of intracellular reactive oxygen species (ROS) generation. Treatment of HepG2 cells with capsaicin failed to alter ACC and ACLY protein expression, suggesting ACC and ACLY might not be the specific targets of capsaicin to induce apoptosis. An accumulation of malonyl-CoA level following FASN inhibition represented a major cause of mitochondrial-dependent apoptotic induction instead of deprivation of fatty acid per se. Here, we also obtained similar results with C75 that exhibited apoptosis induction by reducing the levels of fatty acid without any change in the abundance of FASN expression along with increasing ROS production. Collectively, our results provide novel evidence that capsaicin exhibits a potent anti-cancer property by targeting FASN protein in HepG2 cells.	[Impheng, Hathaichanok; Srisawang, Piyarat] Naresuan Univ, Fac Med Sci, Dept Physiol, Phitsanulok, Thailand; [Pongcharoen, Sutatip] Naresuan Univ, Fac Med, Dept Med, Phitsanulok, Thailand; [Richert, Lysiane] Univ Franche Comte, Fac Med & Pharm, Lab Toxicol Cellulaire, F-25030 Besancon, France; [Pekthong, Dumrongsak] Naresuan Univ, Fac Pharmaceut Sci, Dept Pharm Practice, Phitsanulok, Thailand	Naresuan University; Naresuan University; Universite de Franche-Comte; Naresuan University	Pekthong, D (corresponding author), Naresuan Univ, Fac Pharmaceut Sci, Dept Pharm Practice, Phitsanulok, Thailand.	dumrongsakp@yahoo.com; piyarats@nu.ac.th		Impheng, Hathaichanok/0000-0001-8350-1692	Naresuan University, Thailand [R2556B068]	Naresuan University, Thailand	This work has been accomplished with supporting funds from Naresuan University, Thailand, grant number: R2556B068, http://www.research.nu.ac.th/dra_eng/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie-Viollon C, 2010, TOXICOL IN VITRO, V24, P346, DOI 10.1016/j.tiv.2009.05.021; Adan-Gokbulut A, 2013, CURR MED CHEM, V20, P108; Agostini M, 2014, MOL CANCER THER, V13, P585, DOI 10.1158/1535-7163.MCT-12-1136; Amantini C, 2007, J NEUROCHEM, V102, P977, DOI 10.1111/j.1471-4159.2007.04582.x; Amantini C, 2009, CARCINOGENESIS, V30, P1320, DOI 10.1093/carcin/bgp138; Aza-Gonzalez C, 2011, PLANT CELL REP, V30, P695, DOI 10.1007/s00299-010-0968-8; Bandyopadhyay S, 2006, CANCER RES, V66, P5934, DOI 10.1158/0008-5472.CAN-05-3197; Biswas S, 2012, CANCER METAST REV, V31, P689, DOI 10.1007/s10555-012-9384-6; Chang HC, 2011, HUM EXP TOXICOL, V30, P1657, DOI 10.1177/0960327110396530; Chang LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099254; Chen C, 2014, J BIOL CHEM, V289, P17184, DOI 10.1074/jbc.M114.550806; Chen D, 2012, INT J UROL, V19, P662, DOI 10.1111/j.1442-2042.2012.02981.x; Chen HW, 2012, PROSTATE CANCER P D, V15, P260, DOI 10.1038/pcan.2012.15; De Schrijver E, 2003, CANCER RES, V63, P3799; Flavin R, 2010, FUTURE ONCOL, V6, P551, DOI [10.2217/fon.10.11, 10.2217/FON.10.11]; Fritz V, 2013, ONCOGENE, V32, P5101, DOI 10.1038/onc.2012.523; Gelebart P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033738; Gonzales CB, 2014, ORAL ONCOL, V50, P437, DOI 10.1016/j.oraloncology.2013.12.023; Huang SP, 2009, ANTICANCER RES, V29, P165; Ip SW, 2012, HUM EXP TOXICOL, V31, P539, DOI 10.1177/0960327111417269; Ip SW, 2012, ENVIRON TOXICOL, V27, P332, DOI 10.1002/tox.20646; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; Jackowski S, 2000, BBA-MOL CELL BIOL L, V1483, P301, DOI 10.1016/S1388-1981(99)00203-6; Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012; Kant S, 2014, BBA-GEN SUBJECTS, V1840, P294, DOI 10.1016/j.bbagen.2013.09.020; Kant S, 2012, BBA-GEN SUBJECTS, V1820, P1764, DOI 10.1016/j.bbagen.2012.07.010; Koukourakis MI, 2006, CANCER SCI, V97, P1056, DOI 10.1111/j.1349-7006.2006.00298.x; Lau JK, 2014, APOPTOSIS, V19, P1190, DOI 10.1007/s10495-014-1007-y; Lee JS, 2013, PHYTOTHER RES, V27, P713, DOI 10.1002/ptr.4778; Li XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070987; Lin CH, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-46; Lu HF, 2010, J AGR FOOD CHEM, V58, P12999, DOI 10.1021/jf103335w; Macho A, 1999, CELL DEATH DIFFER, V6, P155, DOI 10.1038/sj.cdd.4400465; Manohar M, 2013, J NUTR BIOCHEM, V24, P940, DOI 10.1016/j.jnutbio.2012.06.013; Mashima T, 2009, BRIT J CANCER, V100, P1369, DOI 10.1038/sj.bjc.6605007; Mason P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033823; Mergler S, 2012, CELL SIGNAL, V24, P233, DOI 10.1016/j.cellsig.2011.09.005; Do MT, 2013, FOOD CHEM, V141, P2591, DOI 10.1016/j.foodchem.2013.04.125; Notarnicola M, 2012, ANTICANCER RES, V32, P2585; Palanivel K, 2014, J CELL BIOCH; Pandey PR, 2011, BREAST CANCER RES TR, V130, P387, DOI 10.1007/s10549-010-1300-6; Paumen MB, 1997, BIOCHEM BIOPH RES CO, V231, P523, DOI 10.1006/bbrc.1997.6089; Paumen MB, 1997, J BIOL CHEM, V272, P3324, DOI 10.1074/jbc.272.6.3324; Pekthong D, 2009, CHEM-BIOL INTERACT, V179, P247, DOI 10.1016/j.cbi.2008.10.054; Pizer ES, 2000, CANCER RES, V60, P213; Pizer ES, 1998, CANCER RES, V58, P4611; Pramanik KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020151; Reilly CA, 2003, CHEM RES TOXICOL, V16, P336, DOI 10.1021/tx025599q; Relat J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-280; Rossato FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101060; Sanchez AM, 2006, APOPTOSIS, V11, P89, DOI 10.1007/s10495-005-3275-z; Sanchez AM, 2007, APOPTOSIS, V12, P2013, DOI 10.1007/s10495-007-0119-z; Seguin F, 2012, BRIT J CANCER, V107, P977, DOI 10.1038/bjc.2012.355; Shimizu M, 2005, CLIN CANCER RES, V11, P2735, DOI 10.1158/1078-0432.CCR-04-2014; Shimizu T, 2013, J GASTROENTEROL; Skrzypski M, 2014, CELL SIGNAL, V26, P41, DOI 10.1016/j.cellsig.2013.09.014; Smith B, 2014, MOLECULES, V19, P3988, DOI 10.3390/molecules19043988; Smyth MJ, 1996, BIOCHEM J, V316, P25, DOI 10.1042/bj3160025; Song HJ, 2012, PROSTAG LEUKOTR ESS, V87, P197, DOI 10.1016/j.plefa.2012.09.002; Tao L, 2014, MOL NUTR FOOD RES, V58, P665, DOI 10.1002/mnfr.201300427; Vandhana S, 2013, BBA-MOL CELL BIOL L, V1831, P1458, DOI 10.1016/j.bbalip.2013.06.005; Wang Y, 2012, ASIAN PAC J CANCER P, V13, P5573, DOI 10.7314/APJCP.2012.13.11.5573; Xue CS, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-30; Yan YF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085374, 10.1371/journal.pone.0097697]; Yang G, 2010, CHEM-BIOL INTERACT, V185, P12, DOI 10.1016/j.cbi.2010.02.017; Yang KM, 2009, CELL MOL BIOL LETT, V14, P497, DOI 10.2478/s11658-009-0016-2; Yang ZH, 2010, UROLOGY, V75, P735, DOI 10.1016/j.urology.2009.03.042; Yoon S, 2007, J BIOL CHEM, V282, P26122, DOI 10.1074/jbc.M702854200; Zecchin KG, 2011, LAB INVEST, V91, P232, DOI 10.1038/labinvest.2010.157; Zhang JH, 2013, ONCOL LETT, V5, P43, DOI 10.3892/ol.2012.991; Zhao P, 2014, ONCOL LETT, V8, P765, DOI 10.3892/ol.2014.2159; Zheng J, 2012, ONCOL LETT, V4, P1151, DOI 10.3892/ol.2012.928; Zhou WB, 2003, CANCER RES, V63, P7330; Zhou WB, 2007, CANCER RES, V67, P2964, DOI 10.1158/0008-5472.CAN-06-3439	74	26	28	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107842	10.1371/journal.pone.0107842	http://dx.doi.org/10.1371/journal.pone.0107842			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255125	Green Published, Green Submitted, gold			2022-12-25	WOS:000344862300036
J	Einarsdottir, HK; Stapleton, NM; Scherjon, S; Andersen, JT; Rispens, T; van der Schoot, CE; Vidarsson, G				Einarsdottir, Helga K.; Stapleton, Nigel M.; Scherjon, Sicco; Andersen, Jan Terje; Rispens, Theo; van der Schoot, C. Ellen; Vidarsson, Gestur			On the Perplexingly Low Rate of Transport of IgG2 across the Human Placenta	PLOS ONE			English	Article							NEONATAL FC-RECEPTOR; IMMUNOGLOBULIN-G; HALF-LIFE; STRUCTURAL ISOFORMS; CRYSTAL-STRUCTURE; HUMAN-ANTIBODIES; HUMAN-PREGNANCY; LIGHT-CHAIN; BINDING; FETAL	The neonatal receptor, FcRn, mediates both serum half-life extension as well as active transport of maternal IgG to the fetus during pregnancy. Therefore, transport efficiency and half-life go hand-in-hand. However, while the half-life of the human IgG2 subclass is comparable to IgG1, the placental transport of IgG2 is not, with the neonatal IgG1 levels generally exceeding maternal levels at birth, but not for IgG2. We hypothesized that the unique short-hinged structure of IgG2, which enables its kappa-, but not lambda-isotype to form at least three different structural isoforms, might be a contributing factor to these differences. To investigate whether there was any preference for either light chain, we measured placental transport of IgG subclasses as well as kappa/lambda-light chain isotypes of IgG1 and IgG2 in 27 matched mother-child pairs. We also studied the half-life of IgG1 and IgG2 light chain isotypes in mice, as well as that of synthesized IgG2 structural isotypes kappa A and kappa B. In order to investigate serum clearance of IgG1 and IgG2 light-chain isotypes in humans, we quantified the relative proportions of IgG1 and IgG2 light chains in hypogammaglobulinemia patients four weeks after IVIg infusion and compared to the original IVIg isotype composition. None of our results indicate any light chain preference in either of the FcRn mediated mechanisms; half-life extension or maternal transport.	[Einarsdottir, Helga K.; Stapleton, Nigel M.; van der Schoot, C. Ellen; Vidarsson, Gestur] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunohematol, Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands; [Scherjon, Sicco] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynacol, Groningen, Netherlands; [Andersen, Jan Terje] CIR, Oslo, Norway; [Andersen, Jan Terje] Oslo Univ Hosp, Dept Immunol, Oslo, Norway; [Rispens, Theo] Univ Amsterdam, Acad Med Ctr, Dept Immunopathol, Sanquin Res & Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; University of Oslo; University of Amsterdam; Academic Medical Center Amsterdam	Vidarsson, G (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunohematol, Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands.	G.Vidarsson@sanquin.nl	Andersen, Jan Terje/AAB-6209-2020; Vidarsson, Gestur/A-9909-2009	Vidarsson, Gestur/0000-0001-5621-003X; Andersen, Jan Terje/0000-0003-1710-1628	Landsteiner Foundation for Blood Transfusion Research (LSBR) [0721]; Research Council of Norway through Centres of Excellence [179573]; Research Council of Norway [230526/F20]; South-Eastern Norway Regional Health Authority [39375]	Landsteiner Foundation for Blood Transfusion Research (LSBR); Research Council of Norway through Centres of Excellence; Research Council of Norway(Research Council of Norway); South-Eastern Norway Regional Health Authority	The work of HKE was supported by grant 0721 from the Landsteiner Foundation for Blood Transfusion Research (LSBR). JTA was supported in part by the Research Council of Norway through its Centres of Excellence funding scheme (project number 179573), the Research Council of Norway (Grant no. 230526/F20) and the South-Eastern Norway Regional Health Authority (Grant no. 39375). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Cervenak J, 2013, MABS-AUSTIN, V5, P860, DOI 10.4161/mabs.26507; Chen PG, 2010, BLOOD, V116, P3660, DOI 10.1182/blood-2010-05-284919; Dillon TM, 2008, J BIOL CHEM, V283, P16206, DOI 10.1074/jbc.M709988200; Einarsdottir H, 2014, TRANSFUSION, V54, P665, DOI 10.1111/trf.12334; Einarsdottir HK, 2013, GLYCOCONJUGATE J, V30, P147, DOI 10.1007/s10719-012-9381-6; Gurbaxani B, 2006, MOL IMMUNOL, V43, P1462, DOI 10.1016/j.molimm.2005.07.032; HAMILTON RG, 1987, CLIN CHEM, V33, P1707; HARALDSSON A, 1992, ANN CLIN BIOCHEM, V29, P271, DOI 10.1177/000456329202900303; HARALDSSON A, 1991, ANN CLIN BIOCHEM, V28, P461, DOI 10.1177/000456329102800507; Hogarth PM, 2012, NAT REV DRUG DISCOV, V11, P311, DOI 10.1038/nrd2909; ISRAEL EJ, 1995, J IMMUNOL, V154, P6246; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kim JK, 1999, EUR J IMMUNOL, V29, P2819, DOI 10.1002/(SICI)1521-4141(199909)29:09<2819::AID-IMMU2819>3.0.CO;2-6; Kim J, 2009, J IMMUNOL, V182, P2583, DOI 10.4049/jimmunol.0803247; Lencer WI, 2005, TRENDS CELL BIOL, V15, P5, DOI 10.1016/j.tcb.2004.11.004; Liu XD, 2007, J IMMUNOL, V179, P2999, DOI 10.4049/jimmunol.179.5.2999; Lyden TW, 2001, J IMMUNOL, V166, P3882, DOI 10.4049/jimmunol.166.6.3882; MALEK A, 1994, AM J REPROD IMMUNOL, V32, P8, DOI 10.1111/j.1600-0897.1994.tb00873.x; Malek A, 1996, AM J REPROD IMMUNOL, V36, P248; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Martinez T, 2008, BIOCHEMISTRY-US, V47, P7496, DOI 10.1021/bi800576c; Mohanty S, 2010, J REPROD IMMUNOL, V84, P133, DOI 10.1016/j.jri.2009.10.008; Montano RF, 2002, J IMMUNOL, V168, P224, DOI 10.4049/jimmunol.168.1.224; Mousavi SA, 2007, HEPATOLOGY, V46, P871, DOI 10.1002/hep.21748; Neuber T, 2014, MABS-AUSTIN, V6, P928, DOI 10.4161/mabs.28744; Newton EE, 2005, J CELL SCI, V118, P2461, DOI 10.1242/jcs.02367; Petkova SB, 2006, J EXP MED, V203, P275, DOI 10.1084/jem.20051951; RAGHAVAN M, 1995, BIOCHEMISTRY-US, V34, P14649, DOI 10.1021/bi00045a005; Roux KH, 1997, J IMMUNOL, V159, P3372; Saeland E, 2003, J IMMUNOL, V170, P6158, DOI 10.4049/jimmunol.170.12.6158; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; Stapleton NM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1608; STORY CM, 1994, J EXP MED, V180, P2377, DOI 10.1084/jem.180.6.2377; Sun Y, 1999, INFECT IMMUN, V67, P1172, DOI 10.1128/IAI.67.3.1172-1179.1999; Takizawa T, 2005, J IMMUNOL, V175, P2331, DOI 10.4049/jimmunol.175.4.2331; Tzaban S, 2009, J CELL BIOL, V185, P673, DOI 10.1083/jcb.200809122; Vidarsson G, 2006, BLOOD, V108, P3573, DOI 10.1182/blood-2006-05-024539; Vink T, 2014, METHODS, V65, P5, DOI 10.1016/j.ymeth.2013.07.018; Ward ES, 2005, MOL BIOL CELL, V16, P2028, DOI 10.1091/mbc.E04-08-0735; West AP, 2000, BIOCHEMISTRY-US, V39, P9698, DOI 10.1021/bi000749m; Wypych J, 2008, J BIOL CHEM, V283, P16194, DOI 10.1074/jbc.M709987200; Zuckier LS, 1998, CANCER RES, V58, P3905	43	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108319	10.1371/journal.pone.0108319	http://dx.doi.org/10.1371/journal.pone.0108319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251461	gold, Green Submitted, Green Published			2022-12-25	WOS:000342492700109
J	Shlyonsky, V; Dupuis, F; Gall, D				Shlyonsky, Vadim; Dupuis, Freddy; Gall, David			The OpenPicoAmp: An Open-Source Planar Lipid Bilayer Amplifier for Hands-On Learning of Neuroscience	PLOS ONE			English	Article							GRAMICIDIN-A; MEMBRANES; CHANNEL; PERFORMANCE	Understanding the electrical biophysical properties of the cell membrane can be difficult for neuroscience students as it relies solely on lectures of theoretical models without practical hands on experiments. To address this issue, we developed an open-source lipid bilayer amplifier, the OpenPicoAmp, which is appropriate for use in introductory courses in biophysics or neurosciences at the undergraduate level, dealing with the electrical properties of the cell membrane. The amplifier is designed using the common lithographic printed circuit board fabrication process and off-the-shelf electronic components. In addition, we propose a specific design for experimental chambers allowing the insertion of a commercially available polytetrafluoroethylene film. We provide a complete documentation allowing to build the amplifier and the experimental chamber. The students hand-out giving step-by step instructions to perform a recording is also included. Our experimental setup can be used in basic experiments in which students monitor the bilayer formation by capacitance measurement and record unitary currents produced by ionic channels like gramicidin A dimers. Used in combination with a low-cost data acquisition board this system provides a complete solution for hands-on lessons, therefore improving the effectiveness in teaching basic neurosciences or biophysics.	[Shlyonsky, Vadim] Univ Libre Bruxelles, Lab Physiol & Physiopathol, Brussels, Belgium; [Dupuis, Freddy] Univ Libre Bruxelles, Serv Ondes & Signaux, Brussels, Belgium; [Gall, David] Univ Libre Bruxelles, ULB Neurosci Inst, Lab Neurophysiol, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles	Gall, D (corresponding author), Univ Libre Bruxelles, Lab Physiol & Physiopathol, Brussels, Belgium.	dgall@ulb.ac.be		Shlyonsky, Vadim/0000-0003-2999-6553	Fonds d'Encouragement a l'Enseignement of the Universite Libre de Bruxelles	Fonds d'Encouragement a l'Enseignement of the Universite Libre de Bruxelles	This project has received support from the Fonds d'Encouragement a l'Enseignement of the Universite Libre de Bruxelles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, NAT METHODS, V10, P591; DEMPSTER J, 2001, BIOL TECHNIQUES SERI; Deslauriers L, 2011, SCIENCE, V332, P862, DOI 10.1126/science.1201783; FINKELSTEIN A, 1981, J MEMBRANE BIOL, V59, P155, DOI 10.1007/BF01875422; Freeman S, 2014, P NATL ACAD SCI USA, V111, P8410, DOI 10.1073/pnas.1319030111; Haak DC, 2011, SCIENCE, V332, P1213, DOI 10.1126/science.1204820; HLADKY SB, 1972, BIOCHIM BIOPHYS ACTA, V274, P294, DOI 10.1016/0005-2736(72)90178-2; Kapoor R, 2008, JOVE-J VIS EXP, V20, P1033; KOLB HA, 1977, BIOCHIM BIOPHYS ACTA, V464, P127, DOI 10.1016/0005-2736(77)90376-5; Land BR, 2001, J NEUROSCI METH, V106, P47, DOI 10.1016/S0165-0270(01)00328-4; Marzullo TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030837; MUELLER P, 1967, BIOCHEM BIOPH RES CO, V26, P398, DOI 10.1016/0006-291X(67)90559-1; MUELLER P, 1962, NATURE, V194, P979, DOI 10.1038/194979a0; Pearce JM, 2012, SCIENCE, V337, P1303, DOI 10.1126/science.1228183; Prober CG, 2012, NEW ENGL J MED, V366, P1657, DOI 10.1056/NEJMp1202451; TIEN HT, 1966, NATURE, V212, P718, DOI 10.1038/212718a0; WHITE SH, 1972, BIOPHYS J, V12, P432, DOI 10.1016/S0006-3495(72)86095-8	17	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108097	10.1371/journal.pone.0108097	http://dx.doi.org/10.1371/journal.pone.0108097			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251830	Green Published, Green Submitted, gold			2022-12-25	WOS:000342492700078
J	Suetsugu, N; Takami, T; Ebisu, Y; Watanabe, H; Iiboshi, C; Doi, M; Shimazaki, K				Suetsugu, Noriyuki; Takami, Tsuneaki; Ebisu, Yuuta; Watanabe, Harutaka; Iiboshi, Chihoko; Doi, Michio; Shimazaki, Ken-ichiro			Guard Cell Chloroplasts Are Essential for Blue Light-Dependent Stomatal Opening in Arabidopsis	PLOS ONE			English	Article							MEMBRANE H+-ATPASE; VICIA-FABA L; PLASMA-MEMBRANE; RED-LIGHT; BACKGROUND ILLUMINATION; SIGNAL-TRANSDUCTION; ABSCISIC-ACID; PRIMARY STEP; CO2; PROTOPLASTS	Blue light (BL) induces stomatal opening through the activation of H+-ATPases with subsequent ion accumulation in guard cells. In most plant species, red light (RL) enhances BL-dependent stomatal opening. This RL effect is attributable to the chloroplasts of guard cell, the only cells in the epidermis possessing this organelle. To clarify the role of chloroplasts in stomatal regulation, we investigated the effects of RL on BL-dependent stomatal opening in isolated epidermis, guard cell protoplasts, and intact leaves of Arabidopsis thaliana. In isolated epidermal tissues and intact leaves, weak BL superimposed on RL enhanced stomatal opening while BL alone was less effective. In guard cell protoplasts, RL enhanced BL-dependent H+-pumping and DCMU, a photosynthetic electron transport inhibitor, eliminated this effect. RL enhanced phosphorylation levels of the H+-ATPase in response to BL, but this RL effect was not suppressed by DCMU. Furthermore, DCMU inhibited both RL-induced and BL-dependent stomatal opening in intact leaves. The photosynthetic rate in leaves correlated positively with BL-dependent stomatal opening in the presence of DCMU. We conclude that guard cell chloroplasts provide ATP and/or reducing equivalents that fuel BL-dependent stomatal opening, and that they indirectly monitor photosynthetic CO2 fixation in mesophyll chloroplasts by absorbing PAR in the epidermis.	[Suetsugu, Noriyuki; Takami, Tsuneaki; Watanabe, Harutaka; Iiboshi, Chihoko; Shimazaki, Ken-ichiro] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan; [Ebisu, Yuuta] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan; [Doi, Michio] Kyushu Univ, Fac Art & Sci, Fukuoka 812, Japan	Kyushu University; Kyushu University; Kyushu University	Shimazaki, K (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan.	kenrcb@kyushu-u.org	Suetsugu, Noriyuki/AAB-5274-2019	Suetsugu, Noriyuki/0000-0002-3328-3313	JSPS KAKENHI [21227001]; Grants-in-Aid for Scientific Research [26251032] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (No. 21227001; http://www.jsps.go.jp/j-grantsinaid/) to KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSMANN SM, 1988, PLANT PHYSIOL, V87, P226, DOI 10.1104/pp.87.1.226; ASSMANN SM, 1993, ANNU REV CELL BIOL, V9, P345, DOI 10.1146/annurev.cb.09.110193.002021; Doi M, 2004, J EXP BOT, V55, P517, DOI 10.1093/jxb/erh044; Doi M, 2008, PLANT PHYSIOL, V147, P922, DOI 10.1104/pp.108.118950; Emi T, 2001, PLANT PHYSIOL, V125, P1115, DOI 10.1104/pp.125.2.1115; Fujita T, 2013, NEW PHYTOL, V199, P395, DOI 10.1111/nph.12261; GAUTIER H, 1992, PLANT PHYSIOL, V98, P34, DOI 10.1104/pp.98.1.34; Goh CH, 2002, PLANT J, V32, P623, DOI 10.1046/j.1365-313X.2002.01451.x; GOTOW K, 1985, PLANT PHYSIOL, V79, P825, DOI 10.1104/pp.79.3.825; Inoue S, 2008, P NATL ACAD SCI USA, V105, P5626, DOI 10.1073/pnas.0709189105; Inoue S, 2011, PLANT PHYSIOL, V156, P117, DOI 10.1104/pp.111.175943; KARLSSON PE, 1986, PHYSIOL PLANTARUM, V66, P202, DOI 10.1111/j.1399-3054.1986.tb02409.x; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; Kinoshita T, 1999, EMBO J, V18, P5548, DOI 10.1093/emboj/18.20.5548; Kinoshita T, 2002, PLANT CELL PHYSIOL, V43, P1359, DOI 10.1093/pcp/pcf167; Lasceve G, 1993, PHYSIOL PLANTARUM, V120, P605; Lawson T, 2009, NEW PHYTOL, V181, P13, DOI 10.1111/j.1469-8137.2008.02685.x; LEE J, 1992, J EXP BOT, V43, P951, DOI 10.1093/jxb/43.7.951; Marten H, 2007, PLANT J, V50, P29, DOI 10.1111/j.1365-313X.2006.03026.x; Marten I, 2010, PLANT BIOLOGY, V12, P64, DOI 10.1111/j.1438-8677.2010.00384.x; MAWSON BT, 1993, PLANTA, V191, P293, DOI 10.1007/BF00195685; Mott KA, 2008, PLANT CELL ENVIRON, V31, P1299, DOI 10.1111/j.1365-3040.2008.01845.x; Mott KA, 2009, PLANT CELL ENVIRON, V32, P1479, DOI 10.1111/j.1365-3040.2009.02022.x; NELSON SD, 1975, CAN J BOT, V53, P1, DOI 10.1139/b75-001; OGAWA T, 1978, PLANTA, V142, P61, DOI 10.1007/BF00385121; OGAWA T, 1981, PLANT SCI LETT, V22, P103, DOI 10.1016/0304-4211(81)90131-0; Olsen RL, 2002, NEW PHYTOL, V153, P497, DOI 10.1046/j.0028-646X.2001.00337.x; Roelfsema MRG, 2006, PLANT CELL ENVIRON, V29, P1595, DOI 10.1111/j.1365-3040.2006.01536.x; Roelfsema MRG, 2005, NEW PHYTOL, V167, P665, DOI 10.1111/j.1469-8137.2005.01460.x; Roelfsema MRG, 2002, PLANT J, V32, P65, DOI 10.1046/j.1365-313X.2002.01403.x; Roelfsema MRG, 2001, PLANT J, V26, P1, DOI 10.1046/j.1365-313x.2001.01000.x; SCHWARTZ A, 1984, PLANTA, V161, P129, DOI 10.1007/BF00395472; SHARKEY TD, 1981, PLANT PHYSIOL, V68, P1170, DOI 10.1104/pp.68.5.1170; SHIMAZAKI K, 1989, PLANT PHYSIOL, V91, P459, DOI 10.1104/pp.91.2.459; SHIMAZAKI K, 1985, PLANT PHYSIOL, V78, P211, DOI 10.1104/pp.78.2.211; SHIMAZAKI K, 1989, PLANT PHYSIOL, V90, P1057, DOI 10.1104/pp.90.3.1057; Shimazaki K, 1987, PLANT PHYSIOL, V319, P324; Shimazaki K, 2007, ANNU REV PLANT BIOL, V58, P219, DOI 10.1146/annurev.arplant.57.032905.105434; SKAAR H, 1978, PHYSIOL PLANTARUM, V43, P390, DOI 10.1111/j.1399-3054.1978.tb01601.x; Takemiya A, 2006, P NATL ACAD SCI USA, V103, P13549, DOI 10.1073/pnas.0602503103; Takemiya A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3094; Takemiya A, 2010, PLANT PHYSIOL, V153, P1555, DOI 10.1104/pp.110.155689; TALBOTT LD, 1993, PLANT PHYSIOL, V102, P1163, DOI 10.1104/pp.102.4.1163; Tominaga M, 2001, PLANT CELL PHYSIOL, V42, P795, DOI 10.1093/pcp/pce101; Ueno K, 2005, PLANT CELL PHYSIOL, V46, P955, DOI 10.1093/pcp/pci104; Vavasseur A, 2005, NEW PHYTOL, V165, P665, DOI 10.1111/j.1469-8137.2004.01276.x; Wang Y, 2011, PLANT CELL PHYSIOL, V52, P479, DOI 10.1093/pcp/pcr005; Willmer C., 1996, STOMATA, P1; ZEIGER E, 1983, PHOTOCHEM PHOTOBIOL, V38, P627, DOI 10.1111/j.1751-1097.1983.tb03394.x; Zhang X, 2004, PLANT PHYSIOL, V136, P4150, DOI 10.1104/pp.104.046573	51	51	53	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108374	10.1371/journal.pone.0108374	http://dx.doi.org/10.1371/journal.pone.0108374			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250952	Green Submitted, Green Published, gold			2022-12-25	WOS:000342492700119
J	Tsoi, SC; Aiya, UV; Wasner, KD; Phan, ML; Pytte, CL; Vicario, DS				Tsoi, Shuk C.; Aiya, Utsav V.; Wasner, Kobi D.; Phan, Mimi L.; Pytte, Carolyn L.; Vicario, David S.			Hemispheric Asymmetry in New Neurons in Adulthood Is Associated with Vocal Learning and Auditory Memory	PLOS ONE			English	Article							FINCHES TAENOPYGIA-GUTTATA; ZEBRA FINCH; GENE-EXPRESSION; HUMAN SPEECH; PROJECTION NEURONS; PATTERN SEPARATION; BIRDSONG MEMORY; SOCIAL-CHANGE; CANARY BRAIN; SONG	Many brain regions exhibit lateral differences in structure and function, and also incorporate new neurons in adulthood, thought to function in learning and in the formation of new memories. However, the contribution of new neurons to hemispheric differences in processing is unknown. The present study combines cellular, behavioral, and physiological methods to address whether 1) new neuron incorporation differs between the brain hemispheres, and 2) the degree to which hemispheric lateralization of new neurons correlates with behavioral and physiological measures of learning and memory. The songbird provides a model system for assessing the contribution of new neurons to hemispheric specialization because songbird brain areas for vocal processing are functionally lateralized and receive a continuous influx of new neurons in adulthood. In adult male zebra finches, we quantified new neurons in the caudomedial nidopallium (NCM), a forebrain area involved in discrimination and memory for the complex vocalizations of individual conspecifics. We assessed song learning and recorded neural responses to song in NCM. We found significantly more new neurons labeled in left than in right NCM; moreover, the degree of asymmetry in new neuron numbers was correlated with the quality of song learning and strength of neuronal memory for recently heard songs. In birds with experimentally impaired song quality, the hemispheric difference in new neurons was diminished. These results suggest that new neurons may contribute to an allocation of function between the hemispheres that underlies the learning and processing of complex signals.	[Tsoi, Shuk C.; Pytte, Carolyn L.] CUNY, Grad Ctr, Dept Biol, New York, NY 10021 USA; [Aiya, Utsav V.; Phan, Mimi L.; Vicario, David S.] Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA; [Wasner, Kobi D.; Pytte, Carolyn L.] CUNY, Queens Coll, Dept Psychol, New York, NY 10021 USA	City University of New York (CUNY) System; Rutgers State University New Brunswick; City University of New York (CUNY) System; Queens College NY (CUNY)	Vicario, DS (corresponding author), Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA.	vicario@rci.rutgers.edu		Phan, Mimi/0000-0002-2548-1408	National Institute on Deafness and Other Communication Disorders [DC008854, DC008854-S1]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD068960]; Busch Biomedical Grant Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD068960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008854] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Busch Biomedical Grant Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the National Institute on Deafness and Other Communication Disorders (http://www.nidcd.nih.gov, DC008854, DC008854-S1) to D. S. V.; the Eunice Kennedy Shriver National Institute of Child Health and Human Development (https://www.nichd.nih.gov, HD068960) to C. L. P., M. L. P.; and the Busch Biomedical Grant Program (http://ored.rutgers.edu/content/busch-biomedical-grant-program-1) to M. L. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar E, 2008, J NEUROSCI, V28, P5394, DOI 10.1523/JNEUROSCI.5706-07.2008; Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; Alary M, 2013, SCHIZOPHR RES, V149, P42, DOI 10.1016/j.schres.2013.06.003; Anderson ML, 2011, EUR J NEUROSCI, V33, P175, DOI 10.1111/j.1460-9568.2010.07486.x; Avey MT, 2005, BEHAV BRAIN RES, V165, P247, DOI 10.1016/j.bbr.2005.07.002; Barker JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063692; Barnea A, 2006, BEHAV BRAIN RES, V167, P63, DOI 10.1016/j.bbr.2005.08.018; Bishop DVM, 2013, SCIENCE, V340, DOI 10.1126/science.1230531; Bolhuis JJ, 2006, NAT REV NEUROSCI, V7, P347, DOI 10.1038/nrn1904; Bolhuis JJ, 2010, NAT REV NEUROSCI, V11, P747, DOI 10.1038/nrn2931; Borta A, 2007, J NEUROCHEM, V100, P587, DOI 10.1111/j.1471-4159.2006.04241.x; Bottjer SW, 2000, J COMP NEUROL, V420, P244; Brainard MS, 2013, ANNU REV NEUROSCI, V36, P489, DOI 10.1146/annurev-neuro-060909-152826; Capper-Loup C, 2008, NEUROSCI LETT, V447, P106, DOI 10.1016/j.neulet.2008.09.071; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; Curlik DM, 2011, J COGNITIVE NEUROSCI, V23, P2159, DOI 10.1162/jocn.2010.21597; CYNX J, 1992, P NATL ACAD SCI USA, V89, P1372, DOI 10.1073/pnas.89.4.1372; Dolcos F, 2002, NEUROSCI BIOBEHAV R, V26, P819, DOI 10.1016/S0149-7634(02)00068-4; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Floody OR, 1997, HORM BEHAV, V31, P25, DOI 10.1006/hbeh.1997.1368; George I, 2005, J COMP NEUROL, V488, P48, DOI 10.1002/cne.20584; George I., 2010, 2 HALVES BRAIN, P91; Gil-Mohapel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075125; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; Goto K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015468; Gotts SJ, 2013, P NATL ACAD SCI USA, V110, pE3435, DOI 10.1073/pnas.1302581110; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Guillery RW, 1997, J COMP NEUROL, V386, P2, DOI 10.1002/(SICI)1096-9861(19970915)386:1<2::AID-CNE2>3.0.CO;2-6; Gunturkun O, 2000, CURR BIOL, V10, P1079, DOI 10.1016/S0960-9822(00)00671-0; Hauber ME, 2007, J COMP PHYSIOL A, V193, P765, DOI 10.1007/s00359-007-0231-0; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hirnstein M, 2014, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00997; Holman SD, 1998, BEHAV NEUROSCI, V112, P979, DOI 10.1037/0735-7044.112.4.979; Hopf L, 2013, J INT NEUROPSYCH SOC, V19, P1042, DOI 10.1017/S1355617713000751; Hornickel J, 2009, AUDIOL NEURO-OTOL, V14, P198, DOI 10.1159/000188533; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Khurshid N, 2010, FASEB J, V24, P3681, DOI 10.1096/fj.09-146746; KIRN JR, 1993, J NEUROSCI, V13, P1654; KIRN JR, 1991, J NEUROSCI, V11, P1756; Kishimoto N, 2013, NAT NEUROSCI, V16, P884, DOI 10.1038/nn.3409; Klur S, 2009, HIPPOCAMPUS, V19, P800, DOI 10.1002/hipo.20562; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Langers DRM, 2005, NEUROIMAGE, V28, P490, DOI 10.1016/j.neuroimage.2005.06.024; Li XC, 2000, P NATL ACAD SCI USA, V97, P8584, DOI 10.1073/pnas.140222497; Lipkind D, 2002, BEHAV BRAIN RES, V133, P31, DOI 10.1016/S0166-4328(01)00416-8; Lister JP, 2006, HIPPOCAMPUS, V16, P946, DOI 10.1002/hipo.20221; Manns M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1699; Manns M, 2009, EXP BRAIN RES, V199, P323, DOI 10.1007/s00221-009-1702-z; Minagawa-Kawai Y, 2011, DEV COGN NEUROS-NETH, V1, P217, DOI 10.1016/j.dcn.2011.03.005; Moorman S, 2012, P NATL ACAD SCI USA, V109, P12782, DOI 10.1073/pnas.1207207109; Moreno M, 2014, NEUROBIOL AGING, V35, P680, DOI 10.1016/j.neurobiolaging.2013.08.034; Nikkhah G, 2001, J NEUROSCI, V21, P6252, DOI 10.1523/JNEUROSCI.21-16-06252.2001; Nordeen EJ, 2009, EUR J NEUROSCI, V30, P662, DOI 10.1111/j.1460-9568.2009.06849.x; NOTTEBOHM F, 1971, J EXP ZOOL, V177, P229, DOI 10.1002/jez.1401770210; O'Keeffe GC, 2009, CELL CYCLE, V8, P2888, DOI 10.4161/cc.8.18.9512; Petkov Christopher I, 2012, Front Evol Neurosci, V4, P12, DOI 10.3389/fnevo.2012.00012; Phan ML, 2010, P NATL ACAD SCI USA, V107, P2301, DOI 10.1073/pnas.0900091107; Phan ML, 2006, P NATL ACAD SCI USA, V103, P1088, DOI 10.1073/pnas.0510136103; Poirier C, 2009, J NEUROSCI, V29, P2252, DOI 10.1523/JNEUROSCI.4650-08.2009; Pytte CL, 2007, DEV NEUROBIOL, V67, P1699, DOI 10.1002/dneu.20520; Pytte CL, 2010, BEHAV BRAIN RES, V211, P141, DOI 10.1016/j.bbr.2010.03.029; Remage-Healey L, 2012, J NEUROPHYSIOL, V107, P1621, DOI 10.1152/jn.00749.2011; Remage-Healey L, 2010, P NATL ACAD SCI USA, V107, P3852, DOI 10.1073/pnas.0906572107; Riederer P, 2012, J NEURAL TRANSM, V119, P953, DOI 10.1007/s00702-012-0775-1; Riters LV, 2012, FRONT NEUROENDOCRIN, V33, P194, DOI 10.1016/j.yfrne.2012.04.002; Riters LV, 2011, NEUROSCI BIOBEHAV R, V35, P1837, DOI 10.1016/j.neubiorev.2010.12.017; Rogers LJ, 2014, GENESIS; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; Saper CB, 1996, J COMP NEUROL, V364, P5; Scharff C, 2000, NEURON, V25, P481, DOI 10.1016/S0896-6273(00)80910-1; Simonyan K, 2013, NEUROIMAGE, V70, P21, DOI 10.1016/j.neuroimage.2012.12.042; Simonyan K, 2012, BRAIN LANG, V122, P142, DOI 10.1016/j.bandl.2011.12.009; Sockman KW, 2008, DEV NEUROBIOL, V68, P656, DOI 10.1002/dneu.20611; Stefanits H, 2012, ACTA NEUROPATHOL, V123, P449, DOI 10.1007/s00401-011-0936-6; Suthers RA, 1997, J NEUROBIOL, V33, P632, DOI 10.1002/(SICI)1097-4695(19971105)33:5<632::AID-NEU10>3.0.CO;2-B; Suthers RA, 2002, P NATL ACAD SCI USA, V99, P5680, DOI 10.1073/pnas.042103199; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Terpstra NJ, 2004, J NEUROSCI, V24, P4971, DOI 10.1523/JNEUROSCI.0570-04.2004; Vallortigara G, 1999, BRAIN RES REV, V30, P164, DOI 10.1016/S0165-0173(99)00012-0; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; VICARIO DS, 1991, J NEUROBIOL, V22, P63, DOI 10.1002/neu.480220107; Voss HU, 2007, P NATL ACAD SCI USA, V104, P10667, DOI 10.1073/pnas.0611515104; Walton C, 2012, J NEUROSCI, V32, P761, DOI 10.1523/JNEUROSCI.3434-11.2012; Wang NG, 2002, J NEUROSCI, V22, P10864; Wang YA, 2010, P NATL ACAD SCI USA, V107, P12676, DOI 10.1073/pnas.1006645107; Wilbrecht L, 2002, J COMP PHYSIOL A, V188, P909, DOI 10.1007/s00359-002-0355-1; Wilbrecht L, 2002, J NEUROSCI, V22, P825, DOI 10.1523/JNEUROSCI.22-03-00825.2002; Wilbrecht L, 2006, J NEUROSCI, V26, P9135, DOI 10.1523/JNEUROSCI.4869-05.2006; WILLIAMS H, 1992, J NEUROBIOL, V23, P1006, DOI 10.1002/neu.480230807; Zheng H, 2013, NEUROPSYCHOPHARMACOL, V38, P770, DOI 10.1038/npp.2012.242	90	15	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108929	10.1371/journal.pone.0108929	http://dx.doi.org/10.1371/journal.pone.0108929			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251077	Green Published, gold			2022-12-25	WOS:000342492700158
J	Payne, LJ; Eves, RL; Jia, L; Mak, AS				Payne, Laura J.; Eves, Robert L.; Jia, Lilly; Mak, Alan S.			p53 Down Regulates PDGF-Induced Formation of Circular Dorsal Ruffles in Rat Aortic Smooth Muscle Cells	PLOS ONE			English	Article							PROTEIN-PHOSPHATASE-ACTIVITIES; PODOSOME FORMATION; GROWTH-FACTOR; RHO-GTPASES; C-CBL; INVASION; MIGRATION; RECEPTOR; PATHWAY; PTEN	The tumor suppressor, p53, negatively regulates cell migration and invasion in addition to its role in apoptosis, cell cycle regulation and senescence. Here, we study the roles of p53 in PDGF-induced circular dorsal ruffle (CDR) formation in rat aortic smooth muscle (RASM) cells. In primary and immortalized RASM cells, up-regulation of p53 expression or increase in activity with doxorubicin inhibits CDR formation. In contrast, shRNA-knockdown of p53 or inhibition of its activity with pifithrin a promotes CDR formation. p53 acts by up-regulating PTEN expression, which antagonizes Rac and Cdc42 activation. Both lipid and protein phosphatase activities of PTEN are required for maximal suppression of CDR, but the lipid activity clearly plays the dominant role. N-WASP, the downstream effector of Cdc42, is the major positive contributor to CDR formation in RASM, and is an indirect target of p53. The Rac effector, WAVE2, appears to also play a minor role, while WAVE1 has no significant effect in CDR formation. In sum, we propose that p53 suppresses PDGF-induced CDR formation in RASM cells by upregulating PTEN leading mainly to the inhibition of the Cdc42-N-WASP pathway.	[Payne, Laura J.; Eves, Robert L.; Jia, Lilly; Mak, Alan S.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	Queens University - Canada	Mak, AS (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	maka@queensu.ca			Ontario Heart and Stroke Foundation [HSFO T7264]; Canadian Institute of Health Research CIHR [MOP-79468]	Ontario Heart and Stroke Foundation(Heart & Stroke Foundation of Ontario); Canadian Institute of Health Research CIHR(Canadian Institutes of Health Research (CIHR))	Ontario Heart and Stroke Foundation HSFO T7264 (http://www.heartandstroke.on.ca/site/c.pvI3IeNWJwE/b.3581583/k.F7E3/Heart_Disease_Stroke_and_Healthy_Living.htm); Canadian Institute of Health Research CIHR MOP-79468 (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashur-Fabian C, 2004, P NATL ACAD SCI USA, V101, P12236, DOI 10.1073/pnas.0404998101; Beaty BT, 2013, MOL BIOL CELL, V24, P1661, DOI 10.1091/mbc.E12-12-0908; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BOCHATONPIALLAT ML, 1992, DIFFERENTIATION, V49, P175, DOI 10.1111/j.1432-0436.1992.tb00665.x; Bravo-Cordero JJ, 2012, CURR OPIN CELL BIOL, V24, P277, DOI 10.1016/j.ceb.2011.12.004; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Davidson L, 2010, ONCOGENE, V29, P687, DOI 10.1038/onc.2009.384; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; Destaing O, 2010, MOL BIOL CELL, V21, P4108, DOI 10.1091/mbc.E10-07-0580; Eden S, 2002, MECH REGULATION WAVE; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Eves R, 2006, J CELL SCI, V119, P1691, DOI 10.1242/jcs.02881; Furnari FB, 1998, CANCER RES, V58, P5002; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; GROTENDORST GR, 1982, J CELL PHYSIOL, V113, P261, DOI 10.1002/jcp.1041130213; Gu ZZ, 2011, J CELL BIOL, V193, P61, DOI 10.1083/jcb.201007003; Guo FK, 2004, ONCOGENE, V23, P5577, DOI 10.1038/sj.onc.1207752; Guo FK, 2003, J BIOL CHEM, V278, P14414, DOI 10.1074/jbc.M300341200; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hoon JL, 2012, MOL CELL BIOL, V32, P4246, DOI 10.1128/MCB.00551-12; Itoh T, 2013, J BIOCHEM, V153, P21, DOI 10.1093/jb/mvs138; Janouskova H, 2013, CANCER LETT, V336, P307, DOI 10.1016/j.canlet.2013.03.018; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Ladwein M, 2008, FEBS LETT, V582, P2066, DOI 10.1016/j.febslet.2008.04.033; Legg JA, 2007, MOL BIOL CELL, V18, P678, DOI 10.1091/mbc.E06-06-0569; Leslie NR, 2007, CURR BIOL, V17, P115, DOI 10.1016/j.cub.2006.12.026; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Louis SF, 2010, EXP CLIN CARDIOL, V15, pE75; Mak AS, 2011, CELL ADHES MIGR, V5, P144, DOI 10.4161/cam.5.2.14375; Mak AS, 2014, CELL ADHES MIGR, V8, P8, DOI DOI 10.4161/CAM.27841; Mukhopadhyay UK, 2010, MOL CELL BIOL, V30, P4980, DOI 10.1128/MCB.00004-10; Mukhopadhyay UK, 2009, CELL CYCLE, V8, P2481, DOI 10.4161/cc.8.16.9269; Mukhopadhyay UK, 2009, MOL CELL BIOL, V29, P3088, DOI 10.1128/MCB.01816-08; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Orth JD, 2006, CANCER RES, V66, P11094, DOI 10.1158/0008-5472.CAN-06-3397; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; Peleg B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018635; Poon JS, 2010, CELL CYCLE, V9, P4450, DOI 10.4161/cc.9.22.13936; Quintavalle M, 2010, J CELL BIOL, V189, P13, DOI 10.1083/jcb.200912096; Sanematsu F, 2013, J BIOL CHEM, V288, P8092, DOI 10.1074/jbc.M112.410423; Shen B, 2013, NATURE, V503, P131, DOI 10.1038/nature12613; Spiering D, 2011, CELL ADHES MIGR, V5, P170, DOI 10.4161/cam.5.2.14403; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Szczepanowska J, 2009, ACTA BIOCHIM POL, V56, P225; Ucuzian AA, 2010, J BIOMED MATER RES A, V94A, P988, DOI 10.1002/jbm.a.32786; Webb BA, 2005, AM J PHYSIOL-CELL PH, V289, pC898, DOI 10.1152/ajpcell.00095.2005; Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066; Yang WW, 2008, INT J CANCER, V123, P2020, DOI 10.1002/ijc.23735; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; Zhao Zhuo-Shen, 2012, Cell Logist, V2, P59	51	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108257	10.1371/journal.pone.0108257	http://dx.doi.org/10.1371/journal.pone.0108257			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247424	Green Published, gold, Green Submitted			2022-12-25	WOS:000342351800076
J	Curran, KL; Porter, LABB; Lope, JDC; Willadsen, G; Fisher, R; Johnson, N; Campbell, E; VonBergen, B; Winfrey, D; Hadley, M; Kerndt, T				Curran, Kristen L.; Porter, Latoya Allen Brittany Bronson; Lope, Joseph Dodge Chelsea; Willadsen, Gail; Fisher, Rachel; Johnson, Nicole; Campbell, Elizabeth; VonBergen, Brett; Winfrey, Devon; Hadley, Morgan; Kerndt, Thomas			Circadian Genes, xBmal1 and xNocturnin, Modulate the Timing and Differentiation of Somites in Xenopus laevis	PLOS ONE			English	Article							WIDE EXPRESSION ANALYSIS; NONCANONICAL E-BOX; VERTEBRATE SEGMENTATION; SUPRACHIASMATIC NUCLEUS; REGULATED GENE; CLOCK; MOUSE; PROTEIN; NOCTURNIN; NOTCH	We have been investigating whether xBmal1 and xNocturnin play a role in somitogenesis, a cyclic developmental process with an ultradian period. Previous work from our lab shows that circadian genes (xPeriod1, xPeriod2, xBmal1, and xNocturnin) are expressed in developing somites. Somites eventually form the vertebrae, muscles of the back, and dermis. In Xenopus, a pair of somites is formed about every 50 minutes from anterior to posterior. We were intrigued by the co-localization of circadian genes in an embryonic tissue known to be regulated by an ultradian clock. Cyclic expression of genes involved in Notch signaling has been implicated in the somite clock. Disruption of Notch signaling in humans has been linked to skeletal defects in the vertebral column. We found that both depletion (morpholino) and overexpression (mRNA) of xBMAL1 protein (bHLH transcription factor) or xNOCTURNIN protein (deadenylase) on one side of the developing embryo led to a significant decrease in somite number with respect to the untreated side (p<0.001). These manipulations also significantly affect expression of a somite clock component (xESR9; p<0.05). We observed opposing effects on somite size. Depletion of xBMAL1 or xNOCTURNIN caused a statistically significant decrease in somite area (quantified using NIH ImageJ; p<0.002), while overexpression of these proteins caused a significant dose dependent increase in somite area (p<0.02; p<0.001, respectively). We speculate that circadian genes may play two separate roles during somitogenesis. Depletion and overexpression of xBMAL1 and NOCTURNIN both decrease somite number and influence expression of a somite clock component, suggesting that these proteins may modulate the timing of the somite clock in the undifferentiated presomitic mesoderm. The dosage dependent effects on somite area suggest that xBMAL1 and xNOCTURNIN may also act during somite differentiation to promote myogenesis.	[Curran, Kristen L.; Porter, Latoya Allen Brittany Bronson; Lope, Joseph Dodge Chelsea; Willadsen, Gail; Fisher, Rachel; Johnson, Nicole; Campbell, Elizabeth; VonBergen, Brett; Winfrey, Devon; Hadley, Morgan; Kerndt, Thomas] Univ Wisconsin, Dept Biol Sci, Whitewater, WI 53190 USA	University of Wisconsin System	Curran, KL (corresponding author), Univ Wisconsin, Dept Biol Sci, Whitewater, WI 53190 USA.	currank@uww.edu		Zwifelhofer, Nicole/0000-0001-9577-3994; Allen, Latoya/0000-0003-1486-8487	National Science Foundation [RUI 0948502]; University of Wisconsin; University of Wisconsin Whitewater: Office for Undergraduate Research; Beta Beta Beta National Biological Honors Society; WISCAMP: Wisconsin Louis Stokes Alliance for Minority Participation; Direct For Biological Sciences [0948502] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Wisconsin; University of Wisconsin Whitewater: Office for Undergraduate Research; Beta Beta Beta National Biological Honors Society; WISCAMP: Wisconsin Louis Stokes Alliance for Minority Participation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by National Science Foundation (NSF.gov), RUI 0948502, to KC; University of Wisconsin Whitewater: Research and Sponsored Programs (http://uwworsp.org/), Faculty Development Grant to KC and GEARUP Grant to KC; University of Wisconsin Whitewater: Office for Undergraduate Research, Undergraduate Research Grants (http://www.uww.edu/urp/), to BBP, JD, CL, MH, GW, EC, and NJ; Beta Beta Beta National Biological Honors Society (http://www.tri-beta.org/), to BBP, MH, NJ, MH, and EC; McNair Scholars (http://mcnairscholars.com/ and http://www.uww.edu/acadsupport/mcnair) to LA; and WISCAMP: Wisconsin Louis Stokes Alliance for Minority Participation (http://wiscamp.engr.wisc.edu/index.php) to LA and DW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JL, 2010, P NATL ACAD SCI USA, V107, P19090, DOI 10.1073/pnas.1014523107; Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; Baggs JE, 2003, CURR BIOL, V13, P189, DOI 10.1016/S0960-9822(03)00014-9; Baggs Julie E, 2006, Methods Mol Biol, V317, P243; Bajard L, 2014, DEVELOPMENT, V141, P1381, DOI 10.1242/dev.093435; Barrantes ID, 1999, CURR BIOL, V9, P470, DOI 10.1016/S0960-9822(99)80212-7; Bessho Y, 2003, GENE DEV, V17, P1451, DOI 10.1101/gad.1092303; Bessho Y, 2001, GENES CELLS, V6, P175, DOI 10.1046/j.1365-2443.2001.00409.x; BRIVANLOU AH, 1989, DEVELOPMENT, V106, P611; Buhr Ethan D, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-25950-0_1; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chatterjee S, 2013, J CELL SCI, V126, P2213, DOI 10.1242/jcs.120519; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; CONLON RA, 1995, DEVELOPMENT, V121, P1533; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Curran KL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002749; Davis RL, 2001, DEV CELL, V1, P553, DOI 10.1016/S1534-5807(01)00054-5; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; Delaunay F, 2003, GENE EXPR PATTERNS, V3, P319, DOI 10.1016/S1567-133X(03)00050-4; Dequeant ML, 2006, SCIENCE, V314, P1595, DOI 10.1126/science.1133141; Dias AS, 2014, SCIENCE, V343, P791, DOI 10.1126/science.1247575; Dolatshad H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009855; DONIACH T, 1995, MECH DEVELOP, V53, P403, DOI 10.1016/0925-4773(95)00457-2; Douris N, 2008, ANN MED, V40, P622, DOI 10.1080/07853890802084878; Duffield GE, 2009, CURR BIOL, V19, P297, DOI 10.1016/j.cub.2008.12.052; Dunty WC, 2008, DEVELOPMENT, V135, P85, DOI 10.1242/dev.009266; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Ferjentsik Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000662; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fujimoto K, 2007, INT J MOL MED, V19, P925; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gilbert MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017051; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Gomez C, 2008, NATURE, V454, P335, DOI 10.1038/nature07020; Green C B, 1997, Methods Mol Biol, V85, P219; Green CB, 2007, P NATL ACAD SCI USA, V104, P9888, DOI 10.1073/pnas.0702448104; Green CB, 1999, DEV BRAIN RES, V117, P109, DOI 10.1016/S0165-3806(99)00109-1; Green CB, 1996, P NATL ACAD SCI USA, V93, P14884, DOI 10.1073/pnas.93.25.14884; Green CB, 2001, MECH DEVELOP, V101, P105, DOI 10.1016/S0925-4773(00)00559-1; Guo HG, 2006, J NEUROSCI, V26, P6406, DOI 10.1523/JNEUROSCI.4676-05.2006; HAMILTON L, 1969, J EMBRYOL EXP MORPH, V22, P253; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Herrgen L, 2010, CURR BIOL, V20, P1244, DOI 10.1016/j.cub.2010.06.034; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Inada Y, 2014, FEBS LETT, V588, P459, DOI 10.1016/j.febslet.2013.12.007; JEN Y, 1992, GENE DEV, V6, P1466, DOI 10.1101/gad.6.8.1466; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Kawai M, 2010, P NATL ACAD SCI USA, V107, P10508, DOI 10.1073/pnas.1000788107; KINTNER CR, 1985, J EMBRYOL EXP MORPH, V89, P37; Kovacikova Z, 2006, J BIOL RHYTHM, V21, P140, DOI 10.1177/0748730405285876; Krol AJ, 2011, DEVELOPMENT, V138, P2783, DOI 10.1242/dev.063834; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee B, 2010, J BIOL RHYTHM, V25, P410, DOI 10.1177/0748730410381229; Lefta M, 2011, CURR TOP DEV BIOL, V96, P231, DOI 10.1016/B978-0-12-385940-2.00009-7; Li XD, 2005, DEV BRAIN RES, V158, P31, DOI 10.1016/j.devbrainres.2005.05.005; Li Y, 2003, DIFFERENTIATION, V71, P83, DOI 10.1046/j.1432-0436.2003.700608.x; Liu XR, 2002, MOL CELL BIOL, V22, P7501, DOI 10.1128/MCB.22.21.7501-7511.2002; Lopez TP, 2013, P NATL ACAD SCI USA, V110, pE2019, DOI 10.1073/pnas.1222115110; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Mara A, 2007, NAT CELL BIOL, V9, P523, DOI 10.1038/ncb1578; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; Morimoto M, 2005, NATURE, V435, P354, DOI 10.1038/nature03591; Nishikawa S, 2013, J REPROD DEVELOP, V59, P258, DOI 10.1262/jrd.2013-001; Oates AC, 2012, DEVELOPMENT, V139, P625, DOI 10.1242/dev.063735; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Oishi K, 2005, DNA RES, V12, P191, DOI 10.1093/dnares/dsi003; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pando MP, 2002, BIOESSAYS, V24, P419, DOI 10.1002/bies.10091; PENG HB, 1991, METHOD CELL BIOL, V36, P657; Pourquie O, 2004, MECH DEVELOP, V121, P1069, DOI 10.1016/j.mod.2004.05.002; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schroter C, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001364; Sladek M, 2004, P NATL ACAD SCI USA, V101, P6231, DOI 10.1073/pnas.0401149101; Sladek M, 2007, AM J PHYSIOL-REG I, V292, pR1224, DOI 10.1152/ajpregu.00184.2006; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Tiedemann HB, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002586; Uriu K, 2010, P NATL ACAD SCI USA, V107, P4979, DOI 10.1073/pnas.0907122107; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Ward SM, 2010, J BIOL CHEM, V285, P38987, DOI 10.1074/jbc.M110.175182; Yagita K, 2010, P NATL ACAD SCI USA, V107, P3846, DOI 10.1073/pnas.0913256107; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhang XP, 2012, NUCLEIC ACIDS RES, V40, P3419, DOI 10.1093/nar/gkr1297	84	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e108266	10.1371/journal.pone.0108266	http://dx.doi.org/10.1371/journal.pone.0108266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238599	Green Submitted, Green Published, gold			2022-12-25	WOS:000342491600090
J	Mehta, AJ; Kloog, I; Zanobetti, A; Coull, BA; Sparrow, D; Vokonas, P; Schwartz, J				Mehta, Amar J.; Kloog, Itai; Zanobetti, Antonella; Coull, Brent A.; Sparrow, David; Vokonas, Pantel; Schwartz, Joel			Associations between Changes in City and Address Specific Temperature and QT Interval - The VA Normative Aging Study	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; AUTONOMIC NERVOUS-SYSTEM; AMBIENT-TEMPERATURE; AIR-POLLUTION; CARDIOVASCULAR MORTALITY; US CITIES; EXPOSURE; ABNORMALITIES; INFLAMMATION; POPULATION	Background: The underlying mechanisms of the association between ambient temperature and cardiovascular morbidity and mortality are not well understood, particularly for daily temperature variability. We evaluated if daily mean temperature and standard deviation of temperature was associated with heart rate-corrected QT interval ( QTc) duration, a marker of ventricular repolarization in a prospective cohort of older men. Methods: This longitudinal analysis included 487 older men participating in the VA Normative Aging Study with up to three visits between 2000-2008 (n = 743). We analyzed associations between QTc and moving averages (1-7, 14, 21, and 28 days) of the 24-hour mean and standard deviation of temperature as measured from a local weather monitor, and the 24-hour mean temperature estimated from a spatiotemporal prediction model, in time-varying linear mixed-effect regression. Effect modification by season, diabetes, coronary heart disease, obesity, and age was also evaluated. Results: Higher mean temperature as measured from the local monitor, and estimated from the prediction model, was associated with longer QTc at moving averages of 21 and 28 days. Increased 24-hr standard deviation of temperature was associated with longer QTc at moving averages from 4 and up to 28 days; a 1.9 degrees C interquartile range increase in 4-day moving average standard deviation of temperature was associated with a 2.8 msec (95% CI: 0.4, 5.2) longer QTc. Associations between 24-hr standard deviation of temperature and QTc were stronger in colder months, and in participants with diabetes and coronary heart disease. Conclusion/Significance: In this sample of older men, elevated mean temperature was associated with longer QTc, and increased variability of temperature was associated with longer QTc, particularly during colder months and among individuals with diabetes and coronary heart disease. These findings may offer insight of an important underlying mechanism of temperature-related cardiovascular morbidity and mortality in an older population.	[Mehta, Amar J.; Kloog, Itai; Zanobetti, Antonella; Schwartz, Joel] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Exposure Epidemiol & Risk Program, Boston, MA 02115 USA; [Kloog, Itai] Ben Gurion Univ Negev, Dept Geog & Environm Dev, IL-84105 Beer Sheva, Israel; [Coull, Brent A.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Sparrow, David; Vokonas, Pantel] Vet Affairs Boston Healthcare Syst, VA Normat Aging Study, Boston, MA USA; [Sparrow, David; Schwartz, Joel] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Sparrow, David; Vokonas, Pantel] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Harvard University; Harvard T.H. Chan School of Public Health; Ben Gurion University; Harvard University; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Boston University	Mehta, AJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Exposure Epidemiol & Risk Program, Boston, MA 02115 USA.	amehta@hsph.harvard.edu			National Institute of Environmental Health Sciences [ES014663-01A2, 2RO1-ES015172, ES014663, ES00002]; National Institute of Environmental Health Sciences (EPA Clean Air Research Center) [RD83479701*]; Cooperative Studies Program/Epidemiology Research and Information Center of the US Department of Veterans Affairs; Massachusetts Veterans Epidemiology Research and Information Center, Boston, Massachusetts; VA Research Career Scientist award; National Institutes of Health [R01-AG002287, R01-AG018436, R29-AG007465]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002, R01ES014663, R01ES015172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R29AG007465, R01AG002287, R01AG018436] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Environmental Health Sciences (EPA Clean Air Research Center); Cooperative Studies Program/Epidemiology Research and Information Center of the US Department of Veterans Affairs(US Department of Veterans Affairs); Massachusetts Veterans Epidemiology Research and Information Center, Boston, Massachusetts; VA Research Career Scientist award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institute of Environmental Health Sciences (ES014663-01A2, 2RO1-ES015172, ES014663, ES00002, and EPA Clean Air Research Center grant RD83479701*). The Veterans Affairs (VA) Normative Aging Study is supported by the Cooperative Studies Program/Epidemiology Research and Information Center of the US Department of Veterans Affairs and is a component of the Massachusetts Veterans Epidemiology Research and Information Center, Boston, Massachusetts. Support was also provided by a VA Research Career Scientist award (to AS) and by National Institutes of Health grants R01-AG002287, R01-AG018436, and R29-AG007465. This research was also supported by a VA Research Career Scientist award to David Sparrow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.* This publication's contents are solely the responsibility of the grantee and do not necessarily represent the official views of the US EPA. Further, US EPA does not endorse the purchase of any commercial products or services mentioned in the publication.	Arizona Center for Education and Research on Therapeutics, 2010, TORS LIST DRUGS RISK; Baja ES, 2010, ENVIRON HEALTH PERSP, V118, P840, DOI 10.1289/ehp.0901396; Balding DJ, 2004, APPL LONGITUDINAL AN; Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40; Bednar MM, 2001, PROG CARDIOVASC DIS, V43, P1, DOI 10.1053/pcad.2001.21469; BELL B, 1972, AGING HUM DEVELOP, V3, P5, DOI 10.2190/GGVP-XLB5-PC3N-EF0G; BELLAVERE F, 1988, BRIT HEART J, V59, P379; BEXTON RS, 1986, BRIT HEART J, V55, P253; Braga ALF, 2001, EPIDEMIOLOGY, V12, P662; Braga ALF, 2002, ENVIRON HEALTH PERSP, V110, P859, DOI 10.1289/ehp.02110859; Bruce-Low SS, 2006, AVIAT SPACE ENVIR MD, V77, P915; Choy AMJ, 1998, AM HEART J, V136, P664, DOI 10.1016/S0002-8703(98)70014-6; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; DEKKER JM, 1994, CIRCULATION, V90, P779, DOI 10.1161/01.CIR.90.2.779; Goodman PG, 2004, ENVIRON HEALTH PERSP, V112, P179, DOI 10.1289/ehp.6451; Greenland P, 2003, AM J CARDIOL, V91, P1068, DOI 10.1016/S0002-9149(03)00150-4; Guo YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016511; Halonen JI, 2011, OCCUP ENVIRON MED, V68, P296, DOI 10.1136/oem.2010.056507; Halonen JI, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-42; Hampel R, 2010, ENVIRON HEALTH PERSP, V118, P1755, DOI 10.1289/ehp.1001995; Hernan MA, 2006, BASIC CLIN PHARMACOL, V98, P237, DOI 10.1111/j.1742-7843.2006.pto_329.x; Hoffmann B, 2012, ENVIRON HEALTH PERSP, V120, P241, DOI 10.1289/ehp.1103647; Kloog I, 2012, SCI TOTAL ENVIRON, V432, P85, DOI 10.1016/j.scitotenv.2012.05.095; Lin HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066403; Maule S, 2008, HYPERTENS RES, V31, P2003, DOI 10.1291/hypres.31.2003; O'Neill MS, 2003, AM J EPIDEMIOL, V157, P1074, DOI 10.1093/aje/kwg096; Okamoto-Mizuno K, 2009, EUR J APPL PHYSIOL, V105, P191, DOI 10.1007/s00421-008-0889-1; Park SK, 2005, ENVIRON HEALTH PERSP, V113, P304, DOI 10.1289/ehp.7447; Plavcova E, 2010, INT J BIOMETEOROL, V54, P539, DOI 10.1007/s00484-010-0303-7; Pope CA, 2001, ENVIRON HEALTH PERSP, V109, P711, DOI 10.2307/3454788; Ren CZ, 2011, AM J EPIDEMIOL, V173, P1013, DOI 10.1093/aje/kwq477; Roden DM, 2008, HEART RHYTHM, V5, P1213, DOI 10.1016/j.hrthm.2008.05.008; Schauble CL, 2012, OCCUP ENVIRON MED, V69, P670, DOI 10.1136/oemed-2011-100469; SCHOUTEN EG, 1991, CIRCULATION, V84, P1516, DOI 10.1161/01.CIR.84.4.1516; Schwartz J, 2005, EPIDEMIOLOGY, V16, P67, DOI 10.1097/01.ede.0000147114.25957.71; Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203; Wilker EH, 2012, ENVIRON HEALTH PERSP, V120, P1083, DOI 10.1289/ehp.1104380; Wu SW, 2013, ENVIRON RES, V120, P82, DOI 10.1016/j.envres.2012.08.008; Xu ZW, 2014, EPIDEMIOLOGY, V25, P313, DOI 10.1097/EDE.0000000000000066; Yamamoto S, 2007, J OCCUP HEALTH, V49, P199, DOI 10.1539/joh.49.199; Yu WW, 2012, INT J BIOMETEOROL, V56, P569, DOI 10.1007/s00484-011-0497-3; Zanobetti A, 2014, OCCUP ENVIRON MED, V71, P201, DOI 10.1136/oemed-2013-101526; Zanobetti A, 2012, P NATL ACAD SCI USA, V109, P6608, DOI 10.1073/pnas.1113070109; Zeger SL, 2000, ENVIRON HEALTH PERSP, V108, P419, DOI 10.2307/3454382	45	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e106258	10.1371/journal.pone.0106258	http://dx.doi.org/10.1371/journal.pone.0106258			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238150	gold, Green Published, Green Submitted			2022-12-25	WOS:000342491600006
J	Vincent, EE; Coelho, PP; Blagih, J; Griss, T; Viollet, B; Jones, RG				Vincent, E. E.; Coelho, P. P.; Blagih, J.; Griss, T.; Viollet, B.; Jones, R. G.			Differential effects of AMPK agonists on cell growth and metabolism	ONCOGENE			English	Article							ACTIVATED PROTEIN-KINASE; LKB1-AMPK PATHWAY; CANCER-CELLS; MITOCHONDRIAL DYSFUNCTION; LUNG-CANCER; METFORMIN; LKB1; PHOSPHORYLATION; SURVIVAL; INHIBITION	As a sensor of cellular energy status, the AMP-activated protein kinase (AMPK) is believed to act in opposition to the metabolic phenotypes favored by proliferating tumor cells. Consequently, compounds known to activate AMPK have been proposed as cancer therapeutics. However, the extent to which the anti-neoplastic properties of these agonists are mediated by AMPK is unclear. Here we examined the AMPK dependence of six commonly used AMPK agonists (metformin, phenformin, 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), 2-deoxy-D-glucose (2DG), salicylate and A-769662) and their influence on cellular processes often deregulated in tumor cells. We demonstrate that the majority of these agonists display AMPK-independent effects on cell proliferation and metabolism with only the synthetic activator, A-769662, exerting AMPK-dependent effects on these processes. We find that A-769662 promotes an AMPK-dependent increase in mitochondrial spare respiratory capacity. Finally, contrary to the view of AMPK activity being tumor suppressive, we find that A-769662 confers a selective proliferative advantage to tumor cells growing under nutrient deprivation. Our results indicate that many of the antigrowth properties of these agonists cannot be attributed to AMPK activity in cells, and thus any observed effects using these agonists should be confirmed using AMPK-deficient cells. Ultimately, our data urge caution not only regarding the type of AMPK agonist proposed for cancer treatment but also the context in which they are used.	[Vincent, E. E.; Coelho, P. P.; Blagih, J.; Griss, T.; Jones, R. G.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada; [Vincent, E. E.; Coelho, P. P.; Blagih, J.; Griss, T.; Jones, R. G.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Viollet, B.] INSERM, Inst Cochin, U1016, Paris, France; [Viollet, B.] CNRS, UMR 8104, Paris, France; [Viollet, B.] Univ Paris 05, Sorbonne Paris Cite, Paris, France	McGill University; McGill University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Jones, RG (corresponding author), McGill Univ, Dept Physiol, Goodman Canc Res Ctr, 3655 Promenade Sir William Osler,Room 705, Montreal, PQ H3G 1Y6, Canada.	russell.jones@mcgill.ca	Jones, Russell/AAC-2861-2022; Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017; Jones, Russell Graham/ABD-5261-2021	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Jones, Russell Graham/0000-0003-2250-4675; Vincent, Emma/0000-0002-8917-7384	McGill Integrated Cancer Research Training Program (MICRTP); Fonds de researche Sante Quebec; Canadian Institute Health Research (CIHR) [MOP-93799]; Canadian Cancer Society [2010-700586]; Terry Fox Research Foundation [TEF-116128]	McGill Integrated Cancer Research Training Program (MICRTP); Fonds de researche Sante Quebec; Canadian Institute Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Terry Fox Research Foundation	We acknowledge Douglas Elder and Nicole Beauchemin, and members of the Jones Laboratory for critical reading of this manuscript. EEV, PPC and TG were funded by the McGill Integrated Cancer Research Training Program (MICRTP) and JB was funded by Fonds de researche Sante Quebec. This work was supported by grants to RGJ from the Canadian Institute Health Research (CIHR) (MOP-93799), Canadian Cancer Society (2010-700586) and Terry Fox Research Foundation (TEF-116128). This work is dedicated to the memory of Rosalind Goodman.	Appleyard MVCL, 2012, BRIT J CANCER, V106, P1117, DOI 10.1038/bjc.2012.56; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; BRODY TM, 1956, J PHARMACOL EXP THER, V117, P39; Bungard D, 2010, SCIENCE, V329, P1201, DOI 10.1126/science.1191241; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chhipa RR, 2010, CELL SIGNAL, V22, P1554, DOI 10.1016/j.cellsig.2010.05.024; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; CRISSMAN HA, 1973, J CELL BIOL, V59, P766, DOI 10.1083/jcb.59.3.766; DAVIES SP, 1990, EUR J BIOCHEM, V187, P183, DOI 10.1111/j.1432-1033.1990.tb15293.x; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; Dupuy F, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-18; Dykens JA, 2008, TOXICOL APPL PHARM, V233, P203, DOI 10.1016/j.taap.2008.08.013; El-Masry OS, 2012, ONCOL LETT, V3, P224, DOI 10.3892/ol.2011.458; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Elder DJE, 1996, CANCER RES, V56, P2273; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Faubert B., 2014, CANC LETT; Faubert B, 2014, P NATL ACAD SCI USA, V111, P2554, DOI 10.1073/pnas.1312570111; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Garber K, 2006, SCIENCE, V312, P1158, DOI 10.1126/science.312.5777.1158; GIARDIELLO FM, 1987, NEW ENGL J MED, V316, P1511, DOI 10.1056/NEJM198706113162404; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2013, DIABETES, V62, P2164, DOI 10.2337/db13-0368; Hardie DG, 2011, BIOCHEM SOC T, V39, P1, DOI 10.1042/BST0390001; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hearle N, 2006, CLIN CANCER RES, V12, P3209, DOI 10.1158/1078-0432.CCR-06-0083; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huang X, 2008, BIOCHEM J, V412, P211, DOI 10.1042/BJ20080557; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kim IY, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00175; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Liang JY, 2013, CANCER RES, V73, P2929, DOI 10.1158/0008-5472.CAN-12-3876; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; PACHMAN LM, 1971, J CLIN INVEST, V50, P226, DOI 10.1172/JCI106478; Pollak M, 2013, J CLIN INVEST, V123, P3693, DOI 10.1172/JCI67232; Rosilio C, 2013, CANCER LETT, V336, P114, DOI 10.1016/j.canlet.2013.04.015; Sanchez-Cespedes M, 2007, ONCOGENE, V26, P7825, DOI 10.1038/sj.onc.1210594; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shackelford DB, 2009, P NATL ACAD SCI USA, V106, P11137, DOI 10.1073/pnas.0900465106; Shu Y, 2007, J CLIN INVEST, V117, P1422, DOI 10.1172/JCI30558; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Vincent EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066963; VINCENT MF, 1992, BIOCHEM J, V281, P267, DOI 10.1042/bj2810267; Wu N, 2011, NEOPLASMA, V58, P482, DOI 10.4149/neo_2011_06_482; Zadra G, 2014, EMBO MOL MED, V6, P519, DOI 10.1002/emmm.201302734; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zannella VE, 2011, RADIOTHER ONCOL, V99, P293, DOI 10.1016/j.radonc.2011.05.049	63	96	98	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2015	34	28					3627	3639		10.1038/onc.2014.301	http://dx.doi.org/10.1038/onc.2014.301			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM4TZ	25241895	Green Accepted			2022-12-25	WOS:000357679100002
J	Liu, XW; Ridgway, ND				Liu, Xinwei; Ridgway, Neale D.			Characterization of the Sterol and Phosphatidylinositol 4-Phosphate Binding Properties of Golgi-Associated OSBP-Related Protein 9 (ORP9)	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; OXYSTEROL; TRANSPORT; MEMBRANE; CHOLESTEROL; 25-HYDROXYCHOLESTEROL; PHOSPHORYLATION; FLUORESCENT; ACTIVATION; APPARATUS	Oxysterol binding protein (OSBP) and OSBP-related proteins (ORPS) have a conserved lipid-binding fold that accommodates cholesterol, oxysterols and/or phospholipids. The diversity of OSBP/ORPs and their potential ligands has complicated the analysis of transfer and signalling properties of this mammalian gene family. In this study we explored the use of the fluorescent sterol cholestatrienol (CTL) to measure sterol binding by ORP9 and competition by other putative ligands. Relative to cholesterol, CTL and dehydroergosterol (DHE) were poor ligands for OSBP. In contrast, both long (ORP9L) and short (ORP9S) variants of ORP9 rapidly extracted CTL, and to a lesser extent DHE, from liposomes. ORP9L and ORP9S also extracted [P-32] phosphatidylinositol 4-phosphate (PI-4P) from liposomes, which was inhibited by mutating two conserved histidine residues (HH(488,489)AA) at the entrance to the binding pocket but not by a mutation in the lid region that inhibited cholesterol binding. Results of direct binding and competition assays showed that phosphatidylserine was poorly extracted from liposomes by ORP9 compared to CTL and PI-4P. ORP9L and PI-4P did not co-localize in the trans-Golgi/TGN of HeLa cells, and siRNA silencing of ORP9L expression did not affect PI-4P distribution in the Golgi apparatus. However, transient overexpression of ORP9L or ORP9S in CHO cells, but not the corresponding PI-4P binding mutants, prevented immunostaining of Golgi-associated PI-4P. The apparent sequestration of Golgi PI-4P by ORP9S was identified as a possible mechanism for its growth inhibitory effects. These studies identify ORP9 as a dual sterol/PI-4P binding protein that could regulate PI-4P in the Golgi apparatus.	[Ridgway, Neale D.] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; Dalhousie Univ, Dept Biochem, Halifax, NS, Canada; Dalhousie Univ, Dept Mol Biol, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Ridgway, ND (corresponding author), Dalhousie Univ, Dept Pediat, Halifax, NS, Canada.	nridgway@dal.ca		Ridgway, Neale/0000-0002-0441-6228	Canadian Institutes of Health Research [MOP-15284]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding to NDR received from the Canadian Institutes of Health Research (Grant number MOP-15284). http://www.cihr-irsc.gc.ca/e/193.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerji S, 2010, MOL BIOL CELL; Beh CT, 2009, MOL CELL BIOCHEM, V326, P9, DOI 10.1007/s11010-008-9999-7; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Goto A, 2012, MOL BIOL CELL, V23, P3624, DOI 10.1091/mbc.E12-04-0283; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; KANDUTSCH AA, 1981, J BIOL CHEM, V256, P3068; Lehto M, 2005, EXP CELL RES, V310, P445, DOI 10.1016/j.yexcr.2005.08.003; Lessmann E, 2007, CELL SIGNAL, V19, P384, DOI 10.1016/j.cellsig.2006.07.009; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Maeda K, 2013, NATURE, V501, P257, DOI 10.1038/nature12430; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Ngo M, 2009, MOL BIOL CELL, V20, P1388, DOI 10.1091/mbc.E08-09-0905; Ngo MH, 2010, BIOCHEM J, V429, P13, DOI 10.1042/BJ20100263; Nishimura T, 2013, MOL BIOL CELL, V24, P3534, DOI 10.1091/mbc.E13-05-0250; Ohvo-Rekila H, 2000, CHEM PHYS LIPIDS, V105, P167, DOI 10.1016/S0009-3084(00)00122-5; Olkkonen VM, 2013, PROG LIPID RES, V52, P529, DOI 10.1016/j.plipres.2013.06.004; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; Scheidt HA, 2003, J BIOL CHEM, V278, P45563, DOI 10.1074/jbc.M303567200; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; Suchanek M, 2007, BIOCHEM J, V405, P473, DOI 10.1042/BJ20070176; Tong J, 2013, STRUCTURE, V21, P1203, DOI 10.1016/j.str.2013.05.007; Wang C, 2002, BIOCHEM J, V361, P461, DOI 10.1042/0264-6021:3610461; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Wyles JP, 2004, EXP CELL RES, V297, P533, DOI 10.1016/j.yexcr.2004.03.052; Xu Z, 2008, BIOCHEMISTRY-US, V47, P11134, DOI 10.1021/bi801328u; Zhou Y, 2010, EXP CELL RES, V316, P3304, DOI 10.1016/j.yexcr.2010.06.008	34	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108368	10.1371/journal.pone.0108368	http://dx.doi.org/10.1371/journal.pone.0108368			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255026	Green Published, gold, Green Submitted			2022-12-25	WOS:000344862300075
J	Alanne-Kinnunen, M; Lappalainen, J; Oorni, K; Kovanen, PT				Alanne-Kinnunen, Mervi; Lappalainen, Jani; Oorni, Katariina; Kovanen, Petri T.			Activated Human Mast Cells Induce LOX-1-Specific Scavenger Receptor Expression in Human Monocyte-Derived Macrophages	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; LOX-1 EXPRESSION; ENDOTHELIAL-CELLS; UP-REGULATION; NITRIC-OXIDE; TNF-ALPHA; PLAQUE; ATHEROSCLEROSIS; DIFFERENTIATION; INFLAMMATION	Objective: Activated mast cells in atherosclerotic lesions degranulate and release bioactive compounds capable of regulating atherogenesis. Here we examined the ability of activated human primary mast cells to regulate the expression of the major scavenger receptors in cultured human primary monocyte-derived macrophages (HMDMs). Results: Components released by immunologically activated human primary mast cells induced a transient expression of lectin-like oxidized LDL receptor (LOX-1) mRNA in HMDMs, while the expression of two other scavenger receptors, MSR1 and CD36, remained unaffected. The LOX-1-inducing secretory components were identified as histamine, tumor necrosis factor alpha (TNF-alpha), and transforming growth factor beta (TGF-beta 1), which exhibited a synergistic effect on LOX-1 mRNA expression. Histamine induced a transient expression of LOX-1 protein. Mast cell-induced increase in LOX-1 expression was not associated with increased uptake of oxidized LDL by the macrophages. Conclusions: Mast cell-derived histamine, TNF-alpha, and TGF-beta 1 act in concert to induce a transient increase in LOX-1 expression in human primary monocyte-derived macrophages. The LOX-1-inducing activity potentially endows mast cells a hitherto unrecognized role in the regulation of innate immune reactions in atherogenesis.	[Alanne-Kinnunen, Mervi; Lappalainen, Jani; Oorni, Katariina; Kovanen, Petri T.] Wihuri Res Inst, SF-00140 Helsinki, Finland	Wihuri Research Institute	Kovanen, PT (corresponding author), Wihuri Res Inst, SF-00140 Helsinki, Finland.	petri.kovanen@wri.fi	Oorni, Katariina/G-2484-2011	Oorni, Katariina/0000-0002-9525-0250; Kinnunen, Mervi/0000-0002-2448-8763	Academy of Finland	Academy of Finland(Academy of Finland)	Wihuri Research Institute is maintained by the Jenny and Antti Wihuri Foundation. This study was also supported by a grant from the Academy of Finland to K.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjuman A, 2013, DIABETES VASC DIS RE, V10, P442, DOI 10.1177/1479164113489042; Bot I, 2007, CIRCULATION, V115, P2516, DOI 10.1161/CIRCULATIONAHA.106.660472; Campbell LA, 2013, PATHOG DIS, V69, P1, DOI 10.1111/2049-632X.12058; Chu EM, 2013, BBA-MOL CELL BIOL L, V1831, P378, DOI 10.1016/j.bbalip.2012.10.009; Cominacini L, 2003, J AM COLL CARDIOL, V42, P1838, DOI 10.1016/j.jacc.2003.06.011; Cominacini L, 2001, J BIOL CHEM, V276, P13750, DOI 10.1074/jbc.M010612200; Dichlberger A, 2011, J LIPID RES, V52, P2198, DOI 10.1194/jlr.M019737; Ding Z, 2014, CARDIOVASC RES; Draude G, 2000, AM J PHYSIOL-HEART C, V278, pH1042, DOI 10.1152/ajpheart.2000.278.4.H1042; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Halvorsen B, 2008, PROG CARDIOVASC DIS, V51, P183, DOI 10.1016/j.pcad.2008.09.001; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Hashizume M, 2012, CYTOKINE, V58, P424, DOI 10.1016/j.cyto.2012.02.010; Hofnagel O, 2004, ARTERIOSCL THROM VAS, V24, P1789, DOI 10.1161/01.ATV.0000140061.89096.2b; Hsu HY, 1996, J BIOL CHEM, V271, P7767, DOI 10.1074/jbc.271.13.7767; Hsu HY, 2000, J BIOL CHEM, V275, P41035, DOI 10.1074/jbc.M003464200; Hu CP, 2008, J BIOL CHEM, V283, P10226, DOI 10.1074/jbc.M708820200; Kaakinen R, 2007, ATHEROSCLEROSIS, V192, P323, DOI 10.1016/j.atherosclerosis.2006.08.001; Kaartinen M, 1996, CIRCULATION, V94, P2787, DOI 10.1161/01.CIR.94.11.2787; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Kohro Takahide, 2004, J Atheroscler Thromb, V11, P88; KOKKONEN JO, 1985, J BIOL CHEM, V260, P4756; Kovanen PT, 2007, IMMUNOL REV, V217, P105, DOI 10.1111/j.1600-065X.2007.00515.x; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Laine P, 1999, CIRCULATION, V99, P361, DOI 10.1161/01.CIR.99.3.361; Lappalainen J, 2007, CLIN EXP ALLERGY, V37, P1404, DOI 10.1111/j.1365-2222.2007.02778.x; Li L, 2004, CIRC RES, V94, P892, DOI 10.1161/01.RES.0000124920.09738.26; Lindstedt KA, 2004, CURR OPIN LIPIDOL, V15, P567, DOI 10.1097/00041433-200410000-00011; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; NOZAKI S, 1995, J CLIN INVEST, V96, P1859, DOI 10.1172/JCI118231; R Development Core Team, 2009, R FDN STAT COMP; Shibata T, 2011, J BIOL CHEM, V286, P19943, DOI 10.1074/jbc.M110.187047; Tanimoto A, 2001, FEBS LETT, V508, P345, DOI 10.1016/S0014-5793(01)03073-3; Theoharides TC, 2007, IMMUNOL REV, V217, P65, DOI 10.1111/j.1600-065X.2007.00519.x; Triggiani M, 2007, J ALLERGY CLIN IMMUN, V119, P472, DOI 10.1016/j.jaci.2006.09.027; Wang KY, 2000, FEBS LETT, V473, P345, DOI 10.1016/S0014-5793(00)01560-X	36	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108352	10.1371/journal.pone.0108352	http://dx.doi.org/10.1371/journal.pone.0108352			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250731	Green Published, Green Submitted, gold			2022-12-25	WOS:000342492700117
J	Conde, E; Suarez-Gauthier, A; Benito, A; Garrido, P; Garcia-Campelo, R; Biscuola, M; Paz-Ares, L; Hardisson, D; de Castro, J; Camacho, MC; Rodriguez-Abreu, D; Abdulkader, I; Ramirez, J; Reguart, N; Salido, M; Pijuan, L; Arriola, E; Sanz, J; Folgueras, V; Villanueva, N; Gomez-Roman, J; Hidalgo, M; Lopez-Rios, F				Conde, Esther; Suarez-Gauthier, Ana; Benito, Amparo; Garrido, Pilar; Garcia-Campelo, Rosario; Biscuola, Michele; Paz-Ares, Luis; Hardisson, David; de Castro, Javier; Camacho, M. Carmen; Rodriguez-Abreu, Delvys; Abdulkader, Ihab; Ramirez, Josep; Reguart, Noemi; Salido, Marta; Pijuan, Lara; Arriola, Edurne; Sanz, Julian; Folgueras, Victoria; Villanueva, Noemi; Gomez-Roman, Javier; Hidalgo, Manuel; Lopez-Rios, Fernando			Accurate Identification of ALK Positive Lung Carcinoma Patients: Novel FDA-Cleared Automated Fluorescence In Situ Hybridization Scanning System and Ultrasensitive Immunohistochemistry	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; KINASE GENE REARRANGEMENTS; COPY NUMBER; FUSION GENE; CANCER; ADENOCARCINOMA; FISH; EGFR; CRIZOTINIB; MUTATIONS	In Background: Based on the excellent results of the clinical trials with ALK-inhibitors, the importance of accurately identifying ALK positive lung cancer has never been greater. However, there are increasing number of recent publications addressing discordances between FISH and IHC. The controversy is further fuelled by the different regulatory approvals. This situation prompted us to investigate two ALK IHC antibodies (using a novel ultrasensitive detection-amplification kit) and an automated ALK FISH scanning system (FDA-cleared) in a series of non-small cell lung cancer tumor samples. Methods: Forty-seven ALK FISH-positive and 56 ALK FISH-negative NSCLC samples were studied. All specimens were screened for ALK expression by two IHC antibodies (clone 5A4 from Novocastra and clone D5F3 from Ventana) and for ALK rearrangement by FISH (Vysis ALK FISH break-apart kit), which was automatically captured and scored by using Bioview's automated scanning system. Results: All positive cases with the IHC antibodies were FISH-positive. There was only one IHC-negative case with both antibodies which showed a FISH-positive result. The overall sensitivity and specificity of the IHC in comparison with FISH were 98% and 100%, respectively. Conclusions: The specificity of these ultrasensitive IHC assays may obviate the need for FISH confirmation in positive IHC cases. However, the likelihood of false negative IHC results strengthens the case for FISH testing, at least in some situations.	[Conde, Esther; Suarez-Gauthier, Ana] Univ San Pablo CEU, Hosp Univ Madrid Sanchinarro, Ctr Integral Oncol Clara Campal, Lab Dianas Terapeuticas, Madrid, Spain; [Benito, Amparo; Garrido, Pilar] Hosp Ramon & Cajal, E-28034 Madrid, Spain; [Garcia-Campelo, Rosario] CHU A Coruna, La Coruna, Spain; [Biscuola, Michele; Paz-Ares, Luis] Hosp Virgen Rocio, Seville, Spain; [Hardisson, David; de Castro, Javier] Autonomous Univ Madrid, Fac Med, Univ Hosp La Paz, IdiPAZ,Hosp Paz Inst Hlth Res, E-28049 Madrid, Spain; [Camacho, M. Carmen; Rodriguez-Abreu, Delvys] Hosp Insular Gran Canaria, Las Palmas Gran Canaria, Spain; [Abdulkader, Ihab] CHU Santiago De Compostela, Santiago De Compostela, Spain; [Ramirez, Josep; Reguart, Noemi] Hosp Clin Barcelona, Barcelona, Spain; [Salido, Marta; Pijuan, Lara; Arriola, Edurne] Hosp Mar Parc Salut Mar, Barcelona, Spain; [Sanz, Julian] Hosp Clin San Carlos, Madrid, Spain; [Folgueras, Victoria; Villanueva, Noemi] Univ Oviedo, Hosp Cent Asturias, E-33080 Oviedo, Spain; [Gomez-Roman, Javier] Hosp Marques Valdecilla, Santander, Spain; [Hidalgo, Manuel] Univ San Pablo CEU, Hosp Univ Madrid Sanchinarro, Ctr Integral Oncol Clara Campal, Dept Oncol, Madrid, Spain	San Pablo CEU University; Hospital Universitario Ramon y Cajal; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Virgen del Rocio University Hospital; Autonomous University of Madrid; Hospital Universitario La Paz; University of Barcelona; Hospital Clinic de Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Hospital Clinico San Carlos; Central University Hospital Asturias; University of Oviedo; Hospital Universitario Marques de Valdecilla (HUMV); San Pablo CEU University	Lopez-Rios, F (corresponding author), Univ San Pablo CEU, Hosp Univ Madrid Sanchinarro, Ctr Integral Oncol Clara Campal, Lab Dianas Terapeuticas, Madrid, Spain.	flopezrios@hmhospitales.com	GARRIDO, PILAR/D-5187-2017; HIDALGO, MANUEL/I-4995-2015; Hardisson, David/A-6259-2011; Hardisson, David/E-2832-2010; Sanz, Julian/G-5276-2013; Paz-Ares, Luis/AAH-2750-2019; Garrido, Pilar/C-8677-2012; Hardisson, David/AAN-3833-2020; José Javier, Gómez-Román/AAC-8156-2021	GARRIDO, PILAR/0000-0002-5899-6125; HIDALGO, MANUEL/0000-0002-3765-3318; Hardisson, David/0000-0002-2183-3699; Sanz, Julian/0000-0002-3049-9338; Garrido, Pilar/0000-0002-5899-6125; José Javier, Gómez-Román/0000-0002-2849-9435; Ramirez, Jose/0000-0002-7833-1374; Arriola, Edurne/0000-0001-8960-7519; De Castro, Javier/0000-0002-3622-6306; Salido, Marta/0000-0001-9988-5977; Rodriguez-Abreu, Delvys/0000-0003-0506-1366	Abbott; Pfizer; Fundacion Mutua Madrilena; Fondo de Investigaciones Sanitarias [PI11/02866]	Abbott(Abbott Laboratories); Pfizer(Pfizer); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	This work was partially supported by Abbott, Pfizer, Fundacion Mutua Madrilena and Fondo de Investigaciones Sanitarias (PI11/02866). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali G, 2014, ARCH PATHOL LAB MED; Blackhall FH, 2012, PREVALENCE CLIN OUTC; Brevet M, 2010, J MOL DIAGN, V12, P169, DOI 10.2353/jmoldx.2010.090140; Cabillic F, 2014, J THORAC ONCOL, V9, P295, DOI 10.1097/JTO.0000000000000072; Calio A, 2014, J THORAC ONCOL, V9, P729, DOI 10.1097/JTO.0000000000000109; Camidge DR, 2013, CANCER-AM CANCER SOC, V119, P3968, DOI 10.1002/cncr.28311; Conde E, 2013, HISTOPATHOLOGY, V62, P609, DOI 10.1111/his.12037; Conklin CMJ, 2013, J THORAC ONCOL, V8, P45, DOI 10.1097/JTO.0b013e318274a83e; Dacic S, 2013, J CLIN PATHOL, V66, P870, DOI 10.1136/jclinpath-2012-201336; De P, 2010, J CLIN ONCOL, V28, P4289, DOI 10.1200/JCO.2010.29.5071; Demidova I, 2014, ARCH PATHOL LAB MED, V138, P794, DOI 10.5858/arpa.2012-0762-OA; Fukui T, 2012, LUNG CANCER, V77, P319, DOI 10.1016/j.lungcan.2012.03.013; Gainor JF, 2013, CLIN CANCER RES, V19, P4273, DOI 10.1158/1078-0432.CCR-13-0318; Gridelli C, 2014, CANCER TREAT REV, V40, P300, DOI 10.1016/j.ctrv.2013.07.002; Grimm EE, 2010, AM J CLIN PATHOL, V134, P284, DOI 10.1309/AJCPUQB18XZOHHBJ; Han XH, 2013, VIRCHOWS ARCH, V463, P583, DOI 10.1007/s00428-013-1472-7; Inamura K, 2009, MODERN PATHOL, V22, P508, DOI 10.1038/modpathol.2009.2; Karachaliou N, 2013, J THORAC ONCOL, V8, P255, DOI 10.1097/JTO.0b013e318282ddc3; Kim H, 2013, HISTOPATHOLOGY, V62, P305, DOI 10.1111/j.1365-2559.2012.04356.x; Laffert MV, 2013, LUNG CANCER, V81, P200, DOI 10.1016/j.lungcan.2013.04.015; Le Quesne J, 2014, J THORAC ONCOL, V9, P769, DOI 10.1097/JTO.0000000000000157; Li TH, 2014, J THORAC ONCOL, V9, P18, DOI 10.1097/JTO.0000000000000030; Li YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080475, 10.1371/journal.pone.0070390]; Lindeman NI, 2013, ARCH PATHOL LAB MED, V137, P828, DOI [10.5858/arpa.2012-0720-OA, 10.1097/JTO.0b013e318290868f]; Martinez P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052261; McLeer-Florin A, 2012, J THORAC ONCOL, V7, P348, DOI 10.1097/JTO.0b013e3182381535; Minca EC, 2013, J MOL DIAGN, V15, P341, DOI 10.1016/j.jmoldx.2013.01.004; Murakami Y, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00024; Nakamura H, 2013, J CLIN PATHOL, V66, P705, DOI 10.1136/jclinpath-2012-201329; Nishino M, 2012, MODERN PATHOL, V25, P1462, DOI 10.1038/modpathol.2012.109; Nitta H, 2013, J THORAC ONCOL, V8, P1019, DOI 10.1097/JTO.0b013e31829ebb4d; Paik JH, 2012, LUNG CANCER, V76, P403, DOI 10.1016/j.lungcan.2011.11.008; Paik JH, 2011, J THORAC ONCOL, V6, P466, DOI 10.1097/JTO.0b013e31820b82e8; Proietti A, 2014, CANCER CYTOPATHOL, V122, P445, DOI 10.1002/cncy.21418; Riely GJ, 2011, J NATL COMPR CANC NE, V9, P1328, DOI 10.6004/jnccn.2011.0113; Rodig SJ, 2009, CLIN CANCER RES, V15, P5216, DOI 10.1158/1078-0432.CCR-09-0802; Salido M, 2011, J THORAC ONCOL, V6, P21, DOI 10.1097/JTO.0b013e3181fb7cd6; Sauter G, 2009, J CLIN ONCOL, V27, P1323, DOI 10.1200/JCO.2007.14.8197; Savic S, 2013, J THORAC ONCOL, V8, P1004, DOI 10.1097/JTO.0b013e3182936ca9; Selinger CI, 2013, MODERN PATHOL, V26, P1545, DOI 10.1038/modpathol.2013.87; Shaw AT, 2013, ANN ONCOL, V24, P59, DOI 10.1093/annonc/mds242; Shaw AT, 2014, NEW ENGL J MED, V370, P1189, DOI [10.1056/NEJMoa1311107, 10.1056/NEJMc1404894]; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Sholl LM, 2013, J THORAC ONCOL, V8, P322, DOI 10.1097/JTO.0b013e31827db604; Sun JM, 2012, J THORAC ONCOL, V7, pE36, DOI 10.1097/JTO.0b013e318274694e; Takamochi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069794; Takeuchi K, 2013, J THORAC ONCOL, V8, pE67, DOI 10.1097/JTO.0b013e318293e1ff; Thunnissen E, 2012, VIRCHOWS ARCH, V461, P245, DOI 10.1007/s00428-012-1281-4; To KF, 2013, J THORAC ONCOL, V8, P883, DOI 10.1097/JTO.0b013e3182904e22; Travis WD., 2004, TRAVIS WB WHO CLASSI; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Tuononen K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/757490; Wallander ML, 2012, ARCH PATHOL LAB MED, V136, P796, DOI 10.5858/arpa.2011-0321-OA; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Wong DWS, 2009, CANCER-AM CANCER SOC, V115, P1723, DOI 10.1002/cncr.24181; Wu YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070839; Wynes MW, 2014, J THORAC ONCOL, V9, P631, DOI 10.1097/JTO.0000000000000115; Yang JJ, 2014, CLIN CANCER RES, V20, P1383, DOI 10.1158/1078-0432.CCR-13-0699; Ying J, 2013, ANN ONCOL, V24, P2589, DOI 10.1093/annonc/mdt295; Yoshida A, 2011, AM J SURG PATHOL, V35, P1226, DOI 10.1097/PAS.0b013e3182233e06; Zhou JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092828	61	53	55	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107200	10.1371/journal.pone.0107200	http://dx.doi.org/10.1371/journal.pone.0107200			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25248157	Green Submitted, Green Published, gold			2022-12-25	WOS:000342351800018
J	Lenartowicz, M; Starzynski, RR; Krzeptowski, W; Grzmil, P; Bednarz, A; Ogorek, M; Pierzchala, O; Staron, R; Gajowiak, A; Lipinski, P				Lenartowicz, Malgorzata; Starzynski, Rafal R.; Krzeptowski, Wojciech; Grzmil, Pawel; Bednarz, Aleksandra; Ogorek, Mateusz; Pierzchala, Olga; Staron, Robert; Gajowiak, Anna; Lipinski, Pawel			Haemolysis and Perturbations in the Systemic Iron Metabolism of Suckling, Copper-Deficient Mosaic Mutant Mice - An Animal Model of Menkes Disease	PLOS ONE			English	Article							ERYTHROCYTE SUPEROXIDE-DISMUTASE; TRANSPORTING ATPASE ATP7A; FERROPORTIN EXPRESSION; OXIDATIVE STRESS; HEME; CERULOPLASMIN; ANEMIA; KIDNEY; GENE; TRAFFICKING	The biological interaction between copper and iron is best exemplified by the decreased activity of multicopper ferroxidases under conditions of copper deficiency that limits the availability of iron for erythropoiesis. However, little is known about how copper deficiency affects iron homeostasis through alteration of the activity of other copper-containing proteins, not directly connected with iron metabolism, such as superoxide dismutase 1 (SOD1). This antioxidant enzyme scavenges the superoxide anion, a reactive oxygen species contributing to the toxicity of iron via the Fenton reaction. Here, we analyzed changes in the systemic iron metabolism using an animal model of Menkes disease: copper-deficient mosaic mutant mice with dysfunction of the ATP7A copper transporter. We found that the erythrocytes of these mutants are copper-deficient, display decreased SOD1 activity/expression and have cell membrane abnormalities. In consequence, the mosaic mice show evidence of haemolysis accompanied by haptoglobin-dependent elimination of haemoglobin (Hb) from the circulation, as well as the induction of haem oxygenase 1 (HO1) in the liver and kidney. Moreover, the hepcidin-ferroportin regulatory axis is strongly affected in mosaic mice. These findings indicate that haemolysis is an additional pathogenic factor in a mouse model of Menkes diseases and provides evidence of a new indirect connection between copper deficiency and iron metabolism.	[Lenartowicz, Malgorzata; Grzmil, Pawel; Bednarz, Aleksandra; Ogorek, Mateusz; Pierzchala, Olga] Jagiellonian Univ, Inst Zool, Dept Genet & Evolut, PL-30060 Krakow, Poland; [Starzynski, Rafal R.; Staron, Robert; Gajowiak, Anna; Lipinski, Pawel] Polish Acad Sci, Inst Genet & Anim Breeding, Dept Mol Biol, Magdalenka, Poland; [Krzeptowski, Wojciech] Jagiellonian Univ, Inst Zool, Dept Cell Biol & Imaging, PL-30060 Krakow, Poland	Jagiellonian University; Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences; Jagiellonian University	Lenartowicz, M (corresponding author), Jagiellonian Univ, Inst Zool, Dept Genet & Evolut, PL-30060 Krakow, Poland.	malgorzata.lenartowicz@uj.edu.pl; p.lipinski@ighz.pl		Bednarz, Aleksandra/0000-0003-2256-2998; , Rafal/0000-0002-7470-0507; Grzmil, Pawel/0000-0001-9780-2007	National Science Center of Poland [K/PBO/000142]; National Science Centre [2012/05/B/NZ4/02423]; Jagiellonian University; European Union	National Science Center of Poland(National Science Centre, Poland); National Science Centre(National Science Centre, Poland); Jagiellonian University; European Union(European Commission)	This work was supported by grant no. K/PBO/000142 from the National Science Center of Poland. This work was supported by The National Science Centre grant 2012/05/B/NZ4/02423 and partially by funding from the Jagiellonian University within the SET project, which is cofinanced by the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWARTHA KA, 1980, RES VET SCI, V28, P101, DOI 10.1016/S0034-5288(18)32781-4; Ascenzi P, 2005, IUBMB LIFE, V57, P749, DOI 10.1080/15216540500380871; Batts KP, 2007, MODERN PATHOL, V20, pS31, DOI 10.1038/modpathol.3800715; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Bothwell, 1980, METHODS HEMATOLOGY, V1, P90; Bouton C, 2002, J BIOL CHEM, V277, P31220, DOI 10.1074/jbc.M203276200; CARTWRIGHT GE, 1956, BLOOD, V11, P143, DOI 10.1182/blood.V11.2.143.143; Chen HJ, 2006, J NUTR, V136, P1236, DOI 10.1093/jn/136.5.1236; Chung J, 2004, P NATL ACAD SCI USA, V101, P2700, DOI 10.1073/pnas.0306622101; Chung J, 2004, J NUTR, V134, P517, DOI 10.1093/jn/134.3.517; Collins JF, 2010, NUTR REV, V68, P133, DOI 10.1111/j.1753-4887.2010.00271.x; De Domenico I, 2007, EMBO J, V26, P2823, DOI 10.1038/sj.emboj.7601735; Delaby C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042199; Dey S, 2012, J BIOL CHEM, V287, P26630, DOI 10.1074/jbc.M112.341255; Etzerodt A, 2013, ANTIOXID REDOX SIGN, V18, P2254, DOI 10.1089/ars.2012.4605; EVANS GW, 1973, PHYSIOL REV, V53, P535, DOI 10.1152/physrev.1973.53.3.535; Fagoonee S, 2005, AM J PATHOL, V166, P973, DOI 10.1016/S0002-9440(10)62319-X; Ganz T, 2005, CELL METAB, V1, P155, DOI 10.1016/j.cmet.2005.02.005; Gozzelino R, 2014, ANTIOXID REDOX SIGN, V20, P1754, DOI 10.1089/ars.2013.5666; Grzelak A, 2009, CELL MOL BIOL LETT, V14, P23, DOI 10.2478/s11658-008-0031-8; Gulec S, 2014, J NUTR, V144, P12, DOI 10.3945/jn.113.183160; Gulec S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066010; HARRIS ZL, 1995, P NATL ACAD SCI USA, V92, P2539, DOI 10.1073/pnas.92.7.2539; Hart EB, 1928, J BIOL CHEM, V77, P796; Hayashi H, 2013, MED MOL MORPHOL, V46, P133, DOI 10.1007/s00795-013-0015-2; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Iuchi Y, 2007, BIOCHEM J, V402, P219, DOI 10.1042/BJ20061386; Kirby BJ, 1998, J INORG BIOCHEM, V71, P189, DOI 10.1016/S0162-0134(98)10053-3; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; La Fontaine S, 2007, ARCH BIOCHEM BIOPHYS, V463, P149, DOI 10.1016/j.abb.2007.04.021; LEE GR, 1968, J CLIN INVEST, V47, P2058, DOI 10.1172/JCI105891; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Lenartowicz M, 2001, FOLIA HISTOCHEM CYTO, V39, P275; Lenartowicz M., 2000, NUTR RES, V10, P1519, DOI [10.1016/S0271-5317(00)00230-X, DOI 10.1016/S0271-5317(00)00230-X]; Lenartowicz M, 2012, METALLOMICS, V4, P197, DOI 10.1039/c1mt00134e; Lenartowicz M, 2011, GENE EXPR PATTERNS, V11, P41, DOI 10.1016/j.gep.2010.09.001; Lenartowicz M, 2010, BIOL TRACE ELEM RES, V136, P204, DOI 10.1007/s12011-009-8533-4; Linz R, 2008, AM J PHYSIOL-RENAL, V294, pF53, DOI 10.1152/ajprenal.00314.2007; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Lutsenko S, 2010, CURR OPIN CHEM BIOL, V14, P211, DOI 10.1016/j.cbpa.2010.01.003; Maines MD, 2005, ANTIOXID REDOX SIGN, V7, P1761, DOI 10.1089/ars.2005.7.1761; Malyszko J, 2007, KIDNEY BLOOD PRESS R, V30, P15, DOI 10.1159/000098522; Matak P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059538; Mercer JFB, 2003, BIOMETALS, V16, P175, DOI 10.1023/A:1020719016675; Moller LB, 2009, BIOCHIMIE, V91, P1273, DOI 10.1016/j.biochi.2009.05.011; Nielsen MJ, 2010, ANTIOXID REDOX SIGN, V12, P261, DOI 10.1089/ars.2009.2792; OKAHATA S, 1980, EUR J PEDIATR, V134, P121, DOI 10.1007/BF01846029; Palek J, 1995, HEMATOLOGY, P690; Patel BN, 1997, J BIOL CHEM, V272, P20185, DOI 10.1074/jbc.272.32.20185; PHILLIPS M, 1986, BIOCHEM J, V238, P177, DOI 10.1042/bj2380177; Prohaska JR, 2012, BIOMETALS, V25, P633, DOI 10.1007/s10534-012-9521-2; Prohaska JR, 2011, ADV NUTR, V2, P89, DOI 10.3945/an.110.000208; PROHASKA JR, 1983, J NUTR, V113, P2048, DOI 10.1093/jn/113.10.2048; SALIN ML, 1981, BIOCHEM J, V195, P229, DOI 10.1042/bj1950229; Starzynski RR, 2013, BIOCHEM J, V449, P69, DOI 10.1042/BJ20121139; Starzynski RR, 2009, BIOCHEM J, V420, P383, DOI 10.1042/BJ20082137; SuzukiKurasaki M, 1997, J HISTOCHEM CYTOCHEM, V45, P1493, DOI 10.1177/002215549704501106; Thackeray EW, 2011, J CLIN GASTROENTEROL, V45, P153, DOI 10.1097/MCG.0b013e3181dc25f7; Thomsen JH, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/523652; van den Berg TK, 2005, TRENDS IMMUNOL, V26, P506, DOI 10.1016/j.it.2005.07.008; Van den Berghe PVE, 2007, BIOCHEM J, V407, P49, DOI 10.1042/BJ20070705; Vinchi F, 2013, CIRCULATION, V127, P1317, DOI 10.1161/CIRCULATIONAHA.112.130179; Vulpe CD, 1999, NAT GENET, V21, P195, DOI 10.1038/5979; West EC, 2004, EXP BIOL MED, V229, P756, DOI 10.1177/153537020422900807; WILLIAMS DM, 1975, P SOC EXP BIOL MED, V149, P534, DOI 10.3181/00379727-149-38844; YOSHIDA K, 1995, NAT GENET, V9, P267, DOI 10.1038/ng0395-267; Zaffanello M, 2006, ACTA PAEDIATR, V95, P785, DOI 10.1080/08035250500538957; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X	69	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107641	10.1371/journal.pone.0107641	http://dx.doi.org/10.1371/journal.pone.0107641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247420	Green Published, gold, Green Submitted			2022-12-25	WOS:000342351800028
J	Wang, LX; Ma, RX; Kang, ZP; Zhang, YP; Ding, HC; Guo, WN; Gao, Q; Xu, M				Wang, Lixin; Ma, Ruixia; Kang, Zhaopeng; Zhang, Yupeng; Ding, Hongcheng; Guo, Weina; Gao, Qing; Xu, Min			Effect of IL-17A on the Migration and Invasion of NPC Cells and Related Mechanisms	PLOS ONE			English	Article							NF-KAPPA-B; NASOPHARYNGEAL CARCINOMA-CELLS; P38 MAPK; BREAST-CANCER; EMT; ACTIVATION; EXPRESSION; INTERLEUKIN-17; INHIBITION; OVEREXPRESSION	In carcinogenesis, inflammasomes may play contradictory roles through facilitating anti-tumor immunity or inducing oncogenic factors. Their function in cancer remains poorly characterized. In this study, we explored the effect of interleukin-17A (IL-17A) on the migration and invasion activity of nasopharyngeal carcinoma (NPC) cell lines and account for related mechanisms. Our results revealed that exogenous IL-17A promoted cell migration and invasion significantly in both NPC-039 and CNE-2Z cell lines. In addition, the expression of matrix metalloproteinase-2 (MMP-2)/-9 and Vimentin could be elevated by IL-17A stimulation; meanwhile the expression of E-cadherin was decreased. The results also show that IL-17A could activate the p38 signaling pathway in IL-17A-stimulated NPC-039 and CNE-2Z cell lines. Combining treatment with a p38 inhibitor (SB203580) resulted in decreased invasion capabilities of NPC-039 and CNE-2Z cell lines. SB203580 also inhibited the expression of MMP-2/-9 and increased the expression of E-cadherin in IL-17A-stimulated NPC-039 and CNE-2Z cell lines. IL-17A also could activate NF-kappa B in NPC-039 and CNE-2Z cell lines. In summary, our data show that IL-17A promote the cell migration and invasion of NPC cells. The effect of IL-17A on cell migration and invasion may be mediated via regulation of the expression of MMP-2/-9 and epithelial-mesenchymal transition (EMT) via p38-NF-kappa B signaling pathway. Thus, IL-17A or its related signaling pathways may be a promising target for preventing and inhibiting NPC metastasis.	[Wang, Lixin; Zhang, Yupeng; Xu, Min] Xi An Jiao Tong Univ, Hosp 2, Dept Otolaryngol Head & Neck Surg, Xian 710049, Peoples R China; [Wang, Lixin; Ding, Hongcheng; Guo, Weina] Hubei Med Univ, Affiliated Peoples Hosp, Dept Otolaryngol Head & Neck Surg, Shiyan, Peoples R China; [Ma, Ruixia; Kang, Zhaopeng] Hosp Affiliated Ningxia Med Univ, Dept Otolaryngol Head & Neck Surg, Yin Chuan, Peoples R China; [Gao, Qing] Xi An Jiao Tong Univ, Affiliated Hosp 2, Sch Med, Dept Obstet & Gynecol, Xian 710049, Peoples R China	Xi'an Jiaotong University; Ningxia Medical University; Xi'an Jiaotong University	Xu, M (corresponding author), Xi An Jiao Tong Univ, Hosp 2, Dept Otolaryngol Head & Neck Surg, Xian 710049, Peoples R China.	dqinggao@163.com; tougaoyouxiang2014@163.com			National Natural Science Foundation of China [81070536]; Natural Science Foundation of Shaanxi Province [2014JM4143]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province)	The project was supported by National Natural Science Foundation of China (No. 81070536) and Natural Science Foundation of Shaanxi Province (2014JM4143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHASE HB, 1958, BRIT J RADIOL, V31, P65, DOI 10.1259/0007-1285-31-362-65; Chen KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072927; Chua DTT, 2001, CANCER-AM CANCER SOC, V92, P2845, DOI 10.1002/1097-0142(20011201)92:11<2845::AID-CNCR10133>3.0.CO;2-7; Cortez DM, 2007, AM J PHYSIOL-HEART C, V293, pH3356, DOI 10.1152/ajpheart.00928.2007; Das Roy L, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-225; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Du JW, 2012, MOL MED REP, V6, P1099, DOI 10.3892/mmr.2012.1036; Folgueras AR, 2004, INT J DEV BIOL, V48, P411, DOI 10.1387/ijdb.041811af; Gao C, 2009, CELL MOL NEUROBIOL, V29, P1161, DOI 10.1007/s10571-009-9409-z; Gao Q, 2014, HUM PATHOL, V45, P372, DOI 10.1016/j.humpath.2013.10.001; Hyun YS, 2012, CARCINOGENESIS, V33, P931, DOI 10.1093/carcin/bgs106; Kiefel H, 2012, CARCINOGENESIS, V33, P1919, DOI 10.1093/carcin/bgs220; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021816; Li M, 2012, COMPUT METHODS BIOME; Liang RR, 2012, INT J ONCOL, V41, P969, DOI 10.3892/ijo.2012.1510; Lin ML, 2007, ANTICANCER RES, V27, P3313; Lin ML, 2010, MOL CARCINOGEN, V49, P783, DOI 10.1002/mc.20652; Noubade R, 2011, BLOOD, V118, P3290, DOI 10.1182/blood-2011-02-336552; Oshima T, 2008, INT J ONCOL, V33, P573, DOI 10.3892/ijo_00000042; Palomer A, 2002, BIOORG MED CHEM LETT, V12, P533, DOI 10.1016/S0960-894X(01)00800-9; Pongcharoen S, 2006, AM J REPROD IMMUNOL, V55, P291, DOI 10.1111/j.1600-0897.2006.00366.x; Radisky DC, 2007, NAT CELL BIOL, V9, P361, DOI 10.1038/ncb0407-361; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Shalom-Barak T, 1998, J BIOL CHEM, V273, P27467, DOI 10.1074/jbc.273.42.27467; Sun XJ, 2013, ASIAN PAC J CANCER P, V14, P5533, DOI 10.7314/APJCP.2013.14.9.5533; Taggart CC, 2005, J EXP MED, V202, P1659, DOI 10.1084/jem.20050768; Tokuda H, 2004, J CELL BIOCHEM, V91, P1053, DOI 10.1002/jcb.20004; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Vittal R, 2013, AM J PHYSIOL-LUNG C, V304, pL401, DOI 10.1152/ajplung.00080.2012; Waugh T R, 1935, Can Med Assoc J, V33, P542; Wei JL, 2013, CELL BIOL INT, V37, P1016, DOI 10.1002/cbin.10125; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zarogoulidis P, 2014, CANCER INVEST, V32, P197, DOI 10.3109/07357907.2014.898156; Zhai XL, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0970-z; Zhu XW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2195	35	17	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e108060	10.1371/journal.pone.0108060	http://dx.doi.org/10.1371/journal.pone.0108060			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244643	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800065
J	Babapoor, S; Fleming, E; Wu, R; Dadras, SS				Babapoor, Sankhiros; Fleming, Elizabeth; Wu, Rong; Dadras, Soheil S.			A Novel miR-451a isomiR, Associated with Amelanotypic Phenotype, Acts as a Tumor Suppressor in Melanoma by Retarding Cell Migration and Invasion	PLOS ONE			English	Article							MICRORNA TRANSCRIPTOME; EXPRESSION; CANCER; MICROPHTHALMIA; RESISTANCE; SURVIVAL; PATHWAY; MIR-211; LOCUS; GENE	miRNAs are key regulatory small non-coding RNAs involved in critical steps of melanoma tumorigenesis; however, the relationship between sequence specific variations at the 59 or 39 termini (isomiR) of a miRNA and cancer phenotype remains unclear. Deep-sequencing and qRT-PCR showed reduced expression of miR-144/451a cluster and most abundant isomiR (miR451a.1) in dysplastic nevi, in-situ and invasive melanomas compared to common nevi and normal skin (n = 101). miRNA in situ hybridization reproducibly confirmed lost miR-451a.1 in melanoma compared to nevus cells or adjacent keratinocytes. Significantly higher expression of miR-451a.1 was associated with amelanotic phenotype in melanomas (n = 47). In contrast, miR-451a was associated with melanotic phenotype, absent pagetoid scatter of intraepidermal melanocytes, superficial spreading histological subtype and tumor inflammation. Sequencing miRNAs from cultured melanocytes with cytoplasmic melanin gradient (light, medium to dark) showed absent miR-451a while revealing other melanin-associated miRNAs, e.g. miR-30b, miR-100 and miR-590 in darkly and let-7a, let-7i and let-7f in lightly to moderately pigmented cultured melanocytes. Ectopic expression of miR-144/451a in melanoma cell lines resulted in markedly higher levels of mature miR-451a.1 than miR451a or miR-144; and significantly retarded cell migration and inhibited invasion in a glucose-sensitive manner. Surprisingly, these effects were not mediated by calcium binding protein 39 (CAB39), a proven miR451a gene target. miR-144/miR-451a cluster is a novel miRNA locus with tumor suppressive activity in melanoma.	[Babapoor, Sankhiros; Fleming, Elizabeth; Dadras, Soheil S.] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Wu, Rong] Univ Connecticut, Ctr Hlth, CICATS Biostat Ctr, Farmington, CT USA; [Dadras, Soheil S.] Univ Connecticut, Ctr Hlth, Dept Dermatol, Farmington, CT USA	University of Connecticut; University of Connecticut; University of Connecticut	Dadras, SS (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA.	dadras@uchc.edu			Melanoma Research Foundation; American Cancer Society [IRG-06-002-01]	Melanoma Research Foundation; American Cancer Society(American Cancer Society)	This work was funded by the Melanoma Research Foundation Career Development Award to SSD and the American Cancer Society (IRG-06-002-01) to SSD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HW, 2010, MOL HUM REPROD, V16, P463, DOI 10.1093/molehr/gaq017; Bandres E, 2009, CLIN CANCER RES, V15, P2281, DOI 10.1158/1078-0432.CCR-08-1818; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bergamaschi A, 2012, ONCOGENE, V31, P39, DOI 10.1038/onc.2011.223; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Chan E, 2011, CELL CYCLE, V10, P1845, DOI 10.4161/cc.10.11.15777; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Dadras SS, 2011, ARCH PATHOL LAB MED, V135, P860, DOI 10.1043/2009-0623-RAR1.1; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Doeden K, 2009, J CUTAN PATHOL, V36, P772, DOI 10.1111/j.1600-0560.2008.01166.x; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Fu HJ, 2005, FEBS LETT, V579, P3849, DOI 10.1016/j.febslet.2005.05.064; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Godshalk SE, 2011, ONCOGENE, V30, P1542, DOI 10.1038/onc.2010.536; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Guo L, 2013, GENE, V527, P624, DOI 10.1016/j.gene.2013.06.083; Hanna JA, 2012, BIOTECHNIQUES, V52, P235, DOI 10.2144/000113837; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Howlader N NA, 2013, SEER STAT FACT SHEET; Hsiao JJ, 2014, ARCH BIOCH BIOPHYSIC; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Kozubek J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072699; Levy C, 2010, MOL CELL, V40, P841, DOI 10.1016/j.molcel.2010.11.020; M D, 2001, Methods Mol Med, V58, P61, DOI 10.1385/1-59259-137-X:061; Ma ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020494; Marti E, 2010, NUCLEIC ACIDS RES, V38, P7219, DOI 10.1093/nar/gkq575; Masaki S, 2007, BIOCHEM BIOPH RES CO, V364, P509, DOI 10.1016/j.bbrc.2007.10.077; Mazar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013779; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Penna E, 2011, EMBO J; Poell JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043569; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Segura MF, 2010, CLIN CANCER RES, V16, P1577, DOI 10.1158/1078-0432.CCR-09-2721; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Slominski AT, 2014, MAYO CLIN PROC, V89, P429, DOI 10.1016/j.mayocp.2014.02.009; Tian Y, 2012, INT J ONCOL, V40, P1105, DOI 10.3892/ijo.2011.1306; Vaz Candida, 2013, BMC Res Notes, V6, P390, DOI 10.1186/1756-0500-6-390; Viros A, 2008, PLOS MED, V5, P941, DOI 10.1371/journal.pmed.0050120; Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642; Xu Y, 2012, BRIT J CANCER, V106, P553, DOI 10.1038/bjc.2011.568; Zhu N, 2004, BRIT J CANCER, V90, P1457, DOI 10.1038/sj.bjc.6601698	43	43	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107502	10.1371/journal.pone.0107502	http://dx.doi.org/10.1371/journal.pone.0107502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25237911	Green Published, Green Submitted, gold			2022-12-25	WOS:000342491600028
J	Hertlein, G; Muller, S; Garcia-Gonzalez, E; Poppingal, L; Sussmuth, RD; Genersch, E				Hertlein, Gillian; Mueller, Sebastian; Garcia-Gonzalez, Eva; Poppingal, Lena; Suessmuth, Roderich D.; Genersch, Elke			Production of the Catechol Type Siderophore Bacillibactin by the Honey Bee Pathogen Paenibacillus larvae	PLOS ONE			English	Article							DIFFERENTIALLY VIRULENT GENOTYPES; IRON-CONTAINING CELLS; AMERICAN FOULBROOD; SUBSP LARVAE; BACILLUS-SUBTILIS; CAUSATIVE AGENT; ETIOLOGIC AGENT; APIS-MELLIFERA; PEPTIDE SYNTHETASES; BIOSYNTHESIS	The Gram-positive bacterium Paenibacillus larvae is the etiological agent of American Foulbrood. This bacterial infection of honey bee brood is a notifiable epizootic posing a serious threat to global honey bee health because not only individual larvae but also entire colonies succumb to the disease. In the recent past considerable progress has been made in elucidating molecular aspects of host pathogen interactions during pathogenesis of P. larvae infections. Especially the sequencing and annotation of the complete genome of P. larvae was a major step forward and revealed the existence of several giant gene clusters coding for non-ribosomal peptide synthetases which might act as putative virulence factors. We here present the detailed analysis of one of these clusters which we demonstrated to be responsible for the biosynthesis of bacillibactin, a P. larvae siderophore. We first established culture conditions allowing the growth of P. larvae under iron-limited conditions and triggering siderophore production by P. larvae. Using a gene disruption strategy we linked siderophore production to the expression of an uninterrupted bacillibactin gene cluster. In silico analysis predicted the structure of a trimeric trithreonyl lactone (DHB-Gly-Thr)(3) similar to the structure of bacillibactin produced by several Bacillus species. Mass spectrometric analysis unambiguously confirmed that the siderophore produced by P. larvae is identical to bacillibactin. Exposure bioassays demonstrated that P. larvae bacillibactin is not required for full virulence of P. larvae in laboratory exposure bioassays. This observation is consistent with results obtained for bacillibactin in other pathogenic bacteria.	[Hertlein, Gillian; Garcia-Gonzalez, Eva; Poppingal, Lena; Genersch, Elke] Inst Bee Res, Dept Mol Microbiol & Bee Dis, Hohen Neuendorf, Germany; [Mueller, Sebastian; Suessmuth, Roderich D.] Tech Univ Berlin, Inst Chem, Berlin, Germany; [Genersch, Elke] Free Univ Berlin, Inst Microbiol & Epizoot, Berlin, Germany	Technical University of Berlin; Free University of Berlin	Genersch, E (corresponding author), Inst Bee Res, Dept Mol Microbiol & Bee Dis, Hohen Neuendorf, Germany.	elke.genersch@rz.hu-berlin.de		Sussmuth, Roderich/0000-0001-7027-2069; Genersch, Elke/0000-0001-7906-4530	Ministries for Agriculture from Brandenburg and Sachsen-Anhalt, Germany; German Research Foundation [1121, GE 1365/1-1]; Cluster of Excellence "Unifying Concepts in Catalysis" (UniCat)	Ministries for Agriculture from Brandenburg and Sachsen-Anhalt, Germany; German Research Foundation(German Research Foundation (DFG)); Cluster of Excellence "Unifying Concepts in Catalysis" (UniCat)(German Research Foundation (DFG))	EG was supported by grants from the Ministries for Agriculture from Brandenburg and Sachsen-Anhalt, Germany. GH, EG-G, and LP were supported through the German Research Foundation (Graduate School 1121 and grant GE 1365/1-1). SM was supported by the Cluster of Excellence "Unifying Concepts in Catalysis" (UniCat) coordinated by TU Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abergel RJ, 2006, P NATL ACAD SCI USA, V103, P18499, DOI 10.1073/pnas.0607055103; Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anand S, 2010, NUCLEIC ACIDS RES, V38, pW487, DOI 10.1093/nar/gkq340; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Ashiralieva A, 2006, APIDOLOGIE, V37, P411, DOI 10.1051/apido:2006028; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Cendrowski S, 2004, MOL MICROBIOL, V51, P407, DOI 10.1046/j.1365-2958.2003.03861.x; Chen XH, 2009, J MOL MICROB BIOTECH, V16, P14, DOI 10.1159/000142891; Ciche TA, 2003, APPL ENVIRON MICROB, V69, P4706, DOI 10.1128/AEM.69.8.4706-4713.2003; COX CD, 1979, J BACTERIOL, V137, P357, DOI 10.1128/JB.137.1.357-364.1979; Crailsheim K, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.05; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; DINGMAN DW, 1983, APPL ENVIRON MICROB, V46, P860, DOI 10.1128/AEM.46.4.860-869.1983; Djukic M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090914; do Nascimento AM, 2004, INSECT BIOCHEM MOLEC, V34, P415, DOI 10.1016/j.ibmb.2003.12.003; Dorsey CW, 2004, MICROBIOL-SGM, V150, P3657, DOI 10.1099/mic.0.27371-0; Dunkov B, 2006, INSECT BIOCHEM MOLEC, V36, P300, DOI 10.1016/j.ibmb.2006.01.007; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Funfhaus A, 2013, ENVIRON MICROBIOL, V15, P2951, DOI 10.1111/1462-2920.12229; Funfhaus A, 2012, ENV MICROBIOL REP, V4, P194, DOI 10.1111/j.1758-2229.2011.00320.x; Funfhaus A, 2009, ENV MICROBIOL REP, V1, P240, DOI 10.1111/j.1758-2229.2009.00039.x; Garcia-Gonzalez E, 2014, MICROBIOLOGYOPEN, V3, P642, DOI 10.1002/mbo3.195; Garcia-Gonzalez E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004284; Garcia-Gonzalez E, 2014, ENVIRON MICROBIOL, V16, P1297, DOI 10.1111/1462-2920.12417; Garcia-Gonzalez E, 2013, ENVIRON MICROBIOL, V15, P2894, DOI 10.1111/1462-2920.12167; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Geiser DL, 2012, BBA-GEN SUBJECTS, V1820, P437, DOI 10.1016/j.bbagen.2011.07.011; Genersch E, 2006, INT J SYST EVOL MICR, V56, P501, DOI 10.1099/ijs.0.63928-0; Genersch E, 2005, APPL ENVIRON MICROB, V71, P7551, DOI 10.1128/AEM.71.11.7551-7555.2005; Genersch E, 2003, APIDOLOGIE, V34, P195, DOI 10.1051/apido:2003025; Genersch E, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.02; Genersch E, 2010, APPL MICROBIOL BIOT, V87, P87, DOI 10.1007/s00253-010-2573-8; Genersch E, 2010, J INVERTEBR PATHOL, V103, pS10, DOI 10.1016/j.jip.2009.06.015; Gisder S, 2011, ENVIRON MICROBIOL, V13, P404, DOI 10.1111/j.1462-2920.2010.02346.x; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; GROSSMAN TH, 1993, J BACTERIOL, V175, P6203, DOI 10.1128/JB.175.19.6203-6211.1993; Heyndrickx M, 1996, INT J SYST BACTERIOL, V46, P270, DOI 10.1099/00207713-46-1-270; Hsu CY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000395; Hsu CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019088; Keim CN, 2002, MICRON, V33, P53, DOI 10.1016/S0968-4328(00)00071-8; Kilwinski J, 2004, VET MICROBIOL, V104, P31, DOI 10.1016/j.vetmic.2004.08.001; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Koppisch AT, 2008, BIOMETALS, V21, P581, DOI 10.1007/s10534-008-9144-9; Kucharski R, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.27; KUTERBACH DA, 1986, J EXP BIOL, V126, P389; KUTERBACH DA, 1982, SCIENCE, V218, P695, DOI 10.1126/science.218.4573.695; May JJ, 2001, J BIOL CHEM, V276, P7209, DOI 10.1074/jbc.M009140200; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Miethke M, 2006, MOL MICROBIOL, V61, P1413, DOI 10.1111/j.1365-2958.2006.05321.x; Muller S, 2014, ANGEW CHEM INT EDIT, DOI [10.1002/anie.201, DOI 10.1002/ANIE.201]; Murray KD, 2008, J MICROBIOL METH, V75, P325, DOI 10.1016/j.mimet.2008.07.007; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Neuendorf S, 2004, MICROBIOL-SGM, V150, P2381, DOI 10.1099/mic.0.27125-0; Perez-Miranda S, 2007, J MICROBIOL METH, V70, P127, DOI 10.1016/j.mimet.2007.03.023; Pfleger BF, 2008, P NATL ACAD SCI USA, V105, P17133, DOI 10.1073/pnas.0808118105; Poppinga L, 2012, J APPL MICROBIOL, V112, P430, DOI 10.1111/j.1365-2672.2011.05214.x; Poppinga L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002716; Rauch S, 2009, APPL ENVIRON MICROB, V75, P3344, DOI 10.1128/AEM.02839-08; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Raza W, 2010, CURR MICROBIOL, V61, P390, DOI 10.1007/s00284-010-9624-3; REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; Rowland BM, 1996, GENE, V178, P119, DOI 10.1016/0378-1119(96)00349-6; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schafer MO, 2014, VET MICROBIOL, V170, P291, DOI 10.1016/j.vetmic.2014.02.006; Schneider A, 1998, ARCH MICROBIOL, V169, P404, DOI 10.1007/s002030050590; Segond D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003935; Skaar EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000949; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; Steinkraus KH, 1998, ACTA BIOTECHNOL, V18, P123, DOI 10.1002/abio.370180206; Tang XN, 2013, IUBMB LIFE, V65, P863, DOI 10.1002/iub.1211; Trauger JW, 2000, NATURE, V407, P215, DOI 10.1038/35025116; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Wen YP, 2011, ENVIRON MICROBIOL, V13, P2726, DOI 10.1111/j.1462-2920.2011.02542.x; Wilson MK, 2006, BIOCHEM BIOPH RES CO, V348, P320, DOI 10.1016/j.bbrc.2006.07.055; Winkelmann G, 2002, BIOCHEM SOC T, V30, P691, DOI 10.1042/BST0300691; Yue D, 2008, ENVIRON MICROBIOL, V10, P1612, DOI 10.1111/j.1462-2920.2008.01579.x	79	36	36	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e108272	10.1371/journal.pone.0108272	http://dx.doi.org/10.1371/journal.pone.0108272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25237888	Green Published, Green Submitted, gold			2022-12-25	WOS:000342491600092
J	Lei, CL; Massart, R; Suderman, MJ; Machnes, Z; Elgbeili, G; Laplante, DP; Szyf, M; King, S				Lei Cao-Lei; Massart, Renaud; Suderman, Matthew J.; Machnes, Ziv; Elgbeili, Guillaume; Laplante, David P.; Szyf, Moshe; King, Suzanne			DNA Methylation Signatures Triggered by Prenatal Maternal Stress Exposure to a Natural Disaster: Project Ice Storm	PLOS ONE			English	Article							EPIGENETIC REGULATION; PREFRONTAL CORTEX; IMMUNE FUNCTION; RHESUS MACAQUE; PROFILES; PROMOTER; BEHAVIOR; PREGNANCY; ORIGINS; WEIGHT	Background: Prenatal maternal stress (PNMS) predicts a wide variety of behavioral and physical outcomes in the offspring. Although epigenetic processes may be responsible for PNMS effects, human research is hampered by the lack of experimental methods that parallel controlled animal studies. Disasters, however, provide natural experiments that can provide models of prenatal stress. Methods: Five months after the 1998 Quebec ice storm we recruited women who had been pregnant during the disaster and assessed their degrees of objective hardship and subjective distress. Thirteen years later, we investigated DNA methylation profiling in T cells obtained from 36 of the children, and compared selected results with those from saliva samples obtained from the same children at age 8. Results: Prenatal maternal objective hardship was correlated with DNA methylation levels in 1675 CGs affiliated with 957 genes predominantly related to immune function; maternal subjective distress was uncorrelated. DNA methylation changes in SCG5 and LTA, both highly correlated with maternal objective stress, were comparable in T cells, peripheral blood mononuclear cells (PBMCs) and saliva cells. Conclusions: These data provide first evidence in humans supporting the conclusion that PNMS results in a lasting, broad, and functionally organized DNA methylation signature in several tissues in offspring. By using a natural disaster model, we can infer that the epigenetic effects found in Project Ice Storm are due to objective levels of hardship experienced by the pregnant woman rather than to her level of sustained distress.	[Lei Cao-Lei; King, Suzanne] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Lei Cao-Lei; Elgbeili, Guillaume; King, Suzanne] Douglas Hosp, Res Ctr, Psychosocial Res Div, Montreal, PQ, Canada; [Massart, Renaud; Machnes, Ziv; Szyf, Moshe] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Suderman, Matthew J.] McGill Univ, Dept Pharmacol & Therapeut, Sackler Program Epigenet & Dev Psychobiol, Montreal, PQ, Canada; [Suderman, Matthew J.] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada; [Szyf, Moshe] McGill Univ, Sackler Program Epigenet & Dev Psychobiol, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University	Szyf, M (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.	moshe.szyf@mcgill.ca	King, Suzanne/AAM-8541-2020	King, Suzanne/0000-0003-3055-6846; Massart, Renaud/0000-0002-1631-1853; Cao, Lei/0000-0001-8202-2358; Laplante, David P./0000-0002-9723-1141; Suderman, Matthew/0000-0002-2715-9930	Canadian Institute of Health Research (CIHR) [MOP-1150067]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research was supported by a grant (MOP-1150067) from the Canadian Institute of Health Research (CIHR) (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer ME, 2010, NEUROIMMUNOMODULAT, V17, P192, DOI 10.1159/000258721; Borghol N, 2012, INT J EPIDEMIOL, V41, P62, DOI 10.1093/ije/dyr147; Brunet A, 2003, CAN J PSYCHIAT, V48, P56, DOI 10.1177/070674370304800111; Charil A, 2010, BRAIN RES REV, V65, P56, DOI 10.1016/j.brainresrev.2010.06.002; Coe CL, 2008, CURR DIR PSYCHOL SCI, V17, P36, DOI 10.1111/j.1467-8721.2008.00544.x; Coe CL, 2005, NEUROSCI BIOBEHAV R, V29, P39, DOI 10.1016/j.neubiorev.2004.11.003; Dancause KN, 2013, EARLY HUM DEV, V89, P773, DOI 10.1016/j.earlhumdev.2013.06.006; Dancause KN, 2012, PEDIATR RES, V71, P126, DOI 10.1038/pr.2011.18; Devlin AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012201; Entringer S, 2008, DEV PSYCHOBIOL, V50, P579, DOI 10.1002/dev.20316; Farber CR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-34; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; King S, 2012, BIRTH DEFECTS RES C, V96, P273, DOI 10.1002/bdrc.21026; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Labonte B, 2013, AM J PSYCHIAT, V170, P511, DOI 10.1176/appi.ajp.2012.12050627; Labonte B, 2012, ARCH GEN PSYCHIAT, V69, P722, DOI 10.1001/archgenpsychiatry.2011.2287; Laplante DP, 2007, INFANCY, V12, P69, DOI 10.1111/j.1532-7078.2007.tb00234.x; Laplante DP, 2008, J AM ACAD CHILD PSY, V47, P1063, DOI 10.1097/CHI.0b013e31817eec80; Laplante DP, 2004, PEDIATR RES, V56, P400, DOI 10.1203/01.PDR.0000136281.34035.44; Lazarus R.S., 1991, EMOTION ADAPTATION; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Liu Y, 2012, EPIGENETICS-US, V7, P735, DOI 10.4161/epi.20734; Massart R, 2014, NEUROSCIENCE, V268, P139, DOI 10.1016/j.neuroscience.2014.03.021; Mbikay M, 2001, BIOCHEM J, V357, P329, DOI 10.1042/0264-6021:3570329; McGowan PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014739; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Mehta D, 2013, P NATL ACAD SCI USA, V110, P8302, DOI 10.1073/pnas.1217750110; Mulligan C, 2012, EPIGENETICS, V7; Mychasiuk R, 2011, DEV NEUROSCI-BASEL, V33, P159, DOI 10.1159/000330034; Oberlander TF, 2008, MOL PSYCHIATR, V13, P65, DOI 10.1038/sj.mp.4002007; Pena CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039791; Pincus-Knackstedt MK, 2006, J IMMUNOL, V177, P8484, DOI 10.4049/jimmunol.177.12.8484; Provencal N, 2012, J NEUROSCI, V32, P15626, DOI 10.1523/JNEUROSCI.1470-12.2012; Radtke KM, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.21; RAZIN A, 1984, BIOCHIM BIOPHYS ACTA, V782, P331, DOI 10.1016/0167-4781(84)90043-5; Rivest S, 2010, PROG BRAIN RES, V181, P43, DOI 10.1016/S0079-6123(08)81004-7; ROULEAU J, 1992, J BIOL CHEM, V267, P7368; Stiller AL, 2011, PSYCHONEUROENDOCRINO, V36, P1383, DOI 10.1016/j.psyneuen.2011.03.012; Szyf M, 2012, CLIN GENET, V81, P341, DOI 10.1111/j.1399-0004.2012.01843.x; Szyf M, 2013, J GENET GENOMICS, V40, P331, DOI 10.1016/j.jgg.2013.06.004; Szyf M, 2013, NAT NEUROSCI, V16, P2, DOI 10.1038/nn.3286; Talge NM, 2007, J CHILD PSYCHOL PSYC, V48, P245, DOI 10.1111/j.1469-7610.2006.01714.x; Tivol EA, 1996, CURR OPIN IMMUNOL, V8, P822, DOI 10.1016/S0952-7915(96)80011-2; Uddin M, 2010, P NATL ACAD SCI USA, V107, P9470, DOI 10.1073/pnas.0910794107; van Os J, 1998, BRIT J PSYCHIAT, V172, P324, DOI 10.1192/bjp.172.4.324; Veru F, 2014, STRESS, V17, P133, DOI 10.3109/10253890.2013.876404; Viveros-Paredes JM, 2006, INT IMMUNOPHARMACOL, V6, P774, DOI 10.1016/j.intimp.2005.11.011; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; Weiss DS, 1997, HDB PRACTITIONERS, P399; Wright RJ, 2010, AM J RESP CRIT CARE, V182, P25, DOI 10.1164/rccm.200904-0637OC	53	70	70	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107653	10.1371/journal.pone.0107653	http://dx.doi.org/10.1371/journal.pone.0107653			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238154	Green Published, gold			2022-12-25	WOS:000342491600038
J	Schu, DJ; Scruggs, JM; Geissinger, JS; Michel, KG; Stevens, AM				Schu, Daniel J.; Scruggs, Jessica M.; Geissinger, Jared S.; Michel, Katherine G.; Stevens, Ann M.			Acyl-Homoserine Lactone Recognition and Response Hindering the Quorum-Sensing Regulator EsaR	PLOS ONE			English	Article							STEWARTII SUBSP STEWARTII; PANTOEA-STEWARTII; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; ACYLHOMOSERINE LACTONE; SSP STEWARTII; DNA; PROTEIN; LUXR; TRANSCRIPTION	During quorum sensing in the plant pathogen Pantoea stewartii subsp. stewartii, EsaI, an acyl-homoserine lactone (AHL) synthase, and the transcription factor EsaR coordinately control capsular polysaccharide production. The capsule is expressed only at high cell density when AHL levels are high, leading to inactivation of EsaR. In lieu of detailed structural information, the precise mechanism whereby EsaR recognizes AHL and is hindered by it, in a response opposite to that of most other LuxR homologues, remains unresolved. Hence, a random mutagenesis genetic approach was designed to isolate EsaR* variants that are immune to the effects of AHL. Error-prone PCR was used to generate the desired mutants, which were subsequently screened for their ability to repress transcription in the presence of AHL. Following sequencing, site-directed mutagenesis was used to generate all possible mutations of interest as single, rather than multiple amino acid substitutions. Eight individual amino acids playing a critical role in the AHL-insensitive phenotype have been identified. The ability of EsaR* variants to bind AHL and the effect of individual substitutions on the overall conformation of the protein were examined through in vitro assays. Six EsaR* variants had a decreased ability to bind AHL. Fluorescence anisotropy was used to examine the relative DNA binding affinity of the final two EsaR* variants, which retained some AHL binding capability but remained unresponsive to it, perhaps due to an inability of the N-terminal domain to transduce information to the C-terminal domain.	[Schu, Daniel J.; Scruggs, Jessica M.; Geissinger, Jared S.; Michel, Katherine G.; Stevens, Ann M.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Stevens, AM (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	ams@vt.edu		Stevens, Ann/0000-0002-4942-0124; Michel, Katherine/0000-0002-1852-9450	National Science Foundation [MCB-0919984]; Direct For Biological Sciences [0919984] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation grant MCB-0919984 (AMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson S, 2006, J BACTERIOL, V188, P1451, DOI 10.1128/JB.188.4.1451-1461.2006; Bottomley MJ, 2007, J BIOL CHEM, V282, P13592, DOI 10.1074/jbc.M700556200; BRADSHAWROUSE JJ, 1981, APPL ENVIRON MICROB, V42, P344, DOI 10.1128/AEM.42.2.344-350.1981; Carlier AL, 2006, J BACTERIOL, V188, P4581, DOI 10.1128/JB.00211-06; Castang S, 2006, J BIOL CHEM, V281, P29972, DOI 10.1074/jbc.M601666200; Chen GZ, 2011, MOL CELL, V42, P199, DOI 10.1016/j.molcel.2011.04.003; CHOI SH, 1992, J BACTERIOL, V174, P4064, DOI 10.1128/jb.174.12.4064-4069.1992; COPLIN DL, 1990, MOL PLANT MICROBE IN, V3, P271, DOI 10.1094/MPMI-3-271; Dykxhoorn DM, 1996, GENE, V177, P133, DOI 10.1016/0378-1119(96)00289-2; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; LiCata VJ, 2008, METHOD CELL BIOL, V84, P243, DOI 10.1016/S009l-679X(07)84009-X; Lintz MJ, 2011, P NATL ACAD SCI USA, V108, P15763, DOI 10.1073/pnas.1112398108; Minogue TD, 2005, MOL MICROBIOL, V56, P189, DOI 10.1111/j.1365-2958.2004.04529.x; Minogue TD, 2002, MOL MICROBIOL, V44, P1625, DOI 10.1046/j.1365-2958.2002.02987.x; Morohoshi T, 2007, J BACTERIOL, V189, P8333, DOI 10.1128/JB.01054-07; Nallamsetty S, 2005, PROTEIN SCI, V14, P2964, DOI 10.1110/ps.051718605; Pompeani AJ, 2008, MOL MICROBIOL, V70, P76, DOI 10.1111/j.1365-2958.2008.06389.x; Ramachandran R, 2013, APPL ENVIRON MICROB, V79, P6244, DOI 10.1128/AEM.01744-13; Schu DJ, 2011, J BACTERIOL, V193, P6315, DOI 10.1128/JB.05956-11; Schu DJ, 2009, J BACTERIOL, V191, P7402, DOI 10.1128/JB.00994-09; Shafikhani S, 1997, BIOTECHNIQUES, V23, P304, DOI 10.2144/97232rr01; Shong J, 2013, ACS CHEM BIOL, V8, P789, DOI 10.1021/cb3006402; Sjobolm S, 2006, MOL MICROBIOL, V60, P1474, DOI 10.1111/j.1365-2958.2006.05210.x; Stevens AM, 1999, AM SOC MICROBIOLOGY, P231; Stevens AM, 2011, CHEM REV, V111, P4, DOI 10.1021/cr100064s; Tsai CS, 2010, MOL MICROBIOL, V77, P1072, DOI 10.1111/j.1365-2958.2010.07279.x; Vannini A, 2002, ACTA CRYSTALLOGR D, V58, P1362, DOI 10.1107/S0907444902010028; von Bodman SB, 2003, J BACTERIOL, V185, P7001, DOI 10.1128/JB.185.23.7001-7007.2003; Williams JW, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.70; Yang YL, 2011, BIOPHYS CHEM, V159, P188, DOI 10.1016/j.bpc.2011.06.008; Yao Y, 2006, J MOL BIOL, V355, P262, DOI 10.1016/j.jmb.2005.10.041; Zhang RG, 2002, NATURE, V417, P971, DOI 10.1038/nature00833	33	5	5	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107687	10.1371/journal.pone.0107687	http://dx.doi.org/10.1371/journal.pone.0107687			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238602	Green Submitted, gold, Green Published			2022-12-25	WOS:000342491600042
J	Zhang, WL; Mottillo, EP; Zhao, JW; Gartung, A; VanHecke, GC; Lee, JF; Maddipati, KR; Xu, HY; Ahn, YH; Proia, RL; Granneman, JG; Lee, MJ				Zhang, Wenliang; Mottillo, Emilio P.; Zhao, Jiawei; Gartung, Allison; VanHecke, Garrett C.; Lee, Jen-Fu; Maddipati, Krishna R.; Xu, Haiyan; Ahn, Young-Hoon; Proia, Richard L.; Granneman, James G.; Lee, Menq-Jer			Adipocyte Lipolysis-stimulated Interleukin-6 Production Requires Sphingosine Kinase 1 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipose Tissue; AP1 Transcription Factor (AP-1); c-Jun N-terminal Kinase (JNK); Inflammation; Interleukin 6 (IL-6); Lipolysis; Beta 3 Adrenergic Receptor; Hormone-sensitive Lipase; Sphingosine Kinase	HORMONE-SENSITIVE LIPASE; SUBCUTANEOUS ADIPOSE-TISSUE; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; FATTY-ACIDS; SPHINGOSINE-1-PHOSPHATE; OBESITY; INFLAMMATION; RECEPTOR; 1-PHOSPHATE	Adipocyte lipolysis can increase the production of inflammatory cytokines such as interleukin-6 (IL-6) that promote insulin resistance. However, the mechanisms that link lipolysis with inflammation remain elusive. Acute activation of (3)-adrenergic receptors (ADRB3) triggers lipolysis and up-regulates production of IL-6 in adipocytes, and both of these effects are blocked by pharmacological inhibition of hormone-sensitive lipase. We report that stimulation of ADRB3 induces expression of sphingosine kinase 1 (SphK1) and increases sphingosine 1-phosphate production in adipocytes in a manner that also depends on hormone-sensitive lipase activity. Mechanistically, we found that adipose lipolysis-induced SphK1 up-regulation is mediated by the c-Jun N-terminal kinase (JNK)/activating protein-1 signaling pathway. Inhibition of SphK1 by sphingosine kinase inhibitor 2 diminished the ADRB3-induced IL-6 production both in vitro and in vivo. Induction of IL-6 by ADRB3 activation was suppressed by siRNA knockdown of Sphk1 in cultured adipocytes and was severely attenuated in Sphk1 null mice. Conversely, ectopic expression of SphK1 increased IL-6 expression in adipocytes. Collectively, these data demonstrate that SphK1 is a critical mediator in lipolysis-triggered inflammation in adipocytes.	[Zhang, Wenliang; Mottillo, Emilio P.; Zhao, Jiawei; Gartung, Allison; Lee, Jen-Fu; Maddipati, Krishna R.; Granneman, James G.; Lee, Menq-Jer] Wayne State Univ, Dept Pathol, Detroit, MI 48202 USA; [Zhang, Wenliang; Zhao, Jiawei; Gartung, Allison; Lee, Jen-Fu; Maddipati, Krishna R.; Lee, Menq-Jer] Wayne State Univ, Bioact Lipid Res Program, Detroit, MI 48202 USA; [Mottillo, Emilio P.; Granneman, James G.] Wayne State Univ, Ctr Integrat Metab & Endocrine Res, Detroit, MI 48202 USA; [VanHecke, Garrett C.; Ahn, Young-Hoon] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA; [Granneman, James G.] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48202 USA; [Lee, Menq-Jer] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48202 USA; [Lee, Menq-Jer] Wayne State Univ, Cardiovasc Res Inst, Detroit, MI 48202 USA; [Xu, Haiyan] Brown Univ, Dept Med, Alpert Med Sch, Providence, RI 02912 USA; [Proia, Richard L.] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20814 USA	Wayne State University; Wayne State University; Wayne State University; Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Brown University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Granneman, JG (corresponding author), Wayne State Univ, Sch Med, Ctr Integrat Metab & Endocrine Res, 540 E Canfield Ave,Lande 103, Detroit, MI 48201 USA.	jgranne@med.wayne.edu; Menqjer.lee@wayne.edu	Maddipati, Krishna Rao/H-3569-2019; Maddipati, Krishna Rao/G-1859-2011; Proia, Richard L/A-7908-2012; LEE, JEN-FU/GRO-3670-2022	Maddipati, Krishna Rao/0000-0003-1445-791X; Maddipati, Krishna Rao/0000-0003-1445-791X; Proia, Richard/0000-0003-0456-1270	National Institutes of Health [HL-071071, DK-076229, DK-062292]; Intramural Research Program of the National Institutes of Health, NIDDK; Michigan Diabetes Research and Training Center (National Institutes of Health) [5P600-DK020572]; Canadian Institutes of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, P30DK020572, R01DK062292, ZIADK056014, R56DK062292, ZIADK056015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Michigan Diabetes Research and Training Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by National Institutes of Health Grants HL-071071 (to M.-J. L.), DK-076229 and DK-062292 (to J. G. G.), the Intramural Research Program of the National Institutes of Health, NIDDK (to R. L. P.), and by a Pilot and Feasibility Grant from the Michigan Diabetes Research and Training Center (National Institutes of Health Grant 5P600-DK020572) (to M. L.).; Supported by a doctoral research award from the Canadian Institutes of Health Research.	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Andersson CX, 2008, DIABETES-METAB RES, V24, P595, DOI 10.1002/dmrr.889; Bachmaier K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030742; Baker DA, 2010, J IMMUNOL, V185, P2570, DOI 10.4049/jimmunol.1000644; Bastard JP, 2000, J CLIN ENDOCR METAB, V85, P3338, DOI 10.1210/jc.85.9.3338; Bezaire V, 2009, P NUTR SOC, V68, P350, DOI 10.1017/S0029665109990279; Claus TH, 2005, J PHARMACOL EXP THER, V315, P1396, DOI 10.1124/jpet.105.086926; Das Arghya, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P23; Ebdrup S, 2007, J MED CHEM, V50, P5449, DOI 10.1021/jm0607653; Eckel RH, 2004, CIRCULATION, V110, P2968, DOI 10.1161/01.CIR.0000140086.88453.9A; Engeland A, 2003, AM J EPIDEMIOL, V157, P517, DOI 10.1093/aje/kwf219; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; French KJ, 2006, J PHARMACOL EXP THER, V318, P596, DOI 10.1124/jpet.106.101345; Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917; Granneman JG, 2005, AM J PHYSIOL-ENDOC M, V289, pE608, DOI 10.1152/ajpendo.00009.2005; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hla T, 1999, BIOCHEM PHARMACOL, V58, P201; Hsu A, 2012, INT J ONCOL, V40, P1619, DOI 10.3892/ijo.2012.1379; Hu W, 2009, J LIPID RES, V50, P1852, DOI 10.1194/jlr.M800635-JLR200; Igarashi Y, 1998, ACTA BIOCHIM POL, V45, P299, DOI 10.18388/abp.1998_4226; Jiao P, 2011, OBESITY, V19, P483, DOI 10.1038/oby.2010.200; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee MJ, 2001, MOL CELL, V8, P693, DOI 10.1016/S1097-2765(01)00324-0; Makki Kassem, 2013, ISRN Inflamm, V2013, P139239, DOI 10.1155/2013/139239; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702; Mottillo EP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1188, DOI 10.1152/ajpendo.00051.2007; Mottillo EP, 2012, J BIOL CHEM, V287, P25038, DOI 10.1074/jbc.M112.374041; Mottillo EP, 2011, AM J PHYSIOL-ENDOC M, V301, pE122, DOI 10.1152/ajpendo.00039.2011; Mottillo EP, 2010, BBA-MOL CELL BIOL L, V1801, P1048, DOI 10.1016/j.bbalip.2010.04.012; Muradashvili N, 2014, AM J PHYSIOL-CELL PH, V307, pC169, DOI 10.1152/ajpcell.00305.2013; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Poirier P, 2006, ARTERIOSCL THROM VAS, V26, P968, DOI 10.1161/01.ATV.0000216787.85457.f3; Ross JS, 2013, J BIOL CHEM, V288, P22193, DOI 10.1074/jbc.M113.477786; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Skoura A, 2011, ARTERIOSCL THROM VAS, V31, P81, DOI 10.1161/ATVBAHA.110.213496; Spiegel S, 1999, J LEUKOCYTE BIOL, V65, P341, DOI 10.1002/jlb.65.3.341; Strom K, 2009, FASEB J, V23, P2307, DOI 10.1096/fj.08-120923; Szczepankiewicz BG, 2006, J MED CHEM, V49, P3563, DOI 10.1021/jm060199b; Turpeinen T, 2010, J PHARMACOL EXP THER, V333, P310, DOI 10.1124/jpet.109.157438; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Wang J, 2014, AM J PHYSIOL-ENDOC M, V306, pE756, DOI 10.1152/ajpendo.00549.2013; Zhang WL, 2013, PROSTAG OTH LIPID M, V106, P62, DOI 10.1016/j.prostaglandins.2013.06.001	46	48	51	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32178	32185		10.1074/jbc.M114.601096	http://dx.doi.org/10.1074/jbc.M114.601096			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25253697	Green Published, hybrid			2022-12-25	WOS:000345314700045
J	Miyanaga, A; Cieslak, J; Shinohara, Y; Kudo, F; Eguchi, T				Miyanaga, Akimasa; Cieslak, Jolanta; Shinohara, Yuji; Kudo, Fumitaka; Eguchi, Tadashi			The Crystal Structure of the Adenylation Enzyme VinN Reveals a Unique beta-Amino Acid Recognition Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASE; ACYL-AMP LIGASE; MYCOBACTERIUM-TUBERCULOSIS; STARTER UNIT; SUBSTRATE-SPECIFICITY; CONFERRING CODE; BIOSYNTHESIS; DOMAINS; MODEL; ANTIBIOTICS	Adenylation enzymes play important roles in the biosynthesis and degradation of primary and secondary metabolites. Mechanistic insights into the recognition of alpha-amino acid substrates have been obtained for alpha-amino acid adenylation enzymes. The Asp residue is invariant and is essential for the stabilization of the alpha-amino group of the substrate. In contrast, the beta-amino acid recognition mechanism of adenylation enzymes is still unclear despite the importance of beta-amino acid activation for the biosynthesis of various natural products. Herein, we report the crystal structure of the stand-alone adenylation enzyme VinN, which specifically activates (2S, 3S)-3-methylaspartate (3-MeAsp) in vicenistatin biosynthesis. VinN has an overall structure similar to that of other adenylation enzymes. The structure of the complex with 3-MeAsp revealed that a conserved Asp(230) residue is used in the recognition of the beta-amino group of 3-MeAsp similar to alpha-amino acid adenylation enzymes. A mutational analysis and structural comparison with alpha-amino acid adenylation enzymes showed that the substrate-binding pocket of VinN has a unique architecture to accommodate 3-MeAsp as a beta-amino acid substrate. Thus, the VinN structure allows the first visualization of the interaction of an adenylation enzyme with a beta-amino acid and provides new mechanistic insights into the selective recognition of beta-amino acids in this family of enzymes.	[Miyanaga, Akimasa; Kudo, Fumitaka] Tokyo Inst Technol, Dept Chem, Meguro Ku, Tokyo 1528551, Japan; [Cieslak, Jolanta; Shinohara, Yuji; Eguchi, Tadashi] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528551, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Eguchi, T (corresponding author), Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, 2-12-1 O Okayama, Tokyo 1528551, Japan.	eguchi@cms.titech.ac.jp	Eguchi, Tadashi/B-9339-2015; Kudo, Fumitaka/C-9216-2015; Miyanaga, Akimasa/C-1472-2015	Eguchi, Tadashi/0000-0002-7830-7104; Kudo, Fumitaka/0000-0002-4788-0063; Miyanaga, Akimasa/0000-0003-2219-6051	Japanese Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science; Nagase Science and Technology Foundation; Takeda Science Foundation	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nagase Science and Technology Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by grants-in-aid for scientific research in innovative areas from the Japanese Ministry of Education, Culture, Sports, Science and Technology, grants-in-aid for young scientists (B) from the Japan Society for the Promotion of Science, the Nagase Science and Technology Foundation, and the Takeda Science Foundation.	Amagai K, 2013, CHEMBIOCHEM, V14, P1998, DOI 10.1002/cbic.201300370; Arora P, 2009, NAT CHEM BIOL, V5, P166, DOI 10.1038/nchembio.143; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Chen CY, 2009, P NATL ACAD SCI USA, V106, P3764, DOI 10.1073/pnas.0900266106; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Drake EJ, 2010, BIOCHEMISTRY-US, V49, P9292, DOI 10.1021/bi101226n; Du LQ, 2008, BIOCHEMISTRY-US, V47, P11473, DOI 10.1021/bi801363b; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eppelmann K, 2002, BIOCHEMISTRY-US, V41, P9718, DOI 10.1021/bi0259406; Fortin PD, 2007, NATURE, V448, P824, DOI 10.1038/nature06068; Goyal A, 2006, ACTA CRYSTALLOGR F, V62, P350, DOI 10.1107/S1744309106005938; Goyal A, 2012, J MOL BIOL, V416, P221, DOI 10.1016/j.jmb.2011.12.031; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Herbst DA, 2013, J BIOL CHEM, V288, P1991, DOI 10.1074/jbc.M112.420182; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hughes AJ, 2011, CHEM BIOL, V18, P165, DOI 10.1016/j.chembiol.2010.12.014; Jorgensen H, 2009, CHEM BIOL, V16, P1109, DOI 10.1016/j.chembiol.2009.09.014; Khayatt BI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062136; Kudo F, 2014, NAT PROD REP, V31, P1056, DOI 10.1039/c4np00007b; Lee TV, 2010, J BIOL CHEM, V285, P2415, DOI 10.1074/jbc.M109.071324; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maruyama C, 2012, NAT CHEM BIOL, V8, P791, DOI [10.1038/NCHEMBIO.1040, 10.1038/nchembio.1040]; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; Mootz HD, 1997, J BACTERIOL, V179, P6843, DOI 10.1128/jb.179.21.6843-6850.1997; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishio M, 2014, PHYS CHEM CHEM PHYS, V16, P12648, DOI 10.1039/c4cp00099d; Rachid S, 2007, J BIOL CHEM, V282, P21810, DOI 10.1074/jbc.M703439200; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Reger AS, 2008, BIOCHEMISTRY-US, V47, P8016, DOI 10.1021/bi800696y; Rouhiainen L, 2004, APPL ENVIRON MICROB, V70, P686, DOI 10.1128/AEM.70.2.686-692.2004; SHINDO K, 1993, J ANTIBIOT, V46, P1076, DOI 10.7164/antibiotics.46.1076; Shinohara Y, 2011, J AM CHEM SOC, V133, P18134, DOI 10.1021/ja208927r; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Stevens BW, 2006, BIOCHEMISTRY-US, V45, P15495, DOI 10.1021/bi061788m; Takaishi M, 2013, J ANTIBIOT, V66, P691, DOI 10.1038/ja.2013.76; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Thirlway J, 2012, ANGEW CHEM INT EDIT, V51, P7181, DOI 10.1002/anie.201202043; Udwary DW, 2007, P NATL ACAD SCI USA, V104, P10376, DOI 10.1073/pnas.0700962104; Uguru GC, 2004, J AM CHEM SOC, V126, P5032, DOI 10.1021/ja048778y; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Van Lanen SG, 2006, J BIOL CHEM, V281, P29633, DOI 10.1074/jbc.M605887200; Villiers BRM, 2009, CHEMBIOCHEM, V10, P671, DOI 10.1002/cbic.200800553; Wackler B, 2012, CHEMBIOCHEM, V13, P1798, DOI 10.1002/cbic.201200187; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Yonus H, 2008, J BIOL CHEM, V283, P32484, DOI 10.1074/jbc.M800557200	48	32	32	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31448	31457		10.1074/jbc.M114.602326	http://dx.doi.org/10.1074/jbc.M114.602326			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25246523	hybrid, Green Published			2022-12-25	WOS:000344549900047
J	Chuang, C; Ramaker, MA; Kaur, S; Csomos, RA; Kroner, KT; Bleedorn, JA; Schaefer, SL; Muir, P				Chuang, Connie; Ramaker, Megan A.; Kaur, Sirjaut; Csomos, Rebecca A.; Kroner, Kevin T.; Bleedorn, Jason A.; Schaefer, Susan L.; Muir, Peter			Radiographic Risk Factors for Contralateral Rupture in Dogs with Unilateral Cranial Cruciate Ligament Rupture	PLOS ONE			English	Article							PLATEAU LEVELING OSTEOTOMY; STIFLE JOINT; OSTEOARTHRITIS; SYNOVITIS; DISEASE; PROGRESSION; PREVALENCE; DEFICIENCY; WEIGHT; ANGLES	Background: Complete cranial cruciate ligament rupture (CR) is a common cause of pelvic limb lameness in dogs. Dogs with unilateral CR often develop contralateral CR over time. Although radiographic signs of contralateral stifle joint osteoarthritis (OA) influence risk of subsequent contralateral CR, this risk has not been studied in detail. Methodology/Principal Findings: We conducted a retrospective longitudinal cohort study of client-owned dogs with unilateral CR to determine how severity of radiographic stifle synovial effusion and osteophytosis influence risk of contralateral CR over time. Detailed survival analysis was performed for a cohort of 85 dogs after case filtering of an initial sample population of 513 dogs. This population was stratified based on radiographic severity of synovial effusion (graded on a scale of 0, 1, and 2) and severity of osteophytosis (graded on a scale of 0, 1, 2, and 3) of both index and contralateral stifle joints using a reproducible scoring method. Severity of osteophytosis in the index and contralateral stifles was significantly correlated. Rupture of the contralateral cranial cruciate ligament was significantly influenced by radiographic OA in both the index and contralateral stifles at diagnosis. Odds ratio for development of contralateral CR in dogs with severe contralateral radiographic stifle effusion was 13.4 at one year after diagnosis and 11.4 at two years. Odds ratio for development of contralateral CR in dogs with severe contralateral osteophytosis was 9.9 at one year after diagnosis. These odds ratios were associated with decreased time to contralateral CR. Breed, age, body weight, gender, and tibial plateau angle did not significantly influence time to contralateral CR. Conclusion: Subsequent contralateral CR is significantly influenced by severity of radiographic stifle effusion and osteophytosis in the contralateral stifle, suggesting that synovitis and arthritic joint degeneration are significant factors in the disease mechanism underlying the arthropathy.	[Muir, Peter] Univ Wisconsin, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA; Univ Wisconsin, Sch Vet Med, Dept Surg Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Muir, P (corresponding author), Univ Wisconsin, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA.	muirp@vetmed.wisc.edu	Bleedorn, Jason A/AAE-2115-2019; Mickelson, Megan/AAB-4563-2020; Muir, Peter/AAH-8057-2021	Bleedorn, Jason A/0000-0003-2987-7722; Mickelson, Megan/0000-0002-8197-9315; Muir, Peter/0000-0003-0028-6005	Merial Summer Scholars Program, University of Wisconsin-Madison, School of Veterinary Medicine; Clinical and Translational Science Award (CTSA) program, through the NIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000427]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER	Merial Summer Scholars Program, University of Wisconsin-Madison, School of Veterinary Medicine; Clinical and Translational Science Award (CTSA) program, through the NIH National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Connie Chuang was supported by the Merial Summer Scholars Program, University of Wisconsin-Madison, School of Veterinary Medicine. The project described was also supported by the Clinical and Translational Science Award (CTSA) program, through the NIH National Center for Advancing Translational Sciences (NCATS), grant UL1TR000427. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Abel SB, 2003, AM J VET RES, V64, P1117, DOI 10.2460/ajvr.2003.64.1117; BENNETT D, 1988, J SMALL ANIM PRACT, V29, P275, DOI 10.1111/j.1748-5827.1988.tb02286.x; Bleedorn JA, 2011, VET SURG, V40, P531, DOI 10.1111/j.1532-950X.2011.00841.x; Buote N, 2009, VET SURG, V38, P481, DOI 10.1111/j.1532-950X.2009.00532.x; Cabrera SY, 2008, JAVMA-J AM VET MED A, V232, P889, DOI 10.2460/javma.232.6.889; Comerford EJ, 2011, VET COMP ORTHOPAED, V24, P91, DOI 10.3415/VCOT-10-04-0055; COOPER C, 1992, ANN RHEUM DIS, V51, P80, DOI 10.1136/ard.51.1.80; de Bruin T, 2007, VET REC, V161, P745, DOI 10.1136/vr.161.22.745; Doom M, 2008, VET IMMUNOL IMMUNOP, V125, P143, DOI 10.1016/j.vetimm.2008.05.023; DOVERSPIKE M, 1993, J AM ANIM HOSP ASSOC, V29, P167; Erne JB, 2009, JAVMA-J AM VET MED A, V235, P386, DOI 10.2460/javma.235.4.386; Fuller MC, 2014, JAVMA-J AM VET MED A, V244, P328, DOI 10.2460/javma.244.3.328; GOLDBERG VM, 1982, J BONE JOINT SURG AM, V64, P900, DOI 10.2106/00004623-198264060-00014; Gordon-Evans WJ, 2013, JAVMA-J AM VET MED A, V243, P675, DOI 10.2460/javma.243.5.675; Hill CL, 2001, J RHEUMATOL, V28, P1330; Inauen R, 2009, VET COMP ORTHOPAED, V22, P16, DOI 10.3415/VCOT-07-08-0078; Innes JF, 2004, VET RADIOL ULTRASOUN, V45, P143, DOI 10.1111/j.1740-8261.2004.04024.x; Kobayashi S, 2006, J ORTHOP RES, V24, P1509, DOI 10.1002/jor.20183; Krasnokutsky S, 2011, ARTHRITIS RHEUM-US, V63, P2983, DOI 10.1002/art.30471; Might KR, 2013, VET SURG, V42, P392, DOI 10.1111/j.1532-950X.2012.01064.x; MOORE KW, 1995, AUST VET J, V72, P281, DOI 10.1111/j.1751-0813.1995.tb03555.x; Mostafa AA, 2009, AM J VET RES, V70, P498, DOI 10.2460/ajvr.70.4.498; Muir P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025331; Nelson SA, 2013, VET SURG, V42, P38, DOI 10.1111/j.1532-950X.2012.01052.x; Nielen ALJ, 2001, AM J VET RES, V62, P1198, DOI 10.2460/ajvr.2001.62.1198; Sabanci SS, 2014, VET COMP ORTHOPAED, V27, P135, DOI 10.3415/VCOT-13-04-0043; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; Sumner JP, 2010, VET SURG, V39, P936, DOI 10.1111/j.1532-950X.2010.00738.x; WHITEHAIR JG, 1993, J AM VET MED ASSOC, V203, P1016; Wilke VL, 2006, JAVMA-J AM VET MED A, V228, P61, DOI 10.2460/javma.228.1.61; Wilke VL, 2005, JAVMA-J AM VET MED A, V227, P1604, DOI 10.2460/javma.2005.227.1604; Witsberger TH, 2008, JAVMA-J AM VET MED A, V232, P1818, DOI 10.2460/javma.232.12.1818	32	27	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e106389	10.1371/journal.pone.0106389	http://dx.doi.org/10.1371/journal.pone.0106389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254499	Green Published, gold, Green Submitted			2022-12-25	WOS:000344862300009
J	Edvardsen, RB; Leininger, S; Kleppe, L; Skaftnesmo, KO; Wargelius, A				Edvardsen, Rolf B.; Leininger, Sven; Kleppe, Lene; Skaftnesmo, Kai Ove; Wargelius, Anna			Targeted Mutagenesis in Atlantic Salmon (Salmo salar L.) Using the CRISPR/Cas9 System Induces Complete Knockout Individuals in the F0 Generation	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; RAINBOW-TROUT; OCULOCUTANEOUS ALBINISM; XENOPUS-TROPICALIS; TYROSINASE GENE; IMMUNE-SYSTEM; FISH EMBRYOS; MEDAKA FISH; ZEBRAFISH; GENOME	Understanding the biological function behind key proteins is of great concern in Atlantic salmon, both due to a high commercial importance and an interesting life history. Until recently, functional studies in salmonids appeared to be difficult. However, the recent discovery of targeted mutagenesis using the CRISPR/Cas9 (clustered regularly interspaced palindromic repeats/CRISPR-associated) system enables performing functional studies in Atlantic salmon to a great extent. We used the CRISPR/Cas9 system to target two genes involved in pigmentation, tyrosinase (tyr) and solute carrier family 45, member 2 (slc45a2). Embryos were assayed for mutation rates at the 17 somite stage, where 40 and 22% of all injected embryos showed a high degree of mutation induction for slc45a2 and tyr, respectively. At hatching this mutation frequency was also visible for both targeted genes, displaying a graded phenotype ranging from complete lack of pigmentation to partial loss and normal pigmentation. CRISPRslc45a2/Cas9 injected embryos showing a complete lack of pigmentation or just a few spots of pigments also lacked wild type sequences when assaying more than 80 (slc45a2) sequence clones from whole embryos. This indicates that CRISPR/Cas9 can induce double-allelic knockout in the F0 generation. However, types and frequency of indels might affect the phenotype. Therefore, the variation of indels was assayed in the graded pigmentation phenotypes produced by CRISPR/Cas9-slc45a2. The results show a tendency for fewer types of indels formed in juveniles completely lacking pigmentation compared to juveniles displaying partial pigmentation. Another interesting observation was a high degree of the same indel type in different juveniles. This study shows for the first time successful use of the CRISPR/Cas9 technology in a marine cold water species. Targeted double-allelic mutations were obtained and, though the level of mosaicism has to be considered, we demonstrate that F0 fish can be used for functional studies in Atlantic salmon.	[Edvardsen, Rolf B.; Leininger, Sven; Kleppe, Lene; Skaftnesmo, Kai Ove; Wargelius, Anna] Inst Marine Res, N-5024 Bergen, Norway	Institute of Marine Research - Norway	Wargelius, A (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	anna.wargelius@imr.no	Skaftnesmo, kai ove/AAF-6071-2021; Kleppe, Lene/AGH-3308-2022	Edvardsen, Rolf/0000-0001-8430-8042	Norwegian Research Council [221648/O30]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	The project was supported by the Norwegian Research Council (http://www.forskningsradet.no), project number 221648/O30. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Blitz IL, 2013, GENESIS, V51, P827, DOI 10.1002/dvg.22719; Boonanuntanasarn S, 2005, BIOCHEM BIOPH RES CO, V336, P438, DOI 10.1016/j.bbrc.2005.08.113; Boonanuntanasarn S, 2004, PIGM CELL RES, V17, P413, DOI 10.1111/j.1600-0749.2004.00166.x; Boonanuntanasarn S, 2003, BIOCHEM BIOPH RES CO, V310, P1089, DOI 10.1016/j.bbrc.2003.09.127; Boonanuntanasarn S, 2002, MAR BIOTECHNOL, V4, P256, DOI 10.1007/s10126-002-0017-x; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Davidson WS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-403; Dong ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028897; Dooley CM, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12053; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Fukamachi S, 2008, GENETICS, V178, P761, DOI 10.1534/genetics.107.073387; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gorodilov YN, 1996, ENVIRON BIOL FISH, V47, P109, DOI 10.1007/BF00005034; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Iida A, 2004, PIGM CELL RES, V17, P158, DOI 10.1046/j.1600-0749.2003.00122.x; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Koga A, 1999, PIGM CELL RES, V12, P252, DOI 10.1111/j.1600-0749.1999.tb00758.x; Li M, 2014, GENETICS; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Page-McCaw PS, 2004, NAT NEUROSCI, V7, P1329, DOI 10.1038/nn1344; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Yano A, 2013, EVOL APPL, V6, P486, DOI 10.1111/eva.12032; Yoshizaki G, 2000, INT J DEV BIOL, V44, P323	32	106	117	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108622	10.1371/journal.pone.0108622	http://dx.doi.org/10.1371/journal.pone.0108622			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254960	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000344862300099
J	Han, DS; Chu-Su, Y; Chiang, CK; Tseng, FY; Tseng, PH; Chen, CL; Wu, KD; Yang, WS				Han, Der-Sheng; Chu-Su, Yu; Chiang, Chih-Kang; Tseng, Fen-Yu; Tseng, Ping-Huei; Chen, Chi-Ling; Wu, Kwan-Dun; Yang, Wei-Shiung			Serum Myostatin Is Reduced in Individuals with Metabolic Syndrome	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SKELETAL-MUSCLE MASS; MICE; DIFFERENTIATION; ELISA	Aims: Myostatin is a negative regulator of skeletal muscle mass and may also modulate energy metabolism secondarily. We aim to investigate the relationship between serum myostatin and the metabolic variables in diabetic (DM) and non-diabetic subjects. Materials and Methods: A cross-sectional study recruiting 246 consecutive DM patients and 82 age-and gender-matched non-diabetic individuals at a medical center was conducted. The variables of anthropometry and blood chemistry were obtained. Serum myostatin level was measured with enzyme immunoassay. Results: DM group had lower serum myostatin compared with non-diabetics (7.82 versus 9.28 ng/ml, p<0.01). Sixty-two percent of the recruited individuals had metabolic syndrome (MetS). The patients with MetS had significantly lower serum myostatin than those without (7.39 versus 9.49 ng/ml, p<0.001). The serum myostatin level decreased with increasing numbers of the MetS components (p for trend<0.001). The patients with higher body mass index, larger abdominal girth, lower high-density lipoprotein cholesterol (HDL-C), and higher triglycerides had lower serum myostatin than those without. The serum myostatin level was independently negatively related to larger abdominal girth, higher triglycerides, and lower HDL-C after adjustment. The odds ratios for MetS, central obesity, low HDL-C, high triglycerides, and DM were 0.85, 0.88, 0.89, 0.85, and 0.92, respectively, when serum myostatin increased per 1 ng/mL, in the binary logistic regression models. Conclusions: Lower serum myostatin independently associated with MetS, central obesity, low HDL-C, and high triglycerides after adjustment. Higher serum myostatin is associated with favorable metabolic profiles.	[Han, Der-Sheng] Natl Taiwan Univ Hosp, BeiHu Branch, Dept Phys Med & Rehabil, Taipei 100, Taiwan; [Han, Der-Sheng] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei 100, Taiwan; [Chu-Su, Yu] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 100, Taiwan; [Chiang, Chih-Kang; Tseng, Fen-Yu; Tseng, Ping-Huei; Wu, Kwan-Dun; Yang, Wei-Shiung] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chu-Su, Yu] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Han, Der-Sheng; Tseng, Ping-Huei; Chen, Chi-Ling; Yang, Wei-Shiung] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Chen, Chi-Ling] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Yang, Wei-Shiung] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Wu, KD (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	kdwu@ntuh.gov.tw; wsyang@ntu.edu.tw	Tseng, Ping-Huei/GZA-8772-2022	CHIANG, CHIH-KANG/0000-0001-9021-4616; YANG, WEI-SHIUNG/0000-0001-5087-373X; HAN, DER-SHENG/0000-0001-7642-8060; WU, KWAN-DUN/0000-0002-3339-1509; TSENG, PING-HUEI/0000-0002-7483-7538; Tseng, Fen-Yu/0000-0003-1571-5255	National Taiwan University Hospital (NTUH) [99-M1401, 100-M1694, 101-S1919]; National Science Council (NSC) of Taiwan [100-2314-B-002-014, 100-2314-B-002-083]	National Taiwan University Hospital (NTUH); National Science Council (NSC) of Taiwan(Ministry of Science and Technology, Taiwan)	The study was sponsored by grants from National Taiwan University Hospital (NTUH 99-M1401, 100-M1694, and 101-S1919) and National Science Council (NSC 100-2314-B-002-014, 100-2314-B-002-083) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Brandt C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037236; Chien YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071900; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Feldman BJ, 2006, P NATL ACAD SCI USA, V103, P15675, DOI 10.1073/pnas.0607501103; Guo W, 2008, J BIOL CHEM, V283, P9136, DOI 10.1074/jbc.M708968200; Han DS, 2011, CLIN ENDOCRINOL, V75, P857, DOI 10.1111/j.1365-2265.2011.04120.x; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Hittel DS, 2009, DIABETES, V58, P30, DOI 10.2337/db08-0943; Johnson DW, 2007, NEPHROLOGY, V12, P391, DOI 10.1111/j.1440-1797.2007.00804.x; JONES G, 1994, J IMMUNOL METHODS, V177, P1, DOI 10.1016/0022-1759(94)90136-8; Kim HS, 2001, BIOCHEM BIOPH RES CO, V281, P902, DOI 10.1006/bbrc.2001.4435; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lin J, 2002, BIOCHEM BIOPH RES CO, V291, P701, DOI 10.1006/bbrc.2002.6500; Nguyen MH, 2011, THESCIENTIFICWORLDJO, V11, P1525, DOI 10.1100/tsw.2011.137; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Rebbapragada A, 2003, MOL CELL BIOL, V23, P7230, DOI 10.1128/MCB.23.20.7230-7242.2003; Reisz-Porszasz S, 2003, AM J PHYSIOL-ENDOC M, V285, pE876, DOI 10.1152/ajpendo.00107.2003; Rios R, 2004, ENDOCRINOLOGY, V145, P2795, DOI 10.1210/en.2003-1166; Shim WS, 2006, DIABETES RES CLIN PR, V73, P284, DOI 10.1016/j.diabres.2006.02.001; Wintgens KF, 2012, CLIN CHIM ACTA, V413, P1288, DOI 10.1016/j.cca.2012.04.023; Yang WS, 2007, AM J CLIN NUTR, V86, P509, DOI 10.1093/ajcn/86.2.509; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	27	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108230	10.1371/journal.pone.0108230	http://dx.doi.org/10.1371/journal.pone.0108230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254550	Green Submitted, Green Published, gold			2022-12-25	WOS:000344862300065
J	Bettenworth, D; Lenz, P; Krausewitz, P; Bruckner, M; Ketelhut, S; Domagk, D; Kemper, B				Bettenworth, Dominik; Lenz, Philipp; Krausewitz, Philipp; Brueckner, Markus; Ketelhut, Steffi; Domagk, Dirk; Kemper, Bjoern			Quantitative Stain-Free and Continuous Multimodal Monitoring of Wound Healing In Vitro with Digital Holographic Microscopy	PLOS ONE			English	Article							PHASE-CONTRAST MICROSCOPY; CELL-PROLIFERATION; CACO-2 CELLS; GROWTH; MIGRATION; ASSAY; WATER; PHOSPHORYLATION; EXPRESSION; APOPTOSIS	Impaired epithelial wound healing has significant pathophysiological implications in several conditions including gastrointestinal ulcers, anastomotic leakage and venous or diabetic skin ulcers. Promising drug candidates for accelerating wound closure are commonly evaluated in in vitro wound assays. However, staining procedures and discontinuous monitoring are major drawbacks hampering accurate assessment of wound assays. We therefore investigated digital holographic microscopy (DHM) to appropriately monitor wound healing in vitro and secondly, to provide multimodal quantitative information on morphological and functional cell alterations as well as on motility changes upon cytokine stimulation. Wound closure as reflected by proliferation and migration of Caco-2 cells in wound healing assays was studied and assessed in time-lapse series for 40 h in the presence of stimulating epidermal growth factor (EGF) and inhibiting mitomycin c. Therefore, digital holograms were recorded continuously every thirty minutes. Morphological changes including cell thickness, dry mass and tissue density were analyzed by data from quantitative digital holographic phase microscopy. Stimulation of Caco-2 cells with EGF or mitomycin c resulted in significant morphological changes during wound healing compared to control cells. In conclusion, DHM allows accurate, stain-free and continuous multimodal quantitative monitoring of wound healing in vitro and could be a promising new technique for assessment of wound healing.	[Bettenworth, Dominik; Lenz, Philipp; Krausewitz, Philipp; Brueckner, Markus; Domagk, Dirk] Univ Hosp Munster, Dept Med B, Munster, Germany; [Ketelhut, Steffi; Kemper, Bjoern] Univ Munster, Ctr Biomed Opt & Photon, D-48149 Munster, Germany; [Ketelhut, Steffi; Kemper, Bjoern] Univ Munster, Biomed Technol Ctr, D-48149 Munster, Germany	University of Munster; University of Munster; University of Munster	Bettenworth, D (corresponding author), Univ Hosp Munster, Dept Med B, Munster, Germany.	dominik.bettenworth@ukmuenster.de; bkemper@uni-muenster.de		Kemper, Bjorn/0000-0003-3693-9397; Bettenworth, Dominik/0000-0002-1435-4825	Deutsche Forschungsgemeinschaft; University of Muenster; German Federal Ministry of Education and Research (BMBF) [FKZ13N10937]; Faculty of Medicine, Westfalische Wilhelms-Universitat Munster; Deutsche Forschungsgemeinschaft, Munster, Germany [SFB 656]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Muenster; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Faculty of Medicine, Westfalische Wilhelms-Universitat Munster; Deutsche Forschungsgemeinschaft, Munster, Germany(German Research Foundation (DFG))	The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Fund of University of Muenster. The authors also gratefully acknowledge partial financial support from the German Federal Ministry of Education and Research (BMBF) to B. K. within the focus program "Biophotonics, FKZ13N10937" (URL: http://www.bmbf.de/en/index.php). P. Lenz was supported by a research fellowship from the Faculty of Medicine, Westfalische Wilhelms-Universitat Munster and the Deutsche Forschungsgemeinschaft, collaborative research center SFB 656, Munster, Germany (URL: http://campus.uni-muenster.de/index.php?id = 31&L = 1). M. Bruckner was supported by a "Gerok" rotational position of the Deutsche Forschungsgemeinschaft (DFG) (URL: http://www.dfg.de/en/index.jsp). D. Bettenworth was supported by a research fellowship from the Faculty of Medicine, Westfalische Wilhelms-Universitat Munster (URL: http://campus.uni-muenster.de/index.php?id = 31&L = 1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARER R, 1952, NATURE, V169, P366, DOI 10.1038/169366b0; Basson MD, 2002, METABOLISM, V51, P1525, DOI 10.1053/meta.2002.36303; Bauwens A, 2011, THROMB HAEMOSTASIS, V105, P515, DOI 10.1160/TH10-02-0140; BISHOP WP, 1994, AM J PHYSIOL-GASTR L, V267, pG892, DOI 10.1152/ajpgi.1994.267.5.G892; BLAIS A, 1987, J MEMBRANE BIOL, V99, P113, DOI 10.1007/BF01871231; Bonfiglio V, 2006, EXP EYE RES, V83, P1366, DOI 10.1016/j.exer.2006.07.014; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; BURK RR, 1973, P NATL ACAD SCI USA, V70, P369, DOI 10.1073/pnas.70.2.369; Carl D, 2004, APPL OPTICS, V43, P6536, DOI 10.1364/AO.43.006536; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen MJ, 2008, CURR NEUROPHARMACOL, V6, P102, DOI 10.2174/157015908784533879; CIACCI C, 1993, GASTROENTEROLOGY, V105, P93, DOI 10.1016/0016-5085(93)90014-4; Coffey RJ, 1995, J CLIN GASTROENTEROL, V21, pS36; CRISSMAN HA, 1973, J CELL BIOL, V59, P766, DOI 10.1083/jcb.59.3.766; CROSS HS, 1991, AM J PHYSIOL, V261, pC1173; Curl CL, 2004, PFLUG ARCH EUR J PHY, V448, P462, DOI 10.1007/s00424-004-1248-7; DIGNASS A, 1994, J CLIN INVEST, V94, P376, DOI 10.1172/JCI117332; Ekpenyong AE, 2012, J BIOPHOTONICS, DOI [10.1002/jbio.201200113:n/a-n/a, DOI 10.1002/JBIO.201200113:N/A-N/A]; Flanigan TL, 2008, AM J SURG, V196, P683, DOI 10.1016/j.amjsurg.2008.07.016; Greve B, 2012, STRAHLENTHER ONKOL, V188, P1038, DOI 10.1007/s00066-012-0223-z; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Jones M. K., 1999, Frontiers in Bioscience, V4, pD303; Jourdain P, 2011, J NEUROSCI, V31, P11846, DOI 10.1523/JNEUROSCI.0286-11.2011; JUMARIE C, 1991, J CELL PHYSIOL, V149, P24, DOI 10.1002/jcp.1041490105; Karrasch T, 2006, J CELL PHYSIOL, V207, P809, DOI 10.1002/jcp.20626; Karrasch T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026340; Keese CR, 2004, P NATL ACAD SCI USA, V101, P1554, DOI 10.1073/pnas.0307588100; Kemper B, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2798639; Kemper B, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3431712; Kemper B, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2204609; Klokkers J, 2009, AM J PHYSIOL-RENAL, V297, pF693, DOI 10.1152/ajprenal.00136.2009; Kuhn J, 2012, ASSAY DRUG DEV TECHN; Kuhn J, 2013, ASSAY DRUG DEV TECHN, V11, P101, DOI 10.1089/adt.2012.476; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Langehanenberg P, 2008, APPL OPTICS, V47, pD176, DOI 10.1364/AO.47.00D176; Lee K, 2013, SENSORS-BASEL, V13, P4170, DOI 10.3390/s130404170; Lenz P, 2013, INTEGR BIOL-UK, V5, P624, DOI 10.1039/c2ib20227a; Leoni G, 2013, J CLIN INVEST, V123, P443, DOI 10.1172/JCI65831; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lloyd AC, 2013, CELL, V154, P1194, DOI 10.1016/j.cell.2013.08.053; Maltseva I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069642; Mann CJ, 2005, OPT EXPRESS, V13, P8693, DOI 10.1364/OPEX.13.008693; Marquet P, 2005, OPT LETT, V30, P468, DOI 10.1364/OL.30.000468; MERTZ HR, 1991, MED CLIN N AM, V75, P799, DOI 10.1016/S0025-7125(16)30412-6; Mir M, 2011, P NATL ACAD SCI USA, V108, P13124, DOI 10.1073/pnas.1100506108; Msaki A, 2011, MOL BIOL CELL, V22, P3032, DOI 10.1091/mbc.E11-04-0280; Neurath MF, 2010, GASTROENTEROLOGY, V139, P1837, DOI 10.1053/j.gastro.2010.10.007; Pantelis D, 2010, LANGENBECK ARCH SURG, V395, P1039, DOI 10.1007/s00423-010-0703-5; Park YK, 2008, P NATL ACAD SCI USA, V105, P13730, DOI 10.1073/pnas.0806100105; Pavillon N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030912; Perdikis DA, 1998, DIGEST DIS SCI, V43, P1537, DOI 10.1023/A:1018871016691; Popescu G, 2008, AM J PHYSIOL-CELL PH, V295, pC538, DOI 10.1152/ajpcell.00121.2008; Przibilla S, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.9.097001; Rappaz B, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3147385; ROSS DW, 1981, VIRCHOWS ARCH B, V37, P225, DOI 10.1007/BF02892571; Sakalar C, 2013, MOL CELL BIOCHEM, V383, P243, DOI 10.1007/s11010-013-1772-x; Shih YT, 2012, CELL SIGNAL, V24, P779, DOI 10.1016/j.cellsig.2011.11.013; Simon B, 2010, J BIOPHOTONICS, V3, P462, DOI 10.1002/jbio.200900094; Singh A, 2012, BIOINFORMATICS, V28, pI495, DOI 10.1093/bioinformatics/bts410; Walsh MF, 2004, CELL PROLIFERAT, V37, P427, DOI 10.1111/j.1365-2184.2004.00324.x; Wang YX, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/715843; Wang Z, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3656732; Wu SC, 2010, J AM PODIAT MED ASSN, V100, P385, DOI 10.7547/1000385; Zhao K, 2012, MOL BIOL REP, V39, P2607, DOI 10.1007/s11033-011-1013-x	64	61	61	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107317	10.1371/journal.pone.0107317	http://dx.doi.org/10.1371/journal.pone.0107317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251440	Green Submitted, Green Published, gold			2022-12-25	WOS:000342492700027
J	Chirayil, S; Wu, Q; Amezcua, C; Luebke, KJ				Chirayil, Sara; Wu, Qiong; Amezcua, Carlos; Luebke, Kevin J.			NMR Characterization of an Oligonucleotide Model of the MiR-21 Pre-Element	PLOS ONE			English	Article							RNA HAIRPIN LOOP; POSTTRANSCRIPTIONAL REGULATION; MICRORNA-21 TARGETS; NUCLEAR EXPORT; APICAL-LOOP; INVASION; MIRNA; RECOGNITION; BIOGENESIS; EXPRESSION	We have used NMR spectroscopy to characterize an oligonucleotide stem loop structure based on the pre-element of an oncogenic microRNA, miR-21. This predicted stem-loop structure is cleaved from the precursor of miR-21 (pre-miR-21) by the nuclease Dicer. It is also a critical feature recognized by the protein complex that converts the primary transcript (pri-miR-21) into the pre-miRNA. The secondary structure of the native sequence is poorly defined by NMR due to rapid exchange of imino protons with solvent; however, replacement of two adjacent putative GNU base pairs with GNC base pairs retains the conformation of the hairpin observed by chemical probing and stabilizes it sufficiently to observe most of the imino proton resonances of the molecule. The observed resonances are consistent with the predicted secondary structure. In addition, a peak due to a loop uridine suggests an interaction between it and a bulged uridine in the stem. Assignment of non-exchangeable proton resonances and characterization of NOEs and coupling constants allows inference of the following features of the structure: extrahelicity of a bulged adenosine, deviation from A-form geometry in a base-paired stem, and consecutive stacking of the adenosines in the 59 side of the loop, the guanosine of the closing base pair, and a cross-strand adenosine. Modeling of the structure by restrained molecular dynamics suggests a basis for the interaction between the loop uridine, the bulged uridine in the stem, and an ANU base pair in the stem.	[Chirayil, Sara; Luebke, Kevin J.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA; [Wu, Qiong; Amezcua, Carlos] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Amezcua, Carlos] Baxter Healthcare, Med Prod Div, Struct Elucidat Grp, Round Lake, IL USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Baxter International Inc	Luebke, KJ (corresponding author), SRI Int, Biosci Div, Harrisonburg, VA 22802 USA.	kevin.luebke@gmail.com			National Institute of General Medical Science [R01GM088842]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088842] Funding Source: NIH RePORTER	National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institute of General Medical Science, R01GM088842, to KJL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAIN FHT, 1995, J MOL BIOL, V250, P333, DOI 10.1006/jmbi.1995.0381; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bose D, 2012, ANGEW CHEM INT EDIT, V51, P1019, DOI 10.1002/anie.201106455; Butcher SE, 1997, EMBO J, V16, P7490, DOI 10.1093/emboj/16.24.7490; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Chirayil S, 2009, NUCLEIC ACIDS RES, V37, P5486, DOI 10.1093/nar/gkp549; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diaz JP, 2014, RNA, V20, P528, DOI 10.1261/rna.042911.113; Divakaran V, 2008, CIRC RES, V103, P1072, DOI 10.1161/CIRCRESAHA.108.183087; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fountain MA, 1996, BIOCHEMISTRY-US, V35, P6539, DOI 10.1021/bi952697k; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; JAEGER JA, 1993, BIOCHEMISTRY-US, V32, P12522, DOI 10.1021/bi00097a032; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Laing LG, 1996, BIOCHEMISTRY-US, V35, P13586, DOI 10.1021/bi961310q; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lunse CE, 2010, ANGEW CHEM INT EDIT, V49, P4674, DOI 10.1002/anie.200906919; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Maiti M, 2012, BIOORG MED CHEM LETT, V22, P1709, DOI 10.1016/j.bmcl.2011.12.103; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Moriyama T, 2009, MOL CANCER THER, V8, P1067, DOI 10.1158/1535-7163.MCT-08-0592; Murata A, 2013, BIOORG MED CHEM LETT, V23, P252, DOI 10.1016/j.bmcl.2012.10.108; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Schoniger C, 2013, BIOORGAN MED CHEM, V21, P6115, DOI 10.1016/j.bmc.2013.03.040; Schwalbe M, 2008, NUCLEIC ACIDS RES, V36, P1681, DOI 10.1093/nar/gkn006; Sich C, 1997, BIOCHEMISTRY-US, V36, P13989, DOI 10.1021/bi971207g; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; van Rooij E, 2008, CIRC RES, V103, P919, DOI 10.1161/CIRCRESAHA.108.183426; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; VANDENHOOGEN YT, 1988, EUR J BIOCHEM, V173, P295; VARANI G, 1991, Q REV BIOPHYS, V24, P479, DOI 10.1017/S0033583500003875; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yoo JS, 2001, BIOPHYS J, V80, P1957, DOI 10.1016/S0006-3495(01)76165-6; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zhang XX, 2010, NUCLEIC ACIDS RES, V38, P7689, DOI 10.1093/nar/gkq645; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	56	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108231	10.1371/journal.pone.0108231	http://dx.doi.org/10.1371/journal.pone.0108231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250627	Green Published, Green Submitted, gold			2022-12-25	WOS:000342492700098
J	Rankin, TL; Sponaugle, S				Rankin, Tauna L.; Sponaugle, Su			Characteristics of Settling Coral Reef Fish Are Related to Recruitment Timing and Success	PLOS ONE			English	Article							LARVAL-JUVENILE TRANSITION; LIFE-HISTORY TRAITS; POSTSETTLEMENT SURVIVAL; SELECTIVE MORTALITY; ENVIRONMENTAL-INFLUENCES; STEGASTES-PARTITUS; BICOLOR DAMSELFISH; DENSITY-DEPENDENCE; MARINE RESERVES; GROWTH	Many marine populations exhibit high variability in the recruitment of young into the population. While environmental cycles and oceanography explain some patterns of replenishment, the role of other growth-related processes in influencing settlement and recruitment is less clear. Examination of a 65-mo. time series of recruitment of a common coral reef fish, Stegastes partitus, to the reefs of the upper Florida Keys revealed that during peak recruitment months, settlement stage larvae arriving during dark lunar phases grew faster as larvae and were larger at settlement compared to those settling during the light lunar phases. However, the strength and direction of early trait-mediated selective mortality also varied by settlement lunar phase such that the early life history traits of 2-4 week old recruit survivors that settled across the lunar cycle converged to more similar values. Similarly, within peak settlement periods, early life history traits of settling larvae and selective mortality of recruits varied by the magnitude of the settlement event: larvae settling in larger events had longer PLDs and consequently were larger at settlement than those settling in smaller pulses. Traits also varied by recruitment habitat: recruits surviving in live coral habitat (vs rubble) or areas with higher densities of adult conspecifics were those that were larger at settlement. Reef habitats, especially those with high densities of territorial conspecifics, are more challenging habitats for young fish to occupy and small settlers (due to lower larval growth and/or shorter PLDs) to these habitats have a lower chance of survival than they do in rubble habitats. Settling reef fish are not all equal and the time and location of settlement influences the likelihood that individuals will survive to contribute to the population.	[Rankin, Tauna L.; Sponaugle, Su] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Biol & Fisheries, Miami, FL 33149 USA; [Rankin, Tauna L.] NOAA, Natl Marine Fisheries Serv, Off Habitat Conservat, Coral Reef Conservat Program, Silver Spring, MD USA; [Sponaugle, Su] Oregon State Univ, Hatfield Marine Sci Ctr, Dept Integrat Biol, Newport, OR 97365 USA	University of Miami; National Oceanic Atmospheric Admin (NOAA) - USA; Oregon State University	Sponaugle, S (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Biol & Fisheries, Miami, FL 33149 USA.	su.sponaugle@oregonstate.edu			National Science Foundation [OCE-9986359, OCE 0550732]; University of Miami Maytag Fellowship; Harding Michel Biological Oceanography Fellowship; National Oceanic and Atmospheric Administration Center for Sponsored Coastal Ocean Research [NA11NOS4780045]	National Science Foundation(National Science Foundation (NSF)); University of Miami Maytag Fellowship; Harding Michel Biological Oceanography Fellowship; National Oceanic and Atmospheric Administration Center for Sponsored Coastal Ocean Research(National Oceanic Atmospheric Admin (NOAA) - USA)	This study was made possible through National Science Foundation grants OCE-9986359 to S. Sponaugle and OCE 0550732 to R. K. Cowen, S. Sponaugle, C. Paris and V. Kourafalou. T. Rankin was also supported by a University of Miami Maytag Fellowship and Harding Michel Biological Oceanography Fellowship. During the preparation of the manuscript, S. Sponaugle received support from National Oceanic and Atmospheric Administration Center for Sponsored Coastal Ocean Research under award NA11NOS4780045 to the University of Miami. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2006, CORAL REEFS, V25, P19, DOI 10.1007/s00338-005-0044-y; Almany GR, 2004, ECOLOGY, V85, P2872, DOI 10.1890/03-3166; Almany GR, 2003, ECOLOGY, V84, P1920, DOI 10.1890/0012-9658(2003)084[1920:PEICRF]2.0.CO;2; ANDERSON J T, 1988, Journal of Northwest Atlantic Fishery Science, V8, P55; Baumann H, 2003, ICES J MAR SCI, V60, P243, DOI 10.1016/S1054-3139(03)00019-5; Ben-Tzvi O, 2007, LIMNOL OCEANOGR, V52, P2618, DOI 10.4319/lo.2007.52.6.2618; Bergenius MAJ, 2005, MAR BIOL, V147, P291, DOI 10.1007/s00227-005-1575-z; Bergenius MAJ, 2002, OECOLOGIA, V131, P521, DOI 10.1007/s00442-002-0918-4; Bonin MC, 2009, CORAL REEFS, V28, P265, DOI 10.1007/s00338-008-0451-y; Botello G, 2006, MAR ECOL PROG SER, V312, P149, DOI 10.3354/meps312149; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; CALEY MJ, 1993, MAR BIOL, V117, P33, DOI 10.1007/BF00346423; COWEN RK, 1991, MAR ECOL PROG SER, V69, P9, DOI 10.3354/meps069009; D'Alessandro E, 2007, MAR ECOL PROG SER, V331, P85, DOI 10.3354/meps331085; Doherty Peter J., 2002, P327, DOI 10.1016/B978-012615185-5/50019-0; Dorsey S., 1999, THESIS STATE U NEW Y; EMERY AR, 1973, COPEIA, P590; Emery AR, 1968, THESIS U MIAMI CORAL; Grorud-Colvert K, 2009, MAR BIOL, V156, P277, DOI 10.1007/s00227-008-1082-0; Hamilton SL, 2008, P NATL ACAD SCI USA, V105, P1561, DOI 10.1073/pnas.0707676105; Hawn AT, 2005, B MAR SCI, V77, P309; Hernandez-Leon S, 2002, J PLANKTON RES, V24, P935, DOI 10.1093/plankt/24.9.935; Hernandez-Leon S, 2008, FISH FISH, V9, P138, DOI 10.1111/j.1467-2979.2008.00272.x; Hixon MA, 2011, B MAR SCI, V87, P727, DOI 10.5343/bms.2010.1055; Hoey AS, 2004, OECOLOGIA, V139, P23, DOI 10.1007/s00442-004-1489-3; Holbrook SJ, 2003, OECOLOGIA, V135, P532, DOI 10.1007/s00442-003-1220-9; Holmes TH, 2006, MAR ECOL PROG SER, V317, P203, DOI 10.3354/meps317203; Holmes TH, 2009, OECOLOGIA, V159, P401, DOI 10.1007/s00442-008-1220-x; Houde Edward D., 2002, P64; JOHANNES R E, 1978, Environmental Biology of Fishes, V3, P65, DOI 10.1007/BF00006309; Johnson DW, 2008, OECOLOGIA, V155, P43, DOI 10.1007/s00442-007-0882-0; Johnson DW, 2012, MAR ECOL PROG SER, V471, P151, DOI 10.3354/meps10028; JONES GP, 1990, ECOLOGY, V71, P1691, DOI 10.2307/1937578; Lecchini D, 2007, J EXP MAR BIOL ECOL, V341, P85, DOI 10.1016/j.jembe.2006.10.006; Lemberget T, 2009, OECOLOGIA, V159, P83, DOI 10.1007/s00442-008-1212-x; Macpherson E, 2005, MAR BIOL, V148, P167, DOI 10.1007/s00227-005-0059-5; Marshall DJ, 2003, MAR ECOL PROG SER, V255, P145, DOI 10.3354/meps255145; McCormick MI, 2004, OIKOS, V106, P225, DOI 10.1111/j.0030-1299.2004.13131.x; Nemeth R.S., 1997, P1017; Nemeth RS, 1998, ENVIRON BIOL FISH, V53, P129, DOI 10.1023/A:1007402104047; Ohman MC, 1998, J EXP MAR BIOL ECOL, V225, P219, DOI 10.1016/S0022-0981(97)00224-4; RANDALL JOHN E., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMI, V5, P665; Rankin TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016814; Raventos N, 2005, ESTUAR COAST SHELF S, V63, P479, DOI 10.1016/j.ecss.2004.11.018; ROBERTSON DR, 1992, MAR BIOL, V114, P527, DOI 10.1007/BF00357250; ROBERTSON DR, 1988, ECOLOGY, V69, P370, DOI 10.2307/1940435; ROBERTSON DR, 1990, J EXP MAR BIOL ECOL, V144, P49; Samhouri JF, 2009, ECOLOGY, V90, P1009, DOI 10.1890/07-1161.1; SCHMALE MC, 1981, ANIM BEHAV, V29, P1172, DOI 10.1016/S0003-3472(81)80069-3; Searcy SP, 2001, ECOLOGY, V82, P2452; Shima JS, 2009, ECOLOGY, V90, P1255, DOI 10.1890/08-0029.1; Shima JS, 2003, ECOLOGY, V84, P46, DOI 10.1890/0012-9658(2003)084[0046:CDDEOC]2.0.CO;2; Sponaugle S, 2006, MAR ECOL PROG SER, V308, P1, DOI 10.3354/meps308001; Sponaugle S, 2005, LIMNOL OCEANOGR, V50, P1033, DOI 10.4319/lo.2005.50.4.1033; Sponaugle S, 2004, J FISH BIOL, V64, P34, DOI 10.1111/j.1095-8649.2004.00279.x; Sponaugle S, 2012, CORAL REEFS, V31, P641, DOI 10.1007/s00338-012-0915-y; Sponaugle S, 2011, AQUAT BIOL, V13, P263, DOI 10.3354/ab00370; Sponaugle S, 1996, MAR FRESHWATER RES, V47, P433, DOI 10.1071/MF9960433; Sponaugle S, 2006, INTEGR COMP BIOL, V46, P623, DOI 10.1093/icb/icl014; Steele MA, 1998, MAR ECOL PROG SER, V172, P115, DOI 10.3354/meps172115; SWEATMAN HPA, 1983, MAR BIOL, V75, P225, DOI 10.1007/BF00406006; TUPPER M, 1994, MAR ECOL PROG SER, V108, P225, DOI 10.3354/meps108225; VICTOR BC, 1986, ECOL MONOGR, V56, P145, DOI 10.2307/1942506; Vigliola L, 2002, OECOLOGIA, V131, P89, DOI 10.1007/s00442-001-0866-4; WILKINSON L, 1992, SYSTAT SYSTEM STAT; Wilson DT, 2002, MAR ECOL PROG SER, V231, P247, DOI 10.3354/meps231247; Zar JH, 1999, BIOSTATISTICAL ANAL	67	20	20	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108871	10.1371/journal.pone.0108871	http://dx.doi.org/10.1371/journal.pone.0108871			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250964	Green Submitted, Green Published, gold			2022-12-25	WOS:000342492700157
J	Simmons, G; Clarke, D; McKee, J; Young, P; Meers, J				Simmons, Greg; Clarke, Daniel; McKee, Jeff; Young, Paul; Meers, Joanne			Discovery of a Novel Retrovirus Sequence in an Australian Native Rodent (Melomys burtoni): A Putative Link between Gibbon Ape Leukemia Virus and Koala Retrovirus	PLOS ONE			English	Article							TRANSMISSION; EVOLUTION; INVASION	Gibbon ape leukaemia virus (GALV) and koala retrovirus (KoRV) share a remarkably close sequence identity despite the fact that they occur in distantly related mammals on different continents. It has previously been suggested that infection of their respective hosts may have occurred as a result of a species jump from another, as yet unidentified vertebrate host. To investigate possible sources of these retroviruses in the Australian context, DNA samples were obtained from 42 vertebrate species and screened using PCR in order to detect proviral sequences closely related to KoRV and GALV. Four proviral partial sequences totalling 2880 bases which share a strong similarity with KoRV and GALV were detected in DNA from a native Australian rodent, the grassland melomys, Melomys burtoni. We have designated this novel gammaretrovirus Melomys burtoni retrovirus (MbRV). The concatenated nucleotide sequence of MbRV shares 93% identity with the corresponding sequence from GALV-SEATO and 83% identity with KoRV. The geographic ranges of the grassland melomys and of the koala partially overlap. Thus a species jump by MbRV from melomys to koalas is conceivable. However the genus Melomys does not occur in mainland South East Asia and so it appears most likely that another as yet unidentified host was the source of GALV.	[Simmons, Greg; Meers, Joanne] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [Clarke, Daniel; Young, Paul] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia; [McKee, Jeff] Ecosure, West Burleigh, Qld, Australia	University of Queensland; University of Queensland; El Colegio de la Frontera Sur (ECOSUR)	Simmons, G (corresponding author), Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia.	g.simmons@uq.edu.au	Young, Paul R/A-6176-2010	Young, Paul R/0000-0002-2040-5190	Australian Research Council [LP0453692]	Australian Research Council(Australian Research Council)	This work was funded by Australian Research Council Linkage Grant no. LP0453692, http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Avila-Arcos MC, 2013, MOL BIOL EVOL, V30, P299, DOI 10.1093/molbev/mss223; Breed B, 2007, NATIVE RATS MICE; Bromham L, 2002, TRENDS ECOL EVOL, V17, P91, DOI 10.1016/S0169-5347(01)02394-1; BURTONBOY G, 1993, ARCH VIROL, V130, P289, DOI 10.1007/BF01309661; CALLAHAN R, 1979, J VIROL, V30, P124, DOI 10.1128/JVI.30.1.124-131.1979; CAMPBELL NJH, 1995, MOL ECOL, V4, P407, DOI 10.1111/j.1365-294X.1995.tb00234.x; CANFIELD PJ, 1988, AUST VET J, V65, P327, DOI 10.1111/j.1751-0813.1988.tb14518.x; Cui J, 2012, J GEN VIROL, V93, P2037, DOI 10.1099/vir.0.043760-0; DEPAOLI A, 1973, J AM VET MED ASSOC, V163, P624; Fiebig U, 2006, J VIROL, V80, P5651, DOI 10.1128/JVI.02597-05; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hanger JJ, 2000, J VIROL, V74, P4264, DOI 10.1128/JVI.74.9.4264-4272.2000; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; JOHNSEN DO, 1971, J AM VET MED ASSOC, V159, P563; Ladds PW., 2009, PATHOLOGY AUSTR NATI, P91; LIEBER MM, 1975, P NATL ACAD SCI USA, V72, P2315, DOI 10.1073/pnas.72.6.2315; Macdonald D, 2001, GIBBONS ENCY MAMMALS, P398; Martin J, 1999, J VIROL, V73, P2442, DOI 10.1128/JVI.73.3.2442-2449.1999; Martin R, 1983, COMPLETE BOOK AUSTR; Melzer A, 2000, CONSERV BIOL, V14, P619, DOI 10.1046/j.1523-1739.2000.99383.x; Miyazawa T, 2011, J VET MED SCI, V73, P65, DOI 10.1292/jvms.10-0250; Nowak M, 1999, MAMMALS WORLD, P1548; Oliveira NM, 2006, J VIROL, V80, P3104, DOI 10.1128/JVI.80.6.3104-3107.2006; Phillips SS, 2000, CONSERV BIOL, V14, P650, DOI 10.1046/j.1523-1739.2000.99387.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2018, FIGTREE; Redhead T, 1983, COMPLETE BOOK AUSTR, P370; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowe KC, 2008, MOL PHYLOGENET EVOL, V47, P84, DOI 10.1016/j.ympev.2008.01.001; Rulli SJ, 2008, J VIROL, V82, P6566, DOI 10.1128/JVI.01357-07; Shojima T, 2013, J VIROL; Simmons GS, 2012, AUST VET J, V90, P404, DOI 10.1111/j.1751-0813.2012.00964.x; Stoye JP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-241; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarlinton R, 2008, CELL MOL LIFE SCI, V65, P3413, DOI 10.1007/s00018-008-8499-y; Tarlinton R, 2005, J GEN VIROL, V86, P783, DOI 10.1099/vir.0.80547-0; Tarlinton RE, 2006, NATURE, V442, P79, DOI 10.1038/nature04841; TODARO GJ, 1975, VIROLOGY, V67, P335, DOI 10.1016/0042-6822(75)90435-3; Worely M, 1993, P AM ASS ZOO VET, P181; Xu WQ, 2013, P NATL ACAD SCI USA, V110, P11547, DOI 10.1073/pnas.1304704110	41	31	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e106954	10.1371/journal.pone.0106954	http://dx.doi.org/10.1371/journal.pone.0106954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251014	Green Published, gold			2022-12-25	WOS:000342492700021
J	Ragu, S; Dardalhon, M; Sharma, S; Iraqui, I; Buhagiar-Labarchede, G; Grondin, V; Kienda, G; Vernis, L; Chanet, R; Kolodner, RD; Huang, ME; Faye, G				Ragu, Sandrine; Dardalhon, Michele; Sharma, Sushma; Iraqui, Ismail; Buhagiar-Labarchede, Geraldine; Grondin, Virginie; Kienda, Guy; Vernis, Laurence; Chanet, Roland; Kolodner, Richard D.; Huang, Meng-Er; Faye, Gerard			Loss of the Thioredoxin Reductase Trr1 Suppresses the Genomic Instability of Peroxiredoxin tsa1 Mutants	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; YAP1 TRANSCRIPTION FACTOR; OXIDATIVE STRESS; DNA-DAMAGE; RIBONUCLEOTIDE REDUCTASE; NUCLEAR-LOCALIZATION; ESCHERICHIA-COLI; THIOL PEROXIDASE; REDOX REGULATION; IRON-METABOLISM	The absence of Tsa1, a key peroxiredoxin that scavenges H2O2 in Saccharomyces cerevisiae, causes the accumulation of a broad spectrum of mutations. Deletion of TSA1 also causes synthetic lethality in combination with mutations in RAD51 or several key genes involved in DNA double-strand break repair. In the present study, we propose that the accumulation of reactive oxygen species (ROS) is the primary cause of genome instability of tsa1 Delta cells. In searching for spontaneous suppressors of synthetic lethality of tsa1 Delta rad51 Delta double mutants, we identified that the loss of thioredoxin reductase Trr1 rescues their viability. The trr1 Delta mutant displayed a Can(R) mutation rate 5-fold lower than wild-type cells. Additional deletion of TRR1 in tsa1 Delta mutant reduced substantially the Can(R) mutation rate of tsa1 Delta strain (33-fold), and to a lesser extent, of rad51 Delta strain (4-fold). Loss of Trr1 induced Yap1 nuclear accumulation and over-expression of a set of Yap1-regulated oxidoreductases with antioxidant properties that ultimately re-equilibrate intracellular redox environment, reducing substantially ROS-associated DNA damages. This trr1 Delta -induced effect was largely thioredoxin-dependent, probably mediated by oxidized forms of thioredoxins, the primary substrates of Trr1. Thioredoxin Trx1 and Trx2 were constitutively and strongly oxidized in the absence of Trr1. In trx1 Delta trx2 Delta cells, Yap1 was only moderately activated; consistently, the trx1 Delta trx2 Delta double deletion failed to efficiently rescue the viability of tsa1 Delta rad51 Delta. Finally, we showed that modulation of the dNTP pool size also influences the formation of spontaneous mutation in trr1 Delta and trx1 Delta trx2 Delta strains. We present a tentative model that helps to estimate the respective impact of ROS level and dNTP concentration in the generation of spontaneous mutations.	[Ragu, Sandrine; Dardalhon, Michele; Iraqui, Ismail; Buhagiar-Labarchede, Geraldine; Grondin, Virginie; Kienda, Guy; Vernis, Laurence; Chanet, Roland; Huang, Meng-Er; Faye, Gerard] CNRS, UMR3348, F-91405 Orsay, France; [Ragu, Sandrine; Dardalhon, Michele; Iraqui, Ismail; Buhagiar-Labarchede, Geraldine; Grondin, Virginie; Kienda, Guy; Vernis, Laurence; Chanet, Roland; Huang, Meng-Er; Faye, Gerard] Inst Curie, Ctr Rech, F-91405 Orsay, France; [Sharma, Sushma] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Umea University; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Huang, ME (corresponding author), CNRS, UMR3348, F-91405 Orsay, France.	meng-er.huang@curie.fr	Vernis, Laurence/B-7414-2019; /L-1666-2018	Sharma, Sushma/0000-0003-2713-5813; /0000-0001-7878-0877	Centre National de la Recherche Scientifique and Institut Curie; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026017, R01GM026017] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique and Institut Curie(Centre National de la Recherche Scientifique (CNRS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by the Centre National de la Recherche Scientifique and the Institut Curie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boisnard S, 2009, EUKARYOT CELL, V8, P1429, DOI 10.1128/EC.00106-09; Camier S, 2007, FREE RADICAL BIO MED, V42, P1008, DOI 10.1016/j.freeradbiomed.2006.12.027; Carmel-Harel O, 2001, MOL MICROBIOL, V39, P595, DOI 10.1046/j.1365-2958.2001.02255.x; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; Collart M, 1993, CURRENT PROTOCOL S23; Dardalhon M, 2012, FREE RADICAL BIO MED, V52, P2254, DOI 10.1016/j.freeradbiomed.2012.04.004; Datta A, 2000, MOL CELL, V6, P593, DOI 10.1016/S1097-2765(00)00058-7; Davidson MB, 2012, EMBO J, V31, P895, DOI 10.1038/emboj.2011.485; de Groot MJL, 2007, MICROBIOL-SGM, V153, P3864, DOI 10.1099/mic.0.2007/009969-0; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Fu Y, 2008, FEMS MICROBIOL REV, V32, P908, DOI 10.1111/j.1574-6976.2008.00126.x; Garcia-Santamarina S, 2013, ANTIOXID REDOX SIGN, V18, P1549, DOI 10.1089/ars.2012.5037; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Godon C, 1998, J BIOL CHEM, V273, P22480, DOI 10.1074/jbc.273.35.22480; Gon S, 2011, P NATL ACAD SCI USA, V108, P19311, DOI 10.1073/pnas.1113664108; Gulshan K, 2011, J BIOL CHEM, V286, P34071, DOI 10.1074/jbc.M111.251298; Heer D, 2009, APPL ENVIRON MICROB, V75, P7631, DOI 10.1128/AEM.01649-09; Herrero E, 2008, BBA-GEN SUBJECTS, V1780, P1217, DOI 10.1016/j.bbagen.2007.12.004; Huang ME, 2005, MOL CELL, V17, P709, DOI 10.1016/j.molcel.2005.02.008; Huang ME, 2003, P NATL ACAD SCI USA, V100, P11529, DOI 10.1073/pnas.2035018100; Izawa S, 1999, J BIOL CHEM, V274, P28459, DOI 10.1074/jbc.274.40.28459; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Kemp M, 2008, FREE RADICAL BIO MED, V44, P921, DOI 10.1016/j.freeradbiomed.2007.11.008; Kumar C, 2011, EMBO J, V30, P2044, DOI 10.1038/emboj.2011.105; Lai LC, 2005, MOL CELL BIOL, V25, P4075, DOI 10.1128/MCB.25.10.4075-4091.2005; Lai LC, 2006, EUKARYOT CELL, V5, P1468, DOI 10.1128/EC.00107-06; Laureti L, 2013, DNA REPAIR, V12, P300, DOI 10.1016/j.dnarep.2013.01.009; Lea D, 1948, J GENET, V49, P264; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Lopez-Mirabal HR, 2008, BBA-MOL CELL RES, V1783, P629, DOI 10.1016/j.bbamcr.2007.10.013; Mason JT, 2006, BIOCHEMISTRY-US, V45, P13409, DOI 10.1021/bi061136y; Mihaylova VT, 2003, MOL CELL BIOL, V23, P3265, DOI 10.1128/MCB.23.9.3265-3273.2003; Monje-Casas F, 2004, BIOCHEM J, V383, P139, DOI 10.1042/BJ20040851; MULLER EGD, 1991, J BIOL CHEM, V266, P9194; Northam MR, 2010, GENETICS, V184, P27, DOI 10.1534/genetics.109.107482; Ogusucu R, 2009, J BIOL CHEM, V284, P5546, DOI 10.1074/jbc.M805526200; Okazaki S, 2005, ANTIOXID REDOX SIGN, V7, P327, DOI 10.1089/ars.2005.7.327; Okazaki S, 2007, MOL CELL, V27, P675, DOI 10.1016/j.molcel.2007.06.035; Park SG, 2000, J BIOL CHEM, V275, P5723, DOI 10.1074/jbc.275.8.5723; PARKER KR, 1987, MUTAT RES, V189, P11, DOI 10.1016/0165-1218(87)90028-0; Ragu S, 2007, P NATL ACAD SCI USA, V104, P9747, DOI 10.1073/pnas.0703192104; Sabouri N, 2008, NUCLEIC ACIDS RES, V36, P5660, DOI 10.1093/nar/gkn555; Salin H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-333; Sha W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074939; Shackelford RE, 2000, FREE RADICAL BIO MED, V28, P1387, DOI 10.1016/S0891-5849(00)00224-0; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shor E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003680; Tachibana T, 2009, J BIOL CHEM, V284, P4464, DOI 10.1074/jbc.M807583200; Tang HMV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000697; Toledano MB, 2004, TRENDS BIOCHEM SCI, V29, P351, DOI 10.1016/j.tibs.2004.05.005; Toledano MB, 2007, FEBS LETT, V581, P3598, DOI 10.1016/j.febslet.2007.07.002; Trotter EW, 2003, EMBO REP, V4, P184, DOI 10.1038/sj.embor.embor729; Trotter EW, 2005, EUKARYOT CELL, V4, P392, DOI 10.1128/EC.4.2.392-400.2005; Trotter EW, 2002, MOL MICROBIOL, V46, P869, DOI 10.1046/j.1365-2958.2002.03216.x; Tsaponina O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002061; van den Brink J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-100; Veal EA, 2003, J BIOL CHEM, V278, P30896, DOI 10.1074/jbc.M303542200; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; Watanabe T, 2014, J TOXICOL SCI, V39, P51, DOI 10.2131/jts.39.51; Wong CM, 2004, J BIOL CHEM, V279, P23207, DOI 10.1074/jbc.M402095200; Wong CM, 2002, J BIOL CHEM, V277, P5385, DOI 10.1074/jbc.M106846200; Yan C, 1998, EMBO J, V17, P7416, DOI 10.1093/emboj/17.24.7416; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	64	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108123	10.1371/journal.pone.0108123	http://dx.doi.org/10.1371/journal.pone.0108123			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247923	gold, Green Published, Green Submitted			2022-12-25	WOS:000342351800064
J	Romagny, S; Thomas-Danguin, T; Coureaud, G				Romagny, Sebastien; Thomas-Danguin, Thierry; Coureaud, Gerard			Newborn Rabbit Perception of 6-Odorant Mixtures Depends on Configural Processing and Number of Familiar Elements	PLOS ONE			English	Article							ODOR MIXTURES; BEHAVIORAL EVIDENCE; UNIQUE CUE; EXPERIENCE; PHEROMONE; COMPONENTS	Perception of odors, i.e. usually of mixtures of odorants, is elemental (the odorants' odor qualities are perceived in the mixture) or configural (the odor quality of the mixture differs from the one of each odorant). In human adults, the Red Cordial (RC) mixture is a configurally-processed, 6-odorant mixture. It evokes a red cordial odor quality while none of the elements carries that odor. Interestingly, in newborn rabbits, the same RC mixture is weak configurally perceived: the newborns behaviorally respond to all the elements after conditioning to the whole mixture, but not to the mixture after conditioning to a single element. Thus, they perceive in the RC mixture both the odor quality of the RC configuration and the quality of each element. Here, we aimed to determine whether this perception is modulated by quantitative (number of elements) and/or qualitative bits of information (nature of elements) previously learned by the animals. Newborns were conditioned to RC sub-mixtures of different complexity and composition before behavioral testing to RC. Pups generalized their sucking-related response to RC after learning at least 4 odorants. In contrast, after conditioning to sub-mixtures of another 6-odorant mixture, the elementally perceived M V mixture, pups responded to M V after learning one or two odorants. The different generalization to RC and M V mixtures after learning some of their elements is discussed according to three hypotheses: i) the configural perception of RC sub-mixtures, ii) the ratio of familiar/unfamiliar individual information elementally and configurally perceived, iii) the perception of RC becoming purely elemental. The results allow the first hypothesis to be dismissed, while further experiments are required to distinguish between the remaining two.	[Romagny, Sebastien; Thomas-Danguin, Thierry; Coureaud, Gerard] Ctr Sci Gout & Alimentat, Res Ctr Taste & Feeding Behav, Dijon, France	Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	Coureaud, G (corresponding author), Ctr Sci Gout & Alimentat, Res Ctr Taste & Feeding Behav, Dijon, France.	gerard.coureaud@u-bourgogne.fr	Coureaud, Gérard/N-9108-2017; Thomas-Danguin, Thierry/D-9234-2011; Coureaud, Gérard/ABF-1205-2020	Coureaud, Gérard/0000-0001-6754-3884; Thomas-Danguin, Thierry/0000-0002-9756-355X; Coureaud, Gérard/0000-0001-6754-3884; Romagny, Sebastien/0000-0002-8111-6499	Burgundy Region council; Fond Europeen de Developpement Economique; MEMOLAP [ANR-2010-JCJC-1410-1]; French Ministry of Higher Education and Research	Burgundy Region council(Region Bourgogne-Franche-Comte); Fond Europeen de Developpement Economique; MEMOLAP; French Ministry of Higher Education and Research	This work was supported by grants from the Burgundy Region council, the Fond Europeen de Developpement Economique, and the ANR-2010-JCJC-1410-1 MEMOLAP to GC and TTD. SR was funded by the French Ministry of Higher Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkat S, 2012, CHEM SENSES, V37, P159, DOI 10.1093/chemse/bjr086; BILKO A, 1994, PHYSIOL BEHAV, V56, P907, DOI 10.1016/0031-9384(94)90322-0; Charra R, 2013, BEHAV BRAIN RES, V237, P129, DOI 10.1016/j.bbr.2012.09.017; Counet C, 2002, J AGR FOOD CHEM, V50, P2385, DOI 10.1021/jf0114177; Coureaud G, 2002, DEV PSYCHOBIOL, V40, P372, DOI 10.1002/dev.10038; Coureaud G, 2001, ANIM BEHAV, V61, P153, DOI 10.1006/anbe.2000.1563; Coureaud G, 2006, CURR BIOL, V16, P1956, DOI 10.1016/j.cub.2006.08.030; Coureaud G, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3319; Coureaud G, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00211; Coureaud G, 2011, CHEM SENSES, V36, P693, DOI [10.1093/chemse/bjr049, 10.1093/chemse/bjr040]; Coureaud G, 2010, J COMP PHYSIOL A, V196, P779, DOI 10.1007/s00359-010-0548-y; Coureaud G, 2009, J EXP BIOL, V212, P2525, DOI 10.1242/jeb.032235; Coureaud G, 2008, PHYSIOL BEHAV, V95, P194, DOI 10.1016/j.physbeh.2008.05.018; Deisig N, 2003, LEARN MEMORY, V10, P199, DOI 10.1101/lm.55803; Giurfa M, 2003, BEHAV BRAIN RES, V145, P161, DOI 10.1016/S0166-4328(03)00104-9; Gottfried JA, 2009, CURR OPIN NEUROBIOL, V19, P422, DOI 10.1016/j.conb.2009.07.012; Harris JA, 2006, PSYCHOL REV, V113, P584, DOI 10.1037/0033-295X.113.3.584; HUDSON R, 1983, BEHAVIOUR, V85, P260, DOI 10.1163/156853983X00255; Jinks A, 1999, PERCEPTION, V28, P395, DOI 10.1068/p2898; Kay LM, 2005, BEHAV NEUROSCI, V119, P726, DOI 10.1037/0735-7044.119.3.726; KEIL W, 1990, PHYSIOL BEHAV, V47, P525, DOI 10.1016/0031-9384(90)90120-S; LAING DG, 1989, PHYSIOL BEHAV, V46, P809, DOI 10.1016/0031-9384(89)90041-3; LASKA M, 1993, J COMP PHYSIOL A, V173, P249; Le Berre E, 2008, CHEM SENSES, V33, P193, DOI 10.1093/chemse/bjm080; Livermore A, 1996, J EXP PSYCHOL HUMAN, V22, P267, DOI 10.1037/0096-1523.22.2.267; Livermore A, 1998, PERCEPT PSYCHOPHYS, V60, P650, DOI 10.3758/BF03206052; Montigny D, 2006, PHYSIOL BEHAV, V89, P742, DOI 10.1016/j.physbeh.2006.08.022; Niessing J, 2010, NATURE, V465, P47, DOI 10.1038/nature08961; Pearce JM, 2001, ANNU REV PSYCHOL, V52, P111, DOI 10.1146/annurev.psych.52.1.111; Pearce JM, 1997, J EXP PSYCHOL ANIM B, V23, P84; PEARCE JM, 1987, PSYCHOL REV, V94, P61, DOI 10.1037/0033-295X.94.1.61; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RESCORLA RA, 1973, J COMP PHYSIOL PSYCH, V85, P331, DOI 10.1037/h0035046; RESCORLA RA, 1985, J EXP PSYCHOL ANIM B, V11, P356, DOI 10.1037/0097-7403.11.3.356; RESCORLA RA, 1972, J COMP PHYSIOL PSYCH, V79, P307, DOI 10.1037/h0032553; Riffell JA, 2012, CURR OPIN NEUROBIOL, V22, P236, DOI 10.1016/j.conb.2012.02.013; Sinding C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053534; Sinding C, 2011, J EXP BIOL, V214, P4171, DOI 10.1242/jeb.063610; Stevenson RJ, 2001, Q J EXP PSYCHOL-A, V54, P561, DOI 10.1080/02724980042000246; Thomas-Danguin T, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00504; Valentincic T, 2000, J EXP BIOL, V203, P3307; Weiss T, 2012, P NATL ACAD SCI USA, V109, P19959, DOI 10.1073/pnas.1208110109; Wilson DA, 2003, NEUROSCI BIOBEHAV R, V27, P307, DOI 10.1016/S0149-7634(03)00050-2; Wilson DA, 2004, NEUROSCIENTIST, V10, P513, DOI 10.1177/1073858404267048; Wilson DA, 2011, NEURON, V72, P506, DOI 10.1016/j.neuron.2011.10.027; ZARROW MX, 1965, SCIENCE, V150, P1835, DOI 10.1126/science.150.3705.1835	46	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107560	10.1371/journal.pone.0107560	http://dx.doi.org/10.1371/journal.pone.0107560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25248149	gold, Green Published, Green Submitted			2022-12-25	WOS:000342351800026
J	Kim, EH; Lee, JS; Lee, NR; Baek, SY; Kim, EJ; Lee, SJ; Kim, IS				Kim, Eun Hye; Lee, Ji-Sook; Lee, Na Rae; Baek, Seung Yeop; Kim, Eun Jeong; Lee, Soo Jin; Kim, In Sik			Regulation of Constitutive Neutrophil Apoptosis Due to House Dust Mite Allergen in Normal and Allergic Rhinitis Subjects	PLOS ONE			English	Article							ASTHMA; CHALLENGE; CELLS; PATHOPHYSIOLOGY; PROTEIN; IGE	House dust mite (HDM) is a primary allergen in allergic rhinitis (AR) and asthma. Neutrophil apoptosis is associated with allergic diseases and innate immunity to infection. The present study examined how HDM affects constitutive neutrophil apoptosis in normal and AR subjects. Total IgE increased in AR subjects when compared to normal subjects, and patients with AR were HDM-specific IgE positive (+), which is specific IgE to Dermatophagoides pteronissinus and Dermatophagoides farinae. In normal and AR subjects, neutrophil apoptosis was inhibited by extract of Dermatophagoides pteronissinus (DP), but not by extract of Dermatophagoides farina (DF). Aprotinin (serine protease inhibitor) and E64 (cysteine protease inhibitor) have no effect on neutrophil apoptosis due to DP. The anti-apoptotic effect of DP was blocked by TLR4i, an inhibitor of TLR4, rottlerin, an inhibitor of PKC delta, PD98059, an inhibitor of ERK, and BAY-11-7085, an inhibitor of NF-kappa B. DP induced PKC delta, ERK, and NF-kappa B activation in a time-dependent manner. DP inhibited the cleavage of procaspase 3 and procaspase 9. The expression of IL-6, IL-8, TNF-alpha, G-CSF, GM-CSF, and CCL2 increased in the supernatant collected from the normal and AR neutrophils after DP treatment and the supernatant inhibited the apoptosis of normal and AR neutrophils. In summary, DP has anti-apoptotic effects on neutrophils of normal and AR subjects through the TLR4/PKC delta/ERK/NF-kappa B pathway, and this finding may contribute to solution of the pathogenic mechanism of allergic diseases triggered by DP.	[Kim, Eun Hye; Lee, Na Rae; Kim, In Sik] Eulji Univ, Sch Med, Dept Biomed Lab Sci, Taejon, South Korea; [Lee, Ji-Sook] Wonkwang Hlth Sci Univ, Dept Clin Lab Sci, Iksan, South Korea; [Baek, Seung Yeop; Kim, Eun Jeong; Kim, In Sik] Eulji Univ, Grad Sch, Dept Senior Hlthcare, Plus Program BK21, Taejon, South Korea; [Lee, Soo Jin] Eulji Univ, Sch Med, Dept Pediat, Taejon, South Korea	Eulji University; Eulji University; Eulji University	Lee, SJ (corresponding author), Eulji Univ, Sch Med, Dept Pediat, Taejon, South Korea.	sjlee@eulji.ac.kr; orientree@eulji.ac.kr			EMBRI Grants from the Eulji University [2012EMBRIDJ0001]	EMBRI Grants from the Eulji University	This research was supported by EMBRI Grants 2012EMBRIDJ0001 from the Eulji University. The authors thank normal volunteers and AR patients who participate in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASCOM R, 1988, AM REV RESPIR DIS, V138, P406, DOI 10.1164/ajrccm/138.2.406; Bousquet J, 2008, ALLERGIC RHINITIS IT; Bronnert M, 2012, CLIN EXP ALLERGY, V42, P1406, DOI 10.1111/j.1365-2222.2012.04035.x; Cui YB, 2013, MOL BIOL REP, V40, P681, DOI 10.1007/s11033-012-2108-8; Ekman AK, 2009, INT ARCH ALLERGY IMM, V149, P154, DOI 10.1159/000189199; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hamouda S, 2008, CLIN EXP ALLERGY, V38, P761, DOI 10.1111/j.1365-2222.2008.02953.x; Jacquet A, 2011, TRENDS MOL MED, V17, P604, DOI 10.1016/j.molmed.2011.05.014; Jeffery Peter K, 2006, BMC Pulm Med, V6 Suppl 1, pS5, DOI 10.1186/1471-2466-6-S1-S5; Kemp AS, 2009, PAEDIATR RESPIR REV, V10, P63, DOI 10.1016/j.prrv.2009.02.002; Kennedy AD, 2009, IMMUNOL RES, V43, P25, DOI 10.1007/s12026-008-8049-6; Kilpatrick LE, 2006, J LEUKOCYTE BIOL, V80, P1512, DOI 10.1189/jlb.0406284; Kim IS, 2013, MOL BIOL REP, V40, P5875, DOI 10.1007/s11033-013-2695-z; Lambrecht BN, 2013, EUR J IMMUNOL, V43, P3125, DOI 10.1002/eji.201343730; Lee JS, 2008, CYTOKINE, V42, P365, DOI 10.1016/j.cyto.2008.03.010; LIM MC, 1995, AM J RESP CRIT CARE, V151, P136, DOI 10.1164/ajrccm.151.1.7812543; Liu CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075983; Luo HBR, 2008, AM J HEMATOL, V83, P288, DOI 10.1002/ajh.21078; Monteseirin J, 2009, J INVEST ALLERG CLIN, V19, P340; Nakanishi W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078099; Pelikan Z, 2013, AM J RHINOL ALLERGY, V27, P345, DOI [10.2500/ajra.2013.27.3933a, 10.2500/ajra.2013.27.3933]; Rondon C, 2012, J ALLERGY CLIN IMMUN, V129, P1460, DOI 10.1016/j.jaci.2012.02.032; Ryu JH, J ALLERGY CLIN IMMUN, V131, P549; Saffar AS, 2007, J IMMUNOL, V178, P2535, DOI 10.4049/jimmunol.178.4.2535; Scheel-Toellner D, 2004, BIOCHEM SOC T, V32, P461, DOI 10.1042/BST0320461; Simon HU, 2003, IMMUNOL REV, V193, P101, DOI 10.1034/j.1600-065X.2003.00038.x; Sin Betul, 2011, Proc Am Thorac Soc, V8, P106, DOI 10.1513/pats.201008-057RN; Thomas WR, 2010, TRENDS MOL MED, V16, P321, DOI 10.1016/j.molmed.2010.04.008; Thomas WR, 2002, INT ARCH ALLERGY IMM, V129, P1, DOI 10.1159/000065179; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Wagener AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080257; Witko-Sarsat V, 2011, TRENDS IMMUNOL, V32, P117, DOI 10.1016/j.it.2011.01.001; Yang EJ, 2012, J CELL PHYSIOL, V227, P2567, DOI 10.1002/jcp.22995	33	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e105814	10.1371/journal.pone.0105814	http://dx.doi.org/10.1371/journal.pone.0105814			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243400	gold, Green Submitted, Green Published			2022-12-25	WOS:000343679800006
J	Scalschi, L; Camanes, G; Llorens, E; Fernandez-Crespo, E; Lopez, MM; Garcia-Agustin, P; Vicedo, B				Scalschi, Loredana; Camanes, Gemma; Llorens, Eugenio; Fernandez-Crespo, Emma; Lopez, Maria M.; Garcia-Agustin, Pilar; Vicedo, Begonya			Resistance Inducers Modulate Pseudomonas syringae pv. Tomato Strain DC3000 Response in Tomato Plants	PLOS ONE			English	Article							ACID-INDUCED RESISTANCE; ALTERNATE SIGMA-FACTOR; HEXANOIC ACID; DEPENDENT DEFENSES; EFFECTOR PROTEINS; BOTRYTIS-CINEREA; SECRETION SYSTEM; INNATE IMMUNITY; III SECRETION; CELL-DEATH	The efficacy of hexanoic acid (Hx) as an inducer of resistance in tomato plants against Pseudomonas syringae pv. tomato DC3000 was previously demonstrated, and the plant response was characterized. Because little is known about the reaction of the pathogen to this effect, the goal of the present work was to determine whether the changes in the plant defence system affect the pathogen behaviour. This work provides the first demonstration of the response of the pathogen to the changes observed in plants after Hx application in terms of not only the population size but also the transcriptional levels of genes involved in quorum sensing establishment and pathogenesis. Therefore, it is possible that Hx treatment attenuates the virulence and survival of bacteria by preventing or diminishing the appearance of symptoms and controlling the growth of the bacteria in the mesophyll. It is interesting to note that the gene transcriptional changes in the bacteria from the treated plants occur at the same time as the changes in the plants. Hx is able to alter bacteria pathogenesis and survival only when it is applied as a resistance inducer because the changes that it promotes in plants affect the bacteria.	[Scalschi, Loredana; Camanes, Gemma; Llorens, Eugenio; Fernandez-Crespo, Emma; Garcia-Agustin, Pilar; Vicedo, Begonya] Univ Jaume 1, ESTCE, Dept Ciencies Agr & Medi Nat, Grp Bioquim & Biotecnol,Area Fisiol Vegetal, Castellon de La Plana, Spain; [Lopez, Maria M.] IVIA, Dept Protecc Vegetal Biotecnol, Moncada, Valencia, Spain	Universitat Jaume I	Vicedo, B (corresponding author), Univ Jaume 1, ESTCE, Dept Ciencies Agr & Medi Nat, Grp Bioquim & Biotecnol,Area Fisiol Vegetal, Castellon de La Plana, Spain.	bvicedo@camn.uji.es	Lopez, Maria/HHC-3659-2022; Scalschi, Loredana/AAB-1665-2019; Llorens, Eugenio/E-5917-2015; López, Maria M/D-2584-2015; García-Agustín, Pilar/AAB-3073-2020; Camañes, Gemma/H-6131-2016; Fernandez, Emma/L-2221-2017; Vicedo, Begonya/ABF-9900-2020	Llorens, Eugenio/0000-0003-1931-1071; Camañes, Gemma/0000-0001-6407-9246; Fernandez, Emma/0000-0003-2746-334X; Vicedo, Begonya/0000-0002-3055-0463; Scalschi, Loredana/0000-0002-6314-4402; Garcia Agustin, Pilar/0000-0001-7238-8524	Ministerio de Educacion [AP2008-01064]; National RD Plan [AGL2010-22300-C03-02]; Projecte d'investigacio cientifica i desenvolupament tecnologic del Pla de promocio de la investigacio de la Universitat Jaume I [P1.1B2013-75]	Ministerio de Educacion; National RD Plan; Projecte d'investigacio cientifica i desenvolupament tecnologic del Pla de promocio de la investigacio de la Universitat Jaume I	LS is the recipient of a PhD fellowship from the Ministerio de Educacion (Grant AP2008-01064) (http://www.mecd.gob.es/servicios-al-ciudadano-mecd/catalogo-servicios/becas-ayudas-subvenciones/para-estudiar/universidad/doctorado.html). This work was supported by AGL2010-22300-C03-02: National R&D Plan (http://www.idi.mineco.gob.es/portal/site/MICINN/menuitem.7eeac5cd345b4f34f09dfd1001432ea0/?vgnextoid = fe5aec1eb658c310VgnVCM1000001d04140aRCRD&lang_choosen=en), and P1.1B2013-75: Projecte d'investigacio cientifica i desenvolupament tecnologic del Pla de promocio de la investigacio de la Universitat Jaume I (http://www.uji.es/ocit/pinv13/#1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch RB, 2005, FEMS MICROBIOL LETT, V245, P1, DOI 10.1016/j.femsle.2005.02.025; Alvarez B, 2008, MICROBIOL-SGM, V154, P3590, DOI 10.1099/mic.0.2008/019448-0; Beattie GA, 1999, PHYTOPATHOLOGY, V89, P353, DOI 10.1094/PHYTO.1999.89.5.353; BENDER CL, 1987, PHYSIOL MOL PLANT P, V30, P273, DOI 10.1016/0885-5765(87)90040-3; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; Bertani I, 2003, ARCH MICROBIOL, V180, P264, DOI 10.1007/s00203-003-0586-8; Boureau T, 2002, MOL PLANT PATHOL, V3, P451, DOI 10.1046/j.1364-3703.2002.00139.x; Brooks DM, 2005, MOL PLANT PATHOL, V6, P629, DOI [10.1111/j.1364-3703.2005.00311.x, 10.1111/J.1364-3703.2005.00311.X]; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Chatterjee A, 2007, APPL ENVIRON MICROB, V73, P3684, DOI 10.1128/AEM.02445-06; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Cui HT, 2009, CELL MICROBIOL, V11, P1453, DOI 10.1111/j.1462-5822.2009.01359.x; FERGUSON IB, 1985, PLANT PHYSIOL, V77, P969, DOI 10.1104/pp.77.4.969; Haapalainen M, 2009, MOL PLANT MICROBE IN, V22, P282, DOI 10.1094/MPMI-22-3-0282; Haque Md. Manjurul, 2005, Journal of General Plant Pathology, V71, P47, DOI 10.1007/s10327-004-0158-z; Hirano SS, 2000, MICROBIOL MOL BIOL R, V64, P624, DOI 10.1128/MMBR.64.3.624-653.2000; ICHIHARA A, 1977, J AM CHEM SOC, V99, P636, DOI 10.1021/ja00444a067; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Kersey CM, 2012, MOL PLANT PATHOL, V13, P58, DOI 10.1111/j.1364-3703.2011.00726.x; KING EO, 1954, J LAB CLIN MED, V44, P301; Kravchuk Z, 2011, J PLANT PHYSIOL, V168, P359, DOI 10.1016/j.jplph.2010.07.028; Lee J, 2012, PLANT PHYSIOL, V158, P1803, DOI 10.1104/pp.111.190686; Leyva MO, 2008, PLANT PATHOL, V57, P1038, DOI 10.1111/j.1365-3059.2008.01891.x; Lin NC, 2005, MOL PLANT MICROBE IN, V18, P43, DOI 10.1094/MPMI-18-0043; Lindeberg M, 2005, MOL PLANT MICROBE IN, V18, P275, DOI 10.1094/MPMI-18-0275; Lindgren PB, 1997, ANNU REV PHYTOPATHOL, V35, P129, DOI 10.1146/annurev.phyto.35.1.129; Llorens E, 2013, J PLANT PHYSIOL, V170, P146, DOI 10.1016/j.jplph.2012.09.018; Loh J, 2002, CURR OPIN PLANT BIOL, V5, P285, DOI 10.1016/S1369-5266(02)00274-1; Melotto M, 2008, ANNU REV PHYTOPATHOL, V46, P101, DOI 10.1146/annurev.phyto.121107.104959; Miller MR, 2005, J THEOR BIOL, V236, P198, DOI 10.1016/j.jtbi.2005.03.005; Mogollón Ortiz Ángela María, 2012, Rev. Fac. Nac. Agron. Medellín, V65, P6327; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; Nomura K, 2011, P NATL ACAD SCI USA, V108, P10774, DOI 10.1073/pnas.1103338108; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Ordax M, 2006, APPL ENVIRON MICROB, V72, P3482, DOI 10.1128/AEM.72.5.3482-3488.2006; Papp-Wallace KM, 2008, J BACTERIOL, V190, P6517, DOI 10.1128/JB.00772-08; Pastor V, 2013, ENVIRON EXP BOT, V94, P46, DOI 10.1016/j.envexpbot.2012.02.013; Pfeiffer J, 2002, INFECT IMMUN, V70, P3930, DOI 10.1128/IAI.70.7.3930-3934.2002; RAHME LG, 1992, J BACTERIOL, V174, P3499, DOI 10.1128/JB.174.11.3499-3507.1992; REINHART RA, 1988, ARCH INTERN MED, V148, P2415, DOI 10.1001/archinte.148.11.2415; ROUSE DI, 1985, PHYTOPATHOLOGY, V75, P505, DOI 10.1094/Phyto-75-505; Scalschi L, 2013, MOL PLANT PATHOL, V14, P342, DOI 10.1111/mpp.12010; Sreedharan A, 2006, MOL PLANT MICROBE IN, V19, P768, DOI 10.1094/MPMI-19-0768; Ton J, 2004, PLANT J, V38, P119, DOI 10.1111/j.1365-313X.2004.02028.x; van Dijk K, 1999, J BACTERIOL, V181, P4790, DOI 10.1128/JB.181.16.4790-4797.1999; Vicedo B, 2009, MOL PLANT MICROBE IN, V22, P1455, DOI 10.1094/MPMI-22-11-1455; von Bodman SB, 2003, ANNU REV PHYTOPATHOL, V41, P455, DOI 10.1146/annurev.phyto.41.052002.095652; Weingart H, 2004, MOL PLANT MICROBE IN, V17, P1095, DOI 10.1094/MPMI.2004.17.10.1095; XIAO YX, 1994, J BACTERIOL, V176, P3089, DOI 10.1128/JB.176.10.3089-3091.1994; XIAO YX, 1994, J BACTERIOL, V176, P1025, DOI 10.1128/JB.176.4.1025-1036.1994; Xin XF, 2013, ANNU REV PHYTOPATHOL, V51, P473, DOI 10.1146/annurev-phyto-082712-102321; Yao N, 2002, MOL PLANT MICROBE IN, V15, P1000, DOI 10.1094/MPMI.2002.15.10.1000; Yu XL, 2013, P NATL ACAD SCI USA, V110, pE425, DOI 10.1073/pnas.1221892110; Zhao YF, 2003, PLANT J, V36, P485, DOI 10.1046/j.1365-313X.2003.01895.x	55	19	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e106429	10.1371/journal.pone.0106429	http://dx.doi.org/10.1371/journal.pone.0106429			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244125	Green Submitted, Green Published, gold			2022-12-25	WOS:000343679800013
J	Horackova, J; Jurickova, L; Sizling, AL; Jarosik, V; Pysek, P				Horackova, Jitka; Jurickova, Lucie; Sizling, Arnost L.; Jarosik, Vojtech; Pysek, Petr			Invasiveness Does Not Predict Impact: Response of Native Land Snail Communities to Plant Invasions in Riparian Habitats	PLOS ONE			English	Article							IMPATIENS-GLANDULIFERA; SPECIES RICHNESS; SPATIAL AUTOCORRELATION; ALIEN PLANTS; VEGETATIVE REGENERATION; REYNOUTRIA POLYGONACEAE; DIVERSITY; ABUNDANCE; CONSEQUENCES; TAXA	Studies of plant invasions rarely address impacts on molluscs. By comparing pairs of invaded and corresponding uninvaded plots in 96 sites in floodplain forests, we examined effects of four invasive alien plants (Impatiens glandulifera, Fallopia japonica, F. sachalinensis, and F.xbohemica) in the Czech Republic on communities of land snails. The richness and abundance of living land snail species were recorded separately for all species, rare species listed on the national Red List, and small species with shell size below 5 mm. The significant impacts ranged from 16-48% reduction in snail species numbers, and 29-90% reduction in abundance. Small species were especially prone to reduction in species richness by all four invasive plant taxa. Rare snails were also negatively impacted by all plant invaders, both in terms of species richness or abundance. Overall, the impacts on snails were invader-specific, differing among plant taxa. The strong effect of I. glandulifera could be related to the post-invasion decrease in abundance of tall nitrophilous native plant species that are a nutrient-rich food source for snails in riparian habitats. Fallopia sachalinensis had the strongest negative impact of the three knotweeds, which reflects differences in their canopy structure, microhabitat humidity and litter decomposition. The ranking of Fallopia taxa according to the strength of impacts on snail communities differs from ranking by their invasiveness, known from previous studies. This indicates that invasiveness does not simply translate to impacts of invasion and needs to be borne in mind by conservation and management authorities.	[Horackova, Jitka; Jarosik, Vojtech; Pysek, Petr] Charles Univ Prague, Fac Sci, Dept Ecol, Prague 2, Czech Republic; [Horackova, Jitka; Jurickova, Lucie] Charles Univ Prague, Fac Sci, Dept Zool, Prague 2, Czech Republic; [Sizling, Arnost L.] Charles Univ Prague, Ctr Theoret Study, Prague 1, Czech Republic; [Sizling, Arnost L.] Acad Sci Czech Republ, Prague 1, Czech Republic; [Jarosik, Vojtech; Pysek, Petr] Acad Sci Czech Republ, Inst Bot, Dept Invas Ecol, CS-25243 Pruhonice, Czech Republic	Charles University Prague; Charles University Prague; Charles University Prague; Czech Academy of Sciences; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Horackova, J (corresponding author), Charles Univ Prague, Fac Sci, Dept Ecol, Prague 2, Czech Republic.	jitka.horackova@gmail.com	Jurickova, Lucie/R-8812-2017; Sizling, Arnost/H-3660-2017; Pysek, Petr/B-1957-2012; Horackova, Jitka/B-9972-2017	Jurickova, Lucie/0000-0001-5163-1222; Sizling, Arnost/0000-0002-3543-2976; Horackova, Jitka/0000-0003-3776-041X	Grant Agency of Charles University in Prague [40007]; Academy of Sciences of the Czech Republic [RVO 67985939]; Praemium Academiae award from the Academy of Sciences of the Czech Republic	Grant Agency of Charles University in Prague; Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Praemium Academiae award from the Academy of Sciences of the Czech Republic	This work was supported by grant of the Grant Agency of Charles University in Prague no. 40007 and institutional resources of Ministry of Education, Youth and Sports of the Czech Republic (http://www.msmt.cz/). PP was supported by long-term research development project no. RVO 67985939 (Academy of Sciences of the Czech Republic) and acknowledges the support by Praemium Academiae award from the Academy of Sciences of the Czech Republic (http://www.cas.cz/). The fundcrs had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, EC HUM WELL BEING SY; Bailey J. P., 2000, Watsonia, V23, P93; Bates D., 2011, PACKAGE LME4 LINEAR, V1; BAUR B, 1990, J ANIM ECOL, V59, P301, DOI 10.2307/5174; BEERLING DJ, 1993, J ECOL, V81, P367, DOI 10.2307/2261507; BEERLING DJ, 1991, BIOL CONSERV, V55, P329, DOI 10.1016/0006-3207(91)90036-9; BEERLING DJ, 1994, J ECOL, V82, P959, DOI 10.2307/2261459; Beran L, 2005, RED LIST FBREATENED, P67; Bimova K, 2003, PLANT ECOL, V166, P1, DOI 10.1023/A:1023299101998; Bimova K, 2001, PLANT INVASIONS: SPECIES ECOLOGY AND ECOSYSTEM MANAGEMENT, P283; Bjornstad ON, 2001, ENVIRON ECOL STAT, V8, P53, DOI 10.1023/A:1009601932481; Bjornstadt ON, 2008, NCF SPATIAL NONPARAM; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Brabec J, 2000, FOLIA GEOBOT, V35, P27, DOI 10.1007/BF02803085; Cameron RAD, 2005, J CONCHOL, V38, P529; Cejka T, 2008, J MOLLUS STUD, V74, P37, DOI 10.1093/mollus/eym041; Cernohorsky NH, 2010, J CONCHOL, V40, P233; Chittka L, 2001, NATURE, V411, P653, DOI 10.1038/35079676; Cliff A. D., 1981, SPATIAL PROCESSES MO; Cushman JH, 2010, BIOL INVASIONS, V12, P2765, DOI 10.1007/s10530-009-9682-2; DAISIE, 2009, HDB ALIEN SPECIES EU; Dangles Olivier, 2002, Biological Invasions, V4, P441, DOI 10.1023/A:1023698121141; Dibble KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046161; Durst SL, 2008, J ARID ENVIRON, V72, P1644, DOI 10.1016/j.jaridenv.2008.04.003; Dvorakova J, 2012, MALACOLOGIA, V55, P151; Ernst CM, 2005, BIOL INVASIONS, V7, P417, DOI 10.1007/s10530-004-4062-4; Gaertner M, 2011, ENVIRON MANAGE, V48, P57, DOI 10.1007/s00267-011-9675-7; Gaertner M, 2009, PROG PHYS GEOG, V33, P319, DOI 10.1177/0309133309341607; Gerber E, 2008, BIOL CONSERV, V141, P646, DOI 10.1016/j.biocon.2007.12.009; GOODFRIEND GA, 1986, SYST ZOOL, V35, P204, DOI 10.2307/2413431; Gordon DR, 1998, ECOL APPL, V8, P975, DOI 10.1890/1051-0761(1998)008[0975:EOINIP]2.0.CO;2; Gratton C, 2006, ECOL APPL, V16, P622, DOI 10.1890/1051-0761(2006)016[0622:AFWRFR]2.0.CO;2; Greenwood H, 2004, DIVERS DISTRIB, V10, P485, DOI 10.1111/j.1366-9516.2004.00104.x; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Hausdorf B, 2007, BASIC APPL ECOL, V8, P125, DOI 10.1016/j.baae.2006.03.005; Hedge P, 2000, AUSTRAL ECOL, V25, P150, DOI 10.1111/j.1442-9993.2000.tb00015.x; Hejda M, 2006, BIOL CONSERV, V132, P143, DOI 10.1016/j.biocon.2006.03.025; Hejda M, 2009, J ECOL, V97, P393, DOI 10.1111/j.1365-2745.2009.01480.x; Herrera AM, 2003, BIOL INVASIONS, V5, P167, DOI 10.1023/A:1026190115521; Hladyz S, 2011, J APPL ECOL, V48, P443, DOI 10.1111/j.1365-2664.2010.01924.x; Horackova J, 2014, COMMUNITY ECOL, V15, P44, DOI [10.1556/ComEc.15.2014.1.5, 10.1556/COMEC.15.2014.1.5]; Hulme PE, 2006, J APPL ECOL, V43, P43, DOI 10.1111/j.1365-2664.2005.01102.x; Hulme PE, 2013, TRENDS ECOL EVOL, V28, P212, DOI 10.1016/j.tree.2012.10.010; Ilg C, 2009, HYDROBIOLOGIA, V621, P63, DOI 10.1007/s10750-008-9632-5; Jurickova L, 2008, EUR J SOIL BIOL, V44, P172, DOI 10.1016/j.ejsobi.2007.07.001; Kappes H, 2007, ECOSYSTEMS, V10, P734, DOI 10.1007/s10021-007-9052-9; Kennedy TA, 2005, ECOL APPL, V15, P2072, DOI 10.1890/04-1533; Kerney MP, 1983, LANDSCHNECKEN NORDUN; Lambrinos John G., 2000, Diversity and Distributions, V6, P217, DOI 10.1046/j.1472-4642.2000.00086.x; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lenz TI, 2003, AUSTRAL ECOL, V28, P23, DOI 10.1046/j.1442-9993.2003.01238.x; Leslie AJ, 2001, BIOL CONSERV, V98, P347, DOI 10.1016/S0006-3207(00)00177-4; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Malikova L., 2010, Ecohydrology and Hydrobiology, V10, P81, DOI 10.2478/v10104-009-0050-8; Mandak B, 2004, PRESLIA, V76, P15; Martin K, 2004, J BIOGEOGR, V31, P531, DOI 10.1046/j.1365-2699.2003.01005.x; Milton SJ, 2007, J ECOL, V95, P648, DOI 10.1111/j.1365-2745.2007.01247.x; Mincheva T, 2014, ACTA OECOL, V54, P29, DOI 10.1016/j.actao.2013.03.010; Moravcova L., 2011, NeoBiota, P31, DOI 10.3897/neobiota.9.1266; Palkovai K, 2007, THESIS U S BOHEMIA C; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; PINHEIRO J., 2009, NLME LINEAR NONLINEA; Powell KI, 2011, AM J BOT, V98, P539, DOI 10.3732/ajb.1000402; PYSEK P, 1995, BIOL CONSERV, V74, P41, DOI 10.1016/0006-3207(95)00013-T; Pysek P, 2003, AM J BOT, V90, P1487, DOI 10.3732/ajb.90.10.1487; PYSEK P, 1993, J BIOGEOGR, V20, P413, DOI 10.2307/2845589; Pysek P, 2008, TRENDS ECOL EVOL, V23, P237, DOI 10.1016/j.tree.2008.02.002; Pysek P, 2012, PRESLIA, V84, P575; Pysek P, 2012, PRESLIA, V84, P155; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; R Development Core Team, 2009, R FDN STAT COMP; Reinhardt F., 2003, UMWELTBUNDESAMT FORS, V86, P211; Ricciardi A, 2007, BIOL INVASIONS, V9, P309, DOI 10.1007/s10530-006-9034-4; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; ROLLO CD, 1991, MALACOLOGIA, V33, P199; Ruckli R, 2013, ACTA OECOL, V47, P16, DOI 10.1016/j.actao.2012.10.011; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Skalova H, 2012, ANN BOT-LONDON, V110, P1429, DOI 10.1093/aob/mcr316; Skalova H, 2011, PERSPECT PLANT ECOL, V13, P173, DOI 10.1016/j.ppees.2011.03.005; SLOBODCHIKOFF CN, 1977, ECOLOGY, V58, P1171, DOI 10.2307/1936939; Sokal R. R., 2012, BIOMETRY; SOKAL RR, 1978, BIOL J LINN SOC, V10, P199, DOI 10.1111/j.1095-8312.1978.tb00013.x; Stoll P, 2012, BASIC APPL ECOL, V13, P232, DOI 10.1016/j.baae.2012.03.004; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Topp W, 2008, BIOL INVASIONS, V10, P381, DOI 10.1007/s10530-007-9137-6; Traveset A, 2006, TRENDS ECOL EVOL, V21, P208, DOI 10.1016/j.tree.2006.01.006; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Vila M, 2010, FRONT ECOL ENVIRON, V8, P135, DOI 10.1890/080083; Vrchotova N, 2007, ACTA CHROMATOGR, V19, P21; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Wilkie L, 2007, BIOL INVASIONS, V9, P477, DOI 10.1007/s10530-006-9055-z; Zuur Alain F., 2009, P1	98	10	11	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e108296	10.1371/journal.pone.0108296	http://dx.doi.org/10.1371/journal.pone.0108296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238059	gold, Green Published, Green Submitted			2022-12-25	WOS:000342491600093
J	Vizcarra, CL; Bor, B; Quinlan, ME				Vizcarra, Christina L.; Bor, Batbileg; Quinlan, Margot E.			The Role of Formin Tails in Actin Nucleation, Processive Elongation, and Filament Bundling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOLOGY-2 DOMAIN; MOLECULAR-BASIS; ATP-ACTIN; ADP-ACTIN; CAPPUCCINO; SPIRE; MECHANISM; MICROTUBULES; PROTEINS; PROFILIN	Formins are multidomain proteins that assemble actin in a wide variety of biological processes. They both nucleate and remain processively associated with growing filaments, in some cases accelerating filament growth. The well conserved formin homology 1 and 2 domains were originally thought to be solely responsible for these activities. Recently a role in nucleation was identified for the Diaphanous autoinhibitory domain ( DAD), which is C-terminal to the formin homology 2 domain. The C-terminal tail of the Drosophila formin Cappuccino ( Capu) is conserved among FMN formins but distinct from other formins. It does not have a DAD domain. Nevertheless, we find that Capu-tail plays a role in filament nucleation similar to that described for mDia1 and other formins. Building on this, replacement of Capu-tail with DADs from other formins tunes nucleation activity. Capu-tail has low-affinity interactions with both actin monomers and filaments. Removal of the tail reduces actin filament binding and bundling. Furthermore, when the tail is removed, we find that processivity is compromised. Despite decreased processivity, the elongation rate of filaments is unchanged. Again, replacement of Capu-tail with DADs from other formins tunes the processive association with the barbed end, indicating that this is a general role for formin tails. Our data show a role for the Capu-tail domain in assembling the actin cytoskeleton, largely mediated by electrostatic interactions. Because of its multifunctionality, the formin tail is a candidate for regulation by other proteins during cytoskeletal rearrangements.	[Vizcarra, Christina L.; Quinlan, Margot E.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Bor, Batbileg] Univ Calif Los Angeles, Mol Biol Interdept PhD Program, Los Angeles, CA 90095 USA; [Quinlan, Margot E.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Quinlan, ME (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 611 Charles E Young Dr E, Los Angeles, CA 90095 USA.	margot@chem.ucla.edu	Bor, Batbileg/AAY-8795-2021	Bor, Batbileg/0000-0002-1797-1730	National Institutes of Health [F32GM087857, R01GM096133]; Whitcome fellowship (UCLA); Burroughs-Welcome Fund Career Award in the Biomedical Sciences; March of Dimes Foundation [1-FY12-442]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM087857, R01GM096133] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitcome fellowship (UCLA); Burroughs-Welcome Fund Career Award in the Biomedical Sciences(Burroughs Wellcome Fund); March of Dimes Foundation(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health National Research Service Award Postdoctoral Fellowship F32GM087857 (to C. L. V.) and National Institutes of Health Grant R01GM096133 (to M. E. Q.). This work was also supported by a Whitcome fellowship (UCLA) (to B. B.), by a Burroughs-Welcome Fund Career Award in the Biomedical Sciences (to M. E. Q.), and by March of Dimes Foundation Grant 1-FY12-442 (to M. E. Q.).	Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bois J. S., 2007, THESIS CALTECH; Bor B, 2012, MOL BIOL CELL, V23, P3801, DOI 10.1091/mbc.E12-04-0288; Breitsprecher D, 2012, SCIENCE, V336, P1164, DOI 10.1126/science.1218062; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Chhabra ES, 2006, J BIOL CHEM, V281, P26754, DOI 10.1074/jbc.M604666200; Dahlgaard K, 2007, DEV CELL, V13, P539, DOI 10.1016/j.devcel.2007.09.003; Dirks RM, 2007, SIAM REV, V49, P65, DOI 10.1137/060651100; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; EMMONS S, 1995, GENE DEV, V9, P2482, DOI 10.1101/gad.9.20.2482; Gaillard J, 2011, MOL BIOL CELL, V22, P4575, DOI 10.1091/mbc.E11-07-0616; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Gould CJ, 2011, CURR BIOL, V21, P384, DOI 10.1016/j.cub.2011.01.047; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Heimsath EG, 2012, J BIOL CHEM, V287, P3087, DOI 10.1074/jbc.M111.312207; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kupi T, 2013, EUR BIOPHYS J BIOPHY, V42, P757, DOI 10.1007/s00249-013-0922-0; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; MANSEAU LJ, 1989, GENE DEV, V3, P1437, DOI 10.1101/gad.3.9.1437; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Mouilleron S, 2008, EMBO J, V27, P3198, DOI 10.1038/emboj.2008.235; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Otomo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012896; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Paul AS, 2009, J BIOL CHEM, V284, P12533, DOI 10.1074/jbc.M808587200; Pechlivanis M, 2009, J BIOL CHEM, V284, P25324, DOI 10.1074/jbc.M109.030320; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Quinlan ME, 2013, DEVELOPMENT, V140, P4417, DOI 10.1242/dev.097337; Ramabhadran V, 2013, J BIOL CHEM, V288, P26847, DOI 10.1074/jbc.M113.472415; Rosales-Nieves AE, 2006, NAT CELL BIOL, V8, P367, DOI 10.1038/ncb1385; Roth-Johnson EA, 2014, J BIOL CHEM, V289, P4395, DOI 10.1074/jbc.M113.499921; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Scott BJ, 2011, MOL BIOL CELL, V22, P3826, DOI 10.1091/mbc.E11-06-0492; Smith MB, 2010, CYTOSKELETON, V67, P693, DOI 10.1002/cm.20481; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Thompson ME, 2013, NAT STRUCT MOL BIOL, V20, P111, DOI 10.1038/nsmb.2462; Tu DQ, 2012, P NATL ACAD SCI USA, V109, pE3424, DOI 10.1073/pnas.1203035109; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Vizcarra CL, 2011, P NATL ACAD SCI USA, V108, P11884, DOI 10.1073/pnas.1105703108; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Zeth K, 2011, J BIOL CHEM, V286, P30732, DOI 10.1074/jbc.M111.257782; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057; Zuchero J Bradley, 2007, Methods Mol Biol, V370, P213	53	26	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30602	30613		10.1074/jbc.M114.588368	http://dx.doi.org/10.1074/jbc.M114.588368			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25246531	hybrid, Green Published			2022-12-25	WOS:000344549700037
J	Lian, J; Lu, Y; Xu, P; Ai, A; Zhou, GD; Liu, W; Cao, YL; Zhang, WJ				Lian, Jie; Lu, Yang; Xu, Peng; Ai, Ai; Zhou, Guangdong; Liu, Wei; Cao, Yilin; Zhang, Wen Jie			Prevention of Liver Fibrosis by Intrasplenic Injection of High-Density Cultured Bone Marrow Cells in a Rat Chronic Liver Injury Model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; PARTIAL-HEPATECTOMY; CO-TRANSPLANTATION; PROGENITOR CELLS; STROMAL CELLS; PORTAL-HYPERTENSION; IN-VIVO; ANGIOGENESIS; THERAPY	Endothelial progenitor cells (EPCs) from bone marrow have proven to be functional for the prevention of liver fibrosis in chronic liver injury. However, expansion of EPCs in culture is complicated and expansive. Previously, we have established a simple method that could enrich and expand EPCs by simple seeding bone marrow cells in high density dots. The purpose of this study is to evaluate whether cells derived from high-density (HD) culture of rat bone marrow cells could prevent the liver fibrosis in a chronic liver injury rat model, induced by carbon tetrachloride (CCl4). Flow cytometric analysis showed that cells from HD culture were enriched for EPCs, expressing high levels of EPC markers. Intrasplenic injection of HD cultured bone marrow cells in the CCl4-induced liver injury rat showed an enhanced antifibrogenic effect compared with animals treated with cells from regular-density culture. The antifibrogenic effect was demonstrated by biochemical and histological analysis 4 weeks post-transplantation. Furthermore, cells from HD culture likely worked through increasing neovascularization, stimulating liver cell proliferation, and suppressing pro-fibrogenic factor expression. HD culture, which is a simple and cost-effective procedure, could potentially be used to expand bone marrow cells for the treatment of liver fibrosis.	[Lian, Jie; Lu, Yang; Xu, Peng; Ai, Ai; Zhou, Guangdong; Liu, Wei; Cao, Yilin; Zhang, Wen Jie] Shanghai Jiao Tong Univ, Dept Plast & Reconstruct Surg, Sch Med,Shanghai Peoples Hosp 9, Shanghai Key Lab Tissue Engn,Natl Tissue Engn Ctr, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Zhang, WJ (corresponding author), Shanghai Jiao Tong Univ, Dept Plast & Reconstruct Surg, Sch Med,Shanghai Peoples Hosp 9, Shanghai Key Lab Tissue Engn,Natl Tissue Engn Ctr, Shanghai 200030, Peoples R China.	wenjieboshi@aliyun.cn	Xu, Pengcheng/J-1429-2012	Xu, Pengcheng/0000-0001-8651-208X	Major State Basic Research Development Program of China [2007CB948004, 2011CB964704]; National Basic Research Program of China [30800231, 31170944]	Major State Basic Research Development Program of China(National Basic Research Program of China); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the Major State Basic Research Development Program of China (2007CB948004, 2011CB964704), and the National Basic Research Program of China (30800231, 31170944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Porada G, 2010, EXP HEMATOL, V38, P574, DOI 10.1016/j.exphem.2010.04.007; Assy N, 1999, J HEPATOL, V30, P911, DOI 10.1016/S0168-8278(99)80147-0; Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F; Carvalho AB, 2008, STEM CELLS, V26, P1307, DOI 10.1634/stemcells.2007-0941; Chamberlain J, 2007, HEPATOLOGY, V46, P1935, DOI 10.1002/hep.21899; Corpechot C, 2002, HEPATOLOGY, V35, P1010, DOI 10.1053/jhep.2002.32524; Couto BG, 2011, LIVER INT, V31, P391, DOI 10.1111/j.1478-3231.2010.02424.x; Foubert P, 2008, CIRC RES, V103, P751, DOI 10.1161/CIRCRESAHA.108.175083; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Kuo TK, 2008, GASTROENTEROLOGY, V134, P2111, DOI 10.1053/j.gastro.2008.03.015; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Lee DS, 2004, TRANSPL P, V36, P2255, DOI 10.1016/j.transproceed.2004.08.073; Lee JS, 2007, HEPATOLOGY, V45, P817, DOI 10.1002/hep.21564; Lu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107127; Mallet VO, 2002, HEPATOLOGY, V35, P799, DOI 10.1053/jhep.2002.32530; Mohammad-Gharibani P, 2013, CYTOTHERAPY, V15, P1073, DOI 10.1016/j.jcyt.2013.05.002; Muller AMS, 2012, P NATL ACAD SCI USA, V109, P5820, DOI 10.1073/pnas.1120237109; Nakamura T, 2007, GASTROENTEROLOGY, V133, P91, DOI 10.1053/j.gastro.2007.03.110; Nakamura T, 2012, EUR J CLIN INVEST, V42, P717, DOI 10.1111/j.1365-2362.2011.02637.x; Patsenker E, 2009, HEPATOLOGY, V50, P1501, DOI 10.1002/hep.23144; Peng L, 2011, HEPATOLOGY, V54, P820, DOI 10.1002/hep.24434; Ross MA, 2001, HEPATOLOGY, V34, P1135, DOI 10.1053/jhep.2001.29624; Sakaida I, 2004, HEPATOLOGY, V40, P1304, DOI 10.1002/hep.20452; Sakamoto M, 2013, J GASTROEN HEPATOL, V28, P168, DOI 10.1111/j.1440-1746.2012.07238.x; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Shimizu H, 2001, J HEPATOL, V34, P683, DOI 10.1016/S0168-8278(00)00055-6; Stockmann C, 2010, P NATL ACAD SCI USA, V107, P4329, DOI 10.1073/pnas.0912766107; Taniguchi E, 2006, GASTROENTEROLOGY, V130, P521, DOI 10.1053/j.gastro.2005.10.050; Taniguchi E, 2001, J HISTOCHEM CYTOCHEM, V49, P121, DOI 10.1177/002215540104900112; Taura K, 2008, GASTROENTEROLOGY, V135, P1729, DOI 10.1053/j.gastro.2008.07.065; Terai S, 2006, STEM CELLS, V24, P2292, DOI 10.1634/stemcells.2005-0542; Thabut D, 2010, J HEPATOL, V53, P976, DOI 10.1016/j.jhep.2010.07.004; Ueno T, 2006, MED MOL MORPHOL, V39, P16, DOI 10.1007/s00795-006-0311-1; Wang XL, 2003, BLOOD, V101, P4201, DOI 10.1182/blood-2002-05-1338; Xiao N, 2013, CYTOTHERAPY, V15, P1374, DOI 10.1016/j.jcyt.2013.06.013; Yoshiji H, 2003, GUT, V52, P1347, DOI 10.1136/gut.52.9.1347	37	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e103603	10.1371/journal.pone.0103603	http://dx.doi.org/10.1371/journal.pone.0103603			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255097	Green Published, gold, Green Submitted			2022-12-25	WOS:000344862300004
J	Skarin, H; Segerman, B				Skarin, Hanna; Segerman, Bo			Plasmidome Interchange between Clostridium botulinum, Clostridium novyi and Clostridium haemolyticum Converts Strains of Independent Lineages into Distinctly Different Pathogens	PLOS ONE			English	Article							ALPHA-TOXIN PRODUCTION; MOLECULAR CHARACTERIZATION; BACILLARY HEMOGLOBINURIA; GENOME SEQUENCE; AVIAN BOTULISM; GENE CLUSTERS; C2 TOXIN; BACTERIOPHAGES; TOOL; IDENTIFICATION	Clostridium botulinum (group III), Clostridium novyi and Clostridium haemolyticum are well-known pathogens causing animal botulism, gas gangrene/black disease, and bacillary hemoglobinuria, respectively. A close genetic relationship exists between the species, which has resulted in the collective term C. novyi sensu lato. The pathogenic traits in these species, e. g., the botulinum neurotoxin and the novyi alpha toxin, are mainly linked to a large plasmidome consisting of plasmids and circular prophages. The plasmidome of C. novyi sensu lato has so far been poorly characterized. In this study we explored the genomic relationship of a wide range of strains of C. novyi sensu lato with a special focus on the dynamics of the plasmidome. Twenty-four genomes were sequenced from strains selected to represent as much as possible the genetic diversity in C. novyi sensu lato. Sixty-one plasmids were identified in these genomes and 28 of them were completed. The genomic comparisons revealed four separate lineages, which did not strictly correlate with the species designations. The plasmids were categorized into 13 different plasmid groups on the basis of their similarity and conservation of plasmid replication or partitioning genes. The plasmid groups, lineages and species were to a large extent entwined because plasmids and toxin genes had moved across the lineage boundaries. This dynamic process appears to be primarily driven by phages. We here present a comprehensive characterization of the complex species group C. novyi sensu lato, explaining the intermixed genetic properties. This study also provides examples how the reorganization of the botulinum toxin and the novyi alpha toxin genes within the plasmidome has affected the pathogenesis of the strains.	[Skarin, Hanna; Segerman, Bo] Natl Vet Inst SVA, Dept Bacteriol, Uppsala, Sweden; [Skarin, Hanna] Swedish Univ Agr Sci SLU, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden	National Veterinary Institute SVA; Swedish University of Agricultural Sciences	Segerman, B (corresponding author), Natl Vet Inst SVA, Dept Bacteriol, Uppsala, Sweden.	bo.segerman@sva.se		Skarin, Hanna/0000-0002-7690-3113	EU-project AniBioThreat [Home/2009/ISEC/AG/191]; Prevention of and Fight against Crime Programme of the European Union, European Commission-Directorate General Home Affairs; Swedish Civil Contingencies Agency (MSB)	EU-project AniBioThreat; Prevention of and Fight against Crime Programme of the European Union, European Commission-Directorate General Home Affairs; Swedish Civil Contingencies Agency (MSB)	This work was supported by/executed in the framework of the EU-project AniBioThreat (grant agreement: Home/2009/ISEC/AG/191) with the financial support from the Prevention of and Fight against Crime Programme of the European Union, European Commission-Directorate General Home Affairs. This publication reflects the views only of the author, and the European Commission cannot be held responsible for any use which may be made of the information contained therein. This work was also supported by the Swedish Civil Contingencies Agency (MSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039107; Anza I, 2014, ANAEROBE, V26, P20, DOI 10.1016/j.anaerobe.2014.01.002; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bender LC, 1999, J ZOO WILDLIFE MED, V30, P293; Bettegowda C, 2006, NAT BIOTECHNOL, V24, P1573, DOI 10.1038/nbt1256; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; East AK, 1996, INT J SYST BACTERIOL, V46, P1105, DOI 10.1099/00207713-46-4-1105; EKLUND MW, 1971, SCIENCE, V172, P480, DOI 10.1126/science.172.3982.480; EKLUND MW, 1974, SCIENCE, V186, P456, DOI 10.1126/science.186.4162.456; EKLUND MW, 1976, INFECT IMMUN, V14, P793, DOI 10.1128/IAI.14.3.793-803.1976; Fatmawati NND, 2013, ACTA MED OKAYAMA, V67, P9; Franciosa G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004829; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HASSAN KA, 2013, GENOME ANNOUNCEMENTS, V0001; Hauer PJ, 2004, ANAEROBE, V10, P243, DOI 10.1016/j.anaerobe.2004.04.006; Hauschild A.H.W., 1989, FOODBORNE BACTERIAL, P112; Heffron A, 2007, J MED MICROBIOL, V56, P196, DOI 10.1099/jmm.0.46802-0; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Hill KK, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-66; Hoshino S, 2012, J BIOL CHEM, V287, P32103, DOI 10.1074/jbc.M112.373803; INOUE K, 1968, J VIROL, V2, P537, DOI 10.1128/JVI.2.5.537-540.1968; Itoh H, 1987, NIPPON JUISHIKAI ZAS, V40, P365; Kubota T, 1996, BIOCHEM BIOPH RES CO, V224, P843, DOI 10.1006/bbrc.1996.1110; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Liu BH, 2012, BIOINFORMATICS, V28, P2870, DOI 10.1093/bioinformatics/bts563; Marshall KM, 2007, BIOCHEM BIOPH RES CO, V361, P49, DOI 10.1016/j.bbrc.2007.06.166; Marshall KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011087; McGuigan CC, 2002, J MED MICROBIOL, V51, P971, DOI 10.1099/0022-1317-51-11-971; MCHUGH GL, 1977, ANTIMICROB AGENTS CH, V12, P423, DOI 10.1128/AAC.12.3.423; NAKAMURA S, 1983, J GEN MICROBIOL, V129, P1473; NISHIDA S, 1964, J BACTERIOL, V88, P1636, DOI 10.1128/JB.88.6.1636-1640.1964; OAKLEY CL, 1947, J GEN MICROBIOL, V1, P91, DOI 10.1099/00221287-1-1-91; Oaks JL, 1997, J VET DIAGN INVEST, V9, P324, DOI 10.1177/104063879700900319; OGUMA K, 1976, J GEN MICROBIOL, V92, P67, DOI 10.1099/00221287-92-1-67; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sakaguchi Y, 2005, P NATL ACAD SCI USA, V102, P17472, DOI 10.1073/pnas.0505503102; Sakaguchi Y, 2009, J BACTERIOL, V191, P3282, DOI 10.1128/JB.01797-08; Sasaki Y, 2001, INT J SYST EVOL MICR, V51, P901, DOI 10.1099/00207713-51-3-901; Sasaki Y, 2000, RES VET SCI, V69, P289, DOI 10.1053/rvsc.2000.0431; SCHALLEHN G, 1980, FEMS MICROBIOL LETT, V7, P83, DOI 10.1111/j.1574-6941.1980.tb01581.x; Shinozuka Y, 2011, J VET MED SCI, V73, P255, DOI 10.1292/jvms.10-0231; Skarin H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-185; Skarin H, 2010, AVIAN PATHOL, V39, P511, DOI 10.1080/03079457.2010.526923; SMITH LD, 1978, HEALTH LAB SCI, V15, P74; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; Stockdale C, 2005, AUST VET J, V83, P362, DOI 10.1111/j.1751-0813.2005.tb15635.x; Takeda M, 2005, AVIAN DIS, V49, P376, DOI 10.1637/7347-022305R1.1; Tian RM, 2011, GENOME, V54, P546, DOI 10.1139/G11-019; Zhang Z, 2013, APPL ENVIRON MICROB, V79, P3856, DOI 10.1128/AEM.00080-13	52	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107777	10.1371/journal.pone.0107777	http://dx.doi.org/10.1371/journal.pone.0107777			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254374	Green Submitted, gold, Green Published			2022-12-25	WOS:000344862300032
J	Chen, DD; Feng, JY; Huang, L; Zhang, QL; Wu, JQ; Zhu, XC; Duan, YW; Xu, ZN				Chen, Dandan; Feng, Junyin; Huang, Lei; Zhang, Qinglin; Wu, Jiequn; Zhu, Xiangcheng; Duan, Yanwen; Xu, Zhinan			Identification and Characterization of a New Erythromycin Biosynthetic Gene Cluster in Actinopolyspora erythraea YIM90600, a Novel Erythronolide-Producing Halophilic Actinomycete Isolated from Salt Field	PLOS ONE			English	Article							SACCHAROPOLYSPORA-ERYTHRAEA; AEROMICROBIUM-ERYTHREUM; SP-NOV; IMPROVEMENT; STRAIN; DERIVATIVES; MACROLIDES; RESISTANCE; MECHANISM; KETOLIDES	Erythromycins (Ers) are clinically potent macrolide antibiotics in treating pathogenic bacterial infections. Microorganisms capable of producing Ers, represented by Saccharopolyspora erythraea, are mainly soil-dwelling actinomycetes. So far, Actinopolyspora erythraea YIM90600, a halophilic actinomycete isolated from Baicheng salt field, is the only known Er-producing extremophile. In this study, we have reported the draft genome sequence of Ac. erythraea YIM90600, genome mining of which has revealed a new Er biosynthetic gene cluster encoding several novel Er metabolites. This Er gene cluster shares high identity and similarity with the one of Sa. erythraea NRRL2338, except for two absent genes, eryBI and eryG. By correlating genotype and chemotype, the biosynthetic pathways of 39-demethyl-erythromycin C, erythronolide H (EH) and erythronolide I have been proposed. The formation of EH is supposed to be sequentially biosynthesized via C-6/C-18 epoxidation and C-14 hydroxylation from 6-deoxyerythronolide B. Although an in vitro enzymatic activity assay has provided limited evidence for the involvement of the cytochrome P450 oxidase EryF Ac (derived from Ac. erythraea YIM90600) in the catalysis of a two-step oxidation, resulting in an epoxy moiety, the attempt to construct an EH-producing Sa. erythraea mutant via gene complementation was not successful. Characterization of EryK Ac (derived from Ac. erythraea YIM90600) in vitro has confirmed its unique role as a C-12 hydroxylase, rather than a C-14 hydroxylase of the erythronolide. Genomic characterization of the halophile Ac. erythraea YIM90600 will assist us to explore the great potential of extremophiles, and promote the understanding of EH formation, which will shed new insights into the biosynthesis of Er metabolites.	[Chen, Dandan; Huang, Lei; Xu, Zhinan] Zhejiang Univ, Dept Chem & Biol Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Dandan; Feng, Junyin; Zhang, Qinglin; Wu, Jiequn] Chinese Acad Sci, Shanghai Inst Organ Chem, Huzhou Ctr Biosynthet Innovat, Huzhou, Peoples R China; [Zhu, Xiangcheng; Duan, Yanwen] Hunan Engn Res Ctr Combinatorial Biosynth & Natr, Changsha, Hunan, Peoples R China; [Zhu, Xiangcheng; Duan, Yanwen] Cent South Univ, Xiangya Int Acad Translat Med, Changsha, Hunan, Peoples R China	Zhejiang University; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Central South University	Xu, ZN (corresponding author), Zhejiang Univ, Dept Chem & Biol Engn, Hangzhou 310003, Zhejiang, Peoples R China.	znxu@zju.edu.cn	Chen, Dan/GRY-2691-2022; zhu, xiangcheng/M-1017-2018	Chen, Dan/0000-0002-1570-9034; Xu, Zhinan/0000-0001-7833-026X; zhu, xiangcheng/0000-0002-9191-6676	National Natural Science Foundation of China [21176214, 20832009, 91213303]; National High Technology Research and Development Program of China [2012AA02A705, 2012AA022105A, 2011AA02A114]; 973 program [2010CB833200, 2012CB721100]; Chinese Ministry of Education 111 Project [B08034]; CAS of China [KJCX2-YW-H201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); 973 program(National Basic Research Program of China); Chinese Ministry of Education 111 Project; CAS of China	This work was supported in part by grants from the National Natural Science Foundation of China (21176214, 20832009, and 91213303), the National High Technology Research and Development Program of China (2012AA02A705, 2012AA022105A and 2011AA02A114), "973 program" (2010CB833200 and 2012CB721100), the Chinese Ministry of Education 111 Project B08034, and CAS (KJCX2-YW-H201) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; BRIGHT GM, 1988, J ANTIBIOT, V41, P1029, DOI 10.7164/antibiotics.41.1029; Butler MS, 2008, NAT PROD REP, V25, P475, DOI 10.1039/b514294f; Chen DD, 2013, J BACTERIOL, V195, P1931, DOI 10.1128/JB.00033-13; Chen DD, 2012, APPL ENVIRON MICROB, V78, P5093, DOI 10.1128/AEM.00450-12; Chen Y, 2008, APPL ENVIRON MICROB, V74, P1820, DOI 10.1128/AEM.02770-07; CORTES J, 1990, NATURE, V348, P176, DOI 10.1038/348176a0; CUPPVICKERY JR, 1995, NAT STRUCT BIOL, V2, P144, DOI 10.1038/nsb0295-144; Gaisser S, 2002, MOL MICROBIOL, V44, P771, DOI 10.1046/j.1365-2958.2002.02910.x; Gaisser S, 1998, MOL GEN GENET, V258, P78, DOI 10.1007/s004380050709; GASC JC, 1991, J ANTIBIOT, V44, P313, DOI 10.7164/antibiotics.44.313; Heller S, 2007, ANTIMICROB AGENTS CH, V51, P1956, DOI 10.1128/AAC.00062-07; Huang SX, 2009, ORG LETT, V11, P1353, DOI 10.1021/ol900143j; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; LABEDA DP, 1987, INT J SYST BACTERIOL, V37, P19, DOI 10.1099/00207713-37-1-19; LARSEN H, 1986, FEMS MICROBIOL LETT, V39, P3; Leclercq R, 2002, CLIN INFECT DIS, V34, P482, DOI 10.1086/324626; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; MCGUIRE JM, 1952, ANTIBIOT CHEMOTHER, V2, P281; Mikami Y, 1999, J ANTIBIOT, V52, P201, DOI 10.7164/antibiotics.52.201; MILLER ES, 1991, INT J SYST BACTERIOL, V41, P363, DOI 10.1099/00207713-41-3-363; MORIMOTO S, 1984, J ANTIBIOT, V37, P187, DOI 10.7164/antibiotics.37.187; Oliynyk M, 2007, NAT BIOTECHNOL, V25, P447, DOI 10.1038/nbt1297; OMURA S, 1987, J MED CHEM, V30, P1941, DOI 10.1021/jm00394a001; Or YS, 2000, J MED CHEM, V43, P1045, DOI 10.1021/jm990618n; PAULUS TJ, 1990, J BACTERIOL, V172, P2541, DOI 10.1128/jb.172.5.2541-2546.1990; Quiros LM, 1998, MOL MICROBIOL, V28, P1177, DOI 10.1046/j.1365-2958.1998.00880.x; Reeves AR, 2008, APPL ENVIRON MICROB, V74, P7383, DOI 10.1128/AEM.01759-08; Reeves AR, 2007, METAB ENG, V9, P293, DOI 10.1016/j.ymben.2007.02.001; RODRIGUEZ AM, 1995, FEMS MICROBIOL LETT, V127, P117; Shen B, 1996, P NATL ACAD SCI USA, V93, P6600, DOI 10.1073/pnas.93.13.6600; Staunton J, 1997, CHEM REV, V97, P2611, DOI 10.1021/cr9600316; Summers RG, 1997, MICROBIOL-UK, V143, P3251, DOI 10.1099/00221287-143-10-3251; Tang SK, 2011, INT J SYST EVOL MICR, V61, P1693, DOI 10.1099/ijs.0.022319-0; Thibodeaux CJ, 2008, ANGEW CHEM INT EDIT, V47, P9814, DOI 10.1002/anie.200801204; Wang GQ, 2004, ORG LETT, V6, P4455, DOI 10.1021/ol048336r; WEBER JM, 1990, J BACTERIOL, V172, P2372, DOI 10.1128/jb.172.5.2372-2383.1990; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P577, DOI 10.1128/AAC.39.3.577; Wu JQ, 2011, APPL ENVIRON MICROB, V77, P7508, DOI 10.1128/AEM.06034-11; Zhao LX, 2011, J NAT PROD, V74, P1990, DOI 10.1021/np200603g; Zhi XY, 2009, INT J SYST EVOL MICR, V59, P589, DOI 10.1099/ijs.0.65780-0	43	15	16	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108129	10.1371/journal.pone.0108129	http://dx.doi.org/10.1371/journal.pone.0108129			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250723	Green Published, Green Submitted, gold			2022-12-25	WOS:000342492700083
J	Ely, KH; Matsuoka, M; DeBerge, MP; Ruby, JA; Liu, J; Schneider, MJ; Wang, Y; Hahn, YS; Enelow, RI				Ely, Kenneth H.; Matsuoka, Mitsuo; DeBerge, Matthew P.; Ruby, Jessica A.; Liu, Jun; Schneider, Mark J.; Wang, Yan; Hahn, Young S.; Enelow, Richard I.			Tissue-Protective Effects of NKG2A in Immune-Mediated Clearance of Virus Infection	PLOS ONE			English	Article							REGULATORY T-CELLS; STAPHYLOCOCCUS-AUREUS PNEUMONIA; LUNG INJURY; INFLUENZA INFECTION; INHIBITORY RECEPTORS; CUTTING EDGE; TNF-ALPHA; NK CELLS; EXPRESSION; RECOGNITION	Virus infection triggers a CD8(+) T cell response that aids in virus clearance, but also expresses effector functions that may result in tissue injury. CD8(+) T cells express a variety of activating and inhibiting ligands, though regulation of the expression of inhibitory receptors is not well understood. The ligand for the inhibitory receptor, NKG2A, is the non-classical MHC-I molecule Qa1(b), which may also serve as a putative restricting element for the T cell receptors of purported regulatory CD8(+) T cells. We have previously shown that Qa1(b)-null mice suffer considerably enhanced immunopathologic lung injury in the context of CD8(+) T cell-mediated clearance of influenza infection, as well as evidence in a non-viral system that failure to ligate NKG2A on CD8(+) effector T cells may represent an important component of this process. In this report, we examine the requirements for induction of NKG2A expression, and show that NKG2A expression by CD8(+) T cells occurs as a result of migration from the MLN to the inflammatory lung environment, irrespective of peripheral antigen recognition. Further, we confirmed that NKG2A is a mediator in limiting immunopathology in virus infection using mice with a targeted deletion of NKG2A, and infecting the mutants with two different viruses, influenza and adenovirus. In neither infection is virus clearance altered. In influenza infection, the enhanced lung injury was associated with increased chemoattractant production, increased infiltration of inflammatory cells, and significantly enhanced alveolar hemorrhage. The primary mechanism of enhanced injury was the loss of negative regulation of CD8(+) T cell effector function. A similar effect was observed in the livers of mutant mice infected intravenously with adenovirus. These results demonstrate the immunoregulatory role of CD8(+) NKG2A expression in virus infection, which negatively regulates T cell effector functions and contributes to protection of tissue integrity during virus clearance.	[Ely, Kenneth H.; Matsuoka, Mitsuo; DeBerge, Matthew P.; Ruby, Jessica A.; Schneider, Mark J.; Wang, Yan; Enelow, Richard I.] Geisel Sch Med Dartmouth, Dept Med, Lebanon, NH 03756 USA; [Liu, Jun] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Hahn, Young S.] Univ Virginia, Sch Med, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Enelow, Richard I.] Geisel Sch Med Dartmouth, Dept Microbiol Immunol, Lebanon, NH USA	Dartmouth College; Yale University; University of Virginia; Dartmouth College	Ely, KH (corresponding author), Geisel Sch Med Dartmouth, Dept Med, Lebanon, NH 03756 USA.	kenneth.ely@dartmouth.edu; mitsuo.matsuoka@dartmouth.edu			Brody Pulmonary Fibrosis Research Fund; National Institutes of Health [U19AI083024]; NATIONAL CANCER INSTITUTE [P30CA044579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063222] Funding Source: NIH RePORTER	Brody Pulmonary Fibrosis Research Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was made possible by the generous support of the Brody Pulmonary Fibrosis Research Fund. It was also funded by National Institutes of Health grants U19AI083024 (RIE) and U19AI083024 (YSH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong NJ, 2006, MAMM GENOME, V17, P273, DOI 10.1007/s00335-005-0123-y; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bertone S, 1999, EUR J IMMUNOL, V29, P23, DOI 10.1002/(SICI)1521-4141(199901)29:01<23::AID-IMMU23>3.0.CO;2-Y; Billiau A, 2006, ANTIVIR RES, V71, P108, DOI 10.1016/j.antiviral.2006.03.006; Brooks AG, 1997, J EXP MED, V185, P795, DOI 10.1084/jem.185.4.795; Bruder D, 2006, VIRAL IMMUNOL, V19, P147, DOI 10.1089/vim.2006.19.147; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Cho JH, 2011, BLOOD, V118, P116, DOI 10.1182/blood-2010-11-317396; DeBerge MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079340; Deberge MP, 2014, J IMMUNOL; Enelow RI, 1998, J CLIN INVEST, V102, P1653, DOI 10.1172/JCI4174; Fukumoto J, 2013, AM J PHYSIOL-CELL PH, V305, pC182, DOI 10.1152/ajpcell.00086.2013; Fuller MJ, 2013, P NATL ACAD SCI USA, V110, P15001, DOI 10.1073/pnas.1312772110; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Hillaire MLB, 2013, CURR OPIN VIROL, V3, P430, DOI 10.1016/j.coviro.2013.05.002; Hu D, 2004, NAT IMMUNOL, V5, P516, DOI 10.1038/ni1063; Isogawa M, 2005, IMMUNITY, V23, P53, DOI 10.1016/j.immuni.2005.05.005; Kim TS, 2011, TRENDS IMMUNOL, V32, P225, DOI 10.1016/j.it.2011.02.006; Kudva A, 2011, J IMMUNOL, V186, P1666, DOI 10.4049/jimmunol.1002194; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Lassen MG, 2010, J IMMUNOL, V184, P2693, DOI 10.4049/jimmunol.0901362; Le Drean E, 1998, EUR J IMMUNOL, V28, P264, DOI 10.1002/(SICI)1521-4141(199801)28:01<264::AID-IMMU264>3.0.CO;2-O; Lu LR, 2007, IMMUNITY, V26, P593, DOI 10.1016/j.immuni.2007.03.017; Lu LR, 2008, P NATL ACAD SCI USA, V105, P19420, DOI 10.1073/pnas.0810383105; Maier H, 2007, J IMMUNOL, V178, P2714, DOI 10.4049/jimmunol.178.5.2714; Mingari MC, 1998, P NATL ACAD SCI USA, V95, P1172, DOI 10.1073/pnas.95.3.1172; Moser JM, 2002, NAT IMMUNOL, V3, P189, DOI 10.1038/ni757; Peltola VT, 2004, PEDIATR INFECT DIS J, V23, pS87, DOI 10.1097/01.inf.0000108197.81270.35; Petrie EJ, 2008, J EXP MED, V205, P725, DOI 10.1084/jem.20072525; Plougastel B, 1996, IMMUNOGENETICS, V44, P286, DOI 10.1007/BF02602558; Pociask DA, 2013, AM J PATHOL, V182, P1286, DOI 10.1016/j.ajpath.2012.12.007; Robinson KM, 2014, J INFECT DIS, V209, P865, DOI 10.1093/infdis/jit527; Robinson KM, 2013, J IMMUNOL, V191, P5153, DOI 10.4049/jimmunol.1301237; Rouse BT, 2006, IMMUNOL REV, V212, P272, DOI 10.1111/j.0105-2896.2006.00412.x; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Sheng ZM, 2011, P NATL ACAD SCI USA, V108, P16416, DOI 10.1073/pnas.1111179108; Sheu BC, 2005, CANCER RES, V65, P2921, DOI 10.1158/0008-5472.CAN-04-2108; Small BA, 2001, J EXP MED, V194, P1835, DOI 10.1084/jem.194.12.1835; Srikiatkhachorn A, 2010, VIRAL IMMUNOL, V23, P639, DOI 10.1089/vim.2010.0076; Sue RD, 2004, J IMMUNOL, V172, P3860, DOI 10.4049/jimmunol.172.6.3860; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Suresh M, 2005, J VIROL, V79, P202, DOI 10.1128/JVI.79.1.202-213.2005; Suvas S, 2006, J IMMUNOL, V176, P1703, DOI 10.4049/jimmunol.176.3.1703; Us D, 2008, MIKROBIYOL BUL, V42, P365; Veiga-Parga T, 2013, IMMUNOL REV, V255, P182, DOI 10.1111/imr.12085; Vivier E, 2004, NAT REV IMMUNOL, V4, P190, DOI 10.1038/nri1306; Watanabe T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001218; Watanabe T, 2009, P NATL ACAD SCI USA, V106, P588, DOI 10.1073/pnas.0806959106; Weissler KA, 2014, IMMUNOL REV, V259, P11, DOI 10.1111/imr.12177; Wortzman ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068911; Xu LM, 2004, J IMMUNOL, V173, P721, DOI 10.4049/jimmunol.173.2.721; Zhao MQ, 2000, J CLIN INVEST, V106, pR49, DOI 10.1172/JCI9786; Zhou J, 2008, J IMMUNOL, V180, P25, DOI 10.4049/jimmunol.180.1.25	54	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108385	10.1371/journal.pone.0108385	http://dx.doi.org/10.1371/journal.pone.0108385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251060	Green Submitted, gold, Green Published			2022-12-25	WOS:000342492700120
J	Lazic, M; Inzaugarat, ME; Povero, D; Zhao, IC; Chen, M; Nalbandian, M; Miller, YI; Chernavsky, AC; Feldstein, AE; Sears, DD				Lazic, Milos; Inzaugarat, Maria Eugenia; Povero, Davide; Zhao, Iris C.; Chen, Mark; Nalbandian, Madlena; Miller, Yury I.; Chernavsky, Alejandra C.; Feldstein, Ariel E.; Sears, Dorothy D.			Reduced Dietary Omega-6 to Omega-3 Fatty Acid Ratio and 12/15-Lipoxygenase Deficiency Are Protective against Chronic High Fat Diet-Induced Steatohepatitis	PLOS ONE			English	Article							INSULIN-RESISTANCE; FISH-OIL; METABOLIC SYNDROME; GLYCOGEN-SYNTHESIS; HEPATIC STEATOSIS; LIVER; OBESITY; INFLAMMATION; MICE; N-3	Obesity is associated with metabolic perturbations including liver and adipose tissue inflammation, insulin resistance, and type 2 diabetes. Omega-6 fatty acids (omega 6) promote and omega-3 fatty acids (omega 3) reduce inflammation as they can be metabolized to pro-and anti-inflammatory eicosanoids, respectively. 12/15-lipoxygenase (12/15-LO) enzymatically produces some of these metabolites and is induced by high fat (HF) diet. We investigated the effects of altering dietary omega 6/omega 3 ratio and 12/15-LO deficiency on HF diet-induced tissue inflammation and insulin resistance. We examined how these conditions affect circulating concentrations of oxidized metabolites of omega 6 arachidonic and linoleic acids and innate and adaptive immune system activity in the liver. For 15 weeks, wild-type (WT) mice were fed either a soybean oil-enriched HF diet with high dietary omega 6/omega 3 ratio (11: 1, HFH), similar to Western-style diet, or a fat Kcal-matched, fish oil-enriched HF diet with a low dietary omega 6/omega 3 ratio of 2.7:1 (HFL). Importantly, the total saturated, monounsaturated and polyunsaturated fat content was matched in the two HF diets, which is unlike most published fish oil studies in mice. Despite modestly increased food intake, WT mice fed HFL were protected from HFH-diet induced steatohepatitis, evidenced by decreased hepatic mRNA expression of pro-inflammatory genes and genes involved in lymphocyte homing, and reduced deposition of hepatic triglyceride. Furthermore, oxidized metabolites of omega 6 arachidonic acid were decreased in the plasma of WT HFL compared to WT HFH-fed mice. 12/15-LO knockout (KO) mice were also protected from HFH-induced fatty liver and elevated mRNA markers of inflammation and lymphocyte homing. 12/15-LOKO mice were protected from HFH-induced insulin resistance but reducing dietary omega 6/omega 3 ratio in WT mice did not ameliorate insulin resistance or adipose tissue inflammation. In conclusion, lowering dietary omega 6/omega 3 ratio in HF diet significantly reduces steatohepatitis.	[Lazic, Milos; Povero, Davide; Feldstein, Ariel E.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Inzaugarat, Maria Eugenia; Chernavsky, Alejandra C.] CONICET UBA, Inst Immunol Genet & Metab, Buenos Aires, DF, Argentina; [Zhao, Iris C.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Chen, Mark; Nalbandian, Madlena; Miller, Yury I.; Sears, Dorothy D.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of California System; University of California San Diego; University of California System; University of California San Diego	Sears, DD (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	dsears@ucsd.edu	Sears, Dorothy D/AHE-5524-2022	Sears, Dorothy D/0000-0002-9260-3540	P. Robert Majumder Charitable Foundation; NIH [DK076852, DK082451, HL055798]; CONICET PIP [051/2011]; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL055798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076852, R01DK082451] Funding Source: NIH RePORTER	P. Robert Majumder Charitable Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CONICET PIP(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the P. Robert Majumder Charitable Foundation to DDS, NIH grants DK076852 and DK082451 to AEF, HL055798 to YIM, and CONICET PIP 051/2011 to ACC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2007, NUTR REV, V65, pS57, DOI 10.1111/j.1753-4887.2007.tb00329.x; Bolick DT, 2005, ARTERIOSCL THROM VAS, V25, P2301, DOI 10.1161/01.ATV.0000186181.19909.a6; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909; Byrne CD, 2010, PROSTAG LEUKOTR ESS, V82, P265, DOI 10.1016/j.plefa.2010.02.012; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Chakrabarti SK, 2009, OBESITY, V17, P1657, DOI 10.1038/oby.2009.192; Chapman J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013959; Chikano S, 2000, GUT, V47, P779, DOI 10.1136/gut.47.6.779; Cicinnati VR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-350; Copaci Ionel, 2006, J Gastrointestin Liver Dis, V15, P363; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Ding J, 2013, CELL REP, V5, P248, DOI 10.1016/j.celrep.2013.08.032; Fedor D, 2009, CURR OPIN CLIN NUTR, V12, P138, DOI 10.1097/MCO.0b013e3283218299; FEI HH, 1993, ARTERIOSCLER THROMB, V13, P1711, DOI 10.1161/01.ATV.13.11.1711; Feldstein AE, 2010, J LIPID RES, V51, P3046, DOI 10.1194/jlr.M007096; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Guebre-Xabier M, 2000, HEPATOLOGY, V31, P633, DOI 10.1002/hep.510310313; Hoek-van den Hil EF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051588; Ikemoto S, 1996, METABOLISM, V45, P1539, DOI 10.1016/S0026-0495(96)90185-7; Jucker BM, 1999, DIABETES, V48, P134, DOI 10.2337/diabetes.48.1.134; Kuda O, 2009, DIABETOLOGIA, V52, P941, DOI 10.1007/s00125-009-1305-z; Lopez-Vicario C, 2014, GUT, V63, P344, DOI 10.1136/gutjnl-2012-303179; Martinez-Clemente M, 2010, HEPATOLOGY, V52, P1980, DOI 10.1002/hep.23928; Matsuzawa Y, 2006, FEBS LETT, V580, P2917, DOI 10.1016/j.febslet.2006.04.028; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miller YI, 2005, ARTERIOSCL THROM VAS, V25, P1213, DOI 10.1161/01.ATV.0000159891.73193.31; Miller YI, 2003, J BIOL CHEM, V278, P1561, DOI 10.1074/jbc.M209634200; Natarajan R, 2001, ARTERIOSCL THROM VAS, V21, P1408, DOI 10.1161/hq0901.095278; Neschen S, 2006, DIABETES, V55, P924, DOI 10.2337/diabetes.55.04.06.db05-0985; Nobili V, 2011, ARCH DIS CHILD, V96, P350, DOI 10.1136/adc.2010.192401; Nunemaker CS, 2008, AM J PHYSIOL-ENDOC M, V295, pE1065, DOI 10.1152/ajpendo.90371.2008; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Rossmeisl M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038834; Rossmeisl M, 2009, OBESITY, V17, P1023, DOI 10.1038/oby.2008.602; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Sears DD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007250; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Staels B, 2006, NAT MED, V12, P54, DOI 10.1038/nm0106-54; Svegliati-Baroni G, 2006, AM J PATHOL, V169, P846, DOI 10.2353/ajpath.2006.050953; Valenzuela R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046400; Wang HN, 2008, WORLD J GASTROENTERO, V14, P7240, DOI 10.3748/wjg.14.7240; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Weitz D, 2010, CARDIOL REV, V18, P258, DOI 10.1097/CRD.0b013e3181ea0de0; Wong CY, 2010, DIABETIC MED, V27, P54, DOI 10.1111/j.1464-5491.2009.02869.x; Yu CR, 2008, J IMMUNOL, V181, P1190, DOI 10.4049/jimmunol.181.2.1190	51	41	42	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107658	10.1371/journal.pone.0107658	http://dx.doi.org/10.1371/journal.pone.0107658			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251155	Green Published, Green Submitted, gold			2022-12-25	WOS:000342492700038
J	Priester, C; Schmitt, S; Peixoto, TP				Priester, Christopher; Schmitt, Sebastian; Peixoto, Tiago P.			Limits and Trade-Offs of Topological Network Robustness	PLOS ONE			English	Article							COMPLEX; OPTIMIZATION; INTERNET	We investigate the trade-off between the robustness against random and targeted removal of nodes from a network. To this end we utilize the stochastic block model to study ensembles of infinitely large networks with arbitrary large-scale structures. We present results from numerical two-objective optimization simulations for networks with various fixed mean degree and number of blocks. The results provide strong evidence that three different blocks are sufficient to realize the best trade-off between the two measures of robustness, i. e. to obtain the complete front of Pareto-optimal networks. For all values of the mean degree, a characteristic three block structure emerges over large parts of the Pareto-optimal front. This structure can be often characterized as a core-periphery structure, composed of a group of core nodes with high degree connected among themselves and to a periphery of low-degree nodes, in addition to a third group of nodes which is disconnected from the periphery, and weakly connected to the core. Only at both extremes of the Pareto-optimal front, corresponding to maximal robustness against random and targeted node removal, a two-block core-periphery structure or a one-block fully random network are found, respectively.	[Priester, Christopher] Tech Univ Darmstadt, Inst Festkorperphys, Darmstadt, Germany; [Schmitt, Sebastian] Honda Res Inst Europe GmbH, Offenbach, Germany; [Peixoto, Tiago P.] Univ Bremen, Inst Theoret Phys, D-28359 Bremen, Germany	Technical University of Darmstadt; Honda Motor Company; University of Bremen	Priester, C (corresponding author), Tech Univ Darmstadt, Inst Festkorperphys, Darmstadt, Germany.	christopher@fkp.tu-darmstadt.de	Peixoto, Tiago P./E-8756-2011	Peixoto, Tiago P./0000-0002-4505-0517	University of Bremen, zentrale Forschunsforderung Linie 04	University of Bremen, zentrale Forschunsforderung Linie 04	TPP was funded by the University of Bremen, zentrale Forschunsforderung Linie 04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Honda Research Institute Europe GmbH provided support in the form of salaries for authors CP and SS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albert R, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.025103; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Back T., 1997, IEEE Transactions on Evolutionary Computation, V1, P3, DOI 10.1109/4235.585888; Beume N, 2007, EUR J OPER RES, V181, P1653, DOI 10.1016/j.ejor.2006.08.008; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Brede M, 2009, PHYS LETT A, V373, P3910, DOI 10.1016/j.physleta.2009.08.049; Brede M, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.066104; Bujok M, 2014, ARXIV14042580CONDMAT; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Cancho RFI, 2003, LECT NOTES PHYS, V625, P114; Carvalho R, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016106; Coello CAC., 2007, EVOLUTIONARY ALGORIT, V5; Coello CAC, 2005, EVOLUTIONARY MULTIOB, P7, DOI DOI 10.1007/1-84628-137-7_2; Cohen R, 2001, PHYS REV LETT, V86, P3682, DOI 10.1103/PhysRevLett.86.3682; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Colizza V, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198701; Cornelius SP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2939; Deb K., 1995, Complex Systems, V9, P115; Deb K., 2001, WIL INT S SYS OPT; Decelle A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.065701; Dodds PS, 2003, P NATL ACAD SCI USA, V100, P12516, DOI 10.1073/pnas.1534702100; Doyle JC, 2005, P NATL ACAD SCI USA, V102, P14497, DOI 10.1073/pnas.0501426102; Herrmann HJ, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/01/P01027; Hines P, 2010, CHAOS, V20, DOI 10.1063/1.3489887; HOLLAND PW, 1983, SOC NETWORKS, V5, P109, DOI 10.1016/0378-8733(83)90021-7; Ishibuchi H, 2008, IEEE C EVOL COMPUTAT, P2419, DOI 10.1109/CEC.2008.4631121; Karrer B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.016107; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Mathias N, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.021117; Netotea S, 2006, CELL IMMUNOL, V244, P80, DOI 10.1016/j.cellimm.2006.12.007; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Peixoto TP, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.011047; Peixoto TP, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.148701; Peixoto TP, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.118703; Peixoto TP, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.056122; Peixoto TP, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.041908; Rosas-Casals M, 2007, INT J BIFURCAT CHAOS, V17, P2465, DOI 10.1142/S0218127407018531; Schneider CM, 2011, P NATL ACAD SCI USA, V108, P3838, DOI 10.1073/pnas.1009440108; Scott DM, 2006, J TRANSP GEOGR, V14, P215, DOI 10.1016/j.jtrangeo.2005.10.003; Simon D., 2013, EVOLUTIONARY OPTIMIZ; Szejka A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021908; Valente AXCN, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118702; Verma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05638	46	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108215	10.1371/journal.pone.0108215	http://dx.doi.org/10.1371/journal.pone.0108215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250565	Green Submitted, gold, Green Published			2022-12-25	WOS:000342492700097
J	Uddin, MN; Kaczmarczyk, A; Vincze, E				Uddin, Mohammad Nasir; Kaczmarczyk, Agnieszka; Vincze, Eva			Effects of Zn Fertilization on Hordein Transcripts at Early Developmental Stage of Barley Grain and Correlation with Increased Zn Concentration in the Mature Grain	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; SEED STORAGE PROTEINS; WHEAT; ZINC; BIOFORTIFICATION; COORDINATION; PROLAMIN; IRON; SUPPRESSION; GERMINATION	Zinc deficiency is causing malnutrition for nearly one third of world populations. It is especially relevant in cereal-based diets in which low amounts of mineral and protein are present. In biological systems, Zn is mainly associated with protein. Cereal grains contain the highest Zn concentration during early developmental stage. Although hordeins are the major storage proteins in the mature barley grain and suggested to be involved in Zn binding, very little information is available regarding the Zn fertilization effects of hordein transcripts at early developmental stage and possible incorporation of Zn with hordein protein of matured grain. Zinc fertilization experiments were conducted in a greenhouse with barley cv. Golden Promise. Zn concentration of the matured grain was measured and the results showed that the increasing Zn fertilization increased grain Zn concentration. Quantitative real time PCR showed increased level of total hordein transcripts upon increasing level of Zn fertilization at 10 days after pollination. Among the hordein transcripts the amount of B-hordeins was highly correlated with the Zn concentration of matured grain. In addition, protein content of the matured grain was analysed and a positive linear relationship was found between the percentage of B-hordein and total grain Zn concentration while Chordein level decreased. Zn sensing dithizone assay was applied to localize Zn in the matured grain. The Zn distribution was not limited to the embryo and aleurone layer but was also present in the outer part of the endosperm (sub-aleurone layers) which known to be rich in proteins including B-hordeins. Increased Zn fertilization enriched Zn even in the endosperm. Therefore, the increased amount of B-hordein and decreased C-hordein content suggested that B-hordein upregulation or difference between B and C hordein could be one of the key factors for Zn biofortification of cereal grains due to the Zn fertilization.	[Uddin, Mohammad Nasir; Kaczmarczyk, Agnieszka; Vincze, Eva] Aarhus Univ, Fac Sci & Technol, Dept Mol Biol & Genet, Slagelse, Denmark	Aarhus University	Vincze, E (corresponding author), Aarhus Univ, Fac Sci & Technol, Dept Mol Biol & Genet, Slagelse, Denmark.	eva.vincze@agrsci.dk			Danish Fodevareforskningsprogrammet [3304-FVFP-09-B-004]	Danish Fodevareforskningsprogrammet	Funding provided by The Danish Fodevareforskningsprogrammet 2009; grant #: 3304-FVFP-09-B-004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026325; Andreini C, 2009, ACCOUNTS CHEM RES, V42, P1471, DOI 10.1021/ar900015x; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Baik BK, 2008, J CEREAL SCI, V48, P233, DOI 10.1016/j.jcs.2008.02.002; BARTELS D, 1986, PLANT SCI, V46, P117, DOI 10.1016/0168-9452(86)90118-4; Betts M.J., 2003, BIOINFORMA GENET, DOI DOI 10.1002/9780470059180.CH13; Breiteneder H, 2004, J ALLERGY CLIN IMMUN, V113, P821, DOI [10.1016/j.jaci.2004.01.779, 10.1016/j.jaci.2004.01.079]; Broadley MR, 2007, NEW PHYTOL, V173, P677, DOI 10.1111/j.1469-8137.2007.01996.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cakmak I, 2010, J AGR FOOD CHEM, V58, P9092, DOI 10.1021/jf101197h; Cakmak I, 2008, PLANT SOIL, V302, P1, DOI 10.1007/s11104-007-9466-3; Chen F, 2008, BIOL TRACE ELEM RES, V121, P171, DOI 10.1007/s12011-007-8042-2; Corbo MD, 2013, J AM ACAD DERMATOLOG; Dikeman E, 1982, CEREAL CHEM, V59; Gomez-Becerra HF, 2010, EUPHYTICA, V171, P23, DOI 10.1007/s10681-009-9984-6; GUPTA RB, 1993, J CEREAL SCI, V18, P23, DOI 10.1006/jcrs.1993.1031; Haase H, 2013, BIOFACTORS; Hansen M, 2007, J EXP BOT, V58, P3987, DOI 10.1093/jxb/erm254; Hansen TH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-12; Holding DR, 2013, SEED GENOMICS, P138; Hotz C., 2004, FOOD NUTR BULL, V25, P194; Iwai T, 2012, PLANT PHYSL; Kaczmarczyk A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-184; Kanerva P, 2011, IMMUNOCHEMICAL ANAL; KREIS M, 1985, J MOL BIOL, V183, P499, DOI 10.1016/0022-2836(85)90017-8; Kutman UB, 2010, CEREAL CHEM, V87, P1, DOI 10.1094/CCHEM-87-1-0001; Kutman UB, 2012, PLANT SOIL, V361, P177, DOI 10.1007/s11104-012-1300-x; Lange M, 2007, J AGR FOOD CHEM, V55, P6074, DOI 10.1021/jf0709505; Lombi E, 2011, ENVIRON EXP BOT, V72, P3, DOI 10.1016/j.envexpbot.2010.04.005; Lombi E, 2011, J EXP BOT, V62, P273, DOI 10.1093/jxb/erq270; LORENZ K, 1977, J AGR FOOD CHEM, V25, P806, DOI 10.1021/jf60212a053; Macewicz J, 2006, ACTA PHYSIOL PLANT, V28, P409, DOI 10.1007/BF02706623; MacGregor A.W., 1993, BARLEY CHEM TECHNOLO; MAGER M, 1953, J HISTOCHEM CYTOCHEM, V1, P493, DOI 10.1177/1.6.493; Maret W, 2013, ADV NUTR, V4, P82, DOI 10.3945/an.112.003038; Maret W, 2012, J INORG BIOCHEM, V111, P110, DOI 10.1016/j.jinorgbio.2011.11.018; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; MCNARY WF, 1954, J HISTOCHEM CYTOCHEM, V2, P185, DOI 10.1177/2.3.185; Molina-Cano JL, 2002, J CEREAL SCI, V36, P39, DOI 10.1006/jcrs.2002.0440; Neal AL, 2013, J BIOL INORG CHEM, V18, P557, DOI 10.1007/s00775-013-1000-x; Onda Y, 2011, PLANT SIGNAL BEHAV, V6, P1966, DOI 10.4161/psb.6.12.17967; Ozturk L, 2006, PHYSIOL PLANTARUM, V128, P144, DOI 10.1111/j.1399-3054.2006.00737.x; Peck AW, 2008, J CEREAL SCI, V47, P266, DOI 10.1016/j.jcs.2007.04.006; Persson DP, 2009, METALLOMICS, V1, P418, DOI 10.1039/b905688b; RECHINGER KB, 1993, PLANT J, V4, P841, DOI 10.1046/j.1365-313X.1993.04050841.x; Sadras V, 2002, AUST J AGR RES, V53, P587, DOI 10.1071/AR01150; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; Shewry P. R., 1993, P131; Shewry P.R., 2002, BARLEY SCI RECENT AD, P503; SHEWRY PR, 1978, J SCI FOOD AGR, V29, P433, DOI 10.1002/jsfa.2740290505; SHEWRY PR, 1985, BIOCHEM GENET, V23, P391, DOI 10.1007/BF00499082; SHEWRY PR, 1995, BIOL REV, V70, P375, DOI 10.1111/j.1469-185X.1995.tb01195.x; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; SHEWRY PR, 1990, BIOCHEM J, V267, P1; Shewry PR, 1999, SEED PROTEINS, P11; Shewry PR, 1996, CEREAL GRAIN QUAL, P227, DOI [10.1007/978-94-009-1513-8_8, DOI 10.1007/978-94-009-1513-8_8]; Sreenivasulu N, 2008, PLANT PHYSIOL, V146, P1738, DOI 10.1104/pp.107.111781; STARKS TL, 1985, J AGR FOOD CHEM, V33, P691, DOI 10.1021/jf00064a032; Stein AJ, 2010, PLANT SOIL, V335, P133, DOI 10.1007/s11104-009-0228-2; Stomph TJ, 2011, ANN BOT-LONDON, V107, P927, DOI 10.1093/aob/mcr040; Stomph TJ, 2009, TRENDS PLANT SCI, V14, P123, DOI 10.1016/j.tplants.2009.01.001; Tatham AS, 2012, J CEREAL SCI, V55, P79, DOI 10.1016/j.jcs.2011.10.013; Thaimattam R, 2002, ACTA CRYSTALLOGR D, V58, P1448, DOI 10.1107/S0907444902011769; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tosi P, 2011, ANN BOT-LONDON, V108, P23, DOI 10.1093/aob/mcr098; Triboi E, 2003, J EXP BOT, V54, P1731, DOI 10.1093/jxb/erg183; Uddin MN, 2014, CEREAL CHEM, V91, P228, DOI 10.1094/CCHEM-09-13-0175-N; Vader LW, 2002, J EXP MED, V195, P643, DOI 10.1084/jem.20012028; Wei YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045428; White PJ, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00080; White PJ, 2009, NEW PHYTOL, V182, P49, DOI 10.1111/j.1469-8137.2008.02738.x; Zhao J, 2010, EUPHYTICA, V172, P395, DOI 10.1007/s10681-009-0064-8	73	9	9	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108546	10.1371/journal.pone.0108546	http://dx.doi.org/10.1371/journal.pone.0108546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250985	gold, Green Published, Green Submitted			2022-12-25	WOS:000342492700140
J	Bardia, A; Tiwari, SK; Vishwakarma, SK; Habeeb, MA; Nallari, P; Sultana, SA; Pasha, SA; Reddy, YP; Khan, AA				Bardia, Avinash; Tiwari, Santosh K.; Vishwakarma, Sandeep K.; Habeeb, Md. Aejaz; Nallari, Pratibha; Sultana, Shaik A.; Pasha, Shaik A.; Reddy, Yugandhar P.; Khan, Aleem A.			Haplotype Analyses of DNA Repair Gene Polymorphisms and Their Role in Ulcerative Colitis	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; BLADDER-CANCER RISK; BREAST-CANCER; COLORECTAL-CANCER; XRCC3 POLYMORPHISMS; SKIN-CANCER; CELLS; ASSOCIATIONS; POPULATION; RAD51	Ulcerative colitis (UC) is a major clinical form of inflammatory bowel disease. UC is characterized by mucosal inflammation limited to the colon, always involving the rectum and a variable extent of the more proximal colon in a continuous manner. Genetic variations in DNA repair genes may influence the extent of repair functions, DNA damage, and thus the manifestations of UC. This study thus evaluated the role of polymorphisms of the genes involved in DNA repair mechanisms. A total of 171 patients and 213 controls were included. Genotyping was carried out by ARMS PCR and PCR-RFLP analyses for RAD51, XRCC3 and hMSH2 gene polymorphisms. Allelic and genotypic frequencies were computed in both control & patient groups and data was analyzed using appropriate statistical tests. The frequency of 'A' allele of hMSH2 in the UC group caused statistically significant increased risk for UC compared to controls (OR 1.64, 95% CI 1.16-2.31, p = 0.004). Similarly, the CT genotype of XRCC3 gene was predominant in the UC group and increased the risk for UC by 1.75 fold compared to controls (OR 1.75, 95% CI 1.15-2.67, p = 0.03), further confirming the risk of 'T' allele in UC. The GC genotype frequency of RAD51 gene was significantly increased (p = 0.02) in the UC group (50.3%) compared to controls (38%). The GC genotype significantly increased the risk for UC compared to GG genotype by 1.73 fold (OR 1.73, 95% CI 1.14-2.62, p = 0.02) confirming the strong association of 'C' allele with UC. Among the controls, the SNP loci combination of hMSH2: XRCC3 were in perfect linkage. The GTC and ACC haplotypes were found to be predominant in UC than controls with a 2.28 and 2.93 fold significant increase risk of UC.	[Bardia, Avinash; Tiwari, Santosh K.; Vishwakarma, Sandeep K.; Habeeb, Md. Aejaz; Khan, Aleem A.] Deccan Coll Med Sci, Ctr Liver Res & Diagnost, Hyderabad, Andhra Pradesh, India; [Nallari, Pratibha] Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India; [Sultana, Shaik A.; Pasha, Shaik A.] King Saud Univ, Coll Appl Med Sci, Riyadh, Saudi Arabia; [Reddy, Yugandhar P.] Osmania Univ, Univ Coll Sci, Dept Zool, Neurobiol Lab, Hyderabad 500007, Andhra Pradesh, India	Osmania University; King Saud University; Osmania University	Khan, AA (corresponding author), Deccan Coll Med Sci, Ctr Liver Res & Diagnost, Hyderabad, Andhra Pradesh, India.	aleem_a_khan@rediffmail.com	Vishwakarma, Dr. Sandeep Kumar/ADU-4497-2022; shaik, Asma Sultana/E-1284-2016; SHAIK, A P/F-3672-2014	Vishwakarma, Dr. Sandeep Kumar/0000-0001-5731-8210; SHAIK, A P/0000-0001-5541-3986				Abreu MT, 2006, MT SINAI J MED, V73, P1067; Benhamou S, 2000, MUTAT RES-REV MUTAT, V462, P149, DOI 10.1016/S1383-5742(00)00032-6; Chio YH, 2009, HERED CANCER CLIN PR, V7, P1; Costa S, 2008, BREAST CANCER RES TR, V109, P183, DOI 10.1007/s10549-007-9637-1; Cui X, 1999, MUTAT RES-DNA REPAIR, V434, P75, DOI 10.1016/S0921-8777(99)00010-5; Danese S, 2006, WORLD J GASTROENTERO, V12, P4807; Fontana L, 2008, ANTICANCER RES, V28, P1853; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Furusho JKY, 2007, W J GASTROENTEROL, V13, P5577; Gao LB, 2011, BREAST CANCER RES TR, V125, P827, DOI 10.1007/s10549-010-0995-8; Goode EL, 2002, CANCER EPIDEM BIOMAR, V11, P1513; Hosseini M, 2013, MOL BIOL REP, V40, P665, DOI 10.1007/s11033-012-2105-y; Improta G, 2008, ANTICANCER RES, V28, P2941; Jacobsen NR, 2004, CANCER LETT, V213, P67, DOI 10.1016/j.canlet.2004.04.033; Jacobsen NR, 2003, CANCER EPIDEM BIOMAR, V12, P584; Jarosinska MW, 2009, POL MERKUR LEKARSKI, V26, P455; Krupa R, 2011, MOL BIOL REP, V38, P2849, DOI 10.1007/s11033-010-0430-6; Kuschel B, 2002, HUM MOL GENET, V11, P1399, DOI 10.1093/hmg/11.12.1399; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Makowska HR, 2012, POL J PATHOL, V3, P193; Matullo G, 2001, INT J CANCER, V92, P562, DOI 10.1002/ijc.1228; Mitchell RJ, 2002, AM J EPIDEMIOL, V156, P885, DOI 10.1093/aje/kwf139; Mort R, 2003, BRIT J CANCER, V89, P333, DOI 10.1038/sj.bjc.6601061; Pachkowski BF, 2006, CANCER RES, V66, P2860, DOI 10.1158/0008-5472.CAN-05-3388; Poplawski T, 2005, BREAST CANCER RES TR, V94, P199, DOI 10.1007/s10549-005-4793-7; Sant L, 2011, BMC CANCER, V11, P1471; Shen HB, 2004, CANCER LETT, V206, P51, DOI 10.1016/j.canlet.2003.09.003; Shen M, 2003, CANCER EPIDEM BIOMAR, V12, P1234; Sun HM, 2011, BREAST CANCER RES TR, V125, P157, DOI 10.1007/s10549-010-0922-z; Tauchi H, 2002, NATURE, V420, P93, DOI 10.1038/nature01125; Wang WW, 2001, CANCER EPIDEM BIOMAR, V10, P955; Winsey SL, 2000, CANCER RES, V60, P5612; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154	34	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108562	10.1371/journal.pone.0108562	http://dx.doi.org/10.1371/journal.pone.0108562			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247297	Green Submitted, Green Published, gold			2022-12-25	WOS:000342351800099
J	Caballero, E; Soto, C; Olivares, A; Altamirano, C				Caballero, Eduardo; Soto, Carmen; Olivares, Araceli; Altamirano, Claudia			Potential Use of Avocado Oil on Structured Lipids MLM-Type Production Catalysed by Commercial Immobilised Lipases	PLOS ONE			English	Article							MILK FAT SUBSTITUTES; CAPRYLIC-ACID; DOCOSAHEXAENOIC ACID; ACYL MIGRATION; SOYBEAN OIL; SESAME OIL; FISH-OIL; ACIDOLYSIS; TRANSESTERIFICATION; STABILITY	Structured Lipids are generally constituents of functional foods. Growing demands for SL are based on a fuller understanding of nutritional requirements, lipid metabolism, and improved methods to produce them. Specifically, this work was aimed to add value to avocado oil by producing dietary triacylglycerols (TAG) containing medium-chain fatty acids (M) at positions sn-1,3 and long-chain fatty acids (L) at position sn-2. These MLM-type structured lipids (SL) were produced by interesterification of caprylic acid (CA) (C8:0) and avocado oil (content of C18:1). The regiospecific sn-1,3 commercial lipases Lipozyme RM IM and TL IM were used as biocatalysts to probe the potential of avocado oil to produce SL. Reactions were performed at 30-50 degrees C for 24 h in solvent-free media with a substrate molar ratio of 1:2 (TAG:CA) and 4-10% w/w enzyme content. The lowest incorporation of CA (1.1% mol) resulted from Lipozyme RM IM that was incubated at 50 degrees C. The maximum incorporation of CA into sn-1,3 positions of TAG was 29.2% mol. This result was obtained at 30 degrees C with 10% w/w Lipozyme TL IM, which is the highest values obtained in solvent-free medium until now for structured lipids of low-calories. This strategy opens a new market to added value products based on avocado oil.	[Caballero, Eduardo; Soto, Carmen; Olivares, Araceli; Altamirano, Claudia] CREAS, CONICYT Reg, GORE Reg Valparaiso, Valparaiso, IN 46383 USA; [Caballero, Eduardo; Soto, Carmen; Olivares, Araceli; Altamirano, Claudia] Pontificia Univ Catolica Valparaiso, Escuela Ingn Bioquim, Valparaiso, Chile	Pontificia Universidad Catolica de Valparaiso	Caballero, E (corresponding author), CREAS, CONICYT Reg, GORE Reg Valparaiso, Valparaiso, IN 46383 USA.	ecaballero@creas.cl	Soto, Carmen/A-3145-2011	Altamirano, Claudia/0000-0002-6389-086X	FONDECYT Iniciacion [11110382]; Centro Regional de Estudios en Alimentos Saludables (CREAS-PUCV); CONICYT-Regional, GORE Region de Valparaiso [R12C1001]	FONDECYT Iniciacion(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Centro Regional de Estudios en Alimentos Saludables (CREAS-PUCV)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT Regional/CREAS); CONICYT-Regional, GORE Region de Valparaiso	The authors are grateful for the financial support of "FONDECYT Iniciacion no 11110382" (www.fondecyt.cl) and Centro Regional de Estudios en Alimentos Saludables (CREAS-PUCV) (www.creas.cl), CONICYT-Regional, GORE Region de Valparaiso R12C1001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arifin N, 2012, FOOD BIOPROCESS TECH, V5, P216, DOI 10.1007/s11947-010-0325-5; Auerbach Michael H., 2001, P485; Berasategi I, 2012, FOOD CHEM, V132, P439, DOI 10.1016/j.foodchem.2011.11.018; Du W, 2005, J MOL CATAL B-ENZYM, V37, P68, DOI 10.1016/j.molcatb.2005.09.008; Esteban L, 2011, BIOCHEM ENG J, V54, P62, DOI 10.1016/j.bej.2011.01.009; Feltes MMC, 2009, GRASAS ACEITES, V60, P168, DOI 10.3989/gya.074708; FINLEY JW, 1994, J AGR FOOD CHEM, V42, P495, DOI 10.1021/jf00038a046; Fomuso LB, 2002, FOOD RES INT, V35, P15, DOI 10.1016/S0963-9969(00)00158-7; Fomuso LB, 1998, J AM OIL CHEM SOC, V75, P405, DOI 10.1007/s11746-998-0059-y; Hamam F, 2005, FOOD CHEM, V91, P583, DOI 10.1016/j.foodchem.2004.05.024; Hasan F, 2006, ENZYME MICROB TECH, V39, P235, DOI 10.1016/j.enzmictec.2005.10.016; HAYES JR, 1994, J AGR FOOD CHEM, V42, P474, DOI 10.1021/jf00038a043; Houde A, 2004, APPL BIOCHEM BIOTECH, V118, P155, DOI 10.1385/ABAB:118:1-3:155; Hoy Carl-Erik, 2001, P209; Illanes A., 1999, ELECTRON J BIOTECHN, V2, P1, DOI [10.2225/vol2-issue1-fulltext-2, DOI 10.2225/V0L2-ISSUE1-FULLTEXT-2]; Itabaiana I, 2013, J MOL CATAL B-ENZYM, V96, P34, DOI 10.1016/j.molcatb.2013.06.008; Karabulut I, 2010, J AM OIL CHEM SOC, V87, P1301, DOI 10.1007/s11746-010-1613-y; Kim BH, 2005, J AGR FOOD CHEM, V53, P8033, DOI 10.1021/jf0509761; Kim BH, 2006, J AGR FOOD CHEM, V54, P5132, DOI 10.1021/jf060607k; Kim IH, 2001, FOOD RES INT, V34, P301, DOI 10.1016/S0963-9969(00)00167-8; Lee JeungHee, 2006, Handbook of functional lipids, P489; Moreno AO, 2003, J AGR FOOD CHEM, V51, P2216, DOI 10.1021/jf0207934; Moreno PAG, 2004, BIOTECHNOL PROGR, V20, P1044, DOI 10.1021/bp034314c; Nunes PA, 2011, J AM OIL CHEM SOC, V88, P473, DOI 10.1007/s11746-010-1702-y; Pieterse Z, 2005, NUTRITION, V21, P67, DOI 10.1016/j.nut.2004.09.010; Pizarro C, 2012, J MOL CATAL B-ENZYM, V78, P111, DOI 10.1016/j.molcatb.2012.03.012; Sahin N, 2005, J AGR FOOD CHEM, V53, P5779, DOI 10.1021/jf050465e; Senanayake SPJN, 2004, FOOD CHEM, V85, P489, DOI 10.1016/S0308-8146(02)00412-0; Sharma R, 2001, BIOTECHNOL ADV, V19, P627, DOI 10.1016/S0734-9750(01)00086-6; Sim JH, 2013, INT J SCI RES PUBLIC, V3, P1; Simas A, 2009, 17 EUR BIOM C EXH HA; Tecelao C, 2012, BIOCHEM ENG J, V67, P104, DOI 10.1016/j.bej.2012.06.001; Teng Y, 2007, ANAL BIOCHEM, V363, P297, DOI 10.1016/j.ab.2007.01.026; Turan S, 2006, J FOOD LIPIDS, V13, P306, DOI 10.1111/j.1745-4522.2006.00054.x; Wang YY, 2012, FOOD BIOPROD PROCESS, V90, P707, DOI 10.1016/j.fbp.2012.02.003; Woolf A., 2008, GOURMET HLTH PROMOTI, P73; Yang TK, 2005, FOOD CHEM, V92, P101, DOI 10.1016/j.foodchem.2004.07.007; Zhang H, 2001, J AM OIL CHEM SOC, V78, P57, DOI 10.1007/s11746-001-0220-4; Zou XQ, 2011, J AGR FOOD CHEM, V59, P6055, DOI 10.1021/jf200619v	39	23	24	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107749	10.1371/journal.pone.0107749	http://dx.doi.org/10.1371/journal.pone.0107749			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25248107	Green Published, Green Submitted, gold			2022-12-25	WOS:000342351800033
J	Le Guiner, C; Stieger, K; Toromanoff, A; Guilbaud, M; Mendes-Madeira, A; Devaux, M; Guigand, L; Cherel, Y; Moullier, P; Rolling, F; Adjali, O				Le Guiner, Caroline; Stieger, Knut; Toromanoff, Alice; Guilbaud, Mickael; Mendes-Madeira, Alexandra; Devaux, Marie; Guigand, Lydie; Cherel, Yan; Moullier, Philippe; Rolling, Fabienne; Adjali, Oumeya			Transgene Regulation Using the Tetracycline-Inducible TetR-KRAB System after AAV-Mediated Gene Transfer in Rodents and Nonhuman Primates	PLOS ONE			English	Article							RECOMBINANT-ADENOASSOCIATED-VIRUS; SKELETAL-MUSCLE; INTRAMUSCULAR INJECTION; IMMUNE-RESPONSES; MAMMALIAN-CELLS; TIGHT CONTROL; VIRAL VECTOR; FACTOR-IX; IN-VIVO; EXPRESSION	Numerous studies have demonstrated the efficacy of the Adeno-Associated Virus (AAV)-based gene delivery platform in vivo. The control of transgene expression in many protocols is highly desirable for therapeutic applications and/or safety reasons. To date, the tetracycline and the rapamycin dependent regulatory systems have been the most widely evaluated. While the long-term regulation of the transgene has been obtained in rodent models, the translation of these studies to larger animals, especially to nonhuman primates (NHP), has often resulted in an immune response against the recombinant regulator protein involved in transgene expression regulation. These immune responses were dependent on the target tissue and vector delivery route. Here, using AAV vectors, we evaluated a doxycyclin-inducible system in rodents and macaques in which the TetR protein is fused to the human Kruppel associated box (KRAB) protein. We demonstrated long term gene regulation efficiency in rodents after subretinal and intramuscular administration of AAV5 and AAV1 vectors, respectively. However, as previously described for other chimeric transactivators, the TetR-KRAB-based system failed to achieve long term regulation in the macaque after intramuscular vector delivery because of the development of an immune response. Thus, immunity against the chimeric transactivator TetR-KRAB emerged as the primary limitation for the clinical translation of the system when targeting the skeletal muscle, as previously described for other regulatory proteins. New developments in the field of chimeric drug-sensitive transactivators with the potential to not trigger the host immune system are still needed.	[Le Guiner, Caroline; Stieger, Knut; Toromanoff, Alice; Guilbaud, Mickael; Mendes-Madeira, Alexandra; Devaux, Marie; Moullier, Philippe; Rolling, Fabienne; Adjali, Oumeya] Nantes Univ Hosp, Atlantic Gene Therapies, INSERM, UMR 1089, Nantes, France; [Stieger, Knut] Univ Giessen, Fac Med, Dept Ophthalmol, D-35390 Giessen, Germany; [Guigand, Lydie; Cherel, Yan] INRA, UMR 703, F-44026 Nantes, France; [Guigand, Lydie; Cherel, Yan] ONIRIS, Atlantic Gene Therapies, Nantes, France; [Moullier, Philippe] Univ Florida, Dept Mol Genet, Gainesville, FL USA; [Moullier, Philippe] Univ Florida, Dept Microbiol, Gainesville, FL USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Justus Liebig University Giessen; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Rolling, F (corresponding author), Nantes Univ Hosp, Atlantic Gene Therapies, INSERM, UMR 1089, Nantes, France.	fabienne.rolling@univ-nantes.fr; oumeya.adjali@univ-nantes.fr	Stieger, Knut/A-1600-2012	Stieger, Knut/0000-0002-8298-5629	INSERM; INRA; University Hospital of Nantes; Fondation pour la Therapie Genique en Pays de Loire; The Region Pays de La Loire (IMBIO-CD network); AFM-Telethon (Association Francaise contre les Myopathies)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INRA; University Hospital of Nantes; Fondation pour la Therapie Genique en Pays de Loire(European Commission); The Region Pays de La Loire (IMBIO-CD network)(Region Pays de la Loire); AFM-Telethon (Association Francaise contre les Myopathies)	Financial supports came from the INSERM, the INRA, the University Hospital of Nantes, the Fondation pour la Therapie Genique en Pays de Loire, The Region Pays de La Loire (IMBIO-CD network) and the AFM-Telethon (Association Francaise contre les Myopathies). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda VR, 2004, BLOOD, V103, P85, DOI 10.1182/blood-2003-05-1446; Barde I, 2009, J VIROL, V83, P5574, DOI 10.1128/JVI.00001-09; Bohl D, 1998, BLOOD, V92, P1512, DOI 10.1182/blood.V92.5.1512.417k43_1512_1517; Bryant LR, 2013, PERS CONTIN PHILOS, P55; Bulliard Y, 2006, J BIOL CHEM, V281, P35742, DOI 10.1074/jbc.M602843200; Chenuaud P, 2004, MOL THER, V9, P410, DOI 10.1016/j.ymthe.2003.12.015; DEUSCHLE U, 1995, MOL CELL BIOL, V15, P1907; Favre D, 2002, J VIROL, V76, P11605, DOI 10.1128/JVI.76.22.11605-11611.2002; Folliot S, 2003, J GENE MED, V5, P493, DOI 10.1002/jgm.367; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Gaudet D, 2013, GENE THER, V20, P361, DOI 10.1038/gt.2012.43; Ginhoux F, 2004, MOL THER, V10, P279, DOI 10.1016/j.ymthe.2004.05.012; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Latta-Mahieu M, 2002, HUM GENE THER, V13, P1611, DOI 10.1089/10430340260201707; Le Guiner C, 2007, CURR GENE THER, V7, P334; Lebherz C, 2005, HUM GENE THER, V16, P178, DOI 10.1089/hum.2005.16.178; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Marquis J, 2009, GENE THER, V16, P70, DOI 10.1038/gt.2008.138; Mays LE, 2013, AAV8 INDUCES TOLERAN; Melchiorri D, 2013, NAT REV DRUG DISCOV, V12, P719, DOI 10.1038/nrd3835-c1; Monahan PE, 2000, MOL MED TODAY, V6, P433, DOI 10.1016/S1357-4310(00)01810-4; Moosmann P, 1997, BIOL CHEM, V378, P669, DOI 10.1515/bchm.1997.378.7.669; Nowrouzi A, 2012, MOL THER, V20, P1177, DOI 10.1038/mt.2012.47; Ohshima S, 2009, MOL THER, V17, P73, DOI 10.1038/mt.2008.225; Penaud-Budloo M, 2008, J VIROL, V82, P7875, DOI 10.1128/JVI.00649-08; Pichard V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051952; Rivera VM, 2005, BLOOD, V105, P1424, DOI 10.1182/blood-2004-06-2501; Rivera VM, 1996, NAT MED, V2, P1028, DOI 10.1038/nm0996-1028; Rivera VM, 1999, P NATL ACAD SCI USA, V96, P8657, DOI 10.1073/pnas.96.15.8657; Rolling F, 1999, HUM GENE THER, V10, P641, DOI 10.1089/10430349950018715; Snyder RO, 1999, J GENE MED, V1, P166; Stieger K, 2007, GENE THER, V14, P1668, DOI 10.1038/sj.gt.3303034; Stieger K, 2006, MOL THER, V13, P967, DOI 10.1016/j.ymthe.2005.12.001; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Toniatti C, 2004, GENE THER, V11, P649, DOI 10.1038/sj.gt.3302251; Toromanoff A, 2008, MOL THER, V16, P1291, DOI 10.1038/mt.2008.87; Toromanoff A, 2010, MOL THER, V18, P151, DOI 10.1038/mt.2009.251; Vandenberghe LH, 2006, NAT MED, V12, P967, DOI 10.1038/nm1445; Vilaboa N, 2006, CURR GENE THER, V6, P421, DOI 10.2174/156652306777934829; Wang L, 2005, GENE THER, V12, P1453, DOI 10.1038/sj.gt.3302539; Weber M, 2003, MOL THER, V7, P774, DOI 10.1016/S1525-0016(03)00098-4; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yang ZL, 2009, VIROLOGY, V391, P221, DOI 10.1016/j.virol.2009.06.014; Ye XH, 1999, SCIENCE, V283, P88, DOI 10.1126/science.283.5398.88	46	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e102538	10.1371/journal.pone.0102538	http://dx.doi.org/10.1371/journal.pone.0102538			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25248159	Green Submitted, Green Published, gold			2022-12-25	WOS:000342351800002
J	Meijer, MF; Boerboom, AL; Stevens, M; Bulstra, SK; Reininga, IHF				Meijer, Marrigje F.; Boerboom, Alexander L.; Stevens, Martin; Bulstra, Sjoerd K.; Reininga, Inge H. F.			Assessment of Prosthesis Alignment after Revision Total Knee Arthroplasty Using EOS 2D and 3D Imaging: A Reliability Study	PLOS ONE			English	Article							LOWER-EXTREMITY; REPRODUCIBILITY; REHABILITATION; AGREEMENT; POSITION; ROTATION; SYSTEM	Introduction: A new low-dose X-ray device, called EOS, has been introduced for determining lower-limb alignment in 2D and 3D. Reliability has not yet been assessed when using EOS on lower limbs containing a knee prosthesis. Therefore purpose of this study was to determine intraobserver and interobserver reliability of EOS 2D and 3D knee prosthesis alignment measurements after revision total knee arthroplasty (rTKA). Methods: Forty anteroposterior and lateral images of 37 rTKA patients were included. Two observers independently performed measurements on these images twice. Varus/valgus angles were measured in 2D (VV2D) and 3D (VV3D). Intraclass correlation coefficients and the Bland and Altman method were used to determine reliability. T-tests were used to test potential differences. Results: Intraobserver and interobserver reliability were excellent for VV2D and VV3D. No significant difference or bias between the first and second measurements or the two observers was found. A significant mean and absolute difference of respectively 1.00 degrees and 1.61 degrees existed between 2D and 3D measurements. Conclusions: EOS provides reliable varus/valgus measurements in 2D and 3D for the alignment of the knee joint with a knee prosthesis. However, significant differences exist between varus/valgus measurements in 2D and 3D.	[Meijer, Marrigje F.; Boerboom, Alexander L.; Stevens, Martin; Bulstra, Sjoerd K.] Univ Groningen, Univ Med Ctr Groningen, Dept Orthopaed, Groningen, Netherlands; [Reininga, Inge H. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Trauma Surg, Groningen, Netherlands	University of Groningen; University of Groningen	Meijer, MF (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Orthopaed, Groningen, Netherlands.	M.F.Meijer@umcg.nl	Reininga, Inge H.F./H-4250-2013; Stevens, Martin/A-5196-2013	Reininga, Inge H.F./0000-0003-1341-845X; Stevens, Martin/0000-0001-8183-6894				Baker P, 2012, CLIN ORTHOP RELAT R, V470, P2244, DOI 10.1007/s11999-012-2278-7; Beckerman H, 2001, QUAL LIFE RES, V10, P571, DOI 10.1023/A:1013138911638; Bittersohl B, 2013, J BONE JOINT SURG AM, V95A, DOI 10.2106/JBJS.K.01591; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brouwer R W, 2007, J Knee Surg, V20, P210; Choong PF, 2009, J ARTHROPLASTY, V24, P560, DOI 10.1016/j.arth.2008.02.018; Cohen JA, 1960, EDUC PSYCHOL MEAS, V33, P159; de Vet HCW, 2001, INT J TECHNOL ASSESS, V17, P479, DOI 10.1017/S0266462301107038; Dubousset J, 2005, B ACAD NAT MED PARIS, V189, P287, DOI 10.1016/S0001-4079(19)33584-8; EOS-imaging, 2011, STEREOS WORKST OP MA; Fleiss J.L., 1986, DESIGN ANAL CLIN EXP; Gheno R, 2012, EUR RADIOL, V22, P765, DOI 10.1007/s00330-011-2308-y; Guenoun B, 2012, ORTHOP TRAUMATOL-SUR, V98, P506, DOI 10.1016/j.otsr.2012.03.014; Ilharreborde B, 2011, SPINE, V36, pE1306, DOI 10.1097/BRS.0b013e3182293548; JEFFERY RS, 1991, J BONE JOINT SURG BR, V73, P709, DOI 10.1302/0301-620X.73B5.1894655; Kalifa G, 1998, PEDIATR RADIOL, V28, P557, DOI 10.1007/s002470050413; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lazennec JY, 2011, ORTHOP TRAUMATOL-SUR, V97, P373, DOI 10.1016/j.otsr.2011.02.006; Longstaff LM, 2009, J ARTHROPLASTY, V24, P570, DOI 10.1016/j.arth.2008.03.002; Lonner JH, 1996, CLIN ORTHOP RELAT R, P102; Ohl X, 2010, SURG RADIOL ANAT, V32, P153, DOI 10.1007/s00276-009-0566-z; Radtke K, 2010, ARCH ORTHOP TRAUM SU, V130, P451, DOI 10.1007/s00402-009-0999-1; Rankin G, 1998, CLIN REHABIL, V12, P187, DOI 10.1191/026921598672178340; RITTER MA, 1994, CLIN ORTHOP RELAT R, P153; Rousseau MA, 2007, SPINE, V32, P2569, DOI 10.1097/BRS.0b013e318158cba2; Sheng PY, 2006, J BONE JOINT SURG AM, V88A, P1425, DOI 10.2106/JBJS.E.00737; Somoskeoy S, 2012, SPINE J, V12, P1052, DOI 10.1016/j.spinee.2012.10.002; STRATFORD P, 1989, PHYS THER, V69, P299, DOI 10.1093/ptj/69.4.299a; Swanson KE, 2000, CLIN ORTHOP RELAT R, P246; Thelen P, 2012, SKELETAL RADIOL, V41, P1287, DOI 10.1007/s00256-012-1438-x; Vidal C, 2013, EUR SPINE J, V22, P1362, DOI 10.1007/s00586-013-2752-2	31	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e104613	10.1371/journal.pone.0104613	http://dx.doi.org/10.1371/journal.pone.0104613			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247714	Green Published, Green Submitted, gold			2022-12-25	WOS:000342351800006
J	Singh, H; Nero, TL; Wang, Y; Parker, MW; Nie, GY				Singh, Harmeet; Nero, Tracy L.; Wang, Yao; Parker, Michael W.; Nie, Guiying			Activity-Modulating Monoclonal Antibodies to the Human Serine Protease HtrA3 Provide Novel Insights into Regulating HtrA Proteolytic Activities	PLOS ONE			English	Article							HIGH-TEMPERATURE REQUIREMENT; CANCER-CELL-LINES; CRYSTAL-STRUCTURE; QUALITY CONTROL; A3 HTRA3; TROPHOBLAST INVASION; INDUCED CYTOTOXICITY; FUNCTIONAL-ANALYSIS; LUNG-CANCER; PROTEINS	Mammalian HtrA (high temperature requirement factor A) proteases, comprising 4 multi-domain members HtrA1-4, play important roles in a number of normal cellular processes as well as pathological conditions such as cancer, arthritis, neurodegenerative diseases and pregnancy disorders. However, how HtrA activities are regulated is not well understood, and to date no inhibitors specific to individual HtrA proteins have been identified. Here we investigated five HtrA3 monoclonal antibodies (mAbs) that we have previously produced, and demonstrated that two of them regulated HtrA3 activity in an opposing fashion: one inhibited while the other stimulated. The inhibitory mAb also blocked HtrA3 activity in trophoblast cells and enhanced migration and invasion, confirming its potential in vivo utility. To understand how the binding of these mAbs modulated HtrA3 protease activity, their epitopes were visualized in relation to a 3-dimensional HtrA3 homology model. This model suggests that the inhibitory HtrA3 mAb blocks substrate access to the protease catalytic site, whereas the stimulatory mAb may bind to the PDZ domain alone or in combination with the N-terminal and protease domains. Since HtrA1, HtrA3 and HtrA4 share identical domain organization, our results establish important foundations for developing potential therapeutics to target these HtrA proteins specifically for the treatment of a number of diseases, including cancer and pregnancy disorders.	[Singh, Harmeet; Wang, Yao; Nie, Guiying] MIMR PHI Inst Med Res, Clayton, Vic, Australia; [Singh, Harmeet; Wang, Yao; Nie, Guiying] Monash Univ, Clayton, Vic, Australia; [Nero, Tracy L.; Parker, Michael W.] St Vincents Inst Med Res, ACRF Rational Drug Discovery Ctr, Fitzroy, Vic 3065, Australia; [Parker, Michael W.] Univ Melbourne, Mol Sci & Biotechnol Inst Biol21, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia	Prince Henry's Institute of Medical Research; Monash University; St. Vincent's Institute of Medical Research; University of Melbourne	Singh, H (corresponding author), MIMR PHI Inst Med Res, Clayton, Vic, Australia.	harmeet.singh@mimr-phi.org; guiying.nie@mimr-phi.org	Parker, Michael W/F-9069-2013	Parker, Michael W/0000-0002-3101-1138; Nero, Tracy/0000-0002-3393-1843; Nie, Guiying/0000-0001-9641-087X	National Health and Medical Research Council (NHMRC) of Australia Fellowship [1041835]; Program grant [494802]; Bill & Melinda Gates Foundation [OPP1025076, OPP1086155]; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council (NHMRC) of Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Program grant; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Victorian Government's Operational Infrastructure Support Program	This work was supported by the National Health and Medical Research Council (NHMRC) of Australia Fellowship #1041835 (to GN) and Program grant #494802, the Bill & Melinda Gates Foundation (OPP1025076 and OPP1086155 to GN) and the Victorian Government's Operational Infrastructure Support Program. MWP is a NHMRC Senior Principal Research Fellow (#1021645). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Prince Henry's Institute data audit number for this work is 13-19.	Beleford D, 2010, CLIN CANCER RES, V16, P398, DOI 10.1158/1078-0432.CCR-09-1677; Beleford D, 2010, J BIOL CHEM, V285, P12011, DOI 10.1074/jbc.M109.097790; Bohrmann B, 2012, J ALZHEIMERS DIS, V28, P49, DOI 10.3233/JAD-2011-110977; Bowden MA, 2006, GYNECOL ONCOL, V103, P253, DOI 10.1016/j.ygyno.2006.03.006; Brekke OH, 2003, NAT REV DRUG DISCOV, V2, P52, DOI 10.1038/nrd984; Chien J, 2009, CURR CANCER DRUG TAR, V9, P451, DOI 10.2174/156800909788486704; Chien J, 2006, J CLIN INVEST, V116, P1994, DOI 10.1172/JCI27698; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; Dynon K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045956; Eigenbrot C, 2012, STRUCTURE, V20, P1040, DOI 10.1016/j.str.2012.03.021; Faccio L, 2000, J BIOL CHEM, V275, P2581, DOI 10.1074/jbc.275.4.2581; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Gray CW, 2000, EUR J BIOCHEM, V267, P5699, DOI 10.1046/j.1432-1327.2000.01589.x; Hara K, 2009, NEW ENGL J MED, V360, P1729, DOI 10.1056/NEJMoa0801560; Hu SI, 1998, J BIOL CHEM, V273, P34406, DOI 10.1074/jbc.273.51.34406; Kim DY, 2005, J BIOCHEM MOL BIOL, V38, P266; Krawczyk A, 2011, J VIROL, V85, P1793, DOI 10.1128/JVI.01924-10; Krem MM, 1999, J BIOL CHEM, V274, P28063, DOI 10.1074/jbc.274.40.28063; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Krojer T, 2008, P NATL ACAD SCI USA, V105, P7702, DOI 10.1073/pnas.0803392105; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li Y, 2011, J CLIN ENDOCR METAB, V96, P403, DOI 10.1210/jc.2010-1405; Meltzer M, 2009, RES MICROBIOL, V160, P660, DOI 10.1016/j.resmic.2009.07.012; Milner JM, 2008, ARTHRITIS RHEUM-US, V58, P3644, DOI 10.1002/art.24046; MohamedMohaideen NN, 2008, BIOCHEMISTRY-US, V47, P6092, DOI 10.1021/bi701929m; Narklewicz J, 2008, CLIN BIOCHEM, V41, P561, DOI 10.1016/j.clinbiochem.2008.01.004; Nie G, 2006, PLACENTA, V27, P491, DOI 10.1016/j.placenta.2005.03.009; Nie GY, 2003, MOL HUM REPROD, V9, P279, DOI 10.1093/molehr/gag036; Nie GY, 2006, BIOL REPROD, V74, P366, DOI 10.1095/biolreprod.105.047324; Nie GY, 2003, BIOCHEM J, V371, P39, DOI 10.1042/BJ20021569; Polur I, 2010, HISTOL HISTOPATHOL, V25, P599, DOI 10.14670/HH-25.599; Runyon ST, 2007, PROTEIN SCI, V16, P2454, DOI 10.1110/ps.073049407; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Shen QT, 2009, P NATL ACAD SCI USA, V106, P4858, DOI 10.1073/pnas.0811780106; Singh H, 2010, PLACENTA, V31, P1085, DOI 10.1016/j.placenta.2010.10.003; Singh H, 2013, J CANCER, V4, P152, DOI 10.7150/jca.5702; Singh H, 2012, BIOTECHNIQUES, V52, P23, DOI 10.2144/000113798; Singh H, 2011, HUM REPROD, V26, P748, DOI 10.1093/humrep/der019; Suzuki Y, 2004, CELL DEATH DIFFER, V11, P208, DOI 10.1038/sj.cdd.4401343; Than NG, 2008, PLACENTA, V29, pS83, DOI 10.1016/j.placenta.2007.10.008; Tocharus J, 2004, DEV GROWTH DIFFER, V46, P257; Truebestein L, 2011, NAT STRUCT MOL BIOL, V18, P386, DOI 10.1038/nsmb.2013; TULIP WR, 1992, J MOL BIOL, V227, P122, DOI 10.1016/0022-2836(92)90687-F; Wang LJ, 2012, MOL CELL BIOL, V32, P3707, DOI 10.1128/MCB.00223-12; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Zumbrunn J, 1996, FEBS LETT, V398, P187, DOI 10.1016/S0014-5793(96)01229-X; Zurawa-Janicka D, 2010, EXPERT OPIN THER TAR, V14, P665, DOI 10.1517/14728222.2010.487867	51	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108235	10.1371/journal.pone.0108235	http://dx.doi.org/10.1371/journal.pone.0108235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25248123	gold, Green Published			2022-12-25	WOS:000342351800073
J	Zhu, LHJ; Holmes, BR; Aronin, N; Brodsky, MH				Zhu, Lihua J.; Holmes, Benjamin R.; Aronin, Neil; Brodsky, Michael H.			CRISPRseek: A Bioconductor Package to Identify Target-Specific Guide RNAs for CRISPR-Cas9 Genome-Editing Systems	PLOS ONE			English	Article							HUMAN-CELLS; CAS SYSTEM; CRISPR/CAS; NUCLEASES; NICKASES; BIOLOGY; DNA	CRISPR-Cas systems are a diverse family of RNA-protein complexes in bacteria that target foreign DNA sequences for cleavage. Derivatives of these complexes have been engineered to cleave specific target sequences depending on the sequence of a CRISPR-derived guide RNA (gRNA) and the source of the Cas9 protein. Important considerations for the design of gRNAs are to maximize aimed activity at the desired target site while minimizing off-target cleavage. Because of the rapid advances in the understanding of existing CRISPR-Cas9-derived RNA-guided nucleases and the development of novel RNA-guided nuclease systems, it is critical to have computational tools that can accommodate a wide range of different parameters for the design of target-specific RNA-guided nuclease systems. We have developed CRISPRseek, a highly flexible, open source software package to identify gRNAs that target a given input sequence while minimizing off-target cleavage at other sites within any selected genome. CRISPRseek will identify potential gRNAs that target a sequence of interest for CRISPR-Cas9 systems from different bacterial species and generate a cleavage score for potential off-target sequences utilizing published or user-supplied weight matrices with position-specific mismatch penalty scores. Identified gRNAs may be further filtered to only include those that occur in paired orientations for increased specificity and/or those that overlap restriction enzyme sites. For applications where gRNAs are desired to discriminate between two related sequences, CRISPRseek can rank gRNAs based on the difference between predicted cleavage scores in each input sequence. CRISPRseek is implemented as a Bioconductor package within the R statistical programming environment, allowing it to be incorporated into computational pipelines to automate the design of gRNAs for target sequences identified in a wide variety of genome-wide analyses. CRISPRseek is available under the GNU General Public Licence v3.0 at http://www.bioconductor.org.	[Zhu, Lihua J.; Brodsky, Michael H.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Zhu, Lihua J.; Brodsky, Michael H.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Zhu, Lihua J.] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Holmes, Benjamin R.] MIT, Broad Inst MIT & Harvard, McGovern Inst Brain Res, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Holmes, Benjamin R.] MIT, Broad Inst MIT & Harvard, McGovern Inst Brain Res, Dept Biol Engn, Cambridge, MA 02139 USA; [Aronin, Neil] Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA 01605 USA; [Aronin, Neil] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Zhu, LHJ (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	julie.zhu@umassmed.edu; michael.brodsky@umassmed.edu		Zhu, Lihua/0000-0001-7416-0590	CHDI Foundation; National Institutes of Health [R01GM084361, R01NS38194]; National Science Foundation graduate fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038194] Funding Source: NIH RePORTER	CHDI Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation graduate fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support provided by the CHDI Foundation (http://chdifoundation.org), gifts for Huntington's Disease research at the University of Massachusetts, by the National Institutes of Health (http://www.nih.gov, R01GM084361 to M.H.B.and R01NS38194 to N.A.) and by a National Science Foundation graduate fellowship (http://www.nsf.gov, to B.R.H.).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae S., 2014, BIOINFORMATICS; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Esvelt K. M., 2013, NAT METHODS; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Ihaka RGR, 1996, J COMPUT GRAPH STAT, V5, P5; Koonin Eugene V, 2009, F1000 Biol Rep, V1, P95; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Pfister EL, 2009, CURR BIOL, V19, P774, DOI 10.1016/j.cub.2009.03.030; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sah DWY, 2011, J CLIN INVEST, V121, P500, DOI 10.1172/JCI45130; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Tsai S. Q., 2014, NAT BIOTECHNOL; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Xiao A, 2014, BIOINFORMATICS	30	98	106	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108424	10.1371/journal.pone.0108424	http://dx.doi.org/10.1371/journal.pone.0108424			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247697	Green Published, gold, Green Submitted			2022-12-25	WOS:000342351800086
J	Curciarello, R; Steele, A; Cooper, D; MacDonald, TT; Kruidenier, L; Kudo, T				Curciarello, Renata; Steele, Alison; Cooper, Dianne; MacDonald, Thomas T.; Kruidenier, Laurens; Kudo, Takahiro			The Role of Galectin-1 and Galectin-3 in the Mucosal Immune Response to Citrobacter rodentium Infection	PLOS ONE			English	Article							DENDRITIC CELLS; EPITHELIAL-CELLS; HELICOBACTER-PYLORI; ADHESION; MACROPHAGES; EXPRESSION; INFLAMMATION; LECTIN; MICE; PHAGOCYTOSIS	Despite their abundance at gastrointestinal sites, little is known about the role of galectins in gut immune responses. We have therefore investigated the Citrobacter rodentium model of colonic infection and inflammation in Galectin-1 or Galectin-3 null mice. Gal-3 null mice showed a slight delay in colonisation after inoculation with C. rodentium and a slight delay in resolution of infection, associated with delayed T cell, macrophage and dendritic cell infiltration into the gut mucosa. However, Gal-1 null mice also demonstrated reduced T cell and macrophage responses to infection. Despite the reduced T cell and macrophage response in Gal-1 null mice, there was no effect on C. rodentium infection kinetics and pathology. Overall, Gal-1 and Gal-3 play only a minor role in immunity to a gut bacterial pathogen.	[Curciarello, Renata; Steele, Alison; MacDonald, Thomas T.; Kruidenier, Laurens; Kudo, Takahiro] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Immunol & Infect Dis, London, England; [Cooper, Dianne] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England	University of London; Queen Mary University London; University of London; Queen Mary University London	MacDonald, TT (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Immunol & Infect Dis, London, England.	t.t.macdonald@qmul.ac.uk			Arthritis Research United Kingdom [18103]; William Harvey Research Foundation; Versus Arthritis [18103] Funding Source: researchfish	Arthritis Research United Kingdom(Versus Arthritis); William Harvey Research Foundation; Versus Arthritis(Versus Arthritis)	Supported by the Arthritis Research United Kingdom (non clinical career development fellowship 18103 to DC) and, in part, the William Harvey Research Foundation (http://www.whrf.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardes ES, 2006, AM J PATHOL, V168, P1910, DOI 10.2353/ajpath.2006.050636; Bickle Q, 2007, PARASITE IMMUNOL, V29, P93, DOI 10.1111/j.1365-3024.2006.00923.x; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; Bresalier RS, 1996, CANCER RES, V56, P4354; Breuilh L, 2007, INFECT IMMUN, V75, P5148, DOI 10.1128/IAI.02006-06; Colnot C, 1998, IMMUNOLOGY, V94, P290, DOI 10.1046/j.1365-2567.1998.00517.x; Cooper D, 2008, J LEUKOCYTE BIOL, V83, P1459, DOI 10.1189/jlb.1207831; Dann SM, 2008, J IMMUNOL, V180, P6816, DOI 10.4049/jimmunol.180.10.6816; Dennis A, 2008, INFECT IMMUN, V76, P4978, DOI 10.1128/IAI.00736-08; Fernandez GC, 2005, GLYCOBIOLOGY, V15, P519, DOI 10.1093/glycob/cwi026; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Fowler M, 2006, CELL MICROBIOL, V8, P44, DOI 10.1111/j.1462-5822.2005.00599.x; Gil CD, 2006, INFLAMM RES, V55, P99, DOI 10.1007/s00011-005-0059-4; He J, 2006, LAB INVEST, V86, P578, DOI 10.1038/labinvest.3700420; Higgins LM, 1999, INFECT IMMUN, V67, P3031, DOI 10.1128/IAI.67.6.3031-3039.1999; Hsu DK, 2009, J INVEST DERMATOL, V129, P573, DOI 10.1038/jid.2008.276; Huflejt ME, 1997, J BIOL CHEM, V272, P14294, DOI 10.1074/jbc.272.22.14294; Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772; John CM, 2002, CELL MICROBIOL, V4, P649, DOI 10.1046/j.1462-5822.2002.00219.x; Kuwabara I, 1996, J IMMUNOL, V156, P3939; La M, 2003, AM J PATHOL, V163, P1505, DOI 10.1016/S0002-9440(10)63507-9; Lim JW, 2003, INT J BIOCHEM CELL B, V35, P1284, DOI 10.1016/S1357-2725(03)00051-7; Lippert E, 2007, GUT, V56, P43, DOI 10.1136/gut.2005.081646; Lippert E, 2008, CLIN EXP IMMUNOL, V152, P285, DOI 10.1111/j.1365-2249.2008.03618.x; Liu FT, 2002, BBA-GEN SUBJECTS, V1572, P263, DOI 10.1016/S0304-4165(02)00313-6; LIU FT, 1995, AM J PATHOL, V147, P1016; Malik RKJ, 2009, GLYCOBIOLOGY, V19, P1402, DOI 10.1093/glycob/cwp077; Marches O, 2008, CELL MICROBIOL, V10, P1104, DOI 10.1111/j.1462-5822.2007.01112.x; Mercier S, 2008, VIROLOGY, V371, P121, DOI 10.1016/j.virol.2007.09.034; Mey A, 1996, J IMMUNOL, V156, P1572; Nieminen J, 2008, J IMMUNOL, V180, P2466, DOI 10.4049/jimmunol.180.4.2466; Nio-Kobayashi J, 2009, J HISTOCHEM CYTOCHEM, V57, P41, DOI 10.1369/jhc.2008.952317; Norling LV, 2008, FASEB J, V22, P682, DOI 10.1096/fj.07-9268com; Ochieng J, 2002, GLYCOCONJUGATE J, V19, P527, DOI 10.1023/B:GLYC.0000014082.99675.2f; Okumura CYM, 2008, CELL MICROBIOL, V10, P2078, DOI 10.1111/j.1462-5822.2008.01190.x; Sano H, 2000, J IMMUNOL, V165, P2156, DOI 10.4049/jimmunol.165.4.2156; Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592; Santucci L, 2003, GASTROENTEROLOGY, V124, P1381, DOI 10.1016/S0016-5085(03)00267-1; Sato S, 2002, J IMMUNOL, V168, P1813, DOI 10.4049/jimmunol.168.4.1813; SATO S, 1993, EXP CELL RES, V207, P8, DOI 10.1006/excr.1993.1157; Stowell SR, 2008, J IMMUNOL, V180, P3091, DOI 10.4049/jimmunol.180.5.3091; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Wiles S, 2004, CELL MICROBIOL, V6, P963, DOI 10.1111/j.1462-5822.2004.00414.x; YAMAOKA A, 1995, J IMMUNOL, V154, P3479; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737	45	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107933	10.1371/journal.pone.0107933	http://dx.doi.org/10.1371/journal.pone.0107933			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243744	Green Submitted, Green Published, gold			2022-12-25	WOS:000343679800057
J	Lysaght, AC; Yuan, Q; Fan, Y; Kalwani, N; Caruso, P; Cunnane, M; Lanske, B; Stankovic, KM				Lysaght, Andrew C.; Yuan, Quan; Fan, Yi; Kalwani, Neil; Caruso, Paul; Cunnane, MaryBeth; Lanske, Beate; Stankovic, Konstantina M.			FGF23 Deficiency Leads to Mixed Hearing Loss and Middle Ear Malformation in Mice	PLOS ONE			English	Article							VITAMIN-D; OTITIS-MEDIA; HYPOPHOSPHATEMIC RICKETS; TUMORAL CALCINOSIS; KLOTHO PROTEIN; EXPRESSION; PHOSPHATE; HYPERPHOSPHATEMIA; ABLATION; MUTATION	Fibroblast growth factor 23 (FGF23) is a circulating hormone important in phosphate homeostasis. Abnormal serum levels of FGF23 result in systemic pathologies in humans and mice, including renal phosphate wasting diseases and hyperphosphatemia. We sought to uncover the role FGF23 plays in the auditory system due to shared molecular mechanisms and genetic pathways between ear and kidney development, the critical roles multiple FGFs play in auditory development and the known hearing phenotype in mice deficient in klotho (KL), a critical co-factor for FGF23 signaling. Using functional assessments of hearing, we demonstrate that Fgf23(+/-) mice are profoundly deaf. Fgf23(+/-) mice have moderate hearing loss above 20 kHz, consistent with mixed conductive and sensorineural pathology of both middle and inner ear origin. Histology and high-voltage X-ray computed tomography of Fgf23(-/-) mice demonstrate dysplastic bulla and ossicles; Fgf23(+/-) mice have near-normal morphology. The cochleae of mutant mice appear nearly normal on gross and microscopic inspection. In wild type mice, FGF23 is ubiquitously expressed throughout the cochlea. Measurements from Fgf23(-/-) mice do not match the auditory phenotype of Kl(-/-) mice, suggesting that loss of FGF23 activity impacts the auditory system via mechanisms at least partially independent of KL. Given the extensive middle ear malformations and the overlap of initiation of FGF23 activity and Eustachian tube development, this work suggests a possible role for FGF23 in otitis media.	[Lysaght, Andrew C.] Harvard MIT Joint Div Hlth Sci & Technol, Program Speech & Hearing Biosci & Technol, Cambridge, MA 02139 USA; [Lysaght, Andrew C.; Kalwani, Neil; Stankovic, Konstantina M.] Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA; [Yuan, Quan; Fan, Yi; Lanske, Beate] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; [Caruso, Paul; Cunnane, MaryBeth] Massachusetts Eye & Ear Infirm, Dept Radiol, Boston, MA 02114 USA; [Caruso, Paul; Cunnane, MaryBeth] Harvard Univ, Sch Med, Boston, MA USA; [Stankovic, Konstantina M.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA; [Stankovic, Konstantina M.] Massachusetts Eye & Ear Infirm, Dept Otolaryngol, Boston, MA 02114 USA	Harvard University; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard School of Dental Medicine; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary	Lysaght, AC (corresponding author), Harvard MIT Joint Div Hlth Sci & Technol, Program Speech & Hearing Biosci & Technol, Cambridge, MA 02139 USA.	andrew_lysaght@meei.harvard.edu	Kalwani, Neil Manohar/AAE-4680-2022; yuan, quan/GZM-5597-2022	Kalwani, Neil Manohar/0000-0003-0075-6206; Lanske, Beate/0000-0003-4638-804X; Yuan, Quan/0000-0002-2836-1081	National Institute on Deafness and Other Communication Disorders [K08 DC010419]; Bertarelli Foundation; National Institute of Diabetes and Digestive and Kidney Diseases grant [DK097105]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K08DC010419, T32DC000038] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Bertarelli Foundation; National Institute of Diabetes and Digestive and Kidney Diseases grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors are grateful for support from National Institute on Deafness and Other Communication Disorders grant K08 DC010419 (KMS), the Bertarelli Foundation (KMS) and National Institute of Diabetes and Digestive and Kidney Diseases grant DK097105 (BL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsmadi O, 2009, EUR J HUM GENET, V17, P14, DOI 10.1038/ejhg.2008.141; Bai XY, 2004, ENDOCRINOLOGY, V145, P5269, DOI 10.1210/en.2004-0233; BALDURSSON H, 1969, J BONE JOINT SURG AM, VA 51, P913, DOI 10.2106/00004623-196951050-00008; Benet-Pages A, 2005, HUM MOL GENET, V14, P385, DOI 10.1093/hmg/ddi034; Bergwitz C, 2010, ANNU REV MED, V61, P91, DOI 10.1146/annurev.med.051308.111339; Bondy J, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.6.e72; Carpinelli MR, 2011, HEARING RES, V275, P105, DOI 10.1016/j.heares.2010.12.009; Casselbrant ML, 2005, CURR OPIN ALLERGY CL, V5, P1, DOI 10.1097/00130832-200502000-00002; Caye-Thomasen P, 2013, OTOLARYNG HEAD NECK, V148, pE37, DOI 10.1177/0194599813476257; DAVIES M, 1984, ANN INTERN MED, V100, P230, DOI 10.7326/0003-4819-100-2-230; Depreux FFS, 2008, J CLIN INVEST, V118, P651, DOI 10.1172/JCI32899; Farrow EG, 2011, P NATL ACAD SCI USA, V108, pE1146, DOI 10.1073/pnas.1110905108; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Humes HD, 1999, ANN NY ACAD SCI, V884, P15, DOI 10.1111/j.1749-6632.1999.tb00278.x; Izzedine H, 2004, KIDNEY INT, V65, P369, DOI 10.1111/j.1523-1755.2004.00390.x; Kamemori M, 2002, HEARING RES, V171, P103, DOI 10.1016/S0378-5955(02)00483-5; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Kuro-O M, 2008, BIOL CHEM, V389, P233, DOI 10.1515/BC.2008.028; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Liberman MC, 2006, JARO-J ASSOC RES OTO, V7, P211, DOI 10.1007/s10162-006-0035-x; Liu SG, 2006, AM J PHYSIOL-ENDOC M, V291, pE38, DOI 10.1152/ajpendo.00008.2006; Minami SB, 2004, J NEUROSCI RES, V78, P383, DOI 10.1002/jnr.20267; Nakatani T, 2009, FASEB J, V23, P433, DOI 10.1096/fj.08-114397; NIDCD, 2010, STAT EP QUICK STAT; Olauson H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003975; Paradise JL, 1997, PEDIATRICS, V99, P318, DOI 10.1542/peds.99.3.318; Pickles JO, 2002, AUDIOL NEURO-OTOL, V7, P36, DOI 10.1159/000046861; Schimmang T, 2007, INT J DEV BIOL, V51, P473, DOI 10.1387/ijdb.072334ts; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2004, BIOCHEM BIOPH RES CO, V314, P409, DOI 10.1016/j.bbrc.2003.12.102; Sitara D, 2004, MATRIX BIOL, V23, P421, DOI 10.1016/j.matbio.2004.09.007; Takumida M, 2009, ACTA OTO-LARYNGOL, V129, P1340, DOI 10.3109/00016480902725254; Torban E, 2009, ANNU REV MED, V60, P339, DOI 10.1146/annurev.med.60.052307.120752; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; Uemaetomari I, 2005, HEARING RES, V209, P86, DOI 10.1016/j.heares.2005.06.010; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Vemaraju S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003068; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Xie J, 2011, HEARING RES, V281, P28, DOI 10.1016/j.heares.2011.05.008; Yoshiko Y, 2007, BONE, V40, P1565, DOI 10.1016/j.bone.2007.01.017; Yuan Q, 2011, J BONE MINER RES, V26, P2026, DOI 10.1002/jbmr.433	41	23	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107681	10.1371/journal.pone.0107681	http://dx.doi.org/10.1371/journal.pone.0107681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243481	Green Published, gold, Green Submitted			2022-12-25	WOS:000343679800043
J	Mobley, ML; Cleary, MJ; Burke, IC				Mobley, Megan L.; Cleary, Matthew J.; Burke, Ingrid C.			Inorganic Nitrogen Supply and Dissolved Organic Nitrogen Abundance across the US Great Plains	PLOS ONE			English	Article							CENTRAL GRASSLAND REGION; TEMPORAL VARIATION; SOIL CARBON; MINERALIZATION; PLANTS; ECOSYSTEMS; RESPONSES; MICROBES; GRADIENT; CYCLE	Across US Great Plains grasslands, a gradient of increasing mean annual precipitation from west to east corresponds to increasing aboveground net primary productivity (ANPP) and increasing N-limitation. Previous work has shown that there is no increase in net N mineralization rates across this gradient, leading to the question of where eastern prairie grasses obtain the nitrogen to support production. One as-yet unexamined source is soil organic N, despite abundant literature from other ecosystems showing that plants take up dissolved soil organic N. This study measured KCl-extractable dissolved organic N (DON) in surface soils across the grassland productivity gradient. We found that KCl-extractable DON pools increased from west to east. If available to and used by plants, this DON may help explain the high ANPP in the eastern Great Plains. These results suggest a need for future research to determine whether, in what quantities, and in what forms prairie grasses use organic N to support primary production.	[Mobley, Megan L.; Cleary, Matthew J.; Burke, Ingrid C.] Univ Wyoming, Dept Bot, Laramie, WY 82071 USA; [Mobley, Megan L.; Burke, Ingrid C.] Univ Wyoming, Helga Otto Haub Sch Environm & Nat Resources, Laramie, WY 82071 USA; [Burke, Ingrid C.] Univ Wyoming, Program Ecol, Laramie, WY 82071 USA	University of Wyoming; University of Wyoming; University of Wyoming	Mobley, ML (corresponding author), Univ Wyoming, Dept Bot, Laramie, WY 82071 USA.	meg.mobley@alumni.duke.edu	Burke, Ingrid/A-1420-2009; Mobley, Megan/AAF-3560-2020; Mobley, Megan L/A-5402-2010	Burke, Ingrid/0000-0003-4717-6399; Mobley, Megan/0000-0002-6046-8380; Mobley, Megan L/0000-0002-6046-8380	University of Wyoming Excellence Funds	University of Wyoming Excellence Funds	This research was funded by the University of Wyoming Excellence Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber JD, 1997, ECOL MODEL, V101, P61, DOI 10.1016/S0304-3800(97)01953-4; [Anonymous], 2011, NRSP3 NAT ATM DEP PR; Bardgett RD, 2003, ECOLOGY, V84, P1277, DOI 10.1890/0012-9658(2003)084[1277:SMCEWP]2.0.CO;2; Barrett JE, 2002, J VEG SCI, V13, P383, DOI 10.1111/j.1654-1103.2002.tb02062.x; Burke IC, 1997, ECOLOGY, V78, P1330, DOI 10.1890/0012-9658(1997)078[1330:RATVIN]2.0.CO;2; Copley PW, 1972, EVALUATION BIOL N2 F; Dodd J.L., 1979, Ecological Studies, V32, P43; DUBOIS JD, 1983, AM J BOT, V70, P8, DOI 10.1002/j.1537-2197.1983.tb12426.x; Hobbie JE, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00324; HOOK PB, 1995, SOIL SCI SOC AM J, V59, P831, DOI 10.2136/sssaj1995.03615995005900030028x; Hooper DU, 1999, BIOGEOCHEMISTRY, V46, P247, DOI 10.1007/BF01007582; Hsu J., 1996, MULTIPLE COMP THEORY; Inselsbacher E, 2012, NEW PHYTOL, V195, P329, DOI 10.1111/j.1469-8137.2012.04169.x; Jones DL, 2006, SOIL BIOL BIOCHEM, V38, P991, DOI 10.1016/j.soilbio.2005.08.012; Jones DL, 2004, SOIL BIOL BIOCHEM, V36, P749, DOI 10.1016/j.soilbio.2004.01.003; Jones DL, 2005, SOIL BIOL BIOCHEM, V37, P413, DOI 10.1016/j.soilbio.2004.08.008; LAUENROTH WK, 1978, OECOLOGIA, V36, P211, DOI 10.1007/BF00349810; McCulley RL, 2009, OECOLOGIA, V159, P571, DOI 10.1007/s00442-008-1229-1; McGuire AD, 1995, J BIOGEOGR, V22, P785, DOI 10.2307/2845980; Murphy KL, 2002, J VEG SCI, V13, P395, DOI 10.1111/j.1654-1103.2002.tb02063.x; Nasholm T, 2009, NEW PHYTOL, V182, P31, DOI 10.1111/j.1469-8137.2008.02751.x; Neff JC, 2003, FRONT ECOL ENVIRON, V1, P205, DOI 10.1890/1540-9295(2003)001[0205:BITCDO]2.0.CO;2; OWENSBY CE, 1970, J RANGE MANAGE, V23, P341, DOI 10.2307/3896163; PARTON WJ, 1987, SOIL SCI SOC AM J, V51, P1173, DOI 10.2136/sssaj1987.03615995005100050015x; R Development Core Team, 2012, R LANG ENV STAT COMP; RISSER PG, 1982, ECOLOGY, V63, P1342, DOI 10.2307/1938862; Robertson GP, 1999, LT EC RES NETWK SER, V2, P258; Running S.W., 1993, SCALING PHYSL PROCES, P141, DOI DOI 10.1016/B978-0-12-233440-5.50014-2; SALA OE, 1988, ECOLOGY, V69, P40, DOI 10.2307/1943158; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; STANFORD G, 1972, SOIL SCI SOC AM PRO, V36, P465, DOI 10.2136/sssaj1972.03615995003600030029x; U.S. Environmental Protection Agency Clean Air Markets Division, 2011, CLEAN AIR STAT NETW; VANMIEGROET H, 1995, SOIL SCI SOC AM J, V59, P549, DOI 10.2136/sssaj1995.03615995005900020040x; Vinton MA, 1997, OECOLOGIA, V110, P393, DOI 10.1007/s004420050174; WEST NE, 1977, OECOLOG PLANTAR, V12, P45	35	3	3	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107775	10.1371/journal.pone.0107775	http://dx.doi.org/10.1371/journal.pone.0107775			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244190	Green Submitted, Green Published, gold			2022-12-25	WOS:000343679800049
J	Pereira, SS; Moreira-Dill, LS; Morais, MSS; Prado, NDR; Barros, ML; Koishi, AC; Mazarrotto, GACA; Goncalves, GM; Zuliani, JP; Calderon, LA; Soares, AM; da Silva, LHP; dos Santos, CND; Fernandes, CFC; Stabeli, RG				Pereira, Soraya S.; Moreira-Dill, Leandro S.; Morais, Michelle S. S.; Prado, Nidiane D. R.; Barros, Marcos L.; Koishi, Andrea C.; Mazarrotto, Giovanny A. C. A.; Goncalves, Giselle M.; Zuliani, Juliana P.; Calderon, Leonardo A.; Soares, Andreimar M.; Pereira da Silva, Luiz H.; Duarte dos Santos, Claudia N.; Fernandes, Carla F. C.; Stabeli, Rodrigo G.			Novel Camelid Antibody Fragments Targeting Recombinant Nucleoprotein of Araucaria hantavirus: A Prototype for an Early Diagnosis of Hantavirus Pulmonary Syndrome	PLOS ONE			English	Article							SINGLE-DOMAIN ANTIBODIES; HEAVY-CHAIN ANTIBODIES; MAJOR ANTIGENIC DOMAIN; NUCLEOCAPSID PROTEIN; HEMORRHAGIC-FEVER; RENAL SYNDROME; IN-VITRO; MONOCLONAL-ANTIBODIES; LIGHT-CHAINS; EXPRESSION	In addition to conventional antibodies, camelids produce immunoglobulins G composed exclusively of heavy chains in which the antigen binding site is formed only by single domains called VHH. Their particular characteristics make VHHs interesting tools for drug-delivery, passive immunotherapy and high-throughput diagnosis. Hantaviruses are rodent-borne viruses of the Bunyaviridae family. Two clinical forms of the infection are known. Hemorrhagic Fever with Renal Syndrome (HFRS) is present in the Old World, while Hantavirus Pulmonary Syndrome (HPS) is found on the American continent. There is no specific treatment for HPS and its diagnosis is carried out by molecular or serological techniques, using mainly monoclonal antibodies or hantavirus nucleoprotein (N) to detect IgM and IgG in patient serum. This study proposes the use of camelid VHHs to develop alternative methods for diagnosing and confirming HPS. Phage display technology was employed to obtain VHHs. After immunizing one Lama glama against the recombinant N protein (prND85) of a Brazilian hantavirus strain, VHH regions were isolated to construct an immune library. VHHs were displayed fused to the M13KO7 phage coat protein III and the selection steps were performed on immobilized prND85. After selection, eighty clones recognized specifically the N protein. These were sequenced, grouped based mainly on the CDRs, and five clones were analyzed by western blot (WB), surface plasmon resonance (SPR) device, and ELISA. Besides the ability to recognize prND85 by WB, all selected clones showed affinity constants in the nanomolar range. Additionaly, the clone KC329705 is able to detect prND85 in solution, as well as the native viral antigen. Findings support the hypothesis that selected VHHs could be a powerful tool in the development of rapid and accurate HPS diagnostic assays, which are essential to provide supportive care to patients and reduce the high mortality rate associated with hantavirus infections.	[Pereira, Soraya S.; Moreira-Dill, Leandro S.; Morais, Michelle S. S.; Prado, Nidiane D. R.; Barros, Marcos L.; Goncalves, Giselle M.; Zuliani, Juliana P.; Calderon, Leonardo A.; Soares, Andreimar M.; Pereira da Silva, Luiz H.; Fernandes, Carla F. C.; Stabeli, Rodrigo G.] Fiocruz Rondonia, Fundacao Oswaldo Cruz, Porto Velho, RO, Brazil; [Koishi, Andrea C.; Mazarrotto, Giovanny A. C. A.; Duarte dos Santos, Claudia N.] Fiocruz Parana, Inst Carlos Chagas, Curitiba, Parana, Brazil; [Zuliani, Juliana P.; Calderon, Leonardo A.; Stabeli, Rodrigo G.] Univ Fed Rondonia, UNIR, Dept Med, Porto Velho, RO, Brazil; [Fernandes, Carla F. C.] CEPEM, Ctr Pesquisa Med Trop, Porto Velho, RO, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal de Rondonia	Fernandes, CFC (corresponding author), Fiocruz Rondonia, Fundacao Oswaldo Cruz, Porto Velho, RO, Brazil.	carlaceledonio@fiocruz.br; stabeli@fiocruz.br	Moreira-Dill, Leandro/D-5024-2015; Koishi, Andrea/N-2484-2013; de A Calderon, Leonardo/K-8515-2012; Soares, Andreimar M/K-5556-2014; dos Santos, Claudia Duarte/P-4868-2019; dos Santos, Claudia Nunes Duarte/E-1857-2018; Zuliani, JP/P-3633-2019; Soares, Andrei/ABG-3545-2020; Zuliani, Juliana P/G-2329-2015; Pereira, Soraya Santos/ABA-2753-2020; Soares, Andreimar/AAE-4657-2021; Stabeli, Rodrigo Guerino/G-1721-2017	Moreira-Dill, Leandro/0000-0003-2977-0001; Koishi, Andrea/0000-0002-3542-1353; de A Calderon, Leonardo/0000-0003-2669-092X; dos Santos, Claudia Duarte/0000-0001-8707-6638; dos Santos, Claudia Nunes Duarte/0000-0001-8707-6638; Zuliani, JP/0000-0001-9221-7749; Pereira, Soraya Santos/0000-0003-2116-7670; Stabeli, Rodrigo Guerino/0000-0002-0476-920X; Soares, Andreimar/0000-0003-1032-2188	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [477760/2012-0]; Secretaria de Estado do Planejamento (CNPq-SEPLAN-RO) [454534/2011-6]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Secretaria de Estado do Planejamento (CNPq-SEPLAN-RO)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), grant number: 477760/2012-0; Secretaria de Estado do Planejamento (CNPq-SEPLAN-RO), grant number: 454534/2011-6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson K, 1999, ANAL CHEM, V71, P2475, DOI 10.1021/ac981271j; [Anonymous], 2010, Drug Discov Today Technol, V7, pe95, DOI 10.1016/j.ddtec.2010.03.002; CDC, 2012, US HPS CAS STAT EXP; Chotwiwatthanakun C, 2001, TOXICON, V39, P1487, DOI 10.1016/S0041-0101(01)00108-8; Conrath KE, 2003, DEV COMP IMMUNOL, V27, P87, DOI 10.1016/S0145-305X(02)00071-X; Doyle PJ, 2008, MOL IMMUNOL, V45, P3703, DOI 10.1016/j.molimm.2008.06.005; Ducancel F, 2012, MABS-AUSTIN, V4, P445, DOI 10.4161/mabs.20776; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Elgh F, 1996, J VIROL METHODS, V59, P161, DOI 10.1016/0166-0934(96)02042-3; Figueiredo LTM, 2008, BRAZ J MED BIOL RES, V41, P596, DOI 10.1590/S0100-879X2008000700008; Garaicoechea L, 2008, J VIROL, V82, P9753, DOI 10.1128/JVI.00436-08; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Goldman ER, 2006, ANAL CHEM, V78, P8245, DOI 10.1021/ac0610053; Gott P, 1997, VIRUS GENES, V14, P31, DOI 10.1023/A:1007983306341; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Harmsen MM, 2006, APPL MICROBIOL BIOT, V72, P544, DOI 10.1007/s00253-005-0300-7; Hultberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017665; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; KARLSSON R, 1991, J IMMUNOL METHODS, V145, P229, DOI 10.1016/0022-1759(91)90331-9; Kent U M, 1994, Methods Mol Biol, V34, P13; Koh WWL, 2010, J BIOL CHEM, V285, P19116, DOI 10.1074/jbc.M110.116699; Lafaye P, 2009, MOL IMMUNOL, V46, P695, DOI 10.1016/j.molimm.2008.09.008; Li JD, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-339; Lubega GW, 2002, EXP PARASITOL, V102, P9, DOI 10.1016/S0014-4894(02)00140-6; LUNDKVIST A, 1993, ARCH VIROL, V132, P255, DOI 10.1007/BF01309537; Mazzarotto GCA, 2009, J VIROL METHODS, V162, P96, DOI 10.1016/j.jviromet.2009.07.022; Moreli ML, 2005, DIAGNOSIS DETECTION; MUYLDERMANS S, 1994, PROTEIN ENG, V7, P1129, DOI 10.1093/protein/7.9.1129; Muyldermans S, 2001, J Biotechnol, V74, P277; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nguyen VK, 2002, IMMUNOGENETICS, V54, P39, DOI 10.1007/s00251-002-0433-0; Nguyen VK, 1999, MOL IMMUNOL, V36, P515, DOI 10.1016/S0161-5890(99)00067-X; NICHOL ST, 1993, SCIENCE, V262, P914, DOI 10.1126/science.8235615; Olichon A, 2007, J BIOL CHEM, V282, P36314, DOI 10.1074/jbc.M704908200; Plyusnin A, 1996, J GEN VIROL, V77, P2677, DOI 10.1099/0022-1317-77-11-2677; Raboni SM, 2005, J MED VIROL, V76, P553, DOI 10.1002/jmv.20398; Raboni SM, 2005, AM J TROP MED HYG, V72, P800, DOI 10.4269/ajtmh.2005.72.800; Raboni SM, 2012, AM J TROP MED HYG, V87, P371, DOI 10.4269/ajtmh.2012.11-0762; Raboni SM, 2007, DIAGN MICR INFEC DIS, V58, P89, DOI 10.1016/j.diagmicrobio.2006.11.012; Richard G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069495; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; RUO SL, 1991, ARCH VIROL, V119, P1, DOI 10.1007/BF01314318; Russel M., 2006, BACTERIOPHAGES, P146; Saerens D, 2008, SENSORS-BASEL, V8, P4669, DOI 10.3390/s8084669; Saerens D, 2008, CURR OPIN PHARMACOL, V8, P600, DOI 10.1016/j.coph.2008.07.006; Schmaljohn C, 1997, EMERG INFECT DIS, V3, P95, DOI 10.3201/eid0302.970202; Schmidt J, 2005, VIRUS GENES, V30, P37, DOI 10.1007/s11262-004-4580-2; Schoonooghe S, 2012, IMMUNOBIOLOGY, V217, P1266, DOI 10.1016/j.imbio.2012.07.009; Sherwood LJ, 2007, J INFECT DIS, V196, pS213, DOI 10.1086/520586; Strokappe N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033298; Tanha J, 2002, J IMMUNOL METHODS, V263, P97, DOI 10.1016/S0022-1759(02)00027-3; Thys B, 2010, ANTIVIR RES, V87, P257, DOI 10.1016/j.antiviral.2010.05.012; van der Vaart JM, 2006, VACCINE, V24, P4130, DOI 10.1016/j.vaccine.2006.02.045; Vincke Cecile, 2012, Methods Mol Biol, V911, P15, DOI 10.1007/978-1-61779-968-6_2; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; Vu KB, 1997, MOL IMMUNOL, V34, P1121, DOI 10.1016/S0161-5890(97)00146-6; Wang CY, 2007, HYBRIDOMA, V26, P42, DOI 10.1089/hyb.2006.035; WANG M, 1993, J GEN VIROL, V74, P1115, DOI 10.1099/0022-1317-74-6-1115; ZOLLER LG, 1993, J CLIN MICROBIOL, V31, P1194	60	14	16	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e108067	10.1371/journal.pone.0108067	http://dx.doi.org/10.1371/journal.pone.0108067			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243411	gold, Green Submitted, Green Published			2022-12-25	WOS:000343679800066
J	Tugues, S; Roche, F; Noguer, O; Orlova, A; Bhoi, S; Padhan, N; Aring;kerud, P; Honjo, S; Selvaraju, RK; Mazzone, M; Tolmachev, V; Claesson-Welsh, L				Tugues, Sonia; Roche, Francis; Noguer, Oriol; Orlova, Anna; Bhoi, Sujata; Padhan, Narendra; Akerud, Peter; Honjo, Satoshi; Selvaraju, Ram Kumar; Mazzone, Massimiliano; Tolmachev, Vladimir; Claesson-Welsh, Lena			Histidine-Rich Glycoprotein Uptake and Turnover Is Mediated by Mononuclear Phagocytes	PLOS ONE			English	Article							LIVER-CIRRHOSIS; PLASMA-PROTEIN; CELL; FIBRINOLYSIS; DEFICIENCY; INHIBITOR; CYSTATINS; FRAGMENT; THERAPY; SYSTEM	Histidine-rich glycoprotein (HRG) is implicated in tumor growth and metastasis by regulation of angiogenesis and inflammation. HRG is produced by hepatocytes and carried to tissues via the circulation. We hypothesized that HRG's tissue distribution and turnover may be mediated by inflammatory cells. Biodistribution parameters were analyzed by injection of radiolabeled, bioactive HRG in the circulation of healthy and tumor-bearing mice. I-125-HRG was cleared rapidly from the blood and taken up in tissues of healthy and tumor-bearing mice, followed by degradation, to an increased extent in the tumor-bearing mice. Steady state levels of HRG in the circulation were unaffected by the tumor disease both in murine tumor models and in colorectal cancer (CRC) patients. Importantly, stromal pools of HRG, detected in human CRC microarrays, were associated with inflammatory cells. In agreement, microautoradiography identified I-125-HRG in blood vessels and on CD45-positive leukocytes in mouse tissues. Moreover, radiolabeled HRG bound in a specific, heparan sulfate-independent manner, to differentiated human monocytic U937 cells in vitro. Suppression of monocyte differentiation by systemic treatment of mice with anti-colony stimulating factor-1 neutralizing antibodies led to reduced blood clearance of radiolabeled HRG and to accumulation of endogenous HRG in the blood. Combined, our data show that mononuclear phagocytes have specific binding sites for HRG and that these cells are essential for uptake of HRG from blood and distribution of HRG in tissues. Thereby, we confirm and extend our previous report that inflammatory cells mediate the effect of HRG on tumor growth and metastatic spread.	[Tugues, Sonia; Roche, Francis; Noguer, Oriol; Bhoi, Sujata; Padhan, Narendra; Honjo, Satoshi; Claesson-Welsh, Lena] Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Orlova, Anna; Selvaraju, Ram Kumar] Uppsala Univ, Preclin PET Platform, Dept Med Chem, Uppsala, Sweden; [Akerud, Peter] Uppsala Univ, Univ Hosp, Dept Surg Sci, Uppsala, Sweden; [Mazzone, Massimiliano] Katholieke Univ Leuven, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, Dept Oncol, Leuven, Belgium; [Mazzone, Massimiliano] Vlaams Inst Biotechnol, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, Leuven, Belgium; [Tolmachev, Vladimir] Uppsala Univ, Rudbeck Lab, Dept Radiol Oncol & Radiat Sci, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University Hospital; KU Leuven; Flanders Institute for Biotechnology (VIB); Uppsala University	Claesson-Welsh, L (corresponding author), Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden.	lena.welsh@igp.uu.se	Tolmachev, Vladimir/T-3722-2017; Selvaraju, Ram Kumar/AAZ-5507-2020; Tolmachev, Vladimir/U-3107-2019; Orlova, Anna/S-9692-2019	Tolmachev, Vladimir/0000-0002-6122-1734; Selvaraju, Ram Kumar/0000-0001-9219-1497; Tolmachev, Vladimir/0000-0002-6122-1734; Orlova, Anna/0000-0001-6120-2683; Mazzone, Massimiliano/0000-0001-8824-4015	Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation; URPP "Translational cancer research'' from the University of Zurich; Uppsala-Orebro Regional Research Council; Manpei Suzuki Diabetes Foundation; Japan Society for Promotion of Science (JSPS)	Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); URPP "Translational cancer research'' from the University of Zurich; Uppsala-Orebro Regional Research Council; Manpei Suzuki Diabetes Foundation; Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Swedish Cancer Foundation and the Knut and Alice Wallenberg Foundation to Lena Claesson-Welsh. Sonia Tugues was funded by a grant from the URPP "Translational cancer research'' from the University of Zurich. Peter Akerud was supported by the Uppsala-Orebro Regional Research Council. Satoshi Honjo was supported by a postdoctoral grant from Manpei Suzuki Diabetes Foundation and the Japan Society for Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson M, 2003, BIOCHEM SOC SYMP, V70, P179, DOI 10.1042/bss0700179; Borza DB, 1996, BIOCHEMISTRY-US, V35, P1925, DOI 10.1021/bi952061t; CHANG NS, 1992, IMMUNOLOGY, V77, P532; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Dixelius J, 2006, CANCER RES, V66, P2089, DOI 10.1158/0008-5472.CAN-05-2217; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Heneweer C, 2011, J NUCL MED, V52, P625, DOI 10.2967/jnumed.110.083998; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; KOIDE T, 1986, BIOCHEMISTRY-US, V25, P2220, DOI 10.1021/bi00356a055; Lee C, 2009, FRONT BIOSCI-LANDMRK, V14, P2911, DOI 10.2741/3422; LEEBEEK FWG, 1989, J LAB CLIN MED, V113, P493; LIJNEN HR, 1980, J BIOL CHEM, V255, P214; LIJNEN HR, 1981, THROMB RES, V23, P121, DOI 10.1016/0049-3848(81)90245-0; Mamoune A, 1998, J AUTOIMMUN, V11, P485, DOI 10.1006/jaut.1998.0225; MCFARLANE AS, 1958, NATURE, V182, P53, DOI 10.1038/182053a0; MOORE S, 1958, FED PROC, V17, P1107; MORGAN WT, 1986, BIOCHEM MED METAB B, V36, P210, DOI 10.1016/0885-4505(86)90127-1; Olsson AK, 2004, CANCER RES, V64, P599, DOI 10.1158/0008-5472.CAN-03-1941; OLSSON I, 1983, CANCER RES, V43, P5862; Poon IKH, 2011, BLOOD, V117, P2093, DOI 10.1182/blood-2010-09-303842; Poon IKH, 2009, BIOCHEM J, V424, P27, DOI 10.1042/BJ20090794; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Rydengard V, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000116; SAITO H, 1982, AM J MED, V73, P179, DOI 10.1016/0002-9343(82)90175-9; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Shannon O, 2010, BLOOD, V116, P2365, DOI 10.1182/blood-2010-02-271858; Tsuchida-Straeten N, 2005, J THROMB HAEMOST, V3, P865, DOI 10.1111/j.1538-7836.2005.01238.x; Tugues S, 2012, CANCER RES, V72, P1953, DOI 10.1158/0008-5472.CAN-11-2194; Vanwildemeersch M, 2006, J BIOL CHEM, V281, P10298, DOI 10.1074/jbc.M508483200; Vayrynen JP, 2013, BRIT J CANCER, V109, P1839, DOI 10.1038/bjc.2013.508; Wakabayashi S, 2013, INT REV CEL MOL BIO, V304, P467, DOI 10.1016/B978-0-12-407696-9.00009-9	31	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107483	10.1371/journal.pone.0107483	http://dx.doi.org/10.1371/journal.pone.0107483			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243896	Green Published, gold			2022-12-25	WOS:000343679800035
J	Varea-Sanchez, M; Montoto, LG; Tourmente, M; Roldan, ERS				Varea-Sanchez, Maria; Montoto, Laura Gomez; Tourmente, Maximiliano; Roldan, Eduardo R. S.			Postcopulatory Sexual Selection Results in Spermatozoa with More Uniform Head and Flagellum Sizes in Rodents	PLOS ONE			English	Article							SPERM COMPETITION; PROTAMINE GENES; EVOLUTION; VELOCITY; LENGTH; MORPHOLOGY; DESIGN	Interspecific comparative studies have shown that, in most taxa, postcopulatory sexual selection (PCSS) in the form of sperm competition drives the evolution of longer and faster swimming sperm. Work on passserine birds has revealed that PCSS also reduces variation in sperm size between males at the intraspecific level. However, the influence of PCSS upon intramale sperm size diversity is poorly understood, since the few studies carried out to date in birds have yielded contradictory results. In mammals, PCSS increases sperm size but there is little information on the effects of this selective force on variations in sperm size and shape. Here, we test whether sperm competition associates with a reduction in the degree of variation of sperm dimensions in rodents. We found that as sperm competition levels increase males produce sperm that are more similar in both the size of the head and the size of the flagellum. On the other hand, whereas with increasing levels of sperm competition there is less variation in head length in relation to head width (ratio CV head length/CV head width), there is no relation between variation in head and flagellum sizes (ratio CV head length/CV flagellum length). Thus, it appears that, in addition to a selection for longer sperm, sperm competition may select more uniform sperm heads and flagella, which together may enhance swimming velocity. Overall, sperm competition seems to drive sperm components towards an optimum design that may affect sperm performance which, in turn, will be crucial for successful fertilization.	[Varea-Sanchez, Maria; Montoto, Laura Gomez; Tourmente, Maximiliano; Roldan, Eduardo R. S.] CSIC, Museo Nacl Ciencias Nat, Reprod Ecol & Biol Grp, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Roldan, ERS (corresponding author), CSIC, Museo Nacl Ciencias Nat, Reprod Ecol & Biol Grp, E-28006 Madrid, Spain.	roldane@mncn.csic.es	Roldan, Eduardo R.S./M-7947-2014; Tourmente, Maximiliano/I-2852-2019	Roldan, Eduardo R.S./0000-0002-7545-4248; Tourmente, Maximiliano/0000-0002-5833-9117	Spanish Ministry of Economy and Competitiveness; Ministry of Education and Science; "Juan de la Cierva" postdoctoral fellowship from the Ministry of Economy and Competitiveness	Spanish Ministry of Economy and Competitiveness(Spanish Government); Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); "Juan de la Cierva" postdoctoral fellowship from the Ministry of Economy and Competitiveness	This work was supported by the Spanish Ministry of Economy and Competitiveness. L. G. M. held a scholarship (FPI) from the Ministry of Education and Science. M. T. holds a "Juan de la Cierva" postdoctoral fellowship from the Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer M, 2007, REP FERT DEV, V18, P797; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; Birkhead TR, 1998, SPERM COMPETITION SE; Breed WG, 2007, J ZOOL, V272, P299, DOI 10.1111/j.1469-7998.2006.00269.x; Calhim S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000413; Calhim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028809; Fabre PH, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-88; Fitzpatrick JL, 2011, EVOLUTION, V65, P3006, DOI 10.1111/j.1558-5646.2011.01343.x; Fitzpatrick JL, 2009, P NATL ACAD SCI USA, V106, P1128, DOI 10.1073/pnas.0809990106; Gillies EA, 2009, J FLUID MECH, V625, P445, DOI 10.1017/S0022112008005685; GOMENDIO M, 1991, P ROY SOC B-BIOL SCI, V243, P181, DOI 10.1098/rspb.1991.0029; Gomendio M, 2008, INT J DEV BIOL, V52, P439, DOI 10.1387/ijdb.082595mg; Gomendio M, 2011, P ROY SOC B-BIOL SCI, V278, P3135, DOI 10.1098/rspb.2011.0275; Montoto LG, 2011, REPRODUCTION, V142, P819, DOI 10.1530/REP-11-0232; Montoto LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018173; HARCOURT AH, 1981, NATURE, V293, P55, DOI 10.1038/293055a0; Humphries S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-319; Immler S, 2008, EVOLUTION, V62, P1538, DOI 10.1111/j.1558-5646.2008.00393.x; Immler S, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.1040; Immler S, 2012, P ROY SOC B-BIOL SCI, V279, P4174, DOI 10.1098/rspb.2012.1398; Inaba K, 2011, MOL HUM REPROD, V17, P524, DOI 10.1093/molehr/gar034; Kleven O, 2008, EVOLUTION, V62, P494, DOI 10.1111/j.1558-5646.2007.00287.x; Laskemoen T, 2013, BEHAV ECOL SOCIOBIOL, V67, P301, DOI 10.1007/s00265-012-1450-0; Lijfield JT, 2010, PLOS ONE, V5; Luke L, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115956; Lupold S, 2009, P R SOC B, V276, P1175, DOI 10.1098/rspb.2008.1645; Lupold S, 2009, EVOLUTION, V63, P391, DOI 10.1111/j.1558-5646.2008.00571.x; Malo AF, 2005, BIOL REPROD, V72, P822, DOI 10.1095/biolreprod.104.036368; Malo AF, 2006, BIOL LETTERS, V2, P246, DOI 10.1098/rsbl.2006.0449; Martin-Coello J, 2009, P ROY SOC B-BIOL SCI, V276, P2427, DOI 10.1098/rspb.2009.0257; PARKER GA, 1993, P ROY SOC B-BIOL SCI, V253, P245, DOI 10.1098/rspb.1993.0110; Roldan ERS, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P539, DOI 10.1016/B978-0-12-372568-4.00014-8; ROLDAN ERS, 1992, BIOL REV, V67, P551, DOI 10.1111/j.1469-185X.1992.tb01193.x; Sandera M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068427; Thitipramote N, 2011, ACTA ZOOL-STOCKHOLM, V92, P201, DOI 10.1111/j.1463-6395.2010.00453.x; Tourmente M, 2013, EVOLUTION, V67, P1838, DOI 10.1111/evo.12079; Tourmente M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021244; Tourmente M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-12; van der Horst G, 2014, MOL REPROD DEV, V81, P204, DOI 10.1002/mrd.22277; van der Horst G, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-351	40	26	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e108148	10.1371/journal.pone.0108148	http://dx.doi.org/10.1371/journal.pone.0108148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243923	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800071
J	Shiffman, D; Pare, G; Oberbauer, R; Louie, JZ; Rowland, CM; Devlin, JJ; Mann, JF; McQueen, MJ				Shiffman, Dov; Pare, Guillaume; Oberbauer, Rainer; Louie, Judy Z.; Rowland, Charles M.; Devlin, James J.; Mann, Johannes F.; McQueen, Matthew J.			A Gene Variant in CERS2 Is Associated with Rate of Increase in Albuminuria in Patients with Diabetes from ONTARGET and TRANSCEND	PLOS ONE			English	Article							CERAMIDE SYNTHASE 2; HIGH-RISK PATIENTS; TELMISARTAN; DISEASE; INTOLERANT; RAMIPRIL; EVENTS; TRIALS; LOCI	Although albuminuria and subsequent advanced stage chronic kidney disease are common among patients with diabetes, the rate of increase in albuminuria varies among patients. Since genetic variants associated with estimated glomerular filtration rate (eGFR) were identified in cross sectional studies, we asked whether these variants were also associated with rate of increase in albuminuria among patients with diabetes from ONTARGET and TRANSCEND-randomized controlled trials of ramipril, telmisartan, both, or placebo. For 16 genetic variants associated with eGFR at a genome-wide level, we evaluated the association with annual rate of increase in albuminuria estimated from urine albumin: creatinine ratio (uACR). One of the variants (rs267734) was associated with rate of increase in albuminuria. The annual rate of increase in albuminuria among risk homozygotes (69% of the study population) was 11.3% (95%CI; 7.5% to 15.3%), compared with 5.0% (95% CI; 3.3% to 6.8%) for heterozygotes (27% of the population), and 1.7% (95% CI; -1.7% to 5.3%) for non-risk homozygotes (4% of the population); P = 0.0015 for the difference between annual rates in the three genotype groups. These estimates were adjusted for age, sex, ethnicity, and principal component of genetic heterogeneity. Among patients without albuminuria at baseline (uACR<30 mg/g), each risk allele was associated with 50% increased risk of incident albuminuria (OR = 1.50; 95% CI 1.15 to 1.95; P = 0.003) after further adjustment for traditional risk factors including baseline uACR and eGFR. The rs267734 variant is in almost perfect linkage-disequilibrium (r(2) = 0.94) with rs267738, a single nucleotide polymorphism encoding a glutamic acid to alanine change at position 115 of the ceramide synthase 2 (CERS2) encoded protein. However, it is unknown whether CERS2 function influences albuminuria. In conclusion, we found that rs267734 in CERS2 is associated with rate of increase in albuminuria among patients with diabetes and elevated risk of cardiovascular disease.	[Shiffman, Dov; Louie, Judy Z.; Rowland, Charles M.; Devlin, James J.] Celera, Alameda, CA 94502 USA; [Pare, Guillaume; McQueen, Matthew J.] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Pare, Guillaume; McQueen, Matthew J.] McMaster Univ, Hamilton, ON, Canada; [Oberbauer, Rainer] KH Elisabethinen, Dept Nephrol, Linz, Austria; [Oberbauer, Rainer] Med Univ Vienna, Dept Nephrol, Vienna, Austria; [Mann, Johannes F.] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany	McMaster University; Population Health Research Institute; McMaster University; Ordensklinikum Linz Elisabethinen; Medical University of Vienna; University of Erlangen Nuremberg	Shiffman, D (corresponding author), Celera, Alameda, CA 94502 USA.	dov.shiffman@celera.com	Mann, Johannes/AAI-8803-2020; Pare, Guillaume/T-9631-2018	Pare, Guillaume/0000-0002-6795-4760	European Community [241544]; Celera; Boehringer Ingelheim	European Community(European Commission); Celera; Boehringer Ingelheim(Boehringer Ingelheim)	The research leading to these results has received funding from the European Community's Seventh Framework Programme under the grant agreement n o 241544. Funding for ONTARGET and TRANSCEND Studies: Boehringer Ingelheim. The funders had no role in study design, data collection and analysis, decision to publish. Co-authors DS, JZL, CMR, and JJD are employed by Celera. Celera provided support in the form of salaries for authors DS, JZL, CMR, and JJD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adler AI, 2003, KIDNEY INT, V63, P225, DOI 10.1046/j.1523-1755.2003.00712.x; Boger CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002292; Boger CA, 2011, J AM SOC NEPHROL, V22, P555, DOI 10.1681/ASN.2010060598; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deshmukh HA, 2013, DIABETIC MED, V30, P1230, DOI 10.1111/dme.12211; Ellis JW, 2012, HUM MOL GENET, V21, P3293, DOI 10.1093/hmg/dds138; Fellay J, 2010, NATURE, V464, P405, DOI 10.1038/nature08825; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Imgrund S, 2009, J BIOL CHEM, V284, P33549, DOI 10.1074/jbc.M109.031971; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Mann JFE, 2003, J AM SOC NEPHROL, V14, P641, DOI 10.1097/01.ASN.0000051594.21922.99; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pinheiro JC, 2012, NLME LINEAR NONLINEA, P1; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Retnakaran R, 2006, DIABETES, V55, P1832, DOI 10.2337/db05-1620; Shiffman D, 2005, AM J HUM GENET, V77, P596, DOI 10.1086/491674; Teo KK, 2004, AM HEART J, V148, P52, DOI 10.1016/j.ahj.2004.03.020; U. S. Renal Data System, 2012, USRDS 2012 ANN DAT R; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Yusuf S, 2008, LANCET, V372, P1174, DOI 10.1016/S0140-6736(08)61242-8; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	24	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e106631	10.1371/journal.pone.0106631	http://dx.doi.org/10.1371/journal.pone.0106631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238615	gold, Green Published, Green Submitted			2022-12-25	WOS:000342491600010
J	Yuan, C; Gao, JY; Guo, JC; Bai, L; Marshall, C; Cai, ZY; Wang, LM; Xiao, M				Yuan, Chan; Gao, Junying; Guo, Jichao; Bai, Lei; Marshall, Charles; Cai, Zhiyou; Wang, Linmei; Xiao, Ming			Dimethyl Sulfoxide Damages Mitochondrial Integrity and Membrane Potential in Cultured Astrocytes	PLOS ONE			English	Article							CYTOCHROME-C RELEASE; GLUTAMATE TRANSPORTERS; SEVERE NEUROTOXICITY; CEREBRAL-ISCHEMIA; DMSO; DIMETHYLSULFOXIDE; ENCEPHALOPATHY; INFUSION; INJURY; GLT-1	Dimethyl sulfoxide (DMSO) is a polar organic solvent that is used to dissolve neuroprotective or neurotoxic agents in neuroscience research. However, DMSO itself also has pharmacological and pathological effects on the nervous system. Astrocytes play a central role in maintaining brain homeostasis, but the effect and mechanism of DMSO on astrocytes has not been studied. The present study showed that exposure of astrocyte cultures to 1% DMSO for 24 h did not significantly affect cell survival, but decreased cell viability and glial glutamate transporter expression, and caused mitochondrial swelling, membrane potential impairment and reactive oxygen species production, and subsequent cytochrome c release and caspase-3 activation. DMSO at concentrations of 5% significantly inhibited cell variability and promoted apoptosis of astrocytes, accompanied with more severe mitochondrial damage. These results suggest that mitochondrial impairment is a primary event in DMSO-induced astrocyte toxicity. The potential cytotoxic effects on astrocytes need to be carefully considered during investigating neuroprotective or neurotoxic effects of hydrophobic agents dissolved by DMSO.	[Yuan, Chan; Gao, Junying; Guo, Jichao; Bai, Lei; Wang, Linmei; Xiao, Ming] Nanjing Med Univ, Dept Anat, Jiangsu Prov Key Lab Neurodegenerat, Nanjing, Jiangsu, Peoples R China; [Marshall, Charles] Univ Kentucky, Ctr Excellence Rural Hlth, Dept Rehabil Sci, Hazard, KY USA; [Cai, Zhiyou] Anhui Med Univ, Luan Peoples Hosp, Affiliated Hosp, Dept Neurol, Luan, Anhui, Peoples R China	Nanjing Medical University; University of Kentucky; Anhui Medical University	Xiao, M (corresponding author), Nanjing Med Univ, Dept Anat, Jiangsu Prov Key Lab Neurodegenerat, Nanjing, Jiangsu, Peoples R China.	mingx@njmu.edu.cn	Cai, Zhiyou/K-2206-2019	Cai, Zhiyou/0000-0002-9552-4020	National Natural Science Foundation of China [81271210]; Qing Lan Project of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qing Lan Project of Jiangsu Higher Education Institutions	Funding was provided by the National Natural Science Foundation of China (81271210) and the Qing Lan Project of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.	Abdelkefi A, 2009, BONE MARROW TRANSPL, V44, P323, DOI 10.1038/bmt.2009.13; Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a; An SJ, 2002, MOL CELLS, V13, P476; Authier N, 2002, TOXICOL LETT, V132, P117, DOI 10.1016/S0378-4274(02)00052-8; Balakin KV, 2006, CURR MED CHEM, V13, P223, DOI 10.2174/092986706775197917; Bauwens D, 2005, LEUKEMIA LYMPHOMA, V46, P1671, DOI 10.1080/10428190500235611; Borutaite V, 2010, ENVIRON MOL MUTAGEN, V51, P406, DOI 10.1002/em.20564; Budinich CS, 2013, PHARMACOL BIOCHEM BE, V108, P66, DOI 10.1016/j.pbb.2013.04.001; Capriotti Kara, 2012, J Clin Aesthet Dermatol, V5, P24; Cavaletti G, 2000, TOXICOL LETT, V118, P103, DOI 10.1016/S0378-4274(00)00269-1; Chandra J, 2000, FREE RADICAL BIO MED, V29, P323, DOI 10.1016/S0891-5849(00)00302-6; Chazotte Brad, 2011, Cold Spring Harb Protoc, V2011, P895, DOI 10.1101/pdb.prot5641; DHODAPKAR M, 1994, AM J HEMATOL, V45, P187, DOI 10.1002/ajh.2830450218; Di Giorgio AM, 2008, RESTOR NEUROL NEUROS, V26, P501; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Fossum EN, 2008, BRAIN RES, V1204, P53, DOI 10.1016/j.brainres.2008.02.022; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Gogvadze V, 2006, CHEM-BIOL INTERACT, V163, P4, DOI 10.1016/j.cbi.2006.04.010; Gogvadze V, 2006, BBA-BIOENERGETICS, V1757, P639, DOI 10.1016/j.bbabio.2006.03.016; Gorter JA, 2002, J COMP NEUROL, V442, P365, DOI 10.1002/cne.10101; Gurtovenko AA, 2007, J PHYS CHEM B, V111, P10453, DOI 10.1021/jp073113e; Hanslick JL, 2009, NEUROBIOL DIS, V34, P1, DOI 10.1016/j.nbd.2008.11.006; Higman MA, 2000, BONE MARROW TRANSPL, V26, P797, DOI 10.1038/sj.bmt.1702589; Jacob SW, 2009, PHARMACOL REP, V61, P225, DOI 10.1016/S1734-1140(09)70026-X; Julien C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040020; Junior AM, 2008, BONE MARROW TRANSPL, V41, P95, DOI 10.1038/sj.bmt.1705883; Kim K, 2011, J CELL PHYSIOL, V226, P2484, DOI 10.1002/jcp.22609; Kovacs Z, 2011, J NEUROSCI METH, V197, P133, DOI 10.1016/j.jneumeth.2011.02.005; Lu CB, 2001, EXP NEUROL, V170, P180, DOI 10.1006/exnr.2001.7686; Marcacci G, 2009, BONE MARROW TRANSPL, V44, P133, DOI 10.1038/bmt.2008.442; Mueller LP, 2007, EUR J HAEMATOL, V78, P527, DOI 10.1111/j.1600-0609.2007.00851.x; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Notman R, 2006, J AM CHEM SOC, V128, P13982, DOI 10.1021/ja063363t; Otrock ZK, 2008, HAEMATOLOGICA, V93, pE36, DOI 10.3324/haematol.12249; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Phillis JW, 1998, NEUROSCI LETT, V244, P109, DOI 10.1016/S0304-3940(98)00139-6; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Santos NC, 2003, BIOCHEM PHARMACOL, V65, P1035, DOI 10.1016/S0006-2952(03)00002-9; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Sesso A, 2012, ANAT REC, V295, P1647, DOI 10.1002/ar.22553; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Shimizu S, 1997, NEUROSCI LETT, V239, P125, DOI 10.1016/S0304-3940(97)00915-4; Suski JM, 2012, METHODS MOL BIOL, V810, P183, DOI 10.1007/978-1-61779-382-0_12; Tapia R, 1996, Rev Bras Biol, V56 Su 1 Pt 1, P165; Trotti D, 1998, TRENDS PHARMACOL SCI, V19, P328, DOI 10.1016/S0165-6147(98)01230-9; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; Turan NN, 2008, ANN VASC SURG, V22, P98, DOI 10.1016/j.avsg.2007.07.023; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Windrum P, 2003, BONE MARROW TRANSPL, V31, P315, DOI 10.1038/sj.bmt.1703848; Yu ZW, 1998, BIOPHYS CHEM, V70, P35, DOI 10.1016/S0301-4622(97)00100-2; Zeng XN, 2007, MOL CELL NEUROSCI, V34, P34, DOI 10.1016/j.mcn.2006.09.008; Zhao B, 2012, MOLECULES, V17, P2725, DOI 10.3390/molecules17032725	52	96	97	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107447	10.1371/journal.pone.0107447	http://dx.doi.org/10.1371/journal.pone.0107447			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238609	Green Submitted, Green Published, gold			2022-12-25	WOS:000342491600026
J	Nitta, RT; Gholamin, S; Feroze, AH; Agarwal, M; Cheshier, SH; Mitra, SS; Li, G				Nitta, R. T.; Gholamin, S.; Feroze, A. H.; Agarwal, M.; Cheshier, S. H.; Mitra, S. S.; Li, G.			Casein kinase 2 alpha regulates glioblastoma brain tumor-initiating cell growth through the beta-catenin pathway	ONCOGENE			English	Article							CANCER STEM-CELL; PROTEIN-KINASE; SELF-RENEWAL; IN-VIVO; ALPHA-CATENIN; CK2; INHIBITION; EXPRESSION; NOTCH; TUMORIGENICITY	Glioblastoma (GBM) is the most common and fatal primary brain tumor in humans, and it is essential that new and better therapies are developed to treat this disease. Previous research suggests that casein kinase 2 (CK2) may be a promising therapeutic target for GBMs. CK2 has enhanced expression or activity in numerous cancers, including GBM, and it has been demonstrated that inhibitors of CK2 regressed tumor growth in GBM xenograft mouse models. Our studies demonstrate that the CK2 subunit, CK2 alpha, is overexpressed in and has an important role in regulating brain tumor-initiating cells (BTIC) in GBM. Initial studies showed that two GBM cell lines (U87-MG and U138) transduced with CK2 alpha had enhanced proliferation and anchorage-independent growth. Inhibition of CKa using siRNA or small-molecule inhibitors (TBBz, CX-4945) reduced cell growth, decreased tumor size, and increased survival rates in GBM xenograft mouse models. We also verified that inhibition of CK2 alpha decreased the activity of a well-known GBM-initiating cell regulator, beta-catenin. Loss of CK2 alpha decreased two beta-catenin-regulated genes that are involved in GBM-initiating cell growth, OCT4 and NANOG. To determine the importance of CK2 alpha in GBM stem cell maintenance, we reduced CK2 alpha activity in primary GBM samples and tumor spheres derived from GBM patients. We discovered that loss of CK2 alpha activity reduced the sphere-forming capacity of BTIC and decreased numerous GBM stem cell markers, including CD133, CD90, CD49f and A2B5. Our study suggests that CK2 alpha is involved in GBM tumorigenesis by maintaining BTIC through the regulation of beta-catenin.	[Nitta, R. T.; Gholamin, S.; Agarwal, M.; Cheshier, S. H.; Mitra, S. S.; Li, G.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Gholamin, S.; Feroze, A. H.; Cheshier, S. H.; Mitra, S. S.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Li, G (corresponding author), Stanford Univ, Sch Med, Dept Neurosurg, 1201 Welch Rd P309, Stanford, CA 94305 USA.	gordonli@stanford.edu		Gholamin, Sharareh/0000-0001-7425-6074; Li, Gordon/0000-0001-8372-0676	K08 Mentored Research Grant [NIH-KNS085333A]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS085333] Funding Source: NIH RePORTER	K08 Mentored Research Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Albert Wong for the use of equipment and resources. We also thank Tim Bui for his useful discussions and Cheryl Christensen for her critical review of the paper. This work was supported by the K08 Mentored Research Grant (NIH-KNS085333A) as well as the generous donation from Mr Keith Tsu and Ms Carmelita Ko.	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Adesina AM, 2009, HUM PATHOL, V40, P843, DOI 10.1016/j.humpath.2008.10.022; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Beier Christoph P, 2011, Front Biosci (Elite Ed), V3, P701, DOI 10.2741/e280; Cheong JW, 2010, ANTICANCER RES, V30, P4625; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; D'Amour KA, 2002, NAT MED, V8, P213, DOI 10.1038/nm0302-213; Dalerba P, 2007, CELL STEM CELL, V1, P241, DOI 10.1016/j.stem.2007.08.012; Del Vecchio CA, 2012, CANCER RES, V72, P2657, DOI 10.1158/0008-5472.CAN-11-2656; Dixit D, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.10; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; He J, 2012, CURR MED CHEM, V19, P6050; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huillard E, 2010, MOL CELL BIOL, V30, P2737, DOI 10.1128/MCB.01566-09; Ikushima H, 2011, J BIOL CHEM, V286, P41434, DOI 10.1074/jbc.M111.300863; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee Y, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-52; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Louis D, 1997, WHO CLASSIFICATION T, P33; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Moucadel V, 2011, ONCOTARGET, V2, P997; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Nager Mireia, 2012, Chemother Res Pract, V2012, P192362, DOI 10.1155/2012/192362; Nitta RT, 2011, ONCOGENE, V30, P234, DOI 10.1038/onc.2010.414; Nitta RT, 2010, METHOD ENZYMOL, V484, P531, DOI [10.1016/S0076-6879(10)84026-1, 10.1016/B978-0-12-381298-8.00026-5]; Olsen BB, 2010, ONCOGENE, V29, P6016, DOI 10.1038/onc.2010.337; Pagano MA, 2008, BIOCHEM J, V415, P353, DOI 10.1042/BJ20080309; Pierfelice TJ, 2008, COLD SH Q B, V73, P367, DOI 10.1101/sqb.2008.73.013; Ponce DP, 2011, MOL CELL BIOCHEM, V356, P127, DOI 10.1007/s11010-011-0965-4; Ponce DP, 2011, J CELL PHYSIOL, V226, P1953, DOI 10.1002/jcp.22527; Prudent R, 2010, CANCER RES, V70, P9865, DOI 10.1158/0008-5472.CAN-10-0917; Prudent R, 2010, METHOD ENZYMOL, V485, P597, DOI [10.1016/B978-0-12-381296-4.00031-2, 10.1016/S0076-6879(10)85031-1]; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Scharenberg CW, 2002, BLOOD, V99, P507, DOI 10.1182/blood.V99.2.507; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Son YH, 2013, ARCH PHARM RES, V36, P840, DOI 10.1007/s12272-013-0103-9; Song DH, 2003, J BIOL CHEM, V278, P24018, DOI 10.1074/jbc.M212260200; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Trembley JH, 2010, BIOFACTORS, V36, P187, DOI 10.1002/biof.96; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137; Zhang SL, 2013, J CELL MOL MED, V17, P854, DOI 10.1111/jcmm.12068; Zhang SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038996; Zheng Y, 2013, CLIN CANCER RES, V19, P6484, DOI 10.1158/1078-0432.CCR-13-0265	47	42	44	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2015	34	28					3688	3699		10.1038/onc.2014.299	http://dx.doi.org/10.1038/onc.2014.299			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM4TZ	25241897	Green Accepted			2022-12-25	WOS:000357679100007
J	Eckert, ESP; Reckmann, I; Hellwig, A; Rohling, S; El-Battari, A; Wieland, FT; Popoff, V				Eckert, Elias S. P.; Reckmann, Ingeborg; Hellwig, Andrea; Roehling, Simone; El-Battari, Assou; Wieland, Felix T.; Popoff, Vincent			Golgi Phosphoprotein 3 Triggers Signal-mediated Incorporation of Glycosyltransferases into Coatomer-coated (COPI) Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; TRANSMEMBRANE DOMAINS; TUMOR PROGRESSION; POOR-PROGNOSIS; PROTEIN; GOLPH3; LOCALIZATION; TRANSPORT; RETENTION; BINDING	Newly synthesized membrane and secreted proteins undergo a series of posttranslational modifications in the Golgi apparatus, including attachment of carbohydrate moieties. The final structure of so-formed glycans is determined by the order of execution of the different glycosylation steps, which seems intimately related to the spatial distribution of glycosyltransferases and glycosyl hydrolases within the Golgi apparatus. How cells achieve an accurate localization of these enzymes is not completely understood but might involve dynamic processes such as coatomer-coated (COPI) vesicle-mediated trafficking. In yeast, this transport is likely to be regulated by vacuolar protein sorting 74 (Vps74p), a peripheral Golgi protein able to interact with COPI coat as well as with a binding motif present in the cytosolic tails of some mannosyltransferases. Recently, Golgi phosphoprotein 3 (GOLPH3), the mammalian homolog of Vps74, has been shown to control the Golgi localization of core 2 N-acetyl-glucosamine- transferase 1. Here, we highlight a role of GOLPH3 in the spatial localization of alpha-2,6-sialyltransferase 1. We show, for the first time, that GOLPH3 supports incorporation of both core 2N-acetylglucosamine-transferase 1 and alpha-2,6-sialyltransferase 1 into COPI vesicles. Depletion of GOLPH3 altered the subcellular localization of these enzymes. In contrast, galactosyltransferase, an enzyme that does not interact with GOLPH3, was neither incorporated into COPI vesicles nor was dependent on GOLPH3 for proper localization.	[Eckert, Elias S. P.; Reckmann, Ingeborg; Roehling, Simone; Wieland, Felix T.; Popoff, Vincent] Heidelberg Univ, Heidelberg Univ Biochem Ctr BZH, INF 328, D-69120 Heidelberg, Germany; [Hellwig, Andrea] Heidelberg Univ, Interdisciplinary Ctr Neurosci IZN, INF 364, D-69120 Heidelberg, Germany; [El-Battari, Assou] Aix Marseille Univ, INSERM, UMR 911, Ctr Rech Oncobiol & Oncopharmacol CR02, F-13284 Marseille, France	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Popoff, V (corresponding author), Heidelberg Univ, Heidelberg Univ Biochem Ctr BZH, INF 328, D-69120 Heidelberg, Germany.	vincent.popoff@espci.org			Federation of the Societies of Biochemistry and Molecular Biology (FEBS)	Federation of the Societies of Biochemistry and Molecular Biology (FEBS)	Supported by a Federation of the Societies of Biochemistry and Molecular Biology (FEBS) long term fellowship. To whom correspondence should be addressed. E-mail: vincent.popoff@espci.org.	Adolf F, 2013, TRAFFIC, V14, P922, DOI 10.1111/tra.12084; Ali MF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.346528; BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; Cheong FY, 2010, TRAFFIC, V11, P1180, DOI 10.1111/j.1600-0854.2010.01092.x; COLLEY KJ, 1992, J BIOL CHEM, V267, P7784; DAHDAL RY, 1993, J BIOL CHEM, V268, P26310; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; El-Battari A, 2003, GLYCOBIOLOGY, V13, P941, DOI 10.1093/glycob/cwg117; Engling A, 2002, J CELL SCI, V115, P3619, DOI 10.1242/jcs.00036; Faulstich D, 1996, J CELL BIOL, V135, P53, DOI 10.1083/jcb.135.1.53; Fenteany FH, 2005, J BIOL CHEM, V280, P5423, DOI 10.1074/jbc.M412396200; Franco M, 1996, J BIOL CHEM, V271, P1573, DOI 10.1074/jbc.271.3.1573; Glick BS, 1997, FEBS LETT, V414, P177, DOI 10.1016/S0014-5793(97)00984-8; Gommel D, 1999, FEBS LETT, V447, P179, DOI 10.1016/S0014-5793(99)00246-X; Hatakeyama S, 2010, INT J CANCER, V127, P1052, DOI 10.1002/ijc.25117; Hill CAS, 2005, CANCER LETT, V217, P105, DOI 10.1016/j.canlet.2004.06.038; Hu BS, 2013, TUMOR BIOL, V34, P515, DOI 10.1007/s13277-012-0576-z; Hua X, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-127; Isaji T, 2014, J BIOL CHEM, V289, P20694, DOI 10.1074/jbc.M113.542688; Jackson CL, 2009, J CELL SCI, V122, P443, DOI 10.1242/jcs.032581; Kunigou O, 2011, ONCOL REP, V26, P1337, DOI 10.3892/or.2011.1413; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li FG, 1996, J BIOL CHEM, V271, P3255, DOI 10.1074/jbc.271.6.3255; Li H, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-168; Li XY, 2011, J NEURO-ONCOL, V105, P159, DOI 10.1007/s11060-011-0573-x; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; Maccioni HJF, 2011, J NEUROCHEM, V117, P589, DOI 10.1111/j.1471-4159.2011.07232.x; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; MASIBAY AS, 1993, J BIOL CHEM, V268, P9908; McEver RP, 1997, J CLIN INVEST, V100, P485, DOI 10.1172/JCI119556; Merte J, 2010, NAT CELL BIOL, V12, P41, DOI 10.1038/ncb2002; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; MUNRO S, 1991, EMBO J, V10, P3577, DOI 10.1002/j.1460-2075.1991.tb04924.x; Nakashima-Kamimura N, 2005, J CELL SCI, V118, P5357, DOI 10.1242/jcs.02645; Ng MM, 2013, MOL BIOL CELL, V24, P796, DOI 10.1091/mbc.E12-07-0525; NILSSON T, 1994, EMBO J, V13, P562, DOI 10.1002/j.1460-2075.1994.tb06294.x; Patterson GH, 2008, CELL, V133, P1055, DOI 10.1016/j.cell.2008.04.044; Pereira NA, 2014, J BIOL CHEM, V289, P14762, DOI 10.1074/jbc.M114.548305; Popoff V., 2011, COLD SPRING HARB PER, V3; Quintero CA, 2008, BIOCHEM J, V412, P19, DOI 10.1042/BJ20071725; Reinhard C, 2003, P NATL ACAD SCI USA, V100, P8253, DOI 10.1073/pnas.1432391100; Sahlmuller MC, 2011, TRAFFIC, V12, P682, DOI 10.1111/j.1600-0854.2011.01177.x; Schaub BE, 2006, MOL BIOL CELL, V17, P5153, DOI 10.1091/mbc.E06-08-0665; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Serafini Tito, 1992, V219, P286; Shimodaira K, 1997, CANCER RES, V57, P5201; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Tu LN, 2012, TRAFFIC, V13, P1496, DOI 10.1111/j.1600-0854.2012.01403.x; Tu LN, 2010, CELL MOL LIFE SCI, V67, P29, DOI 10.1007/s00018-009-0126-z; Wang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045622; Wood CS, 2009, J CELL BIOL, V187, P967, DOI 10.1083/jcb.200909063; Wu CC, 2000, TRAFFIC, V1, P963, DOI 10.1034/j.1600-0854.2000.011206.x; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390; Zeng ZL, 2012, CLIN CANCER RES, V18, P4059, DOI 10.1158/1078-0432.CCR-11-3156; Zerfaoui M, 2002, GLYCOBIOLOGY, V12, P15, DOI 10.1093/glycob/12.1.15; Zhou JX, 2012, J NEURO-ONCOL, V110, P195, DOI 10.1007/s11060-012-0970-9	58	48	48	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31319	31329		10.1074/jbc.M114.608182	http://dx.doi.org/10.1074/jbc.M114.608182			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25246532	Green Published, hybrid			2022-12-25	WOS:000344549900036
J	Nishikawa, K; Seo, N; Torii, M; Ma, N; Muraoka, D; Tawara, I; Masuya, M; Tanaka, K; Takei, Y; Shiku, H; Katayama, N; Kato, T				Nishikawa, Kenichiro; Seo, Naohiro; Torii, Mie; Ma, Nei; Muraoka, Daisuke; Tawara, Isao; Masuya, Masahiro; Tanaka, Kyosuke; Takei, Yoshiyuki; Shiku, Hiroshi; Katayama, Naoyuki; Kato, Takuma			Interleukin-17 Induces an Atypical M2-Like Macrophage Subpopulation That Regulates Intestinal Inflammation	PLOS ONE			English	Article							SODIUM-INDUCED COLITIS; BOWEL-DISEASE; ANTIINFLAMMATORY MACROPHAGES; DENDRITIC CELLS; IN-VITRO; T-CELLS; RESPONSES; MICE; POLARIZATION; DIFFERENTIATION	Interleukin 17 (IL-17) is a pleiotropic cytokine that acts on both immune and non-immune cells and is generally implicated in inflammatory and autoimmune diseases. Although IL-17 as well as their source, mainly but not limited to Th17 cells, is also abundant in the inflamed intestine, the role of IL-17 in inflammatory bowel disease remains controversial. In the present study, by using IL-17 knockout (KO) mice, we investigated the role of IL-17 in colitis, with special focus on the macrophage subpopulations. Here we show that IL-17KO mice had increased susceptibility to DSS-induced colitis which was associated with decrease in expression of mRNAs implicated in M2 and/or wound healing macrophages, such as IL-10, IL-1 receptor antagonist, arginase 1, cyclooxygenase 2, and indoleamine 2,3-dioxygenase. Lamina propria leukocytes from inflamed colon of IL-17KO mice contained fewer CD11b(+)Ly6C(+)MHC Class II+ macrophages, which were derived, at least partly, from blood monocytes, as compared to those of WT mice. FACS-purified CD11b(+) cells from WT mice, which were more abundant in Ly6C(+)MHC Class II+ cells, expressed increased levels of genes associated M2/wound healing macrophages and also M1/proinflammatory macrophages. Depletion of this population by topical administration of clodronate-liposome in the colon of WT mice resulted in the exacerbation of colitis. These results demonstrate that IL-17 confers protection against the development of severe colitis through the induction of an atypical M2-like macrophage subpopulation. Our findings reveal a previously unappreciated mechanism by which IL-17 exerts a protective function in colitis.	[Nishikawa, Kenichiro; Tawara, Isao; Masuya, Masahiro; Katayama, Naoyuki] Mie Univ, Grad Sch Med, Dept Hematol & Oncol, Tsu, Mie 514, Japan; [Seo, Naohiro; Muraoka, Daisuke; Shiku, Hiroshi] Mie Univ, Grad Sch Med, Dept Immunogene Therapy, Tsu, Mie 514, Japan; [Torii, Mie; Kato, Takuma] Mie Univ, Grad Sch Med, Dept Cellular & Mol Immunol, Tsu, Mie 514, Japan; [Ma, Nei] Suzuka Univ Med Sci, Fac Hlth Sci, Suzuka, Mie, Japan; [Tanaka, Kyosuke; Takei, Yoshiyuki] Mie Univ, Grad Sch Med, Tsu, Mie 514, Japan	Mie University; Mie University; Mie University; Mie University	Kato, T (corresponding author), Mie Univ, Grad Sch Med, Dept Cellular & Mol Immunol, Tsu, Mie 514, Japan.	katotaku@doc.medic.mie-u.ac.jp	Shiku, Hiroshi/U-7321-2019	Ma, Ning/0000-0001-7315-8835; Shiku, Hiroshi/0000-0002-0362-755X; Tanaka, Kyosuke/0000-0002-1402-7832	Japan Society for the Promotion of Science [25670553]; Grants-in-Aid for Scientific Research [25670553] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (25670553) to Dr. Takuma Kato. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen GH, 2007, AM J PATHOL, V170, P1028, DOI 10.2353/ajpath.2007.060595; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Grainger JR, 2013, NAT MED, V19, P713, DOI 10.1038/nm.3189; Hansell CAH, 2011, IMMUNOL CELL BIOL, V89, P197, DOI 10.1038/icb.2010.147; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Hueber W, 2012, GUT; Hundorfean G, 2012, INFLAMM BOWEL DIS, V18, P180, DOI 10.1002/ibd.21677; Ito R, 2008, BIOCHEM BIOPH RES CO, V377, P12, DOI 10.1016/j.bbrc.2008.09.019; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kayama H, 2012, P NATL ACAD SCI USA, V109, P5010, DOI 10.1073/pnas.1114931109; Kostadinova FI, 2010, J LEUKOCYTE BIOL, V88, P133, DOI 10.1189/jlb.1109768; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; Liu LX, 2012, J THORAC ONCOL, V7, P1091, DOI 10.1097/JTO.0b013e3182542752; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Medina-Contreras O, 2011, J CLIN INVEST, V121, P4787, DOI 10.1172/JCI59150; Monteleone I, 2011, GASTROENTEROLOGY, V141, P237, DOI 10.1053/j.gastro.2011.04.007; Nair MG, 2003, IMMUNOL LETT, V85, P173, DOI 10.1016/S0165-2478(02)00225-0; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; PERRY DG, 1995, J IMMUNOL METHODS, V181, P269, DOI 10.1016/0022-1759(95)00011-X; Qualls JE, 2006, J LEUKOCYTE BIOL, V80, P802, DOI 10.1189/jlb.1205734; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Schepp-Berglind J, 2012, J IMMUNOL, V188, P6309, DOI 10.4049/jimmunol.1200553; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Tang C, 2012, IMMUNITY, V37, P957, DOI 10.1016/j.immuni.2012.11.010; Targan SR, 2012, GASTROENTEROLOGY, V143, pE26, DOI 10.1053/j.gastro.2012.07.084; Torii M, 2010, EUR J IMMUNOL, V40, P787, DOI 10.1002/eji.200939724; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Vos ACW, 2011, GASTROENTEROLOGY, V140, P221, DOI 10.1053/j.gastro.2010.10.008; Wang L, 2008, INT IMMUNOL, V20, P57, DOI 10.1093/intimm/dxm124; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Zhang Z, 2006, INFLAMM BOWEL DIS, V12, P382, DOI 10.1097/01.MIB.0000218764.06959.91; Zigmond E, 2013, TRENDS IMMUNOL, V34, P162, DOI 10.1016/j.it.2013.02.001; Zizzo G, 2013, J IMMUNOL, V190, P5237, DOI 10.4049/jimmunol.1203017; Zizzo G, 2012, J IMMUNOL, V189, P3508, DOI 10.4049/jimmunol.1200662	43	44	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108494	10.1371/journal.pone.0108494	http://dx.doi.org/10.1371/journal.pone.0108494			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254662	gold, Green Published, Green Submitted			2022-12-25	WOS:000344862300090
J	Seifert, L; Komar, J; Crettenand, F; Millet, G				Seifert, Ludovic; Komar, John; Crettenand, Florent; Millet, Gregoire			Coordination Pattern Adaptability: Energy Cost of Degenerate Behaviors	PLOS ONE			English	Article							BIOLOGICAL-SYSTEMS; DYNAMICAL-SYSTEMS; MOVEMENT SYSTEMS; VARIABILITY; COMPLEXITY; VELOCITY; BREASTSTROKE; PERSPECTIVE; SWIMMERS; VALIDITY	This study investigated behavioral adaptability, which could be defined as a blend between stability and flexibility of the limbs movement and their inter-limb coordination, when individuals received informational constraints. Seven expert breaststroke swimmers performed three 200-m in breaststroke at constant submaximal intensity. Each trial was performed randomly in a different coordination pattern: 'freely-chosen', 'maximal glide' and 'minimal glide'. Two underwater and four aerial cameras enabled 3D movement analysis in order to assess elbow and knee angles, elbow-knee pair coordination, intra-cyclic velocity variations of the center of mass, stroke rate and stroke length and inter-limb coordination. The energy cost of locomotion was calculated from gas exchanges and blood lactate concentration. The results showed significantly higher glide, intra-cyclic velocity variations and energy cost under 'maximal glide' compared to 'freely-chosen' instructional conditions, as well as higher reorganization of limb movement and inter-limb coordination (p < 0.05). In the 'minimal glide' condition, the swimmers did not show significantly shorter glide and lower energy cost, but they exhibited significantly lower deceleration of the center of mass, as well as modified limb movement and inter-limb coordination (p < .05). These results highlight that a variety of structural adaptations can functionally satisfy the task-goal.	[Seifert, Ludovic; Komar, John] Univ Rouen, Fac Sports Sci, CETAPS, EA 3832, Mont St Aignan, France; [Crettenand, Florent; Millet, Gregoire] Univ Lausanne, Fac Biol & Med, Dept Physiol, ISSUL Inst Sport Sci, Lausanne, Switzerland	Universite de Rouen Normandie; University of Lausanne	Seifert, L (corresponding author), Univ Rouen, Fac Sports Sci, CETAPS, EA 3832, Mont St Aignan, France.	ludovic.seifert@univ-rouen.fr	SEIFERT, Ludovic/AAI-7486-2020; Millet, Grégoire/M-3220-2019; Millet, Gregoire P/F-4104-2012; Komar, John/ABD-4094-2020	SEIFERT, Ludovic/0000-0003-1712-5013; Millet, Grégoire/0000-0001-8081-4423; Millet, Gregoire P/0000-0001-8081-4423; Komar, John/0000-0002-2063-4065				Barbosa T, 2006, PORTUGUESE J SPORTS, VX, P192, DOI DOI 10.1055/s-2005-837450; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein NA, 1996, DEXTERITY ITS DEV, P9; Chollet D, 2004, INT J SPORTS MED, V25, P486, DOI 10.1055/s-2004-820943; Cohen D., 1988, STAT POWER ANAL BEHA; Davids K, 2003, SPORTS MED, V33, P245, DOI 10.2165/00007256-200333040-00001; Davids K, 2008, DYNAMICS SKILL ACQUI; Davids K., 2006, MOVEMENT SYSTEM VARI; Davids K, 2010, EXERC SPORT SCI REV, V38, P86, DOI 10.1097/JES.0b013e3181d4968b; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; di Prampero PE, 1999, RESP PHYSIOL, V118, P103, DOI 10.1016/S0034-5687(99)00083-3; DIEDRICH FJ, 1995, J EXP PSYCHOL HUMAN, V21, P183, DOI 10.1037/0096-1523.21.1.183; DIPRAMPERO PE, 1986, INT J SPORTS MED, V7, P55, DOI 10.1055/s-2008-1025736; Duffield R, 2004, J SCI MED SPORT, V7, P11, DOI 10.1016/S1440-2440(04)80039-2; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Fernandes RJ, 2006, J SPORT MED PHYS FIT, V46, P373; Glazier PS, 2009, J BIOMECH, V42, P2694, DOI 10.1016/j.jbiomech.2009.08.001; Hamill J, 2000, J APPL BIOMECH, V16, P407, DOI 10.1123/jab.16.4.407; Howell D, 2002, STAT METHODS PSYCHOL; Johnson H.W., 1961, PERCEPT MOTOR SKILLS, V13, P163; Kelso S., 1995, DYNAMIC PATTERNS SEL; Komar J, 2013, J APPL BIOMECH; Leblanc H, 2007, INT J SPORTS MED, V28, P140, DOI 10.1055/s-2006-924205; Mason Paul H., 2010, Biology Theory, V5, P277; MCELROY K, 1976, AUSTR J HLTH PHYS ED, V71, P25; Newell K., 1985, DIFFERING PERSPECTIV, P295, DOI [https://doi.org/10.1016/S0166-4115(08)62541-8, DOI 10.1016/S0166-4115(08)62541-8, 10.1016/S0166-4115(08)62541-8]; Nigg BM, 1983, BIOMECHANICS MED SWI, VV, P72; Price CJ, 2002, TRENDS COGN SCI, V6, P416, DOI 10.1016/S1364-6613(02)01976-9; Psycharakis SG, 2011, J BIOMECH, V44, P1752, DOI 10.1016/j.jbiomech.2011.04.004; Psycharakis SG, 2009, J SCI MED SPORT, V12, P262, DOI 10.1016/j.jsams.2007.11.008; Ranganathan R, 2010, EXP BRAIN RES, V202, P755, DOI 10.1007/s00221-010-2177-7; Rodriguez FA, 2008, INT J SPORTS MED, V29, P120, DOI 10.1055/s-2007-964973; Rodriguez FA, 2000, J SPORT MED PHYS FIT, V40, P87; Seifert L, 2011, HUM MOVEMENT SCI, V30, P550, DOI 10.1016/j.humov.2010.12.003; Seifert L, 2013, J SCI MED SPORT; Seifert L, 2007, HUM MOVEMENT SCI, V26, P68, DOI 10.1016/j.humov.2006.09.003; Seifert L, 2013, SPORTS MED, V43, P167, DOI 10.1007/s40279-012-0011-z; Seifert L, 2010, HUM MOVEMENT SCI, V29, P103, DOI 10.1016/j.humov.2009.05.003; Sparrow WA, 1998, PSYCHON B REV, V5, P173, DOI 10.3758/BF03212943; Takagi Hideki, 2004, Sports Biomech, V3, P15, DOI 10.1080/14763140408522827; Tononi G, 1999, P NATL ACAD SCI USA, V96, P3257, DOI 10.1073/pnas.96.6.3257; Toussaint H, 2005, ANIM BIOL, V55, P17, DOI 10.1163/1570756053276907; van Emmerik REA, 2000, J APPL BIOMECH, V16, P394, DOI 10.1123/jab.16.4.394; Vilas-Boas J P, 1996, BIOMECHANICS MED SWI, P167; Vilas-Boas J.P., 2011, WORLD BOOK SWIMMING, P119; Warren WH, 2006, PSYCHOL REV, V113, P358, DOI 10.1037/0033-295X.113.2.358; Whitacre JM, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-6; Winter EM, 2001, J SPORT SCI, V19, P761, DOI 10.1080/026404101317015429	48	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107839	10.1371/journal.pone.0107839	http://dx.doi.org/10.1371/journal.pone.0107839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255016	gold, Green Published, Green Submitted			2022-12-25	WOS:000344862300035
J	Singh, M; Bisht, IS; Kumar, S; Dutta, M; Bansal, KC; Karale, M; Sarker, A; Amri, A; Kumar, S; Datta, SK				Singh, Mohar; Bisht, Ishwari Singh; Kumar, Sandeep; Dutta, Manoranjan; Bansal, Kailash Chander; Karale, Moreshwar; Sarker, Ashutosh; Amri, Ahmad; Kumar, Shiv; Datta, Swapan Kumar			Global Wild Annual Lens Collection: A Potential Resource for Lentil Genetic Base Broadening and Yield Enhancement	PLOS ONE			English	Article							CORE COLLECTIONS; MORPHOLOGICAL TRAITS; ASSOCIATION; DIVERSITY; DISTANCES; ALGORITHM; GERMPLASM; TAXONOMY; TAXA; L.	Crop wild relatives (CWRs) are invaluable gene sources for various traits of interest, yet these potential resources are themselves increasingly threatened by the impact of climate change as well as other anthropogenic and socio-economic factors. The prime goal of our research was to cover all aspects of wild Lens genetic resource management like species characterization, agro-morphological evaluation, diversity assessment, and development of representative sets for its enhanced utilization in lentil base broadening and yield improvement initiatives. We characterized and evaluated extensively, the global wild annual Lens taxa, originating from twenty seven counties under two agro-climatic conditions of India consecutively for three cropping seasons. Results on various qualitative and quantitative characters including two foliar diseases showed wide variations for almost all yield attributing traits including multiple disease resistance in the wild species, L. nigricans and L. ervoides accessions. The core set developed from the entire Lens taxa had maximum representation from Turkey and Syria, indicating rich diversity in accessions originating from these regions. Diversity analysis also indicated wide geographical variations across genepool as was reflected in the core set. Potential use of core set, as an initial starting material, for genetic base broadening of cultivated lentil was also suggested.	[Singh, Mohar; Bisht, Ishwari Singh; Kumar, Sandeep; Dutta, Manoranjan; Bansal, Kailash Chander; Karale, Moreshwar] Natl Bur Plant Genet Resources, New Delhi, India; [Sarker, Ashutosh] Int Ctr Agr Res Dry Areas, South Asia & China Reg Programme, New Delhi, India; [Amri, Ahmad] Int Ctr Agr Res Dry Areas, Tunisia, Tunisia; [Kumar, Shiv] Int Ctr Agr Res Dry Areas, Rabat, Morocco; [Datta, Swapan Kumar] Indian Council Agr Res, Div Crop Sci, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Institut des Regions Arides; CGIAR; International Center for Agricultural Research in the Dry Areas (ICARDA); Indian Council of Agricultural Research (ICAR)	Singh, M (corresponding author), Natl Bur Plant Genet Resources, New Delhi, India.	singhmohar_2003@yahoo.com	KUMAR, SANDEEP/GZA-7182-2022		DAC-ICAR-ICARDA collaborative research programme (Department of Agriculture and Cooperation Govt of India-Indian Council of Agricultural Research and International Centre for Agricultural Research in Dry Areas, Aleppo, Syria)	DAC-ICAR-ICARDA collaborative research programme (Department of Agriculture and Cooperation Govt of India-Indian Council of Agricultural Research and International Centre for Agricultural Research in Dry Areas, Aleppo, Syria)	This research was funded by the DAC-ICAR-ICARDA collaborative research programme (Department of Agriculture and Cooperation Govt of India-Indian Council of Agricultural Research and International Centre for Agricultural Research in Dry Areas, Aleppo, Syria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez M. T., 1997, Journal of Genetics and Breeding, V51, P91; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Balfourier F, 2007, THEOR APPL GENET, V114, P1265, DOI 10.1007/s00122-007-0517-1; Bari A, 2012, GENET RESOUR CROP EV, V59, P1465, DOI 10.1007/s10722-011-9775-5; BROWN AHD, 1989, GENOME, V31, P818, DOI 10.1139/g89-144; Brown AHD, 1989, USE PLANT GENETIC RE, P136; Cooper DC, 2000, BROADENING GENETIC B, P480; Borba TCD, 2009, GENETICA, V137, P293, DOI 10.1007/s10709-009-9380-0; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Duran Y, 2004, THEOR APPL GENET, V108, P1265, DOI 10.1007/s00122-003-1542-3; Duvick DN, 1984, ECO BOT, V38, P151, DOI DOI 10.1007/BF02858829; Erskine W., 2009, LENTIL BOT PRODUCTIO; Ferguson M., 1996, Anadolu, V6, P159; Ferguson ME, 2000, BOT J LINN SOC, V133, P41, DOI 10.1111/j.1095-8339.2000.tb01536.x; Ferguson ME, 1998, GENET RESOUR CROP EV, V45, P549, DOI 10.1023/A:1008640201896; Ford R, 1997, EUPHYTICA, V96, P247, DOI 10.1023/A:1003097600701; Frankel O. H., 1984, Genetic manipulation: impact on man and society., P161; Frankel O.H., 1984, GENETICS NEW FRONTIE, VIV; Gouesnard B, 2001, J HERED, V92, P93, DOI 10.1093/jhered/92.1.93; Gowda J, 2012, INDIAN J PLANT GENET, V26, P13; Gupta D, 2006, GENET RESOUR CROP EV, V53, P1233, DOI 10.1007/s10722-005-2932-y; Gur A, 2004, PLOS BIOL, V2, P1610, DOI 10.1371/journal.pbio.0020245; IBPGR/ICARDA, 1993, LENT DESCR IBPGR SEC, P1; Jansen J, 2007, THEOR APPL GENET, V114, P421, DOI 10.1007/s00122-006-0433-9; Khazaei H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063107; Kim KW, 2007, BIOINFORMATICS, V23, P2155, DOI 10.1093/bioinformatics/btm313; Kumar GR, 2010, BIOTECHNOL ADV, V28, P451, DOI 10.1016/j.biotechadv.2010.02.007; Lane A, 2007, ICRISAT CGIAR 35 ANN; Lazaro A, 2001, GENET RESOUR CROP EV, V48, P239, DOI 10.1023/A:1011234126154; Maxted N., 2012, BOCCONEA, V24, P5, DOI [10.7320/Bocc25.005, DOI 10.7320/B0CC25.005)]; Maxted N., 2008, CROP WILD RELATIVE C; Maxted N, 2012, CROP SCI, V52, P774, DOI 10.2135/cropsci2011.08.0415; Mayee C.D., 1986, TECHNICAL B MARATHWA, V1, P218; Melchinger AE, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P99; MOLL RH, 1965, GENETICS, V52, P139; Muehlbauer F.J., 1987, CHICKPEA, P99; MUENCH DG, 1991, EUPHYTICA, V56, P213, DOI 10.1007/BF00042366; Naghavi MR, 2005, J INTEGR PLANT BIOL, V47, P375, DOI 10.1111/j.1744-7909.2005.00058.x; Perrier X., 2003, GENETIC DIVERSITY CU, P43; PUNDIR RPS, 1985, EUPHYTICA, V34, P697, DOI 10.1007/BF00035406; Royo C, 2010, FIELD CROP RES, V119, P91, DOI 10.1016/j.fcr.2010.06.020; SCOTT JM, 1993, WILDLIFE MONOGR, P1; Shannon C., 1964, MATH THEORY COMMUNIC; Singh M, 2011, NAT SEM CONT APPR CR, P365; Singh M, 2013, PLANT BREEDING, V132, P667, DOI 10.1111/pbr.12089; Solh M, 1981, PLANT GENET RESOUR, P54; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Sonnante G, 2009, REND LINCEI-SCI FIS, V20, P21, DOI 10.1007/s12210-009-0002-7; Stehno Z, 2006, CZECH J GENET PLANT, V42, P117, DOI DOI 10.17221/3641-CJGPB; Tan A., 2002, P195, DOI 10.1079/9780851995229.0195; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Thachuk C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-243; Tiwari KR, 1997, CAN J PLANT PATHOL, V19, P267, DOI 10.1080/07060669709500522; Upadhyaya HD, 2003, GENET RESOUR CROP EV, V50, P539, DOI 10.1023/A:1023980713848; Upadhyaya HD, 2003, GENET RESOUR CROP EV, V50, P139, DOI 10.1023/A:1022945715628; Vieira EA, 2007, GENET MOL BIOL, V30, P392, DOI 10.1590/S1415-47572007000300016; Wang LX, 2006, EUPHYTICA, V151, P215, DOI 10.1007/s10681-006-9142-3; Yan W, 2007, CROP SCI, V47, P869, DOI 10.2135/cropsci2006.07.0444	58	35	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107781	10.1371/journal.pone.0107781	http://dx.doi.org/10.1371/journal.pone.0107781			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254552	gold, Green Published, Green Submitted			2022-12-25	WOS:000344862300033
J	Salvi, D; Macali, A; Mariottini, P				Salvi, Daniele; Macali, Armando; Mariottini, Paolo			Molecular Phylogenetics and Systematics of the Bivalve Family Ostreidae Based on rRNA Sequence-Structure Models and Multilocus Species Tree	PLOS ONE			English	Article							SPACER 2 ITS2; SECONDARY STRUCTURE; OYSTERS CRASSOSTREA; MITOCHONDRIAL-DNA; COMMON CORE; GENE TREES; IDENTIFICATION; 16S; SACCOSTREA; EVOLUTION	The bivalve family Ostreidae has a worldwide distribution and includes species of high economic importance. Phylogenetics and systematic of oysters based on morphology have proved difficult because of their high phenotypic plasticity. In this study we explore the phylogenetic information of the DNA sequence and secondary structure of the nuclear, fast-evolving, ITS2 rRNA and the mitochondrial 16S rRNA genes from the Ostreidae and we implemented a multi-locus framework based on four loci for oyster phylogenetics and systematics. Sequence-structure rRNA models aid sequence alignment and improved accuracy and nodal support of phylogenetic trees. In agreement with previous molecular studies, our phylogenetic results indicate that none of the currently recognized subfamilies, Crassostreinae, Ostreinae, and Lophinae, is monophyletic. Single gene trees based on Maximum likelihood (ML) and Bayesian (BA) methods and on sequence-structure ML were congruent with multilocus trees based on a concatenated (ML and BA) and coalescent based (BA) approaches and consistently supported three main clades: (I) Crassostrea, (II) Saccostrea, and (III) an Ostreinae-Lophinae lineage. Therefore, the subfamily Crassotreinae (including Crassostrea), Saccostreinae subfam. nov. (including Saccostrea and tentatively Striostrea) and Ostreinae (including Ostreinae and Lophinae taxa) are recognized. Based on phylogenetic and biogeographical evidence the Asian species of Crassostrea from the Pacific Ocean are assigned to Magallana gen. nov., whereas an integrative taxonomic revision is required for the genera Ostrea and Dendostrea. This study pointed out the suitability of the ITS2 marker for DNA barcoding of oyster and the relevance of using sequence-structure rRNA models and features of the ITS2 folding in molecular phylogenetics and taxonomy. The multilocus approach allowed inferring a robust phylogeny of Ostreidae providing a broad molecular perspective on their systematics.	[Salvi, Daniele] Univ Porto, InBIO, Ctr Invest Biodiversidade & Recursos Genet, CIBIO, Vairao, Portugal; [Macali, Armando; Mariottini, Paolo] Univ Roma Tre, Dipartimento Sci, Rome, Italy	Universidade do Porto; Roma Tre University	Salvi, D (corresponding author), Univ Porto, InBIO, Ctr Invest Biodiversidade & Recursos Genet, CIBIO, Campus Agrario Vairao, Vairao, Portugal.	danielesalvi.bio@gmail.com	Salvi, Daniele/I-6360-2013; Macali, Armando/D-6147-2018	Salvi, Daniele/0000-0002-3804-2690; Macali, Armando/0000-0001-8227-1282	University of Roma Tre; project "Genomics and Evolutionary Biology" - North Portugal Regional Operational Program under NSRF through the European Regional Development Fund [ON.2]; Fundacao para a Ciencia e Tecnologia (FCT, Portugal) under the Programa Operacional Potencial Humano - Quadro de Referencia Estrategico Nacional funds from the European Social Fund [SFRH/BPD/66592/2009]; Portuguese Ministerio da Educacao e Ciencia	University of Roma Tre; project "Genomics and Evolutionary Biology" - North Portugal Regional Operational Program under NSRF through the European Regional Development Fund; Fundacao para a Ciencia e Tecnologia (FCT, Portugal) under the Programa Operacional Potencial Humano - Quadro de Referencia Estrategico Nacional funds from the European Social Fund(Portuguese Foundation for Science and Technology); Portuguese Ministerio da Educacao e Ciencia(Portuguese Foundation for Science and Technology)	PM wishes to thank the University of Roma Tre for financial support. DS is supported by the project "Genomics and Evolutionary Biology" co-financed by North Portugal Regional Operational Program (ON.2) under NSRF through the European Regional Development Fund and by the post-doctoral grant SFRH/BPD/66592/2009 by Fundacao para a Ciencia e Tecnologia (FCT, Portugal) under the Programa Operacional Potencial Humano - Quadro de Referencia Estrategico Nacional funds from the European Social Fund and Portuguese Ministerio da Educacao e Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral VSD, 2014, J MAR BIOL ASSOC UK, V94, P811, DOI DOI 10.1017/S0025315414000058; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bouchet P, 2014, OSTREIDAE RAFINESQUE; Bouchet P, 2014, OSTREINAE RAFINESQUE; Buchheim MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016931; Bussarawit Somchai, 2006, Phuket Marine Biological Center Research Bulletin, V67, P1; Coleman AW, 2007, NUCLEIC ACIDS RES, V35, P3322, DOI 10.1093/nar/gkm233; de Melo AGC, 2010, GENET MOL BIOL, V33, P564, DOI 10.1590/S1415-47572010000300030; Crocetta F, 2015, J MAR BIOL ASSOC UK, V95, P111, DOI 10.1017/S0025315414001027; Cross I, 2006, J AOAC INT, V89, P144; Danic-Tchaleu Gwenaelle, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-400; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Degnan JH, 2006, PLOS GENET, V2, P762, DOI 10.1371/journal.pgen.0020068; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Ferguson JWH, 2002, BIOL J LINN SOC, V75, P509, DOI 10.1046/j.1095-8312.2002.00042.x; Foighil DO, 2000, MOL PHYLOGENET EVOL, V15, P301, DOI 10.1006/mpev.1999.0755; GUNTER G, 1950, AM MIDL NAT, V43, P438, DOI 10.2307/2421912; GUTELL RR, 1993, NUCLEIC ACIDS RES, V21, P3055, DOI 10.1093/nar/21.13.3055; GUTELL RR, 1988, NUCLEIC ACIDS RES, V16, pR175, DOI 10.1093/nar/16.suppl.r175; HARRY HW, 1985, VELIGER, V28, P121; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Huber Markus, 2010, P1; Jobb G, 2008, TREEFINDER VERSION O; Joseph N, 1999, NUCLEIC ACIDS RES, V27, P4533, DOI 10.1093/nar/27.23.4533; Jozefowicz CJ, 1998, MOL PHYLOGENET EVOL, V10, P426, DOI 10.1006/mpev.1998.0529; Keller A, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-4; Keller A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-218; Klinbunga S, 2005, MAR BIOTECHNOL, V7, P306, DOI 10.1007/s10126-004-0036-x; Klinbunga S, 2003, MAR BIOTECHNOL, V5, P27, DOI 10.1007/s10126-002-0047-4; Koetschan C, 2012, MOL PHYLOGENET EVOL, V63, P585, DOI 10.1016/j.ympev.2012.01.026; KORRINGA P., 1952, QUART REV BIOL, V27, P266, DOI 10.1086/399023; Lam K, 2004, RAFFLES B ZOOL, V52, P11; Lam K, 2003, AQUACULTURE, V228, P1, DOI 10.1016/S0044-8486(03)00215-1; Lam K, 2006, J MOLLUS STUD, V72, P235, DOI 10.1093/mollus/eyl002; Lapegue S, 2002, BIOL BULL-US, V202, P232, DOI 10.2307/1543473; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LITTLEWOOD DTJ, 1994, MOL PHYLOGENET EVOL, V3, P221, DOI 10.1006/mpev.1994.1024; Liu J, 2011, MOL ECOL RESOUR, V11, P820, DOI 10.1111/j.1755-0998.2011.03025.x; Lopez-Flores I, 2004, GENE, V339, P181, DOI 10.1016/j.gene.2004.06.049; Lydeard C, 2000, MOL PHYLOGENET EVOL, V15, P83, DOI 10.1006/mpev.1999.0719; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Markert SM, 2012, PLANT BIOLOGY, V14, P987, DOI 10.1111/j.1438-8677.2012.00576.x; Matsumoto M, 2003, MOL PHYLOGENET EVOL, V27, P429, DOI 10.1016/S1055-7903(03)00013-7; McVay JD, 2013, J PHYLOGEN EVOLUTION, V1, P3, DOI DOI 10.4172/jpgeb.1000114; Melo CMR, 2010, BIOL INVASIONS, V12, P441, DOI 10.1007/s10530-009-9475-7; Michot B, 1999, NUCLEIC ACIDS RES, V27, P2271, DOI 10.1093/nar/27.11.2271; Muller T, 2007, RNA, V13, P1469, DOI 10.1261/rna.617107; OFOIGHIL D, 1995, J EXP MAR BIOL ECOL, V192, P211; Oliverio M, 2002, MOL PHYLOGENET EVOL, V25, P63, DOI 10.1016/S1055-7903(02)00227-0; Oliverio M, 2001, J MOLLUS STUD, V67, P243, DOI 10.1093/mollus/67.2.243; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Palumbi S., 1991, SIMPLE FOOLS GUIDE P; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; Rambaut A., 2012, FIGTREE V1 4; Rambaut A., 2007, TRACER V1 5; Reece KS, 2008, MAR BIOL, V153, P709, DOI 10.1007/s00227-007-0846-2; Ren JF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-394; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Rosenberg NA, 2003, EVOLUTION, V57, P1465, DOI 10.1554/03-012; Ruesink JL, 2005, ANNU REV ECOL EVOL S, V36, P643, DOI 10.1146/annurev.ecolsys.36.102003.152638; Salvi D, 2012, MOL PHYLOGENET EVOL, V65, P792, DOI 10.1016/j.ympev.2012.07.017; Salvi D, 2010, MOL PHYLOGENET EVOL, V56, P1059, DOI 10.1016/j.ympev.2010.04.025; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Schultz J, 2005, RNA, V11, P361, DOI 10.1261/rna.7204505; Schultz J, 2009, MOL PHYLOGENET EVOL, V52, P520, DOI 10.1016/j.ympev.2009.01.008; Seibel PN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-498; Seibel Philipp N, 2008, BMC Res Notes, V1, P91, DOI 10.1186/1756-0500-1-91; Seilacher A., 1985, Lecture Notes in Earth Sciences, V1, P421; Stenzel H., 1971, TREATISE INVERTEBR N, pN953; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Varela ES, 2007, J MOLLUS STUD, V73, P229, DOI 10.1093/mollus/eym018; Waller Thomas R., 1998, P1; Wang HY, 2008, J SHELLFISH RES, V27, P481, DOI 10.2983/0730-8000(2008)27[481:IOCAAR]2.0.CO;2; Wang YP, 2004, BIOL BULL-US, V206, P46, DOI 10.2307/1543197; Wiemers M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-300; Wolf M, 2014, GENE, V546, P145, DOI 10.1016/j.gene.2014.05.065; Yu ZN, 2003, J SHELLFISH RES, V22, P31	78	61	62	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108696	10.1371/journal.pone.0108696	http://dx.doi.org/10.1371/journal.pone.0108696			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250663	Green Published, Green Submitted, gold			2022-12-25	WOS:000342492700150
J	Viain, A; Savard, JPL; Gilliland, S; Perry, MC; Guillemette, M				Viain, Anouck; Savard, Jean-Pierre L.; Gilliland, Scott; Perry, Matthew C.; Guillemette, Magella			Do Seaducks Minimise the Flightless Period?: Inter- and Intra-Specific Comparisons of Remigial Moult	PLOS ONE			English	Article							WHITE-CROWNED SPARROWS; EIDERS SOMATERIA-SPECTABILIS; FEATHER GROWTH; COMMON EIDERS; WING MOLT; BODY-MASS; NUTRITIONAL STRESS; ENERGY-EXPENDITURE; HARLEQUIN DUCKS; BARNACLE GEESE	Remigial moult is one of the crucial events in the annual life cycle of waterfowl as it is energetically costly, lasts several weeks, and is a period of high vulnerability due to flightlessness. In waterfowl, remigial moult can be considered as an energy-predation trade-off, meaning that heavier individuals would minimise the flightless period by increasing feather growth rate and energy expenditure. Alternatively, they could reduce body mass at the end of this period, thereby reducing wing-loading to increase flight capability. We studied timing of remigial moult, primary growth rates, flightlessness duration, and the pattern of body mass variation in 5 species of captive seaducks (Melanitta fusca, M. perspicillata, Clangula hyemalis, Histrionicus histrionicus, and Somateria mollissima) ranging in size from 0.5 to 2.0 kg. Their feather growth rates weakly increased with body mass (M-0.059) and no correlation was found at the intra-specific level. Consequently, heavier seaduck species and especially heavier individuals had a longer flightless period. Although birds had access to food ad libidum, body mass first increased then decreased, the latter coinciding with maximum feather growth rate. Level of body mass when birds regained flight ability was similar to level observed at the beginning of remigial moult, suggesting they were not using a strategic reduction of body mass to reduce the flightlessness duration. We suggest that the moulting strategy of seaducks may be the result of a compromise between using an intense moult strategy (simultaneous moult) and a low feather growth rate without prejudice to feather quality. Despite the controlled captive status of the studied seaducks, all five species as well as both sexes within each species showed timing of moult reflecting that of wild birds, suggesting there is a genetic component acting to shape moult timing within wild birds.	[Viain, Anouck; Guillemette, Magella] Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada; [Savard, Jean-Pierre L.] Environm Canada, Sci & Technol, Ste Foy, PQ, Canada; [Gilliland, Scott] Environm Canada, Canadian Wildlife Serv, Sackville, NB, Canada; [Perry, Matthew C.] US Fish & Wildlife Serv, Patuxent Wildlife Res Ctr, USGS, Laurel, MD 20708 USA	University of Quebec; Environment & Climate Change Canada; Environment & Climate Change Canada; Canadian Wildlife Service; United States Department of the Interior; United States Geological Survey; US Fish & Wildlife Service	Viain, A (corresponding author), Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada.	anouck.viain@uqar.ca			Environment Canada; Fondation de l'Universite du Quebec a Rimouski; Canadian Natural Sciences and Engineering Research Council (NSERC)	Environment Canada(CGIAR); Fondation de l'Universite du Quebec a Rimouski; Canadian Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	AV was partially financed during this project through Environment Canada funding contribution and was supported by a grant from the Fondation de l'Universite du Quebec a Rimouski. This study was funded through the Environment Canada and the Canadian Natural Sciences and Engineering Research Council (NSERC) discovery and equipment grants to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PA, 2000, CONDOR, V102, P703, DOI 10.1650/0010-5422(2000)102[0703:TABOHD]2.0.CO;2; ANKNEY CD, 1979, AUK, V96, P68; BERGMAN G, 1982, Ornis Fennica, V59, P77; Bond AL, 2013, CONDOR, V115, P348, DOI 10.1525/cond.2013.110062; Booth Chris J., 2006, British Birds, V99, P533; Brown CR, 1996, PHYSIOL ZOOL, V69, P1036, DOI 10.1086/physzool.69.5.30164245; Burtt EH, 1999, AUK, V116, P364, DOI 10.2307/4089371; Catry P, 2013, POLAR BIOL, V36, P837, DOI 10.1007/s00300-013-1309-5; Dawson A, 2000, P ROY SOC B-BIOL SCI, V267, P2093, DOI 10.1098/rspb.2000.1254; Dawson A, 2004, IBIS, V146, P493, DOI 10.1111/j.1474-919x.2004.00290.x; de la Hera I, 2009, BIOL J LINN SOC, V97, P98, DOI 10.1111/j.1095-8312.2008.01189.x; Dickson RD, 2012, CAN J ZOOL, V90, P932, DOI 10.1139/Z2012-061; DOUTHWAITE R J, 1976, Wildfowl, V27, P123; Figuerola J, 2003, ANIM BEHAV, V65, P551, DOI 10.1006/anbe.2003.2072; Fox AD, 2005, J AVIAN BIOL, V36, P538, DOI 10.1111/j.0908-8857.2005.03301.x; Fox AD, 2014, WILDFOWL SP IN PRESS; Fox AD, 2008, J AVIAN BIOL, V39, P35, DOI 10.1111/j.0908-8857.2008.04135.x; Fox Anthony D., 1999, Wildfowl, V49, P45; Fox AD, 2011, J ORNITHOL, V152, P727, DOI 10.1007/s10336-011-0656-7; FRIMER O, 1994, ARCTIC, V47, P137; Ginn H. B., 1983, MOULT BIRDS BTO GUID; Good PI, 2006, RESAMPLING METHODS P, P5, DOI 10.1007/0-8176-4444-X_2; Griggio M, 2009, J EVOLUTION BIOL, V22, P782, DOI 10.1111/j.1420-9101.2009.01700.x; Guillemette M, 2005, IBIS, V147, P301, DOI 10.1111/j.1474-919x.2005.00402.x; Guillemette M, 2007, ECOLOGY, V88, P2936, DOI 10.1890/06-1751.1; Guillemette M, 2012, J EXP BIOL, V215, P3161, DOI 10.1242/jeb.061119; Hedenstrom A, 1999, J EXP BIOL, V202, P67; Hogan D, 2012, THESIS SIMON FRASER; Hogan D, 2013, J WILDLIFE MANAGE, V77, P701, DOI 10.1002/jwmg.507; Hohman William L., 1992, P128; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Howell M. D., 2002, THESIS AUBURN U AUBU; Iverson SA, 2007, J WILDLIFE MANAGE, V71, P1220, DOI 10.2193/2006-433; JEPSEN P U, 1984, Polar Research, V2, P19, DOI 10.1111/j.1751-8369.1984.tb00483.x; JOENSEN A H, 1973, Danish Review of Game Biology, V8, P1; Kahm M, 2010, J STAT SOFTW, V33, P1; KING JR, 1985, AM ZOOL, V25, P955; Langston NE, 1996, OIKOS, V76, P498, DOI 10.2307/3546343; Legendre P, 2011, LMODE12 MODEL 2 REGR; MEWALDT LR, 1978, AUK, V95, P168, DOI 10.2307/4085508; Moore PG, 2001, J MAR BIOL ASSOC UK, V81, P1067; MORGAN R, 1986, BRIT BIRDS, V79, P338; Mosbech A, 1999, ARCTIC, V52, P188; MURPHY ME, 1988, CAN J ZOOL, V66, P1403, DOI 10.1139/z88-206; MURPHY ME, 1987, PHYSIOL ZOOL, V60, P279, DOI 10.1086/physzool.60.2.30158652; MURPHY ME, 1992, ORNIS SCAND, V23, P304, DOI 10.2307/3676654; Ouellet JF, 2008, CAN J ZOOL, V86, P462, DOI 10.1139/Z08-021; OWEN M, 1979, CONDOR, V81, P42, DOI 10.2307/1367855; Palmer R.S., 1972, AVIAN BIOL, V2, P65; PAYNE RB, 1972, AVIAN BIOL, V2, P104; PEHRSSON O, 1987, CONDOR, V89, P329, DOI 10.2307/1368485; Petersen M. R., 2003, Wildfowl, V54, P103; Petersen MR, 1999, AUK, V116, P1009, DOI 10.2307/4089681; PETERSEN MR, 1981, CONDOR, V83, P256, DOI 10.2307/1367319; Pinheiro J., 2019, NLME LINEAR NONLINEA; Portugal SJ, 2007, J EXP BIOL, V210, P1391, DOI 10.1242/jeb.004598; Portugal SJ, 2010, J ORNITHOL, V151, P443, DOI 10.1007/s10336-009-0474-3; PREVOST Y, 1983, ARDEA, V71, P199; PYLE P, 2008, IDENTIFICATION GUI 2; Robertson G. J., 1997, Wildfowl, V48, P147; Robertson GJ, 2002, BIRDS N AM; Rohwer S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000132; RUDEBECK G, 1950, OIKOS, V2, P65, DOI 10.2307/3564663; Salomonsen F., 1968, WILDFOWL, V19, P5; Serra L, 2007, J EVOLUTION BIOL, V20, P2028, DOI 10.1111/j.1420-9101.2007.01360.x; Serra L, 2001, J AVIAN BIOL, V32, P377, DOI 10.1111/j.0908-8857.2001.320415.x; Serra L., 2006, ACTA ZOOL SINICA, V52, P451; SJOBERG K, 1988, IBIS, V130, P164, DOI 10.1111/j.1474-919X.1988.tb00968.x; Smith William E., 2006, British Birds, V99, P264; Swaddle JP, 1999, J AVIAN BIOL, V30, P351, DOI 10.2307/3677007; Swaddle JP, 1997, CAN J ZOOL, V75, P1135, DOI 10.1139/z97-136; TUCKER VA, 1991, AUK, V108, P108; van de Wetering D, 2000, CONDOR, V102, P228, DOI 10.1650/0010-5422(2000)102[0228:BWAFGO]2.0.CO;2; Walsberg G.E., 1983, P161; Weber TP, 2005, BIOL LETT-UK, V1, P27, DOI 10.1098/rsbl.2004.0244; Williams TD, 2012, GEN COMP ENDOCR, V176, P286, DOI 10.1016/j.ygcen.2011.11.028	77	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107929	10.1371/journal.pone.0107929	http://dx.doi.org/10.1371/journal.pone.0107929			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251375	Green Published, gold, Green Submitted			2022-12-25	WOS:000342492700058
J	Zhang, XL; Wu, MH; Jiang, H; Hao, J; Zhang, QL; Zhu, Q; Saren, GW; Zhang, Y; Meng, XH; Yue, X				Zhang, Xiaoli; Wu, Minghui; Jiang, Hong; Hao, Jing; Zhang, Qingli; Zhu, Qing; Saren, Gaowa; Zhang, Yun; Meng, Xiaohui; Yue, Xin			Angiotensin II Upregulates Endothelial Lipase Expression via the NF-Kappa B and MAPK Signaling Pathways	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; PLATELET-AGGREGATION; MESSENGER-RNA; IN-VIVO; ATHEROSCLEROSIS; INFLAMMATION; SYSTEM; KINASE; HYPERTENSION; ASSOCIATION	Background: Angiotensin II (AngII) participates in endothelial damage and inflammation, and accelerates atherosclerosis. Endothelial lipase (EL) is involved in the metabolism and clearance of high density lipoproteins (HDL), the serum levels of which correlate negatively with the onset of cardiovascular diseases including atherosclerosis. However, the relationship between AngII and EL is not yet fully understood. In this study, we investigated the effects of AngII on the expression of EL and the signaling pathways that mediate its effects in human umbilical vein endothelial cells (HUVECs). Methods and Findings: HUVECs were cultured in vitro with different treatments as follows: 1) The control group without any treatment; 2) AngII treatment for 0 h, 4 h, 8 h, 12 h and 24 h; 3) NF-kappa B activation inhibitor pyrrolidine dithiocarbamate (PDTC) pretreatment for 1 h before AngII treatment; and 4) mitogen-activated protein kinase (MAPK) p38 inhibitor (SB203580) pretreatment for 1 h before AngII treatment. EL levels in each group were detected by immunocytochemical staining and western blotting. HUVECs proliferation was detected by MTT and proliferating cell nuclear antigen (PCNA) immunofluorescence staining. NF-kappa B (NF-kappa B) p65, MAPK p38, c-Jun N-terminal kinase (JNK), extracellular signal-regulated kinase (ERK) and phosphorylated extracellular signal-regulated kinase (p-ERK) expression levels were assayed by western blotting. The results showed that the protein levels of EL, NF-kappa B p65, MAPK p38, JNK, and p-ERK protein levels, in addition to the proliferation of HUVECs, were increased by AngII. Both the NF-kappa B inhibitor (PDTC) and the MAPK p38 inhibitor (SB203580) partially inhibited the effects of AngII on EL expression. Conclusion: AngII may upregulate EL protein expression via the NF-kappa B and MAPK signaling pathways.	[Zhang, Xiaoli; Hao, Jing] Chinese Minist Educ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Jinan, Peoples R China; [Zhang, Xiaoli; Hao, Jing] Chinese Minist Publ Hlth, Qilu Hosp, Dept Cardiol, Jinan, Peoples R China; [Wu, Minghui; Jiang, Hong; Zhu, Qing; Saren, Gaowa; Zhang, Yun; Yue, Xin] Shandong Univ, Sch Med, Dept Histol & Embryol, Minist Educ Expt Teratol,Key Lab, Jinan 250100, Peoples R China; [Zhang, Qingli] Shandong Univ, Sch Med, Dept Morphol Lab, Jinan 250100, Peoples R China; [Meng, Xiaohui] Shandong Univ, Sch Med, Inst Diagnost, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University	Yue, X (corresponding author), Chinese Minist Educ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Jinan, Peoples R China.	dryx@sina.com			Natural Science Foundation of Shandong Province [Y2008C47]; Shandong Department of Science and Technology Plan Project [2012GSF11848]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Shandong Department of Science and Technology Plan Project	This study was supported by the Natural Science Foundation of Shandong Province (NO. Y2008C47) and Shandong Department of Science and Technology Plan Project (NO. 2012GSF11848). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annema W, 2005, NAT REV DRUG DISCOV, V4, P193; Badellino KO, 2008, CIRCULATION, V117, P678, DOI 10.1161/CIRCULATIONAHA.107.707349; Badellino KO, 2006, PLOS MED, V3, P245, DOI 10.1371/journal.pmed.0030022; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Brasier AR, 2002, ARTERIOSCL THROM VAS, V22, P1257, DOI 10.1161/01.ATV.0000021412.56621.A2; Broedl UC, 2004, CIRC RES, V94, P1554, DOI 10.1161/01.RES.0000130657.00222.39; Cai GJ, 2012, MOL BIOL REP, V39, P9879, DOI 10.1007/s11033-012-1854-y; Choi SY, 2002, J LIPID RES, V43, P1763, DOI 10.1194/jlr.R200011-JLR200; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2004, CIRCULATION, V110, P3849, DOI 10.1161/01.CIR.0000150540.54220.C4; Daugherty A, 2004, TRENDS CARDIOVAS MED, V14, P117, DOI 10.1016/j.tcm.2004.01.002; DING YA, 1985, THROMB HAEMOSTASIS, V54, P717; Dol F, 2001, J CARDIOVASC PHARM, V38, P395, DOI 10.1097/00005344-200109000-00008; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gilmore TD, 1999, ONCOGENE, V18, P6842, DOI 10.1038/sj.onc.1203237; Goldstein DM, 2005, CURR TOP MED CHEM, V5, P1017, DOI 10.2174/1568026054985939; Halkin A, 2002, AM J MED, V112, P126, DOI 10.1016/S0002-9343(01)01001-4; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hirata K, 2000, BIOCHEM BIOPH RES CO, V272, P90, DOI 10.1006/bbrc.2000.2747; Huan C, 2013, THESIS NANFANG MED U; Ishida T, 2004, J BIOL CHEM, V279, P45085, DOI 10.1074/jbc.M406360200; Jacobsen JCB, 2008, AM J PHYSIOL-REG I, V294, pR1379, DOI 10.1152/ajpregu.00407.2007; Jagroop IA, 2000, J HUM HYPERTENS, V14, P581, DOI 10.1038/sj.jhh.1001102; Jaye M, 1999, NAT GENET, V21, P424, DOI 10.1038/7766; Jiang YN, 2000, STROKE, V31, P2319, DOI 10.1161/01.STR.31.10.2319; Jin WJ, 2003, CIRC RES, V92, P644, DOI 10.1161/01.RES.0000064502.47539.6D; Kempe S, 2005, NUCLEIC ACIDS RES, V33, P5308, DOI 10.1093/nar/gki836; Larsson PT, 2000, BLOOD COAGUL FIBRIN, V11, P61, DOI 10.1097/00001721-200011010-00007; [马天容 Ma Tianrong], 2006, [中国动脉硬化杂志, Chinese Journal of Arteriosclerosis], V14, P471; Mazzolai L, 2006, CURR HYPERTENS REP, V8, P47, DOI 10.1007/s11906-006-0040-9; Mogielnicki A, 2005, THROMB HAEMOSTASIS, V93, P1069, DOI 10.1160/TH04-10-0701; Monaco C, 2004, P NATL ACAD SCI USA, V101, P5634, DOI 10.1073/pnas.0401060101; Nishimura H, 1999, THROMB HAEMOSTASIS, V82, P1516; Nishimura H, 1997, THROMB HAEMOSTASIS, V77, P1189; Paradis ME, 2006, J LIPID RES, V47, P2808, DOI 10.1194/jlr.P600002-JLR200; Paravicini TM, 2012, J AM SOC HYPERTENS, V6, P169, DOI 10.1016/j.jash.2012.01.002; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; POPLAWSKI A, 1970, EXPERIENTIA, V26, P86, DOI 10.1007/BF01900409; Pueyo ME, 2000, ARTERIOSCL THROM VAS, V20, P45; RIDKER PM, 1993, CIRCULATION, V87, P1969, DOI 10.1161/01.CIR.87.6.1969; Schiffrin EL, 2004, AM J PHYSIOL-HEART C, V287, pH435, DOI 10.1152/ajpheart.00262.2004; Singaraja RR, 2013, CIRC-CARDIOVASC GENE, V6, P54, DOI 10.1161/CIRCGENETICS.111.962613; SWARTZ SL, 1990, THROMB HAEMOSTASIS, V63, P87; Tian B, 2003, RECENT PROG HORM RES, V58, P95, DOI 10.1210/rp.58.1.95; VANLEEUWEN RTJ, 1994, CIRCULATION, V90, P362, DOI 10.1161/01.CIR.90.1.362; Weiss D, 2001, CIRCULATION, V103, P448; Wilson HM, 1997, NEPHRON, V77, P197, DOI 10.1159/000190273; Xu J, 2012, PROGR MODERN BIOMEDI, V33, P6447; Yogi A, 2011, HYPERTENSION, V57, P809, DOI 10.1161/HYPERTENSIONAHA.110.162719	51	17	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107634	10.1371/journal.pone.0107634	http://dx.doi.org/10.1371/journal.pone.0107634			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250890	gold, Green Submitted, Green Published			2022-12-25	WOS:000342492700036
J	Freidl, GS; de Bruin, E; van Beek, J; Reimerink, J; de Wit, S; Koch, G; Vervelde, L; van den Ham, HJ; Koopmans, MPG				Freidl, Gudrun S.; de Bruin, Erwin; van Beek, Janko; Reimerink, Johan; de Wit, Sjaak; Koch, Guus; Vervelde, Lonneke; van den Ham, Henk-Jan; Koopmans, Marion P. G.			Getting More Out of Less - A Quantitative Serological Screening Tool for Simultaneous Detection of Multiple Influenza A Hemagglutinin-Types in Chickens	PLOS ONE			English	Article							CROSS-PROTECTION; VIRUS-INFECTION; ANTIBODIES; SUBTYPES; IMMUNOASSAY; RESPONSES; EPITOPE; H5	Current avian influenza surveillance in poultry primarily targets subtypes of interest for the veterinary sector (H5, H7). However, as virological and serological evidence suggest, surveillance of additional subtypes is important for public health as well as for the poultry industry. Therefore, we developed a protein microarray enabling simultaneous identification of antibodies directed against different HA-types of influenza A viruses in chickens. The assay successfully discriminated negative from experimentally and naturally infected, seropositive chickens. Sensitivity and specificity depended on the cutoff level used but ranged from 84.4% to 100% and 100%, respectively, for a cut off level of >= 1:40, showing minimal cross reactivity. As this testing platform is also validated for the use in humans, it constitutes a surveillance tool that can be applied in human-animal interface studies.	[Freidl, Gudrun S.; van Beek, Janko; van den Ham, Henk-Jan; Koopmans, Marion P. G.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Freidl, Gudrun S.; de Bruin, Erwin; van Beek, Janko; Reimerink, Johan; Koopmans, Marion P. G.] Natl Inst Publ Hlth & Environm, RIVM, Ctr Infect Dis Control,Div Virol, Ctr Infect Dis Res Diagnost & Perinatal Screening, NL-3720 BA Bilthoven, Netherlands; [de Wit, Sjaak] GD Anim Hlth Serv AHS, Deventer, Netherlands; [Koch, Guus] Cent Vet Inst, Lelystad, Netherlands; [Vervelde, Lonneke] Univ Utrecht, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Netherlands National Institute for Public Health & the Environment; Wageningen University & Research; Utrecht University	Freidl, GS (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	gudrun.freidl@rivm.nl	Vervelde, Lonneke/C-7707-2013; van den Ham, HJ/ABF-1071-2021	Vervelde, Lonneke/0000-0003-2241-1743; van den Ham, Henk-Jan/0000-0001-8582-5404	European Commission FP7 program [278976]; Ministry of Economic Affairs, the Netherlands; Biotechnology and Biological Sciences Research Council [BBS/E/D/20241864] Funding Source: researchfish; BBSRC [BBS/E/D/20241864] Funding Source: UKRI	European Commission FP7 program; Ministry of Economic Affairs, the Netherlands(Ministry of Economic Affairs, Netherlands); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was funded by the European Commission's FP7 program under the umbrella of the Antigone project - ANTIcipating the global onset of novel epidemics (project number 278976, http://antigonefp7.eu/). Part of the serum samples were generated within the FES program on Avian Influenza financed by the Ministry of Economic Affairs, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIR GM, 1981, P NATL ACAD SCI-BIOL, V78, P7639, DOI 10.1073/pnas.78.12.7639; [Anonymous], 1980, B WORLD HEALTH ORGAN, V58, P585; Boni MF, 2013, J INFECT DIS, V208, P554, DOI 10.1093/infdis/jit224; Boon ACM, 2004, J IMMUNOL, V172, P2453, DOI 10.4049/jimmunol.172.4.2453; Cattoli G, 2011, J VIROL, V85, P8718, DOI 10.1128/JVI.02403-10; Chen YX, 2009, J INFECT DIS, V199, P49, DOI 10.1086/594374; Comin A, 2013, INFLUENZA OTHER RESP, V7, P257, DOI 10.1111/j.1750-2659.2012.00391.x; Ducatez MF, 2011, J CLIN MICROBIOL, V49, P3531, DOI 10.1128/JCM.01279-11; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Escorcia M, 2010, BMC VET RES, V6, P57; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Freidl G.S., 2014, EURO SURVEILL; Gonzales JL, 2013, INFLUENZA OTHER RESP, V7, P6, DOI 10.1111/j.1750-2659.2012.00348.x; Kayali G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026818; Koopmans M, 2012, CLIN MICROBIOL INFEC, V18, P797, DOI 10.1111/j.1469-0691.2011.03701.x; Ladman BS, 2008, AVIAN DIS, V52, P623, DOI 10.1637/8282-031208-Reg.1; Latorre-Margalef N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003443; Lee CW, 2006, CLIN VACCINE IMMUNOL, V13, P395, DOI 10.1128/CVI.13.3.395-402.2006; Lu HG, 2004, AVIAN DIS, V48, P263, DOI 10.1637/7064; Lupiani B, 2010, AVIAN DIS, V54, P668, DOI 10.1637/8818-040209-ResNote.1; Molesti E, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/457932; Mueller M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009097; Nguyen HH, 2001, J INFECT DIS, V183, P368, DOI 10.1086/318084; Peiris JSM, 2009, REV SCI TECH OIE, V28, P161, DOI 10.20506/rst.28.1.1871; Pinette MM, 2014, J IMMUNOL METHODS, V405, P167, DOI 10.1016/j.jim.2014.02.004; Reperant LA, 2009, REV SCI TECH OIE, V28, P137, DOI 10.20506/rst.28.1.1876; SHARMA JM, 1991, VET IMMUNOL IMMUNOP, V30, P13, DOI 10.1016/0165-2427(91)90004-V; Smirnov YA, 1999, ACTA VIROL, V43, P237; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Tumpey TM, 2001, J VIROL, V75, P5141, DOI 10.1128/JVI.75.11.5141-5150.2001; Vervelde Lonneke, 2011, BMC Proc, V5 Suppl 4, pS5, DOI 10.1186/1753-6561-5-S4-S5; Wang XR, 2010, J VIROL METHODS, V167, P119, DOI 10.1016/j.jviromet.2010.03.021; Watson DS, 2009, J IMMUNOL METHODS, V340, P123, DOI 10.1016/j.jim.2008.10.007; WOOD JM, 1994, VACCINE, V12, P167, DOI 10.1016/0264-410X(94)90056-6; World Health Organization, 2011, MAN LAB DIAGN VIR SU; World Organisation for Animal Health (OIE), 2012, AV INFL OIE TERR MAN	38	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108043	10.1371/journal.pone.0108043	http://dx.doi.org/10.1371/journal.pone.0108043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25248105	Green Published, gold, Green Submitted			2022-12-25	WOS:000342351800057
J	Meng, XZ; Lin, O; Wang, F; Jiang, YZ; Song, Y				Meng, Xiangzhi; Lin, Ou; Wang, Fang; Jiang, Yuzheng; Song, Yan			Reading Performance Is Enhanced by Visual Texture Discrimination Training in Chinese-Speaking Children with Developmental Dyslexia	PLOS ONE			English	Article							SPATIAL ATTENTION; NEURAL DEFICITS; SEGMENTATION; DIFFICULTIES	Background: High order cognitive processing and learning, such as reading, interact with lower-level sensory processing and learning. Previous studies have reported that visual perceptual training enlarges visual span and, consequently, improves reading speed in young and old people with amblyopia. Recently, a visual perceptual training study in Chinese-speaking children with dyslexia found that the visual texture discrimination thresholds of these children in visual perceptual training significantly correlated with their performance in Chinese character recognition, suggesting that deficits in visual perceptual processing/learning might partly underpin the difficulty in reading Chinese. Methodology/Principal Findings: To further clarify whether visual perceptual training improves the measures of reading performance, eighteen children with dyslexia and eighteen typically developed readers that were age-and IQ-matched completed a series of reading measures before and after visual texture discrimination task (TDT) training. Prior to the TDT training, each group of children was split into two equivalent training and non-training groups in terms of all reading measures, IQ, and TDT. The results revealed that the discrimination threshold SOAs of TDT were significantly higher for the children with dyslexia than for the control children before training. Interestingly, training significantly decreased the discrimination threshold SOAs of TDT for both the typically developed readers and the children with dyslexia. More importantly, the training group with dyslexia exhibited significant enhancement in reading fluency, while the non-training group with dyslexia did not show this improvement. Additional follow-up tests showed that the improvement in reading fluency is a long-lasting effect and could be maintained for up to two months in the training group with dyslexia. Conclusion/Significance: These results suggest that basic visual perceptual processing/learning and reading ability in Chinese might at least partially rely on overlapping mechanisms.	[Meng, Xiangzhi; Lin, Ou] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China; [Wang, Fang; Song, Yan] Beijing Normal Univ, McGovern Inst Brain Res, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Jiang, Yuzheng] Beijing Jiaotong Univ, Sch Languages & Commun, Beijing, Peoples R China; [Wang, Fang; Song, Yan] Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, Beijing 100875, Peoples R China; [Meng, Xiangzhi] Peking Univ, Joint PekingU PolyU Ctr Child Dev & Learning, Beijing 100871, Peoples R China	Peking University; Beijing Normal University; Beijing Jiaotong University; Beijing Normal University; Peking University	Song, Y (corresponding author), Beijing Normal Univ, McGovern Inst Brain Res, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	songyan@bnu.edu.cn		Song, Yan/0000-0002-5923-7673	Natural Science Foundation of China [81371206]; National Key Basic Research Program of China [2014CB846103]; NSFC [81171016, 31271203]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the Natural Science Foundation of China (81371206) to XM, National Key Basic Research Program of China (2014CB846103) to YS, and NSFC (81171016, 31271203) to XZ and YS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 2000, P NATL ACAD SCI USA, V97, P6832, DOI 10.1073/pnas.97.12.6832; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; An A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034826; Bernard JB, 2012, VISION RES, V66, P17, DOI 10.1016/j.visres.2012.06.012; Bhide A, 2013, MIND BRAIN EDUC, V7, P113, DOI 10.1111/mbe.12016; BRADLEY L, 1978, NATURE, V271, P746, DOI 10.1038/271746a0; Censor N, 2009, J VISION, V9, DOI 10.1167/9.4.12; Chouake T, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00014; Chung STL, 2004, VISION RES, V44, P695, DOI 10.1016/j.visres.2003.09.028; Chung STL, 2013, VISION RES, V77, P41, DOI 10.1016/j.visres.2012.11.009; Chung STL, 2011, INVEST OPHTH VIS SCI, V52, P1164, DOI 10.1167/iovs.10-6034; Facoetti A, 2000, CORTEX, V36, P109, DOI 10.1016/S0010-9452(08)70840-2; Facoetti A, 2003, COGNITIVE BRAIN RES, V15, P154, DOI 10.1016/S0926-6410(02)00148-9; Farmer ME, 1995, PSYCHON B REV, V2, P460, DOI 10.3758/BF03210983; Franceschini S, 2013, CURR BIOL, V23, P462, DOI 10.1016/j.cub.2013.01.044; Franceschini S, 2012, CURR BIOL, V22, P814, DOI 10.1016/j.cub.2012.03.013; Gibson Eleanor Jack, 1969, PRINCIPLES PERCEPTUA; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Lin O, 2013, THESIS PEKING U BEIJ; Lovio R, 2012, SCIENCE, V271, P77; Martelli M, 2009, J VISION, V9, DOI 10.1167/9.4.14; Merzenich MM, 1996, SCIENCE, V271, P77, DOI 10.1126/science.271.5245.77; Moritz C, 2013, READ WRIT, V26, P739, DOI 10.1007/s11145-012-9389-0; Norton ES, 2012, ANNU REV PSYCHOL, V63, P427, DOI 10.1146/annurev-psych-120710-100431; Polat U, 2009, VISION RES, V49, P2566, DOI 10.1016/j.visres.2009.06.005; Ramus F, 2003, CURR OPIN NEUROBIOL, V13, P212, DOI 10.1016/S0959-4388(03)00035-7; Roach NW, 2008, VISION RES, V48, P193, DOI 10.1016/j.visres.2007.11.001; Schubo A, 2001, J EXP PSYCHOL HUMAN, V27, P919; Schwartz S, 2002, P NATL ACAD SCI USA, V99, P17137, DOI 10.1073/pnas.242414599; Shaywitz BA, 2004, BIOL PSYCHIAT, V55, P926, DOI 10.1016/j.biopsych.2003.12.019; Shaywitz BA, 2001, CLIN NEUROSCI RES, V1, P291, DOI 10.1016/S1566-2772(01)00015-9; Shaywitz SE, 2005, BIOL PSYCHIAT, V57, P1301, DOI 10.1016/j.biopsych.2005.01.043; Siok WT, 2004, NATURE, V431, P71, DOI 10.1038/nature02865; Stein J, 1997, TRENDS NEUROSCI, V20, P147, DOI 10.1016/S0166-2236(96)01005-3; STEIN JF, 1994, INT J PSYCHOPHYSIOL, V18, P241, DOI 10.1016/0167-8760(94)90010-8; Sterkin A, 2009, VISION RES, V49, P1784, DOI 10.1016/j.visres.2009.04.013; TALLAL P, 1980, BRAIN LANG, V9, P182, DOI 10.1016/0093-934X(80)90139-X; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; Temple E, 2003, P NATL ACAD SCI USA, V100, P2860, DOI 10.1073/pnas.0030098100; WAGNER RK, 1987, PSYCHOL BULL, V101, P192, DOI 10.1037/0033-2909.101.2.192; Wang F, 2013, VISION RES, V93, P1, DOI 10.1016/j.visres.2013.10.004; Wang R, 2013, J VISION, V13, DOI 10.1167/13.5.9; Wang X., 1993, CHINESE CHARACTER RE; Wang ZK, 2014, DYSLEXIA, V20, P280, DOI 10.1002/dys.1475; Witton C, 1998, CURR BIOL, V8, P791, DOI 10.1016/S0960-9822(98)70320-3; Xue J, 2013, J PSYCHOLINGUIST RES, V42, P433, DOI 10.1007/s10936-012-9228-0; Yotsumoto Y, 2008, NEURON, V57, P827, DOI 10.1016/j.neuron.2008.02.034; You HL, 2011, NEUROIMAGE, V57, P760, DOI 10.1016/j.neuroimage.2010.12.003; Yu D, 2013, VISION RES, V50, P36; Yu DY, 2010, VISION RES, V50, P860, DOI 10.1016/j.visres.2010.02.006; Zhang H. C., 1985, RAVEN STANDARD PROGR; Zorzi M, 2012, P NATL ACAD SCI USA, V109, P11455, DOI 10.1073/pnas.1205566109	52	22	26	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108274	10.1371/journal.pone.0108274	http://dx.doi.org/10.1371/journal.pone.0108274			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP8TL	25247602	Green Published, Green Submitted, gold			2022-12-25	WOS:000342351800077
J	Vieira, WLS; Vieira, KS; Nobrega, RP; Guedes, PF; Montenegro, P; Pereira, GA; Santana, GG; Alves, RRN; Almeida, WO; Vasconcellos, A				Silva Vieira, Washington Luiz; Vieira, Kleber Silva; Nobrega, Romulo Pantoja; Guedes, Paulo Fernandes; Montenegro, Pereira; Pereira Filho, Gentil Alves; Santana, Gindomar Gomes; Nobrega Alves, Romulo Romeu; Almeida, Waltecio Oliveira; Vasconcellos, Alexandre			Species Richness and Evidence of Random Patterns in Assemblages of South American Titanosauria during the Late Cretaceous (Campanian-Maastrichtian)	PLOS ONE			English	Article							NULL MODEL ANALYSIS; COOCCURRENCE; DINOSAUR; BIODIVERSITY; COMMUNITIES; COMPETITION; DIVERSITY; EVOLUTION; SAUROPODA; BIRDS	The Titanosauria were much diversified during the Late Cretaceous, but paleobiological information concerning these sauropods continues to be scarce and no studies have been conducted utilizing modern methods of community analysis to infer possible structural patterns of extinct assemblages. The present study sought to estimate species richness and to investigate the existence of structures in assemblages of the South American Titanosauria during the Late Cretaceous. Estimates of species richness were made utilizing a nonparametric estimator and null models of species co-occurrences and overlapping body sizes were applied to determine the occurrence of structuring in this assemblages. The high estimate of species richness (n = 57) may have been influenced by ecological processes associated with extinction events of sauropod groups and with the structures of the habitats that provided abundant support to the maintenance of large numbers of species. The pseudocommunity analysis did not differ from that expected by chance, indicating the lack of structure in these assemblages. It is possible that these processes originated from phylogenetic inertia, associated with the occurrence of stabilized selection. Additionally, stochastic extinction events and historical factors may also have influenced the formation of the titanosaurian assemblages, in detriment to ecological factors during the Late Cretaceous. However, diagenetic and biostratinomic processes, influenced by the nature of the sedimentary paleoenvironment, could have rendered a random arrangement that would make assemblage structure undetectable.	[Silva Vieira, Washington Luiz; Vieira, Kleber Silva; Nobrega, Romulo Pantoja; Guedes, Paulo Fernandes] Univ Fed Paraiba, Dept Sistemat & Ecol, Lab Ecofisiol Anim, BR-58059900 Joao Pessoa, PB, Brazil; [Pereira Filho, Gentil Alves] Museu Zool Univ Sao Paulo, Sao Paulo, Brazil; [Santana, Gindomar Gomes; Nobrega Alves, Romulo Romeu] Univ Estadual Paraiba, Programa Posgrad Ecol & Conservacao PPGEC, Dept Biol, Campina Grande, Paraiba, Brazil; [Nobrega Alves, Romulo Romeu] Univ Estadual Paraiba, Dept Biol, Campina Grande, Paraiba, Brazil; [Almeida, Waltecio Oliveira] Univ Reg Cariri URCA, Ctr Ciencias Biol & Saude, Dept Quim Biol, Campus Do Pimenta, CE, Brazil; [Vasconcellos, Alexandre] Univ Fed Paraiba, Dept Sistemat & Ecol, BR-58059900 Joao Pessoa, PB, Brazil	Universidade Federal da Paraiba; Universidade de Sao Paulo; Universidade Estadual da Paraiba; Universidade Estadual da Paraiba; Universidade Regional do Cariri; Universidade Federal da Paraiba	Vieira, WLS (corresponding author), Univ Fed Paraiba, Dept Sistemat & Ecol, Lab Ecofisiol Anim, BR-58059900 Joao Pessoa, PB, Brazil.	wlsvieira@yahoo.com.br	Santana, Gindomar/E-8417-2013; Vasconcellos, Alexandre/GNW-5099-2022; Vieira, Kleber/C-1354-2013; Montenegro, Paulo/I-5864-2016; Vasconcellos, Alexandre/I-4115-2012; Almeida, Waldemar S/N-4641-2015; Alves, Rômulo Romeu Nóbrega/A-7026-2009; Vieira, Washington Luiz/U-1122-2019; Vieira, Kleber/AAF-8220-2019; de Oliveira Almeida, Waltecio/E-2911-2016	Vasconcellos, Alexandre/0000-0001-7211-7097; Vieira, Kleber/0000-0001-7664-6236; Montenegro, Paulo/0000-0002-3256-8691; Vasconcellos, Alexandre/0000-0001-7211-7097; Almeida, Waldemar S/0000-0002-7382-8373; Alves, Rômulo Romeu Nóbrega/0000-0001-6824-0797; Vieira, Washington Luiz/0000-0002-0673-262X; de Oliveira Almeida, Waltecio/0000-0002-1446-8339				Apesteguia S, 2007, GONDWANA RES, V12, P533, DOI 10.1016/j.gr.2007.04.007; Armin Kellner Alexander Wilhelm, 2005, Arquivos do Museu Nacional Rio de Janeiro, V63, P529; Moreira LFB, 2012, AMPHIBIA-REPTILIA, V33, P261, DOI 10.1163/156853812X641721; Barrett PM, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P125; Behrensmeyer AK, 2000, PALEOBIOLOGY, V26, P103, DOI 10.1666/0094-8373(2000)26[103:TAP]2.0.CO;2; Behrensmeyer AK, 2003, PALAEOBIOLOGY, P318; Bloch CP, 2007, OIKOS, V116, P395, DOI 10.1111/j.0030-1299.2007.15391.x; Candeiro CRA, 2006, GEOBIOS-LYON, V39, P319, DOI 10.1016/j.geobios.2005.10.003; CASE TJ, 1974, P NATL ACAD SCI USA, V71, P3073, DOI 10.1073/pnas.71.8.3073; Colston TJ, 2010, BIOL J LINN SOC, V101, P476, DOI 10.1111/j.1095-8312.2010.01502.x; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Colwell RK, 2013, ESTIMATES STAT ESTIM; CONNOR EF, 1979, ECOLOGY, V60, P1132, DOI 10.2307/1936961; De Almeida Campos Diogenes, 2005, Arquivos do Museu Nacional Rio de Janeiro, V63, P565; Diniz-Filho Jose Alexandre, 1998, Revista Brasileira de Biologia, V58, P649, DOI 10.1590/S0034-71081998000400012; Edinger EN, 2003, PALAEOBIOLOGY, VII, P273; Farlow JO, 2002, HIST BIOL, V16, P21, DOI DOI 10.1080/0891296031000154687; Fastovsky DE., 2012, DINOSAURS CONCISE NA, V2; Fiorillo AR, 2004, DINOSAURIA, 2ND EDITION, P607; Gainsbury AM, 2003, BIOTROPICA, V35, P503, DOI 10.1111/j.1744-7429.2003.tb00607.x; Garcia R, 2014, PREPRINT, DOI [10.5710/AMGH.16.07.2014.829, DOI 10.5710/AMGH.16.07.2014.829]; Gonzalez Riga BJ, 2010, PALEONTOLOGIA DINOSA, P125; Gotelli N., 2001, ECOSIM NULL MODELS S, V78, DOI 10.5281/zenodo.16504; Gotelli NJ, 1997, OIKOS, V80, P311, DOI 10.2307/3546599; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gotelli NJ, 2001, GLOBAL ECOL BIOGEOGR, V10, P337, DOI 10.1046/j.1466-822X.2001.00249.x; Hocknull SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006190; Horner-Devine MC, 2007, ECOLOGY, V88, P1345, DOI 10.1890/06-0286; Kellner AWA, 2000, AN ACAD BRAS CIENC, V72, P509, DOI 10.1590/S0001-37652000000400005; Lieberman SS., 1986, ACTA ZOOL MEX, V15, P1; LOSOS JB, 1992, SYST BIOL, V41, P403, DOI 10.2307/2992583; Luiselli L, 2008, ACTA OECOL, V34, P80, DOI 10.1016/j.actao.2008.04.001; Luiselli L, 2006, OIKOS, V114, P193, DOI 10.1111/j.2006.0030-1299.14064.x; MacArthur R.H., 1972, pvii; Mannion PD, 2011, BIOL REV, V86, P157, DOI 10.1111/j.1469-185X.2010.00139.x; Mannion PD, 2010, PALEOBIOLOGY, V36, P253, DOI 10.1666/08085.1; Martinelli Agustin G., 2004, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V6, P257; MAZZETTA G. V., 2004, HIST BIOL, V16, P1; Miller JR, 2000, ECOL APPL, V10, P1732, DOI 10.2307/2641235; Noto CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012553; Novas F, 2009, AGE DINOSAURS S AM L; PECZKIS J, 1994, J VERTEBR PALEONTOL, V14, P520; Peres-Neto PR, 2001, OIKOS, V93, P110, DOI 10.1034/j.1600-0706.2001.930112.x; Piratelli Augusto Joao, 2001, Revista Brasileira de Zoologia, V18, P305; Poropat SF, 2014, GONDWANA RES; Powell JE., 2003, RECORDS QUEEN VICTOR, V111, P1; Rogers KC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P50; Salgado L, 2000, AMEGHINIANA, V37, P259; Salgado Leonardo, 1997, Ameghiniana, V34, P3; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Santucci R.M., 2001, BRAZ J GENET, V31, P307; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; Sertich JJW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009789; SIMBERLOFF D, 1981, EVOLUTION, V35, P1206, DOI 10.1111/j.1558-5646.1981.tb04990.x; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; STRONG DR, 1979, EVOLUTION, V33, P897, DOI 10.1111/j.1558-5646.1979.tb04743.x; Tiho S, 2007, EUR J SOIL BIOL, V43, P84, DOI 10.1016/j.ejsobi.2006.10.004; TOFT CA, 1985, COPEIA, P1; Ulrich W, 2004, OIKOS, V107, P603, DOI 10.1111/j.0030-1299.2004.12981.x; Upchurch P, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P104; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Vandermeer J.H., 1972, Annual Rev Ecol Syst, V3, P107, DOI 10.1146/annurev.es.03.110172.000543; Vitt LJ, 2005, P NATL ACAD SCI USA, V102, P7877, DOI 10.1073/pnas.0501104102; Walther BA, 2005, ECOGRAPHY, V28, P815, DOI 10.1111/j.2005.0906-7590.04112.x; Wedel MJ, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P201; Whitlock JA, 2011, ROUTL FILM GUIDEBOOK, V6, P1; Whitlock JA, 2011, ZOOL J LINN SOC-LOND, V161, P872, DOI 10.1111/j.1096-3642.2010.00665.x; Wilson JA, 2003, J SYST PALAEONTOL, V1, P125, DOI 10.1017/S1477201903001044; Wilson JA, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P15; WINEMILLER KO, 1990, ECOL MONOGR, V60, P27, DOI 10.2307/1943025; Zaher H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016663	72	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108307	10.1371/journal.pone.0108307	http://dx.doi.org/10.1371/journal.pone.0108307			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247998	gold, Green Published			2022-12-25	WOS:000342351800080
J	Xiong, F; Yin, YL; Dube, B; Page, P; Vinet, A				Xiong, Feng; Yin, Yalin; Dube, Bruno; Page, Pierre; Vinet, Alain			Electrophysiological Changes Preceding the Onset of Atrial Fibrillation after Coronary Bypass Grafting Surgery	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; POWER SPECTRAL-ANALYSIS; FAST FOURIER-TRANSFORM; RISK-FACTOR; INTERVAL DYNAMICS; AUTONOMIC TONE; MECHANISMS; PREDICTION; IMPACT; DISPERSION	Background: The incidence of Post-CABG atrial fibrillation (AF) lies between 25% and 40%. It worsens morbidity and raises post-operative costs. Detection of incoming AF soon enough for prophylactic intervention would be helpful. The study is to investigate the electrophysiological changes preceding the onset of AF and their relationship to the preoperative risk. Methods and Results: Patients were recorded continuously for the first four days after coronary artery bypass grafting surgery (CABG) with three unipolar electrodes sutured to the atria (AEG). The patients experiencing an AF lasting more than 10 minutes were selected and the two hours before the onset were analyzed. Four variables were found to show significant changes in the two hours prior to the first prolonged AF: increasing rate of premature atrial activation, increasing incidence of short transient arrhythmias, acceleration of heart rate, and rise of low frequency content of heart rate. The main contrast was between the first and last hour before AF onset. Preoperative risk was not predictive of the onset time of AF and did not correlate with the amplitude of changes prior to AF. Conclusions: Post-CABG AF were preceded by electrophysiological changes occurring in the last hour before the onset of the arrhythmia, whereas none of these changes was found to occur in all AF patients. The risk was a weighted sum of factors related to the density of premature activations and the state of atrial substrate reflected by the sinus rhythm and its frequency content prior to AF. Preoperative risk score seems unhelpful in setting a detection threshold for the AF onset.	[Xiong, Feng; Yin, Yalin; Dube, Bruno; Page, Pierre; Vinet, Alain] Univ Montreal, Hop Sacre Coeur Montreal, Res Ctr, Montreal, PQ, Canada; [Xiong, Feng; Page, Pierre] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Dube, Bruno; Vinet, Alain] Univ Montreal, Inst Biomed Engn, Montreal, PQ, Canada; [Page, Pierre] Univ Montreal, Dept Surg, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Vinet, A (corresponding author), Univ Montreal, Hop Sacre Coeur Montreal, Res Ctr, Montreal, PQ, Canada.	alain.vinet@umontreal.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [121654]; Mathematics of Information Technology and Complex Systems, Canada (Mitacs) [R13584]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Mathematics of Information Technology and Complex Systems, Canada (Mitacs)	This study was supported by grants from: Natural Sciences and Engineering Research Council of Canada (NSERC: 121654 http://www.nserc-crsng.gc.ca); the Mathematics of Information Technology and Complex Systems, Canada (Mitacs, R13584 http://www.mitacs.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almassi GH, 1999, ANN THORAC SURG, V68, P391, DOI 10.1016/S0003-4975(99)00537-8; Amar D, 2004, J AM COLL CARDIOL, V44, P1248, DOI 10.1016/j.jacc.2004.05.078; Amar D, 2003, J AM COLL CARDIOL, V42, P1262, DOI 10.1016/S0735-1097(03)00955-0; Amar D, 2002, ANESTHESIOLOGY, V96, P352, DOI 10.1097/00000542-200202000-00021; Amar David, 2002, Heart Dis, V4, P117; [Anonymous], 2002, STAT METHODS ANAL RE; [Anonymous], 2011, CLUSTER ANAL; Aranki SF, 1996, CIRCULATION, V94, P390, DOI 10.1161/01.CIR.94.3.390; Arias MA, 2006, CHEST, V129, P828, DOI 10.1378/chest.129.3.828; Ashar MS, 2000, J CARDIOVASC ELECTR, V11, P1300, DOI 10.1046/j.1540-8167.2000.01300.x; Auer J, 2005, J CARDIOVASC SURG, V46, P583; Auer J, 2005, J CARDIAC SURG, V20, P425, DOI 10.1111/j.1540-8191.2005.2004123.x; Bernet F, 2006, EUR J MED RES, V11, P114; Bramer S, 2010, ANN THORAC SURG, V90, P443, DOI 10.1016/j.athoracsur.2010.03.083; Budeus M, 2006, INT J CARDIOL, V106, P67, DOI 10.1016/j.ijcard.2004.12.062; Camm AJ, 1996, EUR HEART J, V17, P354; Chemla D, 2005, INT J CARDIOL, V104, P307, DOI 10.1016/j.ijcard.2004.12.018; CHEUNG DW, 1981, J PHYSIOL-LONDON, V314, P445, DOI 10.1113/jphysiol.1981.sp013718; Comtois P, 2011, CHAOS, V21, DOI 10.1063/1.3544470; Contreras AE, 2010, MEDICINA-BUENOS AIRE, V70, P339; Creswell LL, 2001, J THORAC CARDIOV SUR, V121, P638, DOI 10.1067/mtc.2001.114347; Curran J, 2007, CIRC RES, V100, P391, DOI 10.1161/01.RES.0000258172.74570.e6; David B, 2000, APPL LOGISTIC REGRES; David W., 1999, APPL SURVIVAL ANAL R; DAVIES MJ, 1972, BRIT HEART J, V34, P520; Dimmer C, 2003, EUROPACE, V5, P1, DOI 10.1053/eupc.2002.0273; Dimmer C, 1998, AM J CARDIOL, V82, P22, DOI 10.1016/S0002-9149(98)00231-8; Dube B, 2009, PHYSIOL MEAS, V30, P1303, DOI 10.1088/0967-3334/30/12/002; Echahidi N, 2007, CIRCULATION, V116, pI213, DOI 10.1161/CIRCULATIONAHA.106.681304; El-Chami MF, 2010, J AM COLL CARDIOL, V55, P1370, DOI 10.1016/j.jacc.2009.10.058; Fagard RH, 1998, ACTA CARDIOL, V53, P211; Filardo G, 2010, ANN THORAC SURG, V90, P474, DOI 10.1016/j.athoracsur.2010.02.081; FROST L, 1995, J ELECTROCARDIOL, V28, P297, DOI 10.1016/S0022-0736(05)80047-0; Fynn SP, 2003, J CARDIOVASC ELECTR, V14, P485, DOI 10.1046/j.1540-8167.2003.02388.x; Grimaldi D, 2010, CLIN NEUROPHYSIOL, V121, P1142, DOI 10.1016/j.clinph.2010.01.028; Haghjoo Majid, 2008, Indian Pacing Electrophysiol J, V8, P94; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Hakala T, 2002, EUR J CARDIO-THORAC, V22, P939, DOI 10.1016/S1010-7940(02)00565-1; Healey JS, 2003, AM J CARDIOL, V91, p9G, DOI 10.1016/S0002-9149(03)00227-3; Hogue CW, 2000, ANN THORAC SURG, V69, P300, DOI 10.1016/S0003-4975(99)01267-9; Hogue CW, 1998, CIRCULATION, V98, P429, DOI 10.1161/01.CIR.98.5.429; Hogue CW, 2005, CHEST, V128, p9S, DOI 10.1378/chest.128.2_suppl.9S; Hsu LF, 2004, CIRCULATION, V109, P828, DOI 10.1161/01.CIR.0000116753.56467.BC; Janse MJ, 2007, AM J PHYSIOL-HEART C, V292, pH2561, DOI 10.1152/ajpheart.00167.2007; Jongnarangsin K, 2009, CARDIOL CLIN, V27, P69, DOI 10.1016/j.ccl.2008.09.011; Kalavrouziotis D, 2007, CHEST, V131, P833, DOI 10.1378/chest.06-0735; KAMATH MV, 1993, CRIT REV BIOMED ENG, V21, P245; Katra RP, 2005, CIRC RES, V96, P535, DOI 10.1161/01.RES.0000159387.00749.3c; Katsouras G, 2009, HEART RHYTHM, V6, P1465, DOI 10.1016/j.hrthm.2009.07.034; Li Z, 2002, J ELECTROCARDIOL, V35, P227, DOI 10.1054/jelc.2002.33973; LIPPMAN N, 1994, AM J PHYSIOL, V267, pH411, DOI 10.1152/ajpheart.1994.267.1.H411; Lo LW, 2011, J CARDIOVASC ELECTR, V22, P1049, DOI 10.1111/j.1540-8167.2011.02029.x; Lu ZB, 2008, CIRC-ARRHYTHMIA ELEC, V1, P184, DOI 10.1161/CIRCEP.108.784272; Maisel WH, 2001, ANN INTERN MED, V135, P1061, DOI 10.7326/0003-4819-135-12-200112180-00010; Mathew JP, 2004, JAMA-J AM MED ASSOC, V291, P1720, DOI 10.1001/jama.291.14.1720; MOE GK, 1964, AM HEART J, V67, P200, DOI 10.1016/0002-8703(64)90371-0; MOE GK, 1959, AM HEART J, V58, P59, DOI 10.1016/0002-8703(59)90274-1; Motsinger Alison A, 2006, Pac Symp Biocomput, P584, DOI 10.1142/9789812701626_0054; Mueller XM, 2002, WORLD J SURG, V26, P639, DOI 10.1007/s00268-001-0296-9; Nadeau R, 2007, ANADOLU KARDIYOL DER, V7, P34; Najafi M, 2009, J THORAC CARDIOV SUR, V137, P304, DOI 10.1016/j.jtcvs.2008.08.001; Nattel S, 2011, CAN J CARDIOL, V27, P19, DOI 10.1016/j.cjca.2010.11.004; Nilsson KR, 2010, HEART, V96, P838, DOI 10.1136/hrt.2009.180182; Olgin JE, 1998, CIRCULATION, V98, P2608, DOI 10.1161/01.CIR.98.23.2608; Oliveira M, 2010, REV PORT CARDIOL, V29, P375; Oliveira M, 2009, INT J CARDIOL, V136, P130, DOI 10.1016/j.ijcard.2008.04.097; Page P, 2006, AUTON NEUROSCI-BASIC, V128, P9, DOI 10.1016/j.autneu.2005.11.006; Pellman J, 2010, J MOL CELL CARDIOL, V48, P461, DOI 10.1016/j.yjmcc.2009.09.001; Persson PB, 1997, AM J PHYSIOL-REG I, V273, pR1201, DOI 10.1152/ajpregu.1997.273.4.R1201; Pichlmaier AM, 1998, HEART, V80, P467, DOI 10.1136/hrt.80.5.467; Pichon A, 2006, J ELECTROCARDIOL, V39, P31, DOI 10.1016/j.jelectrocard.2005.08.001; Poli Samantha, 2003, Ann Ist Super Sanita, V39, P195; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; Radmehr Hassan, 2011, Acta Med Iran, V49, P89; Raman T, 2011, J THORAC CARDIOVASC; Reich DL, 2002, ANESTH ANALG, V95, P273, DOI 10.1097/00000539-200208000-00003; Rossi P, 2009, J INTERV CARD ELECTR, V24, P37, DOI 10.1007/s10840-008-9286-2; Ryu Jae Kean, 2009, Korean Circ J, V39, P93, DOI 10.4070/kcj.2009.39.3.93; Schmitt J, 2009, EUR HEART J, V30, P1038, DOI 10.1093/eurheartj/ehn579; Shah DC, 2001, J CARDIOVASC ELECTR, V12, P600, DOI 10.1046/j.1540-8167.2001.00600.x; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Silva Rogerio Gomes da, 2004, Arq Bras Cardiol, V83, P105; Singh D., 2004, Journal of Medical Engineering & Technology, V28, P263, DOI 10.1080/03091900410001662350; Sohn Gwan Hyeop, 2009, Korean Circ J, V39, P100, DOI 10.4070/kcj.2009.39.3.100; SPACH MS, 1986, CIRC RES, V58, P356, DOI 10.1161/01.RES.58.3.356; Svedjeholm R, 2000, SCAND CARDIOVASC J, V34, P516; Tan AY, 2010, J CARDIOVASC PHARM; Taylor AD, 2002, HEART, V88, P499, DOI 10.1136/heart.88.5.499; Tran CT, 2009, CARDIOLOGY, V114, P1, DOI 10.1159/000209264; Vikman S, 1999, CIRCULATION, V100, P2079, DOI 10.1161/01.CIR.100.20.2079; Waktare JEP, 2001, EUR HEART J, V22, P333, DOI 10.1053/euhj.2000.2517; Zaman AG, 2000, CIRCULATION, V101, P1403, DOI 10.1161/01.CIR.101.12.1403; Zhu DWX, 2010, HEART RHYTHM, V7, P1464, DOI 10.1016/j.hrthm.2010.07.017; Zimmermann M, 2001, J CARDIOVASC ELECTR, V12, P285, DOI 10.1046/j.1540-8167.2001.00285.x	94	2	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107919	10.1371/journal.pone.0107919	http://dx.doi.org/10.1371/journal.pone.0107919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247814	gold, Green Submitted, Green Published			2022-12-25	WOS:000342351800047
J	Benard, A; Goossens-Beumer, IJ; van Hoesel, AQ; Horati, H; Putter, H; Zeestraten, ECM; van de Velde, CJH; Kuppen, PJK				Benard, Anne; Goossens-Beumer, Ines J.; van Hoesel, Anneke Q.; Horati, Hamed; Putter, Hein; Zeestraten, Eliane C. M.; van de Velde, Cornelis J. H.; Kuppen, Peter J. K.			Prognostic Value of Polycomb Proteins EZH2, BMI1 and SUZ12 and Histone Modification H3K27me3 in Colorectal Cancer	PLOS ONE			English	Article							CELL LUNG-CANCER; BREAST-CANCER; STEM-CELLS; EXPRESSION; CARCINOMA; STAGE; COMPLEXES; SUPPRESSES; APOPTOSIS; PREDICTS	Numerous changes in epigenetic mechanisms have been described in various types of tumors. In search for new biomarkers, we investigated the expression of Polycomb-group (PcG) proteins EZH2, BMI1 and SUZ12 and associated histone modification H3K27me3 in colorectal cancer. Nuclear expression of PcG proteins and histone modification H3K27me3 were immunohistochemically (IHC) stained on a tissue microarray (TMA), including 247 tumor tissues and 47 normal tissues, and scored using the semi-automated Ariol system. Tumor tissues showed higher expression of EZH2 (p = 0.05) and H3K27me3 (p<0.001) as compared to their normal counterparts. Combined marker trend analyses indicated that an increase in the number of markers showing high expression was associated with better prognosis. High expression of all four markers in the combined marker analyses was correlated with the best patient survival and the longest recurrence-free survival, with overall survival (p = 0.01, HR 0.42(0.21-0.84)), disease-free survival (p = 0.007, HR 0.23(0.08-0.67) and local recurrence-free survival (p = 0.02, HR 0.30(0.11-0.84)). In conclusion, we found that expression of PcG proteins and H3K27me3 showed prognostic value in our study cohort. Better stratification of patients was obtained by combining the expression data of the investigated biomarkers as compared to the individual markers, underlining the importance of investigating multiple markers simultaneously.	[Benard, Anne; Goossens-Beumer, Ines J.; van Hoesel, Anneke Q.; Horati, Hamed; Zeestraten, Eliane C. M.; van de Velde, Cornelis J. H.; Kuppen, Peter J. K.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; [Putter, Hein] Leiden Univ, Med Ctr, Dept Med Stat, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Benard, A (corresponding author), Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands.	p.j.k.kuppen@lumc.nl	van de Velde, Cornelis/AAY-8360-2020; Putter, Hein/C-2244-2018; Kuppen, Peter/J-2342-2016	Putter, Hein/0000-0001-5395-1422; Kuppen, Peter/0000-0002-0294-3251				Allegra E, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-206; Aloia L, 2013, DEVELOPMENT, V140, P2525, DOI 10.1242/dev.091553; Behrens C, 2013, CLIN CANCER RES, V19, P6556, DOI 10.1158/1078-0432.CCR-12-3946; Benard A, 2013, BRIT J CANCER, V109, P3073, DOI 10.1038/bjc.2013.654; Bender S, 2013, CANCER CELL, V24, P660, DOI 10.1016/j.ccr.2013.10.006; Benoit YD, 2013, EXP CELL RES, V319, P1463, DOI 10.1016/j.yexcr.2013.04.006; Chen XH, 2013, INT J ONCOL, V43, P1467, DOI 10.3892/ijo.2013.2062; Crea F, 2012, ANN ONCOL, V23, P1207, DOI 10.1093/annonc/mdr387; Cui YJ, 2013, CELL PHYSIOL BIOCHEM, V31, P778, DOI 10.1159/000350095; de Maat MFG, 2010, CLIN CANCER RES, V16, P2811, DOI 10.1158/1078-0432.CCR-09-2717; Du JJ, 2010, MED ONCOL, V27, P1273, DOI 10.1007/s12032-009-9373-y; Edge SB, 2010, AJCC CANC STAGING MA; Fluge O, 2009, BRIT J CANCER, V101, P1282, DOI 10.1038/sj.bjc.6605333; Gialmanidis IP, 2013, LUNG, V191, P511, DOI 10.1007/s00408-013-9490-4; Ha SY, 2012, PATHOL RES PRACT, V208, P462, DOI 10.1016/j.prp.2012.05.012; He AB, 2012, GENE DEV, V26, P37, DOI 10.1101/gad.173930.111; Hinz S, 2008, TUMOR BIOL, V29, P323, DOI 10.1159/000170879; Hoeben KWJ, 2013, ANN ONCOL, V24, P974, DOI 10.1093/annonc/mds576; Holm K, 2012, MOL ONCOL, V6, P494, DOI 10.1016/j.molonc.2012.06.002; Hosogane M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003698; Li H, 2012, MOL CANCER RES, V10, P1462, DOI 10.1158/1541-7786.MCR-12-0335; Maertens GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006380; Malouf GG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r144; Manoranjan B, 2013, STEM CELLS, V31, P1266, DOI 10.1002/stem.1401; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Mu ZM, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-70; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Pietersen AM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2214; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Ruan ZP, 2013, INT J ONCOL, V42, P261, DOI 10.3892/ijo.2012.1693; Siddique HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052993; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Tong Q, 2014, J IMMUNOL, V192, P5012, DOI 10.4049/jimmunol.1302943; van den Broek CBM, 2013, ACTA ONCOL, V52, P941, DOI 10.3109/0284186X.2012.739730; van Engeland M, 2011, J CLIN ONCOL, V29, P1382, DOI 10.1200/JCO.2010.28.2319; van Nes JGH, 2011, BREAST CANCER RES TR, V125, P671, DOI 10.1007/s10549-010-0854-7; Wang CG, 2010, WORLD J GASTROENTERO, V16, P2421, DOI 10.3748/wjg.v16.i19.2421; Wu ZY, 2013, J NEUROL SCI, V335, P191, DOI 10.1016/j.jns.2013.09.030; Yonemitsu Y, 2009, HUM PATHOL, V40, P1304, DOI 10.1016/j.humpath.2009.01.017; Yoshikawa R, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-461; Zeestraten EC, 2013, BR J CANC	42	50	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e108265	10.1371/journal.pone.0108265	http://dx.doi.org/10.1371/journal.pone.0108265			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243792	Green Published, gold, Green Submitted			2022-12-25	WOS:000343679800082
J	Broekhuis, JR; Verhey, KJ; Jansen, G				Broekhuis, Joost R.; Verhey, Kristen J.; Jansen, Gert			Regulation of Cilium Length and Intraflagellar Transport by the RCK-Kinases ICK and MOK in Renal Epithelial Cells	PLOS ONE			English	Article							KINESIN-2 MOTOR KIF17; CILIARY LENGTH; PROTEIN-KINASE; FLAGELLAR LENGTH; MOLECULAR-CLONING; COMPLEX; GENE; MAK; PHOSPHORYLATION; IDENTIFICATION	Primary cilia are important sensory organelles. They exist in a wide variety of lengths, which could reflect different cell-specific functions. How cilium length is regulated is unclear, but it probably involves intraflagellar transport (IFT), which transports protein complexes along the ciliary axoneme. Studies in various organisms have identified the small, conserved family of ros-cross hybridizing kinases (RCK) as regulators of cilium length. Here we show that Intestinal Cell Kinase (ICK) and MAPK/MAK/MRK overlapping kinase (MOK), two members of this family, localize to cilia of mouse renal epithelial (IMCD-3) cells and negatively regulate cilium length. To analyze the effects of ICK and MOK on the IFT machinery, we set up live imaging of five fluorescently tagged IFT proteins: KIF3B, a subunit of kinesin-II, the main anterograde IFT motor, complex A protein IFT43, complex B protein IFT20, BBSome protein BBS8 and homodimeric kinesin KIF17, whose function in mammalian cilia is unclear. Interestingly, all five proteins moved at similar to 0.45 mu m/s in anterograde and retrograde direction, suggesting they are all transported by the same machinery. Moreover, GFP tagged ICK and MOK moved at similar velocities as the IFT proteins, suggesting they are part of, or transported by the IFT machinery. Indeed, loss-or gain-of-function of ICK affected IFT speeds: knockdown increased anterograde velocities, whereas overexpression reduced retrograde speed. In contrast, MOK knockdown or overexpression did not affect IFT speeds. Finally, we found that the effects of ICK or MOK knockdown on cilium length and IFT are suppressed by rapamycin treatment, suggesting that these effects require the mTORC1 pathway. Our results confirm the importance of RCK kinases as regulators of cilium length and IFT. However, whereas some of our results suggest a direct correlation between cilium length and IFT speed, other results indicate that cilium length can be modulated independent of IFT speed.	[Broekhuis, Joost R.; Jansen, Gert] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands; [Verhey, Kristen J.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI USA	Erasmus University Rotterdam; Erasmus MC; University of Michigan System; University of Michigan	Jansen, G (corresponding author), Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands.	g.jansen@erasmusmc.nl	Jansen, Gert/HCI-8852-2022	Jansen, Gert/0000-0002-7524-171X	National Institutes of Health [RO1 GM070862]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Dutch Kidney Foundation (http://www. nierstichting. nl, C06.2199 to GJ) and the National Institutes of Health ( http://www.nih.gov, RO1 GM070862 to KJV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 1995, ONCOGENE, V11, P2187; Arts HH, 2011, J MED GENET, V48, P390, DOI 10.1136/jmg.2011.088864; Avasthi P, 2012, DIFFERENTIATION, V83, pS30, DOI 10.1016/j.diff.2011.11.015; Bengs F, 2005, MOL MICROBIOL, V55, P1606, DOI 10.1111/j.1365-2958.2005.04498.x; Berman SA, 2003, CURR BIOL, V13, P1145, DOI 10.1016/S0960-9822(03)00415-9; Besschetnova TY, 2010, CURR BIOL, V20, P182, DOI 10.1016/j.cub.2009.11.072; BLADT F, 1993, DIFFERENTIATION, V53, P115, DOI 10.1111/j.1432-0436.1993.tb00651.x; Broekhuis JR, 2013, INT REV CEL MOL BIO, V303, P101, DOI 10.1016/B978-0-12-407697-6.00003-9; Burghoorn J, 2007, P NATL ACAD SCI USA, V104, P7157, DOI 10.1073/pnas.0606974104; Chaya T, 2014, EMBO J, V33, P1227, DOI 10.1002/embj.201488175; Dishinger JF, 2010, NAT CELL BIOL, V12, P703, DOI 10.1038/ncb2073; Doroquez DB, 2014, ELIFE, V3, DOI 10.7554/eLife.01948; Engel BD, 2012, J CELL BIOL, V199, P151, DOI 10.1083/jcb.201206068; Engel BD, 2011, CYTOSKELETON, V68, P188, DOI 10.1002/cm.20504; Engel BD, 2009, J CELL BIOL, V187, P81, DOI 10.1083/jcb.200812084; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Fu Z, 2005, MOL CELL BIOL, V25, P6047, DOI 10.1128/MCB.25.14.6047-6064.2005; Gopalan G, 1999, MOL REPROD DEV, V52, P9, DOI 10.1002/(SICI)1098-2795(199901)52:1&lt;9::AID-MRD2&gt;3.0.CO;2-O; Hammond JW, 2010, J CELL BIOL, V189, P1013, DOI 10.1083/jcb.201001057; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hilton LK, 2013, CURR BIOL, V23, P2208, DOI 10.1016/j.cub.2013.09.038; Insinna C, 2008, DEV BIOL, V316, P160, DOI 10.1016/j.ydbio.2008.01.025; Lahiry P, 2009, AM J HUM GENET, V84, P134, DOI 10.1016/j.ajhg.2008.12.017; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Ludington WB, 2013, P NATL ACAD SCI USA, V110, P3925, DOI 10.1073/pnas.1217354110; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Miyata Y, 1999, GENES CELLS, V4, P299, DOI 10.1046/j.1365-2443.1999.00261.x; Miyoshi K, 2011, ACTA MED OKAYAMA, V65, P279; Miyoshi K, 2009, BIOCHEM BIOPH RES CO, V388, P757, DOI 10.1016/j.bbrc.2009.08.099; Moon H, 2014, P NATL ACAD SCI USA, V111, P8541, DOI 10.1073/pnas.1323161111; NIGGEMANN B, 1992, EUR J PEDIATR, V151, P73, DOI 10.1007/BF02073899; Omori Y, 2010, P NATL ACAD SCI USA, V107, P22671, DOI 10.1073/pnas.1009437108; Ozgul RK, 2011, AM J HUM GENET, V89, P253, DOI 10.1016/j.ajhg.2011.07.005; Sharma N, 2011, MOL BIOL CELL, V22, P806, DOI 10.1091/mbc.E10-03-0269; Silverman MA, 2009, TRENDS CELL BIOL, V19, P306, DOI 10.1016/j.tcb.2009.04.002; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; Sohara E, 2008, J AM SOC NEPHROL, V19, P469, DOI 10.1681/ASN.2006090985; Sung CH, 2013, NAT CELL BIOL, V15, P1387, DOI 10.1038/ncb2888; Tammachote R, 2009, HUM MOL GENET, V18, P3311, DOI 10.1093/hmg/ddp272; Togawa K, 2000, J CELL PHYSIOL, V183, P129, DOI 10.1002/(SICI)1097-4652(200004)183:1<129::AID-JCP15>3.0.CO;2-S; Tucker BA, 2011, P NATL ACAD SCI USA, V108, pE569, DOI 10.1073/pnas.1108918108; Van den Eynde B, 1999, J EXP MED, V190, P1793, DOI 10.1084/jem.190.12.1793; Weber JD, 2012, CELL CYCLE, V11, P236, DOI 10.4161/cc.11.2.19022; Wu D, 2012, J BIOL CHEM, V287, P12510, DOI 10.1074/jbc.M111.302117; Xia L, 2002, J BIOL CHEM, V277, P35422, DOI 10.1074/jbc.M203940200; Yang T, 2002, BIOMOL ENG, V19, P1, DOI 10.1016/S1389-0344(02)00002-3; Yang Y, 2013, EMBO REP, V14, P741, DOI 10.1038/embor.2013.80; Ye F, 2013, ELIFE, V2, DOI 10.7554/eLife.00654; Yuan SAL, 2012, P NATL ACAD SCI USA, V109, P2021, DOI 10.1073/pnas.1112834109	49	55	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e108470	10.1371/journal.pone.0108470	http://dx.doi.org/10.1371/journal.pone.0108470			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243405	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800090
J	Song, SJ; Zhang, XY; Wu, HH; Han, Y; Zhang, JZ; Ma, EB; Guo, YP				Song, Shaojuan; Zhang, Xueyao; Wu, Haihua; Han, Yan; Zhang, Jianzhen; Ma, Enbo; Guo, Yaping			Molecular Basis for Antioxidant Enzymes in Mediating Copper Detoxification in the Nematode Caenorhabditis elegans	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; LIFE-SPAN; DAMAGE THEORY; C. ELEGANS; TOXICITY; RESPONSES; MUTANTS; AGE-1; ACTIVATION; RESISTANCE	Antioxidant enzymes play a major role in defending against oxidative damage by copper. However, few studies have been performed to determine which antioxidant enzymes respond to and are necessary for copper detoxification. In this study, we examined both the activities and mRNA levels of SOD, CAT, and GPX under excessive copper stress in Caenorhabditis elegans, which is a powerful model for toxicity studies. Then, taking advantage of the genetics of this model, we assessed the lethal concentration (LC50) values of copper for related mutant strains. The results showed that the SOD, CAT, and GPX activities were significantly greater in treated groups than in controls. The mRNA levels of sod-3, sod-5, ctl-1, ctl-2, and almost all gpx genes were also significantly greater in treated groups than in controls. Among tested mutants, the sod-5, ctl-1, gpx-3, gpx-4, and gpx-6 variants exhibited hypersensitivity to copper. The strains with SOD or CAT over expression were reduced sensitive to copper. Mutations in daf-2 and age-1, which are involved in the insulin/insulin-like growth factor-1 signaling pathway, result in reduced sensitivity to stress. Here, we showed that LC50 values for copper in daf-2 and age-1 mutants were significantly greater than in N2 worms. However, the LC50 values in daf-16; daf-2 and daf-16; age-1 mutants were significantly reduced than in daf-2 and age-1 mutants, implying that reduced copper sensitivity is influenced by DAF-16-related functioning. SOD, CAT, and GPX activities and the mRNA levels of the associated copper responsive genes were significantly increased in daf-2 and age-1 mutants compared to N2. Additionally, the activities of SOD, CAT, and GPX were greater in these mutants than in N2 when treated with copper. Our results not only support the theory that antioxidant enzymes play an important role in copper detoxification but also identify the response and the genes involved in these processes.	[Song, Shaojuan; Zhang, Xueyao; Wu, Haihua; Zhang, Jianzhen; Ma, Enbo] Shanxi Univ, Inst Appl Biol, Taiyuan, Shanxi, Peoples R China; [Han, Yan; Guo, Yaping] Shanxi Univ, Sch Life Sci, Taiyuan, Shanxi, Peoples R China	Shanxi University; Shanxi University	Ma, EB (corresponding author), Shanxi Univ, Inst Appl Biol, Taiyuan, Shanxi, Peoples R China.	maenbo2003@sxu.edu.cn; guoyp1955@163.com			National Natural Science Foundation of China [31071980, 31201548]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Natural Science Foundation of China (YP, G: 31071980; HH, W: 31201548). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsyte D, 2001, FASEB J, V15, P627, DOI 10.1096/fj.99-0966com; Benner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025624; Boveris A, 2012, J INORG BIOCHEM, V116, P63, DOI 10.1016/j.jinorgbio.2012.07.004; Boyd Windy A, 2012, Methods Mol Biol, V889, P15, DOI 10.1007/978-1-61779-867-2_3; Boyd WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007024; BRENNER S, 1974, GENETICS, V77, P71; Chu KW, 2005, AQUAT TOXICOL, V74, P320, DOI 10.1016/j.aquatox.2005.06.006; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gems D, 2009, CELL CYCLE, V8, P1681, DOI 10.4161/cc.8.11.8595; GOTH L, 1991, CLIN CHIM ACTA, V196, P143, DOI 10.1016/0009-8981(91)90067-M; Hall J, 2012, TOXICOL SCI, V128, P418, DOI 10.1093/toxsci/kfs166; Hedges KA, 2010, THESIS HUMBOLDT STAT; Heidler T, 2010, BIOGERONTOLOGY, V11, P183, DOI 10.1007/s10522-009-9239-x; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Houthoofd K, 2005, AGING CELL, V4, P87, DOI 10.1111/j.1474-9726.2005.00150.x; Jiang WD, 2011, AQUAT TOXICOL, V105, P543, DOI 10.1016/j.aquatox.2011.08.012; Jin YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000053; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Jonker MJ, 2004, ENVIRON TOXICOL CHEM, V23, P1529, DOI 10.1897/03-49; Li M, 2006, CHEMOSPHERE, V62, P565, DOI 10.1016/j.chemosphere.2005.06.029; Li Ya-juan, 2012, Huanjing Kexue, V33, P2368; Lushchak VI, 2011, AQUAT TOXICOL, V101, P13, DOI 10.1016/j.aquatox.2010.10.006; Maria VL, 2013, AQUAT TOXICOL, V144, P284, DOI 10.1016/j.aquatox.2013.10.009; Mattie MD, 2008, J MOL BIOL, V383, P1008, DOI 10.1016/j.jmb.2008.08.080; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; McElwee MK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-698; McElwee MK, 2011, ENVIRON TOXICOL CHEM, V30, P2135, DOI 10.1002/etc.603; McElwee MK, 2009, J MOL BIOL, V393, P1013, DOI 10.1016/j.jmb.2009.08.077; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Mosleh YY, 2006, CHEMOSPHERE, V64, P121, DOI 10.1016/j.chemosphere.2005.10.045; Mostofa MG, 2013, ECOTOXICOLOGY, V22, P959, DOI 10.1007/s10646-013-1073-x; ORR WC, 1992, ARCH BIOCHEM BIOPHYS, V297, P35, DOI 10.1016/0003-9861(92)90637-C; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Petriv OI, 2004, J BIOL CHEM, V279, P19996, DOI 10.1074/jbc.M400207200; Pham AN, 2013, J CATAL, V301, P54, DOI 10.1016/j.jcat.2013.01.025; Portman D. S., 2006, WORMBOOK WORMBOOK; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Rice JR, 2014, ENVIRON TOXICOL CHEM, V33, P82, DOI 10.1002/etc.2394; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Song MO, 2014, EXP CELL RES, V322, P39, DOI 10.1016/j.yexcr.2014.01.013; Song MO, 2011, BBA-MOL CELL RES, V1813, P102, DOI 10.1016/j.bbamcr.2010.09.009; Song MO, 2009, PHYSIOL GENOMICS, V38, P386, DOI 10.1152/physiolgenomics.00083.2009; [宋少娟 SONG Shaojuan], 2008, [四川动物, Sichuan Journal of Zoology], V27, P832; Srivastava S, 2006, AQUAT TOXICOL, V80, P405, DOI 10.1016/j.aquatox.2006.10.006; Stuerzenbaum Stephen, 2012, Frontiers in Genetics, V3, P216, DOI 10.3389/fgene.2012.00216; Tatara CP, 1998, AQUAT TOXICOL, V42, P255, DOI 10.1016/S0166-445X(97)00104-5; Trevisan R, 2011, AQUAT TOXICOL, V101, P64, DOI 10.1016/j.aquatox.2010.09.003; Tvermoes BE, 2010, J CELL SCI, V123, P2123, DOI 10.1242/jcs.065433; VANFLETEREN JR, 1995, FASEB J, V9, P1355, DOI 10.1096/fasebj.9.13.7557026; Vigneshkumar B, 2013, ENVIRON TOXICOL, V28, P313, DOI 10.1002/tox.20722; WILLIAMS PL, 1990, ENVIRON TOXICOL CHEM, V9, P1285, DOI [10.1897/1552-8618(1990)9[1285:ATTUTN]2.0.CO;2, 10.1002/etc.5620091007]; Wu F, 2011, ENVIRON EARTH SCI, V64, P761, DOI 10.1007/s12665-010-0897-4; Xiaochun P, 2012, HUBEI AGR SCI, V51, P250; Yanase S, 2002, MECH AGEING DEV, V123, P1579, DOI 10.1016/S0047-6374(02)00093-3; [杨慧敏 Yang Huimin], 2012, [四川动物, Sichuan Journal of Zoology], V31, P236; Yu ZY, 2012, CHEMOSPHERE, V87, P1361, DOI 10.1016/j.chemosphere.2012.02.029	58	21	24	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107685	10.1371/journal.pone.0107685	http://dx.doi.org/10.1371/journal.pone.0107685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243607	Green Submitted, Green Published, gold			2022-12-25	WOS:000343679800044
J	Zhong, BS; Zhang, YL; Yan, YB; Wang, ZY; Ying, SJ; Huang, MR; Wang, F				Zhong, Bushuai; Zhang, Yanli; Yan, Yibo; Wang, Ziyu; Ying, Shijia; Huang, Mingrui; Wang, Feng			MicroRNA-Mediated Myostatin Silencing in Caprine Fetal Fibroblasts	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; SHORT HAIRPIN RNAS; TARGET MESSENGER-RNAS; NUCLEAR EXPORT; GENE; EXPRESSION; INTERFERENCE; SHEEP; INHIBITION; MYOBLASTS	Myostatin functions as a negative regulator of skeletal muscle growth by suppressing proliferation and differentiation of myoblasts. Dysfunction of the myostatin gene, either due to natural mutation or genetic manipulations such as knockout or knockdown, has been reported to increase muscle mass in mammalian species. RNA interference (RNAi) mediated by microRNAs (miRNAs) is a promising method for gene knockdown studies. In the present study, transient and stable silencing of the myostatin gene in caprine fetal fibroblasts (CFF) was evaluated using the two most effective constructs selected from four different miRNA expression constructs screened in 293FT cells. Using these two miRNA constructs, we achieved up to 84% silencing of myostatin mRNA in transiently transfected CFF cells and up to 31% silencing in stably transfected CFF cells. Moreover, off-target effects due to induction of interferon (IFN) response genes, such as interferon beta (IFN-beta) and 2'-5'-oligoadenylate synthetase 2 (OAS2), were markedly fewer in stably transfected CFF cells than in transiently transfected cells. Stable expression of anti-myostatin miRNA with minimal induction of interferon shows great promise for increasing muscle mass in transgenic goats.	[Zhong, Bushuai; Zhang, Yanli; Yan, Yibo; Wang, Ziyu; Huang, Mingrui; Wang, Feng] Nanjing Agr Univ, Jiangsu Livestock Embryo Engn Lab, Nanjing, Jiangsu, Peoples R China; [Zhong, Bushuai; Zhang, Yanli; Ying, Shijia; Wang, Feng] Nanjing Agr Univ, Jiangsu Engn Technol Res Ctr Meat Sheep & Goat In, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University	Huang, MR (corresponding author), Nanjing Agr Univ, Jiangsu Livestock Embryo Engn Lab, Nanjing, Jiangsu, Peoples R China.	hmr@njau.edu.cn; caeet@njau.edu.cn			National Major Special Projects on New Cultivation for Transgenic Organisms [2013ZX08008-003]; National Science and Technology program [2011BAD19B02]; National Natural Science Foundation of China [31272443]	National Major Special Projects on New Cultivation for Transgenic Organisms; National Science and Technology program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by National Major Special Projects on New Cultivation for Transgenic Organisms (2013ZX08008-003), the National Science and Technology program (2011BAD19B02) and National Natural Science Foundation of China (31272443). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ambros Victor, 2004, Methods Mol Biol, V265, P131; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Borel Florie, 2011, J RNAi Gene Silencing, V7, P434; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Giering JC, 2008, MOL THER, V16, P1630, DOI 10.1038/mt.2008.144; Grimm D, 2007, J CLIN INVEST, V117, P3633, DOI 10.1172/JCI34129; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hu SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058521; Hu SW, 2011, BIOTECHNOL LETT, V33, P1949, DOI 10.1007/s10529-011-0667-8; Huang ZQ, 2012, BIOCHEM BIOPH RES CO, V423, P265, DOI 10.1016/j.bbrc.2012.05.106; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jadhav V, 2012, BIOTECHNOL BIOENG, V109, P1376, DOI 10.1002/bit.24490; Jain H, 2010, J BIOTECHNOL, V145, P99, DOI 10.1016/j.jbiotec.2009.10.017; Jiao J, 2011, J ANIM SCI, V89, P3099, DOI 10.2527/jas.2010-3827; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu CX, 2012, BIOCHEM BIOPH RES CO, V422, P381, DOI 10.1016/j.bbrc.2012.04.151; Liu YP, 2008, NUCLEIC ACIDS RES, V36, P2811, DOI 10.1093/nar/gkn109; Liu YP, 2009, MOL THER, V17, P1712, DOI 10.1038/mt.2009.176; Lu J, 2013, MOL BIOL REP, V40, P4101, DOI 10.1007/s11033-013-2494-6; Lu J, 2012, BIOCHEM GENET, V50, P838, DOI 10.1007/s10528-012-9524-2; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Magee TR, 2006, J GENE MED, V8, P1171, DOI 10.1002/jgm.946; Manjunath N, 2009, ADV DRUG DELIVER REV, V61, P732, DOI 10.1016/j.addr.2009.03.004; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Raad H, 2013, FREE RADICAL BIO MED, V56, P216, DOI 10.1016/j.freeradbiomed.2012.09.003; Rios R, 2004, ENDOCRINOLOGY, V145, P2795, DOI 10.1210/en.2003-1166; Roberts TC, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.15; Sato F, 2006, AM J PHYSIOL-CELL PH, V291, pC538, DOI 10.1152/ajpcell.00543.2005; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Singh SK, 2011, PHARM RES-DORDR, V28, P873, DOI 10.1007/s11095-010-0343-z; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Stewart CK, 2008, BIOCHEM BIOPH RES CO, V370, P113, DOI 10.1016/j.bbrc.2008.03.041; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; Subramanyam D, 2011, CURR OPIN GENET DEV, V21, P498, DOI 10.1016/j.gde.2011.04.011; Tang DY, 2012, J BIOTECHNOL, V158, P69, DOI 10.1016/j.jbiotec.2012.01.008; Tessanne K, 2012, MOL REPROD DEV, V79, P176, DOI 10.1002/mrd.22007; Tripathi AK, 2011, J MUSCLE RES CELL M, V32, P23, DOI 10.1007/s10974-011-9245-x; Tripathi AK, 2012, J BIOTECHNOL, V160, P140, DOI 10.1016/j.jbiotec.2012.03.001; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Wiener P, 2002, GENET SEL EVOL, V34, P221, DOI [10.1186/1297-9686-34-2-221, 10.1051/gse:2002005]; Xiao SQ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-491; Yi R, 2005, RNA, V11, P220, DOI 10.1261/rna.7233305; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zhu XL, 2000, FEBS LETT, V474, P71, DOI 10.1016/S0014-5793(00)01570-2	59	2	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107071	10.1371/journal.pone.0107071	http://dx.doi.org/10.1371/journal.pone.0107071			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244645	Green Submitted, Green Published, gold			2022-12-25	WOS:000343679800017
J	Buhrmann, C; Kraehe, P; Lueders, C; Shayan, P; Goel, A; Shakibaei, M				Buhrmann, Constanze; Kraehe, Patricia; Lueders, Cora; Shayan, Parviz; Goel, Ajay; Shakibaei, Mehdi			Curcumin Suppresses Crosstalk between Colon Cancer Stem Cells and Stromal Fibroblasts in the Tumor Microenvironment: Potential Role of EMT	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; CHRONIC LYMPHOCYTIC-LEUKEMIA; FACTOR-KAPPA-B; E-CADHERIN EXPRESSION; GROWTH-FACTOR-BETA; COLORECTAL-CANCER; TGF-BETA; IN-VITRO; DIFFERENTIATION; ACTIVATION	Objective: Interaction of stromal and tumor cells plays a dynamic role in initiating and enhancing carcinogenesis. In this study, we investigated the crosstalk between colorectal cancer (CRC) cells with stromal fibroblasts and the anti-cancer effects of curcumin and 5-Fluorouracil (5-FU), especially on cancer stem cell (CSC) survival in a 3D-co-culture model that mimics in vivo tumor microenvironment. Methods: Colon carcinoma cells HCT116 and MRC-5 fibroblasts were co-cultured in a monolayer or high density tumor microenvironment model in vitro with/without curcumin and/or 5-FU. Results: Monolayer tumor microenvironment co-cultures supported intensive crosstalk between cancer cells and fibroblasts and enhanced up-regulation of metastatic active adhesion molecules (beta 1-integrin, ICAM-1), transforming growth factor-beta signaling molecules (TGF-beta 3, p-Smad2), proliferation associated proteins (cyclin D1, Ki-67) and epithelial-to-mesenchymal transition (EMT) factor (vimentin) in HCT116 compared with tumor mono-cultures. High density tumor microenvironment co-cultures synergistically increased tumor-promoting factors (NF-kappa B, MMP-13), TGF-beta 3, favored CSC survival (characterized by up-regulation of CD133, CD44, ALDH1) and EMT-factors (increased vimentin and Slug, decreased E-cadherin) in HCT116 compared with high density HCT116 mono-cultures. Interestingly, this synergistic crosstalk was even more pronounced in the presence of 5-FU, but dramatically decreased in the presence of curcumin, inducing biochemical changes to mesenchymal-epithelial transition (MET), thereby sensitizing CSCs to 5-FU treatment. Conclusion: Enrichment of CSCs, remarkable activation of tumor-promoting factors and EMT in high density co-culture highlights that the crosstalk in the tumor microenvironment plays an essential role in tumor development and progression, and this interaction appears to be mediated at least in part by TGF-beta and EMT. Modulation of this synergistic crosstalk by curcumin might be a potential therapy for CRC and suppress metastasis.	[Buhrmann, Constanze; Kraehe, Patricia; Shakibaei, Mehdi] Univ Munich, Inst Anat, Munich, Germany; [Lueders, Cora] German Heart Inst, Lab Tissue Engn, Dept Thorac & Cardiovasc Surg, Berlin, Germany; [Shayan, Parviz] Invest Inst Mol Biol Syst Transfer, Tehran, Iran; [Shayan, Parviz] Univ Tehran, Fac Vet Med, Dept Parasitol, Tehran, Iran; [Goel, Ajay] Baylor Univ, Med Ctr, Baylor Res Inst, Gastrointestinal Canc Res Lab,Div Gastroenterol, Dallas, TX 75207 USA	University of Munich; German Heart Center Berlin; University of Tehran; Baylor Scott & White Health; Baylor University; Baylor University Medical Center	Goel, A (corresponding author), Baylor Univ, Med Ctr, Baylor Res Inst, Gastrointestinal Canc Res Lab,Div Gastroenterol, Dallas, TX 75207 USA.	ajay.goel@baylorhealth.edu; mehdi.shakibaei@med.uni-muenchen.de	Prof. Dr. Shakibaei, Mehdi/AAA-7004-2020	Prof. Dr. Shakibaei, Mehdi/0000-0002-6304-7506; Goel, Ajay/0000-0003-1396-6341; Buhrmann, Constanze/0000-0002-0786-0463				Abdul Khalek Feras J, 2010, Gastrointest Cancer Res, pS16; Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Bartolome R. A., 2013, ONCOGENE; Bharti AC, 2002, ANN NY ACAD SCI, V973, P392, DOI 10.1111/j.1749-6632.2002.tb04671.x; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Boman BM, 2008, J CLIN ONCOL, V26, P2828, DOI 10.1200/JCO.2008.17.6941; Bonnomet A, 2012, ONCOGENE, V31, P3741, DOI 10.1038/onc.2011.540; Boral Debasish, 2012, Front Biosci (Elite Ed), V4, P2502; Buggins AGS, 2010, CANCER RES, V70, P7523, DOI 10.1158/0008-5472.CAN-10-1634; Buhrmann C, 2011, J BIOL CHEM, V286, P28556, DOI 10.1074/jbc.M111.256180; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; De Carlo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069760; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; DIMANCHEBOITREL MT, 1994, INT J CANCER, V56, P512, DOI 10.1002/ijc.2910560410; Du BY, 2006, CHEMOTHERAPY, V52, P23, DOI 10.1159/000090238; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Gout S, 2008, CANCER MICROENVIRON, V1, P69, DOI 10.1007/s12307-008-0007-2; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Gunasinghe NPAD, 2012, CANCER METAST REV, V31, P469, DOI 10.1007/s10555-012-9377-5; Halttunen T, 1996, GASTROENTEROLOGY, V111, P1252, DOI 10.1053/gast.1996.v111.pm8898639; Hsu RYC, 2011, CANCER RES, V71, P1989, DOI 10.1158/0008-5472.CAN-10-2833; Huang MY, 2010, ONCOL REP, V24, P1241, DOI 10.3892/or_00000978; Javelaud D, 2005, ONCOGENE, V24, P7624, DOI 10.1038/sj.onc.1208900; Jemal Ahmedin, 2009, V471, P3, DOI 10.1007/978-1-59745-416-2_1; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kanwar SS, 2011, PHARM RES-DORDR, V28, P827, DOI 10.1007/s11095-010-0336-y; Kim HI, 2008, CANCER PREV RES, V1, P385, DOI 10.1158/1940-6207.CAPR-08-0087; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Langenskiold M, 2013, SCAND J GASTROENTERO, V48, P563, DOI 10.3109/00365521.2012.708939; Le NH, 2008, BRIT J CANCER, V98, P1886, DOI 10.1038/sj.bjc.6604401; Lee CW, 2007, AM J PHYSIOL-LUNG C, V292, pL799, DOI 10.1152/ajplung.00311.2006; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li CY, 2013, TUMOR BIOL, V34, P735, DOI 10.1007/s13277-012-0601-2; Li HC, 2007, J CELL BIOCHEM, V101, P805, DOI 10.1002/jcb.21159; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Mukaratirwa S, 2005, INT J EXP PATHOL, V86, P219, DOI 10.1111/j.0959-9673.2005.00425.x; Mukhopadhyay A, 2001, ONCOGENE, V20, P7597, DOI 10.1038/sj.onc.1204997; Park JS, 2009, ANTICANCER RES, V29, P355; Patel BB, 2008, INT J CANCER, V122, P267, DOI 10.1002/ijc.23097; Patten PEM, 2008, BLOOD, V111, P5173, DOI 10.1182/blood-2007-08-108605; Pepper C, 2011, CELL PROLIFERAT, V44, P380, DOI 10.1111/j.1365-2184.2011.00760.x; Pin AL, 2011, CANCER MICROENVIRON, V4, P127, DOI 10.1007/s12307-011-0070-y; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Pourreyron C, 2003, INT J CANCER, V104, P28, DOI 10.1002/ijc.10898; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC183, DOI 10.1152/ajpcell.1999.277.2.C183; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Schiavoni G, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00090; Shakibaei M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085397; Shakibaei M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057218; Shehzad A, 2013, BIOFACTORS, V39, P56, DOI 10.1002/biof.1068; Shephard P, 2004, AM J PATHOL, V164, P2055, DOI 10.1016/S0002-9440(10)63764-9; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Swartz MA, 2012, CANCER RES, V72, P2473, DOI 10.1158/0008-5472.CAN-12-0122; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Todaro M, 2010, GASTROENTEROLOGY, V138, P2151, DOI 10.1053/j.gastro.2009.12.063; Vaiopoulos AG, 2013, J MOL MED BERL; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Xue X, 2013, CARCINOGENESIS, V34, P163, DOI 10.1093/carcin/bgs313; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yu YJ, 2009, TRANSL ONCOL, V2, P321, DOI 10.1593/tlo.09193; Zhang N, 2008, MOLECULES, V13, P1551, DOI 10.3390/molecules13081551	77	97	107	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107514	10.1371/journal.pone.0107514	http://dx.doi.org/10.1371/journal.pone.0107514			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238234	gold, Green Published, Green Submitted			2022-12-25	WOS:000342491600031
J	Le Bourgot, C; Ferret-Bernard, S; Le Normand, L; Savary, G; Menendez-Aparicio, E; Blat, S; Appert-Bossard, E; Respondek, F; Le Huerou-Luron, I				Le Bourgot, Cindy; Ferret-Bernard, Stephanie; Le Normand, Laurence; Savary, Gerard; Menendez-Aparicio, Enrique; Blat, Sophie; Appert-Bossard, Emmanuelle; Respondek, Frederique; Le Huerou-Luron, Isabelle			Maternal Short-Chain Fructooligosaccharide Supplementation Influences Intestinal Immune System Maturation in Piglets	PLOS ONE			English	Article							DIETARY FRUCTOOLIGOSACCHARIDES; FRUCTO-OLIGOSACCHARIDE; INSULIN SENSITIVITY; COLONIC MICROBIOTA; IMMUNOGLOBULIN-A; INTERFERON-GAMMA; TGF-BETA; EXPRESSION; PREGNANCY; CELLS	Peripartum nutrition is crucial for developing the immune system of neonates. We hypothesized that maternal short-chain fructooligosaccharide (scFOS) supplementation could accelerate the development of intestinal immunity in offspring. Thirty-four sows received a standard or a scFOS supplemented diet (10 g scFOS/d) for the last 4 weeks of gestation and the 4 weeks of lactation. Colostrum and milk immunoglobulins (Ig) and TGF beta 1 concentrations were evaluated on the day of delivery and at d 6 and d 21 postpartum. Piglet intestinal structure, the immunologic features of jejunal and ileal Peyer's patches, and mesenteric lymph node cells were analysed at postnatal d 21. Short-chain fatty acid concentrations were measured over time in the intestinal contents of suckling and weaned piglets. Colostral IgA (P<0.05) significantly increased because of scFOS and TGF beta 1 concentrations tended to improve (P<0.1). IFN gamma secretion by stimulated Peyer's patch and mesenteric lymph node cells, and secretory IgA production by unstimulated Peyer's patch cells were increased (P<0.05) in postnatal d 21 scFOS piglets. These differences were associated with a higher proportion of activated CD25+CD4 alpha+ T cells among the CD4+ helper T lymphocytes (P<0.05) as assessed by flow cytometry. IFN gamma secretion was positively correlated with the population of activated T lymphocytes (P<0.05). Total short-chain fatty acids were unchanged between groups during lactation but were higher in caecal contents of d 90 scFOS piglets (P<0.05); specifically propionate, butyrate and valerate. In conclusion, we demonstrated that maternal scFOS supplementation modified the intestinal immune functions in piglets in association with increased colostral immunity. Such results underline the key role of maternal nutrition in supporting the postnatal development of mucosal immunity.	[Le Bourgot, Cindy; Ferret-Bernard, Stephanie; Le Normand, Laurence; Savary, Gerard; Menendez-Aparicio, Enrique; Blat, Sophie; Le Huerou-Luron, Isabelle] INRA UR1341 ADNC, St Gilles, France; [Appert-Bossard, Emmanuelle; Respondek, Frederique] Tereos Syral, Markolsheim, France	INRAE	Le Huerou-Luron, I (corresponding author), INRA UR1341 ADNC, St Gilles, France.	isabelle.luron@rennes.inra.fr	Ferret-Bernard, Stéphanie/AAD-4465-2019	Ferret-Bernard, Stéphanie/0000-0002-1439-9206; Luron, Isabelle/0000-0002-1769-5246	company Beghin-Meiji	company Beghin-Meiji	The study was supported by the company Beghin-Meiji. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Adlerberth I, 2009, ACTA PAEDIATR, V98, P229, DOI 10.1111/j.1651-2227.2008.01060.x; Adogony V, 2007, J ANIM PHYSIOL AN N, V91, P169, DOI 10.1111/j.1439-0396.2007.00688.x; Ando T, 2007, J ALLERGY CLIN IMMUN, V120, P916, DOI 10.1016/j.jaci.2007.05.023; Arredouani M, 2003, IMMUNOLOGY, V108, P144, DOI 10.1046/j.1365-2567.2003.01569.x; Bakker-Zierikzee AM, 2005, BRIT J NUTR, V94, P783, DOI 10.1079/BJN20051451; Berg EL, 2005, J ANIM SCI, V83, P1549; Brandtzaeg F, 1998, DEV BIOLOGICALS, V92, P93; Brandtzaeg P, 2003, INT J MED MICROBIOL, V293, P3, DOI 10.1078/1438-4221-00241; Cecchini DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072766; Czech A, 2010, POL J VET SCI, V13, P525; De Vuyst L, 2013, J APPL MICROBIOLOGY; Delmee E, 2006, LIFE SCI, V79, P1007, DOI 10.1016/j.lfs.2006.05.013; Desbuards N, 2012, BRIT J NUTR, V107, P1245, DOI 10.1017/S0007114511004363; Donnet-Hughes A, 2000, IMMUNOL CELL BIOL, V78, P74, DOI 10.1046/j.1440-1711.2000.00882.x; Dourmad JY, 1996, J ANIM SCI, V74, P2211; Fujiwara R, 2008, BRIT J NUTR, V99, P1174, DOI 10.1017/S0007114507862349; Fujiwara R, 2010, BRIT J NUTR, V103, P530, DOI 10.1017/S000711450999198X; Gibson GR, 2004, NUTR RES REV, V17, P259, DOI 10.1079/NRR200479; Gourbeyre P, 2012, J AGR FOOD CHEM, V60, P11942, DOI 10.1021/jf3036403; Harris NL, 2006, J IMMUNOL, V177, P6256, DOI 10.4049/jimmunol.177.9.6256; Haverson K, 2009, INT ARCH ALLERGY IMM, V150, P192, DOI 10.1159/000218123; Hedemann MS, 2009, BRIT J NUTR, V102, P117, DOI 10.1017/S0007114508143549; Hosono A, 2003, BIOSCI BIOTECH BIOCH, V67, P758, DOI 10.1271/bbb.67.758; HOWARD MD, 1995, J NUTR, V125, P2604; Ibnou-Zekri N, 2003, INFECT IMMUN, V71, P428, DOI 10.1128/IAI.71.1.428-436.2003; Iijima H, 2001, REV MED VIROL, V11, P117, DOI 10.1002/rmv.307; Inman C. F., 2005, Pig Journal, V55, P211; JOUANY JP, 1981, REPROD NUTR DEV, V21, P871, DOI 10.1051/rnd:19810701; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kelly D, 2000, P NUTR SOC, V59, P177, DOI 10.1017/S0029665100000197; Konkel JE, 2011, TRENDS MOL MED, V17, P668, DOI 10.1016/j.molmed.2011.07.002; LEWIS DB, 1986, J EXP MED, V163, P1018, DOI 10.1084/jem.163.4.1018; Makino H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078331; Manhart N, 2003, NUTRITION, V19, P657, DOI 10.1016/S0899-9007(03)00059-5; Marodi Laszlo, 2001, Pediatric Research, V49, P316; Nakamura Y, 2004, CLIN EXP IMMUNOL, V137, P52, DOI 10.1111/j.1365-2249.2004.02487.x; Nakanishi Y, 2005, CYTOTECHNOLOGY, V47, P69, DOI 10.1007/s10616-005-3776-1; Nguyen TV, 2007, VET IMMUNOL IMMUNOP, V117, P236, DOI 10.1016/j.vetimm.2007.02.013; Niers LEM, 2007, CLIN EXP IMMUNOL, V149, P344, DOI 10.1111/j.1365-2249.2007.03421.x; Pan XD, 2009, J ZHEJIANG UNIV-SC B, V10, P258, DOI 10.1631/jzus.B0820261; Pere MC, 2007, J ANIM SCI, V85, P101, DOI 10.2527/jas.2006-130; Perez PF, 2007, PEDIATRICS, V119, pE724, DOI 10.1542/peds.2006-1649; Peroni DG, 2009, PEDIAT ALLERG IMM-UK, V20, P42, DOI 10.1111/j.1399-3038.2008.00737.x; Respondek F, 2008, J NUTR, V138, P1712, DOI 10.1093/jn/138.9.1712; Respondek F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071026; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Salmon H, 1999, VET IMMUNOL IMMUNOP, V72, P143, DOI 10.1016/S0165-2427(99)00127-0; Salmon H, 2009, DEV COMP IMMUNOL, V33, P384, DOI 10.1016/j.dci.2008.07.007; Scholtens PAMJ, 2008, J NUTR, V138, P1141, DOI 10.1093/jn/138.6.1141; Shadid R, 2007, AM J CLIN NUTR, V86, P1426, DOI 10.1093/ajcn/86.5.1426; Swanson KS, 2002, J NUTR, V132, P980, DOI 10.1093/jn/132.5.980; Tourais-Esteves I, 2008, DEV COMP IMMUNOL, V32, P1231, DOI 10.1016/j.dci.2008.03.011; Tsukahara T, 2003, J NUTR SCI VITAMINOL, V49, P414, DOI 10.3177/jnsv.49.414; Verhasselt V, 2008, NAT MED, V14, P170, DOI 10.1038/nm1718; WILSON CB, 1986, J CLIN INVEST, V77, P860, DOI 10.1172/JCI112383	56	46	47	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107508	10.1371/journal.pone.0107508	http://dx.doi.org/10.1371/journal.pone.0107508			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238157	Green Published, Green Submitted, gold			2022-12-25	WOS:000342491600030
J	Xu, WL; Wang, ZX; Liu, Y				Xu, Wenlong; Wang, Zixing; Liu, Yin			The Characterization of microRNA-Mediated Gene Regulation as Impacted by Both Target Site Location and Seed Match Type	PLOS ONE			English	Article							TRANSLATIONAL REPRESSION; PROTEIN; DATABASE; BIOGENESIS; EXPRESSION; PREDICTION	MicroRNAs (miRNAs) are small RNA molecules that play important roles in gene regulation and translational repression. The mechanisms that facilitate miRNA target binding and recognition have been extensively studied in recent years. However, it is still not well known how the miRNA regulation is affected by the location and the flanking sequences of miRNA target sites. In this study, we systematically quantify the contribution of a wide spectrum of target sites on miRNA-mediated gene expression regulation. Our study investigates target sites located in four different gene regions, including 3' untranslated regions, coding sequences, 59 untranslated regions and promoter regions. We have also introduced four additional non-canonical types of seed matches beyond the canonical seed matches, and included them in our study. Computational analysis of quantitative proteomic data has demonstrated that target sites located in different regions impact the miRNA-mediated repression differently but synergistically. In addition, we have shown the synergistic effects among non-canonical seed matches and canonical ones that enhance the miRNA regulatory effects. Further systematic analysis on the site accessibility near the target regions and the secondary structure of the mRNA sequences have demonstrated substantial variations among target sites of different locations and of different types of seed matches, suggesting the mRNA secondary structure could explain some of the difference in the miRNA regulatory effects impacted by these different target sites. Our study implies miRNAs might regulate their targets under different mechanisms when target sites vary in both their locations and the types of seed matches they contain.	[Xu, Wenlong; Wang, Zixing; Liu, Yin] Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, Houston, TX 77030 USA; [Liu, Yin] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Liu, Y (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, Houston, TX 77030 USA.	Yin.Liu@uth.tmc.edu			NIH [R01 LM010022]; University of Texas Health Science Center at Houston; NATIONAL LIBRARY OF MEDICINE [R01LM010022] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Health Science Center at Houston; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work is supported in part by NIH grant R01 LM010022 and the seed grant from the University of Texas Health Science Center at Houston. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018067; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gu WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063403; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hausser J, 2013, GENOME RES, V23, P604, DOI 10.1101/gr.139758.112; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004527; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu CC, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt435; Megraw M, 2007, NUCLEIC ACIDS RES, V35, pD149, DOI 10.1093/nar/gkl904; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; Piriyapongsa J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033888; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Schnall-Levin M, 2011, GENOME RES, V21, P1395, DOI 10.1101/gr.121210.111; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shahi P, 2006, NUCLEIC ACIDS RES, V34, pD115, DOI 10.1093/nar/gkj093; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Wang ZX, 2013, BIOINFORMATICS, V29, P2633, DOI 10.1093/bioinformatics/btt443; Xu WL, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S7-S4	40	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e108260	10.1371/journal.pone.0108260	http://dx.doi.org/10.1371/journal.pone.0108260			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238537	Green Published, gold, Green Submitted			2022-12-25	WOS:000342491600089
J	Huang, YP; Nokhrin, S; Hassanzadeh-Ghassabeh, G; Yu, CH; Yang, HJ; Barry, AN; Tonelli, M; Markley, JL; Muyldermans, S; Dmitriev, OY; Lutsenko, S				Huang, Yiping; Nokhrin, Sergiy; Hassanzadeh-Ghassabeh, Gholamreza; Yu, Corey H.; Yang, Haojun; Barry, Amanda N.; Tonelli, Marco; Markley, John L.; Muyldermans, Serge; Dmitriev, Oleg Y.; Lutsenko, Svetlana			Interactions between Metal-binding Domains Modulate Intracellular Targeting of Cu(I)-ATPase ATP7B, as Revealed by Nanobody Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPPER-TRANSPORTING ATPASE; WILSONS-DISEASE PROTEIN; N-TERMINAL DOMAIN; FUNCTIONAL-PROPERTIES; TRAFFICKING; RELAXATION; MENKES; SITES; CELLS; MUTATIONS	The biologically and clinically important membrane transporters are challenging proteins to study because of their low level of expression, multidomain structure, and complex molecular dynamics that underlies their activity. ATP7B is a copper transporter that traffics between the intracellular compartments in response to copper elevation. The N-terminal domain of ATP7B (N-ATP7B) is involved in binding copper, but the role of this domain in trafficking is controversial. To clarify the role of N-ATP7B, we generated nanobodies that interact with ATP7B in vitro and in cells. In solution NMR studies, nanobodies revealed the spatial organization of N-ATP7B by detecting transient functionally relevant interactions between metal-binding domains 1-3. Modulation of these interactions by nanobodies in cells enhanced relocalization of the endogenous ATP7B toward the plasma membrane linking molecular and cellular dynamics of the transporter. Stimulation of ATP7B trafficking by nanobodies in the absence of elevated copper provides direct evidence for the important role of N-ATP7B structural dynamics in regulation of ATP7B localization in a cell.	[Huang, Yiping; Yang, Haojun; Barry, Amanda N.; Lutsenko, Svetlana] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Nokhrin, Sergiy; Yu, Corey H.; Dmitriev, Oleg Y.] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Hassanzadeh-Ghassabeh, Gholamreza; Muyldermans, Serge] Vrije Univ Brussel, Struct Biol Res Ctr, B-1050 Brussels, Belgium; [Hassanzadeh-Ghassabeh, Gholamreza] VIB, Nanobody Serv Facil, B-1050 Brussels, Belgium; [Tonelli, Marco; Markley, John L.] Univ Wisconsin, Dept Biochem, Natl Magnet Resonance Facil Madison, Madison, WI 53706 USA	Johns Hopkins University; University of Saskatchewan; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); University of Wisconsin System; University of Wisconsin Madison	Dmitriev, OY (corresponding author), 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	Oleg.Dmitriev@usask.ca; Lutsenko@jhmi.edu	Muyldermans, Serge/AAC-7374-2019; Muyldermans, Serge V/C-6418-2016; Dmitriev, Oleg/AAB-7830-2019	Muyldermans, Serge/0000-0002-3678-3575; Muyldermans, Serge V/0000-0002-3678-3575; Barry, Amanda/0000-0002-7992-0322	National Institutes of Health [GM067166]; Canadian Institutes of Health Research; Saskatchewan Health Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM067166, P41GM103399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Saskatchewan Health Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM067166 (to S. L.) and the Canadian Institutes of Health Research and Saskatchewan Health Research Foundation grants (to O. D.).	Achila D, 2006, P NATL ACAD SCI USA, V103, P5729, DOI 10.1073/pnas.0504472103; Altintas I, 2013, J CONTROL RELEASE, V165, P110, DOI 10.1016/j.jconrel.2012.11.007; Banci L, 2008, BIOCHEMISTRY-US, V47, P7423, DOI 10.1021/bi8004736; Banci L, 2009, BIOCHEMISTRY-US, V48, P7849, DOI 10.1021/bi901003k; Banci L, 2009, J BIOL CHEM, V284, P9354, DOI 10.1074/jbc.M805981200; Barnes N, 2009, TRAFFIC, V10, P767, DOI 10.1111/j.1600-0854.2009.00901.x; Braiterman LT, 2014, P NATL ACAD SCI USA, V111, pE1364, DOI 10.1073/pnas.1314161111; Cater MA, 2004, BIOCHEM J, V380, P805, DOI 10.1042/BJ20031804; Cater MA, 2007, BIOCHEM J, V401, P143, DOI 10.1042/BJ20061055; Dayie KT, 1996, ANNU REV PHYS CHEM, V47, P243, DOI 10.1146/annurev.physchem.47.1.243; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiDonato M, 1997, J BIOL CHEM, V272, P33279, DOI 10.1074/jbc.272.52.33279; DiDonato M, 2000, BIOCHEMISTRY-US, V39, P1890, DOI 10.1021/bi992222j; Dmitriev O, 2006, P NATL ACAD SCI USA, V103, P5302, DOI 10.1073/pnas.0507416103; Dolgova NV, 2013, BIOCHEM J, V454, P147, DOI 10.1042/BJ20121656; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Forbes JR, 1999, J BIOL CHEM, V274, P12408, DOI 10.1074/jbc.274.18.12408; Hasan NM, 2012, J BIOL CHEM, V287, P36041, DOI 10.1074/jbc.M112.370403; Hasan NM, 2012, CURR TOP MEMBR, V69, P137, DOI 10.1016/B978-0-12-394390-3.00006-9; Hassanzadeh-Ghassabeh G, 2013, NANOMEDICINE-UK, V8, P1013, DOI [10.2217/nnm.13.86, 10.2217/NNM.13.86]; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; LeShane ES, 2010, J BIOL CHEM, V285, P6327, DOI 10.1074/jbc.M109.074633; Lutsenko S, 1997, J BIOL CHEM, V272, P18939, DOI 10.1074/jbc.272.30.18939; Morgan CT, 2004, J BIOL CHEM, V279, P36363, DOI 10.1074/jbc.M404553200; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Petris MJ, 2002, J BIOL CHEM, V277, P46736, DOI 10.1074/jbc.M208864200; Pilankatta Rajendra, 2011, J Biol Chem, V286, P7389, DOI 10.1074/jbc.M110.171454; Ries J, 2012, NAT METHODS, V9, P582, DOI [10.1038/NMETH.1991, 10.1038/nmeth.1991]; Tsay MJ, 2004, BBA-MOL BASIS DIS, V1688, P78, DOI 10.1016/j.bbadis.2003.11.001; Tsivkovskii R, 2002, J BIOL CHEM, V277, P976, DOI 10.1074/jbc.M109368200; Vanderwerf SM, 2001, J BIOL CHEM, V276, P36289, DOI 10.1074/jbc.M102055200; Walker JM, 2002, J BIOL CHEM, V277, P27953, DOI 10.1074/jbc.M203845200; Yatsunyk LA, 2007, J BIOL CHEM, V282, P8622, DOI 10.1074/jbc.M609533200; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022; Zhu JJ, 2012, BIOCHEM J, V448, P73, DOI 10.1042/BJ20120537	37	29	29	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.580845	http://dx.doi.org/10.1074/jbc.M114.580845			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25253690	Green Published, hybrid			2022-12-25	WOS:000345335000025
J	Frazilio, FO; Otsuki, DA; Noel-Morgan, J; Maximino, JR; Oliveira, GP; Chadi, G; Auler, JOC; Fantoni, DT				Frazilio, Fabricio O.; Otsuki, Denise Aya; Noel-Morgan, Jessica; Maximino, Jessica Ruivo; Oliveira, Gabriela Pintar; Chadi, Gerson; Costa Auler, Jose Otavio, Jr.; Fantoni, Denise Tabacchi			Evaluation of Neuronal Apoptosis Precursors in an Experimental Model of Acute Normovolemic Hemodilution	PLOS ONE			English	Article							BCL-2 PROTEIN EXPRESSION; HYPOXIC CEREBRAL INJURY; DNA FRAGMENTATION; NEWBORN PIGLETS; NITRIC-OXIDE; CASPASE-3 ACTIVATION; NUCLEAR MECHANISMS; COGNITIVE FUNCTION; CARDIAC-SURGERY; ANEMIA	Background: The effects of acute anemia on neuronal cells and the safe limits of hematocrit are not well established. The objective of this study was to evaluate neuronal pro-and anti-apoptotic Bax and Bcl-x proteins, caspase-3 and -9 activity, and DNA fragmentation after acute normovolemic hemodilution (ANH). Methods: Twenty-four pigs were anesthetized and randomized into 4 groups: Sham, ANH to 15% hematocrit (ANH15%), ANH to 10% hematocrit (ANH10%) and hypoxia (Hx). ANH was achieved by simultaneous blood withdrawal and hydroxyethyl starch infusion. Hx consisted of ventilation with a 6% inspired oxygen fraction for 60 minutes. Bax and Bcl-x proteins as well as DNA fragmentation were evaluated in cortical nuclear and mitochondrial fractions. Caspase-3 and -9 activity was evaluated in the cortical mitochondrial and hippocampal cytosolic fractions. The data were compared using analysis of variance followed by Tukey's test (P<0.05). Results: No changes were observed in Bax protein expression after hemodilution in the ANH15% and ANH10% groups compared to the Sham group. Bax expression in the Hx group was increased in the nuclear and mitochondrial fractions compared to all other groups. No significant difference was observed in Bcl-x expression. Caspase-3 and -9 activity in the cytosolic and mitochondrial fractions was different in the Hx group compared to all other groups. No statistical significance in DNA fragmentation was found among the Sham, ANH15% or ANH10% groups. Conclusion: ANH to 10 and 15% hematocrit did not induce alterations in apoptosis precursors, suggesting that cerebral oxygenation was preserved during these anemic states.	[Frazilio, Fabricio O.; Otsuki, Denise Aya; Noel-Morgan, Jessica; Costa Auler, Jose Otavio, Jr.; Fantoni, Denise Tabacchi] Univ Sao Paulo, Fac Med, Dept Anesthesia & Surg Intens Care, Lab Anesthesiol LIM08, Sao Paulo, Brazil; [Maximino, Jessica Ruivo; Oliveira, Gabriela Pintar; Chadi, Gerson] Univ Sao Paulo, Fac Med, Dept Neurol, Neuroregenerat Ctr LIM45, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Fantoni, DT (corresponding author), Univ Sao Paulo, Fac Med, Dept Anesthesia & Surg Intens Care, Lab Anesthesiol LIM08, Sao Paulo, Brazil.	dfantoni@usp.br	Auler, José Otavio Costa/C-4492-2017; Fantoni, Denise T/C-5602-2012; Noel-Morgan, Jessica/B-4177-2013; de Oliveira, Gabriela/L-8269-2013	Auler, José Otavio Costa/0000-0002-3919-1743; Fantoni, Denise T/0000-0002-8452-2038; Noel-Morgan, Jessica/0000-0001-9569-3353; de Oliveira, Gabriela/0000-0002-8375-1883	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [08/50060-1, 09/52486-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/DS Anestesiologia FMUSP)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/DS Anestesiologia FMUSP)	This study was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 08/50060-1, 09/52486-9) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/DS Anestesiologia FMUSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter W, 2001, BIOL NEONATE, V79, P187; [Anonymous], 1996, GUIDE CARE USE LAB A; BOOTH RFG, 1978, BIOCHEM J, V176, P365, DOI 10.1042/bj1760365; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briet F, 2009, CAN J ANAESTH, V56, P921, DOI 10.1007/s12630-009-9201-z; BROWN MM, 1985, BRAIN, V108, P81, DOI 10.1093/brain/108.1.81; Davoli MA, 2002, NEUROSCIENCE, V115, P125, DOI 10.1016/S0306-4522(02)00376-7; Delivoria-Papadopou M, 2008, SEMIN PERINATOL, V32, P334, DOI 10.1053/j.semperi.2008.07.002; Delivoria-Papadopoulos M, 2004, CLIN PERINATOL, V31, P91, DOI 10.1016/j.clp.2004.03.007; Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446; Hare GMT, 2003, J APPL PHYSIOL, V94, P2058, DOI 10.1152/japplphysiol.00931.2002; Hare GMT, 2007, J APPL PHYSIOL, V103, P1021, DOI 10.1152/japplphysiol.01315.2006; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Huang ZY, 2011, CLIN SCI, V121, P57, DOI 10.1042/CS20100435; Ickx BE, 2000, ANESTHESIOLOGY, V93, P1011, DOI 10.1097/00000542-200010000-00024; Jung SH, 2009, J KOREAN MED SCI, V24, P812, DOI 10.3346/jkms.2009.24.5.812; Khurana P, 2002, NEUROCHEM RES, V27, P931, DOI 10.1023/A:1020347732741; Li M, 2010, ANESTHESIOLOGY, V113, P845, DOI 10.1097/ALN.0b013e3181eaaef9; Lin KC, 2012, J TRAUMA ACUTE CARE, V72, P650, DOI 10.1097/TA.0b013e31823c575f; Mathew JP, 2007, ANESTHESIOLOGY, V107, P577, DOI 10.1097/01.anes.0000281896.07256.71; McLaren AT, 2007, AM J PHYSIOL-REG I, V292, pR403, DOI 10.1152/ajpregu.00403.2006; Meier J, 2004, SHOCK, V22, P240, DOI 10.1097/01.shk.0000131192.02909.4c; Mishra OP, 2006, NEUROSCIENCE, V141, P1339, DOI 10.1016/j.neuroscience.2006.05.005; Mishra OP, 2006, BRAIN RES, V1101, P20, DOI 10.1016/j.brainres.2006.05.021; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Murray D, 2004, EUR SPINE J, V13, pS72, DOI 10.1007/s00586-004-0755-8; New HV, 2009, VOX SANG, V96, P62, DOI 10.1111/j.1423-0410.2008.01105.x; Otsuki DA, 2007, BRIT J ANAESTH, V98, P29, DOI 10.1093/bja/ael312; Parikh NA, 2003, NEUROCHEM RES, V28, P1351, DOI 10.1023/A:1024992214886; Reasoner DK, 1996, ANESTH ANALG, V82, P61, DOI 10.1097/00000539-199601000-00011; Sakamoto T, 2002, ANN THORAC SURG, V73, P180, DOI 10.1016/S0003-4975(01)03274-X; Shoemaker W.C., 1995, TXB CRITICAL CARE, P85; Su DS, 2006, CAN J ANAESTH, V53, P1220, DOI 10.1007/BF03021584; Weiskopf RB, 2000, ANESTHESIOLOGY, V92, P1646, DOI 10.1097/00000542-200006000-00023; Yu Qiong, 2011, Front Biosci (Elite Ed), V3, P978; Zhang TJ, 2006, ANESTH ANALG, V102, P1018, DOI 10.1213/01.ane.0000199221.96250.8c	36	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108366	10.1371/journal.pone.0108366	http://dx.doi.org/10.1371/journal.pone.0108366			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254661	gold, Green Published, Green Submitted			2022-12-25	WOS:000344862300074
J	Healy, K; Hamilton, G; Crepeau, T; Healy, S; Unlu, I; Farajollahi, A; Fonseca, DM				Healy, Kristen; Hamilton, George; Crepeau, Taryn; Healy, Sean; Unlu, Isik; Farajollahi, Ary; Fonseca, Dina M.			Integrating the Public in Mosquito Management: Active Education by Community Peers Can Lead to Significant Reduction in Peridomestic Container Mosquito Habitats	PLOS ONE			English	Article							AEDES-AEGYPTI CONTROL; ASIAN TIGER MOSQUITO; WILLINGNESS-TO-PAY; INFORMATION PACKETS; HEALTH-EDUCATION; CONTROL PROGRAM; ALBOPICTUS; PARTICIPATION; NEIGHBORHOODS; INVOLVEMENT	Mosquito species that utilize peridomestic containers for immature development are commonly aggressive human biters, and because they often reach high abundance, create significant nuisance. One of these species, the Asian tiger mosquito Aedes albopictus, is an important vector of emerging infectious diseases, such as dengue, chikungunya, and Zika fevers. Integrated mosquito management (IMM) of Ae. albopictus is particularly difficult because it requires access to private yards in urban and suburban residences. It has become apparent that in the event of a public health concern due to this species, homeowners will have to be active participants in the control process by reducing mosquito habitats in their properties, an activity known as source reduction. However, limited attempts at quantifying the effect of source reduction by homeowners have had mixed results. Of note, many mosquito control programs in the US have some form of education outreach, however the primary approach is often passive focusing on the distribution of education materials as flyers. In 2010, we evaluated the use of active community peer education in a source reduction program, using AmeriCorps volunteers. The volunteers were mobilized over a 4-week period, in two areas with approximately 1,000 residences each in urban Mercer and suburban Monmouth counties in New Jersey, USA. The volunteers were first provided training on peridomestic mosquitoes and on basic approaches to reducing the number of container habitats for mosquito larvae in backyards. Within the two treatment areas the volunteers successfully engaged 758 separate homes. Repeated measures analysis of variance showed a significant reduction in container habitats in the sites where the volunteers actively engaged the community compared to untreated control areas in both counties. Our results suggest that active education using community peer educators can be an effective means of source reduction, and a critical tool in the arsenal against peridomestic mosquitoes.	[Healy, Kristen; Hamilton, George; Fonseca, Dina M.] Rutgers State Univ, Dept Entomol, Ctr Vector Biol, New Brunswick, NJ 08903 USA; [Crepeau, Taryn; Healy, Sean] Monmouth Cty Mosquito Exterminat Commiss, Eatontown, NJ USA; [Unlu, Isik; Farajollahi, Ary] Mercer Cty Mosquito Commiss, West Trenton, NJ USA	Rutgers State University New Brunswick	Healy, K (corresponding author), Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA.	khealy@lsu.edu	Fonseca, Dina/HHS-1320-2022; Fonseca, Dina Madeira/B-9951-2011	Fonseca, Dina Madeira/0000-0003-4726-7100; Healy, Kristen/0000-0002-3208-6537	United States Department of Agriculture (USDA) [USDA-ARS-58-6615-8-105]; Rutgers University [USDA-ARS-58-6615-8-105]	United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); Rutgers University	This work was funded by a cooperative Agreement between the United States Department of Agriculture (USDA) and Rutgers University (USDA-ARS-58-6615-8-105) entitled "Area-wide Pest Management Program for the Asian Tiger Mosquito in New Jersey." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baly A, 2007, T ROY SOC TROP MED H, V101, P578, DOI 10.1016/j.trstmh.2007.01.002; Bartlett-Healy K, 2012, J MED ENTOMOL, V49, P813, DOI 10.1603/ME11031; Bartlett-Healy K, 2011, INT J ENV RES PUB HE, V8, P1358, DOI 10.3390/ijerph8051358; Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848; Brieger WR, 1996, ACTA TROP, V61, P93, DOI 10.1016/0001-706X(95)00104-M; Crepeau TN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060524; Dickinson K, 2012, VECTOR-BORNE ZOONOT, V12, P886, DOI 10.1089/vbz.2011.0810; Focks AD, 2003, REV ENTOMOLOGICAL RE; Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511; Fonseca DM, 2014, MED VET ENT IN PRESS; Gubler DJ, 1996, ACTA TROP, V61, P169, DOI 10.1016/0001-706X(95)00103-L; Halasa YA, 2012, J AM MOSQUITO CONTR, V28, P225, DOI 10.2987/12-6243R.1; Hawley W. A., 1988, J AM MOSQ CONTROL S, V1, P1; LaDeau SL, 2013, INT J ENV RES PUB HE, V10, P1505, DOI 10.3390/ijerph10041505; LEONTSINI E, 1993, T ROY SOC TROP MED H, V87, P267, DOI 10.1016/0035-9203(93)90120-F; LLOYD LS, 1992, AM J TROP MED HYG, V46, P635, DOI 10.4269/ajtmh.1992.46.635; Medical Reserve Corps, 2011, DIV CIV VOL MED RES; MITCHELL CJ, 1991, J AM MOSQUITO CONTR, V7, P446; New Jersey Weather and Climate Network, 2014, MONTHL PREC SO NEW J; Perez D, 2007, TROP MED INT HEALTH, V12, P664, DOI 10.1111/j.1365-3156.2007.01833.x; Phanthumachinda B., 1985, Mosquito-Borne Diseases Bulletin, V2, P1; Richards SL, 2008, J MED ENTOMOL, V45, P617, DOI 10.1603/0022-2585(2008)45[617:IOSROT]2.0.CO;2; SCHREIBER ET, 1995, J AM MOSQUITO CONTR, V11, P186; SCHREIBER ET, 1994, J AM MOSQUITO CONTR, V10, P154; Soedarmo Sumarmo Poorwo, 1993, Tropical Medicine, V35, P315; Spiegel JM, 2007, TROP MED INT HEALTH, V12, P503, DOI 10.1111/j.1365-3156.2007.01818.x; Swaddiwudhipong Witaya, 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P200; United State Department of Agriculture, 2014, COOP EXT SYST OFF; Unlu I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077999; Unlu I, 2011, PEST MANAG SCI, V67, P965, DOI 10.1002/ps.2140; Warner DG, 2005, J MED LIBR ASSOC, V93, P243; WINCH P, 1992, HEALTH POLICY PLANN, V7, P342, DOI 10.1093/heapol/7.4.342; Worobey J, 2013, J AM MOSQUITO CONTR, V29, P78, DOI 10.2987/12-6296R.1	33	43	43	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108504	10.1371/journal.pone.0108504	http://dx.doi.org/10.1371/journal.pone.0108504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255027	Green Submitted, gold, Green Published			2022-12-25	WOS:000344862300091
J	Kyto, V; Sipila, J; Rautava, P				Kyto, Ville; Sipila, Jussi; Rautava, Paivi			Likelihood and Predictors of ST-Elevation in Patients Hospitalized for Myocardial Infarction	PLOS ONE			English	Article							ASSOCIATION TASK-FORCE; DISCHARGE REGISTER; TRENDS; AGE; OUTCOMES; MANAGEMENT; THERAPY; DISEASE; POPULATION; GUIDELINES	Importance: Emergency treatment options in myocardial infarction are guided by presence or absence of ST-elevations in electrocardiography. Occurrence and factors associated with ST-presentation in different population groups are however inadequately known. Objective: To determine likelihood and patient features associated with ST-elevations in myocardial infarction. Design: Nationwide registry study including 22 hospitals with angiolaboratory during an eight year period in Finland. Setting: Hospitalized care. Participants: 68,162 consecutive patients aged >= 30 with myocardial infarction. Measures: Likelihood and patient features associated with presence of ST-elevations. Results: Myocardial infarction presented with ST-elevation in 37.5% (CI 37.0-37.9%) and without in 62.5% (CI 61.9-63.1%) of patients, p<0.0001. Majority of patients aged 30-59 years with myocardial infarction had ST-elevation, but among octogenarians ST-elevations were present in only 24.7%. Presence of ST-elevations decreased with age by estimated 15.6% (CI 15.0-16.2%) per 10 year increase (p<0.0001). Men aged 40-79 years had significantly higher rate for ST-elevation myocardial infarction compared to women. Sex-based difference in presentation of myocardial infarction declined with increasing age. Overall, men had a 13% (CI 11-15%, p<0.0001) higher relative risk for ST-elevations compared to women when adjusted for age and co-morbidities. Diabetes, atrial fibrillation, peripheral or cerebral artery disease, chronic pulmonary disease, malignancy, and renal insufficiency were associated with absence of ST-elevations in myocardial infarction in multivariate analysis. Conclusions and Relevance: Myocardial infarction presents with ST-elevations more commonly in men. Presence of ST-elevations decreases with increasing age. Diabetes, atrial fibrillation, peripheral or cerebral artery disease, chronic pulmonary disease, malignancy, and renal insufficiency are associated with absence of ST-elevations in myocardial infarction. These findings may help to predict likelihood of ST-elevations in a patient with myocardial infarction.	[Kyto, Ville; Sipila, Jussi; Rautava, Paivi] Turku Univ Hosp, Ctr Heart, Div Clin Neurosci, Neurol & Clin Res Ctr, FIN-20520 Turku, Finland; [Kyto, Ville; Sipila, Jussi; Rautava, Paivi] Univ Turku, PET Ctr, Turku, Finland	University of Turku; University of Turku	Kyto, V (corresponding author), Turku Univ Hosp, Ctr Heart, Div Clin Neurosci, Neurol & Clin Res Ctr, FIN-20520 Turku, Finland.	ville.kyto@utu.fi	Sipilä, Jussi/C-8585-2015; Kytö, Ville/D-7971-2014	Sipilä, Jussi/0000-0003-0183-9054; Kytö, Ville/0000-0002-4521-1093	clinical research foundation of Turku University Hospital	clinical research foundation of Turku University Hospital	This study was supported by the clinical research foundation of Turku University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2013, J AM COLL CARDIOL, V61, pE179, DOI 10.1016/j.jacc.2013.01.014; Bahrmann P, 2011, CLIN RES CARDIOL, V100, P457, DOI 10.1007/s00392-010-0269-9; Barnabas O, 2013, J GERIATR CARDIOL, V10, P377, DOI 10.3969/j.issn.1671-5411.2013.04.008; Braunstein JB, 2002, CHEST, V121, P906, DOI 10.1378/chest.121.3.906; Camm AJ, 2012, EUR HEART J, V33; Crandall CJ, 2013, ENDOCRIN METAB CLIN, V42, P227, DOI 10.1016/j.ecl.2013.02.003; Cushman M, 1999, CIRCULATION, V100, P717, DOI 10.1161/01.CIR.100.7.717; Davies AR, 2007, EUR HEART J, V28, P2142, DOI 10.1093/eurheartj/ehm272; Gilstad JR, 2009, ARCH GERONTOL GERIAT, V48, P155, DOI 10.1016/j.archger.2007.12.006; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Harkonen JT, 2011, ALCOHOL ALCOHOLISM, V46, P349, DOI 10.1093/alcalc/agr025; Jennings SM, 2012, HEART, V98, P1285, DOI 10.1136/heartjnl-2012-301822; Kyto V, 2013, HEART, V99, P1681, DOI 10.1136/heartjnl-2013-304449; Levi M, 2014, THROMB RES, V133, pS70, DOI 10.1016/S0049-3848(14)50012-6; MACDONALD RG, 1986, CIRCULATION, V74, P973, DOI 10.1161/01.CIR.74.5.973; MAUTNER SL, 1993, J AM COLL CARDIOL, V21, P1312, DOI 10.1016/0735-1097(93)90302-H; McManus DD, 2011, AM J MED, V124, P40, DOI 10.1016/j.amjmed.2010.07.023; Mohebali D, 2014, J AM GERIATR SOC, V62, P529, DOI 10.1111/jgs.12700; Morel O, 2013, SEMIN THROMB HEMOST, V39, P477, DOI 10.1055/s-0033-1343888; Nauta ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026917; O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6; Ortolani P, 2013, AM HEART J, V166, P846, DOI 10.1016/j.ahj.2013.08.026; Pajunen P, 2005, EUR J CARDIOV PREV R, V12, P132, DOI 10.1097/00149831-200504000-00007; Peterson ED, 2008, AM HEART J, V156, P1045, DOI 10.1016/j.ahj.2008.07.028; Roe MT, 2010, J AM COLL CARDIOL, V56, P254, DOI 10.1016/j.jacc.2010.05.008; Rosengren A, 2004, EUR HEART J, V25, P663, DOI 10.1016/j.ehj.2004.02.023; Salomaa V, 2013, HEART, V99, P954, DOI 10.1136/heartjnl-2012-303216; Spinetti G, 2008, CARDIOVASC RES, V78, P265, DOI 10.1093/cvr/cvn039; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Sund R, 2012, SCAND J PUBLIC HEALT, V40, P505, DOI 10.1177/1403494812456637; Tayebjee MH, 2005, AM J CARDIOL, V96, P339, DOI 10.1016/j.amjcard.2005.03.072; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Wang TY, 2012, J AM COLL CARDIOL, V59, P891, DOI 10.1016/j.jacc.2011.09.075; Wu Q, 2011, J BIOL CHEM, V286, P14737, DOI 10.1074/jbc.R110.191791; Yeh ETH, 2009, J AM COLL CARDIOL, V53, P2231, DOI 10.1016/j.jacc.2009.02.050; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Yusuf SW, 2012, CLIN CARDIOL, V35, P443, DOI 10.1002/clc.22007; Zhang ZF, 2012, AM J CARDIOL, V109, P1097, DOI 10.1016/j.amjcard.2011.12.001	40	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108440	10.1371/journal.pone.0108440	http://dx.doi.org/10.1371/journal.pone.0108440			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254632	Green Published, gold, Green Submitted			2022-12-25	WOS:000344862300082
J	Tarella, C; Gueli, A; Delaini, F; Rossi, A; Barbui, AM; Gritti, G; Boschini, C; Caracciolo, D; Bruna, R; Ruella, M; Gottardi, D; Passera, R; Rambaldi, A				Tarella, Corrado; Gueli, Angela; Delaini, Federica; Rossi, Andrea; Barbui, Anna Maria; Gritti, Giuseppe; Boschini, Cristina; Caracciolo, Daniele; Bruna, Riccardo; Ruella, Marco; Gottardi, Daniela; Passera, Roberto; Rambaldi, Alessandro			Rate of Primary Refractory Disease in B and T-Cell Non-Hodgkin's Lymphoma: Correlation with Long-Term Survival	PLOS ONE			English	Article							ELDERLY-PATIENTS; CHOP CHEMOTHERAPY; RITUXIMAB; MULTICENTER; IMPROVES; TRANSPLANTATION; MANAGEMENT; FEATURES; LIFE	Background: Primary refractory disease is a main challenge in the management of non-Hodgkin's Lymphoma (NHL). This survey was performed to define the rate of refractory disease to first-line therapy in B and T-cell NHL subtypes and the long-term survival of primary refractory compared to primary responsive patients. Methods: Medical records were reviewed of 3,106 patients who had undergone primary treatment for NHL between 1982 and 2012, at the Hematology Centers of Torino and Bergamo, Italy. Primary treatment included CHOP or CHOP-like regimens (63.2%), intensive therapy with autograft (16.9%), or other therapies (19.9%). Among B-cell NHL, 1,356 (47.8%) received first-line chemotherapy with rituximab. Refractory disease was defined as stable/progressive disease, or transient response with disease progression within six months. Results: Overall, 690 (22.2%) patients showed primary refractory disease, with a higher incidence amongst T-cell compared to B-cell NHL (41.9% vs. 20.5%, respectively, p<0.001). Several other clinico-pathological factors at presentation were variably associated with refractory disease, including histological aggressive disease, unfavorable clinical presentation, Bone Marrow involvement, low lymphocyte/ monocyte ration and male gender. Amongst B-cell NHL, the addition of rituximab was associated with a marked reduction of refractory disease (13.6% vs. 26.7% for non-supplemented chemotherapy, p<0.001). Overall, primary responsive patients had a median survival of 19.8 years, compared to 1.3 yr. for refractory patients. A prolonged survival was consistently observed in all primary responsive patients regardless of the histology. The long life expectancy of primary responsive patients was documented in both series managed before and after 2.000. Response to first line therapy resulted by far the most predictive factor for long-term outcome (HR for primary refractory disease: 16.52, p<0.001). Conclusion: Chemosensitivity to primary treatment is crucial for the long-term survival in NHL. This supports the necessity of studies aimed to early identify refractory disease and to develop different treatment strategies for responsive and refractory patients.	[Tarella, Corrado; Gueli, Angela; Caracciolo, Daniele; Bruna, Riccardo; Ruella, Marco; Gottardi, Daniela] Univ Turin, Dept Biotechnol & Life Sci, Turin, Italy; [Tarella, Corrado; Gueli, Angela; Bruna, Riccardo; Ruella, Marco; Gottardi, Daniela] Mauriziano Hosp, Hematol & Cell Therapy Div, Turin, Italy; [Delaini, Federica; Rossi, Andrea; Barbui, Anna Maria; Gritti, Giuseppe; Boschini, Cristina] AO Papa Giovanni XXIII, Hematol Unit, Bergamo, Italy; [Delaini, Federica; Rossi, Andrea; Barbui, Anna Maria; Gritti, Giuseppe; Boschini, Cristina] AO Papa Giovanni XXIII, Bone Marrow Transplant Unit, Bergamo, Italy; [Caracciolo, Daniele; Rambaldi, Alessandro] AO Citta Salute, Div Hematol 1, Turin, Italy; [Passera, Roberto] Univ Turin, Div Nucl Med, Turin, Italy	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; ASST Papa Giovanni XXIII; ASST Papa Giovanni XXIII; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin	Tarella, C (corresponding author), Univ Turin, Dept Biotechnol & Life Sci, Turin, Italy.	corrado.tarella@unito.it	gueli, angela/K-9786-2016; Rambaldi, Alessandro/M-6172-2019; Ruella, Marco/GQP-8473-2022; Gritti, Giuseppe/K-7321-2019; Rambaldi, Alessandro/P-2603-2018; Passera, Roberto/ABI-7086-2020	gueli, angela/0000-0003-3674-109X; Rambaldi, Alessandro/0000-0002-3739-7502; Gritti, Giuseppe/0000-0002-6789-5123; Rambaldi, Alessandro/0000-0002-3739-7502; Passera, Roberto/0000-0003-3372-2248; Boschini, Cristina/0000-0001-6905-7038; Ruella, Marco/0000-0003-4301-5811	Associazione Italiana per la Ricerca contro il Cancro (AIRC); Associazione Italiana Lotta alla Leucemia (AIL); Ministero dell'Istruzione; dell'Universitae della Ricerca (MIUR); Regione Piemonte (Ricerca Finalizzata and the Piedmont Regional Government)	Associazione Italiana per la Ricerca contro il Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana Lotta alla Leucemia (AIL); Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universitae della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Regione Piemonte (Ricerca Finalizzata and the Piedmont Regional Government)	This work was supported in part by grants from Associazione Italiana per la Ricerca contro il Cancro (AIRC), Associazione Italiana Lotta alla Leucemia (AIL), Ministero dell'Istruzione, dell'Universitae della Ricerca (MIUR) and Regione Piemonte (Ricerca Finalizzata and the Piedmont Regional Government). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage JO, 2012, AM J HEMATOL, V87, P512, DOI 10.1002/ajh.23144; Aukema SM, 2011, BLOOD, V117, P2319, DOI 10.1182/blood-2010-09-297879; Cabanillas Fernando, 2011, Clin Lymphoma Myeloma Leuk, V11 Suppl 1, pS87, DOI 10.1016/j.clml.2011.03.029; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Cheson BD, 2012, CANCER-AM CANCER SOC, V118, P3128, DOI 10.1002/cncr.26510; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; COX DR, 1972, J R STAT SOC B, V34, P187; Cuccuini W, 2012, BLOOD, V119, P4619, DOI 10.1182/blood-2012-01-406033; d'Amore F, 2012, J CLIN ONCOL, V30, P3093, DOI 10.1200/JCO.2011.40.2719; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Elstrom RL, 2012, LEUKEMIA LYMPHOMA, V53, P1469, DOI 10.3109/10428194.2012.656629; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; Gallamini A, 2007, BLOOD, V110, P2316, DOI 10.1182/blood-2007-02-074641; Galli M, 2005, HAEMATOLOGICA, V90, P1643; Gisselbrecht C, 1998, BLOOD, V92, P76; Leskov I, 2013, ONCOGENE, V32, P1066, DOI 10.1038/onc.2012.117; Li ZM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041658, 10.1371/journal.pone.0053176]; Lunning MA, 2012, BLOOD REV, V26, P279, DOI 10.1016/j.blre.2012.09.004; Mahadevan D, 2011, J CLIN ONCOL, V29, P1876, DOI 10.1200/JCO.2010.32.7171; Maloney DG, 2008, BONE MARROW TRANSPL, V42, pS35, DOI 10.1038/bmt.2008.110; MANTEL N, 1959, J NATL CANCER I, V22, P719; Moskowitz C, 2012, BEST PRACT RES CL HA, V25, P41, DOI 10.1016/j.beha.2012.01.008; Mounier N, 2003, BLOOD, V101, P4279, DOI 10.1182/blood-2002-11-3442; Muller C, 2012, BLOOD, V119, P3276, DOI 10.1182/blood-2011-09-380949; Pfreundschuh M, 2011, LANCET ONCOL, V12, P1013, DOI 10.1016/S1470-2045(11)70235-2; Piccaluga PP, 2013, J CLIN ONCOL, V31, P3019, DOI 10.1200/JCO.2012.42.5611; Rambaldi A, 2013, AM J HEMATOL, V88, P1062, DOI 10.1002/ajh.23566; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Royo C, 2011, SEMIN CANCER BIOL, V21, P322, DOI 10.1016/j.semcancer.2011.09.007; Sawas A, 2011, CURR OPIN HEMATOL, V18, P280, DOI 10.1097/MOH.0b013e328347786d; Schneider CK, 2012, NAT BIOTECHNOL, V30, P1179, DOI 10.1038/nbt.2447; Sehn LH, 2005, J CLIN ONCOL, V23, P5027, DOI 10.1200/JCO.2005.09.137; Snuderl M, 2010, AM J SURG PATHOL, V34, P327, DOI 10.1097/PAS.0b013e3181cd3aeb; Surveillance Epidemiology and End Results (SEER) Program, SEER STAT DAT INC SE; Sweetenham J, 2008, HEMATOL ONCOL CLIN N, V22, P965, DOI 10.1016/j.hoc.2008.07.009; Tan D, 2013, BLOOD, V122, P981, DOI 10.1182/blood-2013-03-491514; Tarella C, 2008, J CLIN ONCOL, V26, P3166, DOI 10.1200/JCO.2007.14.4204; Tarella C, 2011, J CLIN ONCOL, V29, P814, DOI 10.1200/JCO.2010.28.9777; Wilson WH, 2012, HAEMATOL-HEMATOL J, V97, P758, DOI 10.3324/haematol.2011.056531; Zinzani PL, 2013, AM J HEMATOL, V88, P185, DOI 10.1002/ajh.23372	40	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e106745	10.1371/journal.pone.0106745	http://dx.doi.org/10.1371/journal.pone.0106745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255081	Green Published, Green Submitted, gold			2022-12-25	WOS:000344862300012
J	Wang, HL; Zhang, TE; Yin, LT; Pang, M; Guan, L; Liu, HL; Zhang, JH; Meng, XL; Bai, JZ; Zheng, GP; Yin, GR				Wang, Hai-Long; Zhang, Tie-E; Yin, Li-Tian; Pang, Min; Guan, Li; Liu, Hong-Li; Zhang, Jian-Hong; Meng, Xiao-Li; Bai, Ji-Zhong; Zheng, Guo-Ping; Yin, Guo-Rong			Partial Protective Effect of Intranasal Immunization with Recombinant Toxoplasma gondii Rhoptry Protein 17 against Toxoplasmosis in Mice	PLOS ONE			English	Article							IMMUNE-RESPONSE; IMMUNOGLOBULIN-A; DNA VACCINE; ORAL INFECTION; TISSUE CYSTS; BALB/C MICE; T-CELLS; SAG1; ANTIGEN; RESISTANCE	Toxoplasma gondii (T. gondii) is an obligate intracellular protozoan parasite that infects a variety of mammals, including humans. An effective vaccine for this parasite is therefore needed. In this study, RH strain T. gondii rhoptry protein 17 was expressed in bacteria as a fusion with glutathione S-transferase (GST) and the recombinant proteins (rTgROP17) were purified via GST-affinity chromatography. BALB/c mice were nasally immunised with rTgROP17, and induction of immune responses and protection against chronic and lethal T. gondii infections were investigated. The results revealed that mice immunised with rTgROP17 produced high levels of specific anti-rTgROP17 IgGs and a mixed IgG1/IgG2a response of IgG2a predominance. The systemic immune response was associated with increased production of Th1 (IFN-gamma and IL-2) and Th2 (IL-4) cytokines, and enhanced lymphoproliferation (stimulation index, SI) in the mice immunised with rTgROP17. Strong mucosal immune responses with increased secretion of TgROP17-specific secretory IgA (SIgA) in nasal, vaginal and intestinal washes were also observed in these mice. The vaccinated mice displayed apparent protection against chronic RH strain infection as evidenced by their lower liver and brain parasite burdens (59.17% and 49.08%, respectively) than those of the controls. The vaccinated mice also exhibited significant protection against lethal infection of the virulent RH strain (survival increased by 50%) compared to the controls. Our data demonstrate that rTgROP17 can trigger strong systemic and mucosal immune responses against T. gondii and that ROP17 is a promising candidate vaccine for toxoplasmosis.	[Wang, Hai-Long; Zhang, Tie-E; Guan, Li; Liu, Hong-Li; Zhang, Jian-Hong; Meng, Xiao-Li; Yin, Guo-Rong] Shanxi Med Univ, Res Inst Med Parasitol, Taiyuan, Shanxi, Peoples R China; [Yin, Li-Tian] Shanxi Med Univ, Dept Physiol, Key Lab Cellular Physiol Coconstructed Prov, Taiyuan, Shanxi, Peoples R China; [Pang, Min] Shanxi Med Univ, Affiliated Hosp 1, Dept Resp, Taiyuan, Shanxi, Peoples R China; [Bai, Ji-Zhong] Univ Auckland, Dept Physiol, Fac Med & Hlth Sci, Auckland, New Zealand; [Zheng, Guo-Ping] Shanxi Med Univ, Dept Biochem & Mol Biol, Taiyuan, Shanxi, Peoples R China	Shanxi Medical University; Shanxi Medical University; Shanxi Medical University; University of Auckland; Shanxi Medical University	Wang, HL (corresponding author), Shanxi Med Univ, Res Inst Med Parasitol, Taiyuan, Shanxi, Peoples R China.	longwty@163.com; guorongyin@163.com	Zheng, Guoping/AAF-2332-2019	Bai, Jizhong/0000-0003-0667-8640; zheng, guoping/0000-0002-5551-4522	National Natural Science Foundation of China [81071374]; Natural Science Found of Shanxi Province [2012011036-2]; Technique Innovation of Shanxi Medical University [01201103]; Shanxi Medical University [201202]; Research Fund for the Doctoral Program of Shanxi Medical University [03201307]; College Students Innovation and Entrepreneurship Training Programs of Shanxi Province [2011120]; Advanced Program for Returned Scholars of Shanxi Province Science and Technology Activities; Biology Postdoctoral Mobile Research Station of Shanxi Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Found of Shanxi Province; Technique Innovation of Shanxi Medical University; Shanxi Medical University; Research Fund for the Doctoral Program of Shanxi Medical University; College Students Innovation and Entrepreneurship Training Programs of Shanxi Province; Advanced Program for Returned Scholars of Shanxi Province Science and Technology Activities; Biology Postdoctoral Mobile Research Station of Shanxi Medical University	This work was supported by the National Natural Science Foundation of China (No. 81071374), the Natural Science Found of Shanxi Province (No. 2012011036-2), the Technique Innovation of Shanxi Medical University (No. 01201103), the 331 Early Career Researcher Grant of Shanxi Medical University (No. 201202), the Research Fund for the Doctoral Program of Shanxi Medical University (No. 03201307), the College Students Innovation and Entrepreneurship Training Programs of Shanxi Province (No. 2011120) and the Advanced Program for Returned Scholars of Shanxi Province Science and Technology Activities. This work was also supported by the Biology Postdoctoral Mobile Research Station of Shanxi Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Bradley PJ, 2007, CURR OPIN MICROBIOL, V10, P582, DOI 10.1016/j.mib.2007.09.013; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; BRINKMANN V, 1993, MOL IMMUNOL, V30, P353, DOI 10.1016/0161-5890(93)90064-I; Butcher BA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002236; Buxton D, 2007, VET PARASITOL, V149, P25, DOI 10.1016/j.vetpar.2007.07.003; Debard N, 1996, INFECT IMMUN, V64, P2158, DOI 10.1128/IAI.64.6.2158-2166.1996; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; Dlugonska H, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/632424; Doskaya M, 2007, VACCINE, V25, P1824, DOI 10.1016/j.vaccine.2006.10.060; Dubey JP, 2009, VET PARASITOL, V164, P89, DOI 10.1016/j.vetpar.2009.05.018; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; Dziadek B, 2012, EXP PARASITOL, V131, P133, DOI 10.1016/j.exppara.2012.02.026; Dziadek B, 2011, VACCINE, V29, P821, DOI 10.1016/j.vaccine.2010.11.002; Dziadek B, 2009, EXP PARASITOL, V123, P81, DOI 10.1016/j.exppara.2009.06.002; El Hajj H, 2006, PROTEOMICS, V6, P5773, DOI 10.1002/pmic.200600187; Fentress SJ, 2012, CELL MICROBIOL, V14, P1921, DOI 10.1111/cmi.12022; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; Golkar M, 2007, VACCINE, V25, P4301, DOI 10.1016/j.vaccine.2007.02.057; Hutchings AB, 2004, J VIROL, V78, P947, DOI 10.1128/JVI.78.2.947-957.2004; Igarashi M, 2010, REV BRAS PARASITOL V, V19, P210, DOI 10.1590/S1984-29612010000400004; Jensen KDC, 2013, INFECT IMMUN, V81, P2156, DOI 10.1128/IAI.01185-12; Khaminets A, 2010, CELL MICROBIOL, V12, P939, DOI 10.1111/j.1462-5822.2010.01443.x; Khosroshahi KH, 2012, PARASITOL RES, V111, P403, DOI 10.1007/s00436-012-2852-7; Letscher-Bru V, 1998, INFECT IMMUN, V66, P4503; Liu CS, 2010, VACCINE, V28, P4153, DOI 10.1016/j.vaccine.2010.04.016; Liu Q, 2013, HUM VACCIN IMMUNOTHE, V10; Liu Q, 2012, HUM VACC IMMUNOTHER, V8, P1305, DOI 10.4161/hv.21006; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; LUNDEN A, 1993, INFECT IMMUN, V61, P2639; Martin V, 2004, CLIN DIAGN LAB IMMUN, V11, P704, DOI 10.1128/CDLI.11.4.704-710.2004; MICHETTI P, 1992, INFECT IMMUN, V60, P1786, DOI 10.1128/IAI.60.5.1786-1792.1992; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Nie H, 2011, VET PARASITOL, V181, P215, DOI 10.1016/j.vetpar.2011.04.039; Ong YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026369; Ong YC, 2010, J BIOL CHEM, V285, P28731, DOI 10.1074/jbc.M110.112359; Parmley S, 2002, J INFECT DIS, V185, pS90, DOI 10.1086/338464; Peixoto L, 2010, CELL HOST MICROBE, V8, P208, DOI 10.1016/j.chom.2010.07.004; Qiu W, 2009, EMBO J, V28, P969, DOI 10.1038/emboj.2009.24; Qu DF, 2013, EXP PARASITOL, V135, P234, DOI 10.1016/j.exppara.2013.07.013; Sibley LD, 2010, CURR OPIN BIOTECH, V21, P592, DOI 10.1016/j.copbio.2010.05.009; TAGUCHI T, 1990, J IMMUNOL METHODS, V128, P65, DOI 10.1016/0022-1759(90)90464-7; Velge-Roussel F, 2000, INFECT IMMUN, V68, P969, DOI 10.1128/IAI.68.2.969-972.2000; Wang Hai-long, 2014, Chinese Journal of Parasitology and Parasitic Diseases, V32, P29; Wang HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070884; Wang Hai-long, 2012, Chinese Journal of Parasitology and Parasitic Diseases, V30, P27; Wang HX, 2009, EXP PARASITOL, V122, P226, DOI 10.1016/j.exppara.2009.04.002; WINNER L, 1991, INFECT IMMUN, V59, P977, DOI 10.1128/IAI.59.3.977-982.1991; Xiang W, 2009, VET PARASITOL, V166, P1, DOI 10.1016/j.vetpar.2009.08.014; Yamamoto M, 2012, VIRULENCE, V3, P77, DOI 10.4161/viru.3.1.18340; Yamamoto M, 2009, J EXP MED, V206, P2747, DOI 10.1084/jem.20091703; Yang XY, 2010, VACCINE, V28, P737, DOI 10.1016/j.vaccine.2009.10.065; Yin Guo-rong, 2007, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V25, P290; Yin LT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082765; Yu HJ, 2013, VET PARASITOL, V197, P670, DOI 10.1016/j.vetpar.2013.06.013; Yuan ZG, 2011, VACCINE, V29, P6614, DOI 10.1016/j.vaccine.2011.06.110; Yuan ZG, 2011, CLIN VACCINE IMMUNOL, V18, P119, DOI 10.1128/CVI.00312-10; Zaman M, 2013, DRUG DELIV TRANSL RE, V3, P100, DOI 10.1007/s13346-012-0085-z	58	18	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108377	10.1371/journal.pone.0108377	http://dx.doi.org/10.1371/journal.pone.0108377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255141	gold, Green Published, Green Submitted			2022-12-25	WOS:000344862300076
J	Casalegno, S; Bennie, JJ; Inger, R; Gaston, KJ				Casalegno, Stefano; Bennie, Jonathan J.; Inger, Richard; Gaston, Kevin J.			Regional Scale Prioritisation for Key Ecosystem Services, Renewable Energy Production and Urban Development	PLOS ONE			English	Article							DECISION-MAKING; LAND-USE; BIODIVERSITY; CONSERVATION; SATELLITE; SUPPORT; CARBON; REFLECTANCE; LANDSCAPES; BENEFITS	Although the importance of addressing ecosystem service benefits in regional land use planning and decision-making is evident, substantial practical challenges remain. In particular, methods to identify priority areas for the provision of key ecosystem services and other environmental services (benefits from the environment not directly linked to the function of ecosystems) need to be developed. Priority areas are locations which provide disproportionally high benefits from one or more service. Here we map a set of ecosystem and environmental services and delineate priority areas according to different scenarios. Each scenario is produced by a set of weightings allocated to different services and corresponds to different landscape management strategies which decision makers could undertake. Using the county of Cornwall, U. K., as a case study, we processed gridded maps of key ecosystem services and environmental services, including renewable energy production and urban development. We explored their spatial distribution patterns and their spatial covariance and spatial stationarity within the region. Finally we applied a complementarity-based priority ranking algorithm (zonation) using different weighting schemes. Our conclusions are that (i) there are two main patterns of service distribution in this region, clustered services (including agriculture, carbon stocks, urban development and plant production) and dispersed services (including cultural services, energy production and floods mitigation); (ii) more than half of the services are spatially correlated and there is high non-stationarity in the spatial covariance between services; and (iii) it is important to consider both ecosystem services and other environmental services in identifying priority areas. Different weighting schemes provoke drastic changes in the delineation of priority areas and therefore decision making processes need to carefully consider the relative values attributed to different services.	[Casalegno, Stefano; Bennie, Jonathan J.; Inger, Richard; Gaston, Kevin J.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England	University of Exeter	Casalegno, S (corresponding author), Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England.	stefano@casalegno.net	Inger, Richard/D-3445-2009; BITOUN, RACHEL Elisabeth/AAC-9538-2021	Inger, Richard/0000-0003-1660-3706; BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Bennie, Jonathan/0000-0003-4394-2041; Gaston, Kevin J./0000-0002-7235-7928				Anderson BJ, 2009, J APPL ECOL, V46, P888, DOI 10.1111/j.1365-2664.2009.01666.x; [Anonymous], 2005, FARM MAN HDB; ASRAR G, 1984, AGRON J, V76, P300, DOI 10.2134/agronj1984.00021962007600020029x; ASTER, 2012, ADV SPAC THERM EM RE; Bagstad K, 2012, TECHNICAL REPORT; Bateman IJ, 2013, SCIENCE, V341, P45, DOI 10.1126/science.1234379; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Casalegno S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068437; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Chan KMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024378; Clark JS, 2001, SCIENCE, V293, P657, DOI 10.1126/science.293.5530.657; CLIFFORD P, 1989, BIOMETRICS, V45, P123, DOI 10.2307/2532039; Cornwall Council, 2009, TECHNICAL REPORT; Cornwall Council, 2012, SOL PHOT APPL CORNW; Cornwall Council, 2012, WIND TURB OP CORNW; Cornwall online, 2013, CORNW GOLF COURS DIR; Daily GC, 2008, P NATL ACAD SCI USA, V105, P9455, DOI 10.1073/pnas.0804960105; Daily GC, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P3; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; de Groot RS, 2010, ECOL COMPLEX, V7, P260, DOI 10.1016/j.ecocom.2009.10.006; DEFRA, 2012, TECHNICAL REPORT; Duran AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082643; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; Edina, 2008, DIG ORD SURV GB SURF; Eigenbrod F, 2010, BIOL CONSERV, V143, P2487, DOI 10.1016/j.biocon.2010.06.015; Eigenbrod F, 2009, P ROY SOC B-BIOL SCI, V276, P2903, DOI 10.1098/rspb.2009.0528; Environmental Agency, 2011, TECHNICAL REPORT; Environmental Agency, 2012, TECHNICAL REPORT; EPIA, 2013, GLOB MARK OUTL PHOT; Estoque RC, 2013, LANDSCAPE URBAN PLAN, V116, P60, DOI 10.1016/j.landurbplan.2013.04.008; European Environment Agency, 2000, CORINE LAND COV 2000; Frank S, 2012, ECOL INDIC, V21, P30, DOI 10.1016/j.ecolind.2011.04.027; Fu B, 2012, ECOL ENG NULL; Gaston KJ, 2013, J APPL ECOL, V50, P830, DOI 10.1111/1365-2664.12087; Geneletti Davide, 2011, International Journal of Biodiversity Science Ecosystem Services & Management, V7, P143, DOI 10.1080/21513732.2011.617711; Goldstein JH, 2012, P NATL ACAD SCI US; GRASS Development Team, 2012, GEOGRAPHIC RESOURCES; Hauck J, 2013, ENVIRON SCI POLICY, V25, P13, DOI 10.1016/j.envsci.2012.08.001; HOLMGREN P, 1994, HYDROL PROCESS, V8, P327, DOI 10.1002/hyp.3360080405; Jones RJA, 2005, EUR J SOIL SCI, V56, P655, DOI 10.1111/j.1365-2389.2005.00728.x; Jose Martinez-Harms Maria, 2012, International Journal of Biodiversity Science Ecosystem Services & Management, V8, P17, DOI 10.1080/21513732.2012.663792; JRC, 2003, MAPS ORG CARB CONT S; JRC, 2012, PHOT GEOGR INF SYST; Kempeneers P, 2011, IEEE T GEOSCI REMOTE, V49, P4977, DOI 10.1109/TGRS.2011.2158548; Koschke L, 2012, ECOL INDIC, V21, P54, DOI 10.1016/j.ecolind.2011.12.010; Lemes P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054323; Less Favoured Areas (England), 2010, TECHNICAL REPORT; Luisetti T, 2011, OCEAN COAST MANAGE, V54, P212, DOI 10.1016/j.ocecoaman.2010.11.003; Maes J, 2012, ECOSYST SERV, V1, P31, DOI 10.1016/j.ecoser.2012.06.004; Paula BM, 2012, AGR ECOSYST ENVIRON, V154, P34, DOI 10.1016/j.agee.2011.07.010; McKenzie E, 2014, ENVIRON PLANN C, V32, P320, DOI 10.1068/c12292j; Millennium Ecosystem Assessment, 2005, 281 WORLD RES I MILL, DOI [10.1196/annals.1439.003, DOI 10.1196/ANNALS.1439.003]; Milne R, 1997, J ENVIRON MANAGE, V49, P413, DOI 10.1006/jema.1995.0118; MODIS, 2013, MOD RES IM SPECTR MO; Moilanen A, 2005, P ROY SOC B-BIOL SCI, V272, P1885, DOI 10.1098/rspb.2005.3164; Moilanen A, 2008, ZONATION SOFTWARE SP; Moilanen A, 2011, ECOL APPL, V21, P1419, DOI 10.1890/10-1865.1; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; National Trust, 2013, NAT TRUST GARD PARKS; Natural England, 2012, MON ENG NAT ENV SURV; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Paruelo JM, 1997, ECOLOGY, V78, P953, DOI 10.1890/0012-9658(1997)078[0953:AEFNFT]2.0.CO;2; Pekkarinen A, 2008, ISPRS J PHOTOGRAMM; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Plummer ML, 2009, FRONT ECOL ENVIRON, V7, P38, DOI 10.1890/080091; POTTER CS, 1993, GLOBAL BIOGEOCHEM CY, V7, P811, DOI 10.1029/93GB02725; QGIS Development Team, 2018, QGIS GEOGR INF SYST; R Development Core Team, 2014, R LANG ENV STAT COMP; Revolutionary energy maker, 2014, AGR SYST; Running SW, 2004, CONTINUOUS SATELLITE; Russel H, 2005, WATER SCI TECHNOL, V52, DOI [10.1007/1-4020-3297-8, DOI 10.1007/1-4020-3297-8.URL]; Scolozzi R, 2012, ECOL INDIC, V21, P134, DOI 10.1016/j.ecolind.2011.07.019; SELLERS PJ, 1992, REMOTE SENS ENVIRON, V42, P187, DOI 10.1016/0034-4257(92)90102-P; Suri M, 2007, LECT NOTES GEOINF CA, P259, DOI 10.1007/978-3-540-36731-4_11; Tang ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019116; Thomas CD, 2013, ECOL LETT, V16, P39, DOI 10.1111/ele.12054; Trepel M, 2010, ECOL COMPLEX, V7, P320, DOI 10.1016/j.ecocom.2010.02.006; TUCKER CJ, 1985, SCIENCE, V227, P369, DOI 10.1126/science.227.4685.369; Vihervaara Petteri, 2012, International Journal of Biodiversity Science Ecosystem Services & Management, V8, P169, DOI 10.1080/21513732.2012.686120; Zhao B, 2004, LAND USE POLICY, V21, P139, DOI 10.1016/j.landusepol.2003.10.003	81	18	19	4	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107822	10.1371/journal.pone.0107822	http://dx.doi.org/10.1371/journal.pone.0107822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250775	Green Published, gold, Green Submitted			2022-12-25	WOS:000342492700050
J	Dana, H; Chen, TW; Hu, A; Shields, BC; Guo, CY; Looger, LL; Kim, DS; Svoboda, K				Dana, Hod; Chen, Tsai-Wen; Hu, Amy; Shields, Brenda C.; Guo, Caiying; Looger, Loren L.; Kim, Douglas S.; Svoboda, Karel			Thy1-GCaMP6 Transgenic Mice for Neuronal Population In Vivo	PLOS ONE			English	Article							FLUORESCENT CA2+ INDICATOR; IMAGING NEURAL ACTIVITY; CALCIUM INDICATOR; MOTOR CORTEX; MOUSE; EXPRESSION; PROTEINS; SIGNALS	Genetically-encoded calcium indicators (GECIs) facilitate imaging activity of genetically defined neuronal populations in vivo. The high intracellular GECI concentrations required for in vivo imaging are usually achieved by viral gene transfer using adeno-associated viruses. Transgenic expression of GECIs promises important advantages, including homogeneous, repeatable, and stable expression without the need for invasive virus injections. Here we present the generation and characterization of transgenic mice expressing the GECIs GCaMP6s or GCaMP6f under the Thy1 promoter. We quantified GCaMP6 expression across brain regions and neurons and compared to other transgenic mice and AAV-mediated expression. We tested three mouse lines for imaging in the visual cortex in vivo and compared their performance to mice injected with AAV expressing GCaMP6. Furthermore, we show that GCaMP6 Thy1 transgenic mice are useful for long-term, high-sensitivity imaging in behaving mice.	[Dana, Hod; Chen, Tsai-Wen; Hu, Amy; Shields, Brenda C.; Guo, Caiying; Looger, Loren L.; Kim, Douglas S.; Svoboda, Karel] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Svoboda, K (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	svobodak@janelia.hhmi.org		Dana, Hod/0000-0002-8093-2363; Chen, Tsai-Wen/0000-0001-6782-3819; Kim, Douglas/0000-0001-9029-314X	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Funding provided by Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Atkin SD, 2009, J NEUROSCI METH, V181, P212, DOI 10.1016/j.jneumeth.2009.05.006; Behringer R., 2013, MANIPULATING MOUSE E; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Chen Q, 2012, NEURON, V76, P297, DOI 10.1016/j.neuron.2012.07.011; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Diez-Garcia J, 2005, EUR J NEUROSCI, V22, P627, DOI 10.1111/j.1460-9568.2005.04250.x; Direnberger S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2035; Donello JE, 1998, J VIROL, V72, P5085, DOI 10.1128/JVI.72.6.5085-5092.1998; Dong H.W., 2008, ALLEN REFERENCE ATLA; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Guo ZCV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088678; Guo ZCV, 2014, NEURON, V81, P179, DOI 10.1016/j.neuron.2013.10.020; Hasan MT, 2004, PLOS BIOL, V2, P763, DOI 10.1371/journal.pbio.0020163; Heim N, 2007, NAT METHODS, V4, P127, DOI 10.1038/nmeth1009; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Hires SA, 2008, BRAIN CELL BIOL, V36, P69, DOI 10.1007/s11068-008-9029-4; Horikawa K, 2010, NAT METHODS, V7, P729, DOI 10.1038/nmeth.1488; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Loeb JE, 1999, HUM GENE THER, V10, P2295, DOI 10.1089/10430349950016942; Margolis DJ, 2012, NAT NEUROSCI, V15, P1539, DOI 10.1038/nn.3240; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Peters AJ, 2014, NATURE, V510, P263, DOI 10.1038/nature13235; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tallini YN, 2007, CIRC RES, V101, P1300, DOI 10.1161/CIRCRESAHA.107.149484; Thestrup T, 2014, NAT METHODS, V11, P175, DOI [10.1038/NMETH.2773, 10.1038/nmeth.2773]; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wallace DJ, 2008, NAT METHODS, V5, P797, DOI 10.1038/NMETH.1242; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012	38	269	269	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108697	10.1371/journal.pone.0108697	http://dx.doi.org/10.1371/journal.pone.0108697			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250714	gold, Green Published, Green Submitted			2022-12-25	WOS:000342492700151
J	Martin, PR; Ghalambor, CK				Martin, Paul R.; Ghalambor, Cameron K.			When David Beats Goliath: The Advantage of Large Size in Interspecific Aggressive Contests Declines over Evolutionary Time	PLOS ONE			English	Article							COMPETITION; ORGANIZATION; ECOLOGY; NECTAR; WOODCREEPERS; HUMMINGBIRDS; MORPHOLOGY; PATTERNS; BEHAVIOR; BIRDS	Body size has long been recognized to play a key role in shaping species interactions. For example, while small species thrive in a diversity of environments, they typically lose aggressive contests for resources with larger species. However, numerous examples exist of smaller species dominating larger species during aggressive interactions, suggesting that the evolution of traits can allow species to overcome the competitive disadvantage of small size. If these traits accumulate as lineages diverge, then the advantage of large size in interspecific aggressive interactions should decline with increased evolutionary distance. We tested this hypothesis using data on the outcomes of 23,362 aggressive interactions among 246 bird species pairs involving vultures at carcasses, hummingbirds at nectar sources, and antbirds and woodcreepers at army ant swarms. We found the advantage of large size declined as species became more evolutionarily divergent, and smaller species were more likely to dominate aggressive contests when interacting with more distantly-related species. These results appear to be caused by both the evolution of traits in smaller species that enhanced their abilities in aggressive contests, and the evolution of traits in larger species that were adaptive for other functions, but compromised their abilities to compete aggressively. Specific traits that may provide advantages to small species in aggressive interactions included well-developed leg musculature and talons, enhanced flight acceleration and maneuverability, novel fighting behaviors, and traits associated with aggression, such as testosterone and muscle development. Traits that may have hindered larger species in aggressive interactions included the evolution of morphologies for tree trunk foraging that compromised performance in aggressive contests away from trunks, and the evolution of migration. Overall, our results suggest that fundamental trade-offs, such as those associated with body size, are more likely to break down over evolutionary time, changing the rules that govern species interactions and structure ecological communities.	[Martin, Paul R.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Ghalambor, Cameron K.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Ghalambor, Cameron K.] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA	Queens University - Canada; Colorado State University; Colorado State University	Martin, PR (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	pm45@queensu.ca	Ghalambor, Cameron/V-4486-2019; Ghalambor, Cameron/HGE-0411-2022	Ghalambor, Cameron/0000-0003-2515-4981; 	Natural Sciences and Engineering Research Council of Canada [RGPIN/355519-2008]; Baillie Family Chair Endowment; Good Family Fellowship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Baillie Family Chair Endowment; Good Family Fellowship	The authors' work was funded by the Natural Sciences and Engineering Research Council of Canada (Discovery Grant RGPIN/355519-2008; www.nserc-crsng.gc.ca), a Baillie Family Chair Endowment, and a Good Family Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DL, 2006, AM NAT, V167, P216, DOI 10.1086/498622; Barton K., 2013, MUMIN MULTI MODEL IN; Bates D., 2011, IME4 LINEAR MIXED EF; Bonner J.T., 2006, WHY SIZE MATTERS; BROWN JH, 1986, NATURE, V324, P248, DOI 10.1038/324248a0; BURGER J, 1978, CONDOR, V80, P15, DOI 10.2307/1367786; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; COLE BJ, 1983, J ANIM ECOL, V52, P339, DOI 10.2307/4557; del Hoyo J., 2003, HDB BIRDS WORLD, V8; Del Hoyo J, 1999, HDB BIRDS WORLD, V5; DesGranges J.-L., 1980, MIGRANT BIRDS NEOTRO, P395; DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B; Donadio E, 2006, AM NAT, V167, P524, DOI 10.1086/501033; FEINSINGER P, 1979, AM NAT, V113, P481, DOI 10.1086/283408; FEINSINGER P, 1975, AM NAT, V109, P217, DOI 10.1086/282988; FEINSINGER P, 1978, AM ZOOL, V18, P779; FEINSINGER P, 1976, ECOL MONOGR, V46, P257, DOI 10.2307/1942255; FEINSINGER P, 1985, ECOL MONOGR, V55, P1, DOI 10.2307/1942523; Freshwater C, 2014, ECOLOGY, V95, P2334, DOI 10.1890/13-2016.1; Gelman A., 2014, ARM DATA ANAL USING; GILL FB, 1982, IBIS, V124, P44, DOI 10.1111/j.1474-919X.1982.tb03739.x; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hino Teruaki, 2005, Ornithological Science, V4, P89, DOI 10.2326/osj.4.89; KODRICBROWN A, 1978, ECOLOGY, V59, P285, DOI 10.2307/1936374; Konig C., 1983, P153; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEISLER B, 1992, IBIS, V134, P77; LENSKI RE, 1988, EVOLUTION, V42, P433, DOI 10.1111/j.1558-5646.1988.tb04150.x; LYON DL, 1976, WILSON BULL, V88, P280; Maddison W.P., 1986, MACCLADE VERSION 10; Martin PR, 2015, INTEGRATIVE ORGANISMAL BIOLOGY, P291; MORSE DH, 1974, AM NAT, V108, P818, DOI 10.1086/282957; ORIANS GH, 1961, ECOL MONOGR, V31, P285, DOI 10.2307/1948556; ORIANS GH, 1963, EVOLUTION, V17, P449, DOI 10.1111/j.1558-5646.1963.tb03301.x; Pinheiro JC, 2012, NLME LINEAR NONLINEA, P1; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; R Core Team, 2014, R LANG ENV STAT COMP; Ripley B, 2012, SUPPORT FUNCTIONS DA; SHARP WARD M., 1957, JOUR WILDLIFE MANAGEMENT, V21, P242, DOI 10.2307/3797597; Stiles F.G., 1973, University of California Publications Zoology, V97, P1; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanner CJ, 2009, ANIM BEHAV, V77, P297, DOI 10.1016/j.anbehav.2008.10.016; Thompson J. N., 2005, INTERSPEC INTERACT; Violle C, 2011, ECOL LETT, V14, P782, DOI 10.1111/j.1461-0248.2011.01644.x; WALLACE MP, 1987, AUK, V104, P290, DOI 10.1093/auk/104.2.290; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; White C.M., 1994, NEW WORLD VULTURES G; Willis E. O., 1966, Living Bird, V5, P187; WILLIS E O, 1979, Papeis Avulsos de Zoologia (Sao Paulo), V33, P27; WILLIS E O, 1983, Revista Brasileira de Biologia, V43, P133; WILLIS EDWIN O., 1967, UNIV CALIF PUBL ZOOL, V79, P1; WILLIS EO, 1978, ANNU REV ECOL SYST, V9, P243, DOI 10.1146/annurev.es.09.110178.001331; WILLIS EO, 1982, CONDOR, V84, P272, DOI 10.2307/1367369; WILLIS EO, 1972, WILSON BULL, V84, P377; Willis EO, 1992, ZOOLOGIA, V8, P151; Zuur Alain F., 2009, P1	58	45	45	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108741	10.1371/journal.pone.0108741	http://dx.doi.org/10.1371/journal.pone.0108741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250781	Green Submitted, Green Published, gold			2022-12-25	WOS:000342492700153
J	Miotto, LS; de Rezende, CA; Bernardes, A; Serpa, VI; Tsang, A; Polikarpov, I				Miotto, Lis Schwartz; de Rezende, Camila Alves; Bernardes, Amanda; Serpa, Viviane Isabel; Tsang, Adrian; Polikarpov, Igor			The Characterization of the Endoglucanase Cel12A from Gloeophyllum trabeum Reveals an Enzyme Highly Active on beta-Glucan	PLOS ONE			English	Article							SUBSTRATE-SPECIFICITY; MIXED-LINKAGE; FAMILY 12; ASPERGILLUS; PURIFICATION; CELLULASES; EXPRESSION; CELLULOSE; CLONING; DEGRADATION	The basidiomycete fungus Gloeophyllum trabeum causes a typical brown rot and is known to use reactive oxygen species in the degradation of cellulose. The extracellular Cel12A is one of the few endo-1,4-beta-glucanase produced by G. trabeum. Here we cloned cel12A and heterologously expressed it in Aspergillus niger. The identity of the resulting recombinant protein was confirmed by mass spectrometry. We used the purified GtCel12A to determine its substrate specificity and basic biochemical properties. The G. trabeum Cel12A showed highest activity on beta-glucan, followed by lichenan, carboxymethylcellulose, phosphoric acid swollen cellulose, microcrystalline cellulose, and filter paper. The optimal pH and temperature for enzymatic activity were, respectively, 4.5 and 50 degrees C on beta-glucan. Under these conditions specific activity was 239.2 +/- 9.1 U mg(-1) and the half-life of the enzyme was 84.6 +/- 3.5 hours. Thermofluor studies revealed that the enzyme was most thermal stable at pH 3. Using beta-glucan as a substrate, the K-m was 3.2 +/- 0.5 mg mL(-1) and the V-max was 0.41 +/- 0.02 mu mol min(-1). Analysis of the effects of GtCel12A on oat spelt and filter paper by scanning electron microscopy revealed the morphological changes taking place during the process.	[Miotto, Lis Schwartz; Bernardes, Amanda; Serpa, Viviane Isabel; Polikarpov, Igor] Univ Sao Paulo, Inst Fis Sao Carlos, Grp Biotecnol Mol, BR-05508 Sao Paulo, Brazil; [de Rezende, Camila Alves] Univ Estadual Campinas, Inst Quim, Campinas, SP, Brazil; [Tsang, Adrian] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada	Universidade de Sao Paulo; Universidade Estadual de Campinas; Concordia University - Canada	Polikarpov, I (corresponding author), Univ Sao Paulo, Inst Fis Sao Carlos, Grp Biotecnol Mol, BR-05508 Sao Paulo, Brazil.	ipolikarpov@ifsc.usp.br	Polikarpov, Igor/D-2575-2012; Rezende, Camila/C-3914-2012; Bernardes, Amanda/H-8910-2012	Rezende, Camila/0000-0002-2072-1361; Polikarpov, Igor/0000-0001-9496-4174	Brazilian funding agency Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/56255-9, 2009/52840-7, 2010/52362-5, 2012/22802-9, 2009/08233-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [490022/2009-0]	Brazilian funding agency Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding provided via grants from Brazilian funding agency Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) #2008/56255-9, 2009/52840-7, 2010/52362-5, 2012/22802-9 to IP and #2009/08233-9 to LSM and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) via grant #490022/2009-0 to IP. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Bauer MW, 1999, J BACTERIOL, V181, P284, DOI 10.1128/JB.181.1.284-290.1999; Birsan C, 1998, BIOCHEM SOC T, V26, P156, DOI 10.1042/bst0260156; Bok JD, 1998, APPL ENVIRON MICROB, V64, P4774; Buckeridge MS, 2004, CEREAL CHEM, V81, P115, DOI 10.1094/CCHEM.2004.81.1.115; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CARPITA NC, 1984, PLANT PHYSIOL, V76, P205, DOI 10.1104/pp.76.1.205; Cohen R, 2005, APPL ENVIRON MICROB, V71, P2412, DOI 10.1128/AEM.71.5.2412-2417.2005; Debets AJM, 1986, FUNGAL GENET NEWSL, V33, P44, DOI [10.4148/1941-4765.1575, DOI 10.4148/1941-4765.1575]; dos Santos WD, 2011, ROUTES TO CELLULOSIC ETHANOL, P15, DOI 10.1007/978-0-387-92740-4_2; Dourado F, 1998, J ADHES SCI TECHNOL, V12, P1081, DOI 10.1163/156856198X00740; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Gama FM, 1997, BIOCATAL BIOTRANSFOR, V15, P221, DOI 10.3109/10242429709103511; Gloster TM, 2007, J BIOL CHEM, V282, P19177, DOI 10.1074/jbc.M700224200; Goodell B, 2003, ACS SYM SER, V845, P97; Grishutin SG, 2006, CARBOHYD RES, V341, P218, DOI 10.1016/j.carres.2005.11.011; Henriksson G, 1999, EUR J BIOCHEM, V259, P88, DOI 10.1046/j.1432-1327.1999.00011.x; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Kuhad Ramesh Chander, 2011, Enzyme Res, V2011, P280696, DOI 10.4061/2011/280696; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Murphy C, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar020; Pauly M, 1999, GLYCOBIOLOGY, V9, P93, DOI 10.1093/glycob/9.1.93; Prates ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059069; Ragaee SM, 2008, CEREAL CHEM, V85, P283, DOI 10.1094/CCHEM-85-3-0283; Sandgren M, 2001, J MOL BIOL, V308, P295, DOI 10.1006/jmbi.2001.4583; Schulein M, 1997, J BIOTECHNOL, V57, P71, DOI 10.1016/S0168-1656(97)00090-4; Shimokawa T, 2008, APPL ENVIRON MICROB, V74, P5857, DOI 10.1128/AEM.00435-08; Sims REH, 2010, BIORESOURCE TECHNOL, V101, P1570, DOI 10.1016/j.biortech.2009.11.046; Storms R, 2005, PLASMID, V53, P191, DOI 10.1016/j.plasmid.2004.10.001; Tambor JH, 2012, APPL MICROBIOL BIOT, V93, P203, DOI 10.1007/s00253-011-3419-8; Tiwari U, 2009, CEREAL CHEM, V86, P290, DOI 10.1094/CCHEM-86-3-0290; Vincken JP, 1997, CARBOHYD RES, V298, P299, DOI 10.1016/S0008-6215(96)00325-4; Wicher KB, 2001, APPL MICROBIOL BIOT, V55, P578, DOI 10.1007/s002530000559; WOOD PJ, 1994, CARBOHYD POLYM, V25, P331, DOI 10.1016/0144-8617(94)90059-0; WOOD PJ, 1978, CEREAL CHEM, V55, P952; WOOD TM, 1988, METHOD ENZYMOL, V160, P87; WOOD TM, 1988, METHOD ENZYMOL, V160, P19	38	23	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108393	10.1371/journal.pone.0108393	http://dx.doi.org/10.1371/journal.pone.0108393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251390	Green Published, gold, Green Submitted			2022-12-25	WOS:000342492700123
J	Pace, J; Lee, N; Naik, HS; Ganapathysubramanian, B; Lubberstedt, T				Pace, Jordon; Lee, Nigel; Naik, Hsiang Sing; Ganapathysubramanian, Baskar; Luebberstedt, Thomas			Analysis of Maize (Zea mays L.) Seedling Roots with the High-Throughput Image Analysis Tool ARIA (Automatic Root Image Analysis)	PLOS ONE			English	Article							SOFTWARE; SYSTEM; TRAITS; GROWTH; ASSOCIATION; ARCHITECTURE; PLATFORM; FIELD; RHIZO	The maize root system is crucial for plant establishment as well as water and nutrient uptake. There is substantial genetic and phenotypic variation for root architecture, which gives opportunity for selection. Root traits, however, have not been used as selection criterion mainly due to the difficulty in measuring them, as well as their quantitative mode of inheritance. Seedling root traits offer an opportunity to study multiple individuals and to enable repeated measurements per year as compared to adult root phenotyping. We developed a new software framework to capture various traits from a single image of seedling roots. This framework is based on the mathematical notion of converting images of roots into an equivalent graph. This allows automated querying of multiple traits simply as graph operations. This framework is furthermore extendable to 3D tomography image data. In order to evaluate this tool, a subset of the 384 inbred lines from the Ames panel, for which extensive genotype by sequencing data are available, was investigated. A genome wide association study was applied to this panel for two traits, Total Root Length and Total Surface Area, captured from seedling root images from WinRhizo Pro 9.0 and the current framework (called ARIA) for comparison using 135,311 single nucleotide polymorphism markers. The trait Total Root Length was found to have significant SNPs in similar regions of the genome when analyzed by both programs. This high-throughput trait capture software system allows for large phenotyping experiments and can help to establish relationships between developmental stages between seedling and adult traits in the future.	[Pace, Jordon; Luebberstedt, Thomas] Iowa State Univ, Dept Agron, Ames, IA 50011 USA; [Lee, Nigel; Naik, Hsiang Sing; Ganapathysubramanian, Baskar] Iowa State Univ, Dept Mech Engn, Ames, IA USA	Iowa State University; Iowa State University	Pace, J (corresponding author), Iowa State Univ, Dept Agron, Ames, IA 50011 USA.	jmpace1@iastate.edu		Lubberstedt, Thomas/0000-0002-0526-0798	National Science Foundation [EPS-1101284, CMMI-1149365]	National Science Foundation(National Science Foundation (NSF))	National Science Foundation Grant Number EPS-1101284 and CMMI-1149365. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghani AH, 2013, EUPHYTICA, V189, P123, DOI 10.1007/s10681-012-0759-0; Aiken RM, 1996, ANNU REV PHYTOPATHOL, V34, P325, DOI 10.1146/annurev.phyto.34.1.325; Armengaud P, 2009, PLANT J, V57, P945, DOI 10.1111/j.1365-313X.2008.03739.x; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brewer MT, 2006, PLANT PHYSIOL, V141, P15, DOI 10.1104/pp.106.077867; Chavarria-Krauser A, 2008, NEW PHYTOL, V177, P811, DOI 10.1111/j.1469-8137.2007.02299.x; Clark RT, 2013, PLANT CELL ENVIRON, V36, P454, DOI 10.1111/j.1365-3040.2012.02587.x; Clark RT, 2011, PLANT PHYSIOL, V156, P455, DOI 10.1104/pp.110.169102; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Feldman L., 1994, P29; Furbank RT, 2011, TRENDS PLANT SCI, V16, P635, DOI 10.1016/j.tplants.2011.09.005; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gruber BD, 2013, PLANT PHYSIOL, V163, P161, DOI 10.1104/pp.113.218453; Hake S.C., 2009, HDB MAIZE ITS BIOL; Hammer GL, 2009, CROP SCI, V49, P299, DOI 10.2135/cropsci2008.03.0152; HOPPE DC, 1986, CAN J BOT, V64, P2524, DOI 10.1139/b86-335; Iyer-Pascuzzi AS, 2010, PLANT PHYSIOL, V152, P1148, DOI 10.1104/pp.109.150748; JORDAN WR, 1983, AGR WATER MANAGE, V7, P281, DOI 10.1016/0378-3774(83)90090-2; KNUTH DE, 1977, INFORM PROCESS LETT, V6, P1, DOI 10.1016/0020-0190(77)90002-3; Landi P, 1998, MAYDICA, V43, P111; Landi P, 2001, MAYDICA, V46, P177; Le Bot J, 2010, PLANT SOIL, V326, P261, DOI 10.1007/s11104-009-0005-2; Liu JC, 2008, PLANT SOIL, V305, P253, DOI 10.1007/s11104-008-9562-z; Lobet G, 2011, PLANT PHYSIOL, V157, P29, DOI 10.1104/pp.111.179895; LYNCH J, 1995, PLANT PHYSIOL, V109, P7, DOI 10.1104/pp.109.1.7; Meuwissen THE, 2001, GENETICS, V157, P1819; Nagel KA, 2012, FUNCT PLANT BIOL, V39, P891, DOI 10.1071/FP12023; NASS HG, 1971, CROP SCI, V11, P655, DOI 10.2135/cropsci1971.0011183X001100050015x; Pritchard JK, 2000, GENETICS, V155, P945; Romay MC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r55; Salvi RTaS, 2007, QTLS GEN CONTR ROOT, P13; Samudrala S, 2013, COMP MATER SCI, V77, P335, DOI 10.1016/j.commatsci.2013.04.038; Trachsel S, 2011, PLANT SOIL, V341, P75, DOI 10.1007/s11104-010-0623-8; Wang LY, 2009, PLANT PHYSIOL, V149, P1632, DOI 10.1104/pp.108.134072; Wodo O, 2013, ENERG ENVIRON SCI, V6, P3060, DOI 10.1039/c3ee41224e; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zeng G, 2008, NEW PHYTOL, V177, P549, DOI 10.1111/j.1469-8137.2007.02271.x; Zhu JM, 2006, THEOR APPL GENET, V113, P1, DOI 10.1007/s00122-006-0260-z	39	61	63	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108255	10.1371/journal.pone.0108255	http://dx.doi.org/10.1371/journal.pone.0108255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251072	gold, Green Published, Green Submitted			2022-12-25	WOS:000342492700103
J	Yanala, UR; Johanning, JM; Pipinos, II; Larsen, G; Velander, WH; Carlson, MA				Yanala, Ujwal R.; Johanning, Jason M.; Pipinos, Iraklis I.; Larsen, Gustavo; Velander, William H.; Carlson, Mark A.			Development of a Fatal Noncompressible Truncal Hemorrhage Model with Combined Hepatic and Portal Venous Injury in Normothermic Normovolemic Swine	PLOS ONE			English	Article							COMBAT CASUALTY CARE; OPERATION-IRAQI-FREEDOM; FIBRIN SEALANT FOAM; FLUID RESUSCITATION; LIVER-INJURIES; CLOSED-ABDOMEN; BLOOD-LOSS; DEATH; TRAUMA; WOUNDS	Noncompressible truncal hemorrhage and brain injury currently account for most early mortality of warfighters on the battlefield. There is no effective treatment for noncompressible truncal hemorrhage, other than rapid evacuation to a surgical facility. The availability of an effective field treatment for noncompressible truncal hemorrhage could increase the number of warfighters salvaged from this frequently-lethal scenario. Our intent was to develop a porcine model of noncompressible truncal hemorrhage with a similar to 50% one-hour mortality so that we could develop new treatments for this difficult problem. Normovolemic normothermic domestic swine (barrows, 3 months old, 34-36 kg) underwent one of three injury types through a midline incision: 1) central stellate injury (N = 6); 2) excision of a portal vein branch distal to the main PV trunk (N = 6); or 3) hemi-transection of the left lateral lobe of the liver at its base (N = 10). The one-hour mortality of these injuries was 0, 82, and 40%, respectively; the final mean arterial pressure was 65, 24, and 30 mm Hg, respectively; and the final hemoglobin was 8.3, 2.3, and 3.6 g/dL, respectively. Hemi-transection of the left lateral lobe of the liver appeared to target our desired mortality rate better than the other injury mechanisms.	[Yanala, Ujwal R.; Carlson, Mark A.] Univ Nebraska, Med Ctr, Dept Surg, Omaha, NE 68182 USA; [Johanning, Jason M.; Pipinos, Iraklis I.] Univ Nebraska, Med Ctr, Dept Vasc Surg, Omaha, NE USA; [Carlson, Mark A.] Univ Nebraska, Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA; [Yanala, Ujwal R.; Johanning, Jason M.; Pipinos, Iraklis I.; Carlson, Mark A.] VA Nebraska Western Iowa Hlth Care Syst, Dept Surg, Omaha, NE USA; [Larsen, Gustavo; Velander, William H.] Univ Nebraska, Dept Chem & Biomol Engn, Lincoln, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; University of Nebraska System; University of Nebraska Lincoln	Carlson, MA (corresponding author), Univ Nebraska, Med Ctr, Dept Surg, Omaha, NE 68182 USA.	macarlso@unmc.edu	yanala, ujwal/AGE-1225-2022	Pipinos, Iraklis/0000-0001-6873-6346; Yanala, Ujwal/0000-0002-1344-9208	United States Army [W81XWH-11-1-0836]	United States Army(United States Department of DefenseUnited States Army)	This study was supported by a grant from the United States Army (http://www.usamraa.army.mil) to MAC, contract number W81XWH-11-1-0836. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Veterinary Medical Association Panel on Euthanasia, 2013, AVMA GUID EUTH AN; Bebarta VS, 2013, J TRAUMA ACUTE CARE, V75, P920, DOI 10.1097/TA.0b013e3182a539b8; BELLAMY RF, 1986, ANN EMERG MED, V15, P1384, DOI 10.1016/S0196-0644(86)80920-9; BELLAMY RF, 1984, MIL MED, V149, P55; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Blackbourne LH, 2012, J TRAUMA ACUTE CARE, V73, pS372, DOI 10.1097/TA.0b013e3182755662; Blackbourne LH, 2010, J TRAUMA, V69, pS1, DOI 10.1097/TA.0b013e3181e4206f; Burris D, 1999, J TRAUMA, V46, P216, DOI 10.1097/00005373-199902000-00003; BUSH JA, 1955, AM J PHYSIOL, V181, P9, DOI 10.1152/ajplegacy.1955.181.1.9; Butler F, 2011, J TRAUMA, V70, pS11, DOI 10.1097/TA.0b013e31821a4b90; Butler FK, 2012, J TRAUMA ACUTE CARE, V73, pS395, DOI 10.1097/TA.0b013e3182754850; Calcaterra J, 2013, BIOMACROMOLECULES, V14, P169, DOI 10.1021/bm301579p; Carlson MA, 2014, J SURG RES, V187, P334, DOI 10.1016/j.jss.2013.09.039; Chambers LW, 2006, J TRAUMA, V60, P1155, DOI 10.1097/01.ta.0000220340.91356.7e; Chandler WL, 1995, SEMIN THROMB HEMOST, V21, P1; Devlin JJ, 2009, J TRAUMA, V67, P895, DOI 10.1097/TA.0b013e3181b837ab; Duggan M, 2013, J TRAUMA ACUTE CARE, V74, P1462, DOI 10.1097/TA.0b013e31828da937; Duggan MJ, 2014, J SURG RES, V187, P536, DOI 10.1016/j.jss.2013.12.005; Duggan MJ, 2013, J SURG RES, V182, P101, DOI 10.1016/j.jss.2012.07.048; Dutton RP, 2002, J TRAUMA, V52, P1141, DOI 10.1097/00005373-200206000-00020; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Eastridge BJ, 2011, J TRAUMA, V71, pS4, DOI 10.1097/TA.0b013e318221147b; Frith D, 2012, THROMB RES, V129, P551, DOI 10.1016/j.thromres.2011.11.053; Gerhardt RT, 2012, FUNDAMENTALS COMBAT; Holcomb JB, 2003, J TRAUMA, V54, pS46, DOI 10.1097/01.TA.0000051936.91915.A2; Holcomb JB, 1999, J TRAUMA, V46, P49, DOI 10.1097/00005373-199901000-00009; Holcomb JB, 2000, J TRAUMA, V49, P246, DOI 10.1097/00005373-200008000-00010; Holcomb JB, 2007, ANN SURG, V245, P986, DOI 10.1097/01.sla.0000259433.03754.98; Katzenell U, 2012, MIL MED, V177, P1065, DOI 10.7205/MILMED-D-12-00161; Kelly JF, 2008, J TRAUMA, V64, pS21, DOI 10.1097/TA.0b013e318160b9fb; Kheirabadi BS, 2008, J SURG RES, V144, P145, DOI 10.1016/j.jss.2007.02.012; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Lowe GDO, 2004, ANN CLIN BIOCHEM, V41, P430, DOI 10.1258/0004563042466884; McSwain NE, 2011, J TRAUMA, V70, pS2, DOI 10.1097/TA.0b013e31821b201d; Morrison JJ, 2013, J TRAUMA ACUTE CARE, V75, pS263, DOI 10.1097/TA.0b013e318299da0a; National Research Council, 2011, GUIDE CARE USE LAB A, DOI [10.17226/12910, DOI 10.17226/12910]; Neter J, 1990, APPL LINEAR STAT MOD; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Peev MP, 2014, J TRAUMA ACUTE CARE, V76, P619, DOI 10.1097/TA.0000000000000126; Pusateri AE, 2006, J TRAUMA, V60, P674, DOI 10.1097/01.ta.0000196672.47783.fd; Simmons JW, 2011, J TRAUMA, V71, pS82, DOI 10.1097/TA.0b013e3182218ddb; United States Department of Agriculture, 2013, AN WELF ACT AN WELF; Wachtel TL, 1972, 734 US ARM AER RES L; White JM, 2011, ANN SURG, V253, P1184, DOI 10.1097/SLA.0b013e31820752e3; White JM, 2011, J TRAUMA, V71, pS131, DOI 10.1097/TA.0b013e3182219302	45	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108293	10.1371/journal.pone.0108293	http://dx.doi.org/10.1371/journal.pone.0108293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251401	Green Submitted, Green Published, gold			2022-12-25	WOS:000342492700107
J	Huang, YC; Wei, KC; Chang, CN; Chen, PY; Hsu, PW; Chen, CP; Lu, CS; Wang, HL; Gutmann, DH; Yeh, TH				Huang, Yin-Cheng; Wei, Kuo-Chen; Chang, Chen-Nen; Chen, Pin-Yuan; Hsu, Peng-Wei; Chen, Carl P.; Lu, Chin-Song; Wang, Hung-Li; Gutmann, David H.; Yeh, Tu-Hsueh			Transglutaminase 2 Expression Is Increased as a Function of Malignancy Grade and Negatively Regulates Cell Growth in Meningioma	PLOS ONE			English	Article							REVEALS; MARKER; TGM2; NF2; CLASSIFICATION; PROGRESSION	Most meningiomas are benign, but some clinical-aggressive tumors exhibit brain invasion and cannot be resected without significant complications. To identify molecular markers for these clinically-aggressive meningiomas, we performed microarray analyses on 24 primary cultures from 21 meningiomas and 3 arachnoid membranes. Using this approach, increased transglutaminase 2 (TGM2) expression was observed, which was subsequently validated in an independent set of 82 meningiomas by immunohistochemistry. Importantly, the TGM2 expression level was associated with increasing WHO malignancy grade as well as meningioma recurrence. Inhibition of TGM2 function by siRNA or cystamine induced meningioma cell death, which was associated with reduced AKT phosphorylation and caspase-3 activation. Collectively, these findings suggest that TGM2 expression increases as a function of malignancy grade and tumor recurrence and that inhibition of TGM2 reduces meningioma cell growth.	[Huang, Yin-Cheng; Wei, Kuo-Chen; Chang, Chen-Nen; Chen, Pin-Yuan; Hsu, Peng-Wei] Chang Gung Mem Hosp Linkou, Dept Neurosurg, Taoyuan, Taiwan; [Lu, Chin-Song; Yeh, Tu-Hsueh] Chang Gung Mem Hosp Linkou, Dept Neurol, Taoyuan, Taiwan; [Lu, Chin-Song; Yeh, Tu-Hsueh] Chang Gung Mem Hosp Linkou, Neurosci Res Ctr, Taoyuan, Taiwan; [Chen, Carl P.] Chang Gung Mem Hosp Linkou, Dept Rehabil, Taoyuan, Taiwan; [Huang, Yin-Cheng; Wei, Kuo-Chen; Chang, Chen-Nen; Chen, Pin-Yuan; Hsu, Peng-Wei; Chen, Carl P.; Lu, Chin-Song; Wang, Hung-Li; Yeh, Tu-Hsueh] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Gutmann, David H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO USA	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Washington University (WUSTL)	Yeh, TH (corresponding author), Chang Gung Mem Hosp Linkou, Dept Neurol, Taoyuan, Taiwan.	do2739@adm.cgmh.org.tw	Yeh, Tu-Hsueh/H-4700-2019	Wei, Kuochen/0000-0003-3505-2196; Gutmann, David/0000-0002-3127-5045	National Science Council Taiwan [NSC 100-2314-B-182A-015-MY3, NSC 100-2321-B-182A-001]; Chang Gung Medical Foundation Taiwan [CMRPG392052, CMRPG392201]	National Science Council Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Medical Foundation Taiwan	This work was supported by the National Science Council Taiwan (NSC 100-2314-B-182A-015-MY3 to Y.H.; NSC 100-2321-B-182A-001- to T.Y.) and the Chang Gung Medical Foundation Taiwan (grant number CMRPG392052 to Y. H.; CMRPG392201 to T.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarhus M, 2011, ACTA NEUROCHIR, V153, P447, DOI 10.1007/s00701-010-0906-0; Ai LB, 2008, CARCINOGENESIS, V29, P510, DOI 10.1093/carcin/bgm280; Choi CM, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-119; Commins Deborah L, 2007, Neurosurg Focus, V23, pE3; Deshmukh H, 2008, ONCOGENE, V27, P4745, DOI 10.1038/onc.2008.110; Fu J, 2013, NEURO-ONCOLOGY, V15, P1353, DOI 10.1093/neuonc/not079; Fujisawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034437; Goutagny S, 2010, CLIN CANCER RES, V16, P4155, DOI 10.1158/1078-0432.CCR-10-0891; HITCHCOCK E, 1987, J NEURO-ONCOL, V5, P357, DOI 10.1007/BF00148393; Jin T, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-64; Kalamarides M, 2011, ONCOGENE, V30, P2333, DOI 10.1038/onc.2010.609; Kalamarides M, 2008, BRAIN PATHOL, V18, P62, DOI 10.1111/j.1750-3639.2007.00105.x; Kim DS, 2009, CANCER LETT, V273, P243, DOI 10.1016/j.canlet.2008.08.015; Kruger U, 2007, OLIGONUCLEOTIDES, V17, P237, DOI 10.1089/oli.2006.0065; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Martinez-Glez V, 2009, INT J ONCOL, V34, P493, DOI 10.3892/ijo_00000174; Mawrin C, 2010, J NEURO-ONCOL, V99, P379, DOI 10.1007/s11060-010-0342-2; Miyoshi N, 2010, ANN SURG ONCOL, V17, P967, DOI 10.1245/s10434-009-0865-y; Park KS, 2010, J CANCER RES CLIN, V136, P493, DOI 10.1007/s00432-009-0681-6; Peyre M, 2013, ONCOGENE, V32, P4264, DOI 10.1038/onc.2012.436; Riemenschneider MJ, 2006, LANCET NEUROL, V5, P1045, DOI 10.1016/S1474-4422(06)70625-1; Sasaki T, 2003, NEUROSURGERY, V52, P892, DOI 10.1227/01.NEU.0000053368.73552.BB; SCHNITT SJ, 1986, AM J SURG PATHOL, V10, P640, DOI 10.1097/00000478-198609000-00006; Siegel M, 2007, PHARMACOL THERAPEUT, V115, P232, DOI 10.1016/j.pharmthera.2007.05.003; Sun YL, 2008, J PROTEOME RES, V7, P3847, DOI 10.1021/pr800153s; TANAKA K, 1989, CANCER, V64, P2243, DOI 10.1002/1097-0142(19891201)64:11<2243::AID-CNCR2820641110>3.0.CO;2-S; Wang Tzu-Hao, 2004, Chang Gung Med J, V27, P243; Wang XL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036663, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0040084, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0045036, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045380]; Wang Z, 2012, AMINO ACIDS, V42, P939, DOI 10.1007/s00726-011-1008-x; Wiemels J, 2010, J NEURO-ONCOL, V99, P307, DOI 10.1007/s11060-010-0386-3; Yuan L, 2007, ONCOGENE, V26, P2563, DOI 10.1038/sj.onc.1210048; Yuan L, 2005, MOL CANCER THER, V4, P1293, DOI 10.1158/1535-7163.MCT-04-0328; Yuan LY, 2011, J NEURO-ONCOL, V103, P207, DOI 10.1007/s11060-010-0379-2	33	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108228	10.1371/journal.pone.0108228	http://dx.doi.org/10.1371/journal.pone.0108228			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247996	Green Published, Green Submitted, gold			2022-12-25	WOS:000342351800072
J	Vishram, JKK; Borglykke, A; Andreasen, AH; Jeppesen, J; Ibsen, H; Jorgensen, T; Palmieri, L; Giampaoli, S; Donfrancesco, C; Kee, F; Mancia, G; Cesana, G; Kuulasmaa, K; Salomaa, V; Sans, S; Ferrieres, J; Dallongeville, J; Soderberg, S; Arveiler, D; Wagner, A; Tunstall-Pedoe, H; Drygas, W; Olsen, MH				Vishram, Julie K. K.; Borglykke, Anders; Andreasen, Anne H.; Jeppesen, Jorgen; Ibsen, Hans; Jorgensen, Torben; Palmieri, Luigi; Giampaoli, Simona; Donfrancesco, Chiara; Kee, Frank; Mancia, Giuseppe; Cesana, Giancarlo; Kuulasmaa, Kari; Salomaa, Veikko; Sans, Susana; Ferrieres, Jean; Dallongeville, Jean; Soderberg, Stefan; Arveiler, Dominique; Wagner, Aline; Tunstall-Pedoe, Hugh; Drygas, Wojciech; Olsen, Michael H.		MORGAM Project	Impact of Age and Gender on the Prevalence and Prognostic Importance of the Metabolic Syndrome and Its Components in Europeans. The MORGAM Prospective Cohort Project	PLOS ONE			English	Article							INTERNATIONAL-DIABETES-FEDERATION; CHOLESTEROL EDUCATION-PROGRAM; CARDIOVASCULAR-DISEASE; ALL-CAUSE; DIFFERENT DEFINITIONS; CRITICAL-APPRAISAL; RISK-FACTORS; MORTALITY; HEART; AMERICAN	Objective: To investigate the influence of age and gender on the prevalence and cardiovascular disease (CVD) risk in Europeans presenting with the Metabolic Syndrome (MetS). Methods: Using 36 cohorts from the MORGAM-Project with baseline between 1982-1997, 69094 men and women aged 19-78 years, without known CVD, were included. During 12.2 years of follow-up, 3.7%/2.1% of men/women died due to CVD. The corresponding percentages for fatal and nonfatal coronary heart disease (CHD) and stroke were 8.3/3.8 and 3.1/2.5. Results: The prevalence of MetS, according to modified definitions of the International Diabetes Federation (IDF) and the revised National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATPIII), increased across age groups for both genders (P<0.0001); with a 5-fold increase in women from ages 19-39 years to 60-78 years (7.4%/7.6% to 35.4%/37.6% for IDF/NCEP-ATPIII) and a 2-fold increase in men (5.3%/10.5% to 11.5%/21.8%). Using multivariate-adjusted Cox regressions, the associations between MetS and all three CVD events were significant (P<0.0001). For IDF/NCEP-ATPIII in men and women, hazard ratio (HR) for CHD was 1.60/1.62 and 1.93/2.03, for CVD mortality 1.73/1.65 and 1.77/2.06, and for stroke 1.51/1.53 and 1.58/1.77. Whereas in men the HRs for CVD events were independent of age (MetS*age, P>0.05), in women the HRs for CHD declined with age (HRs 3.23/3.98 to 1.55/1.56; MetS*age, P = 0.01/P = 0.001 for IDF/NCEP-ATPIII) while the HRs for stroke tended to increase (HRs 1.31/1.25 to 1.55/1.83; MetS*age, P>0.05). Conclusion: In Europeans, both age and gender influenced the prevalence of MetS and its prognostic significance. The present results emphasise the importance of being critical of MetS in its current form as a marker of CVD especially in women, and advocate for a redefinition of MetS taking into account age especially in women.	[Vishram, Julie K. K.; Jeppesen, Jorgen] Univ Copenhagen, Glostrup Hosp, Dept Internal Med, Glostrup, Denmark; [Vishram, Julie K. K.; Borglykke, Anders; Andreasen, Anne H.; Jorgensen, Torben] Univ Copenhagen, Glostrup Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Ibsen, Hans] Holbaek Univ Hosp, Div Cardiol, Holbaek, Denmark; [Palmieri, Luigi; Giampaoli, Simona] Natl Inst Hlth, Natl Ctr Epidemiol Surveillance & Hlth Promot, Cerebro & Cardiovasc Epidemiol Unit, Rome, Italy; [Kee, Frank] Queens Univ Belfast, UKCRC Ctr Excellence Publ Hlth Res NI, Belfast, Antrim, North Ireland; [Mancia, Giuseppe] Clin Med & Ist Auxolog Italiano, Milan, Italy; [Cesana, Giancarlo] Univ Milano Bicocca, Res Ctr Publ Hlth, Monza, Italy; [Kuulasmaa, Kari; Salomaa, Veikko] Natl Inst Hlth & Welf THL, Helsinki, Finland; [Sans, Susana] Dept Hlth, Barcelona, Spain; [Ferrieres, Jean] Toulouse Univ, Sch Med, Rangueil Hosp, Dept Cardiol, Toulouse, France; [Dallongeville, Jean] Inst Pasteur, F-59019 Lille, France; [Soderberg, Stefan] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Arveiler, Dominique; Wagner, Aline] Umea Univ, Ctr Heart, Umea, Sweden; [Arveiler, Dominique; Wagner, Aline] Univ Strasbourg, Fac Med, Dept Epidemiol & Publ Hlth, Strasbourg, France; [Tunstall-Pedoe, Hugh] Univ Dundee, Ninewells Hosp, Cardiovasc Epidemiol Unit, Dundee, Scotland; [Tunstall-Pedoe, Hugh] Sch Med, Dundee, Scotland; [Drygas, Wojciech] Natl Inst Cardiol, CVD Prevent & Hlth Promot, Dept Epidemiol, Warsaw, Poland; [Olsen, Michael H.] Odense Univ Hosp, Ctr Individualized Med Arterial Dis CIMA, Dept Endocrinol, DK-5000 Odense, Denmark; [Olsen, Michael H.] Northwest Univ, HART, Potchefstroom, South Africa	University of Copenhagen; University of Copenhagen; Istituto Superiore di Sanita (ISS); Queens University Belfast; IRCCS Istituto Auxologico Italiano; University of Milano-Bicocca; Finland National Institute for Health & Welfare; CHU de Toulouse; Universite de Franche-Comte; Universite Federale Toulouse Midi-Pyrenees (ComUE); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Umea University; Umea University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Dundee; University of Dundee; Institute of Cardiology - Poland; University of Southern Denmark; Odense University Hospital; North West University - South Africa	Vishram, JKK (corresponding author), Univ Copenhagen, Glostrup Hosp, Dept Internal Med, Glostrup, Denmark.	julievishram@hotmail.com	Sans, Susana/ABD-5378-2021; Olsen, Michael H/H-8176-2014; Söderberg, Stefan/AAG-3881-2019; PALMIERI, LUIGI/O-1845-2017; Jørgensen, Torben/Z-1335-2018; Drygas, Wojciech/GLR-9863-2022; Ferrieres, Jean/S-7993-2016; donfrancesco, chiara/K-1460-2016	Sans, Susana/0000-0002-0400-5197; Söderberg, Stefan/0000-0001-9225-1306; PALMIERI, LUIGI/0000-0002-4298-2642; Kuulasmaa, Kari/0000-0003-2165-1411; Ferrieres, Jean/0000-0001-6144-1297; Olsen, Michael Hecht/0000-0003-2230-5780; Jorgensen, Torben/0000-0001-9453-2830; Andreasen, Anne Helms/0000-0002-2350-9884; Drygas, Wojciech/0000-0002-4351-6459; donfrancesco, chiara/0000-0002-8040-5571	European Community [HEALTH-F4-2007-201413, HEALTH-F3-2010-242244]; Novo Nordisk Fonden [NNF13OC0003736] Funding Source: researchfish	European Community(European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors did not receive any funding for this study, but overall this work has been sustained by the MORGAM Project's current funding: European Community FP 7 projects ENGAGE (HEALTH-F4-2007-201413), and CHANCES (HEALTH-F3-2010-242244). This has supported central coordination, workshops and part of the activities of the MORGAM Data Centre, at THL in Helsinki, Finland. MORGAM Participating Centres are funded by regional and national governments, research councils, charities, and other local sources. Salary for JKV was partly covered by Interreg IVA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Ascaso JF, 2011, EUR J INTERN MED, V22, P177, DOI 10.1016/j.ejim.2010.12.011; ASPLUND K, 1988, ACTA MED SCAND, P26; Assmann G, 2007, AM J CARDIOL, V99, P541, DOI 10.1016/j.amjcard.2006.08.045; Athyros VG, 2005, DIABETES OBES METAB, V7, P397, DOI 10.1111/j.1463-1326.2004.00409.x; Bayturan O, 2010, ARCH INTERN MED, V170, P478, DOI 10.1001/archinternmed.2009.551; Benetos A, 2008, AM J CARDIOL, V102, P188, DOI 10.1016/j.amjcard.2008.03.037; Dekker JM, 2005, CIRCULATION, V112, P666, DOI 10.1161/CIRCULATIONAHA.104.516948; Esposito K, 2012, DIABETES CARE, V35, P2402, DOI 10.2337/dc12-0336; Evans A, 2005, INT J EPIDEMIOL, V34, P21, DOI 10.1093/ije/dyh327; Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; Ford ES, 2003, JAMA-J AM MED ASSOC, V287, P356; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Giampaoli S, 2009, PREV MED, V48, P525, DOI 10.1016/j.ypmed.2009.03.017; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hildrum B, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-220; Ho JS, 2008, AM J CARDIOL, V102, P689, DOI 10.1016/j.amjcard.2008.05.010; Hu G, 2004, ARCH INTERN MED, V164, P1066, DOI 10.1001/archinte.164.10.1066; Hunt KJ, 2004, CIRCULATION, V110, P1251, DOI 10.1161/01.CIR.0000140762.04598.F9; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lawlor DA, 2006, DIABETOLOGIA, V49, P41, DOI 10.1007/s00125-005-0040-3; Mancia G, 2008, J HYPERTENS, V26, P1602, DOI 10.1097/HJH.0b013e328302f10d; Mancia G, 2007, HYPERTENSION, V49, P40, DOI 10.1161/01.HYP.0000251933.22091.24; McNeill AM, 2005, DIABETES CARE, V28, P385, DOI 10.2337/diacare.28.2.385; MORGAM Manual, 2001, URNNBNFIFE20041529 M; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Niemela M, 2007, URNNBNFIFE20071495 M; Qiao Q, 2006, DIABETOLOGIA, V49, P2837, DOI 10.1007/s00125-006-0438-6; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Sarwar N, 2010, LANCET, V375, P1634, DOI 10.1016/S0140-6736(10)60545-4; Sattar N, 2008, LANCET, V371, P1927, DOI 10.1016/S0140-6736(08)60602-9; Sundstrom J, 2006, DIABETES CARE, V29, P1673, DOI 10.2337/dc06-0664; Tuntall-Pedoe H, 2003, MONICA MONOGRAPH MUL; Turnbull F, 2003, LANCET, V362, P1527; Vishram JKK, 2012, HYPERTENSION, V60, P1117, DOI 10.1161/HYPERTENSIONAHA.112.201400; Wang JJ, 2007, EUR HEART J, V28, P857, DOI 10.1093/eurheartj/ehl524; Wilson PWF, 1999, ARCH INTERN MED, V159, P1104, DOI 10.1001/archinte.159.10.1104; Woodward M, 2009, EUR J CARDIOV PREV R, V16, P210, DOI 10.1097/HJR.0b013e3283282f8d	41	81	83	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107294	10.1371/journal.pone.0107294	http://dx.doi.org/10.1371/journal.pone.0107294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244618	Green Published, gold, Green Submitted			2022-12-25	WOS:000343679800028
J	Wu, Q; Jiang, D; Minor, M; Chu, HW				Wu, Qun; Jiang, Di; Minor, Maisha; Chu, Hong Wei			Electronic Cigarette Liquid Increases Inflammation and Virus Infection in Primary Human Airway Epithelial Cells	PLOS ONE			English	Article							HUMAN RHINOVIRUS INFECTION; INNATE IMMUNITY; VAPOR EXTRACT; HOST-DEFENSE; SMOKE; SPLUNC1; EXPRESSION; EXPOSURE; NICOTINE; MARKERS	Background/Objective: The use of electronic cigarettes (e-cigarettes) is rapidly increasing in the United States, especially among young people since e-cigarettes have been perceived as a safer alternative to conventional tobacco cigarettes. However, the scientific evidence regarding the human health effects of e-cigarettes on the lung is extremely limited. The major goal of our current study is to determine if e-cigarette use alters human young subject airway epithelial functions such as inflammatory response and innate immune defense against respiratory viral (i.e., human rhinovirus, HRV) infection. Methodology/Main Results: We examined the effects of e-cigarette liquid (e-liquid) on pro-inflammatory cytokine (e.g., IL-6) production, HRV infection and host defense molecules (e. g., short palate, lung, and nasal epithelium clone 1, SPLUNC1) in primary human airway epithelial cells from young healthy non-smokers. Additionally, we examined the role of SPLUNC1 in lung defense against HRV infection using a SPLUNC1 knockout mouse model. We found that nicotine-free e-liquid promoted IL-6 production and HRV infection. Addition of nicotine into e-liquid further amplified the effects of nicotine-free e-liquid. Moreover, SPLUNC1 deficiency in mice significantly increased lung HRV loads. E-liquid inhibited SPLUNC1 expression in primary human airway epithelial cells. These findings strongly suggest the deleterious health effects of e-igarettes in the airways of young people. Our data will guide future studies to evaluate the impact of e-cigarettes on lung health in human populations, and help inform the public about potential health risks of e-cigarettes.	[Wu, Qun; Jiang, Di; Minor, Maisha; Chu, Hong Wei] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA	National Jewish Health	Wu, Q (corresponding author), Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA.	wuq@njhealth.org			The Flight Attendant Medical and Research Institute (FAMRI) Young Clinical Scientist Award [123254]; FAMRI Clinical Innovator Award [072148]; National Institutes of Health [R01 HL088264]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088264] Funding Source: NIH RePORTER	The Flight Attendant Medical and Research Institute (FAMRI) Young Clinical Scientist Award; FAMRI Clinical Innovator Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by The Flight Attendant Medical and Research Institute (FAMRI) Young Clinical Scientist Award (grant number 123254) to QW & FAMRI Clinical Innovator Award (grant number 072148) and the National Institutes of Health grant (R01 HL088264) to HWC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baqir M, 2008, RESP MED, V102, P1604, DOI 10.1016/j.rmed.2008.05.002; Bartlett NW, 2008, NAT MED, V14, P199, DOI 10.1038/nm1713; Bertholon JF, 2013, REV MAL RESPIR, V30, P752, DOI 10.1016/j.rmr.2013.03.003; Bhowmik A, 2000, THORAX, V55, P114, DOI 10.1136/thorax.55.2.114; BLAKE GH, 1988, ANN INTERN MED, V109, P198, DOI 10.7326/0003-4819-109-3-198; Broekhuizen R, 2006, THORAX, V61, P17, DOI 10.1136/thx.2005.041996; Bullen C, 2010, TOB CONTROL, V19, P98, DOI 10.1136/tc.2009.031567; Callahan-Lyon P, 2014, TOB CONTROL, V23, P36, DOI 10.1136/tobaccocontrol-2013-051470; Caramori G, 2014, INT J CHRONIC OBSTR, V9, P397, DOI 10.2147/COPD.S42544; Cervellati F, 2014, TOXICOL IN VITRO, V28, P999, DOI 10.1016/j.tiv.2014.04.012; Chan-Yeung M, 2003, RESPIROLOGY, V8, P131, DOI 10.1046/j.1440-1843.2003.00453.x; Chu HW, 2007, J IMMUNOL, V179, P3995, DOI 10.4049/jimmunol.179.6.3995; Chu HW, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-155; COHEN S, 1993, AM J PUBLIC HEALTH, V83, P1277, DOI 10.2105/AJPH.83.9.1277; Comer DM, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-32; Corey C, 2013, MMWR-MORBID MORTAL W, V62, P729; Cressey D, 2014, NATURE, V508, P159, DOI 10.1038/508159a; DiFranza JR, 2004, PEDIATRICS, V113, P1007; Durmowicz EL, 2014, TOB CONTROL, V23, P41, DOI 10.1136/tobaccocontrol-2013-051468; Farsalinos KE, 2013, INT J ENV RES PUB HE, V10, P5146, DOI 10.3390/ijerph10105146; FDA Administration, 2010, SUMM RES LAB AN EL C, P1; Flouris AD, 2013, INHAL TOXICOL, V25, P91, DOI 10.3109/08958378.2012.758197; Fornander L, 2011, PROTEOM CLIN APPL, V5, P513, DOI 10.1002/prca.201100016; Gally F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051784; Gally F, 2011, AM J PATHOL, V178, P2159, DOI 10.1016/j.ajpath.2011.01.026; George SN, 2014, EUR RESPIR J, V44, P87, DOI 10.1183/09031936.00223113; Gross CA, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-30; Hacievliyagil SS, 2013, NIGER J CLIN PRACT, V16, P76, DOI 10.4103/1119-3077.106771; Hua M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2324; Hudy MH, 2010, EUR RESPIR J, V35, P1256, DOI 10.1183/09031936.00128809; Hudy MH, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-88; Irander K, 2014, INT J PEDIATR OTORHI, V78, P618, DOI 10.1016/j.ijporl.2014.01.014; Jiang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052969; Jiang NF, 2000, TOXICOL APPL PHARM, V163, P221, DOI 10.1006/taap.1999.8886; Kode A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-132; KOYAMA S, 1991, AM J PHYSIOL, V261, pL126, DOI 10.1152/ajplung.1991.261.2.L126; Li Q, 2012, CELL BIOCHEM BIOPHYS, V62, P421, DOI 10.1007/s12013-011-9324-z; Liu YF, 2013, STAT INTERFACE, V6, P1; Maestrelli P, 2001, AM J RESP CRIT CARE, V164, pS76, DOI 10.1164/ajrccm.164.supplement_2.2106067; Mallia P, 2011, AM J RESP CRIT CARE, V183, P734, DOI 10.1164/rccm.201006-0833OC; Manzo ND, 2010, J TOXICOL ENV HEAL A, V73, P565, DOI 10.1080/15287390903566625; Mosser AG, 2005, AM J RESP CRIT CARE, V171, P645, DOI 10.1164/rccm.200407-970OC; Moyer TP, 2002, CLIN CHEM, V48, P1460; Polosa R, 2013, EUR RESPIR J, V41, P716, DOI 10.1183/09031936.00073312; Rohde G, 2008, INFECTION, V36, P427, DOI 10.1007/s15010-008-7327-5; Romagna G, 2013, INHAL TOXICOL, V25, P354, DOI 10.3109/08958378.2013.793439; Rusznak C, 2001, CLIN EXP ALLERGY, V31, P226, DOI 10.1046/j.1365-2222.2001.01000.x; Sayeed S, 2013, INFECT IMMUN, V81, P285, DOI 10.1128/IAI.00500-12; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Seemungal TAR, 2000, EUR RESPIR J, V16, P677, DOI 10.1034/j.1399-3003.2000.16d19.x; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Stock Ingo, 2014, Med Monatsschr Pharm, V37, P44; Wieslander G, 2001, OCCUP ENVIRON MED, V58, P649, DOI 10.1136/oem.58.10.649; Wu Q, 2013, VIROLOGY, V446, P199, DOI 10.1016/j.virol.2013.08.005; Wu Q, 2012, INNATE IMMUN-LONDON, V18, P617, DOI 10.1177/1753425911429837; Wu Q, 2012, J ALLERGY CLIN IMMUN, V129, P825, DOI 10.1016/j.jaci.2011.10.043; Zhang GL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063486, 10.1371/journal.pone.0080969, 10.1371/journal.pone.0059428, 10.1371/journal.pone.0059254, 10.1371/journal.pone.0064689]; Zhang WY, 2011, RESPIROLOGY, V16, P508, DOI 10.1111/j.1440-1843.2010.01920.x	58	111	113	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e108342	10.1371/journal.pone.0108342	http://dx.doi.org/10.1371/journal.pone.0108342			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244293	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800086
J	Ghoneim, N; Bauchart-Thevret, C; Oosterloo, B; Stoll, B; Kulkarni, M; de Pipaon, MS; Zamora, IJ; Olutoye, OO; Berg, B; Wittke, A; Burrin, DG				Ghoneim, Nada; Bauchart-Thevret, Caroline; Oosterloo, Berthe; Stoll, Barbara; Kulkarni, Madhulika; Saenz de Pipaon, Miguel; Zamora, Irving J.; Olutoye, Oluyinka O.; Berg, Brian; Wittke, Anja; Burrin, Douglas G.			Delayed Initiation but Not Gradual Advancement of Enteral Formula Feeding Reduces the Incidence of Necrotizing Enterocolitis (NEC) in Preterm Pigs	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; HUMAN-MILK; PROTEIN; PATHOGENESIS; INFANTS; COLONIZATION; CALPROTECTIN; DYSFUNCTION; NUTRITION; RESPONSES	Enteral formula feeding is a risk factor for necrotizing enterocolitis (NEC) in premature infants, yet studies are conflicting regarding the safest timing for introduction and advancement of feeds. Our aim was to test the effects of early vs. late initiation and abrupt vs. gradual advancement of enteral feeding of an intact vs. hydrolyzed protein formula on NEC incidence and severity in preterm pigs. In Experiment 1, preterm pigs received total parenteral nutrition (TPN) at birth with abrupt initiation of enteral formula feeds (50% full intake) on d of life (DOL) 2 (EA) or 5 (LA) while PN continued. Pigs were also fed formula containing either intact or hydrolyzed protein. In Experiment 2, preterm pigs received TPN at birth with enteral, hydrolyzed-protein formula feeds introduced on DOL 2 either abruptly (EA; 50% full feeds) or gradually (EG; 10-50% full feeds over 5 d) while PN continued. NEC incidence and severity were assessed based on macroscopic and histological scoring. In Experiment 1, NEC incidence (41% vs. 70%, P<0.05) and severity were reduced in LA vs. EA groups and LA was associated with a higher survival rate, daily weight gain and jejunum villus height. Piglets fed hydrolyzed vs. intact protein formula had lower stomach content weights and similar NEC incidence. In Experiment 2, NEC incidence and severity were not different between pigs the EG vs. EA group. Proinflammatory gene expression (IL-1 beta, IL-6 and S100A9) in the ileum was lower in both LA and EG vs. EA groups. In conclusion, delayed initiation but not gradual advancement of enteral feeding is protective against NEC in preterm pigs. Feeding hydrolyzed vs. intact protein formula improved gastric transit without affecting the NEC incidence.	[Ghoneim, Nada; Kulkarni, Madhulika] Texas Childrens Hosp, Baylor Coll Med, Sect Neonatol, Div Pediat Surg,Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Bauchart-Thevret, Caroline; Oosterloo, Berthe; Stoll, Barbara; Burrin, Douglas G.] Texas Childrens Hosp, Baylor Coll Med, ARS, USDA,Childrens Nutr Res Ctr,Div Pediat Surg,Micha, Houston, TX 77030 USA; [Burrin, Douglas G.] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat,Div Pediat Surg, Michael E DeBakey Dept Surg,Sect Gastroenterol He, Houston, TX 77030 USA; [Zamora, Irving J.; Olutoye, Oluyinka O.] Texas Childrens Hosp, Baylor Coll Med, Michael E DeBakey Dept Surg, Div Pediat Surg, Houston, TX 77030 USA; [Saenz de Pipaon, Miguel] La Paz Univ Hosp, Dept Neonatol, Madrid, Spain; [Berg, Brian; Wittke, Anja] Mead Johnson Pediat Nutr Inst, Evansville, IN USA	Baylor College of Medicine; Baylor College of Medicine; United States Department of Agriculture (USDA); Baylor College of Medicine; Baylor College of Medicine; Hospital Universitario La Paz	Burrin, DG (corresponding author), Texas Childrens Hosp, Baylor Coll Med, ARS, USDA,Childrens Nutr Res Ctr,Div Pediat Surg,Micha, Houston, TX 77030 USA.	dburrin@bcm.edu	Oosterloo, Neelke/AAU-4700-2020; Burrin, Douglas/AID-0081-2022; olutoye, oluyinka/AAI-8093-2021; de Pipaón, Miguel Sáenz/AAA-3851-2019; olutoye, oluyinka/AFL-2055-2022	de Pipaón, Miguel Sáenz/0000-0002-4793-1561; Burrin, Douglas/0000-0002-8792-3339	U.S. Department of Agriculture, Agricultural Research Service [58-6250-6-001]; Spanish government [BA/12/00086]; Mead Johnson Pediatric Nutrition Institute; Whitlock Foundation; Texas Medical Center Digestive Diseases Center (NIH) [P30 DK-56338]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER; ARS [ARS-0426348] Funding Source: Federal RePORTER	U.S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Spanish government(Spanish GovernmentEuropean Commission); Mead Johnson Pediatric Nutrition Institute; Whitlock Foundation; Texas Medical Center Digestive Diseases Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding was provided by U.S. Department of Agriculture, Agricultural Research Service under Cooperative Agreement Number 58-6250-6-001, Spanish government fund BA/12/00086 and grant support from the Mead Johnson Pediatric Nutrition Institute, the Whitlock Foundation and the Texas Medical Center Digestive Diseases Center (NIH Grant P30 DK-56338). The funder [Mead Johnson Pediatric Nutrition Institute] provided support in the form of salaries for authors [BB and AW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aydemir G, 2012, CLIN LAB, V58, P841, DOI 10.7754/Clin.Lab.2012.111214; BELL MJ, 1978, NEW ENGL J MED, V298, P281; Berseth CL, 2003, PEDIATRICS, V111, P529, DOI 10.1542/peds.111.3.529; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Bjornvad CR, 2008, AM J PHYSIOL-GASTR L, V295, pG1092, DOI 10.1152/ajpgi.00414.2007; Boirie Y, 1997, P NATL ACAD SCI USA, V94, P14930, DOI 10.1073/pnas.94.26.14930; Bombell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000504.pub3; Caplan M, 2007, J PEDIATR-US, V150, P329, DOI 10.1016/j.jpeds.2007.01.027; Caplan Michael S, 2005, Semin Pediatr Surg, V14, P145, DOI 10.1053/j.sempedsurg.2005.05.002; Cilieborg MS, 2012, EARLY HUM DEV, V88, pS41, DOI 10.1016/j.earlhumdev.2011.12.027; Claud Erika C., 2009, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V8, P248; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Frost BL, 2008, SEMIN PERINATOL, V32, P100, DOI 10.1053/j.semperi.2008.01.001; Gribar SC, 2009, J IMMUNOL, V182, P636, DOI 10.4049/jimmunol.182.1.636; Hackam DJ, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/475415; Hackam DJ, 2013, SEMIN PEDIATR SURG, V22, P76, DOI 10.1053/j.sempedsurg.2013.01.003; Henry MCW, 2009, ANNU REV MED, V60, P111, DOI 10.1146/annurev.med.60.050207.092824; Lin PW, 2008, SEMIN PERINATOL, V32, P70, DOI 10.1053/j.semperi.2008.01.004; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Liu YY, 2009, AM J PHYSIOL-GASTR L, V297, pG442, DOI 10.1152/ajpgi.00182.2009; LUCAS A, 1990, LANCET, V336, P1519, DOI 10.1016/0140-6736(90)93304-8; Mihatsch WA, 2002, PEDIATRICS, V110, P1199, DOI 10.1542/peds.110.6.1199; Mihatsch WA, 2001, ACTA PAEDIATR, V90, P196, DOI 10.1080/080352501300049442; Morgan J, 2013, COCHRANE DB SYST REV, V28; NEWPORT MJ, 1985, J PEDIATR GASTR NUTR, V4, P639, DOI 10.1097/00005176-198508000-00025; Sangild PT, 2006, EXP BIOL MED, V231, P1695, DOI 10.1177/153537020623101106; Sangild PT, 2006, GASTROENTEROLOGY, V130, P1776, DOI 10.1053/j.gastro.2006.02.026; Schanler RJ, 1999, CLIN PERINATOL, V26, P379, DOI 10.1016/S0095-5108(18)30058-7; Siggers J, 2011, AM J PHYSIOL-GASTR L, V301, pG435, DOI 10.1152/ajpgi.00400.2010; Siggers RH, 2011, J NUTR BIOCHEM, V22, P511, DOI 10.1016/j.jnutbio.2010.08.002; Sisk PM, 2007, J PERINATOL, V27, P428, DOI 10.1038/sj.jp.7211758; Terrin G, 2012, ARCH DIS CHILD, V97, P1102, DOI 10.1136/archdischild-2012-302698; Thymann T, 2009, AM J PHYSIOL-GASTR L, V297, pG1115, DOI 10.1152/ajpgi.00261.2009; Tudehope DI, 2005, J PAEDIATR CHILD H, V41, P167, DOI 10.1111/j.1440-1754.2005.00581.x; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Young C, 2009, PEDIATR RES, V65, p91R, DOI 10.1203/PDR.0b013e31819dba7d; Young L, 2013, COCHRANE DB SYST REV, V5	37	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e106888	10.1371/journal.pone.0106888	http://dx.doi.org/10.1371/journal.pone.0106888			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238061	Green Published, gold, Green Submitted			2022-12-25	WOS:000342491600013
J	Gong, G; Yuan, LB; Cai, L; Ran, MR; Zhang, YL; Gong, HQ; Dai, XM; Wu, W; Dong, HL				Gong, Gu; Yuan, Libang; Cai, Lin; Ran, Maorong; Zhang, Yulan; Gong, Huaqu; Dai, Xuemei; Wu, Wei; Dong, Hailong			Tetramethylpyrazine Suppresses Transient Oxygen-Glucose Deprivation-Induced Connexin32 Expression and Cell Apoptosis via the ERK1/2 and p38 MAPK Pathway in Cultured Hippocampal Neurons	PLOS ONE			English	Article							JUNCTIONAL INTERCELLULAR COMMUNICATION; CEREBRAL-ISCHEMIA; GLOBAL-ISCHEMIA; FOCAL ISCHEMIA; IN-VITRO; RAT; INJURY; CHANNELS; NEUROPROTECTION; KINASE	Tetramethylpyrazine (TMP) has been widely used in China as a drug for the treatment of various diseases. Recent studies have suggested that TMP has a protective effect on ischemic neuronal damage. However, the exact mechanism is still unclear. This study aims to investigate the mechanism of TMP mediated ischemic hippocampal neurons injury induced by oxygen-glucose deprivation (OGD). The effect of TMP on hippocampal neurons viability was detected by MTT assay, LDH release assay and apoptosis rate was measured by flow cytometry. TMP significantly suppressed neuron apoptosis in a concentration-dependent manner. TMP could significantly reduce the elevated levels of connexin32 (Cx32) induced by OGD. Knockdown of Cx32 by siRNA attenuated OGD injury. Moreover, our study showed that viability was increased in siRNA-Cx32-treated-neurons, and neuron apoptosis was suppressed by activating Bcl-2 expression and inhibiting Bax expression. Over expression of Cx32 could decrease neurons viability and increase LDH release. Furthermore, OGD increased phosphorylation of ERK1/2 and p38, whose inhibitors relieved the neuron injury and Cx32 up-regulation. Taken together, TMP can reverse the OGD-induced Cx32 expression and cell apoptosis via the ERK1/2 and p38 MAPK pathways.	[Gong, Gu; Yuan, Libang; Cai, Lin; Ran, Maorong; Zhang, Yulan; Gong, Huaqu; Dai, Xuemei; Wu, Wei] Gen Hosp Chengdu Mil Area Command, Dept Anesthesia, Chengdu, Sichuan, Peoples R China; [Dong, Hailong] Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesia, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University	Wu, W (corresponding author), Gen Hosp Chengdu Mil Area Command, Dept Anesthesia, Chengdu, Sichuan, Peoples R China.	weiwuchengdu@163.com; hailongdongxa@163.com		Dong, Hailong/0000-0001-8984-9067	Scientific Foundation of Health Department of Sichuan Province [110469]	Scientific Foundation of Health Department of Sichuan Province	This research was funded by the Scientific Foundation of Health Department of Sichuan Province (grant number 110469). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Barr TP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056744; Bethel A, 1997, STROKE, V28, P609, DOI 10.1161/01.STR.28.3.609; Chen HJ, 2012, REV NEUROSCIENCE, V23, P279, DOI 10.1515/revneuro-2012-0001; CHENG Y, 1994, NEUROCHEM RES, V19, P1557, DOI 10.1007/BF00969006; Cho JH, 2002, CARCINOGENESIS, V23, P1163, DOI 10.1093/carcin/23.7.1163; Davoli MA, 2002, NEUROSCIENCE, V115, P125, DOI 10.1016/S0306-4522(02)00376-7; de Pina-Benabou MH, 2005, STROKE, V36, P2232, DOI 10.1161/01.STR.0000182239.75969.d8; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Edwards GO, 2008, TOXICOLOGY, V253, P46, DOI 10.1016/j.tox.2008.08.010; Elshami AA, 1996, GENE THER, V3, P85; Frantseva MV, 2002, J NEUROSCI, V22, P644, DOI 10.1523/JNEUROSCI.22-03-00644.2002; Gao Q, 2005, NEUROSCIENCE, V136, P123, DOI 10.1016/j.neuroscience.2005.06.091; Godoi GL, 2013, NEUROCHEM RES, V38, P2359, DOI 10.1007/s11064-013-1147-4; Hartman RE, 2005, BRAIN RES, V1043, P48, DOI 10.1016/j.brainres.2005.02.030; Igarashi I, 2014, EXP TOXICOL PATHOL, V66, P103, DOI 10.1016/j.etp.2013.10.002; Jung JY, 2013, J CELL PHYSIOL, V228, P2243, DOI 10.1002/jcp.24393; Kao TK, 2013, EXP NEUROL, V247, P188, DOI 10.1016/j.expneurol.2013.04.010; Kiprianova I, 1999, EXP NEUROL, V159, P511, DOI 10.1006/exnr.1999.7109; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Liang JM, 2013, MOLECULES, V18, P12777, DOI 10.3390/molecules181012777; Ma Lu, 2008, Sichuan Da Xue Xue Bao Yi Xue Ban, V39, P207; Nakase T, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/147946; Neise D, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.386; Oguro K, 2001, J NEUROSCI, V21, P7534, DOI 10.1523/JNEUROSCI.21-19-07534.2001; Okamoto T, 2011, EXP CELL RES, V317, P348, DOI 10.1016/j.yexcr.2010.10.018; Ramalingam V., 2013, J BASIC MICROBIOL; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ran X, 2011, PHARM BIOL, V49, P1180, DOI 10.3109/13880209.2011.576346; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Silva CG, 2007, NEUROBIOL DIS, V27, P182, DOI 10.1016/j.nbd.2007.04.018; Sutherland BA, 2012, INT J STROKE, V7, P407, DOI 10.1111/j.1747-4949.2012.00770.x; Tang QQ, 2012, BRAIN RES, V1488, P81, DOI 10.1016/j.brainres.2012.09.034; Toth S, 2013, AM J CHINESE MED, V41, P817, DOI 10.1142/S0192415X13500559; van Spronsen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074907; Vinken M, 2006, CELL SIGNAL, V18, P592, DOI 10.1016/j.cellsig.2005.08.012; Vinken M, 2008, HEPATOLOGY, V47, P1077, DOI 10.1002/hep.22049; Vinken M, 2010, CELL MOL LIFE SCI, V67, P907, DOI 10.1007/s00018-009-0220-2; Widgerow AD, 2012, ANN PLAST SURG; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Yang SR, 2005, J VET MED SCI, V67, P291, DOI 10.1292/jvms.67.291; Zhang JY, 2013, MOLECULES, V18, P12793, DOI 10.3390/molecules181012793	42	30	31	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e105944	10.1371/journal.pone.0105944	http://dx.doi.org/10.1371/journal.pone.0105944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25237906	gold, Green Submitted, Green Published			2022-12-25	WOS:000342491600004
J	Balce, DR; Allan, ERO; McKenna, N; Yates, RM				Balce, Dale R.; Allan, Euan R. O.; McKenna, Neil; Yates, Robin M.			gamma-Interferon-inducible Lysosomal Thiol Reductase (GILT) Maintains Phagosomal Proteolysis in Alternatively Activated Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cysteine Protease; Lysosome; Macrophage; Oxidation-Reduction (Redox); Proteolysis; Reductase; Phagosome	NADPH OXIDASE ACTIVITY; MHC CLASS-II; PROTEASE ACTIVITY; REACTIVE OXYGEN; CATHEPSIN-S; CYSTEINE PROTEASES; ANTIGEN; THIOREDOXIN; CELLS; REDOX	Background: GILT is known to reduce disulfide bonds in endosomes, lysosomes, and phagosomes. Results: GILT, in addition to reducing disulfide bonds, maintains phagosomal proteolytic activity, particularly in alternatively activated macrophages. Conclusion: GILT maintains activity of cysteine proteases in phagosomes. Significance: These results reveal a novel role for GILT that may affect antigen processing and efficiency of hydrolysis of phagocytosed protein. Although it is known that lysosomal cysteine cathepsins require a reducing environment for optimal activity, it is not firmly established how these enzymes are maintained in their reduced-active state in the acidic and occasionally oxidative environment within phagosomes and lysosomes. -Interferon-inducible lysosomal thiol reductase (GILT) has been the only enzyme described in the endosomes, lysosomes, and phagosomes with the potential to catalyze the reduction of cysteine cathepsins. Our goal in the current study was to assess the effect of GILT on major phagosomal functions with an emphasis on proteolytic efficiency in murine bone marrow-derived macrophages. Assessment of phagosomal disulfide reduction upon internalization of IgG-opsonized experimental particles confirmed a major role for GILT in phagosomal disulfide reduction in both resting and interferon--activated macrophages. Furthermore we observed a decrease in early phagosomal proteolytic efficiency in GILT-deficient macrophages, specifically in the absence of an NADPH oxidase-mediated respiratory burst. This deficiency was more prominent in IL-4-activated macrophages that inherently possess lower levels of NADPH oxidase activity. Finally, we provide evidence that GILT is required for optimal activity of the lysosomal cysteine protease, cathepsin S. In summary, our results suggest a role for GILT in maintaining cysteine cathepsin proteolytic efficiency in phagosomes, particularly in the absence of high NADPH oxidase activity, which is characteristic of alternatively activated macrophages.	[Balce, Dale R.; Allan, Euan R. O.; McKenna, Neil; Yates, Robin M.] Univ Calgary, Dept Comparat Biol & Expt Med, Fac Vet Med, Calgary, AB T2N 4N1, Canada; [McKenna, Neil; Yates, Robin M.] Univ Calgary, Dept Biochem & Mol Biol, Fac Med, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Yates, RM (corresponding author), Univ Calgary, Dept Comparat Biol & Expt Med, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	rmyates@ucalgary.ca	Yates, Robin/K-5032-2015	Yates, Robin/0000-0003-3122-1845	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Canadian Institutes of Health Research and Natural Sciences and Engineering Research Council of Canada.	ANJANEYULU PSR, 1987, INT J PEPT PROT RES, V30, P117; Balce DR, 2011, BLOOD, V118, P4199, DOI 10.1182/blood-2011-01-328906; Barry ZT, 2012, J BIOL CHEM, V287, P27723, DOI 10.1074/jbc.M111.332684; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Carlson BA, 2009, MOLECULES, V14, P3509, DOI 10.3390/molecules14093509; CARRAWAY KL, 1970, BIOCHIM BIOPHYS ACTA, V200, P564, DOI 10.1016/0005-2795(70)90112-1; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chiang HS, 2011, FREE RADICAL BIO MED, V51, P688, DOI 10.1016/j.freeradbiomed.2011.05.015; Claus V, 1998, J BIOL CHEM, V273, P9842, DOI 10.1074/jbc.273.16.9842; COLLINS DS, 1991, J IMMUNOL, V147, P4054; Fernandez-Boyanapalli RF, 2009, BLOOD, V113, P2047, DOI 10.1182/blood-2008-05-160564; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Go YM, 2008, BBA-GEN SUBJECTS, V1780, P1271, DOI 10.1016/j.bbagen.2008.01.011; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Goldstein OG, 2008, CANCER IMMUNOL IMMUN, V57, P1461, DOI 10.1007/s00262-008-0483-8; Haque MA, 2002, J EXP MED, V195, P1267, DOI 10.1084/jem.20011853; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Huynh KK, 2007, MICROBIOL MOL BIOL R, V71, P452, DOI 10.1128/MMBR.00003-07; Kerblat I, 1999, IMMUNOLOGY, V97, P62; Kotsias F, 2013, ANTIOXID REDOX SIGN, V18, P714, DOI 10.1089/ars.2012.4557; Lennon-Dumenil AM, 2002, J EXP MED, V196, P529, DOI 10.1084/jem.20020327; Li YB, 1998, BIOCHEM BIOPH RES CO, V253, P295, DOI 10.1006/bbrc.1998.9729; Lim JC, 2008, J BIOL CHEM, V283, P28873, DOI 10.1074/jbc.M804087200; Lockwood TD, 2002, ANTIOXID REDOX SIGN, V4, P681, DOI 10.1089/15230860260220193; Lockwood TD, 2013, METALLOMICS, V5, P110, DOI 10.1039/c2mt20156a; Lockwood TD, 2000, ANTIOXID REDOX SIGN, V2, P851, DOI 10.1089/ars.2000.2.4-851; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; Nunes P, 2013, TRAFFIC, V14, P1118, DOI 10.1111/tra.12115; Phan UT, 2000, J BIOL CHEM, V275, P25907, DOI 10.1074/jbc.M003459200; Phipps-Yonas H, 2013, EUR J IMMUNOL, V43, P65, DOI 10.1002/eji.201242379; Pillay CS, 2002, BIOCHEM J, V363, P417, DOI 10.1042/0264-6021:3630417; PISONI RL, 1990, J CELL BIOL, V110, P327, DOI 10.1083/jcb.110.2.327; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; Roilides E, 1997, J IMMUNOL, V158, P322; Rybicka JM, 2012, EMBO J, V31, P932, DOI 10.1038/emboj.2011.440; Rybicka JM, 2010, P NATL ACAD SCI USA, V107, P10496, DOI 10.1073/pnas.0914867107; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Serinkan BF, 2005, CELL DEATH DIFFER, V12, P1141, DOI 10.1038/sj.cdd.4401619; Shrimali RK, 2008, J BIOL CHEM, V283, P20181, DOI 10.1074/jbc.M802559200; Singh R, 2010, SCIENCE, V328, P1394, DOI 10.1126/science.1189176; Sinnathamby G, 2004, J IMMUNOL, V172, P6607, DOI 10.4049/jimmunol.172.11.6607; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; STEPHEN AG, 1993, BIOCHEM J, V291, P345, DOI 10.1042/bj2910345; Tian W, 2008, BLOOD, V112, P3867, DOI 10.1182/blood-2007-11-126029; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; VanderVen BC, 2009, TRAFFIC, V10, P372, DOI [10.1111/j.1600-0854.2008.00877.x, 10.1111/j.1600-0854.2009.00877.x]; Voss EW, 1996, BIOTECHNIQUES, V20, P286; Wang Y, 2007, KIDNEY INT, V72, P290, DOI 10.1038/sj.ki.5002275; Welch JS, 2002, J BIOL CHEM, V277, P42821, DOI 10.1074/jbc.M205873200; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yamamoto M, 2003, J CLIN INVEST, V112, P1395, DOI 10.1172/JCI200317700; Yates RM, 2005, TRAFFIC, V6, P413, DOI 10.1111/j.1600-0854.2005.00284.x; Yates Robin A., 2008, V445, P311, DOI 10.1007/978-1-59745-157-4_20; Yates RM, 2013, ANTIOXID REDOX SIGN, V18, P628, DOI 10.1089/ars.2012.4898; Zeng MY, 2013, BLOOD, V121, P3473, DOI 10.1182/blood-2012-10-461913	58	51	51	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31891	31904		10.1074/jbc.M114.584391	http://dx.doi.org/10.1074/jbc.M114.584391			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25253686	hybrid, Green Published			2022-12-25	WOS:000345314700020
J	Pisani, F; Mola, MG; Simone, L; Rosito, S; Alberga, D; Mangiatordi, GF; Lattanzi, G; Nicolotti, O; Frigeri, A; Svelto, M; Nicchia, GP				Pisani, Francesco; Mola, Maria Grazia; Simone, Laura; Rosito, Stefania; Alberga, Domenico; Mangiatordi, Giuseppe Felice; Lattanzi, Gianluca; Nicolotti, Orazio; Frigeri, Antonio; Svelto, Maria; Nicchia, Grazia Paola			Identification of a Point Mutation Impairing the Binding between Aquaporin-4 and Neuromyelitis Optica Autoantibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVISED DIAGNOSTIC-CRITERIA; MOLECULAR-DYNAMICS; ORTHOGONAL ARRAYS; WATER CHANNEL; MULTIPLE-SCLEROSIS; HUMAN-COMPLEMENT; AQP4 POOLS; MECHANISM; ACTIVATION; EXPRESSION	Neuromyelitis optica (NMO) is characterized by the presence of pathogenic autoantibodies (NMO-IgGs) against supra-molecular assemblies of aquaporin-4 (AQP4), known as orthogonal array of particles (OAPs). NMO-IgGs have a polyclonal origin and recognize different conformational epitopes involving extracellular AQP4 loops A, C, and E. Here we hypothesize a pivotal role for AQP4 transmembrane regions (TMs) in epitope assembly. On the basis of multialignment analysis, mutagenesis, NMO-IgG binding, and cytotoxicity assay, we have disclosed the key role of aspartate 69 (Asp(69)) of TM2 for NMO-IgG epitope assembly. Mutation of Asp(69) to histidine severely impairs NMO-IgG binding for 85.7% of the NMO patient sera analyzed here. Although Blue Native-PAGE, total internal reflection fluorescence microscopy, and water transport assays indicate that the OAP Asp(69) mutant is similar in structure and function to the wild type, molecular dynamic simulations have revealed that the (DH)-H-69 mutation has the effect of altering the structural rearrangements of extracellular loop A. In conclusion, Asp(69) is crucial for the spatial control of loop A, the particular molecular conformation of which enables the assembly of NMO-IgG epitopes. These findings provide additional clues for new strategies for NMO treatment and a wealth of information to better approach NMO pathogenesis.	[Pisani, Francesco; Mola, Maria Grazia; Simone, Laura; Rosito, Stefania; Frigeri, Antonio; Svelto, Maria; Nicchia, Grazia Paola] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, I-70126 Bari, Italy; [Pisani, Francesco; Mola, Maria Grazia; Simone, Laura; Rosito, Stefania; Frigeri, Antonio; Svelto, Maria; Nicchia, Grazia Paola] Univ Bari Aldo Moro, Ctr Excellence Comparat Genom, I-70126 Bari, Italy; [Mangiatordi, Giuseppe Felice; Nicolotti, Orazio] Univ Bari Aldo Moro, Dipartimento Farm Sci Farmaco, I-70126 Bari, Italy; [Alberga, Domenico; Lattanzi, Gianluca] Univ Bari Aldo Moro, Dipartimento Interateneo Fis M Merlin, INFN, I-70126 Bari, Italy; [Alberga, Domenico; Lattanzi, Gianluca] Univ Bari Aldo Moro, TIRES, I-70126 Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Istituto Nazionale di Fisica Nucleare (INFN); Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Nicchia, GP (corresponding author), Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, I-70126 Bari, Italy.	graziapaola.nicchia@uniba.it	PISANI, Francesco/AAC-1749-2019; Lattanzi, Gianluca/E-1753-2011; Svelto, Maria/P-6186-2014; Simone, Laura/B-2093-2017; Mangiatordi, Giuseppe Felice/AAH-9527-2020; frigeri, Antonio/AAC-6336-2022; Mola, Maria Grazia/I-3507-2019; Alberga, Domenico/K-3272-2019; Lattanzi, Gianluca/AAA-3173-2019; Nicolotti, Orazio/F-3209-2012	PISANI, Francesco/0000-0001-8511-117X; Lattanzi, Gianluca/0000-0002-0808-6457; Simone, Laura/0000-0002-3540-4895; Mola, Maria Grazia/0000-0002-4421-9237; Alberga, Domenico/0000-0002-9475-9602; Lattanzi, Gianluca/0000-0002-0808-6457; Nicolotti, Orazio/0000-0001-6533-5539; Svelto, Maria/0000-0002-5584-9541; Frigeri, Antonio/0000-0002-5284-2934; Mangiatordi, Giuseppe Felice/0000-0003-4042-2841	Italian Ministry of University and Research [RBFR12SJA8]	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by Italian Ministry of University and Research Project Firb "Futuro in Ricerca" RBFR12SJA8.	ADELMAN SA, 1976, J CHEM PHYS, V64, P2375, DOI 10.1063/1.432526; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; FREEDMAN J, 1977, VOX SANG, V33, P212, DOI 10.1111/j.1423-0410.1977.tb04466.x; Hinson SR, 2007, NEUROLOGY, V69, P2221, DOI 10.1212/01.WNL.0000289761.64862.ce; Hinson SR, 2012, P NATL ACAD SCI USA, V109, P1245, DOI 10.1073/pnas.1109980108; Ho JD, 2009, P NATL ACAD SCI USA, V106, P7437, DOI 10.1073/pnas.0902725106; HUGHESJONES NC, 1977, NATURE, V270, P613, DOI 10.1038/270613a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iorio R, 2013, J AUTOIMMUN, V40, P21, DOI 10.1016/j.jaut.2012.07.008; Jarius S, 2007, NAT CLIN PRACT NEURO, V3, DOI 10.1038/ncpneuro0501; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kalluri SR, 2010, ARCH NEUROL-CHICAGO, V67, P1201, DOI 10.1001/archneurol.2010.269; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Matiello M, 2011, NEUROLOGY, V77, P1149, DOI 10.1212/WNL.0b013e31822f045b; Matiello M, 2013, JAMA NEUROL, V70, P1118, DOI 10.1001/jamaneurol.2013.3124; Mola MG, 2009, ANAL CHEM, V81, P8219, DOI 10.1021/ac901526k; Nelson PA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015050; Nicchia GP, 2008, J NEUROCHEM, V105, P2156, DOI 10.1111/j.1471-4159.2008.05302.x; Nicchia GP, 2011, NEUROSCIENCE, V197, P80, DOI 10.1016/j.neuroscience.2011.09.023; Nicchia GP, 2010, NEUROSCIENCE, V168, P903, DOI 10.1016/j.neuroscience.2010.02.008; Nicchia G.P., 2013, WILEY INTERDISCIPLIN; Nicchia GP, 2008, GLIA, V56, P869, DOI 10.1002/glia.20661; Nicchia GP, 2009, GLIA, V57, P1363, DOI 10.1002/glia.20855; Nordlund HR, 2003, FEBS LETT, V555, P449, DOI 10.1016/S0014-5793(03)01302-4; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Phuan PW, 2012, J BIOL CHEM, V287, P13829, DOI 10.1074/jbc.M112.344325; Pisani F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079185; Pisani F, 2011, J BIOL CHEM, V286, P9216, DOI 10.1074/jbc.M110.123000; Pittock SJ, 2013, LANCET NEUROL, V12, P554, DOI 10.1016/S1474-4422(13)70076-0; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ratelade J, 2012, INT J BIOCHEM CELL B, V44, P1519, DOI 10.1016/j.biocel.2012.06.013; Ratelade J, 2012, ACTA NEUROPATHOL, V123, P861, DOI 10.1007/s00401-012-0986-4; Rossi A, 2012, TRAFFIC, V13, P43, DOI 10.1111/j.1600-0854.2011.01299.x; Rossi A, 2010, J BIOL CHEM, V285, P4562, DOI 10.1074/jbc.M109.069245; Schrodinger, 2013, MAESTR VERS 9 5 REL; SCHUMAKER VN, 1986, MOL IMMUNOL, V23, P557, DOI 10.1016/0161-5890(86)90119-7; SLEDGE CR, 1973, J BIOL CHEM, V248, P2818; Slotkin W, 2013, GENOME MED, V5, DOI 10.1186/gm508; Verbavatz JM, 1997, J CELL SCI, V110, P2855; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74	44	21	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30578	30589		10.1074/jbc.M114.582221	http://dx.doi.org/10.1074/jbc.M114.582221			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25239624	Green Published, hybrid			2022-12-25	WOS:000344549700035
J	Bisio, M; Bosca, A; Pasquale, V; Berdondini, L; Chiappalone, M				Bisio, Marta; Bosca, Alessandro; Pasquale, Valentina; Berdondini, Luca; Chiappalone, Michela			Emergence of Bursting Activity in Connected Neuronal Sub-Populations	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; SPINAL NETWORKS; PATTERNS; CULTURES; OSCILLATIONS; MONOLAYERS	Uniform and modular primary hippocampal cultures from embryonic rats were grown on commercially available micro-electrode arrays to investigate network activity with respect to development and integration of different neuronal populations. Modular networks consisting of two confined active and inter-connected sub-populations of neurons were realized by means of bi-compartmental polydimethylsiloxane structures. Spontaneous activity in both uniform and modular cultures was periodically monitored, from three up to eight weeks after plating. Compared to uniform cultures and despite lower cellular density, modular networks interestingly showed higher firing rates at earlier developmental stages, and network-wide firing and bursting statistics were less variable over time. Although globally less correlated than uniform cultures, modular networks exhibited also higher intra-cluster than inter-cluster correlations, thus demonstrating that segregation and integration of activity coexisted in this simple yet powerful in vitro model. Finally, the peculiar synchronized bursting activity shown by confined modular networks preferentially propagated within one of the two compartments ('dominant'), even in cases of perfect balance of firing rate between the two sub-populations. This dominance was generally maintained during the entire monitored developmental frame, thus suggesting that the implementation of this hierarchy arose from early network development.	[Bisio, Marta; Bosca, Alessandro; Pasquale, Valentina; Berdondini, Luca; Chiappalone, Michela] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Genoa, Italy	Istituto Italiano di Tecnologia - IIT	Chiappalone, M (corresponding author), Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Genoa, Italy.	michela.chiappalone@iit.it	Berdondini, Luca/O-3201-2013; Pasquale, Valentina/M-4659-2019	Berdondini, Luca/0000-0001-9521-2812; Pasquale, Valentina/0000-0002-4499-9536; Chiappalone, Michela/0000-0003-1427-5147	European Union [284772 BRAIN BOW]	European Union(European Commission)	The research leading to these results has received funding from the European Union's Seventh Framework Programme (ICT-FET FP7/2007-2013, FET Young Explorers scheme) under grant agreement no 284772 BRAIN BOW (www.brainbowproject.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baruchi I, 2008, EUR J NEUROSCI, V28, P1825, DOI 10.1111/j.1460-9568.2008.06487.x; Berdondini L, 2006, SENSOR ACTUAT B-CHEM, V114, P530, DOI 10.1016/j.snb.2005.04.042; Biffi E, 2013, PLOS ONE, V8; Blau A, 2009, J BIOSCIENCES, V34, P59, DOI 10.1007/s12038-009-0009-3; Boehler MD, 2012, J NEUROSCI METH, V203, P344, DOI 10.1016/j.jneumeth.2011.09.020; Bonifazi P, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00040; Boucsein C, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00032; Branch DW, 1998, MED BIOL ENG COMPUT, V36, P135, DOI 10.1007/BF02522871; Chiappalone M, 2006, BRAIN RES, V1093, P41, DOI 10.1016/j.brainres.2006.03.049; DULCEY CS, 1991, SCIENCE, V252, P551, DOI 10.1126/science.2020853; Dworak BJ, 2009, LAB CHIP, V9, P404, DOI 10.1039/b806689b; Frega M, 2012, NEUROTOXICOL TERATOL, V34, P116, DOI 10.1016/j.ntt.2011.08.001; Garofalo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006482; Gasparini, 2013, FRONTIERS NEUROENGIN, V6, DOI DOI 10.3389/FNENG.2013.00010; GEORGER JH, 1992, THIN SOLID FILMS, V210, P716, DOI 10.1016/0040-6090(92)90383-M; Ham MI, 2008, J COMPUT NEUROSCI, V24, P346, DOI 10.1007/s10827-007-0059-1; Harris KD, 2005, NAT REV NEUROSCI, V6, P399, DOI 10.1038/nrn1669; Hebb Donald O., 1949, ORG BEHAV; Kanagasabapathi TT, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036010; Keefer EW, 2001, J NEUROPHYSIOL, V86, P3030, DOI 10.1152/jn.2001.86.6.3030; le Feber J, 2007, J NEURAL ENG, V4, P54, DOI 10.1088/1741-2560/4/2/006; Levy O, 2012, EUR J NEUROSCI, V35, P1753, DOI 10.1111/j.1460-9568.2012.08094.x; Maccione A, 2012, J NEUROSCI METH, V207, P161, DOI 10.1016/j.jneumeth.2012.04.002; Maccione A, 2009, J NEUROSCI METH, V177, P241, DOI 10.1016/j.jneumeth.2008.09.026; Macis E, 2007, J NEUROSCI METH, V161, P88, DOI 10.1016/j.jneumeth.2006.10.015; Marconi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034648; Mata A, 2005, BIOMED MICRODEVICES, V7, P281, DOI 10.1007/s10544-005-6070-2; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Novellino A, 2011, Front Neuroeng, V4, P4, DOI 10.3389/fneng.2011.00004; Pasquale V, 2010, J COMPUT NEUROSCI, V29, P213, DOI 10.1007/s10827-009-0175-1; Petrelli A, 2013, LAB CHIP, V13, P4419, DOI 10.1039/c3lc50564b; Raichman N, 2008, J NEUROSCI METH, V170, P96, DOI 10.1016/j.jneumeth.2007.12.020; Rieke F., 1997, SPIKES EXPLORING NEU; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Shein Idelson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014443; Shein-Idelson Mark, 2011, Front Neuroeng, V4, P10, DOI 10.3389/fneng.2011.00010; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; STREIT J, 1993, J NEUROPHYSIOL, V70, P871, DOI 10.1152/jn.1993.70.3.871; Taylor Anne M., 2011, Critical Reviews in Biomedical Engineering, V39, P185, DOI 10.1615/CritRevBiomedEng.v39.i3.20; Taylor AM, 2010, CURR OPIN NEUROBIOL, V20, P640, DOI 10.1016/j.conb.2010.07.011; TORIMITSU K, 1990, DEV BRAIN RES, V51, P128, DOI 10.1016/0165-3806(90)90265-Z; Van Pelt J, 2004, NEUROSCI LETT, V361, P86, DOI 10.1016/j.neulet.2003.12.062; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; Yvon C, 2005, EXP BRAIN RES, V165, P139, DOI 10.1007/s00221-005-2286-x	46	46	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107400	10.1371/journal.pone.0107400	http://dx.doi.org/10.1371/journal.pone.0107400			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250616	Green Published, Green Submitted, gold			2022-12-25	WOS:000342492700030
J	Deakin, A; Duddy, G; Wilson, S; Harrison, S; Latcham, J; Fulleylove, M; Fung, S; Smith, J; Pedrick, M; McKevitt, T; Felton, L; Morley, J; Quint, D; Fattah, D; Hayes, B; Gough, J; Solari, R				Deakin, Angela; Duddy, Graham; Wilson, Steve; Harrison, Steve; Latcham, Judi; Fulleylove, Mick; Fung, Sylvia; Smith, Jason; Pedrick, Mike; McKevitt, Tom; Felton, Leigh; Morley, Joanne; Quint, Diana; Fattah, Dilniya; Hayes, Brian; Gough, Jade; Solari, Roberto			Characterisation of a K390R ITK Kinase Dead Transgenic Mouse - Implications for ITK as a Therapeutic Target	PLOS ONE			English	Article							T-CELL KINASE; TEC FAMILY KINASE; MURINE B-CELLS; TYROSINE KINASE; MICE LACKING; IFN-GAMMA; AIRWAY HYPERRESPONSIVENESS; CYTOKINE PRODUCTION; ALLERGIC-ASTHMA; IGE PRODUCTION	Interleukin-2 inducible tyrosine kinase (ITK) is expressed in T cells and plays a critical role in signalling through the T cell receptor. Evidence, mainly from knockout mice, has suggested that ITK plays a particularly important function in Th2 cells and this has prompted significant efforts to discover ITK inhibitors for the treatment of allergic disease. However, ITK is known to have functions outside of its kinase domain and in general kinase knockouts are often not good models for the behaviour of small molecule inhibitors. Consequently we have developed a transgenic mouse where the wild type Itk allele has been replaced by a kinase dead Itk allele containing an inactivating K390R point mutation (Itk-KD mice). We have characterised the immune phenotype of these naive mice and their responses to airway inflammation. Unlike Itk knockout (Itk(-/-)) mice, T-cells from Itk-KD mice can polymerise actin in response to CD3 activation. The lymph nodes from Itk-KD mice showed more prominent germinal centres than wild type mice and serum antibody levels were significantly abnormal. Unlike the Itk(-/-), gamma delta T cells in the spleens of the Itk-KD mice had an impaired ability to secrete Th2 cytokines in response to anti-CD3 stimulation whilst the expression of ICOS was not significantly different to wild type. However ICOS expression is markedly increased on alpha beta CD3(+) cells from the spleens of naive Itk-KD compared to WT mice. The Itk-KD mice were largely protected from inflammatory symptoms in an Ovalbumin model of airway inflammation. Consequently, our studies have revealed many similarities but some differences between Itk(-/-) and Itk-KD transgenic mice. The abnormal antibody response and enhanced ICOS expression on CD3+ cells has implications for the consideration of ITK as a therapeutic target.	[Deakin, Angela; Felton, Leigh; Morley, Joanne; Quint, Diana; Fattah, Dilniya; Hayes, Brian; Gough, Jade; Solari, Roberto] GlaxoSmithKline, Resp Therapy Area, Stevenage, Herts, England; [Duddy, Graham; Wilson, Steve; Harrison, Steve; Latcham, Judi; Fulleylove, Mick; Fung, Sylvia; Smith, Jason] GlaxoSmithKline, Lab Anim Sci, Stevenage, Herts, England; [Pedrick, Mike; McKevitt, Tom] GlaxoSmithKline, Platform Technol & Sci, Stevenage, Herts, England	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Solari, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airway Dis Infect Sect, Norfolk Pl, London, England.	roberto.2.solari@gsk.com			GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	All studies were fully funded by GlaxoSmithKline and performed at GlaxoSmithKline. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andreotti AH, 2010, ITK COLD SPRING HARB, V7; Au-Yeung BB, 2006, J IMMUNOL, V176, P3895, DOI 10.4049/jimmunol.176.7.3895; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Ching KA, 2000, J IMMUNOL, V165, P256, DOI 10.4049/jimmunol.165.1.256; COFFMAN RL, 1986, J IMMUNOL, V136, P4538; Dombroski D, 2005, J IMMUNOL, V174, P1385, DOI 10.4049/jimmunol.174.3.1385; Donnadieu E, 2001, J IMMUNOL, V166, P5540, DOI 10.4049/jimmunol.166.9.5540; Felices M, 2008, J IMMUNOL, V180, P3007, DOI 10.4049/jimmunol.180.5.3007; Felices M, 2009, P NATL ACAD SCI USA, V106, P8308, DOI 10.1073/pnas.0808459106; Ferrara TJ, 2006, J ALLERGY CLIN IMMUN, V117, P780, DOI 10.1016/j.jaci.2005.12.1330; FINKELMAN FD, 1988, J IMMUNOL, V140, P1022; Fischer AM, 2004, J BIOL CHEM, V279, P29816, DOI 10.1074/jbc.M312848200; Forssell J, 2005, AM J RESP CELL MOL, V32, P511, DOI 10.1165/rcmb.2004-0348OC; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Grasis JA, 2003, J IMMUNOL, V170, P3971, DOI 10.4049/jimmunol.170.8.3971; Graves PE, 2005, J ALLERGY CLIN IMMUN, V116, P650, DOI 10.1016/j.jaci.2005.05.004; Harling JD, 2013, J BIOL CHEM, V288, P28195, DOI 10.1074/jbc.M113.474114; Heyeck SD, 1997, J BIOL CHEM, V272, P25401, DOI 10.1074/jbc.272.40.25401; Hu JF, 2008, J IMMUNOL, V180, P6544, DOI 10.4049/jimmunol.180.10.6544; ISAKSON PC, 1982, J EXP MED, V155, P734, DOI 10.1084/jem.155.3.734; Iyer AS, 2008, J IMMUNOL, V180, P7869, DOI 10.4049/jimmunol.180.12.7869; Jain N, 2013, NAT MED, V19, P1632, DOI 10.1038/nm.3393; Kannan AK, 2013, J ALLERGY CLIN IMMUN, V132, P811, DOI 10.1016/j.jaci.2013.04.033; Kaur M, 2012, EUR J PHARM SCI, V47, P574, DOI 10.1016/j.ejps.2012.07.013; Khurana D, 2007, J IMMUNOL, V178, P3575, DOI 10.4049/jimmunol.178.6.3575; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Kobayashi T, 2000, J IMMUNOL, V164, P3855, DOI 10.4049/jimmunol.164.7.3855; Lee SH, 2011, ANN HUM GENET, V75, P359, DOI 10.1111/j.1469-1809.2010.00637.x; Liao XC, 1995, IMMUNITY, V3, P757, DOI 10.1016/1074-7613(95)90065-9; Matsumoto Y, 2002, INT ARCH ALLERGY IMM, V129, P327, DOI 10.1159/000067589; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Miller AT, 2004, IMMUNITY, V21, P67, DOI 10.1016/j.immuni.2004.06.009; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mueller C, 2003, J IMMUNOL, V170, P5056, DOI 10.4049/jimmunol.170.10.5056; Qi Q, 2009, BLOOD, V114, P564, DOI 10.1182/blood-2008-12-196345; Sahu N, 2008, J IMMUNOL, V181, P6125, DOI 10.4049/jimmunol.181.9.6125; Sahu N, 2008, J IMMUNOL, V180, P3833, DOI 10.4049/jimmunol.180.6.3833; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Schaeffer EM, 2001, NAT IMMUNOL, V2, P1183, DOI 10.1038/ni734; Singleton KL, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001821; SNAPPER CM, 1988, J IMMUNOL, V140, P2121; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Tan YX, 2014, NAT IMMUNOL, V15, P186, DOI 10.1038/ni.2772; von Bonin A, 2011, EXP DERMATOL, V20, P41, DOI 10.1111/j.1600-0625.2010.01198.x	44	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107490	10.1371/journal.pone.0107490	http://dx.doi.org/10.1371/journal.pone.0107490			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250764	Green Published, gold, Green Submitted			2022-12-25	WOS:000342492700033
J	Snelling, TJ; Genc, B; McKain, N; Watson, M; Waters, SM; Creevey, CJ; Wallace, RJ				Snelling, Timothy J.; Genc, Bugra; McKain, Nest; Watson, Mick; Waters, Sinead M.; Creevey, Christopher J.; Wallace, R. John			Diversity and Community Composition of Methanogenic Archaea in the Rumen of Scottish Upland Sheep Assessed by Different Methods	PLOS ONE			English	Article							DIRECTED PCR PRIMERS; RIBOSOMAL-RNA GENE; PHYLOGENETIC ANALYSIS; BUBALUS-BUBALIS; 16S; IDENTIFICATION; BACTERIAL; METHANE; DATABASE; BIAS	Ruminal archaeomes of two mature sheep grazing in the Scottish uplands were analysed by different sequencing and analysis methods in order to compare the apparent archaeal communities. All methods revealed that the majority of methanogens belonged to the Methanobacteriales order containing the Methanobrevibacter, Methanosphaera and Methanobacteria genera. Sanger sequenced 1.3 kb 16S rRNA gene amplicons identified the main species of Methanobrevibacter present to be a SGMT Clade member Mbb. millerae (>= 91% of OTUs); Methanosphaera comprised the remainder of the OTUs. The primers did not amplify ruminal Thermoplasmatales-related 16S rRNA genes. Illumina sequenced V6-V8 16S rRNA gene amplicons identified similar Methanobrevibacter spp. and Methanosphaera clades and also identified the Thermoplasmatales-related order as 13% of total archaea. Unusually, both methods concluded that Mbb. ruminantium and relatives from the same clade (RO) were almost absent. Sequences mapping to rumen 16S rRNA and mcrA gene references were extracted from Illumina metagenome data. Mapping of the metagenome data to 16S rRNA gene references produced taxonomic identification to Order level including 2-3% Thermoplasmatales, but was unable to discriminate to species level. Mapping of the metagenome data to mcrA gene references resolved 69% to unclassified Methanobacteriales. Only 30% of sequences were assigned to species level clades: of the sequences assigned to Methanobrevibacter, most mapped to SGMT (16%) and RO (10%) clades. The Sanger 16S amplicon and Illumina metagenome mcrA analyses showed similar species richness (Chao1 Index 19-35), while Illumina metagenome and amplicon 16S rRNA analysis gave lower richness estimates (10-18). The values of the Shannon Index were low in all methods, indicating low richness and uneven species distribution. Thus, although much information may be extracted from the other methods, Illumina amplicon sequencing of the V6-V8 16S rRNA gene would be the method of choice for studying rumen archaeal communities.	[Snelling, Timothy J.; McKain, Nest; Wallace, R. John] Univ Aberdeen, Rowett Inst Nutr & Hlth, Bucksburn, Aberdeen, Scotland; [Genc, Bugra] Ondokuz Mayis Univ, Fac Vet Med, Dept Anim Nutr & Nutr Dis, Samsun, Turkey; [Watson, Mick] ARK Genom, Roslin Inst, Easter Bush, Midlothian, Scotland; [Waters, Sinead M.] TEAGASC, Grange, Anim & Grassland Res & Innovat Ctr, Anim & Biosci Res Dept, Dunsany, Meath, Ireland; [Creevey, Christopher J.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Ceredigion, Wales	University of Aberdeen; Ondokuz Mayis University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; Teagasc; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Wallace, RJ (corresponding author), Univ Aberdeen, Rowett Inst Nutr & Hlth, Bucksburn, Aberdeen, Scotland.	john.wallace@abdn.ac.uk	Creevey, Christopher James/A-1836-2013	Creevey, Christopher James/0000-0001-7183-1555; /0000-0002-8952-8826; Watson, Mick/0000-0003-4211-0358	Rural and Environment Science and Analytical Services Division (RESAS) of the Scottish Government; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J004243/1, BB/J004235/1]; Technology Strategy Board [TS/J000108/1, TS/J000116/1]; Turkish Higher Education Council; BBSRC Institute Strategic Programme Grant, Rumen Systems Biology [BB/J004413/1]; BBSRC [BBS/E/D/20231761, BBS/E/W/10964A01A, BBS/E/W/10964A01B, BBS/E/D/20310000, BBS/E/W/10964A01C, BBS/E/D/20211551, BBS/E/D/20211553] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/W/10964A01B, BBS/E/D/20310000, BBS/E/D/20231761, BBS/E/D/20211553, BBS/E/W/10964A01C, BBS/E/D/20211551, BBS/E/W/10964A01A] Funding Source: researchfish	Rural and Environment Science and Analytical Services Division (RESAS) of the Scottish Government; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Technology Strategy Board; Turkish Higher Education Council(Ministry of National Education - Turkey); BBSRC Institute Strategic Programme Grant, Rumen Systems Biology(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The Rowett Institute of Nutrition and Health is funded by the Rural and Environment Science and Analytical Services Division (RESAS) of the Scottish Government. Research at The Roslin Institute was supported by the Biotechnology and Biological Sciences Research Council (BBSRC; BB/J004243/1, BB/J004235/1), and by the Technology Strategy Board (TS/J000108/1, TS/J000116/1). BG thanks the Turkish Higher Education Council for the award of a travelling fellowship. CJC was supported by the BBSRC Institute Strategic Programme Grant, Rumen Systems Biology (BB/J004413/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cavicchioli R, 2011, NAT REV MICROBIOL, V9, P51, DOI 10.1038/nrmicro2482; CHAO A, 1984, SCAND J STAT, V11, P265; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Czerkawski J W, 1969, World Rev Nutr Diet, V11, P240; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edwards JE, 2004, ANTON LEEUW INT J G, V86, P263, DOI 10.1023/B:ANTO.0000047942.69033.24; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Franzolin R, 2012, MICROB ECOL, V64, P131, DOI 10.1007/s00248-012-0007-0; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Huber T, 2004, BIOINFORMATICS, V20; Intergovernmental Panel on Climate Change, 2022, CLIM CHANG 2022 IMP, P1; Jeyanathan J, 2011, FEMS MICROBIOL ECOL, V76, P311, DOI 10.1111/j.1574-6941.2011.01056.x; King EE, 2011, APPL ENVIRON MICROB, V77, P5682, DOI 10.1128/AEM.05130-11; Kittelmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047879; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Luo YH, 2012, ARCHAEA, V2012, DOI 10.1155/2012/605289; Mosoni P, 2011, J ANIM SCI, V89, P783, DOI 10.2527/jas.2010-2947; Moss AR, 2000, ANN ZOOTECH, V49, P231, DOI 10.1051/animres:2000119; Ozutsumi Y, 2012, ANIM SCI J, V83, P727, DOI 10.1111/j.1740-0929.2012.01023.x; Paul K, 2012, APPL ENVIRON MICROB, V78, P8245, DOI 10.1128/AEM.02193-12; Popova M, 2013, APPL ENVIRON MICROB, V79, P1777, DOI 10.1128/AEM.03115-12; Poulsen M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2432; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santamaria M, 2012, BRIEF BIOINFORM, V13, P682, DOI 10.1093/bib/bbs036; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scottish government, 2010, ABSTR SCOTT AGR STAT; Shakya M, 2013, ENVIRON MICROBIOL, V15, P1882, DOI 10.1111/1462-2920.12086; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shin EC, 2004, ANAEROBE, V10, P313, DOI 10.1016/j.anaerobe.2004.08.002; Singh KM, 2012, RES VET SCI, V92, P451, DOI 10.1016/j.rvsc.2011.03.022; Skillman LC, 2006, LETT APPL MICROBIOL, V42, P222, DOI [10.1111/j.1472-765X.2005.01833.x, 10.1111/j.1472-765X.2005.01833.X]; Skillman LC, 2004, ANAEROBE, V10, P277, DOI 10.1016/j.anaerobe.2004.05.003; St-Pierre B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-1; Sundset MA, 2009, FEMS MICROBIOL ECOL, V70, P553, DOI 10.1111/j.1574-6941.2009.00750.x; Sundset M, 2009, MICROB ECOL, V57, P335, DOI 10.1007/s00248-008-9414-7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thorpe A, 2009, CLIMATIC CHANGE, V93, P407, DOI 10.1007/s10584-008-9506-x; Tymensen LD, 2012, APPL ENVIRON MICROB, V78, P4051, DOI 10.1128/AEM.07994-11; Whitford M F, 2001, BMC Microbiol, V1, P5, DOI 10.1186/1471-2180-1-5; Wright AJ, 2007, LIBR J, V132, P73; Wright ADG, 2006, ANAEROBE, V12, P134, DOI 10.1016/j.anaerobe.2006.02.002; Wright ADG, 2004, APPL ENVIRON MICROB, V70, P1263, DOI 10.1128/AEM.70.3.1263-1270.2004; Wright ADG, 2003, J MICROBIOL METH, V55, P337, DOI 10.1016/S0167-7012(03)00169-6; Wright ADG, 2008, MICROB ECOL, V56, P390, DOI 10.1007/s00248-007-9351-x; Yanagita K, 2000, BIOSCI BIOTECH BIOCH, V64, P1737, DOI 10.1271/bbb.64.1737; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	55	25	27	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e106491	10.1371/journal.pone.0106491	http://dx.doi.org/10.1371/journal.pone.0106491			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250654	Green Published, Green Submitted, gold			2022-12-25	WOS:000342492700014
J	Bohla, D; Herold, M; Panzer, I; Buxa, MK; Ali, T; Demmers, J; Kruger, M; Scharfe, M; Jarek, M; Bartkuhn, M; Renkawitz, R				Bohla, Dorte; Herold, Martin; Panzer, Imke; Buxa, Melanie K.; Ali, Tamer; Demmers, Jeroen; Krueger, Marcus; Scharfe, Maren; Jarek, Michael; Bartkuhn, Marek; Renkawitz, Rainer			A Functional Insulator Screen Identifies NURF and dREAM Components to Be Required for Enhancer-Blocking	PLOS ONE			English	Article							GENE-EXPRESSION; DROSOPHILA MYB; EPIGENETIC REGULATION; ENRICHMENT ANALYSIS; BITHORAX COMPLEX; CHROMATIN; PROTEIN; CTCF; PROMOTER; BOUNDARY	Chromatin insulators of higher eukaryotes functionally divide the genome into active and inactive domains. Furthermore, insulators regulate enhancer/promoter communication, which is evident from the Drosophila bithorax locus in which a multitude of regulatory elements control segment specific gene activity. Centrosomal protein 190 (CP190) is targeted to insulators by CTCF or other insulator DNA-binding factors. Chromatin analyses revealed that insulators are characterized by open and nucleosome depleted regions. Here, we wanted to identify chromatin modification and remodelling factors required for an enhancer blocking function. We used the well-studied Fab-8 insulator of the bithorax locus to apply a genome-wide RNAi screen for factors that contribute to the enhancer blocking function of CTCF and CP190. Among 78 genes required for optimal Fab-8 mediated enhancer blocking, all four components of the NURF complex as well as several subunits of the dREAM complex were most evident. Mass spectrometric analyses of CTCF or CP190 bound proteins as well as immune precipitation confirmed NURF and dREAM binding. Both co-localise with most CP190 binding sites in the genome and chromatin immune precipitation showed that CP190 recruits NURF and dREAM. Nucleosome occupancy and histone H3 binding analyses revealed that CP190 mediated NURF binding results in nucleosomal depletion at CP190 binding sites. Thus, we conclude that CP190 binding to CTCF or to other DNA binding insulator factors mediates recruitment of NURF and dREAM. Furthermore, the enhancer blocking function of insulators is associated with nucleosomal depletion and requires NURF and dREAM.	[Bohla, Dorte; Herold, Martin; Panzer, Imke; Buxa, Melanie K.; Ali, Tamer; Bartkuhn, Marek; Renkawitz, Rainer] Univ Giessen, Inst Genet, D-35390 Giessen, Germany; [Ali, Tamer] Benha Univ, Fac Sci, Banha, Egypt; [Demmers, Jeroen] Erasmus MC, Prote Ctr, Rotterdam, Netherlands; [Krueger, Marcus] Max Planck Inst Heart & Lung Res, Biomol Mass Spectrometry, Bad Nauheim, Germany; [Scharfe, Maren; Jarek, Michael] Helmholtz Ctr Infect Res, Braunschweig, Germany	Justus Liebig University Giessen; Egyptian Knowledge Bank (EKB); Benha University; Erasmus University Rotterdam; Erasmus MC; Max Planck Society; Helmholtz Association; Helmholtz-Center for Infection Research	Renkawitz, R (corresponding author), Univ Giessen, Inst Genet, D-35390 Giessen, Germany.	rainer.renkawitz@gen.bio.uni-giessen.de	Demmers, Jeroen AA/F-4046-2016	Demmers, Jeroen AA/0000-0002-8757-9611; Bartkuhn, Marek/0000-0001-6872-9082	DFG [TRR81]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067761] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the DFG, TRR81 (http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahanger SH, 2013, NUCLEUS-AUSTIN, V4, P115, DOI 10.4161/nucl.23389; Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Bai L, 2010, TRENDS GENET, V26, P476, DOI 10.1016/j.tig.2010.08.003; Barges S, 2000, DEVELOPMENT, V127, P779; Bartkuhn M, 2009, EMBO J, V28, P877, DOI 10.1038/emboj.2009.34; Beall EL, 2002, NATURE, V420, P833, DOI 10.1038/nature01228; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Ciavatta D, 2007, J MOL BIOL, V373, P233, DOI 10.1016/j.jmb.2007.07.065; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; DeMare LE, 2013, GENOME RES, V23, P1224, DOI 10.1101/gr.156570.113; Feller C, 2012, NUCLEIC ACIDS RES, V40, P1509, DOI 10.1093/nar/gkr869; FRASCH M, 1986, J CELL SCI, V82, P155; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Gan M, 2011, J BIOSCIENCES, V36, P425, DOI 10.1007/s12038-011-9089-y; Gaszner M, 1999, GENE DEV, V13, P2098, DOI 10.1101/gad.13.16.2098; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Georlette D, 2007, GENE DEV, V21, P2880, DOI 10.1101/gad.1600107; Gerasimova TI, 2007, MOL CELL, V28, P761, DOI 10.1016/j.molcel.2007.09.024; Gurudatta BV, 2013, CELL CYCLE, V12, P1605, DOI 10.4161/cc.24742; Herold M, 2012, DEVELOPMENT, V139, P1045, DOI 10.1242/dev.065268; Hochheimer A, 2002, NATURE, V420, P439, DOI 10.1038/nature01167; Holohan EE, 2007, PLOS GENET, V3, P1211, DOI 10.1371/journal.pgen.0030112; Holwerda SJB, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0369; Korenjak M, 2004, CELL, V119, P181, DOI 10.1016/j.cell.2004.09.034; Kugler SJ, 2010, MOL BIOL CELL, V21, P3443, DOI 10.1091/mbc.E10-03-0212; Kyrchanova O, 2011, NUCLEIC ACIDS RES, V39, P3042, DOI 10.1093/nar/gkq1248; Lee H, 2012, MOL CELLULAR BIOL; Lee H, 2010, MOL CELL BIOL, V30, P2563, DOI 10.1128/MCB.01075-09; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Li HB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003436; Li M, 2010, MOL CELL BIOL, V30, P1067, DOI 10.1128/MCB.00183-09; Macaluso M, 2006, ONCOGENE, V25, P5263, DOI 10.1038/sj.onc.1209680; Martinez-Balbas MA, 1998, P NATL ACAD SCI USA, V95, P132, DOI 10.1073/pnas.95.1.132; Mohan M, 2007, EMBO J, V26, P4203, DOI 10.1038/sj.emboj.7601851; Moshkin YM, 2012, MOL CELL BIOL, V32, P675, DOI 10.1128/MCB.06365-11; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Ohtsuki S, 1998, GENE DEV, V12, P3325, DOI 10.1101/gad.12.21.3325; Ong CT, 2013, CELL, V155, P148, DOI 10.1016/j.cell.2013.08.052; PARKHURST SM, 1988, GENE DEV, V2, P1205, DOI 10.1101/gad.2.10.1205; Perez-Lluch S, 2008, NUCLEIC ACIDS RES, V36, P6926, DOI 10.1093/nar/gkn818; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Raab JR, 2010, NAT REV GENET, V11, P439, DOI 10.1038/nrg2765; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Roy S, 2007, MOL GENET GENOMICS, V277, P273, DOI 10.1007/s00438-006-0187-8; Schoenfelder S, 2010, CURR OPIN GENET DEV, V20, P127, DOI 10.1016/j.gde.2010.02.002; Schwartz YB, 2012, GENOME RES, V22, P2188, DOI 10.1101/gr.138156.112; Sim CK, 2012, GENE DEV, V26, P2483, DOI 10.1101/gad.201665.112; Smith ST, 2009, DEV BIOL, V328, P518, DOI 10.1016/j.ydbio.2008.12.039; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; TSUKIYAMA T, 1995, CELL, V83, P1021, DOI 10.1016/0092-8674(95)90217-1; Tyler JK, 1996, MOL CELL BIOL, V16, P6149; Van Bortle K, 2012, GENOME RES, V22, P2176, DOI 10.1101/gr.136788.111; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; Wen H, 2008, GENE DEV, V22, P601, DOI 10.1101/gad.1626308; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yang JP, 2012, CURR OPIN GENET DEV, V22, P86, DOI 10.1016/j.gde.2011.12.007; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; ZHAO K, 1995, CELL, V81, P879, DOI 10.1016/0092-8674(95)90008-X	60	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107765	10.1371/journal.pone.0107765	http://dx.doi.org/10.1371/journal.pone.0107765			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247414	Green Published, Green Submitted, gold			2022-12-25	WOS:000342351800036
J	Leo, CH; Jelinic, M; Gooi, JH; Tare, M; Parry, LJ				Leo, Chen Huei; Jelinic, Maria; Gooi, Jon H.; Tare, Marianne; Parry, Laura J.			A Vasoactive Role for Endogenous Relaxin in Mesenteric Arteries of Male Mice	PLOS ONE			English	Article							NITRIC-OXIDE; MYOGENIC REACTIVITY; PREGNANCY; VASODILATION; HYPERPOLARIZATION; DYSFUNCTION; RELAXATION; ACTIVATION; INCREASES; EDHF	The peptide hormone relaxin has striking effects on the vascular system. Specifically, endogenous relaxin treatment reduces myogenic reactivity through nitric oxide (NO)-mediated vasorelaxation and increases arterial compliance in small resistance arteries. However, less is known about the vascular roles of endogenous relaxin, particularly in males. Therefore, we used male wild-type (Rln(+/+)) and relaxin knockout (Rln(-/-)) mice to test the hypothesis that passive wall properties and vascular reactivity in mesenteric arteries would be compromised in Rln(-/-) mice. Passive compliance was determined in arteries (n = 8-9) mounted on a pressure myograph and in Ca2+-free Krebs containing 2 mM EGTA. Passive volume compliance was significantly (P = 0.01) decreased in the mesenteric arteries of Rln(-/-) mice. Vascular reactivity was assessed using wire myography. In mesenteric arteries (n = 5) of Rln(-/-) mice, there was a significant (P<0.03) increase in sensitivity to the vasoconstrictors phenylephrine and thromboxane-mimetic U41669. This enhanced responsiveness to vasoconstrictors was abolished by endothelial denudation, and attributed to impaired NO and prostanoid pathways in Rln(-/-) mice. Sensitivity to the endothelial agonist acetylcholine was significantly (n = 7-9, P <= 0.03) decreased, and this was abolished in the presence of the cyclooxygenase inhibitor, indomethacin (2 mu M). This indicates that prostanoid vasoconstrictor pathways were upregulated in the mesenteric arteries of Rln(-/-) mice. In summary, we demonstrate endothelial dysfunction and impaired arterial wall remodeling in male mice deficient in relaxin. Thus, our results highlight a role for endogenous relaxin in the maintenance of normal mesenteric artery structure and function in males.	[Leo, Chen Huei; Jelinic, Maria; Gooi, Jon H.; Parry, Laura J.] Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia; [Jelinic, Maria] Univ Melbourne, Dept Physiol, Parkville, Vic 3052, Australia; [Tare, Marianne] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia	University of Melbourne; University of Melbourne; Monash University	Parry, LJ (corresponding author), Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia.	ljparry@unimelb.edu.au	leo, Chen huei/ABD-2155-2020; Gooi, Jonathan/AAS-7982-2020	leo, Chen huei/0000-0003-1424-9694; Gooi, Jonathan/0000-0002-8839-1602; Parry, Laura/0000-0002-6883-3418; Jelinic, Maria/0000-0001-9773-4972	Australian Research Council [LP110200543]; Australian and New Zealand Medical Research and Technology in Victoria Grant; Novartis Pharma AG; Australian Postgraduate Award	Australian Research Council(Australian Research Council); Australian and New Zealand Medical Research and Technology in Victoria Grant; Novartis Pharma AG; Australian Postgraduate Award(Australian Government)	The research was funded by an Australian Research Council Linkage Grant (LP110200543) and an Australian and New Zealand Medical Research and Technology in Victoria Grant, with partial funding from Novartis Pharma AG. MJ received an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Y, 2005, J HYPERTENS, V23, P767, DOI 10.1097/01.hjh.0000163145.12707.63; Bani D, 1998, HYPERTENSION, V31, P1240, DOI 10.1161/01.HYP.31.6.1240; BANISACCHI T, 1995, BRIT J PHARMACOL, V116, P1589, DOI 10.1111/j.1476-5381.1995.tb16377.x; Cecelja M, 2013, ARTERY RES, V7, P22, DOI 10.1016/j.artres.2012.09.001; Chan SL, 2011, FASEB J, V25, P3229, DOI 10.1096/fj.10-175471; Coleman HA, 2004, CLIN EXP PHARMACOL P, V31, P641, DOI 10.1111/j.1440-1681.2004.04053.x; Conrad KP, 2011, AM J PHYSIOL-REG I, V301, pR267, DOI 10.1152/ajpregu.00156.2011; Conrad KP, 2010, HYPERTENSION, V56, P2, DOI 10.1161/HYPERTENSIONAHA.109.133926; Conrad KP, 2004, ENDOCRINOLOGY, V145, P3289, DOI 10.1210/en.2003-1612; Danielson LA, 1999, J CLIN INVEST, V103, P525, DOI 10.1172/JCI5630; Debrah DO, 2006, ENDOCRINOLOGY, V147, P5126, DOI 10.1210/en.2006-0567; Debrah DO, 2011, J APPL PHYSIOL, V111, P260, DOI 10.1152/japplphysiol.00845.2010; Du XJ, 2003, CARDIOVASC RES, V57, P395, DOI 10.1016/S0008-6363(02)00663-6; Failli P, 2001, FASEB J, V15, P252, DOI 10.1096/fj.01-0569fje; Feletou M, 2011, BRIT J PHARMACOL, V164, P894, DOI 10.1111/j.1476-5381.2011.01276.x; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Gooi JH, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108118; Holobotovskyy V, 2013, CIRC RES, V112, P781, DOI 10.1161/CIRCRESAHA.111.300142; Jelinic M, 2014, FASEB J, V28, P275, DOI 10.1096/fj.13-233429; Leo CH, 2011, BRIT J PHARMACOL, V162, P365, DOI 10.1111/j.1476-5381.2010.01023.x; Leo CH, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000493; Li Y, 2005, REGUL PEPTIDES, V132, P41, DOI 10.1016/j.regpep.2005.09.009; McGuane JT, 2011, ENDOCRINOLOGY, V152, P2786, DOI 10.1210/en.2010-1126; Novak J, 2001, J CLIN INVEST, V107, P1469, DOI 10.1172/JCI11975; Novak J, 2002, AM J PHYSIOL-REG I, V283, pR349, DOI 10.1152/ajpregu.00635.2001; Novak J, 2006, FASEB J, V20, P2352, DOI 10.1096/fj.06-6263com; Sandow SL, 2007, TRENDS PHARMACOL SCI, V28, P61, DOI 10.1016/j.tips.2006.12.007; Tare M, 2000, BRIT J PHARMACOL, V130, P605, DOI 10.1038/sj.bjp.0703332; van Drongelen J, 2013, PEPTIDES, V49, P41, DOI 10.1016/j.peptides.2013.08.020; van Drongelen J, 2012, J APPL PHYSIOL, V112, P962, DOI 10.1152/japplphysiol.00470.2011; Drongelen J, 2011, AM J PHYSIOL-HEART C, V300, pH1609, DOI 10.1152/ajpheart.00360.2010; Vanhoutte PM, 2009, ACTA PHYSIOL, V196, P193, DOI 10.1111/j.1748-1716.2009.01964.x; Vodstrcil LA, 2012, FASEB J, V26, P4035, DOI 10.1096/fj.12-210567; Wang WZ, 2013, AM J PHYSIOL-HEART C, V305, pH521, DOI 10.1152/ajpheart.00810.2012; Xu Q, 2010, HYPERTENSION, V55, P1260, DOI 10.1161/HYPERTENSIONAHA.109.149369; Zhao L, 1999, ENDOCRINOLOGY, V140, P445, DOI 10.1210/en.140.1.445	36	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107382	10.1371/journal.pone.0107382	http://dx.doi.org/10.1371/journal.pone.0107382			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243460	Green Published, gold			2022-12-25	WOS:000343679800031
J	Xuan, YH; Bin Huang, B; Tian, HS; Chi, LS; Duan, YM; Wang, X; Zhu, ZX; Cai, WH; Zhu, YT; Wei, TM; Ye, HB; Cong, WT; Jin, LT				Xuan, Yuan Hu; Bin Huang, Bin; Tian, Hai Shan; Chi, Li Sha; Duan, Yuan Meng; Wang, Xi; Zhu, Zhong Xin; Cai, Wan Hui; Zhu, Yu Ting; Wei, Tie Min; Ye, Hong Bo; Cong, Wei Tao; Jin, Li Tai			High-Glucose Inhibits Human Fibroblast Cell Migration in Wound Healing via Repression of bFGF-Regulating JNK Phosphorylation	PLOS ONE			English	Article							GROWTH-FACTOR; DIABETIC CARDIOMYOPATHY; OXIDATIVE STRESS; RHO-KINASE; METALLOTHIONEIN; SKIN; DYSFUNCTION; ACTIVATION; GENERATION; PREVENTION	One of the major symptoms of diabetes mellitus (DM) is delayed wound healing, which affects large populations of patients worldwide. However, the underlying mechanism behind this illness remains elusive. Skin wound healing requires a series of coordinated processes, including fibroblast cell proliferation and migration. Here, we simulate DM by application of high glucose (HG) in human foreskin primary fibroblast cells to analyze the molecular mechanism of DM effects on wound healing. The results indicate that HG, at a concentration of 30 mM, delay cell migration, but not cell proliferation. bFGF is known to promote cell migration that partially rescues HG effects on cell migration. Molecular and cell biology studies demonstrated that HG enhanced ROS production and repressed JNK phosphorylation, but did not affect Rac1 activity. JNK and Rac1 activation were known to be important for bFGF regulated cell migration. To further confirm DM effects on skin repair, a type 1 diabetic rat model was established, and we observed the efficacy of bFGF on both normal and diabetic rat skin repair. Furthermore, proteomic studies identified an increase of Annexin A2 protein nitration in HG-stressed fibroblasts and the nitration was protected by activation of bFGF signaling. Treatment with FGFR1 and JNK inhibitors delayed cell migration and increased Annexin A2 nitration levels, indicating that Annexin A2 nitration is modulated by bFGF signaling via activation of JNK. Together with these results, our data suggests that the HG-mediated delay of cell migration is linked to the inhibition of bFGF signaling, specifically through JNK suppression.	[Xuan, Yuan Hu; Bin Huang, Bin; Tian, Hai Shan; Chi, Li Sha; Duan, Yuan Meng; Zhu, Zhong Xin; Cai, Wan Hui; Zhu, Yu Ting; Cong, Wei Tao; Jin, Li Tai] Wenzhou Med Univ, Sch Pharmaceut Sci, Key Lab Biotechnol Pharmaceut Engn, Wenzhou, Peoples R China; [Bin Huang, Bin] Wenzhou Med Univ, Affiliated Hosp 3, Wenzhou, Peoples R China; [Wang, Xi] Wenzhou Med Univ, Affiliated Wenling Hosp, Wenling, Peoples R China; [Wei, Tie Min] Wenzhou Med Univ, Affiliated Hosp 5, Lishui, Peoples R China; [Ye, Hong Bo] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Stanford University	Cong, WT (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Key Lab Biotechnol Pharmaceut Engn, Wenzhou, Peoples R China.	cwt97126@126.com; jin_litai@126.com		, Yuanhu/0000-0002-4704-8090	National Nature Science Foundation of China [81371753, 81300171, 81201245, 81170750]; Zhejiang Provincial Natural Science Foundation [LQ12H07002]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents; Zhejiang Provincial Key Research Group [2010R50042]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents; Zhejiang Provincial Key Research Group	This work was supported by the National Nature Science Foundation of China (81371753, 81300171, 81201245, 81170750), the Zhejiang Provincial Natural Science Foundation (LQ12H07002), the Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents (to L.T.J.), Zhejiang Provincial Key Research Group (2010R50042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Bachschmid MM, 2010, FREE RADICAL BIO MED, V49, P1221, DOI 10.1016/j.freeradbiomed.2010.07.005; Barwise JL, 1996, J CELL SCI, V109, P247; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Braiman-Wiksman L, 2007, TOXICOL PATHOL, V35, P767, DOI 10.1080/01926230701584189; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cai L, 2005, DIABETES, V54, P1829, DOI 10.2337/diabetes.54.6.1829; Cai L, 2006, J AM COLL CARDIOL, V48, P1688, DOI 10.1016/j.jacc.2006.07.022; Cong WT, 2013, AM J PHYSIOL-ENDOC M, V304, pE826, DOI 10.1152/ajpendo.00570.2012; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Haynes V, 2010, AM J PHYSIOL-ENDOC M, V298, pE978, DOI 10.1152/ajpendo.00739.2009; House SL, 2003, CIRCULATION, V108, P3140, DOI 10.1161/01.CIR.0000105723.91637.1C; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jin LT, 2008, ANAL BIOCHEM, V383, P137, DOI 10.1016/j.ab.2008.04.048; Kanazawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012228; Khullar M, 2010, CAN J PHYSIOL PHARM, V88, P233, DOI 10.1139/Y10-016; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Kurokawa K, 2005, BIOCHEM SOC T, V33, P631, DOI 10.1042/BST0330631; Lamers ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022865; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lerman OZ, 2003, AM J PATHOL, V162, P303, DOI 10.1016/S0002-9440(10)63821-7; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Morel E, 2009, J BIOL CHEM, V284, P1604, DOI 10.1074/jbc.M806499200; Park SJ, 2012, MOL CELLS, V33, P141, DOI 10.1007/s10059-012-2192-6; Rankin CR, 2013, J BIOL CHEM, V288, P15229, DOI 10.1074/jbc.M112.440909; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Smith LG, 2004, CURR BIOL, V14, pR109, DOI 10.1016/j.cub.2004.01.016; Tao LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026055; Vlahopoulos S, 2004, BIOCHEMISTRY-MOSCOW+, V69, P844, DOI 10.1023/B:BIRY.0000040215.02460.45; Wagner W, 2007, J CELL MOL MED, V11, P1342, DOI 10.1111/j.1582-4934.2007.00037.x; Wang YA, 2010, J PROTEOME RES, V9, P4254, DOI 10.1021/pr100349g; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Xie J, 2008, CLIN EXP DERMATOL, V33, P176, DOI 10.1111/j.1365-2230.2007.02573.x; Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62; Yang Y, 2011, BIOMATERIALS, V32, P4243, DOI 10.1016/j.biomaterials.2011.02.042; Yu P, 2011, BIOCHEM BIOPH RES CO, V409, P350, DOI 10.1016/j.bbrc.2011.05.024; Zhai HY, 2011, J NEUROSCI, V31, P14346, DOI 10.1523/JNEUROSCI.3299-11.2011; Zhang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067268	41	76	84	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e108182	10.1371/journal.pone.0108182	http://dx.doi.org/10.1371/journal.pone.0108182			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244316	gold, Green Published, Green Submitted			2022-12-25	WOS:000343679800074
J	Hai, RT; Wang, YL; Wang, XH; Du, ZZ; Li, Y				Hai, Reti; Wang, Yulin; Wang, Xiaohui; Du, Zhize; Li, Yuan			Impacts of Multiwalled Carbon Nanotubes on Nutrient Removal from Wastewater and Bacterial Community Structure in Activated Sludge	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; PHOSPHORUS REMOVAL; TITANIUM-DIOXIDE; NANOPARTICLES; TOXICITY; SILVER; ZNO	Background: The increasing use of multiwalled carbon nanotubes (MWCNTs) will inevitably lead to the exposure of wastewater treatment facilities. However, knowledge of the impacts of MWCNTs on wastewater nutrient removal and bacterial community structure in the activated sludge process is sparse. Aims: To investigate the effects of MWCNTs on wastewater nutrient removal, and bacterial community structure in activated sludge. Methods: Three triplicate sequencing batch reactors (SBR) were exposed to wastewater which contained 0, 1, and 20 mg/L MWCNTs. MiSeq sequencing was used to investigate the bacterial community structures in activated sludge samples which were exposed to different concentrations of MWCNTs. Results: Exposure to 1 and 20 mg/L MWCNTs had no acute (1 day) impact on nutrient removal from wastewater. After long-term (180 days) exposure to 1 mg/L MWCNTs, the average total nitrogen (TN) removal efficiency was not significantly affected. TN removal efficiency decreased from 84.0% to 71.9% after long-term effects of 20 mg/L MWCNTs. After long-term exposure to 1 and 20 mg/L MWCNTs, the total phosphorus removal efficiencies decreased from 96.8% to 52.3% and from 98.2% to 34.0% respectively. Further study revealed that long-term exposure to 20 mg/L MWCNTs inhibited activities of ammonia monooxygenase and nitrite oxidoreductase. Long-term exposure to 1 and 20 mg/L MWCNTs both inhibited activities of exopolyphosphatase and polyphosphate kinase. MiSeq sequencing data indicated that 20 mg/L MWCNTs significantly decreased the diversity of bacterial community in activated sludge. Long-term exposure to 1 and 20 mg/L MWCNTs differentially decreased the abundance of nitrifying bacteria, especially ammonia-oxidizing bacteria. The abundance of PAOs was decreased after long-term exposure to 20 mg/L MWCNTs. The abundance of glycogen accumulating organisms (GAOs) was increased after long-term exposure to 1 mg/L MWCNTs. Conclusion: MWCNTs have adverse effects on biological wastewater nutrient removal, and altered the diversity and structure of bacterial community in activated sludge.	[Hai, Reti; Wang, Yulin; Wang, Xiaohui; Du, Zhize; Li, Yuan] Beijing Univ Chem Technol, Beijing Engn Res Ctr Environm Mat Water Purificat, Beijing 100029, Peoples R China	Beijing University of Chemical Technology	Wang, XH (corresponding author), Beijing Univ Chem Technol, Beijing Engn Res Ctr Environm Mat Water Purificat, Beijing 100029, Peoples R China.	wangxiaohui2008@gmail.com	Yulin, Wang/AAL-3345-2021	Wang, Yulin/0000-0002-9899-7712	International Science-Technology Cooperation Program of China [2013DFR60250]; Fundamental Research Funds for the Central Universities [ZY1306]; State Key Joint Laboratory of Environment Simulation and Pollution Control [3K06ESPCT]	International Science-Technology Cooperation Program of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); State Key Joint Laboratory of Environment Simulation and Pollution Control	This study was supported by the International Science-Technology Cooperation Program of China (2013DFR60250), the Fundamental Research Funds for the Central Universities (ZY1306) and special fund of State Key Joint Laboratory of Environment Simulation and Pollution Control (3K06ESPCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; Arias LR, 2009, LANGMUIR, V25, P3003, DOI 10.1021/la802769m; Ayarza JM, 2011, MICROB ECOL, V61, P486, DOI 10.1007/s00248-010-9762-y; Begum SA, 2012, WORLD J MICROB BIOT, V28, P2181, DOI 10.1007/s11274-012-1024-3; Blinova I, 2010, ENVIRON POLLUT, V158, P41, DOI 10.1016/j.envpol.2009.08.017; Chen YG, 2012, ENVIRON SCI TECHNOL, V46, P12452, DOI 10.1021/es302646q; Ganesh R, 2010, ENVIRON SCI TECHNOL, V44, P7808, DOI 10.1021/es101355k; Garcia A, 2012, J HAZARD MATER, V199, P64, DOI 10.1016/j.jhazmat.2011.10.057; Gillan DC, 2004, APPL ENVIRON MICROB, V70, P3772, DOI 10.1128/AEM.70.6.3772-3775.2004; Gottschalk F, 2009, ENVIRON SCI TECHNOL, V43, P9216, DOI 10.1021/es9015553; Goyal D, 2010, LETT APPL MICROBIOL, V51, P428, DOI 10.1111/j.1472-765X.2010.02913.x; Han YG, 2012, NEUROTOXICOLOGY, V33, P1128, DOI 10.1016/j.neuro.2012.06.004; Kang S, 2008, ENVIRON SCI TECHNOL, V42, P7528, DOI 10.1021/es8010173; Kang S, 2008, LANGMUIR, V24, P6409, DOI 10.1021/la800951v; Li Q, 2013, CHEM ENG J, V217, P28, DOI 10.1016/j.cej.2012.12.005; Liang ZH, 2010, WATER RES, V44, P5432, DOI 10.1016/j.watres.2010.06.060; Luongo LA, 2010, J HAZARD MATER, V178, P356, DOI 10.1016/j.jhazmat.2010.01.087; Maynard AD, 2006, NATURE, V444, P267, DOI 10.1038/444267a; McIlroy S, 2009, ENV MICROBIOL REP, V1, P563, DOI 10.1111/j.1758-2229.2009.00082.x; Mu H, 2011, BIORESOURCE TECHNOL, V102, P10305, DOI 10.1016/j.biortech.2011.08.100; Mu H, 2011, WATER RES, V45, P5612, DOI 10.1016/j.watres.2011.08.022; Muller J, 2008, CHEM RES TOXICOL, V21, P1698, DOI 10.1021/tx800101p; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Paradise M, 2007, MATER DESIGN, V28, P1477, DOI 10.1016/j.matdes.2006.03.008; Park HD, 2004, WATER RES, V38, P3275, DOI 10.1016/j.watres.2004.04.047; Sheng ZY, 2011, WATER RES, V45, P6039, DOI 10.1016/j.watres.2011.08.065; van der Gast CJ, 2008, ENVIRON MICROBIOL, V10, P1411, DOI 10.1111/j.1462-2920.2007.01550.x; Van Nostrand JD, 2009, ENVIRON MICROBIOL, V11, P2611, DOI 10.1111/j.1462-2920.2009.01986.x; Wang XS, 2009, NANO LETT, V9, P3137, DOI 10.1021/nl901260b; Yan H, 2006, CHEMOSPHERE, V62, P142, DOI 10.1016/j.chemosphere.2005.03.075; Yin Y, 2008, WATER SCI TECHNOL, V58, P623, DOI 10.2166/wst.2008.698; Yin YX, 2009, J ENVIRON SCI HEAL A, V44, P661, DOI 10.1080/10934520902847695; Zheng X, 2012, ENVIRON SCI TECHNOL, V46, P7182, DOI 10.1021/es300777b; Zheng X, 2011, ENVIRON SCI TECHNOL, V45, P7284, DOI 10.1021/es2008598; Zheng XO, 2011, ENVIRON SCI TECHNOL, V45, P2826, DOI 10.1021/es2000744	35	38	41	6	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107345	10.1371/journal.pone.0107345	http://dx.doi.org/10.1371/journal.pone.0107345			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238404	Green Submitted, gold, Green Published			2022-12-25	WOS:000342491600024
J	Heimesaat, MM; Dunay, IR; Schulze, S; Fischer, A; Grundmann, U; Alutis, M; Kuhl, AA; Tamas, A; Toths, G; Dunay, MP; Gobel, UB; Reglodi, D; Bereswil, S				Heimesaat, Markus M.; Dunay, Ildiko R.; Schulze, Silvia; Fischer, Andre; Grundmann, Ursula; Alutis, Marie; Kuehl, Anja A.; Tamas, Andrea; Toths, Gabor; Dunay, Miklos P.; Goebel, Ulf B.; Reglodi, Dora; Bereswil, Stefan			Pituitary Adenylate Cyclase-Activating Polypeptide Ameliorates Experimental Acute Ileitis and Extra-Intestinal Sequelae	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; TOXOPLASMA-GONDII; ORAL INFECTION; IL-10 PRODUCTION; IN-VITRO; PACAP; VIP; MICE; RECEPTORS; INDUCTION	Background: The neuropeptide Pituitary adenylate cyclase-activating polypeptide ( PACAP) plays pivotal roles in immunity and inflammation. So far, potential immune-modulatory properties of PACAP have not been investigated in experimental ileitis. Methodology/Principal Findings: Mice were perorally infected with Toxoplasma (T.) gondii to induce acute ileitis (day 0) and treated daily with synthetic PACAP38 from day 1 to 6 post infection (p.i.; prophylaxis) or from day 4 to 6 p.i. (therapy). Whereas placebo-treated control mice suffered from acute ileitis at day 7 p.i. and succumbed to infection, intestinal immunopathology was ameliorated following PACAP prophylaxis. PACAP-treated mice exhibited increased abundance of small intestinal FOXP3+ cells, but lower numbers of ileal T lymphocytes, neutrophils, monocytes and macrophages, which was accompanied by less ileal expression of pro-inflammatory cytokines such as IL-23p19, IL-22, IFN-gamma, and MCP-1. Furthermore, PACAP-treated mice displayed higher anti-inflammatory IL-4 concentrations in mesenteric lymph nodes and liver and higher systemic anti-inflammatory IL-10 levels in spleen and serum as compared to control animals at day 7 p.i. Remarkably, PACAP-mediated anti-inflammatory effects could also be observed in extra-intestinal compartments as indicated by reduced pro-inflammatory mediator levels in spleen (TNF-alpha, nitric oxide) and liver (TNF-alpha, IFN-gamma, MCP-1, IL-6) and less severe histopathological sequelae in lungs and kidneys following prophylactic PACAP treatment. Strikingly, PACAP prolonged survival of T. gondii infected mice in a time-of-treatment dependent manner. Conclusion/Significance: Synthetic PACAP ameliorates acute small intestinal inflammation and extra-intestinal sequelae by down-regulating Th1-type immunopathology, reducing oxidative stress and up-regulating anti-inflammatory cytokine responses. These findings provide novel potential treatment options of inflammatory bowel diseases.	[Heimesaat, Markus M.; Schulze, Silvia; Fischer, Andre; Grundmann, Ursula; Alutis, Marie; Goebel, Ulf B.; Bereswil, Stefan] Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany; [Dunay, Ildiko R.] Univ Magdeburg, Dept Microbiol & Hyg, D-39106 Magdeburg, Germany; [Kuehl, Anja A.] Charite, Dept Med Gastroenterol Infect Dis & Rheumatol 1, RCIS, D-13353 Berlin, Germany; [Tamas, Andrea; Reglodi, Dora] Univ Pecs, Dept Anat, PTE MTA Lendulet PACAP Res Team, Pecs, Hungary; [Toths, Gabor] Univ Szeged, Dept Med Chem, Szeged, Hungary; [Dunay, Miklos P.] Szent Istvan Univ Budapest, Fac Vet Med, Dept & Clin Surg & Ophthalmol, Budapest, Hungary	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Otto von Guericke University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Pecs; Szeged University; Hungarian University of Agriculture & Life Sciences	Heimesaat, MM (corresponding author), Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany.	markus.heimesaat@charite.de		Kuhl, Anja/0000-0003-2293-5387; Heimesaat, Markus/0000-0001-6399-651X	German Research Foundation (DFG) [G0363/12-1, SFB633, TP A7, TP Z1, TP B6, SFB854, TP25]; German Federal Ministry of Education and Research (BMBF) [TP1.1]; OTKA [K104984]; PTE-MTA Lendulet; TAMOP [4.2.2.A- 11/1/KONV-2012-0024]; European Union; State of Hungary; European Social Fund [TAMOP 4.2.4. A/2-11-1-2012-0001]; Arimura Foundation	German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); PTE-MTA Lendulet; TAMOP; European Union(European Commission); State of Hungary; European Social Fund(European Social Fund (ESF)); Arimura Foundation	This work was supported by grants from the German Research Foundation (DFG) to SB and UBG (G0363/12-1, CampyGerm; SFB633, TP A7), AAK (SFB633, TP Z1), MMH (SFB633, TP B6), IRD (SFB854, TP25) and from the German Federal Ministry of Education and Research (BMBF) to SB (TP1.1). Furthermore, financial support from OTKA K104984, PTE-MTA Lendulet, TAMOP (4.2.2.A- 11/1/KONV-2012-0024), the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4. A/2-11-1-2012-0001 'National Excellence Program', Magyary Zoltan Scholarship, Arimura Foundation to AT and DR is deeply acknowledged. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abad C, 2003, GASTROENTEROLOGY, V124, P961, DOI 10.1053/gast.2003.50141; Abad C, 2006, CURR TOP MED CHEM, V6, P151, DOI 10.2174/156802606775270288; Abad C, 2001, J IMMUNOL, V167, P3182, DOI 10.4049/jimmunol.167.6.3182; Arimura A, 2006, ANN NY ACAD SCI, V1070, P1, DOI 10.1196/annals.1317.093; Azuma YT, 2008, J CELL PHYSIOL, V216, P111, DOI 10.1002/jcp.21381; Basset Christelle, 2002, Science Progress, V85, P33, DOI 10.3184/003685002783238861; Bereswill S, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-19; Bereswill S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020953; Bereswill S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015099; Buzoni-Gatel D, 2006, CELL MICROBIOL, V8, P535, DOI 10.1111/j.1462-5822.2006.00692.x; Delgado M, 2009, CELL DEATH DIFFER, V16, P406, DOI 10.1038/cdd.2008.161; Delgado M, 2005, J IMMUNOL, V175, P7311, DOI 10.4049/jimmunol.175.11.7311; Delgado M, 1999, J IMMUNOL, V162, P1707; Delgado M, 2003, ANN NY ACAD SCI, V992, P141, DOI 10.1111/j.1749-6632.2003.tb03145.x; Delgado M, 1999, J IMMUNOL, V162, P1200; Delgado M, 1999, J IMMUNOL, V163, P3629; Delgado M, 2000, EUR J IMMUNOL, V30, P3236, DOI 10.1002/1521-4141(200011)30:11<3236::AID-IMMU3236>3.0.CO;2-L; Delgado M, 2001, J IMMUNOL, V167, P966, DOI 10.4049/jimmunol.167.2.966; DELGADO M, 1995, J NEUROIMMUNOL, V62, P137, DOI 10.1016/0165-5728(95)00105-6; Delgado M, 2006, ANN NY ACAD SCI, V1070, P233, DOI 10.1196/annals.1317.020; Delgado M, 2009, HUM IMMUNOL, V70, P300, DOI 10.1016/j.humimm.2009.01.020; Elekes K, 2011, PEPTIDES, V32, P1439, DOI 10.1016/j.peptides.2011.05.008; Erridge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009125; Ganea D, 2002, CRIT REV ORAL BIOL M, V13, P229, DOI 10.1177/154411130201300303; Gomariz RP, 2006, ANN NY ACAD SCI, V1070, P51, DOI 10.1196/annals.1317.031; Gonzalez-Rey E, 2006, ANN NY ACAD SCI, V1070, P303, DOI 10.1196/annals.1317.032; Haag LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035988; Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497; Heimesaat MM, 2011, EUR J MICROBIOL IMMU, V1, P228, DOI 10.1556/EuJMI.1.2011.3.7; Heimesaat MM, 2013, EUR J MICROBIOL IMMU, V3, P36, DOI 10.1556/EuJMI.3.2013.1.5; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Horvath G, 2011, J MOL NEUROSCI, V43, P67, DOI 10.1007/s12031-010-9428-8; Jankovic D, 2010, MUCOSAL IMMUNOL, V3, P239, DOI 10.1038/mi.2010.8; Ji HF, 2013, HEPATOLOGY, V57, P1225, DOI 10.1002/hep.25802; Kato H, 2004, MULT SCLER J, V10, P651, DOI 10.1191/1352458504ms1096oa; Khan AM, 2011, J INVEST MED, V59, P793, DOI 10.2310/JIM.0b013e31821452a2; Khan IA, 1997, P NATL ACAD SCI USA, V94, P13955, DOI 10.1073/pnas.94.25.13955; LASKIN DL, 1995, ANNU REV PHARMACOL, V35, P655, DOI 10.1146/annurev.pharmtox.35.1.655; Liesenfeld O, 2002, J INFECT DIS, V185, pS96, DOI 10.1086/338006; Liesenfeld O, 1996, J EXP MED, V184, P597, DOI 10.1084/jem.184.2.597; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; Mennechet FJD, 2002, J IMMUNOL, V168, P2988, DOI 10.4049/jimmunol.168.6.2988; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; Moody TW, 2011, CURR OPIN ENDOCRINOL, V18, P61, DOI 10.1097/MED.0b013e328342568a; Munoz M, 2011, IMMUNOL REV, V240, P269, DOI 10.1111/j.1600-065X.2010.00992.x; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Nemetz N, 2008, INT J CANCER, V122, P1803, DOI 10.1002/ijc.23308; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Podolsky DK, 2002, BEST PRACT RES CL GA, V16, P933, DOI 10.1053/bega.2002.0354; Szakaly P, 2011, NEUROPEPTIDES, V45, P113, DOI 10.1016/j.npep.2010.12.003; Tan YV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061200; Tan YV, 2009, P NATL ACAD SCI USA, V106, P2012, DOI 10.1073/pnas.0812257106; Vaudry D, 2000, PHARMACOL REV, V52, P269; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Vossenkamper A, 2004, EUR J IMMUNOL, V34, P3197, DOI 10.1002/eji.200424993; Yoshihara S, 2004, REGUL PEPTIDES, V123, P161, DOI 10.1016/j.regpep.2004.04.023	57	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e108389	10.1371/journal.pone.0108389	http://dx.doi.org/10.1371/journal.pone.0108389			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238233	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000342491600095
J	Wang, JH; Zhu, LS; Wang, Q; Wang, J; Xie, H				Wang, Jinhua; Zhu, Lusheng; Wang, Qi; Wang, Jun; Xie, Hui			Isolation and Characterization of Atrazine Mineralizing Bacillus subtilis Strain HB-6	PLOS ONE			English	Article							S-TRIAZINE RING; GENE TRZN; DEGRADING BACTERIUM; METABOLIC ABILITY; PSEUDOMONAS SP; CYANURIC ACID; DEGRADATION; BIODEGRADATION; SOIL; CULTURE	Atrazine is a widely used herbicide with great environmental concern due to its high potential to contaminate soil and waters. An atrazine-degrading bacterial strain HB-6 was isolated from industrial wastewater and the 16S rRNA gene sequencing identified HB-6 as a Bacillus subtilis. PCR assays indicated that HB-6 contained atrazine-degrading genes trzN, atzB and atzC. The strain HB-6 was capable of utilizing atrazine and cyanuric acid as a sole nitrogen source for growth and even cleaved the s-triazine ring and mineralized atrazine. The strain demonstrated a very high efficiency of atrazine biodegradation with a broad optimum pH and temperature ranges and could be enhanced by cooperating with other bacteria, suggesting its huge potential for remediation of atrazine-contaminated sites. To our knowledge, there are few Bacillus subtilis strains reported that can mineralize atrazine, therefore, the present work might provide some new insights on atrazine remediation.	[Wang, Jinhua; Zhu, Lusheng; Wang, Qi; Wang, Jun; Xie, Hui] Shandong Agr Univ, Shandong Univ, Key Lab Agr Environm, Coll Resources & Environm, Tai An, Shandong, Peoples R China; [Wang, Jinhua] Nankai Univ, Minist Educ, Key Lab Pollut Proc & Environm Criteria, Tianjin, Peoples R China	Shandong Agricultural University; Shandong University; Nankai University	Zhu, LS (corresponding author), Shandong Agr Univ, Shandong Univ, Key Lab Agr Environm, Coll Resources & Environm, Tai An, Shandong, Peoples R China.	lushzhu@sdau.edu.cn	Zhu, Lusheng/AAY-8181-2020	Wang, Jun/0000-0002-9976-4910	National Natural Science Foundation of China [21377075, 21277083, 41071164, 41001152]; Specialized Research Fund for the Doctoral Program of Higher Education [20113702110007]; Natural Science Foundation of Shandong [ZR2013DQ007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Shandong(Natural Science Foundation of Shandong Province)	The present study was supported by Grants from the National Natural Science Foundation of China (Nos. 21377075, 21277083, 41071164 and 41001152), the Specialized Research Fund for the Doctoral Program of Higher Education (20113702110007) and Natural Science Foundation of Shandong (ZR2013DQ007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbeli Z, 2010, FEMS MICROBIOL ECOL, V73, P611, DOI 10.1111/j.1574-6941.2010.00905.x; Azmi W, 1998, ENZYME MICROB TECH, V22, P185, DOI 10.1016/S0141-0229(97)00159-2; BEHKI RM, 1994, J AGR FOOD CHEM, V42, P1237, DOI 10.1021/jf00041a036; Cai B, 2003, LETT APPL MICROBIOL, V36, P272, DOI 10.1046/j.1472-765X.2003.01307.x; CHRISTIANSEN N, 1995, WATER SCI TECHNOL, V31, P249, DOI 10.1016/0273-1223(95)00172-J; COOK AM, 1985, BIOCHEM J, V231, P25, DOI 10.1042/bj2310025; de Souza ML, 1998, J BACTERIOL, V180, P1951, DOI 10.1128/JB.180.7.1951-1954.1998; Devers M, 2007, FEMS MICROBIOL LETT, V273, P78, DOI 10.1111/j.1574-6968.2007.00792.x; Fazlurrahman, 2009, LETT APPL MICROBIOL, V49, P721, DOI 10.1111/j.1472-765X.2009.02724.x; Ghosh PK, 2004, WATER RES, V38, P2277, DOI 10.1016/j.watres.2003.10.059; Jacob CC, 2012, TOXICOL SCI, V126, P317, DOI 10.1093/toxsci/kfr348; Karns JS, 1999, APPL ENVIRON MICROB, V65, P3512; Li QY, 2008, J ENVIRON SCI-CHINA, V20, P1226, DOI 10.1016/S1001-0742(08)62213-5; MANDELBAUM RT, 1995, APPL ENVIRON MICROB, V61, P1451, DOI 10.1128/AEM.61.4.1451-1457.1995; MANDELBAUM RT, 1993, APPL ENVIRON MICROB, V59, P1695, DOI 10.1128/AEM.59.6.1695-1701.1993; Martinez B, 2001, J BACTERIOL, V183, P5684, DOI 10.1128/JB.183.19.5684-5697.2001; Mukherjee AK, 2012, ENVIRON SCI POLLUT R, V19, P3380, DOI 10.1007/s11356-012-0862-8; Mulbry WW, 2002, FEMS MICROBIOL LETT, V206, P75, DOI 10.1111/j.1574-6968.2002.tb10989.x; NAGY I, 1995, APPL ENVIRON MICROB, V61, P2056, DOI 10.1128/AEM.61.5.2056-2060.1995; Ostrofsky EB, 2002, SOIL BIOL BIOCHEM, V34, P1449, DOI 10.1016/S0038-0717(02)00089-5; Piutti S, 2003, FEMS MICROBIOL LETT, V221, P111, DOI 10.1016/S0378-1097(03)00168-X; Quan CS, 2005, APPL MICROBIOL BIOT, V66, P702, DOI 10.1007/s00253-004-1683-6; RADOSEVICH M, 1995, APPL ENVIRON MICROB, V61, P297, DOI 10.1128/AEM.61.1.297-302.1995; Rousseaux S, 2001, FEMS MICROBIOL ECOL, V36, P211, DOI 10.1111/j.1574-6941.2001.tb00842.x; Satsuma K, 2010, APPL MICROBIOL BIOT, V86, P1585, DOI 10.1007/s00253-010-2460-3; Seffernick JL, 2001, J BACTERIOL, V183, P2405, DOI 10.1128/JB.183.8.2405-2410.2001; Shapir N, 2005, APPL ENVIRON MICROB, V71, P2214, DOI 10.1128/AEM.71.5.2214-2220.2005; Shenoy K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030611; Siripattanakul S, 2009, J APPL MICROBIOL, V106, P986, DOI 10.1111/j.1365-2672.2008.04075.x; Smith D, 2005, FEMS MICROBIOL ECOL, V53, P265, DOI 10.1016/j.femsec.2004.12.011; Strong LC, 2002, APPL ENVIRON MICROB, V68, P5973, DOI 10.1128/AEM.68.12.5973-5980.2002; Struthers JK, 1998, APPL ENVIRON MICROB, V64, P3368; Vaishampayan PA, 2007, INT BIODETER BIODEGR, V60, P273, DOI 10.1016/j.ibiod.2007.05.001; Vibber LL, 2007, APPL MICROBIOL BIOT, V75, P921, DOI 10.1007/s00253-007-0871-6; Viegas CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037140; Wackett LP, 2002, APPL MICROBIOL BIOT, V58, P39, DOI 10.1007/s00253-001-0862-y; Wang JH, 2011, ENVIRON GEOCHEM HLTH, V33, P259, DOI 10.1007/s10653-010-9337-3; Wang QF, 2012, INT BIODETER BIODEGR, V71, P61, DOI 10.1016/j.ibiod.2012.04.005; Yang CY, 2010, BIODEGRADATION, V21, P97, DOI 10.1007/s10532-009-9284-9; Zhang Y, 2012, J HAZARD MATER, V237, P376, DOI 10.1016/j.jhazmat.2012.08.047; Zhang Y, 2011, INT BIODETER BIODEGR, V65, P1140, DOI 10.1016/j.ibiod.2011.08.010; Zhao ZY, 2010, ENVIRON ENG SCI, V27, P939, DOI 10.1089/ees.2010.0101; Zissi U, 2001, BIOTECHNOL BIOENG, V72, P49, DOI 10.1002/1097-0290(20010105)72:1<49::AID-BIT7>3.0.CO;2-X	43	21	28	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107270	10.1371/journal.pone.0107270	http://dx.doi.org/10.1371/journal.pone.0107270			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238246	Green Submitted, gold, Green Published			2022-12-25	WOS:000342491600023
J	Zhong, XX; Li, Q; Yu, H; Kong, LF				Zhong, Xiaoxiao; Li, Qi; Yu, Hong; Kong, Lingfeng			SNP Mining in Crassostrea gigas EST Data: Transferability to Four Other Crassostrea Species, Phylogenetic Inferences and Outlier SNPs under Selection	PLOS ONE			English	Article							NUCLEOTIDE POLYMORPHISM MARKERS; PACIFIC OYSTER; PORTUGUESE OYSTER; GENOME SCANS; DNA SEQUENCE; MITOCHONDRIAL; IDENTIFICATION; ANGULATA; LOCI; STRESS	Oysters, with high levels of phenotypic plasticity and wide geographic distribution, are a challenging group for taxonomists and phylogenetics. Our study is intended to generate new EST-SNP markers and to evaluate their potential for cross-species utilization in phylogenetic study of the genus Crassostrea. In the study, 57 novel SNPs were developed from an EST database of C. gigas by the HRM (high-resolution melting) method. Transferability of 377 SNPs developed for C. gigas was examined on four other Crassostrea species: C. sikamea, C. angulata, C. hongkongensis and C. ariakensis. Among the 377 primer pairs tested, 311 (82.5%) primers showed amplification in C. sikamea, 353 (93.6%) in C. angulata, 254 (67.4%) in C. hongkongensis and 253 (67.1%) in C. ariakensis. A total of 214 SNPs were found to be transferable to all four species. Phylogenetic analyses showed that C. hongkongensis was a sister species of C. ariakensis and that this clade was sister to the clade containing C. sikamea, C. angulata and C. gigas. Within this clade, C. gigas and C. angulata had the closest relationship, with C. sikamea being the sister group. In addition, we detected eight SNPs as potentially being under selection by two outlier tests (fdist and hierarchical methods). The SNPs studied here should be useful for genetic diversity, comparative mapping and phylogenetic studies across species in Crassostrea and the candidate outlier SNPs are worth exploring in more detail regarding association genetics and functional studies.	[Zhong, Xiaoxiao; Li, Qi; Yu, Hong; Kong, Lingfeng] Ocean Univ China, Minist Educ, Key Lab Mariculture, Qingdao, Peoples R China	Ocean University of China	Li, Q (corresponding author), Ocean Univ China, Minist Educ, Key Lab Mariculture, Qingdao, Peoples R China.	gili66@ouc.edu.cn	Zhong, Xiaoxiao/HGU-6374-2022; Kong, Lingfeng/AAG-2473-2019; Kong, Lingfeng/AAJ-3402-2021	Kong, Lingfeng/0000-0001-5263-1697; 	863 Program [2012AA10A405-6]; 973 Program [2010CB126406]; National Natural Science Foundation of China [31372524]	863 Program(National High Technology Research and Development Program of China); 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the grants from 863 Program (2012AA10A405-6), 973 Program (2010CB126406), and National Natural Science Foundation of China (31372524). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANKS MA, 1994, MAR BIOL, V121, P127, DOI 10.1007/BF00349481; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bierne N, 2011, MOL ECOL, V20, P2044, DOI 10.1111/j.1365-294X.2011.05080.x; Boudry P, 2003, AQUACULTURE, V228, P15, DOI 10.1016/S0044-8486(03)00443-5; Boudry P, 1998, J EXP MAR BIOL ECOL, V226, P279, DOI 10.1016/S0022-0981(97)00250-5; Chamary JV, 2004, MOL BIOL EVOL, V21, P1014, DOI 10.1093/molbev/msh087; Cunningham C, 2006, MAR BIOTECHNOL, V8, P521, DOI 10.1007/s10126-006-6013-9; De Wit P, 2013, MOL ECOL, V22, P2884, DOI 10.1111/mec.12081; Di Ciano-Oliveira C, 2006, ACTA PHYSIOL, V187, P257, DOI 10.1111/j.1748-1716.2006.01535.x; Evans TG, 2008, J EXP BIOL, V211, P3636, DOI 10.1242/jeb.022160; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Fleury E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-341; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Gracey AY, 2004, P NATL ACAD SCI USA, V101, P16970, DOI 10.1073/pnas.0403627101; HARRY HW, 1985, VELIGER, V28, P121; Hedgecock D., 1995, P115, DOI 10.1016/B978-012690685-1/50009-6; Hedgecock D, 2004, J SHELLFISH RES, V23, P379; Hoelzer GA, 1997, EVOLUTION, V51, P622, DOI 10.1111/j.1558-5646.1997.tb02451.x; Hubert S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-191; Huvet A, 2002, AQUAT LIVING RESOUR, V15, P45, DOI 10.1016/S0990-7440(01)01148-2; Huvet A, 2001, MAR BIOTECHNOL, V3, P448, DOI 10.1007/s10126-001-0017-2; IMAI TAKEO, 1961, TOHOKU JOUR AGRIC RES, V12, P125; Jenny MJ, 2007, MAR BIOTECHNOL, V9, P577, DOI 10.1007/s10126-007-9041-1; Jin YL, 2014, GENES GENOM, V36, P129, DOI 10.1007/s13258-013-0150-0; Klinbunga S, 2003, MAR BIOTECHNOL, V5, P27, DOI 10.1007/s10126-002-0047-4; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Lapegue S, 2004, J SHELLFISH RES, V23, P759; Lapegue S, 2002, BIOL BULL-US, V202, P232, DOI 10.2307/1543473; Li JR, 2012, MOL ECOL, V21, P28, DOI 10.1111/j.1365-294X.2011.05308.x; Li Q, 2002, J SHELLFISH RES, V21, P811; Li Q, 2009, ELECTRON J BIOTECHN, V12, DOI 10.2225/vol12-issue3-fulltext-9; Liu ZJ, 2004, AQUACULTURE, V238, P1, DOI 10.1016/j.aquaculture.2004.05.027; Lopez-Flores I, 2004, GENE, V339, P181, DOI 10.1016/j.gene.2004.06.049; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Messmer AM, 2011, AQUACULTURE, V320, P183, DOI 10.1016/j.aquaculture.2010.09.033; Milano I, 2014, MOL ECOL, V23, P118, DOI 10.1111/mec.12568; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Ollitrault P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-13; Reddy MRK, 2010, PLANT BREEDING, V129, P514, DOI 10.1111/j.1439-0523.2009.01723.x; Reece KS, 2008, MAR BIOL, V153, P709, DOI 10.1007/s00227-007-0846-2; Ren JF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-394; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; TACK JF, 1992, HYDROBIOLOGIA, V247, P109, DOI 10.1007/BF00008209; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanguy A, 2008, GENE, V408, P27, DOI 10.1016/j.gene.2007.10.021; Wang HY, 2008, J SHELLFISH RES, V27, P481, DOI 10.2983/0730-8000(2008)27[481:IOCAAR]2.0.CO;2; Williams EJB, 2000, NATURE, V407, P900, DOI 10.1038/35038066; Wu XY, 2010, MOL PHYLOGENET EVOL, V57, P448, DOI 10.1016/j.ympev.2010.05.029; Xia JJ, 2009, J MOLLUS STUD, V75, P139, DOI 10.1093/mollus/eyp001; Yeh F.C., 1999, POPGENE VERSION 1 32; Yu H, 2012, MOL BIOL REP, V39, P999, DOI 10.1007/s11033-011-0825-z; Yu ZN, 2003, J SHELLFISH RES, V22, P31; Zeid M, 2010, FIELD CROP RES, V118, P28, DOI 10.1016/j.fcr.2010.03.014; Zhao ZG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045675, 10.1371/journal.pone.0046244]; Zhong XX, 2014, AQUACULT INT, V22, P1877, DOI 10.1007/s10499-014-9789-z; Zhong XX, 2013, J WORLD AQUACULT SOC, V44, P455, DOI 10.1111/jwas.12044	59	10	11	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e108256	10.1371/journal.pone.0108256	http://dx.doi.org/10.1371/journal.pone.0108256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238392	Green Published, Green Submitted, gold			2022-12-25	WOS:000342491600088
J	Fan, MM; Zhang, YJ; Huang, ZQ; Liu, J; Guo, XM; Zhang, H; Luo, HH				Fan, Miaomiao; Zhang, Yijun; Huang, Zhuoqiong; Liu, Jun; Guo, Xuemin; Zhang, Hui; Luo, Haihua			Optimizations of SiRNA Design for the Activation of Gene Transcription by Targeting the TATA-Box Motif	PLOS ONE			English	Article							SMALL INTERFERING RNAS; CHEMICAL-MODIFICATION; MAMMALIAN-CELLS; FUNCTIONAL SIRNAS; HIV-1 INFECTION; ENZYME COMPLEX; PROMOTER; EXPRESSION; THERAPY; DNA	Small interfering RNAs (siRNAs) are widely used to repress gene expression by targeting mRNAs. Some reports reveal that siRNAs can also activate or inhibit gene expression through targeting the gene promoters. Our group has found that microRNAs (miRNAs) could activate gene transcription via interaction with the TATA-box motif in gene promoters. To investigate whether siRNA targeting the same region could upregulate the promoter activity, we test the activating efficiency of siRNAs targeting the TATA-box motif of 16 genes and perform a systematic analysis to identify the common features of the functional siRNAs for effective activation of gene promoters. Further, we try various modifications to improve the activating efficiency of siRNAs and find that it is quite useful to design the promoter-targeting activating siRNA by following several rules such as (a) complementary to the TATA-box-centered region; (b) UA usage at the first two bases of the antisense strand; (c) twenty-three nucleotides (nts) in length; (d) 2'-O-Methyl (2'-OMe) modification at the 3' terminus of the antisense strand; (e) avoiding mismatches at the 3' end of the antisense strand. The optimized activating siRNAs potently enhance the expression of interleukin-2 (IL-2) gene in human and mouse primary CD4(+) T cells with a long-time effect. Taken together, our study provides a guideline for rational design the promoter-targeting siRNA to sequence-specifically enhance gene expression.	[Fan, Miaomiao; Zhang, Yijun; Huang, Zhuoqiong; Liu, Jun; Guo, Xuemin; Zhang, Hui; Luo, Haihua] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Human Virol, Guangzhou 510275, Guangdong, Peoples R China; [Fan, Miaomiao; Zhang, Yijun; Huang, Zhuoqiong; Liu, Jun; Guo, Xuemin; Zhang, Hui; Luo, Haihua] Sun Yat Sen Univ, Zhongshan Sch Med, Key Lab Trop Dis Control, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, H (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Inst Human Virol, Guangzhou 510275, Guangdong, Peoples R China.	zhangh92@mail.sysu.edu.cn; luohh@mail.sysu.edu.cn	Zhang, Yijun/J-5485-2017	Zhang, Yijun/0000-0001-7971-2200	National Special Research Program of China [2013ZX10001004]; National Basic Research Program of China (973 Program) [2010CB912202]; Guangdong Innovative Research Team Program [2009010058]; National Natural Science Foundation of China [30972620, 81301431]; Natural Science Foundation of Guangdong [9251008901000022]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20090171110083]; China Postdoctoral Science Foundation [2012M511866, 2013T60824]	National Special Research Program of China; National Basic Research Program of China (973 Program)(National Basic Research Program of China); Guangdong Innovative Research Team Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was funded by National Special Research Program of China for Important Infectious Diseases (No. 2013ZX10001004), National Basic Research Program of China (973 Program) (No. 2010CB912202), Guangdong Innovative Research Team Program (No. 2009010058), National Natural Science Foundation of China (No. 30972620), Natural Science Foundation of Guangdong (No. 9251008901000022), Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20090171110083) to H.Z., National Natural Science Foundation of China (No. 81301431), China Postdoctoral Science Foundation (No. 2012M511866 and No. 2013T60824) to Y.J.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allerson CR, 2005, J MED CHEM, V48, P901, DOI 10.1021/jm049167j; Amarzguioui M, 2003, NUCLEIC ACIDS RES, V31, P589, DOI 10.1093/nar/gkg147; Ansari AZ, 2002, CURR OPIN CHEM BIOL, V6, P765, DOI 10.1016/S1367-5931(02)00377-0; Ansari AZ, 2001, CHEM BIOL, V8, P583, DOI 10.1016/S1074-5521(01)00037-0; Arora PS, 2002, J AM CHEM SOC, V124, P13067, DOI 10.1021/ja0208355; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; BLAKE KR, 1985, BIOCHEMISTRY-US, V24, P6139, DOI 10.1021/bi00343a016; Bramsen JB, 2009, NUCLEIC ACIDS RES, V37, P2867, DOI 10.1093/nar/gkp106; Chiu YL, 2003, RNA, V9, P1034, DOI 10.1261/rna.5103703; Chu YJ, 2010, NUCLEIC ACIDS RES, V38, P7736, DOI 10.1093/nar/gkq648; Cook PD, 1999, NUCLEOS NUCLEOT NUCL, V18, P1141, DOI 10.1080/07328319908044652; Corey DR, 2007, J CLIN INVEST, V117, P3615, DOI 10.1172/JCI33483; CUMMINS LL, 1995, NUCLEIC ACIDS RES, V23, P2019, DOI 10.1093/nar/23.11.2019; Dreos R, 2013, NUCLEIC ACIDS RES, V41, pD157, DOI 10.1093/nar/gks1233; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Engels JW, 2013, NEW BIOTECHNOL, V30, P302, DOI 10.1016/j.nbt.2012.07.002; Gitlin L, 2002, NATURE, V418, P430, DOI 10.1038/nature00873; Gleave ME, 2005, NAT REV CANCER, V5, P468, DOI 10.1038/nrc1631; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hall AHS, 2006, NUCLEIC ACIDS RES, V34, P2773, DOI 10.1093/nar/gkl339; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Herweijer H, 2003, GENE THER, V10, P453, DOI 10.1038/sj.gt.3301983; Hu WY, 2002, CURR BIOL, V12, P1301, DOI 10.1016/S0960-9822(02)00975-2; Huang V, 2012, NUCLEIC ACIDS RES, V40, P1695, DOI 10.1093/nar/gkr934; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Jacque JM, 2002, NATURE, V418, P435, DOI 10.1038/nature00896; Jagla B, 2005, RNA, V11, P864, DOI 10.1261/rna.7275905; Janowski BA, 2005, NAT CHEM BIOL, V1, P216, DOI 10.1038/nchembio725; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Jeffries CD, 2011, RNA, V17, P675, DOI 10.1261/rna.2006511; Jinek M, 2010, NAT STRUCT MOL BIOL, V17, P238, DOI 10.1038/nsmb.1768; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Kane M, 2013, NATURE, V502, P563, DOI 10.1038/nature12653; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kulkarni M, 2010, BIOCHEM SOC T, V38, P242, DOI 10.1042/BST0380242; Kwonj Y, 2004, J AM CHEM SOC, V126, P15940, DOI 10.1021/ja0445140; Layzer JM, 2004, RNA, V10, P766, DOI 10.1261/rna.5239604; Lee NS, 2002, NAT BIOTECHNOL, V20, P500, DOI 10.1038/nbt0502-500; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Li S, 2000, GENE THER, V7, P31, DOI 10.1038/sj.gt.3301110; Liao JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010563; Lima WF, 2012, CELL, V150, P883, DOI 10.1016/j.cell.2012.08.014; Liu B, 2003, CHEM BIOL, V10, P909, DOI 10.1016/j.chembiol.2003.09.008; Majmudar CY, 2005, CURR OPIN CHEM BIOL, V9, P467, DOI 10.1016/j.cbpa.2005.08.012; Manoharan M, 1999, BBA-GENE STRUCT EXPR, V1489, P117, DOI 10.1016/S0167-4781(99)00138-4; Mantei A, 2008, EUR J IMMUNOL, V38, P2616, DOI 10.1002/eji.200738075; MILLER PS, 1982, BIOCHEMISTRY-US, V21, P2507, DOI 10.1021/bi00539a033; MONIA BP, 1993, J BIOL CHEM, V268, P14514; Moses J, 2010, RNA, V16, P430, DOI 10.1261/rna.1808510; Nishi K, 2013, RNA, V19, P17, DOI 10.1261/rna.034769.112; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Prakash TP, 2005, J MED CHEM, V48, P4247, DOI 10.1021/jm050044o; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Schwartz JC, 2008, NAT STRUCT MOL BIOL, V15, P842, DOI 10.1038/nsmb.1444; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; Shabalina SA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-65; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Suzuki K, 2011, RNA BIOL, V8, P1035, DOI 10.4161/rna.8.6.16264; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Ui-Tei K, 2008, NUCLEIC ACIDS RES, V36, P2136, DOI 10.1093/nar/gkn042; van Werven FJ, 2009, NAT STRUCT MOL BIOL, V16, P1043, DOI 10.1038/nsmb.1674; Vollmer J, 2004, OLIGONUCLEOTIDES, V14, P23, DOI 10.1089/154545704322988021; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Wilson C, 2006, CURR OPIN CHEM BIOL, V10, P607, DOI 10.1016/j.cbpa.2006.10.001; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Yamagishi M, 2009, MICROBES INFECT, V11, P500, DOI 10.1016/j.micinf.2009.02.003; Younger ST, 2011, NUCLEIC ACIDS RES, V39, P5682, DOI 10.1093/nar/gkr155; Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002; Zhang YJ, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-23	85	9	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108253	10.1371/journal.pone.0108253	http://dx.doi.org/10.1371/journal.pone.0108253			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250958	gold, Green Published, Green Submitted			2022-12-25	WOS:000342492700102
J	Ayala-Lujan, JL; Vijayakumar, V; Gong, M; Smith, R; Santiago, AE; Ruiz-Perez, F				Luis Ayala-Lujan, Jorge; Vijayakumar, Vidhya; Gong, Mei; Smith, Rachel; Santiago, Araceli E.; Ruiz-Perez, Fernando			Broad Spectrum Activity of a Lectin-Like Bacterial Serine Protease Family on Human Leukocytes	PLOS ONE			English	Article							PATHOGENIC ESCHERICHIA-COLI; AUTOTRANSPORTER PROTEIN; HEMOGLOBIN PROTEASE; SHIGELLA-FLEXNERI; CELLS; GLYCOSYLATION; EXPRESSION; BINDING; MUCIN; ENTEROBACTERIACEAE	The serine protease autotransporter from Enterobacteriaceae (SPATE) family, which number more than 25 proteases with apparent diverse functions, have been phylogenetically divided into two distinct classes, designated 1 and 2. We recently demonstrated that Pic and Tsh, two members of the class-2 SPATE family produced by intestinal and extraintestinal pathogenic E. coli, were able to cleave a number of O-glycosylated proteins on neutrophils and lymphocytes resulting in impaired leukocyte functions. Here we show that most members of the class-2 SPATE family have lectin-like properties and exhibit differential protease activity reliant on glycoprotein type and cell lineage. Protease activity was seen in virtually all tested O-glycosylated proteins including CD34, CD55, CD164, TIM1, TIM3, TIM4 and C1-INH. We also show that although SPATE proteins bound and cleaved glycoproteins more efficiently on granulocytes and monocytes, they also targeted glycoproteins on B, T and natural killer lymphocytes. Finally, we found that the characteristic domain-2 of class-2 SPATEs is not required for glycoprotease activity, but single amino acid mutations in Pic domain-1 to those residues naturally occurring in domain-1 of SepA, were sufficient to hamper Pic glycoprotease activity. This study shows that most class-2 SPATEs have redundant activities and suggest that they may function as immunomodulators at several levels of the immune system.	[Luis Ayala-Lujan, Jorge; Vijayakumar, Vidhya; Gong, Mei; Smith, Rachel; Santiago, Araceli E.; Ruiz-Perez, Fernando] Univ Virginia, Sch Med, Dept Pediat, Charlottesville, VA 22908 USA; [Luis Ayala-Lujan, Jorge] Univ Autonoma Zacatecas, Unidad Acad Ciencias Quim, Zacatecas, Mexico; [Vijayakumar, Vidhya] Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University of Virginia; Universidad Autonoma de Zacatecas; University System of Maryland; University of Maryland Baltimore	Ruiz-Perez, F (corresponding author), Univ Virginia, Sch Med, Dept Pediat, Charlottesville, VA 22908 USA.	fr3d@virginia.edu			University of Maryland, Baltimore; Cooperative Research Centers sub Award [SR00001795]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090873] Funding Source: NIH RePORTER	University of Maryland, Baltimore; Cooperative Research Centers sub Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the University of Maryland, Baltimore. Enterics Research Investigational Network. Cooperative Research Centers sub Award SR00001795 to F.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; BENNETT KL, 1995, J CELL BIOL, V131, P1623, DOI 10.1083/jcb.131.6.1623; Bestebroer J, 2007, BLOOD, V109, P2936, DOI 10.1182/blood-2006-06-015461; Cai SH, 2003, J IMMUNOL, V171, P4786, DOI 10.4049/jimmunol.171.9.4786; Carlow DA, 2009, IMMUNOL REV, V230, P75, DOI 10.1111/j.1600-065X.2009.00797.x; Clark MC, 2012, ANN NY ACAD SCI, V1253, P58, DOI 10.1111/j.1749-6632.2011.06304.x; COYNE KE, 1992, J IMMUNOL, V149, P2906; Dutta PR, 2002, INFECT IMMUN, V70, P7105, DOI 10.1128/IAI.70.12.7105-7113.2002; Gomis SM, 2001, CAN J VET RES, V65, P1; Gutierrez-Jimenez J, 2008, MICROB PATHOGENESIS, V45, P115, DOI 10.1016/j.micpath.2008.04.006; Harrington SM, 2009, INFECT IMMUN, V77, P2465, DOI 10.1128/IAI.01494-08; Hart E, 2008, INFECT IMMUN, V76, P5247, DOI 10.1128/IAI.00770-08; Henderson IR, 1999, INFECT IMMUN, V67, P5587, DOI 10.1128/IAI.67.11.5587-5596.1999; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Hsiao CC, 2009, FEBS LETT, V583, P3285, DOI 10.1016/j.febslet.2009.09.001; Kane LP, 2010, J IMMUNOL, V184, P2743, DOI 10.4049/jimmunol.0902937; Kumar P, 2013, INFECT IMMUN; Laszik Z, 1996, BLOOD, V88, P3010, DOI 10.1182/blood.V88.8.3010.bloodjournal8883010; Leyton DL, 2012, NAT REV MICROBIOL, V10, P213, DOI 10.1038/nrmicro2733; Navarro-Garcia F, 2010, INFECT IMMUN, V78, P4101, DOI 10.1128/IAI.00523-10; Otto BR, 2005, J BIOL CHEM, V280, P17339, DOI 10.1074/jbc.M412885200; Otto BR, 1998, J EXP MED, V188, P1091, DOI 10.1084/jem.188.6.1091; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Park M, 2003, J CELL PHYSIOL, V196, P512, DOI 10.1002/jcp.10332; Ruiz-Perez F, 2013, CELL MOL LIFE SCI; Ruiz-Perez F, 2011, P NATL ACAD SCI USA, V108, P12881, DOI 10.1073/pnas.1101006108; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SIMMONS DL, 1992, J IMMUNOL, V148, P267; Souza MA, 2013, GLYCOCONJUGATE J, V30, P641, DOI 10.1007/s10719-012-9464-4; Wang J, 2008, J IMMUNOL, V180, P1686, DOI 10.4049/jimmunol.180.3.1686; Watt SM, 2000, LEUKEMIA LYMPHOMA, V37, P1, DOI 10.3109/10428190009057625; WIKEN M, 1988, SCAND J IMMUNOL, V28, P457, DOI 10.1111/j.1365-3083.1988.tb01476.x; Yen YT, 2008, TRENDS MICROBIOL, V16, P370, DOI 10.1016/j.tim.2008.05.003	33	17	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107920	10.1371/journal.pone.0107920	http://dx.doi.org/10.1371/journal.pone.0107920			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251283	Green Published, gold, Green Submitted			2022-12-25	WOS:000342492700057
J	Milella, M				Milella, Marco			The Influence of Life History and Sexual Dimorphism on Entheseal Changes in Modern Humans and African Great Apes	PLOS ONE			English	Article							MUSCULOSKELETAL STRESS MARKERS; UNDERSTANDING MUSCLE MARKERS; SUBSISTENCE STRATEGY CHANGES; STANDARDIZED SCORING METHOD; TENDINOUS INSERTIONS; DENTAL DEVELOPMENT; MOUNTAIN GORILLAS; SIZE VARIATION; PAN-PANISCUS; HUMAN GROWTH	Entheseal changes have been widely studied with regard to their correlation to biomechanical stress and their usefulness for biocultural reconstructions. However, anthropological and medical studies have demonstrated the marked influence of both age and sex on the development of these features. Studies of entheseal changes are mostly aimed in testing functional hypotheses and are mostly focused on modern humans, with few data available for non-human primates. The lack of comparative studies on the effect of age and sex on entheseal changes represent a gap in our understanding of the evolutionary basis of both development and degeneration of the human musculoskeletal system. The aim of the present work is to compare age trajectories and patterns of sexual dimorphism in entheseal changes between modern humans and African great apes. To this end we analyzed 23 postcranial entheses in a human contemporary identified skeletal collection (N = 484) and compared the results with those obtained from the analysis of Pan (N = 50) and Gorilla (N = 47) skeletal specimens. Results highlight taxon-specific age trajectories possibly linked to differences in life history schedules and phyletic relationships. Robusticity trajectories separate Pan and modern humans from Gorilla, whereas enthesopathic patterns are unique in modern humans and possibly linked to their extended potential lifespan. Comparisons between sexes evidence a decreasing dimorphism in robusticity from Gorilla, to modern humans to Pan, which is likely linked to the role played by size, lifespan and physical activity on robusticity development. The present study confirms previous hypotheses on the possible relevance of EC in the study of life history, pointing moreover to their usefulness in evolutionary studies.	Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland	University of Zurich	Milella, M (corresponding author), Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland.	marco.milella@aim.uzh.ch	Milella, Marco/D-5070-2017	Milella, Marco/0000-0003-1027-6601				al-Oumaoui I, 2004, INT J OSTEOARCHAEOL, V14, P343, DOI 10.1002/oa.719; [Anonymous], 2009, ENTHESOPATHIES ACTIV; Barak MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077687; Benjamin M, 2008, CLIN RADIOL, V63, P691, DOI 10.1016/j.crad.2007.12.011; Benjamin M, 2007, ARTHRITIS RHEUM, V56, P224, DOI 10.1002/art.22290; Benjamin M, 1995, REPETITIVE MOTION DISORDERS OF THE UPPER EXTREMITY, P185; Benjamin M, 2002, COMP BIOCHEM PHYS A, V133, P931, DOI 10.1016/S1095-6433(02)00138-1; Benjamin M, 2009, ANN RHEUM DIS, V68, P1003, DOI 10.1136/ard.2008.091074; Bogin B, 1996, AM J HUM BIOL, V8, P703, DOI 10.1002/(SICI)1520-6300(1996)8:6<703::AID-AJHB2>3.0.CO;2-U; Bolter DR, 2012, AM J PHYS ANTHROPOL, V147, P629, DOI 10.1002/ajpa.22025; Bolter DR, 2011, AM J PHYS ANTHROPOL, V145, P647, DOI 10.1002/ajpa.21517; Cardoso FA, 2010, AM J PHYS ANTHROPOL, V141, P550, DOI 10.1002/ajpa.21171; Dean MC, 2010, PHILOS T R SOC B, V365, P3397, DOI 10.1098/rstb.2010.0052; DEROUSSEAU CJ, 1985, AM J PHYS ANTHROPOL, V67, P177, DOI 10.1002/ajpa.1330670303; DeRousseau CJ, 2005, AM J PHYS ANTHROPOL, V61, P483; DeRousseau CJ, 2005, AM J PHYS ANTHROPOL, V68, P157; DeSilva JM, 2012, J HUM EVOL, V63, P536, DOI 10.1016/j.jhevol.2012.06.006; Doran DM, 1997, J HUM EVOL, V32, P323, DOI 10.1006/jhev.1996.0095; DORFL J, 1980, J ANAT, V131, P229; DORFL J, 1980, J ANAT, V131, P179; Drapeau MSM, 2008, HOMO, V59, P93, DOI 10.1016/j.jchb.2007.12.004; Durigon M, 1991, PATHOLOGIE INSERTION; DUTOUR O, 1986, AM J PHYS ANTHROPOL, V71, P221, DOI 10.1002/ajpa.1330710209; Eshed V, 2004, AM J PHYS ANTHROPOL, V123, P303, DOI 10.1002/ajpa.10312; Facchini F., 2006, COLLECTIONS OSTEOLOG, P67; FRAYER DW, 1985, ANNU REV ANTHROPOL, V14, P429, DOI 10.1146/annurev.an.14.100185.002241; Havelkova P, 2013, INT J OSTEOARCHAEOL, V23, P237, DOI 10.1002/oa.2294; Havelkova P, 2011, INT J OSTEOARCHAEOL, V21, P487, DOI 10.1002/oa.1164; HAWKEY DE, 1995, INT J OSTEOARCHAEOL, V5, P324, DOI 10.1002/oa.1390050403; Hawkey DE, 1998, INT J OSTEOARCHAEOL, V8, P326, DOI 10.1002/(SICI)1099-1212(1998090)8:5<326::AID-OA437>3.0.CO;2-W; Henderson C, 2013, HOMO, V64, P491, DOI 10.1016/j.jchb.2013.08.002; Henderson CY, 2013, INT J OSTEOARCHAEOL, V23, P152, DOI 10.1002/oa.2287; Henderson C. Y., 2010, 18 EUR M PAL ASS VIE; HOYTE DAN, 1966, AM J PHYS ANTHROPOL, V24, P205, DOI 10.1002/ajpa.1330240209; Jiang YB, 2002, SKELETAL RADIOL, V31, P522, DOI 10.1007/s00256-002-0536-6; Jones NB, 2006, SCH AM RES, P231; JURMAIN R, 1989, AM J PHYS ANTHROPOL, V80, P229, DOI 10.1002/ajpa.1330800211; Jurmain R, 2000, J HUM EVOL, V39, P185, DOI 10.1006/jhev.2000.0413; Jurmain R, 2010, 4 FEB FOLL WORKSH MU; Kaplan H, 2000, EVOL ANTHROPOL, V9, P156, DOI 10.1002/1520-6505(2000)9:4<156::AID-EVAN5>3.0.CO;2-7; Karasik D, 2010, BONE, V46, P1226, DOI 10.1016/j.bone.2010.01.382; Kelley J, 2010, P NATL ACAD SCI USA, V107, P1035, DOI 10.1073/pnas.0906206107; Kikuchi Y, 2012, J ANAT, V220, P29, DOI 10.1111/j.1469-7580.2011.01451.x; Leigh SR, 1996, AM J PHYS ANTHROPOL, V101, P455, DOI 10.1002/(SICI)1096-8644(199612)101:4<455::AID-AJPA2>3.0.CO;2-V; Leigh SR, 1996, AM J PHYS ANTHROPOL, V99, P43, DOI 10.1002/(SICI)1096-8644(199601)99:1<43::AID-AJPA3>3.0.CO;2-0; Lieberman DE, 2007, J HUM EVOL, V52, P647, DOI 10.1016/j.jhevol.2006.12.005; Lieverse AR, 2013, AM J PHYS ANTHROPOL, V150, P421, DOI 10.1002/ajpa.22217; Lieverse AR, 2009, AM J PHYS ANTHROPOL, V138, P458, DOI 10.1002/ajpa.20964; Lovejoy C.O., 1989, P103; Lovell NC, 1999, INT J OSTEOARCHAEOL, V9, P248, DOI 10.1002/(SICI)1099-1212(199907/08)9:4<248::AID-OA484>3.0.CO;2-P; Lovell NC, 1997, YEARB PHYS ANTHROPOL, V40, P139; Maggiano IS, 2008, AM J PHYS ANTHROPOL, V136, P470, DOI 10.1002/ajpa.20830; Marchi D, 2008, AM J PHYS ANTHROPOL, V137, P188, DOI 10.1002/ajpa.20855; Marchi D, 2010, AM J PHYS ANTHROPOL, V143, P198, DOI 10.1002/ajpa.21306; Mariotti V, 2004, COLLEGIUM ANTROPOL, V28, P145; Mariotti V, 2007, COLLEGIUM ANTROPOL, V31, P291; Martin-Dupont S, 2006, JOINT BONE SPINE, V73, P303, DOI 10.1016/j.jbspin.2005.05.005; Milella M, 2009, WORKSH MUSC STRESS M; Milella M, 2010, THESIS U BOLOGNA BOL; Milella M, 2013, AM J PHYS ANTHROPOL, V150, P198; Milella M, 2012, AM J PHYS ANTHROPOL, V148, P379, DOI 10.1002/ajpa.22060; Milz S, 2004, ANN RHEUM DIS, V63, P1015, DOI 10.1136/ard.2003.016378; MOLLESON T, 1989, ANTIQUITY, V63, P356, DOI 10.1017/S0003598X00076079; Molnar P, 2006, AM J PHYS ANTHROPOL, V129, P12, DOI 10.1002/ajpa.20234; MOLNAR S, 1971, AM J PHYS ANTHROPOL, V34, P175, DOI 10.1002/ajpa.1330340204; Morbeck ME, 2002, INTERD T GERONT GERI, V31, P48; Morimoto N, 2008, J ANAT, V212, P627, DOI 10.1111/j.1469-7580.2008.00884.x; Morimoto N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041980; Morimoto N, 2011, ANAT REC, V294, P1433, DOI 10.1002/ar.21424; Morimoto N, 2011, ANAT REC, V294, P589, DOI 10.1002/ar.21346; Myatt JP, 2012, J ANAT, V220, P13, DOI 10.1111/j.1469-7580.2011.01443.x; Niinimaki S, 2012, AM J PHYS ANTHROPOL, V147, P618, DOI 10.1002/ajpa.22023; Niinimaki S, 2011, INT J OSTEOARCHAEOL, V21, P292, DOI 10.1002/oa.1134; ORTNER DJ, 1981, IDENTIFICATION PATHO; Patel BA, 2013, ANAT REC, V296, P545, DOI 10.1002/ar.22669; Peterson J, 1998, INT J OSTEOARCHAEOL, V8, P378, DOI 10.1002/(SICI)1099-1212(1998090)8:5<378::AID-OA436>3.0.CO;2-I; POPE NS, 1989, BONE, V10, P109, DOI 10.1016/8756-3282(89)90007-0; R Core Team, 2012, R LANG ENV STAT COMP; Revelle W, 2014, PSYCH P PERSONALITY; RICHMOND BG, 1995, J HUM EVOL, V29, P229, DOI 10.1006/jhev.1995.1058; Robb JE, 1998, INT J OSTEOARCHAEOL, V8, P363, DOI 10.1002/(SICI)1099-1212(1998090)8:5<363::AID-OA438>3.0.CO;2-K; Robson SL, 2008, J ANAT, V212, P394, DOI 10.1111/j.1469-7580.2008.00867.x; Robson SL, 2006, SCH AM RES, P17; Rogers J., 1995, FIELD GUIDE JOINT DI; ROTHSCHILD BM, 1989, SEMIN ARTHRITIS RHEU, V18, P267, DOI 10.1016/0049-0172(89)90048-6; RUFF CB, 1992, ANNU REV ANTHROPOL, V21, P407; Ruff CB, 2013, J HUM EVOL, V65, P693, DOI 10.1016/j.jhevol.2013.06.008; Ryan TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041037; Schultz A. H., 1956, P965; Schultz AH, 1944, AM J PHYS ANTHROP-NE, V2, P1, DOI 10.1002/ajpa.1330020102; Schultz AH, 1940, CONTRIB EMBRYOL, V28, P3; Schultz AH, 1939, B HIST MED, V7, P581; Schwartz GT, 2012, CURR ANTHROPOL, V53, pS395, DOI 10.1086/667591; Shaw CN, 2012, AM J PHYS ANTHROPOL, V147, P187, DOI 10.1002/ajpa.21635; Shaw CN, 2011, AM J PHYS ANTHROPOL, V144, P22, DOI 10.1002/ajpa.21363; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; Steen SL, 1998, INT J OSTEOARCHAEOL, V8, P341, DOI 10.1002/(SICI)1099-1212(1998090)8:5<341::AID-OA441>3.0.CO;2-B; SUMNER DR, 1989, AM J PHYS ANTHROPOL, V79, P225, DOI 10.1002/ajpa.1330790210; Tsegai ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078781; van Schaik CP, 2006, SCH AM RES, P127; Villotte Sebastien, 2006, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V18, P65; Villotte S, 2014, J ARCHAEOL SCI, V43, P168, DOI 10.1016/j.jas.2013.12.009; Villotte S, 2010, J HUM EVOL, V59, P35, DOI 10.1016/j.jhevol.2010.02.001; Villotte S, 2010, AM J PHYS ANTHROPOL, V142, P224, DOI 10.1002/ajpa.21217; Watts E, 1993, AM J PHYS ANTHR S, V16, P206; Weiss E, 2004, AM J PHYS ANTHROPOL, V125, P232, DOI 10.1002/ajpa.10397; Weiss E, 2003, AM J PHYS ANTHROPOL, V121, P230, DOI 10.1002/ajpa.10226; Wilczak CA, 1998, INT J OSTEOARCHAEOL, V8, P311, DOI 10.1002/(SICI)1099-1212(1998090)8:5<311::AID-OA443>3.0.CO;2-E; WOOD BA, 1976, J ZOOL, V180, P15; Zihlman AL, 2007, J ZOOL, V273, P63, DOI 10.1111/j.1469-7998.2007.00301.x; Zollikofer CPE, 2012, PROG BRAIN RES, V195, P273, DOI 10.1016/B978-0-444-53860-4.00013-1; Zollikofer CPE, 2010, SEMIN CELL DEV BIOL, V21, P441, DOI 10.1016/j.semcdb.2009.10.012	112	9	10	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107963	10.1371/journal.pone.0107963	http://dx.doi.org/10.1371/journal.pone.0107963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251439	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000342492700062
J	Zhou, Y; Zhang, SJ; Liu, Y; Yang, HS				Zhou, Yi; Zhang, Shaojun; Liu, Ying; Yang, Hongsheng			Biologically Induced Deposition of Fine Suspended Particles by Filter-Feeding Bivalves in Land-Based Industrial Marine Aquaculture Wastewater	PLOS ONE			English	Article							MULTI-TROPHIC AQUACULTURE; MUSSELS MYTILUS-EDULIS; SCALLOP CHLAMYS-FARRERI; SALMO-SALAR; COASTAL WATERS; EUTROPHIC BAY; SYSTEMS; GROWTH; CHINA; BIODEPOSITION	Industrial aquaculture wastewater contains large quantities of suspended particles that can be easily broken down physically. Introduction of macro-bio-filters, such as bivalve filter feeders, may offer the potential for treatment of fine suspended matter in industrial aquaculture wastewater. In this study, we employed two kinds of bivalve filter feeders, the Pacific oyster Crassostrea gigas and the blue mussel Mytilus galloprovincialis, to deposit suspended solids from marine fish aquaculture wastewater in flow-through systems. Results showed that the biodeposition rate of suspended particles by C. gigas (shell height: 8.67+/-0.99 cm) and M. galloprovincialis (shell height: 4.43+/-0.98 cm) was 77.84+/-7.77 and 6.37+/-0.67 mg ind(-1).d(-1), respectively. The total solid suspension (TSS) deposition rates of oyster and mussel treatments were 3.73+/-0.27 and 2.76+/-0.20 times higher than that of the control treatment without bivalves, respectively. The TSS deposition rates of bivalve treatments were significantly higher than the natural sedimentation rate of the control treatment (P<0.001). Furthermore, organic matter and C, N in the sediments of bivalve treatments were significantly lower than those in the sediments of the control (P<0.05). It was suggested that the filter feeders C. gigas and M. galloprovincialis had considerable potential to filter and accelerate the deposition of suspended particles from industrial aquaculture wastewater, and simultaneously yield value-added biological products.	[Zhou, Yi; Zhang, Shaojun; Liu, Ying; Yang, Hongsheng] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS	Zhou, Y (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.	yizhou@qdio.ac.cn	Zhou, Yi/F-4219-2011	Zhou, Yi/0000-0001-7300-0173	Hi-Tech Research and Development Program (863) of China [2006AA100305]; National Natural Science Foundation of China [41176140/30972268]; National Science & Technology Pillar Program during the 12th Five-year Plan Period [2011BAD13B06]	Hi-Tech Research and Development Program (863) of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program during the 12th Five-year Plan Period	This research was supported by the Hi-Tech Research and Development Program (863) of China (No. 2006AA100305), the National Natural Science Foundation of China (No. 41176140/30972268), and the Key Projects in the National Science & Technology Pillar Program during the 12th Five-year Plan Period (2011BAD13B06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa K. Y, 1971, Venus Kyoto, V30, P113; CHEN SL, 1993, AQUACULTURE, V112, P143, DOI 10.1016/0044-8486(93)90440-A; Chopin T, 2001, J PHYCOL, V37, P975, DOI 10.1046/j.1529-8817.2001.01137.x; Cripps SJ, 2000, AQUACULT ENG, V22, P33, DOI 10.1016/S0144-8609(00)00031-5; Dame RF, 1996, ECOLOGY MARINE BIVAL; Giles H, 2004, MAR ECOL PROG SER, V282, P205, DOI 10.3354/meps282205; Haamer J, 1996, AMBIO, V25, P356; Handa A, 2012, AQUACULTURE, V356, P328, DOI 10.1016/j.aquaculture.2012.04.048; HATCHER A, 1994, MAR ECOL PROG SER, V115, P219, DOI 10.3354/meps115219; Haven S, 1966, LIMNOLOGY OCEANOGRRA, V11, P487; KAUTSKY N, 1987, MAR ECOL PROG SER, V38, P201, DOI 10.3354/meps038201; MacDonald BA, 2011, AQUACULTURE, V314, P244, DOI 10.1016/j.aquaculture.2011.01.045; MacMillan JR, 2003, AQUACULTURE, V226, P91, DOI 10.1016/S0044-8486(03)00470-8; Manganaro A, 2009, CHEM ECOL, V25, P467, DOI 10.1080/02757540903325120; Neori A, 2004, AQUACULTURE, V231, P361, DOI 10.1016/j.aquaculture.2003.11.015; Newell RIE, 2004, J SHELLFISH RES, V23, P51; Ni Q, 2007, FISHERY MODERNIZATIO, V34, P7; Petersen J.K., 2014, MARINE POLLUTION B; Prins T.C., 1998, AQUAT ECOL, V31, P349, DOI DOI 10.1023/A:1009924624259; Reid GK, 2010, AQUACULTURE, V299, P165, DOI 10.1016/j.aquaculture.2009.12.002; Sara G, 2012, AQUACULTURE, V324, P259, DOI 10.1016/j.aquaculture.2011.10.042; Stabili L, 2005, WATER RES, V39, P469, DOI 10.1016/j.watres.2004.10.010; Tal Y, 2009, AQUACULTURE, V286, P28, DOI 10.1016/j.aquaculture.2008.08.043; Troell M, 2009, AQUACULTURE, V297, P1, DOI 10.1016/j.aquaculture.2009.09.010; Wang Jun, 2005, Journal of Fishery Sciences of China, V12, P150; Widdows J, 1998, ESTUARIES, V21, P552, DOI 10.2307/1353294; Yu ZH, 2014, AQUACULTURE, V426, P238, DOI 10.1016/j.aquaculture.2014.02.013; Zhou Y, 2006, AQUACULTURE, V252, P264, DOI 10.1016/j.aquaculture.2005.06.046; Zhou Y, 2006, J MARINE SYST, V59, P143, DOI 10.1016/j.jmarsys.2005.11.002; Zhou Y, 2003, WATER RES, V37, P3875, DOI 10.1016/S0043-1354(03)00267-7; Zhou Y, 2006, MAR ECOL PROG SER, V317, P127, DOI 10.3354/meps317127; Zhou Y, 2006, AQUACULTURE, V256, P510, DOI 10.1016/j.aquaculture.2006.02.005	32	8	9	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107798	10.1371/journal.pone.0107798	http://dx.doi.org/10.1371/journal.pone.0107798			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250730	Green Published, gold, Green Submitted			2022-12-25	WOS:000342492700049
J	Wijeyesakere, SJ; Richardson, RJ; Stuckey, JA				Wijeyesakere, Sanjeeva J.; Richardson, Rudy J.; Stuckey, Jeanne A.			Crystal Structure of Patatin-17 in Complex with Aged and Non-Aged Organophosphorus Compounds	PLOS ONE			English	Article							LIPID ACYL-HYDROLASE; PROTEIN; ACETYLCHOLINESTERASE; INHIBITION; POTATO; CLONING; NTE; CRYSTALLOGRAPHY; PURIFICATION; EXPRESSION	Patatin is a non-specific plant lipase and the eponymous member of a broad class of serine hydrolases termed the patatin-like phospholipase domain containing proteins (PNPLAs). Certain PNPLA family members can be inhibited by organophosphorus (OP) compounds. Currently, no structural data are available on the modes of interaction between the PNPLAs and OP compounds or their native substrates. To this end, we present the crystal structure of patatin-17 (pat17) in its native state as well as following inhibition with methyl arachidonyl fluorophosphonate (MAFP) and inhibition/aging with diisopropylphosphorofluoridate (DFP). The native pat17 structure revealed the existence of two portals (portal1 and portal2) that lead to its active-site chamber. The DFP-inhibited enzyme underwent the aging process with the negatively charged phosphoryl oxygen, resulting from the loss of an isopropyl group, being within hydrogen-binding distance to the oxyanion hole. The MAFP-inhibited pat17 structure showed that MAFP did not age following its interaction with the nucleophilic serine residue (Ser77) of pat17 since its O-methyl group was intact. The MAFP moiety is oriented with its phosphoryl oxygen in close proximity to the oxyanion hole of pat17 and its O-methyl group located farther away from the oxyanion hole of pat17 relative to the DFP-bound state. The orientation of the alkoxy oxygens within the two OP compounds suggests a role for the oxyanion hole in stabilizing the emerging negative charge on the oxygen during the aging reaction. The arachidonic acid side chain of MAFP could be contained within portals 1 or 2. Comparisons of pat17 in the native, inhibited, and aged states showed no significant global conformational changes with respect to their C alpha backbones, consistent with observations from other alpha/beta hydrolases such as group VIIA phospholipase A2.	[Wijeyesakere, Sanjeeva J.; Richardson, Rudy J.] Univ Michigan, Dept Environm Hlth Sci, Toxicol Program, Ann Arbor, MI 48109 USA; [Richardson, Rudy J.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Stuckey, Jeanne A.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Stuckey, Jeanne A.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Stuckey, JA (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	jass@umich.edu	Richardson, Rudy J/B-2030-2008	Richardson, Rudy J/0000-0002-2028-5723	U.S. Army Research Laboratory (ARL); U.S. Army Research Office (ARO) [DAAD19-02-1-0388]; University of Michigan Rackham School of Graduate Studies; National Institutes of Health (NIH) under Ruth L. Kirschstein National Research Service Award [ES07062]; U.S. DOE [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]	U.S. Army Research Laboratory (ARL)(United States Department of DefenseUS Army Research Laboratory (ARL)); U.S. Army Research Office (ARO); University of Michigan Rackham School of Graduate Studies(University of Michigan System); National Institutes of Health (NIH) under Ruth L. Kirschstein National Research Service Award; U.S. DOE(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor	This work was funded by grants from the U.S. Army Research Laboratory (ARL) and the U.S. Army Research Office (ARO) (grant DAAD19-02-1-0388) (RJR) and a grant from the University of Michigan Rackham School of Graduate Studies (SJW). SJW was supported by an institutional training grant from the National Institutes of Health (NIH) under Ruth L. Kirschstein National Research Service Award (ES07062) (RJR) and a fellowship from the University of Michigan Rackham School of Graduate Studies (SJW). Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract No. DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS DL, 1988, BIOCHEM J, V252, P199, DOI 10.1042/bj2520199; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bracey MH, 2002, SCIENCE, V298, P1793, DOI 10.1126/science.1076535; Bricogne G., 2010, BUSTER VERSION 2 9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CLOTHIER B, 1981, BIOCHIM BIOPHYS ACTA, V660, P306, DOI 10.1016/0005-2744(81)90175-3; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; del Giudice EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027933; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; Doorn JA, 2001, TOXICOL APPL PHARM, V176, P73, DOI 10.1006/taap.2001.9279; Ehrich M, 2010, HAYES' HANDBOOK OF PESTICIDE TOXICOLOGY, VOLS 1 AND 2, 3RD EDITION, P1479, DOI 10.1016/B978-0-12-374367-1.00069-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FREEDMAN LD, 1957, CHEM REV, V57, P479, DOI 10.1021/cr50015a003; GANAL MW, 1991, MOL GEN GENET, V225, P501, DOI 10.1007/BF00261693; Glynn P, 2003, BIOESSAYS, V25, P742, DOI 10.1002/bies.10322; HIRAYAMA O, 1975, BIOCHIM BIOPHYS ACTA, V384, P127, DOI 10.1016/0005-2744(75)90102-3; Hirschberg HJHB, 2001, EUR J BIOCHEM, V268, P5037, DOI 10.1046/j.0014-2956.2001.02411.x; Hornberg A, 2007, BIOCHEMISTRY-US, V46, P4815, DOI 10.1021/bi0621361; Jianmongkol S, 1999, TOXICOL APPL PHARM, V155, P43, DOI 10.1006/taap.1998.8608; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAYYALI US, 1991, J ANAL TOXICOL, V15, P86, DOI 10.1093/jat/15.2.86; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; Kropp TJ, 2004, BIOCHEMISTRY-US, V43, P3716, DOI 10.1021/bi049960e; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pots AM, 1999, J AGR FOOD CHEM, V47, P4587, DOI 10.1021/jf981180n; Richardson RJ, 2013, CHEM-BIOL INTERACT, V203, P238, DOI 10.1016/j.cbi.2012.10.024; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Samanta U, 2009, BIOCHEM PHARMACOL, V78, P420, DOI 10.1016/j.bcp.2009.04.018; Schrag JD, 1997, METHOD ENZYMOL, V284, P85; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sirin GS, 2012, J PHYS CHEM B, V116, P12199, DOI 10.1021/jp307790v; Stickel F, 2012, GUT, V61, P150, DOI 10.1136/gutjnl-2011-301239; STRICKLAND JA, 1995, PLANT PHYSIOL, V109, P667, DOI 10.1104/pp.109.2.667; Wijeyesakere SJ, 2007, PROTEIN J, V26, P165, DOI 10.1007/s10930-006-9058-8; Wijeyesakere SJ, 2010, HAYES' HANDBOOK OF PESTICIDE TOXICOLOGY, VOLS 1 AND 2, 3RD EDITION, P1435, DOI 10.1016/B978-0-12-374367-1.00067-7; Zhang YK, 2002, J AM CHEM SOC, V124, P10572, DOI 10.1021/ja020243m; Zhu YC, 2005, INSECT BIOCHEM MOLEC, V35, P23, DOI 10.1016/j.ibmb.2004.09.006	42	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108245	10.1371/journal.pone.0108245	http://dx.doi.org/10.1371/journal.pone.0108245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25248161	gold, Green Published, Green Submitted			2022-12-25	WOS:000342351800074
J	Hong, GN; Chen, BB; Li, HD; Zhang, WJ; Zheng, TT; Li, S; Shi, TW; Ao, L; Guo, Z				Hong, Guini; Chen, Beibei; Li, Hongdong; Zhang, Wenjing; Zheng, Tingting; Li, Shan; Shi, Tongwei; Ao, Lu; Guo, Zheng			Similar Source of Differential Blood mRNAs in Lung Cancer and Pulmonary Inflammatory Diseases: Calls for Improved Strategy for Identifying Cancer-Specific Biomarkers	PLOS ONE			English	Article							GENE-EXPRESSION; PERIPHERAL-BLOOD; LYMPHOCYTE SUBSETS; IMMUNE-RESPONSE; OVARIAN-CANCER; WHOLE-BLOOD; PROFILES; CELLS; RATIO; TUBERCULOSIS	Background: Many studies try to identify cancer diagnostic biomarkers by comparing peripheral whole blood (PWB) of cancer samples and healthy controls, explicitly or implicitly assuming that such biomarkers are potential candidate biomarkers for distinguishing cancer from nonmalignant inflammation-associated diseases. Methods: Multiple PWB gene expression profiles for lung cancer/inflammation-associated pulmonary diseases were used for differential mRNAs identification and comparison and for proportion estimation of PWB cell subtypes. Results: The differentially expressed genes (DE genes) between lung cancer/inflammation-associated pulmonary patients and healthy controls were reproducibly identified in different datasets. For these DE genes observed in lung cancer/inflammation-associated pulmonary diseases, more than 90.2% were differentially expressed between myeloid cells and lymphoid cells, with at least 96.8% having consistent directions of regulation (up-or down-regulations) in myeloid cells compared to lymphoid cells, explainable by the shifted populations of PWB cell subtypes under the disease conditions. The comparison of DE genes for lung cancer and inflammation-associated pulmonary diseases showed that the overlapping genes were 100% consistent in the sense of direction of regulation. Conclusions: The differential blood mRNAs observed in lung cancer and in inflammation-associated pulmonary diseases were similar, both mainly reflecting the difference between myeloid cells and lymphoid cells predominantly determined by PWB cell population shifts. Thus, the strategy of comparing cancer with healthy controls may provide little information of the ability of the identified candidate biomarkers in discriminating cancer from inflammation-associated pulmonary diseases.	[Hong, Guini; Li, Hongdong; Zhang, Wenjing; Zheng, Tingting; Li, Shan; Shi, Tongwei; Guo, Zheng] Univ Elect Sci & Technol China, Sch Life Sci, Bioinformat Ctr, Chengdu 610054, Peoples R China; [Ao, Lu; Guo, Zheng] Fujian Med Univ, Sch Basic Med Sci, Dept Bioinformat, Fuzhou, Peoples R China; [Chen, Beibei; Guo, Zheng] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China	University of Electronic Science & Technology of China; Fujian Medical University; Harbin Medical University	Guo, Z (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci, Bioinformat Ctr, Chengdu 610054, Peoples R China.	guoz@ems.hrbmu.edu.cn		, lu/0000-0001-7378-4967	National Natural Science Foundation of China [91029717, 81071646, 81372213, 81201702, 81201822]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (Grant Nos. 91029717,81071646,81372213,81201702 and 81201822; http://www.nsfc.gov.cn). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaroe J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2472; Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098; Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Allantaz F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029979; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Becker AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bloom CI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070630; Cho H, 2009, CANCER IMMUNOL IMMUN, V58, P15, DOI 10.1007/s00262-008-0516-3; Critchley-Thorne RJ, 2007, PLOS MED, V4, P897, DOI 10.1371/journal.pmed.0040176; Critchley-Thorne RJ, 2009, P NATL ACAD SCI USA, V106, P9010, DOI 10.1073/pnas.0901329106; Domagala-Kulawik J, 2007, RESP MED, V101, P1338, DOI 10.1016/j.rmed.2006.10.004; Gaujoux R, 2013, BIOINFORMATICS, V29, P2211, DOI 10.1093/bioinformatics/btt351; Go SI, 2014, LUNG CANCER, V84, P79, DOI 10.1016/j.lungcan.2014.01.014; Guglielmetti L, 2013, INT J TUBERC LUNG D, V17, P825, DOI 10.5588/ijtld.12.0361; Han M, 2008, CLIN CANCER RES, V14, P455, DOI 10.1158/1078-0432.CCR-07-1801; Hassanein M, 2012, CANCER PREV RES, V5, P992, DOI 10.1158/1940-6207.CAPR-11-0441; Hirashima M, 1998, J CANCER RES CLIN, V124, P329, DOI 10.1007/s004320050178; Hong GN, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0950; HONG WS, 1991, JPN J CLIN ONCOL, V21, P87, DOI 10.1093/oxfordjournals.jjco.a039451; Isaksson HS, 2012, ONCOL REP, V27, P1331, DOI 10.3892/or.2012.1680; Koth LL, 2011, AM J RESP CRIT CARE, V184, P1153, DOI 10.1164/rccm.201106-1143OC; Kuss I, 2004, CLIN CANCER RES, V10, P3755, DOI 10.1158/1078-0432.CCR-04-0054; Lonneborg A, 2009, EXPERT REV ANTICANC, V9, P1115, DOI [10.1586/era.09.31, 10.1586/ERA.09.31]; Maertzdorf Jeroen, 2011, PLoS One, V6, pe26938, DOI 10.1371/journal.pone.0026938; Martin KJ, 2001, P NATL ACAD SCI USA, V98, P2646, DOI 10.1073/pnas.041622398; Osman I, 2006, CLIN CANCER RES, V12, P3374, DOI 10.1158/1078-0432.CCR-05-2081; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Rotunno M, 2011, CANCER PREV RES, V4, P1599, DOI 10.1158/1940-6207.CAPR-10-0170; SCHMITT E, 1977, BRIT J HAEMATOL, V35, P11, DOI 10.1111/j.1365-2141.1977.tb00557.x; Showe MK, 2012, ONCOIMMUNOLOGY, V1, P1414, DOI 10.4161/onci.21096; Showe MK, 2009, CANCER RES, V69, P9202, DOI 10.1158/0008-5472.CAN-09-1378; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Twine NC, 2003, CANCER RES, V63, P6069; Visintin I, 2008, CLIN CANCER RES, V14, P1065, DOI 10.1158/1078-0432.CCR-07-1569; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; Zander T, 2011, CLIN CANCER RES, V17, P3360, DOI 10.1158/1078-0432.CCR-10-0533; Zhang M, 2008, BIOINFORMATICS, V24, P2057, DOI 10.1093/bioinformatics/btn365	38	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e108104	10.1371/journal.pone.0108104	http://dx.doi.org/10.1371/journal.pone.0108104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243474	Green Published, gold, Green Submitted			2022-12-25	WOS:000343679800067
J	Mattsson, JM; Ravela, S; Hekim, C; Jonsson, M; Malm, J; Narvanen, A; Stenman, UH; Koistinen, H				Mattsson, Johanna M.; Ravela, Suvi; Hekim, Can; Jonsson, Magnus; Malm, Johan; Narvanen, Ale; Stenman, Ulf-Hikan; Koistinen, Hannu			Proteolytic Activity of Prostate-Specific Antigen (PSA) towards Protein Substrates and Effect of Peptides Stimulating PSA Activity	PLOS ONE			English	Article							HUMAN TISSUE KALLIKREINS; MATRIX METALLOPROTEINASES; SERINE-PROTEASE; HUMAN-SEMEN; EMERGING ROLES; CANCER; BINDING; IDENTIFICATION; SEMENOGELIN; GALECTIN-3	Prostate-specific antigen (PSA or kallikrein-related peptidase-3, KLK3) exerts chymotrypsin-like proteolytic activity. The main biological function of PSA is the liquefaction of the clot formed after ejaculation by cleavage of semenogelins I and II in seminal fluid. PSA also cleaves several other substrates, which may explain its putative functions in prostate cancer and its antiangiogenic activity. We compared the proteolytic efficiency of PSA towards several protein and peptide substrates and studied the effect of peptides stimulating the activity of PSA with these substrates. An endothelial cell tube formation model was used to analyze the effect of PSA-degraded protein fragments on angiogenesis. We showed that PSA degrades semenogelins I and II much more efficiently than other previously identified protein substrates, e.g., fibronectin, galectin-3 and IGFBP-3. We identified nidogen-1 as a new substrate for PSA. Peptides B2 and C4 that stimulate the activity of PSA towards small peptide substrates also enhanced the proteolytic activity of PSA towards protein substrates. Nidogen-1, galectin-3 or their fragments produced by PSA did not have any effect on endothelial cell tube formation. Although PSA cleaves several other protein substrates, in addition to semenogelins, the physiological importance of this activity remains speculative. The PSA levels in prostate are very high, but several other highly active proteases, such as hK2 and trypsin, are also expressed in the prostate and may cleave protein substrates that are weakly cleaved by PSA.	[Mattsson, Johanna M.; Ravela, Suvi; Hekim, Can; Stenman, Ulf-Hikan; Koistinen, Hannu] Univ Helsinki, Biomedicum Helsinki, Dept Clin Chem, Helsinki, Finland; [Mattsson, Johanna M.; Ravela, Suvi; Hekim, Can; Stenman, Ulf-Hikan; Koistinen, Hannu] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Jonsson, Magnus; Malm, Johan] Lund Univ, Dept Lab Med, Sect Clin Chem, Lund, Sweden; [Jonsson, Magnus; Malm, Johan] Lab Med Skane, Lund, Sweden; [Narvanen, Ale] Univ Eastern Finland, Sch Pharm, Kuopio, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Lund University; University of Eastern Finland	Koistinen, H (corresponding author), Univ Helsinki, Biomedicum Helsinki, Dept Clin Chem, Helsinki, Finland.	hannu.k.koistinen@helsinki.fi	Koistinen, Hannu/AGU-1279-2022	Koistinen, Hannu/0000-0003-0926-3109; Stenman, Ulf-Hakan/0000-0002-2695-3454	Academy of Finland [135937, 140929, 263755]; Finnish Cancer Foundation; Sigrid Juselius Foundation; Finska Lakaresallskapet; Helsinki University Central Hospital Research Funds; Biomedicum Helsinki Foundation; Maud Kuistila Memorial Foundation; Fundacion Federico SA; Orion-Farmos Research Foundation	Academy of Finland(Academy of Finland); Finnish Cancer Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finska Lakaresallskapet; Helsinki University Central Hospital Research Funds; Biomedicum Helsinki Foundation; Maud Kuistila Memorial Foundation; Fundacion Federico SA; Orion-Farmos Research Foundation	Funding provided by the Academy of Finland (grants 135937, 140929, 263755 to HK), www.aka.fi; Finnish Cancer Foundation (UHS), www.cancer.fi; Sigrid Juselius Foundation (HK and UHS), www.sigridjuselius.fi; Finska Lakaresallskapet (UHS), www.fls.fi; Helsinki University Central Hospital Research Funds (UHS), www.hus.fi; Biomedicum Helsinki Foundation (JMM), www.biomedicum.fi; Maud Kuistila Memorial Foundation (JMM), http://www.maudkuistilanmuistosaatio.fi; Fundacion Federico SA (JM and MJ); Orion-Farmos Research Foundation (JMM), www.orion.fi/Tutkimus-ja-tuotekehitys/Orion-Farmos-Tutkimussaatio/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSSON PA, 1988, PROSTATE, V12, P39, DOI 10.1002/pros.2990120106; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; CHRISTENSSON A, 1990, EUR J BIOCHEM, V194, P755, DOI 10.1111/j.1432-1033.1990.tb19466.x; Claesson-Welsh L, 1998, P NATL ACAD SCI USA, V95, P5579, DOI 10.1073/pnas.95.10.5579; COHEN P, 1992, J CLIN ENDOCR METAB, V75, P1046, DOI 10.1210/jc.75.4.1046; Coombs GS, 1998, CHEM BIOL, V5, P475, DOI 10.1016/S1074-5521(98)90004-7; de Lamirande E, 2007, SEMIN THROMB HEMOST, V33, P60, DOI 10.1055/s-2006-958463; Debela M, 2006, J BIOL CHEM, V281, P25678, DOI 10.1074/jbc.M602372200; del Toro R, 2010, BLOOD, V116, P4025, DOI 10.1182/blood-2010-02-270819; Denmeade SR, 1997, CANCER RES, V57, P4924; Denmeade SR, 2001, PROSTATE, V48, P1; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fortier AH, 2003, PROSTATE, V56, P212, DOI 10.1002/pros.10256; Fortier AH, 1999, J NATL CANCER I, V91, P1635, DOI 10.1093/jnci/91.19.1635; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; Gately S, 1997, P NATL ACAD SCI USA, V94, P10868, DOI 10.1073/pnas.94.20.10868; Harkonen HH, 2011, CHEMMEDCHEM, V6, P2170, DOI 10.1002/cmdc.201100349; Heidtmann HH, 1999, BRIT J CANCER, V81, P1269, DOI 10.1038/sj.bjc.6692167; Ho MSP, 2008, MICROSC RES TECHNIQ, V71, P387, DOI 10.1002/jemt.20567; Hohenester E, 2013, CELL ADHES MIGR, V7, P56, DOI 10.4161/cam.21831; Hsieh MC, 2000, BBA-PROTEIN STRUCT M, V1481, P75, DOI 10.1016/S0167-4838(00)00116-3; Ishii K, 2004, CANCER LETT, V207, P79, DOI 10.1016/j.canlet.2003.09.029; Jonsson M, 2006, CELL MOL LIFE SCI, V63, P2886, DOI 10.1007/s00018-006-6287-0; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; KOISTINEN H, 1994, CLIN CHEM, V40, P531; Koistinen H, 2002, PROSTATE, V50, P112, DOI 10.1002/pros.10039; Koistinen H, 2008, BIOL CHEM, V389, P633, DOI 10.1515/BC.2008.076; Koistinen H, 2012, KALLIKREIN-RELATED PEPTIDASES, VOL 2: NOVEL CANCER-RELATED BIOMARKERS, P61; Koistinen H, 2014, METHODS MOL BIOL, V1088, P147, DOI 10.1007/978-1-62703-673-3_10; Lawrence MG, 2010, ENDOCR REV, V31, P407, DOI 10.1210/er.2009-0034; LeBeau AM, 2010, BIOL CHEM, V391, P333, DOI 10.1515/BC.2010.044; LILJA H, 1987, J CLIN INVEST, V80, P281, DOI 10.1172/JCI113070; LILJA H, 1985, J CLIN INVEST, V76, P1899, DOI 10.1172/JCI112185; Lilja H, 2008, NAT REV CANCER, V8, P268, DOI 10.1038/nrc2351; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Lopez-Otin C, 2010, NAT REV CANCER, V10, P278, DOI 10.1038/nrc2823; Malm J, 1996, EUR J BIOCHEM, V238, P48, DOI 10.1111/j.1432-1033.1996.0048q.x; Malm J, 2000, PROSTATE, V45, P132, DOI 10.1002/1097-0045(20001001)45:2<132::AID-PROS7>3.0.CO;2-3; Manning ML, 2012, PROSTATE, V72, P1233, DOI 10.1002/pros.22474; Markowska AI, 2010, J EXP MED, V207, P1981, DOI 10.1084/jem.20090121; Mason SD, 2011, TRENDS CELL BIOL, V21, P228, DOI 10.1016/j.tcb.2010.12.002; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Mattsson JM, 2008, PROSTATE, V68, P945, DOI 10.1002/pros.20751; Mattsson JM, 2012, PROSTATE, V72, P1588, DOI 10.1002/pros.22512; Mattsson JM, 2009, SCAND J CLIN LAB INV, V69, P447, DOI 10.1080/00365510903056031; MAYER U, 1993, EUR J BIOCHEM, V217, P877, DOI 10.1111/j.1432-1033.1993.tb18316.x; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; Paju A, 2000, AM J PATHOL, V157, P2011, DOI 10.1016/S0002-9440(10)64840-7; Paju A, 2007, EUR UROL, V52, P1670, DOI 10.1016/j.eururo.2007.01.096; Pakkala M, 2004, J PEPT SCI, V10, P439, DOI 10.1002/psc.557; Ramachandran R, 2012, NAT REV DRUG DISCOV, V11, P69, DOI 10.1038/nrd3615; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; Ries A, 2001, EUR J BIOCHEM, V268, P5119, DOI 10.1046/j.0014-2956.2001.02437.x; Sage J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043494; Saraswati S, 2011, PROSTATE, V71, P197, DOI 10.1002/pros.21236; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SIRES UI, 1993, J BIOL CHEM, V268, P2069; Stenman UH, 2005, SCAND J UROL NEPHROL, V39, P64, DOI 10.1080/03008880510030941; Stenman UH, 1999, SEMIN CANCER BIOL, V9, P83, DOI 10.1006/scbi.1998.0086; Stenman UH, 1997, BRIT J UROL, V79, P53, DOI 10.1111/j.1464-410X.1997.tb00802.x; Thorek DLJ, 2013, THROMB HAEMOSTASIS, V110, P484, DOI 10.1160/TH13-04-0275; Titz B, 2004, CELL MOL LIFE SCI, V61, P1826, DOI 10.1007/s00018-004-4105-0; Veveris-Lowe TL, 2007, SEMIN THROMB HEMOST, V33, P87, DOI 10.1055/s-2006-958467; WATT KWK, 1986, P NATL ACAD SCI USA, V83, P3166, DOI 10.1073/pnas.83.10.3166; Webber MM, 1995, CLIN CANCER RES, V1, P1089; Wu P, 2000, EUR J BIOCHEM, V267, P6212, DOI 10.1046/j.1432-1327.2000.01696.x; Wu P, 2004, PROSTATE, V58, P345, DOI 10.1002/pros.10337; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; ZHANG WM, 1995, CLIN CHEM, V41, P1567	74	22	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107819	10.1371/journal.pone.0107819	http://dx.doi.org/10.1371/journal.pone.0107819			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25237904	Green Published, Green Submitted, gold			2022-12-25	WOS:000342491600052
J	Wang, CJ; Li, Y; Xia, XN; Zheng, KJ				Wang, Changji; Li, Yuan; Xia, Xiaonan; Zheng, Kangjia			An Efficient and Provable Secure Revocable Identity-Based Encryption Scheme	PLOS ONE			English	Article							DUAL SYSTEM ENCRYPTION; HIBE; IBE	Revocation functionality is necessary and crucial to identity-based cryptosystems. Revocable identity-based encryption (RIBE) has attracted a lot of attention in recent years, many RIBE schemes have been proposed in the literature but shown to be either insecure or inefficient. In this paper, we propose a new scalable RIBE scheme with decryption key exposure resilience by combining Lewko and Waters' identity-based encryption scheme and complete subtree method, and prove our RIBE scheme to be semantically secure using dual system encryption methodology. Compared to existing scalable and semantically secure RIBE schemes, our proposed RIBE scheme is more efficient in term of ciphertext size, public parameters size and decryption cost at price of a little looser security reduction. To the best of our knowledge, this is the first construction of scalable and semantically secure RIBE scheme with constant size public system parameters.	[Wang, Changji; Li, Yuan; Xia, Xiaonan; Zheng, Kangjia] Sun Yat Sen Univ, Sch Informat Sci & Technol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Changji; Li, Yuan; Xia, Xiaonan; Zheng, Kangjia] Sun Yat Sen Univ, Guangdong Prov Informat Secur Key Lab, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Wang, CJ (corresponding author), Sun Yat Sen Univ, Sch Informat Sci & Technol, Guangzhou 510275, Guangdong, Peoples R China.	isswchj@mail.sysu.edu.cn			National Natural Science Foundation of China [61173189]; Guangdong Province Information Security Key Laboratory Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Information Security Key Laboratory Project	This paper is jointly supported by the National Natural Science Foundation of China (Grant No. 61173189) and Guangdong Province Information Security Key Laboratory Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boldyreva A, 2008, CCS'08: PROCEEDINGS OF THE 15TH ACM CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY, P417; Boneh D, 2004, LECT NOTES COMPUT SC, V3027, P223; Boneh D, 2003, SIAM J COMPUT, V32, P586, DOI 10.1137/S0097539701398521; Canetti R, 2004, LECT NOTES COMPUT SC, V3027, P207, DOI 10.1007/978-3-540-24676-3_13; Canetti R, 2004, J ACM, V51, P557, DOI 10.1145/1008731.1008734; Gentry C, 2006, LECT NOTES COMPUT SC, V4004, P445; Lee K, 2014, 2014132 CRYPT EPRINT; Lewko A, 2010, LECT NOTES COMPUT SC, V5978, P455, DOI 10.1007/978-3-642-11799-2_27; Libert B, 2009, LECT NOTES COMPUT SC, V5473, P1, DOI 10.1007/978-3-642-00862-7_1; Libert B, 2009, LECT NOTES COMPUT SC, V5443, P235; Naor D., 2001, Advances in Cryptology - CRTPTO 2001. 21st Annual International Cryptology Conference, Proceedings (Lecture Notes in Computer Science Vol.2139), P41; Park S, 2013, 2013880 CRYPT EPRINT; Sahai A, 2005, LECT NOTES COMPUT SC, V3494, P457, DOI 10.1007/11426639_27; Seo JH, 2013, LECT NOTES COMPUT SC, V7778, P216, DOI 10.1007/978-3-642-36362-7_14; Shamir A., 1984, LECT NOTES COMPUTER, P47, DOI [DOI 10.1007/3-540-39568-7, 10.1007/3-540-39568-7_5]; Waters B, 2005, LECT NOTES COMPUT SC, V3494, P114; Waters B, 2009, LECT NOTES COMPUT SC, V5677, P619, DOI 10.1007/978-3-642-03356-8_36; Zhang Y, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/68002	18	2	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e106925	10.1371/journal.pone.0106925	http://dx.doi.org/10.1371/journal.pone.0106925			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238418	Green Published, gold			2022-12-25	WOS:000342491600016
J	Sokabe, M; Fraser, CS				Sokabe, Masaaki; Fraser, Christopher S.			Human Eukaryotic Initiation Factor 2 (eIF2)-GTP-Met-tRNA(i) Ternary Complex and eIF3 Stabilize the 43 S Preinitiation Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cooperativity; Eukaryotic Translation Initiation; Protein-Protein Interaction; Ribosome; Ribosome Function; RNA-binding Protein; eIF1; eIF1A; eIF2; eIF3	40S RIBOSOMAL-SUBUNIT; START CODON SELECTION; MESSENGER-RNA; MULTIFACTOR COMPLEX; PROTEIN-SYNTHESIS; CRYSTAL-STRUCTURE; TRANSLATION; BINDING; RECOGNITION; RECRUITMENT	Background: 43 S preinitiation complex (PIC) formation is an important step for eukaryotic translation initiation. Results: A thermodynamic framework of human 43 S PIC reveals a complicated network of positive and negative cooperativity among the components. Conclusion: eIF2 and eIF3 play essential roles in stabilizing the 43 S PIC. Significance: Quantitative analysis of initiation complex formation leads to understanding of mechanistic details in translation initiation. The formation of a stable 43 S preinitiation complex (PIC) must occur to enable successful mRNA recruitment. However, the contributions of eIF1, eIF1A, eIF3, and the eIF2-GTP-Met-tRNA(i) ternary complex (TC) in stabilizing the 43 S PIC are poorly defined. We have reconstituted the human 43 S PIC and used fluorescence anisotropy to systematically measure the affinity of eIF1, eIF1A, and eIF3j in the presence of different combinations of 43 S PIC components. Our data reveal a complicated network of interactions that result in high affinity binding of all 43 S PIC components with the 40 S subunit. Human eIF1 and eIF1A bind cooperatively to the 40 S subunit, revealing an evolutionarily conserved interaction. Negative cooperativity is observed between the binding of eIF3j and the binding of eIF1, eIF1A, and TC with the 40 S subunit. To overcome this, eIF3 dramatically increases the affinity of eIF1 and eIF3j for the 40 S subunit. Recruitment of TC also increases the affinity of eIF1 for the 40 S subunit, but this interaction has an important indirect role in increasing the affinity of eIF1A for the 40 S subunit. Together, our data provide a more complete thermodynamic framework of the human 43 S PIC and reveal important interactions between its components to maintain its stability.	[Sokabe, Masaaki; Fraser, Christopher S.] Univ Calif Davis, Coll Biol Sci, Dept Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Fraser, CS (corresponding author), Univ Calif Davis, Coll Biol Sci, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	csfraser@ucdavis.edu			National Institutes of Health [RO1 GM092927]; Japan Society for the Promotion of Science (JSPS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM092927 (to C. S. F.). This work was also supported by Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowships for Research Abroad (to M. S.).	Algire MA, 2002, RNA, V8, P382, DOI 10.1017/S1355838202029527; Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Barth-Baus D, 2013, TRANSLATION, V1, DOI 10.4161/trla.24419; BENNE R, 1979, J BIOL CHEM, V254, P3201; Chaudhuri J, 1997, J BIOL CHEM, V272, P7883, DOI 10.1074/jbc.272.12.7883; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; Dennis MD, 2009, J BIOL CHEM, V284, P20615, DOI 10.1074/jbc.M109.007658; Dong JS, 2014, GENE DEV, V28, P502, DOI 10.1101/gad.236547.113; DUNCAN R, 1983, J BIOL CHEM, V258, P7228; ElAntak L, 2010, J MOL BIOL, V396, P1097, DOI 10.1016/j.jmb.2009.12.047; Fekete CA, 2005, EMBO J, V24, P3588, DOI 10.1038/sj.emboj.7600821; Fekete CA, 2007, EMBO J, V26, P1602, DOI 10.1038/sj.emboj.7601613; Feoktistova K, 2013, P NATL ACAD SCI USA, V110, P13339, DOI 10.1073/pnas.1303781110; Firczuk H, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.73; Fletcher CM, 1999, EMBO J, V18, P2631, DOI 10.1093/emboj/18.9.2631; Fraser CS, 2007, MOL CELL, V26, P811, DOI 10.1016/j.molcel.2007.05.019; Fraser CS, 2009, NAT STRUCT MOL BIOL, V16, P397, DOI 10.1038/nsmb.1572; Fraser CS, 2004, J BIOL CHEM, V279, P8946, DOI 10.1074/jbc.M312745200; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Lomakin IB, 2013, NATURE, V500, P307, DOI 10.1038/nature12355; Lorsch JR, 2010, J BIOL CHEM, V285, P21203, DOI 10.1074/jbc.R110.119743; Loughran G, 2012, NUCLEIC ACIDS RES, V40, P2898, DOI 10.1093/nar/gkr1192; Maag D, 2006, J MOL BIOL, V356, P724, DOI 10.1016/j.jmb.2005.11.083; Maag D, 2005, MOL CELL, V17, P265, DOI 10.1016/j.molcel.2004.11.051; Maag D, 2003, J MOL BIOL, V330, P917, DOI 10.1016/S0022-2836(03)00665-X; Majumdar R, 2003, J BIOL CHEM, V278, P6580, DOI 10.1074/jbc.M210357200; Martin-Marcos P, 2014, RNA, V20, P150, DOI 10.1261/rna.042069.113; Martin-Marcos P, 2013, J BIOL CHEM, V288, P27546, DOI 10.1074/jbc.M113.498642; Mathews M. B., 2007, TRANSLATIONAL CONTRO, P87; Nanda JS, 2013, J BIOL CHEM, V288, P5316, DOI 10.1074/jbc.M112.440693; Nanda JS, 2009, J MOL BIOL, V394, P268, DOI 10.1016/j.jmb.2009.09.017; Nielsen KH, 2006, MOL CELL BIOL, V26, P2984, DOI 10.1128/MCB.26.8.2984-2998.2006; Olsen DS, 2003, EMBO J, V22, P193, DOI 10.1093/emboj/cdg030; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Phan L, 2001, EMBO J, V20, P2954, DOI 10.1093/emboj/20.11.2954; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Reibarkh M, 2008, J BIOL CHEM, V283, P1094, DOI 10.1074/jbc.M708155200; Saini AK, 2010, GENE DEV, V24, P97, DOI 10.1101/gad.1871910; Shin BS, 2011, NAT STRUCT MOL BIOL, V18, P1227, DOI 10.1038/nsmb.2133; Sokabe M, 2012, NUCLEIC ACIDS RES, V40, P905, DOI 10.1093/nar/gkr772; Sun CM, 2011, P NATL ACAD SCI USA, V108, P20473, DOI 10.1073/pnas.1116821108; THOMAS A, 1980, EUR J BIOCHEM, V107, P39, DOI 10.1111/j.1432-1033.1980.tb04621.x; Unbehaun A, 2004, GENE DEV, V18, P3078, DOI 10.1101/gad.1255704; Valasek L, 2001, EMBO J, V20, P891, DOI 10.1093/emboj/20.4.891; WEEKS KM, 1992, BIOCHEMISTRY-US, V31, P10281, DOI 10.1021/bi00157a015; Weisser M, 2013, NAT STRUCT MOL BIOL, V20, P1015, DOI 10.1038/nsmb.2622; Yi L, 2010, ANGEW CHEM INT EDIT, V49, P9417, DOI 10.1002/anie.201003834; Yu YP, 2009, NUCLEIC ACIDS RES, V37, P5167, DOI 10.1093/nar/gkp519	51	38	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31827	31836		10.1074/jbc.M114.602870	http://dx.doi.org/10.1074/jbc.M114.602870			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25246524	Green Published, hybrid			2022-12-25	WOS:000345314700014
J	Anne, OS; Bernheim-Groswasser, A				Siton, Orit; Bernheim-Groswasser, Anne			Reconstitution of Actin-based Motility by Vasodilator-stimulated Phosphoprotein (VASP) Depends on the Recruitment of F-actin Seeds from the Solution Produced by Cofilin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENA/VASP PROTEINS; LISTERIA-MONOCYTOGENES; STRUCTURAL BASIS; MYOSIN-X; DYNAMICS; COMPLEX; CYTOSKELETON; POLYMERIZATION; NUCLEATION; FILAMENTS	Vasodilator-stimulated phosphoprotein (VASP) is active in many filopodium-based and cytoskeleton reorganization processes. It is not fully understood how VASP directly functions in actin-based motility and how regulatory proteins affect its function. Here, we combine bead motility assay and single filament experiments. In the presence of a bundling component, actin bundles that grow from the surface of WT-VASP-coated beads induced movement of the beads. VASP promotes actin-based movement alone, in the absence of other actin nucleators. We propose that at physiological salt conditions VASP nucleation activity is too weak to promote motility and bundle formation. Rather, VASP recruits F-actin seeds from the solution and promotes their elongation. Cofilin has a crucial role in the nucleation of these F-actin seeds, notably under conditions of unfavorable spontaneous actin nucleation. We explored the role of multiple VASP variants. We found that the VASP-F-actin binding domain is required for the recruitment of F-actin seeds from the solution. We also found that the interaction of profilin-actin complexes with the VASP-proline- rich domain and the binding of the VASP-F-actin binding domain to the side of growing filaments is critical for transforming actin polymerization into motion. At the single filament level, profilin mediates both filament elongation rate and VASP anti-capping activity. Binding of profilin-actin complexes increases the polymerization efficiency by VASP but decreases its efficiency as an anti-capper; binding of free profilin creates the opposite effect. Finally, we found that an additional component such as methylcellulose or fascin is required for actin bundle formation and motility mediated by VASP.	[Bernheim-Groswasser, Anne] Ben Gurion Univ Negev, Dept Chem Engn, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Bernheim-Groswasser, A (corresponding author), Ben Gurion Univ Negev, Dept Chem Engn, IL-84105 Beer Sheva, Israel.	bernheim@bgu.ac.il	Bernheim, Anne/AAM-5969-2020	Bernheim-Groswasser, Anne/0000-0003-3999-6098	Israel Science Foundation [1534/10]	Israel Science Foundation(Israel Science Foundation)	This work was supported by Israel Science Foundation Grant 1534/10 (to A.B.-G.)	Achard V, 2010, CURR BIOL, V20, P423, DOI 10.1016/j.cub.2009.12.056; Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Amann KJ, 2001, P NATL ACAD SCI USA, V98, P15009, DOI 10.1073/pnas.211556398; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Applewhite DA, 2007, MOL BIOL CELL, V18, P2579, DOI 10.1091/mbc.e06-11-0990; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Bernheim-Groswasser A, 2002, NATURE, V417, P308, DOI 10.1038/417308a; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; Breitsprecher D, 2008, EMBO J, V27, P2943, DOI 10.1038/emboj.2008.211; Brill-Karniely Y, 2009, CHEMPHYSCHEM, V10, P2818, DOI 10.1002/cphc.200900615; Carlier MF, 2007, ANN NY ACAD SCI, V1112, P67, DOI 10.1196/annals.1415.037; CHAKRABORTY T, 1995, EMBO J, V14, P1314, DOI 10.1002/j.1460-2075.1995.tb07117.x; Chereau D, 2006, J STRUCT BIOL, V155, P195, DOI 10.1016/j.jsb.2006.01.012; Danino D, 2001, COLLOID SURFACE A, V183, P113, DOI 10.1016/S0927-7757(01)00543-X; Drees F, 2008, CURR OPIN NEUROBIOL, V18, P53, DOI 10.1016/j.conb.2008.05.007; Ferron F, 2007, EMBO J, V26, P4597, DOI 10.1038/sj.emboj.7601874; Fleming T, 2010, DEV BIOL, V344, P94, DOI 10.1016/j.ydbio.2010.04.025; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gov Nir S, 2012, Bioarchitecture, V2, P11; Hansen SD, 2010, J CELL BIOL, V191, P571, DOI 10.1083/jcb.201003014; Haviv L, 2006, P NATL ACAD SCI USA, V103, P4906, DOI 10.1073/pnas.0508269103; Huttelmaier S, 1999, FEBS LETT, V451, P68, DOI 10.1016/S0014-5793(99)00546-3; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; Ideses Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003297; Irobi E, 2004, EMBO J, V23, P3599, DOI 10.1038/sj.emboj.7600372; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Kuhn TB, 2000, J NEUROBIOL, V44, P126, DOI 10.1002/1097-4695(200008)44:2<126::AID-NEU4>3.0.CO;2-Z; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Lacayo CI, 2007, PLOS BIOL, V5, P2035, DOI 10.1371/journal.pbio.0050233; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Lin WH, 2010, J BIOL CHEM, V285, P36010, DOI 10.1074/jbc.M110.129841; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Michelot A, 2007, CURR BIOL, V17, P825, DOI 10.1016/j.cub.2007.04.037; Neidt EM, 2009, J BIOL CHEM, V284, P673, DOI 10.1074/jbc.M804201200; Ono K, 2008, J CELL SCI, V121, P2662, DOI 10.1242/jcs.034215; Ono S, 1997, J BIOL CHEM, V272, P2527; Pasic L, 2008, J BIOL CHEM, V283, P9814, DOI 10.1074/jbc.M710475200; Plastino J, 2004, CURR BIOL, V14, P1766, DOI 10.1016/j.cub.2004.09.054; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Reymann AC, 2011, MOL BIOL CELL, V22, P2541, DOI 10.1091/mbc.E11-01-0052; Samarin S, 2003, J CELL BIOL, V163, P131, DOI 10.1083/jcb.200303191; Sarmiere PD, 2004, J NEUROBIOL, V58, P103, DOI 10.1002/neu.10267; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; Schirenbeck A, 2006, P NATL ACAD SCI USA, V103, P7694, DOI 10.1073/pnas.0511243103; Siton O, 2011, CURR BIOL, V21, P2092, DOI 10.1016/j.cub.2011.11.010; Skoble J, 2001, J CELL BIOL, V155, P89, DOI 10.1083/jcb.200106061; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Suei S, 2011, J MOL BIOL, V413, P573, DOI 10.1016/j.jmb.2011.08.054; Tahirovic S, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001644; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; Trichet L, 2008, J CELL BIOL, V181, P19, DOI 10.1083/jcb.200710168; Trichet L, 2007, BIOPHYS J, V92, P1081, DOI 10.1529/biophysj.106.091884; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Yoshinaga S, 2012, J NEUROSCI, V32, P11643, DOI 10.1523/JNEUROSCI.0738-12.2012	62	14	14	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31274	31286		10.1074/jbc.M114.586958	http://dx.doi.org/10.1074/jbc.M114.586958			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25246528	hybrid, Green Published			2022-12-25	WOS:000344549900032
J	Awad, FG; Motsa, S; Khumalo, M				Awad, Faiz G.; Motsa, Sandile; Khumalo, Melusi			Heat and Mass Transfer in Unsteady Rotating Fluid Flow with Binary Chemical Reaction and Activation Energy	PLOS ONE			English	Article							CONTINUOUS SOLID SURFACES; BOUNDARY-LAYER BEHAVIOR; STRETCHING SHEET; VISCOUS DISSIPATION; CONVECTION; EQUATIONS; MIXTURE	In this study, the Spectral Relaxation Method (SRM) is used to solve the coupled highly nonlinear system of partial differential equations due to an unsteady flow over a stretching surface in an incompressible rotating viscous fluid in presence of binary chemical reaction and Arrhenius activation energy. The velocity, temperature and concentration distributions as well as the skin-friction, heat and mass transfer coefficients have been obtained and discussed for various physical parametric values. The numerical results obtained by (SRM) are then presented graphically and discussed to highlight the physical implications of the simulations.	[Awad, Faiz G.; Khumalo, Melusi] Univ Johannesburg, Dept Pure & Appl Math, Johannesburg, South Africa; [Motsa, Sandile] Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Pietermaritzburg, South Africa	University of Johannesburg; University of Kwazulu Natal	Motsa, S (corresponding author), Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Pietermaritzburg, South Africa.	sandilemotsa@gmail.com	Khumalo, Melusi/E-9615-2013	Khumalo, Melusi/0000-0001-5411-5389				Abbas Z, 2010, J TAIWAN INST CHEM E, V41, P644, DOI 10.1016/j.jtice.2010.02.002; AbdulMaleque Kh, 2013, J THERMODYNAMICS, V2013, DOI [10.1155/2013/692516, DOI 10.1155/2013/692516]; AbdulMaleque Kh, 2013, ISRN THERMODYNAMICS, V2013, DOI [10.1155/2013/284637, DOI 10.1155/2013/284637]; AbdulMaleque Kh, 2013, BR J APPL SCI TECH, V2013, P131; Abel MS, 2008, APPL MATH MODEL, V32, P1965, DOI 10.1016/j.apm.2007.06.038; Abel MS, 2007, INT J HEAT MASS TRAN, V50, P960, DOI 10.1016/j.ijheatmasstransfer.2006.08.010; AFZAL N, 1993, INT J HEAT MASS TRAN, V36, P1128, DOI 10.1016/S0017-9310(05)80296-0; Bataller RC, 2007, INT J HEAT MASS TRAN, V50, P3152, DOI 10.1016/j.ijheatmasstransfer.2007.01.003; BERGSTROM RW, 1976, J ATMOS SCI, V33, P1234, DOI 10.1175/1520-0469(1976)033<1234:VBLIRF>2.0.CO;2; BESTMAN AR, 1990, INT J ENERG RES, V14, P389, DOI 10.1002/er.4440140403; BESTMAN AR, 1991, INT J ENERG RES, V15, P179, DOI 10.1002/er.4440150305; BRADY JF, 1981, J FLUID MECH, V112, P127, DOI 10.1017/S0022112081000323; Canuto C, 1988, SPECTRAL METHODS EVO; CRANE LJ, 1970, Z ANGEW MATH PHYS, V21, P645, DOI 10.1007/BF01587695; Fang TG, 2012, COMMUN NONLINEAR SCI, V17, P5064, DOI 10.1016/j.cnsns.2012.04.017; Hajmohammadi MR, 2014, INT J HEAT MASS TRAN, V75, P97, DOI 10.1016/j.ijheatmasstransfer.2014.03.065; Hajmohammadi MR, 2014, J MECH SCI TECHNOL, V28, P1849, DOI 10.1007/s12206-014-0332-y; Khan NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095423; Makinde OD, 2011, CHEM ENG COMMUN, V198, P920, DOI 10.1080/00986445.2011.545296; Makinde OD, 2011, AFR MAT, V22, P65, DOI 10.1007/s13370-011-0008-z; Motsa SS, 2014, CHEM ENG COMMUN, V201, P241, DOI 10.1080/00986445.2013.766882; Motsa SS, 2013, NONLINEAR DYNAM, V72, P265, DOI 10.1007/s11071-012-0712-8; Motsa SS, 2012, ABSTR APPL ANAL, DOI 10.1155/2012/203461; Motsa SS, 2013, CENT EUR J PHYS, V11, P363, DOI 10.2478/s11534-013-0182-8; Nazar R, 2004, MECH RES COMMUN, V31, P121, DOI 10.1016/j.mechrescom.2003.09.004; Prasad KV, 2003, INT J NONLIN MECH, V38, P651, DOI 10.1016/S0020-7462(01)00122-6; Rashad A.M., 2014, J EGYPT MATH SOC, V22, P134, DOI 10.1016/j.joems.2013.05.008; SAKIADIS BC, 1961, AICHE J, V7, P221, DOI 10.1002/aic.690070211; SAKIADIS BC, 1961, AICHE J, V7, P26, DOI 10.1002/aic.690070108; Soundalgekar VM., 1976, PUBLICATION I MATH, V20, P215; Trefethen L. N., 2000, SPECTRAL METHODS MAT; WANG CY, 1984, PHYS FLUIDS, V27, P1915, DOI 10.1063/1.864868; Zheng LC, 2011, COMPUT MATH APPL, V62, P1105, DOI 10.1016/j.camwa.2011.02.044	33	117	117	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107622	10.1371/journal.pone.0107622	http://dx.doi.org/10.1371/journal.pone.0107622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250830	Green Published, gold, Green Submitted			2022-12-25	WOS:000342492700035
J	Ma, N; Hu, GL; Zhang, JX; Hua, BZ				Ma, Na; Hu, Guilin; Zhang, Junxia; Hua, Baozhen			Morphological Variation of the Scorpionfly Panorpa obtusa Cheng (Mecoptera: Panorpidae) with a New Synonym	PLOS ONE			English	Article							INTEGRATIVE TAXONOMY; BIODIVERSITY; BIOLOGY; SYSTEMATICS; COMPLEX	Background: The overabundance of synonyms is an unavoidable by-product of taxonomic practice in insects. How to reduce or even eliminate synonymy has long been a great challenge for insect taxonomists. The scorpionflies Panorpa obtusa Cheng, 1949 and Panorpa leei Cheng, 1949 (Insecta: Mecoptera: Panorpidae) were originally described from Taibaishan in the Qinling Mountains with identical collection data and both are based on a single gender, the former on a male and the latter on two females. However, whether P. leei is conspecific with P. obtusa or a good species remains an unsolved problem. Results: On the basis of intensive morphological comparison of 93 males and 53 females of scorpionflies collected from the type locality using light and scanning electron microscopy, we found P. obtusa has considerable morphological variation (especially the wing markings and genitalia in both male and female), and Panorpa leei is totally comprised of one of the morphs of P. obtusa. Conclusions: In combination with identical type localities and overlapping morphological variation, P. leei Cheng is proposed as a junior subjective synonym of P. obtusa Cheng. To avoid synonyms, taxonomists should pay more attention to individual variation and base decisions on a series of specimens to describe new species.	[Ma, Na; Hu, Guilin; Zhang, Junxia; Hua, Baozhen] Northwest A&F Univ, Key Lab Plant Protect Resources & Pest Management, State Key Lab Crop Stress Biol Arid Areas, Minist Educ,Entomol Museum, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Hua, BZ (corresponding author), Northwest A&F Univ, Key Lab Plant Protect Resources & Pest Management, State Key Lab Crop Stress Biol Arid Areas, Minist Educ,Entomol Museum, Yangling, Shaanxi, Peoples R China.	huabzh@nwsuaf.edu.cn			National Natural Science Foundation of China [31172125, 31301898]; China Postdoctoral Science Foundation [2012M520085, 2013T60893]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This research was financially supported by the National Natural Science Foundation of China (grant nos. 31172125 and 31301898) and the China Postdoctoral Science Foundation (grant nos. 2012M520085 and 2013T60893). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BYERS GW, 1983, ANNU REV ENTOMOL, V28, P203, DOI 10.1146/annurev.en.28.010183.001223; CHENG F. Y., 1957, BULL MUS COMP ZOOL HARVARD UNIV, V116, P1; CHENG FUNG YING, 1949, PSYCHE, V56, P139, DOI 10.1155/1949/36572; CHOU I, 1981, Entomotaxonomia, V3, P1; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Esben-Petersen P., 1921, Coll Selys Longchamps Bruxelles, V5, P1; Flint OS, 2013, P BIOL SOC WASH, V126, P120; Godfray HCJ, 2002, NATURE, V417, P17, DOI 10.1038/417017a; Guerra-Garcia J.M., 2008, Zoologica Baetica, V19, P15; LAUDER GV, 1990, ANNU REV ECOL SYST, V21, P317; Li X, 2007, ZOOTAXA, P59; MICHAUX B, 1989, BIOL J LINN SOC, V38, P239, DOI 10.1111/j.1095-8312.1989.tb01577.x; Miyake T., 1911, Entomologist London, V44; Ogai Hideo, 1999, Japanese Journal of Systematic Entomology, V5, P27; Penny N. D., 1997, WORLD CHECKLIST EXTA; Riedel A, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-15; ROSEN D, 1986, AGR ECOSYST ENVIRON, V15, P121, DOI 10.1016/0167-8809(86)90085-X; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Wagele JW, 2005, FDN PHYLOGENETIC SYS; WARD PH, 1979, SYST ENTOMOL, V4, P71, DOI 10.1111/j.1365-3113.1979.tb00612.x; WARD PH, 1983, J NAT HIST, V17, P627, DOI 10.1080/00222938300770521; Wiens JJ, 1999, ANNU REV ECOL SYST, V30, P327, DOI 10.1146/annurev.ecolsys.30.1.327; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x	24	3	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108545	10.1371/journal.pone.0108545	http://dx.doi.org/10.1371/journal.pone.0108545			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250880	Green Published, Green Submitted, gold			2022-12-25	WOS:000342492700139
J	Mustafa, M; Mushtaq, A; Hayat, T; Ahmad, B				Mustafa, Meraj; Mushtaq, Ammar; Hayat, Tasawar; Ahmad, Bashir			Nonlinear Radiation Heat Transfer Effects in the Natural Convective Boundary Layer Flow of Nanofluid Past a Vertical Plate: A Numerical Study	PLOS ONE			English	Article							STAGNATION-POINT FLOW; THERMAL-RADIATION; STRETCHING SHEET; MAGNETIC-FIELD; FLAT-PLATE; THERMOPHORESIS; DIFFUSION; PARTICLES; TRANSPORT	The problem of natural convective boundary layer flow of nanofluid past a vertical plate is discussed in the presence of nonlinear radiative heat flux. The effects of magnetic field, Joule heating and viscous dissipation are also taken into consideration. The governing partial differential equations are transformed into a system of coupled nonlinear ordinary differential equations via similarity transformations and then solved numerically using the Runge-Kutta fourth-fifth order method with shooting technique. The results reveal an existence of point of inflection for the temperature distribution for sufficiently large wall to ambient temperature ratio. Temperature and thermal boundary layer thickness increase as Brownian motion and thermophoretic effects intensify. Moreover temperature increases and heat transfer from the plate decreases with an increase in the radiation parameter.	[Mustafa, Meraj] NUST, Sch Nat Sci, Islamabad, Pakistan; [Mushtaq, Ammar] NUST, RCMS, Islamabad, Pakistan; [Hayat, Tasawar] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Hayat, Tasawar; Ahmad, Bashir] King Abdulaziz Univ, Fac Sci, Dept Math, Jeddah, Saudi Arabia	National University of Sciences & Technology - Pakistan; National University of Sciences & Technology - Pakistan; Quaid I Azam University; King Abdulaziz University	Hayat, T (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad, Pakistan.	pensy_t@yahoo.com	Mustafa Hashmi, Meraj/P-1769-2014; Hayat, Tasawar/E-9449-2015; Hayat, Tasawar/A-3853-2013; Mushtaq, Ammar/O-3326-2013; Ahmad, Bashir/B-1977-2012; Hayat, Tasawar/Y-2524-2019	Mushtaq, Ammar/0000-0001-9548-4631; Ahmad, Bashir/0000-0001-5350-2977; 	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [78-130-35-HiCi]; KAU	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; KAU	This paper is funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant no. 78-130-35-HiCi. The authors, therefore, acknowledge technical and financial support of KAU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2011, ACTA MECH, V218, P195, DOI 10.1007/s00707-010-0414-6; [Anonymous], 2014, J KING SAUD UNIV SCI, DOI DOI 10.1016/j.jksus.2013.08.004; Ashorynejad HR, 2013, HEAT MASS TRANSFER, V49, P427, DOI 10.1007/s00231-012-1087-6; Aziz A, 2012, INT J THERM SCI, V52, P83, DOI 10.1016/j.ijthermalsci.2011.10.001; BATCHELOR GK, 1976, J FLUID MECH, V74, P1, DOI 10.1017/S0022112076001663; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; Buongiorno J, 2009, P ASME 2009 2 MICR N, DOI [10.1115/MNHMT2009-18062, DOI 10.1115/MNHMT2009-18062]; Chen CH, 2000, HEAT MASS TRANSFER, V36, P79, DOI 10.1007/s002310050367; Choi S. U., 1995, DEV APPL NONNEWTONIA, V231, P99; Cortell R, 2008, CHINESE PHYS LETT, V25, P1340, DOI 10.1088/0256-307X/25/4/048; Hady FM, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-229; Hayat T, 2009, Z NATURFORSCH A, V64, P827, DOI 10.1515/zna-2009-1208; Huminic G, 2012, RENEW SUST ENERG REV, V16, P5625, DOI 10.1016/j.rser.2012.05.023; Hunt A. J., 1978, SMALL PARTICLE HEAT; Ibrahim W, 2013, INT J HEAT MASS TRAN, V56, P1, DOI 10.1016/j.ijheatmasstransfer.2012.08.034; Incropera FP., 2011, FUNDAMENTALS HEAT MA; Kandasamy R, 2013, INT J MECH SCI, V70, P146, DOI 10.1016/j.ijmecsci.2013.03.007; KARWE MV, 1988, J HEAT TRANS-T ASME, V110, P655, DOI 10.1115/1.3250542; Khan MS, 2012, INT NANO LETT, V2, DOI 10.1186/2228-5326-2-24; Khan WA, 2010, INT J HEAT MASS TRAN, V53, P2477, DOI 10.1016/j.ijheatmasstransfer.2010.01.032; Kuznetsov AV, 2014, INT J THERM SCI, V77, P126, DOI 10.1016/j.ijthermalsci.2013.10.007; Kuznetsov AV, 2013, INT J HEAT MASS TRAN, V65, P682, DOI 10.1016/j.ijheatmasstransfer.2013.06.054; Kuznetsov AV, 2010, INT J THERM SCI, V49, P243, DOI 10.1016/j.ijthermalsci.2009.07.015; Magyari E, 2011, INT COMMUN HEAT MASS, V38, P554, DOI 10.1016/j.icheatmasstransfer.2011.03.006; Makinde OD, 2013, INT J HEAT MASS TRAN, V62, P526, DOI 10.1016/j.ijheatmasstransfer.2013.03.049; Makinde OD, 2011, INT J THERM SCI, V50, P1326, DOI 10.1016/j.ijthermalsci.2011.02.019; Masuda H., 1993, NETSU BUSSEI, V4, P227, DOI [10.2963/jjtp.7.227, DOI 10.2963/JJTP.7.227]; Mat NAA, 2012, MATH SCI, V6, DOI 10.1186/2251-7456-6-21; Mohamad RB, 2013, HEAT MASS TRANSFER, V49, P1261, DOI 10.1007/s00231-013-1163-6; Motsumi TG, 2012, PHYS SCRIPTA, V86, DOI 10.1088/0031-8949/86/04/045003; Mushtaq A, 2014, J AEROSPACE ENG, V27, DOI 10.1061/(ASCE)AS.1943-5525.0000361; Mushtaq A, 2014, J TAIWAN INST CHEM E, V45, P1176, DOI 10.1016/j.jtice.2013.11.008; Mustafa M, 2014, MECCANICA, V49, P521, DOI 10.1007/s11012-013-9809-5; Mustafa M, 2013, J MECH, V29, P423, DOI 10.1017/jmech.2013.9; Mustafa M, 2011, INT J HEAT MASS TRAN, V54, P5588, DOI 10.1016/j.ijheatmasstransfer.2011.07.021; Mustafa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061859; Mustafaa M, 2013, INT J NUMER METHOD H, V23, P945, DOI 10.1108/HFF-09-2011-0179; Nield DA, 2009, INT J HEAT MASS TRAN, V52, P5792, DOI 10.1016/j.ijheatmasstransfer.2009.07.024; Otanicar TP, 2009, ENVIRON SCI TECHNOL, V43, P6082, DOI 10.1021/es900031j; Pantokratoras A, 2013, PHYS SCRIPTA, V87, DOI 10.1088/0031-8949/87/01/015703; PRATSINIS SE, 1989, J AEROSOL SCI, V20, P101, DOI 10.1016/0021-8502(89)90034-7; Rana P, 2012, COMMUN NONLINEAR SCI, V17, P212, DOI 10.1016/j.cnsns.2011.05.009; Raptis A, 1998, Z ANGEW MATH MECH, V78, P277, DOI 10.1002/(SICI)1521-4001(199804)78:4<277::AID-ZAMM277>3.0.CO;2-F; Rasekh A, 2012, FRONT HEAT MASS TRAN, V3, DOI 10.5098/hmt.v3.4.3003; Rashidi MM, 2013, INT J HEAT MASS TRAN, V62, P515, DOI 10.1016/j.ijheatmasstransfer.2013.03.004; Rosseland S., 1931, ATOMTHEORETISCHER GR, DOI [10.1007/978-3-662-26679-3, DOI 10.1007/978-3-662-26679-3]; Seddeek MA, 2002, INT J HEAT MASS TRAN, V45, P931, DOI 10.1016/S0017-9310(01)00189-2; Sheikholeslami M, 2014, J MOL LIQ, V190, P112, DOI 10.1016/j.molliq.2013.11.002; Sheikholeslami M, 2013, POWDER TECHNOL, V246, P327, DOI 10.1016/j.powtec.2013.05.030; Turkyilmazoglu M, 2014, J HEAT TRANS-T ASME, V136, DOI 10.1115/1.4025730; Turkyilmazoglu M, 2013, INT J HEAT MASS TRAN, V59, P167, DOI 10.1016/j.ijheatmasstransfer.2012.12.009; Tyagi H, 2009, J SOL ENERG-T ASME, V131, DOI 10.1115/1.3197562; Uddin MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049499; WALKER KL, 1979, J COLLOID INTERF SCI, V69, P138, DOI 10.1016/0021-9797(79)90088-2	54	41	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e103946	10.1371/journal.pone.0103946	http://dx.doi.org/10.1371/journal.pone.0103946			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251242	Green Published, gold, Green Submitted			2022-12-25	WOS:000342492700002
J	Senter, P; Harris, SM; Kent, DL				Senter, Phil; Harris, Shannon M.; Kent, Danielle L.			Phylogeny of Courtship and Male-Male Combat Behavior in Snakes	PLOS ONE			English	Article							REPRODUCTIVE-BIOLOGY; MATING-BEHAVIOR; LAMPROPELTIS-GETULUS; MISCELLANEOUS NOTES; SQUAMATE REPTILES; SERPENTES; COLUBRIDAE; VIPERIDAE; MADAGASCARIENSIS; RATTLESNAKE	Background: Behaviors involved in courtship and male-male combat have been recorded in a taxonomically broad sample (76 species in five families) of snakes in the clade Boidae + Colubroidea, but before now no one has attempted to find phylogenetic patterns in such behaviors. Here, we present a study of phylogenetic patterns in such behaviors in snakes. Methodology/Principal Findings: From the literature on courtship and male-male combat in snakes we chose 33 behaviors to analyze. We plotted the 33 behaviors onto a phylogenetic tree to determine whether phylogenetic patterns were discernible. We found that phylogenetic patterns are discernible for some behaviors but not for others. For behaviors with discernible phylogenetic patterns, we used the fossil record to determine minimum ages for the addition of each behavior to the courtship and combat behavioral repertoire of each snake clade. Conclusions/Significance: The phylogenetic patterns of behavior reveal that male-male combat in the Late Cretaceous common ancestors of Boidae and Colubridae involved combatants raising the head and neck and attempting to topple each other. Poking with spurs was added in Boidae. In Lampropeltini the toppling behavior was replaced by coiling without neck-raising, and body-bridging was added. Phylogenetic patterns reveal that courtship ancestrally involved rubbing with spurs in Boidae. In Colubroidea, courtship ancestrally involved chin-rubbing and head-or body-jerking. Various colubroid clades subsequently added other behaviors, e. g. moving undulations in Natricinae and Lampropeltini, coital neck biting in the Eurasian ratsnake clade, and tail quivering in Pantherophis. The appearance of each group in the fossil record provides a minimum age of the addition of each behavior to combat and courtship repertoires. Although many gaps in the story of the evolution of courtship and combat in snakes remain, this study is an important first step in the reconstruction of the evolution of these behaviors in snakes.	[Senter, Phil; Harris, Shannon M.; Kent, Danielle L.] Fayetteville State Univ, Dept Biol Sci, Fayetteville, NC 28301 USA	University of North Carolina; Fayetteville State University	Senter, P (corresponding author), Fayetteville State Univ, Dept Biol Sci, Fayetteville, NC 28301 USA.	psenter@uncfsu.edu						AKESTER J, 1979, HERPETOLOGICA, V35, P124; Akester J., 1983, British Journal of Herpetology, V6, P329; Aldridge RD, 2005, AMPHIBIA-REPTILIA, V26, P576, DOI 10.1163/156853805774806340; Aldridge Robert D., 2003, Boletin de la Asociacion Herpetologica Espanola, V14, P25; Almeida-Santos SM, 2002, AMPHIBIA-REPTILIA, V23, P528; ANDREN C, 1986, Amphibia-Reptilia, V7, P353, DOI 10.1163/156853886X00172; [Anonymous], 1992, HERPETOFAUNA, V22, P14; ANTONIO FB, 1980, HERPETOLOGICA, V36, P231; Auffenberg W., 1988, GRAYS MONITOR LIZARD; Auffenberg W., 1981, BEHAV ECOLOGY KOMODO; Ball Robert L., 1999, African Journal of Herpetology, V48, P27, DOI 10.1080/21564574.1999.9651068; BARKER DG, 1979, COPEIA, P466; BELS V, 1987, J HERPETOL, V21, P350, DOI 10.2307/1563983; BENNION R S, 1976, Herpetologica, V32, P30; BOGERT CHARLES M., 1966, AMER MUS NOVITATES, V2245, P1; Bonine Kevin E., 2004, Herpetological Review, V35, P176; Burbrink FT, 2005, MOL PHYLOGENET EVOL, V34, P167, DOI 10.1016/j.ympev.2004.08.017; BURCHFIELD PM, 1982, J HERPETOL, V16, P376, DOI 10.2307/1563567; Burger R. M, 1996, BULL CHIC HERPETOL S, V31, P57; CAMPBELL JA, 1977, J HERPETOL, V11, P228, DOI 10.2307/1563149; Campbell Jonathan A., 1992, P223; Carpenter C.C., 1977, P335; Carpenter C.C., 1978, P253; Carpenter C.C., 1982, P215; CARPENTER CC, 1977, AM ZOOL, V17, P217; CARPENTER CC, 1978, HERPETOLOGICA, V34, P207; Carr A. F., 1942, PROC NEW ENGLAND ZOOL CLUB, V20, P1; Castoe TA, 2006, MOL PHYLOGENET EVOL, V39, P91, DOI 10.1016/j.ympev.2005.12.014; Cechin Sonia T.Z., 2001, Herpetological Review, V32, P187; Covacevich J., 1975, Victorian Naturalist (Blackburn), V92, P252; Cozzuol MA, 2006, J S AM EARTH SCI, V21, P185, DOI 10.1016/j.jsames.2006.03.005; Curry-Lindahl K, 1956, AFR WILD LIFE, V10, P340; Davis DD, 1936, ZOOL SER FIELD MUS N, V20, P256; de Langlada F.G., 1975, Journal Herpet, V9, P349, DOI 10.2307/1562936; EVERETT C T, 1971, Journal of Herpetology, V5, P189, DOI 10.2307/1562745; Feio Renato N., 1999, Herpetological Review, V30, P99; Fleay D., 1951, WALKABOUT, V17, P10; FORD N B, 1982, Herpetological Review, V13, P72; Garstka W., 1982, SCI AM, V247, P158, DOI DOI 10.1038/SCIENTIFICAMERICAN1182-158; GILLINGHAM J C, 1977, Southwestern Naturalist, V22, P187, DOI 10.2307/3669809; GILLINGHAM J C, 1974, Herpetologica, V30, P309; GILLINGHAM J C, 1987, P184; GILLINGHAM JC, 1983, J HERPETOL, V17, P265, DOI 10.2307/1563829; GILLINGHAM JC, 1979, COPEIA, P319; Gloyd H. K., 1947, Natural History Miscellanea Chicago, VNo. 12, P1; GOLDSMITH SK, 1988, SOUTHWEST NAT, V33, P473, DOI 10.2307/3672215; GRANT GEORGE A., 1956, AFRICAN WILD LIFE, V10, P111; Greene Harry W., 1994, P369; Greene MJ, 2000, HERPETOLOGICA, V56, P166; Haagner G. V., 1991, J HERPETOLOGICAL ASS, V39, P25; Halloy Monique, 2003, Herpetological Review, V34, P153; HAMMERSON GA, 1978, J HERPETOL, V12, P253, DOI 10.2307/1563418; HAMMOND S, 1988, Herpetological Review, V19, P37; HANLON ROBERT W., 1964, HERPETOLOGICA, V20, P143; Harvey E, 1964, AFRICANA, V2, P49; HAYES WK, 1986, J HERPETOL, V20, P246, DOI 10.2307/1563950; Head JJ, 2009, NATURE, V457, P715, DOI 10.1038/nature07671; Holman, 2000, FOSSIL SNAKES N AM O; Holtzman David A., 2001, Herpetological Review, V32, P110; Horn Hans-Georg, 1994, Zoologische Garten, V64, P265; HUNSAKER D, 1962, EVOLUTION, V16, P62, DOI 10.1111/j.1558-5646.1962.tb03198.x; Ivanov M, 2002, ACTA PALAEONTOL POL, V47, P513; KENNEDY JL, 1978, HERPETOLOGICA, V34, P51; Klauber LM, 1956, RATTLESNAKES THEIR H; KROLL JC, 1971, TEX J SCI, V23, P300; KURFESS JF, 1967, COPEIA, P477; Langford Gabriel J., 2004, Herpetological Review, V35, P400; Langkilde T, 2005, J HERPETOL, V39, P325, DOI 10.1670/0022-1511(2005)039[0325:TFOTDI]2.0.CO;2; LEWKE RE, 1979, HERPETOLOGICA, V35, P154; LILLYWHITE HB, 1985, J HERPETOL, V19, P306, DOI 10.2307/1564191; Martin L, 1984, COPEIA, V1984, P774; Martins EP, 1998, ANIM BEHAV, V55, P1685, DOI 10.1006/anbe.1997.0722; McGrew PO, 1959, B AM MUS NAT HIST, V117, P121; Mehta Rita, 2001, African Journal of Herpetology, V50, P115; MOEHN LD, 1967, COPEIA, P480; Mulcahy DG, 2012, MOL PHYLOGENET EVOL, V65, P974, DOI 10.1016/j.ympev.2012.08.018; MURPHY JB, 1978, J HERPETOL, V12, P385, DOI 10.2307/1563620; MURPHY JB, 1980, HERPETOLOGICA, V36, P165; Murphy JB, 1978, J HERPETOL, V12, P4554; Noble GK, 1937, B AM MUS NAT HIST, V73, P673; Palmer WM, 1971, J MITCHELL SOC, V97, P20; PERRY J, 1978, J HERPETOL, V12, P429, DOI 10.2307/1563634; PISANI G R, 1976, Journal of Herpetology, V10, P139, DOI 10.2307/1562795; Pitman CRS, 1974, GUIDE SNAKES UGANDA; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Pyron RA, 2011, MOL PHYLOGENET EVOL, V58, P329, DOI 10.1016/j.ympev.2010.11.006; Rage J.C., 1999, Palaeontologia Africana, V35, P85; Rage JC, 2003, GEODIVERSITAS, V25, P695; Reed Robert N., 2003, Herpetological Review, V34, P111; Rigley L, 1971, J HERPETOL, V5, P55; Ripa Dean, 1994, Bulletin of the Chicago Herpetological Society, V29, P165; Rivas J.A., 2000, THESIS U TENNESSEE K; Ruthven AG, 1912, BIOL BULL-US, V24, P18, DOI 10.2307/1536112; Ruthven AG, 1908, B US NATL MUS, V1, P1; Scanlon JD, 2003, GEOBIOS-LYON, V36, P573, DOI 10.1016/S0016-6995(03)00056-1; SCHUETT GW, 1988, COPEIA, P374; SECOR SM, 1987, HERPETOLOGICA, V43, P15; SHAW CHARLES E., 1951, HERPETOLOGICA, V7, P149; Shetty S, 2002, HERPETOLOGICA, V58, P170, DOI 10.1655/0018-0831(2002)058[0170:TMSOYS]2.0.CO;2; Shine R., 1980, Victorian Naturalist (Blackburn), V97, P188; SHINE R, 1981, J HERPETOL, V15, P101, DOI 10.2307/1563652; Slowinski JB, 2002, MOL PHYLOGENET EVOL, V24, P194, DOI 10.1016/S1055-7903(02)00239-7; Sutherland I. D. W., 1958, Herpetologica, V14, P23; Szyndlar Z, 2003, NONERYCINE BOOIDEA O; TINKLE DW, 1951, COPEIA, P77, DOI 10.2307/1438063; Vidal N, 2005, CR BIOL, V328, P1000, DOI 10.1016/j.crvi.2005.10.001; Walker SE, 1992, J HERPETOL, V30, P416; Woodbury A. M., 1941, Copeia Ann Arbor, V1941, P54, DOI 10.2307/1437720; [No title captured]	109	18	25	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107528	10.1371/journal.pone.0107528	http://dx.doi.org/10.1371/journal.pone.0107528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250782	Green Submitted, Green Published, gold			2022-12-25	WOS:000342492700034
J	Xin, YN; Geng, N; Lin, ZH; Cui, YZ; Duan, HP; Zhang, M; Xuan, SY				Xin, Yong-Ning; Geng, Ning; Lin, Zhong-Hua; Cui, Ya-Zhou; Duan, Hai-Ping; Zhang, Mei; Xuan, Shi-Ying			Serum Complement C3f and Fibrinopeptide A Are Potential Novel Diagnostic Biomarkers for Non-Alcoholic Fatty Liver Disease: A Study in Qingdao Twins	PLOS ONE			English	Article							NORMAL AMINOTRANSFERASE LEVELS; HEPATOCELLULAR-CARCINOMA; INSULIN-RESISTANCE; NATURAL-HISTORY; STEATOHEPATITIS; PROTEOMICS; BIOPSY; TRANSPLANTATION; IDENTIFICATION; MANAGEMENT	Aims: To compare the different serum peptidome patterns between twins with and without non-alcoholic fatty liver disease (NAFLD) in order to help understand the pathogenesis of NAFLD and to identify potential diagnostic and therapeutic targets. Methods: The peptidomics patterns of 63 cases with NAFLD were compared with their twin healthy controls in Qingdao, China. Peptides between 800Da and 3500Da were captured and concentrated using C18 reversed-phase columns, followed by MALDI-TOF mass spectrometry. The sequences of peptides associated with NAFLD were further identified by MALDITOF-TOF. Further validation studies were conducted. One hundred additional serum samples were detected by commercially available ELISA kits to calculate the concentrations of complement C3f and fibrinopeptide A, respectively. The differences of these two peptides in the NAFLD and control groups were compared using SPSS 17.0, respectively. Results: Compared with healthy controls, eleven peaks (861.1, 877.07, 904.5, 1206.57, 1350.64, 1518.7, 1690.9, 1777.94, 2931.29, 3190.4, 3261.4) were up-regulated and 7 peaks (942.44, 1020.47, 1060.06, 1211.7, 1263.63, 1449.76, 2768.3) were down-regulated in the NAFLD group. Two peptides derived from complement C3f and fibrinopeptide A, respectively, had the highest ROC values indistinguishing NAFLD cases from their normal controls. In the validation group, the concentrations of complement C3f and fibrinopeptide A (1466.929 +/- 78.306 pg/ml, 4.189 +/- 0.326 ng/ml, respevtively) in NAFLD group was higher than in control group (complement C3f 1159.357 +/- 99.624 pg/ml, FPA 3.039 +/- 0.483 ng/ml; P<0.05). Conclusions: In this study, we established apeptidomics pattern that could help distinguish NAFLD patients from their twin controls. The differently-regulated peptides identified in our study may be potential diagnostic markers or therapeutic targets for NAFLD.	[Xin, Yong-Ning; Lin, Zhong-Hua; Zhang, Mei; Xuan, Shi-Ying] Qingdao Municipal Hosp, Qingdao, Shandong Provin, Peoples R China; [Geng, Ning] Qingdao Univ, Sch Med, Qingdao 266071, Shandong Provin, Peoples R China; [Cui, Ya-Zhou] Shandong Acad Med Sci, Shandong Med Biotechnol Ctr, Key Lab Modern Med & Technol Shandong Prov, Key Lab,Minist Hlth Biotech Drug, Jinan, Peoples R China; [Duan, Hai-Ping] Qingdao Municipal Ctr Dis Control & Prevent, Qingdao, Shandong Provin, Peoples R China	Qingdao Municipal Hospital; Qingdao University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Xuan, SY (corresponding author), Qingdao Municipal Hosp, Qingdao, Shandong Provin, Peoples R China.	dxyxyn@163.com	dong, quanjiang/AAD-3581-2019		National Natural Science Foundation of China (NSFC) [81170337]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (NSFC, No. 81170337 (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; An YM, 2010, DIS MARKERS, V29, P11, DOI [10.1155/2010/681876, 10.3233/DMA-2010-0721]; Angulo P, 2006, LIVER TRANSPLANT, V12, P523, DOI 10.1002/lt.20738; Bell LN, 2010, HEPATOLOGY, V51, P111, DOI 10.1002/hep.23271; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; Cadranel JF, 2000, HEPATOLOGY, V32, P477, DOI 10.1053/jhep.2000.16602; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Charlton M, 2004, CLIN GASTROENTEROL H, V2, P1048, DOI 10.1016/S1542-3565(04)00440-9; Clark JM, 2006, J CLIN GASTROENTEROL, V40, pS5; De Franceschi L, 2011, PROTEOM CLIN APPL, V5, P78, DOI 10.1002/prca.201000069; Farrell GC, 2007, J GASTROEN HEPATOL, V22, P775, DOI 10.1111/j.1440-1746.2007.05002.x; Fracanzani AL, 2008, HEPATOLOGY, V48, P792, DOI 10.1002/hep.22429; Guttmacher AE, 2002, NEW ENGL J MED, V347, P1512, DOI 10.1056/NEJMra012240; Honda M, 2001, GASTROENTEROLOGY, V120, P955, DOI 10.1053/gast.2001.22468; Issaq HJ, 2002, BIOCHEM BIOPH RES CO, V292, P587, DOI 10.1006/bbrc.2002.6678; Kim WR, 1996, TRANSPLANTATION, V62, P1802, DOI 10.1097/00007890-199612270-00021; Liu JY, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-506; Mazhar SM, 2009, CLIN GASTROENTEROL H, V7, P135, DOI 10.1016/j.cgh.2008.11.023; Melle C, 2004, INT J ONCOL, V24, P885; Mofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229; Muir K, 2013, CANCER RES, V73, P4722, DOI 10.1158/0008-5472.CAN-12-3797; Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623; Musso G, 2009, AM J CLIN NUTR, V89, P558, DOI 10.3945/ajcn.2008.26720; Nomura K, 2012, J NUTR BIOCHEM, V23, P203, DOI 10.1016/j.jnutbio.2011.09.006; O'Hanlon TP, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3506; Pang ZC, 2006, TWIN RES HUM GENET, V9, P758, DOI 10.1375/twin.9.6.758; Pierson NA, 2010, J PHYS CHEM B, V114, P7777, DOI 10.1021/jp102478k; Poynard T, 2000, CAN J GASTROENTEROL, V14, P543, DOI 10.1155/2000/107982; Poynard T, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-34; Profumo A, 2013, J PROTEOMICS, V85, P44, DOI 10.1016/j.jprot.2013.04.029; Rodriguez-Suarez E, 2010, PROTEOM CLIN APPL, V4, P362, DOI 10.1002/prca.200900119; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Talwalkar JA, 2002, CAN J GASTROENTEROL, V16, P718, DOI 10.1155/2002/759701; Tomsey CS, 2001, CROAT MED J, V42, P239; Toshimitsu K, 2007, NUTRITION, V23, P46, DOI 10.1016/j.nut.2006.09.004; van Dongen J, 2012, NAT REV GENET, V13, P640, DOI 10.1038/nrg3243; Vinberg M, 2014, PSYCHONEUROENDOCRINO, V39, P179, DOI 10.1016/j.psyneuen.2013.09.007; Vuppalanchi R, 2009, HEPATOLOGY, V49, P306, DOI 10.1002/hep.22603; Xiao Z, 2005, MOL CELL ENDOCRINOL, V230, P95, DOI 10.1016/j.mce.2004.10.010; Yang HY, 2011, NUTRITION, V27, P943, DOI 10.1016/j.nut.2010.09.004; Yasui K, 2011, CLIN GASTROENTEROL H, V9, P428, DOI 10.1016/j.cgh.2011.01.023; Yilmaz Y, 2009, HEPATOLOGY, V49, P697, DOI 10.1002/hep.22691; Yu CH, 2012, J HEPATOL, V56, P241, DOI 10.1016/j.jhep.2011.05.027; Zhang Q, 2012, CHINESE MED J-PEKING, V125, P2455, DOI 10.3760/cma.j.issn.0366-6999.2012.14.011	44	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108132	10.1371/journal.pone.0108132	http://dx.doi.org/10.1371/journal.pone.0108132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250770	Green Submitted, Green Published, gold			2022-12-25	WOS:000342492700084
J	Zhang, Z; Yu, DK; Lu, J; Zhai, K; Cao, L; Rao, J; Liu, YW; Zhang, XM; Guo, YL				Zhang, Zhi; Yu, Dianke; Lu, Jie; Zhai, Kan; Cao, Lei; Rao, Juan; Liu, Yingwen; Zhang, Xuemei; Guo, Yongli			Functional Genetic Variants of TNFSF15 and Their Association with Gastric Adenocarcinoma: A Case-Control Study	PLOS ONE			English	Article							ENDOTHELIAL GROWTH INHIBITOR; NECROSIS-FACTOR-ALPHA; HELICOBACTER-PYLORI INFECTION; INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; CELL-GROWTH; TRANSCRIPTION FACTOR; UP-REGULATION; TUMOR-GROWTH; NF-Y	The purpose of this study was to identify functional genetic variants in the promoter of tumor necrosis factor superfamily member 15 (TNFSF15) and evaluate their effects on the risk of developing gastric adenocarcinoma. Forty DNA samples from healthy volunteers were sequenced to identify single nucleotide polymorphisms (SNPs) in the TNFSF15 promoter. Two TNFSF15 SNPs (-358T>C and -638A>G) were identified by direct sequencing. Next, genotypes and haplotypes of 470 gastric adenocarcinoma patients and 470 cancer-free controls were analyzed. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated by logistic regression. Serologic tests for Helicobacter pylori infection were measured by enzyme-linked immuno-sorbent assay (ELISA). Subjects carrying the TNFSF15 -358CC genotype were at an elevated risk for developing gastric adenocarcinoma, compared with those with the -358TT genotype (OR 1.42, 95% CI, 1.10 to 2.03). H. pylori infection was a risk factor for developing gastric adenocarcinoma (OR 2.31, 95% CI, 1.76 to 3.04). In the H. pylori infected group, subjects with TNFSF15 -358CC genotype were at higher risks for gastric adenocarcinoma compared with those carrying -358TT genotype (OR: 2.01, 95% CI: 1.65 to 4.25), indicating that H. pylori infection further influenced gastric adenocarcinoma susceptibility. The 2358 T. C polymorphism eliminates a nuclear factor gamma (NF-gamma) binding site and the -358C containing haplotypes showed significantly decreased luciferase expression compared with -358T containing haplotypes. Collectively these findings indicate that functional genetic variants in TNFSF15 may play a role in increasing susceptibility to gastric adenocarcinoma.	[Zhang, Zhi] Tangshan Gongren Hosp, Dept Chemotherapy & Radiotherapy, Tangshan, Peoples R China; [Zhang, Zhi; Cao, Lei; Rao, Juan; Liu, Yingwen; Zhang, Xuemei] Hebei United Univ, Coll Life Sci, Inst Mol Genet, Tangshan, Peoples R China; [Yu, Dianke; Zhai, Kan] Chinese Acad Med Sci, Inst Canc, Dept Etiol Carcinogenesis, Beijing 100730, Peoples R China; [Yu, Dianke; Zhai, Kan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Lu, Jie; Guo, Yongli] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Beijing Key Lab Pediat Otolaryngol Head & Neck Sc, Beijing, Peoples R China	North China University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University	Zhang, XM (corresponding author), Hebei United Univ, Coll Life Sci, Inst Mol Genet, Tangshan, Peoples R China.	jyxuemei@gmail.com; guoyongli@bch.com.cn	LIU, YING/GZL-7252-2022		Program for New Century Excellent Talents in University [NCET-11-0933]; National Natural Science Foundation of China [NSFC-81101483]; Beijing Science and Technology Project [Z131101002813044]; Science Fund for Distinguished Young Scholars of Hebei Scientific Committee [H2012401022]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Science and Technology Project; Science Fund for Distinguished Young Scholars of Hebei Scientific Committee	This work was supported by Program for New Century Excellent Talents in University (NCET-11-0933), the National Natural Science Foundation of China (NSFC-81101483), Beijing Science and Technology Project (Z131101002813044) and the Science Fund for Distinguished Young Scholars of Hebei Scientific Committee (H2012401022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya A, 2003, CANCER RES, V63, P8167; Blankfield RP, 2002, NEW ENGL J MED, V346, P65; Ceribelli M, 2008, MOL CELL BIOL, V28, P2047, DOI 10.1128/MCB.01861-07; Chew LJ, 2002, FASEB J, V16, P742, DOI 10.1096/fj.01-0757fje; CRABTREE JE, 1991, GUT, V32, P1473, DOI 10.1136/gut.32.12.1473; Das SK, 2007, LIFE SCI, V81, P1555, DOI 10.1016/j.lfs.2007.09.027; de Silva PSA, 2012, ALIMENT PHARM THER, V36, P459, DOI 10.1111/j.1365-2036.2012.05214.x; Donati G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002066; Epplein M, 2008, CANCER CAUSE CONTROL, V19, P869, DOI 10.1007/s10552-008-9149-2; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Grimaldo S, 2009, APOPTOSIS, V14, P788, DOI 10.1007/s10495-009-0351-9; Haridas V, 1999, ONCOGENE, V18, P6496, DOI 10.1038/sj.onc.1203059; Hou W, 2005, CLIN CANCER RES, V11, P5595, DOI 10.1158/1078-0432.CCR-05-0384; Jin TC, 2007, CYTOKINE, V40, P115, DOI 10.1016/j.cyto.2007.07.193; Jin T, 2007, BIOCHEM BIOPH RES CO, V364, P1, DOI 10.1016/j.bbrc.2007.09.097; Kakuta Y, 2009, HUM MOL GENET, V18, P1089, DOI 10.1093/hmg/ddp005; Kirikoshi H, 2001, INT J ONCOL, V19, P533; Kohchi C, 1991, Eur Cytokine Netw, V2, P245; Lamb A, 2013, J CELL BIOCHEM, V114, P491, DOI 10.1002/jcb.24389; Barbosa HPM, 2009, WORLD J GASTROENTERO, V15, P1465, DOI 10.3748/wjg.15.1465; Metheny-Barlow Linda J, 2006, Semin Ophthalmol, V21, P49, DOI 10.1080/08820530500511446; Normark S, 2003, ADV CANCER RES, V90, P63, DOI 10.1016/S0065-230X(03)90002-9; Oshima H, 2006, GASTROENTEROLOGY, V131, P1086, DOI 10.1053/j.gastro.2006.07.014; Parr Christian, 2006, Angiogenesis, V9, P73, DOI 10.1007/s10456-006-9033-1; Schaffler A, 2007, TRENDS IMMUNOL, V28, P393, DOI 10.1016/j.it.2007.07.003; Sethi G, 2009, ADV EXP MED BIOL, V647, P207, DOI 10.1007/978-0-387-89520-8_15; Suganuma M, 2005, J CANCER RES CLIN, V131, P305, DOI 10.1007/s00432-004-0652-x; Sugiyama T, 2004, CANCER CHEMOTH PHARM, V54, pS12, DOI 10.1007/s00280-004-0881-3; Thiebaut R, 2009, AM J GASTROENTEROL, V104, P384, DOI 10.1038/ajg.2008.36; TRACEY KJ, 1988, J EXP MED, V167, P1211, DOI 10.1084/jem.167.3.1211; Tremelling M, 2008, INFLAMM BOWEL DIS, V14, P733, DOI 10.1002/ibd.20399; Wang TC, 2000, GASTROENTEROLOGY, V118, P36, DOI 10.1016/S0016-5085(00)70412-4; Wu JH, 2012, BIOCONJUGATE CHEM, V23, P796, DOI 10.1021/bc2006576; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Yang M, 2007, CARCINOGENESIS, V28, P1996, DOI 10.1093/carcin/bgm168; Yu JY, 2001, CIRC RES, V89, P1161, DOI 10.1161/hh2401.101909; Yue TL, 1999, J BIOL CHEM, V274, P1479, DOI 10.1074/jbc.274.3.1479; Zhai YF, 1999, INT J CANCER, V82, P131, DOI 10.1002/(SICI)1097-0215(19990702)82:1<131::AID-IJC22>3.3.CO;2-F; Zhang EW, 2013, EXP THER MED, V5, P282, DOI 10.3892/etm.2012.778; Zhang N, 2010, ANTICANCER RES, V30, P87; Zhang N, 2009, INT J MOL MED, V24, P3, DOI 10.3892/ijmm_00000198; Zhang ZS, 2012, CANCER MICROENVIRON, V5, P237, DOI 10.1007/s12307-012-0117-8; Zhao CH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-419; Zhao D, 2007, CLIN CANCER RES, V13, P2362, DOI 10.1158/1078-0432.CCR-06-2612	44	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108321	10.1371/journal.pone.0108321	http://dx.doi.org/10.1371/journal.pone.0108321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251497	Green Submitted, Green Published, gold			2022-12-25	WOS:000342492700110
J	Bandt, SK; Bundy, DT; Hawasli, AH; Ayoub, KW; Sharma, M; Hacker, CD; Pahwa, M; Leuthardt, EC				Bandt, S. Kathleen; Bundy, David T.; Hawasli, Ammar H.; Ayoub, Kareem W.; Sharma, Mohit; Hacker, Carl D.; Pahwa, Mrinal; Leuthardt, Eric C.			The Role of Resting State Networks in Focal Neocortical Seizures	PLOS ONE			English	Article							MULTIPLE SUBPIAL TRANSECTION; HIGH-FREQUENCY OSCILLATIONS; FUNCTIONAL CONNECTIVITY; REFRACTORY EPILEPSY; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; SURGICAL-TREATMENT; CEREBRAL-CORTEX; BRAIN ACTIVITY; LOBE EPILEPSY	Objective: The role of resting state functional networks in epilepsy is incompletely understood. While some pathologic diagnoses have been shown to have maintained but altered resting state connectivity, others have implicated resting state connectivity in disease progression. However little is known about how these resting state networks influence the behavior of a focal neocortical seizure. Methods: Using data taken from invasively monitored patients with intractable focal neocortical epilepsy, we evaluated network connectivity (as determined by oscillatory covariance of the slow cortical potential (<0.5 Hz)) as it relates to neocortical seizure foci both in the interictal and ictal states. Results: Similar to what has been shown in the past for sleep and anesthesia, electophysiologic resting state networks that are defined by this slow cortical potential covariance maintain their topographic correlation structure throughout an ictal event. Moreover, in the context of focal epilepsy in which the seizure has a specific site of onset, seizure propagation is not chaotic or random. Rather, the seizure (reflected by an elevation of high frequency power) preferentially propagates along the network that contains the seizure onset zone. Significance: Taken together, these findings further undergird the fundamental role of resting state networks, provide novel insights into the network-influenced behavior of seizures, and potentially identify additional targets for surgical disconnection including informing the location for the completion of multiple subpial transections (MSPTs).	[Bandt, S. Kathleen; Hawasli, Ammar H.; Leuthardt, Eric C.] Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO 63130 USA; [Bundy, David T.; Ayoub, Kareem W.; Sharma, Mohit; Hacker, Carl D.; Pahwa, Mrinal; Leuthardt, Eric C.] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Ayoub, Kareem W.; Hacker, Carl D.] Washington Univ, Sch Med, St Louis, MO USA; [Ayoub, Kareem W.] Univ Oxford, Dept Biomed Engn, Oxford, England; [Leuthardt, Eric C.] Washington Univ, Sch Med, Ctr Innovat Neurosci & Technol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Oxford; Washington University (WUSTL)	Bandt, SK (corresponding author), Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO 63130 USA.	bandtk@wudosis.wustl.edu		Bundy, David/0000-0001-6491-044X	Epilepsy Foundation [258885]; American Epilepsy Society; National Institutes of Health [5T32NS007205]; STFC [ST/J001465/1] Funding Source: UKRI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH099877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007205] Funding Source: NIH RePORTER	Epilepsy Foundation; American Epilepsy Society; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was made possible by generous joint support from the Epilepsy Foundation and the American Epilepsy Society (Epilepsy Foundation Grant Number 258885; epilepsyfoundation.org), and the National Institutes of Health (5T32NS007205; nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aykut-Bingol C, 1998, ANN NEUROL, V44, P60, DOI 10.1002/ana.410440112; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Binder DK, 2009, J NEUROSURG, V110, P1170, DOI 10.3171/2008.2.17665; BIRBAUMER N, 1990, PHYSIOL REV, V70, P1, DOI 10.1152/physrev.1990.70.1.1; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Breshears JD, 2010, P NATL ACAD SCI USA, V107, P21170, DOI 10.1073/pnas.1011949107; Crone NE, 2006, PROG BRAIN RES, V159, P275, DOI 10.1016/S0079-6123(06)59019-3; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; Di X., 2013, BRAIN STRUCT FUNCT; Dudek F Edward, 2007, Epilepsy Curr, V7, P140; Engel J, 2008, EPILEPSY COMPREHENSI; Engel J, 2009, EPILEPSIA, V50, P598, DOI 10.1111/j.1528-1167.2008.01917.x; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Goldberg P SDD, 1969, AGRESSOLOGIE S, V10, P541; Greenlee JDW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060783; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gunduz A, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00089; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; He BYJ, 2010, NEURON, V66, P353, DOI 10.1016/j.neuron.2010.04.020; He BJ, 2009, TRENDS COGN SCI, V13, P302, DOI 10.1016/j.tics.2009.04.004; Hermes D, 2010, J NEUROSCI METH, V185, P293, DOI 10.1016/j.jneumeth.2009.10.005; Ko AL, 2013, BRAIN CONNECT, V3, P491, DOI 10.1089/brain.2013.0157; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Kwan P, 2011, NEW ENGL J MED, V365, P919, DOI 10.1056/NEJMra1004418; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Li XW, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00098; Luo CY, 2014, NEUROBIOL AGING, V35, P431, DOI 10.1016/j.neurobiolaging.2013.08.018; Maccotta L, 2013, NEUROIMAGE-CLIN, V2, P862, DOI 10.1016/j.nicl.2013.06.011; Manning JR, 2009, J NEUROSCI, V29, P13613, DOI 10.1523/JNEUROSCI.2041-09.2009; Miller KJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000609; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; MORRELL F, 1989, J NEUROSURG, V70, P231, DOI 10.3171/jns.1989.70.2.0231; PD W, 1967, IEEE T AUDIO ELECTRO, VAU-15, P70; Pizoli CE, 2011, P NATL ACAD SCI USA, V108, P11638, DOI 10.1073/pnas.1109144108; Poudel GR, 2014, J PSYCHIATR NEUROSCI, V39, P87, DOI 10.1503/jpn.120226; Rektorova I, 2014, NEURODEGENER DIS, V13, P186, DOI 10.1159/000354237; Roland JL, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00431; Rosanova M, 2009, J NEUROSCI, V29, P7679, DOI 10.1523/JNEUROSCI.0445-09.2009; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sheline YI, 2010, BIOL PSYCHIAT, V67, P584, DOI 10.1016/j.biopsych.2009.08.024; Spencer SS, 2002, EPILEPSIA, V43, P141, DOI 10.1046/j.1528-1157.2002.28101.x; Spencer SS, 2002, EPILEPSIA, V43, P219, DOI 10.1046/j.1528-1157.2002.26901.x; Tertel K, 2011, COMPUT BIOL MED, V41, P1092, DOI 10.1016/j.compbiomed.2010.11.004; Timofeev I, 2004, NEUROSCIENCE, V123, P299, DOI 10.1016/j.neuroscience.2003.08.051; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; von Lehe M, 2009, BRAIN, V132, P1048, DOI 10.1093/brain/awp047; Werner CJ, 2014, HUM BRAIN MAPP, V35, P2582, DOI 10.1002/hbm.22351; White NS, 2003, NEUROIMAGE, V19, P402, DOI 10.1016/S1053-8119(03)00103-4; Worrell GA, 2004, BRAIN, V127, P1496, DOI 10.1093/brain/awh149	53	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107401	10.1371/journal.pone.0107401	http://dx.doi.org/10.1371/journal.pone.0107401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247680	gold, Green Published, Green Submitted			2022-12-25	WOS:000342351800022
J	Del Prete, D; Lombino, F; Liu, XR; D'Adamio, L				Del Prete, Dolores; Lombino, Franco; Liu, Xinran; D'Adamio, Luciano			APP Is Cleaved by Bace1 in Pre-Synaptic Vesicles and Establishes a Pre-Synaptic Interactome, via Its Intracellular Domain, with Molecular Complexes that Regulate Pre-Synaptic Vesicles Functions	PLOS ONE			English	Article							BETA-PRECURSOR PROTEIN; MEMORY DEFICITS; SYNAPTIC PLASTICITY; FAMILIAL BRITISH; MICE LACKING; MOUSE MODEL; IN-VIVO; DEMENTIA; PHOSPHORYLATION; BINDS	Amyloid Precursor Protein (APP) is a type I membrane protein that undergoes extensive processing by secretases, including BACE1. Although mutations in APP and genes that regulate processing of APP, such as PSENs and BRI2/ITM2B, cause dementias, the normal function of APP in synaptic transmission, synaptic plasticity and memory formation is poorly understood. To grasp the biochemical mechanisms underlying the function of APP in the central nervous system, it is important to first define the sub-cellular localization of APP in synapses and the synaptic interactome of APP. Using biochemical and electron microscopy approaches, we have found that APP is localized in pre-synaptic vesicles, where it is processed by Bace1. By means of a proteomic approach, we have characterized the synaptic interactome of the APP intracellular domain. We focused on this region of APP because in vivo data underline the central funtional and pathological role of the intracellular domain of APP. Consistent with the expression of APP in pre-synaptic vesicles, the synaptic APP intracellular domain interactome is predominantly constituted by pre-synaptic, rather than post-synaptic, proteins. This presynaptic interactome of the APP intracellular domain includes proteins expressed on pre-synaptic vesicles such as the vesicular SNARE Vamp2/Vamp1 and the Ca2+ sensors Synaptotagmin-1/Synaptotagmin-2, and non-vesicular pre-synaptic proteins that regulate exocytosis, endocytosis and recycling of pre-synaptic vesicles, such as target-membrane-SNAREs (Syntaxin-1b, Syntaxin-1a, Snap25 and Snap47), Munc-18, Nsf, alpha/beta/gamma-Snaps and complexin. These data are consistent with a functional role for APP, via its carboxyl-terminal domain, in exocytosis, endocytosis and/or recycling of pre-synaptic vesicles.	[Del Prete, Dolores; Lombino, Franco; D'Adamio, Luciano] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Liu, Xinran] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA	Yeshiva University; Albert Einstein College of Medicine; Yale University	D'Adamio, L (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	luciano.dadamio@einstein.yu.edu		D'Adamio, Luciano/0000-0002-2204-9441; Lombino, Franco Luis/0000-0003-2326-6920; D'Adamio, Luciano/0000-0002-9820-4882; Del Prete, Dolores/0000-0001-9800-6766	Alzheimer's Association [ZEN-11-201425]; Edward N. & Della L. Thome Memorial Foundation; National Institutes of Health (NIH) [R01AG033007, R21AG041577, R01AG041531]; Brigth Focus; NATIONAL INSTITUTE ON AGING [R21AG041577, R01AG033007, R01AG041531] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); Edward N. & Della L. Thome Memorial Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brigth Focus; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Alzheimer's Association (ZEN-11-201425 to L.D.), the Edward N. & Della L. Thome Memorial Foundation grant (to L. D.), the National Institutes of Health (NIH; R01AG033007, R21AG041577 and R01AG041531 to L.D.), and a grant from Brigth Focus (to D.D.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbagallo APM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018006; Barbagallo APM, 2011, J BIOL CHEM, V286, P8717, DOI 10.1074/jbc.C111.219873; Barbagallo APM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015503; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Burre J, 2013, NATURE, V498, pE4, DOI 10.1038/nature12125; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cottrell BA, 2005, ANN NEUROL, V58, P277, DOI 10.1002/ana.20554; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; Diao JJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00592; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; Garringer HJ, 2010, BRAIN STRUCT FUNCT, V214, P235, DOI 10.1007/s00429-009-0221-9; Ghersi E, 2004, J BIOL CHEM, V279, P49105, DOI 10.1074/jbc.M405329200; Ghersi E, 2004, J ALZHEIMERS DIS, V6, P67; Groemer TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018754; Guo QX, 2012, J BIOL CHEM, V287, P2437, DOI 10.1074/jbc.M111.315051; Heber S, 2000, J NEUROSCI, V20, P7951; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Hoe HS, 2012, CNS NEUROSCI THER, V18, P47, DOI 10.1111/j.1755-5949.2010.00221.x; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kandalepas PC, 2013, ACTA NEUROPATHOL; Kitazume S, 2012, J BIOL CHEM; Kohli BM, 2012, J PROTEOME RES, V11, P4075, DOI 10.1021/pr300123g; Korte M, 2012, EXP BRAIN RES, V217, P435, DOI 10.1007/s00221-011-2894-6; Li HM, 2010, P NATL ACAD SCI USA, V107, P17362, DOI 10.1073/pnas.1012568107; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Lombino F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057120; Matrone C, 2012, AGING CELL, V11, P1084, DOI 10.1111/acel.12009; Matrone C, 2011, J NEUROSCI, V31, P11756, DOI 10.1523/JNEUROSCI.1960-11.2011; Matsuda S, 2005, J BIOL CHEM, V280, P28912, DOI 10.1074/jbc.C500217200; Matsuda S, 2008, J NEUROSCI, V28, P8668, DOI 10.1523/JNEUROSCI.2094-08.2008; Matsuda S, 2009, J BIOL CHEM, V284, P15815, DOI 10.1074/jbc.M109.006403; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Muller UC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006288; Nalbantoglu J, 1997, NATURE, V387, P500, DOI 10.1038/387500a0; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Norstrom EM, 2010, J NEUROSCI, V30, P15677, DOI 10.1523/JNEUROSCI.4464-10.2010; Noviello C, 2003, J BIOL CHEM, V278, P31843, DOI 10.1074/jbc.M304133200; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Rhinn H, 2013, NATURE; Rizzoli SO, 2014, EMBO J, V33, P788, DOI 10.1002/embj.201386357; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Royle SJ, 2010, TRAFFIC, V11, P1489, DOI 10.1111/j.1600-0854.2010.01104.x; Sano Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000051; Scheinfeld MH, 2002, J BIOL CHEM, V277, P44195, DOI 10.1074/jbc.M208110200; Scheinfeld MH, 2002, J BIOL CHEM, V277, P3767, DOI 10.1074/jbc.M108357200; Scheinfeld MH, 2003, P NATL ACAD SCI USA, V100, P1729, DOI 10.1073/pnas.0437908100; Sharma M, 2012, EMBO J, V31, P829, DOI 10.1038/emboj.2011.467; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; SUDHOF T, 2011, COLD SPRING HARB PER, V3; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Tamayev R, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-19; Tamayev R, 2012, J NEUROSCI, V32, P5481, DOI 10.1523/JNEUROSCI.5193-11.2012; Tamayev R, 2012, EMBO MOL MED, V4, P171, DOI 10.1002/emmm.201100195; Tamayev R, 2011, EMBO J, V30, P2501, DOI 10.1038/emboj.2011.161; Tamayev R, 2010, P NATL ACAD SCI USA, V107, P20822, DOI 10.1073/pnas.1011689107; Tamayev R, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-28; Tanzi RE, 2012, COLD SPRING HARB PER, V2; Tarr PE, 2002, J BIOL CHEM, V277, P16798, DOI 10.1074/jbc.M110286200; Vassar R, 2014, J NEUROCHEM, V130, P4, DOI 10.1111/jnc.12715; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Vidal R, 1999, NATURE, V399, P776; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320; Zhou DW, 2009, J ALZHEIMERS DIS, V16, P301, DOI 10.3233/JAD-2009-0970; Zhou DW, 2004, J BIOL CHEM, V279, P25374, DOI 10.1074/jbc.M400488200	71	40	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108576	10.1371/journal.pone.0108576	http://dx.doi.org/10.1371/journal.pone.0108576			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247712	gold, Green Published, Green Submitted			2022-12-25	WOS:000342351800102
J	Fortino, V; Kinaret, P; Fyhrquist, N; Alenius, H; Greco, D				Fortino, Vittorio; Kinaret, Pia; Fyhrquist, Nanna; Alenius, Harri; Greco, Dario			A Robust and Accurate Method for Feature Selection and Prioritization from Multi-Class OMICs Data	PLOS ONE			English	Article							GENE SELECTION; RANDOM FOREST; CLASSIFICATION; EXPRESSION; IDENTIFICATION; PREDICTION; DIAGNOSIS; PACKAGE; SKIN	Selecting relevant features is a common task in most OMICs data analysis, where the aim is to identify a small set of key features to be used as biomarkers. To this end, two alternative but equally valid methods are mainly available, namely the univariate (filter) or the multivariate (wrapper) approach. The stability of the selected lists of features is an often neglected but very important requirement. If the same features are selected in multiple independent iterations, they more likely are reliable biomarkers. In this study, we developed and evaluated the performance of a novel method for feature selection and prioritization, aiming at generating robust and stable sets of features with high predictive power. The proposed method uses the fuzzy logic for a first unbiased feature selection and a Random Forest built from conditional inference trees to prioritize the candidate discriminant features. Analyzing several multi-class gene expression microarray data sets, we demonstrate that our technique provides equal or better classification performance and a greater stability as compared to other Random Forest-based feature selection methods.	[Fortino, Vittorio; Kinaret, Pia; Fyhrquist, Nanna; Alenius, Harri; Greco, Dario] FIOH, Unit Syst Toxicol, Helsinki, Finland; [Fortino, Vittorio; Kinaret, Pia; Fyhrquist, Nanna; Alenius, Harri; Greco, Dario] FIOH, Nanosafety Ctr, Helsinki, Finland	Finnish Institute of Occupational Health; Finnish Institute of Occupational Health	Greco, D (corresponding author), FIOH, Unit Syst Toxicol, Helsinki, Finland.	dario.greco@ttl.fi	Greco, Dario/T-7113-2019	Greco, Dario/0000-0001-9195-9003; Kinaret, Pia/0000-0002-3312-5331; Alenius, Harri/0000-0003-0106-8923; Fyhrquist, Nanna Theresia/0000-0002-5408-0005	European Commission [FP7-309329]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work has been supported by the European Commission, under grant agreement FP7-309329 (NANOSOLUTIONS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2009, BIOINFORMATICS, V25, pI313, DOI 10.1093/bioinformatics/btp191; Altmann A, 2010, BIOINFORMATICS, V26, P1340, DOI 10.1093/bioinformatics/btq134; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Cancer Genome Atlas Research Network, 2013, Nat Genet, V45, P1113, DOI 10.1038/ng.2764; Di Meglio P, 2011, IMMUNITY, V35, P857, DOI 10.1016/j.immuni.2011.12.003; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Glez-Pena D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-37; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; He ZY, 2010, COMPUT BIOL CHEM, V34, P215, DOI 10.1016/j.compbiolchem.2010.07.002; Hothorn T., 2006, PARTY LAB RECURSIVE; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jennings CD, 1997, BLOOD, V90, P2863, DOI 10.1182/blood.V90.8.2863; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Kursa MB, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-8; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Mukhopadhyay S, 2011, AM J SURG PATHOL, V35, P15, DOI 10.1097/PAS.0b013e3182036d05; Quaranta M, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008946; R Core Team, 2021, R LANG ENV STAT COMP; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Strobl C, 2008, D91 SECURESCM, V017, P1; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Suarez-Farinas M, 2012, J INVEST DERMATOL, V132, P2552, DOI 10.1038/jid.2012.184; Tarca AL, 2013, BIOINFORMATICS, V29, P2892, DOI 10.1093/bioinformatics/btt492; Tezak Zivana, 2006, Human Genomics, V2, P236; Virtanen Carl, 2008, V141, P87; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Yu H, 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/239628	30	29	29	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107801	10.1371/journal.pone.0107801	http://dx.doi.org/10.1371/journal.pone.0107801			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247789	Green Published, gold, Green Submitted			2022-12-25	WOS:000342351800039
J	Meunier, CL; Malzahn, AM; Boersma, M				Meunier, Cedric L.; Malzahn, Arne M.; Boersma, Maarten			A New Approach to Homeostatic Regulation: Towards a Unified View of Physiological and Ecological Concepts	PLOS ONE			English	Article							FOOD QUALITY FLUCTUATIONS; NUTRIENT LIMITATION; N-P; ORGANISMAL STOICHIOMETRY; OXYRRHIS-MARINA; FRESH-WATER; GROWTH; PHYTOPLANKTON; ZOOPLANKTON; FLEXIBILITY	Stoichiometric homeostasis is the ability of an organism to keep its body chemical composition constant, despite varying inputs. Stoichiometric homeostasis therefore constrains the metabolic needs of consumers which in turn often feed on resources not matching these requirements. In a broader context, homeostasis also relates to the capacity of an organism to maintain other biological parameters (e.g. body temperature) at a constant level over ambient environmental variations. Unfortunately, there are discrepancies in the literature and ecological and physiological definitions of homeostasis are disparate and partly contradictory. Here, we address this matter by reviewing the existing knowledge considering two distinct groups, regulators and conformers and, based on examples of thermo-and osmoregulation, we propose a new approach to stoichiometric homeostasis, unifying ecological and physiological concepts. We suggest a simple and precise graphical way to identify regulators and conformers: for any given biological parameter (e. g. nutrient stoichiometry, temperature), a sigmoidal relation between internal and external conditions can be observed for conformers while an inverse sigmoidal response is characteristic of regulators. This new definition and method, based on well-studied physiological mechanisms, unifies ecological and physiological approaches and is a useful tool for understanding how organisms are affected by and affect their environment.	[Meunier, Cedric L.; Malzahn, Arne M.; Boersma, Maarten] Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Biol Anstalt Helgoland, Helgoland, Germany; [Meunier, Cedric L.] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden; [Malzahn, Arne M.] Sultan Qaboos Univ, Coll Agr & Marine Sci, Dept Marine Sci & Fisheries, Al Khoud, Oman	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Umea University; Sultan Qaboos University	Meunier, CL (corresponding author), Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Biol Anstalt Helgoland, Helgoland, Germany.	cedric.meunier@emg.umu.se	Meunier, Cedric L/K-2792-2015; Malzahn, Arne/AAD-6356-2022; Malzahn, Arne/C-5851-2013; Boersma, Maarten/A-5475-2013	Meunier, Cedric L/0000-0002-4070-4286; Malzahn, Arne/0000-0002-2027-0804; Boersma, Maarten/0000-0003-1010-026X	Deutsche Forschungsgemeinschaft (DFG) [MA 524 14501-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study is financed by the Deutsche Forschungsgemeinschaft (DFG grant # MA 524 14501-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Sanabria EA, 2012, J EXP ZOOL PART A, V317A, P185, DOI 10.1002/jez.1712; ANDERSEN T, 1991, LIMNOL OCEANOGR, V36, P807, DOI 10.4319/lo.1991.36.4.0807; Bamstedt U., 1986, P1; DeMott WR, 2005, OECOLOGIA, V142, P20, DOI 10.1007/s00442-004-1716-y; DROOP MR, 1973, AM ZOOL, V13, P209; Eckert V, 1978, ANIMAL PHYSL; Elser JJ, 1999, ECOLOGY, V80, P735, DOI 10.2307/177013; Frost PC, 2005, OIKOS, V109, P18, DOI 10.1111/j.0030-1299.2005.14049.x; Grover JP, 2003, AM NAT, V162, P29, DOI 10.1086/376577; Hagen W, 2001, ZOOL-ANAL COMPLEX SY, V104, P313, DOI 10.1078/0944-2006-00037; Hall SR, 2005, ECOLOGY, V86, P1894, DOI 10.1890/04-1045; Hessen DO, 2004, ECOLOGY, V85, P1179, DOI 10.1890/02-0251; Hillebrand H, 2013, LIMNOL OCEANOGR, V58, P2076, DOI 10.4319/lo.2013.58.6.2076; Hood JM, 2010, AM NAT, V176, P651, DOI 10.1086/656489; Klausmeier CA, 2004, LIMNOL OCEANOGR, V49, P1463, DOI 10.4319/lo.2004.49.4_part_2.1463; KOOIJMAN SALM, 1995, J THEOR BIOL, V177, P139; Lapucki T, 2008, COMP BIOCHEM PHYS A, V149, P299, DOI 10.1016/j.cbpa.2008.01.009; Leonardos N, 2005, J PHYCOL, V41, P567, DOI 10.1111/j.1529-8817.2005.00082.x; LEVI MP, 1969, PHYTOPATHOLOGY, V59, P460; Malzahn AM, 2007, LIMNOL OCEANOGR, V52, P2062, DOI 10.4319/lo.2007.52.5.2062; Meunier CL, 2012, MAR BIOL, V159, P2241, DOI 10.1007/s00227-012-2009-3; Meunier CL, 2012, HYDROBIOLOGIA, V680, P53, DOI 10.1007/s10750-011-0900-4; Montechiaro F, 2010, J PLANT PHYSIOL, V167, P110, DOI 10.1016/j.jplph.2009.07.013; Mulder K, 2007, ECOL MODEL, V207, P319, DOI 10.1016/j.ecolmodel.2007.05.009; Mulder K, 2007, ECOL MODEL, V202, P427, DOI 10.1016/j.ecolmodel.2006.11.007; PEQUEUX A, 1995, J CRUSTACEAN BIOL, V15, P1, DOI 10.2307/1549010; Persson J, 2010, OIKOS, V119, P741, DOI 10.1111/j.1600-0706.2009.18545.x; RHEE GY, 1978, LIMNOL OCEANOGR, V23, P10, DOI 10.4319/lo.1978.23.1.0010; Richter JB, 1792, NEUEREN GEGENSTAND C; Rout GR, 2003, AGRONOMIE, V23, P3, DOI 10.1051/agro:2002073; Seebacher F, 2005, J COMP PHYSIOL B, V175, P453, DOI 10.1007/s00360-005-0010-6; Sommer U, 2006, OECOLOGIA, V147, P183, DOI 10.1007/s00442-005-0320-0; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Superina M, 2007, COMP BIOCHEM PHYS A, V148, P893, DOI 10.1016/j.cbpa.2007.09.005; Woods HA, 2013, TRENDS ECOL EVOL, V28, P283, DOI 10.1016/j.tree.2012.10.021; Zauke GP, 1998, INT REV HYDROBIOL, V83, P501, DOI 10.1002/iroh.19980830518	36	43	44	4	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107737	10.1371/journal.pone.0107737	http://dx.doi.org/10.1371/journal.pone.0107737			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247989	gold, Green Published			2022-12-25	WOS:000342351800032
J	Xia, X; Wen, R; Chou, TH; Li, YW; Wang, ZY; Porciatti, V				Xia, Xin; Wen, Rong; Chou, Tsung-Han; Li, Yiwen; Wang, Zhengying; Porciatti, Vittorio			Protection of Pattern Electroretinogram and Retinal Ganglion Cells by Oncostatin M after Optic Nerve Injury	PLOS ONE			English	Article							CILIARY NEUROTROPHIC FACTOR; LEUKEMIA-INHIBITORY FACTOR; AXONAL-TRANSPORT; IN-VITRO; GLAUCOMA; CYTOKINE; BDNF; SURVIVAL; DBA/2J; DEATH	Injury to retinal ganglion cell (RGC) axons leads to selective loss of RGCs and vision. Previous studies have shown that exogenous neurotrophic factors promote RGC survival. We investigated the neuroprotective effects of oncostatin M (OSM), a member of the IL-6 family of cytokines, on pattern electroretinogram (PERG) and RGC survival after optic nerve crush (ONcrush) in the mouse. BALB/C mice received ON-crush in the left eyes for either 4-second or 1-second duration (4-s or 1-s). Fluoro-gold retrograde labeling was used to identify RGCs. RGC function was assessed by PERG measurement. OSM or CNTF protein was injected intravitreally immediately after ON-crush. OSM responsive cells were identified by localization of increased STAT3 phosphorylation. Significant higher RGC survival (46% of untreated control) was seen in OSM-treated eyes when assessed 2 weeks after 4-s ON-crush as compared to that (14% of untreated control) of the PBS-treated eyes (P < 0.001). In addition, PERG amplitude was significantly higher in eyes treated with OSM or CNTF 1 week after 1-s ON-crush (36% of baseline) as compared with the amplitude of PBS-treated eyes (19% of the baseline, P = 0.003). An increase in STAT3 phosphorylation was localized in Muller layer after OSM treatment, suggesting that Mu " ller cells mediate the effect of OSM. Our results demonstrate that one single injection of either OSM or CNTF after ON-crush improves RGC survival together with their electrophysiological activity. These data provide proof-of-concept for using neurotrophic factors OSM and CNTF for RGC degenerative diseases, including glaucoma and acute optic nerve trauma.	[Xia, Xin; Wen, Rong; Chou, Tsung-Han; Li, Yiwen; Wang, Zhengying; Porciatti, Vittorio] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Xia, Xin] Jiaotong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai, Peoples R China; [Xia, Xin] Shanghai Key Lab Ocular Fundus Dis, Shanghai, Peoples R China	Bascom Palmer Eye Institute; University of Miami; Shanghai Jiao Tong University	Porciatti, V (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	vporciatti@med.miami.edu		Porciatti, Vittorio/0000-0002-1592-3532	NIH [R01EY019077, R01EY018586, P30EY14801]; Department of Defense [W81XWH-09-1-0674]; Hope for Vision; James and Esther King Biomedical Research Program of the State of Florida; National Natural Science Foundation of China [81100681]; Shanghai First People's Hospital; Shanghai Key Laboratory for Ocular Fundus Diseases; Chinese Scholarship Council; NATIONAL EYE INSTITUTE [P30EY014801, R01EY018586, R01EY019077] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Hope for Vision; James and Esther King Biomedical Research Program of the State of Florida; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai First People's Hospital; Shanghai Key Laboratory for Ocular Fundus Diseases; Chinese Scholarship Council(China Scholarship Council); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grants R01EY019077, R01EY018586, P30EY14801, Department of Defense grant W81XWH-09-1-0674, Hope for Vision, the James and Esther King Biomedical Research Program of the State of Florida. Xin Xia was supported in part by National Natural Science Foundation of China (grant # 81100681), scholarships from Shanghai First People's Hospital, Shanghai Key Laboratory for Ocular Fundus Diseases, and Chinese Scholarship Council. Additional support was provided by an unrestricted grant from Research to Prevent Blindness Inc. to Bascom Palmer Eye Institute. The above funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; Bagli E, 2011, MYSTERY GLAUCOMA, P115, DOI [10.5772/19067, DOI 10.5772/19067]; Boulanger MJ, 2004, ADV PROTEIN CHEM, V68, P107; Bruce A. Gregory, 1992, Progress in Growth Factor Research, V4, P157, DOI 10.1016/0955-2235(92)90029-H; BRUCE AG, 1992, J IMMUNOL, V149, P1271; Canola K, 2007, INVEST OPHTH VIS SCI, V48, P446, DOI 10.1167/iovs.06-0190; Chang EE, 2012, OPHTHALMOLOGY, V119, P979, DOI 10.1016/j.ophtha.2011.11.003; Chen H, 2001, INVEST OPHTH VIS SCI, V42, P966; Chou TH, 2013, INVEST OPHTH VIS SCI, V54, P1236, DOI 10.1167/iovs.12-11188; Dahlmann-Noor AH, 2010, DRUG DISCOV TODAY, V15, P287, DOI 10.1016/j.drudis.2010.02.007; DITTRICH F, 1994, ANN NEUROL, V35, P151, DOI 10.1002/ana.410350206; Grotzinger J, 2002, BBA-MOL CELL RES, V1592, P215, DOI 10.1016/S0167-4889(02)00316-6; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Levin LA, 2002, PROG RETIN EYE RES, V21, P465, DOI 10.1016/S1350-9462(02)00012-5; Levin LA, 2001, J GLAUCOMA, V10, pS19, DOI 10.1097/00061198-200110001-00008; Lindsey JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065966; Ma YT, 1998, J NEUROSCI, V18, P2097; Magharious M, 2011, J PROTEOME RES, V10, P3344, DOI 10.1021/pr2004055; Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380; Miura G, 2009, EXP EYE RES, V89, P49, DOI 10.1016/j.exer.2009.02.009; Miyajima A, 2000, CYTOKINE GROWTH F R, V11, P177, DOI 10.1016/S1359-6101(00)00003-4; Moidunny S, 2010, J NEUROCHEM, V114, P1667, DOI 10.1111/j.1471-4159.2010.06881.x; Morikawa Y, 2004, J NEUROSCI, V24, P1941, DOI 10.1523/JNEUROSCI.4975-03.2004; Nakazawa T, 2002, CURR EYE RES, V24, P114, DOI 10.1076/ceyr.24.2.114.8162; Nakazawa T, 2002, INVEST OPHTH VIS SCI, V43, P3319; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Parrilla-Reverter G, 2009, EXP EYE RES, V89, P32, DOI 10.1016/j.exer.2009.02.015; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; Porciatti V, 1996, P NATL ACAD SCI USA, V93, P14955, DOI 10.1073/pnas.93.25.14955; Porciatti V, 2007, DOC OPHTHALMOL, V115, P145, DOI 10.1007/s10633-007-9059-8; Porciatti V, 2007, INVEST OPHTH VIS SCI, V48, P745, DOI 10.1167/iovs.06-0733; Porciatti V, 2010, MOL VIS, V16, P2939; Qu J, 2010, EXP EYE RES, V91, P48, DOI 10.1016/j.exer.2010.04.002; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; ROSE TM, 1991, P NATL ACAD SCI USA, V88, P8641, DOI 10.1073/pnas.88.19.8641; Tao W., RETIN DEGENER, P401, DOI [10.1007/978-1-59745-186-4_21, DOI 10.1007/978-1-59745-186-4_21]; Tonges L, 2011, J NEUROCHEM, V117, P892, DOI 10.1111/j.1471-4159.2011.07257.x; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; Weiss TW, 2006, FASEB J, V20, P2369, DOI 10.1096/fj.06-5850fje; Wen R, 2006, J NEUROSCI, V26, P13523, DOI 10.1523/JNEUROSCI.4021-06.2006; Wen R, 2012, PROG RETIN EYE RES, V31, P136, DOI 10.1016/j.preteyeres.2011.11.005; Xia X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018282; ZARLING JM, 1986, P NATL ACAD SCI USA, V83, P9739, DOI 10.1073/pnas.83.24.9739; Zhong LC, 2007, INVEST OPHTH VIS SCI, V48, P1212, DOI 10.1167/iovs.06-0757	46	13	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e108524	10.1371/journal.pone.0108524	http://dx.doi.org/10.1371/journal.pone.0108524			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243471	gold, Green Published, Green Submitted			2022-12-25	WOS:000343679800091
J	Liu, HM; Lou, GY; Li, CY; Wang, XD; Cederbaum, AI; Gan, LX; Xie, B				Liu, Hongming; Lou, Guiyu; Li, Chongyi; Wang, Xiaodong; Cederbaum, Arthur I.; Gan, Lixia; Xie, Bin			HBx Inhibits CYP2E1 Gene Expression via Downregulating HNF4 alpha in Human Hepatoma Cells	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; ENRICHED TRANSCRIPTION FACTORS; FACTOR 4 ALPHA; HEPATOCELLULAR-CARCINOMA; CYTOCHROME-P450 2E1; OXIDATIVE STRESS; OXIDANT STRESS; MESSENGER-RNA; 3 BETA; LIVER	CYP2E1, one of the cytochrome P450 mixed-function oxidases located predominantly in liver, plays a key role in metabolism of xenobiotics including ethanol and procarcinogens. Recently, down-expression of CYP2E1 was found in hepatocellular carcinoma (HCC) with the majority to be chronic hepatitis B virus (HBV) carriers. In this study, we tested a hypothesis that HBx may inhibit CYP2E1 gene expression via hepatocyte nuclear factor 4 alpha (HNF4 alpha). By enforced HBx gene expression in cultured HepG2 cells, we determined the effect of HBx on CYP2E1 mRNA and protein expression. With a bioinformatics analysis, we found a consensus HNF-4 alpha binding sequence located on 2318 to 2294 bp upstream of human CYP2E1 promoter. Using reporter gene assay and site-directed mutagenesis, we have shown that mutation of this site dramatically decreased CYP2E1 promoter activity. By silencing endogenous HNF-4 alpha, we have further validated knockdown of HNF-4 alpha significantly decreased CYP2E1 expression. Ectopic overexpression of HBx in HepG2 cells inhibits HNF-4 alpha expression, and HNF-4 alpha levels were inversely correlated with viral proteins both in HBV-infected HepG2215 cells and as well as HBV positive HCC liver tissues. Moreover, the HBx-induced CYP2E1 reduction could be rescued by ectopic supplement of HNF4 alpha protein expression. Furthermore, human hepatoma cells C34, which do not express CYP2E1, shows enhanced cell growth rate compared to E47, which constitutively expresses CYP2E1. In addition, the significantly altered liver proteins in CYP2E1 knockout mice were detected with proteomics analysis. Together, HBx inhibits human CYP2E1 gene expression via downregulating HNF4 alpha which contributes to promotion of human hepatoma cell growth. The elucidation of a HBx-HNF4 alpha-CYP2E1 pathway provides novel insight into the molecular mechanism underlining chronic HBV infection associated hepatocarcinogenesis.	[Liu, Hongming; Xie, Bin] Third Mil Med Univ, Daping Hosp, Dept Hepatobiliary Surg, Chongqing, Peoples R China; [Liu, Hongming; Xie, Bin] Third Mil Med Univ, Inst Surg Res, Chongqing, Peoples R China; [Lou, Guiyu; Li, Chongyi; Gan, Lixia] Third Mil Med Univ, Dept Biochem & Mol Biol, Chongqing, Peoples R China; [Wang, Xiaodong; Cederbaum, Arthur I.] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Wang, Xiaodong] Chongqing Biomean Technol Co Ltd, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Icahn School of Medicine at Mount Sinai	Gan, LX (corresponding author), Third Mil Med Univ, Dept Biochem & Mol Biol, Chongqing, Peoples R China.	ganlixia@yahoo.com; xiebin313@126.com	Lou, Guiyu/AAM-2153-2020		National Natural Science Foundation of China (NSFC) [30772464, 81372270]; NSFC [81270482]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (NSFC) No. 30772464, 81372270 (to Bin Xie), and NSFC No. 81270482 (to Lixia Gan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELRAZZAK Z, 1993, MOL PHARMACOL, V44, P707; Akiyama TE, 2003, BBA-GEN SUBJECTS, V1619, P223, DOI 10.1016/S0304-4165(02)00480-4; Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Bieche I, 2007, PHARMACOGENET GENOM, V17, P731, DOI 10.1097/FPC.0b013e32810f2e58; Brechot C, 2010, PATHOL BIOL, V58, P278, DOI 10.1016/j.patbio.2010.05.001; Cederbaum AI, 2012, CLIN LIVER DIS, V16, P667, DOI 10.1016/j.cld.2012.08.002; Cederbaum AI, 2010, DIGEST DIS, V28, P802, DOI 10.1159/000324289; Cederbaum AI, 2009, ARCH TOXICOL, V83, P519, DOI 10.1007/s00204-009-0432-0; Chen EQ, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-23; Chen MS, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-53; Chen Q, 1997, J BIOL CHEM, V272, P14532, DOI 10.1074/jbc.272.23.14532; Chen YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069389; Chen YP, 2009, CURR DRUG METAB, V10, P567, DOI 10.2174/138920009789375397; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Gonzalez F J, 1990, Princess Takamatsu Symp, V21, P157; Hakkola J, 2003, J PHARMACOL EXP THER, V304, P1048, DOI 10.1124/jpet.102.041582; HAYASHI S, 1991, J BIOCHEM-TOKYO, V110, P559, DOI 10.1093/oxfordjournals.jbchem.a123619; Ho JC, 2004, INT J CANCER, V111, P494, DOI 10.1002/ijc.20282; Hosel M, 2009, HEPATOLOGY, V50, P1773, DOI 10.1002/hep.23226; Hsu JL, 2013, J VIROL, V87, P12675, DOI 10.1128/JVI.01497-13; Kew MC, 2010, PATHOL BIOL, V58, P273, DOI 10.1016/j.patbio.2010.01.005; Kinoshita M, 2002, HEPATOLOGY, V36, P433, DOI 10.1053/jhep.2002.34851; Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155; Lazarevich N. L., 2010, Experimental Oncology, V32, P167; Lee CW, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-136; Li L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005489; LIU SY, 1995, DNA CELL BIOL, V14, P285, DOI 10.1089/dna.1995.14.285; Long Y, 2009, J VIRAL HEPATITIS, V16, P537, DOI 10.1111/j.1365-2893.2009.01089.x; Lu YK, 2010, FREE RADICAL BIO MED, V49, P1406, DOI 10.1016/j.freeradbiomed.2010.07.026; Man XB, 2004, WORLD J GASTROENTERO, V10, P1565, DOI 10.3748/wjg.v10.i11.1565; Ng SA, 2011, J GASTROENTEROL, V46, P974, DOI 10.1007/s00535-011-0415-9; Ning BF, 2010, CANCER RES, V70, P7640, DOI 10.1158/0008-5472.CAN-10-0824; Novak RF, 2000, ARCH PHARM RES, V23, P267, DOI 10.1007/BF02975435; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Peng HM, 2000, ARCH BIOCHEM BIOPHYS, V382, P129, DOI 10.1006/abbi.2000.2001; Schrem H, 2002, PHARMACOL REV, V54, P129, DOI 10.1124/pr.54.1.129; Schutte K, 2009, DIGEST DIS, V27, P80, DOI 10.1159/000218339; Tian YJ, 2012, J VIROL, V86, P1904, DOI 10.1128/JVI.06707-11; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; Wang JF, 2010, CURR DRUG METAB, V11, P342, DOI 10.2174/138920010791514180; Wang SH, 2009, HEPATOLOGY, V50, P1392, DOI 10.1002/hep.23163; Wang ZQ, 2003, BRIT J CLIN PHARMACO, V55, P77, DOI 10.1046/j.1365-2125.2003.01731.x; Wiwi CA, 2004, MOL ENDOCRINOL, V18, P1975, DOI 10.1210/me.2004-0129; Wu DF, 2013, REDOX BIOL, V1, P552, DOI 10.1016/j.redox.2013.10.008; Wu DF, 1999, ALCOHOL CLIN EXP RES, V23, P67; Wu MH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001143; Yin C, 2008, HEPATOLOGY, V48, P1528, DOI 10.1002/hep.22510; Zeng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054188	48	12	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107913	10.1371/journal.pone.0107913	http://dx.doi.org/10.1371/journal.pone.0107913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238230	gold, Green Submitted, Green Published			2022-12-25	WOS:000342491600063
J	Itkonen, HM; Engedal, N; Babaie, E; Luhr, M; Guldvik, IJ; Minner, S; Hohloch, J; Tsourlakis, MC; Schlomm, T; Mills, IG				Itkonen, H. M.; Engedal, N.; Babaie, E.; Luhr, M.; Guldvik, I. J.; Minner, S.; Hohloch, J.; Tsourlakis, M. C.; Schlomm, T.; Mills, I. G.			UAP1 is overexpressed in prostate cancer and is protective against inhibitors of N-linked glycosylation	ONCOGENE			English	Article							ANDROGEN-DEPRIVATION THERAPY; HEXOSAMINE BIOSYNTHETIC-PATHWAY; GLUCOSE-METABOLISM; INSULIN-RESISTANCE; CELL-LINES; EXPRESSION; TRANSFERASE; TUNICAMYCIN; AUTOPHAGY; DIFFERENTIATION	Prostate cancer is the second most common cause of cancer-associated deaths in men, and signaling via a transcription factor called androgen receptor (AR) is an important driver of the disease. Consequently, AR target genes are prominent candidates to be specific for prostate cancer and also important for the survival of the cancer cells. Here we assess the levels of all hexosamine biosynthetic pathway (HBP) enzymes in 15 separate clinical gene expression data sets and identify the last enzyme in the pathway, UDP-N-acetylglucosamine pyrophosphorylase 1 (UAP1), to be highly overexpressed in prostate cancer. We analyzed 3261 prostate cancers on a tissue microarray and found that UAP1 staining correlates negatively with Gleason score (P = 0.0039) and positively with high AR expression (P<0.0001). Cells with high UAP1 expression have 10-fold increased levels of the HBP end-product, UDP-N-acetylglucosamine (UDP-GlcNAc). UDP-GlcNAc is essential for N-linked glycosylation occurring in the endoplasmic reticulum (ER) and high UAP1 expression associates with resistance against inhibitors of N-linked glycosylation (tunicamycin and 2-deoxyglucose) but not with a general ER stress-inducing agent, the calcium ionophore A23187. Knockdown of UAP1 expression re-sensitized cells towards inhibitors of N-linked glycosylation, as measured by proliferation and activation of ER stress markers. Taken together, we have identified an enzyme, UAP1, which is highly overexpressed in prostate cancer and protects cancer cells from ER stress conferring a growth advantage.	[Itkonen, H. M.; Engedal, N.; Luhr, M.; Guldvik, I. J.; Mills, I. G.] Univ Oslo, Ctr Mol Med Norway, Prostate Canc Res Grp, N-0318 Oslo, Norway; [Itkonen, H. M.; Engedal, N.; Luhr, M.; Guldvik, I. J.; Mills, I. G.] Oslo Univ Hosp, Oslo, Norway; [Babaie, E.] Univ Oslo, Biotechnol Ctr Oslo, N-0318 Oslo, Norway; [Minner, S.; Hohloch, J.; Tsourlakis, M. C.] Univ Med Ctr Hamburg Eppendorf, Inst Pathol, Hamburg, Germany; [Schlomm, T.] Univ Med Ctr Hamburg Eppendorf, Dept Urol, Sect Translat Prostate Canc Res, Hamburg, Germany; [Schlomm, T.] Univ Med Ctr Hamburg Eppendorf, Prostate Canc Ctr, Martini Clin, Hamburg, Germany; [Mills, I. G.] Oslo Univ Hosp, Dept Canc Prevent, Oslo, Norway; [Mills, I. G.] Oslo Univ Hosp, Dept Urol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Oslo; University of Oslo	Mills, IG (corresponding author), Univ Oslo, NCMM, Gaustadalleen 21,POB 1137, N-0318 Oslo, Norway.	harri.itkonen@ncmm.uio.no; ian.mills@ncmm.uio.no	Mills, Ian/AAK-9292-2020; Engedal, Nikolai/AAJ-8951-2020	Mills, Ian/0000-0001-5347-5083; Engedal, Nikolai/0000-0003-3718-3464; Schlomm, Thorsten/0000-0001-9557-4653; Itkonen, Harri/0000-0002-5194-7064	Early Stage Researcher fellowship as part of the EU FP7 Marie Curie Integrated Training Network; PRO-NEST (Prostate Research Organizations Network Early Stage Training) Norwegian Cancer Society; Finnish Cultural Foundation; Norwegian Research Council; Helse; University of Oslo through the Centre for Molecular Medicine (Norway), Nordic EMBL (European Molecular Biology Laboratory); Norwegian Cancer Society; EU	Early Stage Researcher fellowship as part of the EU FP7 Marie Curie Integrated Training Network; PRO-NEST (Prostate Research Organizations Network Early Stage Training) Norwegian Cancer Society; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Norwegian Research Council(Research Council of NorwayEuropean Commission); Helse; University of Oslo through the Centre for Molecular Medicine (Norway), Nordic EMBL (European Molecular Biology Laboratory); Norwegian Cancer Society(Norwegian Cancer Society); EU(European Commission)	HMI is funded by an Early Stage Researcher fellowship as part of the EU FP7 Marie Curie Integrated Training Network, PRO-NEST (Prostate Research Organizations Network Early Stage Training) Norwegian Cancer Society and Finnish Cultural Foundation. IGM is supported by funding from the Norwegian Research Council, Helse and the University of Oslo through the Centre for Molecular Medicine (Norway), which is a part of the Nordic EMBL (European Molecular Biology Laboratory) partnership. IGM is also supported by the Norwegian Cancer Society and by EU FP7 funding. IGM holds a visiting scientist position with Cancer Research UK through the Cambridge Research Institute and a Senior Visiting Research Fellowship with Cambridge University through the Department of Oncology. We thank Professor Olli Kallioniemi's group (Institute for Molecular Medicine Finland, Helsinki, Finland) for technical support.	Bassik MC, 2011, P NATL ACAD SCI USA, V108, P11731, DOI 10.1073/pnas.1109035108; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; BERTHON P, 1995, INT J ONCOL, V6, P333; Bosch RR, 2004, ENDOCRINE, V23, P17, DOI 10.1385/ENDO:23:1:17; Braga-Basaria M, 2006, J CLIN ONCOL, V24, P3979, DOI 10.1200/JCO.2006.05.9741; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Chen R, 2013, J CELL BIOCHEM, V114, P816, DOI 10.1002/jcb.24420; Dennis JW, 2009, TRAFFIC, V10, P1569, DOI 10.1111/j.1600-0854.2009.00981.x; Derweesh IH, 2007, BJU INT, V100, P1060, DOI 10.1111/j.1464-410X.2007.07184.x; Diekman AB, 1998, MOL REPROD DEV, V50, P284; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Dricu A, 1997, CANCER RES, V57, P543; Grassian AR, 2011, COLD SH Q B, V76, P313, DOI 10.1101/sqb.2011.76.010967; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Gunter Jennifer H, 2013, Int J Cell Biol, V2013, P834684, DOI 10.1155/2013/834684; Hagisawa S, 2005, GLYCOBIOLOGY, V15, P1016, DOI 10.1093/glycob/cwi086; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Humphrey PA, 2007, J CLIN PATHOL, V60, P35, DOI 10.1136/jcp.2005.036442; Itkonen HM, 2013, CANCER RES, V73, P5277, DOI 10.1158/0008-5472.CAN-13-0549; Itkonen HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065016; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; KELLER RK, 1979, BIOCHEMISTRY-US, V18, P3946, DOI 10.1021/bi00585a016; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.can-03-3645; Krzeslak A, 2012, CLIN EXP MED, V12, P61, DOI 10.1007/s10238-011-0138-5; Kurtoglu M, 2007, MOL CANCER THER, V6, P3049, DOI 10.1158/1535-7163.MCT-07-0310; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Luo J, 2002, CANCER RES, V62, P2220; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Massie CE, 2011, EMBO J, V30, P2719, DOI 10.1038/emboj.2011.158; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; Mio T, 1998, J BIOL CHEM, V273, P14392, DOI 10.1074/jbc.273.23.14392; Monauni T, 2000, DIABETES, V49, P926, DOI 10.2337/diabetes.49.6.926; Moon JS, 2011, BIOCHEM J, V433, P225, DOI 10.1042/BJ20101104; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Nakajima K, 2010, GLYCOBIOLOGY, V20, P865, DOI 10.1093/glycob/cwq044; Patti ME, 1999, DIABETES, V48, P1562, DOI 10.2337/diabetes.48.8.1562; Peneff C, 2001, EMBO J, V20, P6191, DOI 10.1093/emboj/20.22.6191; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Sartor O, 2013, NAT REV CLIN ONCOL, V10, P6, DOI 10.1038/nrclinonc.2012.202; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Wang ZV, 2014, CELL, V156, P1179, DOI 10.1016/j.cell.2014.01.014; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Xi HB, 2011, CANCER CHEMOTH PHARM, V67, P899, DOI 10.1007/s00280-010-1391-0; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058	49	63	63	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2015	34	28					3744	3750		10.1038/onc.2014.307	http://dx.doi.org/10.1038/onc.2014.307			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM4TZ	25241896				2022-12-25	WOS:000357679100012
J	Fernandez, MA; Klutkowski, JA; Freret, T; Wolfe, MS				Fernandez, Marty A.; Klutkowski, Julia A.; Freret, Taylor; Wolfe, Michael S.			Alzheimer Presenilin-1 Mutations Dramatically Reduce Trimming of Long Amyloid beta-Peptides (A beta) by gamma-Secretase to Increase 42-to-40-Residue A beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYL-TERMINAL FRAGMENT; PRECURSOR PROTEIN; TRANSMEMBRANE DOMAIN; INTRAMEMBRANE PROTEOLYSIS; TALKING POINT; DISEASE; CLEAVAGE; A-BETA-42; MECHANISM; ENDOPROTEOLYSIS	The presenilin-containing gamma-secretase complex produces the amyloid beta-peptide (A beta) through intramembrane proteolysis, and >100 presenilin mutations are associated with familial early-onset Alzheimer disease (AD). The question of whether these mutations result in AD through a gain or a loss of function remains highly controversial. Mutations in presenilins increase ratios of 42- to 40-residue A beta critical to pathogenesis, but other A beta s of 38 - 49 residues are also formed by gamma-secretase. Evidence in cells suggests the protease first cleaves substrate within the transmembrane domain at the E site to form 48- or 49-residue A beta. Subsequent cleavage almost every three residues from the C terminus is thought to occur along two pathways toward shorter secreted forms of A beta: A beta 49 -> A beta 46 -> A beta 43 -> A beta 40 and A beta 48 -> A beta 45 -> A beta 42 -> A beta 38. Here we show that the addition of synthetic long A beta peptides (A beta 45- 49) directly into purified preparations of gamma-secretase leads to the formation of A beta 40 and A beta 42 whether the protease complex is detergent-solubilized or reconstituted into lipid vesicles, and the ratios of products A beta 42 to A beta 40 follow a pattern consistent with the dual-pathway hypothesis. Kinetic analysis of five different AD-causing mutations in presenilin-1 revealed that all result in drastic reduction of normal carboxypeptidase function. Altered trimming of long A beta peptides to A beta 40 and A beta 42 by mutant proteases occurs at multiple levels, independent of the effects on initial endoproteolysis at the E site, all conspiring to increase the critical A beta 42/A beta 40 ratio implicated in A beta pathogenesis. Taken together, these results suggest that specific reduction of carboxypeptidase function of gamma-secretase leads to the gain of toxic A beta 42/A beta 40.	Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Wolfe, MS (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, 77 Ave Louis Pasteur,HIM 754, Boston, MA 02115 USA.	mwolfe@partners.org	freret, thomas/B-2068-2012	freret, thomas/0000-0002-4446-4451; Fernandez, Marty/0000-0002-3211-2563	National Institutes of Health [R03 NS081498]; HHMI Gilliam Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS081498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI Gilliam Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R03 NS081498 (to M. S. W.). This work was also supported by an HHMI Gilliam Fellowship (to M. A. F.).	Cacquevel M, 2008, J NEUROCHEM, V104, P210, DOI 10.1111/j.1471-4159.2007.05041.x; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Czirr E, 2008, J BIOL CHEM, V283, P17049, DOI 10.1074/jbc.M802912200; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Fukumori A, 2010, J NEUROSCI, V30, P7853, DOI 10.1523/JNEUROSCI.1443-10.2010; Funamoto S, 2004, BIOCHEMISTRY-US, V43, P13532, DOI 10.1021/bi049399k; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Golde TE, 2013, BBA-BIOMEMBRANES, V1828, P2898, DOI 10.1016/j.bbamem.2013.06.005; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; He G, 2010, NATURE, V467, P95, DOI 10.1038/nature09325; Heilig EA, 2013, J NEUROSCI, V33, P11606, DOI 10.1523/JNEUROSCI.0954-13.2013; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Kimberly WT, 2003, BIOCHEMISTRY-US, V42, P137, DOI 10.1021/bi026888g; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Lefranc-Jullien S, 2006, J NEUROCHEM, V97, P807, DOI 10.1111/j.1471-4159.2006.03748.x; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Mori K, 2010, PSYCHOGERIATRICS, V10, P117, DOI 10.1111/j.1479-8301.2010.00330.x; Okochi M, 2013, CELL REP, V3, P42, DOI 10.1016/j.celrep.2012.11.028; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Page RM, 2008, J BIOL CHEM, V283, P677, DOI 10.1074/jbc.M708754200; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Quintero-Monzon O, 2011, BIOCHEMISTRY-US, V50, P9023, DOI 10.1021/bi2007146; Rivkin A, 2010, BIOORG MED CHEM LETT, V20, P2279, DOI 10.1016/j.bmcl.2010.02.008; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Shimojo M, 2008, J BIOL CHEM, V283, P16488, DOI 10.1074/jbc.M801279200; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yagishita S, 2008, J BIOL CHEM, V283, P733, DOI 10.1074/jbc.M707103200; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200	36	101	101	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31043	31052		10.1074/jbc.M114.581165	http://dx.doi.org/10.1074/jbc.M114.581165			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25239621	hybrid, Green Published			2022-12-25	WOS:000344549900014
J	Maloney, JA; Bainbridge, T; Gustafson, A; Zhang, S; Kyauk, R; Steiner, P; van der Brug, M; Liu, YC; Ernst, JA; Watts, RJ; Atwal, JK				Maloney, Janice A.; Bainbridge, Travis; Gustafson, Amy; Zhang, Shuo; Kyauk, Roxanne; Steiner, Pascal; van der Brug, Marcel; Liu, Yichin; Ernst, James A.; Watts, Ryan J.; Atwal, Jasvinder K.			Molecular Mechanisms of Alzheimer Disease Protection by the A673T Allele of Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY CEREBRAL-HEMORRHAGE; A-BETA; COMMON VARIANTS; MEMORY DEFICITS; APP MUTATIONS; MOUSE MODEL; GENE; PRESENILIN-1; DEMENTIA; CD2AP	Pathogenic mutations in the amyloid precursor protein (APP) gene have been described as causing early onset familial Alzheimer disease (AD). We recently identified a rare APP variant encoding an alanine-to-threonine substitution at residue 673 (A673T) that confers protection against development of AD (Jonsson, T., Atwal, J. K., Steinberg, S., Snaedal, J., Jonsson, P. V., Bjornsson, S., Stefansson, H., Sulem, P., Gudbjartsson, D., Maloney, J., Hoyte, K., Gustafson, A., Liu, Y., Lu, Y., Bhangale, T., Graham, R. R., Huttenlocher, J., Bjornsdottir, G., Andreassen, O. A., Jonsson, E. G., Palotie, A., Behrens, T. W., Magnusson, O. T., Kong, A., Thorsteinsdottir, U., Watts, R. J., and Stefansson, K. (2012) Nature 488, 96-99). The Ala-673 residue lies within the beta-secretase recognition sequence and is part of the amyloid-beta (A beta) peptide cleavage product (position 2 of A beta). We previously demonstrated that the A673T substitution makes APP a less favorable substrate for cleavage by BACE1. In follow-up studies, we confirm that A673T APP shows reduced cleavage by BACE1 in transfected mouse primary neurons and in isogenic human induced pluripotent stem cell-derived neurons. Using a biochemical approach, we show that the A673T substitution modulates the catalytic turnover rate (V-max) of APP by the BACE1 enzyme, without affecting the affinity (K-m) of the APP substrate for BACE1. We also show a reduced level of A beta(1-42) aggregation with A2T A beta peptides, an observation not conserved in A beta(1-40) peptides. When combined in a ratio of 1: 9 A beta(1-42)/A beta(1-40) to mimic physiologically relevant mixtures, A2T retains a trend toward slowed aggregation kinetics. Microglial uptake of the mutant A beta(1-42) peptides correlated with their aggregation level. Cytotoxicity of the mutant A beta peptides was not dramatically altered. Taken together, our findings demonstrate that A673T, a protective allele of APP, reproducibly reduces amyloidogenic processing of APP and also mildly decreases A beta aggregation. These effects could together have an additive or even synergistic impact on the risk of developing AD.	[Maloney, Janice A.; Zhang, Shuo; Kyauk, Roxanne; Steiner, Pascal; Ernst, James A.; Watts, Ryan J.; Atwal, Jasvinder K.] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; [Bainbridge, Travis; Ernst, James A.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Gustafson, Amy; Liu, Yichin] Genentech Inc, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA; [van der Brug, Marcel] Genentech Inc, ITGR Diagnost Discovery, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Ernst, JA (corresponding author), Genentech Inc, Dept Prot Chem, 1 DNA Way, San Francisco, CA 94080 USA.	jernst@gene.com; rwatts@gene.com; jatwal@gene.com						Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Carlson C. B., 2014, SOC NEUR ANN M NOV 1; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cruchaga C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031039; Cruts M, 1998, HUM MOL GENET, V7, P43, DOI 10.1093/hmg/7.1.43; De Jonghe C, 2001, HUM MOL GENET, V10, P1665, DOI 10.1093/hmg/10.16.1665; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; Fagan AM, 2000, ANN NEUROL, V48, P201, DOI 10.1002/1531-8249(200008)48:2<201::AID-ANA10>3.0.CO;2-X; FERNANDEZMADRID I, 1991, ANN NEUROL, V30, P730, DOI 10.1002/ana.410300516; Fleisher AS, 2013, NEUROBIOL AGING, V34, P1, DOI 10.1016/j.neurobiolaging.2012.04.017; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hardy J, 2001, NEUROSCI LETT, V306, P203, DOI 10.1016/S0304-3940(01)01910-3; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kauwe JSK, 2007, ANN NEUROL, V61, P446, DOI 10.1002/ana.21099; Kwok JBJ, 2000, ANN NEUROL, V47, P249, DOI 10.1002/1531-8249(200002)47:2<249::AID-ANA18>3.3.CO;2-#; Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Stine WB, 2011, METHODS MOL BIOL, V670, P13, DOI 10.1007/978-1-60761-744-0_2; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Tamayev R, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-19; Tamayev R, 2012, EMBO MOL MED, V4, P171, DOI 10.1002/emmm.201100195; Tomiyama T, 2008, ANN NEUROL, V63, P377, DOI 10.1002/ana.21321; VAN BROECKHOVEN C, 1990, SCIENCE, V248, P1120, DOI 10.1126/science.1971458; Zhou L, 2011, EMBO MOL MED, V3, P291, DOI 10.1002/emmm.201100138	33	137	140	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					30990	31000		10.1074/jbc.M114.589069	http://dx.doi.org/10.1074/jbc.M114.589069			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25253696	Green Published, hybrid			2022-12-25	WOS:000344549900010
J	Yuan, CB; Velazquez-Marrero, C; Bernardo, A; Treistman, SN				Yuan, Chunbo; Velazquez-Marrero, Cristina; Bernardo, Alexandra; Treistman, Steven N.			Lipids Modulate the Increase of BK Channel Calcium Sensitivity by the beta 1 Subunit	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNELS; LARGE-CONDUCTANCE; K+ CHANNEL; ETHANOL POTENTIATION; BILAYER THICKNESS; CA2+ SENSITIVITY; SURFACE-CHARGE; SMOOTH-MUSCLE; CONSTRICTION; BINDING	Co-expression of the auxiliary beta 1 subunit with the pore forming alpha subunit of BK dramatically alters apparent calcium sensitivity. Investigation of the mechanism underlying the increase in calcium sensitivity of BK in smooth muscle has concentrated on the energetic effect of beta 1's interaction with alpha. We take a novel approach, exploring whether beta 1 modification of calcium sensitivity reflects altered interaction between the channel protein and surrounding lipids. We reconstituted hSlo BK alpha and BK alpha+beta 1 channels into two sets of bilayers. One set contained POPE with POPS, POPG, POPA and POPC, where the length of acyl chains is constant, but surface charge differs. The second set is a series of neutral bilayers formed from DOPE with phosphatidylcholines (PCs) of varying acyl chain lengths:C (14:1), C (18:1), C (22:1) and C (24:1), and with brain sphingomyelin (SPM), in which surface charge is constant, but bilayer thickness varies. The increase in calcium sensitivity caused by the alpha 1 subunit was preserved in negatively charged lipid bilayers but not in neutral bilayers, indicating that modification of apparent Ca2+ sensitivity by beta 1 is modulated by membrane lipids, requiring negatively charged lipids in the membrane. Moreover, the presence of beta 1 reduces BK activity in thin bilayers of PC 14:1 and thick bilayers containing SPM, but has no significant effect on activity of BK in PC 18:1, PC 22:1 and PC 24:1 bilayers. These data suggest that auxiliary beta 1 subunits fine-tune channel gating not only through direct subunit-subunit interactions but also by modulating lipid-protein interactions.	[Yuan, Chunbo; Velazquez-Marrero, Cristina; Bernardo, Alexandra; Treistman, Steven N.] Univ Puerto Rico, Inst Neurobiol, San Juan, PR 00901 USA	University of Puerto Rico	Treistman, SN (corresponding author), Univ Puerto Rico, Inst Neurobiol, San Juan, PR 00901 USA.	Steven.Treistman@upr.edu			National Institutes of Health [R01AA018038-06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018038] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work is funded by National Institutes of Health grant R01AA018038-06 (to SNT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahring PK, 1997, FEBS LETT, V415, P67, DOI 10.1016/S0014-5793(97)01096-X; Bao L, 2005, J GEN PHYSIOL, V126, P393, DOI 10.1085/jgp.200509346; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Chu BS, 1998, MOL PHARMACOL, V54, P397, DOI 10.1124/mol.54.2.397; Connell RJO, 2006, J MEMBRANE BIOL, V213, P143, DOI 10.1007/s00232-006-0034-1; Cox DH, 2000, J GEN PHYSIOL, V116, P411, DOI 10.1085/jgp.116.3.411; Crowley JJ, 2005, MOL PHARMACOL, V68, P4, DOI 10.1124/mol.105.012971; Crowley JJ, 2003, MOL PHARMACOL, V64, P365, DOI 10.1124/mol.64.2.365; Dopico AM, 1996, MOL PHARMACOL, V49, P40; Gillis KD, 2000, PFLUG ARCH EUR J PHY, V439, P655, DOI 10.1007/s004240050990; Gruslova A, 2012, J GEN PHYSIOL, V139, P57, DOI 10.1085/jgp.201110698; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Kittler JT, 2005, P NATL ACAD SCI USA, V102, P14871, DOI 10.1073/pnas.0506653102; Liu GX, 2008, P NATL ACAD SCI USA, V105, P10727, DOI 10.1073/pnas.0805212105; Liu PC, 2004, P NATL ACAD SCI USA, V101, P18217, DOI 10.1073/pnas.0406096102; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; MOCZYDLOWSKI E, 1985, J MEMBRANE BIOL, V83, P273, DOI 10.1007/BF01868701; Nimigean CM, 1999, J GEN PHYSIOL, V113, P425, DOI 10.1085/jgp.113.3.425; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Orio P, 2006, J GEN PHYSIOL, V127, P191, DOI 10.1085/jgp.200509370; Orio P, 2005, J GEN PHYSIOL, V125, P395, DOI 10.1085/jgp.200409236; Park JB, 2003, J GEN PHYSIOL, V121, P375, DOI 10.1085/jgp.200208746; Qian X, 2003, P NATL ACAD SCI USA, V100, P10061, DOI 10.1073/pnas.1731650100; Qian X, 2002, J GEN PHYSIOL, V120, P829, DOI 10.1085/jgp.20028692; Semenov I, 2006, AM J PHYSIOL-LUNG C, V291, pL802, DOI 10.1152/ajplung.00104.2006; Sun XH, 2013, J NEUROSCI, V33, P11253, DOI 10.1523/JNEUROSCI.0620-13.2013; Sweet TB, 2009, J GEN PHYSIOL, V133, P139, DOI 10.1085/jgp.200810129; Valiyaveetil FI, 2002, BIOCHEMISTRY-US, V41, P10771, DOI 10.1021/bi026215y; Wang B, 2006, J GEN PHYSIOL, V128, P731, DOI 10.1085/jgp.200609596; Yuan CB, 2004, BIOPHYS J, V86, P3620, DOI 10.1529/biophysj.103.029678; Yuan C, 2008, J BIOL CHEM, V283, P5090, DOI 10.1074/jbc.M708214200; Yuan CB, 2007, J BIOL CHEM, V282, P7276, DOI 10.1074/jbc.M607593200; Yuan CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027572	35	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107917	10.1371/journal.pone.0107917	http://dx.doi.org/10.1371/journal.pone.0107917			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254644	Green Published, gold, Green Submitted			2022-12-25	WOS:000344862300042
J	Bakker, ENTP; Groma, G; Spijkers, LJA; de Vos, J; van Weert, A; van Veen, H; Everts, V; Arribas, SM; VanBavel, E				Bakker, Erik N. T. P.; Groma, Gergely; Spijkers, Leon J. A.; de Vos, Judith; van Weert, Angela; van Veen, Henk; Everts, Vincent; Arribas, Silvia M.; VanBavel, Ed			Heterogeneity in Arterial Remodeling among Sublines of Spontaneously Hypertensive Rats	PLOS ONE			English	Article							WISTAR-KYOTO RATS; MECHANICAL-PROPERTIES; EXTRACELLULAR-MATRIX; RENOVASCULAR HYPERTENSION; RESISTANCE VESSELS; OXIDATIVE STRESS; PULSE PRESSURE; STIFFNESS; ELASTIN; GROWTH	Objectives: Spontaneously hypertensive rats (SHR) have been used frequently as a model for human essential hypertension. However, both the SHR and its normotensive control, the Wistar Kyoto rat (WKY), consist of genetically different sublines. We tested the hypothesis that the pathophysiology of vascular remodeling in hypertension differs among rat sublines. Methods and Results: We studied mesenteric resistance arteries of WKY and SHR from three different sources, at 6 weeks and 5 months of age. Sublines of WKY and SHR showed differences in blood pressure, body weight, vascular remodeling, endothelial function, and vessel ultrastructure. Common features in small mesenteric arteries from SHR were an increase in wall thickness, wall-to-lumen ratio, and internal elastic lamina thickness. Conclusions: Endothelial dysfunction, vascular stiffening, and inward remodeling of small mesenteric arteries are not common features of hypertension, but are subline-dependent. Differences in genetic background associate with different types of vascular remodeling in hypertensive rats.	[Bakker, Erik N. T. P.; Groma, Gergely; de Vos, Judith; van Weert, Angela; VanBavel, Ed] Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, NL-1105 AZ Amsterdam, Netherlands; [Spijkers, Leon J. A.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med & Nephrol, NL-1105 AZ Amsterdam, Netherlands; [van Veen, Henk; Everts, Vincent] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol, Leeuwenhoek Ctr Adv Microscopy, NL-1105 AZ Amsterdam, Netherlands; [Arribas, Silvia M.] Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Autonomous University of Madrid	Bakker, ENTP (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	n.t.bakker@amc.uva.nl		de Vos, Judith/0000-0003-0736-7449; van Bavel, Ed/0000-0001-8654-986X; Bakker, Erik/0000-0003-2819-5818; Arribas, Silvia M/0000-0001-7103-6105; Groma, Gergely/0000-0001-8487-0465	European Union, Marie Curie ITN [235711]	European Union, Marie Curie ITN	This work was supported by the European Union, Marie Curie ITN number 235711. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribas SM, 2008, AM J PHYSIOL-HEART C, V295, pH2299, DOI 10.1152/ajpheart.00155.2008; Behbahani J, 2010, AM J HYPERTENS, V23, P1273, DOI 10.1038/ajh.2010.161; Bernatova I, 2009, J HYPERTENS, V27, pS27, DOI 10.1097/01.hjh.0000358834.18311.fc; Braun MC, 2013, J HYPERTENS, V31, P2050, DOI 10.1097/HJH.0b013e328362f9a5; Briones AM, 2003, J PHYSIOL-LONDON, V552, P185, DOI 10.1113/jphysiol.2003.046904; Bund SJ, 2001, CLIN SCI, V101, P385, DOI 10.1042/CS20010036; Ceron CS, 2012, MATRIX BIOL, V31, P261, DOI 10.1016/j.matbio.2012.01.009; Condezo-Hoyos L, 2012, J HYPERTENS, V30, P1185, DOI 10.1097/HJH.0b013e328353824b; Cosson E, 2007, AM J PHYSIOL-HEART C, V292, pH2506, DOI 10.1152/ajpheart.00732.2006; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Dingemans KP, 2000, ANAT REC, V258, P1; DOILLON CJ, 1985, COLLAGEN REL RES, V5, P481; HEAGERTY AM, 1993, HYPERTENSION, V21, P391, DOI 10.1161/01.HYP.21.4.391; Hinojos CA, 2005, HYPERTENSION, V45, P698, DOI 10.1161/01.HYP.0000156498.78896.37; Ibrahim J, 2006, CLIN EXP HYPERTENS, V28, P57, DOI 10.1080/10641960500386817; Intengan HD, 1999, CIRCULATION, V100, P2267, DOI 10.1161/01.CIR.100.22.2267; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Intengan HD, 2000, HYPERTENSION, V36, P312, DOI 10.1161/01.HYP.36.3.312; KURTZ TW, 1989, HYPERTENSION, V13, P188, DOI 10.1161/01.HYP.13.2.188; Lichtenstein O, 1998, HYPERTENSION, V32, P346, DOI 10.1161/01.HYP.32.2.346; MacKenna DA, 1997, AM J PHYSIOL-HEART C, V273, pH1576, DOI 10.1152/ajpheart.1997.273.3.H1576; Mathiassen ON, 2007, J HYPERTENS, V25, P1021, DOI 10.1097/HJH.0b013e32805bf8ed; Mulvany MJ, 1999, CARDIOVASC RES, V41, P9, DOI 10.1016/S0008-6363(98)00289-2; MULVANY MJ, 1985, CIRC RES, V57, P794, DOI 10.1161/01.RES.57.5.794; OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282; Rizzi E, 2013, EXP MOL PATHOL, V94, P1, DOI 10.1016/j.yexmp.2012.10.010; Rizzoni D, 2003, CIRCULATION, V108, P2230, DOI 10.1161/01.CIR.0000095031.51492.C5; Safar M, 2001, HYPERTENSION, V38, P1416, DOI 10.1161/hy1201.096538; Van Gorp AW, 2000, AM J PHYSIOL-HEART C, V278, pH1241, DOI 10.1152/ajpheart.2000.278.4.H1241; VanBavel E, 2003, AM J PHYSIOL-HEART C, V285, pH1986, DOI 10.1152/ajpheart.00248.2003; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008; Zhang-James Y, 2013, PHYSIOL GENOMICS, V45, P528, DOI 10.1152/physiolgenomics.00002.2013	32	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107998	10.1371/journal.pone.0107998	http://dx.doi.org/10.1371/journal.pone.0107998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251068	gold, Green Submitted, Green Published			2022-12-25	WOS:000342492700069
J	Braverman, ER; Han, D; Oscar-Berman, M; Karikh, T; Truesdell, C; Dushaj, K; Kreuk, F; Li, M; Stratton, D; Blum, K				Braverman, Eric R.; Han, David; Oscar-Berman, Marlene; Karikh, Tatiana; Truesdell, Courtney; Dushaj, Kristina; Kreuk, Florian; Li, Mona; Stratton, Danielle; Blum, Kenneth			Menopause Analytical Hormonal Correlate Outcome Study (MAHCOS) and the Association to Brain Electrophysiology (P300) in a Clinical Setting	PLOS ONE			English	Article							PLASMA LEPTIN LEVELS; MILD COGNITIVE IMPAIRMENT; SERUM LEPTIN; POSTMENOPAUSAL WOMEN; RISK-FACTORS; BODY-MASS; LUTEINIZING-HORMONE; MOUSE MODEL; WEIGHT-LOSS; SEX	Various studies have demonstrated that increased leptin levels and obesity are inversely related to cognitive decline in menopausal women. It is hypothesized that adiposity is inversely correlated with cognitive decline, as women with increased weight are less vulnerable to diminishing cognition. However, it is increasingly observed that menopausal women, even with increased adiposity, experience significant cognitive decline. Positron emission tomography (PET) has been used to analyze cognitive function and processing in menopausal women. Evoked potentials (P300) and neurophysiologic tests have validated brain metabolism in cognitively impaired patients. Post-hoc analyses of 796 female patients entering PATH Medical Clinic, between January 4, 2009 and February 24, 2013, were performed as part of the "Menopause Analytical Hormonal Correlate Outcome Study" (MAHCOS). Patient age range was 39-76 years (46.7 +/- 0.2). P300 latency and amplitude correlated with a number of hormones: follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol, estrone, estriol, DHEA, pregnenolone, progesterone, free and total testosterone, thyroid stimulating hormone (TSH), Vitamins D 1.25 and D 25OH, leptin, and insulin-like growth factor-binding protein 3 (IGF-BP3). Corrected statistics did not reveal significant associations with P300 latency or amplitude for these hormones except for leptin plasma levels. However, factor analysis showed that FSH and LH clustered together with Vitamin D1.25 and Vitamin D25OH, P300 latency (not amplitude), and log leptin were found to be associated in the same cluster. Utilizing regression analysis, once age adjusted, leptin was the only significant predictor for latency or speed (p = 0.03) with an effect size of 0.23. Higher plasma leptin levels were associated with abnormal P300 speed (OR = 0.98). Our findings show a significant relationship of higher plasma leptin levels, potentially due to leptin resistance, and prolonged P300 latency. This suggests leptin resistance may delay electrophysiological processing of memory and attention, which appears to be the first of such an association.	[Braverman, Eric R.; Karikh, Tatiana; Truesdell, Courtney; Dushaj, Kristina; Kreuk, Florian; Li, Mona; Stratton, Danielle; Blum, Kenneth] PATH Fdn NY, Dept Clin Neurol, New York, NY 10016 USA; [Braverman, Eric R.; Blum, Kenneth] Univ Florida, Coll Med, Dept Psychiat, Gainesville, FL USA; [Braverman, Eric R.; Blum, Kenneth] McKnight Brain Inst, Gainesville, FL USA; [Han, David] Univ Texas San Antonio, Dept Management Sci & Stat, San Antonio, TX USA; [Oscar-Berman, Marlene] Boston Univ, Sch Med, Dept Psychiat, Dept Neurol, Boston, MA 02118 USA; [Oscar-Berman, Marlene] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Oscar-Berman, Marlene] Boston VA Healthcare Syst, Boston, MA USA; [Blum, Kenneth] Univ Vermont, Ctr Clin & Translat Sci, Dept Psychiat, Human Integrated Serv Unit, Burlington, VT USA; [Blum, Kenneth] Inst Integrat Omics & Appl Biotechnol, Medinipur, W Bengal, India; [Blum, Kenneth] Domin Diagnost LLC, North Kingstown, RI USA	State University System of Florida; University of Florida; University of Texas System; University of Texas at San Antonio (UTSA); Boston University; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; University of Vermont	Blum, K (corresponding author), PATH Fdn NY, Dept Clin Neurol, New York, NY 10016 USA.	drd2gene@gmail.com	Braverman, Eric new/ABC-1152-2021	Berman, Marlene Oscar/0000-0003-0100-8883	Life Extension Foundation	Life Extension Foundation	The authors are grateful to the Life Extension Foundation for their generous financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbenhardt C, 2013, J INTERN MED, V274, P163, DOI 10.1111/joim.12062; Abdullah SM, 2007, ATHEROSCLEROSIS, V195, P404, DOI 10.1016/j.atherosclerosis.2006.10.022; Ajala OM, 2013, INT J ENDOCRINOL MET, V11, P27, DOI 10.5812/ijem.6872; al-Hader A A, 1997, Early Pregnancy, V3, P323; Anderer P, 2005, MATURITAS, V51, P254, DOI 10.1016/j.maturitas.2004.08.005; Arnoldussen IAC, 2014, EUR NEUROPSYCHOPHARM, V24, P1982, DOI 10.1016/j.euroneuro.2014.03.002; Asaumi Y, 2014, PSYCHIAT CLIN NEUROS, V68, P558, DOI 10.1111/pcn.12162; Ben Ali S, 2011, CYTOKINE, V56, P338, DOI 10.1016/j.cyto.2011.06.026; Berent-Spillson A, 2010, MENOPAUSE, V17, P692, DOI 10.1097/gme.0b013e3181cc49e9; Beydoun MA, 2008, OBES REV, V9, P204, DOI 10.1111/j.1467-789X.2008.00473.x; Bove RM, 2013, OBESITY, V21, P1343, DOI 10.1002/oby.20212; Braverman ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055398; Bryan KJ, 2010, J NEUROCHEM, V112, P870, DOI 10.1111/j.1471-4159.2009.06502.x; Buchman AS, 2005, NEUROLOGY, V65, P892, DOI 10.1212/01.wnl.0000176061.33817.90; Chakrabarti J, 2013, ANN MED HEALTH SCI R, V3, P191, DOI 10.4103/2141-9248.113660; Cham M, 2014, J NEUROENDOCRINOL, DOI [10.1111/jne.12159, DOI 10.1111/JNE.12159]; Chen XW, 2014, PEPTIDES, V57, P31, DOI 10.1016/j.peptides.2014.04.016; Cronk BB, 2010, ALZ DIS ASSOC DIS, V24, P126, DOI 10.1097/WAD.0b013e3181a6bf3f; Davis Jennifer Duncan, 2008, Curr Aging Sci, V1, P175; Diamanti-Kandarakis E, 2010, MENOPAUSE, V17, P1; El Kholy M, 2007, HORM RES, V68, P272, DOI 10.1159/000104175; Eramudugolla R, 2014, J INT NEUROPSYCH SOC, V20, P444, DOI 10.1017/S1355617714000174; Farr SA, 2006, PEPTIDES, V27, P1420, DOI 10.1016/j.peptides.2005.10.006; Fewlass DC, 2004, FASEB J, V18, P1870, DOI 10.1096/fj.04-2572com; Fischer B, 2014, FERTIL STERIL, V101, P898, DOI 10.1016/j.fertnstert.2014.02.025; FORBES GB, 1983, INT J OBESITY, V7, P99; FOSTER JD, 1993, ENDOCRINOLOGY, V132, P337, DOI 10.1210/en.132.1.337; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fungfuang Wirasak, 2013, Lab Anim Res, V29, P168, DOI 10.5625/lar.2013.29.3.168; Geber S, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-45; Gibbs RB, 2010, ENDOCR REV, V31, P224, DOI 10.1210/er.2009-0036; Greco SJ, 2010, J ALZHEIMERS DIS, V19, P1155, DOI 10.3233/JAD-2010-1308; Gunstad J, 2008, BRAIN RES, V1230, P233, DOI 10.1016/j.brainres.2008.07.045; Harvey J, 2006, PROG LIPID RES, V45, P369, DOI 10.1016/j.plipres.2006.03.001; Hassing LB, 2010, DEMENT GERIATR COGN, V29, P543, DOI 10.1159/000314874; Holden KF, 2009, NEUROBIOL AGING, V30, P1483, DOI 10.1016/j.neurobiolaging.2007.11.024; Howe AS, 2014, BRAIN COGNITION, V86, P64, DOI 10.1016/j.bandc.2014.01.015; Iida Tadayuki, 2011, Hiroshima Journal of Medical Sciences, V60, P71; Jones ME, 2013, J CLIN ENDOCR METAB, V98, P2967, DOI 10.1210/jc.2013-1588; Kamogawa K, 2010, DEMENT GERIATR COGN, V30, P432, DOI 10.1159/000321985; Kanaya AM, 2009, ARCH NEUROL-CHICAGO, V66, P329, DOI 10.1001/archneurol.2008.570; Kanoski SE, 2011, NEUROPSYCHOPHARMACOL, V36, P1859, DOI 10.1038/npp.2011.70; Kass AS, 2010, SCAND J RHEUMATOL, V39, P109, DOI 10.3109/03009740903270607; Kocyigit H, 2013, BOSNIAN J BASIC MED, V13, P192, DOI 10.17305/bjbms.2013.2361; Lee MS, 2013, PROG NEURO-PSYCHOPH, V40, P62, DOI 10.1016/j.pnpbp.2012.08.009; Lee SW, 2012, J OBSTET GYNAECOL, V32, P73, DOI 10.3109/01443615.2011.618893; Li RN, 2014, MOL CELL ENDOCRINOL, V389, P13, DOI 10.1016/j.mce.2013.12.018; Lieb W, 2009, JAMA-J AM MED ASSOC, V302, P2565, DOI 10.1001/jama.2009.1836; Lord C, 2010, MENOPAUSE, V17, P846, DOI 10.1097/gme.0b013e3181e06b83; Mahmud K, 2010, GYNECOL ENDOCRINOL, V26, P81, DOI 10.3109/09513590903184134; Marques-Vidal P, 2010, CLIN ENDOCRINOL, V72, P38, DOI 10.1111/j.1365-2265.2009.03628.x; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Newhouse PA, 2010, MENOPAUSE, V17, P860, DOI 10.1097/gme.0b013e3181e15df4; Nicklas BJ, 1997, J CLIN ENDOCR METAB, V82, P315, DOI 10.1210/jc.82.1.315; O'Connor KA, 2009, MENOPAUSE, V16, P1178, DOI 10.1097/gme.0b013e3181aa192d; Panay N, 2010, CLIMACTERIC, V13, P121, DOI 10.3109/13697131003675922; Parra Mario A, 2012, Front Neurol, V3, P172, DOI 10.3389/fneur.2012.00172; Perez-Gonzalez R, 2011, J ALZHEIMERS DIS, V24, P17, DOI 10.3233/JAD-2011-102070; Polich J, 2000, INT J PSYCHOPHYSIOL, V38, P3, DOI 10.1016/S0167-8760(00)00127-6; Power DA, 2001, DEMENT GERIATR COGN, V12, P167, DOI 10.1159/000051252; Priya T, 2013, DIABETES METAB SYND, V7, P233, DOI 10.1016/j.dsx.2013.06.016; Rance KA, 2007, INT J OBESITY, V31, P1311, DOI 10.1038/sj.ijo.0803535; Razay G, 2006, DEMENT GERIATR COGN, V22, P173, DOI 10.1159/000094586; Ruhl CE, 2004, AM J CLIN NUTR, V80, P576; Ruszkowska B, 2012, J ZHEJIANG UNIV-SC B, V13, P35, DOI 10.1631/jzus.B1100276; Sarac F, 2011, GYNECOL ENDOCRINOL, V27, P273, DOI 10.3109/09513590.2010.491165; Shah NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033308; Short RA, 2001, MAYO CLIN PROC, V76, P906; Siawrys G, 2013, J PHYSIOL PHARMACOL, V64, P513; Soni AC, 2011, MENOPAUSE, V18, P296, DOI 10.1097/gme.0b013e3181f2e611; Sozay S, 1994, Thyroidology, V6, P55; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Thurston RC, 2013, FERTIL STERIL, V100, P793, DOI 10.1016/j.fertnstert.2013.05.005; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Warren MW, 2012, DEMENT GERIATR COGN, V33, P410, DOI 10.1159/000339956; Warren MW, 2012, J ALZHEIMERS DIS, V29, P151, DOI 10.3233/JAD-2012-111385; Weiner MF, 2008, ALZHEIMERS DEMENT, V4, P233, DOI 10.1016/j.jalz.2007.10.016; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Wiacek M, 2010, MENOPAUSE, V18, P1; WICH BK, 1995, ENDOCRIN METAB CLIN, V24, P273, DOI 10.1016/S0889-8529(18)30042-2; Wira CR, 2014, AM J REPROD IMMUNOL, V72, P236, DOI 10.1111/aji.12252; Yan BC, 2011, J NEUROL SCI, V303, P100, DOI 10.1016/j.jns.2010.12.025; Zhou X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072734; Zilberman JM, 2011, SCIENCEDAILY	84	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e105048	10.1371/journal.pone.0105048	http://dx.doi.org/10.1371/journal.pone.0105048			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251414	Green Submitted, Green Published, gold			2022-12-25	WOS:000342492700006
J	Hao, WJ; Fan, SH; Hua, W; Wang, HZ				Hao, Wanjun; Fan, Shihang; Hua, Wei; Wang, Hanzhong			Effective Extraction and Assembly Methods for Simultaneously Obtaining Plastid and Mitochondrial Genomes	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; RAPHANUS-SATIVUS; CHLOROPLAST DNA; BRASSICA-NAPUS; RAPESEED; LEAF; L.	Background: In conventional approaches to plastid and mitochondrial genome sequencing, the sequencing steps are performed separately; thus, plastid DNA (ptDNA) and mitochondrial DNA (mtDNA) should be prepared independently. However, it is difficult to extract pure ptDNA and mtDNA from plant tissue. Following the development of high-throughput sequencing technology, many researchers have attempted to obtain plastid genomes or mitochondrial genomes using high-throughput sequencing data from total DNA. Unfortunately, the huge datasets generated consume massive computing and storage resources and cost a great deal, and even more importantly, excessive pollution reads affect the accuracy of the assembly. Therefore, it is necessary to develop an effective method that can generate base sequences from plant tissue and that is suitable for all plant species. Here, we describe a highly effective, low-cost method for obtaining plastid and mitochondrial genomes simultaneously. Results: First, we obtained high-quality DNA employing Partial Concentration Extraction. Second, we evaluated the purity of the DNA sample and determined the sequencing dataset size employing Vector Control Quantitative Analysis. Third, paired-end reads were obtained using a high-throughput sequencing platform. Fourth, we obtained scaffolds employing Two-step Assembly. Finally, we filled in gaps using specific methods and obtained complete plastid and mitochondrial genomes. To ensure the accuracy of plastid and mitochondrial genomes, we validated the assembly using PCR and Sanger sequencing. Using this method, we obtained complete plastid and mitochondrial genomes with lengths of 153,533 nt and 223,412 nt separately. Conclusion: A simple method for extracting, evaluating, sequencing and assembling plastid and mitochondrial genomes was developed. This method has many advantages: it is timesaving, inexpensive and reproducible and produces high-quality sequence. Furthermore, this method can produce plastid and mitochondrial genomes simultaneously and be used for other plant species. Due to its simplicity and extensive applicability, this method will support research on plant cytoplasmic genomes.	[Hao, Wanjun; Fan, Shihang; Hua, Wei; Wang, Hanzhong] Chinese Acad Agr Sci, Oil Crops Res Inst, Key Lab Biol Sci Oil Crops, Minist Agr, Wuhan, Peoples R China; [Fan, Shihang] Hubei Univ, Coll Life Sci, Wuhan, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Hubei University	Wang, HZ (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Key Lab Biol Sci Oil Crops, Minist Agr, Wuhan, Peoples R China.	wanghz@oilcrops.cn			National High Technology Research and Development Program of China [2013AA102602]; National Key Basic Research Program of China [2011CB109300]; Core Research Budget of the Non-profit Governmental Research Institution [161017]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Key Basic Research Program of China(National Basic Research Program of China); Core Research Budget of the Non-profit Governmental Research Institution	This study was supported by the National High Technology Research and Development Program of China (2013AA102602), the National Key Basic Research Program of China (2011CB109300) and the Core Research Budget of the Non-profit Governmental Research Institution (161017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alverson AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016404; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; Atherton RA, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-22; Chang SX, 2013, J GENET GENOMICS, V40, P117, DOI 10.1016/j.jgg.2013.01.003; Chen JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017662; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Darracq A, 2011, GENOME BIOL EVOL, V3, P723, DOI 10.1093/gbe/evr042; Goremykin VV, 2012, PLANT J, V71, P615, DOI 10.1111/j.1365-313X.2012.05014.x; Handa H, 2003, NUCLEIC ACIDS RES, V31, P5907, DOI 10.1093/nar/gkg795; Hu ZY, 2012, J INTEGR AGR, V11, P1212, DOI 10.1016/S2095-3119(12)60117-8; KEMBLE RJ, 1987, THEOR APPL GENET, V73, P364, DOI 10.1007/BF00262502; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Liu H, 2012, BMC GENOMICS, V12, P163; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Park JY, 2013, THEOR APPL GENET, V126, P1763, DOI 10.1007/s00122-013-2090-0; Shi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031468; Stull GW, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200497; Sugiyama Y, 2005, MOL GENET GENOMICS, V272, P603, DOI 10.1007/s00438-004-1075-8; Tanaka Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-352; Triboush SO, 1998, PLANT MOL BIOL REP, V16, P183, DOI 10.1023/A:1007487806583; Wang J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-675; Wang WQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046747; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Yi X, 2013, GENOME BIOL EVOL, V5, P688, DOI 10.1093/gbe/evt042; Zhang TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030531	26	9	11	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108291	10.1371/journal.pone.0108291	http://dx.doi.org/10.1371/journal.pone.0108291			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251391	gold, Green Published, Green Submitted			2022-12-25	WOS:000342492700106
J	Wu, JH; Xiang, H; Qi, YX; Yang, D; Wang, XJ; Sun, HL; Wang, F; Liu, B				Wu, Jianghong; Xiang, Hui; Qi, Yunxia; Yang, Ding; Wang, Xiaojuan; Sun, Hailian; Wang, Feng; Liu, Bin			Adaptive Evolution of the STRA6 Genes in Mammalian	PLOS ONE			English	Article							COLOR-VISION; MEMBRANE-RECEPTOR; VITAMIN-A; PROTEIN; RESOLUTION; MUTATIONS; SPECTRUM; EYE	Stimulated by retinoic acid 6 (STRA6) is the receptor for retinol binding protein and is relevant for the transport of retinol to specific sites such as the eye. The adaptive evolution mechanism that vertebrates have occupied nearly every habitat available on earth and adopted various lifestyles associated with different light conditions and visual challenges, as well as their role in development and adaptation is thus far unknown. In this work, we have investigated different aspects of vertebrate STRA6 evolution and used molecular evolutionary analyses to detect evidence of vertebrate adaptation to the lightless habitat. Free-ratio model revealed significant rate shifts immediately after the species divergence. The amino acid sites detected to be under positive selection are within the extracellular loops of STRA6 protein. Branch-site model A test revealed that STRA6 has undergone positive selection in the different phyla of mammalian except for the branch of rodent. The results suggest that interactions between different light environments and host may be driving adaptive change in STRA6 by competition between species. In support of this, we found that altered functional constraints may take place at some amino acid residues after speciation. We suggest that STRA6 has undergone adaptive evolution in different branch of vertebrate relation to habitat environment.	[Wu, Jianghong; Qi, Yunxia; Yang, Ding; Wang, Xiaojuan; Sun, Hailian] Chinese Acad Sci, Inner Mongolia Prataculture Res Ctr, Hohhot, Peoples R China; [Wu, Jianghong; Qi, Yunxia; Yang, Ding; Wang, Xiaojuan; Sun, Hailian; Wang, Feng; Liu, Bin] Inner Mongolia Acad Agr & Anim Husb Sci, Anim Husb Inst, Hohhot, Peoples R China; [Wu, Jianghong; Xiang, Hui] Chinese Acad Sci, Kunming Inst Zool, Kunming, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology	Wu, JH (corresponding author), Chinese Acad Sci, Inner Mongolia Prataculture Res Ctr, Hohhot, Peoples R China.	wujianghonglong@126.com; xiangh@mail.kiz.ac.cn	wu, Jianghong/E-7587-2015	wu, Jianghong/0000-0003-4027-2345	National Natural Science Foundation of China [31260538]; Natural Science Foundation of Inner Mongolian [2013MS0414]; Youth Innovation Foundation of IMAAAHS [2013QNJJM03]; State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences [GREKF13-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Inner Mongolian; Youth Innovation Foundation of IMAAAHS; State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China (31260538), the Natural Science Foundation of Inner Mongolian (2013MS0414) and the Youth Innovation Foundation of IMAAAHS (2013QNJJM03). Also supported by State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences (GREKF13-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry DC, 2011, P NATL ACAD SCI USA, V108, P4340, DOI 10.1073/pnas.1011115108; BOUILLET P, 1995, DEV BIOL, V170, P420, DOI 10.1006/dbio.1995.1226; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Chassaing N, 2009, HUM MUTAT, V30, pE673, DOI 10.1002/humu.21023; Fernald RD, 2006, SCIENCE, V313, P1914, DOI 10.1126/science.1127889; Gerkema MP, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0508; Golding GB, 1998, MOL BIOL EVOL, V15, P355, DOI 10.1093/oxfordjournals.molbev.a025932; Jacobs GH, 2008, VISUAL NEUROSCI, V25, P619, DOI 10.1017/S0952523808080760; Joffe B, 2014, EVOL BIOL, V41, P1, DOI 10.1007/s11692-013-9240-9; Kawaguchi R, 2008, J BIOL CHEM, V283, P15160, DOI 10.1074/jbc.M801060200; Kawaguchi R, 2008, BIOCHEMISTRY-US, V47, P5387, DOI 10.1021/bi8002082; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kawaguchi R, 2012, J MEMBRANE BIOL, V245, P731, DOI 10.1007/s00232-012-9463-1; Kelber A, 2006, J EXP BIOL, V209, P781, DOI 10.1242/jeb.02060; Kimball RT, 2013, MOL PHYLOGENET EVOL, V69, P1021, DOI 10.1016/j.ympev.2013.05.029; Kozmik Z, 2008, BRAIN RES BULL, V75, P335, DOI 10.1016/j.brainresbull.2007.10.046; LAND MF, 1992, ANNU REV NEUROSCI, V15, P1, DOI 10.1146/annurev.ne.15.030192.000245; Liu Y, 2010, CURR BIOL, V20, P1834, DOI 10.1016/j.cub.2010.09.008; Lythgoe J.N., 1988, P57; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; Peichl L, 2005, J COMP NEUROL, V486, P197, DOI 10.1002/cne.20491; Poliakov E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049975; Price SA, 2005, BIOL REV, V80, P445, DOI 10.1017/S1464793105006743; Ruiz A, 2012, INVEST OPHTH VIS SCI, V53, P3027, DOI 10.1167/iovs.11-8476; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Szeto W, 2001, CANCER RES, V61, P4197; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BIO203S00; Wheatley M, 2012, BRIT J PHARMACOL, V165, P1688, DOI 10.1111/j.1476-5381.2011.01629.x; Xu HH, 2013, GENE, V530, P208, DOI 10.1016/j.gene.2013.08.034; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yuri Tamaki, 2013, Biology - Basel, V2, P419, DOI 10.3390/biology2010419; Zhao HB, 2009, P NATL ACAD SCI USA, V106, P8980, DOI 10.1073/pnas.0813201106	38	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108388	10.1371/journal.pone.0108388	http://dx.doi.org/10.1371/journal.pone.0108388			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251323	gold, Green Published, Green Submitted			2022-12-25	WOS:000342492700122
J	Gao, XG; Yourick, JJ; Sprando, RL				Gao, Xiugong; Yourick, Jeffrey J.; Sprando, Robert L.			Transcriptomic Characterization of C57BL/6 Mouse Embryonic Stem Cell Differentiation and Its Modulation by Developmental Toxicants	PLOS ONE			English	Article							IN-VITRO; TEST EST; TOXICITY; EMBRYOTOXICITY; CULTURES; TOXICOGENOMICS; REQUIREMENTS; DERIVATION; HISTORY; INVITRO	The Tox21 program calls for transforming toxicology testing from traditional in vivo tests to less expensive and higher throughput in vitro methods. In developmental toxicology, a spectrum of alternative methods including cell line based tests has been developed. In particular, embryonic stem cells (ESCs) have received widespread attention as a promising alternative model for developmental toxicity assessment. Here, we characterized gene expression changes during mouse ESC differentiation and their modulation by developmental toxicants. C57BL/6 ESCs were allowed to differentiate spontaneously and RNA of vehicle controls was collected at 0, 24, 48, 72, 96, 120 and 168 h after embryoid body (EB) formation; RNA of compound-exposed EBs were collected at 24 h. Samples were hybridized to Affymetrix Mouse Gene 2.0 ST Array; using stringent cut-off criteria of Bonferroni-adjusted p<0.05 and fold change >2.0, a total of 1996 genes were found differentially expressed among the vehicle controls at different time points. Gene ontology (GO) analysis showed these regulated genes were mostly involved in differentiation-related processes such as development, morphogenesis, metabolism, cell differentiation, cell organization and biogenesis, embryonic development, and reproduction. Biomarkers of all three germ layers or of their derivative early cell types were identified in the gene list. Principal component analysis (PCA) based on these genes showed that the unexposed vehicle controls appeared in chronological order in the PCA plot, and formed a differentiation track when connected. Cultures exposed to thalidomide, monobutyl phthalate, or valproic acid deviated significantly from the differentiation track, manifesting the capacity of the differentiation track to identify the modulating effects of diverse developmental toxicants. The differentiation track defined in this study may be further exploited as a baseline for developmental toxicity testing, with compounds causing significant deviation from the differentiation track being predicted as potential developmental toxicants.	[Gao, Xiugong; Yourick, Jeffrey J.; Sprando, Robert L.] US FDA, Ctr Food Safety & Appl Nutr, Div Toxicol, Off Appl Res & Safety Assessment, Laurel, MD 20705 USA	US Food & Drug Administration (FDA)	Gao, XG (corresponding author), US FDA, Ctr Food Safety & Appl Nutr, Div Toxicol, Off Appl Res & Safety Assessment, Laurel, MD 20705 USA.	xiugong.gao@fda.hhs.gov						Alsdorf Rachel, 2005, Expert Opin Drug Saf, V4, P345, DOI 10.1517/14740338.4.2.345; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Auerbach W, 2011, ADV PROTOCOLS ANIMAL, P327; De Smedt A, 2008, TOXICOL IN VITRO, V22, P1789, DOI 10.1016/j.tiv.2008.07.003; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FLINT OP, 1984, TOXICOL APPL PHARM, V76, P383, DOI 10.1016/0041-008X(84)90020-6; Genschow E, 2004, ATLA-ALTERN LAB ANIM, V32, P209, DOI 10.1177/026119290403200305; HEUER J, 1993, TOXICOL IN VITRO, V7, P551, DOI 10.1016/0887-2333(93)90064-C; Hofer T, 2004, ARCH TOXICOL, V78, P549, DOI 10.1007/s00204-004-0577-9; Hu ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Hubbard KS, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-127; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jelier R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r96; Jergil M, 2011, TOXICOL SCI, V121, P328, DOI 10.1093/toxsci/kfr070; Keskintepe L, 2007, TRANSGENIC RES, V16, P751, DOI 10.1007/s11248-007-9125-8; Lein P, 2005, ENVIRON TOXICOL PHAR, V19, P735, DOI 10.1016/j.etap.2004.12.035; LENZ W, 1988, TERATOLOGY, V38, P203, DOI 10.1002/tera.1420380303; Lyche JL, 2009, J TOXICOL ENV HEAL B, V12, P225, DOI 10.1080/10937400903094091; MARTIN GR, 1977, DEV BIOL, V61, P230, DOI 10.1016/0012-1606(77)90294-9; Marx-Stoelting P, 2009, ATLA-ALTERN LAB ANIM, V37, P313, DOI 10.1177/026119290903700314; Massague J, 2012, FEBS LETT, V586, P1953, DOI 10.1016/j.febslet.2012.03.023; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; NEW DAT, 1976, J REPROD FERTIL, V48, P219; Okuda A, 1998, EMBO J, V17, P2019, DOI 10.1093/emboj/17.7.2019; Pennings JLA, 2011, TOXICOLOGY, V284, P63, DOI 10.1016/j.tox.2011.03.017; Riebeling C, 2012, CRIT REV TOXICOL, V42, P443, DOI 10.3109/10408444.2012.674483; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Schulpen Sjors H W, 2013, Methods Mol Biol, V947, P375, DOI 10.1007/978-1-62703-131-8_27; Shukla SJ, 2010, DRUG DISCOV TODAY, V15, P997, DOI 10.1016/j.drudis.2010.07.007; Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Spielmann Horst, 1997, In Vitro Toxicology, V10, P119; Spielmann H, 2006, ATLA-ALTERN LAB ANIM, V34, P365, DOI 10.1177/026119290603400405; Spielmann H, 2009, ATLA-ALTERN LAB ANIM, V37, P641, DOI 10.1177/026119290903700609; Steinberg MS, 2007, CURR OPIN GENET DEV, V17, P281, DOI 10.1016/j.gde.2007.05.002; Tandon S, 2012, J PHARM BIOALLIED SC, V4, P96, DOI 10.4103/0975-7406.94808; Therapontos C, 2009, P NATL ACAD SCI USA, V106, P8573, DOI 10.1073/pnas.0901505106; Tichy ED, 2011, EXP BIOL MED, V236, P987, DOI 10.1258/ebm.2011.011107; Tong WD, 2004, MUTAT RES-FUND MOL M, V549, P241, DOI 10.1016/j.mrfmmm.2003.12.024; Tong WD, 2003, ENVIRON HEALTH PERSP, V111, P1819, DOI 10.1289/ehp.6497; van Dartel DAM, 2011, REPROD TOXICOL, V32, P235, DOI 10.1016/j.reprotox.2011.04.008; van Dartel DAM, 2011, TOXICOL SCI, V119, P126, DOI 10.1093/toxsci/kfq291; van Dartel DAM, 2010, TOXICOL APPL PHARM, V243, P420, DOI 10.1016/j.taap.2009.12.021; van Dartel DAM, 2009, REPROD TOXICOL, V27, P93, DOI 10.1016/j.reprotox.2008.12.009; Williams ES, 2009, CRIT REV TOXICOL, V39, P553, DOI 10.1080/10408440903036056; Yuan XL, 2011, J APPL TOXICOL, V31, P421, DOI 10.1002/jat.1601	48	13	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108510	10.1371/journal.pone.0108510	http://dx.doi.org/10.1371/journal.pone.0108510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247782	Green Published, gold, Green Submitted			2022-12-25	WOS:000342351800095
J	Niccolai, V; Klepp, A; Weissler, H; Hoogenboom, N; Schnitzler, A; Biermann-Ruben, K				Niccolai, Valentina; Klepp, Anne; Weissler, Hannah; Hoogenboom, Nienke; Schnitzler, Alfons; Biermann-Ruben, Katja			Grasping Hand Verbs: Oscillatory Beta and Alpha Correlates of Action-Word Processing	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; LANGUAGE DOMINANCE; FUNCTIONAL-ROLE; EEG; IMAGERY; BRAIN; MU; REPRESENTATIONS; SYNCHRONIZATION; FREQUENCY	The grounded cognition framework proposes that sensorimotor brain areas, which are typically involved in perception and action, also play a role in linguistic processing. We assessed oscillatory modulation during visual presentation of single verbs and localized cortical motor regions by means of isometric contraction of hand and foot muscles. Analogously to oscillatory activation patterns accompanying voluntary movements, we expected a somatotopically distributed suppression of beta and alpha frequencies in the motor cortex during processing of body-related action verbs. Magnetoencephalographic data were collected during presentation of verbs that express actions performed using the hands (H) or feet (F). Verbs denoting no bodily movement (N) were used as a control. Between 150 and 500 msec after visual word onset, beta rhythms were suppressed in H and F in comparison with N in the left hemisphere. Similarly, alpha oscillations showed left-lateralized power suppression in the H-N contrast, although at a later stage. The cortical oscillatory activity that typically occurs during voluntary movements is therefore found to somatotopically accompany the processing of body-related verbs. The combination of a localizer task with the oscillatory investigation applied to verb reading as in the present study provides further methodological possibilities of tracking language processing in the brain.	[Niccolai, Valentina; Klepp, Anne; Weissler, Hannah; Hoogenboom, Nienke; Schnitzler, Alfons; Biermann-Ruben, Katja] Univ Dusseldorf, Fac Med, Inst Clin Neurosci & Med Psychol Med, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Niccolai, V (corresponding author), Univ Dusseldorf, Fac Med, Inst Clin Neurosci & Med Psychol Med, Dusseldorf, Germany.	Valentina.Niccolai@hhu.de	Schnitzler, Alfons/Q-5520-2019; Schnitzler, Alfons/K-4625-2014; Schnitzler, Alfons/AAT-1054-2021	Schnitzler, Alfons/0000-0002-6414-7939; Schnitzler, Alfons/0000-0002-6414-7939; 	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 991/1, B03]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 991/1, B03). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemanno F, 2012, BRAIN RES, V1484, P39, DOI 10.1016/j.brainres.2012.09.030; Aziz-Zadeh L, 2006, CURR BIOL, V16, P1818, DOI 10.1016/j.cub.2006.07.060; Babiloni C, 2002, NEUROIMAGE, V17, P559, DOI 10.1006/nimg.2002.1192; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Biemann C., 2007, P CORP LING 2007; Boulenger V, 2012, NEUROIMAGE, V59, P3502, DOI 10.1016/j.neuroimage.2011.11.011; Boulenger V, 2009, CEREB CORTEX, V19, P1905, DOI 10.1093/cercor/bhn217; Buccino G, 2005, COGNITIVE BRAIN RES, V24, P355, DOI 10.1016/j.cogbrainres.2005.02.020; Burianova H, 2013, NEUROIMAGE, V71, P50, DOI 10.1016/j.neuroimage.2013.01.001; Canolty RT, 2007, FRONT NEUROSCI-SWITZ, V1, P185, DOI 10.3389/neuro.01.1.1.014.2007; Corballis MC, 2009, HUM MOVEMENT SCI, V28, P556, DOI 10.1016/j.humov.2009.07.003; Crone NE, 1998, BRAIN, V121, P2271, DOI 10.1093/brain/121.12.2271; de Lange FP, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.007.2008; de Zubicaray G, 2013, J COGNITIVE NEUROSCI, V25, P1957, DOI 10.1162/jocn_a_00437; Desai RH, 2011, J COGNITIVE NEUROSCI, V23, P2376, DOI 10.1162/jocn.2010.21596; Doyle LMF, 2005, CLIN NEUROPHYSIOL, V116, P1879, DOI 10.1016/j.clinph.2005.03.017; Ehrenstein W. H., 2008, AUGE OHR HAND FUSS B; Fisher AE, 2008, INT J PSYCHOPHYSIOL, V68, P111, DOI 10.1016/j.ijpsycho.2007.12.005; Fodor J. A, 2001, MIND DOESNT WORK WAY; Formaggio E, 2010, MAGN RESON IMAGING, V28, P1403, DOI 10.1016/j.mri.2010.06.030; Formaggio E, 2008, BRAIN TOPOGR, V21, P100, DOI 10.1007/s10548-008-0058-1; Glenberg AM, 2008, CURR BIOL, V18, pR290, DOI 10.1016/j.cub.2008.02.036; Grabner RH, 2007, BRAIN RES BULL, V72, P57, DOI 10.1016/j.brainresbull.2007.01.001; Gross J, 2000, J PHYSIOL-LONDON, V527, P623, DOI 10.1111/j.1469-7793.2000.00623.x; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Hari R, 1997, INT J PSYCHOPHYSIOL, V26, P51, DOI 10.1016/S0167-8760(97)00755-1; Hauk O, 2004, CLIN NEUROPHYSIOL, V115, P1090, DOI 10.1016/j.clinph.2003.12.020; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hirata M, 2004, NEUROIMAGE, V23, P46, DOI 10.1016/j.neuroimage.2004.05.009; Holler Y, 2013, INT J PSYCHOPHYSIOL, V87, P35, DOI 10.1016/j.ijpsycho.2012.10.015; Hoogenboom N, 2010, NEUROIMAGE, V51, P1162, DOI 10.1016/j.neuroimage.2010.03.041; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kemmerer D, 2008, BRAIN LANG, V107, P16, DOI 10.1016/j.bandl.2007.09.003; Kemmerer D, 2012, CORTEX, V48, P826, DOI 10.1016/j.cortex.2010.11.001; Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512; Koelewijn T, 2008, NEUROIMAGE, V40, P767, DOI 10.1016/j.neuroimage.2007.12.018; Lakoff G, 1999, PHILOS FISH EMBODIED; Lange J, 2012, CEREB CORTEX, V22, P2564, DOI 10.1093/cercor/bhr329; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; May ES, 2012, NEUROIMAGE, V62, P1965, DOI 10.1016/j.neuroimage.2012.05.071; Meteyard L, 2012, CORTEX, V48, P788, DOI 10.1016/j.cortex.2010.11.002; Mima T, 1999, J CLIN NEUROPHYSIOL, V16, P501, DOI 10.1097/00004691-199911000-00002; Moreno I, 2013, BRAIN COGNITION, V82, P236, DOI 10.1016/j.bandc.2013.04.010; Nakagawa K, 2011, NEUROREPORT, V22, P217, DOI 10.1097/WNR.0b013e328344b480; Neininger B, 2003, NEUROPSYCHOLOGIA, V41, P53, DOI 10.1016/S0028-3932(02)00126-4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Pfurtscheller G, 2000, CLIN NEUROPHYSIOL, V111, P1873, DOI 10.1016/S1388-2457(00)00428-4; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 1997, INT J PSYCHOPHYSIOL, V26, P121, DOI 10.1016/S0167-8760(97)00760-5; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Postle N, 2008, NEUROIMAGE, V43, P634, DOI 10.1016/j.neuroimage.2008.08.006; Pulvermuller F, 1999, CEREB CORTEX, V9, P497, DOI 10.1093/cercor/9.5.497; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Pulvermuller F, 2005, J COGNITIVE NEUROSCI, V17, P884, DOI 10.1162/0898929054021111; Pulvermuller F, 2005, EUR J NEUROSCI, V21, P793, DOI 10.1111/j.1460-9568.2005.03900.x; Pulvermuller F, 2001, BRAIN LANG, V78, P143, DOI 10.1006/brln.2000.2390; Pylyshyn Z., 1984, COMPUTATION COGNITIO; Repetto C, 2013, NEUROPSYCHOLOGIA, V51, P8, DOI 10.1016/j.neuropsychologia.2012.11.001; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Ruschemeyer SA, 2007, J COGNITIVE NEUROSCI, V19, P855, DOI 10.1162/jocn.2007.19.5.855; Sakreida K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00125; Salmelin R, 2000, BRAIN, V123, P1184, DOI 10.1093/brain/123.6.1184; Schnitzler A, 1997, NEUROIMAGE, V6, P201, DOI 10.1006/nimg.1997.0286; Shtyrov Y, 2004, EUR J NEUROSCI, V19, P1083, DOI 10.1111/j.0953-816X.2004.03126.x; Singh KD, 2002, NEUROIMAGE, V16, P103, DOI 10.1006/nimg.2001.1050; Tecchio F, 2008, NEUROIMAGE, V40, P256, DOI 10.1016/j.neuroimage.2007.11.038; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; van Elk M, 2010, NEUROIMAGE, V50, P665, DOI 10.1016/j.neuroimage.2009.12.123; Vigliocco G, 2006, CEREB CORTEX, V16, P1790, DOI 10.1093/cercor/bhj115; Vingerhoets G, 2013, CORTEX, V49, P172, DOI 10.1016/j.cortex.2011.11.003; Willems RM, 2011, PSYCHOL SCI, V22, P849, DOI 10.1177/0956797611412387; Willems RM, 2010, PSYCHOL SCI, V21, P67, DOI 10.1177/0956797609354072	75	17	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108059	10.1371/journal.pone.0108059	http://dx.doi.org/10.1371/journal.pone.0108059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25248152	Green Submitted, Green Published, gold			2022-12-25	WOS:000342351800058
J	Butler, IA; Siletti, K; Oxley, PR; Kronauer, DJC				Butler, Ian A.; Siletti, Kimberly; Oxley, Peter R.; Kronauer, Daniel J. C.			Conserved Microsatellites in Ants Enable Population Genetic and Colony Pedigree Studies across a Wide Range of Species	PLOS ONE			English	Article							SIMPLE SEQUENCES; DRAFT GENOME; PCR PRIMERS; DNA MARKERS; ARMY ANTS; LOCI; EVOLUTION; FORMICIDAE; DIVERSIFICATION; DIVERSITY	Broadly applicable polymorphic genetic markers are essential tools for population genetics, and different types of markers have been developed for this purpose. Microsatellites have been employed as particularly polymorphic markers for over 20 years. However, PCR primers for microsatellite loci are often not useful outside the species for which they were designed. This implies that a new set of loci has to be identified and primers developed for every new study species. To overcome this constraint, we identified 45 conserved microsatellite loci based on the eight currently available ant genomes and designed primers for PCR amplification. Among these loci, we chose 24 for in-depth study in six species covering six different ant subfamilies. On average, 11.16 of these 24 loci were polymorphic and in Hardy-Weinberg equilibrium in any given species. The average number of alleles for these polymorphic loci within single populations of the different species was 4.59. This set of genetic markers will thus be useful for population genetic and colony pedigree studies across a wide range of ant species, supplementing the markers available for previously studied species and greatly facilitating the study of the many ant species lacking genetic markers. Our study shows that it is possible to develop microsatellite loci that are both conserved over a broad range of taxa, yet polymorphic within species. This should encourage researchers to develop similar tools for other large taxonomic groups.	[Butler, Ian A.; Siletti, Kimberly; Oxley, Peter R.; Kronauer, Daniel J. C.] Rockefeller Univ, Lab Insect Social Evolut, New York, NY 10021 USA	Rockefeller University	Butler, IA (corresponding author), Rockefeller Univ, Lab Insect Social Evolut, 1230 York Ave, New York, NY 10021 USA.	ibutler@rockefeller.edu		Butler, Ian/0000-0002-1386-2430	Rockefeller University	Rockefeller University	Funding was provided by The Rockefeller University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ascunce MS, 2009, MOL ECOL RESOUR, V9, P1476, DOI 10.1111/j.1755-0998.2009.02688.x; Azuma N, 2004, MOL ECOL NOTES, V4, P608, DOI 10.1111/j.1471-8286.2004.00752.x; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; Buschiazzo E, 2009, AUST J ZOOL, V57, P175, DOI 10.1071/ZO09038; Buschiazzo E, 2006, BIOESSAYS, V28, P1040, DOI 10.1002/bies.20470; Buschiazzo E, 2010, GENOME BIOL EVOL, V2, P153, DOI 10.1093/gbe/evq007; Dalecky A, 2002, MOL ECOL NOTES, V2, P404, DOI 10.1046/j.1471-8286.2002.00254.x; Dawson DA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-176; Dawson DA, 2010, MOL ECOL RESOUR, V10, P475, DOI 10.1111/j.1755-0998.2009.02775.x; Debout GDG, 2007, MOL ECOL NOTES, V7, P607, DOI 10.1111/j.1471-8286.2006.01647.x; Debout GDG, 2006, MOL ECOL NOTES, V6, P182, DOI 10.1111/j.1471-8286.2005.01186.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Erayman M, 2014, TURK J AGRIC FOR, V38, P32, DOI 10.3906/tar-1303-47; Ezenwa VO, 1998, MOL PHYLOGENET EVOL, V10, P168, DOI 10.1006/mpev.1998.0528; FITZSIMMONS NN, 1995, MOL BIOL EVOL, V12, P432; Fournier D, 2005, MOL ECOL NOTES, V5, P239, DOI 10.1111/j.1471-8286.2005.00889.x; Frizzi F, 2009, CONSERV GENET RESOUR, V1, P425, DOI 10.1007/s12686-009-9098-4; Garke C, 2012, ANIM GENET, V43, P419, DOI 10.1111/j.1365-2052.2011.02284.x; Gagnaire PA, 2013, EVOLUTION, V67, P2483, DOI 10.1111/evo.12075; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gyllenstrand N, 2002, MOL ECOL NOTES, V2, P67, DOI 10.1046/j.1471-8286.2002.00152.x; Hansson B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031667; Huang MH, 2013, MOL ECOL, V22, P1998, DOI 10.1111/mec.12218; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Jungmann L, 2010, GENOME, V53, P698, DOI [10.1139/G10-055, 10.1139/g10-055]; Kakazu Sergio, 2013, BMC Res Notes, V6, P328, DOI 10.1186/1756-0500-6-328; Kronauer DJC, 2007, CURR BIOL, V17, pR753, DOI 10.1016/j.cub.2007.06.057; Kronauer DJC, 2007, MOL ECOL NOTES, V7, P688, DOI 10.1111/j.1471-8286.2007.01693.x; Kronauer DJC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-20; Kronauer DJC, 2011, CONSERV GENET RESOUR, V3, P61, DOI 10.1007/s12686-010-9290-6; Kuo HC, 2014, MAR DRUGS, V12, P2397, DOI 10.3390/md12052397; Leclercq S, 2010, GENOME BIOL EVOL, V2, P325, DOI 10.1093/gbe/evq023; Leniaud L, 2013, INSECT SOC, V60, P337, DOI 10.1007/s00040-013-0298-2; Libbrecht R, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-212; LITT M, 1989, AM J HUM GENET, V44, P397; Maudet C, 2001, GENET SEL EVOL, V33, pS193, DOI 10.1186/BF03500880; Mishina T, 2014, ICHTHYOL RES, V61, P169, DOI 10.1007/s10228-014-0388-9; Molnar RI, 2012, G3-GENES GENOM GENET, V2, P1027, DOI 10.1534/g3.112.003129; Moore SS, 1998, ANIM GENET, V29, P33, DOI 10.1046/j.1365-2052.1998.00234.x; MOORE SS, 1991, GENOMICS, V10, P654, DOI 10.1016/0888-7543(91)90448-N; Moreau CS, 2013, EVOLUTION, V67, P2240, DOI 10.1111/evo.12105; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Nygaard S, 2011, GENOME RES, V21, P1339, DOI 10.1101/gr.121392.111; Oxley PR, 2014, CURR BIOL, V24, P451, DOI 10.1016/j.cub.2014.01.018; Paton T, 2002, P ROY SOC B-BIOL SCI, V269, P839, DOI 10.1098/rspb.2002.1961; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Pol RG, 2008, INSECT SOC, V55, P91, DOI 10.1007/s00040-007-0975-0; Qian ZQ, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.7101; Rubin BE, 2009, MOL ECOL RESOUR, V9, P1212, DOI 10.1111/j.1755-0998.2009.02614.x; Rubin BER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033394; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Seppa P, 2012, MOL ECOL, V21, P5880, DOI 10.1111/mec.12070; Smith CR, 2011, P NATL ACAD SCI USA, V108, P5667, DOI 10.1073/pnas.1007901108; Smith CD, 2011, P NATL ACAD SCI USA, V108, P5673, DOI 10.1073/pnas.1008617108; Steiner FM, 2007, MOL ECOL NOTES, V7, P498, DOI 10.1111/j.1471-8286.2006.01633.x; Steinmeyer C, 2012, INSECT SOC, V59, P499, DOI 10.1007/s00040-012-0244-8; Stolle E, 2013, GENOME BIOL EVOL, V5, P151, DOI 10.1093/gbe/evs133; Suefuji M, 2011, CONSERV GENET RESOUR, V3, P229, DOI 10.1007/s12686-010-9329-8; Suen G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002007; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang JL, 2014, MOL ECOL RESOUR, V14, P541, DOI 10.1111/1755-0998.12210; Wang S, 2012, NAT METHODS, V9, P808, DOI [10.1038/NMETH.2023, 10.1038/nmeth.2023]; WEBER JL, 1989, AM J HUM GENET, V44, P388; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108	73	19	19	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107334	10.1371/journal.pone.0107334	http://dx.doi.org/10.1371/journal.pone.0107334			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244681	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800029
J	Chakraborty, D; Maity, A; Jha, T; Mondal, NB				Chakraborty, Debanjana; Maity, Arindam; Jha, Tarun; Mondal, Nirup Bikash			Spermicidal and Contraceptive Potential of Desgalactotigonin: A Prospective Alternative of Nonoxynol-9	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ALBUM SEED EXTRACT; IN-VITRO; VIABILITY ASSESSMENT; HIV; LACTOBACILLI; TRANSMISSION; SPERMATOZOA; ACQUISITION; FERTILITY	Crude decoction of Chenopodium album seed showed spermicidal effect at MIC 2 mg/ml in earlier studies. Systematic isolation, characterization and evaluation revealed that the major metabolite Desgalactotigonin (DGT) is the most effective principle in both in vitro and in vivo studies. The in vitro studies comprises (a) rat and human sperm motility and immobilizing activity by Sander-Cramer assay; (b) sperm membrane integrity was observed by HOS test and electron microscopy; (c) microbial potential was examined in Lactobacillus broth culture, and (d) the hemolytic index was determined by using rat RBCs. The in vivo contraceptive efficacy was evaluated by intra uterine application of DGT in rat. Lipid peroxidation and induction of apoptosis by DGT on human spermatozoa were also studied. The minimum effective concentration (MEC) of DGT that induced instantaneous immobilization in vitro was 24.18 mu M for rat and 58.03 mu M for human spermatozoa. Microbial study indicated DGT to be friendly to Lactobacillus acidophilus. Implantation was prevented in DGT treated uterine horn while no hindrance occurred in the untreated contra lateral side. At the level of EC50, DGT induced apoptosis in human spermatozoa as determined by increased labeling with Annexin-V and decreased polarization of sperm mitochondria. Desgalactotigonin emerged 80 and 2x10(4) times more potent than the decoction and Nonoxynol-9 respectively. It possesses mechanism based detrimental action on both human and rat spermatozoa and spares lactobacilli and HeLa cells at MEC which proves its potential as a superior ingredient for the formulation of a contraceptive safer/compatible to vaginal microflora.	[Chakraborty, Debanjana; Maity, Arindam; Mondal, Nirup Bikash] Indian Inst Chem Biol, Dept Chem, Council Sci & Ind Res, Kolkata, W Bengal, India; [Jha, Tarun] Jadavpur Univ, Div Med & Pharmaceut Chem, Dept Pharmaceut Technol, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Jadavpur University	Mondal, NB (corresponding author), Indian Inst Chem Biol, Dept Chem, Council Sci & Ind Res, Kolkata, W Bengal, India.	nirup@iicb.res.in	Maity, Arindam/AAQ-4943-2020; Jha, Tarun/AAH-3939-2019	Maity, Arindam/0000-0002-9418-6963; Jha, Tarun/0000-0002-9996-738X; Mondal, Nirup Bikash/0000-0002-5784-105X	Indian Council for Medical Research (ICMR), Delhi [59/3/2007/BMS/TRM]	Indian Council for Medical Research (ICMR), Delhi	Indian Council for Medical Research (ICMR), Delhi project No 59/3/2007/BMS/TRM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, WORLD POP DAT SHEET; [Anonymous], 1995, ICPD 94 SUMM PROGR A; Anzar M, 2002, BIOL REPROD, V66, P354, DOI 10.1095/biolreprod66.2.354; Bains R, 2006, ACTA ANAESTH SCAND, V50, P572, DOI 10.1111/j.1399-6576.2006.00988.x; Bharitkar YP, 2013, CONTRACEPTION, V88, P133, DOI 10.1016/j.contraception.2012.11.017; Bhowal SK, 2008, CONTRACEPTION, V77, P214, DOI 10.1016/j.contraception.2007.09.014; BRIGGERS JD, 1977, METHODS MAMMALION EM, P41; Buege J A, 1978, Methods Enzymol, V52, P302; Castle PE, 1998, CONTRACEPTION, V58, P51, DOI 10.1016/S0010-7824(98)00059-6; Chaoui D, 2006, CYTOM PART B-CLIN CY, V70B, P189, DOI 10.1002/cyto.b.20100; Chattopadhyay D, 1998, FITOTERAPIA, V69, P365; CUNEO MF, 2006, FERTIL STERIL, V85, P1840; D'Cruz OJ, 1999, MOL HUM REPROD, V5, P421, DOI 10.1093/molehr/5.5.421; Das N, 2011, CONTRACEPTION, V83, P167, DOI 10.1016/j.contraception.2010.05.009; Doncel GF, 2006, HUM REPROD UPDATE, V12, P103, DOI 10.1093/humupd/dmi040; Flajshans M, 2004, CELL BIOL INT, V28, P955, DOI 10.1016/j.cellbi.2004.07.014; FOWLER PT, 2003, AAPS PHARMSCITECH, V4, P1; GARNER DL, 1995, BIOL REPROD, V53, P276, DOI 10.1095/biolreprod53.2.276; Green TR, 2001, FERTIL STERIL, V76, P157, DOI 10.1016/S0015-0282(01)01830-1; Hawes SE, 1996, J INFECT DIS, V174, P1058, DOI 10.1093/infdis/174.5.1058; Jain RK, 2009, HUM REPROD, V24, P590, DOI 10.1093/humrep/den415; KEMPF C, 1991, J ACQ IMMUN DEF SYND, V4, P828; KLEBANOFF SJ, 1991, J EXP MED, V174, P289, DOI 10.1084/jem.174.1.289; Kuete V, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-42; Kumar S, 2009, INT J BIOL CHEM SCI, V3, P628; Kumar S, 2008, CONTRACEPTION, V77, P456, DOI 10.1016/j.contraception.2008.02.006; Kumar S, 2007, CONTRACEPTION, V75, P71, DOI 10.1016/j.contraception.2006.07.015; Kumar S, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-102; Lavaud Catherine, 2000, Fitoterapia, V71, P338, DOI 10.1016/S0367-326X(99)00166-5; Lee CH, 1996, CONTRACEPTION, V54, P131, DOI 10.1016/S0010-7824(96)00168-0; Maikhuri JP, 2003, CONTRACEPTION, V67, P403, DOI 10.1016/S0010-7824(03)00022-2; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; McFarland J, 1907, J AMER MED ASSOC, V49, P1176; Niksirat H, 2013, ZOOL ANZ, V252, P226, DOI 10.1016/j.jcz.2012.06.002; Paira P, 2009, BIOORG MED CHEM LETT, V19, P4786, DOI 10.1016/j.bmcl.2009.06.049; Pape W, 1987, MOL TOXICOL, V88, P525; Paul D, 2006, CONTRACEPTION, V73, P284, DOI 10.1016/j.contraception.2005.07.014; Renner R, 1997, ENVIRON SCI TECHNOL, V31, pA316, DOI 10.1021/es972366q; Roddy RE, 1998, NEW ENGL J MED, V339, P504, DOI 10.1056/NEJM199808203390803; Saha P, 2010, REPROD SCI, V17, P454, DOI 10.1177/1933719110361378; Sander F. V., 1941, HUM FERTIL, V6, P134; Shah HC, 2008, DRUG DISCOV THER, V2, P200; Shah V, 2005, ANTIMICROB AGENTS CH, V49, P4093, DOI 10.1128/AAC.49.10.4093-4100.2005; Singh KK, 2012, CONTRACEPTION, V85, P122, DOI 10.1016/j.contraception.2011.04.013; Suleiman SA, 1996, J ANDROL, V17, P530; Thiele B, 1997, CHEM REV, V97, P3247, DOI 10.1021/cr970323m; United Nations Population Fund, 2011, STAT WORLD POP; *WHO, 2002, REPROD HEALTH MATTER, V10, P175; *WHO, 1999, LAB MAN EX HUM SEM C; Yan W, 1996, PHYTOCHEMISTRY, V42, P1417, DOI 10.1016/0031-9422(96)00131-8	50	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107164	10.1371/journal.pone.0107164	http://dx.doi.org/10.1371/journal.pone.0107164			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243914	gold, Green Published, Green Submitted			2022-12-25	WOS:000343679800022
J	Fan, LH; Li, J; Yu, ZF; Dang, XQ; Wang, KZ				Fan, Lihong; Li, Jia; Yu, Zefeng; Dang, Xiaoqian; Wang, Kunzheng			Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Prevents Steroid-Associated Osteonecrosis of the Femoral Head in Rabbits by Promoting Angiogenesis and Inhibiting Apoptosis	PLOS ONE			English	Article							GENE-EXPRESSION; DOWN-REGULATION; CELL-DEATH; MECHANISMS; INDUCTION; BONE; GLUCOCORTICOIDS; FACTOR-1-ALPHA; HIF-1-ALPHA; ACTIVATION	The purpose of this study was to investigate the preventive effect of ethyl 3,4-dihydroxybenzoate(EDHB) on steroid-associated femoral head osteonecrosis(ONFH) in a rabbit model. New Zealand white rabbits were randomly divided into two groups (prevention group and model group), each containing 24 rabbits. Osteonecrosis was induced by lipopolysaccharide(LPS) combined with methylprednisolone(MPS). The prevention group received an intraperitoneal injection of EDHB at 50 mg/kg body weight every other day starting three days before establishing rabbit models of osteonecrosis, for a total of nine doses. Osteonecrosis was verified by haematoxylin-eosin (HE) staining. The expression of HIF-1 alpha and VEGF was analyzed by immunohistochemistry. Angiogenesis, apoptosis and microstructural parameters were also analyzed. The rabbit models of osteonecrosis were successfully established and observed by HE staining. Histopathological observations indicated that EDHB reduced the rate of empty lacunae and the incidence of osteonecrosis. Immunohistochemical staining for HIF-1 alpha and VEGF suggested that EDHB therapy inhibited degradation of HIF-1 alpha and promoted expression of VEGF. Ink artery infusion angiography and microvessel density analysis revealed that there were more microvessels in the prevention group than in the model group. The TUNEL apoptosis assay suggested that EDHB intervention could reduce the number of apoptotic cells in avascular osteonecrosis of the femoral head. Micro-CT scanning indicated that the treatment group had better microstructural parameters than the model group. EDHB prevents steroid-associated osteonecrosis of the femoral head in rabbits by promoting angiogenesis and inhibiting apoptosis of bone cells and hematopoietic tissue.	[Fan, Lihong; Li, Jia; Yu, Zefeng; Dang, Xiaoqian; Wang, Kunzheng] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Orthoped, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University	Wang, KZ (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Orthoped, Xian, Shaanxi, Peoples R China.	drwangkunzheng@163.com			National Natural Science Foundation of China [81101363, 81371944]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant no. 81101363 and 81371944; URLs: http://isisn.nsfc.gov.cn/egrantweb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmal M, 2009, ORTHOP CLIN N AM, V40, P235, DOI 10.1016/j.ocl.2009.01.004; Baay-Guzman GJ, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-60; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Calder JDF, 2004, J BONE JOINT SURG BR, V86B, P1209, DOI 10.1302/0301-620X.86B8.14834; Castro F P Jr, 2000, Am J Orthop (Belle Mead NJ), V29, P187; Chen MH, 2013, INT J CLIN EXP PATHO, V6, P2312; Chen N, 2009, J BIOL CHEM, V284, P10004, DOI 10.1074/jbc.M805997200; Chu PWY, 2010, EUR J PHARMACOL, V633, P24, DOI 10.1016/j.ejphar.2010.02.008; Ding H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063628; Erler JT, 2004, MOL CELL BIOL, V24, P2875, DOI 10.1128/MCB.24.7.2875-2889.2004; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fulda S, 2007, CELL CYCLE, V6, P790, DOI 10.4161/cc.6.7.4084; Harada I, 1992, Nihon Seikeigeka Gakkai Zasshi, V66, P763; Hsieh MM, 2007, BLOOD, V110, P2140, DOI 10.1182/blood-2007-02-073254; Kasiganesan H, 2007, ACTA PHYSIOL, V190, P163, DOI 10.1111/j.1748-1716.2007.01676.x; Kelly BD, 2003, CIRC RES, V93, P1074, DOI 10.1161/01.RES.0000102937.50486.1B; Kerachian MA, 2009, J STEROID BIOCHEM, V114, P121, DOI 10.1016/j.jsbmb.2009.02.007; Li XD, 2005, OSTEOPOROSIS INT, V16, P101, DOI 10.1007/s00198-004-1649-7; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mont MA, 1996, CLIN ORTHOP RELAT R, P169, DOI 10.1097/00003086-199603000-00020; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Powell C, 2011, CLIN REV ALLERG IMMU, V41, P102, DOI 10.1007/s12016-010-8217-z; Qin L, 2006, BONE, V39, P863, DOI 10.1016/j.bone.2006.04.018; Riddle RC, 2009, J MOL MED, V87, P583, DOI 10.1007/s00109-009-0477-9; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shen X, 2009, J ORTHOP RES, V27, P1298, DOI 10.1002/jor.20886; Sowter HM, 2001, CANCER RES, V61, P6669; Thomas R, 2008, PROSTATE, V68, P1405, DOI 10.1002/pros.20808; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Tian L, 2013, J ZHEJIANG UNIV-SC B, V14, P426, DOI 10.1631/jzus.B1200311; Tsai CC, 2011, BLOOD, V117, P459, DOI 10.1182/blood-2010-05-287508; Warnecke C, 2003, FASEB J, V17, P1186, DOI 10.1096/fj.02-1062fje; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Wen Q, 2008, GENE THER, V15, P1523, DOI 10.1038/gt.2008.110	35	29	34	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107774	10.1371/journal.pone.0107774	http://dx.doi.org/10.1371/journal.pone.0107774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244080	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800048
J	Li, J; Liu, Y; Wang, JW; Gao, Y; Hu, YT; He, JJ; Yu, XY; Hu, HG; Yuan, Y; Zhang, SZ; Ding, KF				Li, Jun; Liu, Yue; Wang, Jian-Wei; Gao, Yang; Hu, Ye-Ting; He, Jin-Jie; Yu, Xiu-Yan; Hu, Han-Guang; Yuan, Ying; Zhang, Su-Zhan; Ding, Ke-Feng			Oxaliplatin-Based Adjuvant Chemotherapy without Radiotherapy Can Improve the Survival of Locally-Advanced Rectal Cancer	PLOS ONE			English	Article							TOTAL MESORECTAL EXCISION; PREOPERATIVE RADIOTHERAPY; RANDOMIZED-TRIAL; COLON-CANCER; RADIATION; SURGERY; THERAPY	Objective: To assess the impact of oxaliplatin-containing adjuvant chemotherapy on the survival of patients with locally-advanced rectal cancer. Methods: Data on patients with pathologically-confirmed T3/4 or N1/2 rectal cancer who accepted radical surgery at our center from January 2002 to June 2009 were reviewed retrospectively. The patients' 5-year overall survival (OS), diseasespecific survival (DSS), and recurrence-free survival (RFS) were analyzed by comparing those who accepted radical surgery only (Group S) with those who accepted radical surgery and oxaliplatin-containing adjuvant chemotherapy (Group SO). Results: A total of 236 patients were analyzed (Group S 135; Group SO 101). Group S patients were older and had a higher proportion with stage II disease and more perioperative complications than those in Group SO (P<0.05). The OS and DSS of patients with stage III disease under 50 years of age or with mucinous adenocarcinoma were higher in Group SO than Group S (P<0.05). In addition, the OS of patients with stage N2b disease was higher in Group SO than Group S (P=0.016), and the OS of patients with stage N1a or N2b disease who received more than 8 weeks of oxaliplatin-containing chemotherapy was also higher in Group SO than Group S (P<0.05). Although the OS and DSS of patients with stage II disease in Group SO showed a tendency towards improvement, the differences between the groups were not statistically significant. Conclusion: Adjuvant oxaliplatin-containing chemotherapy can improve the survival of patients with locally-advanced low and middle rectal cancers in comparison with observation. Randomized, prospective trials are warranted to confirm this benefit of oxaliplatin for rectal cancer.	[Li, Jun; Wang, Jian-Wei; He, Jin-Jie; Yu, Xiu-Yan; Zhang, Su-Zhan; Ding, Ke-Feng] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Surg Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Jun; Liu, Yue; Wang, Jian-Wei; Gao, Yang; Hu, Ye-Ting; He, Jin-Jie; Yu, Xiu-Yan; Hu, Han-Guang; Yuan, Ying; Zhang, Su-Zhan; Ding, Ke-Feng] China Natl Minist Educ, Key Lab Canc Prevent & Intervent, Hangzhou, Zhejiang, Peoples R China; [Hu, Han-Guang; Yuan, Ying] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Ding, KF (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Surg Oncol, Hangzhou 310003, Zhejiang, Peoples R China.	dingkefeng@zju.edu.cn			National Natural Science Foundation of China [81301890]; Zhejiang Provincial Natural Science Foundation of China [LY13H160010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Natural Science Foundation of China (No. 81301890, http://www.nsfc.gov.cn/) and Zhejiang Provincial Natural Science Foundation of China (No. LY13H160010, http://www.zjnsf.gov.cn/index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Arnott SJ, 1996, LANCET, V348, P1610; Aschele C, 2011, J CLIN ONCOL, V29, P2773, DOI 10.1200/JCO.2010.34.4911; Bosset JF, 2006, NEW ENGL J MED, V355, P1114, DOI 10.1056/NEJMoa060829; China Ministry of Health, 2010, NAT GUID DIAGN TREAT; Daniels IR, 2004, FRONT RADIAT THER ON, V38, P28; Ding KF, 2009, SURG ENDOSC, V23, P854, DOI 10.1007/s00464-008-9990-0; Folkesson J, 2005, J CLIN ONCOL, V23, P5644, DOI 10.1200/JCO.2005.08.144; Gerard JP, 2012, J CLIN ONCOL, V30, P4558, DOI 10.1200/JCO.2012.42.8771; Gray R, 2001, LANCET, V358, P1291; Haller DG, 2011, J CLIN ONCOL, V29, P1465, DOI 10.1200/JCO.2010.33.6297; Heald RJ, 1998, ARCH SURG-CHICAGO, V133, P894, DOI 10.1001/archsurg.133.8.894; Junichi K KF, 2014, J CLIN ONCOL S, V32; Kachnic LA, 2008, J CLIN ONCOL, V26, P350, DOI 10.1200/JCO.2007.14.6365; Roh MS, 2009, J CLIN ONCOL, V27, P5124, DOI 10.1200/JCO.2009.22.0467; Schrag D, 2014, J CLIN ONCOL, V32, P513, DOI 10.1200/JCO.2013.51.7904; Stephens RJ, 2010, J CLIN ONCOL, V28, P4233, DOI 10.1200/JCO.2009.26.5264; van Gijn W, 2011, LANCET ONCOL, V12, P575, DOI 10.1016/S1470-2045(11)70097-3; Wo JY, 2011, SEMIN RADIAT ONCOL, V21, P212, DOI 10.1016/j.semradonc.2011.02.007; Wolff HA, 2011, ONCOLOGIST, V16, P621, DOI 10.1634/theoncologist.2010-0414; Yong S H BN, 2014, J CLIN ONCOL S, V32; Yothers G, 2011, J CLIN ONCOL, V29, P3768, DOI 10.1200/JCO.2011.36.4539	22	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107872	10.1371/journal.pone.0107872	http://dx.doi.org/10.1371/journal.pone.0107872			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243406	Green Published, gold, Green Submitted			2022-12-25	WOS:000343679800054
J	Zeng, F; Lu, SH; Li, SZ; Li, XJ; Pan, F				Zeng, Fei; Lu, Siheng; Li, Sizhao; Li, Xiaojun; Pan, Feng			Frequency Selectivity in Pulse Responses of Pt/Poly(3-exylthiophene-2,5-Diyl)/Polyethylene Oxide + Li+/Pt Hetero-Junction	PLOS ONE			English	Article							EMITTING ELECTROCHEMICAL-CELLS; P-N-JUNCTION; MEMORY DEVICES; MEMRISTOR; ELECTROLYTES; PERFORMANCE; TRANSISTORS; SYSTEMS	Pt/poly(3-hexylthiophene-2,5-diyl)/polyethylene oxide + Li+/Pt hetero junctions were fabricated, and their pulse responses were studied. The direct current characteristics were not symmetric in the sweeping range of 62 V. Negative differential resistance appeared in the input range of 0 to 2 V because of de-doping (or reduction) in the side with the semiconductor layer. The device responded stably to a train of pulses with a fixed frequency. The inverse current after a pulse was related to the back-migrated ions. Importantly, the weight calculated based on the inverse current strength, was depressed during low-frequency stimulations but was potentiated during high-frequency stimulations when pulses were positive. Therefore, frequency selectivity was first observed in a semiconducting polymer/electrolyte hetero junction. Detailed analysis of the pulse response showed that the input frequency could modulate the timing of ion doping, de-doping, and re-doping at the semiconducting polymer/electrolyte interface, which then resulted in the frequency selectivity. Our study suggests that the simple redox process in semiconducting polymers can be modulated and used in signal handling or the simulation of bio-learning.	[Zeng, Fei; Lu, Siheng; Li, Sizhao; Li, Xiaojun; Pan, Feng] Tsinghua Univ, Sch Mat Sci & Engn, Adv Mat Lab MOE, Beijing 100084, Peoples R China	Tsinghua University	Zeng, F (corresponding author), Tsinghua Univ, Sch Mat Sci & Engn, Adv Mat Lab MOE, Beijing 100084, Peoples R China.	zengfei@mail.tsinghua.edu.cn; panf@mail.tsinghua.edu.cn	Pan, Feng/I-8392-2012	Pan, Feng/0000-0002-3788-7894	National Natural Science foundation of China [51371103, 51231004]; National Basic Research Program of China [2010CB832905]; National Hi-tech (R& D) project of China [2012AA03A706, 2013AA030801, SS2014AA032604]; Research Project of Chinese Ministry of Education [113007A]	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Hi-tech (R& D) project of China(National High Technology Research and Development Program of China); Research Project of Chinese Ministry of Education(Ministry of Education, China)	This work was supported by National Natural Science foundation of China (Grant Nos. 51371103 and 51231004), National Basic Research Program of China (Grant No. 2010CB832905) and National Hi-tech (R& D) project of China (Grant Nos. 2012AA03A706, 2013AA030801 and SS2014AA032604), the Research Project of Chinese Ministry of Education (No. 113007A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Adamatzky A., 2014, MEMRISTOR NETWORKS; Ali Y, 2013, APPL SURF SCI, V280, P950, DOI 10.1016/j.apsusc.2013.05.116; ARMAND M, 1989, FARADAY DISCUSS, V88, P65, DOI 10.1039/dc9898800065; Barman S, 2008, J AM CHEM SOC, V130, P11073, DOI 10.1021/ja802673w; Bouwer RKM, 2012, J MATER CHEM, V22, P15412, DOI 10.1039/c2jm32993j; Chen HF, 2012, J MATER CHEM, V22, P9556, DOI 10.1039/c2jm30443k; Corish J, 2005, SYNTHETIC MET, V151, P49, DOI 10.1016/j.synthmet.2005.02.016; Edman L, 2004, APPL PHYS LETT, V84, P3744, DOI 10.1063/1.1737483; Erokhin V, 2005, J APPL PHYS, V97, DOI 10.1063/1.1861508; Ewbank P. C., 2009, ORGANIC PHOTOVOLTAIC; Heeger A.J., 2010, SEMICONDUCTING METAL; Ho CC, 2011, PHYS CHEM CHEM PHYS, V13, P17729, DOI 10.1039/c1cp21861a; Hu YF, 2009, J AM CHEM SOC, V131, P18236, DOI 10.1021/ja908962b; Javier AE, 2011, ANGEW CHEM INT EDIT, V50, P9848, DOI 10.1002/anie.201102953; Jo SH, 2010, NANO LETT, V10, P1297, DOI 10.1021/nl904092h; Johansson P, 2001, POLYMER, V42, P6573, DOI 10.1016/S0032-3861(01)00101-X; Kaur A, 2011, MATER CHEM PHYS, V131, P436, DOI 10.1016/j.matchemphys.2011.10.001; Kumar R, 2012, J AM CHEM SOC, V134, P14869, DOI 10.1021/ja304458s; Lai QX, 2010, ADV MATER, V22, P2448, DOI 10.1002/adma.201000282; Li SZ, 2013, J MATER CHEM C, V1, P5292, DOI 10.1039/c3tc30575a; Liao CT, 2012, PHYS CHEM CHEM PHYS, V14, P1262, DOI 10.1039/c1cp23336j; Liu J, 2012, J AM CHEM SOC, V134, P901, DOI 10.1021/ja210936n; Maclnnes D, 1981, J CHEM SOC CHEM COMM, P317, DOI [10.1039/c39810000317, DOI 10.1039/C39810000317]; Matyba P, 2009, NAT MATER, V8, P672, DOI [10.1038/NMAT2478, 10.1038/nmat2478]; Meier SB, 2012, PHYS CHEM CHEM PHYS, V14, P10886, DOI 10.1039/c2cp41323j; Ong BS, 2005, ADV MATER, V17, P1141, DOI 10.1002/adma.200401660; Pan F, 2014, MAT SCI ENG R, V83, P1, DOI 10.1016/j.mser.2014.06.002; PEI QB, 1995, SCIENCE, V269, P1086, DOI 10.1126/science.269.5227.1086; Pershin YV, 2011, ADV PHYS, V60, P145, DOI 10.1080/00018732.2010.544961; Petrucci S, 2002, PHYS CHEM CHEM PHYS, V4, P6043, DOI 10.1039/b207898h; Rachmuth G, 2011, P NATL ACAD SCI USA, V108, pE1266, DOI 10.1073/pnas.1106161108; ROBITAILLE CD, 1986, J ELECTROCHEM SOC, V133, P315, DOI 10.1149/1.2108569; Smerieri A, 2008, J APPL PHYS, V104, DOI 10.1063/1.3033399; Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932; Tetzla R, 2013, MEMRISTORS MEMRISTIV; To TT, 2014, PHYS CHEM CHEM PHYS, V16, P4653, DOI [10.1039/c3cp54308k, 10.1039/c3cp54308]; van Reenen S, 2012, ADV FUNCT MATER, V22, P4547, DOI 10.1002/adfm.201200880; Wang ZQ, 2012, ADV FUNCT MATER, V22, P2759, DOI 10.1002/adfm.201103148	39	24	24	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e108316	10.1371/journal.pone.0108316	http://dx.doi.org/10.1371/journal.pone.0108316			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244151	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800085
J	Brandau, S; Jakob, M; Bruderek, K; Bootz, F; Giebel, B; Radtke, S; Mauel, K; Jager, M; Flohe, SB; Lang, S				Brandau, Sven; Jakob, Mark; Bruderek, Kirsten; Bootz, Friedrich; Giebel, Bernd; Radtke, Stefan; Mauel, Katharina; Jaeger, Marcus; Flohe, Stefanie B.; Lang, Stephan			Mesenchymal Stem Cells Augment the Anti-Bacterial Activity of Neutrophil Granulocytes	PLOS ONE			English	Article							HUMAN BONE-MARROW; STROMAL CELLS; INTERNATIONAL-SOCIETY; PERIPHERAL-BLOOD; PLATELET LYSATE; ADIPOSE-TISSUE; PROLIFERATION; THERAPY; TRANSPLANTATION; IMMUNOTHERAPY	Background: Mesenchymal stem cells (MSCs) participate in the regulation of inflammation and innate immunity, for example by responding to pathogen-derived signals and by regulating the function of innate immune cells. MSCs from the bone-marrow and peripheral tissues share common basic cell-biological functions. However, it is unknown whether these MSCs exhibit different responses to microbial challenge and whether this response subsequently modulates the regulation of inflammatory cells by MSCs. Methodology/Principal Findings: We isolated MSCs from human bone-marrow (bmMSCs) and human salivary gland (pgMSCs). Expression levels of TLR4 and LPS-responsive molecules were determined by flow cytometry and quantitative PCR. Cytokine release was determined by ELISA. The effect of supernatants from unstimulated and LPS-stimulated MSCs on recruitment, cytokine secretion, bacterial clearance and oxidative burst of polymorphonuclear neutrophil granulocytes (PMN) was tested in vitro. Despite minor quantitative differences, bmMSCs and pgMSCs showed a similar cell biological response to bacterial endotoxin. Both types of MSCs augmented anti-microbial functions of PMNs LPS stimulation, particularly of bmMSCs, further augmented MSC-mediated activation of PMN. Conclusions/Significance: This study suggests that MSCs may contribute to the resolution of infection and inflammation by promoting the anti-microbial activity of PMNs. This property is exerted by MSCs derived from both the bone-marrow and peripheral glandular tissue.	[Brandau, Sven; Bruderek, Kirsten; Lang, Stephan] Univ Hosp Essen, Dept Otorhinolaryngol, Essen, Germany; [Jakob, Mark; Bootz, Friedrich] Univ Hosp Bonn, Dept Otorhinolaryngol, Bonn, Germany; [Giebel, Bernd; Radtke, Stefan] Univ Hosp Essen, Inst Transfus Med, Essen, Germany; [Mauel, Katharina; Jaeger, Marcus; Flohe, Stefanie B.] Univ Hosp Essen, Dept Trauma Surg, Essen, Germany	University of Duisburg Essen; University of Bonn; University of Duisburg Essen; University of Duisburg Essen	Brandau, S (corresponding author), Univ Hosp Essen, Dept Otorhinolaryngol, Essen, Germany.	sven.brandau@uk-essen.de	Flohe, Stefanie/F-9473-2010; Giebel, Bernd/AAH-1083-2021	Flohe, Stefanie/0000-0001-7032-3380; Giebel, Bernd/0000-0003-2446-948X; Jager, Marcus/0000-0001-9516-1058; Brandau, Sven/0000-0002-2702-4163; Radtke, Stefan/0000-0002-2842-4820				Anker PSI, 2003, HAEMATOLOGICA, V88, P845; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Beyrau M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120134; Bieback K, 2013, TRANSFUS MED HEMOTH, V40, P326, DOI 10.1159/000354061; Bohrnsen F, 2012, EUR ARCH OTO-RHINO-L, V269, P2561, DOI 10.1007/s00405-012-1943-5; Brandau S, 2010, J LEUKOCYTE BIOL, V88, P1005, DOI 10.1189/jlb.0410207; Cassatella MA, 2011, STEM CELLS, V29, P1001, DOI 10.1002/stem.651; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Ciccocioppo R, 2011, GUT, V60, P788, DOI 10.1136/gut.2010.214841; Connick P, 2012, LANCET NEUROL, V11, P150, DOI 10.1016/S1474-4422(11)70305-2; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duijvestein M, 2010, GUT, V59, P1662, DOI 10.1136/gut.2010.215152; Dumitru CA, 2011, INT J CANCER, V129, P859, DOI 10.1002/ijc.25991; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Griffiths S, 2013, CYTOTHERAPY, V15, P1469, DOI 10.1016/j.jcyt.2013.05.020; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Hsu SC, 2013, IMMUNOBIOLOGY, V218, P90, DOI 10.1016/j.imbio.2012.02.007; Jackson WM, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt111; Jakob M, 2013, LARYNGO RHINO OTOL, V92, P462, DOI 10.1055/s-0033-1337982; Jakob M, 2013, HEAD NECK-J SCI SPEC, V35, P1621, DOI 10.1002/hed.23196; Jakob M, 2010, STEM CELLS DEV, V19, P635, DOI 10.1089/scd.2009.0245; Kusadasi N, 2013, SHOCK, V40, P352, DOI 10.1097/SHK.0000000000000039; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; McDonald B, 2011, J MOL MED, V89, P1079, DOI 10.1007/s00109-011-0784-9; Mendes SC, 2005, DEVELOPMENT, V132, P1127, DOI 10.1242/dev.01615; Miao ZN, 2006, CELL BIOL INT, V30, P681, DOI 10.1016/j.cellbi.2006.03.009; Nuschke A., 2013, ORGANOGENESIS, V10; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rinker TE, 2014, INTEGR BIOL-UK, V6, P324, DOI [10.1039/c3ib40194d, 10.1039/c3b40194d]; Rotter N, 2008, STEM CELLS DEV, V17, P509, DOI 10.1089/scd.2007.0180; Seppanen E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062662; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Suttmann H, 2006, CANCER RES, V66, P8250, DOI 10.1158/0008-5472.CAN-06-1416; Swart JF, 2015, ANN RHEUM DIS, V74, P769, DOI 10.1136/annrheumdis-2013-204147; Tondreau T, 2005, STEM CELLS, V23, P1105, DOI 10.1634/stemcells.2004-0330; Trellakis S, 2011, INT J CANCER, V129, P2183, DOI 10.1002/ijc.25892; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Wang DD, 2013, CELL TRANSPLANT, V22, P2267, DOI [10.3727/096368911X582769c, 10.3727/096368911X582769]; Wang L, 2012, J DENT RES, V91, P1003, DOI 10.1177/0022034512460404; Zhang W, 2004, STEM CELLS DEV, V13, P263, DOI 10.1089/154732804323099190	46	63	67	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e106903	10.1371/journal.pone.0106903	http://dx.doi.org/10.1371/journal.pone.0106903			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238158	Green Submitted, Green Published, gold			2022-12-25	WOS:000342491600014
J	Minamida, Y; Someda, M; Yonehara, S				Minamida, Yoshitaka; Someda, Masataka; Yonehara, Shin			FLASH/casp8ap2 Is Indispensable for Early Embryogenesis but Dispensable for Proliferation and Differentiation of ES Cells	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVITY; CAJAL BODIES; FLASH; COACTIVATOR; REPLICATION; ACTIVATION; NUCLEOSOME; CASPASE-8; COMPONENT; RECEPTOR	FLICE/caspase-8-associated huge protein (FLASH)/casp8ap2 is involved in various cellular functions, such as cell cycle progression, transcriptional regulation, the regulation of apoptosis, and the regulation of histone gene expression. The down-regulated expression of FLASH has been shown to inhibit cell cycle progression in the S phase in many kinds of mice and human cell lines and the inhibition of cell cycle progression may be attributed to the suppressed expression of replication-dependent histone genes. We here demonstrated that the induced knockout of FLASH never affected cell cycle progression in ES cells, in which the expression of core histone genes was decreased to levels similar to those in human KB cells sensitive to the knockdown of FLASH. In addition, the FLASH conditional knockout ES cells could differentiate normally into not only mesodermal and endodermal cells, but also trophoblasts. In order to investigate the function of FLASH in early embryogenesis in vivo, we also examined a FLASH mutant mouse, in which FLASH mutant allele did not express FLASH mRNA in embryos and most adult organs, except for the testis. FLASH mutant embryos died between E3.5 and E8.5. Furthermore, the in vitro cultivation of FLASH mutant embryos generated by in vitro fertilization showed embryonic lethality at the pre-implantation stage by inhibiting the hatching of embryos and their adherence to substrates. Taken together, these results indicate that FLASH plays an important role in early embryogenesis, but is not essential for either the proliferation or differentiation of ES cells.	[Minamida, Yoshitaka; Someda, Masataka; Yonehara, Shin] Kyoto Univ, Grad Sch Biostudies, Lab Mol & Cellular Biol, Sakyo Ku, Kyoto, Japan	Kyoto University	Yonehara, S (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Mol & Cellular Biol, Sakyo Ku, Kyoto, Japan.	yonehara@lif.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22370052]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant no. 22370052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm-Kristiansen AH, 2008, ONCOGENE, V27, P4644, DOI 10.1038/onc.2008.105; Barcaroli D, 2006, P NATL ACAD SCI USA, V103, P14802, DOI 10.1073/pnas.0604225103; Barcaroli D, 2006, P NATL ACAD SCI USA, V103, P14808, DOI 10.1073/pnas.0604227103; Bongiorno-Borbone L, 2008, CELL CYCLE, V7, P2357, DOI 10.4161/cc.6344; Callens C, 2012, J CLIN ONCOL, V30, P1966, DOI 10.1200/JCO.2011.39.7661; Chen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032971; Choi YH, 2001, J BIOL CHEM, V276, P25073, DOI 10.1074/jbc.M102941200; Cioce M, 2005, ANNU REV CELL DEV BI, V21, P105, DOI 10.1146/annurev.cellbio.20.010403.103738; De Cola A, 2012, ONCOGENE, V31, P573, DOI 10.1038/onc.2011.274; Flotho C, 2006, BLOOD, V108, P1050, DOI 10.1182/blood-2006-01-0322; Gruber JJ, 2012, MOL CELL, V45, P87, DOI 10.1016/j.molcel.2011.12.020; Gruber JJ, 2009, CELL, V138, P328, DOI 10.1016/j.cell.2009.04.046; Hodl M, 2009, CURR BIOL, V19, P1221, DOI 10.1016/j.cub.2009.05.048; Hummon AB, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-1; Imai Y, 1999, NATURE, V398, P777, DOI 10.1038/19709; Jun JI, 2005, ONCOGENE, V24, P688, DOI 10.1038/sj.onc.1208186; Kino T, 2004, J STEROID BIOCHEM, V92, P357, DOI 10.1016/j.jsbmb.2004.09.003; Kino T, 2003, J BIOL CHEM, V278, P3023, DOI 10.1074/jbc.M209234200; Kiriyama M, 2009, MOL CELL BIOL, V29, P4729, DOI 10.1128/MCB.00289-09; Krieghoff E, 2007, CELL CYCLE, V6, P771, DOI 10.4161/cc.6.7.4046; Lin CJ, 2014, DEV CELL, V30, P268, DOI 10.1016/j.devcel.2014.06.022; Milovic-Holm K, 2007, EMBO J, V26, P391, DOI 10.1038/sj.emboj.7601504; Morgan R, 2004, DEV BIOL, V265, P105, DOI 10.1016/j.ydbio.2003.09.030; Nakagiri S, 2005, MOL CELL BIOL, V25, P9249, DOI 10.1128/MCB.25.21.9249-9258.2005; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Shigeoka T, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni022; Tachiwana H, 2008, NUCLEIC ACIDS RES, V36, P2208, DOI 10.1093/nar/gkn060; Tachiwana H, 2010, P NATL ACAD SCI USA, V107, P10454, DOI 10.1073/pnas.1003064107; Wilson MD, 2008, MOL CELL BIOL, V28, P1503, DOI 10.1128/MCB.01565-07; Wu GM, 2010, DEVELOPMENT, V137, P4159, DOI 10.1242/dev.056630; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Yang XC, 2009, MOL CELL, V36, P267, DOI 10.1016/j.molcel.2009.08.016	32	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e108032	10.1371/journal.pone.0108032	http://dx.doi.org/10.1371/journal.pone.0108032			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238250	Green Published, gold, Green Submitted			2022-12-25	WOS:000342491600079
J	Miyake, T; Kumagi, T; Furukawa, S; Hirooka, M; Kawasaki, K; Koizumi, M; Todo, Y; Yamamoto, S; Abe, M; Kitai, K; Matsuura, B; Hiasa, Y				Miyake, Teruki; Kumagi, Teru; Furukawa, Shinya; Hirooka, Masashi; Kawasaki, Keitarou; Koizumi, Mitsuhito; Todo, Yasuhiko; Yamamoto, Shin; Abe, Masanori; Kitai, Kohichiro; Matsuura, Bunzo; Hiasa, Yoichi			Hyperuricemia Is a Risk Factor for the Onset of Impaired Fasting Glucose in Men with a High Plasma Glucose Level: A Community-Based Study	PLOS ONE			English	Article							SERUM URIC-ACID; FATTY LIVER-DISEASE; TYPE-2 DIABETES-MELLITUS; ENDOTHELIAL DYSFUNCTION; JAPANESE MEN; HEALTH; HYPERTENSION; ASSOCIATION; COHORT; WOMEN	Background: It is not clear whether elevated uric acid is a risk factor for the onset of impaired fasting glucose after stratifying by baseline fasting plasma glucose levels. We conducted a community-based retrospective longitudinal cohort study to clarify the relationship between uric acid levels and the onset of impaired fasting glucose, according to baseline fasting plasma glucose levels. Methods: We enrolled 6,403 persons (3,194 men and 3,209 women), each of whom was 18-80 years old and had >2 annual check-ups during 2003-2010. After excluding persons who had fasting plasma glucose levels >= 6.11 mM and/or were currently taking anti-diabetic agents, the remaining 5,924 subjects were classified into quartiles according to baseline fasting plasma glucose levels. The onset of impaired fasting glucose was defined as fasting plasma glucose >= 6.11 mM during the observation period. Results: In the quartile groups, 0.9%, 2.1%, 3.4%, and 20.2% of the men developed impaired fasting glucose, respectively, and 0.1%, 0.3%, 0.5%, and 5.6% of the women developed impaired fasting glucose, respectively (P trend <0.001). After adjusting for age, body mass index, systolic blood pressure, triacylglycerols, high density lipoprotein-cholesterol, creatinine, fatty liver, family history of diabetes, alcohol consumption, and current smoking, uric acid levels were positively associated with onset of impaired fasting glucose in men with highest-quartile fasting plasma glucose levels (adjusted hazard ratio, 1.003; 95% confidence interval, 1.0001-1.005, P = 0.041). Conclusions: Among men with high fasting plasma glucose, hyperuricemia may be independently associated with an elevated risk of developing impaired fasting glucose.	[Miyake, Teruki; Kumagi, Teru; Hirooka, Masashi; Kawasaki, Keitarou; Koizumi, Mitsuhito; Todo, Yasuhiko; Yamamoto, Shin; Abe, Masanori; Matsuura, Bunzo; Hiasa, Yoichi] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan; [Kumagi, Teru] Ehime Univ, Grad Sch Med, Dept Community Med, Toon, Ehime, Japan; [Furukawa, Shinya] Ehime Univ, Grad Sch Med, Dept Publ Hlth, Toon, Ehime, Japan; [Kawasaki, Keitarou; Koizumi, Mitsuhito; Kitai, Kohichiro] Ehime Gen Hlth Care Assoc, Matsuyama, Ehime, Japan	Ehime University; Ehime University; Ehime University	Hiasa, Y (corresponding author), Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan.	hiasa@m.ehime-u.ac.jp	Furukawa, Shinya/ABB-2804-2020; Hiasa, Yoichi/ABD-2759-2021; Kumagi, Teru/AAS-7427-2021	Furukawa, Shinya/0000-0002-0041-7688; Hiasa, Yoichi/0000-0003-4117-339X; Kumagi, Teru/0000-0002-2292-7750; Miyake, Teruki/0000-0002-9905-5356				American Diabetes Association, 2003, DIABETES CARE S1, V24, ps21; ANTON FM, 1986, METABOLISM, V35, P343; Baker JF, 2005, AM J MED, V118, P816, DOI 10.1016/j.amjmed.2005.03.043; Chen KT, 2003, DIABETES RES CLIN PR, V60, P177, DOI 10.1016/S0168-8227(03)00037-8; Choi HK, 2005, ARTHRITIS RHEUM-US, V52, P283, DOI 10.1002/art.20761; Harita N, 2009, DIABETES CARE, V32, P424, DOI 10.2337/dc08-1265; Jimba S, 2005, DIABETIC MED, V22, P1141, DOI 10.1111/j.1464-5491.2005.01582.x; Johnson RJ, 2009, ENDOCR REV, V30, P96, DOI 10.1210/er.2008-0033; Kato M, 2009, J ATHEROSCLER THROMB, V16, P857; Kawamoto R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065886; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Kojima S, 2003, J GASTROENTEROL, V38, P954, DOI 10.1007/s00535-003-1178-8; Kuzuya T, 2002, DIABETES RES CLIN PR, V55, P65, DOI 10.1016/S0168-8227(01)00365-5; Li YM, 2009, J HEPATOL, V50, P1029, DOI 10.1016/j.jhep.2008.11.021; Meisinger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037180; Miyake T, 2013, J GASTROENTEROL, V48, P413, DOI 10.1007/s00535-012-0650-8; Miyake T, 2012, J GASTROENTEROL, V47, P696, DOI 10.1007/s00535-012-0534-y; Moebus S, 2009, DIABETOLOGIA, V52, P81, DOI 10.1007/s00125-008-1173-y; Moriuchi T, 2010, INTERNAL MED, V49, P1271, DOI 10.2169/internalmedicine.49.3513; Nakanishi N, 2003, EUR J EPIDEMIOL, V18, P523, DOI 10.1023/A:1024600905574; Oda E, 2011, INTERNAL MED, V48, P1785; Quinones Galvan Alfredo, 1995, American Journal of Physiology, V268, pE1; ROUBENOFF R, 1991, JAMA-J AM MED ASSOC, V266, P3004, DOI 10.1001/jama.266.21.3004; Roy D, 1998, AM J PHYSIOL-ENDOC M, V274, pE692, DOI 10.1152/ajpendo.1998.274.4.E692; Sairenchi T, 2004, AM J EPIDEMIOL, V160, P158, DOI 10.1093/aje/kwh183; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Schulz E, 2011, HYPERTENS RES, V34, P665, DOI 10.1038/hr.2011.39; Smelcerovic A, 2013, FOOD CHEM TOXICOL, V55, P493, DOI 10.1016/j.fct.2013.01.052; Sumino H, 1999, LANCET, V354, P650, DOI 10.1016/S0140-6736(99)92381-4; Taniguchi Y, 2001, J HYPERTENS, V19, P1209, DOI 10.1097/00004872-200107000-00005; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; Waki K, 2005, DIABETIC MED, V22, P323, DOI 10.1111/j.1464-5491.2004.01403.x; World Health Organization, 2006, DEF DIAGN DIAB MELL; Yamada T, 2011, DIABETES METAB, V37, P252, DOI 10.1016/j.diabet.2010.10.009; Yamada T, 2010, J GASTROEN HEPATOL, V25, P352, DOI 10.1111/j.1440-1746.2009.05998.x; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1	37	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107882	10.1371/journal.pone.0107882	http://dx.doi.org/10.1371/journal.pone.0107882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25237894	Green Published, gold, Green Submitted			2022-12-25	WOS:000342491600060
J	Vegezzi, G; Anselmi, L; Huynh, J; Barocelli, E; Rozengurt, E; Raybould, H; Sternini, C				Vegezzi, Gaia; Anselmi, Laura; Huynh, Jennifer; Barocelli, Elisabetta; Rozengurt, Enrique; Raybould, Helen; Sternini, Catia			Diet-Induced Regulation of Bitter Taste Receptor Subtypes in the Mouse Gastrointestinal Tract	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; INDUCED OBESITY; SIGNALING MECHANISMS; GUT MICROBIOTA; RAT STOMACH; EXPRESSION; CELLS; ENDOCRINE; NEURONS; FAMILY	Bitter taste receptors and signaling molecules, which detect bitter taste in the mouth, are expressed in the gut mucosa. In this study, we tested whether two distinct bitter taste receptors, the bitter taste receptor 138 (T2R138), selectively activated by isothiocyanates, and the broadly tuned bitter taste receptor 108 (T2R108) are regulated by luminal content. Quantitative RT-PCR analysis showed that T2R138 transcript is more abundant in the colon than the small intestine and lowest in the stomach, whereas T2R108 mRNA is more abundant in the stomach compared to the intestine. Both transcripts in the stomach were markedly reduced by fasting and restored to normal levels after 4 hours re-feeding. A cholesterol-lowering diet, mimicking a diet naturally low in cholesterol and rich in bitter substances, increased T2R138 transcript, but not T2R108, in duodenum and jejunum, and not in ileum and colon. Long-term ingestion of high-fat diet increased T2R138 RNA, but not T2R108, in the colon. Similarly, a-gustducin, a bitter taste receptor signaling molecule, was reduced by fasting in the stomach and increased by lowering cholesterol in the small intestine and by high-fat diet in the colon. These data show that both short and long term changes in the luminal contents alter expression of bitter taste receptors and associated signaling molecules in the mucosa, supporting the proposed role of bitter taste receptors in luminal chemosensing in the gastrointestinal tract. Bitter taste receptors might serve as regulatory and defensive mechanism to control gut function and food intake and protect the body from the luminal environment.	[Vegezzi, Gaia; Anselmi, Laura; Huynh, Jennifer; Rozengurt, Enrique; Sternini, Catia] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, CURE Digest Dis Res Ctr,Digest Dis Div, Los Angeles, CA 90095 USA; [Sternini, Catia] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Rozengurt, Enrique; Sternini, Catia] Greater Los Angeles Hlth Syst, Vet Adm, Los Angeles, CA USA; [Barocelli, Elisabetta] Univ Parma, Dept Pharm, I-43100 Parma, Italy; [Raybould, Helen] Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Parma; University of California System; University of California Davis	Sternini, C (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, CURE Digest Dis Res Ctr,Digest Dis Div, Los Angeles, CA 90095 USA.	csternin@ucla.edu			NIH [DK-R01DK79155, DDK-41004, DK-P3041301]; Stein Oppenheimer; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301, R01DK079155] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stein Oppenheimer; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH DK-R01DK79155 (CS), DDK-41004 (HR), DK-P3041301 (ER), Stein Oppenheimer (CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Anselmi L, 2005, PEPTIDES, V26, P815, DOI 10.1016/j.peptides.2004.12.011; Behrens M, 2011, PHYSIOL BEHAV, V105, P4, DOI 10.1016/j.physbeh.2011.02.010; Buchan AMJ, 1999, AM J PHYSIOL-GASTR L, V277, pG1103, DOI 10.1152/ajpgi.1999.277.6.G1103; Cani PD, 2008, PATHOL BIOL, V56, P305, DOI 10.1016/j.patbio.2007.09.008; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Chen MC, 2006, AM J PHYSL CELL PHYS; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Dong D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-12; FACER P, 1985, GASTROENTEROLOGY, V89, P1366, DOI 10.1016/0016-5085(85)90657-2; Fehr J, 2007, J COMP PHYSIOL A, V193, P21, DOI 10.1007/s00359-006-0168-8; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Finger Thomas E, 2011, F1000 Biol Rep, V3, P20, DOI 10.3410/B3-20; Furness JB, 1999, AM J PHYSIOL-GASTR L, V277, pG922, DOI 10.1152/ajpgi.1999.277.5.G922; Glatzle J, 2003, J PHYSIOL-LONDON, V550, P657, DOI 10.1113/jphysiol.2003.041673; Glendinning JI, 2008, PHYSIOL BEHAV, V93, P757, DOI 10.1016/j.physbeh.2007.11.029; GOEHLER LE, 1988, CELL TISSUE RES, V253, P145; Gulbransen BD, 2008, J NEUROPHYSIOL, V99, P2929, DOI 10.1152/jn.00066.2008; Hao SZ, 2008, AM J PHYSIOL-REG I, V294, pR33, DOI 10.1152/ajpregu.00675.2007; Hao S, 2009, AM J PHYSIOL-REG I, V296, pR528, DOI 10.1152/ajpregu.90423.2008; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Hofer D, 1999, NEWS PHYSIOL SCI, V14, P18; Hofer D, 1996, P NATL ACAD SCI USA, V93, P6631, DOI 10.1073/pnas.93.13.6631; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Jeon TI, 2008, J CLIN INVEST, V118, P3693, DOI 10.1172/JCI36461; Kaji I, 2009, AM J PHYSIOL-GASTR L, V296, pG971, DOI 10.1152/ajpgi.90514.2008; Lee RJ, 2013, INNATE IMMUN; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Mazzoni M, 2013, J CELL MOL MED, V17, P466, DOI 10.1111/jcmm.12026; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Patierno S, 2005, GASTROENTEROLOGY, V128, P2009, DOI 10.1053/j.gastro.2005.03.042; Pham T, 2002, J COMP NEUROL, V450, P292, DOI 10.1002/cne.10311; Prandi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082820; Raybould HE, 1998, NEWS PHYSIOL SCI, V13, P275; Rozengurt N, 2006, AM J PHYSL GASTROINT; Scott K, 2005, NEURON, V48, P455, DOI 10.1016/j.neuron.2005.10.015; Scott K, 2004, CURR OPIN NEUROBIOL, V14, P423, DOI 10.1016/j.conb.2004.06.003; Singh N, 2011, BIOCHEM BIOPH RES CO, V406, P146, DOI 10.1016/j.bbrc.2011.02.016; STERNINI C, 1995, J COMP NEUROL, V358, P531, DOI 10.1002/cne.903580406; Sternini C, 2008, CURR OPIN ENDOCRINOL, V15, P73, DOI 10.1097/MED.0b013e3282f43a73; Sternini C, 2007, AM J PHYSIOL-GASTR L, V292, pG457, DOI 10.1152/ajpgi.00411.2006; Strader AD, 2005, GASTROENTEROLOGY, V128, P175, DOI 10.1053/j.gastro.2004.10.043; STROFF T, 1995, GASTROENTEROLOGY, V109, P89, DOI 10.1016/0016-5085(95)90272-4; Sutherland K, 2007, AM J PHYSIOL-GASTR L, V292, pG1420, DOI 10.1152/ajpgi.00504.2006; Taniguchi K, 2004, J VET MED SCI, V66, P1311, DOI 10.1292/jvms.66.1311; Tepper BJ, 2008, ANNU REV NUTR, V28, P367, DOI 10.1146/annurev.nutr.28.061807.155458; Tepper BJ, 2011, APPETITE, V56, P104, DOI 10.1016/j.appet.2010.11.144; Thomas AP, 2011, J NUTR, V141, P1172, DOI 10.3945/jn.110.127068; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Toshinai K, 2001, BIOCHEM BIOPH RES CO, V281, P1220, DOI 10.1006/bbrc.2001.4518; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; WALSH JH, 1993, GASTROENTEROLOGY, V105, P653, DOI 10.1016/0016-5085(93)90879-H; Wu SV, 2005, PHYSIOL GENOMICS, V22, P139, DOI 10.1152/physiolgenomics.00030.2005; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699; WU V, 1991, GASTROENTEROLOGY, V101, P1552, DOI 10.1016/0016-5085(91)90391-W; Xu J, 2013, MOL HUM REPROD, V19, P17, DOI 10.1093/molehr/gas040; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001	64	45	45	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107732	10.1371/journal.pone.0107732	http://dx.doi.org/10.1371/journal.pone.0107732			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238152	gold, Green Published, Green Submitted			2022-12-25	WOS:000342491600046
J	Bekara, ME; Courcoul, A; Benet, JJ; Durand, B				Bekara, Mohammed El Amine; Courcoul, Aurelie; Benet, Jean-Jacques; Durand, Benoit			Modeling Tuberculosis Dynamics, Detection and Control in Cattle Herds	PLOS ONE			English	Article							APPROXIMATE BAYESIAN COMPUTATION; MYCOBACTERIUM-BOVIS INFECTION; RISK-FACTORS; SIMULATION-MODEL; TRANSMISSION; DIAGNOSIS; STATISTICS; PARAMETERS; HUSBANDRY; EVOLUTION	Epidemiological models are key tools for designing and evaluating detection and control strategies against animal infectious diseases. In France, after decades of decrease of bovine tuberculosis (bTB) incidence, the disease keeps circulating. Increasing prevalence levels are observed in several areas, where the detection and control strategy could be adapted. The objective of this work was to design and calibrate a model of the within-herd transmission of bTB. The proposed model is a stochastic model operating in discrete-time. Three health states were distinguished: susceptible, latent and infected. Dairy and beef herd dynamics and bTB detection and control programs were explicitly represented. Approximate Bayesian computation was used to estimate three model parameters from field data: the transmission parameter when animals are inside (beta(inside)) and outside (beta(outside)) buildings, and the duration of the latent phase. An independent dataset was used for model validation. The estimated median was 0.43 [0.16-0.84] month(-1) for beta(inside) and 0.08 [0.01-0.32] month 21 for beta(outside). The median duration of the latent period was estimated 3.5 [2-8] months. The sensitivity analysis showed only minor influences of fixed parameter values on these posterior estimates. Validation based on an independent dataset showed that in more than 80% of herds, the observed proportion of animals with detected lesions was between the 2.5% and 97.5% percentiles of the simulated distribution. In the absence of control program and once bTB has become enzootic within a herd, the median effective reproductive ratio was estimated to be 2.2 in beef herds and 1.7 in dairy herds. These low estimates are consistent with field observations of a low prevalence level in French bTB-infected herds.	[Bekara, Mohammed El Amine; Courcoul, Aurelie; Durand, Benoit] Univ Paris Est, Anses, Hlth Anim Lab, Epidemiol Unit, Maisons Alfort, France; [Benet, Jean-Jacques] Univ Paris Est, Natl Vet Sch Alfort ENVA, EpiMAI Unit, Maisons Alfort, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); Ecole Nationale Veterinaire d'Alfort (ENVA)	Durand, B (corresponding author), Univ Paris Est, Anses, Hlth Anim Lab, Epidemiol Unit, Maisons Alfort, France.	benoit.durand@anses.fr	Bekara, Mohammed El Amine/AAP-4380-2020; Durand, Benoit/GSE-2511-2022	Durand, Benoit/0000-0003-0669-1394	French Ministry of Agriculture	French Ministry of Agriculture	This work was supported by the French Ministry of Agriculture. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschbacher S, 2012, GENETICS, V192, P1027, DOI 10.1534/genetics.112.143164; Alvarez J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-100; Ameni G, 2007, CLIN VACCINE IMMUNOL, V14, P1356, DOI 10.1128/CVI.00205-07; Ameni G, 2006, CLIN VACCINE IMMUNOL, V13, P1030, DOI 10.1128/CVI.00134-06; [Anonymous], INFECT DIS HUMANS DY; Barlow ND, 1997, PREV VET MED, V32, P57, DOI 10.1016/S0167-5877(97)00002-0; Barnes CP, 2012, STAT COMPUT, V22, P1181, DOI 10.1007/s11222-012-9335-7; Beaumont MA, 2002, GENETICS, V162, P2025; Beaumont MA, 2010, ANNU REV ECOL EVOL S, V41, P379, DOI 10.1146/annurev-ecolsys-102209-144621; Bekara ME, 2014, TRANSBOUND EMERG DIS; Brooks-Pollock E, 2014, NATURE, V511, P228, DOI 10.1038/nature13529; Carnon F, 1985, CONTRIBUTION ETUDE E; Conlan AJK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002730; CORNER LA, 1994, VET MICROBIOL, V40, P53, DOI 10.1016/0378-1135(94)90046-9; Costello E, 1998, VET J, V155, P245, DOI 10.1016/S1090-0233(05)80019-X; Courcoul A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090334; Cousins DV, 2001, REV SCI TECH OIE, V20, P71, DOI 10.20506/rst.20.1.1263; Csillery K, 2012, METHODS ECOL EVOL, V3, P475, DOI 10.1111/j.2041-210X.2011.00179.x; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; deJong MCM, 1995, PREV VET MED, V25, P183, DOI 10.1016/0167-5877(95)00538-2; Del Moral P, 2012, STAT COMPUT, V22, P1009, DOI 10.1007/s11222-011-9271-y; Drovandi CC, 2011, BIOMETRICS, V67, P225, DOI 10.1111/j.1541-0420.2010.01410.x; Filippi S, 2013, STAT APPL GENET MOL, V12, DOI 10.1515/sagmb-2012-0069; Fischer EAJ, 2005, PREV VET MED, V67, P283, DOI 10.1016/j.prevetmed.2004.12.002; Griffin JM, 1999, SELECTED PAPERS, P55; Gumi B, 2011, TROP ANIM HEALTH PRO, V43, P1081, DOI 10.1007/s11250-010-9777-x; Hagan WA, 1973, HAGANS INFECT DIS DO; Kao RR, 1997, P ROY SOC B-BIOL SCI, V264, P1069, DOI 10.1098/rspb.1997.0148; Karolemeas K, 2011, PREV VET MED, V102, P22, DOI 10.1016/j.prevetmed.2011.06.004; Kleeberg H. H., 1960, Journal of the South African Veterinary Medical Association, V31, P213; NEILL SD, 1992, VET REC, V131, P45, DOI 10.1136/vr.131.3.45; O'Reilly L. M., 1988, Irish Veterinary News, V10, P11; Perez AM, 2002, PREV VET MED, V54, P361, DOI 10.1016/S0167-5877(02)00043-0; Pollock JM, 2000, VET REC, V146, P659, DOI 10.1136/vr.146.23.659; Porphyre T, 2008, PREV VET MED, V86, P93, DOI 10.1016/j.prevetmed.2008.03.008; Pouillot W, 2004, VET RES, V35, P53, DOI 10.1051/vetres:2003046; Proano-Perez F, 2009, AM J TROP MED HYG, V81, P1103, DOI 10.4269/ajtmh.2009.09-0182; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RADOSTITS OM, 1994, VET MED TXB DIS CATT; Ramirez-Villaescusa AM, 2010, PREV VET MED, V95, P224, DOI 10.1016/j.prevetmed.2010.03.009; Reynolds D, 2006, VET MICROBIOL, V112, P119, DOI 10.1016/j.vetmic.2005.11.042; Rua-Domenech R. de la, 2006, GVJ - Government Veterinary Journal, V16, P19; Smith RL, 2013, JAVMA-J AM VET MED A, V243, P411, DOI 10.2460/javma.243.3.411; SMITH S, 1994, PEDIATR INFECT DIS J, V13, P538, DOI 10.1097/00006454-199406000-00014; Sunnaker M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002803; Thakur A, 2010, VET WORLD, V3, P409, DOI 10.5455/vetworld.2010.408-413; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; Vial F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018058; Vose D., 2000, RISK ANAL QUANTITATI; Wahlstrom H, 2000, PREV VET MED, V43, P103, DOI 10.1016/S0167-5877(99)00091-4	52	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108584	10.1371/journal.pone.0108584	http://dx.doi.org/10.1371/journal.pone.0108584			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254369	Green Published, gold, Green Submitted			2022-12-25	WOS:000344862300096
J	Haase, D; Rieger, JK; Witten, A; Stoll, M; Bornberg-Bauer, E; Kalbe, M; Reusch, TBH				Haase, David; Rieger, Jennifer K.; Witten, Anika; Stoll, Monika; Bornberg-Bauer, Erich; Kalbe, Martin; Reusch, Thorsten B. H.			Specific Gene Expression Responses to Parasite Genotypes Reveal Redundancy of Innate Immunity in Vertebrates	PLOS ONE			English	Article							DIPLOSTOMUM-PSEUDOSPATHACEUM; 3-SPINED STICKLEBACKS; EYE FLUKE; RNA-SEQ; SYSTEM; INFECTION; EVOLUTION; RECOGNITION; SPATHACEUM	Vertebrate innate immunity is the first line of defense against an invading pathogen and has long been assumed to be largely unspecific with respect to parasite/pathogen species. However, recent phenotypic evidence suggests that immunogenetic variation, i.e. allelic variability in genes associated with the immune system, results in host-parasite genotype-by-genotype interactions and thus specific innate immune responses. Immunogenetic variation is common in all vertebrate taxa and this reflects an effective immunological function in complex environments. However, the underlying variability in host gene expression patterns as response of innate immunity to within-species genetic diversity of macroparasites in vertebrates is unknown. We hypothesized that intra-specific variation among parasite genotypes must be reflected in host gene expression patterns. Here we used high-throughput RNA-sequencing to examine the effect of parasite genotypes on gene expression patterns of a vertebrate host, the three-spined stickleback (Gasterosteus aculeatus). By infecting naive fish with distinct trematode genotypes of the species Diplostomum pseudospathaceum we show that gene activity of innate immunity in three-spined sticklebacks depended on the identity of an infecting macroparasite genotype. In addition to a suite of genes indicative for a general response against the trematode we also find parasite-strain specific gene expression, in particular in the complement system genes, despite similar infection rates of single clone treatments. The observed discrepancy between infection rates and gene expression indicates the presence of alternative pathways which execute similar functions. This suggests that the innate immune system can induce redundant responses specific to parasite genotypes.	[Haase, David; Rieger, Jennifer K.; Reusch, Thorsten B. H.] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Witten, Anika; Stoll, Monika] Univ Munster, Leibniz Inst Arteriosclerosis Res, D-48149 Munster, Germany; [Bornberg-Bauer, Erich] Univ Munster, Inst Evolut & Biodivers, D-48149 Munster, Germany; [Kalbe, Martin] Max Planck Inst Evolutionary Biol, Dept Evolutionary Ecol, Plon, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Munster; University of Munster; Max Planck Society	Haase, D (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany.	dhaase@geomar.de	Bornberg-Bauer, Erich/A-1563-2013; Witten, Anika/C-5297-2019; Reusch, Thorsten B. H./B-9311-2019; Reusch, Thorsten B.H./G-4141-2011	Bornberg-Bauer, Erich/0000-0002-1826-3576; Reusch, Thorsten B. H./0000-0002-8961-4337	Deutsche Forschungsgemeinschaft (DFG) [SPP 1399, RE 1108/13-2, RE 1108/13-1]; GEOMAR Helmholtz Centre for Ocean Research Kiel; Max Planck Institute for Evolutionary Biology	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); GEOMAR Helmholtz Centre for Ocean Research Kiel(Helmholtz Association); Max Planck Institute for Evolutionary Biology(Max Planck Society)	This study was financially supported by the Deutsche Forschungsgemeinschaft (DFG, Priority Programme SPP 1399 "Host-parasite Coevolution"; grant no. RE 1108/13-2 and RE 1108/13-1; dfg.de), GEOMAR Helmholtz Centre for Ocean Research Kiel (www.geomar.de) and the Max Planck Institute for Evolutionary Biology (www.evolbio.mpg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barribeau SM, 2014, P NATL ACAD SCI USA, V111, P3496, DOI 10.1073/pnas.1318628111; Chappell L.H., 1994, P59; Chen HW, 2013, J IMMUNOL, V191, P4194, DOI 10.4049/jimmunol.1300799; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CROWDEN AE, 1980, ANIM BEHAV, V28, P287, DOI 10.1016/S0003-3472(80)80031-5; de Roode JC, 2010, EVOLUTION, V64, P502, DOI 10.1111/j.1558-5646.2009.00845.x; Feulner PGD, 2013, MOL ECOL, V22, P635, DOI 10.1111/j.1365-294X.2012.05680.x; Flainik MF, 2004, TRENDS IMMUNOL, V25, P640, DOI 10.1016/j.it.2004.10.001; Gibson G, 2005, SCIENCE, V307, P1890, DOI 10.1126/science.1109835; Haase D, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0044; Jokela J, 2000, OIKOS, V89, P267, DOI 10.1034/j.1600-0706.2000.890207.x; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kalbe M, 2006, PARASITOLOGY, V132, P105, DOI 10.1017/S0031182005008681; Karvonen A, 2012, P ROY SOC B-BIOL SCI, V279, P171, DOI 10.1098/rspb.2011.0879; Koehler AV, 2012, PARASITOLOGY, V139, P128, DOI 10.1017/S0031182011001739; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lazzaro BP, 2009, PHILOS T R SOC B, V364, P15, DOI 10.1098/rstb.2008.0141; Lenz TL, 2013, MOL ECOL, V22, P774, DOI 10.1111/j.1365-294X.2012.05756.x; Magnadottir B, 2006, FISH SHELLFISH IMMUN, V20, P137, DOI 10.1016/j.fsi.2004.09.006; Maizels RM, 2013, NAT IMMUNOL, V14, P879, DOI 10.1038/ni.2643; Maizels RM, 2012, CURR OPIN IMMUNOL, V24, P459, DOI 10.1016/j.coi.2012.06.003; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Medzhitov R, 2010, NAT IMMUNOL, V11, P551, DOI 10.1038/ni0710-551; Mikes L, 2001, INT J PARASITOL, V31, P245, DOI 10.1016/S0020-7519(00)00165-X; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nish S, 2011, IMMUNITY, V34, P629, DOI 10.1016/j.immuni.2011.05.009; OWEN SF, 1993, J FISH BIOL, V42, P803; Press CM, 1999, FISH SHELLFISH IMMUN, V9, P309, DOI 10.1006/fsim.1998.0181; Rauch G, 2005, J EVOLUTION BIOL, V18, P1069, DOI 10.1111/j.1420-9101.2005.00895.x; Rauch G, 2008, OIKOS, V117, P399, DOI 10.1111/j.2007.0030-1299.16301.x; Rauch G, 2006, BIOL LETT-UK, V2, P382, DOI 10.1098/rsbl.2006.0462; Reusch TBH, 2004, MOL ECOL NOTES, V4, P577, DOI 10.1111/j.1471-8286.2004.00740.x; Seppala O, 2009, P ROY SOC B-BIOL SCI, V276, P691, DOI 10.1098/rspb.2008.1229; Smith KA, 2012, INFECT IMMUN, V80, P3481, DOI 10.1128/IAI.00436-12; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Whitehead A, 2006, MOL ECOL, V15, P1197, DOI 10.1111/j.1365-294X.2006.02868.x; Whyte SK, 2007, FISH SHELLFISH IMMUN, V23, P1127, DOI 10.1016/j.fsi.2007.06.005; WHYTE SK, 1990, J FISH DIS, V13, P281, DOI 10.1111/j.1365-2761.1990.tb00784.x; Workenhe ST, 2010, MOL IMMUNOL, V47, P2525, DOI 10.1016/j.molimm.2010.06.009	41	22	23	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108001	10.1371/journal.pone.0108001	http://dx.doi.org/10.1371/journal.pone.0108001			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254967	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000344862300051
J	Singer, AC; Jarhult, JD; Grabic, R; Khan, GA; Lindberg, RH; Fedorova, G; Fick, J; Bowes, MJ; Olsen, B; Soderstrom, H				Singer, Andrew C.; Jarhult, Josef D.; Grabic, Roman; Khan, Ghazanfar A.; Lindberg, Richard H.; Fedorova, Ganna; Fick, Jerker; Bowes, Michael J.; Olsen, Bjorn; Soderstrom, Hanna			Intra- and Inter-Pandemic Variations of Antiviral, Antibiotics and Decongestants in Wastewater Treatment Plants and Receiving Rivers	PLOS ONE			English	Article							INFLUENZA-VIRUS; ANTIINFLUENZA DRUGS; SEASONAL INFLUENZA; TAMIFLU USE; OSELTAMIVIR; ENVIRONMENT; FATE; RESISTANCE; EMERGENCE; REMOVAL	The concentration of eleven antibiotics (trimethoprim, oxytetracycline, ciprofloxacin, azithromycin, cefotaxime, doxycycline, sulfamethoxazole, erythromycin, clarithromycin, ofloxacin, norfloxacin), three decongestants (naphazoline, oxymetazoline, xylometazoline) and the antiviral drug oseltamivir's active metabolite, oseltamivir carboxylate (OC), were measured weekly at 21 locations within the River Thames catchment in England during the month of November 2009, the autumnal peak of the influenza A[H1N1]pdm09 pandemic. The aim was to quantify the pharmaceutical response to the pandemic and compare this to drug use during the late pandemic (March 2010) and the inter-pandemic periods (May 2011). A large and small wastewater treatment plant (WWTP) were sampled in November 2009 to understand the differential fate of the analytes in the two WWTPs prior to their entry in the receiving river and to estimate drug users using a wastewater epidemiology approach. Mean hourly OC concentrations in the small and large WWTP's influent were 208 and 350 ng/L (max, 2070 and 550 ng/L, respectively). Erythromycin was the most concentrated antibiotic measured in Benson and Oxford WWTPs influent (max = 6,870 and 2,930 ng/L, respectively). Napthazoline and oxymetazoline were the most frequently detected and concentrated decongestant in the Benson WWTP influent (1650 and 67 ng/L) and effluent (696 and 307 ng/L), respectively, but were below detection in the Oxford WWTP. OC was found in 73% of November 2009's weekly river samples (max = 193 ng/L), but only in 5% and 0% of the late-and inter-pandemic river samples, respectively. The mean river concentration of each antibiotic during the pandemic largely fell between 17-74 ng/L, with clarithromycin (max = 292 ng/L) and erythromycin (max = 448 ng/L) yielding the highest single measure. In general, the concentration and frequency of detecting antibiotics in the river increased during the pandemic. OC was uniquely well-suited for the wastewater epidemiology approach owing to its nature as a prodrug, recalcitrance and temporally-and spatially-resolved prescription statistics.	[Singer, Andrew C.; Bowes, Michael J.] NERC, Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Jarhult, Josef D.; Olsen, Bjorn] Uppsala Univ, Infect Dis Sect, Dept Med Sci, Uppsala, Sweden; [Grabic, Roman; Khan, Ghazanfar A.; Lindberg, Richard H.; Fedorova, Ganna; Fick, Jerker; Soderstrom, Hanna] Umea Univ, Dept Chem, Umea, Sweden; [Grabic, Roman; Fedorova, Ganna] Univ South Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, South Bohemian Res Ctr Aquaculture & Biodivers Hy, Vodnany, Czech Republic; [Olsen, Bjorn] Linnaeus Univ, Sect Zoonot Ecol & Epidemiol, Sch Nat Sci, Kalmar, Sweden	UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); Uppsala University; Umea University; University of South Bohemia Ceske Budejovice; Linnaeus University	Singer, AC (corresponding author), NERC, Ctr Ecol & Hydrol, Wallingford, Oxon, England.	acsi@ceh.ac.uk	Jarhult, Josef D./ABE-8149-2020; Grabic, Roman/AAF-5412-2021; Berglund Fick, Jerker/HDO-5788-2022; Bowes, Mike/E-1528-2011; Grabic, Roman/B-1289-2013; Fedorova, Ganna/F-8268-2015; Lindberg, Richard/C-8882-2013; Singer, Andrew/B-3398-2010	Jarhult, Josef D./0000-0002-7075-1059; Grabic, Roman/0000-0002-0935-2075; Bowes, Mike/0000-0002-0673-1934; Grabic, Roman/0000-0002-0935-2075; Singer, Andrew/0000-0003-4705-6063; Fick, Jerker/0000-0002-3949-7371; Olsen, Bjorn/0000-0002-4646-691X; Soderstrom, Hanna/0000-0003-1341-7879	Swedish Research Council Formas; Natural Environment Research Council-Knowledge Transfer (PREPARE) Initiative [NE/F009216/1]; CEH Science Budget; Ministry of Education, Youth and Sports of the Czech Republic CENAKVA [CZ.1.05/2.1.00/01.0024]; Grant Agency of the University of South Bohemia [047/2010/Z]; Natural Environment Research Council [NE/F009410/1, NE/F009216/1] Funding Source: researchfish; NERC [NE/F009410/1, NE/F009216/1] Funding Source: UKRI	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Natural Environment Research Council-Knowledge Transfer (PREPARE) Initiative; CEH Science Budget; Ministry of Education, Youth and Sports of the Czech Republic CENAKVA; Grant Agency of the University of South Bohemia; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors received funding for the collection and analysis from the Swedish Research Council Formas, the Natural Environment Research Council-Knowledge Transfer (PREPARE) Initiative contract NE/F009216/1, CEH Science Budget, the Ministry of Education, Youth and Sports of the Czech Republic CENAKVA No. CZ.1.05/2.1.00/01.0024 and the Grant Agency of the University of South Bohemia No. 047/2010/Z. The authors received in-kind support from G. F. F. Hoffman La Roche Ltd. through donated deuterated OC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach JE, 2013, ANTIMICROB AGENTS CH, V57, P2171, DOI 10.1128/AAC.02126-12; ATLAS RM, 1975, APPL MICROBIOL, V30, P396, DOI 10.1128/AEM.30.3.396-403.1975; Azuma T, 2013, CHEMOSPHERE, V93, P1672, DOI 10.1016/j.chemosphere.2013.05.025; Azuma T, 2012, ENVIRON SCI TECHNOL, V46, P12873, DOI 10.1021/es303203c; Balcan Duygu, 2009, PLoS Curr, V1, pRRN1133; Bowes MJ, 2014, J HYDROL, V517, P1, DOI 10.1016/j.jhydrol.2014.03.063; Chang CC, 2014, COCHRANE DB SYST REV, V3; Chen WY, 2014, ENVIRON POLLUT, V184, P377, DOI 10.1016/j.envpol.2013.09.019; Davey P, 2008, J ANTIMICROB CHEMOTH, V62, P1441, DOI 10.1093/jac/dkn386; Dollery C, 1999, THERAPEUTIC DRUGS, V2; Edlund A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033107; Escher BI, 2010, AQUAT TOXICOL, V96, P194, DOI 10.1016/j.aquatox.2009.10.020; Fick J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000986; Gaze W.H., 2013, EMERG INFECT DIS, V19; Ghosh GC, 2010, ENVIRON HEALTH PERSP, V118, P103, DOI 10.1289/ehp.0900930; Ghosh GC, 2010, CHEMOSPHERE, V81, P13, DOI 10.1016/j.chemosphere.2010.07.023; Gillman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071230; Harvey CL, 2012, HYDROL RES, V43, P618, DOI 10.2166/nh.2012.110; Health Protection Agency, 2010, EP REP PAND H1N1 200; Hutchinson TH, 2009, ENVIRON INT, V35, P931, DOI 10.1016/j.envint.2009.04.001; Ivachtchenko AV, 2013, ANTIVIR RES, V100, P698, DOI 10.1016/j.antiviral.2013.10.008; Jarhult JD, 2012, INFECT ECOL EPIDEMIO, P2; Jarhult JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024742; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub3, 10.1002/14651858.CD008965.pub4]; Kardas P, 2002, J ANTIMICROB CHEMOTH, V49, P897, DOI 10.1093/jac/dkf046; Khan GA, 2012, J PHARMACEUT BIOMED, V66, P24, DOI 10.1016/j.jpba.2012.02.011; Kim WY, 2011, ANTIMICROB AGENTS CH, V55, P5703, DOI 10.1128/AAC.05529-11; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; KOHRING GW, 1989, APPL ENVIRON MICROB, V55, P348, DOI 10.1128/AEM.55.2.348-353.1989; Leknes H, 2012, SCI TOTAL ENVIRON, V414, P632, DOI 10.1016/j.scitotenv.2011.11.004; Lindberg RH, 2014, WATER RES, V58, P221, DOI 10.1016/j.watres.2014.03.076; Llor C, 2013, INT J INFECT DIS, V17, pE168, DOI 10.1016/j.ijid.2012.09.012; Luo YL, 2014, SCI TOTAL ENVIRON, V473, P619, DOI 10.1016/j.scitotenv.2013.12.065; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V60, pI63, DOI 10.1093/jac/dkm161; Michael I, 2013, WATER RES, V47, P957, DOI 10.1016/j.watres.2012.11.027; NHS BSA, 2011, PRESCR AN CHARTS NAT; NHS Information Centre for Health and Social Care, 2011, NUMB GP PRESCR DURG; Ort C, 2006, WATER SCI TECHNOL, V54, P169, DOI 10.2166/wst.2006.591; Ort C, 2005, WATER SCI TECHNOL, V52, P113, DOI 10.2166/wst.2005.0122; Ort C, 2010, ENVIRON SCI TECHNOL, V44, P6289, DOI 10.1021/es100778d; Ort C, 2010, ENVIRON SCI TECHNOL, V44, P6024, DOI 10.1021/es100779n; Perelson AS, 2012, J INFECT DIS, V205, P1642, DOI 10.1093/infdis/jis265; Prasse C, 2010, ENVIRON SCI TECHNOL, V44, P1728, DOI 10.1021/es903216p; Rogers S, 2011, SWINE FLU DATA UK SE; Sacca ML, 2009, CHEMOSPHERE, V75, P28, DOI 10.1016/j.chemosphere.2008.11.060; Singer AC, 2008, ENVIRON HEALTH PERSP, V116, P1563, DOI 10.1289/ehp.11310; Singer AC, 2007, ENVIRON HEALTH PERSP, V115, P102, DOI 10.1289/ehp.9574; Singer AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060221; Singer AC, 2011, ENVIRON HEALTH PERSP, V119, P1084, DOI 10.1289/ehp.1002757; Slater FR, 2011, FEMS MICROBIOL LETT, V315, P17, DOI 10.1111/j.1574-6968.2010.02163.x; Straub JO, 2009, ECOTOX ENVIRON SAFE, V72, P1625, DOI 10.1016/j.ecoenv.2008.09.011; Takanami R., 2012, Journal of Water and Environment Technology, V10, P57, DOI 10.2965/jwet.2012.57; Takanami R., 2010, Journal of Water and Environment Technology, V8, P363, DOI 10.2965/jwet.2010.363; The Health and Social Care Information Centre PSU, 2012, AV DAIL QUANT; TuTiempo.net, 2009, CLIM BENS; Wathen MW, 2013, INFLUENZA OTHER RESP, V7, P76, DOI 10.1111/irv.12049; Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1	57	37	38	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108621	10.1371/journal.pone.0108621	http://dx.doi.org/10.1371/journal.pone.0108621			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254643	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000344862300098
J	Win, AZ; Aparici, CM				Win, Aung Zaw; Aparici, Carina Mari			Normal SUV Values Measured from NaF18-PET/CT Bone Scan Studies	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; STANDARDIZED UPTAKE VALUES; F-18-FLUORIDE PET; FDG PET/CT; METABOLISM; METASTASES; FLUORIDE; SCINTIGRAPHY; RADIONUCLIDE; TECHNOLOGY	Objectives: Cancer and metabolic bone diseases can alter the SUV. SUV values have never been measured from healthy skeletons in NaF18-PET/CT bone scans. The primary aim of this study was to measure the SUV values from normal skeletons in NaF18-PET/CT bone scans. Methods: A retrospective study was carried out involving NaF18-PET/CT bone scans that were done at our institution between January 2010 to May 2012. Our excluding criteria was patients with abnormal real function and patients with past history of cancer and metabolic bone diseases including but not limited to osteoporosis, osteopenia and Paget's disease. Eleven studies met all the criteria. Results: The average normal SUVmax values from 11 patients were: cervical vertebrae 6.84 (range 4.38-8.64), thoracic vertebrae 7.36 (range 6.99-7.66), lumbar vertebrae 7.27 (range 7.04-7.72), femoral head 2.22 (range 1.1-4.3), humeral head 1.82 (range 1.2-2.9), mid sternum 5.51 (range 2.6-8.1), parietal bone 1.71 (range 1.3-2.4). Conclusion: According to our study, various skeletal sites have different normal SUV values. SUV values can be different between the normal bones and bones with tumor or metabolic bone disease. SUV can be used to quantify NaF-18 PET/CT studies. If the SUV values of the normal skeleton are known, they can be used in the characterization of bone lesions and in the assessment of treatment response to bone diseases.	[Win, Aung Zaw] San Francisco VA Med Ctr, Dept Radiol, San Francisco, CA 94121 USA; [Aparici, Carina Mari] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Win, AZ (corresponding author), San Francisco VA Med Ctr, Dept Radiol, San Francisco, CA 94121 USA.	aungzwin@gmail.com			NCI NIH HHS [R01 CA094121] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-beyatti Y, 2012, OSTEOPOROSIS INT, V23, P2535, DOI 10.1007/s00198-011-1889-2; Avery R, 2013, CLIN NUCL MED, V38, P746, DOI 10.1097/RLU.0b013e3182996138; Blake GM, 2011, J CLIN DENSITOM, V14, P263, DOI 10.1016/j.jocd.2011.04.003; Blake GM, 2011, BONE, V49, P537, DOI 10.1016/j.bone.2011.05.031; Brenner W, 2004, J NUCL MED, V45, P1493; Cheng CX, 2013, AM J NUCL MED MOLEC, V3, P118; Cheng G, 2013, ANN HEMATOL, V92, P283, DOI 10.1007/s00277-012-1549-4; Czernin J, 2010, J NUCL MED, V51, P1826, DOI 10.2967/jnumed.110.077933; Duarte Paulo S, 2002, Mol Imaging Biol, V4, P157; Even-Sapir E, 2006, J NUCL MED, V47, P287; Frost ML, 2007, J CLIN DENSITOM, V10, P46, DOI 10.1016/j.jocd.2006.10.006; Frost ML, 2011, J BONE MINER RES, V26, P1002, DOI 10.1002/jbmr.305; Grant FD, 2008, J NUCL MED, V49, P68, DOI 10.2967/jnumed.106.037200; Histed SN, 2012, NUCL MED COMMUN, V33, P349, DOI 10.1097/MNM.0b013e32834ec8a5; Iagaru A, 2013, CLIN NUCL MED, V38, pE290, DOI 10.1097/RLU.0b013e3182815f64; KEYES JW, 1995, J NUCL MED, V36, P1836; Kobayashi N, 2013, CLIN NUCL MED, V38, pE379, DOI 10.1097/RLU.0b013e31828d30c0; Kurdziel KA, 2012, J NUCL MED, V53, P1175, DOI 10.2967/jnumed.111.100883; Laurent V, 2010, EUR J RADIOL, V75, P376, DOI 10.1016/j.ejrad.2009.04.059; Li Y, 2012, BONE, V50, P128, DOI 10.1016/j.bone.2011.09.053; Liu YY, 2009, NUCL MED COMMUN, V30, P895, DOI 10.1097/MNM.0b013e32832f7e6b; MESSA C, 1993, J CLIN ENDOCR METAB, V77, P949, DOI 10.1210/jc.77.4.949; Puri T, 2013, OSTEOPOROSIS INT, V24, P633, DOI 10.1007/s00198-012-2006-x; Sachpekidis C, 2014, EUR J NUCL MED MOL I, V41, P1343, DOI 10.1007/s00259-014-2721-y; Schomburg A, 1996, EUR J NUCL MED, V23, P571, DOI 10.1007/BF00833394; Shin DS, 2008, ANN NUCL MED, V22, P603, DOI 10.1007/s12149-008-0151-2; Suenaga H, 2012, J PROSTHODONT RES, V56, P42, DOI 10.1016/j.jpor.2011.04.002; Waterval JJ, 2013, CLIN NUCL MED, V38, P677, DOI 10.1097/RLU.0b013e31829a013e; Wong KK, 2013, J NUCL MED, V54, P590, DOI 10.2967/jnumed.112.114298; ZASADNY KR, 1993, RADIOLOGY, V189, P847, DOI 10.1148/radiology.189.3.8234714	30	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108429	10.1371/journal.pone.0108429	http://dx.doi.org/10.1371/journal.pone.0108429			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254490	gold, Green Submitted, Green Published			2022-12-25	WOS:000344862300081
J	Blair, MW; Cordoba, JM; Munoz, C; Yuyo, DK				Wohlgemuth Blair, Matthew; Marcela Cordoba, Juana; Munoz, Claritza; Yuyo, Deissy K.			BAC-End Microsatellites from Intra and Inter-Genic Regions of the Common Bean Genome and Their Correlation with Cytogenetic Features	PLOS ONE			English	Article							PHASEOLUS-VULGARIS L.; INTEGRATED LINKAGE MAP; PHOSPHORUS ACQUISITION; MARKERS; DIVERSITY; GENES; IDENTIFICATION; POLYMORPHISM; MESOAMERICAN; REPEATS	Highly polymorphic markers such as simple sequence repeats (SSRs) or microsatellites are very useful for genetic mapping. In this study novel SSRs were identified in BAC-end sequences (BES) from non-contigged, non-overlapping bacterial artificial clones (BACs) in common bean (Phaseolus vulgaris L.). These so called "singleton'' BACs were from the G19833 Andean gene pool physical map and the new BES-SSR markers were used for the saturation of the inter-gene pool, DOR364xG19833 genetic map. A total of 899 SSR loci were found among the singleton BES, but only 346 loci corresponded to the single di- or tri-nucleotide motifs that were likely to be polymorphic (ATT or AG motifs, principally) and useful for primer design and individual marker mapping. When these novel SSR markers were evaluated in the DOR364xG19833 population parents, 136 markers revealed polymorphism and 106 were mapped. Genetic mapping resulted in a map length of 2291 cM with an average distance between markers of 5.2 cM. The new genetic map was compared to the most recent cytogenetic analysis of common bean chromosomes. We found that the new singleton BES-SSR were helpful in filling peri-centromeric spaces on the cytogenetic map. Short genetic distances between some new singleton-derived BES-SSR markers was common showing suppressed recombination in these regions compared to other parts of the genome. The correlation of singleton-derived SSR marker distribution with other cytogenetic features of the bean genome is discussed.	[Wohlgemuth Blair, Matthew] Univ Nacl Colombia, Dept Agron & Ciencias Agr, Palmira, Colombia; [Wohlgemuth Blair, Matthew] Tennessee State Univ, Dept Agr & Nat Sci, Nashville, TN 37203 USA; [Marcela Cordoba, Juana] CORPOICA, Mosquera Cundinamarca, Colombia; [Munoz, Claritza] CIAT, Generat Challenge Program, Cali, Colombia; [Yuyo, Deissy K.] Univ Nacl Colombia, Dept Agron, Fac Agron, Bogota, Colombia	Universidad Nacional de Colombia; Tennessee State University; Corporacion Colombiana de Investigacion Agropecuaria, AGROSAVIA; Alliance; International Center for Tropical Agriculture - CIAT; Universidad Nacional de Colombia	Blair, MW (corresponding author), Univ Nacl Colombia, Dept Agron & Ciencias Agr, Km 12 Via Chapinero, Palmira, Colombia.	mwbeans@gmail.com		Cordoba-Sanchez, Juana Marcela/0000-0002-7389-8304	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding was provided by Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar O, 2008, DIFFERENTIALLY EXPRE; Altrock S, 2011, GENET MOL BIOL, V34, P459, DOI 10.1590/S1415-47572011005000029; Barrera-Figueroa B, 2006, ISOLATION DEHYDRATIO; Beebe SE, 2006, CROP SCI, V46, P413, DOI 10.2135/cropsci2005.0226; Bhore S, 2008, ANAL EXPRESSED SEQUE; Blair M., 2009, GENOME, V52, P1; Blair M, 2008, THEOR APPL GENET, V118, P91, DOI 10.1007/s00122-008-0879-z; Blair MW, 2013, THEOR APPL GENET, V126, P535, DOI 10.1007/s00122-012-1999-z; Blair MW, 2012, MOL ECOL RESOUR, V12, P661, DOI 10.1111/j.1755-0998.2012.03136.x; Blair MW, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-50; Blair MW, 2010, THEOR APPL GENET, V121, P237, DOI 10.1007/s00122-010-1305-x; Blair MW, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-79; Blair MW, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-100; Blair MW, 2003, THEOR APPL GENET, V107, P1362, DOI 10.1007/s00122-003-1398-6; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Cadle-Davidson M, 2006, THEOR APPL GENET, V112, P1452, DOI 10.1007/s00122-006-0247-9; Chacon MI, 2005, THEOR APPL GENET, V110, P432, DOI 10.1007/s00122-004-1842-2; Chaudhary S, 2005, GENE EXPRESSION PROF; Cordoba JM, 2010, PLANT GENOME-US, V3, P154, DOI 10.3835/plantgenome2010.06.0013; Cordoba JM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-436; FONSECA A, 2010, CHROMOSOME RES; Freyre R, 1998, THEOR APPL GENET, V97, P847, DOI 10.1007/s001220050964; Gaitan-Solis E, 2002, CROP SCI, V42, P2128, DOI 10.2135/cropsci2002.2128; Galeano CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028135; Galeano CH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-629; Gepts P., 2001, ENCY GENET, P1444; Grisi MCM, 2007, GENET MOL RES, V6, P691; Guzman S, 1998, GENES ISOLATED DIFFE; Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367; Hanai LR, 2007, GENOME, V50, P266, DOI 10.1139/G07-007; Hanai LR, 2010, MOL BREEDING, V25, P25, DOI 10.1007/s11032-009-9306-7; Hernandez G, 2007, PLANT PHYSIOL, V144, P752, DOI 10.1104/pp.107.096958; Hernandez-Lucero E, 2009, DIFFERENTIAL GENE EX; Kavar T, 2008, MOL BREEDING, V21, P159, DOI 10.1007/s11032-007-9116-8; Lorieux M, 2012, MOL BREEDING, V30, P1231, DOI 10.1007/s11032-012-9706-y; Martins W, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj030; Melotto M, 2005, GENOME, V48, P562, DOI 10.1139/G05-010; Meschini EP, 2008, MOL PLANT MICROBE IN, V21, P459, DOI 10.1094/MPMI-21-4-0459; Metais I, 2002, THEOR APPL GENET, V104, P1346, DOI 10.1007/s00122-002-0901-9; NODARI RO, 1993, THEOR APPL GENET, V85, P513, DOI 10.1007/BF00220907; Pedrosa A, 2003, THEOR APPL GENET, V106, P205, DOI 10.1007/s00122-002-1138-3; Pedrosa-Harand A, 2009, CHROMOSOME RES, V17, P405, DOI 10.1007/s10577-009-9031-4; Reinprecht Y, 2004, CLONING PHENYLPROPAN; Rodriguez-Uribe L, 2004, TRANSCRIPTS DROUGHT; Schlueter J. A., 2008, Tropical Plant Biology, V1, P40, DOI 10.1007/s12042-007-9003-9; Thibivilliers S, 2009, BMC PLANT BIOL, V27, P9; Tian J, 2007, PLANTA, V227, P151, DOI 10.1007/s00425-007-0603-2; VALLEJOS CE, 1992, GENETICS, V131, P733; Vance CP, 2001, PLANT PHYSIOL, V127, P390, DOI 10.1104/pp.010331; Vijayan P, 2008, SUBTRACTION SUPPRESS; Watanabe T, 1999, PARTIAL CDNA T BORCH; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Yu K, 2000, J HERED, V91, P429, DOI 10.1093/jhered/91.6.429	53	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e101873	10.1371/journal.pone.0101873	http://dx.doi.org/10.1371/journal.pone.0101873			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254501	Green Published, gold, Green Submitted			2022-12-25	WOS:000344862300001
J	Li, YS; Chen, BF; Li, XJ; Zhang, WK; Tang, HB				Li, Yu-Sang; Chen, Bei-Fan; Li, Xiao-Jun; Zhang, Wei Kevin; Tang, He-Bin			Cytotoxicity of Polyaniline Nanomaterial on Rat Celiac Macrophages In Vitro	PLOS ONE			English	Article							TOXICITY; CELLS; NANOPARTICLES; NANOFIBERS; PARTICLES; MECHANISM; FORM	Polyaniline nanomaterial (nPANI) is getting popular in many industrial fields due to its conductivity and stability. The fate and effect of nPANI in the environment is of paramount importance towards its technological applications. In this work, the cytotoxicity of nPANI, which was prepared by rapid surface polymerization, was studied on rat celiac macrophages. Cell viability of macrophages treated with various concentrations of nPANI and different periods ranging from 24 to 72 hours was tested by a MTT assay. Damages of nPANI to structures of macrophages were evaluated according to the exposure level of cellular reactive oxygen species (ROS) and change of mitochondrial membrane potential (MMP). We observed no significant effects of nPANI on the survival, ROS level and MMP loss of macrophages at concentrations up to 1 mu g/ml. However, higher dose of nPANI (10 mu g/ml or above) induced cell death, changes of ROS level and MMP. In addition, an increase in the expression level of caspase-3 protein and its activated form was detected in a Western blot assay under the high dose exposure of nPANI. All together, our experimental results suggest that the hazardous potential of nPANI on macrophages is time- and dose-dependent and high dose of nPANI can induce cell apoptosis through caspase-3 mediated pathway.	[Li, Yu-Sang; Chen, Bei-Fan; Li, Xiao-Jun; Zhang, Wei Kevin; Tang, He-Bin] South Cent Univ Nationalities, Coll Pharm, Dept Pharmacol, Wuhan, Peoples R China	South Central Minzu University	Tang, HB (corresponding author), South Cent Univ Nationalities, Coll Pharm, Dept Pharmacol, Wuhan, Peoples R China.	hbtang2006@mail.scuec.edu.cn	Zhang, Wei/M-4241-2019	Zhang, Wei/0000-0003-4960-6137; Li, Yu-Sang/0000-0002-7508-0469; Tang, He-Bin/0000-0002-2673-7882	National Natural Science Foundation of China [81373842, 81101538]; Natural Science Foundation of China Hubei [2013CFB451]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China Hubei	This study was supported by the National Natural Science Foundation of China (81373842, 81101538), and Natural Science Foundation of China Hubei (2013CFB451). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Artetxe U, 2002, PLANT PHYSIOL BIOCH, V40, P859, DOI 10.1016/S0981-9428(02)01446-8; Ayad M, 2013, CHEM ENG J, V217, P460, DOI 10.1016/j.cej.2012.11.099; CHIANG JC, 1986, SYNTHETIC MET, V13, P193, DOI 10.1016/0379-6779(86)90070-6; Chiu WH, 2012, BIOCHEM PHARMACOL, V83, P1159, DOI 10.1016/j.bcp.2012.01.016; Fischer HC, 2007, CURR OPIN BIOTECH, V18, P565, DOI 10.1016/j.copbio.2007.11.008; Huang YF, 2012, POLYMER, V53, P2574, DOI 10.1016/j.polymer.2012.04.022; Humpolicek P, 2012, SYNTHETIC MET, V162, P722, DOI 10.1016/j.synthmet.2012.02.024; Jones CF, 2009, ADV DRUG DELIVER REV, V61, P438, DOI 10.1016/j.addr.2009.03.005; Kawasumi M, 2004, J POLYM SCI POL CHEM, V42, P819, DOI 10.1002/pola.10961; Khan JA, 2014, CR CHIM, V17, P91, DOI 10.1016/j.crci.2013.08.006; Kim HS, 2009, SYNTHETIC MET, V159, P1313, DOI 10.1016/j.synthmet.2009.02.036; Kroll A, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-9; Kurian M, 2006, MACROMOLECULES, V39, P1864, DOI 10.1021/ma052478z; Lewis CW, 2013, FEBS LETT, V587, P3089, DOI 10.1016/j.febslet.2013.08.003; Li J, 2007, MACROMOL RAPID COMM, V28, P740, DOI 10.1002/marc.200600810; Li YH, 2011, SYNTHETIC MET, V161, P56, DOI 10.1016/j.synthmet.2010.10.034; MACDIARMID AG, 1987, SYNTHETIC MET, V18, P285, DOI 10.1016/0379-6779(87)90893-9; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Oh WK, 2011, J NANOSCI NANOTECHNO, V11, P4254, DOI 10.1166/jnn.2011.3662; Pang CF, 2012, AQUAT TOXICOL, V106, P114, DOI 10.1016/j.aquatox.2011.10.005; Patil G, 2012, ENVIRON TOXICOL PHAR, V34, P436, DOI 10.1016/j.etap.2012.05.014; Radad K, 2012, ENVIRON TOXICOL PHAR, V34, P661, DOI 10.1016/j.etap.2012.07.011; Ross MK, 2014, TOXICS, V2, DOI 10.3390/toxics2010017; Service RF, 2004, SCIENCE, V304, P1732, DOI 10.1126/science.304.5678.1732; Singh K, 2013, NANOSCALE, V5, P2411, DOI 10.1039/c3nr33962a; Villalba P, 2012, MAT SCI ENG C-MATER, V32, P594, DOI 10.1016/j.msec.2011.12.017; WAN MX, 1995, J APPL POLYM SCI, V55, P399, DOI 10.1002/app.1995.070550304; Yang CH, 2009, J PHYS CHEM B, V113, P5052, DOI 10.1021/jp811125k; Yslas EI, 2012, CHEMOSPHERE, V87, P1374, DOI 10.1016/j.chemosphere.2012.02.033	30	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107361	10.1371/journal.pone.0107361	http://dx.doi.org/10.1371/journal.pone.0107361			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250578	gold, Green Submitted, Green Published			2022-12-25	WOS:000342492700029
J	Nicosia, A; Maggio, T; Mazzola, S; Gianguzza, F; Cuttitta, A; Costa, S				Nicosia, Aldo; Maggio, Teresa; Mazzola, Salvatore; Gianguzza, Fabrizio; Cuttitta, Angela; Costa, Salvatore			Characterization of Small HSPs from Anemonia viridis Reveals Insights into Molecular Evolution of Alpha Crystallin Genes among Cnidarians	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; SYMBIOTIC SEA-ANEMONE; EST ANALYSIS; THERMAL-STRESS; RESPONSE GENES; B-CRYSTALLIN; COLD STRESS; EXPRESSION; SEQUENCE; GENOME	Gene family encoding small Heat-Shock Proteins (sHSPs containing a-crystallin domain) are found both in prokaryotic and eukaryotic organisms; however, there is limited knowledge of their evolution. In this study, two small HSP genes termed AvHSP28.6 and AvHSP27, both organized in one intron and two exons, were characterised in the Mediterranean snakelocks anemone Anemonia viridis. The release of the genome sequence of Hydra magnipapillata and Nematostella vectensis enabled a comprehensive study of the molecular evolution of a-crystallin gene family among cnidarians. Most of the H. magnipapillata sHSP genes share the same gene organization described for AvHSP28.6 and AvHSP27, differing from the sHSP genes of N. vectensis which mainly show an intronless architecture. The different genomic organization of sHSPs, the phylogenetic analyses based on protein sequences, and the relationships among Cnidarians, suggest that the A. viridis sHSPs represent the common ancestor from which H. magnipapillata genes directly evolved through segmental genome duplication. Additionally retroposition events may be considered responsible for the divergence of sHSP genes of N. vectensis from A. viridis. Analyses of transcriptional expression profile showed that AvHSP28.6 was constitutively expressed among different tissues from both ectodermal and endodermal layers of the adult sea anemones, under normal physiological conditions and also under different stress condition. Specifically, we profiled the transcriptional activation of AvHSP28.6 after challenges with different abiotic/biotic stresses showing induction by extreme temperatures, heavy metals exposure and immune stimulation. Conversely, no AvHSP27 transcript was detected in such dissected tissues, in adult whole body cDNA library or under stress conditions. Hence, the involvement of AvHSP28.6 gene in the sea anemone defensome is strongly suggested.	[Nicosia, Aldo; Cuttitta, Angela] Inst Marine & Coastal Environm IAMC, Natl Res Council, Detached Unit Capo Granitola, Lab Mol Ecol & Biotechnol, Torretta Granitola, Trapani, Italy; [Maggio, Teresa] Inst Environm Protect & Res ISPRA, Palermo, Italy; [Mazzola, Salvatore] Inst Marine & Coastal Environm IAMC, Natl Res Council, Naples, Italy; [Gianguzza, Fabrizio; Costa, Salvatore] Univ Palermo, Dipartimento Sci & Tecnol Biol Chim & Farmaceut, Palermo, Italy	Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); Italian Institute for Environmental Protection & Research (ISPRA); Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); University of Palermo	Cuttitta, A (corresponding author), Inst Marine & Coastal Environm IAMC, Natl Res Council, Detached Unit Capo Granitola, Lab Mol Ecol & Biotechnol, Torretta Granitola, Trapani, Italy.	angela.cuttitta@iamc.cnr.it; costas@unipa.it	Nicosia, Aldo/R-4462-2017; Cuttitta, Angela/AAK-2097-2020	Nicosia, Aldo/0000-0002-1013-2862; Cuttitta, Angela/0000-0002-4896-5114; Costa, Salvatore/0000-0003-2798-4401; GIANGUZZA, Fabrizio/0000-0003-4816-7830; Mazzola, Salvatore/0000-0002-4622-8129				Acunzo J, 2012, INT J BIOCHEM CELL B, V44, P1622, DOI 10.1016/j.biocel.2012.04.002; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Arrigo AP, 2000, PATHOL BIOL, V48, P280; Augusteyn Robert C, 2004, Clin Exp Optom, V87, P356; Augustin R, 2010, ADV EXP MED BIOL, V708, P1; Ball EE, 2004, NAT REV GENET, V5, P567, DOI 10.1038/nrg1402; Bao YB, 2011, FISH SHELLFISH IMMUN, V30, P729, DOI 10.1016/j.fsi.2010.12.002; Basha E, 2010, J BIOL CHEM, V285, P11489, DOI 10.1074/jbc.M109.074088; BRIDGE D, 1992, P NATL ACAD SCI USA, V89, P8750, DOI 10.1073/pnas.89.18.8750; BURTON V, 1988, MOL CELL BIOL, V8, P3550, DOI 10.1128/MCB.8.8.3550; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Colinet H, 2010, FEBS J, V277, P174, DOI 10.1111/j.1742-4658.2009.07470.x; Collins AG, 2002, J EVOLUTION BIOL, V15, P418, DOI 10.1046/j.1420-9101.2002.00403.x; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; DEJONG WW, 1993, MOL BIOL EVOL, V10, P103; Edwards HV, 2011, CELL SIGNAL, V23, P1447, DOI 10.1016/j.cellsig.2011.05.009; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Fontaine JM, 2005, BIOCHEM BIOPH RES CO, V337, P1006, DOI 10.1016/j.bbrc.2005.09.148; Fu XM, 2003, BIOCHEM BIOPH RES CO, V308, P627, DOI 10.1016/S0006-291X(03)01450-5; Fujita Jun, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P243; Ganot P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002187; Goldstone JV, 2008, CELL BIOL TOXICOL, V24, P483, DOI 10.1007/s10565-008-9107-5; Gu J, 2012, INSECT MOL BIOL, V21, P535, DOI 10.1111/j.1365-2583.2012.01158.x; Han YP, 2005, MICROBES INFECT, V7, P335, DOI 10.1016/j.micinf.2004.11.005; Haslbeck M, 2008, J MOL BIOL, V378, P362, DOI 10.1016/j.jmb.2008.01.095; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; INGOLIA TD, 1982, P NATL ACAD SCI-BIOL, V79, P2360, DOI 10.1073/pnas.79.7.2360; Irimia M, 2008, NUCLEIC ACIDS RES, V36, P1703, DOI 10.1093/nar/gkn012; JACOBSEN JV, 1989, PLANT PHYSIOL, V91, P1520, DOI 10.1104/pp.91.4.1520; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Klein SL, 2002, DEV DYNAM, V225, P384, DOI 10.1002/dvdy.10174; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; Kostenko S, 2009, CELL MOL LIFE SCI, V66, P3289, DOI 10.1007/s00018-009-0086-3; Kozlov S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-88; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; Laios E, 1997, MOL CELL BIOCHEM, V173, P153, DOI 10.1023/A:1006844114348; Lambert H, 1999, J BIOL CHEM, V274, P9378, DOI 10.1074/jbc.274.14.9378; LASZLO A, 1992, CELL PROLIFERAT, V25, P59, DOI 10.1111/j.1365-2184.1992.tb01482.x; Li HJ, 2013, AQUAT BIOL, V18, P243, DOI 10.3354/ab00503; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu ZH, 2012, CELL STRESS CHAPERON, V17, P539, DOI 10.1007/s12192-012-0330-x; Marrone V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031750; McGuire VA, 2013, MOL CELL BIOL, V33, P4152, DOI 10.1128/MCB.01691-12; Miller DJ, 2005, TRENDS GENET, V21, P536, DOI 10.1016/j.tig.2005.08.002; Moran Y, 2012, P ROY SOC B-BIOL SCI, V279, P1351, DOI 10.1098/rspb.2011.1731; Morris SC, 2006, PHILOS T R SOC B, V361, P1069, DOI 10.1098/rstb.2006.1846; Moya A, 2012, MOL ECOL, V21, P1158, DOI 10.1111/j.1365-294X.2012.05458.x; Nakamoto H, 2007, CELL MOL LIFE SCI, V64, P294, DOI 10.1007/s00018-006-6321-2; Narbonne GM, 2005, ANNU REV EARTH PL SC, V33, P421, DOI 10.1146/annurev.earth.33.092203.122519; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Nicosia A, 2013, MAR DRUGS, V11, P4213, DOI 10.3390/md11114213; Pacheco A, 2009, MICROBIOL-SGM, V155, P2021, DOI 10.1099/mic.0.025981-0; Park EM, 2008, J ENVIRON BIOL, V29, P577; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Qiu ZJ, 2006, GENOMICS, V88, P230, DOI 10.1016/j.ygeno.2006.02.008; Reitzel AM, 2008, BIOL BULL-US, V214, P233, DOI 10.2307/25470666; Richier S, 2006, FEBS J, V273, P4186, DOI 10.1111/j.1742-4658.2006.05414.x; Rosenfeld GE, 2013, DEV BIOL, V381, P389, DOI 10.1016/j.ydbio.2013.06.025; Rungrassamee W, 2010, DEV COMP IMMUNOL, V34, P1082, DOI 10.1016/j.dci.2010.05.012; Sabourault C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-333; Steele RE, 2002, DEV BIOL, V248, P199, DOI 10.1006/dbio.2002.0744; Sun Y, 2005, FEBS J, V272, P2613, DOI 10.1111/j.1742-4658.2005.04708.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thorsted PB, 1999, PLASMID, V41, P274, DOI 10.1006/plas.1999.1393; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; van Noort JM, 2012, INT J BIOCHEM CELL B, V44, P1670, DOI 10.1016/j.biocel.2011.12.010; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venn AA, 2009, P NATL ACAD SCI USA, V106, P16574, DOI 10.1073/pnas.0902894106; Wan Q, 2012, FISH SHELLFISH IMMUN, V33, P48, DOI 10.1016/j.fsi.2012.03.034; Wettstein G, 2012, INT J BIOCHEM CELL B, V44, P1680, DOI 10.1016/j.biocel.2012.05.024; Yang YZ, 2003, FEBS LETT, V538, P183, DOI 10.1016/S0014-5793(03)00164-9; Yocum GD, 1998, INSECT BIOCHEM MOLEC, V28, P677, DOI 10.1016/S0965-1748(98)00046-0; Zhang AG, 2013, FISH SHELLFISH IMMUN, V34, P1605, DOI 10.1016/j.fsi.2013.03.005; Zhang L, 2010, MOL BIOL REP, V37, P1763, DOI 10.1007/s11033-009-9603-6	78	12	12	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e105908	10.1371/journal.pone.0105908	http://dx.doi.org/10.1371/journal.pone.0105908			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251681	Green Published, Green Submitted, gold			2022-12-25	WOS:000342492700011
J	Pitteri, E; Mongillo, P; Carnier, P; Marinelli, L; Huber, L				Pitteri, Elisa; Mongillo, Paolo; Carnier, Paolo; Marinelli, Lieta; Huber, Ludwig			Part-Based and Configural Processing of Owner's Face in Dogs	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; MONKEYS MACACA-MULATTA; RHESUS-MONKEYS; RACE BIAS; RECOGNITION MEMORY; CANIS-FAMILIARIS; DISCRIMINATION; PERCEPTION; FEATURES; HUMANS	Dogs exhibit characteristic looking patterns when looking at human faces but little is known about what the underlying cognitive mechanisms are and how much these are influenced by individual experience. In Experiment 1, seven dogs were trained in a simultaneous discrimination procedure to assess whether they could discriminate a) the owner's face parts (eyes, nose or mouth) presented in isolation and b) whole faces where the same parts were covered. Dogs discriminated all the three parts of the owner's face presented in isolation, but needed fewer sessions to reach the learning criterion for the eyes than for both nose and mouth. Moreover, covering the eyes region significantly disrupted face discriminability compared to the whole face condition while such difference was not found when the nose or mouth was hidden. In Experiment 2, dogs were presented with manipulated images of the owner's face (inverted, blurred, scrambled, grey-scale) to test the relative contribution of part-based and configural processing in the discrimination of human faces. Furthermore, by comparing the dogs enrolled in the previous experiment and seven 'naive' dogs we examined if the relative contribution of part-based and configural processing was affected by dogs' experience with the face stimuli. Naive dogs discriminated the owner only when configural information was provided, whereas expert dogs could discriminate the owner also when part-based processing was necessary. The present study provides the first evidence that dogs can discriminate isolated internal features of a human face and corroborate previous reports of salience of the eyes region for human face processing. Although the reliance on part-perception may be increased by specific experience, our findings suggest that human face discrimination by dogs relies mainly on configural rather than on part-based elaboration.	[Pitteri, Elisa; Mongillo, Paolo; Carnier, Paolo; Marinelli, Lieta] Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, PD, Italy; [Huber, Ludwig] Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Vienna, Austria; [Huber, Ludwig] Univ Vienna, Vienna, Austria	University of Padua; Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna	Marinelli, L (corresponding author), Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, PD, Italy.	lieta.marinelli@unipd.it	Mongillo, Paolo/ABF-9718-2020; Carnier, Paolo/AAX-6396-2020; Mongillo, Paolo/C-8104-2009	Mongillo, Paolo/0000-0001-8599-4005; Carnier, Paolo/0000-0002-6009-6601; Mongillo, Paolo/0000-0001-8599-4005; MARINELLI, Lieta/0000-0003-0609-2172; Huber, Ludwig/0000-0002-0217-136X	University of Padova, Italy [60A08-4851/14]; ESF Research Networking Programme "CompCog": The Evolution of Social Cognition [06-RNP-020]; Austrian Science Fund (FWF) [P21418]; Vienna Science and Technology Fund (WWTF) [CS11-005]	University of Padova, Italy; ESF Research Networking Programme "CompCog": The Evolution of Social Cognition; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Vienna Science and Technology Fund (WWTF)	E.P. received a PhD grant from the University of Padova, Italy; P. M. received funding from the ESF Research Networking Programme "CompCog": The Evolution of Social Cognition (www.compcog.org) (Grant 06-RNP-020); L. H. received funding from the Austrian Science Fund (FWF grant P21418) and the Vienna Science and Technology Fund (WWTF grant CS11-005); L. M. received funding from the University of Padova, Italy (Grant 60A08-4851/14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi I, 2007, ANIM COGN, V10, P17, DOI 10.1007/s10071-006-0025-8; Allison, 2001, LOGISTIC REGRESSION; Aust U, 2001, ANIM LEARN BEHAV, V29, P107, DOI 10.3758/BF03192820; Aust U, 2010, ANIM COGN, V13, P207, DOI 10.1007/s10071-009-0258-4; Autier-Derian D, 2013, ANIM COGN, V16, P637, DOI 10.1007/s10071-013-0600-8; BRIGHAM JC, 1982, J PERS SOC PSYCHOL, V42, P673, DOI 10.1037/0022-3514.42.4.673; Bruce V, 1999, J EXP PSYCHOL-APPL, V5, P339, DOI 10.1037/1076-898X.5.4.339; Cabeza R, 2000, PSYCHOL SCI, V11, P429, DOI 10.1111/1467-9280.00283; Call J, 2003, J COMP PSYCHOL, V117, P257, DOI 10.1037/0735-7036.117.3.257; CERELLA J, 1980, PATTERN RECOGN, V12, P1, DOI 10.1016/0031-3203(80)90048-5; COSTEN NP, 1994, PERCEPTION, V23, P129, DOI 10.1068/p230129; Dahl CD, 2009, CURR BIOL, V19, P509, DOI 10.1016/j.cub.2009.01.061; Dal Martello MF, 2006, J VISION, V6, P1356, DOI 10.1167/6.12.2; DAVIES G, 1982, J APPL PSYCHOL, V67, P103, DOI 10.1037/0021-9010.67.1.103; DAVIES G, 1977, PERCEPTION, V6, P263, DOI 10.1068/p060263; De Haan M, 2001, DEV COGN NEUROSCI, P381; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; ELLIS HD, 1986, HUM LEARN, V5, P189; FALLSHORE M, 1995, J EXP PSYCHOL LEARN, V21, P1608, DOI 10.1037/0278-7393.21.6.1608; Frowd C, 2007, BRIT J PSYCHOL, V98, P61, DOI 10.1348/000712606X104481; Goldstein AG, 1965, PSYCHON SCI, V3, P447; Gothard KM, 2009, ANIM COGN, V12, P155, DOI 10.1007/s10071-008-0179-7; Guo K, 2010, PERCEPTION, V39, P533, DOI 10.1068/p6517; Guo K, 2009, ANIM COGN, V12, P409, DOI 10.1007/s10071-008-0199-3; Hills PJ, 2013, VIS COGN, V21, P876, DOI 10.1080/13506285.2013.834016; Hills PJ, 2011, VIS COGN, V19, P313, DOI 10.1080/13506285.2010.528250; Hills PJ, 2006, Q J EXP PSYCHOL, V59, P996, DOI 10.1080/17470210600654750; Hirata S, 2010, ANIM COGN, V13, P679, DOI 10.1007/s10071-010-0316-y; Huber L, 2013, LEARN MOTIV, V44, P258, DOI 10.1016/j.lmot.2013.04.005; KEATING CF, 1993, J COMP PSYCHOL, V107, P131, DOI 10.1037/0735-7036.107.2.131; Kelly DJ, 2009, J EXP CHILD PSYCHOL, V104, P105, DOI 10.1016/j.jecp.2009.01.006; KYES RC, 1987, J COMP PSYCHOL, V101, P345, DOI 10.1037/0735-7036.101.4.345; Martin-Malivel J, 2001, ANIM LEARN BEHAV, V29, P10, DOI 10.3758/BF03192812; Martin-Malivel J, 2007, BEHAV NEUROSCI, V121, P1145, DOI 10.1037/0735-7044.121.6.1145; Matsukawa A, 2004, BEHAV PROCESS, V65, P25, DOI 10.1016/S0376-6357(03)00147-5; MCKELVIE SJ, 1976, AM J PSYCHOL, V89, P311, DOI 10.2307/1421414; McKone E, 2007, PERCEPTION, V36, P224, DOI 10.1068/p5499; McKone E, 2009, PSYCHON B REV, V16, P778, DOI 10.3758/PBR.16.5.778; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Mongillo P, 2010, ANIM BEHAV, V80, P1057, DOI 10.1016/j.anbehav.2010.09.014; Nagasawa M, 2011, ANIM COGN, V14, P525, DOI 10.1007/s10071-011-0386-5; Neiworth JJ, 2007, ANIM COGN, V10, P125, DOI 10.1007/s10071-006-0045-4; Parr LA, 2000, J COMP PSYCHOL, V114, P47, DOI 10.1037//0735-7036.114.1.47; Parr LA, 1998, J COGNITIVE NEUROSCI, V10, P615, DOI 10.1162/089892998563013; Parr LA, 2008, J COMP PSYCHOL, V122, P390, DOI 10.1037/0735-7036.122.4.390; Parr LA, 2008, ANIM COGN, V11, P467, DOI 10.1007/s10071-008-0137-4; Parr LA, 2006, BRAIN COGNITION, V62, P30, DOI 10.1016/j.bandc.2006.03.006; Parr LA, 2011, PHILOS T R SOC B, V366, P1764, DOI 10.1098/rstb.2010.0358; Pascalis O, 2002, SCIENCE, V296, P1321, DOI 10.1126/science.1070223; Pascalis O, 1998, BEHAV PROCESS, V43, P87, DOI 10.1016/S0376-6357(97)00090-9; PASCALIS O, 1994, NEUROREPORT, V5, P1721, DOI 10.1097/00001756-199409080-00008; Peirce JW, 2001, BEHAV PROCESS, V55, P13, DOI 10.1016/S0376-6357(01)00158-9; Pezdek K, 2003, J APPL PSYCHOL, V88, P760, DOI 10.1037/0021-9010.88.4.760; Pitteri E, 2014, ANIM COGN, V17, P869, DOI 10.1007/s10071-013-0720-1; Racca A, 2010, ANIM COGN, V13, P525, DOI 10.1007/s10071-009-0303-3; Range F, 2008, ANIM COGN, V11, P339, DOI 10.1007/s10071-007-0123-2; RHODES G, 1989, COGNITION IN INDIVIDUAL AND SOCIAL CONTEXTS, P83; RHODES G, 1989, BRIT J PSYCHOL, V80, P313, DOI 10.1111/j.2044-8295.1989.tb02323.x; ROBERTS T, 1988, PERCEPTION, V17, P475, DOI 10.1068/p170475; Rossion Bruno, 2002, Behav Cogn Neurosci Rev, V1, P63, DOI 10.1177/1534582302001001004; Schwab C, 2006, J COMP PSYCHOL, V120, P169, DOI 10.1037/0735-7036.120.3.169; Schwarzer G, 2005, MEM COGNITION, V33, P344, DOI 10.3758/BF03195322; Sekunova A, 2008, J EXP PSYCHOL HUMAN, V34, P1129, DOI 10.1037/0096-1523.34.5.1129; SERGENT J, 1984, BRIT J PSYCHOL, V75, P221, DOI 10.1111/j.2044-8295.1984.tb01895.x; Sheperd J., 1981, PERCEIVING REMEMBERI, P105; Slone AE, 2000, BASIC APPL SOC PSYCH, V22, P71, DOI 10.1207/15324830051036162; Somppi S, 2014, ANIM COGN, V17, P793, DOI 10.1007/s10071-013-0713-0; Somppi S, 2012, ANIM COGN, V15, P163, DOI 10.1007/s10071-011-0442-1; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Turati C, 2006, CHILD DEV, V77, P297, DOI 10.1111/j.1467-8624.2006.00871.x; Turati C, 2004, CURR DIR PSYCHOL SCI, V13, P5, DOI 10.1111/j.0963-7214.2004.01301002.x; Turati C, 2008, COGNITION, V106, P1300, DOI 10.1016/j.cognition.2007.06.005; Viranyi Z, 2004, BEHAV PROCESS, V66, P161, DOI 10.1016/j.beproc.2004.01.012; WALKERSMITH GJ, 1978, PERCEPT PSYCHOPHYS, V24, P63, DOI 10.3758/BF03202975; Watanabe S, 2001, BEHAV PROCESS, V53, P3, DOI 10.1016/S0376-6357(00)00139-X; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747; Zhu Q, 2010, CURR BIOL, V20, P137, DOI 10.1016/j.cub.2009.11.067	78	27	27	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108176	10.1371/journal.pone.0108176	http://dx.doi.org/10.1371/journal.pone.0108176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ0SJ	25251285	Green Published, Green Submitted, gold			2022-12-25	WOS:000342492700090
J	Smith, JM; Chavez, FP; Francis, CA				Smith, Jason M.; Chavez, Francisco P.; Francis, Christopher A.			Ammonium Uptake by Phytoplankton Regulates Nitrification in the Sunlit Ocean	PLOS ONE			English	Article							MARINE NITRIFYING BACTERIA; HALF-SATURATION CONSTANTS; NITROGEN UPTAKE; MONTEREY BAY; DIFFERENTIAL PHOTOINHIBITION; NATURAL-POPULATIONS; OXIDATION-KINETICS; OXIDIZING ARCHAEA; NITRATE UPTAKE; NITRITE	Nitrification, the microbial oxidation of ammonium to nitrate, is a central part of the nitrogen cycle. In the ocean's surface layer, the process alters the distribution of inorganic nitrogen species available to phytoplankton and produces nitrous oxide. A widely held idea among oceanographers is that nitrification is inhibited by light in the ocean. However, recent evidence that the primary organisms involved in nitrification, the ammonia-oxidizing archaea (AOA), are present and active throughout the surface ocean has challenged this idea. Here we show, through field experiments coupling molecular genetic and biogeochemical approaches, that competition for ammonium with phytoplankton is the strongest regulator of nitrification in the photic zone. During multiday experiments at high irradiance a single ecotype of AOA remained active in the presence of rapidly growing phytoplankton. Over the course of this three day experiment, variability in the intensity of competition with phytoplankton caused nitrification rates to decline from those typical of the lower photic zone (60 nmol L-1 d(-1)) to those in well-lit layers (< 1 nmol L-1 d(-1)). During another set of experiments, nitrification rates exhibited a diel periodicity throughout much of the photic zone, with the highest rates occurring at night when competition with phytoplankton is lowest. Together, the results of our experiments indicate that nitrification rates in the photic zone are more strongly regulated by competition with phytoplankton for ammonium than they are by light itself. This finding advances our ability to model the impact of nitrification on estimates of new primary production, and emphasizes the need to more strongly consider the effects of organismal interactions on nutrient standing stocks and biogeochemical cycling in the surface of the ocean.	[Smith, Jason M.; Chavez, Francisco P.] Monterey Bay Aquarium Res Inst, Div Res, Moss Landing, CA 95039 USA; [Smith, Jason M.; Francis, Christopher A.] Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA	Monterey Bay Aquarium Research Institute; Stanford University	Smith, JM (corresponding author), Monterey Bay Aquarium Res Inst, Div Res, Moss Landing, CA 95039 USA.	jsmith@mbari.org		Smith, Jason Michel/0000-0002-3452-6460; Francis, Christopher/0000-0001-7557-631X	National Science Foundation [OCE-0825363]; Northern California ARCS Foundation; David and Lucile Packard Foundation	National Science Foundation(National Science Foundation (NSF)); Northern California ARCS Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This work was supported in part by the National Science Foundation Grant OCE-0825363 to CAF. Fellowships from the Northern California ARCS Foundation (graduate) and the David and Lucile Packard Foundation (post-doctoral) provided salary support to J.M.S. The David and Lucile Packard Foundation also supported F. P. C through its generous annual grant to MBARI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beman JM, 2008, ISME J, V2, P429, DOI 10.1038/ismej.2007.118; Beman JM, 2012, LIMNOL OCEANOGR, V57, P711, DOI 10.4319/lo.2012.57.3.0711; CAPERON J, 1972, DEEP-SEA RES, V19, P619, DOI 10.1016/0011-7471(72)90090-3; Casciotti KL, 2002, ANAL CHEM, V74, P4905, DOI 10.1021/ac020113w; Chavez FP, 1995, DAHL WS ENV, V18, P149; Church MJ, 2010, ENVIRON MICROBIOL, V12, P679, DOI 10.1111/j.1462-2920.2009.02108.x; Clark DR, 2008, LIMNOL OCEANOGR, V53, P52, DOI 10.4319/lo.2008.53.1.0052; Dore JE, 1996, LIMNOL OCEANOGR, V41, P1619, DOI 10.4319/lo.1996.41.8.1619; DORTCH Q, 1990, MAR ECOL PROG SER, V61, P183, DOI 10.3354/meps061183; DUGDALE RC, 1990, LIMNOL OCEANOGR, V35, P822, DOI 10.4319/lo.1990.35.4.0822; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P685, DOI 10.4319/lo.1967.12.4.0685; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; EPPLEY RW, 1969, J PHYCOL, V5, P375, DOI 10.1111/j.1529-8817.1969.tb02628.x; EPPLEY RW, 1979, NATURE, V282, P677, DOI 10.1038/282677a0; EPPLEY RW, 1969, LIMNOL OCEANOGR, V14, P912, DOI 10.4319/lo.1969.14.6.0912; French E, 2012, APPL ENVIRON MICROB, V78, P5773, DOI 10.1128/AEM.00432-12; Guerrero MA, 1996, MAR ECOL PROG SER, V141, P183, DOI 10.3354/meps141183; Guerrero MA, 1996, MAR ECOL PROG SER, V141, P193, DOI 10.3354/meps141193; HEALEY FP, 1980, MICROBIAL ECOL, V5, P281, DOI 10.1007/BF02020335; Hollibaugh JT, 2011, ISME J, V5, P866, DOI 10.1038/ismej.2010.172; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Horak REA, 2013, ISME J, V7, P2023, DOI 10.1038/ismej.2013.75; HORRIGAN SG, 1981, J MAR RES, V39, P557; HORRIGAN SG, 1990, LIMNOL OCEANOGR, V35, P479, DOI 10.4319/lo.1990.35.2.0479; JACKSON GA, 1980, NATURE, V284, P439, DOI 10.1038/284439a0; KANDA J, 1987, J PLANKTON RES, V9, P79, DOI 10.1093/plankt/9.1.79; KANDA J, 1985, LIMNOL OCEANOGR, V30, P987, DOI 10.4319/lo.1985.30.5.0987; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kudela RM, 1997, J PLANKTON RES, V19, P609, DOI 10.1093/plankt/19.5.609; Lund MB, 2012, ISME J, V6, P1966, DOI 10.1038/ismej.2012.40; MACISAAC JJ, 1972, DEEP-SEA RES, V19, P209, DOI 10.1016/0011-7471(72)90032-0; MACISAAC JJ, 1985, DEEP-SEA RES, V32, P503, DOI 10.1016/0198-0149(85)90042-1; MACISAAC JJ, 1969, DEEP-SEA RES, V16, P45, DOI 10.1016/0011-7471(69)90049-7; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; Merbt SN, 2012, FEMS MICROBIOL LETT, V327, P41, DOI 10.1111/j.1574-6968.2011.02457.x; Mincer TJ, 2007, ENVIRON MICROBIOL, V9, P1162, DOI 10.1111/j.1462-2920.2007.01239.x; Mosier AC, 2011, METHOD ENZYMOL, V486, P205, DOI [10.1016/S0076-6879(11)86009-X, 10.1016/B978-0-12-381294-0.00009-2]; Newell SE, 2013, LIMNOL OCEANOGR, V58, P1491, DOI 10.4319/lo.2013.58.4.1491; OLSON RJ, 1981, J MAR RES, V39, P227; Pedneault E, 2014, SCI REP-UK, V4, DOI 10.1038/srep04661; Pennington JT, 2000, DEEP-SEA RES PT II, V47, P947, DOI 10.1016/S0967-0645(99)00132-0; Santoro AE, 2013, BIOGEOSCI DISCUSS, V10, P5803, DOI DOI 10.5194/BGD-10-5803-2013; Santoro AE, 2011, ISME J, V5, P1796, DOI 10.1038/ismej.2011.58; Sigman DM, 2001, ANAL CHEM, V73, P4145, DOI 10.1021/ac010088e; Smith JM, 2015, MICROB ECOL, V69, P13, DOI 10.1007/s00248-014-0450-1; Smith JM, 2014, ISME J, V8, P1704, DOI 10.1038/ismej.2014.11; WARD BB, 1984, CONT SHELF RES, V3, P383, DOI 10.1016/0278-4343(84)90018-9; WARD BB, 1985, MAR CHEM, V16, P301, DOI 10.1016/0304-4203(85)90052-0; WARD BB, 1989, LIMNOL OCEANOGR, V34, P493, DOI 10.4319/lo.1989.34.3.0493; Ward BB, 2005, MAR ECOL PROG SER, V292, P97, DOI 10.3354/meps292097; WARD BB, 1982, DEEP-SEA RES, V29, P247, DOI 10.1016/0198-0149(82)90112-1; Yool A, 2007, NATURE, V447, P999, DOI 10.1038/nature05885	52	102	104	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108173	10.1371/journal.pone.0108173	http://dx.doi.org/10.1371/journal.pone.0108173			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251022	Green Submitted, gold, Green Published			2022-12-25	WOS:000342492700088
J	Tarunina, M; Hernandez, D; Johnson, CJ; Rybtsov, S; Ramathas, V; Jeyakumar, M; Watson, T; Hook, L; Medvinsky, A; Mason, C; Choo, Y				Tarunina, Marina; Hernandez, Diana; Johnson, Christopher J.; Rybtsov, Stanislav; Ramathas, Vidya; Jeyakumar, Mylvaganam; Watson, Thomas; Hook, Lilian; Medvinsky, Alexander; Mason, Chris; Choo, Yen			Directed Differentiation of Embryonic Stem Cells Using a Bead-Based Combinatorial Screening Method	PLOS ONE			English	Article							HUMAN ES; MONONUCLEAR PHAGOCYTE; GROWTH-FACTORS; IPS CELLS; B-1 CELL; IN-VITRO; B-CELLS; MACROPHAGES; DERIVATION; ACTIVATION	We have developed a rapid, bead-based combinatorial screening method to determine optimal combinations of variables that direct stem cell differentiation to produce known or novel cell types having pre-determined characteristics. Here we describe three experiments comprising stepwise exposure of mouse or human embryonic cells to 10,000 combinations of serum-free differentiation media, through which we discovered multiple novel, efficient and robust protocols to generate a number of specific hematopoietic and neural lineages. We further demonstrate that the technology can be used to optimize existing protocols in order to substitute costly growth factors with bioactive small molecules and/or increase cell yield, and to identify in vitro conditions for the production of rare developmental intermediates such as an embryonic lymphoid progenitor cell that has not previously been reported.	[Tarunina, Marina; Hernandez, Diana; Johnson, Christopher J.; Ramathas, Vidya; Jeyakumar, Mylvaganam; Watson, Thomas; Hook, Lilian; Choo, Yen] Plasticell Ltd, Stevenage Biosci Catalyst, Stevenage, Herts, England; [Hernandez, Diana; Mason, Chris] UCL, Adv Ctr Biochem Engn, London, England; [Rybtsov, Stanislav; Medvinsky, Alexander] Univ Edinburgh, MRC, Ctr Regenerat Med, Inst Stem Cell Res, Edinburgh, Midlothian, Scotland; [Choo, Yen] Progenitor Labs Ltd, Stevenage Biosci Catalyst, Stevenage, Herts, England	University of London; University College London; University of Edinburgh	Choo, Y (corresponding author), Plasticell Ltd, Stevenage Biosci Catalyst, Stevenage, Herts, England.	yen@plasticell.co.uk	Hernandez, Diana/AAE-4613-2021; Rybtsov, Stanislav/U-1006-2017	Rybtsov, Stanislav/0000-0001-7786-1878; Hernandez, Diana/0000-0002-1353-2175; Hook, Lilian/0000-0003-3858-8711; Choo, Yen/0000-0002-3348-9602	United Kingdom Technology Strategy Board [TSB H0028G]; Leukemia and Lymphoma Research; BBSRC; MRC; Biotechnology and Biological Sciences Research Council [BB/H008780/1, BB/D01347X/1] Funding Source: researchfish; BBSRC [BB/H008780/1, BB/D01347X/1] Funding Source: UKRI	United Kingdom Technology Strategy Board; Leukemia and Lymphoma Research; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was partly funded by an United Kingdom Technology Strategy Board grant (TSB H0028G. SR and AM are supported by Leukemia and Lymphoma Research, BBSRC and MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2008, STEM CELLS, V26, P1117, DOI 10.1634/stemcells.2007-1102; Alipio Z, 2010, P NATL ACAD SCI USA, V107, P13426, DOI 10.1073/pnas.1007884107; Almeida SR, 2001, INT IMMUNOL, V13, P1193, DOI 10.1093/intimm/13.9.1193; Anderson JS, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-24; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; BOMBARA C, 1992, J CELL PHYSIOL, V153, P30, DOI 10.1002/jcp.1041530106; BORRELLO MA, 1995, J IMMUNOL, V155, P4155; Buono M, 2010, J EXP MED, V207, P1647, DOI 10.1084/jem.20091022; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chang KH, 2006, BLOOD, V108, P1515, DOI 10.1182/blood-2005-11-011874; Choo Y, 2002, Cell culture, Patent No. 1551954; Choo Yen, 2008, P227, DOI 10.1007/978-1-4020-8502-4_13; Clahsen T, 2008, J LEUKOCYTE BIOL, V84, P1521, DOI 10.1189/jlb.0308178; Cooper O, 2010, MOL CELL NEUROSCI, V45, P258, DOI 10.1016/j.mcn.2010.06.017; de Peppo GM, 2010, TISSUE ENG PT A, V16, P2161, DOI [10.1089/ten.tea.2009.0629, 10.1089/ten.TEA.2009.0629]; Diogo MM, 2008, BIOTECHNOL APPL BIOC, V49, P105, DOI 10.1042/BA20070011; Falk A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029597; Fasano CA, 2010, CELL STEM CELL, V6, P336, DOI 10.1016/j.stem.2010.03.001; Gao JX, 2012, EUR J IMMUNOL, V42, P982, DOI 10.1002/eji.201141519; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Hook L, 2011, NONIMMORTALIZED HUMA; Iacovitti L, 2007, BRAIN RES, V1127, P19, DOI 10.1016/j.brainres.2006.10.022; Irion S, 2008, COLD SH Q B, V73, P101, DOI 10.1101/sqb.2008.73.065; KANTOR AB, 1991, IMMUNOL TODAY, V12, P389, DOI 10.1016/0167-5699(91)90136-H; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lavine KJ, 2006, GENE DEV, V20, P1651, DOI 10.1101/gad.1411406; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; Li O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055319; Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624; Lopes JD, 2009, AN ACAD BRAS CIENC, V81, P489, DOI 10.1590/S0001-37652009000300013; Lu SJ, 2008, BLOOD, V112, P4475, DOI 10.1182/blood-2008-05-157198; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Medvinsky Alexander, 2008, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02a06s4; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; Montecino-Rodriguez E, 2012, IMMUNITY, V36, P13, DOI 10.1016/j.immuni.2011.11.017; Moore KJ, 1998, ARTERIOSCL THROM VAS, V18, P1647, DOI 10.1161/01.ATV.18.10.1647; Moroni E, 2002, J HEMATOTH STEM CELL, V11, P19, DOI 10.1089/152581602753448513; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Nakashima M, 2012, J LEUKOCYTE BIOL, V91, P537, DOI 10.1189/jlb.0411214; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Novaes e Brito R.R., 2010, IMMUNOL IMMUNOGENETI, V2, P31; Rauch PJ, 2012, SCIENCE, V335, P597, DOI 10.1126/science.1215173; Raynaud CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054524; Ribeiro D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015786; Rolny C, 2006, BLOOD, V108, P1877, DOI 10.1182/blood-2006-04-014894; Stall A M, 1996, Semin Immunol, V8, P45, DOI 10.1006/smim.1996.0007; Swistowski A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006233; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Wen LJ, 2005, J IMMUNOL, V174, P6918, DOI 10.4049/jimmunol.174.11.6918; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yoshimoto M, 2011, P NATL ACAD SCI USA, V108, P1468, DOI 10.1073/pnas.1015841108; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhuang LH, 2012, J IMMUNOL METHODS, V385, P1, DOI 10.1016/j.jim.2012.06.008	56	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e104301	10.1371/journal.pone.0104301	http://dx.doi.org/10.1371/journal.pone.0104301			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251366	Green Published, gold, Green Submitted			2022-12-25	WOS:000342492700003
J	Wen, ZL; Huang, W; Feng, YL; Cai, WF; Wang, YH; Wang, XH; Liang, JL; Wani, M; Chen, J; Zhu, P; Chen, JM; Millard, RW; Fan, GC; Wang, YG				Wen, Zhili; Huang, Wei; Feng, Yuliang; Cai, Wenfeng; Wang, Yuhua; Wang, Xiaohong; Liang, Jialiang; Wani, Mashhood; Chen, Jing; Zhu, Pin; Chen, Ji-Mei; Millard, Ronald W.; Fan, Guo-Chang; Wang, Yigang			MicroRNA-377 Regulates Mesenchymal Stem Cell-Induced Angiogenesis in Ischemic Hearts by Targeting VEGF	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INFARCTED MYOCARDIUM; DOWN-REGULATION; UP-REGULATION; CANCER-CELLS; EXPRESSION; HYPOXIA; DEGRADATION; ACTIVATION; PATHWAY	MicroRNAs have been appreciated in various cellular functions, including the regulation of angiogenesis. Mesenchymal-stem-cells (MSCs) transplanted to the MI heart improve cardiac function through paracrine-mediated angiogenesis. However, whether microRNAs regulate MSC induced angiogenesis remains to be clarified. Using microRNA microarray analysis, we identified a microRNA expression profile in hypoxia-treated MSCs and observed that among all dysregulated microRNAs, microRNA-377 was decreased the most significantly. We also validated that vascular endothelial growth factor (VEGF) is a target of microRNA-377 using dual-luciferase reporter assay and Western-blotting. Knockdown of endogenous microRNA-377 promoted tube formation in human umbilical vein endothelial cells. We then engineered rat MSCs with lentiviral vectors to either overexpress microRNA-377 (MSCmiR-377) or knockdown microRNA-377 (MSCAnti-377) to investigate whether microRNA-377 regulated MSC-induced myocardial angiogenesis, using MSCs infected with lentiviral empty vector to serve as controls (MSCNull). Four weeks after implantation of the microRNA-engineered MSCs into the infarcted rat hearts, the vessel density was significantly increased in MSC (Anti-377)-hearts, and this was accompanied by reduced fibrosis and improved myocardial function as compared to controls. Adverse effects were observed in MSCmiR-377-treated hearts, including reduced vessel density, impaired myocardial function, and increased fibrosis in comparison with MSCNull-group. These findings indicate that hypoxia-responsive microRNA-377 directly targets VEGF in MSCs, and knockdown of endogenous microRNA-377 promotes MSC-induced angiogenesis in the infarcted myocardium. Thus, microRNA-377 may serve as a novel therapeutic target for stem cell-based treatment of ischemic heart disease.	[Wen, Zhili] Nanchang Univ, Sch Med, Dept Infect Dis, Nanchang, Jiangxi, Peoples R China; [Wen, Zhili; Huang, Wei; Feng, Yuliang; Cai, Wenfeng; Wang, Yuhua; Liang, Jialiang; Wani, Mashhood; Wang, Yigang] Univ Cincinnati, Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH 45220 USA; [Wang, Xiaohong; Millard, Ronald W.; Fan, Guo-Chang] Univ Cincinnati, Med Ctr, Dept Pharmacol & Cell Biophys, Cincinnati, OH USA; [Chen, Jing] Univ Cincinnati, Med Ctr, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Zhu, Pin; Chen, Ji-Mei] Guangdong Acad Med Sci, Guangdong Cardiovasc Inst, Guangzhou, Guangdong, Peoples R China	Nanchang University; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Wang, YG (corresponding author), Univ Cincinnati, Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH 45220 USA.	yi-gang.wang@uc.edu	wang, xiao/HGB-7081-2022; LIANG, JIALIANG/L-5865-2015; Fan, Guo-Chang/E-1153-2012	wang, xiao/0000-0002-4088-3341; LIANG, JIALIANG/0000-0001-8033-741X; Fan, Guo-Chang/0000-0002-0439-8277; Liang, Jialiang/0000-0002-1556-7195; Huang, Wei/0000-0003-3046-4220; Chen, Jing/0000-0002-6227-7393	National Institutes of Health [HL107957, HL110740, HL-087861]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087861, R01HL110740, R01HL107957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded in part by National Institutes of Health grants HL107957 and HL110740 to Yigang Wang and grant HL-087861 to Guo-Chang Fan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2003, CIRCULATION, V107, P2134, DOI 10.1161/01.CIR.0000062649.63838.C9; Alaiti MA, 2012, J CELL MOL MED, V16, P2413, DOI 10.1111/j.1582-4934.2012.01557.x; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Cochain C, 2013, ANTIOXID REDOX SIGN, V18, P1100, DOI 10.1089/ars.2012.4849; Copland Ian B, 2011, J Cardiovasc Dis Res, V2, P3, DOI 10.4103/0975-3583.78581; Dejean E, 2011, LEUKEMIA, V25, P1882, DOI 10.1038/leu.2011.168; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fasanaro P, 2009, J BIOL CHEM, V284, P35134, DOI 10.1074/jbc.M109.052779; Hassel D, 2012, CIRC RES, V111, P1421, DOI 10.1161/CIRCRESAHA.112.279711; Hu WQ, 2012, CELL RES, V22, P1322, DOI 10.1038/cr.2012.80; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Huang W, 2012, STEM CELLS DEV, V21, P778, DOI 10.1089/scd.2011.0126; Huang W, 2010, J MOL CELL CARDIOL, V48, P702, DOI 10.1016/j.yjmcc.2009.10.032; Jeker LT, 2013, IMMUNOL REV, V253, P65, DOI 10.1111/imr.12061; Jin Yi, 2013, Methods Mol Biol, V936, P117; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lai YL, 2013, INT J ONCOL, V42, P776, DOI 10.3892/ijo.2012.1743; Liang JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046158; Liu F, 2012, KIDNEY BLOOD PRESS R, V35, P182, DOI 10.1159/000331054; Mutharasan RK, 2011, AM J PHYSIOL-HEART C, V301, pH1519, DOI 10.1152/ajpheart.01080.2010; Samper E, 2013, STEM CELL REV REP, V9, P266, DOI 10.1007/s12015-012-9353-z; Sasahira T, 2012, BRIT J CANCER, V107, P700, DOI 10.1038/bjc.2012.330; Staszel T, 2011, POL ARCH MED WEWN, V121, P361, DOI 10.20452/pamw.1093; Stewart DJ, 2009, MOL THER, V17, P1109, DOI 10.1038/mt.2009.70; Tomita S, 2002, J THORAC CARDIOV SUR, V123, P1132, DOI 10.1067/mtc.2002.120716; Wang RZ, 2013, HEPATOLOGY, V58, P642, DOI 10.1002/hep.26373; Wang YG, 2010, AM J PHYSIOL-HEART C, V298, pH275, DOI 10.1152/ajpheart.00765.2009; Xu Q, 2012, NUCLEIC ACIDS RES, V40, P761, DOI 10.1093/nar/gkr730; Yla-Herttuala S, 2007, J AM COLL CARDIOL, V49, P1015, DOI 10.1016/j.jacc.2006.09.053; Yue X, 2012, ONCOL REP, V27, P1200, DOI 10.3892/or.2011.1588; Zhang DS, 2008, J MOL CELL CARDIOL, V44, P281, DOI 10.1016/j.yjmcc.2007.11.010; Zhang Z, 2012, WIRES RNA, V3, P593, DOI 10.1002/wrna.1114; Zhao TQ, 2010, MICROVASC RES, V80, P188, DOI 10.1016/j.mvr.2010.03.014	33	59	63	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e104666	10.1371/journal.pone.0104666	http://dx.doi.org/10.1371/journal.pone.0104666			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251394	Green Published, gold, Green Submitted			2022-12-25	WOS:000342492700004
J	Cimadom, A; Ulloa, A; Meidl, P; Zottl, M; Zottl, E; Fessl, B; Nemeth, E; Dvorak, M; Cunninghame, F; Tebbich, S				Cimadom, Arno; Ulloa, Angel; Meidl, Patrick; Zoettl, Markus; Zoettl, Elisabet; Fessl, Birgit; Nemeth, Erwin; Dvorak, Michael; Cunninghame, Francesca; Tebbich, Sabine			Invasive Parasites, Habitat Change and Heavy Rainfall Reduce Breeding Success in Darwin's Finches	PLOS ONE			English	Article							PHILORNIS-DOWNSI DIPTERA; SMALL GROUND FINCH; INTRODUCED PARASITE; BIRD COMMUNITIES; TREE FINCH; SANTA-CRUZ; FLY; MUSCIDAE; EXTINCTION; ISLAND	Invasive alien parasites and pathogens are a growing threat to biodiversity worldwide, which can contribute to the extinction of endemic species. On the Galapagos Islands, the invasive parasitic fly Philornis downsi poses a major threat to the endemic avifauna. Here, we investigated the influence of this parasite on the breeding success of two Darwin's finch species, the warbler finch (Certhidea olivacea) and the sympatric small tree finch (Camarhynchus parvulus), on Santa Cruz Island in 2010 and 2012. While the population of the small tree finch appeared to be stable, the warbler finch has experienced a dramatic decline in population size on Santa Cruz Island since 1997. We aimed to identify whether warbler finches are particularly vulnerable during different stages of the breeding cycle. Contrary to our prediction, breeding success was lower in the small tree finch than in the warbler finch. In both species P. downsi had a strong negative impact on breeding success and our data suggest that heavy rain events also lowered the fledging success. On the one hand parents might be less efficient in compensating their chicks' energy loss due to parasitism as they might be less efficient in foraging on days of heavy rain. On the other hand, intense rainfalls might lead to increased humidity and more rapid cooling of the nests. In the case of the warbler finch we found that the control of invasive plant species with herbicides had a significant additive negative impact on the breeding success. It is very likely that the availability of insects (i.e. food abundance) is lower in such controlled areas, as herbicide usage led to the removal of the entire understory. Predation seems to be a minor factor in brood loss.	[Cimadom, Arno; Zoettl, Elisabet; Tebbich, Sabine] Univ Vienna, Dept Behav Biol, Vienna, Austria; [Ulloa, Angel; Fessl, Birgit; Cunninghame, Francesca] Charles Darwin Fdn, Santa Cruz Island, Galapagos, Ecuador; [Meidl, Patrick] IST Austria, Klosterneuburg, Austria; [Zoettl, Markus] Univ Cambridge, Dept Zool, Cambridge, England; [Nemeth, Erwin; Dvorak, Michael] BirdLife Austria, Vienna, Austria	University of Vienna; Institute of Science & Technology - Austria; University of Cambridge	Tebbich, S (corresponding author), Univ Vienna, Dept Behav Biol, Vienna, Austria.	sabine.tebbich@univie.ac.at		Fessl, Birgit/0000-0003-1260-6002; Nemeth, Erwin/0000-0001-9438-1411	University of Vienna (Focus of Excellence grant); Galapagos Conservation Trust; Ethologische Gesellschaft e.V.; FWF [V95-B17]	University of Vienna (Focus of Excellence grant); Galapagos Conservation Trust; Ethologische Gesellschaft e.V.; FWF(Austrian Science Fund (FWF))	The study was funded by the University of Vienna (Focus of Excellence grant), the Galapagos Conservation Trust, and the Ethologische Gesellschaft e.V. During the study Sabine Tebbich was funded by the FWF (project number V95-B17) and Arno Cimadom by a scholarship from the University of Vienna. The publication was supported by the publication fund of the University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniazzi LR, 2011, J ZOOL, V283, P126, DOI 10.1111/j.1469-7998.2010.00753.x; Arendt Wayne J., 2000, Ornitologia Neotropical, V11, P13; Betts MG, 2013, FOREST ECOL MANAG, V310, P1036, DOI 10.1016/j.foreco.2013.06.022; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Causton CE, 2006, ANN ENTOMOL SOC AM, V99, P121, DOI 10.1603/0013-8746(2006)099[0121:AITAIF]2.0.CO;2; Cleaveland S., 2002, P139; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; Deem SL, 2008, GALAPAGOS REPORT 200, P125; Dudaniec RY, 2007, BIOL CONSERV, V139, P325, DOI 10.1016/j.biocon.2007.07.006; Dudaniec RY, 2010, BIOL INVASIONS, V12, P581, DOI 10.1007/s10530-009-9464-x; Dudaniec RY, 2006, EMU, V106, P13, DOI 10.1071/MU04040; Dudaniec RY, 2006, AUSTRAL ECOL, V31, P88, DOI 10.1111/j.1442-9993.2006.01553.x; Dvorak M, 2004, ORYX, V38, P171, DOI 10.1017/S0030605304000316; Dvorak M, 2012, ORYX, V46, P78, DOI 10.1017/S0030605311000597; Easton WE, 1998, ECOL APPL, V8, P1092, DOI 10.1890/1051-0761(1998)008[1092:TEOVMO]2.0.CO;2; Fessl B, 2002, IBIS, V144, P445, DOI 10.1046/j.1474-919X.2002.00076.x; Fessl B, 2006, BIOL CONSERV, V127, P55, DOI 10.1016/j.biocon.2005.07.013; Fessl B, 2006, PARASITOLOGY, V133, P739, DOI 10.1017/S0031182006001089; Fessl B, 2010, PHILOS T R SOC B, V365, P1019, DOI 10.1098/rstb.2009.0288; Galligan TH, 2009, BIOL J LINN SOC, V98, P577, DOI 10.1111/j.1095-8312.2009.01309.x; Grant B. R., 1989, EVOLUTIONARY DYNAMIC; Grant PR, 2005, BIOL CONSERV, V122, P499, DOI 10.1016/j.biocon.2004.09.001; Grant PR, 1997, CONSERV BIOL, V11, P119, DOI 10.1046/j.1523-1739.1997.95399.x; Hau M, 2004, OIKOS, V106, P489, DOI 10.1111/j.0030-1299.2004.13206.x; Heenan CB, 2013, AVIAN BIOL RES, V6, P104, DOI 10.3184/003685013X13614670646299; Huber SK, 2008, BIOL CONSERV, V141, P601, DOI 10.1016/j.biocon.2007.11.012; Jager H, 2007, BIOL CONSERV, V140, P297, DOI 10.1016/j.biocon.2007.08.014; Jimenez-Uzcategui G., 2007, GALAPAGOS REPORT, V2006-2007, P136; Kleindorfer S, 2006, J AVIAN BIOL, V37, P69, DOI 10.1111/j.0908-8857.2006.03503.x; Kleindorfer S, 2007, ANIM BEHAV, V74, P795, DOI 10.1016/j.anbehav.2007.01.020; Kleindorfer S, 2009, BIOL J LINN SOC, V98, P313, DOI 10.1111/j.1095-8312.2009.01264.x; Kleindorfer S, 2009, BEHAV ECOL SOCIOBIOL, V63, P731, DOI 10.1007/s00265-008-0706-1; Koop Jennifer A.H., 2013, Reports in Parasitology, V3, P11; Koop JAH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019706; Renteria JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048106; Mauchamp A, 2010, INFORME GALAPAGOS 2O, P111; Mundry R, 2009, AM NAT, V173, P119, DOI 10.1086/593303; O'Connor JA, 2010, ORYX, V44, P588, DOI 10.1017/S0030605310000086; O'Connor JA, 2010, J TROP ECOL, V26, P285, DOI 10.1017/S0266467409990678; O'Connor JA, 2010, BIODIVERS CONSERV, V19, P853, DOI 10.1007/s10531-009-9740-1; Renteria Jorge L., 2006, Galapagos Research, V64, P31; SANTILLO DJ, 1989, J WILDLIFE MANAGE, V53, P64, DOI 10.2307/3801307; STEADMAN DW, 1995, SCIENCE, V267, P1123, DOI 10.1126/science.267.5201.1123; Stoleson SH, 2011, FOREST ECOL MANAG, V262, P1205, DOI 10.1016/j.foreco.2011.06.017; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Tebbich S, 2004, CONDOR, V106, P95, DOI 10.1650/7293; Thiel T, 2005, J WILDLIFE DIS, V41, P342, DOI 10.7589/0090-3558-41.2.342; Towns DR, 2006, BIOL INVASIONS, V8, P863, DOI 10.1007/s10530-005-0421-z; WARNER RE, 1968, CONDOR, V70, P101, DOI 10.2307/1365954; Wiedenfeld David A., 2007, Pacific Conservation Biology, V13, P14; Wiedenfeld David A., 2008, Cotinga, V29, P22; Wikelski M, 2004, ECOL SOC, V9	52	39	39	0	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107518	10.1371/journal.pone.0107518	http://dx.doi.org/10.1371/journal.pone.0107518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25248092	Green Published, gold, Green Submitted			2022-12-25	WOS:000342351800025
J	McKinley, ET; Zhao, P; Coffey, RJ; Washington, MK; Manning, HC				McKinley, Eliot T.; Zhao, Ping; Coffey, Robert J.; Washington, M. Kay; Manning, H. Charles			3 '-Deoxy-3 '-[F-18]-Fluorothymidine PET Imaging Reflects PI3K-mTOR-Mediated Pro-Survival Response to Targeted Therapy in Colorectal Cancer	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; IN-VIVO; PRECLINICAL MODELS; BRAF INHIBITION; TUMOR RESPONSE; BREAST-CANCER; SOLID TUMORS; FLT-PET; RESISTANCE; PROLIFERATION	Biomarkers that predict response to targeted therapy in oncology are an essential component of personalized medicine. In preclinical treatment response studies that featured models of wild-type KRAS or mutant BRAF colorectal cancer treated with either cetuximab or vemurafenib, respectively, we illustrate that [F-18]-FLT PET, a non-invasive molecular imaging readout of thymidine salvage, closely reflects pro-survival responses to targeted therapy that are mediated by PI3K-mTOR activity. Activation of pro-survival mechanisms forms the basis of numerous modes of resistance. Therefore, we conclude that [F-18]-FLT PET may serve a novel and potentially critical role to predict tumors that exhibit molecular features that tend to reflect recalcitrance to MAPK-targeted therapy. Though these studies focused on colorectal cancer, we envision that the results may be applicable to other solid tumors as well.	[McKinley, Eliot T.; Zhao, Ping; Manning, H. Charles] Vanderbilt Univ, Sch Med, Inst Imaging Sci, Nashville, TN 37235 USA; [McKinley, Eliot T.; Manning, H. Charles] Vanderbilt Univ, Sch Med, Dept Biomed Engn, Nashville, TN 37235 USA; [McKinley, Eliot T.; Coffey, Robert J.; Washington, M. Kay] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37235 USA; [Coffey, Robert J.; Washington, M. Kay; Manning, H. Charles] Vanderbilt Univ, Sch Med, Dept Vanderbilt Ingram Canc Ctr, Nashville, TN 37235 USA; [Washington, M. Kay] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37235 USA; [Manning, H. Charles] Vanderbilt Univ, Sch Med, Dept Radiol & Radiol Sci, Nashville, TN 37235 USA; [Manning, H. Charles] Vanderbilt Univ, Sch Med, Dept Neurosurg, Nashville, TN 37235 USA; [Manning, H. Charles] Vanderbilt Univ, Sch Med, Dept Chem & Phys Biol, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Manning, HC (corresponding author), Vanderbilt Univ, Sch Med, Inst Imaging Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	henry.c.manning@vanderbilt.edu			Kleberg Foundation [R25 CA136440, K25 CA127349, P50 CA128323, P50 CA095103, R25 CA092043, R01 CA140628, RC1 CA145138, R01 CA046413, P30 DK058404]; NATIONAL CANCER INSTITUTE [R25CA092043, R01CA140628, K25CA127349, R25CA136440, RC1CA145138, P50CA095103, P50CA128323, R01CA046413] Funding Source: NIH RePORTER	Kleberg Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research funding: R25 CA136440, K25 CA127349, P50 CA128323, P50 CA095103, R25 CA092043, R01 CA140628, RC1 CA145138, R01 CA046413, P30 DK058404, The Kleberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthel H, 2003, CANCER RES, V63, P3791; Bermudez O, 2008, ONCOGENE, V27, P3685, DOI 10.1038/sj.onc.1211040; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Buck JR, 2012, TETRAHEDRON LETT, V53, P4161, DOI 10.1016/j.tetlet.2012.05.137; Choi SJ, 2005, EUR J NUCL MED MOL I, V32, P653, DOI 10.1007/s00259-004-1742-3; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Katz SI, 2011, INT J ONCOL, V39, P91, DOI 10.3892/ijo.2011.1019; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Manning HC, 2008, CLIN CANCER RES, V14, P7413, DOI 10.1158/1078-0432.CCR-08-0239; Mao ML, 2013, CLIN CANCER RES, V19, P657, DOI 10.1158/1078-0432.CCR-11-1446; McKinley ET, 2013, J NUCL MED, V54, P424, DOI 10.2967/jnumed.112.108456; McKinley ET, 2012, ANN NUCL MED, V26, P757, DOI 10.1007/s12149-012-0636-x; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; OGRIS E, 1993, J VIROL, V67, P1765, DOI 10.1128/JVI.67.4.1765-1771.1993; OLIVE M, 1993, IN VITRO CELL DEV-AN, V29A, P239; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Shah C, 2009, CLIN CANCER RES, V15, P4712, DOI 10.1158/1078-0432.CCR-08-2635; Shields AF, 2003, J NUCL MED, V44, P1432; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Solit DB, 2011, NEW ENGL J MED, V364, P772, DOI 10.1056/NEJMcibr1013704; Soloviev D, 2012, EUR J CANCER, V48, P416, DOI 10.1016/j.ejca.2011.11.035; Villanueva J, 2011, CANCER RES, V71, P7137, DOI 10.1158/0008-5472.CAN-11-1243; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Zhang CC, 2012, CLIN CANCER RES, V18, P1303, DOI 10.1158/1078-0432.CCR-11-1433	32	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108193	10.1371/journal.pone.0108193	http://dx.doi.org/10.1371/journal.pone.0108193			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247710	gold, Green Submitted, Green Published			2022-12-25	WOS:000342351800070
J	Dell, AI; Alford, RA; Pearson, RG				Dell, Anthony I.; Alford, Ross A.; Pearson, Richard G.			Intermittent Pool Beds Are Permanent Cyclic Habitats with Distinct Wet, Moist and Dry Phases	PLOS ONE			English	Article							EXPERIMENTAL POND COMMUNITIES; FOOD WEBS; LEAF-LITTER; TERRESTRIAL INVERTEBRATES; TEMPERATURE-DEPENDENCE; TROPHIC INTERACTIONS; RIVER; RESPONSES; DYNAMICS; STREAM	Recognition that intermittent pools are a single habitat phase of an intermittent pool bed that cycles between aquatic and terrestrial habitat greatly enhances their usefulness for addressing general questions in ecology. The aquatic phase has served as a model system in many ecological studies, because it has distinct habitat boundaries in space and time and is an excellent experimental system, but the aquatic to terrestrial transition and terrestrial phase remain largely unstudied. We conducted a field experiment within six replicate natural intermittent pool beds to explore macroinvertebrate community dynamics during the transition from aquatic to terrestrial habitat and during the terrestrial phase. We monitored and compared macroinvertebrate communities within leaf packs that i) remained wet, ii) underwent drying (i.e., started wet and then dried), and iii) remained dry. Our results show that i) a diverse macroinvertebrate community inhabits all phases of intermittent pool beds, ii) pool drying involves colonization by an assemblage of macroinvertebrates not recorded in permanently terrestrial leaf packs, iii) the community within dried leaf packs remains distinct from that of permanently terrestrial leaf packs for an extended period following drying (possibly until subsequent refilling), and iv) there are likely to be strong spatial and temporal resource linkages between the aquatic and terrestrial communities. The unique environmental characteristics of intermittent pool beds, which repeatedly cycle from aquatic to terrestrial habitat, should continue to make them valuable study systems.	[Dell, Anthony I.; Alford, Ross A.; Pearson, Richard G.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Dell, Anthony I.] Univ Gottingen, Dept Biol, D-37073 Gottingen, Germany	James Cook University; University of Gottingen	Dell, AI (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	adell@gwdg.de	Alford, Ross A/H-1577-2011; Pearson, Richard/GQH-2760-2022	Alford, Ross A/0000-0002-3010-6768; Pearson, Richard/0000-0001-6047-031X	School of Marine and Tropical Biology (James Cook University)	School of Marine and Tropical Biology (James Cook University)	This project was supported by funds from the School of Marine and Tropical Biology (James Cook University) to AID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adis J, 2002, FRESHWATER BIOL, V47, P711, DOI 10.1046/j.1365-2427.2002.00892.x; ADIS J, 1992, STUD NEOTROP FAUNA E, V27, P117, DOI 10.1080/01650529209360872; ALFORD RA, 1985, ECOLOGY, V66, P1097, DOI 10.2307/1939161; Alford RA, 1999, RAMAN MANUAL DOCUMEN; Andersson MGI, 2014, ECOLOGY, V95, P1134, DOI 10.1890/13-1300.1; BARCLAY MH, 1966, AUST J MAR FRESH RES, V17, P239; Bardsley L, 1998, ECOLOGY, V79, P1751, DOI 10.2307/176793; Bastow JL, 2002, OECOLOGIA, V131, P261, DOI 10.1007/s00442-002-0879-7; Batzer DP, 2004, WETLANDS, V24, P904, DOI 10.1672/0277-5212(2004)024[0904:MOUIID]2.0.CO;2; BISHOP JA, 1974, HYDROBIOLOGIA, V44, P319, DOI 10.1007/BF00187280; Blaustein L, 1996, OIKOS, V76, P392, DOI 10.2307/3546211; BOULTON A J, 1989, Transactions of the Royal Society of South Australia, V113, P23; Boulton A.J., 1986, Monographiae Biologicae, V61, P313; Boulton AJ, 2003, FRESHWATER BIOL, V48, P1173, DOI 10.1046/j.1365-2427.2003.01084.x; Cadenasso ML, 2003, BIOSCIENCE, V53, P750, DOI 10.1641/0006-3568(2003)053[0750:AFFATO]2.0.CO;2; Carlson A, 2000, P ROY SOC B-BIOL SCI, V267, P1311, DOI 10.1098/rspb.2000.1143; Clements CF, 2013, ECOL EVOL, V3, P5201, DOI 10.1002/ece3.901; Cochran-Stafira DL, 1998, ECOLOGY, V79, P880, DOI 10.1890/0012-9658(1998)079[0880:IBIFWS]2.0.CO;2; Corti R, 2014, FRESHWATER BIOL, V59, P666, DOI 10.1111/fwb.12294; Datry T, 2012, FRESHWATER BIOL, V57, P716, DOI 10.1111/j.1365-2427.2012.02737.x; Davies JN, 2009, J N AM BENTHOL SOC, V28, P491, DOI 10.1899/07-073.1; DEB D, 1995, OIKOS, V72, P245, DOI 10.2307/3546227; Dell AI, 2014, J ANIM ECOL, V83, P70, DOI 10.1111/1365-2656.12081; Dell AI, 2011, P NATL ACAD SCI USA, V108, P10591, DOI 10.1073/pnas.1015178108; Dudgeon D, 1999, ARCH HYDROBIOL, V146, P65; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; ECKBLAD J W, 1973, Hydrobiologia, V41, P199, DOI 10.1007/BF00016446; Eisenberg JNS, 2000, ECOLOGY, V81, P921, DOI 10.1890/0012-9658(2000)081[0921:GFBOAS]2.0.CO;2; Evans JH, 1958, J ECOL, V46, P25; Fashing NJ, 1998, EXP APPL ACAROL, V22, P435, DOI 10.1023/A:1006081622519; FELTON M, 1967, J GEN MICROBIOL, V47, P25, DOI 10.1099/00221287-47-1-25; HARRIS PM, 1995, ECOLOGY, V76, P544, DOI 10.2307/1941212; Hering D, 1997, OECOLOGIA, V111, P261, DOI 10.1007/s004420050234; Hochberg Y., 1987, MULTIPLE COMP PROCED; Iwai N, 2012, OIKOS, V121, P313, DOI 10.1111/j.1600-0706.2011.20128.x; JEFFRIES M, 1994, FRESHWATER BIOL, V32, P603, DOI 10.1111/j.1365-2427.1994.tb01151.x; JENKINS B, 1992, OIKOS, V65, P249, DOI 10.2307/3545016; Kitching R.L., 2000, FOOD WEBS CONTAINER, DOI [10.1017/CBO9780511542107, DOI 10.1017/CBO9780511542107]; Lambeets K, 2008, J ANIM ECOL, V77, P1162, DOI 10.1111/j.1365-2656.2008.01443.x; Lardner B, 2000, OIKOS, V88, P169, DOI 10.1034/j.1600-0706.2000.880119.x; Larned ST, 2007, AQUAT SCI, V69, P554, DOI 10.1007/s00027-007-0930-1; Larned ST, 2010, FRESHWATER BIOL, V55, P717, DOI 10.1111/j.1365-2427.2009.02322.x; Manly BF., 2006, RANDOMIZATION BOOTST; Marsh DM, 2001, CONSERV BIOL, V15, P40, DOI 10.1046/j.1523-1739.2001.00129.x; MCLACHLAN AJ, 1980, OECOLOGIA, V47, P344, DOI 10.1007/BF00398528; MEINTJES S, 1994, HYDROBIOLOGIA, V281, P79, DOI 10.1007/BF00006437; Mielke PW, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-69813-7; Milliman JD, 2008, GLOBAL PLANET CHANGE, V62, P187, DOI 10.1016/j.gloplacha.2008.03.001; Moon H. P., 1956, Proceedings of the Zoological Society of London, Vl26, P327; MORIN PJ, 1995, ECOLOGY, V76, P133, DOI 10.2307/1940637; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; Paetzold A, 2005, ECOSYSTEMS, V8, P748, DOI 10.1007/s10021-005-0004-y; PAINE RT, 1988, ECOLOGY, V69, P1648, DOI 10.2307/1941141; Pawar S, 2012, NATURE, V486, P485, DOI 10.1038/nature11131; PIMM SL, 1988, ECOLOGY, V69, P1669, DOI 10.2307/1941144; POLIS GA, 1991, AM NAT, V138, P123, DOI 10.1086/285208; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Rasmussen NL, 2014, J ANIM ECOL, V83, P1206, DOI 10.1111/1365-2656.12203; Reddy MV., 1995, SOIL ORGANISMS LITTE; Richardson JS, 2010, RIVER RES APPL, V26, P55, DOI 10.1002/rra.1283; RICHARDSON JS, 1992, FRESHWATER BIOL, V27, P169, DOI 10.1111/j.1365-2427.1992.tb00531.x; Skelly DK, 1999, ECOLOGY, V80, P2326, DOI 10.1890/0012-9658(1999)080[2326:LTDDOA]2.0.CO;2; SMITH REW, 1987, HYDROBIOLOGIA, V150, P45, DOI 10.1007/BF00006609; Spencer M, 1999, ECOL LETT, V2, P157; Srivastava DS, 2004, TRENDS ECOL EVOL, V19, P379, DOI 10.1016/j.tree.2004.04.010; STANLEY EH, 1994, AM MIDL NAT, V131, P288, DOI 10.2307/2426255; Stapp P, 1999, NATURE, V401, P467, DOI 10.1038/46769; Stapp P, 2003, OIKOS, V102, P111, DOI 10.1034/j.1600-0706.2003.12445.x; Stehr WC, 1938, ECOLOGY, V19, P294, DOI 10.2307/1929643; Steward AL, 2012, FRONT ECOL ENVIRON, V10, P202, DOI 10.1890/110136; Steward AL, 2011, AQUAT SCI, V73, P551, DOI 10.1007/s00027-011-0217-4; Stoler AB, 2013, OECOLOGIA, V173, P249, DOI 10.1007/s00442-013-2595-x; Stubbington R, 2013, FRESHWATER BIOL, V58, P1202, DOI 10.1111/fwb.12121; Stubbington R, 2009, HYDROBIOLOGIA, V630, P299, DOI 10.1007/s10750-009-9823-8; Symons CC, 2014, ECOL EVOL, V4, P397, DOI 10.1002/ece3.940; TAMM JC, 1984, OECOLOGIA, V61, P417, DOI 10.1007/BF00379645; WEBSTER JR, 1986, ANNU REV ECOL SYST, V17, P567, DOI 10.1146/annurev.es.17.110186.003031; Wentworth C. K., 1922, J GEOL, V30, P377, DOI DOI 10.1086/622910; WIGGINS G B, 1980, Archiv fuer Hydrobiologie Supplement, V58, P97; Wilbur HM, 1997, ECOLOGY, V78, P2279, DOI 10.1890/0012-9658(1997)078[2279:EEOFWC]2.0.CO;2; WILBUR HM, 1985, ECOLOGY, V66, P1106, DOI 10.2307/1939162; Williams D.D., 1987, P1; WILLIAMS D D, 1976, Internationale Revue der Gesamten Hydrobiologie, V61, P761, DOI 10.1002/iroh.19760610604; Williams RJ, 2002, P NATL ACAD SCI USA, V99, P12913, DOI 10.1073/pnas.192448799; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; WINEMILLER KO, 1990, ECOL MONOGR, V60, P331, DOI 10.2307/1943061; Wishart MJ, 2000, AFR ZOOL, V35, P193; Wissinger SA, 1999, ECOLOGY, V80, P2102	89	12	12	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e108203	10.1371/journal.pone.0108203	http://dx.doi.org/10.1371/journal.pone.0108203			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244550	Green Accepted, Green Published, gold			2022-12-25	WOS:000343679800076
J	Lord, DM; Baran, AU; Wood, TK; Peti, W; Page, R				Lord, Dana M.; Baran, Ayse Uzgoren; Wood, Thomas K.; Peti, Wolfgang; Page, Rebecca			BdcA, a Protein Important for Escherichia coli Biofilm Dispersal, Is a Short-Chain Dehydrogenase/Reductase that Binds Specifically to NADPH	PLOS ONE			English	Article							CYCLIC-DI-GMP; CRYSTAL-STRUCTURE; REDUCTASE; COOPERATIVITY; DETERMINANTS; REVEALS	The Escherichia coli protein BdcA (previously referred to as YjgI) plays a key role in the dispersal of cells from bacterial biofilms, and its constitutive activation provides an attractive therapeutic target for dismantling these communities. In order to investigate the function of BdcA at a molecular level, we integrated structural and functional studies. Our 2.05 angstrom structure of BdcA shows that it is a member of the NAD(P)(H)-dependent short-chain dehydrogenase/reductase (SDR) superfamily. Structural comparisons with other members of the SDR family suggested that BdcA binds NADP(H). This was demonstrated experimentally using thermal denaturation studies, which showed that BcdA binds specifically to NADPH. Subsequent ITC experiments further confirmed this result and reported a K-d of 25.9 mu M. Thus, BdcA represents the newest member of the limited number of oxidoreductases shown to be involved in quorum sensing and biofilm dispersal.	[Lord, Dana M.; Page, Rebecca] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Lord, Dana M.] Brown Univ, Grad Program Mol Pharmacol & Physiol, Providence, RI 02912 USA; [Baran, Ayse Uzgoren; Peti, Wolfgang] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Baran, Ayse Uzgoren; Peti, Wolfgang] Brown Univ, Dept Chem, Providence, RI 02912 USA; [Wood, Thomas K.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA; [Wood, Thomas K.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Brown University; Brown University; Brown University; Brown University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Page, R (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.	rebecca_page@brown.edu	Wood, Thomas/GWZ-2481-2022; UZGÖREN-BARAN, AYŞE/G-9260-2013	Wood, Thomas/0000-0001-8962-8571; UZGÖREN-BARAN, AYŞE/0000-0003-1405-2920; Wood, Thomas/0000-0002-6258-529X	National Science Foundation Experimental Program to Stimulate Competitive Research (EPSCoR) graduate fellowship; National Science Foundation-CAREER [MCB0952550]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018728, P30RR031153] Funding Source: NIH RePORTER	National Science Foundation Experimental Program to Stimulate Competitive Research (EPSCoR) graduate fellowship; National Science Foundation-CAREER(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a National Science Foundation Experimental Program to Stimulate Competitive Research (EPSCoR) graduate fellowship to DML and a National Science Foundation-CAREER Award MCB0952550 to RP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beech WB, 2004, CURR OPIN BIOTECH, V15, P181, DOI 10.1016/j.copbio.2004.05.001; Bijtenhoorn P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026278; Buysschaert G, 2013, FEBS J, V280, P1358, DOI 10.1111/febs.12128; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chowdhary PK, 2008, J BIOTECHNOL, V135, P374, DOI 10.1016/j.jbiotec.2008.05.005; Chowdhary PK, 2007, BIOCHEMISTRY-US, V46, P14429, DOI 10.1021/bi701945j; Cos P, 2010, CURR PHARM DESIGN, V16, P2279, DOI 10.2174/138161210791792868; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; D'Argenio DA, 2004, MICROBIOL-SGM, V150, P2497, DOI 10.1099/mic.0.27099-0; Dobretsov S, 2009, BIOFOULING, V25, P413, DOI 10.1080/08927010902853516; Dommaraju SR, 2011, ARCH BIOCHEM BIOPHYS, V512, P167, DOI 10.1016/j.abb.2011.06.006; Dutta D, 2012, PROTEINS, V80, P1250, DOI 10.1002/prot.24024; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Herzberg M, 2006, J BACTERIOL, V188, P587, DOI 10.1128/JB.188.2.587-598.2006; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Krasteva PV, 2012, PROTEIN SCI, V21, P929, DOI 10.1002/pro.2093; Ladenstein R, 2008, CELL MOL LIFE SCI, V65, P3918, DOI 10.1007/s00018-008-8590-4; Lesk AM, 1995, CURR OPIN STRUC BIOL, V5, P775, DOI 10.1016/0959-440X(95)80010-7; Ma Q, 2011, ENVIRON MICROBIOL, V13, P631, DOI 10.1111/j.1462-2920.2010.02368.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mendez-Ortiz MM, 2006, J BIOL CHEM, V281, P8090, DOI 10.1074/jbc.M510701200; Moon HJ, 2012, APPL ENVIRON MICROB, V78, P3079, DOI 10.1128/AEM.07751-11; Nakhamchik A, 2008, APPL ENVIRON MICROB, V74, P4199, DOI 10.1128/AEM.00176-08; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nishioka T, 2012, FEBS J, V279, P3264, DOI 10.1111/j.1742-4658.2012.08713.x; Oliveira T, 2012, J STRUCT BIOL, V177, P543, DOI 10.1016/j.jsb.2011.10.006; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peti W, 2007, PROTEIN EXPRES PURIF, V51, P1, DOI 10.1016/j.pep.2006.06.024; Price AC, 2001, BIOCHEMISTRY-US, V40, P12772, DOI 10.1021/bi010737g; Rao RSP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S14-S14; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Subramanian S, 2011, ACTA CRYSTALLOGR F, V67, P1118, DOI 10.1107/S1744309111030673; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Ueda A, 2010, ENV MICROBIOL REP, V2, P449, DOI 10.1111/j.1758-2229.2010.00171.x; van Os N, 2012, J EXP BIOL, V215, P1515, DOI 10.1242/jeb.069344; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Yamamoto K, 2001, J BIOCHEM, V129, P303, DOI 10.1093/oxfordjournals.jbchem.a002858; Zaccai NR, 2008, PROTEINS, V70, P562, DOI 10.1002/prot.21624	43	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e105751	10.1371/journal.pone.0105751	http://dx.doi.org/10.1371/journal.pone.0105751			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244619	gold, Green Published, Green Submitted			2022-12-25	WOS:000343679800005
J	Morowski, M; Brachs, S; Mielenz, D; Nieswandt, B; Dutting, S				Morowski, Martina; Brachs, Sebastian; Mielenz, Dirk; Nieswandt, Bernhard; Duetting, Sebastian			The Adaptor Protein Swiprosin-1/EFhd2 Is Dispensable for Platelet Function in Mice	PLOS ONE			English	Article							THROMBUS FORMATION; INTEGRIN ACTIVATION; ARTERIAL THROMBOSIS; AGGREGATION; ADHESION; MECHANISMS; RECEPTORS; COLLAGEN; CDC42; RAC1	Background: Platelets are anuclear cell fragments derived from bone marrow megakaryocytes that safeguard vascular integrity, but may also cause pathological vessel occlusion. Reorganizations of the platelet cytoskeleton and agonist-induced intracellular Ca2+-mobilization are crucial for platelet hemostatic function. EF-hand domain containing 2 (EFhd2, Swiprosin-1) is a Ca2+-binding cytoskeletal adaptor protein involved in actin remodeling in different cell types, but its function in platelets is unknown. Objective: Based on the described functions of EFhd2 in immune cells, we tested the hypothesis that EFhd2 is a crucial adaptor protein for platelet function acting as a regulator of Ca2+-mobilization and cytoskeletal rearrangements. Methods and Results: We generated EFhd2-deficient mice and analyzed their platelets in vitro and in vivo. Efhd2(-/-) mice displayed normal platelet count and size, exhibited an unaltered in vivo life span and showed normal Ca2+-mobilization and activation/aggregation responses to classic agonists. Interestingly, upon stimulation of the immunoreceptor tyrosine-based activation motif-coupled receptor glycoprotein (GP) VI, Efhd2(-/-) platelets showed a slightly increased coagulant activity. Furthermore, absence of EFhd2 had no significant impact on integrin-mediated clot retraction, actomyosin rearrangements and spreading of activated platelets on fibrinogen. In vivo EFhd2-deficiency resulted in unaltered hemostatic function and unaffected arterial thrombus formation. Conclusion: These results show that EFhd2 is not essential for platelet function in mice indicating that other cytoskeletal adaptors may functionally compensate its loss.	[Morowski, Martina; Nieswandt, Bernhard; Duetting, Sebastian] Univ Wurzburg, Univ Hosp, Dept Expt Biomed, D-97070 Wurzburg, Germany; [Morowski, Martina; Nieswandt, Bernhard; Duetting, Sebastian] Rudolf Virchow Ctr Expt Biomed, Wurzburg, Germany; [Brachs, Sebastian; Mielenz, Dirk] Univ Hosp Erlangen, Nikolaus Fiebiger Ctr, Dept Internal Med 3, Div Mol Immunol, Erlangen, Germany; [Brachs, Sebastian; Mielenz, Dirk] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany	University of Wurzburg; University of Wurzburg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Dutting, S (corresponding author), Univ Wurzburg, Univ Hosp, Dept Expt Biomed, D-97070 Wurzburg, Germany.	bernhard.nieswandt@virchow.uni-wuerzburg.de; sebastian.duetting@virchow.uni-wuerzburg.de		Brachs, Sebastian/0000-0002-6336-3939	Deutsche Forschungsgemeinschaft [Ni556/10-1]; Rudolf Virchow Center	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Rudolf Virchow Center	This work was supported by the Deutsche Forschungsgemeinschaft (grant Ni556/10-1 to BN) and the Rudolf Virchow Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslan JE, 2013, J THROMB HAEMOST, V11, P35, DOI 10.1111/jth.12051; Avramidou A, 2007, CELL DEATH DIFFER, V14, P1936, DOI 10.1038/sj.cdd.4402206; Bergmeier W, 2009, J THROMB HAEMOST, V7, P187, DOI 10.1111/j.1538-7836.2009.03379.x; Brachs S, 2014, EUR J IMMUNOL, V44, P3206, DOI 10.1002/eji.201444479; Carr ME, 2003, CELL BIOCHEM BIOPHYS, V38, P55, DOI 10.1385/CBB:38:1:55; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; DACHARYPRIGENT J, 1993, BLOOD, V81, P2554; Dutting S, 2012, TRENDS PHARMACOL SCI, V33, P583, DOI 10.1016/j.tips.2012.07.004; Dutting S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-2; Fox JEB, 2001, THROMB HAEMOSTASIS, V86, P198; Freishtat RJ, 2009, AM J RESP CRIT CARE, V179, P467, DOI 10.1164/rccm.200807-1085OC; Hagen S, 2012, CELL CALCIUM, V51, P411, DOI 10.1016/j.ceca.2012.01.004; Huh YH, 2013, CELL MOL LIFE SCI; Jackson SP, 2011, NAT MED, V17, P1423, DOI 10.1038/nm.2515; Jackson SP, 2003, J THROMB HAEMOST, V1, P1602, DOI 10.1046/j.1538-7836.2003.00267.x; Knight CG, 1999, CARDIOVASC RES, V41, P450, DOI 10.1016/S0008-6363(98)00306-X; Kroczek C, 2010, J IMMUNOL, V184, P3665, DOI 10.4049/jimmunol.0903642; Kwon MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071626; Meng XB, 2005, J PROTEOME RES, V4, P2081, DOI 10.1021/pr0502121; Mielenz D, 2005, J IMMUNOL, V174, P3508, DOI 10.4049/jimmunol.174.6.3508; Morgenstern E, 1990, Blood Coagul Fibrinolysis, V1, P543, DOI 10.1097/00001721-199010000-00035; Morowski M, 2013, BLOOD, V121, P4938, DOI 10.1182/blood-2012-10-461459; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Nieswandt B, 2000, BLOOD, V96, P2520; Nieswandt B, 2011, J THROMB HAEMOST, V9, P92, DOI 10.1111/j.1538-7836.2011.04361.x; Nieswandt B, 2001, EMBO J, V20, P2120, DOI 10.1093/emboj/20.9.2120; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; Pleines I, 2013, BLOOD, V122, P3178, DOI 10.1182/blood-2013-03-487942; Pleines I, 2012, BLOOD, V119, P1054, DOI 10.1182/blood-2011-08-372193; Pleines I, 2010, BLOOD, V115, P3364, DOI 10.1182/blood-2009-09-242271; Pleines I, 2009, PFLUG ARCH EUR J PHY, V457, P1173, DOI 10.1007/s00424-008-0573-7; Purohit P, 2014, PLOS ONE IN PRESS; PYTELA R, 1986, SCIENCE, V231, P1559, DOI 10.1126/science.2420006; Ramesh T P, 2009, Immune Netw, V9, P274, DOI 10.4110/in.2009.9.6.274; Renne T, 2012, SEMIN IMMUNOPATHOL, V34, P31, DOI 10.1007/s00281-011-0288-2; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Thylur RP, 2009, J CELL BIOCHEM, V108, P705, DOI 10.1002/jcb.22307; Varga-Szabo D, 2011, CELL CALCIUM, V50, P270, DOI 10.1016/j.ceca.2011.04.002; Vega IE, 2008, J NEUROCHEM, V106, P96, DOI 10.1111/j.1471-4159.2008.05339.x; VERHALLEN PFJ, 1987, BIOCHIM BIOPHYS ACTA, V903, P206, DOI 10.1016/0005-2736(87)90170-2; Yu YB, 2010, PROTEOMICS, V10, P2444, DOI 10.1002/pmic.200900271	41	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107139	10.1371/journal.pone.0107139	http://dx.doi.org/10.1371/journal.pone.0107139			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243606	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800020
J	Mukherjee, N; Sutherland, WJ; Dicks, L; Huge, J; Koedam, N; Dahdouh-Guebas, F				Mukherjee, Nibedita; Sutherland, William J.; Dicks, Lynn; Huge, Jean; Koedam, Nico; Dahdouh-Guebas, Farid			Ecosystem Service Valuations of Mangrove Ecosystems to Inform Decision Making and Future Valuation Exercises	PLOS ONE			English	Article							ECONOMIC VALUATION; BIODIVERSITY LOSS; DELPHI TECHNIQUE; FORESTS; CONSERVATION; PROTECTION; VALUES; CONNECTIVITY; MANAGEMENT; BENEFITS	The valuation of ecosystem services is a complex process as it includes several dimensions (ecological, socio-cultural and economic) and not all of these can be quantified in monetary units. The aim of this paper is to conduct an ecosystem services valuation study for mangroves ecosystems, the results of which can be used to inform governance and management of mangroves. We used an expert-based participatory approach (the Delphi technique) to identify, categorize and rank the various ecosystem services provided by mangrove ecosystems at a global scale. Subsequently we looked for evidence in the existing ecosystem services literature for monetary valuations of these ecosystem service categories throughout the biogeographic distribution of mangroves. We then compared the relative ranking of ecosystem service categories between the monetary valuations and the expert based analysis. The experts identified 16 ecosystem service categories, six of which are not adequately represented in the literature. There was no significant correlation between the expert based valuation (the Delphi technique) and the economic valuation, indicating that the scope of valuation of ecosystem services needs to be broadened. Acknowledging this diversity in different valuation approaches, and developing methodological frameworks that foster the pluralism of values in ecosystem services research, are crucial for maintaining the credibility of ecosystem services valuation. To conclude, we use the findings of our dual approach to valuation to make recommendations on how to assess and manage the ecosystem services provided by mangrove ecosystems.	[Mukherjee, Nibedita; Huge, Jean; Dahdouh-Guebas, Farid] Univ Libre Bruxelles, Lab Syst Ecol & Resource Management, Brussels, Belgium; [Mukherjee, Nibedita; Koedam, Nico; Dahdouh-Guebas, Farid] Vrije Univ Brussel, Lab Plant Biol & Nat Management, Brussels, Belgium; [Sutherland, William J.; Dicks, Lynn] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England; [Huge, Jean] Univ Ghent, Ctr Sustainable Dev, B-9000 Ghent, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Cambridge; Ghent University	Mukherjee, N (corresponding author), Univ Libre Bruxelles, Lab Syst Ecol & Resource Management, Brussels, Belgium.	nibedita.41282@gmail.com	Dicks, Lynn V./AFH-5289-2022; Mukherjee, Nibedita/B-2531-2010	Mukherjee, Nibedita/0000-0002-2970-1498; Huge, Jean/0000-0002-3695-547X; Dicks, Lynn/0000-0002-8304-4468; DAHDOUH-GUEBAS, Farid/0000-0002-5906-8996; Sutherland, William/0000-0002-6498-0437	'Mandat d'Impulsion Scientifique' of the National Science Foundation (FNRS), Belgium [MIS ID 1765914]; "CREC'' (EU IRSES) [247514]; Arcadia; Natural Environment Research Council [NE/K015419/1, NE/J500665/1]; NERC [NE/K015419/1, NE/J500665/1] Funding Source: UKRI	'Mandat d'Impulsion Scientifique' of the National Science Foundation (FNRS), Belgium(Fonds de la Recherche Scientifique - FNRS); "CREC'' (EU IRSES); Arcadia; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	NM was funded by the 'Mandat d'Impulsion Scientifique' (MIS ID 1765914) of the National Science Foundation (FNRS), Belgium and "CREC'' (EU IRSES # 247514). NM would like to thank the British Ecological Society for the Parkyn bursary that made this research possible. WJS is funded by Arcadia. LD is funded by the Natural Environment Research Council (Grant codes NE/K015419/1, NE/J500665/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, EC HUM WELL BEING SY; Avau J, 2011, J COASTAL RES, P1277; Badola R, 2005, ENVIRON CONSERV, V32, P85, DOI 10.1017/S0376892905001967; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barbier EB, 2012, NATURAL CAPITAL ECOL, P38; Barbier EB, 2012, REV ENV ECON POLICY, V6, P1, DOI 10.1093/reep/rer017; Bateman IJ, 2013, SCIENCE, V341, P45, DOI 10.1126/science.1234379; Bateman IJ, 2011, ENVIRON RESOUR ECON, V48, P177, DOI 10.1007/s10640-010-9418-x; Benitez-Capistros F, 2014, ECOL INDIC, V38, P113, DOI 10.1016/j.ecolind.2013.10.019; Brander LM, 2012, ECOSYST SERV, V1, P62, DOI 10.1016/j.ecoser.2012.06.003; Brouwer R, 2013, TEEB FOLLOW STUD EUR, V144; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; Curtis IA, 2004, ECOL ECON, V50, P163, DOI 10.1016/j.ecolecon.2004.02.003; Dahdouh-Guebas F, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-24; Dahdouh-Guebas F., 2013, VERS NOUVELLE SYNTHE, P182; DALKEY N, 1963, MANAGE SCI, V9, P458, DOI 10.1287/mnsc.9.3.458; Das S, 2013, ESTUAR COAST SHELF S, V134, P98, DOI 10.1016/j.ecss.2013.09.021; de Groot R, 2012, ECOSYST SERV, V1, P50, DOI 10.1016/j.ecoser.2012.07.005; De Villiers MR, 2005, MED TEACH, V27, P639, DOI 10.1080/13611260500069947; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Feller IC, 2010, ANNU REV MAR SCI, V2, P395, DOI 10.1146/annurev.marine.010908.163809; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; Gomez-Baggethun E, 2011, PROG PHYS GEOG, V35, P613, DOI 10.1177/0309133311421708; Gomez-Baggethun E, 2010, ECOL ECON, V69, P1209, DOI 10.1016/j.ecolecon.2009.11.007; Hasson F, 2011, TECHNOL FORECAST SOC, V78, P1695, DOI 10.1016/j.techfore.2011.04.005; Hauck J, 2013, ENVIRON SCI POLICY, V25, P13, DOI 10.1016/j.envsci.2012.08.001; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hussain SA, 2010, WETL ECOL MANAG, V18, P321, DOI 10.1007/s11273-009-9173-3; James P, 2009, URBAN FOR URBAN GREE, V8, P65, DOI 10.1016/j.ufug.2009.02.001; Jones DL, 2010, MAR ECOL PROG SER, V401, P245, DOI 10.3354/meps08404; Kareiva P, 2008, SCIENCE, V321, P1638, DOI 10.1126/science.1162756; Laurans Y, 2014, ECOSYST SERV, V7, P98, DOI 10.1016/j.ecoser.2013.10.002; Laurans Y, 2013, J ENVIRON MANAGE, V119, P208, DOI 10.1016/j.jenvman.2013.01.008; Lee SY, 2014, GLOBAL ECOL BIOGEOGR, V23, P726, DOI 10.1111/geb.12155; Lee SY, 2014, GLOBAL ECOL BIOGEOGR; Likert R., 1932, ARCH PSYCHOL, V140, P1, DOI DOI 10.1111/J.1540-5834.2010.00585.X; Liquete C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067737; Liquete C, 2013, ECOL INDIC, V30, P205, DOI 10.1016/j.ecolind.2013.02.013; Long J, 2014, J COASTAL RES, V30, P260, DOI 10.2112/JCOASTRES-D-13-00057.1; Martin-Lopez B, 2014, ECOL INDIC, V37, P220, DOI 10.1016/j.ecolind.2013.03.003; McNally CG, 2011, P NATL ACAD SCI USA, V108, P13945, DOI 10.1073/pnas.1101825108; Mukherjee N, METHODS ECOLOG UNPUB; Mukherjee N, 2011, WELCOME DELPHI SURVE; Mukherjee N, 2014, ECOL EVOL, V4, P2247, DOI 10.1002/ece3.1085; Orsi F, 2011, ECOL INDIC, V11, P337, DOI 10.1016/j.ecolind.2010.06.001; Ostrom E, 2006, P NATL ACAD SCI USA, V103, P19224, DOI 10.1073/pnas.0607962103; Polidoro BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010095; Vo QT, 2012, ECOL INDIC, V23, P431, DOI 10.1016/j.ecolind.2012.04.022; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; Ruckelshaus M., 2013, ECOLOGICAL EC, DOI 10.1016/j.ecolecon.2013.07.009; Salem ME, 2012, SUSTAINABILITY-BASEL, V4, P359, DOI 10.3390/su4030359; Satyanarayana B, 2013, OCEAN COAST MANAGE, V71, P225, DOI 10.1016/j.ocecoaman.2012.10.008; Satyanarayana B, 2012, AMBIO, V41, P513, DOI 10.1007/s13280-012-0248-7; Scolozzi R, 2012, ECOL INDIC, V21, P134, DOI 10.1016/j.ecolind.2011.07.019; Shalisman A, 2014, IMPORTANCE UPTIME; Spalding M., 2010, WETLANDS, V31, P1003, DOI 10.1007/s13157-011-0224-1; Spangenberg JH, 2014, ECOL ECON, V104, P22, DOI 10.1016/j.ecolecon.2014.04.025; Sutherland WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031824; TUROFF M, 1970, TECHNOL FORECAST SOC, V2, P149, DOI 10.1016/0040-1625(70)90161-7; Uddin MS, 2013, ECOSYST SERV, V5, pE88, DOI 10.1016/j.ecoser.2013.07.002; Unsworth RKF, 2008, MAR ECOL PROG SER, V353, P213, DOI 10.3354/meps07199; Van der Ploeg S., 2010, TEEB VALUATION DATAB; Vetter D, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00062.1; von der Gracht HA, 2012, TECHNOL FORECAST SOC, V79, P1525, DOI 10.1016/j.techfore.2012.04.013; Wallington TJ, 2005, BIOSCIENCE, V55, P873, DOI 10.1641/0006-3568(2005)055[0873:EVAOAT]2.0.CO;2; Walters BB, 2008, AQUAT BOT, V89, P220, DOI 10.1016/j.aquabot.2008.02.009; World Water Assessment Programme, 2012, 4 UNESCO WORLD WAT A; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	72	65	68	12	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107706	10.1371/journal.pone.0107706	http://dx.doi.org/10.1371/journal.pone.0107706			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6FX	25243852	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800046
J	Okura, H; Sato, S; Kishikawa, S; Kaneto, S; Nakashima, T; Yoshida, N; Takayanagi, H; Kiyono, H				Okura, Hideaki; Sato, Shintaro; Kishikawa, Sari; Kaneto, Satoshi; Nakashima, Tomoki; Yoshida, Nobuaki; Takayanagi, Hiroshi; Kiyono, Hiroshi			Runx2-I Isoform Contributes to Fetal Bone Formation Even in the Absence of Specific N-Terminal Amino Acids	PLOS ONE			English	Article							CLEIDOCRANIAL DYSPLASIA; TRANSCRIPTION FACTOR; OSTEOBLAST DIFFERENTIATION; EXPRESSION; CBFA1; CHONDROCYTES; PHENOTYPE; PROMOTER; SERIES; FOXP3	The Runt-related transcription factor 2 (Runx2) gene encodes the transcription factor Runx2, which is the master regulator of osteoblast development; insufficiency of this protein causes disorders of bone development such as cleidocranial dysplasia. Runx2 has two isoforms, Runx2-II and Runx2-I, and production of each isoform is controlled by a unique promoter: a distal promoter (P1) and a proximal promoter (P2), respectively. Although several studies have focused on differences and similarities between the two Runx2 isoforms, their individual roles in bone formation have not yet been determined conclusively, partly because a Runx2-I-targeted mouse model is not available. In this study, we established a novel Runx2-manipulated mouse model in which the first ATG of Runx2-I was replaced with TGA (a stop codon), and a neomycin-resistant gene (neo) cassette was inserted at the first intron of Runx2-I. Homozygous Runx2-I neo/neo mice showed severely reduced expression of Runx2-I, whereas Runx2-II expression was largely retained. Runx2-I neo/neo mice showed neonatal lethality, and in these mice, intramembranous ossification was more severely defective than endochondral ossification, presumably because of the greater involvement of Runx2-I, compared with that of Runx2-II in intramembranous ossification. Interestingly, the depletion of neo rescued the above-described phenotypes, indicating that the isoform-specific N-terminal region of Runx2-I is not functionally essential for bone development. Taken together, our results provide a novel clue leading to a better understanding of the roles of Runx2 isoforms in osteoblast development.	[Okura, Hideaki; Sato, Shintaro; Kishikawa, Sari; Kaneto, Satoshi; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol, Tokyo, Japan; [Okura, Hideaki; Kiyono, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba, Japan; [Sato, Shintaro; Kiyono, Hiroshi] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Nakashima, Tomoki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cell Signaling, Tokyo, Japan; [Yoshida, Nobuaki] Univ Tokyo, Inst Med Sci, Lab Dev Genet, Tokyo, Japan; [Takayanagi, Hiroshi] Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo, Japan; [Takayanagi, Hiroshi] Univ Tokyo, Fac Med, Tokyo 113, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Tokyo Medical & Dental University (TMDU); University of Tokyo; University of Tokyo; University of Tokyo	Sato, S (corresponding author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol, Tokyo, Japan.	shinta@ims.u-tokyo.ac.jp; kiyono@ims.u-tokyo.ac.jp	Kiyono, Hiroshi/AAC-6735-2022	Sato, Shintaro/0000-0001-5156-3354	Ministry of Education, Culture, Sports, Science and Technology of Japan [225420, 23659199, 25860353, 23229004]; Global Center of Excellence Program of the Center of Education and Research for Advanced Genome-based Medicine; Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Center of Excellence Program of the Center of Education and Research for Advanced Genome-based Medicine; Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST))	This work is supported by grants from: the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in-Aid for JSPS Fellows [225420 to H. O.], for challenging Exploratory Research [23659199 to S. S.], for Young Scientists B [25860353 to S. S.], and for Scientific Research S [23229004 to H. K.]); the Global Center of Excellence Program of the Center of Education and Research for Advanced Genome-based Medicine (to H. K.); and the Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency (to H. K.).	Banerjee C, 2001, ENDOCRINOLOGY, V142, P4026, DOI 10.1210/en.142.9.4026; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; Hall BK, 2001, J EXP ZOOL, V289, P153, DOI 10.1002/1097-010X(20010215)289:3<153::AID-JEZ1>3.0.CO;2-O; Jeong JH, 2008, J CELL PHYSIOL, V217, P511, DOI 10.1002/jcp.21524; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lam K, 2012, FRONT BIOSCI-LANDMRK, V17, P1120, DOI 10.2741/3977; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; Liu JC, 2011, J BIOL CHEM, V286, P30057, DOI 10.1074/jbc.M111.241505; Lou Y, 2009, HUM MOL GENET, V18, P556, DOI 10.1093/hmg/ddn383; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nagy A, 1998, CURR BIOL, V8, P661, DOI 10.1016/S0960-9822(98)70254-4; Nishikawa K, 2010, J CLIN INVEST, V120, P3455, DOI 10.1172/JCI42528; Ogata N, 2000, J CLIN INVEST, V105, P935, DOI 10.1172/JCI9017; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Park MH, 2001, J BONE MINER RES, V16, P885, DOI 10.1359/jbmr.2001.16.5.885; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; Stock M, 2005, J CELL BIOCHEM, V95, P506, DOI 10.1002/jcb.20471; Sudhakar S, 2001, BIOCHEM BIOPH RES CO, V289, P616, DOI 10.1006/bbrc.2001.6033; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Xiao ZS, 2004, J BIOL CHEM, V279, P20307, DOI 10.1074/jbc.M401109200; Zhang SQ, 2009, J BONE MINER RES, V24, P1889, DOI [10.1359/JBMR.090502, 10.1359/jbmr.090502]	26	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e108294	10.1371/journal.pone.0108294	http://dx.doi.org/10.1371/journal.pone.0108294			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244033	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800084
J	Song, JH; An, N; Chatterjee, S; Kistner-Griffin, E; Mahajan, S; Mehrotra, S; Kraft, AS				Song, J. H.; An, N.; Chatterjee, S.; Kistner-Griffin, E.; Mahajan, S.; Mehrotra, S.; Kraft, A. S.			Deletion of Pim kinases elevates the cellular levels of reactive oxygen species and sensitizes to K-Ras-induced cell killing	ONCOGENE			English	Article							C-MYC; GLUTAMINE-METABOLISM; GENE-EXPRESSION; TRANSGENIC MICE; CANCER; KRAS; GROWTH; DETOXIFICATION; ONCOPROTEIN; COOPERATION	The Pim protein kinases contribute to transformation by enhancing the activity of oncogenic Myc and Ras, which drives significant metabolic changes during tumorigenesis. In this report, we demonstrate that mouse embryo fibroblasts (MEFs) lacking all three isoforms of Pim protein kinases, triple knockout (TKO), cannot tolerate the expression of activated K-Ras (K-Ras(G12V)) and undergo cell death. Transduction of K-Ras(G12V) into these cells markedly increased the level of cellular reactive oxygen species (ROS). The addition of N-acetyl cysteine attenuated ROS production and reversed the cytotoxic effects of K-Ras(G12V) in the TKO MEFs. The altered cellular redox state caused by the loss of Pim occurred as a result of lower levels of metabolic intermediates in the glycolytic and pentose phosphate pathways as well as abnormal mitochondrial oxidative phosphorylation. TKO MEFs exhibit reduced levels of superoxide dismutase (Sod), glutathione peroxidase 4 (Gpx4) and peroxiredoxin 3 (Prdx3) that render them susceptible to killing by K-Ras(G12V)-mediated ROS production. In contrast, the transduction of c-Myc into TKO cells can overcome the lack of Pim protein kinases by regulating cellular metabolism and Sod2. In the absence of the Pim kinases, c-Myc transduction permitted K-Ras(G12V)-induced cell growth by decreasing Ras-induced cellular ROS levels. These results demonstrate that the Pim protein kinases have an important role in regulating cellular redox, metabolism and K-Ras-stimulated cell growth.	[Song, J. H.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Song, J. H.; Chatterjee, S.; Kistner-Griffin, E.; Mahajan, S.; Mehrotra, S.; Kraft, A. S.] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [An, N.; Kraft, A. S.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Chatterjee, S.; Mehrotra, S.] Med Univ S Carolina, Dept Surg, Charleston, SC 29425 USA; [Kistner-Griffin, E.] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Song, JH (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 86 Jonathan Lucas St, Charleston, SC 29425 USA.	songjin@musc.edu; kraft@musc.edu		SONG, JIN/0000-0002-0123-2909	Genomics Shared Resource at Hollings Cancer Center; Seahorse Biosciences Academic Core Facility, Medical University of South Carolina; NIH [P30-CA138313]; DOD [W81XWH-08-PCRP-IDA, R01 CA1732000]; American Cancer Society Institutional Research Grant; NATIONAL CANCER INSTITUTE [R01CA173200, P30CA138313] Funding Source: NIH RePORTER	Genomics Shared Resource at Hollings Cancer Center; Seahorse Biosciences Academic Core Facility, Medical University of South Carolina; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); American Cancer Society Institutional Research Grant(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Genomics Shared Resource at Hollings Cancer Center and Seahorse Biosciences Academic Core Facility, Medical University of South Carolina. We thank Dr Allen J Ebens at Genentech Inc. and Novartis Oncology for providing the Pim kinase inhibitors used in this study. This work was supported by the NIH P30-CA138313, DOD W81XWH-08-PCRP-IDA, R01 CA1732000, and American Cancer Society Institutional Research Grant awarded to the Hollings Cancer Center, Medical University of South Carolina.	Adam M, 2006, CANCER RES, V66, P3828, DOI 10.1158/0008-5472.CAN-05-2309; Agrawal S, 2008, LEUKEMIA, V22, P78, DOI 10.1038/sj.leu.2404988; Beharry Z, 2011, P NATL ACAD SCI USA, V108, P528, DOI 10.1073/pnas.1013214108; Bhalla K, 2011, CANCER RES, V71, P6888, DOI 10.1158/0008-5472.CAN-11-1011; Cai HJ, 2012, CANCER RES, V72, P4672, DOI 10.1158/0008-5472.CAN-12-0228; COMPERE SJ, 1989, P NATL ACAD SCI USA, V86, P2224, DOI 10.1073/pnas.86.7.2224; de Groof AJC, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-54; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Diaz F, 2012, HUM MOL GENET, V21, P5066, DOI 10.1093/hmg/dds350; GAETANI GF, 1989, BLOOD, V73, P334; Gaglio D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.56; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Garcia PD, 2014, CLIN CANCER RES, V20, P1834, DOI 10.1158/1078-0432.CCR-13-2062; Gomez-Duran A, 2012, BBA-MOL BASIS DIS, V1822, P1216, DOI 10.1016/j.bbadis.2012.04.014; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Kim KT, 2005, BLOOD, V105, P1759, DOI 10.1182/blood-2004-05-2006; Langley RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005893; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Liu W, 2012, P NATL ACAD SCI USA, V109, P8983, DOI 10.1073/pnas.1203244109; Lu J, 2013, BLOOD, V122, P1610, DOI 10.1182/blood-2013-01-481457; Menssen A, 2012, P NATL ACAD SCI USA, V109, pE187, DOI 10.1073/pnas.1105304109; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; Podsypanina K, 2008, P NATL ACAD SCI USA, V105, P5242, DOI 10.1073/pnas.0801197105; Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Song JH, 2006, J NEUROSCI, V26, P3299, DOI 10.1523/JNEUROSCI.5572-05.2006; Song JH, 2012, CANCER RES, V72, P294, DOI 10.1158/0008-5472.CAN-11-3240; Soucek L, 2013, GENE DEV, V27, P504, DOI 10.1101/gad.205542.112; Telang S, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-77; Tran PT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002125; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; VERBEEK S, 1991, MOL CELL BIOL, V11, P1176, DOI 10.1128/MCB.11.2.1176; Wang J, 2012, ONCOGENE, V31, P1794, DOI 10.1038/onc.2011.371; Wang JB, 2010, CANCER CELL, P18207; Wasik AM, 2013, SCI REP-UK, V3, DOI [10.1038/srep01400, 10.1038/srep02007]; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Weiner J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040221; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Ziegler M, 2000, EUR J BIOCHEM, V267, P1550, DOI 10.1046/j.1432-1327.2000.01187.x	45	26	26	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2015	34	28					3728	3736		10.1038/onc.2014.306	http://dx.doi.org/10.1038/onc.2014.306			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM4TZ	25241892	Green Accepted			2022-12-25	WOS:000357679100010
J	Daiho, T; Yamasaki, K; Danko, S; Suzuki, H				Daiho, Takashi; Yamasaki, Kazuo; Danko, Stefania; Suzuki, Hiroshi			Second Transmembrane Helix (M2) and Long Range Coupling in Ca2+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; ADP-INSENSITIVE PHOSPHOENZYME; STABLE STRUCTURAL ANALOG; CA2+ TRANSPORT ACTIVITY; CALCIUM-PUMP; CRYSTAL-STRUCTURE; PHOSPHORYLATED INTERMEDIATE; ADENOSINE-TRIPHOSPHATASE; ANGSTROM RESOLUTION; KINETIC-PROPERTIES	The actuator (A) domain of sarco(endo) plasmic reticulum Ca2+-ATPase not only plays a catalytic role but also undergoes large rotational movements that influence the distant transport sites through connections with transmembrane helices M1 and M2. Here we explore the importance of long helix M2 and its junction with the A domain by disrupting the helix structure and elongating with insertions of five glycine residues. Insertions into the membrane region of M2 and the top junctional segment impair Ca2+ transport despite reasonable ATPase activity, indicating that they are uncoupled. These mutants fail to occlude Ca2+. Those at the top segment also exhibited accelerated phosphoenzyme isomerization E1P -> E2P. Insertions into the middle of M2 markedly accelerate E2P hydrolysis and cause strong resistance to inhibition by luminal Ca2+. Insertions along almost the entire M2 region inhibit the dephosphorylated enzyme transition E2 -> E1. The results pinpoint which parts of M2 control cytoplasm gating and which are critical for luminal gating at each stage in the transport cycle and suggest that proper gate function requires appropriate interactions, tension, and/or rigidity in the M2 region at appropriate times for coupling with A domain movements and catalysis.	[Daiho, Takashi; Yamasaki, Kazuo; Danko, Stefania; Suzuki, Hiroshi] Asahikawa Med Univ, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan	Asahikawa Medical College	Daiho, T (corresponding author), Asahikawa Med Univ, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan.	daiho@asahikawa-med.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [23370058] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research C (to T. D.) and B (to H. S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Abe K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1154; Bublitz M, 2010, CURR OPIN STRUC BIOL, V20, P431, DOI 10.1016/j.sbi.2010.06.007; Daiho T, 1999, J BIOL CHEM, V274, P23910, DOI 10.1074/jbc.274.34.23910; Daiho T, 2003, J BIOL CHEM, V278, P39197, DOI 10.1074/jbc.M305200200; Daiho T, 1999, FEBS LETT, V444, P54, DOI 10.1016/S0014-5793(99)00027-7; Daiho T, 2001, J BIOL CHEM, V276, P32771, DOI 10.1074/jbc.M101229200; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Daiho T, 2010, J BIOL CHEM, V285, P24538, DOI 10.1074/jbc.M110.144535; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2009, J BIOL CHEM, V284, P22722, DOI 10.1074/jbc.M109.029702; DEMEIS L, 1980, BIOCHEMISTRY-US, V19, P4252, DOI 10.1021/bi00559a017; DEMEIS L, 1982, J BIOL CHEM, V257, P1289; Einholm AP, 2004, J BIOL CHEM, V279, P15888, DOI 10.1074/jbc.M400158200; Garnett C, 1996, BIOCHEMISTRY-US, V35, P11019, DOI 10.1021/bi960718k; HANEL AM, 1991, BIOCHEMISTRY-US, V30, P11320, DOI 10.1021/bi00111a019; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYTTON J, 1991, J BIOL CHEM, V266, P17067; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; NAKAMURA Y, 1984, J BIOL CHEM, V259, P8183; NAKAMURA Y, 1986, J BIOL CHEM, V261, P3090; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; PRAGER R, 1979, EUR J BIOCHEM, V97, P239, DOI 10.1111/j.1432-1033.1979.tb13108.x; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; Sato K, 2004, J BIOL CHEM, V279, P35595, DOI 10.1074/jbc.M404887200; SHIGEKAWA M, 1978, J BIOL CHEM, V253, P1451; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Wang GL, 2005, J BIOL CHEM, V280, P26508, DOI 10.1074/jbc.M503789200; WEBER K, 1969, J BIOL CHEM, V244, P4406; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Xu C, 2008, J BIOL CHEM, V283, P3297, DOI 10.1074/jbc.M706315200; Yamasaki K, 2004, J BIOL CHEM, V279, P2202, DOI 10.1074/jbc.M309398200; Yamasaki K, 2008, J BIOL CHEM, V283, P29144, DOI 10.1074/jbc.M804596200	49	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31241	31252		10.1074/jbc.M114.584086	http://dx.doi.org/10.1074/jbc.M114.584086			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25246522	Green Published, hybrid			2022-12-25	WOS:000344549900029
J	den Hartigh, LJ; Wang, SR; Goodspeed, L; Ding, YL; Averill, M; Subramanian, S; Wietecha, T; O'Brien, KD; Chait, A				den Hartigh, Laura J.; Wang, Shari; Goodspeed, Leela; Ding, Yilei; Averill, Michelle; Subramanian, Savitha; Wietecha, Tomasz; O'Brien, Kevin D.; Chait, Alan			Deletion of Serum Amyloid A3 Improves High Fat High Sucrose Diet-Induced Adipose Tissue Inflammation and Hyperlipidemia in Female Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CELLULAR CHOLESTEROL EFFLUX; CORONARY-ARTERY-DISEASE; RECEPTOR-DEFICIENT MICE; LDL RECEPTOR; GENE FAMILY; MACROPHAGE ACCUMULATION; SECONDARY AMYLOIDOSIS; HUMAN MONOCYTES; CCL2 PRODUCTION	Serum amyloid A (SAA) increases in response to acute inflammatory stimuli and is modestly and chronically elevated in obesity. SAA3, an inducible form of SAA, is highly expressed in adipose tissue in obese mice where it promotes monocyte chemotaxis, providing a mechanism for the macrophage accumulation that occurs with adipose tissue expansion in obesity. Humans do not express functional SAA3 protein, but instead express SAA1 and SAA2 in hepatic as well as extrahepatic tissues, making it difficult to distinguish between liver and adipose tissue- specific SAA effects. SAA3 does not circulate in plasma, but may exert local effects that impact systemic inflammation. We tested the hypothesis that SAA3 contributes to chronic systemic inflammation and adipose tissue macrophage accumulation in obesity using mice deficient for Saa3 (Saa3(-/-)). Mice were rendered obese by feeding a pro- inflammatory high fat, high sucrose diet with added cholesterol (HFHSC). Both male and female Saa3(-/-) mice gained less weight on the HFHSC diet compared to Saa3(+/+) littermate controls, with no differences in body composition or resting metabolism. Female Saa3(-/-) mice, but not males, had reduced HFHSC diet- induced adipose tissue inflammation and macrophage content. Both male and female Saa3(-/-) mice had reduced liver Saa1 and Saa2 expression in association with reduced plasma SAA. Additionally, female Saa3(-/-) mice, but not males, showed improved plasma cholesterol, triglycerides, and lipoprotein profiles, with no changes in glucose metabolism. Taken together, these results suggest that the absence of Saa3 attenuates liver- specific SAA (i.e., SAA1/2) secretion into plasma and blunts weight gain induced by an obesogenic diet. Furthermore, adipose tissue- specific inflammation and macrophage accumulation are attenuated in female Saa3(-/-) mice, suggesting a novel sexually dimorphic role for this protein. These results also suggest that Saa3 influences liver- specific SAA1/2 expression, and that SAA3 could play a larger role in the acute phase response than previously thought.	[den Hartigh, Laura J.; Wang, Shari; Goodspeed, Leela; Ding, Yilei; Averill, Michelle; Subramanian, Savitha; Chait, Alan] Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA; [Wietecha, Tomasz; O'Brien, Kevin D.] Univ Washington, Dept Med, Div Cardiol, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	den Hartigh, LJ (corresponding author), Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA.	ljdenhartigh@gmail.com	O'Brien, Kevin Douglas/HDO-1461-2022; O'Brien, Kevin/CAH-4638-2022	O'Brien, Kevin Douglas/0000-0002-2293-9196; O'Brien, Kevin/0000-0002-2293-9196; Subramanian, Savitha/0000-0002-4866-2009	University of Washington Nutrition Obesity Research Center [NIDDK P30 DK035816]; Experimental Pathology of Cardiovascular Disease Training Grant [T32 HL007312];  [K01 AT007177-01];  [P01 HL092969];  [R01 HL094352]; National Center for Complementary & Integrative Health [K01AT007177] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094352, T32HL007312, T32HL007028, P01HL092969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK035816, P30DK017047] Funding Source: NIH RePORTER	University of Washington Nutrition Obesity Research Center; Experimental Pathology of Cardiovascular Disease Training Grant; ; ; ; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the University of Washington Nutrition Obesity Research Center (NIDDK P30 DK035816) (LJD), Experimental Pathology of Cardiovascular Disease Training Grant (T32 HL007312) (LJD), K01 AT007177-01 (LJD), P01 HL092969 (LJD, SW, LG, YD, MMA, SS, AC), and R01 HL094352 (LJD, SW, LG, YE, MMA, SS, AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlin S, 2014, AREA, V9; Ahlin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095468; Ahlin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072204; Alam I, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/456456; Ando H, 2004, LIFE SCI, V74, P1817, DOI 10.1016/j.lfs.2003.09.045; [Anonymous], PLOS ONE, V8; Artl A, 2000, ARTERIOSCL THROM VAS, V20, P763, DOI 10.1161/01.ATV.20.3.763; BADOLATO R, 1995, J IMMUNOL, V155, P4004; BADOLATO R, 1994, J EXP MED, V180, P203, DOI 10.1084/jem.180.1.203; BANKA CL, 1995, J LIPID RES, V36, P1058; BENDITT EP, 1989, J EXP MED, V169, P1841, DOI 10.1084/jem.169.5.1841; BENDITT EP, 1977, P NATL ACAD SCI USA, V74, P4025, DOI 10.1073/pnas.74.9.4025; Chiba T, 2009, J LIPID RES, V50, P1353, DOI 10.1194/jlr.M900089-JLR200; Christodoulakos GE, 2007, ATHEROSCLEROSIS, V193, P142, DOI 10.1016/j.atherosclerosis.2006.05.045; Davis KE, 2013, MOL METAB, V2, P227, DOI 10.1016/j.molmet.2013.05.006; De Beer MC, 2014, ARTERIOSCL THROM VAS, V34, P255, DOI 10.1161/ATVBAHA.113.302247; Denis GV, 2013, MOL ASPECTS MED, V34, P59, DOI 10.1016/j.mam.2012.10.004; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fyfe AI, 1997, CIRCULATION, V96, P2914, DOI 10.1161/01.CIR.96.9.2914; Han CY, 2007, DIABETES, V56, P2260, DOI 10.2337/db07-0218; Hollenbach E, 2004, FASEB J, V18, P1550, DOI 10.1096/fj.04-1642fje; Johnson BD, 2004, CIRCULATION, V109, P726, DOI 10.1161/01.CIR.0000115516.54550.B1; KISILEVSKY R, 1992, LAB INVEST, V66, P778; KLUVEBECKERMAN B, 1991, DNA CELL BIOL, V10, P651, DOI 10.1089/dna.1991.10.651; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Krementsov DN, 2014, ANN NEUROL, V75, P50, DOI 10.1002/ana.24020; Lee HY, 2008, J IMMUNOL, V181, P4332, DOI 10.4049/jimmunol.181.6.4332; Lee HY, 2010, EXP MOL MED, V42, P302, DOI 10.3858/emm.2010.42.4.029; Lewis KE, 2004, CIRCULATION, V110, P540, DOI 10.1161/01.CIR.0000136819.93989.E1; Li Y, 2011, ONCOGENE, V30, P3887, DOI 10.1038/onc.2011.112; Liang TS, 2000, BIOCHEM BIOPH RES CO, V270, P331, DOI 10.1006/bbrc.2000.2416; Lin Y, 2001, J BIOL CHEM, V276, P42077, DOI 10.1074/jbc.M107101200; Lindhorst E, 1997, BBA-PROTEIN STRUCT M, V1339, P143, DOI 10.1016/S0167-4838(96)00227-0; Liverton NJ, 1999, J MED CHEM, V42, P2180, DOI 10.1021/jm9805236; LOWELL CA, 1986, J BIOL CHEM, V261, P8442; Matsen ME, 2013, AM J PHYSIOL-ENDOC M, V304, pE734, DOI 10.1152/ajpendo.00488.2012; MCADAM KPWJ, 1976, J EXP MED, V144, P1121, DOI 10.1084/jem.144.4.1121; McLean J., 1987, ANIMAL HUMAN CALORIM; MEEK RL, 1986, J EXP MED, V164, P2006, DOI 10.1084/jem.164.6.2006; Migita K, 1996, LAB INVEST, V75, P371; Montes VN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067709; Morton GJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE392, DOI 10.1152/ajpendo.00546.2010; Muller S, 2002, DIABETOLOGIA, V45, P805, DOI 10.1007/s00125-002-0829-2; O'Hara R, 2000, ARTHRITIS RES, V2, P142, DOI 10.1186/ar78; Pettersson US, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046057; Poitou C, 2005, DIABETOLOGIA, V48, P519, DOI 10.1007/s00125-004-1654-6; Poitou C, 2006, OBESITY, V14, P309, DOI 10.1038/oby.2006.40; Register TC, 2005, J CLIN ENDOCR METAB, V90, P1734, DOI 10.1210/jc.2004-0939; Reigstad CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005842; Ryan AS, 2014, J AM GERIATR SOC, V62, P607, DOI 10.1111/jgs.12749; Scheja L, 2008, EXP DIABETES RES, DOI 10.1155/2008/230837; Schreyer SA, 2002, AM J PHYSIOL-ENDOC M, V282, pE207, DOI 10.1152/ajpendo.2002.282.1.E207; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Sjo holm K, 2005, J CLIN ENDOCR METAB, V90, P2233; Sjoholm K, 2009, CYTOKINE, V48, P260, DOI 10.1016/j.cyto.2009.08.005; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Subramanian S, 2008, ARTERIOSCL THROM VAS, V28, P685, DOI 10.1161/ATVBAHA.107.157685; Subramanian S, 2011, J LIPID RES, V52, P1626, DOI 10.1194/jlr.M016246; Subramanian V, 2009, NESTLE NUTR WORKS SE, V63, P151, DOI 10.1159/000209979; Tsun JGS, 2013, ATHEROSCLEROSIS, V231, P405, DOI 10.1016/j.atherosclerosis.2013.10.008; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; UHLAR CM, 1994, GENOMICS, V19, P228, DOI 10.1006/geno.1994.1052; van Dielen FMH, 2001, INT J OBESITY, V25, P1759, DOI 10.1038/sj.ijo.0801825; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246	65	53	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108564	10.1371/journal.pone.0108564	http://dx.doi.org/10.1371/journal.pone.0108564			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251243	Green Published, gold, Green Submitted			2022-12-25	WOS:000342492700142
J	Griffeth, RJ; Garcia-Parraga, D; Mellado-Lopez, M; Crespo-Picazo, JL; Soriano-Navarro, M; Martinez-Romero, A; Moreno-Manzano, V				Griffeth, Richard J.; Garcia-Parraga, Daniel; Mellado-Lopez, Maravillas; Luis Crespo-Picazo, Jose; Soriano-Navarro, Mario; Martinez-Romero, Alicia; Moreno-Manzano, Victoria			Platelet-Rich Plasma and Adipose-Derived Mesenchymal Stem Cells for Regenerative Medicine-Associated Treatments in Bottlenose Dolphins (Tursiops truncatus)	PLOS ONE			English	Article							GROWTH-FACTOR; PLASTIC-SURGERY; TISSUE-REPAIR; EFFICACY; EXPRESSION; TENDON; LIGAMENT; BIOLOGY; ULCERS; MATRIX	Dolphins exhibit an extraordinary capacity to heal deep soft tissue injuries. Nevertheless, accelerated wound healing in wild or captive dolphins would minimize infection and other side effects associated with open wounds in marine animals. Here, we propose the use of a biological-based therapy for wound healing in dolphins by the application of platelet-rich plasma (PRP). Blood samples were collected from 9 different dolphins and a specific and simple protocol which concentrates platelets greater than two times that of whole blood was developed. As opposed to a commonly employed human protocol for PRP preparation, a single centrifugation for 3 minutes at 900 rpm resulted in the best condition for the concentration of dolphin platelets. By FACS analysis, dolphin platelets showed reactivity to platelet cell-surface marker CD41. Analysis by electron microscopy revealed that dolphin platelets were larger in size than human platelets. These findings may explain the need to reduce the duration and speed of centrifugation of whole blood from dolphins to obtain a 2-fold increase and maintain proper morphology of the platelets. For the first time, levels of several growth factors from activated dolphin platelets were quantified. Compared to humans, concentrations of PDGF-BB were not different, while TGF beta and VEGF-A were significantly lower in dolphins. Additionally, adipose tissue was obtained from cadaveric dolphins found along the Spanish Mediterranean coast, and adipose-derived mesenchymal stem cells (ASCs) were successfully isolated, amplified, and characterized. When dolphin ASCs were treated with 2.5 or 5% dolphin PRP they exhibited significant increased proliferation and improved phagocytotic activity, indicating that in culture, PRP may improve the regenerative capacity of ASCs. Taken together, we show an effective and well-defined protocol for efficient PRP isolation. This protocol alone or in combination with ASCs, may constitute the basis of a biological treatment for wound-healing and tissue regeneration in dolphins.	[Griffeth, Richard J.; Mellado-Lopez, Maravillas; Moreno-Manzano, Victoria] Ctr Invest Principe Felipe, Tissue & Neuronal Regenerat Lab, Valencia, Spain; [Garcia-Parraga, Daniel; Luis Crespo-Picazo, Jose] Oceanog Grp Parques Reunidos, Valencia, Spain; [Mellado-Lopez, Maravillas] Ctr Invest Principe Felipe, Electron Microscopy Unit, Valencia, Spain; [Martinez-Romero, Alicia] Ctr Invest Principe Felipe, Cytom Unit, Valencia, Spain; [Mellado-Lopez, Maravillas; Moreno-Manzano, Victoria] FactorStem Ltd, Valencia, Spain	Prince Felipe Research Center; Prince Felipe Research Center; Prince Felipe Research Center	Moreno-Manzano, V (corresponding author), Ctr Invest Principe Felipe, Tissue & Neuronal Regenerat Lab, Valencia, Spain.	vmorenom@cipf.es	Martínez-Romero, Alicia/ABH-3160-2020; Moreno, Victoria/B-4175-2014; MELLADO LÓPEZ, MARAVILLAS/R-4535-2018	Martínez-Romero, Alicia/0000-0002-5197-0635; Moreno, Victoria/0000-0002-6035-9491; Mellado, Maravillas/0000-0002-6025-8383; Garcia Parraga, Daniel/0000-0002-3335-5831; Soriano Navarro, Mario/0000-0002-7245-2095; Crespo Picazo, Jose Luis/0000-0002-5216-044X	Spanish Ion Channel Initiative [CSD2008-00005]; Instituto de Salud Carlos III [PI10/01683, PI13/00319]	Spanish Ion Channel Initiative; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This study was supported by the Spanish Ion Channel Initiative (CSD2008-00005): VMM, and the Instituto de Salud Carlos III (PI10/01683 and PI13/00319): VMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; ANDREWS EJ, 1993, J AM VET MED ASSOC, V202, P230; Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440; Arenaz-Bua J, 2010, MED ORAL PATOL ORAL, V15, pE483, DOI 10.4317/medoral.15.e483; Bao Philip, 2009, J Surg Res, V153, P347, DOI 10.1016/j.jss.2008.04.023; Borrione P, 2010, AM J PHYS MED REHAB, V89, P854, DOI 10.1097/PHM.0b013e3181f1c1c7; Breen EC, 2007, J CELL BIOCHEM, V102, P1358, DOI 10.1002/jcb.21579; Cervelli V, 2009, TISSUE ENG PART C-ME, V15, P625, DOI [10.1089/ten.tec.2008.0518, 10.1089/ten.TEC.2008.0518]; Cho JW, 2012, INT J MOL MED, V29, P32, DOI 10.3892/ijmm.2011.803; Choi J, 2012, ARCH PLAST SURG-APS, V39, P585, DOI 10.5999/aps.2012.39.6.585; Close B, 1996, LAB ANIM-UK, V30, P293, DOI 10.1258/002367796780739871; de Almeida AM, 2012, AM J SPORT MED, V40, P1282, DOI 10.1177/0363546512441344; De La Mata J, 2013, REUMATOL CLIN, V9, P166, DOI [10.1016/j.reumae.2012.05.006, 10.1016/j.reuma.2012.05.011]; de Vos RJ, 2010, BRIT MED BULL, V95, P63, DOI 10.1093/bmb/ldq006; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Edmonds M, 2000, DIABETES-METAB RES, V16, pS51, DOI 10.1002/1520-7560(200009/10)16:1+<::AID-DMRR142>3.0.CO;2-S; Eggenhofer E, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-12; Eppley BL, 2006, PLAST RECONSTR SURG, V118, p147E, DOI 10.1097/01.prs.0000239606.92676.cf; Eskan MA, 2014, J PERIODONTOL, V85, P661, DOI 10.1902/jop.2013.130260; EZAKI N, 1983, J ANTIBIOT, V36, P1431, DOI 10.7164/antibiotics.36.1431; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Hausman GJ, 2004, J ANIM SCI, V82, P925; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hu ZM, 2009, ORAL SURG ORAL MED O, V107, P43, DOI 10.1016/j.tripleo.2008.06.023; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Janssens JCA, 2008, APPL ENVIRON MICROB, V74, P6639, DOI 10.1128/AEM.01262-08; Johnson SP, 2012, STEM CELLS DEV, V21, P2949, DOI 10.1089/scd.2012.0039; Kim DH, 2011, ANN DERMATOL, V23, P424, DOI 10.5021/ad.2011.23.4.424; Kostelijk EH, 1996, THROMB HAEMOSTASIS, V76, P1086; Li HS, 2013, ADV HEALTHC MATER, V2, P1277, DOI 10.1002/adhm.201200465; Lin CS, 2013, HISTOL HISTOPATHOL, V28, P1109, DOI 10.14670/HH-28.1109; Marx RE, 2004, J ORAL MAXIL SURG, V62, P489, DOI 10.1016/j.joms.2003.12.003; McGowen MR, 2012, P ROY SOC B-BIOL SCI, V279, P3643, DOI 10.1098/rspb.2012.0869; Niemeyer P, 2010, BIOMATERIALS, V31, P3572, DOI 10.1016/j.biomaterials.2010.01.085; Nikolidakis D, 2008, TISSUE ENG PART B-RE, V14, P249, DOI 10.1089/ten.teb.2008.0062; Pallua N, 2010, BURNS, V36, P4, DOI 10.1016/j.burns.2009.05.002; Paoloni J, 2011, CLIN J SPORT MED, V21, P37, DOI 10.1097/JSM.0b013e31820758c7; Perez Amanda G M, 2014, ISRN Hematol, V2014, P176060, DOI 10.1155/2014/176060; Perry BH, 2002, CONTROL CLIN TRIALS, V23, P389, DOI 10.1016/S0197-2456(02)00220-9; PIERCE GF, 1994, AM J PATHOL, V145, P1399; ROBINSON AJ, 1969, SCIENCE, V166, P1420, DOI 10.1126/science.166.3911.1420; Shen YX, 2009, MED HYPOTHESES, V73, P1038, DOI 10.1016/j.mehy.2009.05.021; Silva A, 2009, KNEE SURG SPORT TR A, V17, P676, DOI 10.1007/s00167-009-0762-8; Smiell JM, 1999, WOUND REPAIR REGEN, V7, P335, DOI 10.1046/j.1524-475X.1999.00335.x; Sommeling CE, 2013, J PLAST RECONSTR AES, V66, P301, DOI 10.1016/j.bjps.2012.11.009; Steed DL, 2006, PLAST RECONSTR SURG, V117, p143S, DOI 10.1097/01.prs.0000222526.21512.4c; Swift ME, 1999, LAB INVEST, V79, P1479; Tang YQ, 2002, INFECT IMMUN, V70, P6524, DOI 10.1128/IAI.70.12.6524-6533.2002; Taylor DW, 2011, CLIN J SPORT MED, V21, P344, DOI 10.1097/JSM.0b013e31821d0f65; Tibbs Rita F., 2005, Comparative Clinical Pathology, V14, P95, DOI 10.1007/s00580-005-0567-1; Venn-Watson S, 2011, GEN COMP ENDOCR, V170, P193, DOI 10.1016/j.ygcen.2010.10.005; Villela DL, 2010, GROWTH FACTORS, V28, P111, DOI 10.3109/08977190903468185; Wu CC, 2012, J SEX MED, V9, P2838, DOI 10.1111/j.1743-6109.2012.02881.x; Zasloff M, 2011, J INVEST DERMATOL, V131, P2503, DOI 10.1038/jid.2011.220; Zhang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067303; Zimmermann R, 2003, VOX SANG, V85, P283, DOI 10.1111/j.0042-9007.2003.00361.x	57	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108439	10.1371/journal.pone.0108439	http://dx.doi.org/10.1371/journal.pone.0108439			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251412	Green Published, Green Submitted, gold			2022-12-25	WOS:000342492700125
J	Kamimura, K; Kanefuji, T; Yokoo, T; Abe, H; Suda, T; Kobayashi, Y; Zhang, G; Aoyagi, Y; Liu, D				Kamimura, Kenya; Kanefuji, Tsutomu; Yokoo, Takeshi; Abe, Hiroyuki; Suda, Takeshi; Kobayashi, Yuji; Zhang, Guisheng; Aoyagi, Yutaka; Liu, Dexi			Safety Assessment of Liver-Targeted Hydrodynamic Gene Delivery in Dogs	PLOS ONE			English	Article							HUMAN-FACTOR-IX; NAKED PLASMID DNA; IN-VIVO; PIG-LIVER; IMMUNE ACTIVATION; NONHUMAN-PRIMATES; CATHETER DELIVERY; LONG-TERM; THERAPY; EXPRESSION	Evidence in support of safety of a gene delivery procedure is essential toward gene therapy. Previous studies using the hydrodynamics-based procedure primarily focus on gene delivery efficiency or gene function analysis in mice. The current study focuses on an assessment of the safety of computer-controlled and liver-targeted hydrodynamic gene delivery in dogs as the first step toward hydrodynamic gene therapy in clinic. We demonstrate that the impacts of the hydrodynamic procedure were limited in the injected region and the influences were transient. Histological examination and the hepatic microcirculation measurement using reflectance spectrophotometry reveal that the liver-specific impact of the procedure involves a transient expansion of the liver sinusoids. No systemic damage or toxicity was observed. Physiological parameters, including electrocardiogram, heart rate, blood pressure, oxygen saturation, and body temperature, remained in normal ranges during and after hydrodynamic injection. Body weight was also examined to assess the long-term effects of the procedure in animals who underwent 3 hydrodynamic injections in 6 weeks with 2-week time interval in between. Serum biochemistry analysis showed a transient increase in liver enzymes and a few cytokines upon injection. These results demonstrate that image-guided, liver-specific hydrodynamic gene delivery is safe.	[Kamimura, Kenya; Kanefuji, Tsutomu; Yokoo, Takeshi; Abe, Hiroyuki; Suda, Takeshi; Kobayashi, Yuji; Aoyagi, Yutaka] Niigata Univ, Grad Sch Med & Dent Sci, Div Gastroenterol & Hepatol, Niigata, Japan; [Zhang, Guisheng; Liu, Dexi] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA	Niigata University; University System of Georgia; University of Georgia	Kamimura, K (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Gastroenterol & Hepatol, Niigata, Japan.	kenya-k@med.niigata-u.ac.jp; dliu@uga.edu	Kamimura, Kenya/U-6797-2019	Yokoo, Takeshi/0000-0001-7138-1785	Japanese Society for the Promotion of Sciences [22890064, 23790595, 26860354]; Takara Bio Research Grant from JSGT; Adaptable and Seamless Technology Transfer Program through target-driven R D, JST [AS251Z01854P]; National Institute of Health [EB002946, HL075542]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002946] Funding Source: NIH RePORTER	Japanese Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takara Bio Research Grant from JSGT; Adaptable and Seamless Technology Transfer Program through target-driven R D, JST; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported in part by Grant-in-Aid for Scientific Research from Japanese Society for the Promotion of Sciences 22890064, 23790595, 26860354, and Takara Bio Research Grant from JSGT, and Adaptable and Seamless Technology Transfer Program through target-driven R & D, JST (AS251Z01854P) to KK, and from the National Institute of Health (EB002946 and HL075542) to DL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alino SF, 2007, GENE THER, V14, P334, DOI 10.1038/sj.gt.3302873; Bonamassa B, 2011, PHARM RES-DORDR, V28, P694, DOI 10.1007/s11095-010-0338-9; Brunetti-Pierri N, 2007, MOL THER, V15, P732, DOI 10.1038/sj.mt.6300102; Brunetti-Pierri N, 2012, MOL THER, V20, P1863, DOI 10.1038/mt.2012.143; Brunetti-Pierri N, 2009, MOL THER, V17, P327, DOI 10.1038/mt.2008.257; Carreno O, 2013, EUR SURG RES, V51, P47, DOI 10.1159/000351339; Colombo PP, 2009, RIV PSICHIATR, V44, P15; Eastman SJ, 2002, HUM GENE THER, V13, P2065, DOI 10.1089/10430340260395910; Fabre JW, 2008, GENE THER, V15, P452, DOI 10.1038/sj.gt.3303079; Fedorov A, 2014, J VASC INTERV RADIOL, V25, P789, DOI 10.1016/j.jvir.2013.11.031; German AJ, 2009, DOMEST ANIM ENDOCRIN, V37, P214, DOI 10.1016/j.domaniend.2009.07.001; Ginn SL, 2013, J GENE MED, V15, P65, DOI 10.1002/jgm.2698; Hong KH, 2005, BLOOD, V105, P1405, DOI 10.1182/blood-2004-08-3178; Huang TP, 1997, HEPATOLOGY, V26, P336, DOI 10.1002/hep.510260213; Kamimura K, 2013, JSM GASTROENTEROL HE, V1, P1005; Kamimura K, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.52; Kamimura Kenya, 2011, Pharmaceut Med, V25, P293; Kamimura K, 2010, MOL THER, V18, P93, DOI 10.1038/mt.2009.206; Kamimura K, 2009, MOL THER, V17, P491, DOI 10.1038/mt.2008.294; Kamimura K, 2008, AAPS J, V10, P589, DOI 10.1208/s12248-008-9067-y; Khorsandi SE, 2008, CANCER GENE THER, V15, P225, DOI 10.1038/sj.cgt.7701119; Kim JY, 2007, MOL CELLS, V24, P247; Liakouli V, 2011, AUTOIMMUN REV, V10, P590, DOI 10.1016/j.autrev.2011.04.019; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Miao CH, 2005, HUM GENE THER, V16, P893, DOI 10.1089/hum.2005.16.893; Miao CH, 2003, HUM GENE THER, V14, P1297, DOI 10.1089/104303403322319381; Miao CH, 2001, MOL THER, V3, P947, DOI 10.1006/mthe.2001.0333; Racz Z, 2011, NUCLEIC ACID THER, V21, P215, DOI 10.1089/nat.2010.0248; Suda T, 2008, MOL THER, V16, P1098, DOI 10.1038/mt.2008.66; Suda T, 2007, MOL THER, V15, P2063, DOI 10.1038/sj.mt.6300314; Szczepaniak WS, 2008, TRANSL RES, V152, P213, DOI 10.1016/j.trsl.2008.09.002; Tedgui A, 2001, CIRC RES, V88, P877, DOI 10.1161/hh0901.090440; Vrekoussis T, 2009, ANTICANCER RES, V29, P4995; Yokoo T, 2013, GENE THER, V20, P816, DOI 10.1038/gt.2013.2; Yoshino H, 2006, GENE THER, V13, P1696, DOI 10.1038/sj.gt.3302833; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734	36	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107203	10.1371/journal.pone.0107203	http://dx.doi.org/10.1371/journal.pone.0107203			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251246	Green Published, gold, Green Submitted			2022-12-25	WOS:000342492700023
J	Berliner, N; Teyra, J; Colak, R; Lopez, SG; Kim, PM				Berliner, Niklas; Teyra, Joan; Colak, Recep; Garcia Lopez, Sebastian; Kim, Philip M.			Combining Structural Modeling with Ensemble Machine Learning to Accurately Predict Protein Fold Stability and Binding Affinity Effects upon Mutation	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; AMINO-ACID SUBSTITUTIONS; HOT-SPOTS; SOMATIC MUTATIONS; HUMAN GENOME; WEB SERVER; CANCER; ENERGY; EVOLUTION; SEQUENCE	Advances in sequencing have led to a rapid accumulation of mutations, some of which are associated with diseases. However, to draw mechanistic conclusions, a biochemical understanding of these mutations is necessary. For coding mutations, accurate prediction of significant changes in either the stability of proteins or their affinity to their binding partners is required. Traditional methods have used semi-empirical force fields, while newer methods employ machine learning of sequence and structural features. Here, we show how combining both of these approaches leads to a marked boost in accuracy. We introduce ELASPIC, a novel ensemble machine learning approach that is able to predict stability effects upon mutation in both, domain cores and domain-domain interfaces. We combine semi-empirical energy terms, sequence conservation, and a wide variety of molecular details with a Stochastic Gradient Boosting of Decision Trees (SGB-DT) algorithm. The accuracy of our predictions surpasses existing methods by a considerable margin, achieving correlation coefficients of 0.77 for stability, and 0.75 for affinity predictions. Notably, we integrated homology modeling to enable proteome-wide prediction and show that accurate prediction on modeled structures is possible. Lastly, ELASPIC showed significant differences between various types of disease-associated mutations, as well as between disease and common neutral mutations. Unlike pure sequence-based prediction methods that try to predict phenotypic effects of mutations, our predictions unravel the molecular details governing the protein instability, and help us better understand the molecular causes of diseases.	[Berliner, Niklas; Teyra, Joan; Colak, Recep; Garcia Lopez, Sebastian; Kim, Philip M.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res CCBR, Toronto, ON, Canada; [Kim, Philip M.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Colak, Recep; Kim, Philip M.] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Garcia Lopez, Sebastian] Univ Nacl Colombia, Manizales, Colombia	University of Toronto; University of Toronto; University of Toronto; Universidad Nacional de Colombia	Kim, PM (corresponding author), Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res CCBR, Toronto, ON, Canada.	pi@kimlab.org			Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC [386671]; NSERC PGS-D fellowship	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC PGS-D fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC))	Disorder predictions were performed on the gpc supercomputer at the SciNet HPC Consortium. The authors acknowledge support from the Natural Sciences and Engineering Research Council of Canada (NSERC). PMK acknowledges support from a NSERC Discovery Grant (#386671) and RC from a NSERC PGS-D fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agius R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003216; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andreani J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002677; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bava KA, 2004, NUCLEIC ACIDS RES, V32, pD120, DOI 10.1093/nar/gkh082; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bromberg Y, 2008, BIOINFORMATICS, V24, P2397, DOI 10.1093/bioinformatics/btn435; Caffrey DR, 2004, PROTEIN SCI, V13, P190, DOI 10.1110/ps.03323604; Capriotti E, 2005, BIOINFORMATICS, V21, P54, DOI 10.1093/bioinformatics/bti1109; Capriotti E, 2004, BIOINFORMATICS, V20, P63, DOI 10.1093/bioinformatics/bth928; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Cavallo L, 2003, NUCLEIC ACIDS RES, V31, P3364, DOI 10.1093/nar/gkg601; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Colak R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003030; David A, 2012, HUM MUTAT, V33, P359, DOI 10.1002/humu.21656; De Baets G, 2012, NUCLEIC ACIDS RES, V40, pD935, DOI 10.1093/nar/gkr996; Dehouck Y, 2013, NUCLEIC ACIDS RES, V41, pW333, DOI 10.1093/nar/gkt450; Dehouck Y, 2009, BIOINFORMATICS, V25, P2537, DOI 10.1093/bioinformatics/btp445; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Emahazion T, 2001, TRENDS GENET, V17, P407, DOI 10.1016/S0168-9525(01)02342-3; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Funahashi J, 2003, PROTEIN ENG, V16, P665, DOI 10.1093/protein/gzg083; Gonnelli G, 2012, J BIOTECHNOL, V161, P287, DOI 10.1016/j.jbiotec.2012.06.020; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hagmann M, 1999, SCIENCE, V285, P21; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Masso M, 2008, BIOINFORMATICS, V24, P2002, DOI 10.1093/bioinformatics/btn353; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Mirny LA, 1998, P NATL ACAD SCI USA, V95, P4976, DOI 10.1073/pnas.95.9.4976; Moal IH, 2012, BIOINFORMATICS, V28, P2600, DOI 10.1093/bioinformatics/bts489; Moretti R, 2013, PROTEINS, V81, P1980, DOI 10.1002/prot.24356; Mosca R, 2013, NAT METHODS, V10, P47, DOI [10.1038/NMETH.2289, 10.1038/nmeth.2289]; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Nishi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066273; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Potapov V, 2009, PROTEIN ENG DES SEL, V22, P553, DOI 10.1093/protein/gzp030; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Saunders CT, 2002, J MOL BIOL, V322, P891, DOI 10.1016/S0022-2836(02)00813-6; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Taylor WR, 2000, NATURE, V406, P916, DOI 10.1038/35022623; Team R, 2004, R LANG ENV STAT COMP; Teng SL, 2009, BIOPHYS J, V96, P2178, DOI 10.1016/j.bpj.2008.12.3904; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Teyra J, 2007, PROTEINS, V67, P1087, DOI 10.1002/prot.21394; Teyra J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-398; Tian JA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-370; Torkamani A, 2009, CANCER LETT, V281, P117, DOI 10.1016/j.canlet.2008.11.008; Wainreb G, 2011, BIOINFORMATICS, V27, P3286, DOI 10.1093/bioinformatics/btr576; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Yin S, 2007, STRUCTURE, V15, P1567, DOI 10.1016/j.str.2007.09.024; YUNYU S, 1993, PROTEIN ENG, V6, P289, DOI 10.1093/protein/6.3.289; Zhang Z, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/805827; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	75	53	54	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107353	10.1371/journal.pone.0107353	http://dx.doi.org/10.1371/journal.pone.0107353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243403	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800030
J	Chung, WJ; Cui, YJ; Huang, FYJ; Tu, TH; Yang, TS; Lo, JM; Chiang, CS; Hsu, IC				Chung, Wei-Ju; Cui, Yujia; Huang, Feng-Yun J.; Tu, Tzu-Hui; Yang, Tzu-Sen; Lo, Jem-Mau; Chiang, Chi-Shiun; Hsu, Ian C.			Tc-99m Pyrene Derivative Complex Causes Double-Strand Breaks in dsDNA Mainly through Cluster-Mediated Indirect Effect in Aqueous Solution	PLOS ONE			English	Article							AUGER ELECTRONS; DNA-DAMAGE; MECHANISMS	Radiation therapy for cancer patients works by ionizing damage to nuclear DNA, primarily by creating double-strand breaks (DSB). A major shortcoming of traditional radiation therapy is the set of side effect associated with its long-range interaction with nearby tissues. Low-energy Auger electrons have the advantage of an extremely short effective range, minimizing damage to healthy tissue. Consequently, the isotope Tc-99m, an Auger electron source, is currently being studied for its beneficial potential in cancer treatment. We examined the dose effect of a pyrene derivative Tc-99m complex on plasmid DNA by using gel electrophoresis in both aqueous and methanol solutions. In aqueous solutions, the average yield per decay for double-strand breaks is 0.011 +/- 0.005 at low dose range, decreasing to 0.0005 +/- 0.0003 in the presence of 1 M dimethyl sulfoxide (DMSO). The apparent yield per decay for single-strand breaks (SSB) is 0.04 +/- 0.02, decreasing to approximately a fifth with 1 M DMSO. In methanol, the average yield per decay of DSB is 0.54 +/- 0.06 and drops to undetectable levels in 2 M DMSO. The SSB yield per decay is 7.2 +/- 0.2, changing to 0.4 +/- 0.2 in the presence of 2 M DMSO. The 95% decrease in the yield of DSB in DMSO indicates that the main mechanism for DSB formation is through indirect effect, possibly by cooperative binding or clustering of intercalators. In the presence of non-radioactive ligands at a near saturation concentration, where radioactive Tc compounds do not form large clusters, the yield of SSB stays the same while the yield of DSB decreases to the value in DMSO. DSBs generated by Tc-99m conjugated to intercalators are primarily caused by indirect effects through clustering.	[Chung, Wei-Ju; Cui, Yujia; Huang, Feng-Yun J.; Tu, Tzu-Hui; Lo, Jem-Mau; Chiang, Chi-Shiun; Hsu, Ian C.] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Yang, Tzu-Sen] Taipei Med Univ, Coll Oral Med, Sch Dent Technol, Taipei, Taiwan	National Tsing Hua University; Taipei Medical University	Cui, YJ (corresponding author), Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.	yjcui@mx.nthu.edu.tw; ichsu@mx.nthu.edu.tw	Chiang, Chi-Shiun/A-9562-2008	Chiang, Chi-Shiun/0000-0002-2581-4129	National Science Council, Taiwan [NSC 101-2112-M-007-003-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The authors would like to thank the National Science Council, Taiwan, for supporting this research financially under Contract (grant number: NSC 101-2112-M-007-003-MY3, http://web1.most.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balagurumoorthy P, 2008, RADIAT RES, V170, P70, DOI 10.1667/RR1072.1; Balagurumoorthy P, 2006, RADIAT RES, V166, P333, DOI 10.1667/RR3591.1; Balagurumoorthy P, 2012, INT J RADIAT BIOL, V88, P998, DOI 10.3109/09553002.2012.706360; COWAN R, 1987, J THEOR BIOL, V127, P229, DOI 10.1016/S0022-5193(87)80133-9; Eccles LJ, 2011, MUTAT RES-FUND MOL M, V711, P134, DOI 10.1016/j.mrfmmm.2010.11.003; Esteves T, 2011, J BIOL INORG CHEM, V16, P1141, DOI 10.1007/s00775-011-0803-x; Esteves T, 2010, ORG BIOMOL CHEM, V8, P4104, DOI 10.1039/c0ob00073f; Ftacnikova S, 2000, RADIAT PROT DOSIM, V92, P269, DOI 10.1093/oxfordjournals.rpd.a033292; Hada M, 2008, J RADIAT RES, V49, P203, DOI 10.1269/jrr.07123; Haefliger P, 2005, BIOCONJUGATE CHEM, V16, P582, DOI 10.1021/bc0500084; Hafliger P, 2005, CHEMBIOCHEM, V6, P414, DOI 10.1002/cbic.200400210; HUMM JL, 1989, INT J RADIAT ONCOL, V17, P351, DOI 10.1016/0360-3016(89)90450-1; Jin Y, 2005, J AM CHEM SOC, V127, P8408, DOI 10.1021/ja0503985; Kandaiya IS, 1996, ACTA ONCOL, V35, P803; De Mattos JCP, 2012, MOLECULES, V17, P12974, DOI 10.3390/molecules171112974; Shikazono N, 2009, J RADIAT RES, V50, P27, DOI 10.1269/jrr.08086; Sutherland BM, 2001, RADIAT PROT DOSIM, V97, P33, DOI 10.1093/oxfordjournals.rpd.a006635; Tavares AAS, 2010, MED PHYS, V37, P3551, DOI 10.1118/1.3451117; Trieb M, 2004, NUCLEIC ACIDS RES, V32, P4696, DOI 10.1093/nar/gkh788; Trotta E, 1996, J BIOL CHEM, V271, P27608, DOI 10.1074/jbc.271.44.27608; Vitor RF, 2009, CANCER BIOTHER RADIO, V24, P551, DOI 10.1089/cbr.2009.0647; ZEHFUS MH, 1984, BIOPOLYMERS, V23, P1269, DOI 10.1002/bip.360230711	22	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e108162	10.1371/journal.pone.0108162	http://dx.doi.org/10.1371/journal.pone.0108162			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244160	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800073
J	Gallant, KMH; Gallant, MA; Brown, DM; Sato, AY; Williams, JN; Burr, DB				Gallant, Kathleen M. Hill; Gallant, Maxime A.; Brown, Drew M.; Sato, Amy Y.; Williams, Justin N.; Burr, David B.			Raloxifene Prevents Skeletal Fragility in Adult Female Zucker Diabetic Sprague-Dawley Rats	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; VERTEBRAL FRACTURE RISK; POSTMENOPAUSAL WOMEN; RODENT MODELS; MECHANICAL-PROPERTIES; GLYCEMIC CONTROL; HIP FRACTURE; BONE-DENSITY; TYPE-2; ALENDRONATE	Fracture risk in type 2 diabetes is increased despite normal or high bone mineral density, implicating poor bone quality as a risk factor. Raloxifene improves bone material and mechanical properties independent of bone mineral density. This study aimed to determine if raloxifene prevents the negative effects of diabetes on skeletal fragility in diabetes-prone rats. Adult Zucker Diabetic Sprague-Dawley (ZDSD) female rats (20-week-old, n = 24) were fed a diabetogenic high-fat diet and were randomized to receive daily subcutaneous injections of raloxifene or vehicle for 12 weeks. Blood glucose was measured weekly and glycated hemoglobin was measured at baseline and 12 weeks. At sacrifice, femora and lumbar vertebrae were harvested for imaging and mechanical testing. Raloxifene-treated rats had a lower incidence of type 2 diabetes compared with vehicle-treated rats. In addition, raloxifene-treated rats had blood glucose levels significantly lower than both diabetic vehicle-treated rats as well as vehicle-treated rats that did not become diabetic. Femoral toughness was greater in raloxifene-treated rats compared with both diabetic and non-diabetic vehicle-treated ZDSD rats, due to greater energy absorption in the post-yield region of the stress-strain curve. Similar differences between groups were observed for the structural (extrinsic) mechanical properties of energy-to-failure, post-yield energy-to-failure, and post-yield displacement. These results show that raloxifene is beneficial in preventing the onset of diabetes and improving bone material properties in the diabetes-prone ZDSD rat. This presents unique therapeutic potential for raloxifene in preserving bone quality in diabetes as well as in diabetes prevention, if these results can be supported by future experimental and clinical studies.	[Gallant, Kathleen M. Hill; Gallant, Maxime A.; Brown, Drew M.; Sato, Amy Y.; Williams, Justin N.; Burr, David B.] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Gallant, Kathleen M. Hill] Purdue Univ, Dept Nutr Sci, W Lafayette, IN 47907 USA	Indiana University System; Indiana University Bloomington; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Gallant, KMH (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA.	hillgallant@purdue.edu	Gallant, Kathleen Hill/AAR-8916-2020	Sato, Amy/0000-0001-5061-1369; Williams, Justin/0000-0003-2341-2596	National Institutes of Health [AR047838]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This project was funded by a National Institutes of Health grant (AR047838) to DBB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MR, 2007, ENDOCRINOLOGY, V148, P3908, DOI 10.1210/en.2007-0275; Allen MR, 2006, BONE, V39, P1130, DOI 10.1016/j.bone.2006.05.007; Andersson B, 2002, J CLIN ENDOCR METAB, V87, P122, DOI 10.1210/jc.87.1.122; Barrett-Connor E, 2003, CLIN THER, V25, P919, DOI 10.1016/S0149-2918(03)80114-5; Burr DB, 2009, J ORTHOP RES, V27, P1288, DOI 10.1002/jor.20895; Delmas PD, 2002, J CLIN ENDOCR METAB, V87, P3609, DOI 10.1210/jc.87.8.3609; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Diab T, 2011, J BONE MINER RES, V26, P270, DOI 10.1002/jbmr.197; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Fajardo RJ, 2014, J BONE MINER RES, V29, P1025, DOI 10.1002/jbmr.2210; Gallant MA, 2014, BONE, V61, P191, DOI 10.1016/j.bone.2014.01.009; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Janghorbani M, 2006, DIABETES CARE, V29, P1573, DOI 10.2337/dc06-0440; Matsumura M, 2010, MED PRIN PRACT, V19, P68, DOI 10.1159/000252838; MELTON LJ, 1988, J CLIN EPIDEMIOL, V41, P985; Mori H, 2013, J BONE MINER METAB, V31, P89, DOI 10.1007/s00774-012-0379-8; Narayan KMV, 2003, JAMA-J AM MED ASSOC, V290, P1884, DOI 10.1001/jama.290.14.1884; Reinwald S, 2009, AM J PHYSIOL-ENDOC M, V296, pE765, DOI 10.1152/ajpendo.90937.2008; Sambrook PN, 2004, J INTERN MED, V255, P503, DOI 10.1111/j.1365-2796.2004.01317.x; Sato M, 1996, J PHARMACOL EXP THER, V279, P298; Schwartz AV, 2001, J CLIN ENDOCR METAB, V86, P32, DOI 10.1210/jc.86.1.32; Siris ES, 2005, J BONE MINER RES, V20, P1514, DOI 10.1359/JBMR.050509; Strotmeyer ES, 2005, ARCH INTERN MED, V165, P1612, DOI 10.1001/archinte.165.14.1612; Tiano JP, 2012, ISLETS, V4, P173, DOI 10.4161/isl.19747; Tiano JP, 2011, J CLIN INVEST, V121, P3331, DOI 10.1172/JCI44564; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Vestergaard P, 2011, CALCIFIED TISSUE INT, V89, P265, DOI 10.1007/s00223-011-9515-z; Yamamoto M, 2009, J BONE MINER RES, V24, P702, DOI 10.1359/JBMR.081207	28	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e108262	10.1371/journal.pone.0108262	http://dx.doi.org/10.1371/journal.pone.0108262			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243714	Green Submitted, Green Published, gold			2022-12-25	WOS:000343679800081
J	Mondal, M; Nag, D; Koley, H; Saha, DR; Chatterjee, NS				Mondal, Moumita; Nag, Dhrubajyoti; Koley, Hemanta; Saha, Dhira Rani; Chatterjee, Nabendu Sekhar			The Vibrio cholerae Extracellular Chitinase ChiA2 Is Important for Survival and Pathogenesis in the Host Intestine	PLOS ONE			English	Article							ENTEROTOXIGENIC ESCHERICHIA-COLI; BINDING PROTEINS; BACTERIAL; DETERMINANTS; EXPRESSION; PATHWAY; GROWTH; GENES; ROLES; MODEL	aquatic environments, Vibrio cholerae colonizes mainly on the chitinous surface of copepods and utilizes chitin as the sole carbon and nitrogen source. Of the two extracellular chitinases essential for chitin utilization, the expression of chiA2 is maximally up-regulated in host intestine. Recent studies indicate that several bacterial chitinases may be involved in host pathogenesis. However, the role of V. cholerae chitinases in host infection is not yet known. In this study, we provide evidence to show that ChiA2 is important for V. cholerae survival in intestine as well as in pathogenesis. We demonstrate that ChiA2 de-glycosylates mucin and releases reducing sugars like GlcNAc and its oligomers. Deglycosylation of mucin corroborated with reduced uptake of alcian blue stain by ChiA2 treated mucin. Next, we show that V. cholerae could utilize mucin as a nutrient source. In comparison to the wild type strain, Delta chiA2 mutant was 60-fold less efficient in growth in mucin supplemented minimal media and was also similar to 6-fold less competent to survive when grown in the presence of mucin-secreting human intestinal HT29 epithelial cells. Similar results were also obtained when the strains were infected in mice intestine. Infection with the Delta chiA2 mutant caused similar to 50-fold less fluid accumulation in infant mice as well as in rabbit ileal loop compared to the wild type strain. To see if the difference in survival of the Delta chiA2 mutant and wild type V. cholerae was due to reduced adhesion of the mutant, we monitored binding of the strains on HT29 cells. The initial binding of the wild type and mutant strain was similar. Collectively these data suggest that ChiA2 secreted by V. cholerae in the intestine hydrolyzed intestinal mucin to release GlcNAc, and the released sugar is successfully utilized by V. cholerae for growth and survival in the host intestine.	[Mondal, Moumita; Chatterjee, Nabendu Sekhar] Natl Inst Cholera & Enter Dis, Div Biochem, Kolkata, India; [Nag, Dhrubajyoti; Koley, Hemanta] Natl Inst Cholera & Enter Dis, Div Bacteriol, Kolkata, India; [Saha, Dhira Rani] Natl Inst Cholera & Enter Dis, Div Elect Microscopy, Kolkata, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Chatterjee, NS (corresponding author), Natl Inst Cholera & Enter Dis, Div Biochem, Kolkata, India.	nschatterjee@rediffmail.com			Indian Council of Medical Research	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This study was funded by the Indian Council of Medical Research, internal to our organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba Y, 2000, AM J PHYSIOL-GASTR L, V279, pG437, DOI 10.1152/ajpgi.2000.279.2.G437; Angelichio MJ, 1999, INFECT IMMUN, V67, P3733, DOI 10.1128/IAI.67.8.3733-3739.1999; Bancroft J., 1982, THEORY PRACTICE HIST, P194; Bansil R, 2006, CURR OPIN COLLOID IN, V11, P164, DOI 10.1016/j.cocis.2005.11.001; BASELSKI V, 1977, INFECT IMMUN, V15, P704, DOI 10.1128/IAI.15.3.704-712.1977; Bhowmick R, 2007, J APPL MICROBIOL, V103, P97, DOI 10.1111/j.1365-2672.2006.03253.x; Bhowmick R, 2008, INFECT IMMUN, V76, P4968, DOI 10.1128/IAI.01615-07; Bjork S, 1987, J BIOL CHEM, V271, P33457; Chatterjee SS, 2006, INFECT IMMUN, V74, P1323, DOI 10.1128/IAI.74.2.1323-1338.2006; Chaudhuri S, 2013, MBIO, V006, P12; Chaudhuri S, 2010, APPL ENVIRON MICROB, V76, P7302, DOI 10.1128/AEM.01338-10; Chen HC, 2002, FEMS MICROBIOL LETT, V209, P53, DOI 10.1111/j.1574-6968.2002.tb11108.x; Dai Y, 2003, WORLD J GASTROENTERO, V9, P557, DOI 10.3748/wjg.v9.i3.557; DE SN, 1953, J PATHOL BACTERIOL, V66, P559, DOI 10.1002/path.1700660228; DebRoy S, 2006, P NATL ACAD SCI USA, V103, P19146, DOI 10.1073/pnas.0608279103; Deplancke B, 2002, AM J CLIN NUTR, V76, P1117, DOI 10.1093/ajcn/76.5.1117; Derrien M, 2010, GUT MICROBES, V1, P254, DOI 10.4161/gmic.1.4.12778; FINNE J, 1989, J BIOL CHEM, V264, P5720; Frederiksen RF, 2013, MICROBIOL-SGM, V159, P833, DOI 10.1099/mic.0.051839-0; Ghosh S, 2011, MOL MICROBIOL, V80, P1549, DOI 10.1111/j.1365-2958.2011.07664.x; Helander A, 1997, MICROB PATHOGENESIS, V23, P335, DOI 10.1006/mpat.1997.0163; Hunt DE, 2008, APPL ENVIRON MICROB, V74, P44, DOI 10.1128/AEM.01412-07; HUQ A, 1983, APPL ENVIRON MICROB, V45, P275, DOI 10.1128/AEM.45.1.275-283.1983; Jass JR, 1996, J CLIN PATHOL, V49, P787, DOI 10.1136/jcp.49.10.787; Keyhani NO, 2000, J BIOL CHEM, V275, P33091, DOI 10.1074/jbc.M001044200; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Lamblin G, 2001, GLYCOCONJUGATE J, V18, P661, DOI 10.1023/A:1020867221861; Low D, 2013, GASTROENTEROLOGY, V145, P602, DOI 10.1053/j.gastro.2013.05.017; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Orikoshi H, 2005, APPL ENVIRON MICROB, V71, P1811, DOI 10.1128/AEM.71.4.1811-1815.2005; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Rajpara N, 2013, J PONE, V8; Russel M, 2009, SPECIAL STAIN TECHNI; Sanders NN, 2007, BBA-GEN SUBJECTS, V1770, P839, DOI 10.1016/j.bbagen.2007.01.011; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; STROUS GJ, 1992, CRIT REV BIOCHEM MOL, V27, P57, DOI 10.3109/10409239209082559; Svitil AL, 1997, APPL ENVIRON MICROB, V63, P408, DOI 10.1128/AEM.63.2.408-413.1997; Tran HT, 2011, HISTOL HISTOPATHOL, V26, P1453, DOI 10.14670/HH-26.1453; Wajima T, 2011, MICROB PATHOGENESIS, V51, P243, DOI 10.1016/j.micpath.2011.06.004; Xu Q, 2003, P NATL ACAD SCI USA, V100, P1286, DOI 10.1073/pnas.0337479100; Yamano N, 1997, BIOSCI BIOTECH BIOCH, V61, P1349, DOI 10.1271/bbb.61.1349	42	35	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e103119	10.1371/journal.pone.0103119	http://dx.doi.org/10.1371/journal.pone.0103119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244128	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800001
J	Morley, NJ; Richardson, DJ; Baggs, EM				Morley, Nicholas J.; Richardson, David J.; Baggs, Elizabeth M.			Substrate Induced Denitrification over or under Estimates Shifts in Soil N-2/N2O Ratios	PLOS ONE			English	Article							NITROUS-OXIDE EMISSIONS; N2O EMISSIONS; CARBON; NITRATE; N-2; DINITROGEN; ABUNDANCE; NITRIFICATION; RHIZOSPHERE; BACTERIA	The increase in atmospheric nitrous oxide (N2O), a potent greenhouse and ozone depleting gas, is of serious global concern. Soils are large contributors to this increase through microbial processes that are enhanced in agricultural land due to nitrogenous fertilizer applications. Denitrification, a respiratory process using nitrogen oxides as electron acceptors in the absence of oxygen, is the main source of N2O. The end product of denitrification is benign dinitrogen (N-2) and understanding what regulates the shift in ratio of N2O and N-2 emission is crucial for mitigation strategies. The role of organic carbon in controlling N2O reduction is poorly understood, and mostly based on application of glucose. Here we investigated how a range of carbon compounds (succinate, butyrate, malic acid, acetate, glucose, sucrose and cysteine) affect denitrifier N-2/N2O production stoichiometry under laboratory conditions. The results show that a soil's capability in efficiently reducing N2O to N-2 is C substrate dependent and most compounds tested were different in regards to this efficiency compared to glucose. We challenge the concept of using glucose as a model soil C compound in furthering our understanding of denitrification and specifically the efficiency in the N2O reductase enzyme. Organic acids, commonly exuded by roots, increased N-2/N2O ratios compared to glucose, and therefore mitigated net N2O release and we suggest provides better insights into soil regulatory aspects of N2O reduction. The widespread use of glucose in soil laboratory studies could lead to misleading knowledge on the functioning of denitrification in soils with regards to N2O reduction.	[Morley, Nicholas J.; Baggs, Elizabeth M.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Richardson, David J.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of Aberdeen; University of East Anglia	Morley, NJ (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland.	n.morley@abdn.ac.uk		Baggs, Liz/0000-0003-2014-2148	Biotechnology and Biological Sciences Research Council, BBSRC UK [BB/H013431/1]; BBSRC [BB/H012796/1, BB/H013431/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H013431/1, BB/H012796/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, BBSRC UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was provided by the Biotechnology and Biological Sciences Research Council, BBSRC UK (http://www.bbsrc.ac.uk). Grant number BB/H013431/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam F, 2002, BIOL FERT SOILS, V35, P54, DOI 10.1007/s00374-001-0441-5; Baggs EM, 2008, RAPID COMMUN MASS SP, V22, P1664, DOI 10.1002/rcm.3456; Bakken LR, 2012, PHILOS T R SOC B, V367, P1226, DOI 10.1098/rstb.2011.0321; Bergsma TT, 2001, ENVIRON SCI TECHNOL, V35, P4307, DOI 10.1021/es010885u; Bergstermann A, 2011, SOIL BIOL BIOCHEM, V43, P240, DOI 10.1016/j.soilbio.2010.10.003; Cuhel J, 2010, APPL ENVIRON MICROB, V76, P1870, DOI 10.1128/AEM.02484-09; Dendooven L, 1999, SOIL BIOL BIOCHEM, V31, P727, DOI 10.1016/S0038-0717(98)00171-0; Farrar J, 2003, ECOLOGY, V84, P827, DOI 10.1890/0012-9658(2003)084[0827:HRCTFO]2.0.CO;2; FIRESTONE MK, 1979, APPL ENVIRON MICROB, V38, P673, DOI 10.1128/AEM.38.4.673-679.1979; Giles M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00407; Gillam KM, 2008, CAN J SOIL SCI, V88, P133, DOI 10.4141/CJSS06005; Griffiths RP, 1998, SOIL BIOL BIOCHEM, V30, P1147, DOI 10.1016/S0038-0717(97)00185-5; Groffman PM, 2006, ECOL APPL, V16, P2091, DOI 10.1890/1051-0761(2006)016[2091:MFMDDA]2.0.CO;2; Hallin S, 1998, WATER RES, V32, P13, DOI 10.1016/S0043-1354(97)00199-1; Henderson SL, 2010, APPL ENVIRON MICROB, V76, P2155, DOI 10.1128/AEM.02993-09; Henry S, 2008, ENVIRON MICROBIOL, V10, P3082, DOI 10.1111/j.1462-2920.2008.01599.x; Hochberg Y., 1987, MULTIPLE COMP PROCED; Ishii S, 2011, ISME J, V5, P1936, DOI 10.1038/ismej.2011.69; Jones DL, 1998, PLANT SOIL, V205, P25, DOI 10.1023/A:1004356007312; Lorrain MJ, 2004, ENVIRON TECHNOL, V25, P1041, DOI 10.1080/09593330.2004.9619397; Miller MN, 2008, SOIL BIOL BIOCHEM, V40, P2553, DOI 10.1016/j.soilbio.2008.06.024; Miller MN, 2012, GEODERMA, V170, P48, DOI 10.1016/j.geoderma.2011.11.022; Morley N, 2010, SOIL BIOL BIOCHEM, V42, P1864, DOI 10.1016/j.soilbio.2010.07.008; Morley N, 2008, FEMS MICROBIOL ECOL, V65, P102, DOI 10.1111/j.1574-6941.2008.00495.x; Peterson ME, 2013, SOIL BIOL BIOCHEM, V61, P96, DOI 10.1016/j.soilbio.2013.02.010; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Roobroeck D, 2010, EUR J SOIL SCI, V61, P662, DOI 10.1111/j.1365-2389.2010.01269.x; SCHUSTER M, 1992, FEMS MICROBIOL ECOL, V101, P133, DOI 10.1111/j.1574-6968.1992.tb05769.x; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; SORENSEN J, 1980, APPL ENVIRON MICROB, V39, P105; Wang R, 2013, PLANT SOIL, V363, P175, DOI 10.1007/s11104-012-1264-x; WEIER KL, 1993, SOIL SCI SOC AM J, V57, P66, DOI 10.2136/sssaj1993.03615995005700010013x; Wong BT, 2011, BIORESOURCE TECHNOL, V102, P2427, DOI 10.1016/j.biortech.2010.10.121; Yu KW, 2008, COMMUN SOIL SCI PLAN, V39, P2205, DOI 10.1080/00103620802137639; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	35	25	26	4	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e108144	10.1371/journal.pone.0108144	http://dx.doi.org/10.1371/journal.pone.0108144			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243844	Green Published, Green Submitted, gold			2022-12-25	WOS:000343679800070
J	Srivorakun, H; Singha, K; Fucharoen, G; Sanchaisuriya, K; Fucharoen, S				Srivorakun, Hataichanok; Singha, Kritsada; Fucharoen, Goonnapa; Sanchaisuriya, Kanokwan; Fucharoen, Supan			A Large Cohort of Hemoglobin Variants in Thailand: Molecular Epidemiological Study and Diagnostic Consideration	PLOS ONE			English	Article							HB E-SASKATOON; ALPHA-27(B8) GLU-ASP; COMPLEX INTERACTION; DELETIONAL ALPHA-THALASSEMIA-1; COMPOUND HETEROZYGOSITY; BETA-THALASSEMIA; HEMATOLOGICAL FEATURES; NORTHEAST THAILAND; DHONBURI NEAPOLIS; CHAIN VARIANT	Background: Hemoglobin (Hb) variants are structurally inherited changes of globin chains. Accurate diagnoses of these variants are important for planning of appropriate management and genetic counseling. Since no epidemiological study has been conducted before, we have investigated frequencies, molecular and hematological features of Hb variants found in a large cohort of Thai subjects. Materials and Methods: Study was conducted on 26,013 unrelated subjects, inhabiting in all geographical parts of Thailand over a period of 11 years from January 2002-December 2012. Hb analysis was done on high performance liquid chromatography (HPLC) or capillary electrophoresis (CE). Mutations causing Hb variants were identified using PCR and related techniques. Results: Among 26,013 subjects investigated, 636 (2.4%) were found to carry Hb variants. Of these 636 subjects, 142 (22.4%) carried a-chain variants with 13 different mutations. The remaining included 451 (70.9%) cases with 16 beta-chain variants, 37 (5.8%) cases with Hb Lepore (db-hybrid Hb) and 6 (0.9%) cases with a single delta-chain variant. The most common alpha-globin chain variant was the Hb Q-Thailand (alpha(74GAC-CAC, Asp-His)) which was found in 101 cases (15.8%). For beta-globin chain variants, Hb Hope (beta(136GGT-GAT, Gly-Asp)) and Hb Tak (beta(146+AC, Ter-Thr)) are the two most common ones, found in 121 (19.0%) and 90 (14.2%) cases, respectively. Seven Hb variants have never been found in Thai population. Hb analysis profiles on HPLC or CE of these variants were illustrated to guide presumptive diagnostics. Conclusions: Hb variants are common and heterogeneous in Thai population. With varieties of thalassemias and hemoglobinopathies in the population, interactions between them leading to complex syndromes are common and render their diagnoses difficult in routine practices. Knowledge of the spectrum, molecular basis, genotype-phenotype correlation and diagnostic features should prove useful for prevention and control of the diseases in the region.	[Srivorakun, Hataichanok; Singha, Kritsada; Fucharoen, Goonnapa; Sanchaisuriya, Kanokwan; Fucharoen, Supan] Khon Kaen Univ, Res Ctr, Khon Kaen, Thailand; [Srivorakun, Hataichanok; Singha, Kritsada; Fucharoen, Goonnapa; Sanchaisuriya, Kanokwan; Fucharoen, Supan] Khon Kaen Univ, Dev Med Diagnost Labs, Fac Associated Med Sci, Khon Kaen, Thailand; [Singha, Kritsada] Khon Kaen Univ, Grad Sch, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University; Khon Kaen University	Fucharoen, S (corresponding author), Khon Kaen Univ, Res Ctr, Khon Kaen, Thailand.	supan@kku.ac.th		Singha, Kritsada/0000-0001-8716-5745	National Research University (NRU) program of Khon Kaen University; Commission of Higher Education, Ministry of Education, Thailand; Khon Kaen University, Thailand; Thailand Research Fund (TRF), Thailand [PHD/0042/2556]	National Research University (NRU) program of Khon Kaen University; Commission of Higher Education, Ministry of Education, Thailand; Khon Kaen University, Thailand; Thailand Research Fund (TRF), Thailand(Thailand Research Fund (TRF))	This work was supported by grants from the National Research University (NRU) program of Khon Kaen University and the Commission of Higher Education, Ministry of Education, Thailand. HS is a funding recipient through the post- doctoral program of Khon Kaen University, Thailand. KS is supported by the Royal Golden Jubilee PhD program (PHD/0042/2556) of the Thailand Research Fund (TRF), Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birben E, 2001, HEMOGLOBIN, V25, P409, DOI 10.1081/HEM-100107878; BLACKWELL RQ, 1972, VOX SANG, V22, P469, DOI 10.1111/j.1423-0410.1972.tb03994.x; Boonsa S, 2004, ACTA HAEMATOL-BASEL, V111, P149, DOI 10.1159/000076523; Chaibunruang A, 2013, BLOOD CELL MOL DIS, V51, P89, DOI 10.1016/j.bcmd.2013.04.003; Chaibunruang A, 2012, HEMOGLOBIN, V36, P80, DOI 10.3109/03630269.2011.599465; Chaibunruang A, 2010, BLOOD CELL MOL DIS, V44, P140, DOI 10.1016/j.bcmd.2009.11.008; Changtrakun Y, 2002, ANN HEMATOL, V81, P389, DOI 10.1007/s00277-002-0485-0; CHARACHE S, 1980, AM J HEMATOL, V9, P151, DOI 10.1002/ajh.2830090203; Chunpanich S, 2004, CLIN LAB HAEMATOL, V26, P355, DOI 10.1111/j.1365-2257.2004.00627.x; Chunpanich Sunisa, 2004, Lab Hematol, V10, P215, DOI 10.1532/LH96.04050; Daar S, 2008, EUR J HAEMATOL, V80, P67, DOI 10.1111/j.1600-0609.2007.00989.x; FESSAS P, 1991, HEMOGLOBIN, V15, P345, DOI 10.3109/03630269109027891; Fucharoen G, 2011, INT J LAB HEMATOL, V33, P424, DOI 10.1111/j.1751-553X.2011.01301.x; Fucharoen S, 2005, BLOOD CELL MOL DIS, V35, P196, DOI 10.1016/j.bcmd.2005.05.004; Fucharoen S, 2005, CLIN LAB HAEMATOL, V27, P184, DOI 10.1111/j.1365-2257.2005.00665.x; Fucharoen S, 2005, HEMOGLOBIN, V29, P77, DOI 10.1081/HEM-200047085; Fucharoen S, 2003, EUR J HAEMATOL, V70, P304, DOI 10.1034/j.1600-0609.2003.00049.x; FUCHAROEN S, 1987, HEMOGLOBIN, V11, P65, DOI 10.3109/03630268709036587; Fucharoen S, 2002, HEMOGLOBIN, V26, P261, DOI 10.1081/HEM-120015030; FUCHAROEN S, 1989, HUM GENET, V84, P41, DOI 10.1007/BF00210668; Fucharoen S, 2001, HAEMATOLOGICA, V86, P657; Fucharoen S, 1997, Southeast Asian J Trop Med Public Health, V28 Suppl 3, P110; Fucharoen S, 2001, EUR J HAEMATOL, V66, P312, DOI 10.1034/j.1600-0609.2001.066005312.x; Fucharoen S, 2007, CLIN BIOCHEM, V40, P137, DOI 10.1016/j.clinbiochem.2006.08.008; Giardine B, 2014, NUCLEIC ACIDS RES, V42, pD1063, DOI 10.1093/nar/gkt911; Hutt PJ, 1996, HEMOGLOBIN, V20, P371, DOI 10.3109/03630269609005841; Igarashi Y, 1995, HEMOGLOBIN, V19, P403, DOI 10.3109/03630269509005832; Joutovsky A, 2004, CLIN CHEM, V50, P1736, DOI 10.1373/clinchem.2004.034991; MARENGOROWE AJ, 1968, BIOCHIM BIOPHYS ACTA, V168, P58, DOI 10.1016/0005-2795(68)90233-X; Moghimi B, 2004, HEMOGLOBIN, V28, P353, DOI 10.1081/HEM-200038876; PAGANO L, 1991, BLOOD, V78, P3070; Prakobkaew N, 2010, ACTA HAEMATOL-BASEL, V124, P115, DOI 10.1159/000318015; Sanchaisuriya K, 2005, EUR J HAEMATOL, V74, P221, DOI 10.1111/j.1600-0609.2004.00381.x; Sanchaisuriya K, 2004, CLIN CHIM ACTA, V343, P129, DOI 10.1016/j.cccn.2003.12.029; Sanchaisuriya K, 2001, AM J HEMATOL, V67, P189, DOI 10.1002/ajh.1105; Singha K, 2013, CLIN BIOCHEM, V46, P675, DOI 10.1016/j.clinbiochem.2013.01.022; Singha K, 2013, HEMOGLOBIN, V37, P37, DOI 10.3109/03630269.2012.747964; Singha K, 2012, ANN CLIN BIOCHEM, V49, P445, DOI 10.1258/acb.2012.011234; Singsanan S, 2007, BLOOD CELL MOL DIS, V45, P210; Singsanan S, 2011, HEMOGLOBIN, V35, P103, DOI 10.3109/03630269.2011.557171; Siriratmanawong N, 2009, HEMOGLOBIN, V33, P507, DOI 10.3109/03630260903343780; Srivorakun H, 2011, EUR J HAEMATOL, V87, P68, DOI 10.1111/j.1600-0609.2011.01616.x; Tritipsombut J, 2012, HEMOGLOBIN, V36, P47, DOI 10.3109/03630269.2011.637149; Van Delft P, 2009, INT J LAB HEMATOL, V31, P484, DOI 10.1111/j.1751-553X.2009.01158.x; VELLA F, 1958, NATURE, V182, P460, DOI 10.1038/182460a0; Viprakasit Vip, 2004, Hematology, V9, P151, DOI 10.1080/10245330310001652455; Viprakasit V, 2007, CLIN CHIM ACTA, V376, P179, DOI 10.1016/j.cca.2006.08.016; Weatherall DJ., 2001, THALASSAEMIA SYNDROM, V4th ed; ZENG YT, 1981, HEMOGLOBIN, V5, P679	49	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e108365	10.1371/journal.pone.0108365	http://dx.doi.org/10.1371/journal.pone.0108365			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25244406	Green Published, gold, Green Submitted			2022-12-25	WOS:000343679800087
J	Alifano, M; Mansuet-Lupo, A; Lococo, F; Roche, N; Bobbio, A; Canny, E; Schussler, O; Dermine, H; Regnard, JF; Burroni, B; Goc, J; Biton, J; Ouakrim, H; Cremer, I; Dieu-Nosjean, MC; Damotte, D				Alifano, Marco; Mansuet-Lupo, Audrey; Lococo, Filippo; Roche, Nicolas; Bobbio, Antonio; Canny, Emelyne; Schussler, Olivier; Dermine, Herve; Regnard, Jean-Francois; Burroni, Barbara; Goc, Jeremy; Biton, Jerome; Ouakrim, Hanane; Cremer, Isabelle; Dieu-Nosjean, Marie-Caroline; Damotte, Diane			Systemic Inflammation, Nutritional Status and Tumor Immune Microenvironment Determine Outcome of Resected Non-Small Cell Lung Cancer	PLOS ONE			English	Article							C-REACTIVE PROTEIN; LONG-TERM SURVIVAL; PROGNOSTIC-SIGNIFICANCE; ADJUVANT CHEMOTHERAPY; CONTEXTURE; MARKERS	Background: Hypothesizing that nutritional status, systemic inflammation and tumoral immune microenvironment play a role as determinants of lung cancer evolution, the purpose of this study was to assess their respective impact on long-term survival in resected non-small cell lung cancers (NSCLC). Methods and Findings: Clinical, pathological and laboratory data of 303 patients surgically treated for NSCLC were retrospectively analyzed. C-reactive protein (CRP) and prealbumin levels were recorded, and tumoral infiltration by CD8+ lymphocytes and mature dendritic cells was assessed. We observed that factors related to nutritional status, systemic inflammation and tumoral immune microenvironment were correlated; significant correlations were also found between these factors and other relevant clinical-pathological parameters. With respect to outcome, at univariate analysis we found statistically significant associations between survival and the following variables: Karnofsky index, American Society of Anesthesiologists (ASA) class, CRP levels, prealbumin concentrations, extent of resection, pathologic stage, pT and pN parameters, presence of vascular emboli, and tumoral infiltration by either CD8+ lymphocytes or mature dendritic cells and, among adenocarcinoma type, tumor grade (all p < 0.05). In multivariate analysis, prealbumin levels (Relative Risk (RR): 0.34 [0.16-0.73], p = 0.0056), CD8+ cell count in tumor tissue (RR = 0.37 [0.16-0.83], p = 0.0162), and disease stage (RR 1.73 [1.03-2.89]; 2.99[1.07-8.37], p = 0.0374-stage I vs II vs III-IV) were independent prognostic markers. When taken together, parameters related to systemic inflammation, nutrition and tumoral immune microenvironment allowed robust prognostic discrimination; indeed patients with undetectable CRP, high (>285 mg/L) prealbumin levels and high (>96/mm2) CD8+ cell count had a 5-year survival rate of 80% [60.9-91.1] as compared to 18% [7.9-35.6] in patients with an opposite pattern of values. When stages I-II were considered alone, the prognostic significance of these factors was even more pronounced. Conclusions: Our data show that nutrition, systemic inflammation and tumoral immune contexture are prognostic determinants that, taken together, may predict outcome.	[Alifano, Marco; Bobbio, Antonio; Canny, Emelyne; Schussler, Olivier; Regnard, Jean-Francois] Paris Ctr Univ Hosp, AP HP, Dept Thorac Surg, Paris, France; [Alifano, Marco; Mansuet-Lupo, Audrey; Roche, Nicolas; Regnard, Jean-Francois; Goc, Jeremy; Biton, Jerome; Ouakrim, Hanane; Cremer, Isabelle; Dieu-Nosjean, Marie-Caroline; Damotte, Diane] Univ Paris 05, Paris, France; [Mansuet-Lupo, Audrey; Burroni, Barbara; Damotte, Diane] Paris Ctr Univ Hosp, AP HP, Dept Pathol, Paris, France; [Mansuet-Lupo, Audrey; Goc, Jeremy; Biton, Jerome; Ouakrim, Hanane; Cremer, Isabelle; Dieu-Nosjean, Marie-Caroline; Damotte, Diane] INSERM, U1138, Cordeliers Res Ctr, Paris, France; [Mansuet-Lupo, Audrey; Goc, Jeremy; Biton, Jerome; Ouakrim, Hanane; Cremer, Isabelle; Dieu-Nosjean, Marie-Caroline; Damotte, Diane] Univ Paris 06, UMRS U1138, Paris, France; [Lococo, Filippo; Dermine, Herve] IRCCS Arcispedale Santa Maria Nuova, Unit Thorac Surg, Reggio Emilia, Italy; [Roche, Nicolas] Paris Ctr Univ Hosp, AP HP, Dept Chest Dis, Paris, France	Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; IRCCS Arcispedale S. Maria Nuova; Assistance Publique Hopitaux Paris (APHP)	Alifano, M (corresponding author), Paris Ctr Univ Hosp, AP HP, Dept Thorac Surg, Paris, France.	marco.alifano@cch.aphp.fr	Roche, Nicolas/AAE-9206-2021; Lococo, Filippo/AAB-3408-2021; Goc, Jeremy/O-7254-2018; Roche, Nicolas/AAP-4445-2021; Alifano, Marco/AAN-7800-2020; Cremer, Isabelle/D-4278-2017; Dieu-Nosjean, Marie-Caroline/N-3736-2017; Dieu-Nosjean, Marie-Caroline/AAD-3695-2022	Lococo, Filippo/0000-0002-9383-5554; Goc, Jeremy/0000-0002-4214-8877; Cremer, Isabelle/0000-0002-0963-1031; Dieu-Nosjean, Marie-Caroline/0000-0002-1697-8914; Biton, Jerome/0000-0002-4720-4567; roche, nicolas/0000-0002-3162-5033	Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Paris-Descartes; Universite Pierre et Marie Curie; Labex Immunooncology [11LAXE62_9UMR5872 FRIDMAN]; Fondation ARC pour la Recherche sur le Cancer [SL220110603483]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Paris-Descartes; Universite Pierre et Marie Curie; Labex Immunooncology; Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by 1. Institut National de la Sante et de la Recherche Medicale (INSERM), Universite Paris-Descartes, Universite Pierre et Marie Curie, Labex Immunooncology (11LAXE62_9UMR5872 FRIDMAN). Authors who received the funding: DD, IC, MCDN www.sorbonne-paris-cite.fr. 2. Fondation ARC pour la Recherche sur le Cancer (SL220110603483). Author who received the funding: IC www.fondation-arc.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alifano M, 2011, J THORAC CARDIOV SUR, V142, P1161, DOI 10.1016/j.jtcvs.2011.07.021; Allin KH, 2009, J CLIN ONCOL, V27, P2217, DOI 10.1200/JCO.2008.19.8440; Balkwill F, 2010, CLIN PHARMACOL THER, V87, P401, DOI 10.1038/clpt.2009.312; Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Custodio AB, 2009, J THORAC ONCOL, V4, P891, DOI 10.1097/JTO.0b013e3181a4b8fb; Chandra RK, 1997, AM J CLIN NUTR, V66, P460; Dieu-Nosjean MC, 2008, J CLIN ONCOL, V26, P4410, DOI 10.1200/JCO.2007.15.0284; Fridman WH, 2011, CURR TOP MICROBIOL, V344, P1, DOI 10.1007/82_2010_46; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Goc J, 2014, CANCER RES, V74, P705, DOI 10.1158/0008-5472.CAN-13-1342; Goldstraw P, 2011, LANCET, V378, P1727, DOI 10.1016/S0140-6736(10)62101-0; Haura EB, 2006, CLIN LUNG CANC; Jafri SH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-158; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kawai H, 2012, WORLD J SURG, V36, P2853, DOI 10.1007/s00268-012-1766-y; Kikuchi E, 2007, CANCER SCI, V98, P1424, DOI 10.1111/j.1349-7006.2007.00558.x; Koch A, 2009, J THORAC ONCOL, V4, P326, DOI 10.1097/JTO.0b013e31819578c8; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Mansuet-Lupo A, 2014, CHEST, V146, P633, DOI 10.1378/chest.13-2499; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; Niiya M, 2003, CANCER CHEMOTH PHARM, V52, P391, DOI 10.1007/s00280-003-0665-1; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Remark R, 2013, CLIN CANCER RES, V19, P4079, DOI 10.1158/1078-0432.CCR-12-3847; Schussler O, 2006, AM J RESP CRIT CARE, V173, P1161, DOI 10.1164/rccm.200510-1556OC; Shiels MS, 2013, JNCI-J NATL CANCER I, V105, P1871, DOI 10.1093/jnci/djt309; Simon GR, 2008, CURR TREAT OPTION ON, V9, P300, DOI 10.1007/s11864-008-0075-z; Sobin LH., 2003, INT UNION CANC UICC, V7, DOI [10.1002/0471463752, DOI 10.1002/0471463752]; Tewari N, 2007, LUNG CANCER, V57, P389, DOI 10.1016/j.lungcan.2007.03.017; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Wakelee HA, 2006, CLIN LUNG CANCER, V8, P18, DOI 10.3816/CLC.2006.n.028; Youlden DR, 2008, J THORAC ONCOL, V3, P819, DOI 10.1097/JTO.0b013e31818020eb	31	115	117	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e106914	10.1371/journal.pone.0106914	http://dx.doi.org/10.1371/journal.pone.0106914			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238252	Green Published, gold			2022-12-25	WOS:000342491600015
J	Birdsell, DN; Vogler, AJ; Buchhagen, J; Clare, A; Kaufman, E; Naumann, A; Driebe, E; Wagner, DM; Keim, PS				Birdsell, Dawn N.; Vogler, Amy J.; Buchhagen, Jordan; Clare, Ashley; Kaufman, Emily; Naumann, Amber; Driebe, Elizabeth; Wagner, David M.; Keim, Paul S.			TaqMan Real-Time PCR Assays for Single-Nucleotide Polymorphisms Which Identify Francisella tularensis and Its Subspecies and Subpopulations	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; FORMERLY YERSINIA-PHILOMIRAGIA; TANDEM REPEAT ANALYSIS; MOLECULAR EPIDEMIOLOGY; CLINICAL-SAMPLES; UNITED-STATES; GADUS-MORHUA; ATLANTIC COD; IDENTIFICATION; STRAINS	Francisella tularensis, the etiologic agent of tularemia and a Class A Select Agent, is divided into three subspecies and multiple subpopulations that differ in virulence and geographic distribution. Given these differences, there is a need to rapidly and accurately determine if a strain is F. tularensis and, if it is, assign it to subspecies and subpopulation. We designed TaqMan real-time PCR genotyping assays using eleven single nucleotide polymorphisms (SNPs) that were potentially specific to closely related groups within the genus Francisella, including numerous subpopulations within F. tularensis species. We performed extensive validation studies to test the specificity of these SNPs to particular populations by screening the assays across a set of 565 genetically and geographically diverse F. tularensis isolates and an additional 21 genetic near-neighbor (outgroup) isolates. All eleven assays correctly determined the genetic groups of all 565 F. tularensis isolates. One assay differentiates F. tularensis, F. novicida, and F. hispaniensis from the more genetically distant F. philomiragia and Francisella-like endosymbionts. Another assay differentiates F. tularensis isolates from near neighbors. The remaining nine assays classify F. tularensis-confirmed isolates into F. tularensis subspecies and subpopulations. The genotyping accuracy of these nine assays diminished when tested on outgroup isolates (i.e. non F. tularensis), therefore a hierarchical approach of assay usage is recommended wherein the F. tularensis-specific assay is used before the nine downstream assays. Among F. tularensis isolates, all eleven assays were highly sensitive, consistently amplifying very low concentrations of DNA. Altogether, these eleven TaqMan real-time PCR assays represent a highly accurate, rapid, and sensitive means of identifying the species, subspecies, and subpopulation of any F. tularensis isolate if used in a step-wise hierarchical scheme. These assays would be very useful in clinical, epidemiological, and/or forensic investigations involving F. tularensis.	[Birdsell, Dawn N.; Vogler, Amy J.; Buchhagen, Jordan; Clare, Ashley; Kaufman, Emily; Naumann, Amber; Driebe, Elizabeth; Wagner, David M.; Keim, Paul S.] No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA; [Buchhagen, Jordan; Driebe, Elizabeth; Keim, Paul S.] Translat Genom Res Inst, Flagstaff, AZ USA	Northern Arizona University; Translational Genomics Research Institute	Keim, PS (corresponding author), No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA.	Paul.Keim@nau.edu		Wagner, David/0000-0003-2684-6007	Department of Homeland Security Science and Technology Directorate [NBCH2070001]; Cowden Endowment in Microbiology at Northern Arizona University	Department of Homeland Security Science and Technology Directorate(United States Department of Homeland Security (DHS)); Cowden Endowment in Microbiology at Northern Arizona University	This work was funded by the Department of Homeland Security Science and Technology Directorate via award NBCH2070001 and the Cowden Endowment in Microbiology at Northern Arizona University. Note that the use of products/names does not constitute endorsement by the Department of Homeland Security of the United States. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barns SM, 2005, APPL ENVIRON MICROB, V71, P5494, DOI 10.1128/AEM.71.9.5494-5500.2005; Berdal BP, 2000, SCAND J INFECT DIS, V32, P287, DOI 10.1080/00365540050165938; Birdsell Dawn N, 2009, BMC Res Notes, V2, P223, DOI 10.1186/1756-0500-2-223; Birdsell DN, 2014, US EMERG INFECT DIS, V20; Broekhuijsen M, 2003, J CLIN MICROBIOL, V41, P2924, DOI 10.1128/JCM.41.7.2924-2931.2003; Bystrom M, 2005, J CLIN MICROBIOL, V43, P5355, DOI 10.1128/JCM.43.10.5355-5358.2005; de la Puente-Redondo VA, 2000, J CLIN MICROBIOL, V38, P1016, DOI 10.1128/JCM.38.3.1016-1022.2000; Del Blanco NG, 2002, J CLIN MICROBIOL, V40, P2964, DOI 10.1128/JCM.40.8.2964-2972.2002; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Dolan SA, 1998, CLIN INFECT DIS, V26, P764, DOI 10.1086/517121; Emanuel PA, 2003, J CLIN MICROBIOL, V41, P689, DOI 10.1128/JCM.41.2.689-693.2003; Farlow J, 2005, EMERG INFECT DIS, V11, P1835, DOI 10.3201/eid1112.050728; FORSMAN M, 1995, FEMS MICROBIOL ECOL, V16, P83, DOI 10.1111/j.1574-6941.1995.tb00271.x; FORSMAN M, 1990, APPL ENVIRON MICROB, V56, P949, DOI 10.1128/AEM.56.4.949-955.1990; FORSMAN M, 1994, INT J SYST BACTERIOL, V44, P38, DOI 10.1099/00207713-44-1-38; Foster JT, 2008, J CLIN MICROBIOL, V46, P296, DOI 10.1128/JCM.01496-07; Fujita O, 2006, JPN J INFECT DIS, V59, P46; Fulop M, 1996, AM J TROP MED HYG, V54, P364, DOI 10.4269/ajtmh.1996.54.364; Hardegger D, 2000, J MICROBIOL METH, V41, P45, DOI 10.1016/S0167-7012(00)00135-4; Higgins JA, 2000, AM J TROP MED HYG, V62, P310, DOI 10.4269/ajtmh.2000.62.310; HOLLIS DG, 1989, J CLIN MICROBIOL, V27, P1601, DOI 10.1128/JCM.27.7.1601-1608.1989; HUBER BE, 2009, INT J SYST EVOL MICR; Johansson A, 2004, J BACTERIOL, V186, P5808, DOI 10.1128/JB.186.17.5808-5818.2004; Johansson A, 2000, J CLIN MICROBIOL, V38, P22; Johansson A, 2000, J CLIN MICROBIOL, V38, P4180, DOI 10.1128/JCM.38.11.4180-4185.2000; Johansson A, 2010, INT J SYST EVOL MICR, V60, P1717, DOI 10.1099/ijs.0.022830-0; Keim P, 2007, ANN NY ACAD SCI, V1105, P30, DOI 10.1196/annals.1409.011; Keim P, 2004, INFECT GENET EVOL, V4, P205, DOI 10.1016/j.meegid.2004.02.005; Kugeler KJ, 2006, EMERG INFECT DIS, V12, P1799, DOI 10.3201/eid1211.060629; Kugeler KJ, 2005, APPL ENVIRON MICROB, V71, P7594, DOI 10.1128/AEM.71.11.7594-7597.2005; Layton A, 2006, APPL ENVIRON MICROB, V72, P4214, DOI 10.1128/AEM.01036-05; LONG GW, 1993, J CLIN MICROBIOL, V31, P152, DOI 10.1128/JCM.31.1.152-154.1993; Lovmar L, 2006, HUM MUTAT, V27, P603, DOI 10.1002/humu.20341; Lyko C, 2013, Rev Med Suisse, V9, P1816; Mauel MJ, 2007, J AQUAT ANIM HEALTH, V19, P27, DOI 10.1577/H06-025.1; Michelet L, 2013, VET MICROBIOL, V163, P399, DOI 10.1016/j.vetmic.2013.01.014; Mitchell JL, MOL CELL PROBES, V24, P72; Molins CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010205; Molins CR, 2009, DIAGN MICR INFEC DIS, V64, P6, DOI 10.1016/j.diagmicrobio.2009.01.006; Molins-Schneekloth CR, 2008, APPL ENVIRON MICROB, V74, P336, DOI 10.1128/AEM.01522-07; Ottem KF, 2008, J FISH DIS, V31, P525, DOI 10.1111/j.1365-2761.2008.00930.x; Ottem KF, 2007, ARCH MICROBIOL, V187, P343, DOI 10.1007/s00203-006-0198-1; Pandya GA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-213; Petersen JM, 2010, FUTURE MICROBIOL, V5, P649, DOI 10.2217/FMB.10.17; Popovic T, 2003, CROAT MED J, V44, P336; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Staples JE, 2006, EMERG INFECT DIS, V12, P1113; Sun LV, 2000, J INVERTEBR PATHOL, V76, P301, DOI 10.1006/jipa.2000.4983; Svensson K, 2005, J BACTERIOL, V187, P3903, DOI 10.1128/JB.187.11.3903-3908.2005; Svensson K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008360; Tarnvik A, 2007, ANN NY ACAD SCI, V1105, P378, DOI 10.1196/annals.1409.017; Titball RW, 2007, ANN NY ACAD SCI, V1105, P98, DOI 10.1196/annals.1409.015; Tomaso H, 2007, MOL CELL PROBE, V21, P12, DOI 10.1016/j.mcp.2006.06.001; Ulu-Kilic A, 2013, INFECTION, V41, P391, DOI 10.1007/s15010-012-0355-1; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; Versage JL, 2003, J CLIN MICROBIOL, V41, P5492, DOI 10.1128/JCM.41.12.5492-5499.2003; Vogler AJ, 2008, BIOTECHNIQUES, V44, P201, DOI 10.2144/000112815; Vogler AJ, 2009, J BACTERIOL, V191, P2474, DOI 10.1128/JB.01786-08; WENGER JD, 1989, ANN INTERN MED, V110, P888, DOI 10.7326/0003-4819-110-11-888; Whipp MJ, 2003, J MED MICROBIOL, V52, P839, DOI 10.1099/jmm.0.05245-0	60	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107964	10.1371/journal.pone.0107964	http://dx.doi.org/10.1371/journal.pone.0107964			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238067	gold, Green Submitted, Green Published			2022-12-25	WOS:000342491600069
J	Brenu, EW; Ashton, KJ; Batovska, J; Staines, DR; Marshall-Gradisnik, SM				Brenu, Ekua W.; Ashton, Kevin J.; Batovska, Jana; Staines, Donald R.; Marshall-Gradisnik, Sonya M.			High-Throughput Sequencing of Plasma MicroRNA in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; DIFFERENTIAL EXPRESSION; CIRCULATING MICRORNAS; POTENTIAL BIOMARKERS; GENE-EXPRESSION; DOWN-REGULATION; CANCER; IMMUNE; RNA; APOPTOSIS	Background: MicroRNAs (miRNAs) are known to regulate many biological processes and their dysregulation has been associated with a variety of diseases including Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME). The recent discovery of stable and reproducible miRNA in plasma has raised the possibility that circulating miRNAs may serve as novel diagnostic markers. The objective of this study was to determine the role of plasma miRNA in CFS/ME. Results: Using Illumina high-throughput sequencing we identified 19 miRNAs that were differentially expressed in the plasma of CFS/ME patients in comparison to non-fatigued controls. Following RT-qPCR analysis, we were able to confirm the significant up-regulation of three miRNAs (hsa-miR-127-3p, hsa-miR-142-5p and hsa-miR-143-3p) in the CFS/ME patients. Conclusion: Our study is the first to identify circulating miRNAs from CFS/ME patients and also to confirm three differentially expressed circulating miRNAs in CFS/ME patients, providing a basis for further study to find useful CFS/ME biomarkers.	[Brenu, Ekua W.; Marshall-Gradisnik, Sonya M.] Griffith Univ, Griffith Hlth Ctr, Sch Med Sci, Gold Coast, Qld, Australia; [Brenu, Ekua W.; Staines, Donald R.; Marshall-Gradisnik, Sonya M.] Griffith Univ, Natl Ctr Neuroimmunol & Emerging Dis, Gold Coast, Qld, Australia; [Ashton, Kevin J.; Batovska, Jana] Bond Univ, Fac Hlth Sci & Med, Robina, Qld, Australia; [Staines, Donald R.] Queensland Hlth, Gold Coast Publ Hlth Unit, Gold Coast, Qld, Australia	Griffith University; Griffith University; Bond University; Queensland Health	Brenu, EW (corresponding author), Griffith Univ, Griffith Hlth Ctr, Sch Med Sci, Gold Coast, Qld, Australia.	e.brenu@griffith.edu.au	Ashton, Kevin/R-2147-2016; Batovska, Jana/N-4926-2015	Ashton, Kevin/0000-0001-6106-3425; Batovska, Jana/0000-0002-0919-568X	Mason Foundation [43120]; Alison Hunter Memorial Foundation [HF 201]	Mason Foundation; Alison Hunter Memorial Foundation	This research was funded and supported by the Mason Foundation (grant number 43120) and the Alison Hunter Memorial Foundation (grant number HF 201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2010, CLIN CHEM, V56, P1183, DOI 10.1373/clinchem.2010.144121; Allantaz F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029979; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ansel KM, 2013, IMMUNOL REV, V253, P5, DOI 10.1111/imr.12062; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Brenu EW, 2012, J AFFECT DISORDERS, V141, P261, DOI 10.1016/j.jad.2012.03.037; Brenu EW, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-88; Brenu EW, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-81; Brenu EW, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-1; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Carruthers BM, 2011, J INTERN MED, V270, P327, DOI 10.1111/j.1365-2796.2011.02428.x; Chen CZ, 2013, IMMUNOL REV, V253, P112, DOI 10.1111/imr.12060; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064795; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; De Guire V, 2013, CLIN BIOCHEM, V46, P846, DOI 10.1016/j.clinbiochem.2013.03.015; Ding S, 2012, ARTHRITIS RHEUM-US, V64, P2953, DOI 10.1002/art.34505; Duttagupta R, 2013, WIRES RNA, V4, P129, DOI 10.1002/wrna.1149; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Frampton D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016872; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Hu J, 2013, TRANSPLANTATION, V95, P991, DOI 10.1097/TP.0b013e31828618d8; Ilhan-Mutlu A, 2012, CANCER INVEST, V30, P615, DOI 10.3109/07357907.2012.708071; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Johnston Samantha, 2013, Clin Epidemiol, V5, P105, DOI 10.2147/CLEP.S39876; Kaushik N, 2005, J CLIN PATHOL, V58, P826, DOI 10.1136/jcp.2005.025718; Kennedy G, 2004, J CLIN PATHOL, V57, P891, DOI 10.1136/jcp.2003.015511; Kerr JR, 2008, J CLIN PATHOL, V61, P730, DOI 10.1136/jcp.2007.053553; Kerr JR, 2008, J INFECT DIS, V197, P1171, DOI 10.1086/533453; Kerr Jonathan R, 2008, Curr Rheumatol Rep, V10, P482; Kirschner Michaela B., 2013, Frontiers in Genetics, V4, P94, DOI 10.3389/fgene.2013.00094; Kirschner Michaela B., 2013, Frontiers in Genetics, V4, P56, DOI 10.3389/fgene.2013.00056; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; LERNER MR, 1981, SCIENCE, V211, P400, DOI 10.1126/science.6164096; Liu LP, 2012, MOL MED REP, V5, P753, DOI 10.3892/mmr.2011.696; Long JM, 2012, EXP NEUROL, V235, P402, DOI 10.1016/j.expneurol.2011.12.043; Mas VR, 2013, AM J TRANSPLANT, V13, P11, DOI 10.1111/j.1600-6143.2012.04313.x; McAlexander Melissa A., 2013, Frontiers in Genetics, V4, P83, DOI 10.3389/fgene.2013.00083; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Mo YY, 2012, CELL MOL LIFE SCI, V69, P3529, DOI 10.1007/s00018-012-1123-1; Mosakhani N, 2012, GENE CHROMOSOME CANC, V51, P1, DOI 10.1002/gcc.20925; Nakamoto M, 2005, HUM MOL GENET, V14, P3813, DOI 10.1093/hmg/ddi397; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; O'Neil Dominic, 2013, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0419s103; Parpart Sonya, 2013, Curr Pathobiol Rep, V1, P71; Peschiaroli A, 2013, ONCOGENE, V32, P797, DOI 10.1038/onc.2012.100; Prins JB, 2006, LANCET, V367, P346, DOI 10.1016/S0140-6736(06)68073-2; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Qiu CX, 2012, SCI REP-UK, V2, DOI 10.1038/srep00318; Robertus JL, 2009, MODERN PATHOL, V22, P547, DOI 10.1038/modpathol.2009.10; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Saito Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047396; See DM, 1998, INTEGR PHYS BEH SCI, V33, P280, DOI 10.1007/BF02688668; Shafi G, 2010, CAN J NEUROL SCI, V37, P177, DOI 10.1017/S0317167100009902; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Slezak S, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-39; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Sun W, 2010, ANNU REV BIOMED ENG, V12, P1, DOI 10.1146/annurev-bioeng-070909-105314; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Verhagen APM, 2011, BIOESSAYS, V33, P674, DOI 10.1002/bies.201100048; Vojdani A, 1997, HUM EXP TOXICOL, V16, P485, DOI 10.1177/096032719701600902; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850; Zhang Y, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-23	70	27	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e102783	10.1371/journal.pone.0102783	http://dx.doi.org/10.1371/journal.pone.0102783			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238588	Green Published, Green Submitted, gold			2022-12-25	WOS:000342491600002
J	Horbach, T; Chi, TF; Gotz, C; Sharma, S; Juffer, AH; Dimova, EY; Kietzmann, T				Horbach, Tina; Chi, Tabughang Franklin; Goetz, Claudia; Sharma, Satyan; Juffer, Andre H.; Dimova, Elitsa Y.; Kietzmann, Thomas			GSK3 beta-Dependent Phosphorylation Alters DNA Binding, Transactivity and Half-Life of the Transcription Factor USF2	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; HELIX-LOOP-HELIX; ACTIVATOR INHIBITOR-1 GENE; INDUCIBLE FACTOR-I; ENDOPLASMIC-RETICULUM; HEME OXYGENASE-1; CELL-CYCLE; EXPRESSION; PROMOTER; PROTEINS	The upstream stimulatory factor 2 (USF2) is a regulator of important cellular processes and is supposed to have also a role during tumor development. However, the knowledge about the mechanisms that control the function of USF2 is limited. The data of the current study show that USF2 function is regulated by phosphorylation and identified GSK3 beta as an USF2-phosphorylating kinase. The phosphorylation sites within USF2 could be mapped to serine 155 and threonine 230. In silico analyses of the 3-dimensional structure revealed that phosphorylation of USF2 by GSK3 beta converts it to a more open conformation which may influence transactivity, DNA binding and target gene expression. Indeed, experiments with GSK3 beta- deficient cells revealed that USF2 transactivity, DNA binding and target gene expression were reduced upon lack of GSK3 beta. Further, experiments with USF2 variants mimicking GSK3 beta phosphorylated USF2 in GSK3 beta-deficient cells showed that phosphorylation of USF2 by GSK3 beta did not affect cell proliferation but increased cell migration. Together, this study reports a new mechanism by which USF2 may contribute to cancerogenesis.	[Horbach, Tina; Chi, Tabughang Franklin; Sharma, Satyan; Juffer, Andre H.; Dimova, Elitsa Y.; Kietzmann, Thomas] Univ Oulu, Bioctr Oulu, Fac Biochem & Mol Med, Oulu, Finland; [Horbach, Tina] Univ Kaiserslautern, Dept Chem, D-67663 Kaiserslautern, Germany; [Goetz, Claudia] Univ Saarland, Homburg, Germany	University of Oulu; University of Kaiserslautern; Saarland University	Kietzmann, T (corresponding author), Univ Oulu, Bioctr Oulu, Fac Biochem & Mol Med, Oulu, Finland.	tkietzm@gwdg.de		Dimova, Elitsa/0000-0003-2745-8145; Kietzmann, Thomas/0000-0003-0242-8636; Juffer, Andre/0000-0003-3533-0520	Wilhelm Sander Foundation [2008.043.1]; Biocenter Oulu; Sigrid Juselius Foundation; Finnish Academy of Science	Wilhelm Sander Foundation; Biocenter Oulu; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Academy of Science(Academy of Finland)	This work was supported by grants from the Wilhelm Sander Foundation (Grant 2008.043.1) to EYD, and from Biocenter Oulu, the Sigrid Juselius Foundation and the Finnish Academy of Science to TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Astbury C, 2001, GENE CHROMOSOME CANC, V31, P143, DOI 10.1002/gcc.1128; BAXEVANIS AD, 1993, CURR OPIN GENET DEV, V3, P278, DOI 10.1016/0959-437X(93)90035-N; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chang JTC, 2005, MOL CARCINOGEN, V44, P183, DOI 10.1002/mc.20129; Chen BK, 2007, MOL BIOL CELL, V18, P1118, DOI 10.1091/mbc.E06-09-0797; Chen N, 2006, ONCOGENE, V25, P579, DOI 10.1038/sj.onc.1209079; Cheung E, 1999, BIOCHEM J, V344, P145, DOI 10.1042/0264-6021:3440145; Christensen LL, 2012, J INT CANC; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Corre S, 2005, PIGM CELL RES, V18, P337, DOI 10.1111/j.1600-0749.2005.00262.x; Corre S, 2009, J BIOL CHEM, V284, P18851, DOI 10.1074/jbc.M808605200; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Darrington RS, 2012, INT J CANCER, V131, pE872, DOI 10.1002/ijc.27620; Davis PL, 1999, ONCOGENE, V18, P6000, DOI 10.1038/sj.onc.1202990; Dimova EY, 2006, J BIOL CHEM, V281, P2999, DOI 10.1074/jbc.M512078200; Dimova EY, 2005, THROMB HAEMOSTASIS, V93, P1176, DOI 10.1160/TH04-11-0761; FIOL CJ, 1990, J BIOL CHEM, V265, P6061; Flugel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07; Flugel D, 2012, BLOOD, V119, P1292, DOI 10.1182/blood-2011-08-375014; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Fujii-Yamamoto H, 2005, J BIOL CHEM, V280, P12976, DOI 10.1074/jbc.M412224200; Galibert MD, 2001, EMBO J, V20, P5022, DOI 10.1093/emboj/20.17.5022; Galibert MD, 1997, J IMMUNOL, V159, P6176; Ganjam GK, 2009, J BIOL CHEM, V284, P30783, DOI 10.1074/jbc.M109.045260; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; Groenen PMA, 1996, GENOMICS, V38, P141, DOI 10.1006/geno.1996.0609; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Hill-Kapturczak N, 2003, AM J PHYSIOL-RENAL, V285, pF515, DOI 10.1152/ajprenal.00137.2003; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Immenschuh S, 1998, BIOCHEM J, V334, P141, DOI 10.1042/bj3340141; Ismail PM, 1999, ONCOGENE, V18, P5582, DOI 10.1038/sj.onc.1202932; Jaiswal AS, 2001, J CELL BIOCHEM, V81, P262, DOI 10.1002/1097-4644(20010501)81:2<262::AID-JCB1041>3.0.CO;2-R; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Kitagawa K, 2009, ONCOGENE, V28, P2393, DOI 10.1038/onc.2009.111; Landa I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000637; LEFRANCOISMARTINEZ AM, 1995, J BIOL CHEM, V270, P2640, DOI 10.1074/jbc.270.6.2640; Liu Q, 2004, P NATL ACAD SCI USA, V101, P4302, DOI 10.1073/pnas.0400265101; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo X, 1996, P NATL ACAD SCI USA, V93, P1308, DOI 10.1073/pnas.93.3.1308; Luo X, 1996, MOL CELL BIOL, V16, P1367; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mulholland DJ, 2006, ONCOGENE, V25, P329, DOI 10.1038/sj.onc.1209020; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Nowak M, 2005, MOL CELL BIOL, V25, P1537, DOI 10.1128/MCB.25.4.1537-1548.2005; Nupponen NN, 1998, AM J PATHOL, V153, P141, DOI 10.1016/S0002-9440(10)65554-X; Ocejo-Garcia M, 2005, J PATHOL, V206, P151, DOI 10.1002/path.1775; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Patel S, 2004, BIOCHEM SOC T, V32, P803, DOI 10.1042/BST0320803; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Qyang YB, 1999, MOL CELL BIOL, V19, P1508; REISMAN D, 1993, NUCLEIC ACIDS RES, V21, P345, DOI 10.1093/nar/21.2.345; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sadowski I, 1989, NUCL ACIDS RES, V17; Samoylenko A, 2001, BLOOD, V97, P2657, DOI 10.1182/blood.V97.9.2657; Samoylenko A, 2008, ANTIOXID REDOX SIGN, V10, P1163, DOI 10.1089/ars.2007.1968; Sayasith K, 2005, J BIOL CHEM, V280, P28885, DOI 10.1074/jbc.M413434200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sirito M, 1998, P NATL ACAD SCI USA, V95, P3758, DOI 10.1073/pnas.95.7.3758; SIRITO M, 1994, NUCLEIC ACIDS RES, V22, P427, DOI 10.1093/nar/22.3.427; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; Terragni J, 2011, J BIOL CHEM, V286, P36215, DOI 10.1074/jbc.M111.246116; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Viollet B, 1996, J BIOL CHEM, V271, P1405, DOI 10.1074/jbc.271.3.1405; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; Xiao QX, 2002, AM J PHYSIOL-HEART C, V283, pH213, DOI 10.1152/ajpheart.01085.2001; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	73	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107914	10.1371/journal.pone.0107914	http://dx.doi.org/10.1371/journal.pone.0107914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238393	gold, Green Published, Green Submitted			2022-12-25	WOS:000342491600064
J	Benilova, I; Gallardo, R; Ungureanu, AA; Cano, VC; Snellinx, A; Ramakers, M; Bartic, C; Rousseau, F; Schymkowitz, J; De Strooper, B				Benilova, Iryna; Gallardo, Rodrigo; Ungureanu, Andreea-Alexandra; Cano, Virginia Castillo; Snellinx, An; Ramakers, Meine; Bartic, Carmen; Rousseau, Frederic; Schymkowitz, Joost; De Strooper, Bart			The Alzheimer Disease Protective Mutation A2T Modulates Kinetic and Thermodynamic Properties of Amyloid-beta (A beta) Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR PROTEIN GENE; APP GENE; HIPPOCAMPAL-NEURONS; FIBRILLAR OLIGOMERS; PATHOGENIC MUTATION; TOTTORI D7N; ENGLISH H6R; N-TERMINUS; PEPTIDE; AMYLOIDOGENESIS	Missense mutations in alanine 673 of the amyloid precursor protein (APP), which corresponds to the second alanine of the amyloid beta (A beta) sequence, have dramatic impact on the risk for Alzheimer disease; A2V is causative, and A2T is protective. Assuming a crucial role of amyloid-A beta in neurodegeneration, we hypothesized that both A2V and A2T mutations cause distinct changes in A beta properties that may at least partially explain these completely different phenotypes. Using human APP-overexpressing primary neurons, we observed significantly decreased A beta production in the A2T mutant along with an enhanced A beta generation in the A2V mutant confirming earlier data from non-neuronal cell lines. More importantly, thioflavin T fluorescence assays revealed that the mutations, while having little effect on A beta 42 peptide aggregation, dramatically change the properties of the A beta 40 pool with A2V accelerating and A2T delaying aggregation of the A beta peptides. In line with the kinetic data, A beta A2T demonstrated an increase in the solubility at equilibrium, an effect that was also observed in all mixtures of the A2T mutant with the wild type A beta 40. We propose that in addition to the reduced beta-secretase cleavage of APP, the impaired propensity to aggregate may be part of the protective effect conferred by A2T substitution. The interpretation of the protective effect of this mutation is thus much more complicated than proposed previously.	[Benilova, Iryna; Snellinx, An; De Strooper, Bart] Univ Leuven, VIB Ctr Biol Dis, B-3000 Louvain, Belgium; [Benilova, Iryna; Snellinx, An; De Strooper, Bart] Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Benilova, Iryna; Snellinx, An; De Strooper, Bart] Univ Leuven, Leuven Inst Neurodegenerat Dis, B-3000 Louvain, Belgium; [Gallardo, Rodrigo; Cano, Virginia Castillo; Ramakers, Meine; Rousseau, Frederic; Schymkowitz, Joost] Univ Leuven, VIB Switch Lab, B-3000 Louvain, Belgium; [Gallardo, Rodrigo; Cano, Virginia Castillo; Ramakers, Meine; Rousseau, Frederic; Schymkowitz, Joost] Univ Leuven, SWITCH Lab, Dept Cellular & Mol Med, B-3000 Louvain, Belgium; [Ungureanu, Andreea-Alexandra; Bartic, Carmen] Univ Leuven, Lab Solid State Phys & Magnetism, B-3000 Louvain, Belgium; [Ungureanu, Andreea-Alexandra; Bartic, Carmen] IMEC, B-3001 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven; IMEC	De Strooper, B (corresponding author), Univ Leuven, Ctr Human Genet, VIB Ctr Biol Dis, Herestr 49,Box 602, B-3000 Louvain, Belgium.	bart.destrooper@cme.vib-kuleuven.be	Bartic, Carmen/I-1310-2013; Rousseau, Frederic/J-9044-2016; Schymkowitz, Joost/AAV-3680-2021; Benilova, Iryna/H-6533-2019; de+Strooper, Bart/Z-1638-2019; Bartic, Carmen/AAA-6514-2022; Schymkowitz, Joost/K-7764-2016	Rousseau, Frederic/0000-0002-9189-7399; Bartic, Carmen/0000-0001-9577-2844; Ramakers, Meine/0000-0002-9417-4196; Gallardo, Rodrigo/0000-0003-1584-3564; Schymkowitz, Joost/0000-0003-2020-0168	VIB; University of Leuven; Funds for Scientific Research Flanders; Flanders Institute for Science and Technology; Federal Office for Scientific Affairs of Belgium (Belspo) [P7/16]; KULeuven/Flemish Government	VIB; University of Leuven(KU Leuven); Funds for Scientific Research Flanders; Flanders Institute for Science and Technology; Federal Office for Scientific Affairs of Belgium (Belspo); KULeuven/Flemish Government(KU Leuven)	This work was supported by grants from VIB, University of Leuven, Funds for Scientific Research Flanders, Flanders Institute for Science and Technology, and the Federal Office for Scientific Affairs of Belgium (Belspo), Grant IUAP P7/16, and a Methusalem grant of the KULeuven/Flemish Government (to B. D. S.), and part of this work was done in the frame of ERA-NET NEURON "A beta ID."	Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Broersen K, 2011, PROTEIN ENG DES SEL, V24, P743, DOI 10.1093/protein/gzr020; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Christopeit T, 2005, PROTEIN SCI, V14, P2125, DOI 10.1110/ps.051470405; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; De Strooper B, 2012, NATURE, V488, P38, DOI 10.1038/488038a; DESTROOPER B, 1995, EMBO J, V14, P4932, DOI 10.1002/j.1460-2075.1995.tb00176.x; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; Dubnovitsky A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066101; Eckman CB, 1997, HUM MOL GENET, V6, P2087, DOI 10.1093/hmg/6.12.2087; Giaccone G, 2010, ACTA NEUROPATHOL, V120, P803, DOI 10.1007/s00401-010-0747-1; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Golde TE, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt178; Hardy J, 2014, J INTERN MED, V275, P296, DOI 10.1111/joim.12192; Hashimoto Y, 2014, J NEUROCHEM, V130, P291, DOI 10.1111/jnc.12717; Hori Y, 2007, J BIOL CHEM, V282, P4916, DOI 10.1074/jbc.M608220200; Hortschansky P, 2005, PROTEIN SCI, V14, P2915, DOI 10.1110/ps.051585905; Hortschansky P, 2005, PROTEIN SCI, V14, P1753, DOI 10.1110/ps.041266605; JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kam TI, 2013, J CLIN INVEST, V123, P2791, DOI 10.1172/JCI66827; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kero M, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.09.017; Kim W, 2008, J MOL BIOL, V377, P565, DOI 10.1016/j.jmb.2007.12.079; Kulic L, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.109; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Lin SY, 2003, INT J BIOL MACROMOL, V32, P173, DOI 10.1016/S0141-8130(03)00051-5; Meinhardt J, 2007, PROTEIN SCI, V16, P1214, DOI 10.1110/ps.062734207; Miles LA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01302; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Murakami K, 2010, GERIATR GERONTOL INT, V10, pS169, DOI 10.1111/j.1447-0594.2010.00598.x; Ono K, 2010, J BIOL CHEM, V285, P23184, DOI 10.1074/jbc.M109.086496; PEACOCK ML, 1993, NEUROLOGY, V43, P1254, DOI 10.1212/WNL.43.6.1254; Qahwash I, 2003, J BIOL CHEM, V278, P23187, DOI 10.1074/jbc.M213298200; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Teplow DB, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt203; Vandersteen A, 2012, J BIOL CHEM, V287, P36732, DOI 10.1074/jbc.M112.394635; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Zhou L, 2011, EMBO MOL MED, V3, P291, DOI 10.1002/emmm.201100138	45	116	116	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					30977	30989		10.1074/jbc.M114.599027	http://dx.doi.org/10.1074/jbc.M114.599027			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25253695	hybrid, Green Published			2022-12-25	WOS:000344549900009
J	Potter, MC; Wozniak, KM; Callizot, N; Slusher, BS				Potter, Michelle C.; Wozniak, Krystyna M.; Callizot, Noelle; Slusher, Barbara S.			Glutamate Carboxypeptidase II Inhibition Behaviorally and Physiologically Improves Pyridoxine-Induced Neuropathy in Rats	PLOS ONE			English	Article							N-ACETYLASPARTYLGLUTAMATE NAAG; PERIPHERAL NERVOUS-SYSTEM; THIOL-BASED INHIBITORS; ISCHEMIC BRAIN-INJURY; SENSORY NEUROPATHY; NAALADASE INHIBITION; DIABETIC-NEUROPATHY; GROWTH-FACTOR; PAIN MODEL; NEURONS	Pyridoxine is used as a supplement for treating conditions such as vitamin deficiency as well as neurological disorders such as depression, epilepsy and autism. A significant neurologic complication of pyridoxine therapy is peripheral neuropathy thought to be a result of long-term and high dose usage. Although pyridoxine-induced neuropathy is transient and can remit after its withdrawal, the process of complete recovery can be slow. Glutamate carboxypeptidase II (GCP II) inhibition has been shown to improve symptoms of both chemotherapy-and diabetic-induced neuropathy. This study evaluated if GCP II inhibition could behaviorally and physiologically improve pyridoxine-induced neuropathy. In the current study, high doses of pyridoxine (400 mg/kg, twice a day for seven days) were used to induce neuropathy in rats. An orally bioavailable GCP II inhibitor, 2-(3-mercaptopropyl) pentanedioic acid (2-MPPA), was administered daily at a dose of 30 mg/kg starting from the onset of pyridoxine injections. Body weight, motor coordination, heat sensitivity, electromyographical (EMG) parameters and nerve morphological features were monitored. The results show beneficial effects of GCP II inhibition including normalization of hot plate reaction time, foot fault improvements and increased open field distance travelled. H wave frequency, amplitude and latency as well as sensory nerve conduction velocity (SNCV) were also significantly improved by 2-MPPA. Lastly, GCP II inhibition resulted in morphological protection in the spinal cord and sensory fibers in the lumbar region dorsal root ganglia (DRG). In conclusion, inhibition of GCP II may be beneficial against the peripheral sensory neuropathy caused by pyridoxine.	[Potter, Michelle C.; Wozniak, Krystyna M.; Slusher, Barbara S.] Johns Hopkins Univ, Sch Med, Brain Sci Inst, Baltimore, MD 21218 USA; [Potter, Michelle C.; Slusher, Barbara S.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Slusher, Barbara S.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Slusher, Barbara S.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Callizot, Noelle] Neuro Sys, Dept Neuropharmacol, Gardanne, France	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Slusher, BS (corresponding author), Johns Hopkins Univ, Sch Med, Brain Sci Inst, Baltimore, MD 21218 USA.	bslusher@jhmi.edu			Eisai Inc.; National Institutes of Health [R01 - GCPII 90055369]; Johns Hopkins Brain Science Institute; NATIONAL CANCER INSTITUTE [R01CA161056] Funding Source: NIH RePORTER	Eisai Inc.(Eisai Co Ltd); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Brain Science Institute(Johns Hopkins University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Eisai Inc. (http://us.eisai.com/wps/wcm/connect/Eisai/Home/), National Institutes of Health (www.NIH.gov) grant (R01 - GCPII 90055369) and the Johns Hopkins Brain Science Institute (www.brainscienceinstitute.org). All funding was received by BSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adedoyin MO, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-60; ALBIN RL, 1987, NEUROLOGY, V37, P1729, DOI 10.1212/WNL.37.11.1729; Arkaravichien T, 2003, FOOD CHEM TOXICOL, V41, P1375, DOI 10.1016/S0278-6915(03)00142-X; Bacich DJ, 2005, J NEUROCHEM, V95, P314, DOI 10.1111/j.1471-4159.2005.03361.x; Barinka C, 2012, CURR MED CHEM, V19, P856, DOI 10.2174/092986712799034888; Berent-Spillson A, 2004, J NEUROCHEM, V89, P90, DOI 10.1111/j.1471-4159.2003.02321.x; Bergeron R, 2012, CURR MED CHEM, V19, P1360, DOI 10.2174/092986712799462685; Bosy-Westphal A, 2001, ANN NUTR METAB, V45, P255, DOI 10.1159/000046735; Bruno V, 1998, J NEUROSCI, V18, P9594; Callizot N, 2001, NEUROBIOL DIS, V8, P626, DOI 10.1006/nbdi.2001.0408; Carozzi VA, 2010, NEUROTOX RES, V17, P380, DOI 10.1007/s12640-009-9114-1; Carozzi VA, 2008, J ANAT, V213, P539, DOI 10.1111/j.1469-7580.2008.00984.x; Carpenter KJ, 2003, NEUROPEPTIDES, V37, P298, DOI 10.1016/j.npep.2003.08.001; Chattopadhyay M, 2003, EUR J NEUROSCI, V17, P732, DOI 10.1046/j.1460-9568.2003.02500.x; Chen SR, 2002, J PHARMACOL EXP THER, V300, P662, DOI 10.1124/jpet.300.2.662; Cliffer KD, 1998, MUSCLE NERVE, V21, P1405, DOI 10.1002/(SICI)1097-4598(199811)21:11<1405::AID-MUS7>3.3.CO;2-D; Fricker AC, 2009, NEUROPHARMACOLOGY, V56, P1060, DOI 10.1016/j.neuropharm.2009.03.002; Ghadge GD, 2003, P NATL ACAD SCI USA, V100, P9554, DOI 10.1073/pnas.1530168100; Head KA, 2006, ALTERN MED REV, V11, P294; Helgren ME, 1997, J NEUROSCI, V17, P372, DOI 10.1523/JNEUROSCI.17-01-00372.1997; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Jortner BS, 2000, TOXICOL PATHOL, V28, P54, DOI 10.1177/019262330002800108; Kobayashi C, 2012, BIOL PHARM BULL, V35, P532, DOI 10.1248/bpb.35.532; Kozela E, 2005, PSYCHOPHARMACOLOGY, V183, P275, DOI 10.1007/s00213-005-0182-5; Lipton Stuart A, 2004, NeuroRx, V1, P101, DOI 10.1602/neurorx.1.1.101; Long JB, 2005, EUR J PHARMACOL, V508, P115, DOI 10.1016/j.ejphar.2004.12.008; Losi G, 2004, NEUROPHARMACOLOGY, V46, P490, DOI 10.1016/j.neuropharm.2003.10.007; Majer P, 2003, J MED CHEM, V46, P1989, DOI 10.1021/jm020515w; Majer P, 2006, J MED CHEM, V49, P2876, DOI 10.1021/jm051019l; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; Neale JH, 2011, J NEUROCHEM, V119, P891, DOI 10.1111/j.1471-4159.2011.07380.x; Ollivier-Lanvin K, 2010, EXP NEUROL, V221, P198, DOI 10.1016/j.expneurol.2009.10.023; PARRY GJ, 1985, NEUROLOGY, V35, P1466, DOI 10.1212/WNL.35.10.1466; Peng XQ, 2010, EUR J PHARMACOL, V627, P156, DOI 10.1016/j.ejphar.2009.10.062; Perry TA, 2004, EXP NEUROL, V190, P133, DOI 10.1016/j.expneurol.2004.07.013; Perry T, 2007, EXP NEUROL, V203, P293, DOI 10.1016/j.expneurol.2006.09.028; SCHAUMBURG H, 1983, NEW ENGL J MED, V309, P445, DOI 10.1056/NEJM198308253090801; Slusher BS, 1999, NAT MED, V5, P1396, DOI 10.1038/70971; Takatsu Y, 2011, BRAIN RES, V1371, P82, DOI 10.1016/j.brainres.2010.11.048; Thomas AG, 2009, J NEUROVIROL, V15, P449, DOI 10.3109/13550280903350598; Urazaev AK, 2001, NEUROSCIENCE, V107, P697, DOI 10.1016/S0306-4522(01)00393-1; van der Post JP, 2005, BRIT J CLIN PHARMACO, V60, P128, DOI 10.1111/j.1365-2125.2005.02396.x; Vornov JJ, 2013, J PHARMACOL EXP THER, V346, P406, DOI 10.1124/jpet.113.205039; Witkin JM, 2002, NEUROPHARMACOLOGY, V43, P348, DOI 10.1016/S0028-3908(02)00124-7; Wroblewska B, 1997, J NEUROCHEM, V69, P174; Xi ZX, 2010, J NEUROCHEM, V112, P564, DOI 10.1111/j.1471-4159.2009.06478.x; Yamada T, MOL PAIN, V8, P67; Yamamoto T, 2004, EUR J NEUROSCI, V20, P483, DOI 10.1111/j.1460-9568.2004.03504.x; Zhang W, 2006, J NEUROL SCI, V247, P217, DOI 10.1016/j.jns.2006.05.052; Zhang W, 2002, J NEUROL SCI, V194, P21, DOI 10.1016/S0022-510X(01)00670-0; Zhong CL, 2005, J NEUROTRAUM, V22, P266, DOI 10.1089/neu.2005.22.266	51	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e102936	10.1371/journal.pone.0102936	http://dx.doi.org/10.1371/journal.pone.0102936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254647	Green Published, Green Submitted, gold			2022-12-25	WOS:000344862300002
J	Zhang, J; Sun, X; Zheng, SX; Liu, X; Jin, JH; Ren, Y; Luo, JH				Zhang, Jie; Sun, Xin; Zheng, Sixin; Liu, Xiao; Jin, Jinghua; Ren, Yi; Luo, Jianhong			Myelin Basic Protein Induces Neuron-Specific Toxicity by Directly Damaging the Neuronal Plasma Membrane	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; AXONAL REGENERATION; SPINAL-CORD; CELL-DEATH; IN-VITRO; HIPPOCAMPAL DEMYELINATION; PHOSPHOLIPID ASYMMETRY; UNSTRUCTURED PROTEINS; ACTIN-BINDING	The central nervous system (CNS) insults may cause massive demyelination and lead to the release of myelin-associated proteins including its major component myelin basic protein (MBP). MBP is reported to induce glial activation but its effect on neurons is still little known. Here we found that MBP specifically bound to the extracellular surface of the neuronal plasma membrane and induced neurotoxicity in vitro. This effect of MBP on neurons was basicity-dependent because the binding was blocked by acidic lipids and competed by other basic proteins. Further studies revealed that MBP induced damage to neuronal membrane integrity and function by depolarizing the resting membrane potential, increasing the permeability to cations and other molecules, and decreasing the membrane fluidity. At last, artificial liposome vesicle assay showed that MBP directly disturbed acidic lipid bilayer and resulted in increased membrane permeability. These results revealed that MBP induces neurotoxicity through its direct interaction with acidic components on the extracellular surface of neuronal membrane, which may suggest a possible contribution of MBP to the pathogenesis in the CNS disorders with myelin damage.	[Zhang, Jie; Sun, Xin; Zheng, Sixin; Liu, Xiao; Jin, Jinghua; Luo, Jianhong] Zhejiang Univ, Sch Med, Zhejiang Prov Key Lab Neurobiol, Dept Neurobiol,Key Lab Med Neurobiol,Minist Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Xin] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Neurobiol, Baltimore, MD 21205 USA; [Ren, Yi] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA	Zhejiang University; Johns Hopkins University; State University System of Florida; Florida State University	Luo, JH (corresponding author), Zhejiang Univ, Sch Med, Zhejiang Prov Key Lab Neurobiol, Dept Neurobiol,Key Lab Med Neurobiol,Minist Hlth, Hangzhou 310003, Zhejiang, Peoples R China.	luojianhong@zju.edu.cn	Luo, jian/HGE-7331-2022; ZHANG, Jie/S-6936-2019	ZHANG, Jie/0000-0002-5492-8088; Sun, Xin/0000-0001-8922-6361	National Natural Science Foundation of China [81171164]; National Basic Research Program of China [2010CB912002, 2014CB910300]; Fundamental Research Funds for the Central Universities of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was support by the grants from National Natural Science Foundation of China (81171164) to Jianhong Luo, National Basic Research Program of China (2010CB912002 and 2014CB910300) to Jianhong Luo, and by the Fundamental Research Funds for the Central Universities of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUGHAZALEH RI, 1992, J MEMBRANE BIOL, V128, P153; Aggarwal S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001577; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; BLAKEMORE WF, 1972, J NEUROCYTOL, V1, P413, DOI 10.1007/BF01102943; Boggs JM, 2006, CELL MOL LIFE SCI, V63, P1945, DOI 10.1007/s00018-006-6094-7; Boggs J.M., 1982, LIPID PROTEIN INTERA, P1; Boggs JM, 2006, BIOCHEMISTRY-US, V45, P391, DOI 10.1021/bi0519194; Boggs JM, 2005, BIOCHEMISTRY-US, V44, P3524, DOI 10.1021/bi0473760; Boggs JM, 2000, BIOCHEMISTRY-US, V39, P7799, DOI 10.1021/bi0002129; BOGGS JM, 1977, BIOCHEMISTRY-US, V16, P5420, DOI 10.1021/bi00644a003; Bonetti B, 1997, ANN NEUROL, V42, P74, DOI 10.1002/ana.410420113; BOOTH DA, 1962, J NEUROCHEM, V9, P265, DOI 10.1111/j.1471-4159.1962.tb09448.x; Brosnan CF, 1996, BRAIN PATHOL, V6, P243, DOI 10.1111/j.1750-3639.1996.tb00853.x; Bruckheimer EM, 1996, J LEUKOCYTE BIOL, V59, P784, DOI 10.1002/jlb.59.6.784; Businaro R, 2002, GLIA, V37, P83, DOI 10.1002/glia.10018; Calderon TM, 2006, J NEUROIMMUNOL, V177, P27, DOI 10.1016/j.jneuroim.2006.05.003; Cammer W, 1999, J NEUROL SCI, V168, P116, DOI 10.1016/S0022-510X(99)00181-1; CARLTON WILLIAM W., 1967, LIFE SCI, V6, P11, DOI 10.1016/0024-3205(67)90356-6; Carre JL, 2002, NEUROSCI LETT, V330, P17, DOI 10.1016/S0304-3940(02)00709-7; Daigle JL, 2001, CANCER RES, V61, P8859; DOBROWOLSKI Z, 1986, EUR J CELL BIOL, V41, P65; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; DSouza SD, 1996, J EXP MED, V184, P2361, DOI 10.1084/jem.184.6.2361; Dutta R, 2013, ANN NEUROL, V73, P637, DOI 10.1002/ana.23860; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Filbin MT, 2008, NEURON, V60, P740, DOI 10.1016/j.neuron.2008.12.001; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GAHWILER BH, 1979, NEUROSCI LETT, V11, P317, DOI 10.1016/0304-3940(79)90015-6; GENDELMAN HE, 1985, ANN NEUROL, V18, P324, DOI 10.1002/ana.410180309; Geurts JJG, 2007, J NEUROPATH EXP NEUR, V66, P819, DOI 10.1097/nen.0b013e3181461f54; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Hagemeier K, 2013, GLIA, V61, P1712, DOI 10.1002/glia.22552; Harauz G, 2004, MICRON, V35, P503, DOI 10.1016/j.micron.2004.04.005; Harauz G, 2009, BIOCHEMISTRY-US, V48, P8094, DOI 10.1021/bi901005f; HASTIE AT, 1987, AM REV RESPIR DIS, V135, P848, DOI 10.1164/arrd.1987.135.4.848; Hill CMD, 2005, BIOCHEMISTRY-US, V44, P16672, DOI 10.1021/bi050646+; Hoffmann J A, 1990, Protein Expr Purif, V1, P127, DOI 10.1016/1046-5928(90)90005-J; Hoffmann K, 2008, EXP NEUROL, V210, P308, DOI 10.1016/j.expneurol.2007.11.005; Jeon SB, 2008, J IMMUNOL, V181, P8077, DOI 10.4049/jimmunol.181.11.8077; JO EJ, 1995, BIOCHEMISTRY-US, V34, P13705, DOI 10.1021/bi00041a053; Klein C, 2003, BRAIN RES PROTOC, V11, P46, DOI 10.1016/S1385-299X(03)00016-3; Kuhlmann T, 2002, BRAIN, V125, P2202, DOI 10.1093/brain/awf235; Kumar S, 2002, J NEUROCHEM, V82, P110, DOI 10.1046/j.1471-4159.2002.00943.x; LaPlaca MC, 2009, IEEE ENG MED BIO, P1113, DOI 10.1109/IEMBS.2009.5334457; LAUBSCHER A, 1979, EXPERIENTIA, V35, P1081, DOI 10.1007/BF01949954; LAUBSCHER A, 1979, N-S ARCH PHARMACOL, V310, P87, DOI 10.1007/BF00499878; Lee DHS, 2003, NAT REV DRUG DISCOV, V2, P872, DOI 10.1038/nrd1228; LEHNINGER AL, 1968, P NATL ACAD SCI USA, V60, P1069, DOI 10.1073/pnas.60.4.1069; Libich DS, 2003, PROTEIN SCI, V12, P1507, DOI 10.1110/ps.0303603; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Liuzzo JP, 1999, MOL MED, V5, P334, DOI 10.1007/BF03402069; MARTIN R, 1990, J IMMUNOL, V145, P540; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; McMahon EJ, 2002, J NEUROIMMUNOL, V130, P32, DOI 10.1016/S0165-5728(02)00205-9; MERRITT EA, 1994, PROTEIN SCI, V3, P166; Meyer R, 2001, J NEUROSCI, V21, P6214, DOI 10.1523/JNEUROSCI.21-16-06214.2001; MODESTI NM, 1986, BIOCHEM BIOPH RES CO, V136, P482, DOI 10.1016/0006-291X(86)90466-3; MORGAN DML, 1989, J CELL SCI, V94, P553; Moscarello MA, 1997, ALTSCHUL SY, V4, P13; Powl AM, 2008, BIOCHEMISTRY-US, V47, P4317, DOI 10.1021/bi702409t; Prasad K, 1995, J BIOL CHEM, V270, P30551, DOI 10.1074/jbc.270.51.30551; Qiu S, 2009, J BIOL CHEM, V284, P20285, DOI 10.1074/jbc.M109.004960; Quinn Peter J, 2002, Subcell Biochem, V36, P39; READHEAD C, 1990, ANN NY ACAD SCI, V605, P280; SANKARAM MB, 1989, BIOCHEMISTRY-US, V28, P9699, DOI 10.1021/bi00451a024; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; Smith T, 2000, NAT MED, V6, P62, DOI 10.1038/71548; South SA, 2000, GLIA, V29, P81, DOI 10.1002/(SICI)1098-1136(20000101)29:1<81::AID-GLIA8>3.0.CO;2-O; SPECTOR AA, 1985, J LIPID RES, V26, P1015; Stapulionis R, 2008, J IMMUNOL, V180, P3946, DOI 10.4049/jimmunol.180.6.3946; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Sun X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009380; TERBEEST MBA, 1993, EUR J BIOCHEM, V211, P689; Tian Y, 2008, J NEUROSURG, V109, P881, DOI 10.3171/JNS/2008/109/11/0881; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tsiperson V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015748; Tzeng SF, 1999, NEUROCHEM RES, V24, P255, DOI 10.1023/A:1022514105129; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Vallieres N, 2006, GLIA, V53, P103, DOI 10.1002/glia.20266; Verkleij AJ, 2000, J MEMBRANE BIOL, V178, P1, DOI 10.1007/s002320010009; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; WESTALL FC, 1974, IMMUNOCHEMISTRY, V11, P513, DOI 10.1016/0019-2791(74)90124-4; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zhao HY, 2012, J NEUROSCI, V32, P4600, DOI 10.1523/JNEUROSCI.6184-11.2012	87	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108646	10.1371/journal.pone.0108646	http://dx.doi.org/10.1371/journal.pone.0108646			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255088	Green Published, gold, Green Submitted			2022-12-25	WOS:000344862300100
J	Ceasar, SA; Hodge, A; Baker, A; Baldwin, SA				Ceasar, S. Antony; Hodge, Angela; Baker, Alison; Baldwin, Stephen A.			Phosphate Concentration and Arbuscular Mycorrhizal Colonisation Influence the Growth, Yield and Expression of Twelve PHT1 Family Phosphate Transporters in Foxtail Millet (Setaria italica)	PLOS ONE			English	Article							PHOSPHORUS DEFICIENCY; KINETIC-PROPERTIES; GENOME SEQUENCE; LUPINUS-ALBUS; HOST-PLANT; RICE ROOTS; BARLEY; GENE; ARABIDOPSIS; FUNGI	Phosphorus (P) is an essential element which plays several key roles in all living organisms. Setaria italica (foxtail millet) is a model species for panacoid grasses including several millet species widely grown in arid regions of Asia and Africa, and for the bioenergy crop switchgrass. The growth responses of S. italica to different levels of inorganic phosphate (Pi) and to colonisation with the arbuscular mycorrhizal fungus Funneliformis mosseae (syn. Glomus mosseae) were studied. Phosphate is taken up from the environment by the PHT1 family of plant phosphate transporters, which have been well characterized in several plant species. Bioinformatic analysis identified 12 members of the PHT1 gene family (SiPHT1;1-1;12) in S. italica, and RT and qPCR analysis showed that most of these transporters displayed specific expression patterns with respect to tissue, phosphate status and arbuscular mycorrhizal colonisation. SiPHT1;2 was found to be expressed in all tissues and in all growth conditions tested. In contrast, expression of SiPHT1;4 was induced in roots after 15 days growth in hydroponic medium of low Pi concentration. Expression of SiPHT1;8 and SiPHT1;9 in roots was selectively induced by colonisation with F. mosseae. SiPHT1;3 and SiPHT1;4 were found to be predominantly expressed in leaf and root tissues respectively. Several other transporters were expressed in shoots and leaves during growth in low Pi concentrations. This study will form the basis for the further characterization of these transporters, with the long term goal of improving the phosphate use efficiency of foxtail millet.	[Ceasar, S. Antony; Baker, Alison] Univ Leeds, Fac Biol Sci, Ctr Plant Sci, Leeds, W Yorkshire, England; [Ceasar, S. Antony; Baker, Alison] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; [Baldwin, Stephen A.] Univ Leeds, Fac Biol Sci, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; [Baldwin, Stephen A.] Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds, W Yorkshire, England; [Hodge, Angela] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	University of Leeds; University of Leeds; University of Leeds; University of Leeds; University of York - UK	Baker, A (corresponding author), Univ Leeds, Fac Biol Sci, Ctr Plant Sci, Leeds, W Yorkshire, England.	a.baker@leeds.ac.uk; s.a.baldwin@leeds.ac.uk	CEASAR, STANISLAUS ANTONY/P-2479-2017	CEASAR, STANISLAUS ANTONY/0000-0003-4106-1531; Baker, Alison/0000-0003-2181-4057	European Union [FP7-People-2-11-IIF-Prposal-300672-Acronym IMPACT]	European Union(European Commission)	This work was funded by the European Union through a Marie Curie International Incoming Fellowship to SAC (Fellowship Number: FP7-People-2-11-IIF-Prposal-300672-Acronym IMPACT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai PH, 2009, PLANT J, V57, P798, DOI 10.1111/j.1365-313X.2008.03726.x; Allen MF, 2007, VADOSE ZONE J, V6, P291, DOI 10.2136/vzj2006.0068; Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; [Anonymous], 1982, METHODS PRINCIPLES M; Atkin OK, 2009, NEW PHYTOL, V182, P188, DOI 10.1111/j.1469-8137.2008.02727.x; ATKINSON D, 1973, NEW PHYTOL, V72, P101, DOI 10.1111/j.1469-8137.1973.tb02014.x; Bates TR, 1996, PLANT CELL ENVIRON, V19, P529, DOI 10.1111/j.1365-3040.1996.tb00386.x; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Ceasar SA, 2009, BIOTECHNOL LETT, V31, P779, DOI 10.1007/s10529-009-9933-4; Chen AQ, 2007, NEW PHYTOL, V173, P817, DOI 10.1111/j.1469-8137.2006.01962.x; Chen AQ, 2011, NEW PHYTOL, V189, P1157, DOI 10.1111/j.1469-8137.2010.03556.x; Chiou TJ, 2006, PLANT CELL, V18, P412, DOI 10.1105/tpc.105.038943; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; FITTER AH, 1992, MYCORRHIZAS IN ECOSYSTEMS, P26; FREDEEN AL, 1989, PLANT PHYSIOL, V89, P225, DOI 10.1104/pp.89.1.225; Gilbert N, 2009, NATURE, V461, P1041; Glassop D, 2005, PLANTA, V222, P688, DOI 10.1007/s00425-005-0015-0; Glassop D, 2007, CAN J BOT, V85, P644, DOI 10.1139/B07-070; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Grace EJ, 2009, NEW PHYTOL, V181, P938, DOI 10.1111/j.1469-8137.2008.02720.x; HAJABBASI MA, 1994, PLANT SOIL, V158, P39, DOI 10.1007/BF00007915; Harrison MJ, 2002, PLANT CELL, V14, P2413, DOI 10.1105/tpc.004861; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hodge A, 2001, NEW PHYTOL, V151, P725, DOI 10.1046/j.0028-646x.2001.00200.x; Hodge A, 2010, P NATL ACAD SCI USA, V107, P13754, DOI 10.1073/pnas.1005874107; Hong JJ, 2012, PLANTA, V236, P851, DOI 10.1007/s00425-012-1677-z; Jia HF, 2011, PLANT PHYSIOL, V156, P1164, DOI 10.1104/pp.111.175240; Johnson JF, 1996, PLANT PHYSIOL, V112, P31, DOI 10.1104/pp.112.1.31; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Karandashov V, 2004, P NATL ACAD SCI USA, V101, P6285, DOI 10.1073/pnas.0306074101; Karasawa T, 2012, PLANT CELL ENVIRON, V35, P819, DOI 10.1111/j.1365-3040.2011.02455.x; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Kumar K, 2013, PLANT CELL TISS ORG, V115, P13, DOI 10.1007/s11240-013-0335-x; Leigh J, 2009, NEW PHYTOL, V181, P199, DOI 10.1111/j.1469-8137.2008.02630.x; Li PH, 2011, J EXP BOT, V62, P3031, DOI 10.1093/jxb/err096; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Liu F, 2011, MOL PLANT, V4, P1105, DOI 10.1093/mp/ssr058; Lopez-Bucio J, 2003, CURR OPIN PLANT BIOL, V6, P280, DOI 10.1016/S1369-5266(03)00035-9; Lota F, 2013, PLANT J, V74, P280, DOI 10.1111/tpj.12120; LYNCH J, 1991, CROP SCI, V31, P380, DOI 10.2135/cropsci1991.0011183X003100020031x; Ma Z, 2001, PLANT CELL ENVIRON, V24, P459, DOI 10.1046/j.1365-3040.2001.00695.x; Marsalis MA, 2012, GUIDE NEW MEXICO S A, VA-417, P1; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; Misson J, 2004, PLANT MOL BIOL, V55, P727, DOI 10.1007/s11103-004-1965-5; Muchhal US, 1996, P NATL ACAD SCI USA, V93, P10519, DOI 10.1073/pnas.93.19.10519; Mudge SR, 2002, PLANT J, V31, P341, DOI 10.1046/j.1365-313X.2002.01356.x; Nagy R, 2006, PLANT BIOLOGY, V8, P186, DOI 10.1055/s-2005-873052; Nagy R, 2005, PLANT J, V42, P236, DOI 10.1111/j.1365-313X.2005.02364.x; Neumann G, 2000, ANN BOT-LONDON, V85, P909, DOI 10.1006/anbo.2000.1135; Nussaume L, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00083; Paszkowski U, 2002, P NATL ACAD SCI USA, V99, P13324, DOI 10.1073/pnas.202474599; Picot E, 2010, PLANT J, V64, P165, DOI 10.1111/j.1365-313X.2010.04314.x; Preuss CP, 2010, PLANT PHYSIOL, V152, P1431, DOI 10.1104/pp.109.152009; Rae AL, 2003, PLANT MOL BIOL, V53, P27, DOI 10.1023/B:PLAN.0000009259.75314.15; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; RAO IM, 1989, PLANT PHYSIOL, V90, P814, DOI 10.1104/pp.90.3.814; Rausch C, 2001, NATURE, V414, P462, DOI 10.1038/35106601; Rodriguez D, 1998, PLANT SOIL, V202, P149, DOI 10.1023/A:1004352820444; SANCHEZ PA, 1981, ADV AGRON, V34, P279, DOI 10.1016/S0065-2113(08)60889-5; SANDERS F E, 1973, Pesticide Science, V4, P385, DOI 10.1002/ps.2780040316; Schroeder JI, 2013, NATURE, V497, P60, DOI 10.1038/nature11909; Schunmann PHD, 2004, PLANT PHYSIOL, V136, P4205, DOI 10.1104/pp.104.045823; Secco D, 2013, PLANT CELL, V25, P4285, DOI 10.1105/tpc.113.117325; Shen JB, 2011, PLANT PHYSIOL, V156, P997, DOI 10.1104/pp.111.175232; Shin H, 2004, PLANT J, V39, P629, DOI 10.1111/j.1365-313X.2004.02161.x; SICHER RC, 1988, PLANT SCI, V57, P9, DOI 10.1016/0168-9452(88)90136-7; Sisaphaithong T, 2012, BIOSCI BIOTECH BIOCH, V76, P2364, DOI 10.1271/bbb.120782; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Sun SB, 2012, PLANT PHYSIOL, V159, P1571, DOI 10.1104/pp.112.196345; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tamura Y, 2012, BIOSCI BIOTECH BIOCH, V76, P309, DOI 10.1271/bbb.110684; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Willmann M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00533; Xie XA, 2013, NEW PHYTOL, V198, P836, DOI 10.1111/nph.12188; Xu GH, 2007, J EXP BOT, V58, P2491, DOI 10.1093/jxb/erm096; Yang SY, 2012, PLANT CELL, V24, P4236, DOI 10.1105/tpc.112.104901; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195	77	50	54	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108459	10.1371/journal.pone.0108459	http://dx.doi.org/10.1371/journal.pone.0108459			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251671	Green Published, gold			2022-12-25	WOS:000342492700129
J	Hsiao, PC; Chu, CM; Sung, PY; Perng, WC; Wang, KY				Hsiao, Peng-Ching; Chu, Chi-Ming; Sung, Pei-Yi; Perng, Wann-Cherng; Wang, Kwua-Yun			Differences in COPD Patient Care by Primary Family Caregivers: An Age-Based Study	PLOS ONE			English	Article							EDUCATION-PROGRAM; ELDERLY-PATIENTS; OLDER-ADULTS; HONG-KONG; IMPAIRMENTS; PREVALENCE; COMMUNITY; BURDEN; TAIWAN; HEALTH	Background: Because Taiwan has the fastest aging rate among developed countries, care for the elderly is becoming more prominent in the country. Primary family caregivers play an important role in patient health and health promotion behavior. Chronic obstructive pulmonary disease (COPD), an age-related disease, is a major public health problem with high morbidity and mortality and can be a long-term burden for family members; however, little attention has been given to the differences in COPD care between elder caregivers and other caregivers. This study aimed to investigate the differences between elder family caregivers and non-elder family caregivers caring for COPD patients in Taiwan, including caring behavior, caregiver response, and caring knowledge. Methods: This cross-sectional study was conducted between March 2007 and January 2008; 406 primary family caregivers of COPD patients from the thoracic outpatient departments of 6 hospitals in north-central Taiwan were recruited to answer questionnaires measuring COPD characteristics, care behavior, caregiver response, and COPD knowledge. All questionnaires, which addressed caregiver knowledge, care behaviors, and care reactions, were shown to have acceptable validity and reliability, and the data were analyzed using univariate and generalized linear model techniques. Results: The elder caregivers group had 79 participants, and the non-elder caregivers comprised 327 participants. The COPD-related knowledge scale results were positively correlated with the family caregiver caring behavior scale, suggesting that better COPD-related knowledge among family caregivers may result in improved caring behavior. After adjusting for all possible confounding factors, the elder caregivers had significantly lower COPD-related knowledge than the non-elder caregivers (P < 0.001). However, there were no significant differences in the family caregiver caring behavior scale or the caregiver reaction assessment scale between the two groups. Conclusions: Elder family caregivers require increased education regarding medications and preventive care in COPD patient care.	[Hsiao, Peng-Ching] Tri Serv Gen Hosp, Natl Def Med Ctr, Grad Inst Med Sci, Dept Nursing, Taipei, Taiwan; [Chu, Chi-Ming] Natl Def Med Ctr & Univ, Inst Publ Hlth, Sect Hlth Informat, Taipei, Taiwan; [Sung, Pei-Yi] Taipei Vet Gen Hosp, Dept Nursing, Taoyuan Branch, Taoyuan, Taiwan; [Perng, Wann-Cherng] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Pulm & Crit Care Med, Taipei, Taiwan; [Wang, Kwua-Yun] Taipei Vet Gen Hosp, Natl Def Med Ctr, Grad Inst Med Sci, Dept Nursing, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Taipei Veterans General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Taipei Veterans General Hospital	Wang, KY (corresponding author), Taipei Vet Gen Hosp, Natl Def Med Ctr, Grad Inst Med Sci, Dept Nursing, Taipei, Taiwan.	kywang7@vghtpe.gov.tw		Chu, Cordia/0000-0002-3683-5638	Health Promotion Administration, Ministry of Health and Welfare, Taiwan [DOH96-HP-1101]	Health Promotion Administration, Ministry of Health and Welfare, Taiwan	This study was supported by a grant from Health Promotion Administration, Ministry of Health and Welfare, Taiwan (DOH96-HP-1101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpass F, 2013, J GERONTOL B-PSYCHOL, V68, P783, DOI 10.1093/geronb/gbt060; [Anonymous], 2012, GLOB BRIEF WORLD HLT; Baty F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063285; Bookman A, 2011, FUTURE CHILD, V21, P117; Buurman BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026951; Chan RCK, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-32; Chau PH, 2012, J AM MED DIR ASSOC, V13, P169, DOI 10.1016/j.jamda.2010.07.011; Chen CY, 2010, ARCH GERONTOL GERIAT, V50, pS43, DOI 10.1016/S0167-4943(10)70012-1; Chen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024348; Chiu MYL, 2013, INT J SOC PSYCHIATR, V59, P28, DOI 10.1177/0020764011423171; Coventry PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060532; de Marco R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062985; Dias A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002333; Friedemann ML, 2014, J ADV NURS, V70, P662, DOI 10.1111/jan.12230; Gallart A, 2013, J ADV NURS, V69, P642, DOI 10.1111/j.1365-2648.2012.06049.x; Garrod R, 2002, RESP MED, V96, P725, DOI 10.1053/rmed.2002.1338; GIVEN CW, 1992, RES NURS HEALTH, V15, P271, DOI 10.1002/nur.4770150406; Hiyoshi K, 2009, GAN TO KAGAKU RYO S1, P30; Kernisan LP, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1548; Lange JW, 2011, GERONTOL GERIATR EDU, V32, P164, DOI 10.1080/02701960.2011.572056; Limpawattana P, 2013, J COMMUN HEALTH, V38, P40, DOI 10.1007/s10900-012-9576-6; Lucksted A, 2013, ACTA PSYCHIAT SCAND, V127, P279, DOI 10.1111/j.1600-0447.2012.01901.x; Martin P, 2013, PATIENT EDUC COUNS, V92, P81, DOI 10.1016/j.pec.2013.02.016; Alvarenga MRM, 2011, CIENC SAUDE COLETIVA, V16, P2603, DOI 10.1590/S1413-81232011000500030; Ministry of Health and Welfare, 2011, AG TSUN STRUCK TAIW; Najafzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046746; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Pennacchini M, 2014, Clin Ter, V165, pe219, DOI 10.7417/CT.2014.1723; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Rubio DM, 2003, SOC WORK RES, V27, P94, DOI 10.1093/swr/27.2.94; Smith GR, 2011, PSYCHOL AGING, V26, P584, DOI 10.1037/a0022263; Thielman N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038109; Tsai HH, 2013, SOC PSYCH PSYCH EPID, V48, P1145, DOI 10.1007/s00127-013-0652-8; Vellone Ercole, 2011, Prof Inferm, V64, P237; Wang JJ, 2009, INT PSYCHOGERIATR, V21, P314, DOI 10.1017/S1041610208008211; White R, 2006, Chron Respir Dis, V3, P123, DOI 10.1191/1479972306cd117oa; Woo J, 2011, MED CLIN N AM, V95, P477, DOI 10.1016/j.mcna.2011.02.009; Wu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033857; Yang C, 2000, DEV TESTING CANC CAR	39	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107870	10.1371/journal.pone.0107870	http://dx.doi.org/10.1371/journal.pone.0107870			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ0SJ	25250897	gold, Green Submitted, Green Published			2022-12-25	WOS:000342492700054
J	Launay, E; Guen, CGL; Martinot, A; Assathiany, R; Martin, E; Blanchais, T; Deneux-Tharaux, C; Roze, JC; Chalumeau, M				Launay, Elise; Guen, Christele Gras-Le; Martinot, Alain; Assathiany, Remy; Martin, Elise; Blanchais, Thomas; Deneux-Tharaux, Catherine; Roze, Jean-Christophe; Chalumeau, Martin			Why Children with Severe Bacterial Infection Die: A Population-Based Study of Determinants and Consequences of Suboptimal Care with a Special Emphasis on Methodological Issues	PLOS ONE			English	Article							HEALTH-CARE; CAUSAL INFERENCE; EPIDEMIOLOGY; DELIVERY; QUALITY; SEPSIS	Introduction: Suboptimal care is frequent in the management of severe bacterial infection. We aimed to evaluate the consequences of suboptimal care in the early management of severe bacterial infection in children and study the determinants. Methods: A previously reported population-based confidential enquiry included all children (3 months- 16 years) who died of severe bacterial infection in a French area during a 7-year period. Here, we compared the optimality of the management of these cases to that of pediatric patients who survived a severe bacterial infection during the same period for 6 types of care: seeking medical care by parents, evaluation of sepsis signs and detection of severe disease by a physician, timing and dosage of antibiotic therapy, and timing and dosage of saline bolus. Two independent experts blinded to outcome and final diagnosis evaluated the optimality of these care types. The effect of suboptimal care on survival was analyzed by a logistic regression adjusted on confounding factors identified by a causal diagram. Determinants of suboptimal care were analyzed by multivariate multilevel logistic regression. Results: Suboptimal care was significantly more frequent during early management of the 21 children who died as compared with the 93 survivors: 24% vs 13% (p = 0.003). The most frequent suboptimal care types were delay to seek medical care (20%), under-evaluation of severity by the physician (20%) and delayed antibiotic therapy (24%). Young age (under 1 year) was independently associated with higher risk of suboptimal care, whereas being under the care of a paediatric emergency specialist or a mobile medical unit as compared with a general practitioner was associated with reduced risk. Conclusions: Suboptimal care in the early management of severe bacterial infection had a global independent negative effect on survival. Suboptimal care may be avoided by better training of primary care physicians in the specifics of pediatric medicine.	[Launay, Elise; Guen, Christele Gras-Le; Martin, Elise; Blanchais, Thomas] CHU Nantes, Hop Mere & Enfant, Clin Med Pediat, Fac Med Nantes, F-44035 Nantes 01, France; [Launay, Elise; Deneux-Tharaux, Catherine; Chalumeau, Martin] Paris Descartes Univ, INSERM, Obstetr Perinatal & Pediat Epidemiol Res Team, Res Ctr Epidemiol & Biostat,U1153, Paris, France; [Launay, Elise; Deneux-Tharaux, Catherine; Chalumeau, Martin] Paris Descartes Univ, Sorbonne Paris Cite CRESS, Paris, France; [Guen, Christele Gras-Le] CHU Nantes, Hop Mere & Enfant, Fac Med Nantes, F-44035 Nantes 01, France; [Martinot, Alain] Univ Lille Nord France, CHU Lille, Hop R Salengro, Unite Urgences Pediat & Malad Infect, F-59037 Lille, France; [Assathiany, Remy] AFPA, AREPEGE, Issy Les Moulineaux, France; [Roze, Jean-Christophe] CHU Nantes, Hop Mere & Enfant, Fac Med Nantes, F-44035 Nantes 01, France; [Chalumeau, Martin] Paris Descartes Univ, Hop Necker Enfants Malad, AP HP, Serv Pediat Gen, Paris, France	Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Launay, E (corresponding author), CHU Nantes, Hop Mere & Enfant, Clin Med Pediat, Fac Med Nantes, F-44035 Nantes 01, France.	elise.launay@chu-nantes.fr	Chalumeau, Martin/F-4293-2017; Martinot, Alain/M-6780-2016; Rozé, Jean-Christophe/AAS-1314-2021; deneux-tharaux, catherine/R-1111-2016	Chalumeau, Martin/0000-0001-8175-3706; Martinot, Alain/0000-0002-2146-8273; GRAS-LE GUEN, Christele/0000-0001-9060-2344; Roze, Jean-Christophe/0000-0003-3367-512X; Launay, Elise/0000-0002-4081-4653; deneux-tharaux, catherine/0000-0002-6561-3321	Bettencourt Foundation (Coups d'elan pour la recherche francaise) [1153]	Bettencourt Foundation (Coups d'elan pour la recherche francaise)	The authors received no specific funding for this work. Inserm Unit 1153 received a grant from the Bettencourt Foundation (Coups d'elan pour la recherche francaise) in support of its research activities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens KA, 2013, PAEDIATR PERINAT EP, V27, P258, DOI 10.1111/ppe.12048; Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Ambler G, 2001, J STAT COMPUT SIM, V69, P89, DOI 10.1080/00949650108812083; Aurel M, 2011, ARCH DIS CHILD, V96, P697, DOI 10.1136/adc.2009.180174; Bouvier-Colle MH, 2002, REV EPIDEMIOL SANTE, V50, P203; Calis J, 2013, NEW ENGL J MED, V369, P2062, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Casanova JL, 2007, EMBO J, V26, P915, DOI 10.1038/sj.emboj.7601558; Dharmar M, 2008, J PEDIATR-US, V153, P783, DOI 10.1016/j.jpeds.2008.05.025; Giguere A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004398.pub3; Gilleland J, 2013, BMJ QUAL SAF; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Han YY, 2003, PEDIATRICS, V112, P793, DOI 10.1542/peds.112.4.793; Harnden A, 2009, BRIT J GEN PRACT, V59, P819, DOI 10.3399/bjgp09X472520; Hartman ME, 2013, PEDIATR CRIT CARE ME, V14, P686, DOI 10.1097/PCC.0b013e3182917fad; Health Protection Agency, 2006, GUID PUBL HLTH MAN M; Hernan MA, 2009, AM J EPIDEMIOL, V170, P959, DOI 10.1093/aje/kwp293; Katznelson JH, 2014, PEDIATR EMERG CARE, V30, P397, DOI 10.1097/PEC.0000000000000146; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Launay E, 2013, ARCH DIS CHILD, DOI 101136; Launay E, 2010, PEDIATR CRIT CARE ME, V11, P469, DOI 10.1097/PCC.0b013e3181ce752e; Mant D, 2011, ARCH DIS CHILD, V96, P613, DOI 10.1136/adc.2010.191510; McIntyre PB, 2005, ARCH DIS CHILD, V90, P391, DOI 10.1136/adc.2003.037523; Nadel S, 1998, J ACCID EMERG MED, V15, P298; Ninis N, 2005, BRIT MED J, V330, P1475, DOI 10.1136/bmj.330.7506.1475; Peterson J.W., 1996, MED MICROBIOLOGY; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Slade E, 2003, CRIT CARE, V7, P1, DOI 10.1186/cc1876; Snijders T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd; Societe de Reanimation de Langue Francaise Use of catecholamines during septic shock (adults and children), 15 CONS C FRENCH SOC; Stahl JP, 2013, MED MALADIES INFECT, V43, P75, DOI 10.1016/j.medmal.2013.01.001; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; Thompson M, 2008, BRIT J GEN PRACT, V58, P236, DOI 10.3399/bjgp08X279689; Van den Bruel A, 2010, LANCET, V375, P834, DOI 10.1016/S0140-6736(09)62000-6; Varon E, 2012, CTR NATL REFERENCE P; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]	35	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107286	10.1371/journal.pone.0107286	http://dx.doi.org/10.1371/journal.pone.0107286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247401	Green Submitted, Green Published, gold			2022-12-25	WOS:000342351800020
J	Robinson, AP; Rodgers, JM; Goings, GE; Miller, SD				Robinson, Andrew P.; Rodgers, Jane M.; Goings, Gwendolyn E.; Miller, Stephen D.			Characterization of Oligodendroglial Populations in Mouse Demyelinating Disease Using Flow Cytometry: Clues for MS Pathogenesis	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; GROWTH-FACTOR; CELLS; CNS; DIFFERENTIATION; PROLIFERATION; REMYELINATION; PROGENITORS; EAE; ENCEPHALOMYELITIS	Characterizing and enumerating cells of the oligodendrocyte lineage (OLCs) is crucial for understanding demyelination and therapeutic benefit in models of demyelinating disease in the central nervous system. Here we describe a novel method for the rapid, unbiased analysis of mouse OLCs using flow cytometry. The assay was optimized to maximize viable yield of OLCs and maintain OLC antigen integrity. Panels of antibodies were assembled for simultaneous analysis of seven antigens on individual cells allowing for characterization of oligodendroglial cells throughout the lineage. We verified the utility of the assay with cultured OLCs and through a time course of developmental myelination. Next we employed the assay to characterize OLC populations in two well-characterized models of demyelination: cuprizone-induced demyelination and experimental autoimmune encephalomyelitis (EAE). In EAE we observed a dramatic loss of mature oligodendrocytes coincident with a dramatic expansion of oligodendrocyte progenitors cells (OPCs) at the onset of disease suggesting an attempt of the host to repair myelin. This expanded OPC pool was maintained through remission and relapse suggesting an arrest in differentiation in the face of the chronic autoimmune T cell-mediated inflammatory response. These robust, reproducible changes in OLCs through disease provide a rapid quantitative global analysis of myelin-producing cells in the adult mouse brain and important information regarding effects of disease on oligodendroglial proliferation/differentiation which is useful for defining the pathogenesis and therapy of MS.	[Robinson, Andrew P.; Rodgers, Jane M.; Goings, Gwendolyn E.; Miller, Stephen D.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Robinson, Andrew P.; Rodgers, Jane M.; Goings, Gwendolyn E.; Miller, Stephen D.] Northwestern Univ, Feinberg Sch Med, Interdept Immunobiol Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Miller, SD (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA.	s-d-miller@northwestern.edu	Robinson, Andrew/AAA-9162-2022	Robinson, Andrew/0000-0002-1867-5634	Myelin Repair Foundation; Cancer Center [NCI CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026543] Funding Source: NIH RePORTER	Myelin Repair Foundation; Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Myelin Repair Foundation through funding to SDM (http://www.myelinrepair.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Flow cytometry and FACS experiments were conducted in the Northwestern University Immunobiology Center Flow Cytometry Core Facility and the Robert H. Lurie Comprehensive Cancer Center Flow Cytometry Facility with a Cancer Center Support Grant (NCI CA060553).	Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; BARRES BA, 1992, J NEUROBIOL, V23, P1221, DOI 10.1002/neu.480230912; BEHAR T, 1988, J NEUROSCI RES, V21, P168, DOI 10.1002/jnr.490210209; Crang AJ, 2004, EUR J NEUROSCI, V20, P1445, DOI 10.1111/j.1460-9568.2004.03606.x; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Gonzalez JM, 2005, GLIA, V51, P22, DOI 10.1002/glia.20182; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; LASSMANN H, 1980, ACTA NEUROPATHOL, V51, P191, DOI 10.1007/BF00687386; Lees JR, 2008, J EXP MED, V205, P2633, DOI 10.1084/jem.20080155; Lipton HL, 2005, J IMMUNOL METHODS, V299, P107, DOI 10.1016/j.jim.2005.01.017; Maric D, 2003, J NEUROSCI, V23, P240; Maric Dragan, 2005, Curr Protoc Neurosci, VChapter 3, DOI 10.1002/0471142301.ns0318s33; McCarthy Derrick P, 2012, Methods Mol Biol, V900, P381, DOI 10.1007/978-1-60761-720-4_19; MCMORRIS FA, 1988, J NEUROSCI RES, V21, P199, DOI 10.1002/jnr.490210212; Miller E, 2012, ADV EXP MED BIOL, V724, P222, DOI 10.1007/978-1-4614-0653-2_17; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Panchision DM, 2007, STEM CELLS, V25, P1560, DOI 10.1634/stemcells.2006-0260; Ponomarev ED, 2005, J NEUROSCI RES, V81, P374, DOI 10.1002/jnr.20488; Remington LT, 2007, AM J PATHOL, V170, P1713, DOI 10.2353/ajpath.2007.060783; Reynolds R, 2002, J NEUROCYTOL, V31, P523, DOI 10.1023/A:1025747832215; Shapiro HM, 2003, PRACTICAL FLOW CYTOM; Skripuletz T, 2011, HISTOL HISTOPATHOL, V26, P1585, DOI 10.14670/HH-26.1585; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Sundberg M, 2010, STEM CELL RES, V5, P91, DOI 10.1016/j.scr.2010.04.005; Tripathi RB, 2010, J NEUROSCI, V30, P16383, DOI 10.1523/JNEUROSCI.3411-10.2010; Zeigler Frank, 2007, V407, P323, DOI 10.1007/978-1-59745-536-7_22	28	33	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107649	10.1371/journal.pone.0107649	http://dx.doi.org/10.1371/journal.pone.0107649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247590	Green Submitted, gold, Green Published			2022-12-25	WOS:000342351800029
J	Rossi, JP; Nardin, M; Godefroid, M; Ruiz-Diaz, M; Sergent, AS; Martinez-Meier, A; Paques, L; Rozenberg, P				Rossi, Jean-Pierre; Nardin, Maxime; Godefroid, Martin; Ruiz-Diaz, Manuela; Sergent, Anne-Sophie; Martinez-Meier, Alejandro; Paques, Luc; Rozenberg, Philippe			Dissecting the Space-Time Structure of Tree-Ring Datasets Using the Partial Triadic Analysis	PLOS ONE			English	Article							WOOD DENSITY; SPATIOTEMPORAL DISTRIBUTION; VARIABILITY; GROWTH; ASSEMBLAGES; STABILITY; COMPONENT; WIDTH; COMMUNITY; CLIMATE	Tree-ring datasets are used in a variety of circumstances, including archeology, climatology, forest ecology, and wood technology. These data are based on microdensity profiles and consist of a set of tree-ring descriptors, such as ring width or early/latewood density, measured for a set of individual trees. Because successive rings correspond to successive years, the resulting dataset is a ring variables x trees x time datacube. Multivariate statistical analyses, such as principal component analysis, have been widely used for extracting worthwhile information from ring datasets, but they typically address two-way matrices, such as ring variables x trees or ring variables x time. Here, we explore the potential of the partial triadic analysis (PTA), a multivariate method dedicated to the analysis of three-way datasets, to apprehend the space-time structure of tree-ring datasets. We analyzed a set of 11 tree-ring descriptors measured in 149 georeferenced individuals of European larch (Larix decidua Miller) during the period of 1967-2007. The processing of densitometry profiles led to a set of ring descriptors for each tree and for each year from 1967-2007. The resulting three-way data table was subjected to two distinct analyses in order to explore i) the temporal evolution of spatial structures and ii) the spatial structure of temporal dynamics. We report the presence of a spatial structure common to the different years, highlighting the inter-individual variability of the ring descriptors at the stand scale. We found a temporal trajectory common to the trees that could be separated into a high and low frequency signal, corresponding to inter-annual variations possibly related to defoliation events and a long-term trend possibly related to climate change. We conclude that PTA is a powerful tool to unravel and hierarchize the different sources of variation within tree-ring datasets.	[Rossi, Jean-Pierre; Godefroid, Martin] Ctr Montpellier, Ctr Biol Gest Populat, Inst Natl Rech Agron, Unite Mixte Rech 1062, Montpellier, France; [Nardin, Maxime; Paques, Luc; Rozenberg, Philippe] Ctr Orleans, Inst Natl Rech Agron, Unite Rech Ameliorat Genet & Physiol Forestieres, Orleans, France; [Ruiz-Diaz, Manuela] Univ Nacl Misiones, Misiones, Argentina; [Sergent, Anne-Sophie] Consejo Nacl Invest Cient & Tecn, San Carlos De Bariloche, Rio Negro, Argentina; [Martinez-Meier, Alejandro] INTA, EEA Bariloche, Grp Ecol Forestal, Estn Expt Bariloche, San Carlos De Bariloche, Rio Negro, Argentina	INRAE; Institut de Recherche pour le Developpement (IRD); INRAE; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto Nacional de Tecnologia Agropecuaria (INTA)	Rossi, JP (corresponding author), Ctr Montpellier, Ctr Biol Gest Populat, Inst Natl Rech Agron, Unite Mixte Rech 1062, Montpellier, France.	rossi@supagro.inra.fr		sergent, anne sophie/0000-0002-1662-2053; Rossi, Jean-Pierre/0000-0002-8139-1116; Martinez-Meier, Alejandro/0000-0001-9139-8023	French ministere de l'agriculture; French ministere de l'ecologie	French ministere de l'agriculture; French ministere de l'ecologie	This research was funded by the French ministere de l'agriculture and the French ministere de l'ecologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arseneault D, 1997, ECOLOGY, V78, P1873, DOI 10.1890/0012-9658(1997)078[1873:ROMFDF]2.0.CO;2; Badeau V, 1995, ACTA OECOL, V16, P571; Bergeron Yves, 2002, Dendrochronologia, V20, P175, DOI 10.1078/1125-7865-00015; Bertrand F, 2010, CASE STUD BUS IND GO, V4, P23; Bjornstad O. N, 2012, NCF SPATIAL NONPARAM; Bowman DMJS, 2013, TRENDS PLANT SCI, V18, P11, DOI 10.1016/j.tplants.2012.08.005; Braker Otto U., 2002, Dendrochronologia, V20, P203, DOI 10.1078/1125-7865-00017; Briffa KR, 2004, GLOBAL PLANET CHANGE, V40, P11, DOI 10.1016/S0921-8181(03)00095-X; Bro R, 2003, J CHEMOMETR, V17, P16, DOI 10.1002/cem.773; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P1501, DOI 10.2136/sssaj1994.03615995005800050033x; Carassou L, 2007, MAR BIOL, V150, P697, DOI 10.1007/s00227-006-0389-y; Centofanti M, 1989, REV SCI EAU, V2, P71; Davi NK, 2003, QUATERNARY RES, V60, P252, DOI 10.1016/j.yqres.2003.07.002; de Luis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083550; Decaens T, 2001, ECOGRAPHY, V24, P671, DOI 10.1034/j.1600-0587.2001.240606.x; Decaens T, 2009, J TROP ECOL, V25, P415, DOI 10.1017/S0266467409006075; Dormont L, 2006, OIKOS, V115, P299, DOI 10.1111/j.2006.0030-1299.15010.x; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Ernoult A, 2006, LANDSCAPE ECOL, V21, P631, DOI 10.1007/s10980-005-5321-1; Fonti P, 2013, AM J BOT, V100, P1332, DOI 10.3732/ajb.1200484; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Gaertner JC, 1998, AQUAT LIVING RESOUR, V11, P75, DOI 10.1016/S0990-7440(98)80063-6; Godefroid M, 2013, SOIL BIOL BIOCHEM, V57, P173, DOI 10.1016/j.soilbio.2012.06.019; Goovaerts P, 1998, BIOL FERT SOILS, V27, P315, DOI 10.1007/s003740050439; Gourdol L, 2013, APPL GEOCHEM, V39, P93, DOI 10.1016/j.apgeochem.2013.10.002; GUAY R, 1992, FOREST CHRON, V68, P138, DOI 10.5558/tfc68138-1; HARSHMAN RA, 1994, COMPUT STAT DATA AN, V18, P39, DOI 10.1016/0167-9473(94)90132-5; Ivkovic M, 2004, ANN FOREST SCI, V61, P759, DOI 10.1051/forest:2004072; Ivkovic M, 2013, ANN FOREST SCI, V70, P525, DOI 10.1007/s13595-013-0290-z; Jimenez JJ, 2006, ACTA OECOL, V30, P299, DOI 10.1016/j.actao.2006.06.008; Koprowski M, 2012, ECOL INDIC, V23, P332, DOI 10.1016/j.ecolind.2012.04.007; KROONENBERG PM, 1989, ACTA OECOL-OEC GEN, V10, P245; LAVIT C, 1994, COMPUT STAT DATA AN, V18, P97, DOI 10.1016/0167-9473(94)90134-1; Legendre P., 1998, NUMERICAL ECOLOGY, V24; LHermier des Plantes H., 1976, THESIS U SCI TECHNIQ; Manly B.F.J., 2017, MULTIVARIATE STAT ME; Martin N, 2000, FOOD QUAL PREFER, V11, P487, DOI 10.1016/S0950-3293(00)00021-5; Martinelli N, 2004, GLOBAL PLANET CHANGE, V40, P129, DOI 10.1016/S0921-8181(03)00103-6; Nardin M, 2013, THESIS U ORLEANS; POLGE H, 1978, WOOD SCI TECHNOL, V12, P187, DOI 10.1007/BF00372864; R Core Team, 2014, R LANG ENV STAT COMP; ROBERT P, 1976, ROY STAT SOC C-APP, V25, P257; Rolland A, 2009, WATER RES, V43, P3155, DOI 10.1016/j.watres.2009.03.049; Rolland C, 1998, TREES-STRUCT FUNCT, V13, P40; Rossi JP, 2003, PEDOBIOLOGIA, V47, P497, DOI 10.1016/S0031-4056(04)70228-0; Rubino Darrin L., 2004, Dendrochronologia, V21, P97, DOI 10.1078/1125.7865.00047; Ruiz Diaz Britez M, TREES-STRUCT FUNCT, DOI [10.1007/s00468-00014-01003-00464, DOI 10.1007/S00468-00014-01003-00464]; SCHWEINGRUBER FH, 1988, TREE RING BASICS APP; Spiecker H., 2002, Dendrochronologia, V20, P191, DOI 10.1078/1125-7865-00016; Stadt KJ, 2007, ANN FOREST SCI, V64, P477, DOI 10.1051/forest:2007025; Stanimirova I, 2004, CHEMOMETR INTELL LAB, V73, P219, DOI 10.1016/j.chemolab.2004.03.005; Swing R. E., 1998, INTRO MICRODENSITOME; THIOULOUSE J, 1987, ACTA OECOL-OEC GEN, V8, P463; Thioulouse J, 2004, ECOLOGY, V85, P272, DOI 10.1890/02-0605; TUCKER LR, 1966, PSYCHOMETRIKA, V31, P279, DOI 10.1007/BF02289464; Vivien M, 2003, J CHEMOMETR, V17, P287, DOI 10.1002/cem.802; Zobel B. J., 1995, GENETICS WOOD PRODUC, DOI 10.1007/978-3-642-79514-5	58	4	4	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108332	10.1371/journal.pone.0108332	http://dx.doi.org/10.1371/journal.pone.0108332			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247299	gold, Green Published, Green Submitted			2022-12-25	WOS:000342351800083
J	Shi, Y; Luscher, TF; Camici, GG				Shi, Yi; Luescher, Thomas F.; Camici, Giovanni G.			Dual Role of Endothelial Nitric Oxide Synthase in Oxidized LDL-Induced, p66(Shc)-Mediated Oxidative Stress in Cultured Human Endothelial Cells	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CORONARY-ARTERY-DISEASE; KINASE-C-BETA; SMOOTH-MUSCLE; TETRAHYDROBIOPTERIN LEVELS; DIABETES-MELLITUS; LIFE-SPAN; VITAMIN-E; IN-VITRO; DYSFUNCTION	Background: The aging gene p66(Shc), is an important mediator of oxidative stress-induced vascular dysfunction and disease. In cultured human aortic endothelial cells (HAEC), p66(Shc) deletion increases endothelial nitric oxide synthase (eNOS) expression and nitric oxide (NO) bioavailability via protein kinase B. However, the putative role of the NO pathway on p66(Shc) activation remains unclear. This study was designed to elucidate the regulatory role of the eNOS/NO pathway on p66(Shc) activation. Methods and Results: Incubation of HAEC with oxidized low density lipoprotein (oxLDL) led to phosphorylation of p66(Shc) at Ser-36, resulting in an enhanced production of superoxide anion (O-2(-)). In the absence of oxLDL, inhibition of eNOS by small interfering RNA or L-NAME, induced p66(Shc) phosphorylation, suggesting that basal NO production inhibits O-2(-) production. oxLDL-induced, p66(Shc)-mediated O-2(-) was prevented by eNOS inhibition, suggesting that when cells are stimulated with oxLDL eNOS is a source of reactive oxygen species. Endogenous or exogenous NO donors, prevented p66(Shc) activation and reduced O-2(-) production. Treatment with tetrahydrobiopterin, an eNOS cofactor, restored eNOS uncoupling, prevented p66(Shc) activation, and reduced O-2(-) generation. However, late treatment with tetrahydropterin did not yield the same result suggesting that eNOS uncoupling is the primary source of reactive oxygen species. Conclusions: The present study reports that in primary cultured HAEC treated with oxLDL, p66(Shc)-mediated oxidative stress is derived from eNOS uncoupling. This finding contributes novel information on the mechanisms of p66(Shc) activation and its dual interaction with eNOS underscoring the importance eNOS uncoupling as a putative antioxidant therapeutical target in endothelial dysfunction as observed in cardiovascular disease.	[Shi, Yi; Luescher, Thomas F.; Camici, Giovanni G.] Univ Zurich, Univ Hosp Zurich, Univ Heart Ctr, Zurich, Switzerland; [Shi, Yi; Luescher, Thomas F.; Camici, Giovanni G.] Univ Zurich, Ctr Mol Cardiol, Zurich, Switzerland; [Shi, Yi; Luescher, Thomas F.; Camici, Giovanni G.] Univ Zurich, Ctr Integrat Human Physiol ZHIP, Zurich, Switzerland; [Shi, Yi] Fudan Univ, Zhongshan Hosp, Biomed Res Ctr, Shanghai 200433, Peoples R China	University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Fudan University	Camici, GG (corresponding author), Univ Zurich, Univ Hosp Zurich, Univ Heart Ctr, Campus Schlieren, Zurich, Switzerland.	giovanni.camici@uzh.ch	Shi, Yi/GXG-2318-2022; Camici, Giovanni/H-1631-2018	Camici, Giovanni/0000-0002-0523-0695; Shi, Yi/0000-0003-3005-9655	Swiss National Science Foundation [310030_147017]; Olga Mayenfish foundation; Hartmann Muller foundation; National Nature Science Foundation of China [81373412]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Olga Mayenfish foundation; Hartmann Muller foundation; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The present study was supported by the Swiss National Science Foundation grant number 310030_147017 to GGC, the Olga Mayenfish and the Hartmann Muller foundations. This work was also partly supported by grant from the National Nature Science Foundation of China 81373412 to YS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P445, DOI 10.1161/01.ATV.0000115637.48689.77; BATH PMW, 1993, EUR J CLIN PHARMACOL, V45, P53, DOI 10.1007/BF00315350; Bonfini L, 1996, TRENDS BIOCHEM SCI, V21, P257, DOI 10.1016/S0968-0004(96)10033-5; Camici GG, 2010, GERONTOLOGY; Camici GG, 2008, J APPL PHYSIOL, V105, P1628, DOI 10.1152/japplphysiol.90579.2008; Camici GG, 2007, P NATL ACAD SCI USA, V104, P5217, DOI 10.1073/pnas.0609656104; Channon KM, 2004, TRENDS CARDIOVAS MED, V14, P323, DOI 10.1016/j.tcm.2004.10.003; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Cosentino F, 1999, CARDIOVASC RES, V43, P274, DOI 10.1016/S0008-6363(99)00134-0; Cosentino F, 1998, J CLIN INVEST, V101, P1530, DOI 10.1172/JCI650; Cunnington C, 2012, CIRCULATION, V125, P1356, DOI 10.1161/CIRCULATIONAHA.111.038919; Faria AM, 2012, DIABETES, V61, P1838, DOI 10.2337/db11-1241; Feletou M, 2008, FRONT BIOSCI-LANDMRK, V13, P4198, DOI 10.2741/3000; Fleming I, 2005, CARDIOVASC RES, V65, P897, DOI 10.1016/j.cardiores.2004.11.003; Franzeck FC, ATHEROSCLEROSIS, V220, P282; Fukai T, 2007, ARTERIOSCL THROM VAS, V27, P1493, DOI 10.1161/ATVBAHA.107.148239; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Gao YT, 2007, J BIOL CHEM, V282, P28557, DOI 10.1074/jbc.M704890200; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Heitzer T, 2000, DIABETOLOGIA, V43, P1435, DOI 10.1007/s001250051551; Hink U, 2001, CIRC RES, V88, pE14; Holowatz LA, 2011, J PHYSIOL-LONDON, V589, P4787, DOI 10.1113/jphysiol.2011.212100; Huang A, 2000, J BIOL CHEM, V275, P17399, DOI 10.1074/jbc.M002248200; Kim CS, 2008, CIRC RES, V103, P1441, DOI 10.1161/CIRCRESAHA.108.181644; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Le S, 2001, J BIOL CHEM, V276, P48332, DOI 10.1074/jbc.M106612200; Li HG, 2009, CURR PHARM DESIGN, V15, P3133, DOI 10.2174/138161209789058002; Liu SM, 2006, DIABETES, V55, P2856, DOI 10.2337/db06-0456; Maier W, 2000, J CARDIOVASC PHARM, V35, P173, DOI 10.1097/00005344-200002000-00001; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; MONCADA S, 1991, PHARMACOL REV, V43, P109; MOORADIAN DL, 1995, J CARDIOVASC PHARM, V25, P674, DOI 10.1097/00005344-199504000-00023; Moreau KL, 2012, AM J PHYSIOL-HEART C, V302, pH1211, DOI 10.1152/ajpheart.01065.2011; MORLEY D, 1993, J CARDIOVASC PHARM, V21, P670, DOI 10.1097/00005344-199304000-00023; Mullane KM, 1980, ADV PROSTAGLANDIN TH, V7, P1159; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; Perkins KAA, 2012, N-S ARCH PHARMACOL, V385, P27, DOI 10.1007/s00210-011-0693-z; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Pritchard KA, 2001, J BIOL CHEM, V276, P17621, DOI 10.1074/jbc.C100084200; Rosenblum WI, 1997, STROKE, V28, P186, DOI 10.1161/01.STR.28.1.186; ROSENKRANZWEISS P, 1994, J CLIN INVEST, V93, P2236, DOI 10.1172/JCI117221; RUBANYI GM, 1986, AM J PHYSIOL, V250, pH822, DOI 10.1152/ajpheart.1986.250.5.H822; Sesso HD, 2008, JAMA-J AM MED ASSOC, V300, P2123, DOI 10.1001/jama.2008.600; Shi Y, 2011, ARTERIOSCL THROM VAS, V31, P2090, DOI 10.1161/ATVBAHA.111.229260; Shi Y, 2010, PFLUG ARCH EUR J PHY, V459, P315, DOI 10.1007/s00424-009-0727-2; Shinozaki K, 2000, CIRC RES, V87, P566, DOI 10.1161/01.RES.87.7.566; SOUTHGATE K, 1990, ATHEROSCLEROSIS, V82, P113, DOI 10.1016/0021-9150(90)90150-H; Spescha RD, EUR HEART J, V34, P96; Sud N, 2008, AM J PHYSIOL-CELL PH, V294, pC1407, DOI 10.1152/ajpcell.00384.2007; TAYEH MA, 1989, J BIOL CHEM, V264, P19654; Tomilov AA, J BIOL CHEM, V285, P1153; Ueda S, 2000, J AM COLL CARDIOL, V35, P71, DOI 10.1016/S0735-1097(99)00523-9; VANHOUTTE PM, 1981, EUR J PHARMACOL, V72, P189, DOI 10.1016/0014-2999(81)90273-9; Ward NC, 2007, J HYPERTENS, V25, P227, DOI 10.1097/01.hjh.0000254373.96111.43; WYATT TA, 1991, RES COMMUN CHEM PATH, V74, P3; Yamamori T, 2005, J MOL CELL CARDIOL, V39, P992, DOI 10.1016/j.yjmcc.2005.09.003; Youn JY, 2012, AM J PHYSIOL-HEART C, V302, pH2243, DOI 10.1152/ajpheart.00835.2011; Zou MH, 2002, J CLIN INVEST, V109, P817, DOI 10.1172/JCI200214442	59	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107787	10.1371/journal.pone.0107787	http://dx.doi.org/10.1371/journal.pone.0107787			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247687	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000342351800038
J	Wang, QS; Tian, F; Pan, YC; Buckler, ES; Zhang, ZW				Wang, Qishan; Tian, Feng; Pan, Yuchun; Buckler, Edward S.; Zhang, Zhiwu			A SUPER Powerful Method for Genome Wide Association Study	PLOS ONE			English	Article							LINEAR MIXED MODELS; POPULATION; TRAITS; PHENOTYPES; SELECTION; SOFTWARE; NUMBER	Genome-Wide Association Studies shed light on the identification of genes underlying human diseases and agriculturally important traits. This potential has been shadowed by false positive findings. The Mixed Linear Model (MLM) method is flexible enough to simultaneously incorporate population structure and cryptic relationships to reduce false positives. However, its intensive computational burden is prohibitive in practice, especially for large samples. The newly developed algorithm, FaST-LMM, solved the computational problem, but requires that the number of SNPs be less than the number of individuals to derive a rank-reduced relationship. This restriction potentially leads to less statistical power when compared to using all SNPs. We developed a method to extract a small subset of SNPs and use them in FaST-LMM. This method not only retains the computational advantage of FaST-LMM, but also remarkably increases statistical power even when compared to using the entire set of SNPs. We named the method SUPER (Settlement of MLM Under Progressively Exclusive Relationship) and made it available within an implementation of the GAPIT software package.	[Wang, Qishan; Pan, Yuchun] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai, Peoples R China; [Tian, Feng] China Agr Univ, Natl Maize Improvement Ctr China, Beijing 100094, Peoples R China; [Buckler, Edward S.] USDA ARS, Ithaca, NY 14853 USA; [Buckler, Edward S.; Zhang, Zhiwu] Cornell Univ, Inst Genom Divers, Ithaca, NY USA; [Zhang, Zhiwu] Northeast Agr Univ, Dept Anim Sci, Harbin, Peoples R China; [Zhang, Zhiwu] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA	Shanghai Jiao Tong University; China Agricultural University; United States Department of Agriculture (USDA); Cornell University; Northeast Agricultural University - China; Washington State University	Tian, F (corresponding author), China Agr Univ, Natl Maize Improvement Ctr China, Beijing 100094, Peoples R China.	ft55@cau.edu.cn; panyc@sjtu.edu.cn; zhiwu.zhang@wsu.edu	Zhang, zs/GXN-3521-2022; Buckler, Edward/L-7651-2019; Buckler, Edward/GPS-4932-2022; Zhang, Zhiwu/P-6156-2016	Buckler, Edward/0000-0002-3100-371X; Zhang, Zhiwu/0000-0002-5784-9684; Wang, Qishan/0000-0002-6475-0009	NSF-Plant Genome Program [DBI- 0820619]; National Natural Science Foundation of China [31370043, 31272414]; National 948 Project of China [2011-G2A, 2012-Z26]; National High Technology Research and Development Program of China [2012AA101104, 2012AA10A307]; United States Department of Agriculture's Agricultural Research Service; Direct For Biological Sciences [1238014] Funding Source: National Science Foundation	NSF-Plant Genome Program(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 948 Project of China; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); United States Department of Agriculture's Agricultural Research Service; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by NSF-Plant Genome Program (DBI- 0820619), National Natural Science Foundation of China (grant no 31370043, 31272414), National 948 Project of China (2011-G2A, 2012-Z26), National High Technology Research and Development Program of China (2012AA101104 and 2012AA10A307), and the United States Department of Agriculture's Agricultural Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bernardo R, 2003, THEOR APPL GENET, V107, P1252, DOI 10.1007/s00122-003-1375-0; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Cheng RY, 2010, GENETICS, V185, P1033, DOI 10.1534/genetics.110.116863; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; Henderson C. R, 1984, APPL LINEAR MODELS A; HENDERSON CR, 1953, BIOMETRICS, V9, P226, DOI 10.2307/3001853; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kathiresan S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S17; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; Listgarten J, 2012, NAT METHODS, V9, P525, DOI 10.1038/nmeth.2037; Moonesinghe R, 2007, PLOS MED, V4, P218, DOI 10.1371/journal.pmed.0040028; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Pirinen M, 2012, NAT GENET, V44, P848, DOI 10.1038/ng.2346; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yu JM, 2009, PLANT GENOME-US, V2, P63, DOI 10.3835/plantgenome2008.09.0009; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang Z, 2007, J ANIM SCI, V85, P881, DOI 10.2527/jas.2006-656; Zhang ZJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015314; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhang ZW, 2009, BRIEF BIOINFORM, V10, P664, DOI 10.1093/bib/bbp050; Zhang ZW, 2009, AM J VET RES, V70, P483, DOI 10.2460/ajvr.70.4.483; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Zhou ZK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013219	39	54	62	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107684	10.1371/journal.pone.0107684	http://dx.doi.org/10.1371/journal.pone.0107684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247812	Green Published, gold, Green Submitted			2022-12-25	WOS:000342351800031
J	Canavan, C; Card, T; West, J				Canavan, Caroline; Card, Timothy; West, Joe			The Incidence of Other Gastroenterological Disease following Diagnosis of Irritable Bowel Syndrome in the UK: A Cohort Study	PLOS ONE			English	Article							PRACTICE RESEARCH DATABASE; GENERAL-PRACTICE; CELIAC-DISEASE; RISK-FACTORS; POPULATION; PREVALENCE; EXCLUSION; COMMUNITY; SYMPTOMS; TESTS	Background: Guidelines recommend Irritable Bowel Syndrome (IBS) diagnosis and management in primary care with minimal investigations; however little evidence exists regarding risk of organic gastrointestinal conditions following diagnosis of IBS and how such risks vary over the long term. This study assesses excess incidence of coeliac disease, inflammatory bowel disease (IBD) and colorectal cancer (CRC) and variation with age and time after IBS diagnosis. Methods: IBS patients and controls were identified within the UK Clinical Practice Research Dataset. Incidence rates were calculated and stratified by age and time since IBS diagnosis with incident rate ratios generated. Results: Fifteen years after IBS diagnosis there is a significant cumulative excess incidence of coeliac disease, IBD and CRC in IBS of 3.7% compared to 1.7% in controls. For every 10000 patient years, IBS patients experienced an additional 4 diagnoses of coeliac disease, 13 of IBD and 4 CRCs. In each condition peak excess incidence was in the 6 months following diagnosis. After one year, increased incidence of coeliac disease remained consistent without variation by age. IBD incidence fell slowly, with higher rates in those under 30. CRC incidence was increased only in patients aged 30 to 74 during the first 5 years. Conclusion: Some IBS patients later receive organic gastrointestinal diagnoses, with the early excess incidence likely detected during diagnostic investigation at the time of IBS diagnosis. More than 5 years after IBS diagnosis there is no increased risk of CRC compared to the general population, but a small excess risk of coeliac disease and IBD persists. Overall, though our findings provide reassurance that non/specialists, especially those in primary care, are unlikely to be missing an organic condition in the majority of their patients. This suggests that current guidelines suggesting avoidance of universal referral for these patients are appropriate.	[Canavan, Caroline; Card, Timothy; West, Joe] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England	University of Nottingham	Canavan, C (corresponding author), Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England.	caroline.canavan@nottingham.ac.uk	West, Joe/M-3867-2019; Card, Timothy/J-8651-2013	West, Joe/0000-0002-1135-9356; Card, Timothy/0000-0003-2555-2250	Medical Research Council [G1002360]; Coeliac UK; CORE; MRC [G1002360] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Coeliac UK; CORE(Luxembourg National Research Fund); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a Medical Research Council (www.mrc.ac.uk) Population Health Scientist Fellowship awarded to CC, grant number G1002360 and project funding from Coeliac UK and CORE to JW (https://www.coeliac.org.uk/campaigns-and-research/current-research/what-is-the-occurrence-and-consequence-of-clinically-diagnosed/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begtrup LM, 2013, CLIN GASTROENTEROL H, V11, P956, DOI 10.1016/j.cgh.2012.12.038; Canavan C, 2014, CLIN EPIDEMIOL, V6, P71, DOI 10.2147/CLEP.S40245; Cash BD, 2002, AM J GASTROENTEROL, V97, P2812; Chey WD, 2010, AM J GASTROENTEROL, V105, P859, DOI 10.1038/ajg.2010.55; Clinical Practice Research Dataset, 2012, CPRD GOLD FLAT FIL R; Corinaldesi R, 2009, ALIMENT PHARM THER, V30, P245, DOI 10.1111/j.1365-2036.2009.04041.x; Ford AC, 2009, ARCH INTERN MED, V169, P651, DOI 10.1001/archinternmed.2009.22; Fukuba N, 2013, PREVALENCE IRRITABLE; Hennessy S, 1999, AM J EPIDEMIOL, V149, P195; Huerta C, 2002, PHARMACOEPIDEM DR S, V11, P31, DOI 10.1002/pds.666; Jick H, 1997, LANCET, V349, P525, DOI 10.1016/S0140-6736(97)80084-0; JONES R, 1992, BRIT MED J, V304, P87, DOI 10.1136/bmj.304.6819.87; Lewis JD, 2002, PHARMACOEPIDEM DR S, V11, P211, DOI 10.1002/pds.698; Lewis JD, 2005, PHARMACOEPIDEM DR S, V14, P443, DOI 10.1002/pds.1115; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; Mein SM, 2004, ALIMENT PHARM THER, V19, P1199, DOI 10.1111/j.1365-2036.2004.01958.x; National Institute for Health and Care Excellence, 2008, IRR BOW SYNDR AD DIA; OWENS DM, 1995, ANN INTERN MED, V122, P107, DOI 10.7326/0003-4819-122-2-199501150-00005; Porter CK, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-55; Puri S, 2012, HOSP EPISODE STAT HE; Rodriguez LAG, 2000, SCAND J GASTROENTERO, V35, P306; Rothman K, 2008, MODERN EPIDEMIOLOGY, P168; Ruigomez A, 2003, MATURITAS, V44, P133, DOI 10.1016/S0378-5122(02)00321-3; Spiegel BMR, 2010, AM J GASTROENTEROL, V105, P848, DOI 10.1038/ajg.2010.47; TALLEY NJ, 1995, AM J EPIDEMIOL, V142, P76, DOI 10.1093/oxfordjournals.aje.a117548; TALLEY NJ, 1995, GASTROENTEROLOGY, V109, P1736, DOI 10.1016/0016-5085(95)90738-6; Thompson WG, 2000, GUT, V46, P78, DOI 10.1136/gut.46.1.78; Violato M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041308; West J, 2003, GASTROENTEROLOGY, V125, P429, DOI 10.1016/S0016-5085(03)00891-6	30	30	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e106478	10.1371/journal.pone.0106478	http://dx.doi.org/10.1371/journal.pone.0106478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238408	Green Submitted, Green Published, gold			2022-12-25	WOS:000342491600008
J	Contreras-Jurado, C; Garcia-Serrano, L; Martinez-Fernandez, M; Ruiz-Llorente, L; Paramio, JM; Aranda, A				Contreras-Jurado, Constanza; Garcia-Serrano, Laura; Martinez-Fernandez, Monica; Ruiz-Llorente, Lidia; Paramio, Jesus M.; Aranda, Ana			Impaired Hair Growth and Wound Healing in Mice Lacking Thyroid Hormone Receptors	PLOS ONE			English	Article							STEM-CELLS; KERATINOCYTE PROLIFERATION; EPIDERMAL HOMEOSTASIS; FOLLICLE; SKIN; ALPHA; PPAR; DIFFERENTIATION; MECHANISMS; EXPRESSION	Both clinical and experimental observations show that the skin is affected by the thyroidal status. In hypothyroid patients the epidermis is thin and alopecia is common, indicating that thyroidal status might influence not only skin proliferation but also hair growth. We demonstrate here that the thyroid hormone receptors (TRs) mediate these effects of the thyroid hormones on the skin. Mice lacking TR alpha 1 and TR beta (the main thyroid hormone binding isoforms) display impaired hair cycling associated to a decrease in follicular hair cell proliferation. This was also observed in hypothyroid mice, indicating the important role of the hormone-bound receptors in hair growth. In contrast, the individual deletion of either TR alpha 1 or TR beta did not impair hair cycling, revealing an overlapping or compensatory role of the receptors in follicular cell proliferation. In support of the role of the receptors in hair growth, TR alpha 1/TR beta-deficient mice developed alopecia after serial depilation. These mice also presented a wound-healing defect, with retarded re-epithelialization and wound gaping, associated to impaired keratinocyte proliferation. These results reinforce the idea that the thyroid hormone nuclear receptors play an important role on skin homeostasis and suggest that they could be targets for the treatment of cutaneous pathologies.	[Contreras-Jurado, Constanza; Garcia-Serrano, Laura; Ruiz-Llorente, Lidia; Aranda, Ana] CSIC, Inst Invest Biomed Alberto Sols, Dept Physiopathol Endocrine & Nervous Syst, Madrid, Spain; [Contreras-Jurado, Constanza; Garcia-Serrano, Laura; Ruiz-Llorente, Lidia; Aranda, Ana] Univ Autonoma Madrid, Madrid, Spain; [Martinez-Fernandez, Monica; Paramio, Jesus M.] CIEMAT, Div Biomed, Mol Oncol Unit, E-28040 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas	Paramio, JM (corresponding author), CIEMAT, Div Biomed, Mol Oncol Unit, E-28040 Madrid, Spain.	jesusm.paramio@ciemat.es; aaranda@iib.uam.es	Paramio, Jesus M/M-8482-2014; Aranda, Ana/ABG-8820-2020; Ruiz, Lidia/L-1620-2014	Paramio, Jesus M/0000-0001-7520-3177; Aranda, Ana/0000-0002-8338-9589; Ruiz, Lidia/0000-0003-1430-9618	'Juan de la Cierva' research fellowship [JCI-2010-06167];  [BFU2011-28058];  [RD12/0036/0030];  [S2011/BMD-2328];  [SAF2012-34378];  [RD12/0036/0009];  [S2010/BMD-2470]	'Juan de la Cierva' research fellowship; ; ; ; ; ; 	This work was supported by Grants BFU2011-28058, RD12/0036/0030 and S2011/BMD-2328 to AA, and SAF2012-34378, RD12/0036/0009 and S2010/BMD-2470 to JMP. MM-F is funded by a 'Juan de la Cierva' research fellowship (JCI-2010-06167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan Mohammad Kamrul, 1998, Journal of Medical Investigation, V44, P179; ALEXANDER MV, 1982, ARCH OTOLARYNGOL, V108, P289; Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Aranda Ana, 2013, Pediatr Endocrinol Rev, V11, P2; Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Bikle DD, 2012, REV ENDOCR METAB DIS, V13, P3, DOI 10.1007/s11154-011-9194-0; Billoni N, 2000, BRIT J DERMATOL, V142, P645, DOI 10.1046/j.1365-2133.2000.03408.x; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Braiman-Wiksman L, 2007, TOXICOL PATHOL, V35, P767, DOI 10.1080/01926230701584189; Chapellier B, 2002, EMBO J, V21, P3402, DOI 10.1093/emboj/cdf331; Cianferotti L, 2007, P NATL ACAD SCI USA, V104, P9428, DOI 10.1073/pnas.0702884104; Contreras-Jurado C, 2011, J BIOL CHEM, V286, P24079, DOI 10.1074/jbc.M111.218487; Coulombe PA, 2003, J INVEST DERMATOL, V121, P219, DOI 10.1046/j.1523-1747.2003.12387.x; Feng X, 1997, GENE DEV, V11, P59, DOI 10.1101/gad.11.1.59; Forrest D, 1996, NAT GENET, V13, P354, DOI 10.1038/ng0796-354; Forrest D, 2000, THYROID, V10, P41, DOI 10.1089/thy.2000.10.41; FREINKEL RK, 1972, ARCH DERMATOL, V106, P349, DOI 10.1001/archderm.106.3.349; Garcia-Serrano L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023825; Gothe S, 1999, GENE DEV, V13, P1329, DOI 10.1101/gad.13.10.1329; Guran T, 2009, J PEDIATR ENDOCR MET, V22, P1075; Hanley K, 1997, J CLIN INVEST, V100, P705, DOI 10.1172/JCI119583; Hyter S, 2013, FEBS LETT, V587, P529, DOI 10.1016/j.febslet.2013.01.041; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Karnik P, 2009, J INVEST DERMATOL, V129, P1243, DOI 10.1038/jid.2008.369; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Li JJ, 2010, BIOORG MED CHEM LETT, V20, P306, DOI 10.1016/j.bmcl.2009.10.109; Li M, 2000, NATURE, V407, P633, DOI 10.1038/35036595; Lindenbaum ES, 2001, PLAST RECONSTR SURG, V108, P104, DOI 10.1097/00006534-200107000-00016; Liu YY, 2003, J BIOL CHEM, V278, P38913, DOI 10.1074/jbc.M306120200; Mahajan MA, 2004, MOL CELL BIOL, V24, P4994, DOI 10.1128/MCB.24.11.4994-5004.2004; Martinez-Iglesias O, 2009, CANCER RES, V69, P501, DOI 10.1158/0008-5472.CAN-08-2198; Messenger AG, 2000, BRIT J DERMATOL, V142, P633, DOI 10.1046/j.1365-2133.2000.03521.x; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Pascual A, 2013, BBA-GEN SUBJECTS, V1830, P3908, DOI 10.1016/j.bbagen.2012.03.012; Paus R, 2010, J INVEST DERMATOL, V130, P7, DOI 10.1038/jid.2009.359; Raja, 2007, Front Biosci, V12, P2849; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; Rodriguez-Puebla ML, 1998, CELL GROWTH DIFFER, V9, P31; Safer JD, 2005, ENDOCRINOLOGY, V146, P4425, DOI 10.1210/en.2005-0192; Safer JD, 2004, ENDOCRINOLOGY, V145, P2357, DOI 10.1210/en.2003-1696; Safer JD, 2001, THYROID, V11, P717, DOI 10.1089/10507250152484547; Safer JD, 2013, J THROID RES, V2013, DOI 10.1155/2013/124538; Schmuth M, 2007, HORM METAB RES, V39, P96, DOI 10.1055/s-2007-961808; Schmuth M, 2014, BBA-MOL CELL BIOL L, V1841, P463, DOI 10.1016/j.bbalip.2013.11.012; Schneider IC, 2009, MOL BIOL CELL, V20, P3155, DOI 10.1091/mbc.E09-03-0219; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2002, J INVEST DERMATOL, V119, P1449, DOI 10.1046/j.1523-1747.2002.19617.x; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; TALMI YP, 1989, ANN OTO RHINOL LARYN, V98, P267, DOI 10.1177/000348948909800405; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; van Beek N, 2008, J CLIN ENDOCR METAB, V93, P4381, DOI 10.1210/jc.2008-0283; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010; Wikstrom L, 1998, EMBO J, V17, P455, DOI 10.1093/emboj/17.2.455; WILSON C, 1994, DIFFERENTIATION, V55, P127, DOI 10.1046/j.1432-0436.1994.5520127.x; Wondisford FE, 2003, J INVEST MED, V51, P215, DOI 10.1136/jim-51-04-22; Zhang B, 2012, INT J IMMUNOPATH PH, V25, P859, DOI 10.1177/039463201202500404	60	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108137	10.1371/journal.pone.0108137	http://dx.doi.org/10.1371/journal.pone.0108137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254665	gold, Green Published			2022-12-25	WOS:000344862300058
J	Li, QQ; Liu, JG; Zhang, LT; Liu, Q				Li, Qianqian; Liu, Jianguo; Zhang, Litao; Liu, Qian			De Novo Transcriptome Analysis of an Aerial Microalga Trentepohlia jolithus: Pathway Description and Gene Discovery for Carbon Fixation and Carotenoid Biosynthesis	PLOS ONE			English	Article							RNA-SEQ; PRINTZINA TRENTEPOHLIALES; CHLAMYDOMONAS-REINHARDTII; GREEN-ALGAE; CHLOROPHYTA; GENOME; C-3; ANNOTATION; WATER; TOOL	Background: Algae in the order Trentepohliales have a broad geographic distribution and are generally characterized by the presence of abundant beta-carotene. The many monographs published to date have mainly focused on their morphology, taxonomy, phylogeny, distribution and reproduction; molecular studies of this order are still rare. High-throughput RNA sequencing (RNA-Seq) technology provides a powerful and efficient method for transcript analysis and gene discovery in Trentepohlia jolithus. Methods/Principal Findings: Illumina HiSeq 2000 sequencing generated 55,007,830 Illumina PE raw reads, which were assembled into 41,328 assembled unigenes. Based on NR annotation, 53.28% of the unigenes (22,018) could be assigned to gene ontology classes with 54 subcategories and 161,451 functional terms. A total of 26,217 (63.44%) assembled unigenes were mapped to 128 KEGG pathways. Furthermore, a set of 5,798 SSRs in 5,206 unigenes and 131,478 putative SNPs were identified. Moreover, the fact that all of the C4 photosynthesis genes exist in T. jolithus suggests a complex carbon acquisition and fixation system. Similarities and differences between T. jolithus and other algae in carotenoid biosynthesis are also described in depth. Conclusions/Significance: This is the first broad transcriptome survey for T. jolithus, increasing the amount of molecular data available for the class Ulvophyceae. As well as providing resources for functional genomics studies, the functional genes and putative pathways identified here will contribute to a better understanding of carbon fixation and fatty acid and carotenoid biosynthesis in T. jolithus.	[Li, Qianqian; Liu, Jianguo; Zhang, Litao; Liu, Qian] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Li, Qianqian] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, JG (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.	jgliu@qdio.ac.cn			Chinese National Basic Research Program of China (973 Program) [2011CB2009]; China National Nature Science Foundation [31300330]	Chinese National Basic Research Program of China (973 Program)(National Basic Research Program of China); China National Nature Science Foundation(National Natural Science Foundation of China (NSFC))	This work was financially supported by the Chinese National Basic Research Program of China (973 Program, No. 2011CB2009) and the China National Nature Science Foundation (No. 31300330). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2002, J APPL PHYCOL, V14, P129, DOI 10.1023/A:1019599216554; Abe K, 1998, J MAR BIOTECHNOL, V6, P53; Abe K, 2008, J APPL PHYCOL, V20, P283, DOI 10.1007/s10811-007-9245-9; Aptroot A, 2007, ENVIRON POLLUT, V146, P293, DOI 10.1016/j.envpol.2006.03.018; Aragon C, 2013, PLANT CELL REP, V32, P1807, DOI 10.1007/s00299-013-1493-3; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; BARTLEY GE, 1995, PLANT CELL, V7, P1027, DOI 10.1105/tpc.7.7.1027; Blanc G, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r39; Bochenek M, 2013, NEW PHYTOL, V199, P650, DOI 10.1111/nph.12303; Britton G, 1998, CAROTENOIDS BIOSYNTH, P13; Chambers GK, 2000, COMP BIOCHEM PHYS B, V126, P455, DOI 10.1016/S0305-0491(00)00233-9; Chapman R. L., 1984, SYSTEMATICS GREEN AL, P233; CHAPMAN RL, 1983, AM J BOT, V70, P1340, DOI 10.2307/2443425; Chastain CJ, 2002, PLANT PHYSIOL, V128, P1368, DOI 10.1104/pp.010806; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dere Sukran, 1998, Turkish Journal of Botany, V22, P13; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; FLETCHER RL, 1992, BRIT PHYCOL J, V27, P303, DOI 10.1080/00071619200650281; Gasulla F, 2012, ADV PHOTOSYNTHESIS F; Gaylarde CC, 1999, BIOFOULING, V14, P59, DOI 10.1080/08927019909378397; Gildemeister E, 1916, VOLATILE OILS; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gray DW, 2007, PLANT CELL ENVIRON, V30, P1240, DOI 10.1111/j.1365-3040.2007.01704.x; Guarnieri MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025851; Gupta S, 2004, FOLIA MICROBIOL, V49, P37, DOI 10.1007/BF02931643; Gurtner G., 1995, SYLLABUS BODEN; Haubner N, 2006, MICROB ECOL, V51, P285, DOI 10.1007/s00248-006-9016-1; Hibberd JM, 2010, ANNU REV PLANT BIOL, V61, P181, DOI 10.1146/annurev-arplant-042809-112238; HOFFMANN L, 1989, BOT REV, V55, P77, DOI 10.1007/BF02858529; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kapraun DF, 2007, ANN BOT-LONDON, V99, P677, DOI 10.1093/aob/mcl294; Karsten U, 2007, ALGAE CYANOBACTERIA, P583; Kroth PG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001426; LANGE OL, 1989, BOT ACTA, V102, P306, DOI 10.1111/j.1438-8677.1989.tb00110.x; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Liu GX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037725; Lopez-Bautista JM, 2003, INT J SYST EVOL MICR, V53, P2099, DOI 10.1099/ijs.0.02256-0; Lopez-Bautista JM, 2006, INT J SYST EVOL MICR, V56, P1709, DOI 10.1099/ijs.0.63990-0; Lu XY, 2009, SOIL BIOL BIOCHEM, V41, P1015, DOI 10.1016/j.soilbio.2008.10.028; LuEpez-Bautista J.M., 2002, CONSTANCEA, V83; Lv HX, 2013, GENOMICS, V101, P229, DOI 10.1016/j.ygeno.2013.01.004; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Miller R, 2010, PLANT PHYSIOL, V154, P1737, DOI 10.1104/pp.110.165159; Moroney JV, 1999, PLANT PHYSIOL, V119, P9, DOI 10.1104/pp.119.1.9; Mukherjee R, 2010, J APPL PHYCOL, V22, P569, DOI 10.1007/s10811-009-9495-9; MURATA N, 1982, PLANT CELL PHYSIOL, V23, P1071; Nakano T, 1996, LICHENOLOGIST, V28, P437, DOI 10.1006/lich.1996.0042; Ouyang LL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-396; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Parsley K, 2006, PLANT MOL BIOL, V62, P339, DOI 10.1007/s11103-006-9023-0; Patel S, 2012, INDIAN J MICROBIOL, V52, P3, DOI 10.1007/s12088-011-0148-8; Powell W, 1996, TRENDS PLANT SCI, V1, P215, DOI 10.1016/1360-1385(96)86898-1; PRINTZ HENRIK, 1939, NYTT MAG NATURVIDENSK, V80, P137; Rindi F, 2005, PHYCOLOGIA, V44, P270, DOI 10.2216/0031-8884(2005)44[270:TADOTA]2.0.CO;2; Rindi F, 2002, J PHYCOL, V38, P39, DOI 10.1046/j.1529-8817.2002.01193.x; Rindi F, 2007, PHYCOLOGIA, V46, P698, DOI 10.2216/06-88.1; Rindi F, 2009, MOL PHYLOGENET EVOL, V52, P329, DOI 10.1016/j.ympev.2009.01.009; Rismani-Yazdi H, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-74; Rismani-Yazdi H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-148; Roberts K, 2007, PLANT PHYSIOL, V145, P230, DOI 10.1104/pp.107.102616; Stadhouders R, 2013, NAT PROTOC, V8, P509, DOI 10.1038/nprot.2013.018; Stickforth P, 2003, ARCH MICROBIOL, V179, P409, DOI 10.1007/s00203-003-0545-4; Takaichi S, 2007, CELL MOL LIFE SCI, V64, P2607, DOI 10.1007/s00018-007-7190-z; Takaichi S, 2011, MAR DRUGS, V9, P1101, DOI 10.3390/md9061101; TAN CK, 1993, J APPL PHYCOL, V5, P547, DOI 10.1007/BF02182515; Thompson GA, 1996, BBA-LIPID LIPID MET, V1302, P17, DOI 10.1016/0005-2760(96)00045-8; Tsuji Y, 2009, PLANT CELL PHYSIOL, V50, P318, DOI 10.1093/pcp/pcn200; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; von Dassow P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r114; Wan LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035142; Wang L, 2011, NEW PHYTOL, V190, P9, DOI 10.1111/j.1469-8137.2011.03649.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weise SE, 2011, J EXP BOT, V62, P3109, DOI 10.1093/jxb/err035; Winck FV, 2013, J PROTEOMICS; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Wright RF, 2001, HYDROL EARTH SYST SC, V5, P299, DOI 10.5194/hess-5-299-2001; Wujek D.E., 1997, TRENTEPOHLIALES CEPH; Xu J, 2012, PLOS ONE, V7; Yang SH, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-118; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang XW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-565; Zheng MG, 2013, GENE, V523, P117, DOI 10.1016/j.gene.2013.04.005	86	15	15	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108488	10.1371/journal.pone.0108488	http://dx.doi.org/10.1371/journal.pone.0108488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254555	Green Published, Green Submitted, gold			2022-12-25	WOS:000344862300089
J	Stone, OJ; Biette, KM; Murphy, PJM				Stone, Orrin J.; Biette, Kelly M.; Murphy, Patrick J. M.			Semi-Automated Hydrophobic Interaction Chromatography Column Scouting Used in the Two-Step Purification of Recombinant Green Fluorescent Protein	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; GFP FUSION PROTEINS; RAPID PURIFICATION; MOLECULAR-BIOLOGY; ESCHERICHIA-COLI; EXPRESSION; STUDENTS; PURITY; YIELD	Background: Hydrophobic interaction chromatography (HIC) most commonly requires experimental determination (i.e., scouting) in order to select an optimal chromatographic medium for purifying a given target protein. Neither a two-step purification of untagged green fluorescent protein (GFP) from crude bacterial lysate using sequential HIC and size exclusion chromatography (SEC), nor HIC column scouting elution profiles of GFP, have been previously reported. Methods and Results: Bacterial lysate expressing recombinant GFP was sequentially adsorbed to commercially available HIC columns containing butyl, octyl, and phenyl-based HIC ligands coupled to matrices of varying bead size. The lysate was fractionated using a linear ammonium phosphate salt gradient at constant pH. Collected HIC eluate fractions containing retained GFP were then pooled and further purified using high-resolution preparative SEC. Significant differences in presumptive GFP elution profiles were observed using in-line absorption spectrophotometry (A(395)) and post-run fluorimetry. SDS-PAGE and western blot demonstrated that fluorometric detection was the more accurate indicator of GFP elution in both HIC and SEC purification steps. Comparison of composite HIC column scouting data indicated that a phenyl ligand coupled to a 34 mu m matrix produced the highest degree of target protein capture and separation. Conclusions: Conducting two-step protein purification using the preferred HIC medium followed by SEC resulted in a final, concentrated product with >98% protein purity. In-line absorbance spectrophotometry was not as precise of an indicator of GFP elution as post-run fluorimetry. These findings demonstrate the importance of utilizing a combination of detection methods when evaluating purification strategies. GFP is a well-characterized model protein, used heavily in educational settings and by researchers with limited protein purification experience, and the data and strategies presented here may aid in development other of HIC-compatible protein purification schemes.	[Murphy, Patrick J. M.] Seattle Univ, Interdisciplinary Hlth Sci Res Lab, Coll Nursing, Seattle, WA 98122 USA; Seattle Univ, Coll Sci & Engn, Seattle, WA 98122 USA	Seattle University; Seattle University	Murphy, PJM (corresponding author), Seattle Univ, Interdisciplinary Hlth Sci Res Lab, Coll Nursing, Seattle, WA 98122 USA.	murphyp@seattleu.edu			National Institutes of Health AREA [GM086822]; National Science Foundation [DBI-0960313]; Seattle University College of Science & Engineering Summer Research Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM086822] Funding Source: NIH RePORTER	National Institutes of Health AREA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Seattle University College of Science & Engineering Summer Research Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health AREA grant GM086822 and National Science Foundation major research instrumentation grant DBI-0960313 to PJMM. The Seattle University College of Science & Engineering Summer Research Program provided for fellowship support to OJS and KMB. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Bassiri EA, 2011, BIOCHEM MOL BIOL EDU, V39, P432, DOI 10.1002/bmb.20538; Becker K, 2009, J MOL RECOGNIT, V22, P104, DOI 10.1002/jmr.897; Bender AT, 2000, J BIOL CHEM, V275, P26018, DOI 10.1074/jbc.275.34.26018; Camper DV, 2009, ANAL BIOCHEM, V393, P176, DOI 10.1016/j.ab.2009.07.009; Chew FN, 2009, ELECTROPHORESIS, V30, P3017, DOI 10.1002/elps.200900246; Craggs TD, 2009, CHEM SOC REV, V38, P2865, DOI 10.1039/b903641p; Cummins PM, 2011, METHODS MOL BIOL, V681, P431, DOI 10.1007/978-1-60761-913-0_24; DESCHAMPS JR, 1995, PROTEIN EXPRES PURIF, V6, P555, DOI 10.1006/prep.1995.1073; INOUYE S, 1994, FEBS LETT, V341, P277, DOI 10.1016/0014-5793(94)80472-9; Knutson K, 2010, BIOCHEM MOL BIOL EDU, V38, P317, DOI 10.1002/bmb.20400; Lienqueo ME, 2006, J MOL RECOGNIT, V19, P260, DOI 10.1002/jmr.776; Lienqueo ME, 2007, J CHROMATOGR B, V849, P53, DOI 10.1016/j.jchromb.2006.11.019; Mahn A, 2009, J CHROMATOGR A, V1216, P1838, DOI 10.1016/j.chroma.2008.11.089; McCue JT, 2009, METHOD ENZYMOL, V463, P405, DOI 10.1016/S0076-6879(09)63025-1; McRae SR, 2005, PROTEIN EXPRES PURIF, V41, P121, DOI 10.1016/j.pep.2004.12.030; Murphy Pjm, 2011, J VIS EXP, V55, p[E3060, 3061]; Peckham GD, 2006, PROTEIN EXPRES PURIF, V49, P183, DOI 10.1016/j.pep.2006.03.011; Penna TCV, 2004, APPL BIOCHEM BIOTECH, V113, P469; Remington SJ, 2011, PROTEIN SCI, V20, P1509, DOI 10.1002/pro.684; RodriguezCrespo I, 1996, J BIOL CHEM, V271, P11462, DOI 10.1074/jbc.271.19.11462; Sommer CA, 2004, BIOCHEM MOL BIOL EDU, V32, P7, DOI 10.1002/bmb.2004.494032010290; To BCS, 2011, J CHROMATOGR A, V1218, P427, DOI 10.1016/j.chroma.2010.11.051; Zhuang R, 2008, PROTEIN EXPRES PURIF, V59, P138, DOI 10.1016/j.pep.2008.01.020	23	5	5	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108611	10.1371/journal.pone.0108611	http://dx.doi.org/10.1371/journal.pone.0108611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254496	gold, Green Published, Green Submitted			2022-12-25	WOS:000344862300097
J	Gangooly, S; Muttukrishna, S; Jauniaux, E				Gangooly, Subrata; Muttukrishna, Shanthi; Jauniaux, Eric			In-Vitro Study of the Effect of Anti-Hypertensive Drugs on Placental Hormones and Angiogenic Proteins Synthesis in Pre-Eclampsia	PLOS ONE			English	Article							TYROSINE KINASE 1; OXIDATIVE STRESS; ACTIVIN-A; HYPERTENSIVE DISORDERS; SOLUBLE ENDOGLIN; BLOOD-FLOW; PREGNANCY; INHIBIN; OXYGEN; ALPHA	Introduction: Antihypertensive drugs lower the maternal blood pressure in pre-eclampsia (PE) by direct or central vasodilatory mechanisms but little is known about the direct effects of these drugs on placental functions. Objective: The aim of our study is to evaluate the effect of labetolol, hydralazine, a-methyldopa and pravastatin on the synthesis of placental hormonal and angiogenic proteins know to be altered in PE. Design: Placental villous explants from late onset PE (n = 3) and normotensive controls (n = 6) were cultured for 3 days at 10 and 20% oxygen (O-2) with variable doses anti-hypertensive drugs. The levels of activin A, inhibin A, human Chorionic Gonadotrophin (hCG), soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin (sEng) were measured in explant culture media on day 1, 2 and 3 using standard immunoassays. Data at day 1 and day 3 were compared. Results: Spontaneous secretion of sEndoglin and sFlt-1 were higher (p<0.05) in villous explants from PE pregnancies compared to controls. There was a significant time dependant decrease in the secretion of sFlt-1 and sEndoglin in PE cases, which was seen only for sFlt-1 in controls. In both PE cases and controls the placental protein secretions were not affected by varying doses of anti-hypertensive drugs or the different O-2 concentration cultures, except for Activin, A which was significantly (p<0.05) higher in controls at 10% O-2. Interpretation: Our findings suggest that the changes previously observed in maternal serum hormones and angiogenic proteins level after anti-hypertensive treatment in PE could be due to a systemic effect of the drugs on maternal blood pressure and circulation rather than a direct effect of these drugs on placental biosynthesis and/or secretion.	[Gangooly, Subrata; Muttukrishna, Shanthi; Jauniaux, Eric] UCL, Inst Womens Hlth, London, England; [Muttukrishna, Shanthi] Natl Univ Ireland Univ Coll Cork, Matern Hosp, Dept Obstet & Gynaecol, Anu Res Ctr, Cork, Ireland	University of London; University College London; University College Cork	Jauniaux, E (corresponding author), UCL, Inst Womens Hlth, London, England.	e.jauniaux@ucl.ac.uk						Anderson UD, 2012, PLACENTA, V33, pS42, DOI 10.1016/j.placenta.2011.11.021; Bearfield C, 2005, EUR J ENDOCRINOL, V152, P909, DOI 10.1530/eje.1.01928; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Burton GJ, 2006, METH MOLEC MED, V122, P413; Cindrova-Davies T, 2007, AM J PATHOL, V171, P1168, DOI 10.2353/ajpath.2007.070528; Cohn JN, 2011, J CLIN HYPERTENS, V13, P690, DOI 10.1111/j.1751-7176.2011.00507.x; Costantine MM, 2013, OBSTET GYNECOL, V121, P349, DOI 10.1097/AOG.0b013e31827d8ad5; Duggan ST, 2012, DRUGS, V72, P565, DOI 10.2165/11207180-000000000-00000; FALKAY G, 1994, J RECEPTOR RES, V14, P187, DOI 10.3109/10799899409066030; Gulec UK, 2013, J MATERN-FETAL NEO M, V26, P1228, DOI 10.3109/14767058.2013.776533; Head GA, 1999, ANN NY ACAD SCI, V881, P279, DOI 10.1111/j.1749-6632.1999.tb09370.x; Head GA, 1998, J AUTONOM NERV SYST, V72, P163, DOI 10.1016/S0165-1838(98)00101-5; Hung TH, 2004, AM J PATHOL, V164, P1049, DOI 10.1016/S0002-9440(10)63192-6; Hung TH, 2001, AM J PATHOL, V159, P1031, DOI 10.1016/S0002-9440(10)61778-6; Jauniaux E, 2003, AM J PATHOL, V162, P115, DOI 10.1016/S0002-9440(10)63803-5; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Jauniaux E, 2006, HUM REPROD UPDATE, V12, P747, DOI 10.1093/humupd/dml016; Kattah AG, 2013, ADV CHRONIC KIDNEY D, V20, P229, DOI 10.1053/j.ackd.2013.01.014; Khalil A, 2009, CLIN ENDOCRINOL, V70, P924, DOI 10.1111/j.1365-2265.2008.03426.x; Khalil A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002766; Khong Y, 2011, BEST PRACT RES CL OB, V25, P301, DOI 10.1016/j.bpobgyn.2010.10.012; Kimura C, 2013, J MATERN-FETAL NEO M, V26, P491, DOI 10.3109/14767058.2012.733766; Kleinrouweler CE, 2012, BJOG-INT J OBSTET GY, V119, P778, DOI 10.1111/j.1471-0528.2012.03311.x; Lee SM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.047; LEITCH IM, 1994, CLIN EXP PHARMACOL P, V21, P615, DOI 10.1111/j.1440-1681.1994.tb02562.x; Muttukrishna S, 1996, J CLIN ENDOCR METAB, V81, P3328, DOI 10.1210/jc.81.9.3328; Muttukrishna S, 2004, REPROD BIOMED ONLINE, V8, P712, DOI 10.1016/S1472-6483(10)61653-7; Muttukrishna S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002302; Nadeem L, 2011, AM J PATHOL, V178, P1177, DOI 10.1016/j.ajpath.2010.11.066; Orendi K, 2011, PLACENTA, V32, pS49, DOI 10.1016/j.placenta.2010.11.023; Pidoux G, 2012, PLACENTA, V33, pS81, DOI 10.1016/j.placenta.2011.11.007; Pijnenborg R, 2011, BEST PRACT RES CL OB, V25, P273, DOI 10.1016/j.bpobgyn.2010.10.009; Reddy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004453; Redman CWG, 2012, PLACENTA, V33, pS48, DOI 10.1016/j.placenta.2011.12.006; Royle C, 2009, CYTOKINE, V47, P56, DOI 10.1016/j.cyto.2009.04.006; SIBAI BM, 1993, NEW ENGL J MED, V329, P1213, DOI 10.1056/NEJM199310213291701; Vanderlelie J, 2005, PLACENTA, V26, P53, DOI 10.1016/j.placenta.2004.04.002; Vatten LJ, 2012, ACTA OBSTET GYN SCAN, V91, P1388, DOI 10.1111/j.1600-0412.2012.01516.x; Vest AR, 2012, CARDIOL CLIN, V30, P407, DOI 10.1016/j.ccl.2012.04.005; Watson AL, 1998, J CLIN ENDOCR METAB, V83, P1697, DOI 10.1210/jc.83.5.1697; Williams PJ, 2012, PHARMACOGEN PERS MED, V5, P37, DOI 10.2147/PGPM.S23141; Xu B, 2009, CLIN EXP PHARMACOL P, V36, P839, DOI 10.1111/j.1440-1681.2009.05155.x; Xu B, 2006, J HYPERTENS, V24, P915, DOI 10.1097/01.hjh.0000222762.84605.03; Yu L, 2012, J CLIN ENDOCR METAB, V97, P1370, DOI DOI 10.1210/JC.2011-2729	45	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107644	10.1371/journal.pone.0107644	http://dx.doi.org/10.1371/journal.pone.0107644			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251016	gold, Green Published, Green Submitted			2022-12-25	WOS:000342492700037
J	Gao, Z; Nissen, JC; Ji, KM; Tsirka, SE				Gao, Zhen; Nissen, Jillian C.; Ji, Kyungmin; Tsirka, Stella E.			The Experimental Autoimmune Encephalomyelitis Disease Course Is Modulated by Nicotine and Other Cigarette Smoke Components	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ACETYLCHOLINE-RECEPTOR SUBUNIT; BLOOD-BRAIN-BARRIER; MULTIPLE-SCLEROSIS; T-CELLS; IN-VITRO; ACTIVATION; MICROGLIA; INFLAMMATION; ALPHA-7	Epidemiological studies have reported that cigarette smoking increases the risk of developing multiple sclerosis (MS) and accelerates its progression. However, the molecular mechanisms underlying these effects remain unsettled. We have investigated here the effects of the nicotine and the non-nicotine components in cigarette smoke on MS using the experimental autoimmune encephalomyelitis (EAE) model, and have explored their underlying mechanism of action. Our results show that nicotine ameliorates the severity of EAE, as shown by reduced demyelination, increased body weight, and attenuated microglial activation. Nicotine administration after the development of EAE symptoms prevented further disease exacerbation, suggesting that it might be useful as an EAE/MS therapeutic. In contrast, the remaining components of cigarette smoke, delivered as cigarette smoke condensate (CSC), accelerated and increased adverse clinical symptoms during the early stages of EAE, and we identify a particular cigarette smoke compound, acrolein, as one of the potential mediators. We also show that the mechanisms underlying the opposing effects of nicotine and CSC on EAE are likely due to distinct effects on microglial viability, activation, and function.	[Gao, Zhen; Nissen, Jillian C.; Ji, Kyungmin; Tsirka, Stella E.] SUNY Stony Brook, Sch Med, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Gao, Zhen; Tsirka, Stella E.] SUNY Stony Brook, Sch Med, Program Neurosci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Tsirka, SE (corresponding author), SUNY Stony Brook, Sch Med, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.	styliani-anna.tsirka@stonybrook.edu	Tsirka, Stella/AAD-4018-2019		National Multiple Sclerosis Society [CA1044A1, PP181]; National Aeronautics and Space Administration [NNA14AB04A]; National Institutes of Health [R01NS42168, K12GM102778]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM102778, T32GM007518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042168] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Multiple Sclerosis Society awards CA1044A1 and PP181, National Aeronautics and Space Administration NNA14AB04A and National Institutes of Health R01NS42168 (ST), and National Institutes of Health K12GM102778 to JN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becher B, 2006, J MOL MED, V84, P532, DOI 10.1007/s00109-006-0065-1; Benowitz NL, 1996, BIOMARKERS CIGARETTE, P93; Bhasin M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-10; Burcham PC, 2006, MOL PHARMACOL, V69, P1056, DOI 10.1124/mol.105.018168; Butovsky O, 2006, J CLIN INVEST, V116, P905, DOI 10.1172/JCI26836; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308; Carlens C, 2010, AM J RESP CRIT CARE, V181, P1217, DOI 10.1164/rccm.200909-1338OC; Centonze D, 2009, J NEUROSCI, V29, P3442, DOI 10.1523/JNEUROSCI.5804-08.2009; Chen JG, 2008, TOXICOLOGY, V249, P194, DOI 10.1016/j.tox.2008.05.009; Cloez-Tayarani I, 2007, J LEUKOCYTE BIOL, V81, P599, DOI 10.1189/jlb.0906544; de Vries HE, 2012, EPILEPSIA, V53, P45, DOI 10.1111/j.1528-1167.2012.03702.x; Defaux A, 2011, NEUROSCIENCE; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Handel AE, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016149, 10.1371/journal.pone.0014606]; Hao JW, 2011, EXP NEUROL, V227, P110, DOI 10.1016/j.expneurol.2010.09.020; Hawkins BT, 2004, BRAIN RES, V1027, P48, DOI 10.1016/j.brainres.2004.08.043; Hedstrom AK, 2009, NEUROLOGY, V73, P696, DOI 10.1212/WNL.0b013e3181b59c40; Hernan MA, 2001, AM J EPIDEMIOL, V154, P69, DOI 10.1093/aje/154.1.69; Intorp Michael, 2012, Beitraege zur Tabakforschung International, V25, P361; Jin HJ, 2012, IMMUNOL LETT, V146, P40, DOI 10.1016/j.imlet.2012.02.015; Leung G, 2011, NEUROSCIENCE, V173, P150, DOI 10.1016/j.neuroscience.2010.11.018; Li WW, 2005, J NEUROIMMUNOL, V158, P58, DOI 10.1016/j.jneuroim.2004.08.011; Liu JM, 2011, CANCER EPIDEM BIOMAR, V20, P1760, DOI 10.1158/1055-9965.EPI-10-0987; Liu-Snyder P, 2006, J NEUROSCI RES, V84, P219, DOI 10.1002/jnr.20862; Matsuda R, 2012, INVEST OPHTH VIS SCI, V53, P5475, DOI 10.1167/iovs.12-9935; Matta SG, 2007, PSYCHOPHARMACOLOGY, V190, P269, DOI 10.1007/s00213-006-0441-0; Mehra D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052889; Mikita J, 2011, MULT SCLER J, V17, P2, DOI 10.1177/1352458510379243; Momi N, 2013, ONCOGENE, V32, P1384, DOI 10.1038/onc.2012.163; Moon JH, 2008, EXP MOL MED, V40, P11, DOI 10.3858/emm.2008.40.1.11; Murphy AC, 2010, BRAIN BEHAV IMMUN, V24, P641, DOI 10.1016/j.bbi.2010.01.014; Nizri E, 2009, J IMMUNOL, V183, P6681, DOI 10.4049/jimmunol.0902212; Odoardi F, 2012, NATURE, V488, P675, DOI 10.1038/nature11337; Ohnishi M, 2009, EUR J PHARMACOL, V602, P288, DOI 10.1016/j.ejphar.2008.11.041; Orr-Urtreger A, 2005, NEUROREPORT, V16, P1123, DOI 10.1097/00001756-200507130-00018; Paulson JR, 2010, J PHARMACOL EXP THER, V332, P371, DOI 10.1124/jpet.109.157776; Pillai S, 2012, CURR DRUG TARGETS, V13, P671, DOI 10.2174/138945012800398847; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Pittas F, 2009, J NEUROL, V256, P577, DOI 10.1007/s00415-009-0120-2; Rasmussen S, 2011, ANN NEUROL, V69, P878, DOI 10.1002/ana.22299; Razani-Boroujerdi S, 2007, J IMMUNOL, V179, P2889, DOI 10.4049/jimmunol.179.5.2889; Roemer Ewald, 2012, Beitraege zur Tabakforschung International, V25, P316; Rogers SW, 2001, GLIA, V33, P306, DOI 10.1002/1098-1136(20010315)33:4<306::AID-GLIA1029>3.3.CO;2-N; Rogove AD, 1998, CURR BIOL, V8, P19, DOI 10.1016/S0960-9822(98)70016-8; Rowland LM, 2010, PSYCHOPHARMACOLOGY, V208, P575, DOI 10.1007/s00213-009-1758-2; Salzer J, 2012, MULT SCLER; Shaked I, 2004, J NEUROIMMUNOL, V146, P84, DOI 10.1016/j.jneuroim.2003.10.049; Shi FD, 2009, J IMMUNOL, V182, P1730, DOI 10.4049/jimmunol.182.3.1730; Sundstrom P, 2008, MULT SCLER J, V14, P1031, DOI 10.1177/1352458508093615; Suzuki T, 2006, J NEUROSCI RES, V83, P1461, DOI 10.1002/jnr.20850; van Noort JM, 2011, CNS NEUROL DISORD-DR, V10, P68; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Warren Graham W, 2013, J Carcinog, V12, P1, DOI 10.4103/1477-3163.106680; Wickenden JA, 2003, AM J RESP CELL MOL, V29, P562, DOI 10.1165/rcmb.2002-0235OC; Wu MZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034933; Wui MZ, 2009, GLIA, V57, P1204, DOI 10.1002/glia.20842; Zhai HY, 2011, GLIA, V59, P472, DOI 10.1002/glia.21117; Zhang WP, 2011, J PERIODONTOL, V82, P1071, DOI 10.1902/jop.2010.100540; Zhang Z, 2011, J NEUROIMMUNOL, V237, P73, DOI 10.1016/j.jneuroim.2011.06.006	60	38	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107979	10.1371/journal.pone.0107979	http://dx.doi.org/10.1371/journal.pone.0107979			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250777	Green Submitted, gold, Green Published			2022-12-25	WOS:000342492700067
J	Giuliani, C; Bucci, I; Di Santo, S; Rossi, C; Grassadonia, A; Mariotti, M; Piantelli, M; Monaco, F; Napolitano, G				Giuliani, Cesidio; Bucci, Ines; Di Santo, Serena; Rossi, Cosmo; Grassadonia, Antonino; Mariotti, Marianna; Piantelli, Mauro; Monaco, Fabrizio; Napolitano, Giorgio			Resveratrol Inhibits Sodium/Iodide Symporter Gene Expression and Function in Rat Thyroid Cells	PLOS ONE			English	Article							LINES; BIOAVAILABILITY; HEALTH; IMPACT	Resveratrol is a polyphenol found in grapes and berries that has antioxidant, antiproliferative and anti-inflammatory properties. For these reasons, it is available as a dietary supplement, and it is under investigation in several clinical trials. Few data are available regarding the effects of resveratrol on thyroid function. A previous study showed that resveratrol transiently increases iodide influx in FRTL-5 rat thyroid cells. Indeed, this increase arises after short treatment times (6-12 h), and no further effects are seen after 24 h. The aim of the present study was to investigate the effects of resveratrol on iodide uptake and sodium/iodide symporter expression in thyroid cells after longer times of treatment. For this purpose, the effects of resveratrol were evaluated both in vitro and in vivo using the rat thyroid FRTL-5 cell line and Sprague-Dawley rats, respectively. In FRTL-5 cells, resveratrol decreased the sodium/iodide symporter RNA and protein expression as a function of time. Furthermore, resveratrol decreased cellular iodide uptake after 48 h of treatment. The inhibitory effect of resveratrol on iodide uptake was confirmed in vivo in Sprague-Dawley rats. This study demonstrates that with longer-term treatment, resveratrol is an inhibitor of sodium/iodide symporter gene expression and function in the thyroid. These data suggest that resveratrol can act as a thyroid disruptor, which indicates the need for caution as a supplement and in therapeutic use.	[Giuliani, Cesidio; Bucci, Ines; Di Santo, Serena; Monaco, Fabrizio; Napolitano, Giorgio] G DAnnunzio Univ Chieti Pescara, Dept Med & Sci Aging, Unit Endocrinol, Chieti, Italy; [Giuliani, Cesidio; Bucci, Ines; Di Santo, Serena; Rossi, Cosmo; Grassadonia, Antonino; Mariotti, Marianna; Piantelli, Mauro; Monaco, Fabrizio; Napolitano, Giorgio] G DAnnunzio Univ Chieti Pescara, Aging Res Ctr CeSI, Chieti, Italy; [Grassadonia, Antonino; Piantelli, Mauro] G DAnnunzio Univ Chieti Pescara, Dept Oncol & Neurosci, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Giuliani, C (corresponding author), G DAnnunzio Univ Chieti Pescara, Dept Med & Sci Aging, Unit Endocrinol, Chieti, Italy.	cgiulian@unich.it						Ambesi Impiombato FS., 1986, United States Patent, Patent No. [US 4608341, 4608341]; Boocock DJ, 2007, CANCER EPIDEM BIOMAR, V16, P1246, DOI 10.1158/1055-9965.EPI-07-0022; Catalgol B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00141; Chachay VS, 2011, BRIT J CLIN PHARMACO, V72, P27, DOI 10.1111/j.1365-2125.2011.03966.x; dos Santos MCD, 2011, FOOD CHEM TOXICOL, V49, P2495, DOI 10.1016/j.fct.2011.06.074; Della-Morte D, 2009, NEUROSCIENCE, V159, P993, DOI 10.1016/j.neuroscience.2009.01.017; Duntas LH, 2011, J ENDOCRINOL INVEST, V34, P788, DOI 10.3275/7926; Frombaum M, 2012, BIOCHIMIE, V94, P269, DOI 10.1016/j.biochi.2011.11.001; Giuliani C, 2006, J ENDOCRINOL, V189, P605, DOI 10.1677/joe.1.06486; Giuliani C, 2008, ENDOCRINOLOGY, V149, P84, DOI 10.1210/en.2007-0618; Giuliani C, 2014, FOOD CHEM TOXICOL, V66, P23, DOI 10.1016/j.fct.2014.01.016; Kang HJ, 2011, J KOREAN MED SCI, V26, P893, DOI 10.3346/jkms.2011.26.7.893; Kohn L D, 1995, Vitam Horm, V50, P287, DOI 10.1016/S0083-6729(08)60658-5; KOHN LD, 1989, INT CONGR SER, V818, P243; Larrosa M, 2011, EUR J NUTR, V50, P673, DOI 10.1007/s00394-011-0178-3; Lin R, 2010, THYROID, V20, P1139, DOI 10.1089/thy.2009.0408; Orallo F, 2006, CURR MED CHEM, V13, P87, DOI 10.2174/092986706775197953; Patel KR, 2011, ANN NY ACAD SCI, V1215, P161, DOI 10.1111/j.1749-6632.2010.05853.x; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Riedel C, 2001, J BIOL CHEM, V276, P21458, DOI 10.1074/jbc.M100561200; SAJI M, 1992, P NATL ACAD SCI USA, V89, P1944, DOI 10.1073/pnas.89.5.1944; Schmutzler C, 1997, BIOCHEM BIOPH RES CO, V240, P832, DOI 10.1006/bbrc.1997.7715; Sebai H, 2010, THYROID, V20, P195, DOI 10.1089/thy.2009.0171; Shih A, 2002, J CLIN ENDOCR METAB, V87, P1223, DOI 10.1210/jc.87.3.1223; Smoliga JM, 2011, MOL NUTR FOOD RES, V55, P1129, DOI 10.1002/mnfr.201100143; Stefanska B, 2012, BRIT J PHARMACOL, V167, P279, DOI 10.1111/j.1476-5381.2012.02002.x; Svajger U, 2012, INT REV IMMUNOL, V31, P202, DOI 10.3109/08830185.2012.665108; Timmers S, 2012, AGING-US, V4, P146, DOI 10.18632/aging.100445; Tome-Carneiro J, 2013, CURR PHARM DESIGN, V19, P6064, DOI 10.2174/13816128113199990407; Vang O, 2013, ANN NY ACAD SCI, V1290, P1, DOI 10.1111/nyas.12173; WEISS SJ, 1984, ENDOCRINOLOGY, V114, P1090, DOI 10.1210/endo-114-4-1090; Wenzel E, 2005, MOL NUTR FOOD RES, V49, P472, DOI 10.1002/mnfr.200500010; Yu W, 2012, J CELL BIOCHEM, V113, P752, DOI 10.1002/jcb.23431; Yu XM, 2013, MOL CANCER THER, V12, P1276, DOI 10.1158/1535-7163.MCT-12-0841	34	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107936	10.1371/journal.pone.0107936	http://dx.doi.org/10.1371/journal.pone.0107936			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251397	Green Published, gold, Green Submitted			2022-12-25	WOS:000342492700059
J	Han, J; He, LL; Shi, WL; Xu, XG; Wang, S; Zhang, S; Zhang, Y				Han, Jian; He, Lili; Shi, Wanliang; Xu, Xiaogang; Wang, Sen; Zhang, Shuo; Zhang, Ying			Glycerol Uptake Is Important for L-Form Formation and Persistence in Staphylococcus aureus	PLOS ONE			English	Article							BACTERIAL L-FORMS; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; CELL-WALL; BOVINE MASTITIS; PEPTIDOGLYCAN; ANTIBIOTICS; PROTOPLAST; EXPRESSION; RESISTANCE	S. aureus is a significant human pathogen and has previously been shown to form cell wall deficient forms or L-forms in vitro and in vivo during infection. Despite many previous studies on S. aureus L-forms, the mechanisms of L-form formation in this organism remain unknown. Here we established the L-form model in S. aureus and constructed a transposon mutant library to identify genes involved in L-form formation. Screening of the library for mutants defective in L-form formation identified glpF involved in glycerol uptake being important for L-form formation in S. aureus. Consistent with this observation, glpF was found to be highly expressed in L-form S. aureus but hardly expressed in normal walled form. In addition, glpF mutant was found to be defective in antibiotic persistence. The defect in L-form formation and antibiotic persistence of the glpF mutant could be complemented by the wild type glpF gene. These findings provide new insight into the mechanisms of L-form formation and persistence in S. aureus and may have implications for development of new drugs targeting persisters for improved treatment.	[Han, Jian; He, Lili] Lanzhou Univ, Sch Basic Med Sci, Dept Pathogen Biol, Lanzhou 730000, Peoples R China; [Han, Jian; Shi, Wanliang; Zhang, Shuo; Zhang, Ying] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA; [Xu, Xiaogang] Fudan Univ, Huashan Hosp, Inst Antibiot, Shanghai 200433, Peoples R China; [Wang, Sen; Zhang, Ying] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China	Lanzhou University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Fudan University; Fudan University	Zhang, Y (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.	yzhang@jhsph.edu	XU, XIAOGANG/AAR-8657-2020		China Scholarship Council	China Scholarship Council(China Scholarship Council)	We thank Dominique Missiakas for providing plasmids used in this study. Jian Han was supported by China Scholarship Council.	Allan EJ, 2009, ADV APPL MICROBIOL, V68, P1, DOI 10.1016/S0065-2164(09)01201-5; Bae Taeok, 2008, V416, P103, DOI 10.1007/978-1-59745-321-9_7; BANVILLE RR, 1964, J BACTERIOL, V87, P1192, DOI 10.1128/JB.87.5.1192-1197.1964; Devine KM, 2012, MOL MICROBIOL, V83, P10, DOI 10.1111/j.1365-2958.2011.07922.x; DIENES L, 1951, BACTERIOL REV, V15, P245, DOI 10.1128/MMBR.15.4.245-288.1951; Domingue GJ, 2010, DISCOV MED, V10, P234; Domingue GJ, 1997, CLIN MICROBIOL REV, V10, P320, DOI 10.1128/CMR.10.2.320; Dominguez-Cuevas P, 2012, MOL MICROBIOL, V83, P52, DOI 10.1111/j.1365-2958.2011.07920.x; Fuller E, 2005, ANTIMICROB AGENTS CH, V49, P5075, DOI 10.1128/AAC.49.12.5075-5080.2005; Glover WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007316; Joseleau-Petit D, 2007, J BACTERIOL, V189, P6512, DOI 10.1128/JB.00273-07; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; KHAN SA, 1983, PLASMID, V10, P251, DOI 10.1016/0147-619X(83)90039-2; Klieneberger E, 1935, J PATHOL BACTERIOL, V40, P93, DOI 10.1002/path.1700400108; Leaver M, 2009, NATURE, V457, P849, DOI 10.1038/nature07742; Lechner S, 2012, J MOL MICROB BIOTECH, V22, P235, DOI 10.1159/000342449; Luong TT, 2006, J BACTERIOL, V188, P1899, DOI 10.1128/JB.188.5.1899-1910.2006; Ma C, 2010, FEMS MICROBIOL LETT, V303, P33, DOI 10.1111/j.1574-6968.2009.01857.x; Michailova L, 2007, FEMS MICROBIOL LETT, V268, P88, DOI 10.1111/j.1574-6968.2006.00567.x; OWENS WE, 1987, J CLIN MICROBIOL, V25, P1956, DOI 10.1128/JCM.25.10.1956-1961.1987; SEARS PM, 1987, J AM VET MED ASSOC, V191, P681; Shingaki R, 2003, MICROBIOL-SGM, V149, P2501, DOI 10.1099/mic.0.26259-0; Siddiqui RA, 2006, FEMS MICROBIOL LETT, V258, P305, DOI 10.1111/j.1574-6968.2006.00237.x; Spoering AL, 2006, J BACTERIOL, V188, P5136, DOI 10.1128/JB.00369-06; Stroud RM, 2003, CURR OPIN STRUC BIOL, V13, P424, DOI 10.1016/S0959-440X(03)00114-3; Tanimoto A, 1995, Rinsho Byori, V43, P1061; Zhang Y, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.3	27	21	24	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108325	10.1371/journal.pone.0108325	http://dx.doi.org/10.1371/journal.pone.0108325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251561	gold, Green Published, Green Submitted			2022-12-25	WOS:000342492700111
J	Hu, YH; Kitching, RL; Lan, GY; Zhang, JL; Sha, LQ; Cao, M				Hu, Yue-Hua; Kitching, Roger L.; Lan, Guo-Yu; Zhang, Jiao-Lin; Sha, Li-Qing; Cao, Min			Size-Class Effect Contributes to Tree Species Assembly through Influencing Dispersal in Tropical Forests	PLOS ONE			English	Article							HABITAT ASSOCIATIONS; SPATIAL DISTRIBUTIONS; SEED DISPERSAL; PATTERNS; DIVERSITY; XISHUANGBANNA; MAINTENANCE; COEXISTENCE; MECHANISMS; LIMITATION	We have investigated the processes of community assembly using size classes of trees. Specifically our work examined (1) whether point process models incorporating an effect of size-class produce more realistic summary outcomes than do models without this effect; (2) which of three selected models incorporating, respectively environmental effects, dispersal and the joint-effect of both of these, is most useful in explaining species-area relationships (SARs) and point dispersion patterns. For this evaluation we used tree species data from the 50-ha forest dynamics plot in Barro Colorado Island, Panama and the comparable 20 ha plot at Bubeng, Southwest China. Our results demonstrated that incorporating an sizeclass effect dramatically improved the SAR estimation at both the plots when the dispersal only model was used. The joint effect model produced similar improvement but only for the 50-ha plot in Panama. The point patterns results were not improved by incorporation of size-class effects using any of the three models. Our results indicate that dispersal is likely to be a key process determining both SARs and point patterns. The environment-only model and joint-effects model were effective at the species level and the community level, respectively. We conclude that it is critical to use multiple summary characteristics when modelling spatial patterns at the species and community levels if a comprehensive understanding of the ecological processes that shape species' distributions is sought; without this results may have inherent biases. By influencing dispersal, the effect of size-class contributes to species assembly and enhances our understanding of species coexistence.	[Hu, Yue-Hua; Kitching, Roger L.; Zhang, Jiao-Lin; Sha, Li-Qing; Cao, Min] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Mengla, Yunnan, Peoples R China; [Kitching, Roger L.] Griffith Univ, Griffith Sch Environm, Environm Futures Res Inst, Nathan, Qld 4111, Australia; [Lan, Guo-Yu] Chinese Acad Trop Agr Sci, Rubber Res Inst, Danzhou, Hainan, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Griffith University; Chinese Academy of Tropical Agricultural Sciences	Cao, M (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Mengla, Yunnan, Peoples R China.	caom@xtbg.ac.cn			National Natural Science Foundation of China [31300358]; West Light Foundation of the Chinese Academy of Sciences; National Key Basic Research Program of China [2014CB954100]; QCAS Biotechnology Fund [GJHZ1130]; National Science and Technology Pillar Program [2008BAC39B02]; National Science Foundation of China [31061160188, 31270453]; Chinese Academy of Sciences [2013T2S0029]; National Science Foundation [DEB-0640386, DEB-0425651, DEB-0346488, DEB-0129874, DEB-00753102, DEB-9909347, DEB-9615226, DEB-9405933, DEB-9221033, DEB-9100058, DEB-8906869, DEB-8605042, DEB-8206992, DEB-7922197]; NSF [DEB021104, 021115, 0212284, 0212818, OISE 0314581]; Center for Tropical Forest Science; Smithsonian Tropical Research Institute; John D. and Catherine T. MacArthur Foundation; Mellon Foundation; Small World Institute Fund; U.S. National Science Foundation; Division Of Environmental Biology [1354741] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Basic Research Program of China(National Basic Research Program of China); QCAS Biotechnology Fund; National Science and Technology Pillar Program; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Center for Tropical Forest Science(Smithsonian InstitutionSmithsonian Tropical Research Institute); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); John D. and Catherine T. MacArthur Foundation; Mellon Foundation; Small World Institute Fund; U.S. National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the National Natural Science Foundation of China (31300358), by West Light Foundation of the Chinese Academy of Sciences to Yue-Hua Hu, the National Key Basic Research Program of China (2014CB954100), by the QCAS Biotechnology Fund (GJHZ1130), the National Science and Technology Pillar Program (2008BAC39B02), and the National Science Foundation of China (31061160188, 31270453). Professor Kitching's participation in this project was supported by Chinese Academy of Sciences Visiting Professorship, Grant number 2013T2S0029. The BCI forest dynamics research project was made possible by National Science Foundation grants to Stephen P. Hubbell: DEB-0640386, DEB-0425651, DEB-0346488, DEB-0129874, DEB-00753102, DEB-9909347, DEB-9615226, DEB-9615226, DEB-9405933, DEB-9221033, DEB-9100058, DEB-8906869, DEB-8605042, DEB-8206992, DEB-7922197, and by NSF DEB021104,021115, 0212284,0212818 and OISE 0314581, with additional support from the Center for Tropical Forest Science, the Smithsonian Tropical Research Institute, the John D. and Catherine T. MacArthur Foundation, the Mellon Foundation and the Small World Institute Fund. Numerous organizations have provided funding, principally the U.S. National Science Foundation. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. The BCI plot project is part of the Center for Tropical Forest Science, a global network of large-scale demographic tree plots. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Cheng JJ, 2012, OIKOS, V121, P236, DOI 10.1111/j.1600-0706.2011.19428.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Croat T.B., 1978, FLORA BARRO COLORADO; Diggle P., 2003, STAT ANAL SPATIAL PO; GENTRY AH, 1992, OIKOS, V63, P19, DOI 10.2307/3545512; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Gunatilleke CVS, 2006, J TROP ECOL, V22, P371, DOI 10.1017/S0266467406003282; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; He FL, 1997, J VEG SCI, V8, P105, DOI 10.2307/3237248; He FL, 1996, AM NAT, V148, P719, DOI 10.1086/285950; Hu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038247; Hu YH, 2012, OIKOS, V121, P952, DOI 10.1111/j.1600-0706.2011.19831.x; Hubbell S.P., 2005, BARRO COLORADO FORES; Hubbell Stephen P., 2001, V32, pi; Illian J, 2008, STAT ANAL MODELLING; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Kanagaraj R, 2011, J ECOL, V99, P1441, DOI 10.1111/j.1365-2745.2011.01878.x; Lai JS, 2009, J VEG SCI, V20, P415, DOI 10.1111/j.1654-1103.2009.01065.x; Lan GY, 2009, ECOL RES, V24, P1117, DOI 10.1007/s11284-009-0590-9; Legendre P, 2013, LMODEL2 MODEL II REG; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; Leigh Jr EG, 1982, ECOLOGY TROPICAL FOR; Leithead MD, 2009, COMMUNITY ECOL, V10, P45, DOI 10.1556/ComEc.10.2009.1.6; Levine JM, 2003, ANNU REV ECOL EVOL S, V34, P549, DOI 10.1146/annurev.ecolsys.34.011802.132400; Lin YC, 2011, OECOLOGIA, V165, P175, DOI 10.1007/s00442-010-1718-x; Liu G., 1996, SOIL PHYS CHEM ANAL; McGill BJ, 2010, ECOL LETT, V13, P627, DOI 10.1111/j.1461-0248.2010.01449.x; MCGUINNESS KA, 1984, BIOL REV, V59, P423, DOI 10.1111/j.1469-185X.1984.tb00711.x; Nakashizuka T, 2001, TRENDS ECOL EVOL, V16, P205, DOI 10.1016/S0169-5347(01)02117-6; R Core Team, 2021, R LANG ENV STAT COMP; SCHUPP EW, 1995, AM J BOT, V82, P399, DOI 10.2307/2445586; Seidler TG, 2006, PLOS BIOL, V4, P2132, DOI 10.1371/journal.pbio.0040344; Shen GC, 2013, ECOLOGY, V94, P2436, DOI 10.1890/12-1983.1; Shen GC, 2009, ECOLOGY, V90, P3033, DOI 10.1890/08-1646.1; Turner WR, 2005, ECOGRAPHY, V28, P721, DOI 10.1111/j.2005.0906-7590.04273.x; Valencia R, 2004, J ECOL, V92, P214, DOI 10.1111/j.0022-0477.2004.00876.x; Wang XG, 2011, J ECOL, V99, P1382, DOI 10.1111/j.1365-2745.2011.01857.x; Webb CO, 2000, J ECOL, V88, P464, DOI 10.1046/j.1365-2745.2000.00462.x; WEBSTER R, 1989, J SOIL SCI, V40, P493, DOI 10.1111/j.1365-2389.1989.tb01291.x; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Wiegand T, 2007, P NATL ACAD SCI USA, V104, P19029, DOI 10.1073/pnas.0705621104; Wiegand T, 2013, ECOGRAPHY, V36, P92, DOI 10.1111/j.1600-0587.2012.07361.x; Wiegand T, 2009, AM NAT, V174, pE106, DOI 10.1086/605368; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Zhu Y, 2010, OIKOS, V119, P109, DOI 10.1111/j.1600-0706.2009.17758.x	53	4	4	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108450	10.1371/journal.pone.0108450	http://dx.doi.org/10.1371/journal.pone.0108450			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251538	gold, Green Published			2022-12-25	WOS:000342492700128
J	Odeh, AM; Craik, JD; Ezzeddine, R; Tovmasyan, A; Batinic-Haberle, I; Benov, LT				Odeh, Ahmad M.; Craik, James D.; Ezzeddine, Rima; Tovmasyan, Artak; Batinic-Haberle, Ines; Benov, Ludmil T.			Targeting Mitochondria by Zn(II) N-Alkylpyridylporphyrins: The Impact of Compound Sub-Mitochondrial Partition on Cell Respiration and Overall Photodynamic Efficacy	PLOS ONE			English	Article							PHOTO-TREATMENT; CANCER; DAMAGE; PROTEINS; TOOLS; DEATH	Mitochondria play a key role in aerobic ATP production and redox control. They harness crucial metabolic pathways and control cell death mechanisms, properties that make these organelles essential for survival of most eukaryotic cells. Cancer cells have altered cell death pathways and typically show a shift towards anaerobic glycolysis for energy production, factors which point to mitochondria as potential culprits in cancer development. Targeting mitochondria is an attractive approach to tumor control, but design of pharmaceutical agents based on rational approaches is still not well established. The aim of this study was to investigate which structural features of specially designed Zn(II) N-alkylpyridylporphyrins would direct them to mitochondria and to particular mitochondrial targets. Since Zn(II) N-alkylpyridylporphyrins can act as highly efficient photosensitizers, their localization can be confirmed by photodamage to particular mitochondrial components. Using cultured LS174T adenocarcinoma cells, we found that subcellular distribution of Zn-porphyrins is directed by the nature of the substituents attached to the meso pyridyl nitrogens at the porphyrin ring. Increasing the length of the aliphatic chain from one carbon (methyl) to six carbons (hexyl) increased mitochondrial uptake of the compounds. Such modifications also affected sub-mitochondrial distribution of the Zn-porphyrins. The amphiphilic hexyl derivative (ZnTnHex-2-PyP) localized in the vicinity of cytochrome c oxidase complex, causing its inactivation during illumination. Photoinactivation of critical cellular targets explains the superior efficiency of the hexyl derivative in causing mitochondrial photodamage, and suppressing cellular respiration and survival. Design of potent photosensitizers and redox-active scavengers of free radicals should take into consideration not only selective organelle uptake and localization, but also selective targeting of critical macromolecular structures.	[Odeh, Ahmad M.; Craik, James D.; Ezzeddine, Rima; Benov, Ludmil T.] Kuwait Univ, Fac Med, Dept Biochem, Kuwait, Kuwait; [Tovmasyan, Artak; Batinic-Haberle, Ines] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA	Kuwait University; Duke University	Benov, LT (corresponding author), Kuwait Univ, Fac Med, Dept Biochem, Kuwait, Kuwait.	lbenov@hsc.edu.kw	Tovmasyan, Artak/D-9101-2014; Benov, Ludmil/AAD-3714-2020	Tovmasyan, Artak/0000-0002-8612-1676; Benov, Ludmil/0000-0002-0205-0146; Ezzeddine, Rima/0000-0003-3817-5394	College of Graduate Studies; Kuwait University [YM03/11, SRUL02/13]	College of Graduate Studies; Kuwait University	Funding from the College of Graduate Studies and grants YM03/11, SRUL02/13 from Kuwait University. IBH acknowledges her General Research Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mutairi DA, 2006, FREE RADICAL RES, V40, P477, DOI 10.1080/10715760600577849; Al-Mutairi DA, 2007, BBA-GEN SUBJECTS, V1770, P1520, DOI 10.1016/j.bbagen.2007.06.006; Al-Mutairi DA, 2007, FREE RADICAL RES, V41, P89, DOI 10.1080/10715760600952869; Antonenko YN, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1273, DOI 10.1134/S0006297908120018; Batinic-Haberle I, 2011, FREE RADICAL BIO MED, V51, P1035, DOI 10.1016/j.freeradbiomed.2011.04.046; Benov L, 2002, ARCH BIOCHEM BIOPHYS, V402, P159, DOI 10.1016/S0003-9861(02)00062-0; Benov Ludmil, 2015, Med Princ Pract, V24 Suppl 1, P14, DOI 10.1159/000362416; Benov L, 2012, AMINO ACIDS, V42, P117, DOI 10.1007/s00726-010-0640-1; Benov L, 2011, ANTI-CANCER AGENT ME, V11, P233, DOI 10.2174/187152011795255975; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Borsch M, 2010, PROC SPIE, V7551, DOI 10.1117/12.841284; Bronfman M, 1998, ANAL BIOCHEM, V255, P252, DOI 10.1006/abio.1997.2453; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Davies MJ, 2003, BIOCHEM BIOPH RES CO, V305, P761, DOI 10.1016/S0006-291X(03)00817-9; Davies MJ, 2004, PHOTOCH PHOTOBIO SCI, V3, P17, DOI 10.1039/b307576c; Ezzeddine R, 2013, J BIOL CHEM, V288, P36579, DOI 10.1074/jbc.M113.511642; FISHER HF, 1985, METHOD ENZYMOL, V113, P16; Ford CHJ, 1996, CYTOMETRY, V23, P228; Ford CHJ, 2001, INT J CANCER, V92, P851, DOI 10.1002/ijc.1262; Galluzzi L, 2006, ONCOGENE, V25, P4812, DOI 10.1038/sj.onc.1209598; GIBSON SL, 1983, CANCER RES, V43, P4191; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Hoye AT, 2008, ACCOUNTS CHEM RES, V41, P87, DOI 10.1021/ar700135m; Kessel David, 2010, Methods Mol Biol, V635, P35, DOI 10.1007/978-1-60761-697-9_3; Kim J, 2010, FREE RADICAL BIO MED, V49, P726, DOI 10.1016/j.freeradbiomed.2010.05.013; Kos I, 2009, FREE RADICAL BIO MED, V47, P72, DOI 10.1016/j.freeradbiomed.2009.04.002; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; LOSEVA L P, 1985, Biokhimiya, V50, P2016; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Muramoto K, 2007, P NATL ACAD SCI USA, V104, P7881, DOI 10.1073/pnas.0610031104; Negre-Salvayre A, 2010, FREE RADICAL RES, V44, P1125, DOI 10.3109/10715762.2010.498478; Ogilby PR, 2010, CHEM SOC REV, V39, P3181, DOI 10.1039/b926014p; Pavani C, 2009, PHOTOCH PHOTOBIO SCI, V8, P233, DOI 10.1039/b810313e; Pavani C, 2012, PHOTOCHEM PHOTOBIOL, V88, P774, DOI 10.1111/j.1751-1097.2012.01102.x; Redmond RW, 2006, PHOTOCHEM PHOTOBIOL, V82, P1178, DOI 10.1562/2006-04-14-IR-874; Rodriguez ME, 2010, J BIOMED OPT, P15; Wu SA, 2014, ANTIOXID REDOX SIGN, V20, P733, DOI 10.1089/ars.2013.5229	37	30	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108238	10.1371/journal.pone.0108238	http://dx.doi.org/10.1371/journal.pone.0108238			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250732	Green Submitted, Green Published, gold			2022-12-25	WOS:000342492700100
J	Tanaka, Y; Fordyce, RE				Tanaka, Yoshihiro; Fordyce, R. Ewan			Fossil Dolphin Otekaikea marplesi (Latest Oligocene, New Zealand) Expands the Morphological and Taxonomic Diversity of Oligocene Cetaceans	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; SOUTH CANTERBURY; UPPER MIOCENE; ODONTOCETI; DELPHINOIDEA; MAMMALIA; HISTORY; PHOCOENIDAE; ADAPTATION; EVOLUTION	The Oligocene Epoch was a time of major radiation of the Odontoceti (echolocating toothed whales, dolphins). Fossils reveal many odontocete lineages and considerable structural diversity, but whether the clades include some crown taxa or only archaic groups is contentious. The New Zealand fossil dolphin "Prosqualodon" marplesi (latest Oligocene, >= 23.9 Ma) is here identified as a crown odontocete that represents a new genus, Otekaikea, and adds to the generic diversity of Oligocene odontocetes. Otekaikea marplesi is known only from the holotype, which comprises a partial skeleton from the marine Otekaike Limestone of the Waitaki Valley. Otekaikea marplesi was about 2.5 m long; it had procumbent anterior teeth, and a broad dished face for the nasofacial muscles implicated in production of echolocation sounds. The prominent condyles and unfused cervical vertebrae suggest a flexible neck. A phylogenetic analysis based on morphological features places Otekaikea marplesi in the extinct group Waipatiidae, within the clade Platanistoidea. The phylogeny implies an Oligocene origin for the lineage now represented by the endangered Ganges River dolphin (Platanista gangetica), supporting an Oligocene history for the crown Odontoceti.	[Tanaka, Yoshihiro; Fordyce, R. Ewan] Univ Otago, Dept Geol, Dunedin, New Zealand	University of Otago	Tanaka, Y (corresponding author), Univ Otago, Dept Geol, Dunedin, New Zealand.	yoshihiro.tanaka@otago.ac.nz		Fordyce, Ewan/0000-0002-2656-730X; Tanaka, Yoshihiro/0000-0001-9598-5583	National Geographic Society [4024-88, 4341-90]; Department of Geology, University of Otago	National Geographic Society(National Geographic Society); Department of Geology, University of Otago	Field and lab work was supported by the National Geographic Society (grants 4024-88 and 4341-90) and the Department of Geology, University of Otago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Fernandez G, 2014, J VERTEBR PALEONTOL, V34, P195, DOI 10.1080/02724634.2013.799069; Aguirre-Fernández Gabriel, 2009, Bol. Soc. Geol. Mex, V61, P245; Arnold Peter W., 1996, Memoirs of the Queensland Museum, V39, P141; AYRESS MA, 1993, ALCHERINGA, V17, P125, DOI 10.1080/03115519308619491; Barnes L.G., 1990, P3; Barnes LG, 2010, WILDL PROT DESTR EXT, P445; BARNES LG, 1985, MAR MAMMAL SCI, V1, P149, DOI 10.1111/j.1748-7692.1985.tb00003.x; Bianucci G, 2011, GEOBIOS-LYON, V44, P549, DOI 10.1016/j.geobios.2011.02.009; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Cozzuol Mario A., 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P321; Dal Piaz G, 1917, I GEOL ROY U PADOVA, V5, P1; de Muizon C., 1987, AM MUS NOVIT, V2904, P1; de Muizon Christian, 1994, Proceedings of the San Diego Society of Natural History, V29, P135; Delfortrie E, 1875, ACTES SOC LINNENNE B, P177; DICKSON M. R., 1964, NEW ZEAL J GEOL GEOPHYS, V7, P626; Evans HE, 2013, MILLERS ANATOMY DOG, P872; Fajardo-Mellor L, 2006, MAR MAMMAL SCI, V22, P910, DOI 10.1111/j.1748-7692.2006.00080.x; Flower WH, 1885, INTRO OSTEOLOGY MAMM, pxi; Fordyce R. Ewan, 2002, Smithsonian Contributions to Paleobiology, V93, P185; Fordyce RE, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P459; Fordyce R. Ewan, 1994, Proceedings of the San Diego Society of Natural History, V29, P147; Fordyce RE, 2002, ANTARCT SCI, V14, P37, DOI 10.1017/S0954102002000561; FORDYCE RE, 1980, PALAEOGEOGR PALAEOCL, V31, P319, DOI 10.1016/0031-0182(80)90024-3; FORDYCE RE, 1983, ALCHERINGA, V7, P27, DOI 10.1080/03115518308619631; Fordyce RE., 2001, SECONDARY ADAPTATION, P169; Fordyce RE, 2008, NATURAL HIST CANTERB, P415; Fordyce RE, 2012, J VERTEBR PALEONTOL, V32, P95; Gage M., 1957, NZ GEOLOGICAL SURVEY, V55, P1; Geisler JH, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)480[0001:ANPWCA]2.0.CO;2; Geisler Jonathan H., 2003, Journal of Mammalian Evolution, V10, P23, DOI 10.1023/A:1025552007291; Geisler JH, 2014, NATURE, V508, P383, DOI 10.1038/nature13086; Geisler JH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-112; Ginsburg L, 1971, B MUSEUM NATL HIST N, V6, P161; Godfrey SJ, 2013, CR PALEVOL, V12, P519, DOI 10.1016/j.crpv.2013.03.002; Goloboff P, 2008, CLADISTICS, V24, P91; Graham IJ, 2000, NEW ZEAL J GEOL GEOP, V43, P335, DOI 10.1080/00288306.2000.9514891; Heyning J.E., 1989, NATURAL HIST MUSEUM, V405, P1; Heyning JE, 1997, MAR MAMMAL SCI, V13, P596, DOI 10.1111/j.1748-7692.1997.tb00086.x; Hoch Ella, 2000, Historical Biology, V14, P67; Ichishima Hiroto, 2011, Memoir of the Fukui Prefectural Dinosaur Museum, V10, P63; Jefferson T.A., 2015, COMPREHENSIVE GUIDE; Jenkins D. G., 1971, Paleont Bull Wellington, V42, P1; JENKINS GRAHAM D., 1965, NEW ZEAL J GEOL GEOPHYS, V8, P1088; Kasuya T., 1973, Scientific Rep Whales Res Inst Tokyo, VNo. 25, P1; Kellogg AR., 1936, CARNEGIE I WASHINGTO, V482, P1; Kellogg R, 1928, Q REV BIOL, V3, P29, DOI 10.1086/394293; Kellogg R, 1928, Q REV BIOL, V3, P174, DOI 10.1086/394300; KLIMA M, 1980, Z SAUGETIERKD, V45, P288; Ksepka DT, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0677; Lambert O, 2005, PALAEONTOLOGY, V48, P653, DOI 10.1111/j.1475-4983.2005.00472.x; Lambert O, 2014, NATURWISSENSCHAFTEN, P1; Lambert O, 2008, CR PALEVOL, V7, P361, DOI 10.1016/j.crpv.2008.06.002; Lambert Olivier, 2005, Deinsea (Rotterdam), P7; Leidy J., 1869, J ACAD NATURAL SCI P, V2, P1, DOI DOI 10.5962/BHL.TITLE.20910; Luo Z., 1999, U MICHIGAN PAPERS PA, V31, P1; Maddison WP, 2011, MESQUITE MODULAR SYS; Mchedlidze GA, 1976, OSNOVNYE CHERTY PALE; Mead James G., 2009, Smithsonian Contributions to Zoology, P1; Messenger SL, 1998, SYST BIOL, V47, P90, DOI 10.1080/106351598261058; Moreno F, 1892, MUSEO PLATA REV, V3, P393; Muizon C., 1991, B MUS NATL HIST NA C, V12, P279; Murakami M, 2012, J VERTEBR PALEONTOL, V32, P1157, DOI 10.1080/02724634.2012.677299; Murakami M, 2012, J VERTEBR PALEONTOL, V32, P1172, DOI 10.1080/02724634.2012.694337; Perrin WF., 1975, B SCRIPPS I OCEANOGR, V21; Pyenson ND, 2014, PALAEOGEOGR PALAEOCL, V400, P1, DOI 10.1016/j.palaeo.2014.02.018; Pyenson ND, 2011, J MAMM EVOL, V18, P269, DOI 10.1007/s10914-011-9170-1; Reichenbach L, 1847, RESULTATE GEOLOGISCH; Rommel S., 1990, P29; ROTHAUSEN K, 1968, Palaeontologische Zeitschrift, V42, P83; Gutstein CS, 2014, ANAT REC, V297, P1096, DOI 10.1002/ar.22901; Siryk IM, 1970, GEOL GEOFIZ NOVOSIB, V9, P123; Steeman ME, 2009, SYST BIOL, V58, P573, DOI 10.1093/sysbio/syp060; Struthers J, 1888, J Anat Physiol, V23, P124; Tanaka Y, 2011, NEW OLIGO MIOCENE SQ, P102; True FW, 1910, B AM MUS NAT HIST, V28, P19; Uhen MD, 2007, PALAEONTOL ELECTRON, V10; Uhen MD, 2008, EVOLUTION OF TERTIARY MAMMALS OF NORTH AMERICA, VOL 2, P566; Uhen MD, 2008, J SYST PALAEONTOL, V6, P433, DOI 10.1017/S1477201908002472; Velez-Juarbe J, 2012, J VERTEBR PALEONTOL, V32, P476, DOI 10.1080/02724634.2012.641705; WARD DM, 1975, NEW ZEAL J GEOL GEOP, V18, P881, DOI 10.1080/00288306.1975.10423533; Werth Alexander J., 2004, Aquatic Mammals, V30, P405, DOI 10.1578/AM.30.3.2004.405; WHITMORE FC, 1976, SYST ZOOL, V25, P304, DOI 10.2307/2412507; Xiong Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-20	83	36	38	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107972	10.1371/journal.pone.0107972	http://dx.doi.org/10.1371/journal.pone.0107972			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250733	Green Published, Green Submitted, gold			2022-12-25	WOS:000342492700066
J	Vishavkarma, R; Raghavan, S; Kuyyamudi, C; Majumder, A; Dhawan, J; Pullarkat, PA				Vishavkarma, Renu; Raghavan, Swetavalli; Kuyyamudi, Chandrashekar; Majumder, Abhijit; Dhawan, Jyotsna; Pullarkat, Pramod A.			Role of Actin Filaments in Correlating Nuclear Shape and Cell Spreading	PLOS ONE			English	Article							RUBBER ELASTIC SPHERE; SUBSTRATE STIFFNESS; TRACTION FORCES; STRESS FIBERS; LARGE RANGE; COMPRESSION; RIGIDITY; DIFFERENTIATION; DISPLACEMENTS; MECHANICS	It is well known that substrate properties like stiffness and adhesivity influence stem cell morphology and differentiation. Recent experiments show that cell morphology influences nuclear geometry and hence gene expression profile. The mechanism by which surface properties regulate cell and nuclear properties is only beginning to be understood. Direct transmission of forces as well as chemical signalling are involved in this process. Here, we investigate the formal aspect by studying the correlation between cell spreading and nuclear deformation using Mesenchymal stem cells under a wide variety of conditions. It is observed that a robust quantitative relation holds between the cell and nuclear projected areas, irrespective of how the cell area is modified or when various cytoskeletal or nuclear components are perturbed. By studying the role of actin stress fibers in compressing the nucleus we propose that nuclear compression by stress fibers can lead to enhanced cell spreading due to an interplay between elastic and adhesion factors. The significance of myosin-II in regulating this process is also explored. We demonstrate this effect using a simple technique to apply external compressive loads on the nucleus.	[Vishavkarma, Renu; Raghavan, Swetavalli; Kuyyamudi, Chandrashekar; Pullarkat, Pramod A.] Raman Res Inst, Soft Condensed Matter Grp, Bangalore 560080, Karnataka, India; [Majumder, Abhijit; Dhawan, Jyotsna] TIFR, Natl Ctr Biol Sci, Inst Stem Cell Biol & Regenerat Med, Bangalore, Karnataka, India	Department of Science & Technology (India); Raman Research Institute (RRI); Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Vishavkarma, R (corresponding author), Raman Res Inst, Soft Condensed Matter Grp, Bangalore 560080, Karnataka, India.	renuv@rri.res.in; pramod@rri.res.in	PullarKat, Pramod/J-8789-2012	Maan, Renu/0000-0001-5569-399X; Raghavan, Sweta/0000-0002-7377-7414	Department of Biotechnology; Center for Nanobiotechology grant from Department of Science and Technology; Indo-US Science and Technology Forum; Department of Science and Technology, government of India, through Ramanujan Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR017447] Funding Source: NIH RePORTER	Department of Biotechnology; Center for Nanobiotechology grant from Department of Science and Technology; Indo-US Science and Technology Forum; Department of Science and Technology, government of India, through Ramanujan Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	JD and AM acknowledge support from core funding from the Department of Biotechnology to InStem and a Center for Nanobiotechology grant from Department of Science and Technology and the Indo-US Science and Technology Forum. PP acknowledges support from the Department of Science and Technology, government of India, through Ramanujan Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beer F P, 1992, MECH MAT; Budyna RG, 2008, SHIGLEYS MECH ENG DE; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Chippada U, 2010, J MATER RES, V25, P545, DOI 10.1557/JMR.2010.0067; Choudhary T, 2010, METHODS MOL BIO, V621, P185; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Cuvelier D, 2007, CURR BIOL, V17, P694, DOI 10.1016/j.cub.2007.02.058; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Evans ND, 2009, EUR CELLS MATER, V18, P1; Fardin MA, 2010, SOFT MATTER, V6, P4788, DOI 10.1039/c0sm00252f; Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487; Ghibaudo M, 2008, SOFT MATTER, V4, P1836, DOI 10.1039/b804103b; Han SJ, 2012, BIOPHYS J, V103, P640, DOI 10.1016/j.bpj.2012.07.023; INGBER DE, 1987, IN VITRO CELL DEV B, V23, P387; Jean RP, 2004, J BIOMECH ENG-T ASME, V126, P552, DOI 10.1115/1.1800559; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Khiara T, 2011, BIOCHEM BIOPH RES CO, V409, P1; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Leipzig ND, 2008, BIOPHYS J, V94, P2412, DOI 10.1529/biophysj.107.114207; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Mazumder A, 2010, J R SOC INTERFACE, V7, pS321, DOI 10.1098/rsif.2010.0039.focus; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Nagayama K, 2011, FEBS LETT, V585, P3992, DOI 10.1016/j.febslet.2011.11.006; Roca-Cusachs P, 2008, BIOPHYS J, V94, P4984, DOI 10.1529/biophysj.107.116863; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sen S, 2009, CELL MOL BIOENG, V2, P218, DOI 10.1007/s12195-009-0057-7; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; TATARA Y, 1991, J ENG MATER-T ASME, V113, P285, DOI 10.1115/1.2903407; TATARA Y, 1991, J ENG MATER-T ASME, V113, P292, DOI 10.1115/1.2903408; Tee SY, 2011, BIOPHYS J, V100, pL25, DOI 10.1016/j.bpj.2010.12.3744; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Tojkander S, 2011, CURR BIOL, V21, P539, DOI 10.1016/j.cub.2011.03.007; Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978; Versaevel M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1668; Yan Y, 2009, POWDER TECHNOL, V192, P122, DOI 10.1016/j.powtec.2008.12.006; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041	38	59	59	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107895	10.1371/journal.pone.0107895	http://dx.doi.org/10.1371/journal.pone.0107895			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251154	Green Submitted, gold, Green Published			2022-12-25	WOS:000342492700056
J	Foster, J; Wu, WH; Scott, SG; Bassi, M; Mohan, D; Daoud, Y; Stark, WJ; Jun, AS; Chakravarti, S				Foster, James; Wu, Wai-Hong; Scott, Sherri-Gae; Bassi, Mehak; Mohan, Divya; Daoud, Yassine; Stark, Walter J.; Jun, Albert S.; Chakravarti, Shukti			Transforming Growth Factor beta and Insulin Signal Changes in Stromal Fibroblasts of Individual Keratoconus Patients	PLOS ONE			English	Article							KERATAN SULFATE PROTEOGLYCAN; CORNEAL CONFOCAL MICROSCOPY; TGF-BETA; IN-VITRO; BOVINE KERATOCYTES; EXPRESSION; PHENOTYPE; DIFFERENTIATION; VIVO; TRANSPARENCY	Keratoconus (KC) is a complex thinning disease of the cornea that often requires transplantation. The underlying pathogenic molecular changes in this disease are poorly understood. Earlier studies reported oxidative stress, metabolic dysfunctions and accelerated death of stromal keratocytes in keratoconus (KC) patients. Utilizing mass spectrometry we found reduced stromal extracellular matrix (ECM) proteins in KC, suggesting ECM-regulatory changes that may be due to altered TGF beta signals. Here we investigated properties of stromal cells from donor (DN) and KC corneas grown as fibroblasts in serum containing DMEM: F12 or in serum-free medium containing insulin, transferrin, selenium (ITS). Phosphorylation of SMAD2/3 of the canonical TGF beta pathway, was high in serum-starved DN and KC fibroblast protein extracts, but pSMAD1/5/8 low at base line, was induced within 30 minutes of TGF beta 1 stimulation, more so in KC than DN, suggesting a novel TGF beta 1-SMAD1/5/8 axis in the cornea, that may be altered in KC. The serine/threonine kinases AKT, known to regulate proliferation, survival and biosynthetic activities of cells, were poorly activated in KC fibroblasts in high glucose media. Concordantly, alcohol dehydrogenase 1 (ADH1), an indicator of increased glucose uptake and metabolism, was reduced in KC compared to DN fibroblasts. By contrast, in low glucose (5.5 mM, normoglycemic) serum-free DMEM and ITS, cell survival and pAKT levels were comparable in KC and DN cells. Therefore, high glucose combined with serum-deprivation presents some cellular stress difficult to overcome by the KC stromal cells. Our study provides molecular insights into AKT and TGF beta signal changes in KC, and a mechanism for functional studies of stromal cells from KC corneas.	[Foster, James; Wu, Wai-Hong; Scott, Sherri-Gae; Mohan, Divya; Chakravarti, Shukti] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Daoud, Yassine; Stark, Walter J.; Jun, Albert S.; Chakravarti, Shukti] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Chakravarti, Shukti] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Bassi, Mehak] All India Inst Med Sci, New Delhi, India	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; All India Institute of Medical Sciences (AIIMS) New Delhi	Chakravarti, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	schakra1@jhmi.edu		daoud, yassine/0000-0002-8046-4045	Wilmer Openshaw Keratoconus Fund, National Institute of Health National Eye Institute [EY11654]; Research to Prevent Blindness Dolly Green Special Scholar Award; NATIONAL EYE INSTITUTE [R56EY011654, R01EY011654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	Wilmer Openshaw Keratoconus Fund, National Institute of Health National Eye Institute; Research to Prevent Blindness Dolly Green Special Scholar Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Wilmer Openshaw Keratoconus Fund, National Institute of Health National Eye Institute grant EY11654 (SC), and Research to Prevent Blindness Dolly Green Special Scholar Award (ASJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Arnal E, 2011, INVEST OPHTH VIS SCI, V52, P8592, DOI 10.1167/iovs.11-7732; Bartolome A, 2013, BIOCHEM J, V455, P329, DOI 10.1042/BJ20130562; Bartolome A, 2012, AUTOPHAGY, V8, P1757, DOI 10.4161/auto.21994; Beales MP, 1999, INVEST OPHTH VIS SCI, V40, P1658; Berryhill BL, 2002, INVEST OPHTH VIS SCI, V43, P3416; Boileau C, 2012, NAT GENET, V44, P916, DOI 10.1038/ng.2348; BRON AJ, 1988, CORNEA, V7, P163; Carlson EC, 2005, J BIOL CHEM, V280, P25541, DOI 10.1074/jbc.M500249200; Carlson EC, 2003, MOL VIS, V9, P615; Chaerkady R, 2013, J PROTEOMICS, V87, P122, DOI 10.1016/j.jprot.2013.05.023; Chakravarti S, 2004, INVEST OPHTH VIS SCI, V45, P3475, DOI 10.1167/iovs.04-0343; Cristina Kenney M, 2003, Cont Lens Anterior Eye, V26, P139; Edwards M, 2001, CLIN EXP OPHTHALMOL, V29, P345, DOI 10.1046/j.1442-9071.2001.d01-16.x; Efron N, 2008, CLIN EXP OPTOM, V91, P34, DOI 10.1111/j.1444-0938.2007.00195.x; Engler C, 2011, AM J OPHTHALMOL, V151, P752, DOI 10.1016/j.ajo.2010.11.008; Fink BA, 2010, CORNEA, V29, P65, DOI 10.1097/ICO.0b013e3181ac0518; Foster J, 2014, INVEST OPHTH VIS SCI, V473, P5142; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; FULLWOOD NJ, 1990, BIOCHEM SOC T, V18, P961, DOI 10.1042/bst0180961; FUNDERBURGH JL, 1989, INVEST OPHTH VIS SCI, V30, P2278; Funderburgh JL, 2001, J BIOL CHEM, V276, P44173, DOI 10.1074/jbc.M107596200; Funderburgh ML, 2008, MOL VIS, V14, P308; Hasegawa N, 2000, INVEST OPHTH VIS SCI, V41, P3670; Hassell JR, 2010, EXP EYE RES, V91, P326, DOI 10.1016/j.exer.2010.06.021; He JC, 2008, INVEST OPHTH VIS SCI, V49, P2936, DOI 10.1167/iovs.07-0900; Hollingsworth JG, 2005, OPHTHAL PHYSL OPT, V25, P254, DOI 10.1111/j.1475-1313.2005.00278.x; Hollingsworth JG, 2005, CORNEA, V24, P397, DOI 10.1097/01.ico.0000151548.46231.27; IHALAINEN A, 1986, EUR J CLIN INVEST, V16, P78, DOI 10.1111/j.1365-2362.1986.tb01311.x; Jester JV, 1996, CORNEA, V15, P505; Jester JV, 1997, CORNEA, V16, P177; Jester JV, 2003, EXP EYE RES, V77, P581, DOI 10.1016/S0014-4835(03)00188-X; Jester JV, 2002, EXP EYE RES, V75, P645, DOI 10.1006/exer.2002.2066; Jimenez JO, 1997, OPTOMETRY VISION SCI, V74, P147, DOI 10.1097/00006324-199703000-00025; Joyce NC, 1997, INVEST OPHTH VIS SCI, V38, P1922; Jun AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016437; Kawakita T, 2006, INVEST OPHTH VIS SCI, V47, P1918, DOI 10.1167/iovs.05-1040; Kim WJ, 1999, EXP EYE RES, V69, P475, DOI 10.1006/exer.1999.0719; Klintworth GK, 1999, AM J OPHTHALMOL, V128, P747, DOI 10.1016/S0002-9394(99)00358-X; Lema I, 2005, OPHTHALMOLOGY, V112, P654, DOI 10.1016/j.ophtha.2004.11.050; Lindsay ME, 2011, NATURE, V473, P308, DOI 10.1038/nature10145; Long CJ, 2000, J BIOL CHEM, V275, P13918, DOI 10.1074/jbc.275.18.13918; Lu Y, 2013, NAT GENET, V45, P155, DOI 10.1038/ng.2506; Lwigale PY, 2005, DEV BIOL, V288, P284, DOI 10.1016/j.ydbio.2005.09.046; Maguen E, 2008, CORNEA, V27, P565, DOI 10.1097/ICO.0b013e318165b1cd; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Massague J, 2012, FEBS LETT, V586, P1953, DOI 10.1016/j.febslet.2012.03.023; McMahon TT, 2006, CORNEA, V25, P296, DOI 10.1097/01.ico.0000178728.57435.df; Niederer RL, 2008, INVEST OPHTH VIS SCI, V49, P2964, DOI 10.1167/iovs.07-0968; Nielsen K, 2012, ACTA OPHTHALMOL; Pardali E, 2010, TRENDS CELL BIOL, V20, P556, DOI 10.1016/j.tcb.2010.06.006; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Raj A, 2003, AM J OPHTHALMOL, V135, P746, DOI 10.1016/S0002-9394(03)00096-5; Romero-Jimenez M, 2010, CONTACT LENS ANTERIO, V33, P157, DOI 10.1016/j.clae.2010.04.006; Saika S, 2006, LAB INVEST, V86, P106, DOI 10.1038/labinvest.3700375; Scott SG, 2011, EXP EYE RES, V93, P898, DOI 10.1016/j.exer.2011.10.004; Stramer BM, 2003, INVEST OPHTH VIS SCI, V44, P4237, DOI 10.1167/iovs.02-1188; Su JS, 2006, J BIOL CHEM, V281, P19809, DOI 10.1074/jbc.M603638200; Szczotka-Flynn L, 2008, BRIT J OPHTHALMOL, V92, P1108, DOI 10.1136/bjo.2007.130294; Tan NS, 2004, EMBO J, V23, P4211, DOI 10.1038/sj.emboj.7600437; Tian HY, 2012, EMBO J, V31, P3885, DOI 10.1038/emboj.2012.246; Wilson SE, 2012, EXP EYE RES, V99, P78, DOI 10.1016/j.exer.2012.03.018; Wollensak G, 2004, EYE, V18, P718, DOI 10.1038/sj.eye.6700751; Yanai R, 2002, INVEST OPHTH VIS SCI, V43, P2122; YUE BYJT, 1979, J CLIN INVEST, V63, P545, DOI 10.1172/JCI109335; Zieske JD, 2001, INVEST OPHTH VIS SCI, V42, P1465	67	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e106556	10.1371/journal.pone.0106556	http://dx.doi.org/10.1371/journal.pone.0106556			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247416	Green Published, Green Submitted, gold			2022-12-25	WOS:000342351800012
J	Kenyon, JJ; Nigro, SJ; Hall, RM				Kenyon, Johanna J.; Nigro, Steven J.; Hall, Ruth M.			Variation in the OC Locus of Acinetobacter baumannii Genomes Predicts Extensive Structural Diversity in the Lipooligosaccharide	PLOS ONE			English	Article							CAPSULAR POLYSACCHARIDE; CARBOHYDRATE BACKBONE; CORE OLIGOSACCHARIDE; AMPC GENE; LIPOPOLYSACCHARIDE; RESISTANCE; VARIANTS	Lipooligosaccharide (LOS) is a complex surface structure that is linked to many pathogenic properties of Acinetobacter baumannii. In A. baumannii, the genes responsible for the synthesis of the outer core (OC) component of the LOS are located between ilvE and aspS. The content of the OC locus is usually variable within a species, and examination of 6 complete and 227 draft A. baumannii genome sequences available in GenBank non-redundant and Whole Genome Shotgun databases revealed nine distinct new types, OCL4-OCL12, in addition to the three known ones. The twelve gene clusters fell into two distinct groups, designated Group A and Group B, based on similarities in the genes present. OCL6 (Group B) was unique in that it included genes for the synthesis of L-Rhamnosep. Genetic exchange of the different configurations between strains has occurred as some OC forms were found in several different sequence types (STs). OCL1 (Group A) was the most widely distributed being present in 18 STs, and OCL6 was found in 16 STs. Variation within clones was also observed, with more than one OC locus type found in the two globally disseminated clones, GC1 and GC2, that include the majority of multiply antibiotic resistant isolates. OCL1 was the most abundant gene cluster in both GC1 and GC2 genomes but GC1 isolates also carried OCL2, OCL3 or OCL5, and OCL3 was also present in GC2. As replacement of the OC locus in the major global clones indicates the presence of sub-lineages, a PCR typing scheme was developed to rapidly distinguish Group A and Group B types, and to distinguish the specific forms found in GC1 and GC2 isolates.	[Kenyon, Johanna J.; Nigro, Steven J.; Hall, Ruth M.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Sydney	Hall, RM (corresponding author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.	ruth.hall@sydney.edu.au	Kenyon, Johanna J/AAA-3622-2022	Kenyon, Johanna J/0000-0002-1487-6105; Nigro, Steven/0000-0001-9613-8829	National Health and Medical Research Council of Australia (NHMRC) [APP1026189]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia (NHMRC) grant APP1026189. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amor K, 2000, INFECT IMMUN, V68, P1116, DOI 10.1128/IAI.68.3.1116-1124.2000; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Beceiro A, 2011, ANTIMICROB AGENTS CH, V55, P3370, DOI 10.1128/AAC.00079-11; Di Nocera PP, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-224; Erridge C, 2007, J MED MICROBIOL, V56, P165, DOI 10.1099/jmm.0.46823-0; Fregolino E, 2010, EUR J ORG CHEM, V2010, P1345, DOI 10.1002/ejoc.200901396; Hamidian M, 2014, J ANTIMICROB CHEMOTH, V69, P77, DOI 10.1093/jac/dkt312; Hamidian M, 2013, J ANTIMICROB CHEMOTH, V68, P2682, DOI 10.1093/jac/dkt233; Heinrichs DE, 1998, MOL MICROBIOL, V30, P221, DOI 10.1046/j.1365-2958.1998.01063.x; Hood MI, 2013, INFECT IMMUN, V81, P542, DOI 10.1128/IAI.00704-12; Hu DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070329; Karah N, 2012, DRUG RESIST UPDATE, V15, P237, DOI 10.1016/j.drup.2012.06.001; Kenyon JJ, 2014, RES MICROBIOL, V165, P472, DOI 10.1016/j.resmic.2014.05.034; Kenyon JJ, 2014, GLYCOBIOLOGY, V24, P554, DOI 10.1093/glycob/cwu024; Kenyon JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062160; Koplin R, 1997, J BIOL CHEM, V272, P4121, DOI 10.1074/jbc.272.7.4121; Lees-Miller RG, 2013, MOL MICROBIOL, V89, P816, DOI 10.1111/mmi.12300; Li Q, 2000, MICROBIOLOGY, V146, P2803; Lin L, 2012, MBIO, V3, DOI 10.1128/mBio.00312-12; Luke NR, 2010, INFECT IMMUN, V78, P2017, DOI 10.1128/IAI.00016-10; McQueary CN, 2012, J MICROBIOL, V50, P434, DOI 10.1007/s12275-012-1555-1; Moffatt JH, 2010, ANTIMICROB AGENTS CH, V54, P4971, DOI 10.1128/AAC.00834-10; Nigro SJ, 2011, J ANTIMICROB CHEMOTH, V66, P1504, DOI 10.1093/jac/dkr163; Parker CT, 2008, J BACTERIOL, V190, P5681, DOI 10.1128/JB.00254-08; Pelletier MR, 2013, ANTIMICROB AGENTS CH, V57, P4831, DOI 10.1128/AAC.00865-13; Post V, 2012, J ANTIMICROB CHEMOTH, V67, P1039, DOI 10.1093/jac/dkr586; Rahim R, 2000, MICROBIOL-UK, V146, P2803, DOI 10.1099/00221287-146-11-2803; Russo TA, 2010, INFECT IMMUN, V78, P3993, DOI 10.1128/IAI.00366-10; SCHOLTEN RJPM, 1994, J MED MICROBIOL, V41, P236, DOI 10.1099/00222615-41-4-236; Senchenkova SN, 2014, CARBOHYD RES, V391, P89, DOI 10.1016/j.carres.2014.04.002; Soon RL, 2011, INT J ANTIMICROB AG, V38, P493, DOI 10.1016/j.ijantimicag.2011.07.014; Vinogradov EV, 2002, EUR J BIOCHEM, V269, P422, DOI 10.1046/j.0014-2956.2001.02647.x; Vinogradov EV, 1998, J BIOL CHEM, V273, P28122, DOI 10.1074/jbc.273.43.28122; Zarrilli R, 2013, INT J ANTIMICROB AG, V41, P11, DOI 10.1016/j.ijantimicag.2012.09.008; Zhang G, 2013, CURR OPIN MICROBIOL, V16, P779, DOI 10.1016/j.mib.2013.09.007	36	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107833	10.1371/journal.pone.0107833	http://dx.doi.org/10.1371/journal.pone.0107833			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247305	Green Published, gold, Green Submitted			2022-12-25	WOS:000342351800043
J	Anyaegbu, CC; Lake, RA; Heel, K; Robinson, BW; Fisher, SA				Anyaegbu, Chidozie C.; Lake, Richard A.; Heel, Kathy; Robinson, Bruce W.; Fisher, Scott A.			Chemotherapy Enhances Cross-Presentation of Nuclear Tumor Antigens	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PROGNOSTIC VALUE; DENDRITIC CELLS; LOCALIZATION; CANCER; EXPRESSION; IMMUNOTHERAPY; RESPONSES; PATHWAY; CD8	Cross-presentation of tumor antigen is essential for efficient priming of naive CD8(+) T lymphocytes and induction of effective anti-tumor immunity. We hypothesized that the subcellular location of a tumor antigen could affect the efficiency of cross-presentation, and hence the outcome of anti-tumor responses to that antigen. We compared cross-presentation of a nominal antigen expressed in the nuclear, secretory, or cytoplasmic compartments of B16 melanoma tumors. All tumors expressed similar levels of the antigen. The antigen was cross-presented from all compartments but when the concentration was low, nuclear antigen was less efficiently cross-presented than antigen from other cellular locations. The efficiency of cross-presentation of the nuclear antigen was improved following chemotherapy-induced tumor cell apoptosis and this correlated with an increase in the proportion of effector CTL. These data demonstrate that chemotherapy improves nuclear tumor antigen cross-presentation and could be important for anti-cancer immunotherapies that target nuclear antigens.	[Anyaegbu, Chidozie C.; Lake, Richard A.; Robinson, Bruce W.; Fisher, Scott A.] QEII Med Ctr, NCARD, Nedlands, WA, Australia; [Anyaegbu, Chidozie C.; Lake, Richard A.; Robinson, Bruce W.; Fisher, Scott A.] Univ Western Australia, Sch Med & Pharmacol, QEII Med Ctr, Nedlands, WA 6009, Australia; [Heel, Kathy] Univ Western Australia, Sch Pathol & Lab Med, QEII Med Ctr, Nedlands, WA 6009, Australia	University of Western Australia; University of Western Australia; University of Western Australia	Fisher, SA (corresponding author), QEII Med Ctr, NCARD, Nedlands, WA, Australia.	scott.fisher@uwa.edu.au	Fuller, Kathy A/GWZ-2885-2022; Fuller, Kathy A/C-5454-2011; Robinson, Bruce/N-1900-2014; Fisher, Scott/H-9187-2014	Fuller, Kathy A/0000-0002-3462-7501; Fuller, Kathy A/0000-0002-3462-7501; Anyaegbu, Chidozie/0000-0002-0618-3173; Fisher, Scott/0000-0003-1551-5579	National Health and Medical Research Council of Australia; Insurance Commission of Western Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Insurance Commission of Western Australia	This work was funded by grants from the National Health and Medical Research Council of Australia and the Insurance Commission of Western Australia. The funding bodies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulou E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3039; Alberts B, 2002, MOL BIOL CELL; Andersen MH, 2007, CLIN CANCER RES, V13, P5991, DOI 10.1158/1078-0432.CCR-07-0686; Andrade R, 2010, BIOL CELL, V102, P25, DOI 10.1042/BC20090077; Brusa D, 2008, VACCINE, V26, P6422, DOI 10.1016/j.vaccine.2008.08.063; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; George TC, 2006, J IMMUNOL METHODS, V311, P117, DOI 10.1016/j.jim.2006.01.018; Ingebrigtsen VA, 2012, INT J CANCER, V131, P2528, DOI 10.1002/ijc.27566; Kitamura H, 2013, VIRCHOWS ARCH, V462, P101, DOI 10.1007/s00428-012-1343-7; Kramer A, 2008, P NATL ACAD SCI USA, V105, P11236, DOI 10.1073/pnas.0801967105; Kurts C, 2010, NAT REV IMMUNOL, V10, P403, DOI 10.1038/nri2780; Lake RA, 2005, NAT REV CANCER, V5, P397, DOI 10.1038/nrc1613; Lennerz V, 2005, P NATL ACAD SCI USA, V102, P16013, DOI 10.1073/pnas.0500090102; Lesterhuis WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061895; Lesterhuis WJ, 2011, NAT REV DRUG DISCOV, V10, P591, DOI 10.1038/nrd3500; Lo HW, 2005, CANCER RES, V65, P338; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Marzo AL, 1999, J IMMUNOL, V162, P5838; Marzo AL, 1999, CANCER RES, V59, P1071; Matheoud D, 2010, BLOOD, V115, P4412, DOI 10.1182/blood-2009-11-255935; Nierkens S, 2013, TRENDS IMMUNOL, V34, P361, DOI 10.1016/j.it.2013.02.007; Nowak AK, 2003, J IMMUNOL, V170, P4905, DOI 10.4049/jimmunol.170.10.4905; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Paroli M, 2014, INT J CANCER, V134, P1823, DOI 10.1002/ijc.28515; Presley JF, 2005, BBA-MOL CELL RES, V1744, P259, DOI 10.1016/j.bbamcr.2005.04.010; Quah B.J., 2010, J VIS EXP; Ralhan R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-331; Robinson BWS, 1999, IMMUNOL CELL BIOL, V77, P552, DOI 10.1046/j.1440-1711.1999.00876.x; Rozali EN, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/656340; Schultz-Thater E, 2011, INT J CANCER, V129, P1137, DOI 10.1002/ijc.25777; Segura E, 2011, TRAFFIC, V12, P1677, DOI 10.1111/j.1600-0854.2011.01254.x; Shen LJ, 2004, P NATL ACAD SCI USA, V101, P3035, DOI 10.1073/pnas.0308345101; Steer HJ, 2010, ONCOGENE; Takahara A, 2011, CANCER IMMUNOL IMMUN, V60, P1289, DOI 10.1007/s00262-011-1033-3; Tinguely M, 2008, CANCER SCI, V99, P720, DOI 10.1111/j.1349-7006.2008.00738.x; Van den Broeck W, 2006, J IMMUNOL METHODS, V312, P12, DOI 10.1016/j.jim.2006.01.022; van der Most RG, 2006, CANCER RES, V66, P601, DOI 10.1158/0008-5472.CAN-05-2967; Wolkers MC, 2004, SCIENCE, V304, P1314, DOI 10.1126/science.1096268; Xia WY, 2009, MOL CARCINOGEN, V48, P610, DOI 10.1002/mc.20504; Zeelenberg IS, 2011, J IMMUNOL, V187, P1281, DOI 10.4049/jimmunol.1003905	40	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107894	10.1371/journal.pone.0107894	http://dx.doi.org/10.1371/journal.pone.0107894			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243472	Green Published, gold, Green Submitted			2022-12-25	WOS:000343679800055
J	Gosch, C; Nagesh, KM; Thill, J; Miosic, S; Plaschil, S; Milosevic, M; Olbricht, K; Ejaz, S; Rompel, A; Stich, K; Halbwirth, H				Gosch, Christian; Nagesh, Karthik Mudigere; Thill, Jana; Miosic, Silvija; Plaschil, Sylvia; Milosevic, Malvina; Olbricht, Klaus; Ejaz, Shaghef; Rompel, Annette; Stich, Karl; Halbwirth, Heidi			Isolation of Dihydroflavonol 4-Reductase cDNA Clones from Angelonia x angustifolia and Heterologous Expression as GST Fusion Protein in Escherichia coli	PLOS ONE			English	Article							FLOWER EXTRACTS; SUBSTRATE-SPECIFICITY; MOLECULAR-CLONING; COLORFUL MODEL; BIOSYNTHESIS; DAHLIA; SYNTHASE; PURIFICATION; BIOCHEMISTRY; ARABIDOPSIS	Blue Angelonia 6 angustifolia flowers can show spontaneous mutations resulting in white/blue and white flower colourations. In such a white line, a loss of dihydroflavonol 4-reductase (DFR) activity was observed whereas chalcone synthase and flavanone 3-hydroxylase activity remained unchanged. Thus, cloning and characterization of a DFR of Angelonia flowers was carried out for the first time. Two full length DFR cDNA clones, Ang.DFR1 and Ang.DFR2, were obtained from a diploid chimeral white/blue Angelonia x angustifolia which demonstrated a 99% identity in their translated amino acid sequence. In comparison to Ang.DFR2, Ang.DFR1 was shown to contain an extra proline in a proline-rich region at the N-terminus along with two exchanges at the amino acids 12 and 26 in the translated amino acid sequence. The recombinant Ang. DFR2 obtained by heterologous expression in yeast was functionally active catalyzing the NADPH dependent reduction of dihydroquercetin (DHQ) and dihydromyricetin (DHM) to leucocyanidin and leucomyricetin, respectively. Dihydrokaempferol (DHK) in contrast was not accepted as a substrate despite the presence of asparagine in a position assumed to determine DHK acceptance. We show that substrate acceptance testing of DFRs provides biased results for DHM conversion if products are extracted with ethyl acetate. Recombinant Ang. DFR1 was inactive and functional activity could only be restored via exchanges of the amino acids in position 12 and 26 as well as the deletion of the extra proline. E. coli transformation of the pGEX-6P-1 vector harbouring the Ang. DFR2 and heterologous expression in E. coli resulted in functionally active enzymes before and after GST tag removal. Both the GST fusion protein and purified DFR minus the GST tag could be stored at -80 degrees C for several months without loss of enzyme activity and demonstrated identical substrate specificity as the recombinant enzyme obtained from heterologous expression in yeast.	[Gosch, Christian; Nagesh, Karthik Mudigere; Thill, Jana; Miosic, Silvija; Milosevic, Malvina; Stich, Karl; Halbwirth, Heidi] Vienna Univ Technol, Inst Chem Engn, A-1040 Vienna, Austria; [Plaschil, Sylvia] Julius Kuhn Inst, Inst Breeding Res Hort Crops, Quedlinburg, Germany; [Milosevic, Malvina; Rompel, Annette] Univ Vienna, Dept Biophys Chem, Vienna, Austria; [Olbricht, Klaus] Humboldt Univ, Inst Agr & Hort, D-10099 Berlin, Germany; [Ejaz, Shaghef] Bahauddin Zakariya Univ, Dept Hort, Multan, Pakistan	Technische Universitat Wien; Julius Kuhn-Institut; University of Vienna; Humboldt University of Berlin; Bahauddin Zakariya University	Halbwirth, H (corresponding author), Vienna Univ Technol, Inst Chem Engn, A-1040 Vienna, Austria.	hhalb@mail.zserv.tuwien.ac.at	Ejaz, Shaghef/J-1617-2014; Plaschil, Sylvia/J-5090-2019	Haselmair-Gosch, Christian/0000-0003-3231-0962; Plaschil, Sylvia/0000-0001-6689-4113; Ejaz, Shaghef/0000-0003-4018-9189; Rompel, Annette/0000-0002-5919-0553; Halbwirth, Heidi/0000-0001-9059-5850	Austrian Science Fund (FWF) [P 25399-B16]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	These investigations were supported by a grant from the Austrian Science Fund (FWF): Project P 25399-B16. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albach DC, 2005, AM J BOT, V92, P297, DOI 10.3732/ajb.92.2.297; Almeida R, 2005, TRENDS CELL BIOL, V15, P251, DOI 10.1016/j.tcb.2005.03.006; Armitage AM, 1998, HORTSCIENCE, V33, P508; BAILEY LH, 1947, STANDARD CYCLOPEDIA; Cheng H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072017; CLAUDOT AC, 1992, PHYTOCHEMISTRY, V31, P3377, DOI 10.1016/0031-9422(92)83689-V; Davies KM, 2003, EUPHYTICA, V131, P259, DOI 10.1023/A:1024018729349; Deffieux D, 2009, TETRAHEDRON LETT, V50, P6567, DOI 10.1016/j.tetlet.2009.09.045; Deguchi A, 2013, PLANTA, P1; Des Marais DL, 2008, NATURE, V454, P762, DOI 10.1038/nature07092; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; FISCHER D, 1988, ARCH BIOCHEM BIOPHYS, V264, P40, DOI 10.1016/0003-9861(88)90567-X; Fischer TC, 2003, ARCH BIOCHEM BIOPHYS, V412, P223, DOI 10.1016/S0003-9861(03)00013-4; FORKMANN G, 1984, PLANTA, V161, P261, DOI 10.1007/BF00982923; Gou JY, 2011, PLANT CELL, V23, P1512, DOI 10.1105/tpc.111.084525; Halbwirth H, 2006, PLANT SCI, V170, P587, DOI 10.1016/j.plantsci.2005.10.013; Halbwirth H, 2003, Z NATURFORSCH C, V58, P765; Halbwirth H, 2008, NAT PROD COMMUN, V3, P1259; Halbwirth H, 2009, J AGR FOOD CHEM, V57, P4983, DOI 10.1021/jf900121z; HELLER W, 1985, PLANTA, V165, P284, DOI 10.1007/BF00395052; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Hotzy J, 2013, J BIOL CHEM, V288, P36492, DOI 10.1074/jbc.M113.489385; HSIA C, 1964, J FOOD SCI, V29, P723, DOI 10.1111/j.1365-2621.1964.tb00438.x; ITO S, 1965, J FOOD SCI, V30, P44, DOI 10.1111/j.1365-2621.1965.tb00261.x; Johnson ET, 1999, PLANT J, V19, P81, DOI 10.1046/j.1365-313X.1999.00502.x; Johnson ET, 2001, PLANT J, V25, P325, DOI 10.1046/j.1365-313x.2001.00962.x; Kampny CM, 1995, BOT REV, V61, P350, DOI 10.1007/BF02912622; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; Lukacin R, 1997, EUR J BIOCHEM, V249, P748, DOI 10.1111/j.1432-1033.1997.t01-2-00748.x; Martens S, 2002, FEBS LETT, V531, P453, DOI 10.1016/S0014-5793(02)03583-4; Miosic S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061766; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; Moro FV, 2001, ANN BOT-LONDON, V88, P499, DOI 10.1006/anbo.2001.1473; Ohno S, 2011, J EXP BOT, V62, P5105, DOI 10.1093/jxb/err216; Onozaki T, 1999, SCI HORTIC-AMSTERDAM, V82, P103, DOI 10.1016/S0304-4238(99)00040-0; Peters DJ, 2002, PLANT J, V32, P701, DOI 10.1046/j.1365-313X.2002.01458.x; Petit P, 2007, J MOL BIOL, V368, P1345, DOI 10.1016/j.jmb.2007.02.088; Pfeiffer J, 2006, PLANT PHYSIOL BIOCH, V44, P323, DOI 10.1016/j.plaphy.2006.06.001; Plaschil S, 2008, J APPL BOT FOOD QUAL, V82, P41; Polashock JJ, 2002, PLANT SCI, V163, P241, DOI 10.1016/S0168-9452(02)00087-0; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Saito K, 1999, PLANT J, V17, P181, DOI 10.1046/j.1365-313X.1999.00365.x; SANDERMANN H, 1972, J BIOL CHEM, V247, P5123; SCHWINN KE, 1994, PHYTOCHEMISTRY, V35, P145, DOI 10.1016/S0031-9422(00)90523-5; Shimada N, 2005, J EXP BOT, V56, P2573, DOI 10.1093/jxb/eri251; SMATHERS RU, 1967, J FOOD SCI, V32, P310, DOI 10.1111/j.1365-2621.1967.tb01319.x; Souza VC, 2001, ACTA BOT BRAS, V15, P57; STAFFORD HA, 1985, PHYTOCHEMISTRY, V24, P333; Stich K, 1997, Z NATURFORSCH C, V52, P153; STICH K, 1992, PLANTA, V187, P103, DOI 10.1007/BF00201630; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THOMPSON JD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BIO203S00; Trabelsi N, 2008, ACTA CRYSTALLOGR D, V64, P883, DOI 10.1107/S0907444908017769; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Winefield CS, 2005, PHYSIOL PLANTARUM, V124, P419, DOI 10.1111/j.1399-3054.2005.00531.x; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Xie DY, 2004, PLANT PHYSIOL, V134, P979, DOI 10.1104/pp.103.030221; Zeng G, 1998, BIOTECHNIQUES, V25, P206, DOI 10.2144/98252bm05; Zhou XF, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100143	61	19	20	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107755	10.1371/journal.pone.0107755	http://dx.doi.org/10.1371/journal.pone.0107755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238248	Green Published, Green Submitted, gold			2022-12-25	WOS:000342491600047
J	Xu, F; Rimm, AA; Fu, PF; Krishnamurthi, SS; Cooper, GS				Xu, Fang; Rimm, Alfred A.; Fu, Pingfu; Krishnamurthi, Smitha S.; Cooper, Gregory S.			The Impact of Delayed Chemotherapy on Its Completion and Survival Outcomes in Stage II Colon Cancer Patients	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; ADJUVANT CHEMOTHERAPY; BREAST-CANCER; RECTAL-CANCER; MEDICARE BENEFICIARIES; ELDERLY MEDICARE; THERAPY; INITIATION; POPULATION; SURGERY	Background: Delayed chemotherapy is associated with inferior survival in stage III colon and stage II/III rectal cancer patients, but similar studies have not been performed in stage II colon cancer patients. We investigate the association between delayed and incomplete chemotherapy, and the association of delayed chemotherapy with survival in stage II colon cancer patients. Patients and Methods: Patients (age >= 66) diagnosed as stage II colon cancer and received chemotherapy from 1992 to 2005 were identified from the linked SEER-Medicare database. The association between delayed and incomplete chemotherapy was assessed using unconditional and conditional logistic regressions. Survival outcomes were assessed using stratified Cox regression based on propensity score matched samples. Results: 4,209 stage II colon cancer patients were included, of whom 73.0% had chemotherapy initiated timely (<= 2 months after surgery), 14.7% had chemotherapy initiated with moderate delay (2-3 months), and 12.3% had delayed chemotherapy (>= 3 months). Delayed chemotherapy was associated with not completing chemotherapy (adjusted odds ratio (OR): 1.33 (95% confidence interval: 1.11, 1.59) for moderately delayed group, adjusted OR: 2.60 (2.09, 3.24) for delayed group). Delayed chemotherapy was associated with worse survival outcomes (hazard ratio (HR): 1.75 (1.29, 2.37) for overall survival; HR: 4.23 (2.19, 8.20) for cancer-specific survival). Conclusion: Although the benefit of chemotherapy is unclear in stage II colon cancer patients, delay in initiation of chemotherapy is associated with an incomplete chemotherapy course and poorer survival, especially cancer-specific survival. Causal inference in the association between delayed initiation of chemotherapy and inferior survival requires further investigation.	[Xu, Fang; Rimm, Alfred A.; Fu, Pingfu] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Xu, Fang; Cooper, Gregory S.] Univ Hosp Case Med Ctr, Dept Gastroenterol, Cleveland, OH USA; [Krishnamurthi, Smitha S.] Case Western Reserve Univ, Sch Med, Div Hematol & Oncol, Cleveland, OH USA; [Fu, Pingfu; Krishnamurthi, Smitha S.; Cooper, Gregory S.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University	Xu, F (corresponding author), Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.	youlindi@gmail.com	Krishnamurthi, Smitha/ABB-8593-2021; Fu, Pingfu/O-5415-2019	Fu, Pingfu/0000-0002-2334-5218				Ahmed S, 2010, DIS COLON RECTUM, V53, P1432, DOI 10.1007/DCR.0b013e3181e78815; Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; Biagi JJ, 2011, JAMA-J AM MED ASSOC, V305, P2335, DOI 10.1001/jama.2011.749; Bradley CJ, 2008, ARCH INTERN MED, V168, P521, DOI 10.1001/archinternmed.2007.82; Chau I, 2005, ANN ONCOL, V16, P549, DOI 10.1093/annonc/mdi116; Cheung WY, 2009, DIS COLON RECTUM, V52, P1054, DOI 10.1007/DCR.0b013e3181a51173; Colleoni M, 1998, EUR J CANCER, V34, P1693, DOI 10.1016/S0959-8049(98)00209-3; Delea TE, 2002, VALUE HEALTH, V5, P35, DOI 10.1046/j.1524-4733.2002.51083.x; Des Guetz G, 2010, EUR J CANCER, V46, P1049, DOI 10.1016/j.ejca.2010.01.020; Dobie SA, 2008, CANCER-AM CANCER SOC, V112, P789, DOI 10.1002/cncr.23244; Dobie SA, 2006, JNCI-J NATL CANCER I, V98, P610, DOI 10.1093/jnci/djj159; Engstrom PF, 2009, J NATL COMPR CANC NE, V7, P778, DOI 10.6004/jnccn.2009.0056; Glimelius B, 2005, ACTA ONCOL, V44, P904, DOI 10.1080/02841860500355900a; Grann VR, 2006, JNCI-J NATL CANCER I, V98, P570, DOI 10.1093/jnci/djj184; Gray R, 2007, LANCET, V370, P2020, DOI 10.1016/s0140-6736(07)61866-2; GREGG J, 1994, SOC SCI MED, V39, P519, DOI 10.1016/0277-9536(94)90094-9; HALL WH, 1990, JAMA-J AM MED ASSOC, V264, P1444; Hershman D, 2006, CANCER-AM CANCER SOC, V107, P2581, DOI 10.1002/cncr.22316; Hershman DL, 2006, INT J RADIAT ONCOL, V65, P1353, DOI 10.1016/j.ijrobp.2006.03.048; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; NISSENMEYER R, 1978, CANCER, V41, P2088, DOI 10.1002/1097-0142(197806)41:6<2088::AID-CNCR2820410604>3.0.CO;2-J; Nurgalieva ZZ, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0419-1; O'Connor ES, 2011, J CLIN ONCOL, V29, P3381, DOI 10.1200/JCO.2010.34.3426; Obeidat NA, 2009, AM J GERIATR PHARMAC, V7, P343, DOI 10.1016/j.amjopharm.2009.11.005; Parson LS, 2001, SUGI 26, P26; Poplin EA, 2005, J CLIN ONCOL, V23, P1819, DOI 10.1200/JCO.2005.04.169; POTOSKY AL, 1993, MED CARE, V31, P732; POWE BD, 1995, CANCER NURS, V18, P385; Schabel F, 1977, ADJUVANT THERAPY CAN, P3; Schrag D, 2002, J CLIN ONCOL, V20, P3999, DOI 10.1200/JCO.2002.11.084; Shankar Sharada, 2002, Ethnicity and Disease, V12, P276; Warren JL, 2002, MED CARE, V40, P3	32	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107993	10.1371/journal.pone.0107993	http://dx.doi.org/10.1371/journal.pone.0107993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238395	Green Submitted, Green Published, gold			2022-12-25	WOS:000342491600072
J	Bhattacharya, S; Auldridge, ME; Lehtivuori, H; Ihalainen, JA; Forest, KT				Bhattacharya, Shyamosree; Auldridge, Michele E.; Lehtivuori, Heli; Ihalainen, Janne A.; Forest, Katrina T.			Origins of Fluorescence in Evolved Bacteriophytochromes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fluorescence; Photoreceptor; Protein Engineering; Spectroscopy; Structural Biology; Phytochrome	CHROMOPHORE-BINDING DOMAIN; DEINOCOCCUS-RADIODURANS; BACTERIAL PHYTOCHROME; QUANTUM YIELD; PROTEIN; LIGHT; SPECTROSCOPY; PARAMETERS; RESIDUES; OXYGEN	Use of fluorescent proteins to study in vivo processes in mammals requires near-infrared (NIR) biomarkers that exploit the ability of light in this range to penetrate tissue. Bacteriophytochromes (BphPs) are photoreceptors that couple absorbance of NIR light to photoisomerization, protein conformational changes, and signal transduction. BphPs have been engineered to form NIR fluorophores, including IFP1.4, Wi-Phy, and the iRFP series, initially by replacement of Asp-207 by His. This position was suggestive because its main chain carbonyl is within hydrogen-bonding distance to pyrrole ring nitrogens of the biliverdin chromophore, thus potentially functioning as a crucial transient proton sink during photoconversion. To explain the origin of fluorescence in these phytofluors, we solved the crystal structures of IFP1.4 and a comparison non-fluorescent monomeric phytochrome DrCBD(mon). Met-186 and Val-288 in IFP1.4 are responsible for the formation of a tightly packed hydrophobic hub around the biliverdin D ring. Met-186 is also largely responsible for the blue-shifted IFP1.4 excitation maximum relative to the parent BphP. The structure of IFP1.4 revealed decreased structural heterogeneity and a contraction of two surface regions as direct consequences of side chain substitutions. Unexpectedly, IFP1.4 with Asp-207 reinstalled (IFPrev) has a higher fluorescence quantum yield (approximate to 9%) than most NIR phytofluors published to date. In agreement, fluorescence lifetime measurements confirm the exceptionally long excited state lifetimes, up to 815 ps, in IFP1.4 and IFPrev. Our research helps delineate the origin of fluorescence in engineered BphPs and will facilitate the wide-spread adoption of phytofluors as biomarkers.	[Bhattacharya, Shyamosree; Auldridge, Michele E.; Forest, Katrina T.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Lehtivuori, Heli; Ihalainen, Janne A.] Univ Jyvaskyla, Nanosci Ctr, Dept Biol & Environm Sci, FI-40014 Jyvaskyla, Finland	University of Wisconsin System; University of Wisconsin Madison; University of Jyvaskyla	Ihalainen, JA (corresponding author), Univ Jyvaskyla, POB 35,Survontie 9C, FI-40014 Jyvaskyla, Finland.	janne.ihalainen@jyu.fi; forest@bact.wisc.edu		Ihalainen, Janne/0000-0002-8741-1587; Lehtivuori, Heli/0000-0002-7450-2578	United States DOE [DE-AC02-06CH11357]; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor [085P1000817]	United States DOE(United States Department of Energy (DOE)); Michigan Economic Development Corp.; Michigan Technology Tri-Corridor	We thank Professor Felix Castellano and Dr. Rony S. Khnayzer for generous assistance with absolute quantum yield measurements, Professor Robert Landick for equipment access, and Dr. Kenneth Satyshur for technical assistance. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Dept. of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the United States DOE under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and the Michigan Technology Tri-Corridor (Grant 085P1000817).	Anders K, 2013, J BIOL CHEM, V288, P35714, DOI 10.1074/jbc.M113.510461; Auldridge ME, 2012, J BIOL CHEM, V287, P7000, DOI 10.1074/jbc.M111.295121; Auldridge ME, 2011, CRIT REV BIOCHEM MOL, V46, P67, DOI 10.3109/10409238.2010.546389; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Borg OA, 2008, PHYS CHEM CHEM PHYS, V10, P2528, DOI 10.1039/b719190a; Borucki B, 2005, J BIOL CHEM, V280, P34358, DOI 10.1074/jbc.M505493200; Dasgupta J, 2009, P NATL ACAD SCI USA, V106, P1784, DOI 10.1073/pnas.0812056106; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escobar FV, 2014, BIOCHEMISTRY-US, V53, P20, DOI 10.1021/bi401287u; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Fischer AJ, 2004, P NATL ACAD SCI USA, V101, P17334, DOI 10.1073/pnas.0407645101; Foerstendorf H, 1996, BIOCHEMISTRY-US, V35, P10793, DOI 10.1021/bi960960r; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; JOBSIS FF, 1974, AM REV RESPIR DIS, V110, P58; JOBSIS FF, 1977, ACTA NEUROL SCAND, V56, P452; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Kim PW, 2014, BIOCHEMISTRY-US, V53, P2818, DOI 10.1021/bi500108s; Lehtivuori H, 2013, J PHYS CHEM B, V117, P11049, DOI 10.1021/jp312061b; Magyar C, 2005, NUCLEIC ACIDS RES, V33, pW303, DOI 10.1093/nar/gki409; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller AE, 2006, P NATL ACAD SCI USA, V103, P11136, DOI 10.1073/pnas.0604724103; MUJUMDAR RB, 1993, BIOCONJUGATE CHEM, V4, P105, DOI 10.1021/bc00020a001; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Piatkevich KD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3153; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Shcherbakova DM, 2013, NAT METHODS, V10, P751, DOI 10.1038/nmeth.2521; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Song C, 2011, P NATL ACAD SCI USA, V108, P3842, DOI 10.1073/pnas.1013377108; Stepanenko OV, 2008, CURR PROTEIN PEPT SC, V9, P338, DOI 10.2174/138920308785132668; Suzuki K, 2009, PHYS CHEM CHEM PHYS, V11, P9850, DOI 10.1039/b912178a; Takala H, 2014, NATURE, V509, P245, DOI 10.1038/nature13310; Toh KC, 2011, PHYS CHEM CHEM PHYS, V13, P11985, DOI 10.1039/c1cp00050k; Toh KC, 2010, P NATL ACAD SCI USA, V107, P9170, DOI 10.1073/pnas.0911535107; von Stetten D, 2007, J BIOL CHEM, V282, P2116, DOI 10.1074/jbc.M608878200; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Yang X, 2007, P NATL ACAD SCI USA, V104, P12571, DOI 10.1073/pnas.0701737104; Yang XJ, 2011, NATURE, V479, P428, DOI 10.1038/nature10506; Yang XJ, 2009, P NATL ACAD SCI USA, V106, P15639, DOI 10.1073/pnas.0902178106; Ying BW, 2007, RNA, V13, P2042, DOI 10.1261/rna.637907; Yu D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4626; Zhang JA, 2010, ANGEW CHEM INT EDIT, V49, P5456, DOI 10.1002/anie.201001094	47	55	59	3	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32144	32152		10.1074/jbc.M114.589739	http://dx.doi.org/10.1074/jbc.M114.589739			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25253687	Green Published, hybrid			2022-12-25	WOS:000345314700042
J	Leuck, AM; Johnson, JR; Dunny, GM				Leuck, Anne-Marie; Johnson, James R.; Dunny, Gary M.			A Widely Used In Vitro Biofilm Assay Has Questionable Clinical Significance for Enterococcal Endocarditis	PLOS ONE			English	Article							SURFACE PROTEIN; GENE-EXPRESSION; FAECALIS; ESP; AGGREGATION; VIRULENCE; FREQUENCY; SLIME; VIVO; EEP	Biofilm formation may play an important role in the pathogenesis of infections caused by Enterococcus faecalis, including endocarditis. Most biofilm studies use a polystyrene dish assay to quantify biofilm biomass. However, recent studies of E. faecalis strains in tissue and animal models suggest that polystyrene dish results need to be interpreted with caution. We evaluated 158 clinical E. faecalis isolates using a polystyrene dish assay and found variation in biofilm formation, with many isolates forming little biofilm even when different types of media were used. However, all tested clinical isolates were able to form biofilms on porcine heart valve explants. Dextrose-enhanced biofilm formation in the polystyrene dish assay was found in 6/12 (50%) of clinical isolates tested and may explain some, but not all of the differences between the polystyrene dish assay and the heart valve assay. These findings suggest that in studies assessing the clinical relevance of enterococcal biofilm-forming ability, ex vivo biofilm formation on a relevant tissue surface may be warranted to validate results of in vitro assays.	[Leuck, Anne-Marie; Johnson, James R.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Johnson, James R.] VA Hlth Care Syst, Minneapolis, MN USA; [Dunny, Gary M.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Leuck, AM (corresponding author), Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA.	leuck002@umn.edu			National Institutes of Health Ruth L. Kirschstein National Research Service Award Institutional Research Training Grant [5T32AI055433-09]; National Institute of Allergy and Infectious Diseases at the National Institutes of Health [AI058134]; Office of Research and Development, Medical Research Service, Department of Veterans Affairs [1 I01 CX000192 01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI058134, T32AI055433, R01AI058134] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000920] Funding Source: NIH RePORTER	National Institutes of Health Ruth L. Kirschstein National Research Service Award Institutional Research Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of Research and Development, Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a National Institutes of Health Ruth L. Kirschstein National Research Service Award Institutional Research Training Grant [5T32AI055433-09] and the National Institute of Allergy and Infectious Diseases at the National Institutes of Health [AI058134 to GMD]. This material also is based partly upon work supported by the Office of Research and Development, Medical Research Service, Department of Veterans Affairs [1 I01 CX000192 01 to JRJ]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldassarri L, 2001, MED MICROBIOL IMMUN, V190, P113, DOI 10.1007/s00430-001-0096-8; BALDASSARRI L, 1993, EUR J CLIN MICROBIOL, V12, P866, DOI 10.1007/BF02000411; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Chuang-Smith ON, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015798; DUNNY GM, 1978, P NATL ACAD SCI USA, V75, P3479, DOI 10.1073/pnas.75.7.3479; Frank KL, 2013, INFECT IMMUN, V81, P1696, DOI 10.1128/IAI.01210-12; Frank KL, 2012, INFECT IMMUN, V80, P539, DOI 10.1128/IAI.05964-11; Gao P, 2010, J BACTERIOL, V192, P5489, DOI 10.1128/JB.00725-10; HUYCKE MM, 1995, PLASMID, V34, P152, DOI 10.1006/plas.1995.9992; Kristich CJ, 2008, APPL ENVIRON MICROB, V74, P3377, DOI 10.1128/AEM.02665-07; Kristich CJ, 2004, J BACTERIOL, V186, P154, DOI 10.1128/JB.186.1.154-163.2004; Lebeaux D, 2013, PATHOGENS, V2, P288, DOI 10.3390/pathogens2020288; Lizcano A, 2010, MICROB PATHOGENESIS, V48, P124, DOI 10.1016/j.micpath.2010.01.002; Lopez-Sala P, 2013, ARCH MED RES, V44, P422, DOI 10.1016/j.arcmed.2013.07.003; McBride SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000582; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; OSTROLENK M, 1946, J BACTERIOL, V51, P735, DOI 10.1128/JB.51.6.735-741.1946; Paganelli FL, 2012, TRENDS MICROBIOL, V20, P40, DOI 10.1016/j.tim.2011.11.001; Potera C, 1999, SCIENCE, V283, P1837, DOI 10.1126/science.283.5409.1837; Sandoe JAT, 2006, J ANTIMICROB CHEMOTH, V57, P767, DOI 10.1093/jac/dkl013; Sandoe JAT, 2003, J MED MICROBIOL, V52, P547, DOI 10.1099/jmm.0.05201-0; Schlievert PM, 1998, INFECT IMMUN, V66, P218, DOI 10.1128/IAI.66.1.218-223.1998; Shankar V, 1999, INFECT IMMUN, V67, P193, DOI 10.1128/IAI.67.1.193-200.1999; Tendolkar PM, 2004, INFECT IMMUN, V72, P6032, DOI 10.1128/IAI.72.10.6032-6039.2004; Toledo-Arana A, 2001, APPL ENVIRON MICROB, V67, P4538, DOI 10.1128/AEM.67.10.4538-4545.2001; Udo EE, 2011, MED PRIN PRACT, V20, P259, DOI 10.1159/000321230	26	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107282	10.1371/journal.pone.0107282	http://dx.doi.org/10.1371/journal.pone.0107282			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25255085	Green Published, Green Submitted, gold			2022-12-25	WOS:000344862300020
J	Lin, WS; Hu, LY; Liu, CJ; Hsu, CC; Shen, CC; Wang, YP; Hu, YW; Tsai, CF; Yeh, CM; Chen, PM; Su, TP; Chen, TJ; Lu, T				Lin, Wan-Shan; Hu, Li-Yu; Liu, Chia-Jen; Hsu, Chih-Chao; Shen, Cheng-Che; Wang, Yen-Po; Hu, Yu-Wen; Tsai, Chia-Fen; Yeh, Chiu-Mei; Chen, Pan-Ming; Su, Tung-Ping; Chen, Tzeng-Ji; Lu, Ti			Gastroesophageal Reflux Disease and Risk for Bipolar Disorder: A Nationwide Population-Based Study	PLOS ONE			English	Article							INFLAMMATORY DISEASE; GENERAL-POPULATION; DEPRESSION; ASSOCIATION; SYMPTOMS; PATHOPHYSIOLOGY; INTERLEUKIN-8; PREVALENCE; PERCEPTION; ACTIVATION	Background: Studies have shown that chronic inflammation may play a vital role in the pathophysiology of both gastroesophageal reflux disease (GERD) and bipolar disorder. Among patients with GERD, the risk of bipolar disorder has not been well characterized. Objective: We explored the relationship between GERD and the subsequent development of bipolar disorder, and examined the risk factors for bipolar disorder in patients with GERD. Methods: We identified patients who were diagnosed with GERD in the Taiwan National Health Insurance Research Database. A comparison cohort without GERD was matched according to age, sex, and comorbidities. The occurrence of bipolar disorder was evaluated in both cohorts based on diagnosis and the prescription of medications. Results: The GERD cohort consisted of 21,674 patients, and the comparison cohort consisted of 21,674 matched control patients without GERD. The incidence of bipolar disorder (incidence rate ratio [IRR] 2.29, 95% confidence interval [CI] 1.58-3.36, P < .001) was higher among GERD patients than among comparison cohort. Multivariate, matched regression models showed that the female sex (hazard ratio [HR] 1.78, 95% CI 1.76-2.74, P = .008), being younger than 60 years old (HR 2.35, 95% CI 1.33-4.16, P = .003), and alcohol use disorder (HR 4.89, 95% CI 3.06-7.84, P = .004) were independent risk factors for the development of bipolar disorder among GERD patients. Conclusions: GERD may increase the risk of developing bipolar disorder. Based on our data, we suggest that attention should be focused on female patients younger than 60 years, and patients with alcohol use disorder, following a GERD diagnosis.	[Lin, Wan-Shan; Hu, Li-Yu; Hsu, Chih-Chao; Lu, Ti] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Hu, Li-Yu; Liu, Chia-Jen] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Hu, Li-Yu; Liu, Chia-Jen; Wang, Yen-Po; Hu, Yu-Wen; Tsai, Chia-Fen; Su, Tung-Ping; Chen, Tzeng-Ji] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Liu, Chia-Jen] Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Shen, Cheng-Che] Taichung Vet Gen Hosp, Dept Psychiat, Chiayi Branch, Taipei, Taiwan; [Wang, Yen-Po] Taipei Vet Gen Hosp, Endoscopy Ctr Diag & Treatment, Taipei, Taiwan; [Wang, Yen-Po] Taipei Vet Gen Hosp, Div Gastroenterol, Dept Med, Taipei, Taiwan; [Hu, Yu-Wen] Taipei Vet Gen Hosp, Ctr Canc, Taipei, Taiwan; [Tsai, Chia-Fen; Su, Tung-Ping] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Yeh, Chiu-Mei; Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Chen, Pan-Ming] Taipei Vet Gen Hosp, Dept Psychiat, Su Ao & Yuanshan Branch, Taipei, Taiwan	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taichung Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Lu, T (corresponding author), Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan.	tlu@vghks.gov.tw	Chen, TJ/AAH-8430-2021	Hu, Yu-Wen/0000-0002-7983-415X; Wang, Yen-Po/0000-0002-3769-0020	Taipei Veterans General Hospital [V103B-022, V103E10-001]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This study is supported by a grant from Taipei Veterans General Hospital (V103B-022 and V103E10-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Altomare A, 2013, WORLD J GASTROENTERO, V19, P6523, DOI 10.3748/wjg.v19.i39.6523; Avidan B, 2001, ALIMENT PHARM THER, V15, P1907, DOI 10.1046/j.1365-2036.2001.01131.x; Berk M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-200; Brietzke E, 2009, J AFFECT DISORDERS, V116, P214, DOI 10.1016/j.jad.2008.12.001; Chou PH, 2013, PSYCHOSOMATICS; Etain B, 2008, BIPOLAR DISORD, V10, P867, DOI 10.1111/j.1399-5618.2008.00635.x; Farren CK, 2012, CURR PSYCHIAT REP, V14, P659, DOI 10.1007/s11920-012-0320-9; Fass R, 2008, GASTROENTEROLOGY, V134, P696, DOI 10.1053/j.gastro.2007.12.010; Frey B.N., 2013, BIPOLAR DISORD; Goldstein BI, 2009, J CLIN PSYCHIAT, V70, P1078, DOI 10.4088/JCP.08r04505; Graae L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032304; Hamdani Nora, 2012, Front Biosci (Elite Ed), V4, P2170; Isomoto H, 2004, AM J GASTROENTEROL, V99, P589, DOI 10.1111/j.1572-0241.2004.04110.x; Jansson C, 2007, ALIMENT PHARM THER, V26, P683, DOI 10.1111/j.1365-2036.2007.03411.x; Jansson C, 2010, SCAND J GASTROENTERO, V45, P21, DOI 10.3109/00365520903401967; Jansson C, 2009, CLIN GASTROENTEROL H, V7, P960, DOI 10.1016/j.cgh.2009.03.007; Jung HK, 2011, J NEUROGASTROENTEROL, V17, P14, DOI 10.5056/jnm.2011.17.1.14; Khan NF, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-1; Kim JY, 2013, J NEUROGASTROENTEROL, V19, P344, DOI 10.5056/jnm.2013.19.3.344; Kivimaki M, 2013, MOL PSYCHIAT; Kroon JS, 2013, BIPOLAR DISORD, V15, P306, DOI 10.1111/bdi.12058; Lampa J, 2012, P NATL ACAD SCI USA, V109, P12728, DOI 10.1073/pnas.1118748109; Lu CL, 2005, ALIMENT PHARM THER, V22, P739, DOI 10.1111/j.1365-2036.2005.02664.x; Mikocka-Walus A, 2009, INTERN MED J, V39, P127, DOI 10.1111/j.1445-5994.2008.01862.x; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Minatsuki C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069891; Monkemuller K, 2009, DIGESTION, V79, P186, DOI 10.1159/000211714; Moshkowitz M, 2011, WORLD J GASTROENTERO, V17, P1332, DOI 10.3748/wjg.v17.i10.1332; Pettinati HM, 2013, AM J PSYCHIAT, V170, P23, DOI 10.1176/appi.ajp.2012.12010112; Proudfoot J, 2012, J AFFECT DISORDERS, V143, P196, DOI 10.1016/j.jad.2012.05.052; Sandler RS, 2002, GASTROENTEROLOGY, V122, P1500, DOI 10.1053/gast.2002.32978; Schoeyen HK, 2011, J AFFECT DISORDERS, V129, P68, DOI 10.1016/j.jad.2010.08.012; Souza RF, 2009, GASTROENTEROLOGY, V137, P1776, DOI 10.1053/j.gastro.2009.07.055; Stertz L, 2013, CURR OPIN PSYCHIATR, V26, P19, DOI 10.1097/YCO.0b013e32835aa4b4; Wager-Smith K, 2011, NEUROSCI BIOBEHAV R, V35, P742, DOI 10.1016/j.neubiorev.2010.09.010; Waxmonsky JA, 2005, GEN HOSP PSYCHIAT, V27, P321, DOI 10.1016/j.genhosppsych.2005.05.003; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975	38	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107694	10.1371/journal.pone.0107694	http://dx.doi.org/10.1371/journal.pone.0107694			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT3UZ	25255080	Green Published, gold, Green Submitted			2022-12-25	WOS:000344862300028
J	Schneeberger, K; Courtiol, A; Czirjak, GA; Voigt, CC				Schneeberger, Karin; Courtiol, Alexandre; Czirjak, Gabor A.; Voigt, Christian C.			Immune Profile Predicts Survival and Reflects Senescence in a Small, Long-Lived Mammal, the Greater Sac-Winged Bat (Saccopteryx bilineata)	PLOS ONE			English	Article							BODY ELECTRICAL-CONDUCTIVITY; INNATE IMMUNITY; LIFE-HISTORY; ENVIRONMENTAL-CONDITIONS; PARASITE RESISTANCE; TROPICAL BAT; SOAY SHEEP; IMMUNOSENESCENCE; ECOLOGY; SEX	The immune system imposes costs that may have to be traded against investment of resources in other costly life-history traits. Yet, it is unknown if a trade-off between immunity and longevity occurs in free-ranging mammals. Here, we tested if age and survival, two aspects associated with longevity, are linked to immune parameters in an 8 g bat species. Using a combination of cross-sectional and longitudinal data, we assessed whether total white blood cell (WBC) counts, bacterial killing ability of the plasma (BKA) and immunoglobulin G (IgG) concentration change with age. Furthermore, we asked if these immune parameters impose costs resulting in decreased survival probabilities. We found that WBC counts decreased with age both within and among individuals. IgG concentrations were higher in older individuals, but did not change with age within individuals. Furthermore, individuals with above average WBC counts or IgG concentration had lower probabilities to survive the next six months. High WBC counts and IgG concentrations may reflect infections with parasites and pathogens, however, individuals that were infected with trypanosomes or nematodes showed neither higher WBC counts or IgG concentrations, nor was infection connected with survival rates. BKA was higher in infected compared with uninfected bats, but not related to age or survival. In conclusion, cellular (WBC) and humoral (IgG) parts of the immune system were both connected to age and survival, but not to parasite infections, which supports the hypothesis that energetically costly immunological defences are traded against other costly life-history traits, leading to a reduced lifespan in this free-ranging mammal.	[Schneeberger, Karin; Courtiol, Alexandre; Czirjak, Gabor A.; Voigt, Christian C.] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Schneeberger, Karin; Voigt, Christian C.] Free Univ Berlin, Dept Anim Behav, Berlin, Germany	Leibniz Institut fur Zoo und Wildtierforschung; Free University of Berlin	Schneeberger, K (corresponding author), Leibniz Inst Zoo & Wildlife Res, Berlin, Germany.	schneeberger@izw-berlin.de	Czirják, Gábor Árpád/F-5440-2011; Courtiol, Alexandre/O-3040-2017	Czirják, Gábor Árpád/0000-0001-9488-0069; Courtiol, Alexandre/0000-0003-0637-2959; Schneeberger, Karin/0000-0003-2098-2542	Deutsche Forschungsgemeinschaft (DFG) [Vo 890/25]; Leibniz Institute for Zoo and Wildlife Research	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Leibniz Institute for Zoo and Wildlife Research	Funding was provided by the Deutsche Forschungsgemeinschaft (DFG Vo 890/25) and the Leibniz Institute for Zoo and Wildlife Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LC, 2009, J COMP PHYSIOL B, V179, P315, DOI 10.1007/s00360-008-0315-3; Balomenos D, 2000, IMMUNOL TODAY, V21, P551, DOI 10.1016/S0167-5699(00)01748-5; Belloni V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012940; Bize P, 2014, OECOLOGIA, V174, P1097, DOI 10.1007/s00442-013-2840-3; Blount DG, 2005, VET IMMUNOL IMMUNOP, V108, P399, DOI 10.1016/j.vetimm.2005.06.015; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Bradbury J. W, 1974, Z TIERPSYCHOL, V36, P137, DOI DOI 10.1111/J.1439-0310.1974.TB02130.X; Christe P, 2001, OECOLOGIA, V126, P333, DOI 10.1007/s004420000527; Christe P, 2000, ECOL LETT, V3, P207; Christe P, 2007, J ANIM ECOL, V76, P703, DOI 10.1111/j.1365-2656.2007.01255.x; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Devevey G, 2009, BIOL J LINN SOC, V97, P328, DOI 10.1111/j.1095-8312.2009.01216.x; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Durbin C, 2009, VET CLIN PATH, V38, P157, DOI 10.1111/j.1939-165X.2009.00110.x; Eraud C, 2009, EVOLUTION, V63, P1036, DOI 10.1111/j.1558-5646.2008.00540.x; Fox J., 2014, R COMPANION APPL REG; Franceschi C, 2000, VACCINE, V18, P1717, DOI 10.1016/S0264-410X(99)00513-7; Frasca D, 2005, SEMIN IMMUNOL, V17, P378, DOI 10.1016/j.smim.2005.05.005; Geiger H, 2002, NAT IMMUNOL, V3, P329, DOI 10.1038/ni0402-329; Ginaldi L, 2001, MICROBES INFECT, V3, P851, DOI 10.1016/S1286-4579(01)01443-5; Graham AL, 2010, SCIENCE, V330, P662, DOI 10.1126/science.1194878; Greiner S, 2014, ETHOLOGY, V120, P197, DOI 10.1111/eth.12193; Greiner S, 2011, CAN J ZOOL, V89, P1157, DOI 10.1139/Z11-092; GULLAND FMD, 1992, PARASITOLOGY, V105, P493, DOI 10.1017/S0031182000074679; Hakim FT, 2007, TISSUE ANTIGENS, V70, P179, DOI 10.1111/j.1399-0039.2007.00891.x; Hanssen SA, 2004, P ROY SOC B-BIOL SCI, V271, P925, DOI 10.1098/rspb.2004.2678; Harman D., 1955, AGING THEORY BASED F; Hayward AD, 2011, J EVOLUTION BIOL, V24, P1664, DOI 10.1111/j.1420-9101.2011.02300.x; Hayward AD, 2009, P ROY SOC B-BIOL SCI, V276, P3477, DOI 10.1098/rspb.2009.0906; Kraus C, 2008, P ROY SOC B-BIOL SCI, V275, P1635, DOI 10.1098/rspb.2008.0200; Lee KA, 2006, INTEGR COMP BIOL, V46, P1000, DOI 10.1093/icb/icl049; LEHMANN T, 1993, PARASITOL TODAY, V9, P8, DOI 10.1016/0169-4758(93)90153-7; Linton P-J, 2006, CLIN APPL IMMUNOLOGY, V6, P73; Listi F, 2006, ANN NY ACAD SCI, V1089, P487, DOI 10.1196/annals.1386.013; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Meyer-Lucht Y, 2005, MOL ECOL, V14, P2233, DOI 10.1111/j.1365-294X.2005.02557.x; Monaghan P, 2008, FUNCT ECOL, V22, P371, DOI 10.1111/j.1365-2435.2008.01418.x; Moore MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058976; Moore MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027430; Moore MS, 2011, THESIS BOSTON U; Nagy M, 2007, P ROY SOC B-BIOL SCI, V274, P3019, DOI 10.1098/rspb.2007.1008; Noreen E, 2011, J COMP PHYSIOL B, V181, P649, DOI 10.1007/s00360-011-0553-7; Nussey DH, 2008, FUNCT ECOL, V22, P393, DOI 10.1111/j.1365-2435.2008.01408.x; Nussey DH, 2012, AGING CELL, V11, P178, DOI 10.1111/j.1474-9726.2011.00771.x; Panda A, 2009, TRENDS IMMUNOL, V30, P325, DOI 10.1016/j.it.2009.05.004; Pearce RD, 2008, ACTA CHIROPTEROL, V10, P153, DOI 10.3161/150811008X331171; R Development Core Team, 2005, R LANG ENV STAT COMP; Reth M, 2002, NAT IMMUNOL, V3, P1129, DOI 10.1038/ni1202-1129; Reynolds DS, 2009, J WILDLIFE MANAGE, V73, P1197, DOI 10.2193/2008-151; Ricklefs RE, 2002, TRENDS ECOL EVOL, V17, P462, DOI 10.1016/S0169-5347(02)02578-8; ROSS PS, 1993, J WILDLIFE DIS, V29, P21, DOI 10.7589/0090-3558-29.1.21; Saino N, 1997, P NATL ACAD SCI USA, V94, P549, DOI 10.1073/pnas.94.2.549; Schinnerl M, 2011, J ZOO WILDLIFE MED, V42, P382, DOI 10.1638/2010-0060.1; Schneeberger K, 2013, J EXP BIOL, V216, P4514, DOI 10.1242/jeb.090837; Schneeberger K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054023; Selman C, 2012, TRENDS ECOL EVOL, V27, P570, DOI 10.1016/j.tree.2012.06.006; Speakman JR, 2011, BIOESSAYS, V33, P255, DOI 10.1002/bies.201000132; Stobel K, 2002, INT J MED MICROBIOL, V291, P88; Tieleman BI, 2005, P ROY SOC B-BIOL SCI, V272, P1715, DOI 10.1098/rspb.2005.3155; UTSUYAMA M, 1992, MECH AGEING DEV, V63, P57, DOI 10.1016/0047-6374(92)90016-7; van de Pol M, 2006, AM NAT, V167, P766, DOI 10.1086/503331; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Venables W.N., 2013, MODERN APPL STAT S; Viau M, 2005, CLIN IMMUNOL, V114, P17, DOI 10.1016/j.clim.2004.08.019; Voigt CC, 2001, BEHAV ECOL SOCIOBIOL, V50, P31, DOI 10.1007/s002650100337; Voigt CC, 2008, J MAMMAL, V89, P50, DOI 10.1644/06-MAMM-A-432.1; Voigt CC, 2007, ACTA CHIROPTEROL, V9, P463, DOI 10.3161/1733-5329(2007)9[463:AOFTMA]2.0.CO;2; Wellehan JFX, 2009, COMP IMMUNOL MICROB, V32, P379, DOI 10.1016/j.cimid.2007.11.002; WHITLOCK H. V., 1950, JOUR HELMINTHOL, V24, P47, DOI 10.1017/S0022149X00019106; Wilkinson GS, 2002, AGING CELL, V1, P124, DOI 10.1046/j.1474-9728.2002.00020.x	71	30	31	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e108268	10.1371/journal.pone.0108268	http://dx.doi.org/10.1371/journal.pone.0108268			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254988	Green Published, Green Submitted, gold			2022-12-25	WOS:000344862300067
J	McCoy, CP; O'Neil, EJ; Cowley, JF; Carson, L; De Baroid, AT; Gdowski, GT; Gorman, SP; Jones, DS				McCoy, Colin P.; O'Neil, Edward J.; Cowley, John F.; Carson, Louise; De Baroid, Aine T.; Gdowski, Greg T.; Gorman, Sean P.; Jones, David S.			Photodynamic Antimicrobial Polymers for Infection Control	PLOS ONE			English	Article							SINGLET OXYGEN; RESISTANCE; SUSCEPTIBILITY; PHOTOSENSITIZERS; DISINFECTANTS; INACTIVATION; BIOMATERIALS; PREVENTION; STRATEGIES; BIOFILMS	Hospital-acquired infections pose both a major risk to patient wellbeing and an economic burden on global healthcare systems, with the problem compounded by the emergence of multidrug resistant and biocide tolerant bacterial pathogens. Many inanimate surfaces can act as a reservoir for infection, and adequate disinfection is difficult to achieve and requires direct intervention. In this study we demonstrate the preparation and performance of materials with inherent photodynamic, surface-active, persistent antimicrobial properties through the incorporation of photosensitizers into high density poly(ethylene) (HDPE) using hot-melt extrusion, which require no external intervention except a source of visible light. Our aim is to prevent bacterial adherence to these surfaces and eliminate them as reservoirs of nosocomial pathogens, thus presenting a valuable advance in infection control. A two-layer system with one layer comprising photosensitizer-incorporated HDPE, and one layer comprising HDPE alone is also described to demonstrate the versatility of our approach. The photosensitizer-incorporated materials are capable of reducing the adherence of viable bacteria by up to 3.62 Log colony forming units (CFU) per square centimeter of material surface for methicillin resistant Staphylococcus aureus (MRSA), and by up to 1.51 Log CFU/cm(2) for Escherichia coli. Potential applications for the technology are in antimicrobial coatings for, or materials comprising objects, such as tubing, collection bags, handrails, finger-plates on hospital doors, or medical equipment found in the healthcare setting.	[McCoy, Colin P.; Cowley, John F.; Carson, Louise; De Baroid, Aine T.; Gdowski, Greg T.; Gorman, Sean P.; Jones, David S.] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland; [O'Neil, Edward J.] Syracuse Univ, Ctr Sci & Technol, Blue Highway Inc, Syracuse, NY 13244 USA	Queens University Belfast; Syracuse University	McCoy, CP (corresponding author), Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland.	c.mccoy@qub.ac.uk	McCoy, Colin P/A-6815-2008	McCoy, Colin P/0000-0002-6468-2018; Carson, Louise/0000-0002-2551-7730	Department for Employment and Learning (Northern Ireland); Blue Highway, Inc.; Engineering and Physical Sciences Research Council [1232186] Funding Source: researchfish	Department for Employment and Learning (Northern Ireland); Blue Highway, Inc.; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by funding from the Department for Employment and Learning (Northern Ireland), and Blue Highway, Inc. Blue Highway, Inc. assisted in the study design, data analysis, preparation of the manuscript and decision to publish. The Department of Employment and Learning, Northern Ireland, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardouniotis E, 2001, FEMS MICROBIOL LETT, V203, P263, DOI 10.1111/j.1574-6968.2001.tb10851.x; Block C, 2002, J HOSP INFECT, V51, P201, DOI 10.1053/jhin.2002.1246; Brady C, 2007, J PHYS CHEM B, V111, P527, DOI 10.1021/jp066217i; Craig RA, 2010, J PHARM PHARMACOL, V62, P1359; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Epstein AK, 2011, P NATL ACAD SCI USA, V108, P995, DOI 10.1073/pnas.1011033108; Fulmer PA, 2011, ACS APPL MATER INTER, V3, P2878, DOI 10.1021/am2005465; Alvarez MG, 2012, BIOORGAN MED CHEM, V20, P4032, DOI 10.1016/j.bmc.2012.05.012; Graves N, 2004, EMERG INFECT DIS, V10, P561, DOI 10.3201/eid1004.020754; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hamblin MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI 10.1039/b311900a; Hamblin MR, 2002, J ANTIMICROB CHEMOTH, V49, P941, DOI 10.1093/jac/dkf053; Hamill TM, 2007, EXPERT REV MED DEVIC, V4, P215, DOI 10.1586/17434440.4.2.215; Hancock REW, 2007, NAT REV DRUG DISCOV, V6, P28, DOI 10.1038/nrd2223; Hota B, 2004, CLIN INFECT DIS, V39, P1182, DOI 10.1086/424667; Johnson JR, 2006, ANN INTERN MED, V144, P116, DOI 10.7326/0003-4819-144-2-200601170-00009; KENNEDY JC, 1992, J PHOTOCH PHOTOBIO B, V14, P275, DOI 10.1016/1011-1344(92)85108-7; Knobloch JKM, 2002, J ANTIMICROB CHEMOTH, V49, P683, DOI 10.1093/jac/49.4.683; Krouit M, 2006, BIOORG MED CHEM LETT, V16, P1651, DOI 10.1016/j.bmcl.2005.12.008; Maisch T, 2007, PHOTOCH PHOTOBIO SCI, V6, P545, DOI 10.1039/b614770d; Mathai S, 2007, PHOTOCH PHOTOBIO SCI, V6, P995, DOI 10.1039/b705853e; Mc Cay PH, 2010, MICROBIOL-SGM, V156, P30, DOI 10.1099/mic.0.029751-0; McBain AJ, 2001, INT BIODETER BIODEGR, V47, P55, DOI 10.1016/S0964-8305(01)00037-3; Mccoy CP, 2012, BIOMATERIALS, V33, P7952, DOI 10.1016/j.biomaterials.2012.07.052; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Noguchi N, 1999, FEMS MICROBIOL LETT, V172, P247, DOI 10.1111/j.1574-6968.1999.tb13475.x; O'Hanlon SJ, 2009, INT J ANTIMICROB AG, V33, P427, DOI 10.1016/j.ijantimicag.2008.10.020; Parsons C, 2009, BIOMATERIALS, V30, P597, DOI 10.1016/j.biomaterials.2008.10.015; Pasquier N, 2007, BIOMACROMOLECULES, V8, P2874, DOI 10.1021/bm070353r; Plowman R, 2001, J HOSP INFECT, V47, P198, DOI 10.1053/jhin.2000.0881; Rajamohan G, 2009, J HOSP INFECT, V73, P287, DOI 10.1016/j.jhin.2009.07.015; Ringot C, 2011, BIOMACROMOLECULES, V12, P1716, DOI 10.1021/bm200082d; Russell A.D., 2002, BR J INFECT CONTROL, V3, P22, DOI [10.1177/175717740200300306, DOI 10.1177/175717740200300306]; Ryskova L, 2010, CENT EUR J BIOL, V5, P400, DOI 10.2478/s11535-010-0032-2; Wainwright M, 2004, DRUG FUTURE, V29, P85, DOI 10.1358/dof.2004.029.01.777826; Wainwright M, 1998, J ANTIMICROB CHEMOTH, V42, P13, DOI 10.1093/jac/42.1.13; Wilson BC, 2008, PHYS MED BIOL, V53, pR61, DOI 10.1088/0031-9155/53/9/R01; Yates RR, 1999, CHEST, V115, p24S, DOI 10.1378/chest.115.suppl_1.24S	40	24	24	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108500	10.1371/journal.pone.0108500	http://dx.doi.org/10.1371/journal.pone.0108500			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250740	Green Published, Green Submitted, gold			2022-12-25	WOS:000342492700135
J	Roti, ECR; Ringelstetter, AK; Kropp, J; Abbott, DH; Salih, SM				Roti, Elon C. Roti; Ringelstetter, Ashley K.; Kropp, Jenna; Abbott, David H.; Salih, Sana M.			Bortezomib Prevents Acute Doxorubicin Ovarian Insult and Follicle Demise, Improving the Fertility Window and Pup Birth Weight in Mice	PLOS ONE			English	Article							PROTEASOME INHIBITION; PRIMORDIAL FOLLICLES; DEXRAZOXANE; CANCER; CHEMOTHERAPY; AGENT; GROWTH; WOMEN; CYCLOPHOSPHAMIDE; CARDIOTOXICITY	Increasing numbers of female patients survive cancer, but succumb to primary ovarian insufficiency after chemotherapy. We tested the hypothesis that Bortezomib (Bort) protects ovaries from doxorubicin (DXR) chemotherapy by treating female mice with Bort 1 hour prior to DXR. By preventing DXR accumulation in the ovary, Bort attenuated DXR-induced DNA damage in all ovarian cell types, subsequent gamma H2AFX phosphorylation, and resulting apoptosis in preantral follicles. Bort pretreatment extended the number of litters per mouse, improved litter size and increased pup weight following DXR treatment, thus increasing the duration of post-chemotherapy fertility and improving pup health. As a promising prophylactic ovoprotective agent, Bort does not interfere with cancer treatment, and is currently used as a chemotherapy adjuvant. Bort-based chemoprotection may preserve ovarian function in a non-invasive manner that avoids surgical ovarian preservation, thus diminishing the health complications of premature menopause following cancer treatment.	[Roti, Elon C. Roti; Ringelstetter, Ashley K.; Kropp, Jenna; Abbott, David H.; Salih, Sana M.] Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA; [Roti, Elon C. Roti] Univ Wisconsin, Dept Med, Madison, WI USA; [Abbott, David H.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Kropp, Jenna] Univ Wisconsin, Dept Anim Sci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Roti, ECR (corresponding author), Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA.	rotiroti@wisc.edu; salih@wisc.edu			Wisconsin Alumni Research Foundation; University of Wisconsin Department of Ob/Gyn; NIH [K12 HD0558941]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER	Wisconsin Alumni Research Foundation; University of Wisconsin Department of Ob/Gyn; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Wisconsin Alumni Research Foundation Challenge Grant (ERR), University of Wisconsin Department of Ob/Gyn Start Up and Research and Development funds and NIH training grant K12 HD0558941 (SMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2001, SEMIN ONCOL, V28, P613, DOI 10.1053/sonc.2001.28609; Amato P, 2013, FERTIL STERIL, V100, P1224, DOI 10.1016/j.fertnstert.2013.08.041; Amiri KI, 2004, CANCER RES, V64, P4912, DOI 10.1158/0008-5472.CAN-04-0673; Bar J, 2003, AM J OBSTET GYNECOL, V189, P853, DOI 10.1067/S0002-9378(03)00837-8; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Ben-Aharon I, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-20; Bristol-Gould SK, 2006, DEV BIOL, V298, P149, DOI 10.1016/j.ydbio.2006.06.023; BUSS JL, 1995, ARCH BIOCHEM BIOPHYS, V317, P121, DOI 10.1006/abbi.1995.1143; BUSS JL, 1993, AGENTS ACTIONS, V40, P86, DOI 10.1007/BF01976756; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Della Torre P, 1999, CANCER CHEMOTH PHARM, V43, P151, DOI 10.1007/s002800050876; Della Torre P, 1999, CANCER CHEMOTH PHARM, V44, P138, DOI 10.1007/s002800050958; Eppig JJ, 1996, MOL REPROD DEV, V44, P260, DOI 10.1002/(SICI)1098-2795(199606)44:2&lt;260::AID-MRD17&gt;3.0.CO;2-6; Flaws JA, 1997, BIOL REPROD, V57, P1233, DOI 10.1095/biolreprod57.5.1233; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Green DM, 2009, J CLIN ONCOL, V27, P2374, DOI 10.1200/JCO.2008.21.1839; Hasinoff BB, 1999, ANTI-CANCER DRUG, V10, P47, DOI 10.1097/00001813-199901000-00007; Hasinoff BB, 2003, MOL PHARMACOL, V64, P670, DOI 10.1124/mol.64.3.670; Hasinoff Brian B, 2002, Cardiovasc Toxicol, V2, P111, DOI 10.1385/CT:2:2:111; Hewitt M, 1999, J NATL CANCER I, V91, P1480, DOI 10.1093/jnci/91.17.1480; Huang HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039656; Jeremias I, 1998, BLOOD, V91, P4624, DOI 10.1182/blood.V91.12.4624.412k19_4624_4631; Kerr JB, 2012, REPRODUCTION, V143, P469, DOI 10.1530/REP-11-0430; Kim SY, 2013, CELL DEATH DIFFER, V20, P987, DOI 10.1038/cdd.2013.31; Kiyomiya K, 2001, CANCER RES, V61, P2467; Kiyomiya K, 1998, LIFE SCI, V62, P1853, DOI 10.1016/S0024-3205(98)00151-9; Kujjo LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017877; Li F, 2014, HUM REPROD, V29, P107, DOI 10.1093/humrep/det391; Lyu YL, 2007, CANCER RES, V67, P8839, DOI 10.1158/0008-5472.CAN-07-1649; Nederlof PM, 1995, P NATL ACAD SCI USA, V92, P12060, DOI 10.1073/pnas.92.26.12060; Oktay K, 2006, J CLIN ONCOL, V24, P4044, DOI 10.1200/JCO.2006.06.9823; Oktay K, 2009, PEDIATR BLOOD CANCER, V53, P267, DOI 10.1002/pbc.22003; PEDERSEN T, 1970, J REPROD FERTIL, V21, P81, DOI 10.1530/jrf.0.0210081; Roness H, 2013, HUM REPROD, V28, P46; Roti ECR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042293; Roti ECR, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097030; Smith MA, 1998, J NATL CANCER I, V90, P1269, DOI 10.1093/jnci/90.17.1269; Society AC, 2011, CANC FACTS FIG 2011; Swift LM, 2000, AM J PHYSIOL-HEART C, V278, pH982, DOI 10.1152/ajpheart.2000.278.3.H982; Ting AY, 2010, J ASSIST REPROD GEN, V27, P591, DOI 10.1007/s10815-010-9463-y; Urruticoechea A, 2008, BREAST CANCER RES TR, V110, P411, DOI 10.1007/s10549-007-9745-y; Woodruff TK, 2010, NAT REV CLIN ONCOL, V7, P466, DOI 10.1038/nrclinonc.2010.81; Zelinski MB, 2011, FERTIL STERIL, V95, P1440, DOI 10.1016/j.fertnstert.2011.01.012; Zheng WJ, 2014, HUM MOL GENET, V23, P920, DOI 10.1093/hmg/ddt486	44	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108174	10.1371/journal.pone.0108174	http://dx.doi.org/10.1371/journal.pone.0108174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251158	gold, Green Published, Green Submitted			2022-12-25	WOS:000342492700089
J	Wu, CQ; Yang, M; Li, J; Wang, CB; Cao, T; Tao, KX; Wang, BL				Wu, Chuanqing; Yang, Mei; Li, Juan; Wang, Chengbing; Cao, Ting; Tao, Kaixiong; Wang, Baolin			Talpid3-Binding Centrosomal Protein Cep120 Is Required for Centriole Duplication and Proliferation of Cerebellar Granule Neuron Progenitors	PLOS ONE			English	Article							SONIC HEDGEHOG; PRIMARY CILIUM; MOUSE CEREBELLUM; NERVOUS-SYSTEM; EXPANSION; GENE; POOL; HYDROCEPHALUS; ELONGATION; PRECURSORS	Granule neuron progenitors (GNPs) are the most abundant neuronal type in the cerebellum. GNP proliferation and thus cerebellar development require Sonic hedgehog (Shh) secreted from Purkinje cells. Shh signaling occurs in primary cilia originating from the mother centriole. Centrioles replicate only once during a typical cell cycle and are responsible for mitotic spindle assembly and organization. Recent studies have linked cilia function to cerebellar morphogenesis, but the role of centriole duplication in cerebellar development is not known. Here we show that centrosomal protein Cep120 is asymmetrically localized to the daughter centriole through its interaction with Talpid3 (Ta3), another centrosomal protein. Cep120 null mutant mice die in early gestation with abnormal heart looping. Inactivation of Cep120 in the central nervous system leads to both hydrocephalus, due to the loss of cilia on ependymal cells, and severe cerebellar hypoplasia, due to the failed proliferation of GNPs. The mutant GNPs lack Hedgehog pathway activity. Cell biological studies show that the loss of Cep120 results in failed centriole duplication and consequently ciliogenesis, which together underlie Cep120 mutant cerebellar hypoplasia. Thus, our study for the first time links a centrosomal protein necessary for centriole duplication to cerebellar morphogenesis.	[Wu, Chuanqing; Tao, Kaixiong] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Gen Surg, Wuhan 430074, Hubei, Peoples R China; [Wu, Chuanqing; Yang, Mei; Li, Juan; Wang, Chengbing; Cao, Ting; Wang, Baolin] Cornell Univ, Weill Med Coll, Dept Med Genet, New York, NY 10021 USA; [Wang, Baolin] Cornell Univ, Weill Med Coll, Dept Cell Biol & Dev, New York, NY 10021 USA; [Yang, Mei] Chongqing Med Univ, Inst Neurosci, Dept Human Anat, Chongqing, Peoples R China; [Li, Juan] Shandong Univ, Coll Life Sci, Inst Dev Immunol, Jinan, Shandong, Peoples R China; [Cao, Ting] Nanjing Univ, Inst Life Sci, Nanjing 210008, Jiangsu, Peoples R China	Huazhong University of Science & Technology; Cornell University; Cornell University; Chongqing Medical University; Shandong University; Nanjing University	Tao, KX (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Gen Surg, Wuhan 430074, Hubei, Peoples R China.	tao_kaixiong@163.com; baw2001@med.cornell.edu			National Institutes of Health [R01CA111673, R01GM070820]; CNSF [81172294]; NATIONAL CANCER INSTITUTE [R01CA111673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNSF(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding from National Institutes of Health grants (R01CA111673 and R01GM070820) to BW and a CNSF grant 81172294 to KXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1996, DEV CEREBELLAR SYSTE; Banizs B, 2005, DEVELOPMENT, V132, P5329, DOI 10.1242/dev.02153; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Chizhikov V, 2003, MOL GENET METAB, V80, P54, DOI 10.1016/j.ymgme.2003.08.019; Chizhikov VV, 2007, J NEUROSCI, V27, P9780, DOI 10.1523/JNEUROSCI.5586-06.2007; Comartin D, 2013, CURR BIOL, V23, P1360, DOI 10.1016/j.cub.2013.06.002; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Davey MG, 2006, GENE DEV, V20, P1365, DOI 10.1101/gad.369106; DELCERRO MP, 1972, J COMP NEUROL, V144, P131, DOI 10.1002/cne.901440202; DELCERRO MP, 1969, ANAT RECORD, V165, P127, DOI 10.1002/ar.1091650202; Dubois NC, 2006, GENESIS, V44, P355, DOI 10.1002/dvg.20226; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Han LZ, 2012, J BIOL CHEM, V287, P20483, DOI 10.1074/jbc.M112.359299; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Ishikawa H, 2005, NAT CELL BIOL, V7, P517, DOI 10.1038/ncb1251; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Kobayashi T, 2011, J CELL BIOL, V193, P435, DOI 10.1083/jcb.201101005; Lewis PM, 2004, DEV BIOL, V270, P393, DOI 10.1016/j.ydbio.2004.03.007; Lin YN, 2013, J CELL BIOL, V202, P211, DOI 10.1083/jcb.201212060; Mahjoub MR, 2010, J CELL BIOL, V191, P331, DOI 10.1083/jcb.201003009; Martinez S, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00018; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Noatynska A, 2012, J CELL BIOL, V199, P1025, DOI 10.1083/jcb.201209015; Silverman MA, 2009, TRENDS CELL BIOL, V19, P306, DOI 10.1016/j.tcb.2009.04.002; Spassky N, 2008, DEV BIOL, V317, P246, DOI 10.1016/j.ydbio.2008.02.026; Tasouri E, 2013, PRIMARY CILIA BRAIN; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Wang CB, 2013, J BIOL CHEM, V288, P29518, DOI 10.1074/jbc.M113.492066; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; WELLER RO, 1992, BRAIN PATHOL, V2, P277, DOI 10.1111/j.1750-3639.1992.tb00704.x; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026; Yin YL, 2009, DEVELOPMENT, V136, P655, DOI 10.1242/dev.028464	38	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107943	10.1371/journal.pone.0107943	http://dx.doi.org/10.1371/journal.pone.0107943			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251415	Green Submitted, gold, Green Published			2022-12-25	WOS:000342492700061
J	Chou, CW; Zhuo, YL; Jiang, ZY; Liu, YW				Chou, Chih-Wei; Zhuo, You-Lin; Jiang, Zhe-Yu; Liu, Yi-Wen			The Hemodynamically-Regulated Vascular Microenvironment Promotes Migration of the Steroidogenic Tissue during Its Interaction with Chromaffin Cells in the Zebrafish Embryo	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; INTERRENAL ORGAN; DIGESTIVE-SYSTEM; ADRENAL-CORTEX; MATRIX; EXPRESSION; MORPHOGENESIS; STRESS; IMPACT; FORCES	Background: While the endothelium-organ interaction is critical for regulating cellular behaviors during development and disease, the role of blood flow in these processes is only partially understood. The dorsal aorta performs paracrine functions for the timely migration and differentiation of the sympatho-adrenal system. However, it is unclear how the adrenal cortex and medulla achieve and maintain specific integration and whether hemodynamic forces play a role. Methodology and Principal Findings: In this study, the possible modulation of steroidogenic and chromaffin cell integration by blood flow was investigated in the teleostean counterpart of the adrenal gland, the interrenal gland, in the zebrafish (Danio rerio). Steroidogenic tissue migration and angiogenesis were suppressed by genetic or pharmacologic inhibition of blood flow, and enhanced by acceleration of blood flow upon norepinephrine treatment. Repressed steroidogenic tissue migration and angiogenesis due to flow deficiency were recoverable following restoration of flow. The regulation of interrenal morphogenesis by blood flow was found to be mediated through the vascular microenvironment and the Fibronectin-phosphorylated Focal Adhesion Kinase (Fn-pFak) signaling. Moreover, the knockdown of kruppel-like factor 2a (klf2a) or matrix metalloproteinase 2 (mmp2), two genes regulated by the hemodynamic force, phenocopied the defects in migration, angiogenesis, the vascular microenvironment, and pFak signaling of the steroidogenic tissue observed in flow-deficient embryos, indicating a direct requirement of mechanotransduction in these processes. Interestingly, epithelial-type steroidogenic cells assumed a mesenchymal-like character and downregulated beta-Catenin at cell-cell junctions during interaction with chromaffin cells, which was reversed by inhibiting blood flow or Fn-pFak signaling. Blood flow obstruction also affected the migration of chromaffin cells, but not through mechanosensitive or Fn-pFak dependent mechanisms. Conclusions and Significance: These results demonstrate that hemodynamically regulated Fn-pFak signaling promotes the migration of steroidogenic cells, ensuring their interaction with chromaffin cells along both sides of the midline during interrenal gland development.	[Chou, Chih-Wei; Zhuo, You-Lin; Jiang, Zhe-Yu; Liu, Yi-Wen] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan	Tunghai University	Liu, YW (corresponding author), Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan.	dlslys@thu.edu.tw		Liu, Yi-Wen/0000-0003-0455-1013	Ministry of Science and Technology [101-2313-B-029-001, 102-2628-B-029-002-MY3, 102-2321-B-400-018]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	CWC, YLZ, ZYJ, and YWL were supported by Ministry of Science and Technology (http://web1.most.gov.tw/) grants (101-2313-B-029-001, 102-2628-B-029-002-MY3 and 102-2321-B-400-018). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Alsop D, 2009, COMP BIOCHEM PHYS A, V153, P49, DOI 10.1016/j.cbpa.2008.12.008; Alt B, 2006, DEVELOPMENT, V133, P3797, DOI 10.1242/dev.02550; Banjo T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2978; Bartman T, 2004, PLOS BIOL, V2, P673, DOI 10.1371/journal.pbio.0020129; Bernard P, 2008, BIOL CELL, V100, P167, DOI 10.1042/BC20070072; Bollig F, 2009, DEVELOPMENT, V136, P2883, DOI 10.1242/dev.031773; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chai C, 2003, DEV BIOL, V260, P226, DOI 10.1016/S0012-1606(03)00219-7; Chiu CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043040; Chou CW, 2013, DEV DYNAM, V242, P432, DOI 10.1002/dvdy.23932; Chou CW, 2010, DEV DYNAM, V239, P1995, DOI 10.1002/dvdy.22335; Corti P, 2011, DEVELOPMENT, V138, P1573, DOI 10.1242/dev.060467; Culver JC, 2010, MICROCIRCULATION, V17, P164, DOI 10.1111/j.1549-8719.2010.00025.x; Cummins PM, 2007, AM J PHYSIOL-HEART C, V292, pH28, DOI 10.1152/ajpheart.00304.2006; Dekker RJ, 2005, AM J PATHOL, V167, P609, DOI 10.1016/S0002-9440(10)63002-7; Detry B, 2012, BLOOD, V119, P5048, DOI 10.1182/blood-2011-12-400267; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Field HA, 2003, DEV BIOL, V261, P197, DOI 10.1016/S0012-1606(03)00308-7; Granados-Riveron JT, 2012, CIRC-CARDIOVASC GENE, V5, P132, DOI 10.1161/CIRCGENETICS.111.961086; Gut P, 2005, DEVELOPMENT, V132, P4611, DOI 10.1242/dev.02052; Heikkila M, 2002, ENDOCRINOLOGY, V143, P4358, DOI 10.1210/en.2002-220275; Honjo Y, 2005, DEVELOPMENT, V132, P4461, DOI 10.1242/dev.02026; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Hsu HJ, 2006, NATURE, V439, P480, DOI 10.1038/nature04436; Hsu HJ, 2003, DEVELOPMENT, V130, P2107, DOI 10.1242/dev.00427; Huber K, 2006, DEV BIOL, V298, P335, DOI 10.1016/j.ydbio.2006.07.010; Jeays-Ward K, 2003, DEVELOPMENT, V130, P3663, DOI 10.1242/dev.00591; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Kasemeier-Kulesa JC, 2010, J NEUROSCI, V30, P13078, DOI 10.1523/JNEUROSCI.0892-10.2010; Kenny HA, 2008, J CLIN INVEST, V118, P1367, DOI 10.1172/JCI33775; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Koshida S, 2005, DEV CELL, V8, P587, DOI 10.1016/j.devcel.2005.03.006; Kovacic JC, 2012, CIRCULATION, V125, P1795, DOI 10.1161/CIRCULATIONAHA.111.040352; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; Liu YW, 2006, DEV BIOL, V297, P44, DOI 10.1016/j.ydbio.2006.04.464; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Miano JM, 2006, ZEBRAFISH, V3, P455, DOI 10.1089/zeb.2006.3.455; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Opitz R, 2012, DEV BIOL, V372, P203, DOI 10.1016/j.ydbio.2012.09.011; Packham IM, 2009, PHYSIOL GENOMICS, V38, P319, DOI 10.1152/physiolgenomics.00049.2009; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Park J, 2013, ONCOGENE, DOI [10.1038/onc.2013.1118, DOI 10.1038/ONC.2013.1118]; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Pelster B, 1996, CIRC RES, V79, P358, DOI 10.1161/01.RES.79.2.358; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; Quek SI, 2009, MOL CHARACTERIZATION; Saito D, 2012, SCIENCE, V336, P1578, DOI 10.1126/science.1222369; Santoro MM, 2009, MECH DEVELOP, V126, P638, DOI 10.1016/j.mod.2009.06.1080; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Serluca FC, 2002, CURR BIOL, V12, P492, DOI 10.1016/S0960-9822(02)00694-2; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Singhal PC, 1996, CONNECT TISSUE RES, V33, P257, DOI 10.3109/03008209609028883; Snow CJ, 2008, DEV DYNAM, V237, P2542, DOI 10.1002/dvdy.21670; Sun XJ, 2014, CARCINOGENESIS, V35, P184, DOI 10.1093/carcin/bgt276; Sweeney NV, 2004, CARDIOVASC RES, V63, P625, DOI 10.1016/j.cardiores.2004.05.008; To TT, 2007, MOL ENDOCRINOL, V21, P472, DOI 10.1210/me.2006-0216; Trinh LA, 2004, DEV CELL, V6, P371; Vasilyev A, 2009, PLOS BIOL, V7, P101, DOI 10.1371/journal.pbio.1000009; Vermot J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000246; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Wang L, 2011, BLOOD, V118, P4102, DOI 10.1182/blood-2011-05-353235; Watson O, 2013, CARDIOVASC RES, V100, P252, DOI 10.1093/cvr/cvt170; Weng JH, 2013, NAT CHEM BIOL, V9, P636, DOI [10.1038/NCHEMBIO.1321, 10.1038/nchembio.1321]; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Xu JS, 2001, J CELL BIOL, V154, P1069, DOI 10.1083/jcb.200103111; Yasuda T, 1996, J CLIN INVEST, V98, P1991, DOI 10.1172/JCI119003; Zubair M, 2009, MOL ENDOCRINOL, V23, P1657, DOI 10.1210/me.2009-0055	74	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107997	10.1371/journal.pone.0107997	http://dx.doi.org/10.1371/journal.pone.0107997			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25248158	Green Published, Green Submitted, gold			2022-12-25	WOS:000342351800050
J	Ravetti, MG; Carpi, LC; Goncalves, BA; Frery, AC; Rosso, OA				Gomez Ravetti, Martin; Carpi, Laura C.; Goncalves, Bruna Amin; Frery, Alejandro C.; Rosso, Osvaldo A.			Distinguishing Noise from Chaos: Objective versus Subjective Criteria Using Horizontal Visibility Graph	PLOS ONE			English	Article							TIME-SERIES; COMPLEXITY; NETWORKS; DETERMINISM; ENTROPIES; PATTERNS; SIGNALS	A recently proposed methodology called the Horizontal Visibility Graph (HVG) [Luque et al., Phys. Rev. E., 80, 046103 (2009)] that constitutes a geometrical simplification of the well known Visibility Graph algorithm [Lacasa et al., Proc. Natl. Sci. U.S.A. 105, 4972 (2008)], has been used to study the distinction between deterministic and stochastic components in time series [L. Lacasa and R. Toral, Phys. Rev. E., 82, 036120 (2010)]. Specifically, the authors propose that the node degree distribution of these processes follows an exponential functional of the form P(kappa)similar to exp(-lambda kappa), in which kappa is the node degree and lambda is a positive parameter able to distinguish between deterministic (chaotic) and stochastic (uncorrelated and correlated) dynamics. In this work, we investigate the characteristics of the node degree distributions constructed by using HVG, for time series corresponding to 28 chaotic maps, 2 chaotic flows and 3 different stochastic processes. We thoroughly study the methodology proposed by Lacasa and Toral finding several cases for which their hypothesis is not valid. We propose a methodology that uses the HVG together with Information Theory quantifiers. An extensive and careful analysis of the node degree distributions obtained by applying HVG allow us to conclude that the Fisher-Shannon information plane is a remarkable tool able to graphically represent the different nature, deterministic or stochastic, of the systems under study.	[Gomez Ravetti, Martin; Goncalves, Bruna Amin] Univ Fed Minas Gerais, Dept Prod Engn, Belo Horizonte, MG, Brazil; [Carpi, Laura C.; Frery, Alejandro C.] Univ Fed Alagoas, LaCCAN, Maceio, Alagoas, Brazil; [Rosso, Osvaldo A.] Univ Fed Alagoas, Inst Fis, Maceio, Alagoas, Brazil; [Rosso, Osvaldo A.] ITBA, Buenos Aires, DF, Argentina; [Gomez Ravetti, Martin] Univ Barcelona, Dept Fis Fonamental, Barcelona, Spain; [Goncalves, Bruna Amin] UNA, Ctr Univ, Inst Politecn, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Alagoas; Universidade Federal de Alagoas; University of Barcelona; Centro Universitario de Belo Horizonte; Centro Universitario UNA	Ravetti, MG (corresponding author), Univ Fed Minas Gerais, Dept Prod Engn, Belo Horizonte, MG, Brazil.	martin.ravetti@dep.ufmg.br	Carpi, Laura/F-6970-2015; Frery, Alejandro C./A-8855-2008; Ravetti, Martin/K-1108-2012; Rosso, Osvaldo/O-4929-2019	Carpi, Laura/0000-0003-0344-4486; Frery, Alejandro C./0000-0002-8002-5341; Ravetti, Martin/0000-0001-7781-0034; Rosso, Osvaldo/0000-0002-1288-2528	CNPq; FAPEMIG, Brazil; CNPq, Brazil; Consejo Nacional de Investigaciones Cientcas y Tecnicas (CONICET), Argentina; FAPEAL, Brazil; CAPES; UNA, Brazil	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG, Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Consejo Nacional de Investigaciones Cientcas y Tecnicas (CONICET), Argentina; FAPEAL, Brazil(Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); UNA, Brazil	M.G.R. acknowledges support from CNPq and FAPEMIG, Brazil. L.C.C. acknowledges support from CNPq, Brazil. O.A.R. acknowledges support from Consejo Nacional de Investigaciones Cientcas y Tecnicas (CONICET), Argentina, and FAPEAL, Brazil. B. Amin Goncalves acknowledges support from CAPES and UNA, Brazil. A.C.F. acknowledges support from CNPq and FAPEAL, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanel H.D.I., 1996, ANAL OBSERVED CHAOTI; Abry P, 1996, APPL COMPUT HARMON A, V3, P377, DOI 10.1006/acha.1996.0030; Amigo JM, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/60005; Amigo JM, 2007, EPL-EUROPHYS LETT, V79, DOI 10.1209/0295-5075/79/50001; Amigo JM, 2006, PHYS LETT A, V355, P27, DOI 10.1016/j.physleta.2006.01.093; Amigo JM, 2010, SPRINGER SER SYNERG, P1, DOI 10.1007/978-3-642-04084-9; Arnold, 1965, AMS TRANSLATIONS, V46, P213, DOI 10.1090/trans2/046/11; Arnold V.I., 1968, ERGODIC PROBLEMS CLA, V9; ARONSON DG, 1982, COMMUN MATH PHYS, V83, P303, DOI 10.1007/BF01213607; Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; Bardet JM, 2003, GENERATORS LONG RANG, P579; Beck C., 1995, THERMODYNAMICS CHAOT; BEDDINGTON JR, 1975, NATURE, V255, P58, DOI 10.1038/255058a0; Bohner M., 2009, P 14 INT C DIFF EQ A, P291; Brys G, 2006, COMPUT STAT DATA AN, V50, P733, DOI 10.1016/j.csda.2004.09.012; CAMBANIS S, 1988, PROBAB THEORY REL, V79, P1, DOI 10.1007/BF00319099; Campanharo ASLO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023378; Carpi LC, 2010, PHYSICA A, V389, P2020, DOI 10.1016/j.physa.2010.01.030; Cencini M, 2000, PHYS REV E, V62, P427, DOI 10.1103/PhysRevE.62.427; CHERNIKOV AA, 1988, PHYS TODAY, V41, P27, DOI 10.1063/1.881159; CHIRIKOV BV, 1979, PHYS REP, V52, P263, DOI 10.1016/0370-1573(79)90023-1; De Micco L, 2012, PHYSICA A, V391, P2564, DOI 10.1016/j.physa.2011.12.042; Devaney R., 1989, INTRO CHAOTIC DYNAMI; DEVANEY RL, 1984, PHYSICA D, V10, P387, DOI 10.1016/0167-2789(84)90187-8; Fisher R.A., 1922, PHILOS T ROYAL SOC A, V222, P309, DOI [10.1098/rsta.1922.0009, DOI 10.1098/RSTA.1922.0009]; FRIEDEN BR, 2004, SCI FISHER INFORM UN; Gao ZK, 2013, EPL-EUROPHYS LETT, V103, DOI 10.1209/0295-5075/103/50004; Gao ZK, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032910; GRASSBERGER P, 1983, PHYS REV LETT, V50, P346, DOI 10.1103/PhysRevLett.50.346; HENON M, 1969, Q APPL MATH, V27, P291, DOI 10.1090/qam/253513; HENON M, 1976, COMMUN MATH PHYS, V50, P69, DOI 10.1007/BF01608556; HOLMES P, 1979, PHILOS T R SOC A, V292, P419, DOI 10.1098/rsta.1979.0068; IKEDA K, 1979, OPT COMMUN, V30, P257, DOI 10.1016/0030-4018(79)90090-7; Kantz H, 2000, PHYSICA A, V280, P34, DOI 10.1016/S0378-4371(99)00616-0; KAPLAN DT, 1993, PHYSICA D, V64, P431, DOI 10.1016/0167-2789(93)90054-5; KAPLAN DT, 1992, PHYS REV LETT, V68, P427, DOI 10.1103/PhysRevLett.68.427; Knuth Donald Ervin, 1997, ART COMPUTER PROGRAM, V3; KOLMOGOROV AN, 1958, DOKL AKAD NAUK SSSR+, V119, P861; KURTHS J, 1987, PHYSICA D, V25, P165, DOI 10.1016/0167-2789(87)90099-6; Lacasa L, 2008, P NATL ACAD SCI USA, V105, P4972, DOI 10.1073/pnas.0709247105; Lacasa L, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036120; Larrondo H. A., 2012, MATLAB PROGRAM NOISE; Lorenz E N, 1993, ESSENCE CHAOS; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; Lozi R., 1978, J PHYS PARIS, V39, P9, DOI DOI 10.1051/JPHYSC0L:1978505; Luque B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046103; Luque B, 2012, CHAOS, V22, DOI 10.1063/1.3676686; Luque B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022411; Madiman M, 2007, 2007 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY PROCEEDINGS, VOLS 1-7, P976, DOI 10.1109/ISIT.2007.4557115; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; Nusse H.E., 1994, DYNAMICS NUMERICAL E, V2nd ed.; Olivares F, 2012, PHYS LETT A, V376, P1577, DOI 10.1016/j.physleta.2012.03.039; Olivares F, 2012, PHYSICA A, V391, P2518, DOI 10.1016/j.physa.2011.12.033; OSBORNE AR, 1989, PHYSICA D, V35, P357, DOI 10.1016/0167-2789(89)90075-4; PARDO L, 1994, KYBERNETIKA, V30, P445; Potapov A, 2000, PHYS LETT A, V277, P310, DOI 10.1016/S0375-9601(00)00726-X; Press W., 1992, NUMERICAL RECIPES FO; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; ROSENSTEIN MT, 1994, PHYSICA D, V73, P82, DOI 10.1016/0167-2789(94)90226-7; ROSSLER OE, 1976, PHYS LETT A, V57, P397, DOI 10.1016/0375-9601(76)90101-8; Rosso OA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.154102; Rosso OA, 2013, EUR PHYS J B, V86, DOI [10.1140/epjb/e2013-30764-5, 10.1140/epjb/e2012-30307-8]; Rosso OA, 2012, PHYSICA A, V391, P42, DOI 10.1016/j.physa.2011.07.030; SCHMIDT G, 1985, PHYS REV A, V32, P2994, DOI 10.1103/PhysRevA.32.2994; SCHUSTER HG, 1988, DETERMINISTIC CHAOS; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHAW R, 1981, Z NATURFORSCH A, V36, P80; SINAI I, 1959, DOKL AKAD NAUK SSSR+, V124, P768; Sinai Ya.G., 1972, USPEKHI MAT NAUK, V27, P21, DOI [DOI 10.1070/RM1972V027N04ABEH001383, 10.1070/RM1972v027n04ABEH001383]; Sprott JC, 2012, COMPLEX SYSTEMS, V21, P193; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Strogratz SH, 2000, NONLINEAR DYNAMICS C; SUGIHARA G, 1990, NATURE, V344, P734, DOI 10.1038/344734a0; van Wyk MA, 1997, CHAOS ELECT; Vignat C, 2003, PHYS LETT A, V312, P27, DOI 10.1016/S0375-9601(03)00570-X; WHITEHEAD RR, 1984, PHYSICA D, V13, P401, DOI 10.1016/0167-2789(84)90141-6; Wold H., 1938, STUDY ANAL STATIONAR; Xie W, 2013, PHYSICA A, V390, P3592; Xu XK, 2008, P NATL ACAD SCI USA, V105, P19601, DOI 10.1073/pnas.0806082105; Zanin M, 2012, ENTROPY-SWITZ, V14, P1553, DOI 10.3390/e14081553; Zeng W, 1985, CHINESE PHYS LETT, V2, P293; Zhang J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238701; Zhang J, 2008, PHYSICA D, V237, P2856, DOI 10.1016/j.physd.2008.05.008; ZOGRAFOS K, 1986, CAN J STAT, V14, P355, DOI 10.2307/3315194; Zunino L, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021115; Zunino L, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.046210	88	56	56	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108004	10.1371/journal.pone.0108004	http://dx.doi.org/10.1371/journal.pone.0108004			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247303	Green Published, gold, Green Submitted			2022-12-25	WOS:000342351800051
J	Liu, SL; Li, ZY; Fu, J; Sun, L; Xu, FY; Harada, T; Lou, Y; Chu, M; Sun, Q; Xu, K; Zhang, R; Jin, LH; Xiao, H; Wu, SL				Liu, Shengliang; Li, Zhuying; Fu, Jin; Sun, Liang; Xu, Fengyan; Harada, Toshihide; Lou, Yu; Chu, Ming; Sun, Qi; Xu, Kun; Zhang, Rui; Jin, Lianhong; Xiao, Hui; Wu, Shuliang			The Effects of Harvesting Media on Biological Characteristics and Repair Potential of Neural Stem Cells after Traumatic Brain Injury	PLOS ONE			English	Article							FAS-INDUCED APOPTOSIS; SPINAL-CORD; MULTIPLE MECHANISMS; IN-VITRO; KAPPA-B; DIFFERENTIATION; TRANSPLANTATION; RECOVERY; SURVIVAL; GROWTH	Various solutions are utilized widely for the isolation, harvesting, sorting, testing and transplantation of neural stem cells (NSCs), whereas the effects of harvesting media on the biological characteristics and repair potential of NSCs remain unclear. To examine some of these effects, NSCs were isolated from cortex of E14.5 mice and exposed to the conventional harvesting media [0.9% saline (Saline), phosphate-buffered saline (PBS) or artificial cerebrospinal fluid (ACSF)] or the proliferation culture medium (PCM) for different durations at 4 degrees C. Treated NSCs were grafted by in situ injection into the lesion sites of traumatic brain injury (TBI) mice. In vitro, harvesting media-exposed NSCs displayed time-dependent reduction of viability and proliferation. S phase entry decreased in harvesting media-exposed cells, which was associated with upregulation of p53 protein and downregulation of cyclin E1 protein. Moreover, harvesting media exposure induced the necrosis and apoptosis of NSCs. The levels of Fas-L, cleaved caspase 3 and 8 were increased, which suggests that the death receptor signaling pathway is involved in the apoptosis of NSCs. In addition, exposure to Saline did not facilitate the neuronal differentiation of NSCs, suggesting that Saline exposure may be disadvantageous for neurogenesis. In vivo, NSC-mediated functional recovery in harvesting media-exposed NSC groups was notably attenuated in comparison with the PCM-exposed NSC group. In conclusion, harvesting media exposure modulates the biological characteristics and repair potential of NSCs after TBI. Our results suggest that insight of the effects of harvesting media exposure on NSCs is critical for developing strategies to assure the successful long-term engraftment of NSCs.	[Liu, Shengliang; Sun, Liang; Xu, Fengyan; Sun, Qi; Jin, Lianhong; Wu, Shuliang] Harbin Med Univ, Sch Basic Med Sci, Dept Anat, Harbin, Heilongjiang, Peoples R China; [Li, Zhuying] Heilongjiang Univ Chinese Med, Affiliated Hosp 1, Harbin, Heilongjiang, Peoples R China; [Fu, Jin; Xiao, Hui] Harbin Med Univ, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China; [Harada, Toshihide] Prefectural Univ Hiroshima, Hiroshima, Japan; [Lou, Yu; Chu, Ming; Xu, Kun] Harbin Med Univ, Affiliated Hosp 1, Harbin, Heilongjiang, Peoples R China; [Zhang, Rui] Heilongjiang Univ Chinese Med, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Heilongjiang University of Chinese Medicine; Harbin Medical University; Harbin Medical University; Heilongjiang University of Chinese Medicine	Jin, LH (corresponding author), Harbin Med Univ, Sch Basic Med Sci, Dept Anat, Harbin, Heilongjiang, Peoples R China.	wstjlh@126.com; ybbxuz2001@163.com; wushuliang@ems.hrbmu.edu.cn			National Natural Science Foundation of China [81073162]; Science Foundation for the Returned Overseas Students for Heilongjiang Province [Lc201016]; Heilongjiang Province Office of Education [11551181]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation for the Returned Overseas Students for Heilongjiang Province(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Heilongjiang Province Office of Education	This work was supported by the grants from the National Natural Science Foundation of China (81073162; to S. W.), the Science Foundation for the Returned Overseas Students for Heilongjiang Province (Lc201016; to S. W.) and the Heilongjiang Province Office of Education (11551181; to S. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacigaluppi M, 2009, BRAIN, V132, P2239, DOI 10.1093/brain/awp174; Benner EJ, 2013, NATURE, V497, P369, DOI 10.1038/nature12069; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Buzanska L, 2009, STEM CELLS, V27, P2591, DOI 10.1002/stem.179; Center for Biologics Evaluation and Research Food and Drug Administration, 1998, HUM GENE THER, V9, P1513; Cheema ZF, 1999, J NEUROSCI, V19, P1754; Chi SL, 2006, CANCER RES, V66, P875, DOI 10.1158/0008-5472.CAN-05-2806; Corti S, 2007, BRAIN, V130, P1289, DOI 10.1093/brain/awm043; Cui YF, 2010, BRAIN, V133, P189, DOI 10.1093/brain/awp290; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Davie E, 2012, CURR OPIN CELL BIOL, V24, P838, DOI 10.1016/j.ceb.2012.08.003; Dolezalova D, 2012, STEM CELLS, V30, P1362, DOI 10.1002/stem.1108; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Dunn-Thomas TE, 2008, STEM CELLS DEV, V17, P119, DOI 10.1089/scd.2007.0051; Gibson S, 1999, J BIOL CHEM, V274, P17612, DOI 10.1074/jbc.274.25.17612; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Heldring N, 2012, CNS NEUROL DISORD-DR, V11, P884, DOI 10.2174/1871527311201070884; Hetman M, 2012, PLOS ONE, V7; Huang HY, 2012, STEM CELLS, V30, P2760, DOI 10.1002/stem.1226; Huang J, 2010, CIRC RES, V106, P1753, DOI 10.1161/CIRCRESAHA.109.196030; Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kennea NL, 2005, CELL DEATH DIFFER, V12, P1439, DOI 10.1038/sj.cdd.4401641; Kim SJ, 2004, STEM CELLS, V22, P950, DOI 10.1634/stemcells.22-6-950; Korta DZ, 2012, DEVELOPMENT, V139, P859, DOI 10.1242/dev.074047; Lee IH, 2012, SCIENCE, V336, P225, DOI 10.1126/science.1218395; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Leone DP, 2005, J CELL SCI, V118, P2589, DOI 10.1242/jcs.02396; Li XW, 2012, ACTA BIOMATER, V8, P2087, DOI 10.1016/j.actbio.2012.02.008; Magrassi Lorenzo, 2002, Methods Mol Biol, V198, P327; Meurette O, 2007, CANCER RES, V67, P218, DOI 10.1158/0008-5472.CAN-06-1610; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Moyse E, 2008, CURR STEM CELL RES T, V3, P163, DOI 10.2174/157488808785740334; Nat R, 2001, J CELL MOL MED, V5, P417, DOI 10.1111/j.1582-4934.2001.tb00177.x; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Okano H, 2003, SEMIN CELL DEV BIOL, V14, P191, DOI 10.1016/S1084-9521(03)00011-9; Omerovic J, 2012, J PROTEOME RES, V11, P5157, DOI 10.1021/pr3007304; Opitz T, 2007, NAT PROTOC, V2, P1603, DOI 10.1038/nprot.2007.230; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Ramasamy S, 2013, ARCH BIOCHEM BIOPHYS, V534, P71, DOI 10.1016/j.abb.2013.02.004; Reekmans K, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt147; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rytter A, 2003, J CEREBR BLOOD F MET, V23, P23, DOI 10.1097/01.WCB.0000034361.37277.1B; Skardelly M, 2011, J NEUROTRAUM, V28, P401, DOI 10.1089/neu.2010.1526; SORKIN A, 1993, SCIENCE, V261, P612, DOI 10.1126/science.8342026; Sorkina T, 2002, J BIOL CHEM, V277, P27433, DOI 10.1074/jbc.M201595200; Sousa LP, 2012, P NATL ACAD SCI USA, V109, P4419, DOI 10.1073/pnas.1200164109; Stolzing A, 2006, FREE RADICAL BIO MED, V41, P326, DOI 10.1016/j.freeradbiomed.2006.04.018; Tate MC, 2002, CELL TRANSPLANT, V11, P283; Wang CR, 2013, NAT NEUROSCI, V16, P532, DOI 10.1038/nn.3365; Xiong Y, 2012, ANN NY ACAD SCI, V1270, P51, DOI 10.1111/j.1749-6632.2012.06683.x; Yan J, 2007, PLOS MED, V4, P318, DOI 10.1371/journal.pmed.0040039; Yi L, 2012, CANCER RES, V72, P5635, DOI 10.1158/0008-5472.CAN-12-1451; Zhang YG, 2012, STEM CELLS, V30, P510, DOI 10.1002/stem.1006; Zietlow R, 2012, EXP NEUROL, V235, P563, DOI 10.1016/j.expneurol.2012.03.010	56	2	3	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107865	10.1371/journal.pone.0107865	http://dx.doi.org/10.1371/journal.pone.0107865			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247595	Green Published, gold, Green Submitted			2022-12-25	WOS:000342351800045
J	Sandlund, N; Gjerset, B; Bergh, O; Modahl, I; Olesen, NJ; Johansen, R				Sandlund, Nina; Gjerset, Britt; Bergh, Oivind; Modahl, Ingebjorg; Olesen, Niels Jorgen; Johansen, Renate			Screening for Viral Hemorrhagic Septicemia Virus in Marine Fish along the Norwegian Coastal Line	PLOS ONE			English	Article							HERRING CLUPEA-HARENGUS; PRINCE-WILLIAM-SOUND; FLOUNDER PARALICHTHYS-OLIVACEUS; TURBOT SCOPHTHALMUS-MAXIMUS; COD GADUS-MORHUA; RAINBOW-TROUT; ATLANTIC SALMON; RT-PCR; EXPERIMENTAL-INFECTION; ULCUS-SYNDROME	Viral hemorrhagic septicemia virus (VHSV) infects a wide range of marine fish species. To study the occurrence of VHSV in wild marine fish populations in Norwegian coastal waters and fjord systems a total of 1927 fish from 39 different species were sampled through 5 research cruises conducted in 2009 to 2011. In total, VHSV was detected by rRT-PCR in twelve samples originating from Atlantic herring (Clupea harengus), haddock (Melanogrammus aeglefinus), whiting (Merlangius merlangus) and silvery pout (Gadiculus argenteus). All fish tested positive in gills while four herring and one silvery pout also tested positive in internal organs. Successful virus isolation in cell culture was only obtained from one pooled Atlantic herring sample which shows that today's PCR methodology have a much higher sensitivity than cell culture for detection of VHSV. Sequencing revealed that the positive samples belonged to VHSV genotype Ib and phylogenetic analysis shows that the isolate from Atlantic herring and silvery pout are closely related. All positive fish were sampled in the same area in the northern county of Finnmark. This is the first detection of VHSV in Atlantic herring this far north, and to our knowledge the first detection of VHSV in silvery pout. However, low prevalence of VHSV genotype Ib in Atlantic herring and other wild marine fish are well known in other parts of Europe. Earlier there have been a few reports of disease outbreaks in farmed rainbow trout with VHSV of genotype Ib, and our results show that there is a possibility of transfer of VHSV from wild to farmed fish along the Norwegian coast line. The impact of VHSV on wild fish is not well documented.	[Sandlund, Nina] Inst Marine Res, Res Grp Dis & Pathogen Transmiss, N-5024 Bergen, Norway; [Bergh, Oivind] Inst Marine Res, Res Grp Oceanog & Climate, N-5024 Bergen, Norway; [Gjerset, Britt; Modahl, Ingebjorg; Johansen, Renate] Natl Vet Inst, Virol Sect, Oslo, Norway; [Olesen, Niels Jorgen] Tech Univ Denmark, Virol Sect, Frederiksberg C, Denmark	Institute of Marine Research - Norway; Institute of Marine Research - Norway; Norwegian Veterinary Institute; Technical University of Denmark	Sandlund, N (corresponding author), Inst Marine Res, Res Grp Dis & Pathogen Transmiss, POB 1870, N-5024 Bergen, Norway.	nina.sandlund@imr.no	Bergh, Øivind/AIE-3508-2022; Olesen, Niels Jørgen/AAJ-8851-2021	Bergh, Øivind/0000-0002-9849-025X; Olesen, Niels Jørgen/0000-0002-0152-4135; Sandlund, Nina/0000-0002-3398-6940	Norwegian Research Council [190245, 224931]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	Norwegian Research Council, grants no. 190245 and 224931 (http://www.forskningsradet.no/en/Home_page/1177315753906) RJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hussinee L, 2011, DIS AQUAT ORGAN, V93, P117, DOI 10.3354/dao02285; [Anonymous], 2014, MANUAL DIAGNOSTIC TE; Bain MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010156; Bergh O, 2007, DIS AQUAT ORGAN, V75, P159, DOI 10.3354/dao075159; Brudeseth BE, 2002, DIS AQUAT ORGAN, V52, P21, DOI 10.3354/dao052021; Brudeseth BE, 2008, J VIROL, V82, P10359, DOI 10.1128/JVI.01009-08; Cornwell ER, 2013, J VET DIAGN INVEST, V25, P203, DOI 10.1177/1040638713476865; Dale OB, 2009, DIS AQUAT ORGAN, V85, P93, DOI 10.3354/dao02065; DEKINKELIN P, 1982, J FISH DIS, V5, P57, DOI 10.1111/j.1365-2761.1982.tb00456.x; Dixon PF, 2003, DIS AQUAT ORGAN, V54, P175, DOI 10.3354/dao054175; Dixon PF, 1997, DIS AQUAT ORGAN, V30, P81, DOI 10.3354/dao030081; Dixon PF, 1999, B EUR ASSOC FISH PAT, V19, P60; Duesund H, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-19; Einer-jensen K, 2004, J GEN VIROL, V85, P1167, DOI 10.1099/vir.0.79820-0; Elston RA, 2009, DIS AQUAT ORGAN, V83, P223, DOI 10.3354/dao02005; Gadd T, 2011, J FISH DIS, V34, P517, DOI 10.1111/j.1365-2761.2011.01264.x; Gagne N, 2007, J FISH DIS, V30, P213, DOI 10.1111/j.1365-2761.2007.00802.x; Garver KA, 2013, DIS AQUAT ORGAN, V104, P93, DOI 10.3354/dao02588; Groocock GH, 2012, J WORLD AQUACULT SOC, V43, P459, DOI 10.1111/j.1749-7345.2012.00580.x; Hall LM, 2013, EPIDEMIOLOGY CONTROL, P1; Hershberger PK, 1999, DIS AQUAT ORGAN, V37, P23, DOI 10.3354/dao037023; Hope KM, 2010, J AQUAT ANIM HEALTH, V22, P50, DOI 10.1577/H09-028.1; Iida H, 2003, FISH PATHOL, V38, P87, DOI 10.3147/jsfp.38.87; Isshiki T, 2001, DIS AQUAT ORGAN, V47, P87, DOI 10.3354/dao047087; JENSEN NJ, 1979, NORD VET MED, V31, P222; Johansen R, 2013, MAR ECOL PROG SER, V478, P223, DOI 10.3354/meps10208; Jonstrup SP, 2013, J FISH DIS, V36, P9, DOI 10.1111/j.1365-2761.2012.01416.x; King JA, 2001, DIS AQUAT ORGAN, V47, P81, DOI 10.3354/dao047081; King JA, 2001, DIS AQUAT ORGAN, V47, P25, DOI 10.3354/dao047025; Knusel R, 2007, J FISH DIS, V30, P559, DOI 10.1111/j.1365-2761.2007.00842.x; Kocan RM, 2001, J AQUAT ANIM HEALTH, V13, P77, DOI 10.1577/1548-8667(2001)013&lt;0077:EOVHSA&gt;2.0.CO;2; Kurath G, 2011, CURR OPIN VIROL, V1, P73, DOI 10.1016/j.coviro.2011.05.010; Lovy J, 2013, VET MICROBIOL, V166, P91, DOI 10.1016/j.vetmic.2013.05.019; Marty GD, 2003, CAN J FISH AQUAT SCI, V60, P1258, DOI [10.1139/f03-109, 10.1139/F03-109]; MEYERS TR, 1994, DIS AQUAT ORGAN, V19, P27, DOI 10.3354/dao019027; Mortensen HF, 1999, VIRUS RES, V63, P95, DOI 10.1016/S0168-1702(99)00062-3; Munro E.S., 2013, P 17 ANN M NAT REF L, P22; Nishizawa T, 2006, APPL ENVIRON MICROB, V72, P2373, DOI 10.1128/AEM.72.4.2373-2378.2006; Nordblom B, 1998, REPORT OUTBREAK VIRA; Nordblom B, 2000, REPORT OUTBREAK VIRA; Oidtmann B, 2011, DIS AQUAT ORGAN, V93, P93, DOI 10.3354/dao02298; Olesen NJ, 2013, MONONEGAVIRUSES OF VETERINARY IMPORTANCE, VOL I: PATHOBIOLOGY AND MOLECULAR DIAGNOSIS, P323, DOI 10.1079/9781780641799.0323; Pierce LR, 2012, MOL PHYLOGENET EVOL, V63, P327, DOI 10.1016/j.ympev.2011.12.024; Sandlund N, DIS AQUATIC OR UNPUB; Schonherz AA, 2012, J FISH DIS, V35, P395, DOI 10.1111/j.1365-2761.2012.01358.x; Schonherz AA, 2013, J GEN VIROL, V94, P869, DOI 10.1099/vir.0.048223-0; Silva FFG, 2013, FISH RES, V138, P71, DOI 10.1016/j.fishres.2012.07.013; Skall HF, 2005, DIS AQUAT ORGAN, V66, P145, DOI 10.3354/dao066145; Skall HF, 2005, J FISH DIS, V28, P509, DOI 10.1111/j.1365-2761.2005.00654.x; Smail DA, 2000, DIS AQUAT ORGAN, V41, P231, DOI 10.3354/dao041231; Snow M, 2000, DIS AQUAT ORGAN, V42, P17, DOI 10.3354/dao042017; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson TM, 2011, DIS AQUAT ORGAN, V96, P29, DOI 10.3354/dao02362; Vestergard Jorgensen P.E., 1987, Bulletin of the European Association of Fish Pathologists, V7, P73; Walker P.J., 2000, FAMILY RHAB DOVIRIDA, P563	55	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108529	10.1371/journal.pone.0108529	http://dx.doi.org/10.1371/journal.pone.0108529			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25248078	gold, Green Published, Green Submitted			2022-12-25	WOS:000342351800097
J	Summerton, JC; Martin, GM; Evanseck, JD; Chapman, MS				Summerton, Jean C.; Martin, Gregory M.; Evanseck, Jeffrey D.; Chapman, Michael S.			Common Hydrogen Bond Interactions in Diverse Phosphoryl Transfer Active Sites	PLOS ONE			English	Article							TIME-RESOLVED FTIR; ARGININE KINASE; GTPASE REACTION; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURES; ATP BINDING; RAS; HYDROLYSIS; MECHANISM; PHOSPHATE	Phosphoryl transfer reactions figure prominently in energy metabolism, signaling, transport and motility. Prior detailed studies of selected systems have highlighted mechanistic features that distinguish different phosphoryl transfer enzymes. Here, a top-down approach is developed for comparing statistically the active site configurations between populations of diverse structures in the Protein Data Bank, and it reveals patterns of hydrogen bonding that transcend enzyme families. Through analysis of large samples of structures, insights are drawn at a level of detail exceeding the experimental precision of an individual structure. In phosphagen kinases, for example, hydrogen bonds with the O-3 beta of the nucleotide substrate are revealed as analogous to those in unrelated G proteins. In G proteins and other enzymes, interactions with O-3 beta have been understood in terms of electrostatic favoring of the transition state. Ground state quantum mechanical calculations on model compounds show that the active site interactions highlighted in our database analysis can affect substrate phosphate charge and bond length, in ways that are consistent with prior experimental observations, by modulating hyperconjugative orbital interactions that weaken the scissile bond. Testing experimentally the inference about the importance of O-3 beta interactions in phosphagen kinases, mutation of arginine kinase Arg(280) decreases k(cat), as predicted, with little impact upon K-M.	[Summerton, Jean C.; Martin, Gregory M.; Chapman, Michael S.] Oregon Hlth & Sci Univ, Sch Med, Dept Biochem & Mol Biol, Portland, OR 97201 USA; [Evanseck, Jeffrey D.] Duquesne Univ, Ctr Computat Sci, Pittsburgh, PA 15219 USA; [Evanseck, Jeffrey D.] Duquesne Univ, Dept Chem & Biochem, Pittsburgh, PA 15219 USA	Oregon Health & Science University; Duquesne University; Duquesne University	Chapman, MS (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Biochem & Mol Biol, Portland, OR 97201 USA.	chapmami@ohsu.edu		Evanseck, Jeffrey/0000-0003-2616-7354; Chapman, Michael/0000-0001-8525-8585	National Institutes of Health (NIH) [GM077643]; American Heart Association [09PRE2020112]; Vertex, Inc.; Center for Computational Sciences at Duquesne; National Science Foundation for Computer Resources [CHE-1126465, CHE-0736146]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077643] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1126465] Funding Source: National Science Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Vertex, Inc.(Vertex Pharmaceuticals); Center for Computational Sciences at Duquesne; National Science Foundation for Computer Resources; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Institutes of Health (NIH) GM077643 (MSC) and pre-doctoral fellowships from the American Heart Association (09PRE2020112, JCS) and Vertex, Inc. (JCS), as well as the Center for Computational Sciences at Duquesne and the National Science Foundation for Computer Resources (CHE-1126465 and CHE-0736146, JDE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Furthermore the authors state that they have received funding from a commercial source, Vertex, Inc., and this does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Allin C, 2001, P NATL ACAD SCI USA, V98, P7754, DOI 10.1073/pnas.131549798; Allin C, 2001, BIOCHEMISTRY-US, V40, P3037, DOI 10.1021/bi0017024; Andreassi JL, 2009, BIOCHEMISTRY-US, V48, P6461, DOI 10.1021/bi900537u; Azzi A, 2004, PROTEIN SCI, V13, P575, DOI 10.1110/ps.03428304; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; BLETHEN SL, 1972, ARCH BIOCHEM BIOPHYS, V149, P244, DOI 10.1016/0003-9861(72)90319-0; Cepus V, 1998, BIOCHEMISTRY-US, V37, P10263, DOI 10.1021/bi973183j; Davulcu O, 2011, BIOCHEMISTRY-US, V50, P4011, DOI 10.1021/bi101664u; Du XL, 2009, BIOCHEMISTRY-US, V48, P4538, DOI 10.1021/bi802359b; Du XL, 2004, P NATL ACAD SCI USA, V101, P8858, DOI 10.1073/pnas.0401675101; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Ellington WR, 2001, ANNU REV PHYSIOL, V63, P289, DOI 10.1146/annurev.physiol.63.1.289; Fabiola F, 2002, PROTEIN SCI, V11, P1415, DOI 10.1110/ps.4890102; Fleming I., 2011, MOL ORBITALS ORGANIC; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gattis JL, 2004, BIOCHEMISTRY-US, V43, P8680, DOI 10.1021/bi049793i; Glendening ED, 1998, J COMPUT CHEM, V19, P593, DOI 10.1002/(SICI)1096-987X(19980430)19:6<593::AID-JCC3>3.0.CO;2-M; Glendening ED, 2001, NBO VERSION 5 9 5 9; Glennon TM, 2000, BIOCHEMISTRY-US, V39, P9641, DOI 10.1021/bi000640e; HANSEN DE, 1981, J BIOL CHEM, V256, P5967; Hasemann CA, 1996, STRUCTURE, V4, P1017, DOI 10.1016/S0969-2126(96)00109-8; Holzapfel G, 2012, BIOCHEMISTRY-US, V51, P6114, DOI 10.1021/bi300509j; Jourden MJ, 2005, BBA-PROTEINS PROTEOM, V1751, P178, DOI 10.1016/j.bbapap.2005.06.002; Klahn M, 2006, J AM CHEM SOC, V128, P15310, DOI 10.1021/ja065470t; Landis C. R., 2005, VALENCY BONDING NATU; Larsen TM, 1998, BIOCHEMISTRY-US, V37, P6247, DOI 10.1021/bi980243s; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Leipe DD, 2003, J MOL BIOL, V333, P781, DOI 10.1016/j.jmb.2003.08.040; LOWE G, 1980, J BIOL CHEM, V255, P3944; Maegley KA, 1996, P NATL ACAD SCI USA, V93, P8160, DOI 10.1073/pnas.93.16.8160; Matte A, 1998, STRUCT FOLD DES, V6, P413, DOI 10.1016/S0969-2126(98)00043-4; MIERTUS S, 1981, CHEM PHYS, V55, P117, DOI 10.1016/0301-0104(81)85090-2; Pruett PS, 2003, J BIOL CHEM, V278, P26952, DOI 10.1074/jbc.M212931200; Ramon-Maiques S, 2002, STRUCTURE, V10, P329, DOI 10.1016/S0969-2126(02)00721-9; Ruben EA, 2007, THESIS FLORIDA STATE; Ruben EA, 2008, J AM CHEM SOC, V130, P3349, DOI 10.1021/ja073652x; Schumacher MA, 2000, J MOL BIOL, V298, P875, DOI 10.1006/jmbi.2000.3753; SCHWEINS T, 1995, NAT STRUCT BIOL, V2, P36, DOI 10.1038/nsb0195-36; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Sullivan SM, 2008, P NATL ACAD SCI USA, V105, P13829, DOI 10.1073/pnas.0805364105; Summerton JC, 2012, J PHYS CHEM A, V116, P10209, DOI 10.1021/jp306607k; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Yang Y, 2009, J PHYS CHEM A, V113, P12439, DOI 10.1021/jp902949f; Yousef MS, 2002, ACTA CRYSTALLOGR D, V58, P2009, DOI 10.1107/S0907444902014683; Zhu GY, 2003, J BIOL CHEM, V278, P2452, DOI 10.1074/jbc.M211042200; Zhu Y, 2005, EMBO REP, V6, P681, DOI 10.1038/sj.embor.7400448	47	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e108310	10.1371/journal.pone.0108310	http://dx.doi.org/10.1371/journal.pone.0108310			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238155	Green Published, Green Submitted, gold			2022-12-25	WOS:000342491600094
J	Tierney, DB; Franke, MF; Becerra, MC; Viru, FAA; Bonilla, CA; Sanchez, E; Guerra, D; Munoz, M; Llaro, K; Palacios, E; Mestanza, L; Hurtado, RM; Furin, JJ; Shin, S; Mitnick, CD				Tierney, Dylan B.; Franke, Molly F.; Becerra, Mercedes C.; Alcantara Viru, Felix A.; Bonilla, Cesar A.; Sanchez, Epifanio; Guerra, Dalia; Munoz, Maribel; Llaro, Karim; Palacios, Eda; Mestanza, Lorena; Hurtado, Rocio M.; Furin, Jennifer J.; Shin, Sonya; Mitnick, Carole D.			Time to Culture Conversion and Regimen Composition in Multidrug-Resistant Tuberculosis Treatment	PLOS ONE			English	Article							PREDICTORS	Sputum cultures are an important tool in monitoring the response to tuberculosis treatment, especially in multidrug-resistant tuberculosis. There has, however, been little study of the effect of treatment regimen composition on culture conversion. Well-designed clinical trials of new anti-tuberculosis drugs require this information to establish optimized background regimens for comparison. We conducted a retrospective cohort study to assess whether the use of an aggressive multidrug-resistant tuberculosis regimen was associated with more rapid sputum culture conversion. We conducted Cox proportional-hazards analyses to examine the relationship between receipt of an aggressive regimen for the 14 prior consecutive days and sputum culture conversion. Sputum culture conversion was achieved in 519 (87.7%) of the 592 patients studied. Among patients who had sputum culture conversion, the median time to conversion was 59 days (IQR: 31-92). In 480 patients (92.5% of those with conversion), conversion occurred within the first six months of treatment. Exposure to an aggressive regimen was independently associated with sputum culture conversion during the first six months of treatment (HR: 1.36; 95% CI: 1.10, 1.69). Infection with human immunodeficiency virus (HR 3.36; 95% CI: 1.47, 7.72) and receiving less exposure to tuberculosis treatment prior to the individualized multidrug-resistant tuberculosis regimen (HR: 1.58; 95% CI: 1.28, 1.95) were also independently positively associated with conversion. Tachycardia (HR: 0.77; 95% CI: 0.61, 0.98) and respiratory difficulty (HR: 0.78; 95% CI: 0.62, 0.97) were independently associated with a lower rate of conversion. This study is the first demonstrating that the composition of the multidrug-resistant tuberculosis treatment regimen influences the time to culture conversion. These results support the use of an aggressive regimen as the optimized background regimen in trials of new anti-TB drugs.	[Tierney, Dylan B.; Becerra, Mercedes C.; Shin, Sonya; Mitnick, Carole D.] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Tierney, Dylan B.; Franke, Molly F.; Becerra, Mercedes C.; Alcantara Viru, Felix A.; Guerra, Dalia; Munoz, Maribel; Llaro, Karim; Shin, Sonya; Mitnick, Carole D.] Partners Hlth, Boston, MA USA; [Tierney, Dylan B.; Franke, Molly F.; Becerra, Mercedes C.; Alcantara Viru, Felix A.; Guerra, Dalia; Munoz, Maribel; Llaro, Karim; Shin, Sonya; Mitnick, Carole D.] Socios Salud Sucursal Peru, Lima, Peru; [Franke, Molly F.; Becerra, Mercedes C.; Mitnick, Carole D.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [Bonilla, Cesar A.] Minist Hlth, Natl TB Strategy, Lima, Peru; [Sanchez, Epifanio] Hosp Nacl Sergio E Bernales, Lima, Peru; [Palacios, Eda; Mestanza, Lorena] Asociac Visionarios, Lima, Peru; [Hurtado, Rocio M.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Hurtado, Rocio M.] Global Hlth Comm, Boston, MA USA; [Furin, Jennifer J.] Case Western Reserve Univ, TB Res Unit, Cleveland, OH 44106 USA	Harvard University; Brigham & Women's Hospital; Partners Healthcare System; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Case Western Reserve University	Tierney, DB (corresponding author), Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.	dtierney@partners.org	Franke, Molly/AAK-7559-2020; Mitnick, Carole/GRO-1991-2022; BONILLA-ASALDE, CÉSAR ANTONIO/AHH-6777-2022	Franke, Molly/0000-0002-4890-5728; Mitnick, Carole/0000-0002-3455-658X; BONILLA-ASALDE, CÉSAR ANTONIO/0000-0002-4470-1939	Research Core of the Department of Global Health and Social Medicine at Harvard Medical School; Janssen Pharmaceuticals, Inc.	Research Core of the Department of Global Health and Social Medicine at Harvard Medical School; Janssen Pharmaceuticals, Inc.(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	This work was supported by the Research Core of the Department of Global Health and Social Medicine at Harvard Medical School. The fee for open access publication of this report was paid by a philanthropic contribution to Harvard Medical School from Janssen Pharmaceuticals, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avorn J, 2013, JAMA-J AM MED ASSOC, V309, P1349, DOI 10.1001/jama.2013.623; Basit A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093206; Brust JCM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073975; Brust JCM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015841; Burman WJ, 2010, CLIN INFECT DIS, V50, pS165, DOI 10.1086/651487; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Franke MF, 2013, CLIN INFECT DIS, V56, P770, DOI 10.1093/cid/cis1008; Gler MT, 2012, NEW ENGL J MED, V366, P2151, DOI 10.1056/NEJMoa1112433; Johnson JA, 1998, J HEALTHC MANAG, V43, P1; Kurbatova EV, 2012, INT J TUBERC LUNG D, V16, P1335, DOI 10.5588/ijtld.11.0811; Kurbatova EV, 2011, INT J TUBERC LUNG D, V15, P1553, DOI 10.5588/ijtld.11.0101; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Lienhardt C, 2010, INT J TUBERC LUNG D, V14, P528; Magee MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094890; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Mitnick CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058664; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; Organization WH., 2010, GLOB REC PHYS ACT HL; Putri FA, 2014, INT J TUBERC LUNG D, V18, P564, DOI 10.5588/ijtld.13.0602; Qazi F, 2011, INT J TUBERC LUNG D, V15, P1556, DOI 10.5588/ijtld.10.0679; ROUILLON A, 1976, TUBERCLE, V57, P275, DOI 10.1016/S0041-3879(76)80006-2; Therneau TM, 2000, MODELING SURVIVAL DA; Therneau TM, 1996, 56 MAY CLIN SECT BIO; Velasquez GE, 2014, CLIN INFECT DIS; Visser ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029588; Wallis RS, 2013, CLIN INFECT DIS, V56, P106, DOI 10.1093/cid/cis849; World Health Organization, 2011, WHO GUIDL APPR GUID	27	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e108035	10.1371/journal.pone.0108035	http://dx.doi.org/10.1371/journal.pone.0108035			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25238411	Green Submitted, Green Published, gold			2022-12-25	WOS:000342491600080
J	Singh, P; Thomas, GE; Gireesh, KK; Manna, TK				Singh, Puja; Thomas, Geethu Emily; Gireesh, Koyikulangara K.; Manna, Tapas K.			TACC3 Protein Regulates Microtubule Nucleation by Affecting gamma-Tubulin Ring Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Centrosome; Microtubule; Mitosis; Mitotic Spindle; Tubulin; Microtubule Nucleation; TACC3; {gamma}-Tubulin	CENTROSOMAL PROTEINS; CRYSTAL-STRUCTURE; ORGANIZATION; NINEIN; AURORA; CELLS; PERICENTRIN; CDK5RAP2; INTERACT; DYNAMICS	Background: The nucleation of centrosomal microtubules requires proper regulation of the -tubulin complex proteins. Results: TACC3 depletion impairs microtubule nucleation and disrupts the assembly of the -tubulin ring complex components and their localization at the centrosome. Conclusion: TACC3 is involved in microtubule nucleation and in stabilization of the -tubulin ring complex. Significance: These results provide additional insights into the regulation of centrosomal microtubule nucleation. Centrosome-mediated microtubule nucleation is essential for spindle assembly during mitosis. Although -tubulin complexes have primarily been implicated in the nucleation process, details of the underlying mechanisms remain poorly understood. Here, we demonstrated that a member of the human transforming acidic coiled-coil (TACC) protein family, TACC3, plays a critical role in microtubule nucleation at the centrosome. In mitotic cells, TACC3 knockdown substantially affected the assembly of microtubules in the astral region and impaired microtubule nucleation at the centrosomes. The TACC3 depletion-induced mitotic phenotype was rescued by expression of the TACC3 C terminus predominantly consisting of the TACC domain, suggesting that the TACC domain plays an important role in microtubule assembly. Consistently, experiments with the recombinant TACC domain of TACC3 demonstrated that this domain possesses intrinsic microtubule nucleating activity. Co-immunoprecipitation and sedimentation experiments revealed that TACC3 mediates interactions with proteins of both the -tubulin ring complex (-TuRC) and the -tubulin small complex (-TuSC). Interestingly, TACC3 depletion resulted in reduced levels of -TuRC and increased levels of -TuSC, indicating that the assembly of -TuRC from -TuSC requires TACC3. Detailed analyses suggested that TACC3 facilitates the association of -TuSC-specific proteins with the proteins known to be involved in the assembly of -TuRC. Consistent with such a role for TACC3, the suppression of TACC3 disrupted localization of -TuRC proteins to the centrosome. Our findings reveal that TACC3 is involved in the regulation of microtubule nucleation at the centrosome and functions in the stabilization of the -tubulin ring complex assembly.	[Singh, Puja; Thomas, Geethu Emily; Gireesh, Koyikulangara K.; Manna, Tapas K.] Indian Inst Sci Educ & Res, Sch Biol, Thiruvananthapuram 695016, Kerala, India	Indian Institute of Science Education & Research (IISER) - Thiruvananthapuram	Manna, TK (corresponding author), Indian Inst Sci Educ & Res, Sch Biol, CET Campus, Thiruvananthapuram 695016, Kerala, India.	tmanna@iisertvm.ac.in	SINGH, PUJA/AGE-0583-2022	SINGH, PUJA/0000-0003-1011-7221; Manna, Tapas/0000-0002-2213-6246	Department of Science and Technology, Government of India; Department of Atomic Energy-Board of Research in Nuclear Science, Government of India; University Grant Commission, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Department of Atomic Energy-Board of Research in Nuclear Science, Government of India; University Grant Commission, Government of India(University Grants Commission, India)	This work was supported in part by Department of Science and Technology, Government of India, and Department of Atomic Energy-Board of Research in Nuclear Science, Government of India.; Supported by a fellowship from University Grant Commission, Government of India.	Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Banerjee B, 2014, J CELL BIOL, V204, P947, DOI 10.1083/jcb.201307119; Bellanger JM, 2003, CURR BIOL, V13, P1488, DOI 10.1016/S0960-9822(03)00582-7; Bird AW, 2012, NAT METHODS, V9, P103, DOI [10.1038/NMETH.1803, 10.1038/nmeth.1803]; Bornens M, 2012, SCIENCE, V335, P422, DOI 10.1126/science.1209037; Bouissou A, 2014, EMBO J, V33, P114, DOI 10.1002/embj.201385967; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Calegari F, 2002, P NATL ACAD SCI USA, V99, P14236, DOI 10.1073/pnas.192559699; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; Choi YK, 2010, J CELL BIOL, V191, P1089, DOI 10.1083/jcb.201007030; Ciani B, 2010, P NATL ACAD SCI USA, V107, P19850, DOI 10.1073/pnas.1008502107; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Dos Santos HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062633; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Gergely F, 2000, EMBO J, V19, P241, DOI 10.1093/emboj/19.2.241; Gergely F, 2000, P NATL ACAD SCI USA, V97, P14352, DOI 10.1073/pnas.97.26.14352; Guillet V, 2011, NAT STRUCT MOL BIOL, V18, P915, DOI 10.1038/nsmb.2083; Hood FE, 2013, J CELL BIOL, V202, P463, DOI 10.1083/jcb.201211127; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Jeffery JM, 2013, CELL CYCLE, V12, P899, DOI 10.4161/cc.23879; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Kitagawa D, 2011, CELL, V144, P364, DOI 10.1016/j.cell.2011.01.008; Kittler R, 2005, NAT METHODS, V2, P779, DOI 10.1038/nmeth1005-779; Kollman JM, 2008, MOL BIOL CELL, V19, P207, DOI 10.1091/mbc.E07-09-0879; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Kollman JM, 2010, NATURE, V466, P879, DOI 10.1038/nature09207; Kotak S, 2013, CURR OPIN CELL BIOL, V25, P741, DOI 10.1016/j.ceb.2013.07.008; Lioutas A, 2013, EMBO REP, V14, P829, DOI 10.1038/embor.2013.109; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Manna T, 2006, J BIOL CHEM, V281, P2071, DOI 10.1074/jbc.M510661200; Manna T, 2009, J BIOL CHEM, V284, P15640, DOI 10.1074/jbc.M900343200; Mogensen MM, 2000, J CELL SCI, V113, P3013; Moritz M, 1998, J CELL BIOL, V142, P775, DOI 10.1083/jcb.142.3.775; Muller H, 2010, EMBO J, V29, P3344, DOI 10.1038/emboj.2010.210; Nakamura M, 2012, PLANT J, V71, P216, DOI 10.1111/j.1365-313X.2012.04988.x; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Ou YY, 2002, J CELL SCI, V115, P1825; Peset I, 2008, TRENDS CELL BIOL, V18, P379, DOI 10.1016/j.tcb.2008.06.005; Petry S, 2013, CELL, V152, P768, DOI 10.1016/j.cell.2012.12.044; Raff JW, 2002, TRENDS CELL BIOL, V12, P222, DOI 10.1016/S0962-8924(02)02268-7; Ray A, 2007, CANCER RES, V67, P3767, DOI 10.1158/0008-5472.CAN-06-3065; Ringhoff DN, 2009, MOL BIOL CELL, V20, P3451, DOI 10.1091/mbc.E09-02-0140; Schneider L, 2007, J BIOL CHEM, V282, P29273, DOI 10.1074/jbc.M704151200; Stern AL, 2007, BIOCHEM J, V401, P279, DOI 10.1042/BJ20061049; Stillwell EE, 2004, CELL CYCLE, V3, P923; Thakur HC, 2014, J BIOL CHEM, V289, P74, DOI 10.1074/jbc.M113.532333; Uehara R, 2010, J CELL BIOL, V191, P259, DOI 10.1083/jcb.201004150; Yao R., 2013, ONCOGENE, V33, P1; Yao R, 2007, CANCER SCI, V98, P555, DOI 10.1111/j.1349-7006.2007.00433.x; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	59	20	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31719	31735		10.1074/jbc.M114.575100	http://dx.doi.org/10.1074/jbc.M114.575100			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25246530	Green Published, hybrid			2022-12-25	WOS:000345314700006
J	Prati, F; Goldman-Pinkovich, A; Lizzi, F; Belluti, F; Koren, R; Zilberstein, D; Bolognesi, ML				Prati, Federica; Goldman-Pinkovich, Adele; Lizzi, Federica; Belluti, Federica; Koren, Roni; Zilberstein, Dan; Bolognesi, Maria Laura			Quinone-Amino Acid Conjugates Targeting Leishmania Amino Acid Transporters	PLOS ONE			English	Article							MELAMINE-BASED NITROHETEROCYCLES; UNUSUAL ADENOSINE TRANSPORTER; TRYPANOSOMA-BRUCEI; DRUG TARGETS; BIOLOGICAL EVALUATION; DONOVANI; DERIVATIVES; ARGININE; PROTOZOA; HOMEOSTASIS	The aim of the present study was to investigate the feasibility of targeting Leishmania transporters via appropriately designed chemical probes. Leishmania donovani, the parasite that causes visceral leishmaniasis, is auxotrophic for arginine and lysine and has specific transporters (LdAAP3 and LdAAP7) to import these nutrients. Probes 1-15 were originated by conjugating cytotoxic quinone fragments (II and III) with amino acids (i.e. arginine and lysine) by means of an amide linkage. The toxicity of the synthesized conjugates against Leishmania extracellular (promastigotes) and intracellular (amastigotes) forms was investigated, as well their inhibition of the relevant amino acid transporters. We observed that some conjugates indeed displayed toxicity against the parasites; in particular, 7 was identified as the most potent derivative (at concentrations of 1 mg/mL and 2.5 mg/mL residual cell viability was reduced to 15% and 48% in promastigotes and amastigotes, respectively). Notably, 6, while retaining the cytotoxic activity of quinone II, displayed no toxicity against mammalian THP1 cells. Transport assays indicated that the novel conjugates inhibited transport activity of lysine, arginine and proline transporters. Furthermore, our analyses suggested that the toxic conjugates might be translocated by the transporters into the cells. The non-toxic probes that inhibited transport competed with the natural substrates for binding to the transporters without being translocated. Thus, it is likely that 6, by exploiting amino acid transporters, can selectively deliver its toxic effects to Leishmania cells. This work provides the first evidence that amino acid transporters of the human pathogen Leishmania might be modulated by small molecules, and warrants their further investigation from drug discovery and chemical biology perspectives.	[Prati, Federica; Lizzi, Federica; Belluti, Federica; Bolognesi, Maria Laura] Alma Mater Studiorum Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Goldman-Pinkovich, Adele; Koren, Roni; Zilberstein, Dan] Technion Israel Inst Technol, Fac Biol, Haifa, Israel	University of Bologna; Technion Israel Institute of Technology	Bolognesi, ML (corresponding author), Alma Mater Studiorum Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy.	marialaura.bolognesi@unibo.it	Belluti, Federica/K-9713-2014; Bolognesi, Maria Laura/AAL-8062-2021	Prati, Federica/0000-0002-8483-7646; Bolognesi, Maria Laura/0000-0002-1289-5361	University of Bologna; MIUR [PRIN 201274BNKN_003]; Israel Science Foundation [696/12]	University of Bologna; MIUR(Ministry of Education, Universities and Research (MIUR)); Israel Science Foundation(Israel Science Foundation)	The research in Bolognesi's laboratory was supported by grants from the University of Bologna and MIUR (PRIN 201274BNKN_003). The work in Dan Zilberstein's laboratory was funded by grant number 696/12 from the Israel Science Foundation, founded by the Academy of Science and Humanity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON GW, 1964, J AM CHEM SOC, V86, P1839, DOI 10.1021/ja01063a037; ARISTOFF PA, 1992, J ORG CHEM, V57, P6234, DOI 10.1021/jo00049a035; Azema L, 2004, BIOCHEM PHARMACOL, V67, P459, DOI 10.1016/j.bcp.2003.09.005; Baliani A, 2005, J MED CHEM, V48, P5570, DOI 10.1021/jm050177+; Baliani A, 2009, ORG BIOMOL CHEM, V7, P1154, DOI 10.1039/b813394h; Barak E, 2005, MOL BIOCHEM PARASIT, V141, P99, DOI 10.1016/j.molbiopara.2005.02.004; Barrett MP, 2006, ADV PARASIT, V63, P125, DOI 10.1016/S0065-308X(06)63002-9; Benites J, 2010, EUR J MED CHEM, V45, P6052, DOI 10.1016/j.ejmech.2010.10.006; Bolognesi ML, 2008, BIOORG MED CHEM LETT, V18, P2272, DOI 10.1016/j.bmcl.2008.03.009; Bolognesi ML, 2011, J MED CHEM, V54, P8299, DOI 10.1021/jm200691d; Bonifazi EL, 2010, BIOORGAN MED CHEM, V18, P2621, DOI 10.1016/j.bmc.2010.02.032; CABANTCHIK ZI, 1992, AM J PHYSIOL, V262, pC803, DOI 10.1152/ajpcell.1992.262.4.C803; CARTER NS, 1993, NATURE, V361, P173, DOI 10.1038/361173a0; Chollet C, 2009, BIOORGAN MED CHEM, V17, P2512, DOI 10.1016/j.bmc.2009.01.058; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Cunha S, 2010, QUIM NOVA, V33, P2108, DOI 10.1590/S0100-40422010001000020; Darlyuk I, 2009, J BIOL CHEM, V284, P19800, DOI 10.1074/jbc.M901066200; de Koning HP, 2005, FEMS MICROBIOL REV, V29, P987, DOI 10.1016/j.femsre.2005.03.004; Ehrlich P, 1956, COLLECTED PAPERS P E, V1; Inbar E, 2013, BIOCHEM J, V449, P555, DOI 10.1042/BJ20121262; Inbar E, 2012, AMINO ACIDS, V42, P347, DOI 10.1007/s00726-010-0812-z; Kayashima T, 2010, BIOORGAN MED CHEM, V18, P6305, DOI 10.1016/j.bmc.2010.07.022; Kirk K, 2004, ACTA TROP, V89, P285, DOI 10.1016/j.actatropica.2003.10.002; Klee N, 2010, BIOORG MED CHEM LETT, V20, P4364, DOI 10.1016/j.bmcl.2010.06.070; Klenke B, 2001, J MED CHEM, V44, P3440, DOI 10.1021/jm010854+; Konno H, 2007, TETRAHEDRON, V63, P9502, DOI 10.1016/j.tet.2007.06.082; Kumar K, 2009, ANGEW CHEM INT EDIT, V48, P3224, DOI 10.1002/anie.200803437; Landfear SM, 2010, CLIN PHARMACOL THER, V87, P122, DOI 10.1038/clpt.2009.116; Landfear SM, 2011, EUKARYOT CELL, V10, P483, DOI 10.1128/EC.00287-10; Liegault B, 2008, J ORG CHEM, V73, P5022, DOI 10.1021/jo800596m; Link A, 2009, EUR J MED CHEM, V44, P3665, DOI 10.1016/j.ejmech.2009.02.010; Lizzi F, 2012, J MED CHEM, V55, P10490, DOI 10.1021/jm301112z; Luscher A, 2007, CURR PHARM DESIGN, V13, P555, DOI 10.2174/138161207780162809; Maekawa K, 2005, TETRAHEDRON, V61, P11211, DOI 10.1016/j.tet.2005.09.042; Matlashewski G, 2011, LANCET INFECT DIS, V11, P322, DOI 10.1016/S1473-3099(10)70320-0; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Orhan I, 2010, MAR DRUGS, V8, P47, DOI 10.3390/md8010047; Pieretti S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002012; Reid CM, 2008, BIOORG MED CHEM LETT, V18, P5399, DOI 10.1016/j.bmcl.2008.09.047; Saar Y, 1998, MOL BIOCHEM PARASIT, V95, P9, DOI 10.1016/S0166-6851(98)00062-0; Shaked-Mishan P, 2006, MOL MICROBIOL, V60, P30, DOI 10.1111/j.1365-2958.2006.05060.x; Shaked-Mishan P, 2001, J BIOL CHEM, V276, P3971, DOI 10.1074/jbc.M005423200; Slavic K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-165; Soulere L, 2000, BIOORG MED CHEM LETT, V10, P1347, DOI 10.1016/S0960-894X(00)00233-X; Stewart ML, 2004, ANTIMICROB AGENTS CH, V48, P1733, DOI 10.1128/AAC.48.5.1733-1738.2004; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P439, DOI 10.1016/S0753-3322(02)00284-6; Tye CK, 1998, BIOORG MED CHEM LETT, V8, P811, DOI 10.1016/S0960-894X(98)00095-X; Wenzel IN, 2009, CHEMMEDCHEM, V4, P339, DOI 10.1002/cmdc.200800360	48	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2014	9	9							e107994	10.1371/journal.pone.0107994	http://dx.doi.org/10.1371/journal.pone.0107994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3UZ	25254495	Green Published, gold, Green Submitted			2022-12-25	WOS:000344862300049
J	Barbosa, M; Pestana, J; Soares, AMVM				Barbosa, Miguel; Pestana, Joao; Soares, Amadeu M. V. M.			Predation Life History Responses to Increased Temperature Variability	PLOS ONE			English	Article							DAPHNIA-MAGNA; EVOLUTION; RISK; METABOLISM; PLASTICITY; KAIROMONES; DEPENDENCE; AVOIDANCE; BEHAVIOR; TRAITS	The evolution of life history traits is regulated by energy expenditure, which is, in turn, governed by temperature. The forecasted increase in temperature variability is expected to impose greater stress to organisms, in turn influencing the balance of energy expenditure and consequently life history responses. Here we examine how increased temperature variability affects life history responses to predation. Individuals reared under constant temperatures responded to different levels of predation risk as appropriate: namely, by producing greater number of neonates of smaller sizes and reducing the time to first brood. In contrast, we detected no response to predation regime when temperature was more variable. In addition, population growth rate was slowest among individuals reared under variable temperatures. Increased temperature variability also affected the development of inducible defenses. The combined effects of failing to respond to predation risk, slower growth rate and the miss-match development of morphological defenses supports suggestions that increased variability in temperature poses a greater risk for species adaptation than that posed by a mean shift in temperature.	[Barbosa, Miguel; Pestana, Joao; Soares, Amadeu M. V. M.] Univ Aveiro, Ctr Environm & Marine Studies CESAM, Dept Biol, P-3800 Aveiro, Portugal; [Barbosa, Miguel] Univ St Andrews, Ctr Biol Div, St Andrews, Fife, Scotland; [Barbosa, Miguel] Univ St Andrews, Scottish Oceans Inst, St Andrews, Fife, Scotland; [Soares, Amadeu M. V. M.] Univ Fed Tocantins, Programa Posgrad Prod Vegetal, Gurupi, Brazil	Universidade de Aveiro; University of St Andrews; University of St Andrews; Universidade Federal do Tocantins (UFT)	Barbosa, M (corresponding author), Univ Aveiro, Ctr Environm & Marine Studies CESAM, Dept Biol, P-3800 Aveiro, Portugal.	mb334@st-andrews.ac.uk	Pestana, João L.T./A-9279-2008; Barbosa, Miguel/H-2897-2019; Soares, Amadeu/A-8304-2008	Pestana, João L.T./0000-0003-1322-2959; Soares, Amadeu/0000-0003-0879-9470; Barbosa, Miguel/0000-0003-0327-9580	Fundacao para a Ciencia e Tecnologia [SFRH/BPD/82259/2011]; Bolsista CAPES/BRASIL [A058/2013]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Bolsista CAPES/BRASIL	This study was funded by a Postdoctoral fellowship to MB (SFRH/BPD/82259/2011) Fundacao para a Ciencia e Tecnologia (www.fct.pt/index.phtml.pt) and with a "Bolsista CAPES/BRASIL", (Project A058/2013) to AMVMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; BAIRD DJ, 1991, ECOTOX ENVIRON SAFE, V21, P257, DOI 10.1016/0147-6513(91)90064-V; Boersma M, 1998, AM NAT, V152, P237, DOI 10.1086/286164; Broomhall SD, 2004, J APPL ECOL, V41, P105, DOI 10.1111/j.1365-2664.2004.00883.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Clark RA, 2003, GLOBAL CHANGE BIOL, V9, P1669, DOI 10.1046/j.1365-2486.2003.00685.x; Crawley MJ., 2007, R BOOK; CROWL TA, 1990, SCIENCE, V247, P949, DOI 10.1126/science.247.4945.949; Dallas H, 2008, WATER SA, V34, P393; Dell AI, 2011, P NATL ACAD SCI USA, V108, P10591, DOI 10.1073/pnas.1015178108; Doksaeter A, 2001, HYDROBIOLOGIA, V442, P207, DOI 10.1023/A:1017537012727; Evans JP, 2007, BEHAV ECOL SOCIOBIOL, V61, P719, DOI 10.1007/s00265-006-0302-1; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; HARVELL CD, 1990, Q REV BIOL, V65, P323, DOI 10.1086/416841; HARVEY PH, 1991, AM NAT, V137, P556, DOI 10.1086/285183; HAWKINS AJS, 1995, J THERM BIOL, V20, P23, DOI 10.1016/0306-4565(94)00023-C; Hays W.L., 1994, STATISTICS-ABINGDON, V5th ed.; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Huntingford C, 2013, NATURE, V500, P327, DOI 10.1038/nature12310; Jacobs AFG, 2008, INT J BIOMETEOROL, V52, P271, DOI 10.1007/s00484-007-0121-8; LAW R, 1979, AM NAT, V114, P399, DOI 10.1086/283488; LUDWIG D, 1990, AM NAT, V135, P686, DOI 10.1086/285069; MACARTHUR RH, 1962, P NATL ACAD SCI USA, V48, P1893, DOI 10.1073/pnas.48.11.1893; MACHACEK J, 1991, HYDROBIOLOGIA, V225, P193, DOI 10.1007/BF00028397; McCullagh P, 1989, GEN LINEAR MODELS; MILINSKI M, 1978, NATURE, V275, P642, DOI 10.1038/275642a0; Mora C, 2013, NATURE, V502, P183, DOI 10.1038/nature12540; Morice CP, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017187; *OECD, 2008, DAPHN MAGN REPR TEST; Pestana JLT, 2013, MAR FRESHWATER RES, V64, P679, DOI 10.1071/MF13043; Pitman J., 1993, PROBABILITY; Rahmstorf S, 2011, P NATL ACAD SCI USA, V108, P17905, DOI 10.1073/pnas.1101766108; REZNICK D, 1982, EVOLUTION, V36, P160, DOI 10.1111/j.1558-5646.1982.tb05021.x; Rhines A, 2013, P NATL ACAD SCI USA, V110, pE546, DOI 10.1073/pnas.1218748110; Roff A.D., 1992, EVOLUTION LIFE HIST; Ruxton GD, 1997, P ROY SOC B-BIOL SCI, V264, P409, DOI 10.1098/rspb.1997.0058; Sakwinska O, 1998, FRESHWATER BIOL, V39, P681, DOI 10.1046/j.1365-2427.1998.00320.x; SaLM Kooijman, 2000, DYNAMIC ENERGY MASS, DOI 10.1017/CBO9780511565403; Schmitz OJ, 1997, ECOLOGY, V78, P1388, DOI 10.1890/0012-9658(1997)078[1388:BMTCEO]2.0.CO;2; Stabell OB, 2003, CHEM SENSES, V28, P141, DOI 10.1093/chemse/28.2.141; Stearns S.C., 1992, pi; STIBOR H, 1992, OECOLOGIA, V92, P162, DOI 10.1007/BF00317358; Team RDC, 2013, R LANG ENV STAT COMP; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; Urban MC, 2007, ECOLOGY, V88, P2587, DOI 10.1890/06-1946.1; WARD JV, 1985, HYDROBIOLOGIA, V125, P31, DOI 10.1007/BF00045924; Weetman D, 2002, OIKOS, V98, P299, DOI 10.1034/j.1600-0706.2002.980211.x; WERNER EE, 1983, ECOLOGY, V64, P1540, DOI 10.2307/1937508	50	7	7	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107971	10.1371/journal.pone.0107971	http://dx.doi.org/10.1371/journal.pone.0107971			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25250677	Green Published, Green Submitted, gold			2022-12-25	WOS:000342492700065
J	Carvajal-Gamez, BI; Quintas-Granados, LI; Arroyo, R; Vazquez-Carrillo, LI; Ramon-Luing, LDA; Carrillo-Tapia, E; Alvarez-Sanchez, ME				Isabel Carvajal-Gamez, Bertha; Itzel Quintas-Granados, Laura; Arroyo, Rossana; Isabel Vazquez-Carrillo, Laura; De Los Angeles Ramon-Luing, Lucero; Carrillo-Tapia, Eduardo; Elizbeth Alvarez-Sanchez, Maria			Putrescine-Dependent Re-Localization of TvCP39, a Cysteine Proteinase Involved in Trichomonas vaginalis Cytotoxicity	PLOS ONE			English	Article							ORNITHINE-DECARBOXYLASE; POLYAMINE METABOLISM; AMINE CONTENT; CP65; IRON; INHIBITION; EXPRESSION; FLUID	Polyamines are involved in the regulation of some Trichomonas vaginalis virulence factors such as the transcript, proteolytic activity, and cytotoxicity of TvCP65, a cysteine proteinase (CP) involved in the trichomonal cytotoxicity. In this work, we reported the putrescine effect on TvCP39, other CP that also participate in the trichomonal cytotoxicity. Parasites treated with 1,4-diamino-2-butanone (DAB) (an inhibitor of putrescine biosynthesis), diminished the amount and proteolytic activity of TvCP39 as compared with untreated parasites. Inhibition of putrescine biosynthesis also reduced similar to 80% the tvcp39 mRNA levels according to RT-PCR and qRT-PCR assays. Additionally, actinomycin D-treatment showed that the tvcp39 mRNA half-life decreased in the absence of putrescine. However, this reduction was restored by exogenous putrescine addition, suggesting that putrescine is necessary for tvcp39 mRNA stability. TvCP39 was localized in the cytoplasm but, in DAB treated parasites transferred into exogenous putrescine culture media, TvCP39 was re-localized to the nucleus and nuclear periphery of trichomonads. Interestingly, the amount and proteolytic activity of TvCP39 was recovered as well as the tvcp39 mRNA levels were restored when putrescine exogenous was added to the DAB-treated parasites. In conclusion, our data show that putrescine regulate the TvCP39 expression, protein amount, proteolytic activity, and cellular localization.	[Isabel Carvajal-Gamez, Bertha; Itzel Quintas-Granados, Laura; Isabel Vazquez-Carrillo, Laura; Carrillo-Tapia, Eduardo; Elizbeth Alvarez-Sanchez, Maria] Autonomous Univ Mexico City UACM, Mexico City, DF, Mexico; [Arroyo, Rossana; De Los Angeles Ramon-Luing, Lucero] IPN, Ctr Res & Adv Studies, Dept Infect & Mol Pathogenesis, Mexico City 07738, DF, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Politecnico Nacional - Mexico	Alvarez-Sanchez, ME (corresponding author), Autonomous Univ Mexico City UACM, Mexico City, DF, Mexico.	elizbethalvarezsanchez@yahoo.com.mx	Sanchez, Maria/AGT-2170-2022; Ramon Luing, Lucero/AEX-0055-2022; Sanchez, Maria Elizbeth Alvarez/AAD-9656-2019; Quintas, Laura/A-6317-2014; Verástegui, Rossana Arroyo/ABF-7739-2021	Ramon Luing, Lucero/0000-0003-2004-7570; Sanchez, Maria Elizbeth Alvarez/0000-0002-9212-4451; Verástegui, Rossana Arroyo/0000-0002-8193-9700; QUINTAS GRANADOS, LAURA ITZEL/0000-0002-8622-2004	Universidad Autonoma de la Ciudad de Mexico (UACM); Consejo Nacional de Ciencia y Tecnologia (CONACyT) [83808]; Instituto de Ciencia y Tecnologia del Distrito Federal (ICyT-DF) [PIFUTP08-150]; ICyT-DF Mexico	Universidad Autonoma de la Ciudad de Mexico (UACM); Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Instituto de Ciencia y Tecnologia del Distrito Federal (ICyT-DF); ICyT-DF Mexico	The work was supported by grants from Universidad Autonoma de la Ciudad de Mexico (UACM) and by grants from Consejo Nacional de Ciencia y Tecnologia (CONACyT) (83808) and Instituto de Ciencia y Tecnologia del Distrito Federal (ICyT-DF) (PIFUTP08-150) to MEAS. BICG was supported by a scholarship from ICyT-DF Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Sanchez ME, 2007, MICROBES INFECT, V9, P1597, DOI 10.1016/j.micinf.2007.09.011; Alvarez-Sanchez ME, 2000, MICROB PATHOGENESIS, V28, P193, DOI 10.1006/mpat.1999.0336; Arroyo R, 1995, Arch Med Res, V26, P279; ArteagaNieto P, 1996, INT J PARASITOL, V26, P253, DOI 10.1016/0020-7519(95)00134-4; Becker JVW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-235; Boitz JM, 2009, INFECT IMMUN, V77, P756, DOI 10.1128/IAI.01236-08; Bozner P, 1990, PARASITOLOGY, V102; CALVOMENDEZ C, 1993, INT J PARASITOL, V23, P847, DOI 10.1016/0020-7519(93)90048-4; Cardona-Felix CS, 2011, ACTA CRYSTALLOGR D, V67, P497, DOI 10.1107/S0907444911010547; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Carvajal-Gamez B, 2010, INFECT GENET EVOL, V10, P284, DOI 10.1016/j.meegid.2009.12.008; CHEN KCS, 1979, J CLIN INVEST, V63, P828, DOI 10.1172/JCI109382; COOMBS GH, 1983, PARASITOLOGY, V86, P1, DOI 10.1017/S0031182000057103; Cotch MF, 1997, SEX TRANSM DIS, V24, P353, DOI 10.1097/00007435-199707000-00008; Ramon-Luing LD, 2011, INT J BIOCHEM CELL B, V43, P1500, DOI 10.1016/j.biocel.2011.07.001; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; El-Shazly A. M., 2001, Journal of the Egyptian Society of Parasitology, V31, P545; Alvarez-Sanchez ME, 2008, INT J BIOCHEM CELL B, V40, P2442, DOI 10.1016/j.biocel.2008.04.023; Garcia AF, 2005, INFECT IMMUN, V73, P2602, DOI 10.1128/IAI.73.5.2602-2610.2005; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Grunwald D, 2011, NATURE, V475, P333, DOI 10.1038/nature10318; Guenthner PC, 2005, INFECT IMMUN, V73, P4155, DOI 10.1128/IAI.73.7.4155-4160.2005; He C, 2010, J BIOL CHEM, V285, P18516, DOI 10.1074/jbc.M109.086181; Hernandez-Gutierrez R, 2003, J EUKARYOT MICROBIOL, V50, P696, DOI 10.1111/j.1550-7408.2003.tb00692.x; Hernandez-Gutierrez R, 2004, EXP PARASITOL, V107, P125, DOI 10.1016/j.exppara.2004.05.004; Carvajal-Gamez BI, 2011, MOL BIOCHEM PARASIT, V180, P8, DOI 10.1016/j.molbiopara.2011.07.003; Konjar S, 2010, FEBS LETT, V584, P2201, DOI 10.1016/j.febslet.2010.03.031; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHKER MW, 1991, J EXP MED, V174, P311, DOI 10.1084/jem.174.2.311; Leon-Sicairos CR, 2004, MICROBIOL-SGM, V150, P1131, DOI 10.1099/mic.0.26927-0; Mendoza-Lopez MR, 2000, INFECT IMMUN, V68, P4907, DOI 10.1128/IAI.68.9.4907-4912.2000; NEALE KA, 1990, INFECT IMMUN, V58, P157, DOI 10.1128/IAI.58.1.157-162.1990; PROVENZANO D, 1995, INFECT IMMUN, V63, P3388, DOI 10.1128/IAI.63.9.3388-3395.1995; Ramon-Luing LA, 2010, PROTEOMICS, V10, P435, DOI 10.1002/pmic.200900479; Reis IA, 1999, ANTIMICROB AGENTS CH, V43, P1919, DOI 10.1128/AAC.43.8.1919; RUI H, 1984, INT J ANDROL, V7, P119, DOI 10.1111/j.1365-2605.1984.tb00767.x; SANDERSON BE, 1983, BRIT J VENER DIS, V59, P302; Schwebke JR, 2004, CLIN MICROBIOL REV, V17, P794, DOI 10.1128/CMR.17.4.794-803.2004; Solano-Gonzalez E, 2006, INT J BIOCHEM CELL B, V38, P2114, DOI 10.1016/j.biocel.2006.06.003; Viikki M, 2000, ACTA ONCOL, V39, P71, DOI 10.1080/028418600431003; YARLETT N, 1988, MOL BIOCHEM PARASIT, V31, P1, DOI 10.1016/0166-6851(88)90139-9; YARLETT N, 1994, BIOCHEM SOC T, V22, P875, DOI 10.1042/bst0220875	42	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e107293	10.1371/journal.pone.0107293	http://dx.doi.org/10.1371/journal.pone.0107293			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251406	Green Published, Green Submitted, gold			2022-12-25	WOS:000342492700026
J	Meena, VP; Seenu, V; Sharma, MC; Mallick, SR; Bhalla, AS; Gupta, N; Mohan, A; Guleria, R; Pandey, RM; Luthra, K; Vikram, NK				Meena, Ved Prakash; Seenu, V.; Sharma, M. C.; Mallick, Saumya Ranjan; Bhalla, Ashu Seith; Gupta, Nandita; Mohan, Anant; Guleria, Randeep; Pandey, Ravindra M.; Luthra, Kalpana; Vikram, Naval K.			Relationship of Adipocyte Size with Adiposity and Metabolic Risk Factors in Asian Indians	PLOS ONE			English	Article							BODY-FAT DISTRIBUTION; INSULIN-RESISTANCE; TISSUE CELLULARITY; ABDOMINAL OBESITY; SOUTH ASIANS; ASSOCIATION; DIFFERENTIATION; CONSEQUENCES; OVERWEIGHT; MANAGEMENT	Background: Enlargement of adipocyte is associated with their dysfunction and alterations in metabolic functions. Objectives: We evaluated the association of adipocyte size of subcutaneous and omental adipose tissue with body composition and cardiovascular risk factors in Asian Indians. Methodology: Eighty (40 males and 40 females) non-diabetic adult subjects undergoing elective abdominal surgery were included. Pre-surgery evaluation included anthropometric measurements, % body fat by bioimpedance, abdominal fat area at L2-3 level (computed tomography) and biochemical investigations (fasting blood glucose and insulin, lipids and hsCRP). During surgery, about 5 grams each of omental and subcutaneous adipose tissue was obtained for adipocyte size determination. Results: Females had higher BMI, % body fat, skinfold thickness, total and subcutaneous abdominal fat area as compared to males. Overweight was present in 42.5% and 67.5%, and abdominal obesity in 5% and 52.5% males and females, respectively. Subcutaneous adipocyte size was significantly higher than omental adipocyte size. Omental adipocyte size correlated more strongly than subcutaneous adipocyte size with measures of adiposity (BMI, waist circumference, %BF), total and subcutaneous abdominal fat area and biochemical measures (fasting glucose, total cholesterol, triglycerides and HOMA-IR), the correlations being stronger in females. The correlation of adipocyte size with metabolic parameters was attenuated after adjusting for measures of adiposity. Conclusion: Omental adipocyte size, though smaller than the subcutaneous adipocyte size, was more closely related to measures of adiposity and metabolic parameters. However, the relationship was not independent of measures of adiposity.	[Meena, Ved Prakash; Vikram, Naval K.] All India Inst Med Sci, Dept Med, New Delhi 110029, India; [Seenu, V.] All India Inst Med Sci, Dept Surg Disciplines, New Delhi, India; [Sharma, M. C.; Mallick, Saumya Ranjan] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India; [Bhalla, Ashu Seith] All India Inst Med Sci, Dept Radiodiag, New Delhi 110029, India; [Gupta, Nandita] All India Inst Med Sci, Dept Endocrinol & Metab, New Delhi, India; [Mohan, Anant; Guleria, Randeep] All India Inst Med Sci, Dept Pulm Med, New Delhi, India; [Mohan, Anant; Guleria, Randeep] All India Inst Med Sci, Dept Sleep Disorders, New Delhi, India; [Pandey, Ravindra M.] All India Inst Med Sci, Dept Stat, New Delhi, India; [Luthra, Kalpana] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Vikram, NK (corresponding author), All India Inst Med Sci, Dept Med, New Delhi 110029, India.	navalvikram@gmail.com		mallick, Saumyaranjan/0000-0003-4366-5873				Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Anand SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022112; Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942; Bays Harold, 2006, Expert Rev Cardiovasc Ther, V4, P871; Bhatt SP, 2012, DIABETES TECHNOL THE, V14, P828, DOI 10.1089/dia.2011.0277; Chandalia M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000812; Chandalia M, 2007, J DIABETES COMPLICAT, V21, P128, DOI 10.1016/j.jdiacomp.2006.10.004; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; HAGER A, 1981, BRIT MED BULL, V37, P287; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Indulekha K, 2011, CLIN BIOCHEM, V44, P281, DOI 10.1016/j.clinbiochem.2010.12.015; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Lonn M, 2010, FASEB J, V24, P326, DOI 10.1096/fj.09-133058; Marques BG, 1998, AM J PHYSIOL-REG I, V275, pR1898, DOI 10.1152/ajpregu.1998.275.6.R1898; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meyer LK, 2013, ADIPOCYTE, V2, P217, DOI 10.4161/adip.24953; Misra A, 2006, INT J OBESITY, V30, P106, DOI 10.1038/sj.ijo.0803111; Misra A, 2011, INT J OBESITY, V35, P167, DOI 10.1038/ijo.2010.135; Misra A, 2003, NUTRITION, V19, P457, DOI 10.1016/S0899-9007(02)01003-1; Misra A, 2009, J Assoc Physicians India, V57, P163; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Modi N, 2009, PEDIATR RES, V65, P584, DOI [10.1203/PDR.0b013e31819d98be, 10.1203/01.pdr.0000350364.10602.33]; Mundi MS, 2010, J CLIN ENDOCR METAB, V95, P67, DOI 10.1210/jc.2009-1353; O'Connell J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009997; Razak F, 2007, CIRCULATION, V115, P2111, DOI 10.1161/CIRCULATIONAHA.106.635011; Ridker PM, 2003, AM J CARDIOL, V92, p17K, DOI 10.1016/S0002-9149(03)00774-4; Sanderson JE, 2007, HEART, V93, P1175, DOI 10.1136/hrt.2007.131060; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; SMAS CM, 1995, BIOCHEM J, V309, P697, DOI 10.1042/bj3090697; Sniderman AD, 2007, INT J EPIDEMIOL, V36, P220, DOI 10.1093/ije/dyl245; van Harmelen V, 2003, INT J OBESITY, V27, P889, DOI 10.1038/sj.ijo.0802314; Veilleux A, 2011, DIABETES, V60, P1504, DOI 10.2337/db10-1039; Vikram NK, 2006, INDIAN J MED RES, V124, P677; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560	37	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108421	10.1371/journal.pone.0108421	http://dx.doi.org/10.1371/journal.pone.0108421			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251402	Green Published, Green Submitted, gold			2022-12-25	WOS:000342492700124
J	Vitek, CR; Cakalo, JI; Kruglov, YV; Dumchev, KV; Salyuk, TO; Bozicevic, I; Baughman, AL; Spindler, HH; Martsynovska, VA; Kobyshcha, YV; Abdul-Quader, AS; Rutherford, GW				Vitek, Charles R.; Cakalo, Jurja-Ivana; Kruglov, Yuri V.; Dumchev, Konstantin V.; Salyuk, Tetyana O.; Bozicevic, Ivana; Baughman, Andrew L.; Spindler, Hilary H.; Martsynovska, Violetta A.; Kobyshcha, Yuri V.; Abdul-Quader, Abu S.; Rutherford, George W.			Slowing of the HIV Epidemic in Ukraine: Evidence from Case Reporting and Key Population Surveys, 2005-2012	PLOS ONE			English	Article							EUROPE	Background: Ukraine developed Europe's most severe HIV epidemic due to widespread transmission among persons who inject drugs (PWID). Since 2004, prevention has focused on key populations; antiretroviral therapy (ART) coverage has increased. Recent data show increases in reported HIV cases through 2011, especially attributed to sexual transmission, but also signs of potential epidemic slowing. We conducted a data triangulation exercise to better analyze available data and inform program implementation. Methods and Findings: We reviewed data for 2005 to 2012 from multiple sources, primarily national HIV case reporting and integrated biobehavioral surveillance (IBBS) studies among key populations. Annually reported HIV cases increased at a progressively slower rate through 2011 with recent increases only among older, more immunosuppressed individuals; cases decreased 2.7% in 2012. Among women <25 years of age, cases attributed to heterosexual transmission and HIV prevalence in antenatal screening declined after 2008. Reported cases among young PWID declined by three-fourths. In 2011, integrated biobehavioral surveillance demonstrated decreased HIV prevalence among young members of key populations compared with 2009. HIV infection among female sex workers (FSW) remains strongly associated with a personal history of injecting drug use (IDU). Conclusions: This analysis suggests that Ukraine's HIV epidemic has slowed, with decreasing reported cases and older cases predominating among those diagnosed. Recent decreases in cases and in prevalence support decreased incidence among young PWID and women. Trends among heterosexual men and men who have sex with men (MSM) are less clear; further study and enhanced MSM prevention are needed. FSW appear to have stable prevalence with risk strongly associated with IDU. Current trends suggest the Ukrainian epidemic can be contained with enhanced prevention among key populations and increased treatment access.	[Vitek, Charles R.; Dumchev, Konstantin V.] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Kiev, Ukraine; [Baughman, Andrew L.; Abdul-Quader, Abu S.] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Atlanta, GA USA; [Cakalo, Jurja-Ivana; Bozicevic, Ivana] Univ Zagreb, WHO, Collaborating Ctr HIV Surveillance, Zagreb 41000, Croatia; [Kruglov, Yuri V.; Martsynovska, Violetta A.] Minist Hlth Ukraine, Ukrainian Ctr Socially Dangerous Dis Control, Kiev, Ukraine; [Salyuk, Tetyana O.] Int HIV AIDS Alliance Ukraine, Kiev, Ukraine; [Spindler, Hilary H.; Rutherford, George W.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Kobyshcha, Yuri V.] WHO, Kiev, Ukraine	Centers for Disease Control & Prevention - USA; University of Zagreb; World Health Organization; Ministry of Health of Ukraine; University of California System; University of California San Francisco; World Health Organization	Vitek, CR (corresponding author), Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Kiev, Ukraine.	cxv3@cdc.gov			President's Emergency Plan for AIDS Relief (PEPFAR) through U.S. Centers for Disease Control and Prevention (CDC) [PS001468]; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) [U2GPS001468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER	President's Emergency Plan for AIDS Relief (PEPFAR) through U.S. Centers for Disease Control and Prevention (CDC); National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This project has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC) under the terms of grant PS001468. CDC staff listed as authors participated in study design, data analysis, and preparation of the manuscript but had no role in the funding decision.	Anglemyer A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009153.pub3; Balakireva OM, 2007, MONITORING BEHAV INJ; Balakiryeva O, 2012, BEHAV MONITORING HIV; BBC, 2013, BBC; Bolshov Y., 2012, ANAL REPORT BEHAV MO; Bolshov YS, 2010, MONITORING BEHAV HIV; Diyeva TS, 2007, MONITORING SERVICEPE; Duong YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033328; Dutta A, 2012, CURR OPIN HIV AIDS, V7, P362, DOI 10.1097/COH.0b013e328354a0b5; Ferris-Rotman Amie., 2012, REUTERS; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Grushetsky A, 2012, ANAL REPORT BEHAV MO; Grushetsky A, 2010, BEHAV MONITORING HIV; Grushetsky A., 2010, ANAL REPORT RESULTS; Hamers FF, 1997, AIDS, V11, P1365, DOI 10.1097/00002030-199711000-00011; Hoppenbrouwer J, 2008, HIV AIDS MONITORING; International AIDS Alliance in Ukraine, 2009, CIV SOC LEADS NAT RE; Jarlais DCD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031227; Kleinbaum D, 1988, APPL REGRESSION ANAL; Kruglov YV, 2008, SEX TRANSM INFECT, V84, pI37, DOI 10.1136/sti.2008.031195; Martsinovskaya V, 2010, AIDS 2010 18 INT AID; Ministry of Health of Ukraine, 2012, UKR HARM AIDS RESP P; Pohorila N., 2009, BEHAV MONITORING HIV; Rutherford GW, 2012, BMC PUBLIC HEALTH, V10, P447; SAS Institute Inc, 2013, GENMOD PROC SAS STAT; Spindler H, 2014, AIDS RES HUM RETROV, V30, P407, DOI [10.1089/AID.2013.0237, 10.1089/aid.2013.0237]; Ukrainian Center for Social Reforms (UCSR) State Statistical Committee [Ukraine] Ministry of Health [Ukraine] and Macro International Inc, 2008, UKR DEM HLTH SURV 20; Ukrainian Center for Socially Dangerous Disease Control of the Ministry of Health of Ukraine, 2014, REP TOT NUMB PEOPL W; Ukrainian Center for the Prophylaxis and Control of AIDS, 2011, AN REP DET CURR STAG; UNAIDS Ukraine, 2009, COMPR EXT EV NAT AID; United Nations Economic Commission for Europe, 2000, FERT DECL TRANS EC 1, P189; WHO U, 2013, GLOB REP UNAIDS REP; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; World Health Organisation, 2007, WHO CAS DEF HIV SURV	34	45	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e103657	10.1371/journal.pone.0103657	http://dx.doi.org/10.1371/journal.pone.0103657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251080	gold, Green Published, Green Submitted			2022-12-25	WOS:000342492700001
J	Yang, YH; Dai, B; Howell, P; Wang, XL; Li, KC; Lu, CM				Yang, Yanhui; Dai, Bohan; Howell, Peter; Wang, Xianling; Li, Kuncheng; Lu, Chunming			White and Grey Matter Changes in the Language Network during Healthy Aging	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; LIFE-SPAN; CORTICAL SURFACE; HUMAN BRAIN; COORDINATE SYSTEM; FIBER TRACKING; AGE; ACTIVATION; INFANTS	Neural structures change with age but there is no consensus on the exact processes involved. This study tested the hypothesis that white and grey matter in the language network changes during aging according to a "last in, first out" process. The fractional anisotropy (FA) of white matter and cortical thickness of grey matter were measured in 36 participants whose ages ranged from 55 to 79 years. Within the language network, the dorsal pathway connecting the mid-to-posterior superior temporal cortex (STC) and the inferior frontal cortex (IFC) was affected more by aging in both FA and thickness than the other dorsal pathway connecting the STC with the premotor cortex and the ventral pathway connecting the mid-to-anterior STC with the ventral IFC. These results were independently validated in a second group of 20 participants whose ages ranged from 50 to 73 years. The pathway that is most affected during aging matures later than the other two pathways (which are present at birth). The results are interpreted as showing that the neural structures which mature later are affected more than those that mature earlier, supporting the " last in, first out" theory.	[Yang, Yanhui; Li, Kuncheng] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China; [Yang, Yanhui; Li, Kuncheng] Minist Educ, Key Lab Neurodegenerat Dis, Beijing, Peoples R China; [Dai, Bohan; Lu, Chunming] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Dai, Bohan; Lu, Chunming] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China; [Dai, Bohan; Lu, Chunming] Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, Beijing 100875, Peoples R China; [Howell, Peter] UCL, Div Psychol & Language Sci, London, England; [Wang, Xianling] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China; [Li, Kuncheng] Beijing Key Lab Magnet Resonance Imaging & Brain, Beijing, Peoples R China	Capital Medical University; Beijing Normal University; Beijing Normal University; Beijing Normal University; University of London; University College London; Capital Medical University	Li, KC (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China.	luchunming@bnu.edu.cn; cjr.likuncheng@vip.163.com			National Natural Science Foundation of China [31270023]; Capital Medical University [11JL24]; National Basic Research Program of China (973 Program) [2012CB720704]; Fundamental Research Funds for the Central Universities; Beijing Higher Education Young Elite Teacher Project; State Key Laboratory of Cognitive Neuroscience and Learning	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Capital Medical University; National Basic Research Program of China (973 Program)(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Beijing Higher Education Young Elite Teacher Project; State Key Laboratory of Cognitive Neuroscience and Learning	This work was supported by the National Natural Science Foundation of China (31270023), the Fund of Capital Medical University (No. 11JL24), the National Basic Research Program of China (973 Program; 2012CB720704), the Fundamental Research Funds for the Central Universities, the Beijing Higher Education Young Elite Teacher Project, and the Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwander A, 2007, CEREB CORTEX, V17, P816, DOI 10.1093/cercor/bhk034; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Bartzokis G, 2012, BIOL PSYCHIAT, V72, P1026, DOI 10.1016/j.biopsych.2012.07.010; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; Dehaene-Lambertz G, 2006, P NATL ACAD SCI USA, V103, P14240, DOI 10.1073/pnas.0606302103; Dubois J, 2006, NEUROIMAGE, V30, P1121, DOI 10.1016/j.neuroimage.2005.11.022; Dubois J, 2008, HUM BRAIN MAPP, V29, P14, DOI 10.1002/hbm.20363; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friederici AD, 2006, P NATL ACAD SCI USA, V103, P2458, DOI 10.1073/pnas.0509389103; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Hill J, 2010, P NATL ACAD SCI USA, V107, P13135, DOI 10.1073/pnas.1001229107; Kantarci K, 2011, NEUROLOGY, V77, P26, DOI 10.1212/WNL.0b013e31822313dc; Kochunov P, 2012, NEUROBIOL AGING, V33, P9, DOI 10.1016/j.neurobiolaging.2010.01.014; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Madden DJ, 2004, NEUROIMAGE, V21, P1174, DOI 10.1016/j.neuroimage.2003.11.004; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Perani D, 2011, P NATL ACAD SCI USA, V108, P16056, DOI 10.1073/pnas.1102991108; Pfefferbaum A, 2007, BRAIN, V130, P48, DOI 10.1093/brain/awl242; Salat DH, 2005, ANN NY ACAD SCI, V1064, P37, DOI 10.1196/annals.1340.009; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Sullivan EV, 2010, DEV NEUROPSYCHOL, V35, P233, DOI 10.1080/87565641003689556; Sullivan EV, 2010, NEUROBIOL AGING, V31, P464, DOI 10.1016/j.neurobiolaging.2008.04.007; Sullivan EV, 2002, CEREB CORTEX, V12, P438, DOI 10.1093/cercor/12.4.438; Tamnes CK, 2013, NEUROIMAGE, V68, P63, DOI 10.1016/j.neuroimage.2012.11.039; Wen W, 2011, J NEUROSCI, V31, P1204, DOI 10.1523/JNEUROSCI.4085-10.2011; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Xiong JH, 1995, HUM BRAIN MAPP, V3, P287, DOI 10.1002/hbm.460030404	38	1	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2014	9	9							e108077	10.1371/journal.pone.0108077	http://dx.doi.org/10.1371/journal.pone.0108077			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0SJ	25251441	gold, Green Published, Green Submitted			2022-12-25	WOS:000342492700073
J	Isik, G; Sliepen, K; van Montfort, T; Sanders, RW				Isik, Gozde; Sliepen, Kwinten; van Montfort, Thijs; Sanders, Rogier W.			Enhanced Immunogenicity of HIV-1 Envelope gp140 Proteins Fused to APRIL	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GP120-SPECIFIC IMMUNE-RESPONSES; FACTOR RECEPTOR SUPERFAMILY; CYTIDINE DEAMINASE AID; NEUTRALIZING ANTIBODIES; GLYCOPROTEIN TRIMERS; DENDRITIC CELLS; B-CELLS; RECOMBINANT GLYCOPROTEIN-120; GENETIC VACCINATION	Current HIV-1 vaccines based on the HIV-1 envelope glycoprotein spike (Env), the only relevant target for broadly neutralizing antibodies, are unable to induce protective immunity. Env immunogenicity can be enhanced by fusion to costimulatory molecules involved in B cell activation, such as APRIL and CD40L. Here, we found that Env-APRIL signaled through the two receptors, BCMA and TACI. In rabbits, Env-APRIL induced significantly higher antibody responses against Env compared to unconjugated Env, while the antibody responses against the APRIL component were negligible. To extend this finding, we tested Env-APRIL in mice and found minimal antibody responses against APRIL. Furthermore, Env-CD40L did not induce significant anti-CD40L responses. Thus, in contrast to the 4-helix cytokines IL-21 and GM-CSF, the TNF-superfamily members CD40L and APRIL induced negligible autoantibodies. This study confirms and extends previous work and shows that fusion of Env-based immunogens to APRIL can improve Env immunogenicity and might help in designing HIV vaccines that induce protective humoral immunity.	[Isik, Gozde; Sliepen, Kwinten; van Montfort, Thijs; Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol,Lab Expt Virol, NL-1105 AZ Amsterdam, Netherlands; [Sanders, Rogier W.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	University of Amsterdam; Academic Medical Center Amsterdam; Cornell University	Sanders, RW (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol,Lab Expt Virol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	r.w.sanders@amc.uva.nl		Isik, Gozde/0000-0002-1329-6782	Aids Fonds (the Netherlands) [2009012]; Netherlands Organization for Scientific Research; European Research Council [ERC-StG-2011-280829-SHEV]	Aids Fonds (the Netherlands)(Netherlands Government); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Aids Fonds (the Netherlands), grant #2009012. RWS is a recipient of a Vidi fellowship from the Netherlands Organization for Scientific Research, and a Starting Investigator grant from the European Research Council (ERC-StG-2011-280829-SHEV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON KP, 1989, J INFECT DIS, V160, P960, DOI 10.1093/infdis/160.6.960; Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; BENDTZEN K, 1990, IMMUNOL TODAY, V11, P167, DOI 10.1016/0167-5699(90)90068-K; BENDTZEN K, 1994, J INTERFERON RES, V14, P157, DOI 10.1089/jir.1994.14.157; Binley JM, 2002, J VIROL, V76, P2606, DOI 10.1128/JVI.76.6.2606-2616.2002; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Biragyn A, 2002, BLOOD, V100, P1153, DOI 10.1182/blood-2002-01-0086; Boscardin SB, 2006, J EXP MED, V203, P599, DOI 10.1084/jem.20051639; Bossen C, 2008, BLOOD, V111, P1004, DOI 10.1182/blood-2007-09-110874; Bower JF, 2005, CURR HIV RES, V3, P191, DOI 10.2174/1570162053506937; Bower JF, 2004, J VIROL, V78, P4710, DOI 10.1128/JVI.78.9.4710-4719.2004; Caruso A, 1997, BIOTHERAPY, V10, P29, DOI 10.1007/BF02678215; Casadevall N, 2003, NEPHROL DIAL TRANSPL, V18, P37, DOI 10.1093/ndt/gfg1091; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Eggink D, 2010, VIROLOGY, V401, P236, DOI 10.1016/j.virol.2010.02.019; Elkarim RA, 1998, CLIN IMMUNOL IMMUNOP, V88, P241, DOI 10.1006/clin.1998.4573; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Graudal NA, 2002, ANN RHEUM DIS, V61, P598, DOI 10.1136/ard.61.7.598; Guttman M, 2013, J VIROL, V87, P11462, DOI 10.1128/JVI.01681-13; Hu K, 2013, J IMMUNOL, V191, P1935, DOI 10.4049/jimmunol.1300120; Isik G, 2014, J IMMUNOL, V192, P4628, DOI 10.4049/jimmunol.1303401; Isik G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067309; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Kimberley FC, 2012, J BIOL CHEM, V287, P37434, DOI 10.1074/jbc.M112.406090; Kimberley FC, 2009, FASEB J, V23, P1584, DOI 10.1096/fj.08-124669; Koch M, 2005, VIROLOGY, V340, P277, DOI 10.1016/j.virol.2005.06.034; LAABI Y, 1994, NUCLEIC ACIDS RES, V22, P1147, DOI 10.1093/nar/22.7.1147; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Lori F, 2006, SPRINGER SEMIN IMMUN, V28, P231, DOI 10.1007/s00281-006-0047-y; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Madry C, 1998, INT IMMUNOL, V10, P1693, DOI 10.1093/intimm/10.11.1693; Matthes T, 2011, BLOOD, V118, P1838, DOI 10.1182/blood-2011-01-332940; McCormick AL, 2001, J INFECT DIS, V184, P1423, DOI 10.1086/324371; Melchers M, 2012, J VIROL, V86, P2488, DOI 10.1128/JVI.06259-11; Melchers M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-48; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nayak BP, 2003, J VIROL, V77, P10850, DOI 10.1128/JVI.77.20.10850-10861.2003; Nchinda G, 2008, J CLIN INVEST, V118, P1427, DOI 10.1172/JCI34224; Nimal S, 2006, VACCINE, V24, P3298, DOI 10.1016/j.vaccine.2006.01.020; Nimal S, 2005, VACCINE, V23, P3984, DOI 10.1016/j.vaccine.2005.01.160; NOHRIA A, 1994, BIOTHERAPY, V7, P261, DOI 10.1007/BF01878491; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Parren PWHI, 1997, NAT MED, V3, P366, DOI 10.1038/nm0497-366d; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Sailaja G, 2003, J IMMUNOL, V170, P2496, DOI 10.4049/jimmunol.170.5.2496; Salzer U, 2005, NAT GENET, V37, P820, DOI 10.1038/ng1600; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2011, EXPERT REV VACCINES, V10, P1117, DOI [10.1586/ERV.11.97, 10.1586/erv.11.97]; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Soares H, 2007, J EXP MED, V204, P1095, DOI 10.1084/jem.20070176; Swee LK, 2009, J BIOL CHEM, V284, P27567, DOI 10.1074/jbc.M109.042259; Thompson JA, 2008, J CLIN ONCOL, V26, P2034, DOI 10.1200/JCO.2007.14.5193; TURANO A, 1992, P NATL ACAD SCI USA, V89, P4447, DOI 10.1073/pnas.89.10.4447; van Gils MJ, 2013, VIROLOGY, V435, P46, DOI 10.1016/j.virol.2012.10.004; Van Montfort T, 2011, J BIOL CHEM, V286, P22250, DOI 10.1074/jbc.M111.229625; Van Roey GA, 2012, EUR J IMMUNOL, V42, P353, DOI 10.1002/eji.201141787; vonBulow GU, 1997, SCIENCE, V278, P138, DOI 10.1126/science.278.5335.138; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; WILLIAMS RS, 1991, P NATL ACAD SCI USA, V88, P2726, DOI 10.1073/pnas.88.7.2726; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yu G, 2000, NAT IMMUNOL, V1, P252, DOI 10.1038/79802	69	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107683	10.1371/journal.pone.0107683	http://dx.doi.org/10.1371/journal.pone.0107683			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247707	Green Submitted, Green Published, gold			2022-12-25	WOS:000342351800030
J	Liu, L; Li, LX; Zhou, SD; Jiang, QW; Chen, SD; Gao, YH; Chen, Y				Liu, Li; Li, Lixia; Zhou, Shudong; Jiang, Qingwu; Chen, Sidong; Gao, Yanhui; Chen, Yue			Familial Correlations of Onset Age of Hepatocellular Carcinoma: A Population-Based Case-Control Family Study	PLOS ONE			English	Article							FAILURE TIME DATA; LIVER-CANCER; VIRAL-HEPATITIS; EPIDEMIOLOGY; HISTORY; ASSOCIATION; INFECTION; RISK	Background: There was lack of evidence for familial aggregation in onset age of hepatocellular carcinoma (HCC) in Chinese population. We conducted a population-based case-control family study to examine familial correlation of age of HCC onset in Taixing, China. Methods: A total of 202 cases and 202 matched controls as well as their relatives were included in the study. Lifetime cumulative risks of HCC were estimated using the Kaplan-Meier approach. Cross ratios (CRs) were obtained from stratified Cox proportional hazard models, to assess the familial correlation of onset age. Results: The mean age of HCC onset was decreased as increasing number of HCC cases in a family. The onset age was the earliest for first-degree relatives, intermediate for second-degree relatives, and latest for non-blood relatives (spouse) (log-rank test, P<0.01). The onset age was significantly correlated between probands and their relatives. In stratified Cox proportional hazard models, the CRs for the probands versus their fathers, mothers, siblings and uncles/aunts were 6.25 (95% confidence interval (CI): 1.84-21.25), 9.81 (95% CI: 1.24-77.56), 6.22 (95% CI: 1.37-28.36) and 3.24 (95% CI: 1.26-8.33), respectively. After adjustment for hepatitis B virus infection, the CRs remained significant. Conclusion: This current study suggested a significant correlation of onset age for HCC among blood relatives. Familial HCC cases yielded earlier age of onset and their relatives have higher HCC risk in early age, highlighting intensive surveillance should be start at an earlier age for individuals with family history of HCC.	[Liu, Li; Li, Lixia; Zhou, Shudong; Chen, Sidong; Gao, Yanhui] Guangdong Pharmaceut Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Guangzhou, Guangdong, Peoples R China; [Liu, Li; Li, Lixia; Zhou, Shudong; Chen, Sidong; Gao, Yanhui] Guangdong Pharmaceut Univ, Sch Publ Hlth, Guangdong Key Lab Mol Epidemiol, Guangzhou, Guangdong, Peoples R China; [Jiang, Qingwu] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China; [Chen, Yue] Univ Ottawa, Fac Med, Dept Epidemiol & Community Med, Ottawa, ON, Canada	Guangdong Pharmaceutical University; Guangdong Pharmaceutical University; Fudan University; University of Ottawa	Gao, YH (corresponding author), Guangdong Pharmaceut Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Guangzhou, Guangdong, Peoples R China.	gao_yanhui@163.com		Jiang, Qingwu/0000-0001-8921-3317	National Natural Science Foundations of China [30500421, 81302493]; Natural Science Foundation of Guangdong Province [S2013040013590]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundations of China (Grant No. 30500421 & 81302493; http://www.nsfc.gov.cn/) and Natural Science Foundation of Guangdong Province (Grant No. S2013040013590; http://gdsf.gdstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Franco E, 2012, WORLD J HEPATOL, V4, P74, DOI 10.4254/wjh.v4.i3.74; Gao YH, 2004, CANCER CAUSE CONTROL, V15, P845, DOI 10.1023/B:CACO.0000043435.59195.3c; Hassan MM, 2009, J HEPATOL, V50, P334, DOI 10.1016/j.jhep.2008.08.016; Hsu L, 1999, BIOMETRIKA, V86, P743, DOI 10.1093/biomet/86.4.743; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kim DY, 2012, LIVER CANCER, V1, P2, DOI 10.1159/000339016; Kim JH, 2011, DIGEST DIS, V29, P278, DOI 10.1159/000327559; Kraft P, 2004, STAT MED, V23, P3697, DOI 10.1002/sim.1722; LIN DY, 1994, STAT MED, V13, P2233, DOI 10.1002/sim.4780132105; LOK ASF, 1988, CANCER, V61, P1287, DOI 10.1002/1097-0142(19880401)61:7<1287::AID-CNCR2820610702>3.0.CO;2-D; Marrero JA, 2005, J HEPATOL, V42, P218, DOI 10.1016/j.jhep.2004.10.005; Martins RN, 2004, PHARMACOGENOMICS J, V4, P138, DOI 10.1038/sj.tpj.6500239; OAKES D, 1989, J AM STAT ASSOC, V84, P487, DOI 10.2307/2289934; Osumi T, 2012, PEDIATR BLOOD CANCER, V59, P1332, DOI 10.1002/pbc.24269; Pan N, 2013, CLIN DEV IMMUNOL, V2013; Park CH, 2012, WORLD J GASTROENTERO, V18, P2661, DOI [10.3748/wjg.v18.i21.2661, 10.3748/wjg.v18121.2661]; Risendal B, 2008, CANCER CAUSE CONTROL, V19, P1349, DOI 10.1007/s10552-008-9206-x; Sato M, 2014, J GASTROENTEROL, V49, P748, DOI 10.1007/s00535-013-0826-x; Shih JH, 2002, BIOMETRICS, V58, P502, DOI 10.1111/j.0006-341X.2002.00502.x; Turati F, 2012, HEPATOLOGY, V55, P1416, DOI 10.1002/hep.24794; Yun EH, 2010, BRIT J CANCER, V103, P741, DOI 10.1038/sj.bjc.6605803	23	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108391	10.1371/journal.pone.0108391	http://dx.doi.org/10.1371/journal.pone.0108391			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25247419	Green Submitted, Green Published, gold			2022-12-25	WOS:000342351800084
J	Buhnemann, C; Li, S; Yu, HY; White, HB; Schafer, KL; Llombart-Bosch, A; Machado, I; Picci, P; Hogendoorn, PCW; Athanasou, NA; Noble, JA; Hassan, AB				Buehnemann, Claudia; Li, Simon; Yu, Haiyue; White, Harriet Branford; Schaefer, Karl L.; Llombart-Bosch, Antonio; Machado, Isidro; Picci, Piero; Hogendoorn, Pancras C. W.; Athanasou, Nicholas A.; Noble, J. Alison; Hassan, A. Bassim			Quantification of the Heterogeneity of Prognostic Cellular Biomarkers in Ewing Sarcoma Using Automated Image and Random Survival Forest Analysis	PLOS ONE			English	Article							QUANTITATIVE ASSESSMENT; PROTEIN EXPRESSION; PROTEOMIC ANALYSIS; COLD ISCHEMIA; CANCER; TISSUE; EVOLUTION; FAMILY; TIME; CLASSIFICATION	Driven by genomic somatic variation, tumour tissues are typically heterogeneous, yet unbiased quantitative methods are rarely used to analyse heterogeneity at the protein level. Motivated by this problem, we developed automated image segmentation of images of multiple biomarkers in Ewing sarcoma to generate distributions of biomarkers between and within tumour cells. We further integrate high dimensional data with patient clinical outcomes utilising random survival forest (RSF) machine learning. Using material from cohorts of genetically diagnosed Ewing sarcoma with EWSR1 chromosomal translocations, confocal images of tissue microarrays were segmented with level sets and watershed algorithms. Each cell nucleus and cytoplasm were identified in relation to DAPI and CD99, respectively, and protein biomarkers (e.g. Ki67, pS6, Foxo3a, EGR1, MAPK) localised relative to nuclear and cytoplasmic regions of each cell in order to generate image feature distributions. The image distribution features were analysed with RSF in relation to known overall patient survival from three separate cohorts (185 informative cases). Variation in pre-analytical processing resulted in elimination of a high number of non-informative images that had poor DAPI localisation or biomarker preservation (67 cases, 36%). The distribution of image features for biomarkers in the remaining high quality material (118 cases, 10 4 features per case) were analysed by RSF with feature selection, and performance assessed using internal cross-validation, rather than a separate validation cohort. A prognostic classifier for Ewing sarcoma with low cross-validation error rates (0.36) was comprised of multiple features, including the Ki67 proliferative marker and a sub-population of cells with low cytoplasmic/nuclear ratio of CD99. Through elimination of bias, the evaluation of high-dimensionality biomarker distribution within cell populations of a tumour using random forest analysis in quality controlled tumour material could be achieved. Such an automated and integrated methodology has potential application in the identification of prognostic classifiers based on tumour cell heterogeneity.	[Buehnemann, Claudia; Yu, Haiyue; White, Harriet Branford; Hassan, A. Bassim] Univ Oxford, Sir William Dunn Sch Pathol, Oxford Mol Pathol Inst, CR UK,Tumour Growth Grp, Oxford OX1 3RE, England; [Li, Simon; Yu, Haiyue; Noble, J. Alison] Univ Oxford, Inst Biomed Engn, Dept Engn Sci, Oxford, England; [Schaefer, Karl L.] Univ Dusseldorf, Inst Pathol, Dusseldorf, Germany; [Llombart-Bosch, Antonio; Machado, Isidro] Univ Valencia, Dept Pathol, Valencia, Spain; [Picci, Piero] Rizzoli Inst, Bologna, Italy; [Hogendoorn, Pancras C. W.] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Athanasou, Nicholas A.] Univ Oxford, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England	University of Oxford; University of Oxford; Heinrich Heine University Dusseldorf; University of Valencia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Nuffield Orthopaedic Centre; University of Oxford	Hassan, AB (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, Oxford Mol Pathol Inst, CR UK,Tumour Growth Grp, S Parks Rd, Oxford OX1 3RE, England.	bass.hassan@path.ox.ac.uk	Hogendoorn, Pancras/O-6494-2019; Hogendoorn, Pancras C.W./H-5859-2015; Picci, Piero/J-5979-2016	Hogendoorn, Pancras/0000-0002-1513-8104; Hogendoorn, Pancras C.W./0000-0002-1513-8104; Picci, Piero/0000-0002-8519-4101; Noble, Alison/0000-0002-3060-3772; Li, Simon/0000-0002-7929-2442; Hassan, Andrew/0000-0002-2517-6681	EU [018814, 278742]; EPSRC UK (Oxford Doctoral Training Centre); NIHR-Oxford Biomedical Research Centre; NIHR Biomedical Musculoskeletal Unit; Oxford University; Oxford University Hospitals Trust; Cancer Research UK [A429]; Department of Oncology; Sir William Dunn School of Pathology	EU(European Commission); EPSRC UK (Oxford Doctoral Training Centre)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NIHR-Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Biomedical Musculoskeletal Unit; Oxford University; Oxford University Hospitals Trust; Cancer Research UK(Cancer Research UK); Department of Oncology; Sir William Dunn School of Pathology	This work was supported by EuroBoNeT (018814) and EuroSarc (278742) EU-FP7, EPSRC UK (Oxford Doctoral Training Centre), NIHR-Oxford Biomedical Research Centre and NIHR Biomedical Musculoskeletal Unit, Oxford University and Oxford University Hospitals Trust, Cancer Research UK (A429), the Department of Oncology and Sir William Dunn School of Pathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Lopez-Guerrero JA, 2011, INT J CANCER, V128, P1139, DOI 10.1002/ijc.25424; Bai YL, 2011, LAB INVEST, V91, P1253, DOI 10.1038/labinvest.2011.75; Beck AH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002564; Berger AJ, 2004, CANCER RES, V64, P8767, DOI 10.1158/0008-5472.CAN-04-1384; Bernstein M, 2006, ONCOLOGIST, V11, P503, DOI 10.1634/theoncologist.11-5-503; Bonnas C, 2012, INT J CANCER, V131, P1621, DOI 10.1002/ijc.27422; Bray MA, 2012, J BIOMOL SCREEN, V17, P266, DOI 10.1177/1087057111420292; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Budczies J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051862; Bunyak F, 2011, ADV EXP MED BIOL, V696, P413, DOI 10.1007/978-1-4419-7046-6_41; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Casadonte R, 2011, NAT PROTOC, V6, P1695, DOI 10.1038/nprot.2011.388; Chen X, 2010, STAT PROBABIL LETT, V80, P1313, DOI 10.1016/j.spl.2010.04.011; de Alava E, 2000, CANCER-AM CANCER SOC, V89, P783, DOI 10.1002/1097-0142(20000815)89:4<783::AID-CNCR10>3.0.CO;2-Q; De Palma M, 2012, MOL ONCOL, V6, P111, DOI 10.1016/j.molonc.2012.01.011; De Vito C, 2012, CANCER CELL, V21, P807, DOI 10.1016/j.ccr.2012.04.023; DiVito KA, 2004, LAB INVEST, V84, P1071, DOI 10.1038/labinvest.3700131; Dolled-Filhart M, 2010, METHODS MOL BIOL, V664, P151, DOI 10.1007/978-1-60761-806-5_15; Friedenberger M, 2007, NAT PROTOC, V2, P2285, DOI 10.1038/nprot.2007.320; Gatta G, 2011, EUR J CANCER, V47, P2493, DOI 10.1016/j.ejca.2011.08.008; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Ginty F, 2008, CLIN CANCER RES, V14, P3814, DOI 10.1158/1078-0432.CCR-08-0180; Guo Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-447; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARALICK RM, 1979, P IEEE, V67, P786, DOI 10.1109/PROC.1979.11328; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Holzer TR, 2011, ANTICANCER RES, V31, P2073; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Ishwaran H, 2010, STAT PROBABIL LETT, V80, P1056, DOI 10.1016/j.spl.2010.02.020; Jiang XH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-116; Jones EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024913; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Jones TR, 2005, LECT NOTES COMPUT SC, V3765, P535; Juergens H, 2011, J CLIN ONCOL, V29, P4534, DOI 10.1200/JCO.2010.33.0670; Kayser K, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-48; Klauschen F, 2009, NAT PROTOC, V4, P1305, DOI 10.1038/nprot.2009.129; Klauschen F, 2009, NAT PROTOC, V4, P1006, DOI 10.1038/nprot.2009.94; Lankton S, 2008, IEEE T IMAGE PROCESS, V17, P2029, DOI 10.1109/TIP.2008.2004611; Le Deley MC, 2014, J CLIN ONCOL; Mackintosh C, 2012, ONCOGENE, V31, P1287, DOI 10.1038/onc.2011.317; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Murchison EP, 2012, CELL, V148, P780, DOI 10.1016/j.cell.2011.11.065; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Neumeister VM, 2012, JNCI-J NATL CANCER I, V104, P1815, DOI 10.1093/jnci/djs438; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ottaviano L, 2010, GENE CHROMOSOME CANC, V49, P40, DOI 10.1002/gcc.20717; Pappo AS, 2011, J CLIN ONCOL, V29, P4541, DOI 10.1200/JCO.2010.34.0000; Portier BP, 2013, MODERN PATHOL, V26, P1, DOI 10.1038/modpathol.2012.123; Rahman SMJ, 2011, CANCER RES, V71, P3009, DOI 10.1158/0008-5472.CAN-10-2510; Riggi N, 2010, GENE DEV, V24, P916, DOI 10.1101/gad.1899710; Rittscher J, 2010, ANNU REV BIOMED ENG, V12, P315, DOI 10.1146/annurev-bioeng-070909-105235; Schubert W, 2006, NAT BIOTECHNOL, V24, P1270, DOI 10.1038/nbt1250; Seeley EH, 2011, TRENDS BIOTECHNOL, V29, P136, DOI 10.1016/j.tibtech.2010.12.002; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Sharma H, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-134; Shi T, 2005, MODERN PATHOL, V18, P547, DOI 10.1038/modpathol.3800322; Sompallae Ramakrishna, 2013, Frontiers in Genetics, V4, P209, DOI 10.3389/fgene.2013.00209; Suva ML, 2009, CANCER RES, V69, P1776, DOI 10.1158/0008-5472.CAN-08-2242; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Tyers M, 2003, NATURE, V422, P193, DOI 10.1038/nature01510; van Maldegem AM, 2012, CLIN SARCOMA RES, V2, DOI 10.1186/2045-3329-2-7; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yap TA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003854; Yuan YY, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004330; Zhang C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056772, 10.1371/journal.pone.0081049]	69	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2014	9	9							e107105	10.1371/journal.pone.0107105	http://dx.doi.org/10.1371/journal.pone.0107105			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6FX	25243408	Green Published, gold			2022-12-25	WOS:000343679800018
J	Lee, YH; Su, SB; Huang, CC; Sheu, HM; Tsai, JC; Lin, CH; Wang, YJ; Wang, BJ				Lee, Yu-Hsuan; Su, Shih-Bin; Huang, Chien-Cheng; Sheu, Hamm-Ming; Tsai, Jui-Chen; Lin, Chia-Ho; Wang, Ying-Jan; Wang, Bour-Jr			N-Acetylcysteine Attenuates Hexavalent Chromium-Induced Hypersensitivity through Inhibition of Cell Death, ROS-Related Signaling and Cytokine Expression	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; KAPPA-B; OXIDATIVE STRESS; MOLECULAR-MECHANISMS; ARSENIC TRIOXIDE; REDOX REGULATION; SKIN-DISEASE; CANCER-CELLS; FACTOR-ALPHA; TNF-ALPHA	Chromium hypersensitivity (chromium-induced allergic contact dermatitis) is an important issue in occupational skin disease. Hexavalent chromium (Cr(VI)) can activate the Akt, Nuclear factor kappa B (NF-kappa B), and Mitogen-activated protein kinase (MAPK) pathways and induce cell death, via the effects of reactive oxygen species (ROS). Recently, cell death stimuli have been proposed to regulate the release of inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1). However, the exact effects of ROS on the signaling molecules and cytotoxicity involved in Cr(VI)-induced hypersensitivity have not yet been fully demonstrated. N-acetylcysteine (NAC) could increase glutathione levels in the skin and act as an antioxidant. In this study, we investigated the effects of NAC on attenuating the Cr(VI)-triggered ROS signaling in both normal keratinocyte cells (HaCaT cells) and a guinea pig (GP) model. The results showed the induction of apoptosis, autophagy and ROS were observed after different concentrations of Cr(VI) treatment. HaCaT cells pretreated with NAC exhibited a decrease in apoptosis and autophagy, which could affect cell viability. In addition, Cr (VI) activated the Akt, NF-kappa B and MAPK pathways thereby increasing IL-1 alpha and TNF-alpha production. However, all of these stimulation phenomena could be inhibited by NAC in both of in vitro and in vivo studies. These novel findings indicate that NAC may prevent the development of chromium hypersensitivity by inhibiting of ROS-induced cell death and cytokine expression.	[Lee, Yu-Hsuan; Wang, Ying-Jan; Wang, Bour-Jr] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Su, Shih-Bin] Chi Mei Med Ctr, Dept Occupat Med, Tainan, Taiwan; [Su, Shih-Bin] Southern Taiwan Univ Sci & Technol, Dept Leisure Recreat & Tourism Management, Tainan, Taiwan; [Su, Shih-Bin] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Huang, Chien-Cheng] Chi Mei Med Ctr, Dept Emergency Med, Tainan, Taiwan; [Huang, Chien-Cheng] Southern Taiwan Univ Sci & Technol, Dept Child Care & Educ, Tainan, Taiwan; [Sheu, Hamm-Ming] Natl Cheng Kung Univ, Coll Med, Dept Dermatol, Tainan 70101, Taiwan; [Tsai, Jui-Chen] Natl Cheng Kung Univ, Inst Clin Pharm, Tainan 70101, Taiwan; [Lin, Chia-Ho] Chi Mei Med Ctr, Dept Surg, Div Urol, Liouying, Taiwan; [Lin, Chia-Ho] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Wang, Ying-Jan] Asia Univ, Dept Biomed Informat, Taichung, Taiwan; [Wang, Bour-Jr] Chia Nan Univ Pharm & Sci, Dept Cosmet Sci & Inst Cosmet Sci, Tainan, Taiwan	National Cheng Kung University; Chi Mei Hospital; Southern Taiwan University of Science & Technology; Chi Mei Hospital; Chi Mei Hospital; Southern Taiwan University of Science & Technology; National Cheng Kung University; National Cheng Kung University; Chi Mei Hospital; Southern Taiwan University of Science & Technology; Asia University Taiwan; Chia Nan University of Pharmacy & Science	Wang, YJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan.	yjwang@mail.ncku.edu.tw; pochih.wang@msa.hinet.net	Lee, Yu-Hsuan/AAT-3856-2021	Lee, Yu-Hsuan/0000-0001-7660-3770; Lai, Mei-shu/0000-0001-6130-3468; CHANG, CHIA-HSUIN/0000-0003-0024-6177; Beveridge, Ross/0000-0001-6489-6676; Wu, Ruey-Meei/0000-0002-4947-5467; Lin, Chin-Hsien/0000-0001-8566-7573	Chi Mei Medical Center, Tainan, Taiwan [CMNCKU10110]; National Science Council, Taiwan [NSC-102-2314-B006-034]	Chi Mei Medical Center, Tainan, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the Chi Mei Medical Center, Tainan, Taiwan (CMNCKU10110) and the National Science Council, Taiwan (NSC-102-2314-B006-034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Bonnet MC, 2013, EUR J DERMATOL; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bursch W, 2000, ANN NY ACAD SCI, V926, P1, DOI 10.1111/j.1749-6632.2000.tb05594.x; Cheng Y, 2009, FEBS J, V276, P1291, DOI 10.1111/j.1742-4658.2008.06864.x; Chiu HW, 2010, AUTOPHAGY, V6, P353, DOI 10.4161/auto.6.3.11229; Costa M, 2006, CRIT REV TOXICOL, V36, P155, DOI 10.1080/10408440500534032; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; ENK AH, 1992, P NATL ACAD SCI USA, V89, P1398, DOI 10.1073/pnas.89.4.1398; Faurschou A, 2008, EXP DERMATOL, V17, P992, DOI 10.1111/j.1600-0625.2008.00740.x; Freitas M, 2010, J BIOL INORG CHEM, V15, P1275, DOI 10.1007/s00775-010-0685-3; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Gibson SB, 2013, METHOD ENZYMOL, V528, P217, DOI 10.1016/B978-0-12-405881-1.00013-6; GOOSSENS V, 1995, P NATL ACAD SCI USA, V92, P8115, DOI 10.1073/pnas.92.18.8115; Harris J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00083; Huang J, 2011, ANTIOXID REDOX SIGN, V14, P2215, DOI 10.1089/ars.2010.3554; Jain MV, 2013, J CELL MOL MED, V17, P12, DOI 10.1111/jcmm.12001; Pena-Sanoja MJ, 2013, INVEST CLIN, V54, P325; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Kanzawa T, 2003, CANCER RES, V63, P2103; Khan MI, 2012, BIOMATERIALS, V33, P1477, DOI 10.1016/j.biomaterials.2011.10.080; Khatami A, 2013, INT J DERMATOL, V52, P1513, DOI 10.1111/j.1365-4632.2012.05623.x; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; LOPEZTORRES M, 1994, J INVEST DERMATOL, V102, P476, DOI 10.1111/1523-1747.ep12373032; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Luczak MW, 2013, FREE RADICAL BIO MED, V65, P262, DOI 10.1016/j.freeradbiomed.2013.06.028; Martin BD, 1998, CHEM RES TOXICOL, V11, P1402, DOI 10.1021/tx9801559; Mates JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2; McCall MR, 1999, FREE RADICAL BIO MED, V26, P1034, DOI 10.1016/S0891-5849(98)00302-5; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Paglin S, 2001, CANCER RES, V61, P439; PIGUET PF, 1991, J EXP MED, V173, P673, DOI 10.1084/jem.173.3.673; Polak L, 1983, CHROMIUM METABOLISM; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Raj D, 2006, J INVEST DERMATOL, V126, P243, DOI 10.1038/sj.jid.5700008; Rao GN, 1999, J BIOL CHEM, V274, P6003, DOI 10.1074/jbc.274.9.6003; Robert LR, 2001, FISHERS CONTACT DERM; Robertson JD, 2000, CRIT REV TOXICOL, V30, P609, DOI 10.1080/10408440008951122; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Shelnutt SR, 2007, CRIT REV TOXICOL, V37, P375, DOI 10.1080/10408440701266582; Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4; Son YO, 2013, TOXICOL APPL PHARM, V271, P239, DOI 10.1016/j.taap.2013.04.036; TRAGANOS F, 1994, METHOD CELL BIOL, V41, P185; VANHOOGSTRATEN IMW, 1992, INT ARCH ALLERGY IMM, V97, P258, DOI 10.1159/000236131; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Vlahopoulos S, 1999, BLOOD, V94, P1878, DOI 10.1182/blood.V94.6.1878; Wang BJ, 2010, TOXICOL LETT, V198, P216, DOI 10.1016/j.toxlet.2010.06.024; Wang BJ, 2010, EXP DERMATOL, V19, pE191, DOI 10.1111/j.1600-0625.2009.01045.x; Winyard P G, 1997, Adv Pharmacol, V38, P403; Xie Y, 2014, CELL PHYSIOL BIOCHEM, V33, P705, DOI 10.1159/000358646; Yokoyama T, 2008, AUTOPHAGY, V4, P629, DOI 10.4161/auto.5941; Young CN, 2008, J INVEST DERMATOL, V128, P2606, DOI 10.1038/jid.2008.122; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001	58	135	139	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108317	10.1371/journal.pone.0108317	http://dx.doi.org/10.1371/journal.pone.0108317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25248126	Green Published, Green Submitted, gold			2022-12-25	WOS:000342351800081
J	Lee, YC; Lin, CH; Wu, RM; Lin, JW; Chang, CH; Lai, MS				Lee, Yen-Chieh; Lin, Chin-Hsien; Wu, Ruey-Meei; Lin, Jou-Wei; Chang, Chia-Hsuin; Lai, Mei-Shu			Antihypertensive Agents and Risk of Parkinson's Disease: A Nationwide Cohort Study	PLOS ONE			English	Article							CALCIUM-CHANNEL BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME; OXIDATIVE STRESS; BLOOD-PRESSURE; MPTP MODEL; HYPERTENSION; DEGENERATION; ASSOCIATION; INHIBITION; MANAGEMENT	Background and Purpose: Hypertension has been associated with Parkinson's disease (PD), but data on antihypertensive drugs and PD are inconclusive. We aim to evaluate antihypertensive drugs for an association with PD in hypertensive patients. Methods: Hypertensive patients who were free of PD, dementia and stroke were recruited from 2005-2006 using Taiwan National Health Insurance Database. We examined the association between the use of calcium channel blockers (CCBs), angiotensin converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs) and the incidence of PD using betablockers as the reference. Cox regression model with time-varying medication use was applied. Results: Among 65,001 hypertensive patients with a mean follow-up period of 4.6 years, use of dihydropyridine CCBs, but not non-dihydropyridine CCBs, was associated with a reduced risk of PD (adjusted hazard ratio [aHR] = 0.71; 95% CI, 0.570.90). Additionally, use of central-acting CCBs, rather than peripheral-acting ones, was associated with a decreased risk of PD (aHR =.69 [55-0.87]. Further decreased association was observed for higher cumulative doses of felodipine (aHR = 0.54 [0.36-0.80]) and amlodipine (aHR = 0.60 [0.45-0.79]). There was no association between the use of ACEIs (aHR = 0.80 [0.641.00]) or ARBs (aHR = 0.86 [0.69-1.08]) with PD. A potentially decreased association was only found for higher cumulative use of ACEIs (HR = 0.52 [0.34-0.80]) and ARBs (HR = 0.52 [0.33-0.80]). Conclusions: Our study suggests centrally-acting dihydropyridine CCB use and high cumulative doses of ACEIs and ARBs may associate with a decreased incidence of PD in hypertensive patients. Further long-term follow-up studies are needed to confirm the potential beneficial effects of antihypertensive agents in PD.	[Lee, Yen-Chieh] Cathay Gen Hosp, Dept Family Med, Taipei, Taiwan; [Lin, Chin-Hsien; Wu, Ruey-Meei] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Lin, Jou-Wei; Chang, Chia-Hsuin] Natl Taiwan Univ, Coll Med, Dept Med, Taipei 10764, Taiwan; [Lin, Jou-Wei] Natl Taiwan Univ Hosp, Yun Lin Branch, Ctr Cardiovasc, Dou Liou City, Yun Lin County, Taiwan; [Chang, Chia-Hsuin; Lai, Mei-Shu] Natl Taiwan Univ, Coll Publ Hlth, Inst Prevent Med, Taipei 10764, Taiwan	Cathay General Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Lin, JW (corresponding author), Natl Taiwan Univ, Coll Med, Dept Med, Taipei 10764, Taiwan.	jouweilin@yahoo.com; chiahsuin123@yahoo.com.tw	Lee, Yu-Hsuan/AAT-3856-2021	Lee, Yu-Hsuan/0000-0001-7660-3770; Lai, Mei-shu/0000-0001-6130-3468; CHANG, CHIA-HSUIN/0000-0003-0024-6177; Beveridge, Ross/0000-0001-6489-6676; Wu, Ruey-Meei/0000-0002-4947-5467; Lin, Chin-Hsien/0000-0001-8566-7573				Becker C, 2008, NEUROLOGY, V70, P1438, DOI 10.1212/01.wnl.0000303818.38960.44; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chiang CE, 2010, J FORMOS MED ASSOC, V109, P740, DOI 10.1016/S0929-6646(10)60120-9; Driver JA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d198; Ebrahimi-Fakhari D, 2012, ACTA NEUROPATHOL, V124, P153, DOI 10.1007/s00401-012-1004-6; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Garrido-Gil P, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-38; Grammatopoulos TN, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-1; Hu G, 2007, DIABETES CARE, V30, P842, DOI 10.2337/dc06-2011; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Kupsch A, 1996, BRAIN RES, V741, P185, DOI 10.1016/S0006-8993(96)00917-1; Lee YC, 2013, NEUROLOGY, V81, P410, DOI 10.1212/WNL.0b013e31829d873c; Louis ED, 2009, NEUROEPIDEMIOLOGY, V33, P286, DOI 10.1159/000235641; Marras C, 2012, ANN NEUROL, V71, P362, DOI 10.1002/ana.22616; Munoz A, 2006, NEUROPHARMACOLOGY, V51, P112, DOI 10.1016/j.neuropharm.2006.03.004; NEILDWYER G, 1981, BRIT J CLIN PHARMACO, V11, P549, DOI 10.1111/j.1365-2125.1981.tb01169.x; Pasternak B, 2012, AM J EPIDEMIOL, V175, P627, DOI 10.1093/aje/kwr362; Qiu CX, 2011, HYPERTENSION, V57, P1094, DOI 10.1161/HYPERTENSIONAHA.111.171249; Reardon KA, 2000, AUST NZ J MED, V30, P48, DOI 10.1111/j.1445-5994.2000.tb01054.x; Ritz B, 2010, ANN NEUROL, V67, P600, DOI 10.1002/ana.21937; Rosendorff C, 2007, CIRCULATION, V115, P2761, DOI 10.1161/CIRCULATIONAHA.107.183885; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Schernhammer E, 2011, DIABETES CARE, V34, P1102, DOI 10.2337/dc10-1333; Simon KC, 2010, MOVEMENT DISORD, V25, P1818, DOI 10.1002/mds.23191; Surmeier DJ, 2007, LANCET NEUROL, V6, P933, DOI 10.1016/S1474-4422(07)70246-6; Ton TGN, 2007, PARKINSONISM RELAT D, V13, P165, DOI 10.1016/j.parkreldis.2006.08.011; Wahlqvist ML, 2012, PARKINSONISM RELAT D, V18, P753, DOI 10.1016/j.parkreldis.2012.03.010; Wahner AD, 2008, NEUROLOGY, V70, P1418, DOI 10.1212/01.wnl.0000286942.14552.51; Wright JW, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/860923	29	135	139	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98961	10.1371/journal.pone.0098961	http://dx.doi.org/10.1371/journal.pone.0098961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	25248126	Green Submitted, Green Published, gold			2022-12-25	WOS:000337165600029
J	Liu, MX; Chen, X; Chen, G; Cui, QH; Yan, GY				Liu, Ming-Xi; Chen, Xing; Chen, Geng; Cui, Qing-Hua; Yan, Gui-Ying			A Computational Framework to Infer Human Disease-Associated Long Noncoding RNAs	PLOS ONE			English	Article							GENE-EXPRESSION; BREAST-CANCER; DATABASE; GENOME; PROTEIN; INHIBITOR; MOUSE; OVEREXPRESSION; SUSCEPTIBILITY; IDENTIFICATION	As a major class of noncoding RNAs, long noncoding RNAs (lncRNAs) have been implicated in various critical biological processes. Accumulating researches have linked dysregulations and mutations of lncRNAs to a variety of human disorders and diseases. However, to date, only a few human lncRNAs have been associated with diseases. Therefore, it is very important to develop a computational method to globally predict potential associated diseases for human lncRNAs. In this paper, we developed a computational framework to accomplish this by combining human lncRNA expression profiles, gene expression profiles, and human disease-associated gene data. Applying this framework to available human long intergenic noncoding RNAs (lincRNAs) expression data, we showed that the framework has reliable accuracy. As a result, for non-tissue-specific lincRNAs, the AUC of our algorithm is 0.7645, and the prediction accuracy is about 89%. This study will be helpful for identifying novel lncRNAs for human diseases, which will help in understanding the roles of lncRNAs in human diseases and facilitate treatment. The corresponding codes for our method and the predicted results are all available at http://asdcd.amss.ac.cn/MingXiLiu/lncRNA-disease.html.	[Liu, Ming-Xi; Chen, Xing; Yan, Gui-Ying] Chinese Acad Sci, Acad Math & Syst Sci, Beijing, Peoples R China; [Liu, Ming-Xi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Chen, Xing; Yan, Gui-Ying] Chinese Acad Sci, Ctr Math & Interdisciplinary Sci, Beijing, Peoples R China; [Chen, Geng; Cui, Qing-Hua] Peking Univ, Sch Basic Med Sci, Dept Biomed Informat, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Peking University	Cui, QH (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Biomed Informat, Beijing 100871, Peoples R China.	cuiqinghua@hsc.pku.edu.cn; yangy@amss.ac.cn	Chen, Xing/G-6844-2016	Chen, Xing/0000-0001-9028-5342; Wang, Yunsheng/0000-0001-5003-4434	National Natural Science Foundation of China [10531070, 10721101, 11301517, 11371355, KJCX-YW-S7]; National Center for Mathematics and Interdisciplinary Sciences, CAS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Center for Mathematics and Interdisciplinary Sciences, CAS(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China under Grant Nos. 10531070, 10721101, 11301517, 11371355, KJCX-YW-S7 and National Center for Mathematics and Interdisciplinary Sciences, CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bauer-Mehren A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020284; Bauer-Mehren A, 2010, BIOINFORMATICS, V26, P2924, DOI 10.1093/bioinformatics/btq538; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chen G, 2013, NUCLEIC ACIDS RES, V41, pD983, DOI 10.1093/nar/gks1099; Chung SY, 2011, CANCER SCI, V102, P245, DOI 10.1111/j.1349-7006.2010.01737.x; Claverie JM, 2005, SCIENCE, V309, P1529, DOI 10.1126/science.1116800; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Gatti DM, 2010, PHYSIOL GENOMICS, V42, P456, DOI 10.1152/physiolgenomics.00110.2009; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Haruta N, 2011, P JPN ACAD B-PHYS, V87, P641, DOI 10.2183/pjab.87.641; Hung T, 2010, RNA BIOL, V7, P582, DOI 10.4161/rna.7.5.13216; Iwasaki M, 2012, J DENT RES, V91, P167, DOI 10.1177/0022034511431702; Jordan IK, 2004, MOL BIOL EVOL, V21, P2058, DOI 10.1093/molbev/msh222; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kapushesky M, 2012, NUCLEIC ACIDS RES, V40, pD1077, DOI 10.1093/nar/gkr913; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li P, 2011, NAT PROD COMMUN, V6, P1801; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Masutani H, 2012, J CLIN BIOCHEM NUTR, V50, P23, DOI 10.3164/jcbn.11-36SR; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Mattingly CJ, 2006, J EXP ZOOL PART A, V305A, P689, DOI 10.1002/jez.a.307; Mitsui Sachiko, 2011, Neural Syst Circuits, V1, P5, DOI 10.1186/2042-1001-1-5; Pibouin L, 2002, CANCER GENET CYTOGEN, V133, P55, DOI 10.1016/S0165-4608(01)00634-3; Sakuma Y, 2012, LAB INVEST, V92, P371, DOI 10.1038/labinvest.2011.187; Saviozzi S, 2009, CANCER RES, V69, P3390, DOI 10.1158/0008-5472.CAN-08-2981; Sawaki M, 2012, ONCOL LETT, V3, P61, DOI 10.3892/ol.2011.449; Sonkoly E, 2005, J BIOL CHEM, V280, P24159, DOI 10.1074/jbc.M501704200; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yoshihara C, 2012, ONCOL LETT, V3, P387, DOI 10.3892/ol.2011.467; Yoshihara C, 2012, GEN COMP ENDOCR, V175, P495, DOI 10.1016/j.ygcen.2011.12.009; Yoshihara Eiji, 2011, Japanese Journal of Alcohol Studies & Drug Dependence, V46, P570; Yoshihara K, 2011, GENE CHROMOSOME CANC, V50, P167, DOI 10.1002/gcc.20841; Zhang XQ, 2009, BLOOD, V113, P2526, DOI 10.1182/blood-2008-06-162164	51	195	205	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84408	10.1371/journal.pone.0084408	http://dx.doi.org/10.1371/journal.pone.0084408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	25244184	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460100056
